PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pajarillo, E; Rizor, A; Son, DS; Aschner, M; Lee, E				Pajarillo, Edward; Rizor, Asha; Son, Deok-Soo; Aschner, Michael; Lee, Eunsook			The transcription factor REST up-regulates tyrosine hydroxylase and antiapoptotic genes and protects dopaminergic neurons against manganese toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						manganese; Parkinson disease; neurodegeneration; neurodegenerative disease; neurotoxin; dopaminergic neurons; neuron restrictive silencer factor (NRSF); neurotoxicity; RE1-silencing transcription factor (REST); Tyrosine Hydroxylase	RESTRICTIVE SILENCER FACTOR; OXIDATIVE STRESS; TAMOXIFEN PROTECT; PROMOTER ACTIVITY; NUCLEAR RECEPTOR; IN-VIVO; EXPRESSION; NRSF; REPRESSOR; NRSF/REST	Dopaminergic functions are important for various biological activities, and their impairment leads to neurodegeneration, a hallmark of Parkinson's disease (PD). Chronic manganese (Mn) exposure causes the neurological disorder manganism, presenting symptoms similar to those of PD. Emerging evidence has linked the transcription factor RE1-silencing transcription factor (REST) to PD and also Alzheimer's disease. But REST's role in dopaminergic neurons is unclear. Here, we investigated whether REST protects dopaminergic neurons against Mn-induced toxicity and enhances expression of the dopamine-synthesizing enzyme tyrosine hydroxylase (TH). We report that REST binds to RE1 consensus sites in the TH gene promoter, stimulates TH transcription, and increases TH mRNA and protein levels in dopaminergic cells. REST binding to the TH promoter recruited the epigenetic modifier cAMP-response element-binding protein?binding protein/p300 and thereby up-regulated TH expression. REST relieved Mn-induced repression of TH promoter activity, mRNA, and protein levels and also reduced Mn-induced oxidative stress, inflammation, and apoptosis in dopaminergic neurons. REST reduced Mn-induced proinflammatory cytokines, including tumor necrosis factor ?, interleukin 1? (IL-1?), IL-6, and interferon ?. Moreover, REST inhibited the Mn-induced proapoptotic proteins Bcl-2?associated X protein (Bax) and death-associated protein 6 (Daxx) and attenuated an Mn-induced decrease in the antiapoptotic proteins Bcl-2 and Bcl-xL. REST also enhanced the expression of antioxidant proteins, including catalase, NF-E2?related factor 2 (Nrf2), and heme oxygenase 1 (HO-1). Our findings indicate that REST activates TH expression and thereby protects neurons against Mn-induced toxicity and neurological disorders associated with dopaminergic neurodegeneration.	[Pajarillo, Edward; Rizor, Asha; Lee, Eunsook] Florida A&M Univ, Dept Pharmaceut Sci, Tallahassee, FL 32301 USA; [Son, Deok-Soo] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY 10461 USA	State University System of Florida; Florida A&M University; Meharry Medical College; Yeshiva University	Lee, E (corresponding author), Florida A&M Univ, Dept Pharmaceut Sci, Tallahassee, FL 32301 USA.	eunsook.lee@famu.edu	Pajarillo, Edward Alain/ABF-9202-2021	Pajarillo, Edward Alain/0000-0002-5044-7607; aschner, michael/0000-0002-2619-1656	National Institutes of Health Research [R01 ES024756, U54 MD007582, NCI SC1 CA200519, R01 ES10563, R01 ES07331, 1R21 ES025415]	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Research Grants R01 ES024756, U54 MD007582, NCI SC1 CA200519, R01 ES10563, R01 ES07331, and 1R21 ES025415. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007665; Abramovitz L, 2008, J BIOL CHEM, V283, P110, DOI 10.1074/jbc.M707366200; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Alsulimani HH, 2015, TOX RESEARCH, V31, P347, DOI 10.5487/TR.2015.31.4.347; Aouacheria A, 2017, NEUROCHEM INT, V109, P141, DOI 10.1016/j.neuint.2017.04.009; Bai G, 2003, J NEUROCHEM, V86, P992, DOI 10.1046/j.1471-4159.2003.01922.x; BECK KD, 1991, J NEUROCHEM, V57, P527, DOI 10.1111/j.1471-4159.1991.tb03782.x; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BEROD A, 1982, BRAIN RES, V240, P235, DOI 10.1016/0006-8993(82)90219-0; Blasco H, 2017, CAN J NEUROL SCI, V44, P90, DOI 10.1017/cjn.2016.284; Brene S, 2000, EUR J NEUROSCI, V12, P1525, DOI 10.1046/j.1460-9568.2000.00040.x; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chinta SJ, 2005, INT J BIOCHEM CELL B, V37, P942, DOI 10.1016/j.biocel.2004.09.009; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; COULON JF, 1990, J NEUROCHEM, V55, P1412, DOI 10.1111/j.1471-4159.1990.tb03154.x; Doan KV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12733; Harischandra DS, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00654; Hwang JY, 2018, CURR OPIN NEUROBIOL, V48, P193, DOI 10.1016/j.conb.2017.12.008; Isaev NK, 2018, REV NEUROSCIENCE, V29, P233, DOI 10.1515/revneuro-2017-0051; Johnson J, 2018, NEUROTOXICOLOGY, V64, P230, DOI 10.1016/j.neuro.2017.06.007; Jones FS, 1999, BIOESSAYS, V21, P372, DOI 10.1002/(SICI)1521-1878(199905)21:5<372::AID-BIES3>3.0.CO;2-3; Kawamura M, 2019, NEUROSCI LETT, V699, P59, DOI 10.1016/j.neulet.2019.01.042; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD1284, DOI 10.1093/nar/gkx1188; Kim HS, 2001, J NEUROCHEM, V76, P280, DOI 10.1046/j.1471-4159.2001.00044.x; Kim J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210248; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; Kirn SM, 2006, BIOCHEM BIOPH RES CO, V346, P426, DOI 10.1016/j.bbrc.2006.05.142; Kumasaka MY, 2017, NEUROTOX RES, V32, P661, DOI 10.1007/s12640-017-9783-0; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lee ESY, 2009, TOXICOL SCI, V110, P156, DOI 10.1093/toxsci/kfp081; Lim J, 2000, MOL CELL BIOCHEM, V212, P51, DOI 10.1023/A:1007148719497; Lim J, 2015, NEUROREPORT, V26, P380, DOI 10.1097/WNR.0000000000000356; Lin KH, 2019, FOOD CHEM TOXICOL, V133, DOI 10.1016/j.fct.2019.110765; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Malecki EA, 2001, BRAIN RES BULL, V55, P225, DOI 10.1016/S0361-9230(01)00456-7; Menezes JA, 2014, NEUROTOXICOLOGY, V45, P293, DOI 10.1016/j.neuro.2013.09.006; Messmer K, 2007, INT J DEV NEUROSCI, V25, P29, DOI 10.1016/j.ijdevneu.2006.11.003; Moreno-Gonzalez G, 2008, BIOSCIENCE REP, V28, P177, DOI 10.1042/BSR20080058; Murai K, 2004, NUCLEIC ACIDS RES, V32, P3180, DOI 10.1093/nar/gkh550; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; NEWLAND MC, 1989, EXP NEUROL, V106, P251, DOI 10.1016/0014-4886(89)90157-X; Nomura M, 2005, J MOL BIOL, V354, P903, DOI 10.1016/j.jmb.2005.10.008; Pajarillo E, 2018, NEUROTOXICOLOGY, V65, P280, DOI 10.1016/j.neuro.2017.11.008; Palm K, 1998, J NEUROSCI, V18, P1280; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Perera A, 2015, CELL REP, V11, P283, DOI 10.1016/j.celrep.2015.03.020; Popichak KA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1349-4; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Qi YP, 1997, J NEUROSCI, V17, P1217; Qi ZP, 2019, TOXICOL IND HEALTH, V35, P211, DOI 10.1177/0748233719825720; Sakurada K, 1999, DEVELOPMENT, V126, P4017; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Seth KA, 2001, J BIOL CHEM, V276, P13917, DOI 10.1074/jbc.M007745200; Shimojo M, 2004, LIFE SCI, V74, P2213, DOI 10.1016/j.lfs.2003.08.045; Shimojo M, 2001, J BIOL CHEM, V276, P13121, DOI 10.1074/jbc.M011193200; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Stredrick DL, 2004, NEUROTOXICOLOGY, V25, P543, DOI 10.1016/j.neuro.2003.08.006; Suo HY, 2015, NEUROPHARMACOLOGY, V99, P67, DOI 10.1016/j.neuropharm.2015.07.015; Taylor JM, 2013, NEUROCHEM INT, V62, P803, DOI 10.1016/j.neuint.2012.12.016; Wang P, 2014, EUR NEUROL, V72, P249, DOI 10.1159/000363515; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Yoo JY, 2001, BIOCHEM BIOPH RES CO, V283, P928, DOI 10.1006/bbrc.2001.4857; Yu M, 2013, NEUROBIOL AGING, V34, P916, DOI 10.1016/j.neurobiolaging.2012.06.002; Zhang DH, 2011, TOXICOL APPL PHARM, V254, P65, DOI 10.1016/j.taap.2010.03.023; Zhang K, 2017, BIOL TRACE ELEM RES, V180, P297, DOI 10.1007/s12011-017-0992-4; Zhang ZP, 2017, TOXICOL APPL PHARM, V336, P94, DOI 10.1016/j.taap.2017.10.011; Zhao YG, 2017, MOL NEUROBIOL, V54, P541, DOI 10.1007/s12035-015-9658-4	73	15	15	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3040	3054		10.1074/jbc.RA119.011446	http://dx.doi.org/10.1074/jbc.RA119.011446			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32001620	Green Published, hybrid			2022-12-26	WOS:000519597300014
J	Das, P; Behera, BK; Chatterjee, S; Das, BK; Mohapatra, T				Das, Priyanka; Behera, Bijay Kumar; Chatterjee, Soumendranath; Das, Basanta Kumar; Mohapatra, Trilochan			De novo transcriptome analysis of halotolerant bacterium Staphylococcus sp. strain P-TSB-70 isolated from East coast of India: In search of salt stress tolerant genes	PLOS ONE			English	Article							COMPATIBLE SOLUTE ECTOINE; HALOPHILIC BACTERIUM; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURES; HETEROLOGOUS EXPRESSION; BIOSYNTHESIS GENES; RNA-SEQ; TREHALOSE; TRANSPORTER; RECOGNITION	In the present study, we identified salt stress tolerant genes from the marine bacterium Staphylococcus sp. strain P-TSB-70 through transcriptome sequencing. In favour of whole-genome transcriptome profiling of Staphylococcus sp. strain P-TSB-70 (GenBank Accn. No. KP117091) which tolerated upto 20% NaCl stress, the strain was cultured in the laboratory condition with 20% NaCl stress. Transcriptome analyses were performed by SOLiD4.0 sequencing technology from which 10280 and 9612 transcripts for control and treated, respectively, were obtained. The coverage per base (CPB) statistics were analyzed for both the samples. Gene ontology (GO) analysis has been categorized at varied graph levels based on three primary ontology studies viz. cellular components, biological processes, and molecular functions. The KEGG analysis of the assembled transcripts using KAAS showed presumed components of metabolic pathways which perhaps implicated in diverse metabolic pathways responsible for salt tolerance viz. glycolysis/gluconeogenesis, oxidative phosphorylation, glutathione metabolism, etc. further involving in salt tolerance. Overall, 90 salt stress tolerant genes were identified as of 186 salt-related transcripts. Several genes have been found executing normally in the TCA cycle pathway, integral membrane proteins, generation of the osmoprotectants, enzymatic pathway associated with salt tolerance. Recognized genes fit diverse groups of salt stress genes viz. abc transporter, betaine, sodium antiporter, sodium symporter, trehalose, ectoine, and choline, that belong to different families of genes involved in the pathway of salt stress. The control sample of the bacterium showed elevated high proportion of transcript contigs (29%) while upto 20% salt stress treated sample of the bacterium showed a higher percentage of transcript contigs (31.28%). A total of 1,288 and 1,133 transcript contigs were measured entirely as novel transcript contigs in both control and treated samples, respectively. The structure and function of 10 significant salt stress tolerant genes of Staphylococcus sp. have been analyzed in this study. The information acquired in the present study possibly used to recognize and clone the salt stress tolerant genes and support in developing the salt stress-tolerant plant varieties to expand the agricultural productivity in the saline system.	[Das, Priyanka; Behera, Bijay Kumar; Das, Basanta Kumar] Cent Inland Fisheries Res Inst, ICAR, Biotechnol Lab, Fishery Resource & Environm Management Div, Barakpur, W Bengal, India; [Chatterjee, Soumendranath] Univ Burdwan, Dept Zool, Parasitol & Microbiol Res Lab, Burdwan, W Bengal, India; [Mohapatra, Trilochan] Indian Council Agr Res, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Inland Fisheries Research Institute; University of Burdwan; Indian Council of Agricultural Research (ICAR)	Behera, BK (corresponding author), Cent Inland Fisheries Res Inst, ICAR, Biotechnol Lab, Fishery Resource & Environm Management Div, Barakpur, W Bengal, India.	beherabk18@yahoo.co.in	Behera, Bijay Kumar/AAU-3873-2021; Chatterjee, Soumendranath/ABC-6710-2021; Behera, Bijay Kumar/AGZ-8213-2022	Behera, Bijay Kumar/0000-0003-4960-9768; Chatterjee, Soumendranath/0000-0002-2376-9344; Behera, Bijay Kumar/0000-0003-4960-9768; DAS, BASANTA/0000-0002-6629-8992				Alarico S, 2005, APPL ENVIRON MICROB, V71, P2460, DOI 10.1128/AEM.71.5.2460-2466.2005; Baati H, 2010, CURR MICROBIOL, V60, P157, DOI 10.1007/s00284-009-9516-6; Basyuni M, 2009, J PLANT PHYSIOL, V166, P1786, DOI 10.1016/j.jplph.2009.05.008; Behera Bijay Kumar, 2015, Proceedings of the Indian National Science Academy Part B Biological Sciences, V85, P957, DOI 10.1007/s40011-014-0440-6; Boscari A, 2002, J BACTERIOL, V184, P2654, DOI 10.1128/JB.184.10.2654-2663.2002; Calderon MI, 2004, MICROBIOL-SGM, V150, P3051, DOI 10.1099/mic.0.27122-0; Caton TM, 2004, MICROB ECOL, V48, P449, DOI 10.1007/s00248-004-0211-7; Chen C, 2008, J BACTERIOL, V190, P2717, DOI 10.1128/JB.01585-07; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Choi S, 2014, APPL MICROBIOL BIOT, V98, P807, DOI 10.1007/s00253-013-5436-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Das BK, 2019, GENE, V701, P152, DOI 10.1016/j.gene.2019.03.028; de Carvalho JF, 2013, HEREDITY, V110, P181, DOI 10.1038/hdy.2012.76; de Lorenzo L, 2007, PLANT PHYSIOL, V145, P1521, DOI 10.1104/pp.107.106146; Fan F, 2004, ARCH BIOCHEM BIOPHYS, V421, P149, DOI 10.1016/j.abb.2003.10.003; Fraser KR, 2000, APPL ENVIRON MICROB, V66, P4696, DOI 10.1128/AEM.66.11.4696-4704.2000; Goel D, 2011, J PLANT PHYSIOL, V168, P1286, DOI 10.1016/j.jplph.2011.01.010; GUNN BA, 1983, INT J SYST BACTERIOL, V33, P751, DOI 10.1099/00207713-33-4-751; Hagemann M, 1997, J BACTERIOL, V179, P1727, DOI 10.1128/jb.179.5.1727-1733.1997; HAJEK V, 1992, INT J SYST BACTERIOL, V42, P97, DOI 10.1099/00207713-42-1-97; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Huan P, 2011, MAR BIOTECHNOL, V14, P1; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Huntley P.R, 2009, QUICKGO USER TUTORIA; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Janz D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-150; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Joseph TC, 2010, MOL BIOTECHNOL, V46, P20, DOI 10.1007/s12033-010-9259-4; Joshi A, 2009, PLANT SIGNAL BEHAV, V4, P400, DOI 10.4161/psb.4.5.8387; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; KUSHNER DJ, 1983, J BACTERIOL, V153, P1163, DOI 10.1128/JB.153.3.1163-1171.1983; Lai SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025090; Lambert LH, 1998, INT J SYST BACTERIOL, V48, P511, DOI 10.1099/00207713-48-2-511; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu X, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-12; Liu YQ, 2005, J BACTERIOL, V187, P2501, DOI 10.1128/JB.187.7.2501-2507.2005; Madigan M.T., 2005, BROCK BIOL MICROORGA, V11; Miao ZY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2019-x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nath IVA, 2011, EXTREMOPHILES, V15, P129, DOI 10.1007/s00792-010-0348-x; Ofer N, 2012, APPL ENVIRON MICROB, V78, P7483, DOI 10.1128/AEM.01318-12; Pardo JM, 2010, CURR OPIN BIOTECH, V21, P185, DOI 10.1016/j.copbio.2010.02.005; Pfluger K, 2003, APPL ENVIRON MICROB, V69, P6047, DOI 10.1128/AEM.69.10.6047-6055.2003; Prasath D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099731; Prodhan Shamsul H., 2008, Plant Tissue Culture & Biotechnology, V18, P57; Purvis JE, 2005, APPL ENVIRON MICROB, V71, P3761, DOI 10.1128/AEM.71.7.3761-3769.2005; Rahnama H, 2011, ACTA PHYSIOL PLANT, V33, P1521, DOI 10.1007/s11738-010-0690-8; Rajan LA, 2008, BIOTECHNOL LETT, V30, P1403, DOI 10.1007/s10529-008-9688-3; Razzauti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003929; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanjukta RK, 2013, INDIAN J BIOCHEM BIO, V50, P177; Satpal Turan, 2012, Australian Journal of Crop Science, V6, P1337; Saum SH, 2007, J BACTERIOL, V189, P6968, DOI 10.1128/JB.00775-07; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCHLEIFER KH, 1975, INT J SYST BACTERIOL, V25, P50, DOI 10.1099/00207713-25-1-50; Schubert T, 2007, APPL ENVIRON MICROB, V73, P3343, DOI 10.1128/AEM.02482-06; Sharma CM, 2014, CURR OPIN MICROBIOL, V19, P97, DOI 10.1016/j.mib.2014.06.010; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Solheim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094571; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; TANASUPAWAT S, 1992, INT J SYST BACTERIOL, V42, P577, DOI 10.1099/00207713-42-4-577; Tang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124421; Taponen S, 2012, INT J SYST EVOL MICR, V62, P61, DOI 10.1099/ijs.0.028365-0; Tsai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-13; Tsiamis G, 2008, RES MICROBIOL, V159, P609, DOI 10.1016/j.resmic.2008.09.007; Vernozy-Rozand C, 2000, INT J SYST EVOL MICR, V50, P1521, DOI 10.1099/00207713-50-4-1521; Wang H, 2003, PLANT MOL BIOL, V52, P873, DOI 10.1023/A:1025029026375; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Xiang WL, 2008, WORLD J MICROB BIOT, V24, P2297, DOI 10.1007/s11274-008-9744-0; Xiong WD, 2020, AICHE J, V66, DOI 10.1002/aic.16856; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zou MX, 2012, CHINESE MED J-PEKING, V125, P2289, DOI 10.3760/cma.j.issn.0366-6999.2012.13.009	81	3	4	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228199	10.1371/journal.pone.0228199	http://dx.doi.org/10.1371/journal.pone.0228199			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040520	gold, Green Published			2022-12-26	WOS:000534629400018
J	Rahim, FF; Abdulrahman, SA; Maideen, SFK; Rashid, A				Rahim, Fairuz Fadzilah; Abdulrahman, Surajudeen Abiola; Maideen, Siti Fatimah Kader; Rashid, Abdul			Prevalence and factors associated with prediabetes and diabetes in fishing communities in Penang, Malaysia: A cross-sectional study	PLOS ONE			English	Article							OF-FIT TEST; PHYSICAL-ACTIVITY; RISK; PREDICTORS; EXERCISE; MELLITUS; ADULTS; CARE	Background Diabetes is a metabolic disorder, characterized by hyperglycemic state of the body. A silent killer, which can take the lives of victims if undiagnosed at the earliest stage. Prediabetes has become an important health concern across countries due to its huge potential for the development of diabetes and other complications. The objectives of this study were to determine the prevalence of prediabetes and diabetes and its associated factors among rural fishing communities in Penang, Malaysia. Methods A cross-sectional study was conducted among fishing communities in Southwest District of Penang, Malaysia from August to November 2017. Blood sample (finger prick test) and physical examination were performed on sample of 168 participants consented in this study. Pre-validated Malay versions of International Physical Activity 7 (IPAQ-7) and Perceived Stress Scale (PSS) questionnaires were used to assess the level of physical activity and stress levels of the participants. Multinomial logistic regression models were fitted to identify factors associated with prediabetes and diabetes. Results The prevalence of diabetes and prediabetes were 19.6% (95% CI: 14.3, 26.4) and 10.12% (95% CI: 6.4, 15.7) respectively. The median physical activity (interquartile range) in MET-minutes per week for those with diabetes (1071.0 (2120.0)) and prediabetes (1314.0 (1710.0)) was generally lower as compared to non-diabetes. Majority reported moderate stress (57.3%) from PSS system. Abdominal obesity, family history of diabetes and being hypertensive were significant factors associated with diabetes; while older age, bigger waist circumference and self-perceived poor routine diet were factors associated with prediabetes. Conclusions The screening for prediabetes in this population gives the opportunity to implement lifestyle interventions at the earliest possible, which could prevent the development of diabetes. The identification of diabetic individuals provides an opportunity to conduct health promotion and education to ensure good metabolic control and hence reduce the risks of complications.	[Rahim, Fairuz Fadzilah; Maideen, Siti Fatimah Kader; Rashid, Abdul] RCSI & UCD Malaysia Campus, Dept Publ Hlth Med, George Town, Penang, Malaysia; [Abdulrahman, Surajudeen Abiola] Hlth Educ England, Cambridge, England		Rahim, FF (corresponding author), RCSI & UCD Malaysia Campus, Dept Publ Hlth Med, George Town, Penang, Malaysia.	fairuzfr@yahoo.com	MAIDEEN, SITI FATIMAH KADER/AAM-6119-2021	rashid, abdul/0000-0003-1520-8480	RCSI & UCD Malaysia Campus (RUMC)	RCSI & UCD Malaysia Campus (RUMC)	There is no specific research grant for this study. The authors received support from the RCSI & UCD Malaysia Campus (RUMC) for the medical equipment.	Al-Dubai SAR, 2014, ANN MED HEALTH SCI R, V4, P104, DOI 10.4103/2141-9248.138023; Aladeniyi I., 2017, The Open Public Health Journal, V10, P167, DOI 10.2174/1874944501710010167; Aris T, 2015, NATL HLTH MORBIDITY, VII; Cheng H, 2016, SIMPLE EASY TO USE S, DOI DOI 10.13140/RG.2.2.21067.80165; Chew BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152095; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Chu AHY, 2015, ASIA-PAC J PUBLIC HE, V27, pNP2381, DOI 10.1177/1010539512444120; Colberg SR, 2010, DIABETES CARE, V33, P2692, DOI [10.2337/dc10-1548, 10.2337/dc10-9990]; Fagerland MW, 2012, STATA J, V12, P447, DOI 10.1177/1536867X1201200307; Feisul M. I., 2013, NATL DIABETES REGIST; Goeman JJ, 2006, BIOMETRICS, V62, P980, DOI 10.1111/j.1541-0420.2006.00581.x; Hamasaki H, 2016, WORLD J DIABETES, V7, P243, DOI 10.4239/wjd.v7.i12.243; Harris ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172126; Hilawe EH, 2016, NAGOYA J MED SCI, V78, P475, DOI 10.18999/nagjms.78.4.475; Hoskin Mary A, 2014, Curr Nutr Rep, V3, P364; Hussein Z, 2015, ANN GLOB HEALTH, V81, P851, DOI 10.1016/j.aogh.2015.12.016; IDF, 2018, IDF WP REG IDF W PAC; IPH, 2008, NAT HLTH MORB SURV 2; Jadhav RA, 2017, J PHYS ACT HEALTH, V14, P745, DOI 10.1123/jpah.2016-0632; Kahle EB, 1996, INT J SPORTS MED, V17, P1, DOI 10.1055/s-2007-972799; Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69; Khor G L, 1999, Asia Pac J Clin Nutr, V8, P272, DOI 10.1046/j.1440-6047.1999.00125.x; Li M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005497; Mafauzy M, 2011, Med J Malaysia, V66, P175; Medisana, INVENTORMEDITOUCH 2; MoH, 2009, NATL DIABETES REGIST, V1; Muda WAMW, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0210-z; Mustafa N, 2011, DIABETES CARE, V34, P1362, DOI 10.2337/dc11-0005; Najafipour H, 2015, J DIABETES, V7, P613, DOI 10.1111/1753-0407.12195; Nor N, 2010, ASSESSMENT PHYS ACTI; Okwechime IO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145781; Organization WH, 2018, NONCOMMUNICABLE DIS; PREGIBON D, 1981, ANN STAT, V9, P705, DOI 10.1214/aos/1176345513; Sarzani R, 2008, J HYPERTENS, V26, P831, DOI 10.1097/HJH.0b013e3282f624a0; Shamizadeh T, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3220-z; Shamsuddin N., 2015, INT J PUBLIC HLTH RE, V5, P643; StataCorp, 2013, STAT STAT SOFTW REL; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tan K C, 2015, Malays Fam Physician, V10, P9; Tan MY, 2008, PATIENT EDUC COUNS, V72, P252, DOI 10.1016/j.pec.2008.03.017; Tan S L, 2011, Malays J Nutr, V17, P287; Tee ES, 2017, EUR J CLIN NUTR, V71, P844, DOI 10.1038/ejcn.2017.44; Turner MJ, 2007, AUST FAM PHYSICIAN, V36, P834; Tuso Phillip, 2014, Perm J, V18, P88, DOI 10.7812/TPP/14-002; Mohamud WNW, 2012, DIABETES RES CLIN PR, V96, P90, DOI [10.1016/j.diabres.2011.12.023, 10.1016/j.diabres.2011.11.020]; Wang XP, 2004, PANCREAS, V29, P264, DOI 10.1097/00006676-200411000-00004; WHO, 2016, GLOB REP PSOR; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Health Organization, 2016, GLOB HLTH EST 2016 D; Wu SH, 2017, DIABET METAB SYND OB, V10, P491, DOI 10.2147/DMSO.S136368; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zaki M, 2010, Med J Malaysia, V65 Suppl A, P143; Zhao M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080808	53	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228570	10.1371/journal.pone.0228570	http://dx.doi.org/10.1371/journal.pone.0228570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040497	gold, Green Published			2022-12-26	WOS:000534629400027
J	Astatkie, A				Astatkie, Ayalew			Dynamics of stunting from childhood to youthhood in Ethiopia: Evidence from the Young Lives panel data	PLOS ONE			English	Article							SAFETY NET PROGRAM; MATERNAL EDUCATION; CHILDREN; HEALTH; PREVALENCE; UNDERNUTRITION; MALNUTRITION; INFECTIONS; COUNTRIES; NUTRITION	Introduction Stunting continues to be a public health challenge with grave health, cognitive and economic consequences. Yet, its dynamics along the life course remain not well investigated in Ethiopia and beyond. Methods Longitudinal data generated by following two (younger and older) cohorts of about 3000 children for nearly 15 years were analyzed to investigate the longitudinal dynamics of stunting in Ethiopia. The cross-sectional prevalence of stunting in each round, longitudinal prevalence, and transition probabilities were determined. Multilevel mixed effects ordinal regression was applied to identify the determinants of stunting accounting for child-level and cluster-level variations. Results The cross-sectional prevalence of severe stunting for the younger cohort fluctuated between 21% and 6%, while for the older cohort it fluctuated between 12% and 3%. Moderate stunting fluctuated between 23% and 16% for the younger cohort and between 22% and 8% for the older cohort. The longitudinal prevalence of severe stunting was 10% in both the younger and older cohorts, whereas that of moderate stunting was 20% for the younger cohort and 18% for the older cohort. Children not stunted at baseline had very high probabilities of remaining not stunted through youthhood (87% for the younger and 90% for the older cohorts). Conversely, children with moderate stunting at baseline had high probabilities either remaining moderately stunted or progressing to severe stunting. Furthermore, children who had severe stunting at baseline had high probabilities of either remaining severely stunted or transitioning to moderate stunting. In both cohorts, older age of the child, female sex, having an educated mother, and being from a household with educated head significantly reduced the risk of stunting. Children from households in the top wealth tertile had a significantly lower risk of stunting in the younger cohort, but not in the older cohort. Similarly, Productive Safety Net Programme reduced the risk of stunting in the younger cohort, but not in the older cohort. Conclusion Children not stunted early in life are highly likely to grow into non-stunted adults while children stunted early in life are highly likely to grow into stunted adults. Several child-level, maternal, household and programmatic factors affect the risk of stunting. Efforts to prevent stunting shall commence early in life.	[Astatkie, Ayalew] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia	Hawassa University	Astatkie, A (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia.	ayalewastatkie@gmail.com	Astatkie, Ayalew/I-1167-2019	Astatkie, Ayalew/0000-0002-4840-9601	UK aid from the Department for International Development (DFID)	UK aid from the Department for International Development (DFID)	The data used in this publication come from Young Lives, a 15-year study of the changing nature of childhood poverty in Ethiopia, India (Andhra Pradesh and Telangana), Peru and Vietnam (www.younglives.org.uk).Young Lives has been core-funded by UK aid from the Department for International Development (DFID).	Abdi M, 2017, J INFECT PUBLIC HEAL, V10, P84, DOI 10.1016/j.jiph.2016.02.009; Abera Lamirot, 2018, BMC Res Notes, V11, P557, DOI 10.1186/s13104-018-3666-1; Alelign T, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0084-x; Amare B, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-7; Berhane G., 2011, IMPACT ETHIOPIAS PRO; Berhane G., 2016, PRODUCTIVE SAFETY NE; Bogale TY, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5561-z; Bork KA, 2017, J NUTR, V147, P940, DOI 10.3945/jn.116.243246; Boyden J., 2016, V2nd ed, DOI [10.5255/UKDA-SN-7483-3, DOI 10.5255/UKDA-SN-7483-3]; Briones K, 2017, CONSTRUCTING YOUNG L; Briones K., 2018, GUIDE YOUNG LIVES RO; Cochrane L, 2016, J INT DEV, V28, P649, DOI 10.1002/jid.3234; Crookston BT, 2013, AM J CLIN NUTR, V98, P1555, DOI 10.3945/ajcn.113.067561; Currie J, 2003, Q J ECON, V118, P1495, DOI 10.1162/003355303322552856; Demilew YM, 2018, AFR HEALTH SCI, V18, P756, DOI 10.4314/ahs.v18i3.34; Derso T, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0848-2; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Eshete H, 2017, ETHIOP J HEALTH SCI, V27, P155, DOI 10.4314/ejhs.v27i2.8; Ethiopian Public Health Institute (EPHI) [Ethiopia] and ICF, 2019, ETH MIN DEM HLTH SUR; Fanzo J, 2018, GLOBAL NUTR REPORT S; Feeding the Future, 2018, GLOB FOOD SEC STRAT; Garenne M, 2003, J BIOSOC SCI, V35, P601, DOI 10.1017/S0021932003006047; Gari T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190983; Gunes PM, 2015, ECON EDUC REV, V47, P1, DOI 10.1016/j.econedurev.2015.02.008; Hagos S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170785; Haile D, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0587-9; Headey D, 2018, AGR ECON-BLACKWELL, V49, P765, DOI 10.1111/agec.12458; Hong Rathavuth, 2006, Int J Equity Health, V5, P15, DOI 10.1186/1475-9276-5-15; Hug L., 2020, LEVELS TRENDS CHILD; Lundeen EA, 2014, PUBLIC HEALTH NUTR, V17, P2131, DOI 10.1017/S1368980013003017; Mahmud MA, 2013, PATHOG GLOB HEALTH, V107, P58, DOI 10.1179/2047773213Y.0000000074; Makoka D., 2013, DHS WORKING PAPERS; Menon P, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12620; Mohammed SH, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4229-9; Nguyen NL., 2012, ETHIOPIA J PREVENTIV, V53, P157; Pankhurst A., 2018, YOUNG LIVES ETHIOPIA; Petrou S, 2010, SOC SCI MED, V71, P1366, DOI 10.1016/j.socscimed.2010.06.038; Porter C, 2016, SOC SCI MED, V159, P92, DOI 10.1016/j.socscimed.2016.05.001; Schmidt WP, 2007, EPIDEMIOLOGY, V18, P537, DOI 10.1097/EDE.0b013e318093f3ce; Schmidt WP, 2010, EMERG THEMES EPIDEMI, V7, DOI 10.1186/1742-7622-7-5; StataCorp, 2017, STAT LONG DAT PAN DA; SVEDBERG P, 1990, J DEV STUD, V26, P469, DOI 10.1080/00220389008422165; Takele K, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6984-x; Tariku A, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0433-1; Tariku EZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206659; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Vollmer S, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000206; Wamani H., 2007, BMC Pediatrics, V7; World Health Organization, 2010, NUTR LANDSC INF SYST, DOI 10.1159/000362780.Interpretation; Young Lives, 2018, YOUNG LIV SURV DES S; Young Lives, 2017, GUID YOUNG LIV RES	51	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0229011	10.1371/journal.pone.0229011	http://dx.doi.org/10.1371/journal.pone.0229011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9HH	32032372	Green Published, gold			2022-12-26	WOS:000534626100034
J	Montuelle, SJ; Olson, RA; Curtis, H; Beery, S; Williams, SH				Montuelle, Stephane J.; Olson, Rachel A.; Curtis, Hannah; Beery, Sophia; Williams, Susan H.			Effects of food properties on chewing in pigs: Flexibility and stereotypy of jaw movements in a mammalian omnivore	PLOS ONE			English	Article							HUMAN PERIODONTAL MECHANORECEPTORS; MECHANICAL-PROPERTIES; FRACTURE PROPERTIES; MASTICATION; KINEMATICS; MUSCLE; FORCE; MODULATION; ONTOGENY; PRIMATES	Chewing is a rhythmic oral behavior that requires constant modifications of jaw movements in response to changes in food properties. The food-specific kinematic response is dependent on the potential for kinematic flexibility allowed by morphology and modulation of motor control. This study investigates the effects of food toughness and stiffness on the amplitude and variability of jaw movements during chewing in a typical omnivorous mammalian model (pigs). Jaw movements were reconstructed using X-ray Reconstruction Of Moving Morphology (XROMM) and kinematic data associated with the amplitude of jaw pitch (opening-closing) and jaw yaw ( mediolateral rotation) were extracted for each cycle. Between-food differences were tested for the amplitude of jaw movements during each phase of the gape cycle, as well as in their respective within-food variability, or stereotypy, as indicated by coefficients of variation. With increasing toughness, jaw pitch amplitude is decreased during fast close, larger and more stereotyped during slow close, smaller but more variable during slow open, and more variable during fast open. In addition, when chewing on tougher foods, the amplitude of jaw yaw during slow close only increases in a subset of individuals, but all become less variable (i.e., more stereotyped). In contrast, increasing food stiffness has no effect on the amplitude or the variability of jaw pitch, whereas jaw yaw increases significantly in the majority of individuals studied. Our data demonstrate that food stiffness and toughness both play a role in modulating gape cycle dynamics by altering the trajectory of jaw movements, especially during the slow-close phase and tooth-food-tooth contact, albeit differently. This highlights how a generalist oral morphology such as that of pigs (e.g., bunodont teeth lacking precise occlusion, permissive temporomandibular joint allowing extensive condylar displacements in 3 dimensions) enables organisms to not only adjust chewing movements in their amplitude, but also in their variability.	[Montuelle, Stephane J.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Warrensville Hts, OH 44122 USA; [Montuelle, Stephane J.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci & Prosthodont, Ann Arbor, MI 48109 USA; [Olson, Rachel A.; Beery, Sophia] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Curtis, Hannah; Williams, Susan H.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University; University of Michigan System; University of Michigan; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Montuelle, SJ (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Warrensville Hts, OH 44122 USA.; Montuelle, SJ (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci & Prosthodont, Ann Arbor, MI 48109 USA.	montuell@ohio.edu	Olson, Rachel A/GQH-9186-2022; Beery, Sophia/AFS-5793-2022	Olson, Rachel A/0000-0003-0803-9519; Montuelle, Stephane/0000-0002-8638-9779; Beery, Sophia/0000-0001-7255-0210; Williams, Susan/0000-0003-4167-678X	National Institute of Dental and Craniofacial Research [1R15DE02366801A1]; National Science Foundation [MRI DBI-0922988, IOS1456810]; Ohio Board of Regents; Ohio University Heritage College of Osteopathic Medicine	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Science Foundation(National Science Foundation (NSF)); Ohio Board of Regents; Ohio University Heritage College of Osteopathic Medicine	Fundings for this project was granted to SHW and provided by the National Institute of Dental and Craniofacial Research (1R15DE02366801A1 - https://www.nidcr.nih.gov/), the National Science Foundation (MRI DBI-0922988 and IOS1456810 - https://www.nsf.gov/), the Ohio Board of Regents (https://www.ohiohighered.org/), and the Ohio University Heritage College of Osteopathic Medicine (https://www.ohio.edu/medicine/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal KR, 1997, ARCH ORAL BIOL, V42, P1, DOI 10.1016/S0003-9969(96)00102-1; Agrawal KR, 2000, ARCH ORAL BIOL, V45, P577, DOI 10.1016/S0003-9969(00)00019-4; Agrawal KR, 1998, J DENT RES, V77, P1931, DOI 10.1177/00220345980770111101; Anapol F, 2000, AM J PHYS ANTHROPOL, V112, P595, DOI 10.1002/1096-8644(200008)112:4&lt;595::AID-AJPA11&gt;3.0.CO;2-W; Berthaume MA, 2016, AM J PHYS ANTHROPOL, V159, P79, DOI 10.1002/ajpa.22903; Brainerd EL, 2010, J EXP ZOOL PART A, V313A, P262, DOI 10.1002/jez.589; DEVREE F, 1976, ANN SOC ROY ZOOL BEL, V105, P255; HERRING SW, 1985, AM ZOOL, V25, P339; HERRING SW, 1977, J DENT RES, V56, P1377, DOI 10.1177/00220345770560111701; HUANG X, 1993, J DENT RES, V72, P980, DOI 10.1177/00220345930720061401; HUANG XF, 1994, COMP BIOCHEM PHYS A, V107, P647; Iriarte-Diaz J, 2011, INTEGR COMP BIOL, V51, P307, DOI 10.1093/icb/icr072; KHAN AA, 1993, J TEXTURE STUD, V24, P423, DOI 10.1111/j.1745-4603.1993.tb00052.x; Knorlein BJ, 2016, J EXP BIOL, V219, P3701, DOI 10.1242/jeb.145383; Koc H, 2014, J TEXTURE STUD, V45, P47, DOI 10.1111/jtxs.12051; Lucas P., 2004, DENT FUNCTIONAL MORP; Menegaz RA, 2015, J EXP BIOL, V218, P2573, DOI 10.1242/jeb.119438; Montuelle SJ, 2019, ARCH ORAL BIOL, V98, P226, DOI 10.1016/j.archoralbio.2018.11.024; Montuelle SJ, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.168088; Peyron MA, 1997, J DENT RES, V76, P789, DOI 10.1177/00220345970760031201; Peyron MA, 2002, EXP BRAIN RES, V142, P41, DOI 10.1007/s00221-001-0916-5; Popowics TE, 2004, ARCH ORAL BIOL, V49, P595, DOI 10.1016/j.archoralbio.2004.01.016; Popwics TE, 2001, ARCH ORAL BIOL, V46, P1; Reed DA, 2010, ARCH ORAL BIOL, V55, P946, DOI 10.1016/j.archoralbio.2010.08.008; Ross CF, 2010, J EXP BIOL, V213, P572, DOI 10.1242/jeb.036822; Ross CF, 2007, INTEGR COMP BIOL, V47, P118, DOI 10.1093/icb/icm044; Ross CF, 2007, J EXP BIOL, V210, P1046, DOI 10.1242/jeb.02733; THEXTON AJ, 1980, J NEUROPHYSIOL, V44, P456, DOI 10.1152/jn.1980.44.3.456; Trulsson M, 2006, J ORAL REHABIL, V33, P262, DOI 10.1111/j.1365-2842.2006.01629.x; Trulsson M, 2002, BEHAV BRAIN RES, V135, P27, DOI 10.1016/S0166-4328(02)00151-1; Trulsson M, 1995, INT CONGR SER, V1079, P155; Trulsson M, 2007, ARCH ORAL BIOL, V52, P357, DOI 10.1016/j.archoralbio.2006.09.011; Vinyard CJ, 2008, INTEGR COMP BIOL, V48, P294, DOI 10.1093/icb/icn071; Wainwright PC, 2008, J EXP BIOL, V211, P3523, DOI 10.1242/jeb.007187; Williams SH, 2005, AM J PRIMATOL, V67, P329, DOI 10.1002/ajp.20189; Yamada Y, 1996, BRAIN RES, V706, P237, DOI 10.1016/0006-8993(95)01061-0	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228619	10.1371/journal.pone.0228619	http://dx.doi.org/10.1371/journal.pone.0228619			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032365	Green Published, gold			2022-12-26	WOS:000534626100018
J	Saliakoura, M; Reynoso-Moreno, I; Pozzato, C; Sebastiano, MR; Galie, M; Gertsch, J; Konstantinidou, G				Saliakoura, Maria; Reynoso-Moreno, Ines; Pozzato, Chiara; Rossi Sebastiano, Matteo; Galie, Mirco; Gertsch, Jurg; Konstantinidou, Georgia			The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer	ONCOGENE			English	Article							GENE-EXPRESSION; PHOSPHOLIPASE A(2); GROWTH-FACTOR; FATTY-ACIDS; CYCLOOXYGENASE-2; PHOSPHATIDYLINOSITOL; INDUCTION; LIPIDOME; BREAST; PROGRESSION	Enhanced prostaglandin production promotes the development and progression of cancer. Prostaglandins are generated from arachidonic acid (AA) by the action of cyclooxygenase (COX) isoenzymes. However, how cancer cells are able to maintain an elevated supply of AA for prostaglandin production remains unclear. Here, by using lung cancer cell lines and clinically relevant Kras(G12D)-driven mouse models, we show that the long-chain acyl-CoA synthetase (ACSL3) channels AA into phosphatidylinositols to provide the lysophosphatidylinositol-acyltransferase 1 (LPIAT1) with a pool of AA to sustain high prostaglandin synthesis. LPIAT1 knockdown suppresses proliferation and anchorage-independent growth of lung cancer cell lines, and hinders in vivo tumorigenesis. In primary human lung tumors, the expression of LPIAT1 is elevated compared with healthy tissue, and predicts poor patient survival. This study uncovers the ACSL3-LPIAT1 axis as a requirement for the sustained prostaglandin synthesis in lung cancer with potential therapeutic value.	[Saliakoura, Maria; Pozzato, Chiara; Rossi Sebastiano, Matteo; Konstantinidou, Georgia] Univ Bern, Inst Pharmacol, CH-3010 Bern, Switzerland; [Reynoso-Moreno, Ines; Gertsch, Jurg] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Galie, Mirco] Univ Verona, Dept Neurosci Biomed & Movement, I-37134 Verona, Italy	University of Bern; University of Bern; University of Verona	Konstantinidou, G (corresponding author), Univ Bern, Inst Pharmacol, CH-3010 Bern, Switzerland.	georgia.konstantinidou@pki.unibe.ch	Konstantinidou, Georgia/O-9192-2016	Konstantinidou, Georgia/0000-0001-9513-0286; Saliakoura, Maria/0000-0001-9021-2151; Gertsch, Jurg/0000-0003-0978-1555; GALIE', Mirco/0000-0002-6441-8313; Rossi Sebastiano, Matteo/0000-0002-9925-1904; Reynoso Moreno, Ines del Carmen/0000-0001-7672-8282	Swiss National Science Foundation (SNSF) [PP00P3_163929]; Novartis Foundation for medical-biological research [16C190]; UniBern Forschungsstiftung; SNSF [163359]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Novartis Foundation for medical-biological research; UniBern Forschungsstiftung; SNSF(Swiss National Science Foundation (SNSF))	The authors wish to thank Prof. Hiroyuki Arai (University of Tokyo, Japan) for providing the LPIAT1 antibody [39]. The NSCLC cell lines were a kind gift from Prof. John D. Minna (University of Southwestern Medical Center at Dallas, Texas, USA). Human tissues were provided by the Tissue Bank Bern. We thank Dr. Alexis Traynor-Kaplan (University of Washington, Medicinal Chemistry Mass Spectrometry Center, Washington, USA) for help with MS analysis. This study was supported by the Swiss National Science Foundation (SNSF) professorship PP00P3_163929, Novartis Foundation for medical-biological research #16C190, UniBern Forschungsstiftung (to GK), and SNSF research grant #163359 (to JG).	Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Borer JS, 2005, ARTHRITIS RES THER, V7, pS14, DOI 10.1186/ar1794; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Chicca A, 2017, P NATL ACAD SCI USA, V114, pE5006, DOI 10.1073/pnas.1704065114; D'Souza K, 2014, BBA-BIOMEMBRANES, V1838, P1501, DOI 10.1016/j.bbamem.2013.10.003; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ferrer I, 2018, LUNG CANCER, V124, P53, DOI 10.1016/j.lungcan.2018.07.013; Goldman M, 2018, PREPRINT, DOI DOI 10.1101/326470V3; Harris R. E., 2009, Inflammopharmacology, V17, P55, DOI 10.1007/s10787-009-8049-8; Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; HOLUB BJ, 1971, J LIPID RES, V12, P699; Howe LR, 2002, CANCER RES, V62, P5405; Huang M, 1998, CANCER RES, V58, P1208; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; JUNGALWALA FB, 1984, J LIPID RES, V25, P738; Kaminska K, 2014, FUTURE ONCOL, V10, P2177, DOI 10.2217/fon.14.152; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee HC, 2012, MOL BIOL CELL, V23, P4689, DOI 10.1091/mbc.E12-09-0673; Marino S, 2000, GENE DEV, V14, P994; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Meehan TF, 2015, NUCLEIC ACIDS RES, V43, pD1171, DOI 10.1093/nar/gku1193; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Padanad MS, 2016, CELL REP, V16, P1614, DOI 10.1016/j.celrep.2016.07.009; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; PATTON GM, 1982, J LIPID RES, V23, P190; Perez R, 2006, J LIPID RES, V47, P484, DOI 10.1194/jlr.M500397-JLR200; Phelps RM, 1996, J CELL BIOCHEM, P32; Poligone B, 2001, J BIOL CHEM, V276, P38658, DOI 10.1074/jbc.M106599200; Quach ND, 2014, BIOCHEM PHARMACOL, V90, P338, DOI 10.1016/j.bcp.2014.05.022; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sheng HM, 1998, J BIOL CHEM, V273, P22120, DOI 10.1074/jbc.273.34.22120; Slatter DA, 2016, CELL METAB, V23, P930, DOI 10.1016/j.cmet.2016.04.001; Smakman N, 2005, CLIN CANCER RES, V11, P41; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Surette ME, 1999, CARCINOGENESIS, V20, P757, DOI 10.1093/carcin/20.5.757; Tanaka T, 2003, EUR J BIOCHEM, V270, P1466, DOI 10.1046/j.1432-1033.2003.03512.x; Traynor-Kaplan A, 2017, BBA-MOL CELL BIOL L, V1862, P513, DOI 10.1016/j.bbalip.2017.02.002; TRAYNORKAPLAN AE, 1988, NATURE, V334, P353, DOI 10.1038/334353a0; TRAYNORKAPLAN AE, 1989, J BIOL CHEM, V264, P15668; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang Z, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/132320; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; XIE WL, 1995, J BIOL CHEM, V270, P27622, DOI 10.1074/jbc.270.46.27622; Xie WL, 1996, J BIOL CHEM, V271, P31742, DOI 10.1074/jbc.271.49.31742	53	24	25	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2948	2960		10.1038/s41388-020-1196-5	http://dx.doi.org/10.1038/s41388-020-1196-5		FEB 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32034305	Green Published, hybrid			2022-12-26	WOS:000511752600003
J	Naidu, SK; Nabi, R; Cheemarla, NR; Stanfield, BA; Rider, PJ; Jambunathan, N; Chouljenko, VN; Carter, R; Del Piero, F; Langohr, I; Kousoulas, KG				Naidu, Shan K.; Nabi, Rafiq; Cheemarla, Nagarjuna R.; Stanfield, Brent A.; Rider, Paul J.; Jambunathan, Nithya; Chouljenko, Vladimir N.; Carter, Renee; Del Piero, Fabio; Langohr, Ingeborg; Kousoulas, Konstantin G.			Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1 (F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis	PLOS ONE			English	Article							TYPE-1 UL20 PROTEIN; CYTOPLASMIC VIRION ENVELOPMENT; GLYCOPROTEIN K GK; AMINO-TERMINUS; T-CELLS; GANGLIA; CLEARANCE; INFECTION; ANTIBODY; FUSION	Herpes simplex virus type-1 (HSV-1) can cause severe ocular infection and blindness. We have previously shown that the HSV-1 VC2 vaccine strain is protective in mice and guinea pigs against genital herpes infection following vaginal challenge with HSV-1 or HSV-2. In this study, we evaluated the efficacy of VC2 intramuscular vaccination in mice against herpetic keratitis following ocular challenge with lethal human clinical strain HSV-1(McKrae). VC2 vaccination in mice produced superior protection and morbidity control in comparison to its parental strain HSV-1(F). Specifically, after HSV-1(McKrae) ocular challenge, all VC2 vaccinated-mice survived, while 30% of the HSV-1(F)-vaccinated and 100% of the mock-vaccinated mice died post challenge. VC2-vaccinated mice did not exhibit any symptoms of ocular infection and completely recovered from initial conjunctivitis. In contrast, HSV-1(F)-vaccinated mice developed time-dependent progressive keratitis characterized by corneal opacification, while mockvaccinated animals exhibited more severe stromal keratitis characterized by immune cell infiltration and neovascularization in corneal stroma with corneal opacification. Cornea in VC2immunized mice exhibited significantly increased infiltration of CD3+ T lymphocytes and decreased infiltration of Iba1+ macrophages in comparison to mock-or HSV-1(F)-vaccinated groups. VC2 immunization produced higher virus neutralization titers than HSV-1(F) post challenge. Furthermore, VC-vaccination significantly increased the CD4 T central memory (TCM) subsets and CD8 T effector memory (TEM) subsets in the draining lymph nodes following ocular HSV-1 (McKrae) challenge, then mock-or HSV-1(F)-vaccination. These results indicate that VC2 vaccination produces a protective immune response at the site of challenge to protect against HSV-1-induced ocular pathogenesis.	[Naidu, Shan K.; Nabi, Rafiq; Rider, Paul J.; Jambunathan, Nithya; Chouljenko, Vladimir N.; Kousoulas, Konstantin G.] Louisiana State Univ, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA; [Naidu, Shan K.; Nabi, Rafiq; Cheemarla, Nagarjuna R.; Rider, Paul J.; Jambunathan, Nithya; Chouljenko, Vladimir N.; Del Piero, Fabio; Langohr, Ingeborg; Kousoulas, Konstantin G.] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Stanfield, Brent A.] Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC USA; [Carter, Renee] Louisiana State Univ, Sch Vet Med, Dept Vet Clin Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Duke University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Kousoulas, KG (corresponding author), Louisiana State Univ, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA.; Kousoulas, KG (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	vtgusk@lsu.edu	CHEEMARLA, NAGARJUNA/I-5539-2019; Langohr, Ingeborg M/H-5570-2019; Stanfield, Brent/CAG-1570-2022; Stanfield, Brent/A-3266-2019	CHEEMARLA, NAGARJUNA/0000-0002-8860-2457; Langohr, Ingeborg M/0000-0001-7366-4391; Stanfield, Brent/0000-0002-0966-9662; Rider, Paul/0000-0002-5702-0809; KOUSOULAS, KONSTANTIN/0000-0001-7077-9003; Carter, Renee/0000-0002-7963-9063	Louisiana Board of Regents Governor's Biotechnology grant; Division of Biotechnology & Molecular Medicine, School of Veterinary Medicine;  [P20 NIH:GM103424];  [P30 NIH: GM110670]	Louisiana Board of Regents Governor's Biotechnology grant; Division of Biotechnology & Molecular Medicine, School of Veterinary Medicine; ; 	This research was supported by a Louisiana Board of Regents Governor's Biotechnology grant to K.G.K, Core Facilities supported by P20 NIH:GM103424 and P30 NIH: GM110670, and the Division of Biotechnology & Molecular Medicine, School of Veterinary Medicine.	[Anonymous], 2018, F1000RES; Awasthi S, 2014, J INFECT DIS, V210, P571, DOI 10.1093/infdis/jiu177; Bardel E, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.10; Beauman JG, 2005, AM FAM PHYSICIAN, V72, P1527; Bernstein DI, 2019, VACCINE, V37, P61, DOI 10.1016/j.vaccine.2018.11.042; Bhatta AK, 2018, J DTSCH DERMATOL GES, V16, P685, DOI 10.1111/ddg.13529; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Chouljenko DV, 2012, J VIROL, V86, P4262, DOI 10.1128/JVI.06766-11; Chouljenko VN, 2010, J VIROL, V84, P8596, DOI 10.1128/JVI.00298-10; Chouljenko VN, 2009, J VIROL, V83, P12301, DOI 10.1128/JVI.01329-09; Chowdhury S, 2013, J VIROL, V87, P3305, DOI 10.1128/JVI.02982-12; David AT, 2012, MBIO, V3, DOI 10.1128/mBio.00144-12; Dobbs ME, 2005, J VIROL, V79, P14546, DOI 10.1128/JVI.79.23.14546-14554.2005; Foster TP, 2004, J VIROL, V78, P13262, DOI 10.1128/JVI.78.23.13262-13277.2004; Foster TP, 2004, J VIROL, V78, P5347, DOI 10.1128/JVI.78.10.5347-5357.2004; Halford WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065523; Hollier LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004946.pub2; Hook LM, 2018, VACCINE; Iyer AV, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-317; Jambunathan N, 2011, J VIROL, V85, P12910, DOI 10.1128/JVI.06268-11; Johnson AJ, 2008, J VIROL, V82, P9678, DOI 10.1128/JVI.01159-08; Koelle DM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44084; Koujah L, 2019, CELL MOL LIFE SCI, V76, P405, DOI 10.1007/s00018-018-2938-1; Krawczyk A, 2013, P NATL ACAD SCI USA, V110, P6760, DOI 10.1073/pnas.1220019110; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1160, DOI 10.1001/archopht.1989.01070020226030; Liu SA, 2017, J VIROL; Lobo AM, 2018, OCUL SURF; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Lubinski JM, 2002, J VIROL, V76, P9232, DOI 10.1128/JVI.76.18.9232-9241.2002; Mancini M, 2018, MAMM GENOME, V29, P425, DOI 10.1007/s00335-018-9772-5; Melancon JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-120; Melancon JM, 2005, J VIROL, V79, P299, DOI 10.1128/JVI.79.1.299-313.2005; Melancon JM, 2004, J VIROL, V78, P7329, DOI 10.1128/JVI.78.14.7329-7343.2004; Musarrat F., 2018, J VIROL, V92; Obara Y, 1997, J MED VIROL, V52, P136, DOI 10.1002/(SICI)1096-9071(199706)52:2&lt;136::AID-JMV3&gt;3.0.CO;2-4; Petro C, 2015, ELIFE, V4, DOI 10.7554/eLife.06054; Petro CD, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88529; Piret J, 2015, REV MED VIROL, V25, P300, DOI 10.1002/rmv.1848; Retamal-Diaz AR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00904; Rider PJF, 2018, CURR CLIN MICROBIOL, V5, P55, DOI 10.1007/s40588-018-0082-1; Royer DJ, 2016, J VIROL, V90, P5514, DOI 10.1128/JVI.00517-16; Saied AA, 2014, CURR EYE RES, V39, P596, DOI 10.3109/02713683.2013.855238; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Stanfield BA, 2018, VACCINE, V36, P2842, DOI 10.1016/j.vaccine.2018.03.075; Stanfield BA, 2017, VACCINE, V35, P536, DOI 10.1016/j.vaccine.2016.12.018; Stanfield BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109890; Stuart PM, 2004, J GEN VIROL, V85, P2055, DOI 10.1099/vir.0.80049-0; Treat BR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006732; van Velzen M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003547; Vartak A, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4020012; Wang KN, 2017, J VIROL, V91, DOI 10.1128/JVI.00411-17; Whitley RJ, 1998, CLIN INFECT DIS, V26, P541, DOI 10.1086/514600	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228252	10.1371/journal.pone.0228252	http://dx.doi.org/10.1371/journal.pone.0228252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027675	Green Published, gold			2022-12-26	WOS:000534623800018
J	Nugent, RA; Husain, MJ; Kostova, D; Chaloupka, F				Nugent, Rachel A.; Husain, Muhammad Jami; Kostova, Deliana; Chaloupka, Frank			Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective	PLOS ONE			English	Article								Noncommunicable diseases (NCDs), such as heart disease, cancer, diabetes, and chronic respiratory disease, are responsible for seven out of every 10 deaths worldwide. While NCDs are associated with aging in high-income countries, this representation is often misleading. Over one-third of the 41 million annual deaths from NCDs occur prematurely, defined as under 70 years of age. Most of those deaths occur in low- and middle-income countries (LMICs) where surveillance, treatment, and care of NCDs are often inadequate. In addition to high health and social costs, the economic costs imposed by such high numbers of excess early deaths impede economic development and contribute to global and national inequity. In higher-income countries, NCDs and their risks continue to push health care costs higher. The burden of NCDs is strongly intertwined with economic conditions for good and for harm. Understanding the multiple ways they are connected-through risk factor exposures, access to quality health care, and financial protection among others-will determine which countries are able to improve the healthy longevity of their populations and slow growth in health expenditure particularly in the face of aging populations. The aim of this Special Collection is to provide new evidence to spur those actions.	[Nugent, Rachel A.] RTI Int, Global NCDs, Seattle, WA 98104 USA; [Nugent, Rachel A.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Husain, Muhammad Jami; Kostova, Deliana] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA; [Chaloupka, Frank] Univ Illinois, Chicago, IL USA	Research Triangle Institute; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Nugent, RA (corresponding author), RTI Int, Global NCDs, Seattle, WA 98104 USA.; Nugent, RA (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	rnugent@rti.org		Nugent, Rachel/0000-0001-6421-9077; Husain, Muhammad Jami/0000-0001-6049-0505	Centers for Disease Control and Prevention [NU2GGH001873]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication was supported by Grant or Cooperative Agreement number NU2GGH001873, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the Department of Health and Human Services, The Task Force for Global Health, Inc. or TEPHINET. The funder provided support in the form of salaries for authors (MJH, DK), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205932; Azomahou TT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212015; Bertram MY, 2018, LANCET, V391, P2071, DOI [10.1016/S0140-6736(18)30665-2, 10.1016/s0140-6736(18)30665-2]; Blecher E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208831; Camacho S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208513; Cecchini M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206703; Chacon V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205931; Chaloupka F. J., 1999, NATL BUREAU EC RES W; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; Chen SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206702; Datta BK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208504; Feigl AB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211940; He YY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200665; Husain MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205120; Hutchinson B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223412; Jamison L, 2017, TLS-TIMES LIT SUPPL, P3; Murray J, 2019, NONCOMMUNICABLE DIS; Nargis N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220223; Remler DK, 2004, AM J PUBLIC HEALTH, V94, P225, DOI 10.2105/AJPH.94.2.225; RTI International, 2017, INV CAS NONC DIS PRE; Shang C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208509; Subramanian S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218256; Verguet S, 2015, LANCET GLOB HEALTH, V3, pE206, DOI 10.1016/S2214-109X(15)70095-1; Yurekli AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221556	24	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228564	10.1371/journal.pone.0228564	http://dx.doi.org/10.1371/journal.pone.0228564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027710	gold, Green Published			2022-12-26	WOS:000534623800049
J	Ripka, WL; Orsso, CE; Haqq, AM; Luz, TG; Prado, CM; Ulbricht, L				Ripka, Wagner Luis; Orsso, Camila E.; Haqq, Andrea M.; Luz, Thais Gretis; Prado, Carla M.; Ulbricht, Leandra			Lean mass reference curves in adolescents using dual-energy x-ray absorptiometry (DXA)	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; BODY-COMPOSITION; BONE-DENSITY; CHILDREN; GROWTH; HEALTH; FAT; VALUES; INDEX; RISK	The body composition phenotype of low lean mass (LM) has been associated with metabolic disorders and impaired physical functioning in the pediatric population. Abnormalities in body composition may be identified using reference curves; however, no reference data on LM is available for Brazilian adolescents. The purpose of this study was to present reference data, including percentile curves, of whole body LM, lean mass index (LMI), appendicular lean mass (ALM), and fat mass for Southern Brazilian adolescents. This was a cross-sectional study of adolescents aged 12-17 years from a southern region in Brazil, who had body composition assessed using dual energy x-ray absorptiometry (DXA). Percentile values and reference curves employing the Lambda, Mu and Sigma method (LMS) were computed for LM, LMI (lean mass/height(2)), ALM and fat mass. Data on 541 adolescents (68.6% boys) was included. Sex differences in growth trajectories were observed for absolute and adjusted LM, with boys presenting greater LM quantity with advancing ages than girls (66.9% and 17.4% difference between the ages of 12 and 17 for boys and girls, respectively). The values corresponding to the lowest percentile (3rd) of LMI ranged between 10.63 to 13.93 kg/m(2) in boys and 11.13 to 12.03 kg/m(2) among girls aged 12-17 years. This study established the first LM, LMI, and ALM reference curves in Southern Brazilian adolescents, which can potentially be used in association with functional measures to identify LM abnormalities during growth.	[Ripka, Wagner Luis; Luz, Thais Gretis; Ulbricht, Leandra] Univ Tecnol Fed Parana, Grad Program Biomed Engn, Curitiba, Parana, Brazil; [Orsso, Camila E.; Haqq, Andrea M.; Prado, Carla M.] Univ Alberta, Li Ka Shing Ctr Hlth & Res, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Haqq, Andrea M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	Pontificia Universidade Catolica do Parana; Universidade Federal do Parana; Universidade Tecnologica Federal do Parana; University of Alberta; University of Alberta	Ripka, WL (corresponding author), Univ Tecnol Fed Parana, Grad Program Biomed Engn, Curitiba, Parana, Brazil.	ripka.w@gmail.com	; RIPKA, WAGNER/J-7503-2015	Gretis, Thais/0000-0002-6309-5962; RIPKA, WAGNER/0000-0002-6191-1188	Programa dePesquisa para o Sistema Unico de Saude: Gestao Compartilhada em Saude PPSUS [982/2013, 41614 - FA]; Universidade Tecnologica Federal do Parana; Alberta Diabetes Institute Graduate Studentship; 2018 Alberta SPOR Graduate Studentship in Patient Oriented Research - Canadian Institutes of Health Research; 2018 Alberta SPOR Graduate Studentship in Patient Oriented Research - Alberta Innovates	Programa dePesquisa para o Sistema Unico de Saude: Gestao Compartilhada em Saude PPSUS; Universidade Tecnologica Federal do Parana; Alberta Diabetes Institute Graduate Studentship; 2018 Alberta SPOR Graduate Studentship in Patient Oriented Research - Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); 2018 Alberta SPOR Graduate Studentship in Patient Oriented Research - Alberta Innovates	WLR and LU thank the Programa dePesquisa para o Sistema Unico de Saude: Gestao Compartilhada em Saude PPSUS - edition 04/2012, Project number: 41614 - FA, agreement 982/2013 with Universidade Tecnologica Federal do Parana. The resources were used to cover the expenses of the adolescents' DXA assessment. CEO is supported by the Alberta Diabetes Institute Graduate Studentship and a recipient of the 2018 Alberta SPOR Graduate Studentship in Patient Oriented Research, which is jointly funded by Alberta Innovates and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AP, 2016, LANCET DIABETES ENDO, V4, P254, DOI 10.1016/S2213-8587(15)00418-0; Aragon AA, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0174-y; Burrows R, 2016, PUBLIC HEALTH NUTR, V19, P486, DOI 10.1017/S1368980015001585; Buyken AE, 2011, AM J HUM BIOL, V23, P216, DOI 10.1002/ajhb.21125; Cole TJ, 2015, CLIN ENDOCRINOL, V82, P862, DOI 10.1111/cen.12682; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Guo B, 2016, J BONE MINER METAB, V34, P703, DOI 10.1007/s00774-015-0725-8; Hussain Z, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004194; Indrayan A, 2014, INDIAN PEDIATR, V51, P37, DOI 10.1007/s13312-014-0310-6; Jeddi M, 2015, INT J ENDOCRINOL MET, V13, DOI 10.5812/ijem.25542v2; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kim K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153383; Kim S, 2015, OBES RES CLIN PRACT, V9, P125, DOI 10.1016/j.orcp.2014.05.002; Liu JT, 2019, J CACHEXIA SARCOPENI, V10, P155, DOI 10.1002/jcsm.12361; Marwaha RK, 2017, INDIAN PEDIATR, V54, P193, DOI 10.1007/s13312-017-1029-y; McCarthy HD, 2014, PEDIATR OBES, V9, P249, DOI 10.1111/j.2047-6310.2013.00168.x; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; Nakavachara P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097218; Neu CM, 2002, AM J PHYSIOL-ENDOC M, V283, pE103, DOI 10.1152/ajpendo.00445.2001; Ooi PH, 2020, JPEN-PARENTER ENTER, V44, P407, DOI 10.1002/jpen.1681; Orsso CE, 2019, CLIN NUTR, V38, P2002, DOI 10.1016/j.clnu.2019.04.012; Peterson CM, 2017, JAMA PEDIATR, V171, P629, DOI 10.1001/jamapediatrics.2017.0460; Shepherd JA, 2012, J BONE MINER RES, V27, P2208, DOI 10.1002/jbmr.1654; Ulbricht L, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5216-0; van der Sluis IM, 2002, ARCH DIS CHILD, V87, P341, DOI 10.1136/adc.87.4.341; Webber CE, 2012, J CACHEXIA SARCOPENI, V3, P25, DOI 10.1007/s13539-011-0042-6; Wells JCK, 2002, INT J OBESITY, V26, P947, DOI 10.1038/sj.ijo.0802027; Wells JCK, 2003, P NUTR SOC, V62, P521, DOI 10.1079/PNS2003261; Wells JCK, 2019, ANN NUTR METAB, V75, P103, DOI 10.1159/000503666; Wells JCK, 2014, ADV NUTR, V5, p320S, DOI 10.3945/an.113.005371; Xu SM, 2016, EXP THER MED, V11, P15, DOI 10.3892/etm.2015.2853	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228646	10.1371/journal.pone.0228646	http://dx.doi.org/10.1371/journal.pone.0228646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027713	Green Published, gold			2022-12-26	WOS:000534623800064
J	Dehdasht, G; Ferwati, MS; Zin, RM; Abidin, NZ				Dehdasht, Gholamreza; Ferwati, M. Salim; Zin, Rosli Mohamad; Abidin, Nazirah Zainul			A hybrid approach using entropy and TOPSIS to select key drivers for a successful and sustainable lean construction implementation	PLOS ONE			English	Article							FUZZY TOPSIS; ORGANIZATIONAL CULTURE; SUPPLIER SELECTION; SHANNON ENTROPY; PERFORMANCE; GREEN; BARRIERS; MANAGEMENT; RANKING; MODEL	Successful implementation of the lean concept as a sustainable approach in the construction industry requires the identification of critical drivers in lean construction. Despite this significance, the number of in-depth studies toward understanding the considerable drivers of lean construction implementation is quite limited. There is also a shortage of methodologies for identifying key drivers. To address these challenges, this paper presents a list of all essential drivers within three aspects of sustainability (social, economic, and environmental) and proposes a novel methodology to rank the drivers and identify the key drivers for successful and sustainable lean construction implementation. In this regard, the entropy weighted Technique for Order of Preference by Similarity to Ideal Solution (TOPSIS) was employed in this research. Subsequently, an empirical study was conducted within the Malaysian construction industry to demonstrate the proposed method. Moreover, sensitivity analysis and comparison with the existing method were engaged to validate the stability and accuracy of the achieved results. The significant results obtained in this study are as follows: presenting, verifying and ranking of 63 important drivers; identifying 22 key drivers; proposing an MCDM model of key drivers. The outcomes show that the proposed method in this study is an effective and accurate tool that could help managers make better decisions.	[Dehdasht, Gholamreza; Zin, Rosli Mohamad] Univ Teknol Malaysia, Fac Engn, Sch Civil Engn, Skudai, Malaysia; [Ferwati, M. Salim] Qatar Univ, Coll Engn, Dept Architecture & Urban Planning, Doha, Qatar; [Abidin, Nazirah Zainul] Univ Sains Malaysia, Sch Housing Bldg & Planning, George Town, Malaysia	Universiti Teknologi Malaysia; Qatar University; Universiti Sains Malaysia	Dehdasht, G (corresponding author), Univ Teknol Malaysia, Fac Engn, Sch Civil Engn, Skudai, Malaysia.	dehdasht1387@gmail.com	Dehdasht, Gholamreza/Q-6638-2018	Ferwati, M Salim/0000-0002-0530-4180				Abd Jamil AH, 2016, PROCEDIA COMPUT SCI, V100, P634, DOI 10.1016/j.procs.2016.09.205; Abdul-Rahman H, 2014, MAJOR CAUSES QUALITY; Abidin NZ, 2010, HABITAT INT, V34, P421, DOI 10.1016/j.habitatint.2009.11.011; Abidin NZ., 2009, WORLD ACAD SCI ENG T, V53, P807; Aguado S, 2013, J CLEAN PROD, V47, P141, DOI 10.1016/j.jclepro.2012.11.048; Ahuja Ritu, 2013, Proceedings of the 2012 International Conference on Sustainable Design and Construction. ICSDEC 2012, P903; Akbar ARN, 2015, PROCD SOC BEHV, V170, P37, DOI 10.1016/j.sbspro.2015.01.013; Alaghbari W, 2007, ENG CONSTR ARCHIT MA, V14, P192, DOI 10.1108/09699980710731308; Alarcon LF, 2002, P INT GROUP LEAN CON; Alarcon LF, 2008, REV ING CONSTR, V23, P26; Alinaitwe HM, 2009, J CONSTR DEV CTRIES, V14, P15; Alinezhad A., 2011, J OPTIMIZATION IND E, V7, P23; Ametepey O, 2015, PROCEDIA MANUF, V3, P1682, DOI 10.1016/j.promfg.2015.07.988; Angelis J, 2011, J MANUF TECHNOL MANA, V22, P569, DOI 10.1108/17410381111134446; [Anonymous], 2012, INT J IND ENG COMP, DOI [DOI 10.5267/j.ijiec.2011.12.001, DOI 10.5267/J.IJIEC.2011.12.001]; Anvari A., 2011, WORLD APPL SCI, V15, P19; Arayici Y, 2011, AUTOMAT CONSTR, V20, P189, DOI 10.1016/j.autcon.2010.09.016; Asri M., 2015, ADV ENVIRON BIOL, V9, P172; Aziz RF, 2013, ALEX ENG J, V52, P679, DOI 10.1016/j.aej.2013.04.008; Ballard G, 2007, 23411 CONSTR IND I; Ballard G., 1999, 7 C INT GROUP LEAN C; Ballard G., 2016, P 11 ANN C INT GROUP; Ballard G., 1998, P 6 C INT GROUP LEAR; Ballard G, 1993, P 1 ANN M INT GROUP; Ballard G., 2008, LEAN CONSTRUCTION J; Ballard WB, 1997, WILDLIFE MONOGR, P5; Bandow N, 2018, ENVIRON SCI EUR, V30, DOI 10.1186/s12302-018-0144-2; Bashir AM, 2010, ARCOM DOCT WORKSH; Beale J., 2007, REV ADMINISTRA O FAC, V6, P11; Beikkhakhian Y, 2015, EXPERT SYST APPL, V42, P6224, DOI 10.1016/j.eswa.2015.02.035; Bergmiller G.G., 2009, P 2009 IND ENG RES C; Bhasin S, 2012, J MANUF SYST, V31, P349, DOI 10.1016/j.jmsy.2012.04.002; Bicheno J, 2000, LEAN TOOLBOX PICSIE; Billesbach T. J., 1994, Production and Inventory Management Journal, V35, P40; Bin Ibrahim AR, 2010, BENCHMARKING, V17, P294, DOI 10.1108/14635771011036357; Black JR, 2008, TOYOTA WAY HEALTHCAR; Bortolotti T, 2015, INT J PROD ECON, V160, P182, DOI 10.1016/j.ijpe.2014.10.013; Cain CT, 2008, PROFITABLE PARTNERIN; Carvalho H, 2017, RESOUR CONSERV RECY, V120, P75, DOI 10.1016/j.resconrec.2016.09.025; Chong HY, 2014, INT J OCCUP SAF ERGO, V20, P503, DOI 10.1080/10803548.2014.11077064; Chou JS, 2015, INT J PROJ MANAG, V33, P1136, DOI 10.1016/j.ijproman.2014.12.003; Coffey M., 2000, P 8 ANN C INT GROUP; da Silva FB, 1999, P IGLC; Darko A, 2017, HABITAT INT, V60, P34, DOI 10.1016/j.habitatint.2016.12.007; Degani C.M., 2002, P IGLC; Dehdasht G, 2018, ADV SCI LETT, V24, P4166, DOI 10.1166/asl.2018.11564; Diekmann J, 2003, P 11 ANN C INT GROUP; dos Santos BM, 2019, J CLEAN PROD, V207, P498, DOI 10.1016/j.jclepro.2018.09.235; Dulaimi MF, 2001, PRINCIPLES APPL LEAN; EMUZE F, 2012, ACTA STRUCTILIA, V19, P1; Eriksson PE, 2010, SUPPLY CHAIN MANAG, V15, P394, DOI 10.1108/13598541011068323; FERDOUSI F, 2009, INT J BUS MANAG, V4, P106, DOI DOI 10.5539/ijbm.v4n9p106; Forbes L, 2002, P 1 CIB W107 INT C C; Forghani A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201604; Friege Henning, 2012, Environmental Sciences Europe, V24, P35, DOI 10.1186/2190-4715-24-35; Fu FF, 2015, J INTELL ROBOT SYST, V79, P401, DOI 10.1007/s10846-014-0106-x; Gandhi NS, 2018, J CLEAN PROD, V171, P675, DOI 10.1016/j.jclepro.2017.10.041; Gao Shang, 2014, Journal of Technology Management in China, V9, P155, DOI 10.1108/JTMC-12-2013-0043; Ghani M.K., 2010, SAFETY MALAYSIAN CON; Ghosh M, 2012, J MANUF TECHNOL MANA, V24, P113, DOI 10.1108/17410381311287517; Green S. D., 2002, J CONSTR RES, V3, P147; Green SD, 2005, BUILD RES INF, V33, P498, DOI 10.1080/09613210500285106; Green SD, 1999, P IGLC; Hall M, 2006, SUSTAIN DEV, V14, P205, DOI 10.1002/sd.265; Hallgren M, 2009, INT J OPER PROD MAN, V29, P976, DOI 10.1108/01443570910993456; Helminen M., 2016, DEV INFORM SHARING P; Hinton P.R., 2014, STAT EXPLAINED; Hook M., 2008, LEAN CONSTRUCTION J, P20; Horvath A, 2004, ANNU REV ENV RESOUR, V29, P181, DOI 10.1146/annurev.energy.29.062403.102215; Hosseini S. A. Abbasian, 2012, ICSDC 2011: Integrating Sustainability Practices in the Construction Industry. Proceedings, P414; Howell G., 1998, P 6 ANN C INT GROUP; Howell G., 1997, LEAN CONSTRUCTION, P111; Howell G.A., 1999, P IGLC; Huovila P., 1998, 6 ANN C INT GROUP LE; Hwang C.-L., 1981, MULTIPLE ATTRIBUTE D, P58; Ikuma LH, 2011, J CONSTR ENG M ASCE, V137, P551, DOI 10.1061/(ASCE)CO.1943-7862.0000330; Ilic M, 2016, HABITAT INT, V56, P191, DOI 10.1016/j.habitatint.2016.06.003; Ismail AR., 2013, J APPL SCI, V13, P286, DOI [10.3923/jas.2013.286.293, DOI 10.3923/jas.2013.286.293]; Issa UH, 2013, ALEX ENG J, V52, P697, DOI 10.1016/j.aej.2013.07.003; Janipha NAI, 2013, PROCD SOC BEHV, V101, P53, DOI 10.1016/j.sbspro.2013.07.178; Jeni A, 2013, IMPLEMENTATION LEAN; Jobin M, 2015, APPL MECH MAT; Johansen E., 2007, LEAN CONSTR J, V3, P19; Johansen E., 2002, P 10 ANN C INT GROUP; Martinez-Jurado PJ, 2014, J CLEAN PROD, V85, P134, DOI 10.1016/j.jclepro.2013.09.042; Kabirifar K, 2019, BUILDINGS-BASEL, V9, DOI 10.3390/buildings9010015; Khodeir L. M., 2016, AIN SHAMS ENG J; Kim YW, 2010, J ARCHIT ENG, V16, DOI 10.1061/(ASCE)AE.1943-5568.0000024; Koranda C, 2012, KSCE J CIV ENG, V16, P699, DOI 10.1007/s12205-012-1460-5; Koskela L., 1992, APPL NEW PRODUCTION; Leino A., 2014, P 22 ANN C INT GROUP; Leong MS, 2008, P 16 ANN C INT GROUP; Li PY, 2013, ENVIRON MONIT ASSESS, V185, P2453, DOI 10.1007/s10661-012-2723-9; Li SQ, 2017, RENEW SUST ENERG REV, V71, P846, DOI 10.1016/j.rser.2016.12.112; Li XX, 2011, PROCEDIA ENGINEER, V26, DOI 10.1016/j.proeng.2011.11.2410; Liang DC, 2018, INFORM SCIENCES, V435, P282, DOI 10.1016/j.ins.2018.01.015; Liker J., 2011, TOYOTA WAY CONTINUOU; Lim YenWui I, 2009, ENHANCING MALAYSIA C; Liu JK, 2017, EURASIA J MATH SCI T, V13, P5905, DOI 10.12973/eurasia.2017.01039a; Marhani MA, 2013, PROCD SOC BEHV, V101, P90, DOI 10.1016/j.sbspro.2013.07.182; Marhani MA, 2012, PROCD SOC BEHV, V68, P87, DOI 10.1016/j.sbspro.2012.12.209; Mavi RK, 2016, PROCD SOC BEHV, V235, P216, DOI 10.1016/j.sbspro.2016.11.017; Memon A.H., 2012, INT J ADV APPL SCI, V1, P45, DOI [DOI 10.11591/IJAAS.V1I1.537, DOI 10.11591/ijaas.v1i1.537]; Mitropoulos P, 2007, P IGLC 15 MICH US; Mohd Reza Esa, 2011, Australian Journal of Basic and Applied Sciences, V5, P1806; Mossman A., 2009, LEAN CONSTRUCTION J; Mydin MAO., 2014, MATEC WEB C; Nahmens I., 2009, LEAN CONSTRUCTION J; Nahmens I, 2011, J ARCHIT ENG, V17, P155, DOI 10.1061/(ASCE)AE.1943-5568.0000037; Nordin N., 2010, INT J INNOVATION MAN, V1, P374; Nowotarski P, 2016, PROCEDIA ENGINEER, V161, P1037, DOI 10.1016/j.proeng.2016.08.845; Ogunbiyi Oyedolapo, 2014, Construction Innovation, V14, P88, DOI 10.1108/CI-08-2012-0045; Ogunbiyi O. E, 2014, IMPLEMENTATION LEAN; Ohemeng-Ababio, 2014, J SUSTAIN DEV, V7, P134, DOI [10.5539/jsd.v7n1p134, DOI 10.5539/JSD.V7N1P134]; Oliver N., 1996, BRIT J MANAGE, P1; Onat NC, 2016, SUSTAIN PROD CONSUMP, V6, P12, DOI 10.1016/j.spc.2015.12.003; Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI 10.1016/s0377-2217(03)00020-1; Panizzolo R, 2012, PROD PLAN CONTROL, V23, P769, DOI 10.1080/09537287.2011.642155; Pavez I, 2006, P 14 ANN C INT GROUP; Petcu A.J., 2011, ROMANIAN EC J, V14, P147; Picchi FA, 2004, P 12 ANN C INT GROUP; Polat G., 2004, P 12 ANN C INT GROUP; Qi GY, 2010, J CLEAN PROD, V18, P1358, DOI 10.1016/j.jclepro.2010.04.017; Ramezaniyan M.R., 2012, MANAG SCI LETT, V2, P1511, DOI [10.5267/j.msl.2012.05.017, DOI 10.5267/J.MSL.2012.05.017]; Renault BY, 2016, PROCEDIA ENGINEER, V164, P402, DOI 10.1016/j.proeng.2016.11.637; Rhodes E, 2009, SUPPLY CHAINS TOTAL; Rojo O, 2002, 10 ANN C INT GROUP L; Sacks R., 2009, ANAL FRAMEWORK INTER; Salem O, 2006, J MANAGE ENG, V22, P168, DOI 10.1061/(ASCE)0742-597X(2006)22:4(168); Salem O., 2005, LEAN CONSTRUCTION J, V2, P1; Salonitis K, 2016, PROC CIRP, V57, P189, DOI 10.1016/j.procir.2016.11.033; Salvatierra-Garrido J, 2011, J FINANC MANAG PROP, V16, P8, DOI 10.1108/13664381111116043; Sangwan KS, 2014, INT J PRODUCT PERFOR, V63, P569, DOI 10.1108/IJPPM-06-2013-0105; Sarhan S., 2013, BUILT HUMAN ENV REV; Serpell A., 1996, ANN C INT GROUP LEAN; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Singh B, 2010, INT J LEAN SIX SIG, V1, P157, DOI 10.1108/20401461011049520; SOHAL AS, 1994, INT J OPER PROD MAN, V14, P35, DOI 10.1108/01443579410068639; Song ML, 2017, COMPUT IND ENG, V112, P99, DOI 10.1016/j.cie.2017.07.023; Sumanth D., 1994, PRODUCTIVITY ENG MAN; Sun LY, 2017, ECOL INDIC, V73, P554, DOI 10.1016/j.ecolind.2016.10.018; Taj S, 2011, J MANUF TECHNOL MANA, V22, P223, DOI 10.1108/17410381111102234; Thomas HR, 2003, J CONSTR ENG M ASCE, V129, P251, DOI 10.1061/(ASCE)0733-9364(2003)129:3(251); Thomassen MA, 2003, P 11 ANN C LEAN CONS; Tian G. D., 2019, IEEE T SYSTEMS MAN C; Tommelein, 2002, DESIGN CONSTRUCTION, P221; Tortorella Guilherme Luz, 2017, TQM Journal, V29, P610, DOI 10.1108/TQM-11-2016-0102; Tzortzopoulos P, 1999, P IGLC; Urban W, 2015, PROCD SOC BEHV, V213, P728, DOI 10.1016/j.sbspro.2015.11.527; Urs R, 2014, INT J INNOV RES SCI, V3, P13349; Vinodh S, 2015, INT J LEAN SIX SIG, V6, P313, DOI 10.1108/IJLSS-12-2014-0041; Walton, 1997, LOGISTICS INFORM MAN, V10, P5, DOI DOI 10.1108/09576059710159655; Wang ED, 2017, ENERGY, V125, P197, DOI 10.1016/j.energy.2017.02.131; Wang L, 2018, APPL SOFT COMPUT, V64, P216, DOI 10.1016/j.asoc.2017.12.014; Wincel J., 2013, PEOPLE PROCESS CULTU; Womack J.P., 1996, LEAN THINKING BANISH, V397; Wong WP, 2014, J CLEAN PROD, V85, P51, DOI 10.1016/j.jclepro.2014.05.093; Wood DA, 2016, J NAT GAS SCI ENG, V28, P594, DOI 10.1016/j.jngse.2015.12.021; Wu P., 2011, J ARCHIT ENG, V18, P176; Yazdani M, 2015, VIKOR TOPSIS MAT DES; Yusuf YY, 2002, INT J PROD RES, V40, P4545, DOI 10.1080/00207540210157141; Zavadskas EK, 2016, INT J INF TECH DECIS, V15, P645, DOI 10.1142/S0219622016300019; Zhang HH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177578; Zhou B, 2016, ANN OPER RES, V241, P457, DOI 10.1007/s10479-012-1177-3	164	31	31	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228746	10.1371/journal.pone.0228746	http://dx.doi.org/10.1371/journal.pone.0228746			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9FN	32023306	Green Published, gold			2022-12-26	WOS:000534621500067
J	Dehghani, S; Bahrami, F				Dehghani, Sedigheh; Bahrami, Fariba			How does the CNS control arm reaching movements? Introducing a hierarchical nonlinear predictive control organization based on the idea of muscle synergies	PLOS ONE			English	Article							INTERNAL-MODELS; PRIMARY MOTOR; ADAPTIVE-CONTROL; REPRESENTATIONS; DISCHARGE; FACTORIZATION; COORDINATION; COMBINATIONS; MECHANISMS; KINEMATICS	In this study, we introduce a hierarchical and modular computational model to explain how the CNS (Central Nervous System) controls arm reaching movement (ARM) in the frontal plane and under different conditions. The proposed hierarchical organization was established at three levels: 1) motor planning, 2) command production, and 3) motor execution. Since in this work we are not discussing motion learning, no learning procedure was considered in the model. Previous models mainly assume that the motor planning level produces the desired trajectories of the joints and feeds it to the next level to be tracked. In the proposed model, the motion control is described based on a regulatory control policy, that is, the output of the motor planning level is a step function defining the initial and final desired position of the hand. For the command production level, a nonlinear predictive model was developed to explain how the time-invariant muscle synergies (MSs) are recruited. We used the same computational model to explain the arm reaching motion for a combined ARM task. The combined ARM is defined as two successive ARM such that it starts from point A and reaches to point C via point B. To develop the model, kinematic and kinetic data from six subjects were recorded and analyzed during ARM task performance. The subjects used a robotic manipulator while moving their hand in the frontal plane. The EMG data of 15 muscles were also recorded. The MSs used in the model were extracted from the recorded EMG data. The proposed model explains two aspects of the motor control system by a novel computational approach: 1) the CNS reduces the dimension of the control space using the notion of MSs and thereby, avoids immense computational loads; 2) at the level of motor planning, the CNS generates the desired position of the hand at the starting, via and the final points, and this amounts to a regulatory and non-tracking structure.	[Dehghani, Sedigheh; Bahrami, Fariba] Univ Tehran, Coll Engn, Sch ECE, CIPCE,Human Motor Control & Computat Neurosci Lab, Tehran, Iran	University of Tehran	Bahrami, F (corresponding author), Univ Tehran, Coll Engn, Sch ECE, CIPCE,Human Motor Control & Computat Neurosci Lab, Tehran, Iran.	fbahrami@ut.ac.ir		Dehghani, S/0000-0003-1337-6050	"Cognitive Sciences and Technologies Council (COGC)" of Iran [816]	"Cognitive Sciences and Technologies Council (COGC)" of Iran	This work is a part of the project #816 which is supported by the "Cognitive Sciences and Technologies Council (COGC)" of Iran. Dr. Fariba Bahrami has received this support as the principal supervisor of the project. COGC had provided us with the necessary opportunities (setup and space) for data collection and gave us full authority for publishing the results of the study and the recorded data.	Alessandro Cristiano, 2012, From Animals to Animats 12. Proceedings of the 12th International Conference on Simulation of Adaptive Behavior, SAB 2012, P33, DOI 10.1007/978-3-642-33093-3_4; Alessandro C, 2014, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00191; Alessandro C, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00043; Alexandrov AV, 2011, BIOL CYBERN, V104, P425, DOI 10.1007/s00422-011-0442-x; Alnajjar FS, 2014, MUSCLE SYNERGY FEATU, P245; Andani ME, 2009, BIOL CYBERN, V101, P361, DOI 10.1007/s00422-009-0342-5; Andani ME, 2009, NEUROCOMPUTING, V72, P2310, DOI 10.1016/j.neucom.2008.12.016; Bagheri P, 2013, IET CONTROL THEORY A, V7, P1806, DOI 10.1049/iet-cta.2012.0934; Berger DJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00046; Berniker M., 2005, LINEARITY MOTOR PRIM; Bernshtein NA, 1967, COORDINATION REGULAT, P50; Biess A, 2007, J NEUROSCI, V27, P13045, DOI 10.1523/JNEUROSCI.4334-06.2007; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Borzelli D, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00186; Byadarhaly KV, 2012, NEURAL NETWORKS, V32, P96, DOI 10.1016/j.neunet.2012.02.003; Camacho EF, 2005, MODEL PREDICTIVE CON, P249; Chhabra M, 2006, NEURAL COMPUT, V18, P2320, DOI 10.1162/neco.2006.18.10.2320; Chiovetto E, 2010, NEUROSCIENCE, V170, P1223, DOI 10.1016/j.neuroscience.2010.07.006; Chiovetto E., 2016, ARXIV160306879; Chiovetto E, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00011; Cisek P., 2005, COGN PROCESS, V6, P15, DOI DOI 10.1007/S10339-004-0046-7; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; D'Avella A, 2013, FRONT COMPUT NEUROSC, V7, P1, DOI DOI 10.3389/FNC0M.2013.00042/ABSTRACT; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Darainy M, 2004, J NEUROPHYSIOL, V92, P3344, DOI 10.1152/jn.00596.2004; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; de Rugy A, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00019; Dehghani S, 2010, 2010 17 IR C BIOM EN; Delis I, 2018, SCINTIFIC REPORTS, V8, P1; Delis I, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00399; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Ehrenfeld S, 2013, COMPUTATIONAL ROBOTI, P1; Eskandari AH, 2016, J BIOMECH, V49, P967, DOI 10.1016/j.jbiomech.2015.12.024; FLAMENT D, 1988, J NEUROPHYSIOL, V60, P1268, DOI 10.1152/jn.1988.60.4.1268; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FU QG, 1995, J NEUROPHYSIOL, V73, P836, DOI 10.1152/jn.1995.73.2.836; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gonzalez-Vargas J, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00114; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Heath AC, 2002, TWIN RES, V5, P30, DOI 10.1375/1369052022875; Hirashima M, 2016, NEUROSCI RES, V104, P80, DOI 10.1016/j.neures.2015.12.008; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Hogan N, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00071; Iglesias E. J., 2006, ING DESARRO, V19, P88; Imamizu H, 2009, PSYCHOL RES-PSYCH FO, V73, P527, DOI 10.1007/s00426-009-0235-1; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Kadiallah A, 2011, J NEUROPHYSIOL, V106, P2737, DOI 10.1152/jn.00079.2011; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kawato M, 1987, BIOL CYBERN, V68, P95; Land WM, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00127; Latash ML, 2016, NEUROSCI BIOBEHAV R, V69, P136, DOI 10.1016/j.neubiorev.2016.08.005; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LU P, 1994, J GUID CONTROL DYNAM, V17, P553, DOI 10.2514/3.21233; Manohar SG, 2015, CURR BIOL, V25, P1707, DOI 10.1016/j.cub.2015.05.038; Mehrabi N, 2017, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00143; Miyamoto H., 2004, Systems and Computers in Japan, V35, P48, DOI 10.1002/scj.10377; Momtahan M, 2015, 2015 22ND IRANIAN CONFERENCE ON BIOMEDICAL ENGINEERING (ICBME), P227, DOI 10.1109/ICBME.2015.7404147; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Nakano E, 1999, J NEUROPHYSIOL, V81, P2140, DOI 10.1152/jn.1999.81.5.2140; Nishii J, 2009, NEURAL COMPUT, V21, P2634, DOI 10.1162/neco.2009.06-08-798; Pandy MG, 2001, ANNU REV BIOMED ENG, V3, P245, DOI 10.1146/annurev.bioeng.3.1.245; Popescu FC, 2000, J NEUROPHYSIOL, V84, P2670, DOI 10.1152/jn.2000.84.5.2670; Razavian RS, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00121; Rechy-Ramirez E. J., 2011, STAGES DEV CONTROL S; Reppert TR, 2015, J NEUROSCI, V35, P15369, DOI 10.1523/JNEUROSCI.2621-15.2015; Roh J, 2012, J NEUROPHYSIOL, V107, P2123, DOI 10.1152/jn.00173.2011; Sadeghi M, 2013, EXP BRAIN RES, V229, P221, DOI 10.1007/s00221-013-3606-1; Sarlegna FR, 2009, ADV EXP MED BIOL, V629, P317, DOI 10.1007/978-0-387-77064-2_16; Sartori M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00079; Shadmehr R, 2005, FRON NEUROS, P297; Sharif Shourijeh M, 2014, J COMPUT NONLIN DYNA, V9; Shridhar R, 1997, IND ENG CHEM RES, V36, P729, DOI 10.1021/ie9604280; Teka WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179288; Ting L.H., 2011, MOTOR CONTROL, P102; Ting LH, 2007, PROG BRAIN RES, V165, P299, DOI 10.1016/S0079-6123(06)65019-X; Ting LH, 2015, NEURON, V86, P38, DOI 10.1016/j.neuron.2015.02.042; Ting LH, 2005, J NEUROPHYSIOL, V93, P609, DOI 10.1152/jn.00681.2004; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Towhidkhah F., 1996, MODEL PREDICTIVE IMP; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; Ueyama Y, 2017, J COMPUT NEUROSCI, V43, P93, DOI 10.1007/s10827-017-0650-z; Ueyama Y, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00119; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Waegeman T, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00099; Wise S, 2002, ENCY HUMAN BRAIN, P137, DOI DOI 10.1016/B0-12-227210-2/00216-8; Wojsznis W, 2003, ISA T, V42, P149, DOI 10.1016/S0019-0578(07)60121-9; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Yan X, 2009, LINEAR REGRESSION AN, P108; Zelik KE, 2014, J NEUROPHYSIOL, V111, P1686, DOI 10.1152/jn.00776.2013	94	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228726	10.1371/journal.pone.0228726	http://dx.doi.org/10.1371/journal.pone.0228726			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023300	gold, Green Published			2022-12-26	WOS:000534621500065
J	Lovegrove, A; Wingen, LU; Plummer, A; Wood, A; Passmore, D; Kosik, O; Freeman, J; Mitchell, RAC; Hassell, K; Ulker, M; Tremmel-Bede, K; Rakszegi, M; Bedo, Z; Perretant, MR; Charmet, G; Pont, C; Salse, J; Waite, ML; Ortord, S; Burridge, A; Penny, TK; Shewry, PR; Griffiths, S				Lovegrove, Alison; Wingen, Luzie U.; Plummer, Amy; Wood, Abigail; Passmore, Diana; Kosik, Ondrej; Freeman, Jackie; Mitchell, Rowan A. C.; Hassell, Kirsty; Ulker, Mehmet; Tremmel-Bede, Karolina; Rakszegi, Marianna; Bedo, Zoltan; Perretant, Marie-Reine; Charmet, Gilles; Pont, Caroline; Salse, Jerome; Waite, Michelle Leverington; Ortord, Simon; Burridge, Amanda; Penny, Till K.; Shewry, Peter R.; Griffiths, Simon			Identification of a major QTL and associated molecular marker for high arabinoxylan fibre in white wheat flour	PLOS ONE			English	Article							DIETARY FIBER; ENDOSPERM; VARIABILITY; SUPPRESSION; COMPONENTS; GENES	Dietary fibre (DF) has multiple health benefits and wheat grains are major sources of DF for human health. However, DF is depleted in white wheat flour which is more widely consumed than wholegrain. The major DF component in white flour is the cell wall polysaccharide arabinoxylan (AX). We have identified the Chinese wheat cultivar Yumai 34 as having unusually high contents of AX in both water-soluble and insoluble forms. We have therefore used populations generated from crosses between Yumai 34 and four other wheat cultivars, three with average contents of AX (Ukrainka, Altigo and Claire) and one also having unusually high AX (Valoris), in order to map QTLs for soluble AX (determined as relative viscosity of aqueous extracts of wholemeal flours) and total AX (determined by enzyme fingerprinting of white flour). A number of QTL were mapped, but most were only detected in one or two crosses. However, all four crosses showed strong QTLs for high RV/total AX on chromosome 1B, with Yumai 34 being the increasing parent, and a KASP marker for the Yumai 34 high AX allele was validated by analysis of high AX lines derived from Yumai 34 but selected by biochemical analysis. A QTL for RV was also mapped on chromosome 6B in Yumai 34 x Valoris, with Valoris being the increasing allele, which is consistent with the observation of transgressive segregation for this population. Association studies in an independent germplasm panel identified marker trait associations for relative viscosity in these same locations while direct selection for fibre content in breeding resulted in high levels of enrichment for the Yumai 34 1B allele. The data therefore indicate that marker-assisted breeding can be used to develop wheat with high AX fibre in white flour.	[Lovegrove, Alison; Plummer, Amy; Wood, Abigail; Passmore, Diana; Kosik, Ondrej; Freeman, Jackie; Mitchell, Rowan A. C.; Hassell, Kirsty; Penny, Till K.; Shewry, Peter R.] Rothamsted Res, West Common, Herts, England; [Wingen, Luzie U.; Waite, Michelle Leverington; Ortord, Simon; Griffiths, Simon] John Innes Ctr, Norwich Res Pk,Colney Lane, Norwich, Norfolk, England; [Ulker, Mehmet] Yuzuncu Yil Univ, Fac Agr, Van, Turkey; [Tremmel-Bede, Karolina; Rakszegi, Marianna; Bedo, Zoltan] Agrartud Kutatokozpont, Ctr Agr Res, Martonvasar, Hungary; [Perretant, Marie-Reine; Charmet, Gilles; Pont, Caroline; Salse, Jerome] INRAE UMR GDEC, 5 Chemin Beaulieu, Clermont Ferrand, France; [Burridge, Amanda] Univ Bristol, Life Sci, Bristol, Avon, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Yuzuncu Yil University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; INRAE; University of Bristol	Shewry, PR (corresponding author), Rothamsted Res, West Common, Herts, England.	peter.shewry@rothamsted.ac.uk	Wingen, Luzie/AAF-3703-2019; Kosik, Ondrej/AAR-1206-2021; Hassall, Kirsty/AAD-3222-2019; Rakszegi, Marianna/B-2904-2013; Freeman, Jacqueline/A-4310-2015	Wingen, Luzie/0000-0002-4682-4764; Kosik, Ondrej/0000-0003-3117-0224; Hassall, Kirsty/0000-0003-0033-1136; Burridge, Amanda/0000-0002-0140-5523; Rakszegi, Marianna/0000-0003-0798-8974; Mitchell, Rowan Andrew Craig/0000-0002-1412-8828; Freeman, Jacqueline/0000-0002-2842-8055	Biotechnology and Biological Sciences Research Council (BBSRC) of the UK [BB/P016855/1]; Innovate UK grant [L005654/1]; National Research, Development and Innovation Office (NKFIH) of Hungary [K112169]; BBSRC [BB/K007599/1, BB/T014237/1, BBS/E/C/000I0250, BBS/E/C/000I0280, BBS/E/J/000PR9781, BB/L024543/1, BB/F014996/1, BBS/E/J/000C0617, BBS/E/J/000CA393, BB/L025108/1, BB/L027127/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC) of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovate UK grant(UK Research & Innovation (UKRI)Innovate UK); National Research, Development and Innovation Office (NKFIH) of Hungary; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AL, LW, AP, AW, DM, JF, RACM, MLW, SO, TP PRS and SG received grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the UK, with the work reported forming part of the Designing Future Wheat Institute Strategic Programme [BB/P016855/1], with additional support from Innovate UK grant, L005654/1 "High fibre wheat for healthier white bread". MR received support from the National Research, Development and Innovation Office (NKFIH) of Hungary (project No K112169) "Improvement of bioactive composition and its effects".	Andersson AAM, 2013, FOOD CHEM, V136, P1243, DOI 10.1016/j.foodchem.2012.09.074; [Anonymous], 2019, R LANG ENV STAT COMP; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Bates B, 2014, RESULTS YEARS 1 4 CO; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Charmet G, 2009, EUPHYTICA, V170, P155, DOI 10.1007/s10681-009-0019-0; DOUGLAS SG, 1981, FOOD CHEM, V7, P139, DOI 10.1016/0308-8146(81)90059-5; ENGLYST HN, 1994, ANALYST, V119, P1497, DOI 10.1039/an9941901497; Finnie SM, 2006, CEREAL CHEM, V83, P617, DOI 10.1094/CC-83-0617; Freeman J, 2016, PLANT BIOTECHNOL J, V14, P109, DOI 10.1111/pbi.12361; Gebruers K., 2009, ANAL BIOACTIVE COMPO, P177; Gebruers K, 2008, J AGR FOOD CHEM, V56, P9740, DOI 10.1021/jf800975w; Hajishafiee M, 2016, BRIT J NUTR, V116, P343, DOI 10.1017/S0007114516001938; Laperche A, 2007, THEOR APPL GENET, V115, P399, DOI 10.1007/s00122-007-0575-4; Lovegrove A, 2013, PLANT PHYSIOL, V163, P95, DOI 10.1104/pp.113.222653; Marcotuli I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132787; MARES DJ, 1973, AUST J BIOL SCI, V26, P793, DOI 10.1071/BI9730793; Martinant JP, 1999, J CEREAL SCI, V30, P45, DOI 10.1006/jcrs.1998.0259; Mattei J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0109-9; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Ordaz-Ortiz JJ, 2005, J CEREAL SCI, V42, P119, DOI 10.1016/j.jcs.2005.02.004; Perretant MR, 2000, THEOR APPL GENET, V100, P1167, DOI 10.1007/s001220051420; Pont C, 2019, NAT GENET, V51, P905, DOI 10.1038/s41588-019-0393-z; Quraishi U-M, 2010, FUNCTIONAL INTEGRATE; Quraishi UM, 2009, FUNCT INTEGR GENOMIC, V9, P473, DOI 10.1007/s10142-009-0129-8; Ramirez-Gonzalez RH, 2015, BIOINFORMATICS, V31, P2038, DOI 10.1093/bioinformatics/btv069; Reynolds A, 2019, LANCET, DOI [10.1016/S0140-6736(18)31808-9, DOI 10.1016/S0140-6736(18)31808-9]; SAULNIER L, 1995, J CEREAL SCI, V22, P259, DOI 10.1006/jcrs.1995.0062; Shewry PR, FIBRE RICH WHOLEGRAI; Steer T., 2008, P NUTR SOC, V67, pE363, DOI DOI 10.1017/S0029665108000372; Tremmel-Bede K, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2066-2; Nguyen VL, 2011, CROP SCI, V51, P1143, DOI 10.2135/cropsci2010.08.0484; Wingen LU, 2017, GENETICS, V205, P1657, DOI 10.1534/genetics.116.194688; Yang L, 2016, EUPHYTICA, V208, P205, DOI 10.1007/s10681-015-1576-z	34	6	6	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227826	10.1371/journal.pone.0227826	http://dx.doi.org/10.1371/journal.pone.0227826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023285	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000534621500024
J	Enes, J; Haburcak, M; Sona, S; Gerard, N; Mitchell, AC; Fu, WQ; Birren, SJ				Enes, Joana; Haburcak, Marian; Sona, Surbhi; Gerard, Nega; Mitchell, Alexander C.; Fu, Wenqi; Birren, Susan J.			Satellite glial cells modulate cholinergic transmission between sympathetic neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SYNAPTIC-TRANSMISSION; NEUROTROPHIC FACTOR; ASTROCYTES; EXPRESSION; GANGLIA; SURVIVAL; BDNF; TRKA; NGF	Postganglionic sympathetic neurons and satellite glial cells are the two major cell types of the peripheral sympathetic ganglia. Sympathetic neurons project to and provide neural control of peripheral organs and have been implicated in human disorders ranging from cardiovascular disease to peripheral neuropathies. Here we show that satellite glia regulate synaptic activity of cultured postnatal sympathetic neurons, providing evidence for local ganglionic control of sympathetic drive. In addition to modulating neuron-to-neuron cholinergic neurotransmission, satellite glia promote synapse formation and contribute to neuronal survival. Examination of the cellular architecture of the rat sympathetic ganglia in vivo shows this regulation of neuronal properties takes place during a developmental period in which neuronal morphology and density are actively changing and satellite glia enwrap sympathetic neuronal somata. Cultured satellite glia make and release factors that promote neuronal activity and that can partially rescue the neurons from cell death following nerve growth factor deprivation. Thus, satellite glia play an early and ongoing role within the postnatal sympathetic ganglia, expanding our understanding of the contributions of local and target-derived factors in the regulation of sympathetic neuron function.	[Enes, Joana; Haburcak, Marian; Sona, Surbhi; Gerard, Nega; Mitchell, Alexander C.; Fu, Wenqi; Birren, Susan J.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Enes, Joana; Haburcak, Marian; Sona, Surbhi; Gerard, Nega; Mitchell, Alexander C.; Fu, Wenqi; Birren, Susan J.] Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02453 USA	Brandeis University; Brandeis University	Birren, SJ (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.; Birren, SJ (corresponding author), Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02453 USA.	birren@brandeis.edu	Sona, Surbhi/DYH-6783-2022	Sona, Surbhi/0000-0002-6644-8970; Birren, Susan/0000-0003-0488-0765; Fu, Wenqi/0000-0002-6407-7168	National Institute of Neurological Disorders and Stroke [R01 NS066977, R01 NS-057305, P30 NS-045713]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	SJB received support by National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.gov), Grants R01 NS066977 and R01 NS-057305 and P30 NS-045713 for Core Facilities for Neurobiology at Brandeis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2013, J PHYSIOL-LONDON, V591, P5599, DOI 10.1113/jphysiol.2013.261289; Allen NJ, 2013, CURR OPIN NEUROBIOL, V23, P1027, DOI 10.1016/j.conb.2013.06.004; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Arias ER, 2014, NEUROPHARMACOLOGY, V81, P206, DOI 10.1016/j.neuropharm.2014.02.001; Baldwin KT, 2017, CURR OPIN NEUROBIOL, V45, P113, DOI 10.1016/j.conb.2017.05.006; BARISH ME, 1995, PERSPECT DEV NEUROBI, V2, P357; Barman SM, 2017, FRONTIERS NEUROSCIEN, V11, P1; Buard I, 2010, GLIA, V58, P538, DOI 10.1002/glia.20943; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Campanucci V, 2010, NEURON, V66, P827, DOI 10.1016/j.neuron.2010.06.010; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Corty Megan M, 2013, J Cell Biol, V203, P395, DOI 10.1083/jcb.201306099; Davis BM, 1996, BRAIN RES, V724, P47, DOI 10.1016/0006-8993(96)00265-X; Delvalle NM, 2018, AM J PHYSIOL-GASTR L, V315, pG473, DOI 10.1152/ajpgi.00155.2018; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Elmariah SB, 2004, NEURON GLIA BIOL, V1, P339, DOI 10.1017/S1740925X05000189; Fagan AM, 1996, J NEUROSCI, V16, P6208; Feldman-Goriachnik R, 2018, NEUROSCI LETT, V671, P19, DOI 10.1016/j.neulet.2018.01.051; Freeman MR, 2013, NEURON, V80, P613, DOI 10.1016/j.neuron.2013.10.034; Garden GA, 2012, NEURON, V73, P886, DOI 10.1016/j.neuron.2012.02.017; Gingras J, 2002, J CELL BIOL, V158, P1109, DOI 10.1083/jcb.200203012; Gingras J, 2001, J NEUROBIOL, V48, P228, DOI 10.1002/neu.1053; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hanani M, 2010, BRAIN RES REV, V64, P304, DOI 10.1016/j.brainresrev.2010.04.009; Harrington AW, 2013, NAT REV NEUROSCI, V14, P177, DOI 10.1038/nrn3253; Hawrot E, 1979, Methods Enzymol, V58, P574; Huang TY, 2006, NEUROSCIENCE, V137, P1185, DOI 10.1016/j.neuroscience.2005.10.020; Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004; Jha MK, 2018, PROG NEUROBIOL, V162, P37, DOI 10.1016/j.pneurobio.2017.12.003; Jones EV, 2014, NEURAL PLAST, V2014, P1; Kaye D, 2005, CARDIOVASC RES, V66, P256, DOI 10.1016/j.cardiores.2005.02.012; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Lockhart ST, 2000, J NEUROBIOL, V42, P460, DOI 10.1002/(SICI)1097-4695(200003)42:4<460::AID-NEU7>3.3.CO;2-R; Luther JA, 2013, J NEUROPHYSIOL, V109, P485, DOI 10.1152/jn.00076.2011; MCFARLANE S, 1993, J NEUROSCI, V13, P2591, DOI 10.1523/JNEUROSCI.13-06-02591.1993; McGann JC, 2012, CURR OPIN NEUROBIOL, V22, P850, DOI 10.1016/j.conb.2012.03.009; MCMAHON SB, 1995, NAT MED, V1, P774, DOI 10.1038/nm0895-774; OLAGUE PH, 1978, DEV BIOL, V67, P404, DOI 10.1016/0012-1606(78)90209-9; OLAGUE PH, 1974, P NATL ACAD SCI USA, V71, P3602, DOI 10.1073/pnas.71.9.3602; Pabst M, 2016, NEURON, V90, P853, DOI 10.1016/j.neuron.2016.04.003; Pannasch U, 2014, NAT NEUROSCI, V17, P549, DOI 10.1038/nn.3662; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; Papouin T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0154; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Perez-Gonzalez AP, 2008, J PHYSIOL-LONDON, V586, P4675, DOI 10.1113/jphysiol.2008.160044; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; RAIVICH G, 1991, NEURON, V7, P151, DOI 10.1016/0896-6273(91)90083-C; Retamal MA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00158; Rosa JM, 2015, ELIFE, V4, DOI 10.7554/eLife.09590; RUDGE JS, 1992, EUR J NEUROSCI, V4, P459, DOI 10.1111/j.1460-9568.1992.tb00896.x; RUIT KG, 1990, J NEUROSCI, V10, P2412; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Sharma N, 2010, NEURON, V67, P422, DOI 10.1016/j.neuron.2010.07.018; Slonimsky JD, 2003, MOL CELL NEUROSCI, V23, P648, DOI 10.1016/S1044-7431(03)00102-7; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Thippeswamy T, 2005, GLIA, V49, P197, DOI 10.1002/glia.20105; TROPEA M, 1988, GLIA, V1, P380, DOI 10.1002/glia.440010605; Turko P, 2019, CEREB CORTEX, V29, P1230, DOI 10.1093/cercor/bhy029; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Um JW, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00381; Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; Xie AX, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90565; Zhou XF, 1999, EUR J NEUROSCI, V11, P1711, DOI 10.1046/j.1460-9568.1999.00589.x	72	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0218643	10.1371/journal.pone.0218643	http://dx.doi.org/10.1371/journal.pone.0218643			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017764	Green Submitted, Green Published, gold			2022-12-26	WOS:000534618100003
J	Mija, R; Zubak, I; Schuetz, A; Glas, M; Fung, C; Jakob, SM; Beck, J; Z'Graggen, WJ; Bloch, A				Mija, R.; Zubak, I; Schuetz, A.; Glas, M.; Fung, C.; Jakob, S. M.; Beck, J.; Z'Graggen, W. J.; Bloch, Andreas			Correlation of optic nerve and optic nerve sheath diameter with intracranial pressure in pigs	PLOS ONE			English	Article							NEUROLOGICAL EMERGENCY; SONOGRAPHIC ASSESSMENT; HYPERTENSION; ULTRASOUND; MODEL; NEUROSONOGRAPHY; RELIABILITY; DIAGNOSTICS	Objective Several studies have shown an association between intracranial pressure and the diameter of the optic nerve sheath measured by transbulbar ultrasonography. To understand the pathophysiology of this phenomenon, we aimed to measure the changes of the optic nerve, optic nerve sheath and perineural space separately with increasing intracranial pressure in a porcine model. Methods An external ventricular drain was placed into the third ventricle through a right paramedian burrhole in eight anesthesized pigs. The diameters of the optic nerve and the optic nerve sheath were measured while the intracranial pressure (ICP) was increased in steps of 10mmHg from baseline up to 60 mmHg. Results The median diameters of the optic nerve (ON) increased from 0.36 cm (baseline-95% confidence interval (CI) 0.33 cm to 0.45 cm) to 0.68 cm (95% CI 0.57 cm to 0.82 cm) at ICP of 60 mmHg (p<0.0001) and optic nerve sheath (ONS) from 0.88 cm (95% CI 0.79 cm to 0.98 cm) to 1.24 cm (95% CI 1.02 cm to 1.38 cm) (p<0.002) while the median diameter of the perineural space (PNS) (baseline diameter 95% CI 0.40 cm to 0.59 cm to diameters at ICP 60 95% CI 0.38 cm to 0.62 cm) did not change significantly (p = 0.399). Multiple comparisons allowed differentiation between baseline and values >= 40 mmHg for ON (p = 0.017) and between baseline and values >= 50mmHg for ONS (p = 0.006). A linear correlation between ON (R-2 = 0.513, p<0.0001) and ONS (R-2 = 0.364, p<0.0001) with ICP was found. The median coefficient of variation for intra- and inter-investigator variability was 8% respectively 2.3%. Conclusion Unexpectedly, the increase in ONS diameter with increasing ICP is exclusively related to the increase of the diameter of the ON. Further studies should explore the reasons for this behaviour.	[Mija, R.; Zubak, I; Schuetz, A.; Fung, C.; Beck, J.; Z'Graggen, W. J.] Univ Bern, Bern Univ Hosp, Dept Neurosurg, Inselspital, Bern, Switzerland; [Glas, M.; Jakob, S. M.; Bloch, Andreas] Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Bloch, A (corresponding author), Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland.	andreas.bloch@insel.ch		Z'Graggen, Werner/0000-0002-5684-4419; Zubak, Irena/0000-0001-8474-6421	foundation for research in anesthesia and intensive care medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland [24/2016]	foundation for research in anesthesia and intensive care medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland	AB received a restricted grant from the foundation for research in anesthesia and intensive care medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland. Grant number: 24/2016. URL: https://stiftungschweiz.ch/organisation/stiftung-fuer-die-forschung-inanaesthesiologie-und-intensivmedizin The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anile C, 2012, NEUROL RES, V34, P859, DOI 10.1179/1743132812Y.0000000083; Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Balaratnasingam C, 2014, EXP EYE RES, V121, P11, DOI 10.1016/j.exer.2014.02.008; Bloch A, 2018, SHOCK, V50, P684, DOI 10.1097/SHK.0000000000001085; Bloch A, 2018, INJURY, V49, P532, DOI 10.1016/j.injury.2017.11.036; Bloch A, 2017, SHOCK, V48, P185, DOI 10.1097/SHK.0000000000000824; Merlicco AC, 2018, ACTA NEUROL SCAND, V138, P388, DOI 10.1111/ane.12976; Chen Q, 2017, ACTA OPHTHALMOL, V95, pE481, DOI 10.1111/aos.13473; Dubourg J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-62; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Fernando SM, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4225; Fichtner J, 2016, J NEUROL NEUROSUR PS, V87, P650, DOI 10.1136/jnnp-2015-310853; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Hall SRR, 2004, CAN J ANAESTH, V51, P1025, DOI 10.1007/BF03018493; Hamilton DR, 2011, J ULTRAS MED, V30, P651, DOI 10.7863/jum.2011.30.5.651; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Harrer JU, 2012, ULTRASCHALL MED, V33, P320, DOI 10.1055/s-0031-1299498; Harrer JU, 2012, ULTRASCHALL MED, V33, P218, DOI 10.1055/s-0031-1299455; Janda M, 2012, LAB ANIM-UK, V46, P258, DOI 10.1258/la.2011.011149; Jeub M, 2019, J CLIN NEUROSCIENCE; Kaiser GM, 2007, LAB ANIM-UK, V41, P80, DOI 10.1258/002367707779399509; Lochner P, 2016, J ULTRASOUND, V19, P41, DOI 10.1007/s40477-014-0144-z; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Nusbaum DM, 2015, EXP EYE RES, V136, P38, DOI 10.1016/j.exer.2015.04.014; Nusbaum DM, 2014, AVIAT SPACE ENVIR MD, V85, P50, DOI 10.3357/ASEM.3664.2014; Nusbaum DM, 2013, AVIAT SPACE ENVIR MD, V84, P946, DOI 10.3357/ASEM.3486.2013; Qayyum H, 2013, EUR J EMERG MED, V20, P91, DOI 10.1097/MEJ.0b013e32835105c8; Robba C, 2015, NEUROCRIT CARE, V23, P419, DOI 10.1007/s12028-015-0163-4; Topcuoglu MA, 2015, J NEUROIMAGING, V25, P906, DOI 10.1111/jon.12233; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711	31	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228242	10.1371/journal.pone.0228242	http://dx.doi.org/10.1371/journal.pone.0228242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017786	Green Published, gold			2022-12-26	WOS:000534618100016
J	Moles, L; Gomez, M; Moroder, E; Bustos, G; Melgar, A; del Campo, R; Rodriguez, JM				Moles, Laura; Gomez, Marta; Moroder, Elena; Bustos, Gerardo; Melgar, Ana; del Campo, Rosa; Rodriguez, Juan M.			Staphylococcus epidermidis in feedings and feces of preterm neonates	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; BREAST-MILK; BACTERIAL DIVERSITY; INFANTS; RESISTANCE; MICROBIOTA; MECONIUM; HEALTHY; COLONIZATION; PREVALENCE	Staphylococcus epidermidis has emerged as the leading agent causing neonatal late-onset sepsis in preterm neonates; although the severity of the episodes caused by this species is often underestimated, it might exert relevant short- and long-term detrimental effects on neonatal outcomes. In this context, the objective of this study was to characterize a collection of S. epidermidis strains obtained from meconium and feces of preterm infants, and to assess the potential role of the enteral feeding tubes as potential reservoirs for this microorganism. A total of 26 preterm infants were enrolled in the study. Meconium and fecal samples were collected weekly during their first month of life (n = 92). Feeding samples were collected after their pass through the enteral feeding tubes (n = 84). S. epidermidis was present in the fecal samples of all the infants in, at least, one sampling time at concentrations ranging from 6.5 to 7.8 log(10) CFU/g. Initially, 344 isolates were obtained and pulsed-field gel electrophoresis (PFGE) profiling allowed the reduction of the collection to 101 strains. Among them, multilocus sequence typing (MLST) profiling showed the presence of 32 different sequence types (ST). Globally, most of the STs to hospital-adapted high-risk clones and belonged to clonal complexes (CC) associated to the hospital environment, such as CC2. The virulence gene most commonly detected among the strains was altE. High resistance rates to macrolides and aminoglycosides were detected and 64% of the strains harboured the mecA gene, which was codified in SCCmec types. Our results indicates the existence of a complex and genetically diverse S. epidermidis population in the NICU environment. A better knowledge of S. epidermidis strains may help to devise strategies to avoid their conversion from symbiont to pathobiont microorganisms in the NICUs.	[Moles, Laura; Gomez, Marta; Moroder, Elena; Rodriguez, Juan M.] Univ Complutense Madrid, Dept Nutr & Food Sci, Madrid, Spain; [Gomez, Marta] Hosp Francesc de Borja, Pediat Sevirce, Valencia, Spain; [Bustos, Gerardo; Melgar, Ana] Univ Hosp 12 Octubre, Neonatol Serv, Madrid, Spain; [Bustos, Gerardo; Melgar, Ana] Carlos III Inst, Red Salud Materno Infantil & Desarrollo SAMID, Madrid, Spain; [Bustos, Gerardo] Univ Complutense Madrid, Dept Publ Hlth Mother & Child, Madrid, Spain; [del Campo, Rosa] Univ Hosp Ramon & Cajal, Ramon & Cajal Hlth Res Inst, Microbiol & Parasitol Serv, Madrid, Spain	Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Hospital Universitario Ramon y Cajal	Moles, L (corresponding author), Univ Complutense Madrid, Dept Nutr & Food Sci, Madrid, Spain.	lawita21@hotmail.com	Alegre, Laura Moles/AAX-5445-2020; Rodriguez, Juan Miguel/ABB-6650-2020; BUSTOS, GERARDO/T-9946-2018; del Campo, Rosa/M-9628-2013	Alegre, Laura Moles/0000-0001-6902-2097; Rodriguez, Juan Miguel/0000-0002-1285-9686; BUSTOS, GERARDO/0000-0002-0074-5016; Gomez, Marta/0000-0003-0475-075X; del Campo, Rosa/0000-0003-1147-7923	Ministerio de Economia y Competitividad, Spain [AGL2013-41980-P, AGL2016-75476-R]	Ministerio de Economia y Competitividad, Spain	This work has been funded by grants AGL2013-41980-P and AGL2016-75476-R from the Ministerio de Economia y Competitividad, Spain.	Adams-Chapman I, 2002, CURR OPIN PEDIATR, V14, P157, DOI 10.1097/00008480-200204000-00003; Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Altuntas EG, 2015, LWT-FOOD SCI TECHNOL, V60, P36, DOI 10.1016/j.lwt.2014.07.012; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; BALMER SE, 1989, ARCH DIS CHILD, V64, P1672, DOI 10.1136/adc.64.12.1672; Begovic J, 2013, MICROBIOL RES, V168, P77, DOI 10.1016/j.micres.2012.09.004; Borderon JC, 1996, PATHOL BIOL, V44, P416; Cabrera-Contreras Roberto, 2013, ISRN Microbiol, V2013, P918921, DOI 10.1155/2013/918921; Cabrera-rubio R, 2012, HUMAN MILK MICROBIOM, V1-4, P544; Cacho NT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01470; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; CLSI. Clinical and Laboratory Standards Institute, 2011, PERF STAND ANT SUS S; Conlan S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r64; Damaceno QS, 2017, PROBIOTICS ANTIMICRO, V9, P371, DOI 10.1007/s12602-017-9270-1; Delgado S, 2009, STAPHYLOCOCCUS EPIDE, V11, P1; Dong Y, 2018, VIRULENCE, V9, P621, DOI 10.1080/21505594.2017.1419117; Dong Y, 2014, INT J MED MICROBIOL, V304, P513, DOI 10.1016/j.ijmm.2014.04.013; Du X, 2013, PLOS ONE, V8; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Gomez M, 2016, J PEDIATR GASTR NUTR, V62, P893, DOI 10.1097/MPG.0000000000001104; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hammoud MS, 2012, J PAEDIATR CHILD H, V48, P604, DOI 10.1111/j.1440-1754.2012.02432.x; Heida FH, 2016, CLIN INFECT DIS, V62, P863, DOI 10.1093/cid/ciw016; Heikkila MP, 2003, J APPL MICROBIOL, V95, P471, DOI 10.1046/j.1365-2672.2003.02002.x; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Hurrell E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-146; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Jimenez E, 2008, STAPHYLOCOCCUS EPIDE, V11, P1; Jimenez E, 2008, RES MICROBIOL, V159, P595, DOI 10.1016/j.resmic.2008.09.001; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jimenez E, 2015, J HUM LACT, V31, P406, DOI 10.1177/0890334415585078; Jost T, 2013, BRIT J NUTR, V110, P1253, DOI 10.1017/S0007114513000597; Khan MMA, 2014, J PAK MED ASSOC, V64, P1171; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Lepainteur M, 2013, J HOSP INFECT, V83, P333, DOI 10.1016/j.jhin.2012.11.025; LUNDEQUIST B, 1985, ACTA PAEDIATR SCAND, V74, P45, DOI 10.1111/j.1651-2227.1985.tb10919.x; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Malfertheiner SF, 2017, EUR J CLIN MICROBIOL, V36, P1955, DOI 10.1007/s10096-017-3019-3; Martin R, 2007, RES MICROBIOL, V158, P31, DOI 10.1016/j.resmic.2006.11.004; Martin V, 2012, J HUM LACT, V28, P36, DOI 10.1177/0890334411424729; Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17; Moles L, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.06.003; Moles L, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00012; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Nagpal R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01997; Ogrodzki P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15769-9; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Park B, 2011, INTRANASAL APPL S EP, V6, P6; Perez-Miguel M, 2017, AIP CONF PROC, V1896, DOI 10.1063/1.5007993; Rodas AM, 2005, INT J SYST EVOL MICR, V55, P197, DOI 10.1099/ijs.0.63249-0; Ruiz-Barba JL, 2005, ANAL BIOCHEM, V347, P333, DOI 10.1016/j.ab.2005.09.028; Sakata H, 1985, DEV INTESTINAL FLORA, P186; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Smith B, 2012, PEDIATR RES, V71, P115, DOI 10.1038/pr.2011.1; Soeorg H, 2017, J HUM LACT, V33, P329, DOI 10.1177/0890334417691505; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Tsai MH, 2014, PEDIATR INFECT DIS J, V33, pE7, DOI 10.1097/INF.0b013e3182a72ee0; Villari P, 2000, J CLIN MICROBIOL, V38, P1740, DOI 10.1128/JCM.38.5.1740-1746.2000; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	62	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0227823	10.1371/journal.pone.0227823	http://dx.doi.org/10.1371/journal.pone.0227823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012172	gold, Green Published			2022-12-26	WOS:000534615800013
J	Lubman, DI; Matthews, S; Heilbronn, C; Killian, JJ; Ogeil, RP; Lloyd, B; Witt, K; Crossin, R; Smith, K; Bosley, E; Carney, R; Wilson, A; Eastham, M; Keene, T; Shipp, C; Scott, D				Lubman, Dan, I; Matthews, Sharon; Heilbronn, Cherie; Killian, Jessica J.; Ogeil, Rowan P.; Lloyd, Belinda; Witt, Katrina; Crossin, Rose; Smith, Karen; Bosley, Emma; Carney, Rosemary; Wilson, Alex; Eastham, Matthew; Keene, Toby; Shipp, Carol; Scott, Debbie			The National Ambulance Surveillance System: A novel method for monitoring acute alcohol, illicit and pharmaceutical drug related-harms using coded Australian ambulance clinical records	PLOS ONE			English	Article							OPIOID OVERDOSE; GLOBAL BURDEN; MELBOURNE; DISEASE; TRENDS; DEPENDENCE	Although harmful consumption of alcohol and other drugs (both illicit and pharmaceutical) significantly contribute to global burden of disease, not all harms are captured within existing morbidity data sources. Indeed, harms occurring in the community may be missed or underreported. This paper describes the National Ambulance Surveillance System, a unique Australian system for monitoring and mapping acute harms related to alcohol and other drug consumption. Data are sourced from paramedic electronic patient care records provided by ambulance services from across Australia. Coding occurs in a purpose-built system, by a team of specialised research assistants. Alcohol, and specific illicit and pharmaceutical drugs, rather than broad drug classes, are manually coded and the dataset is reviewed and cleaned prior to analysis. The National Ambulance Surveillance System is an ongoing, dynamic surveillance system of alcohol and other drug-related harms across Australia. The data includes more than 140 output variables per attendance, including individual substances, demographics, temporal, geospatial, and clinical data (e.g., Glasgow Coma Scale score, naloxone provision and response, outcome of attendance). The National Ambulance Surveillance System is an internationally unique population-level surveillance system of acute harms arising from alcohol and other drug consumption. Dissemination of National Ambulance Surveillance System data has been used to inform and evaluate policy approaches and potential points of intervention, as well as guide workforce development needs and clinical practice at the local and national level. This methodology could be replicated in other countries.	[Lubman, Dan, I; Matthews, Sharon; Heilbronn, Cherie; Killian, Jessica J.; Ogeil, Rowan P.; Lloyd, Belinda; Witt, Katrina; Crossin, Rose; Scott, Debbie] Eastern Hlth, Turning Point, Richmond, Vic, Australia; [Lubman, Dan, I; Matthews, Sharon; Heilbronn, Cherie; Killian, Jessica J.; Ogeil, Rowan P.; Lloyd, Belinda; Witt, Katrina; Crossin, Rose; Scott, Debbie] Monash Univ, Eastern Hlth Clin Sch, Box Hill, Vic, Australia; [Lubman, Dan, I; Ogeil, Rowan P.; Witt, Katrina; Crossin, Rose; Scott, Debbie] Monash Univ, Monash Addict Res Ctr, Frankston, Vic, Australia; [Smith, Karen] Ambulance Victoria, Doncaster, Vic, Australia; [Smith, Karen] Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Frankston, Vic, Australia; [Smith, Karen] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia; [Bosley, Emma] Queensland Ambulance Serv, Brisbane, Qld, Australia; [Carney, Rosemary] New South Wales Ambulance, Rozelle, NSW, Australia; [Wilson, Alex] Ambulance Tasmania, Hobart, Tas, Australia; [Eastham, Matthew] St John Ambulance Australia NT Inc, Casuarina, NT, Australia; [Keene, Toby; Shipp, Carol] Australian Capital Terr Ambulance Serv, Fairbairn, ACT, Australia	Turning Point Alcohol & Drug Centre - Australia; Monash University; Monash University; Monash University; Monash University	Lubman, DI (corresponding author), Eastern Hlth, Turning Point, Richmond, Vic, Australia.; Lubman, DI (corresponding author), Monash Univ, Eastern Hlth Clin Sch, Box Hill, Vic, Australia.; Lubman, DI (corresponding author), Monash Univ, Monash Addict Res Ctr, Frankston, Vic, Australia.	dan.lubman@monash.edu	Witt, Katrina/AAN-4554-2020; Killian, Jessica/AAV-3752-2021; Keene, Toby/HGC-3447-2022; Scott, Deborah/ABB-9055-2020	Witt, Katrina/0000-0002-1489-4573; Crossin, Rose/0000-0003-1814-1330; Lubman, Dan/0000-0002-6747-1937; Scott, Deborah/0000-0002-4530-584X; Matthews, Sharon/0000-0003-3105-7029; Smith, Karen/0000-0002-9057-0685	Victorian Department of Health and Human Services; Commonwealth Department of Health (Australia)	Victorian Department of Health and Human Services; Commonwealth Department of Health (Australia)	NAP is funded by the Victorian Department of Health and Human Services and the Commonwealth Department of Health (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DUBL DRUG POL SUMM R; [Anonymous], 2014, GLOB STAT REP ALC HL; Arunogiri S, 2020, ADDICTION, V115, P473, DOI 10.1111/add.14848; Arunogiri S, 2015, AUST NZ J PSYCHIAT, V49, P939, DOI 10.1177/0004867415585323; Australian Institute of Health and Welfare (AIHW), 2017, NAT DRUG STRAT HOUS; Camenga DR, 2015, DRUG ALCOHOL DEPEN, V146, pe237; Centre for Program Evaluation, 2016, EV SYDN CBD ENT PREC; Chou R, 2017, ANN INTERN MED, V167, P867, DOI 10.7326/M17-2224; Coomber K, 2019, DRUG ALCOHOL DEPEN, V205, DOI 10.1016/j.drugalcdep.2019.107685; Cox S, 2013, AUST HEALTH REV, V37, P54, DOI 10.1071/AH11161; Crossin R, 2019, MED J AUSTRALIA, V210, P75, DOI 10.5694/mja2.12036; Crossin R, 2018, DRUG ALCOHOL DEPEN, V190, P46, DOI 10.1016/j.drugalcdep.2018.05.026; Curtis A, 2019, J STUD ALCOHOL DRUGS, V80, P314, DOI 10.15288/jsad.2019.80.314; Degenhardt L, 2014, DRUG ALCOHOL REV, V33, P4, DOI 10.1111/dar.12088; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Dietze PM, 2000, DRUG ALCOHOL REV, V19, P27; Gomes T, 2014, ADDICTION, V109, P1482, DOI 10.1111/add.12598; Heilbronn C, 2013, DRUG ALCOHOL REV, V32, P405, DOI 10.1111/dar.12028; Kaar SJ, 2015, DRUG ALCOHOL DEPEN, V155, P24, DOI 10.1016/j.drugalcdep.2015.08.021; Liew D., 2017, EVIDENCE INFORM INCL; Magura S, 1996, SUBST USE MISUSE, V31, P1131, DOI 10.3109/10826089609063969; Nambiar D, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014854; Nielsen S, 2019, ADDICTION, DOI [10.1136/bmjopen-2019-029170, DOI 10.1136/BMJ0PEN-2019-029170]; Ogeil RP, 2016, ADDICTION, V111, P626, DOI 10.1111/add.13213; Ogeil RP, 2015, AUST NZ J PUBL HEAL, V39, P121, DOI 10.1111/1753-6405.12308; Ogeil RP, 2016, AUST EPIDEMIOL, V23, P49; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Rehm J, 2017, ADDICTION, V112, P968, DOI 10.1111/add.13757; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Saunders JB, 2012, ALCOHOL ALCOHOLISM, V47, P216, DOI 10.1093/alcalc/ags024; Schmidt LA, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P11; Scott D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071385; Seth P, 2018, AM J PUBLIC HEALTH, V108, P500, DOI 10.2105/AJPH.2017.304265; Stockwell T, 2016, ADDICTION, V111, P1203, DOI 10.1111/add.13373; Studdert DM, 2016, INJURY PREV, V22, P314, DOI 10.1136/injuryprev-2015-041933; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; White V., 2016, AUSTR SECONDARY SCH; World Health Organization, 2018, MAN SUBST AB FACTS F	38	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228316	10.1371/journal.pone.0228316	http://dx.doi.org/10.1371/journal.pone.0228316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CX	32004349	Green Published, Green Submitted, gold			2022-12-26	WOS:000534614600032
J	Emelyanov, A; Shtam, T; Kamyshinsky, R; Garaeva, L; Verlov, N; Miliukhina, I; Kudrevatykh, A; Gavrilov, G; Zabrodskaya, Y; Pchelina, S; Konevega, A				Emelyanov, Anton; Shtam, Tatiana; Kamyshinsky, Roman; Garaeva, Luiza; Verlov, Nikolai; Miliukhina, Irina; Kudrevatykh, Anastasia; Gavrilov, Gaspar; Zabrodskaya, Yulia; Pchelina, Sofya; Konevega, Andrey			Cryo-electron microscopy of extracellular vesicles from cerebrospinal fluid	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; ALPHA-SYNUCLEIN; EXOSOMES; MICROVESICLES; MORPHOLOGY; DISEASE; PLASMA	Extracellular vesicles (EVs) are membrane-enclosed vesicles which play important role for cell communication and physiology. EVs are found in many human biological fluids, including blood, breast milk, urine, cerebrospinal fluid (CSF), ejaculate, saliva etc. These nano-sized vesicles contain proteins, mRNAs, microRNAs, non-coding RNAs and lipids that are derived from producing cells. EVs deliver complex sets of biological information to recipient cells thereby modulating their behaviors by their molecular cargo. In this way EVs are involved in the pathological development and progression of many human disorders, including neurodegenerative diseases. In this study EVs purified by ultracentrifugation from CSF of patients with Parkinson's disease (PD) and individuals of the comparison group were characterized using nanoparticle tracking analysis, flow cytometry and cryo-electron microscopy. Vesicular size and the presence of exosomal marker CD9 on the surface provided evidence that most of the EVs were exosome-like vesicles. Cryo-electron microscopy allowed us to visualize a large spectrum of extracellular vesicles of various size and morphology with lipid bilayers and vesicular internal structures. Thus, we described the diversity and new characteristics of the vesicles from CSF suggesting that subpopulations of EVs with different and specific functions may exist.	[Emelyanov, Anton; Shtam, Tatiana; Garaeva, Luiza; Verlov, Nikolai; Miliukhina, Irina; Pchelina, Sofya; Konevega, Andrey] BP Konstantinov Natl Res Ctr, Kurchatov Inst, Petersburg Nucl Phys Inst, Gatchina, Russia; [Emelyanov, Anton; Miliukhina, Irina; Kudrevatykh, Anastasia; Pchelina, Sofya] Pavlov First St Petersburg State Med Univ, St Petersburg, Russia; [Shtam, Tatiana; Kamyshinsky, Roman; Garaeva, Luiza; Verlov, Nikolai; Pchelina, Sofya; Konevega, Andrey] Kurchatov Inst, Natl Res Ctr, Moscow, Russia; [Kamyshinsky, Roman] Russian Acad Sci, Shubnikov Inst Crystallog, Fed Sci Res Ctr Crystallog & Photon, Moscow, Russia; [Kamyshinsky, Roman] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia; [Garaeva, Luiza; Konevega, Andrey] Peter Great St Petersburg Polytech Univ, St Petersburg, Russia; [Miliukhina, Irina; Kudrevatykh, Anastasia; Pchelina, Sofya] Inst Expt Med, St Petersburg, Russia; [Gavrilov, Gaspar] SM Kirov St Petersburg Mil Med Acad, St Petersburg, Russia; [Zabrodskaya, Yulia] Branch Natl Almazov Med Res Ctr, Polenov Neurosurg Inst, St Petersburg, Russia	National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Pavlov First Saint Petersburg State Medical University; National Research Centre - Kurchatov Institute; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; Moscow Institute of Physics & Technology; Peter the Great St. Petersburg Polytechnic University; Institute of Experimental Medicine	Emelyanov, A; Shtam, T (corresponding author), BP Konstantinov Natl Res Ctr, Kurchatov Inst, Petersburg Nucl Phys Inst, Gatchina, Russia.; Emelyanov, A (corresponding author), Pavlov First St Petersburg State Med Univ, St Petersburg, Russia.; Shtam, T (corresponding author), Kurchatov Inst, Natl Res Ctr, Moscow, Russia.	emelyanov_ak@pnpi.nrcki.ru; shtam_ta@pnpi.nrcki.ru	Shtam, Tatyana A/B-1274-2014; Garaeva, Luisa/AAU-2024-2020; Kamyshinsky, Roman/ABB-8378-2020; Kamyshinsky, Roman/ABH-8244-2020; Kamyshinsky, Roman/L-4306-2016	Shtam, Tatyana A/0000-0003-0651-4785; Kamyshinsky, Roman/0000-0002-8546-7763; Kamyshinsky, Roman/0000-0002-8546-7763; Garaeva, Luiza/0000-0003-1219-073X	Russian Science Foundation [19-74-20146, 17-7520159]; Russian Science Foundation [17-75-20159] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	Russian Science Foundation under Grant. 19-74-20146 (ryo-EM experiments) and the Russian Science Foundation under Grant. 17-7520159 (sample preparation, nanoparticle tracking and flow cytometry analyzes).	Arraud N, 2014, J THROMB HAEMOST, V12, P614, DOI 10.1111/jth.12554; Chen WW, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.28; Clemmens H, 2018, BIOCHEM SOC T, V46, P1073, DOI 10.1042/BST20180112; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Eller M, 2011, CLIN CHEM LAB MED, V49, P403, DOI 10.1515/CCLM.2011.077; Erdbrugger U, 2014, CYTOM PART A, V85A, P756, DOI 10.1002/cyto.a.22494; Gallart-Palau X, 2015, SCI REP-UK, V5, DOI 10.1038/srep14664; Greening DW, 2018, EXPERT REV PROTEOMIC, V15, P887, DOI 10.1080/14789450.2018.1537788; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hoenger A, 2014, PROTOPLASMA, V251, P417, DOI 10.1007/s00709-013-0600-1; Hoog JL, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28680; Isola AL, 2017, CURR NEUROPHARMACOL, V15, P157, DOI 10.2174/1570159X14666160825160421; Issman L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083680; Linares R, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29509; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lozano-Ramos I, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27369; Giraldez-Perez RM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0176-9; Martins TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198820; Mielanczyk L, 2014, FOLIA HISTOCHEM CYTO, V52, P1, DOI 10.5603/FHC.2014.0001; Orlov I, 2017, BIOL CELL, V109, P81, DOI 10.1111/boc.201600042; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rood IM, 2010, KIDNEY INT, V78, P810, DOI 10.1038/ki.2010.262; Shtam TA, 2018, BIOCHEM MOSC-SUPPL S, V12, P167, DOI 10.1134/S1990750818020117; Shtam T, 2018, J HEMATOL, V7, P149, DOI 10.14740/jh412w; Shtam T, 2019, BREAST CANCER RES TR, V174, P129, DOI 10.1007/s10549-018-5043-0; Stuendl A, 2016, BRAIN, V139, P481, DOI 10.1093/brain/awv346; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tofaris GK, 2017, J PARKINSON DIS, V7, P569, DOI 10.3233/JPD-171176; Wu YT, 2015, ANALYST, V140, P6631, DOI 10.1039/c5an00688k; Yuana Y, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23262; Yuana Y, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.21494; Zabeo D, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1329476; Zonneveld MI, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24215	36	62	63	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227949	10.1371/journal.pone.0227949	http://dx.doi.org/10.1371/journal.pone.0227949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999742	gold, Green Published			2022-12-26	WOS:000534612400037
J	Gamariel, F; Isaakidis, P; Tarquino, IAP; Beirao, JC; O'Connell, L; Mulieca, N; Gatoma, HP; Cumbe, VFJ; Venables, E				Gamariel, Farisai; Isaakidis, Petros; Pulido Tarquino, Ivan Alejandro; Beirao, Jose Carlos; O'Connell, Lucy; Mulieca, Nordino; Gatoma, Heitor Pedro; Japissane Cumbe, Vasco Francisco; Venables, Emilie			Access to health services for men who have sex with men and transgender women in Beira, Mozambique: A qualitative study	PLOS ONE			English	Article							RISK	Objectives HIV prevalence and incidence are higher among key populations including Men who have Sex with Men (MSM) and transgender women in low and middle income countries, when compared to the general population. Despite World Health Organisation guidelines on the provision of services to key populations recommending an evidence-based, culturally relevant and rights-based approach, uptake of HIV services in many resource-limited and rights-constrained settings remains low. Medecins Sans Frontieres (MSF) has been offering health services for MSM and transgender women in Beira, Mozambique since 2014 using a peer-educator driven model, but uptake of services has not been as high as expected. This qualitative study aimed to learn more about these key populations in Beira, their experiences of accessing MSM- and transgender-friendly services and their use of face-to-face and virtual networks, including social media, for engagement with health care. Methods In-depth interviews were carried out with MSM and transgender women who were 1) enrolled in, 2) disengaged from or 3) never engaged in MSF's programme. Purposive and snowball sampling were used to recruit the different groups of interviewees. Interviews were conducted in Portuguese, transcribed and translated into English before being coded and manually analysed using a thematic network framework. Results Nine transgender women and 18 cisgender MSM participated in the study. Interviewees ranged in age from 19 to 47 years, with a median age of 29. Three main themes emerged from the data: perceptions of stigma and discrimination, experiences of the peer-educator driven model and the use of face-to-face and virtual platforms for communication and engagement, including social media. Interviewees reported experiencing stigma and discrimination because of their gender or sexual identity. HIV-related stigma and health-care setting discrimination, including gossip and breach of confidentiality, were also reported. Although the presence of the peer-educators and their outreach activities were appreciated, they had limited visibility and an over-focus on health and HIV. The face-to-face networks of MSM and transgender women were small and fragmented. Virtual networks such as Facebook were mainly used for flirting, dating and informal communication. Most interviewees were at ease using social media and would consider it as a means of engaging with health messaging. Conclusions MSM and transgender women have challenges in accessing health services due to being stigmatised because of their gender identity and their sexual behaviour, and often experience stigma at home, in health-care facilities and in their communities. Peer-driven models of engagement were appreciated but have limitations. There is an untapped potential for further expansion and engagement with face-to-face and virtual platforms to reach MSM and transgender women in settings with a high HIV burden, and to provide them with essential information about HIV and their health.	[Gamariel, Farisai; Beirao, Jose Carlos; Mulieca, Nordino; Gatoma, Heitor Pedro] Medecins Sans Frontieres, Beira, Mozambique; [Isaakidis, Petros; O'Connell, Lucy; Venables, Emilie] Medecins Sans Frontieres, Southern Africa Med Unit SAMU, Cape Town, South Africa; [Pulido Tarquino, Ivan Alejandro] Medecins Sans Frontieres, Maputo, Mozambique; [Japissane Cumbe, Vasco Francisco] Minist Hlth, Beira, Mozambique; [Venables, Emilie] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa	University of Cape Town	Isaakidis, P (corresponding author), Medecins Sans Frontieres, Southern Africa Med Unit SAMU, Cape Town, South Africa.	Petros.Isaakidis@joburg.msf.org	Pulido Tarquino, Ivan Alejandro/GPS-7553-2022	Pulido Tarquino, Ivan Alejandro/0000-0002-1448-8268; Cumbe, Vasco/0000-0002-1131-8597; Isaakidis, Petros/0000-0002-7881-1554				Ahanda K., 2017, MITIGATING STIGMA HI; Allison Susannah M, 2014, J Int AIDS Soc, V17, P19041, DOI 10.7448/IAS.17.1.19041; Attridge-Stirling J., 2001, THEMATIC NETWORK ANA; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Boogerd EA, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4065; Cao BL, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7251; Hagopian A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1306391; Hassan NR, 2018, HEALTH PLACE, V49, P93, DOI 10.1016/j.healthplace.2017.11.010; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Micheni M, 2017, AIDS PATIENT CARE ST, V31, P113, DOI 10.1089/apc.2016.0213; Muller A, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0124-4; Muller A, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0462-2; Nala R, 2015, AIDS BEHAV, V19, P393, DOI 10.1007/s10461-014-0895-8; OHCHR, 2018, MOZ UN LGBT EXP WELC; Shangani S, 2017, AIDS CARE, V29, P1003, DOI 10.1080/09540121.2017.1282105; Sharma A, 2015, DRIVING HIV RESPONSE; Sjostrand S., 2014, HOMOSEXUALITY DECRIM; Stevens M., 2012, TRANSGENDER PEOPLES; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, ZER DISCR HLTH CAR S; Wirtz AL, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-20; World Health Organization, 2014, POL BRIEF CONS GUID; Young SD, 2013, ANN INTERN MED, V159, P318, DOI 10.7326/0003-4819-159-5-201309030-00005	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228307	10.1371/journal.pone.0228307	http://dx.doi.org/10.1371/journal.pone.0228307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999760	Green Published, gold, Green Submitted			2022-12-26	WOS:000534612400064
J	Kwon, E; Yoo, T; Joung, HY; Jo, YH				Kwon, Eunjin; Yoo, Taesik; Joung, Hye-Young; Jo, Young-Hwan			Hydrocarboxylic acid receptor 1 in BAT regulates glucose uptake in mice fed a high-fat diet	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; COLD-EXPOSURE; OXIDATIVE-METABOLISM; LIPOLYSIS; GPR81; THERMOGENESIS; INHIBITION; SEX; IDENTIFICATION; EXPRESSION	Interscapular brown adipose tissue (BAT) has the capability to take up glucose from the circulation. Despite the important role of BAT in the control of glucose homeostasis, the metabolic fate and function of glucose in BAT remain elusive as there is clear dissociation between glucose uptake and BAT thermogenesis. Interestingly, intracellular glycolysis and lactate production appear to be required for glucose uptake by BAT. Here, we specifically examine whether activation of lactate receptors in BAT plays a key role in regulating glucose homeostasis in mice fed a high-fat diet (HFD). When C57BL/6J mice are given HFD for 5 weeks at 28 degrees C, male, but not female, mice gain body weight and develop hyperglycemia. Importantly, high-fat feeding upregulates expression of the lactate receptor hydroxycarboxylic acid receptor 1 (HCAR1) in female C57BL/6J mice, whereas male C57BL/6J mice show reduced HCAR1 expression in BAT. Treatment with the HCAR1 agonist lowers systemic glucose levels in male DIO mice. This reduction is associated with increased glucose uptake in BAT. Therefore, our results suggest that HCAR1 in BAT may contribute to the development of hyperglycemia in male C57BL/6J DIO mice.	[Kwon, Eunjin; Yoo, Taesik; Joung, Hye-Young; Jo, Young-Hwan] Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10467 USA; [Kwon, Eunjin; Yoo, Taesik; Joung, Hye-Young; Jo, Young-Hwan] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY 10467 USA; [Jo, Young-Hwan] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Jo, YH (corresponding author), Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10467 USA.; Jo, YH (corresponding author), Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY 10467 USA.; Jo, YH (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	young-hwan.jo@einsteinmed.org		Jo, Young-Hwan/0000-0001-6939-8000	NIDDK [RO1DK092246, P30 DK020541]	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK (RO1DK092246) and P30 DK020541 to Y.-H.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Abrantes HD, 2019, J NEUROSCI, V39, P4422, DOI 10.1523/JNEUROSCI.2092-18.2019; Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Albert V, 2016, EMBO MOL MED, V8, P232, DOI 10.15252/emmm.201505610; Blondin DP, 2017, CELL METAB, V25, P438, DOI 10.1016/j.cmet.2016.12.005; Blondin DP, 2015, DIABETES, V64, P2388, DOI 10.2337/db14-1651; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030; Choi DK, 2011, CELL PHYSIOL BIOCHEM, V28, P933, DOI 10.1159/000335807; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Dvorak CA, 2012, ACS MED CHEM LETT, V3, P637, DOI 10.1021/ml3000676; FAIN JN, 1969, J BIOL CHEM, V244, P3500; Feingold KR, 2011, INFLAMM RES, V60, P991, DOI 10.1007/s00011-011-0361-2; Ge H, 2008, J LIPID RES, V49, P797, DOI 10.1194/jlr.M700513-JLR200; Hankir MK, 2017, J NUCL MED, V58, P1100, DOI 10.2967/jnumed.116.186460; Hankir MK, 2016, CELL METAB, V24, P31, DOI 10.1016/j.cmet.2016.05.003; Hao Q, 2015, AM J PHYSIOL-ENDOC M, V308, pE380, DOI 10.1152/ajpendo.00277.2014; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Jeong JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25265-3; Kayali AG, 1998, J BIOL CHEM, V273, P13808, DOI 10.1074/jbc.273.22.13808; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Liu CL, 2012, J PHARMACOL EXP THER, V341, P794, DOI 10.1124/jpet.112.192799; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P609, DOI 10.1139/y86-101; Miralpeix C, 2019, J LIPID RES, V60, P1260, DOI 10.1194/jlr.M092742; Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024; NIKAMI H, 1992, BIOCHEM BIOPH RES CO, V185, P1078, DOI 10.1016/0006-291X(92)91736-A; Offermanns S, 2017, TRENDS ENDOCRIN MET, V28, P227, DOI [10.1016/J.tem.2016.11.007, 10.1016/j.tem.2016.11.007]; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Roberts-Toler C, 2015, OBESITY, V23, P1765, DOI 10.1002/oby.21134; Rodriguez-Cuenca S, 2002, J BIOL CHEM, V277, P42958, DOI 10.1074/jbc.M207229200; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; Skorobogatko Y, 2018, P NATL ACAD SCI USA, V115, P7819, DOI 10.1073/pnas.1801050115; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Sun JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33732; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; VanEppsFung M, 1997, ENDOCRINOLOGY, V138, P5170, DOI 10.1210/en.138.12.5170; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Wallenius K, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92564; Wanders D, 2012, BIOCHEM BIOPH RES CO, V425, P278, DOI 10.1016/j.bbrc.2012.07.082; Weir G, 2018, CELL METAB, V27, P1348, DOI 10.1016/j.cmet.2018.04.020; Winther S, 2018, AM J PHYSIOL-ENDOC M, V314, pE214, DOI 10.1152/ajpendo.00218.2017; YOUNG P, 1985, BIOCHEM BIOPH RES CO, V130, P241, DOI 10.1016/0006-291X(85)90408-5	48	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228320	10.1371/journal.pone.0228320	http://dx.doi.org/10.1371/journal.pone.0228320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999787	gold, Green Published, Green Submitted			2022-12-26	WOS:000534612400067
J	Pitsawong, W; Chenprakhon, P; Dhammaraj, T; Medhanavyn, D; Sucharitakul, J; Tongsook, C; van Berkel, WJH; Chaiyen, P; Miller, AF				Pitsawong, Warintra; Chenprakhon, Pirom; Dhammaraj, Taweesak; Medhanavyn, Dheeradhach; Sucharitakul, Jeerus; Tongsook, Chanakan; van Berkel, Willem J. H.; Chaiyen, Pimchai; Miller, Anne-Frances			Tuning of pK(a) values activates substrates in flavin-dependent aromatic hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin; flavoprotein; enzyme mechanism; enzyme kinetics; nuclear magnetic resonance (NMR); 19F NMR; flavin-dependent monooxygenase; pKa tuning	P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; PARA-HYDROXYBENZOATE HYDROXYLASE; OXYGENASE COMPONENT; F-19 NMR; 3-HYDROXYBENZOATE 6-HYDROXYLASE; ELECTRON-TRANSFER; ESCHERICHIA-COLI; FREE-ENERGY; PROTON; MONOOXYGENASE	Hydroxylation of substituted phenols by flavin-dependent monooxygenases is the first step of their biotransformation in various microorganisms. The reaction is thought to proceed via electrophilic aromatic substitution, catalyzed by enzymatic deprotonation of substrate, in single-component hydroxylases that use flavin as a cofactor (group A). However, two-component hydroxylases (group D), which use reduced flavin as a co-substrate, are less amenable to spectroscopic investigation. Herein, we employed F-19 NMR in conjunction with fluorinated substrate analogs to directly measure pK(a) values and to monitor protein events in hydroxylase active sites. We found that the single-component monooxygenase 3-hydroxybenzoate 6-hydroxylase (3HB6H) depresses the pK(a) of the bound substrate analog 4-fluoro-3-hydroxybenzoate (4F3HB) by 1.6 pH units, consistent with previously proposed mechanisms. F-19 NMR was applied anaerobically to the two-component monooxygenase 4-hydroxyphenylacetate 3-hydroxylase (HPAH), revealing depression of the pK(a) of 3-fluoro-4-hydroxyphenylacetate by 2.5 pH units upon binding to the C-2 component of HPAH. F-19 NMR also revealed a pK(a) of 8.7 ? 0.05 that we attributed to an active-site residue involved in deprotonating bound substrate, and assigned to His-120 based on studies of protein variants. Thus, in both types of hydroxylases, we confirmed that binding favors the phenolate form of substrate. The 9 and 14 kJ/mol magnitudes of the effects for 3HB6H and HPAH-C-2, respectively, are consistent with pK(a) tuning by one or more H-bonding interactions. Our implementation of F-19 NMR in anaerobic samples is applicable to other two-component flavin-dependent hydroxylases and promises to expand our understanding of their catalytic mechanisms.	[Pitsawong, Warintra; Miller, Anne-Frances] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Chenprakhon, Pirom] Mahidol Univ, Inst Innovat Learning, Salaya 73170, Nakhon Pathom, Thailand; [Dhammaraj, Taweesak] Mahasarakham Univ, Fac Pharm, Maha Sarakham 44150, Thailand; [Medhanavyn, Dheeradhach] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Medhanavyn, Dheeradhach] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok 10400, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok 10300, Thailand; [Tongsook, Chanakan] Silpakorn Univ, Fac Sci, Dept Chem, Amphoe Muang 730000, Nakhon Pathom, Thailand; [van Berkel, Willem J. H.] Wageningen Univ & Res, Lab Food Chem, Bornse Weilanden 9, NL-6708 WG Wageningen, Netherlands; [Chaiyen, Pimchai] Vidyasirimedhi Inst Sci & Technol, Sch Biomol Sci & Engn, 555 Moo 1 Payupnai, Wangchan 21210, Rayong, Thailand; [Pitsawong, Warintra] Brandeis Univ, Dept Biochem, Waltham, MA 02453 USA	University of Kentucky; Mahidol University; Mahasarakham University; Mahidol University; Mahidol University; Chulalongkorn University; Silpakorn University; Wageningen University & Research; Vidyasirimedhi Institute of Science & Technology; Brandeis University	Miller, AF (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.; Chaiyen, P (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, 555 Moo 1 Payupnai, Wangchan 21210, Rayong, Thailand.	pimchai.chaiyen@vistec.ac.th; afmill3r2@gmail.com	van Berkel, Willem J.H./O-2431-2014; Dhammaraj, Taweesak/GYJ-3406-2022; pitsawong, warintra/G-1760-2018	van Berkel, Willem J.H./0000-0002-6551-2782; Chenprakhon, Pirom/0000-0002-5927-6920; pitsawong, warintra/0000-0001-5438-1783	Center for Pharmaceutical Development, National Science Foundation [I/UCRC IIP-1540011]; Research Challenge Trust Fund Fellowship; National Science Foundation, Chemistry of Life Processes [CHE-1808433]; Thailand Research Fund [RTA5980001, MRG6180156, RSA5980062]; Thailand Science Research and Innovation Global Partnership Program; Vidyasirimedhi Institute of Science and Technology (VISTEC)	Center for Pharmaceutical Development, National Science Foundation; Research Challenge Trust Fund Fellowship; National Science Foundation, Chemistry of Life Processes(National Science Foundation (NSF)); Thailand Research Fund(Thailand Research Fund (TRF)); Thailand Science Research and Innovation Global Partnership Program; Vidyasirimedhi Institute of Science and Technology (VISTEC)	This work was supported by the Vice President for Research of the University of Kentucky, the Center for Pharmaceutical Development, National Science Foundation Grant I/UCRC IIP-1540011 (to A.-F. M.), a Research Challenge Trust Fund Fellowship (to W. P.), the National Science Foundation, Chemistry of Life Processes Grant CHE-1808433 (to A.-F. M.), the Thailand Research Fund grant RTA5980001, Thailand Science Research and Innovation Global Partnership Program and Vidyasirimedhi Institute of Science and Technology (VISTEC) (to P. Chaiyen), and Thailand Research Fund Grants MRG6180156 (to P. Chenprakhon) and RSA5980062 (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Arunima, 2005, MAGN RESON CHEM, V43, P132, DOI 10.1002/mrc.1520; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Benitez AR, 2019, ACS CATAL, V9, P3633, DOI 10.1021/acscatal.8b04575; Chaiyen P, 2004, BIOCHEMISTRY-US, V43, P3933, DOI 10.1021/bi035734d; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chenprakhon P, 2019, PROTEIN SCI, V28, P8, DOI 10.1002/pro.3525; Chenprakhon P, 2014, BIOCHEMISTRY-US, V53, P4084, DOI 10.1021/bi500480n; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Dhammaraj T, 2016, ACS CHEM BIOL, V11, P2889, DOI 10.1021/acschembio.6b00402; Dhammaraj T, 2015, ACS CATAL, V5, P4492, DOI 10.1021/acscatal.5b00439; Dockrey SAB, 2018, NAT CHEM, V10, P119, DOI [10.1038/NCHEM.2879, 10.1038/nchem.2879]; Dresen C, 2010, J BIOL CHEM, V285, P22264, DOI 10.1074/jbc.M109.099028; DUGAD LB, 1988, BIOCHEMISTRY-US, V27, P4310, DOI 10.1021/bi00412a018; EBERLEIN G, 1983, J AM CHEM SOC, V105, P6685, DOI 10.1021/ja00360a024; ENTSCH B, 1991, J BIOL CHEM, V266, P17341; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; ERNST RR, 1966, REV SCI INSTRUM, V37, P93, DOI 10.1063/1.1719961; ESCHRICH K, 1993, EUR J BIOCHEM, V216, P137, DOI 10.1111/j.1432-1033.1993.tb18125.x; Everill P, 2012, J AM CHEM SOC, V134, P2348, DOI 10.1021/ja210091q; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; Fersht A., 1985, ENZYME STRUCTURE MEC, P174; Gerig J.T., 2003, BIOPHYSICS TXB ONLIN, P1; GERIG JT, 1994, PROG NUCL MAG RES SP, V26, P293, DOI 10.1016/0079-6565(94)80009-X; Holtmann D, 2016, CHEMBIOCHEM, V17, P1391, DOI 10.1002/cbic.201600176; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; HUSAIN M, 1980, J BIOL CHEM, V255, P4189; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Jadan AP, 2004, ADV SYNTH CATAL, V346, P367, DOI 10.1002/adsc.200303146; Kahyaoglu A, 2002, PROTEIN SCI, V11, P965, DOI 10.1110/ps.3890102; Kitevski-LeBlanc JL, 2012, PROG NUCL MAG RES SP, V62, P1, DOI 10.1016/j.pnmrs.2011.06.003; Kommoju PR, 2011, BIOCHEMISTRY-US, V50, P5521, DOI 10.1021/bi200388g; Lin J, 1998, BIOCHEMISTRY-US, V37, P11940, DOI 10.1021/bi980278s; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Montersino S, 2013, J BIOL CHEM, V288, P26235, DOI 10.1074/jbc.M113.479303; Montersino S, 2012, BBA-PROTEINS PROTEOM, V1824, P433, DOI 10.1016/j.bbapap.2011.12.003; ODA Y, 1994, BIOCHEMISTRY-US, V33, P5275, DOI 10.1021/bi00183a034; Ortiz-Maldonado M, 1999, BIOCHEMISTRY-US, V38, P8124, DOI 10.1021/bi990560e; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; PEELEN S, 1993, EUR J BIOCHEM, V218, P345, DOI 10.1111/j.1432-1033.1993.tb18383.x; Perrin D. D., 1983, BUFFERS PH METAL ION, P159; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimviriyakul P, 2018, CHEM SCI, V9, DOI 10.1039/c8sc01482e; Pinthong C, 2017, PROCESS BIOCHEM, V63, P122, DOI 10.1016/j.procbio.2017.08.006; Ridder L, 2003, J PHYS CHEM B, V107, P2118, DOI 10.1021/jp026213n; Ridder L, 2000, J AM CHEM SOC, V122, P8728, DOI 10.1021/ja0007814; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Salopek-Sondi B, 2002, PROTEIN ENG, V15, P855, DOI 10.1093/protein/15.11.855; Sanders LK, 2001, J PHYS CHEM A, V105, P8098, DOI 10.1021/jp011114f; SHOUN H, 1979, J BIOL CHEM, V254, P899; Spencer RGS, 2000, J MAGN RESON, V142, P120, DOI 10.1006/jmre.1999.1925; Stockman BJ, 2008, J AM CHEM SOC, V130, P5870, DOI 10.1021/ja801588u; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2016, FEBS J, V283, P860, DOI 10.1111/febs.13636; Sucharitakul J, 2014, ARCH BIOCHEM BIOPHYS, V555, P33, DOI 10.1016/j.abb.2014.05.009; Sucharitakul J, 2012, BIOCHEMISTRY-US, V51, P4309, DOI 10.1021/bi201823c; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tinikul R, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700632; Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463; Tozawa K, 1996, FEBS LETT, V397, P122, DOI 10.1016/S0014-5793(96)01155-6; Tweedy SE, 2019, J PHYS CHEM B, V123, P8065, DOI 10.1021/acs.jpcb.9b08178; VALCOUR AA, 1986, J MAGN RESON, V66, P536, DOI 10.1016/0022-2364(86)90197-6; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; VANBERKEL WJH, 1989, EUR J BIOCHEM, V179, P307; VERVOORT J, 1992, EUR J BIOCHEM, V206, P479, DOI 10.1111/j.1432-1033.1992.tb16950.x; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Wang XY, 2018, THEOR CHEM ACC, V137, DOI 10.1007/s00214-018-2278-0; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Wongnate T, 2014, J AM CHEM SOC, V136, P241, DOI 10.1021/ja4088055; Zhu YG, 2013, J AM CHEM SOC, V135, P18750, DOI 10.1021/ja410513g	75	6	6	4	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3965	3981		10.1074/jbc.RA119.011884	http://dx.doi.org/10.1074/jbc.RA119.011884			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32014994	hybrid, Green Published			2022-12-26	WOS:000527704400021
J	Brokerhof, IM; Ybema, JF; Bal, PM				Brokerhof, Inge M.; Ybema, Jan Fekke; Bal, P. Matthijs			Illness narratives and chronic patients' sustainable employability: The impact of positive work stories	PLOS ONE			English	Article							BUILD THEORY; CONSTRUCTION; INFORMATION; DISEASES; MODELS; COMMUNICATION; DEFINITION; DISABILITY; EMPLOYMENT; PREVENTION	The number of workers with a chronic disease is steadily growing in industrialized countries. To cope with and to give meaning to their illness, patients construct illness narratives, which are widely shared across patient societies, personal networks and the media. This study investigates the influence of these shared illness narratives on patient's working lives, by examining the impact of reading a positive work story versus negative work story on patients' sustainable employability. We expected that this relationship would be mediated by positive emotions and the extent to which the story enhanced awareness of desires future selves, and moderated by identification with story character. An online field experiment with 166 people with Inflammatory Bowel Disease in The Netherlands showed that while reading a positive story of a patient with the same condition significantly increased positive emotions, these emotions did not influence sustainable employability. However, reading a positive story was related to higher sustainable employability when patients became more aware of their desired possible future work selves. Finally, identification with the story character moderated the impact of story type on sustainable employability. This study showed that personal engagement with a positive work story of a fellow patient is related to higher sustainable employability. Findings can be helpful for health professionals to empower employees with a chronic disease.	[Brokerhof, Inge M.] Vrije Univ Amsterdam, Dept Management & Org, Amsterdam, Netherlands; [Ybema, Jan Fekke] Univ Utrecht, Dept Social Hlth & Organisat Psychol, Utrecht, Netherlands; [Bal, P. Matthijs] Univ Lincoln, Lincoln Int Business Sch, Lincoln, England	Vrije Universiteit Amsterdam; Utrecht University; University of Lincoln	Brokerhof, IM (corresponding author), Vrije Univ Amsterdam, Dept Management & Org, Amsterdam, Netherlands.	i.m.brokerhof@vu.nl		Brokerhof, Inge/0000-0002-0011-4281				Alexander M, 2005, CINEMEDUCATION COMPR; Appel M, 2008, J COMMUN, V58, P62, DOI 10.1111/j.1460-2466.2007.00374.x; Ayers SL, 2007, HEALTH-LONDON, V11, P327, DOI 10.1177/1363459307077547; Bal M., 2009, NARRATOLOGY INTRO TH, V3rd; Bal PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055341; Bambra C, 2005, SOC SCI MED, V60, P1905, DOI 10.1016/j.socscimed.2004.09.002; Beatty JE, 2012, EMPLOY RESPONSIB RIG, V24, P91, DOI 10.1007/s10672-011-9177-z; Brokerhof I, 2018, DIALOGICAL SELF INSP, P29; Brown SD, HDB COUNSELING PSYCH, P740; Buunk AP, 2007, ORGAN BEHAV HUM DEC, V102, P3, DOI 10.1016/j.obhdp.2006.09.007; Buunk BP, 1997, SOCIAL COMP HLTH COP, P359; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Casati J, 2000, DIGEST DIS SCI, V45, P26, DOI 10.1023/A:1005492806777; Charmaz K., 2000, HDB SOCIAL STUDIES H, P277, DOI DOI 10.4135/9781848608412.N18; Christensen TK, 2003, J CAREER DEV, V29, P149, DOI 10.1023/A:1021462028524; Cohen J., 2001, MASS COMMUNICATION S, V4, P245, DOI [10.1207/S15327825MCS0403_01, DOI 10.1207/S15327825MCS0403_01]; COOPER CL, 1994, HUM RELAT, V47, P455, DOI 10.1177/001872679404700405; Creed P A, 2001, J Occup Health Psychol, V6, P324, DOI 10.1037/1076-8998.6.4.324; De Santis JP, 2013, J AM PSYCHIAT NURSES, V19, P36, DOI 10.1177/1078390312474096; Dillard AJ, 2010, SOC SCI MED, V71, P45, DOI 10.1016/j.socscimed.2010.02.038; Djikic M, 2009, CREATIVITY RES J, V21, P24, DOI 10.1080/10400410802633392; Erikson MG, 2007, REV GEN PSYCHOL, V11, P348, DOI 10.1037/1089-2680.11.4.348; FELTON BJ, 1984, SOC SCI MED, V18, P889, DOI 10.1016/0277-9536(84)90158-8; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fleuren BPI, 2018, SCAND J WORK ENV HEA, V44, P475, DOI 10.5271/sjweh.3741; Fleuren BPI, 2016, SCAND J WORK ENV HEA, V42, P557, DOI 10.5271/sjweh.3585; Ford ME., 1992, MOTIVATING HUMANS GO; Frank AW., 2013, WOUNDED STORYTELLER; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; GARRO LC, 1994, SOC SCI MED, V38, P775, DOI 10.1016/0277-9536(94)90150-3; Gibson DE, 2004, J VOCAT BEHAV, V65, P134, DOI 10.1016/S0001-8791(03)00051-4; Green MC, 2003, NARRATIVE IMPACT SOC; Hatfield E., 1994, REV PERSONALITY SOCI, P151; Hayes A.F., 2012, PROCESS VERSATILE CO; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Herxheimer A, 2004, NARRATIVE RES HLTH I, P115; Hinyard LJ, 2007, HEALTH EDUC BEHAV, V34, P777, DOI 10.1177/1090198106291963; Hoffner C, 2005, MEDIA PSYCHOL, V7, P325, DOI 10.1207/S1532785XMEP0704_2; Hogan P.C., 2011, AFFECTIVE NARRATOLOG; Jahoda M., 1982, EMPLOYMENT UNEMPLOYM; Ketokivi K, 2009, EUR SOC, V11, P391, DOI 10.1080/14616690902764815; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Kleinman A., 1988, ENCY HUMAN BIOL; Koel J., 2015, DRIJFVEREN INZETBAAR; Kreuter MW, 2007, ANN BEHAV MED, V33, P221, DOI 10.1007/BF02879904; Le Blanc PM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01690; Lillrank A, 2003, SOC SCI MED, V57, P1045, DOI 10.1016/S0277-9536(02)00479-3; Manago B, 2017, SOC SCI MED, V184, P169, DOI 10.1016/j.socscimed.2017.05.015; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; Marri SR, 2005, INFLAMM BOWEL DIS, V11, P171, DOI 10.1097/00054725-200502000-00011; Mau W, 2005, J RHEUMATOL, V32, P721; McGonagle AK, 2014, J OCCUP HEALTH PSYCH, V19, P385, DOI 10.1037/a0036601; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mussweiler T, 2004, J PERS SOC PSYCHOL, V87, P832, DOI 10.1037/0022-3514.87.6.832; Oyserman D, 2006, J PERS SOC PSYCHOL, V91, P188, DOI 10.1037/0022-3514.91.1.188; Paterson BL, 2001, J NURS SCHOLARSHIP, V33, P21, DOI 10.1111/j.1547-5069.2001.00021.x; Paul KI, 2010, J ORGAN BEHAV, V31, P45, DOI 10.1002/job.622; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; PEARLIN LI, 1981, J HEALTH SOC BEHAV, V22, P337, DOI 10.2307/2136676; Peters ML, 2013, TER PSICOL, V31, P93, DOI 10.4067/S0718-48082013000100009; Prevention CfDCa, 2009, CHRON DIS GLANC 2009; Raad SE, 2009, KWESTIE GEZOND VERST; Richardson Paul W, 2007, Int J Educ Res, V46, P341, DOI 10.1016/j.ijer.2007.06.002; ROBINSON I, 1990, SOC SCI MED, V30, P1173, DOI 10.1016/0277-9536(90)90257-S; (SER) SER, 2009, KWEST GEZ VERST BREE; Sharf BF, 2003, LEA COMMUN SER, P9; Siegrist J, 2004, SOC SCI MED, V58, P1463, DOI 10.1016/S0277-9536(03)00349-6; Sikora S, 2011, PSYCHOL AESTHET CREA, V5, P258, DOI 10.1037/a0021999; Steffen V, 1997, SOC SCI MED, V45, P99, DOI 10.1016/S0277-9536(96)00319-X; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Strauss K, 2012, J APPL PSYCHOL, V97, P580, DOI 10.1037/a0026423; Tu Ha T, 2009, Track Rep, P1; van der Klink JJL, 2016, SCAND J WORK ENV HEA, V42, P71, DOI 10.5271/sjweh.3531; Van Vuuren T, 2015, GEZONDE DUURZAAM INZ; Varekamp I, 2010, OCCUP MED-OXFORD, V60, P287, DOI 10.1093/occmed/kqq078; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Winterbottom A, 2008, SOC SCI MED, V67, P2079, DOI 10.1016/j.socscimed.2008.09.037; Wise M, 2008, PATIENT EDUC COUNS, V70, P348, DOI 10.1016/j.pec.2007.11.009; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; YBEMA JF, 1995, BRIT J SOC PSYCHOL, V34, P279, DOI 10.1111/j.2044-8309.1995.tb01064.x; ZUCKERMAN M, 1983, J BEHAV ASSESS, V5, P119, DOI 10.1007/BF01321444	84	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228581	10.1371/journal.pone.0228581	http://dx.doi.org/10.1371/journal.pone.0228581			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9IO	32040494	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000534629400029
J	Song, CC; Cao, J; Lei, YS; Chi, H; Kong, PY; Chen, GH; Yu, TL; Li, JN; Prajapati, RK; Xia, JJ; Yan, JL				Song, Chengchao; Cao, Jing; Lei, Yongsheng; Chi, Hui; Kong, Pengyu; Chen, Guanghua; Yu, Tailong; Li, Jianan; Prajapati, Ravi Kumar; Xia, Jingjun; Yan, Jinglong			Nuciferine prevents bone loss by disrupting multinucleated osteoclast formation and promoting type H vessel formation	FASEB JOURNAL			English	Article						CD31; Emcn; PDGF-BB; preosteoclast	DC-STAMP; ANGIOGENESIS; DIFFERENTIATION; CELLS; OSTEOGENESIS; INHIBITION; PRECURSORS; PATHWAY	Recently, type H vessels were reported to couple angiogenesis and osteogenesis during osteoclastogenesis, and tartrate-resistant acid phosphatase (Trap)(+) preosteoclasts were found to secrete increased PDGF-BB to promote type H vessel formation. Therefore, utilization of type H vessels may be a strategy to treat diseases involving bone loss. In the present study, we found that nuciferine, a natural bioactive compound, has various effects, including inhibiting osteoclastogenesis and promoting type H vessel formation. Nuciferine inhibited osteoclastogenesis and bone resorption but increased the relative number of Trap(+) preosteoclasts. Nuciferine restrained the expression of osteoclast-specific genes and proteins, promoted PDGF-BB production and potentiated related angiogenic activities by inhibiting the MAPK and NF-kappa B signaling pathways in vitro. We confirmed the bone-protective effects of nuciferine in ovariectomized mice and found that nuciferine treatment increased the PDGF-BB concentration and the number of type H vessels in the femur. In conclusion, our results demonstrated that nuciferine can decrease multinucleated osteoclast formation and promote type H vessel formation through preservation of Trap(+) preosteoclasts via inhibition of the MAPK and NF-kappa B signaling pathways and may be an excellent agent for the treatment of diseases involving bone loss.	[Song, Chengchao; Lei, Yongsheng; Chi, Hui; Kong, Pengyu; Chen, Guanghua; Yu, Tailong; Prajapati, Ravi Kumar; Xia, Jingjun; Yan, Jinglong] Harbin Med Univ, Affiliated Hosp 2, Dept Orthoped, Harbin 150086, Heilongjiang, Peoples R China; [Song, Chengchao; Cao, Jing; Lei, Yongsheng; Chi, Hui] Harbin Med Univ, Minist Educ, Key Lab Myocardial Ischemia, Harbin, Peoples R China; [Cao, Jing] Harbin Med Univ, Affiliated Hosp 2, Dept Otorhinolaryngol Head & Neck Surg, Harbin, Peoples R China; [Li, Jianan] Heilongjiang Prov Hosp, Dept Orthoped, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Yan, JL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Orthoped, Harbin 150086, Heilongjiang, Peoples R China.	yjlhmu@163.com	Xu, Ping/I-1910-2013; Chen, Guanghua/X-2001-2018	Xu, Ping/0000-0002-1516-4986; Chen, Guanghua/0000-0003-1388-5584	National Natural Science Foundation of China [81472107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China, Grant/Award Number: 81472107	An YA, 2019, FASEB J, V33, P12515, DOI 10.1096/fj.201802805RR; Arai A, 2012, J CELL SCI, V125, P2910, DOI 10.1242/jcs.099986; Binkley N, 1998, J BONE MINER RES, V13, P1775, DOI 10.1359/jbmr.1998.13.11.1775; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chang EJ, 2008, J CELL SCI, V121, P2555, DOI 10.1242/jcs.028217; Chen H, 2019, I-PERCEPTION, V10, DOI 10.1177/2041669519864971; Chen X, 2017, FASEB J, V31, P4855, DOI 10.1096/fj.201700316R; Dou C, 2018, ADV SCI, V5, DOI 10.1002/advs.201700578; Gao B, 2019, J CLIN INVEST, V129, P2578, DOI 10.1172/JCI98857; Hadji P, 2019, OSTEOPOROSIS INT, V30, P2391, DOI 10.1007/s00198-019-05103-6; Hotokezaka H, 2007, J CELL BIOCHEM, V101, P122, DOI 10.1002/jcb.21167; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Huang J, 2018, THERANOSTICS, V8, P2435, DOI 10.7150/thno.22144; Imam B, 2019, CUREUS, V11, DOI 10.7759/cureus.5328; Kim JY, 2014, J BONE MINER RES, V29, P1541, DOI 10.1002/jbmr.2183; Kim MJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040431; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Li MJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42484; Liu CM, 2014, MOLECULES, V19, P17829, DOI 10.3390/molecules191117829; Liu W, 2015, J ETHNOPHARMACOL, V165, P83, DOI 10.1016/j.jep.2015.02.015; Liu Y, 2017, DRUG DELIV, V24, P443, DOI 10.1080/10717544.2016.1261381; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyamoto H, 2012, J BIOL CHEM, V287, P32479, DOI 10.1074/jbc.M112.358226; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; Rahman MM, 2015, BIOCHEM BIOPH RES CO, V462, P159, DOI 10.1016/j.bbrc.2015.04.115; Ramasamy SK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13601; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Romeo SG, 2019, NAT CELL BIOL, V21, P430, DOI 10.1038/s41556-019-0304-7; Russell LA, 2018, BEST PRACT RES CL RH, V32, P835, DOI 10.1016/j.berh.2019.04.002; Sakagami N, 2005, MICRON, V36, P688, DOI 10.1016/j.micron.2005.06.008; Stegen S, 2015, BONE, V70, P19, DOI 10.1016/j.bone.2014.09.017; Sun XY, 2019, THERANOSTICS, V9, P5183, DOI 10.7150/thno.33376; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Wang L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.36; Wisitrasameewong W, 2017, J DENT RES, V96, P685, DOI 10.1177/0022034517690490; Wu HC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00939; Wu HB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0540-y; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Xu R, 2018, NAT MED, V24, P823, DOI 10.1038/s41591-018-0020-z; Yang M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16003	41	10	15	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4798	4811		10.1096/fj.201902551R	http://dx.doi.org/10.1096/fj.201902551R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32039519				2022-12-26	WOS:000512568800001
J	Diniz, MDHS; Beleigoli, AMR; Bensenor, IM; Lotufo, PA; Goulart, AC; Barreto, SM				Haueisen Sander Diniz, Maria de Fatima; Rezende Beleigoli, Alline Maria; Bensenor, Isabela M.; Lotufo, Paulo A.; Goulart, Alessandra C.; Barreto, Sandhi Maria			Association between TSH levels within the reference range and adiposity markers at the baseline of the ELSA-Brasil study	PLOS ONE			English	Article							BODY-MASS INDEX; THYROID-STIMULATING HORMONE; SERUM TSH; INSULIN-RESISTANCE; ANTHROPOMETRIC PARAMETERS; FREE T4; OBESITY; THYROTROPIN; DISEASE; HEALTH	Background The association of thyrotropin (TSH) with overall (body mass index, BMI), visceral (waist circumference and steatosis), and upper subcutaneous (neck circumference, NC) adiposity markers is still controversial, and the aim of this study is to assess these associations in the baseline data of a large cohort from ELSA-Brasil. Methods and findings This cross-sectional study included 11,224 participants with normal thyroid function (normal TSH levels). BMI, waist circumference, NC and steatosis, defined by hepatic attenuation (mild or moderate/severe) were the explicative variables. TSH levels were log transformed (logTSH), and multivariate linear regression models were generated to estimate the associations between logTSH and BMI (continuous and categorized), waist circumference, NC, and steatosis after adjusting for sociodemographic characteristics, health behaviors, and comorbidities. The mean age was 51.5 +/- 8.9 years, 5,793 (51.6%) participants were women, 21.8% (n = 2,444) were obese, and 15.1% of the sample was TPOAb positive. The TSH levels were significantly higher in the obese group than in the reference group (<25.0 kg/m(2)). In the multivariable linear regression models, significant associations of logTSH with BMI and obesity were found. LogTSH was associated with waist circumference only among women. NC and steatosis were not related to TSH levels. Conclusions TSH levels were associated with overall adiposity and obesity. Further studies may elucidate reference levels of TSH according to BMI status.	[Haueisen Sander Diniz, Maria de Fatima; Rezende Beleigoli, Alline Maria; Barreto, Sandhi Maria] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Rezende Beleigoli, Alline Maria] Flinders Univ S Australia, Adelaide, SA, Australia; [Bensenor, Isabela M.; Lotufo, Paulo A.] Univ Sao Paulo, Sao Paulo, Brazil; [Bensenor, Isabela M.; Lotufo, Paulo A.; Goulart, Alessandra C.] Univ Sao Paulo HU USP, Hosp Univ, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Flinders University South Australia; Universidade de Sao Paulo	Diniz, MDHS (corresponding author), Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.	mfhsdiniz@yahoo.con.br	Barreto, Sandhi M/D-2855-2014; Goulart, Alessandra C/A-1851-2013; Diniz, Maria de Fatima/D-8933-2018	Barreto, Sandhi M/0000-0001-7383-7811; Goulart, Alessandra C/0000-0003-1076-5210; Diniz, Maria de Fatima/0000-0001-9146-5003; Beleigoli, Alline/0000-0002-7848-3183	Brazilian Ministry of Health (Science and Technology Department-DECIT); Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos); Brazilian Ministry of Science and Technology (CNPq National Research Council) [01 060010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 Mg, 01 06 0115.00 SP, 01 06 0071.00 RJ]	Brazilian Ministry of Health (Science and Technology Department-DECIT); Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos); Brazilian Ministry of Science and Technology (CNPq National Research Council)	Funding: The ELSA-Brasil study was supported by the Brazilian Ministry of Health (Science and Technology Department-DECIT) and the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos and CNPq National Research Council) (grants 01 060010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 Mg, 01 06 0115.00 SP, 01 06 0071.00 RJ).". Grants are for ELSA-Brasil study, not for any individual author.	Abdi H, 2017, ANN NUTR METAB, V70, P338, DOI 10.1159/000477497; Aksoy N, 2015, PAK J MED SCI, V31, P1417, DOI 10.12669/pjms.316.7560; Alevizaki M, 2009, EUR J ENDOCRINOL, V161, P459, DOI 10.1530/EJE-09-0441; Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Asvold BO, 2015, JAMA INTERN MED, V175, P1037, DOI 10.1001/jamainternmed.2015.0930; Asvold BO, 2009, J CLIN ENDOCR METAB, V94, P5023, DOI 10.1210/jc.2009-1180; Barreto SM, 2015, J EPIDEMIOL COMMUNIT, P1; Bastemir M, 2007, SWISS MED WKLY, V137, P431; Bjergved L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093515; Bray GA, 2018, ENDOCR REV, V39, P79, DOI 10.1210/er.2017-00253; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; De Pergola G, 2007, CLIN ENDOCRINOL, V67, P265, DOI 10.1111/j.1365-2265.2007.02874.x; Dvorakova M, 2008, PHYSIOL RES, V57, pS127, DOI 10.33549/physiolres.931497; Endo T, 2008, AM J PHYSIOL-ENDOC M, V295, pE514, DOI 10.1152/ajpendo.90433.2008; Fedeli L, 2013, REV SAUDE PUBL, V47, P1; Fontenelle LC, 2016, HORM METAB RES, V48, P787, DOI 10.1055/s-0042-121421; Fox CS, 2008, ARCH INTERN MED, V168, P587, DOI 10.1001/archinte.168.6.587; Friedrich N, 2010, EXP CLIN ENDOCR DIAB, V118, P266, DOI 10.1055/s-0029-1225616; Gagnon A, 2010, METABOLISM, V59, P547, DOI 10.1016/j.metabol.2009.08.018; Galofre JC, 2008, ANN NUTR METAB, V53, P188, DOI 10.1159/000172981; Gopinath B, 2010, INTERN MED J, V40, P642, DOI 10.1111/j.1445-5994.2009.02156.x; Goulart AC, 2015, SAO PAULO MED J, V133, P115, DOI 10.1590/1516-3180.2014.9150812; Hu F., 2008, OBESITY EPIDEMIOLOGY, P53, DOI DOI 10.1093/ACPROF:OSO/9780195312911; Iacobellis G, 2005, CLIN ENDOCRINOL, V62, P487, DOI 10.1111/j.1365-2265.2005.02247.x; Jaruvongvanich V, 2017, EUR THYROID J, V6, P208, DOI 10.1159/000454920; Jiang DQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116439; Kailajarvi M, 2000, CLIN CHEM, V46, P1395; Kitahara CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034979; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Ladwig R, 2016, BRAZ J MED BIOL RES, V49, DOI [10.1590/1414-431X20165381, 10.1590/1414-431x20165381]; Liu J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00130; Makepeace AE, 2008, CLIN ENDOCRINOL, V69, P648, DOI 10.1111/j.1365-2265.2008.03239.x; Manji N, 2006, CLIN ENDOCRINOL, V64, P125, DOI 10.1111/j.1365-2265.2006.02433.x; Muscogiuri G, 2013, OBESITY, V21, P101, DOI 10.1002/oby.20240; Nannipieri M, 2009, INT J OBESITY, V33, P1001, DOI 10.1038/ijo.2009.140; Nyrnes A, 2006, INT J OBESITY, V30, P100, DOI 10.1038/sj.ijo.0803112; Preis SR, 2010, J CLIN ENDOCR METAB, V95, P3701, DOI 10.1210/jc.2009-1779; Rugge JB, 2015, ANN INTERN MED, V162, P35, DOI 10.7326/M14-1456; Sakurai M, 2014, INTERNAL MED, V53, P669, DOI 10.2169/internalmedicine.53.1387; Sam S, 2018, HORM MOL BIOL CLIN I, V33, DOI 10.1515/hmbci-2018-0014; Sari R, 2003, CLIN ENDOCRINOL, V59, P258, DOI 10.1046/j.1365-2265.2003.01836.x; Schmidt MI, 2013, REV SAUDE PUBL, V47, P105, DOI 10.1590/S0034-8910.2013047003889; Souza AD, 2011, EUR J ENDOCRINOL, V165, P11, DOI 10.1530/EJE-11-0261; Souza AD, 2011, OBESITY FACTS, V4, P175, DOI 10.1159/000327843; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Svare A, 2011, CLIN ENDOCRINOL, V74, P769, DOI 10.1111/j.1365-2265.2011.04009.x; Tiller D, 2016, THYROID, V26, P1205, DOI 10.1089/thy.2015.0410; Witte T, 2017, EUR THYROID J, V6, P12, DOI 10.1159/000450977; World Health Organization, KEY FACTS	50	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228801	10.1371/journal.pone.0228801	http://dx.doi.org/10.1371/journal.pone.0228801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032374	Green Published, gold			2022-12-26	WOS:000534626100026
J	Sun, CJ; Yu, ML; Zeng, ZH; Francis, F; Cui, HX; Verheggen, F				Sun, Changjiao; Yu, Manli; Zeng, Zhanghua; Francis, Frederic; Cui, Haixin; Verheggen, Francois			Biocidal activity of polylactic acid-based nano-formulated abamectin on Acyrthosiphon pisum (Hemiptera: Aphididae) and the aphid predator Adalia bipunctata (Coleoptera: Coccinellidae)	PLOS ONE			English	Article							CONTROLLED-RELEASE; MYZUS-PERSICAE; PESTICIDES; MICROCAPSULES; ENCAPSULATION; INSECTICIDES; VERSATILE; TOXICITY; ADHESION; TRENDS	Abamectin is a common biocide used to control agricultural insect pests. However, the water insolubility of abamectin may result in extra organic solvent introduced in the environment. To solve this issue, it is desirable to develop nanoformulations to encapsulate abamectin with environment-friendly polymers. In this study, two polylactic acid based abamectin nanoformulations were prepared. The average particle sizes, measured by dynamic light scattering and transmission electron microscope, were 240 nm and 150 nm, respectively. The insecticidal activity of these nano-formulated abamectin was examined in the laboratory on the pea aphid, Acyrthosiphon pisum (Hemiptera: Aphididae). The acute toxicity of nano-formulated abamectin on non-target aphid predator Adalia bipunctata (Coleoptera: Coccinellidae) was also evaluated by topical, residual and oral exposure. The two nano-formulated abamectin had comparable insecticidal effect with commercial abamectin formulation against the pea aphid. Taking median lethal concentration (LC50) as the toxicological endpoint, nanoformulations had higher contact toxicity and lower oral toxicity to first-instar larvae of the predator A. bipunctata. These results are expected to contribute to the application of solvent-free nano-formulated pesticides that comply with the integrated pest management (IPM) strategies.	[Sun, Changjiao; Francis, Frederic; Verheggen, Francois] Univ Liege, Gembloux Agrobio Tech, Gembloux, Belgium; [Sun, Changjiao; Yu, Manli; Zeng, Zhanghua; Cui, Haixin] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing, Peoples R China	University of Liege; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS	Verheggen, F (corresponding author), Univ Liege, Gembloux Agrobio Tech, Gembloux, Belgium.	fverheggen@uliege.be	sun, changjiao/ABB-1670-2020	Verheggen, Francois/0000-0002-5849-1661	National Key Research and Development Program of China [2017YFD0200300, 2016YFD0200500]	National Key Research and Development Program of China	This work was supported by the National Key Research and Development Program of China (2017YFD0200300 and 2016YFD0200500).	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Al Antary TM, 2016, EGYPT J BIOL PEST CO, V26, P533; Anjum F, 2016, CROP PROT, V88, P131, DOI 10.1016/j.cropro.2016.06.002; Bai SH, 2016, CHEMOSPHERE, V154, P204, DOI 10.1016/j.chemosphere.2016.03.113; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Boehm AL, 2003, J MICROENCAPSUL, V20, P433, DOI 10.1080/0265204021000058410; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Campolo O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13413-0; Chen HD, 2011, TRENDS FOOD SCI TECH, V22, P585, DOI 10.1016/j.tifs.2011.09.004; Cui B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191742; de Oliveira JL, 2014, BIOTECHNOL ADV, V32, P1550, DOI 10.1016/j.biotechadv.2014.10.010; Department of Economic and Social Affairs of the United Nations Secretariat, 2015, WORLD POP PROSP 2015; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ejima H, 2013, SCIENCE, V341, P154, DOI 10.1126/science.1237265; FINNEY D J, 1971, P333; Gao SC, 2019, PEST MANAG SCI, V75, P2592, DOI 10.1002/ps.5430; Godfray H Charles J, 2014, Philos Trans R Soc Lond B Biol Sci, V369, P20120273, DOI 10.1098/rstb.2012.0273; Guilger M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44421; He S, 2013, J MATER CHEM B, V1, P1270, DOI 10.1039/c2tb00234e; Hulle M, 2020, ENTOMOL GEN, V40, P97, DOI 10.1127/entomologia/2019/0867; Islam T., 2017, Journal of Bangladesh Agricultural University, V15, P234, DOI 10.3329/jbau.v15i2.35068; Jam NA, 2018, ENTOMOL GEN, V38, P173, DOI 10.1127/entomologia/2018/0734; Kah M, 2013, CRIT REV ENV SCI TEC, V43, P1823, DOI 10.1080/10643389.2012.671750; Kah M, 2014, ENVIRON INT, V63, P224, DOI 10.1016/j.envint.2013.11.015; Kaspi R, 2019, BIOL CONTROL, V132, P42, DOI 10.1016/j.biocontrol.2019.01.011; Khandelwal N, 2016, J ENVIRON MANAGE, V184, P157, DOI 10.1016/j.jenvman.2016.09.071; Kim S, 2015, ACS APPL MATER INTER, V7, P6412, DOI 10.1021/acsami.5b01304; Kookana RS, 2014, J AGR FOOD CHEM, V62, P4227, DOI 10.1021/jf500232f; Lee BK, 2016, ADV DRUG DELIVER REV, V107, P176, DOI 10.1016/j.addr.2016.05.020; Lewis KA, 2015, PESTICIDE PROPERTIES; Li D, 2016, CARBOHYD POLYM, V136, P341, DOI 10.1016/j.carbpol.2015.09.050; Liu BX, 2016, COLLOID SURFACE B, V144, P38, DOI 10.1016/j.colsurfb.2016.03.084; Mani M, 2018, BIOCONTROL SCI TECHN, V28, P938, DOI 10.1080/09583157.2018.1487029; Mohammed AAH, 2018, ENTOMOL GEN, V37, P47, DOI 10.1127/entomologia/2017/0471; Nuruzzaman M, 2016, J AGR FOOD CHEM, V64, P1447, DOI 10.1021/acs.jafc.5b05214; Ozawa A, 2016, JPN J APPL ENTOMOL Z, V60, P45, DOI 10.1303/jjaez.2016.45; Papanikolaou NE, 2018, ENVIRON SCI POLLUT R, V25, P10243, DOI 10.1007/s11356-017-8596-2; Rahim MA, 2014, CHEM MATER, V26, P1645, DOI 10.1021/cm403903m; Campos EVR, 2015, AGRON SUSTAIN DEV, V35, P47, DOI 10.1007/s13593-014-0263-0; Ricupero M, 2020, CHEMOSPHERE, V247, DOI 10.1016/j.chemosphere.2019.125728; Roy A, 2014, CENT EUR J CHEM, V12, P453, DOI 10.2478/s11532-013-0405-2; Satehi AB, 2018, ENTOMOL GEN, V37, P77, DOI 10.1127/entomologia/2017/0406; Sileika Tadas S, 2013, Angew Chem Int Ed Engl, V52, P10766, DOI 10.1002/anie.201304922; Silva DE, 2019, CROP PROT, V123, P5, DOI 10.1016/j.cropro.2019.05.014; Ujjan A.A., 2014, J AGRI FOOD APPL SCI, V2, P45; Ullah F, 2019, ENTOMOL GEN, V39, P137, DOI 10.1127/entomologia/2019/0865; Villaverde JJ, 2017, NEW PESTICIDES SOIL, P227, DOI DOI 10.1016/B978-0-12-804299-1.00007-2; Wang AQ, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-017-2405-1; Youn YN, 2003, BIOL CONTROL, V28, P164, DOI 10.1016/S1049-9644(03)00098-7; Yu ML, 2019, RSC ADV, V9, P27096, DOI 10.1039/c9ra05843e; Yu ML, 2017, RSC ADV, V7, P11271, DOI 10.1039/c6ra27345a; Zhang XY, 2015, TOXICOL RES-UK, V4, P160, DOI 10.1039/c4tx00066h	52	9	9	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228817	10.1371/journal.pone.0228817	http://dx.doi.org/10.1371/journal.pone.0228817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032382	Green Published, gold			2022-12-26	WOS:000534626100028
J	Costa, SD; de Andrade, LGM; Barroso, FVC; de Oliveira, CMC; Daher, ED; Fernandes, PFCBC; Esmeraldo, RD; de Sandes-Freitas, TV				Costa, Silvana Daher; Modelli de Andrade, Luis Gustavo; Carvalho Barroso, Francisco Victor; Costa de Oliveira, Claudia Maria; de Francesco Daher, Elizabeth; Branco Camurca Fernandes, Paula Frassinetti Castelo; Esmeraldo, Ronaldo de Matos; de Sandes-Freitas, Taina Veras			The impact of deceased donor maintenance on delayed kidney allograft function: A machine learning analysis	PLOS ONE			English	Article							GRAFT FUNCTION; RENAL-TRANSPLANTATION; PATIENT SURVIVAL; MANAGEMENT GOALS; CADAVERIC KIDNEY; PREDICTION; OUTCOMES; REGULARIZATION; MODELS; BRAZIL	Background This study evaluated the risk factors for delayed graft function (DGF) in a country where its incidence is high, detailing donor maintenance-related (DMR) variables and using machine learning (ML) methods beyond the traditional regression-based models. Methods A total of 443 brain dead deceased donor kidney transplants (KT) from two Brazilian centers were retrospectively analyzed and the following DMR were evaluated using predictive modeling: arterial blood gas pH, serum sodium, blood glucose, urine output, mean arterial pressure, vasopressors use, and reversed cardiac arrest. Results Most patients (95.7%) received kidneys from standard criteria donors. The incidence of DGF was 53%. In multivariable logistic regression analysis, DMR variables did not impact on DGF occurrence. In post-hoc analysis including only KT with cold ischemia time<21h (n = 220), urine output in 24h prior to recovery surgery (OR = 0.639, 95%CI 0.444-0.919) and serum sodium (OR = 1.030, 95%CI 1.052-1.379) were risk factors for DGF. Using elastic net regularized regression model and ML analysis (decision tree, neural network and support vector machine), urine output and other DMR variables emerged as DGF predictors: mean arterial pressure, >= 1 or high dose vasopressors and blood glucose. Conclusions Some DMR variables were associated with DGF, suggesting a potential impact of variables reflecting poor clinical and hemodynamic status on the incidence of DGF.	[Costa, Silvana Daher; Carvalho Barroso, Francisco Victor; de Francesco Daher, Elizabeth; de Sandes-Freitas, Taina Veras] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil; [Costa, Silvana Daher; Costa de Oliveira, Claudia Maria; Branco Camurca Fernandes, Paula Frassinetti Castelo] Walter Cantidio Univ Hosp, Fortaleza, Ceara, Brazil; [Costa, Silvana Daher; Costa de Oliveira, Claudia Maria; Esmeraldo, Ronaldo de Matos; de Sandes-Freitas, Taina Veras] Hosp Geral Fortaleza, Fortaleza, Ceara, Brazil; [Modelli de Andrade, Luis Gustavo] Univ Estadual Paulista, Dept Internal Med, UNESP, Botucatu, SP, Brazil	Universidade Federal do Ceara; Universidade Estadual Paulista	de Sandes-Freitas, TV (corresponding author), Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil.; de Sandes-Freitas, TV (corresponding author), Hosp Geral Fortaleza, Fortaleza, Ceara, Brazil.	taina.sandes@gmail.com	de Andrade, Luis Gustavo Modelli/I-4146-2013; De Francesco Daher, Elizabeth/G-2210-2012	De Francesco Daher, Elizabeth/0000-0003-4189-1738; Sandes-Freitas, Taina/0000-0002-4435-0614; Modelli de Andrade, Luis Gustavo/0000-0002-0230-0766; Carvalho Barroso, Francisco Victor/0000-0003-3152-8839	Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (Funcap); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)	Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (Funcap)(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SDC received support for travel expenses from Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (Funcap) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other authors received no specific funding for this work.	Allen MB, 2016, AM J TRANSPLANT, V16, P181, DOI 10.1111/ajt.13432; Azevedo LS, 2005, TRANSPLANT P, V37, P2746, DOI 10.1016/j.transproceed.2005.05.005; Bunnapradist S, 2003, J AM SOC NEPHROL, V14, P208, DOI 10.1097/01.ASN.0000037678.54984.41; Butala NM, 2013, TRANSPLANTATION, V95, P1008, DOI 10.1097/TP.0b013e3182855544; Cardinal H, 2019, AM J TRANSPLANT, V19, P277, DOI 10.1111/ajt.15127; Chapal M, 2014, KIDNEY INT, V86, P1130, DOI 10.1038/ki.2014.188; de Sandes-Freitas TV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144188; Decruyenaere A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0206-y; Fonseca I, 2015, TRANSPL INT, V28, P738, DOI 10.1111/tri.12543; Franklin GA, 2010, AM SURGEON, V76, P587; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Martinez EG, 2011, TRANSPL P, V43, P2171, DOI 10.1016/j.transproceed.2011.06.051; Goldstein BA, 2017, EUR HEART J, V38, P1805, DOI 10.1093/eurheartj/ehw302; Gutierrez P, 2007, NEPHROL DIAL TRANSPL, V22, P1451, DOI 10.1093/ndt/gfl771; Hannun Pedro Guilherme Coelho, 2019, Braz. J. Nephrol., V41, P284, DOI [10.1590/2175-8239-JBN-2018-0047, 10.1590/2175-8239-jbn-2018-0047]; Helfer MS, 2014, TRANSPL P, V46, P1727, DOI 10.1016/j.transproceed.2014.05.026; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Kers J, 2018, NEPHROL DIAL TRANSPL, V33, P1259, DOI 10.1093/ndt/gfy019; Malinoski DJ, 2013, AM J TRANSPLANT, V13, P993, DOI 10.1111/ajt.12090; Mallon DH, 2013, TRANSPLANTATION, V96, P885, DOI 10.1097/TP.0b013e3182a19348; Rangel EB, 2010, TRANSPL P, V42, P3655, DOI 10.1016/j.transproceed.2010.06.030; Rodrigo E, 2012, AM J TRANSPLANT, V12, P240, DOI 10.1111/j.1600-6143.2011.03810.x; Sandes-Freitas Tainá Veras de, 2019, Braz. J. Nephrol., V41, P166, DOI [10.1590/2175-8239-jbn-2018-0221, 10.1590/2175-8239-JBN-2018-0221]; Silva SFR, 2014, TRANSPL P, V46, P1692, DOI 10.1016/j.transproceed.2014.05.008; Sun QP, 2018, KIDNEY BLOOD PRESS R, V43, P893, DOI 10.1159/000490337; Yoo KD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08008-8; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	27	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228597	10.1371/journal.pone.0228597	http://dx.doi.org/10.1371/journal.pone.0228597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027717	Green Published, gold			2022-12-26	WOS:000534623800054
J	Draijer, C; Speth, JM; Penke, LRK; Zaslona, Z; Bazzill, JD; Lugogo, N; Huang, YJ; Moon, JJ; Peters-Golden, M				Draijer, Christina; Speth, Jennifer M.; Penke, Loka R. K.; Zaslona, Zbigniew; Bazzill, Joseph D.; Lugogo, Njira; Huang, Yvonne J.; Moon, James J.; Peters-Golden, Marc			Resident alveolar macrophage-derived vesicular SOCS3 dampens allergic airway inflammation	FASEB JOURNAL			English	Article						allergic airway inflammation; alveolar macrophages; extracellular vesicles; epithelial cells; liposomes; suppressor of cytokine signaling 3	CYTOKINE SIGNALING 3; LUNG INFLAMMATION; STAT PATHWAY; CELL; EPITHELIUM; ASTHMA; SUPPRESSOR; SECRETION; MODEL; MICE	Resident alveolar macrophages (AMs) suppress allergic inflammation in murine asthma models. Previously we reported that resident AMs can blunt inflammatory signaling in alveolar epithelial cells (ECs) by transcellular delivery of suppressor of cytokine signaling 3 (SOCS3) within extracellular vesicles (EVs). Here we examined the role of vesicular SOCS3 secretion as a mechanism by which AMs restrain allergic inflammatory responses in airway ECs. Bronchoalveolar lavage fluid (BALF) levels of SOCS3 were reduced in asthmatics and in allergen-challenged mice. Ex vivo SOCS3 secretion was reduced in AMs from challenged mice and this defect was mimicked by exposing normal AMs to cytokines associated with allergic inflammation. Both AM-derived EVs and synthetic SOCS3 liposomes inhibited the activation of STAT3 and STAT6 as well as cytokine gene expression in ECs challenged with IL-4/IL-13 and house dust mite (HDM) extract. This suppressive effect of EVs was lost when they were obtained from AMs exposed to allergic inflammation-associated cytokines. Finally, inflammatory cell recruitment and cytokine generation in the lungs of OVA-challenged mice were attenuated by intrapulmonary pretreatment with SOCS3 liposomes. Overall, AM secretion of SOCS3 within EVs serves as a brake on airway EC responses during allergic inflammation, but is impaired in asthma. Synthetic liposomes encapsulating SOCS3 can rescue this defect and may serve as a framework for novel therapeutic approaches targeting airway inflammation.	[Draijer, Christina; Speth, Jennifer M.; Penke, Loka R. K.; Zaslona, Zbigniew; Lugogo, Njira; Huang, Yvonne J.; Peters-Golden, Marc] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Med Sch, 6301 MSRB 3,1150 Med Ctr Dr, Ann Arbor, MI 48109 USA; [Bazzill, Joseph D.; Moon, James J.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Moon, James J.; Peters-Golden, Marc] Univ Michigan, Grad Program Immunol, Med Sch, Ann Arbor, MI 48109 USA; [Moon, James J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Peters-Golden, M (corresponding author), Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Med Sch, 6301 MSRB 3,1150 Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu	PENKE, LOKA RAGHU KUMAR/L-7255-2016; Moon, James J/ABE-4429-2021	Moon, James J/0000-0003-2238-2372; Huang, Yvonne/0000-0002-7497-6597; PENKE, LOKA RAGHU KUMAR/0000-0002-2780-7950; Zaslona, Zbigniew/0000-0003-3361-4140; Speth, Jennifer/0000-0002-7724-6995	National Institutes of Health [R01 HL 12555, R35 H144979]; NIH [T32 HL 7749-23]; American Cancer Society; AHA	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); AHA(American Heart Association)	National Institutes of Health, Grant/Award Number: R01 HL 12555 and R35 H144979; NIH Training, Grant/Award Number: T32 HL 7749-23; American Cancer Society, Grant/Award Number: J.M.S.; AHA, Grant/Award Number: L.R.P	Ashino S, 2014, J ALLERGY CLIN IMMUN, V133, P1162, DOI 10.1016/j.jaci.2013.10.036; Banerjee S, 2017, DRUGS, V77, P521, DOI 10.1007/s40265-017-0701-9; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Calbet M, 2019, J PHARMACOL EXP THER, V370, P137, DOI 10.1124/jpet.119.256263; Careau E, 2004, AM J RESP CELL MOL, V31, P22, DOI 10.1165/rcmb.2003-0229OC; Chung S, 2016, ONCOTARGET, V7, P17532, DOI 10.18632/oncotarget.8162; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; de Oliveira JR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/178369; Draijer C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/632049; Draijer C, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0681-6; Fricker M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00196-2017; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kubo M, 2006, CURR ALLERGY ASTHM R, V6, P32, DOI 10.1007/s11882-006-0007-6; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lee YG, 2015, AM J RESP CELL MOL, V52, P772, DOI 10.1165/rcmb.2014-0255OC; Li RF, 2018, EUR REV MED PHARMACO, V22, P835, DOI 10.26355/eurrev_201802_14320; Matsunaga Y, 2011, BIOCHEM BIOPH RES CO, V404, P261, DOI 10.1016/j.bbrc.2010.11.104; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; Melgert BN, 2010, AM J RESP CELL MOL, V42, P595, DOI 10.1165/rcmb.2009-0016OC; Melgert BN, 2005, CLIN EXP ALLERGY, V35, P1496, DOI 10.1111/j.1365-2222.2005.02362.x; Nasreen N, 2012, INT IMMUNOPHARMACOL, V12, P217, DOI 10.1016/j.intimp.2011.11.014; Zafra MP, 2015, INT J MOL SCI, V16, P5434, DOI 10.3390/ijms16035434; Peters-Golden M, 2004, AM J RESP CELL MOL, V31, P3, DOI 10.1165/rcmb.f279; Salama N, 2013, ARCH ITAL UROL ANDRO, V85, P118, DOI 10.4081/aiua.2013.3.118; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; Schneider DJ, 2017, J BIOL CHEM, V292, P20897, DOI 10.1074/jbc.M117.792416; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Speth JM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131340; Speth JM, 2016, J IMMUNOL, V196, P5112, DOI 10.4049/jimmunol.1502153; Spinelli C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1490144; THEPEN T, 1994, ANN NY ACAD SCI, V725, P200, DOI 10.1111/j.1749-6632.1994.tb39802.x; Vale K, 2016, FUTURE MED CHEM, V8, P405, DOI 10.4155/fmc.16.4; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Yoshimura A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028571; Zaslona Z, 2014, J IMMUNOL, V193, P4245, DOI 10.4049/jimmunol.1400580; Zaslona Z, 2014, J ALLERGY CLIN IMMUN, V133, P379, DOI 10.1016/j.jaci.2013.07.037; Zhou HW, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-7	42	19	20	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4718	4731		10.1096/fj.201903089R	http://dx.doi.org/10.1096/fj.201903089R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030817	Green Published, Green Accepted			2022-12-26	WOS:000512331900001
J	Adenis, L; Gontran, E; Deroulers, C; Grammaticos, B; Juchaux, M; Seksek, O; Badoual, M				Adenis, Leo; Gontran, Emilie; Deroulers, Christophe; Grammaticos, Basile; Juchaux, Marjorie; Seksek, Olivier; Badoual, Mathilde			Experimental and modeling study of the formation of cell aggregates with differential substrate adhesion	PLOS ONE			English	Article							TRANSITION; SIMULATION; MIGRATION; FRACTALS; KINETICS	The study of cell aggregation in vitro has a tremendous importance these days. In cancer biology, aggregates and spheroids serve as model systems and are considered as pseudotumors that are more realistic than 2D cell cultures. Recently, in the context of brain tumors (gliomas), we developed a new poly(ethylene glycol) (PEG)-based hydrogel, with adhesive properties that can be controlled by the addition of poly(L-lysine) (PLL), and a stiffness close to the brain's. This substrate allows the motion of individual cells and the formation of cell aggregates (within one day), and we showed that on a non-adhesive substrate (PEG without PLL is inert for cells), the aggregates are bigger and less numerous than on an adhesive substrate (with PLL). In this article, we present new experimental results on the follow-up of the formation of aggregates on our hydrogels, from the early stages (individual cells) to the late stages (aggregate compaction), in order to compare, for two cell lines (F98 and U87), the aggregation process on the adhesive and non-adhesive substrates. We first show that a spaceless model of perikinetic aggregation can reproduce the experimental evolution of the number of aggregates, but not of the mean area of the aggregates. We thus develop a minimal off-lattice agent-based model, with a few simple rules reproducing the main processes that are at stack during aggregation. Our spatial model can reproduce very well the experimental temporal evolution of both the number of aggregates and their mean area, on adhesive and non-adhesive soft gels and for the two different cell lines. From the fit of the experimental data, we were able to infer the quantitative values of the speed of motion of each cell line, its rate of proliferation in aggregates and its ability to organize in 3D. We also found qualitative differences between the two cell lines regarding the ability of aggregates to compact. These parameters could be inferred for any cell line, and correlated with clinical properties such as aggressiveness and invasiveness.	[Adenis, Leo; Deroulers, Christophe; Grammaticos, Basile; Juchaux, Marjorie; Seksek, Olivier; Badoual, Mathilde] Univ Paris Diderot, Univ Paris Sud, Lab IMNC, CNRS,UMR 8165, F-91405 Orsay, France; [Gontran, Emilie] Univ Paris Sud, INSERM, UMR S 1174, ICPH Interact Cellulaires & Physiopathol Hepat, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Badoual, M (corresponding author), Univ Paris Diderot, Univ Paris Sud, Lab IMNC, CNRS,UMR 8165, F-91405 Orsay, France.	Badoual@imnc.in2p3.fr	Seksek, Olivier/AAO-1837-2020	Seksek, Olivier/0000-0002-3053-3022	GEFLUC association (association des Entreprises Francaises dans la Lutte contre le Cancer); Region Ile-de-France ('DIM Problematiques transversales aux systemes complexes") [ISC-2014-PME-003]	GEFLUC association (association des Entreprises Francaises dans la Lutte contre le Cancer); Region Ile-de-France ('DIM Problematiques transversales aux systemes complexes")(Region Ile-de-France)	This work was supported through a grant of CD from Region Ile-de-France (`DIM Problematiques transversales aux systemes complexes ISC-2014-PME-003") and a grant of MB and OS from the GEFLUC association (association des Entreprises Francaises dans la Lutte contre le Cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported through a grant from Region Ile-de-France ('DIM Problematiques transversales aux systemes complexes ISC-2014-PME-003") and a grant from the GEFLUC association (association des Entreprises Francaises dans la Lutte contre le Cancer).	Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Agnew DJG, 2014, J THEOR BIOL, V352, P16, DOI 10.1016/j.jtbi.2014.02.033; Agosti A, ARXIV190508074QBIOCB; Aubert M, 2006, PHYS BIOL, V3, P93, DOI 10.1088/1478-3975/3/2/001; Aubert M, 2008, ACTA BIOTHEOR, V56, P297, DOI 10.1007/s10441-008-9061-x; Baratchart E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004626; Bubba F, 2019, J THEOR BIOL, V479, P73, DOI 10.1016/j.jtbi.2019.07.002; Chatelain C, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/115013; Deroulers C, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031917; Deutsch A, 2005, CELLULAR AUTOMATON M; Douezan S, 2012, SOFT MATTER, V8, P784, DOI 10.1039/c1sm06399e; Douezan S, 2011, P NATL ACAD SCI USA, V108, P7315, DOI 10.1073/pnas.1018057108; Dufour A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005977; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Glinsky VV, 2003, CANCER RES, V63, P3805; Gontran E, 2018, J APPL POLYM SCI, V135, DOI 10.1002/app.46287; Heer NC, 2017, DEVELOPMENT, V144, P4249, DOI 10.1242/dev.151282; JULLIEN R, 1992, CROAT CHEM ACTA, V65, P215; Khain E, 2007, J STAT PHYS, V128, P209, DOI 10.1007/s10955-006-9194-8; LIN MY, 1989, NATURE, V339, P360, DOI 10.1038/339360a0; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Liu QX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6234; MEAKIN P, 1992, CROAT CHEM ACTA, V65, P237; Molnar B, 2001, CLIN CANCER RES, V7, P4080; Moncho-Jorda A, 2001, EUR PHYS J E, V5, P471, DOI 10.1007/s101890170054; Neelamegham S, 1997, BIOPHYS J, V72, P51, DOI 10.1016/S0006-3495(97)78646-6; Palsson E, 2000, P NATL ACAD SCI USA, V97, P10448, DOI 10.1073/pnas.97.19.10448; Ribeiro C, 2003, DEV BIOL, V260, P1, DOI 10.1016/S0012-1606(03)00211-2; Smoluchowski M., 1916, Z PHYS, V17, P557; Turlier N, 2015, SEMIN CELL DEV BIOL, V47-48, DOI 10.1016/j.semcdb.2015.08.001; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; von Smoluchowski M, 1916, PHYS Z, V17, P585; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; White MD, 2017, CURR OPIN CELL BIOL, V44, P7, DOI 10.1016/j.ceb.2016.11.002; Winters BS, 2005, INT J CANCER, V114, P371, DOI 10.1002/ijc.20722; Woolf N, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.77	37	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0222371	10.1371/journal.pone.0222371	http://dx.doi.org/10.1371/journal.pone.0222371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023245	gold, Green Submitted, Green Published			2022-12-26	WOS:000534621500004
J	Kazachkov, M; Li, Q; Shen, WY; Wang, LP; Gao, P; Xiang, DQ; Datla, R; Zou, JT				Kazachkov, Michael; Li, Qiang; Shen, Wenyun; Wang, Liping; Gao, Peng; Xiang, Daoquan; Datla, Raju; Zou, Jitao			Molecular identification and functional characterization of a cyanogenic glucosyltransferase from flax (Linum unsitatissimum)	PLOS ONE			English	Article							SORGHUM-BICOLOR; SUBCELLULAR-LOCALIZATION; GLUCOSIDE DHURRIN; HIGHER-PLANTS; INVITRO BIOSYNTHESIS; UDP-GLUCOSE; CYANOHYDRIN; USITATISSIMUM; LOTAUSTRALIN; SPECIFICITY	Flax seed has become consumers' choice for not only polyunsaturated alpha-linolenic fatty acid but also nutraceuticals such as lignans and soluble fiber. There is, however, a major drawback of flax as a source of functional food since the seeds contain significant level of cyanogenic glucosides. The final step of cyanogenic glucoside biosynthesis is mediated by UDP-glucose dependent glucosyltransferase. To date, no flax cyanogenic glucosyl transferase genes have been reported with verified biochemical functionality. Here we present a study on the identification and enzymatic characterization of a first flax cyanogenic glucosyltransferase, LuCGT1. We show that LuCGT1 was highly active towards both aliphatic and aromatic substrates. The LuCGT1 gene is expressed in leaf tissues as well as in developing seeds, and its expression level was drastically reduced in flax mutant lines low in cyanogenic glucosides. Identification of LuCGT1 provides a molecular handle for developing gene specific markers for targeted breeding of low cyanogenic glucosides in flax.	[Kazachkov, Michael; Li, Qiang; Shen, Wenyun; Wang, Liping; Gao, Peng; Xiang, Daoquan; Datla, Raju; Zou, Jitao] Natl Res Council Canada, Saskatoon, SK, Canada; [Li, Qiang] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Li, Qiang] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Wang, Liping] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Gao, Peng; Datla, Raju] Univ Saskatchewan, Global Inst Food Secur, Saskatoon, SK, Canada	National Research Council Canada; University of Saskatchewan; Huazhong Agricultural University; University of Guelph; University of Saskatchewan	Zou, JT (corresponding author), Natl Res Council Canada, Saskatoon, SK, Canada.	Jitao.Zou@nrc-cnrc.gc.ca	Datla, Raju/AGR-7376-2022	Gao, Peng/0000-0002-6586-4307; Wang, Liping/0000-0002-2913-311X; Zou, Jitao/0000-0002-1287-6160	National Research Council of Canada core research program; TUFGEN project from Genome Prairie; Genome Canada; National Research Council Canada publication NRCC [56332]	National Research Council of Canada core research program; TUFGEN project from Genome Prairie; Genome Canada(Genome Canada); National Research Council Canada publication NRCC	This research was supported by the National Research Council of Canada core research program and by the TUFGEN project from Genome Prairie and Genome Canada, a not-forprofit organization that is leading's national strategy on genomics. There was no additional external funding received for this study. This is National Research Council Canada publication NRCC#56332.	Andersen MD, 2000, J BIOL CHEM, V275, P1966, DOI 10.1074/jbc.275.3.1966; Barvkar VT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-175; Caputi L, 2012, PLANT J, V69, P1030, DOI 10.1111/j.1365-313X.2011.04853.x; Chin-Fatt A., 2014, THESIS; COLLINGE DB, 1982, ARCH BIOCHEM BIOPHYS, V218, P38, DOI 10.1016/0003-9861(82)90318-6; CUTLER AJ, 1985, ARCH BIOCHEM BIOPHYS, V238, P272, DOI 10.1016/0003-9861(85)90165-1; CUTLER AJ, 1981, J BIOL CHEM, V256, P4253; Forslund K, 2004, PLANT PHYSIOL, V135, P71, DOI 10.1104/pp.103.038059; FREHNER M, 1990, PLANT PHYSIOL, V94, P28, DOI 10.1104/pp.94.1.28; Ghose K, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-82; HAHLBROC.K, 1970, J BIOL CHEM, V245, P917; HALKIER BA, 1990, J BIOL CHEM, V265, P21114; HOSEL W, 1984, ARCH BIOCHEM BIOPHYS, V229, P177, DOI 10.1016/0003-9861(84)90142-5; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; Kannangara R, 2011, PLANT J, V68, P287, DOI 10.1111/j.1365-313X.2011.04695.x; KOCH B, 1992, ARCH BIOCHEM BIOPHYS, V292, P141, DOI 10.1016/0003-9861(92)90062-2; KOCH BM, 1995, ARCH BIOCHEM BIOPHYS, V323, P177; Laursen T, 2016, SCIENCE, V354, P890, DOI 10.1126/science.aag2347; MCFARLANE IJ, 1975, J BIOL CHEM, V250, P4708; Mederacke H, 1996, PHYTOCHEMISTRY, V42, P1517, DOI 10.1016/0031-9422(96)00172-0; MOLLER BL, 1980, J BIOL CHEM, V255, P3049; Nielsen KA, 2008, PHYTOCHEMISTRY, V69, P88, DOI 10.1016/j.phytochem.2007.06.033; POULTON JE, 1988, CIBA F SYMP, V140, P67; SAUNDERS JA, 1978, PLANT PHYSIOL, V61, P154, DOI 10.1104/pp.61.2.154; SAUNDERS JA, 1977, PLANT PHYSIOL, V59, P647, DOI 10.1104/pp.59.4.647; Seigler D.S., 1991, P35; SWAIN E, 1992, PLANT PHYSIOL, V100, P291, DOI 10.1104/pp.100.1.291; SWAIN E, 1994, PLANT PHYSIOL, V106, P437, DOI 10.1104/pp.106.2.437; THAYER SS, 1981, PLANT PHYSIOL, V67, P617, DOI 10.1104/pp.67.4.617; Thorsoe KS, 2005, PLANT PHYSIOL, V139, P664, DOI 10.1104/pp.105.063842; Venglat P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-74; Vetter J, 2000, TOXICON, V38, P11, DOI 10.1016/S0041-0101(99)00128-2; WURTELE ES, 1982, PLANT PHYSIOL, V70, P1732, DOI 10.1104/pp.70.6.1732	33	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227840	10.1371/journal.pone.0227840	http://dx.doi.org/10.1371/journal.pone.0227840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023283	gold, Green Published			2022-12-26	WOS:000534621500025
J	Larson, RN; Brown, JL; Karels, T; Riley, SPD				Larson, Rachel N.; Brown, Justin L.; Karels, Tim; Riley, Seth P. D.			Effects of urbanization on resource use and individual specialization in coyotes (Canis latrans) in southern California	PLOS ONE			English	Article							STABLE-ISOTOPES; DISCRIMINATION FACTORS; HABITAT FRAGMENTATION; FORAGING SPECIALIZATION; DIET SPECIALIZATION; ANTHROPOGENIC FOOD; URBAN; ECOLOGY; CARBON; FOX	Urban environments are unique because fragments of natural or semi-natural habitat are embedded within a potentially permeable matrix of human-dominated areas, creating increased landscape and, potentially, habitat heterogeneity. In addition, urban areas can provide diet subsidies for wildlife species in the form of fruiting ornamental plants, trash, and domestic animals. Ecological opportunity in the forms of habitat and food heterogeneity are thought to be important mechanisms in maintaining individual specialization. Identifying which contexts, traits, and mechanisms determine the success or failure of individuals within an urban wildlife population could potentially provide predictions about which populations may succeed in human-dominated landscapes and which may experience local extinction. We used both scat and stable isotope analysis of whiskers to investigate the degree to which coyotes (Canis latrans) utilized anthropogenic subsidies and exhibited individual diet specialization across the urban-rural gradient in southern California. Land use surrounding scat and isotope sample locations was also evaluated to determine the effect of land cover on diet. Human food constituted a significant portion of urban coyote diet (22% of scats, 38% of diet estimated by stable isotope analysis). Domestic cats (Felis catus) and ornamental fruit and seeds were also important items in urban coyote diets. Consumption of anthropogenic items decreased with decreasing urbanization. In suburban areas, seasonality influenced the frequency of occurrence of anthropogenic subsidies with increased consumption in the dry season. The amount of altered open space (areas such as golf courses, cemeteries, and landscaped parks) nearby had a negative effect on the consumption of anthropogenic items in both urban and suburban areas. Contrary to our hypothesis, urban coyotes displayed reduced between-individual variation compared to suburban and rural coyotes. It is possible that the core urban areas of cities are so densely developed and subsidized that wildlife inhabiting these areas actually have reduced ecological opportunity. Suburban animals had the broadest isotopic niches and maintained similar individual specialization to rural coyotes. Wildlife in suburban areas still have access to relatively undisturbed natural areas while being able to take advantage of anthropogenic subsidies in neighboring residential areas. Therefore, areas with intermediate urban development may be associated with increased ecological opportunity and specialization.	[Larson, Rachel N.; Karels, Tim] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Brown, Justin L.; Riley, Seth P. D.] Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA USA	California State University System; California State University Northridge; United States Department of the Interior	Larson, RN (corresponding author), Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA.	RLarson92@gmail.com		Larson, Rachel/0000-0003-1319-5671	Southern California Research Learning Center	Southern California Research Learning Center	Funding was provided by the Southern California Research Learning Center (https://www.nps.gov/rlc/southerncal/index.htm), no grant number (RNL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; Beier P, 2006, CONNECTIVITY CONSERV, P555, DOI DOI 10.1046/J.1523-1739.2003.01458.X; BEKOFF M, 1977, Mammalian Species, V79, P1; Bolger DT, 1997, ECOL APPL, V7, P552, DOI 10.1890/1051-0761(1997)007[0552:RORTHF]2.0.CO;2; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chomko SA., 1980, MAMMALIAN OSTEOLOGY, P72; Clarke LW, 2013, LANDSCAPE URBAN PLAN, V116, P48, DOI 10.1016/j.landurbplan.2013.04.006; Colding J, 2009, ECOSYSTEMS, V12, P191, DOI 10.1007/s10021-008-9217-1; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; DANNER DA, 1982, J WILDLIFE MANAGE, V46, P240, DOI 10.2307/3808427; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Debelica A., 2009, ATLAS KEY HAIR TERRE; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dunagan SP, 2019, J MAMMAL, V100, P401, DOI 10.1093/jmammal/gyz062; EHLERINGER JR, 1978, OECOLOGIA, V31, P255, DOI 10.1007/BF00346246; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Gehrt S.D., 2011, CITIES ENV, V4, P1, DOI DOI 10.15365/CATE.4132011; Gehrt SD., 2010, URBAN CARNIVORES ECO; Gehrt Stanley D., 2010, P79; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Halfpenny JC., 1986, FIELD GUIDE MAMMAL T; Jahren AH, 2008, P NATL ACAD SCI USA, V105, P17855, DOI 10.1073/pnas.0809870105; Johnson AM, 2016, URBAN ECOSYST, V19, P547, DOI 10.1007/s11252-015-0513-1; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Knudsen R, 2010, J ANIM ECOL, V79, P161, DOI 10.1111/j.1365-2656.2009.01625.x; Larson RN, 2015, WEST N AM NATURALIST, V75, P339, DOI 10.3398/064.075.0311; LEVINS RICHARD, 1968; MAYER WV, 1952, AM MIDL NAT, V48, P480, DOI 10.2307/2422262; McLaren AAD, 2015, WILDLIFE SOC B, V39, P788, DOI 10.1002/wsb.599; Miller CA, 2001, ATTITUDES HOMEOWNERS; Mitchell N, 2015, WILDLIFE RES, V42, P461, DOI 10.1071/WR15020; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moore T.D., 1974, BULLETIN; Morey PS, 2007, AM MIDL NAT, V158, P147, DOI 10.1674/0003-0031(2007)158[147:SATVIT]2.0.CO;2; Morisita M., 1959, MEM FS KYUSHU U    E, V3, P65, DOI DOI 10.18960/SEITAI.11.6_252_4; Murie OJ, 1997, FIELD GUIDE ANIMAL T; Murray M, 2015, ECOGRAPHY, V38, P1235, DOI 10.1111/ecog.01128; NAKAMURA K, 1982, BIOMED MASS SPECTROM, V9, P390, DOI 10.1002/bms.1200090906; Newsome SD, 2015, OECOLOGIA, V178, P115, DOI 10.1007/s00442-014-3205-2; Newsome SD, 2010, J MAMMAL, V91, P1313, DOI 10.1644/09-MAMM-A-362.1; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Poessel SA, 2017, CAN J ZOOL, V95, P287, DOI 10.1139/cjz-2016-0029; Poessel SA, 2016, J MAMMAL, V97, P1414, DOI 10.1093/jmammal/gyw090; R Core Team, 2018, R LANG ENV STAT COMP; Rezendes P, 1999, TRACKING ART SEEING; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; Robertson A, 2015, OECOLOGIA, V178, P31, DOI 10.1007/s00442-014-3202-5; Robertson A, 2014, OECOLOGIA, V176, P409, DOI 10.1007/s00442-014-3019-2; Rodriguez-Robles JA, 2003, COPEIA, P391; Rosenblatt AE, 2015, OECOLOGIA, V178, P5, DOI 10.1007/s00442-014-3201-6; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Sims V, 2008, DIVERS DISTRIB, V14, P387, DOI 10.1111/j.1472-4642.2007.00444.x; Sponarski CC, 2016, HUM DIMENS WILDL, V21, P491, DOI 10.1080/10871209.2016.1190989; TEERI JA, 1976, OECOLOGIA, V23, P1, DOI 10.1007/BF00351210; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Tyrrell LP, 2013, J MAMMAL, V94, P331, DOI 10.1644/12-MAMM-A-035.1; van Dijk J, 2007, WILDLIFE BIOL, V13, P62, DOI 10.2981/0909-6396(2007)13[62:ESAMTA]2.0.CO;2; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; White Lynsey A., 2009, Human Dimensions of Wildlife, V14, P419; Yurkowski DJ, 2016, ECOL EVOL, V6, P1666, DOI 10.1002/ece3.1980; Zabala J, 2003, FOLIA ZOOL, V52, P23	74	19	22	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228881	10.1371/journal.pone.0228881	http://dx.doi.org/10.1371/journal.pone.0228881			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023321	Green Published, gold			2022-12-26	WOS:000534621500073
J	Teodorini, RD; Rycroft, N; Smith-Spark, JH				Teodorini, Rachel D.; Rycroft, Nicola; Smith-Spark, James H.			The off-prescription use of modafinil: An online survey of perceived risks and benefits	PLOS ONE			English	Article							COLLEGE-STUDENTS; NONMEDICAL USE; COGNITIVE ENHANCERS; EXECUTIVE FUNCTION; DRUG FORUM; STIMULANTS; NEUROENHANCEMENT; PERFORMANCE; ATTENTION; ASSOCIATIONS	Cognitive enhancing drugs are claimed to improve cognitive functions such as learning and attention. However, little is known presently about the characteristics of off-prescription cognitive enhancing drug users or their perceived everyday experience with these drugs. As modafinil is the most commonly used off-prescription cognitive enhancing drug, the current study aimed to provide a detailed profile of modafinil users and their experiences and perceptions of this drug. To this end, an online survey, targeting cognitive enhancing drug users and students, was advertised on forum sites. Information was obtained regarding demographic data, illicit drug use, psychiatric diagnosis and experience of modafinil. Of the 404 respondents, 219 reported taking modafinil. Of these the majority were male, American or British, university-educated and currently employed, with a mean age of 27. Overall, modafinil was perceived by users as being safe. Modafinil users reported higher levels of illicit drug use and psychiatric diagnosis than would be expected from population-based data. More frequent reported modafinil use was associated with higher numbers of perceived benefits whilst reported frequency of use was not associated with the number of perceived risks. There was also a tentative link between the reported use of modafinil and the reported presence of psychiatric disorders, largely depression and anxiety. Respondents who had reported a psychiatric diagnosis declared higher subjective benefits of modafinil. This may suggest further beneficial effects of modafinil or it may reflect insufficient medical treatment for psychiatric disorders in some people. Overall, the findings of the current study should be beneficial in informing clinicians and legislative bodies about the modafinil user profile and how modafinil is perceived.	[Teodorini, Rachel D.; Rycroft, Nicola; Smith-Spark, James H.] London South Bank Univ, Div Psychol, London, England	London South Bank University	Teodorini, RD (corresponding author), London South Bank Univ, Div Psychol, London, England.	teodorr2@lsbu.ac.uk		Teodorini, Rachel/0000-0002-9983-7008; Smith-Spark, James/0000-0002-8216-0547	Centre for Addictive Behaviours Research, London South Bank University	Centre for Addictive Behaviours Research, London South Bank University	R.D. Teodorini received a fee-waiver studentship for her doctoral studies from the Centre for Addictive Behaviours Research, London South Bank University. No other funding was received. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of this manuscript.	Ahrnsbrak R, 2017, SUBSTANCE ABUSE MENT; Aikins RD, 2011, J COLL STUDENT DEV, V52, P560, DOI 10.1353/csd.2011.0064; Arria AM, 2008, PHARMACOTHERAPY, V28, P156, DOI 10.1592/phco.28.2.156; Arria AM, 2011, J ATTEN DISORD, V15, P347, DOI 10.1177/1087054710367621; Ballard Robert D, 2008, J Fam Pract, V57, pS24; Ballon JS, 2006, J CLIN PSYCHIAT, V67, P554, DOI 10.4088/JCP.v67n0406; BASTUJI H, 1988, PROG NEURO-PSYCHOPH, V12, P695, DOI 10.1016/0278-5846(88)90014-0; Battleday RM, 2015, EUR NEUROPSYCHOPHARM, V25, P1865, DOI 10.1016/j.euroneuro.2015.07.028; Bisagno V, 2016, PHARMACOL RES, V109, P108, DOI 10.1016/j.phrs.2016.01.013; Bossaer JB, 2013, ACAD MED, V88, P967, DOI 10.1097/ACM.0b013e318294fc7b; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Chiauzzi E, 2013, SUBST USE MISUSE, V48, P661, DOI 10.3109/10826084.2013.800117; Cleveland E, 2016, SOCIETY, V53, P237, DOI 10.1007/s12115-016-0006-8; Darwish M, 2009, CLIN DRUG INVEST, V29, P613, DOI 10.2165/11315280-000000000-00000; Davey Z, 2012, J MENT HEALTH, V21, P386, DOI 10.3109/09638237.2012.682265; DeSantis AD, 2008, J AM COLL HEALTH, V56, P315, DOI 10.3200/JACH.57.3.315-324; Dietz P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00520; Dubljevi V., 2015, NEUROL NEUROSCI, V4, P25, DOI DOI 10.2147/NAN.S61925; EMCDDA, 2013, EUR DRUG REP 2016 TR; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Finke K, 2010, PSYCHOPHARMACOLOGY, V210, P317, DOI 10.1007/s00213-010-1823-x; Fond G, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003366; Gilleen J, 2014, EUR NEUROPSYCHOPHARM, V24, P529, DOI 10.1016/j.euroneuro.2014.01.001; Goss AJ, 2013, J CLIN PSYCHIAT, V74, P1101, DOI 10.4088/JCP.13r08560; Ishizuka T, 2010, NEUROSCI LETT, V483, P193, DOI 10.1016/j.neulet.2010.08.005; Keating GM, 2005, CNS DRUGS, V19, P785, DOI 10.2165/00023210-200519090-00005; Kinman BA, 2017, SUBST USE MISUSE, V52, P1256, DOI 10.1080/10826084.2016.1273954; Lanni C, 2008, PHARMACOL RES, V57, P196, DOI 10.1016/j.phrs.2008.02.004; Lefever S, 2007, BRIT J EDUC TECHNOL, V38, P574, DOI 10.1111/j.1467-8535.2006.00638.x; Lennard N., 2009, VARSITY, V693, P1; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Mache S, 2012, WIEN MED WOCHENSCHR, V162, P262, DOI [10.1007/s10354-012-0115-y, 10.1007/s10354-012-0144-6]; Maier LJ, 2016, ADDICTION, V111, P280, DOI 10.1111/add.13059; Maier LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077967; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Montgomery SA, 2008, INT CLIN PSYCHOPHARM, V23, P63, DOI 10.1097/YIC.0b013e3282f2b3cb; Muhammed K, 2014, MED HEALTH CARE PHIL, V17, P239, DOI 10.1007/s11019-013-9497-x; Nasr S, 2006, J AFFECT DISORDERS, V95, P111, DOI 10.1016/j.jad.2006.01.010; NIDA, 2014, NAT SURV DRUG US HLT; OBrien CP, 2011, GOODMAN GILMANS PHAR, P649; Ott R, 2014, PHARMACOPSYCHIATRY, V47, P22, DOI 10.1055/s-0033-1358682; Outhof Kim, 2016, S AFR FAM PRACT, V58, P16; Penaloza RA, 2013, JAMA INTERN MED, V173, P704, DOI 10.1001/jamainternmed.2013.2807; Petersen MA, 2015, CULT MED PSYCHIAT, V39, P665, DOI 10.1007/s11013-015-9457-4; Price CS, 2005, DEPRESS ANXIETY, V21, P149, DOI 10.1002/da.20075; Rabiner DL, 2009, J ATTEN DISORD, V13, P259, DOI 10.1177/1087054708320399; Ragan CI, 2013, NEUROPHARMACOLOGY, V64, P588, DOI 10.1016/j.neuropharm.2012.06.016; Randall DC, 2005, PHARMACOL BIOCHEM BE, V82, P133, DOI 10.1016/j.pbb.2005.07.019; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Robertson P, 2003, CLIN PHARMACOKINET, V42, P123, DOI 10.2165/00003088-200342020-00002; Ross MM, 2018, ADDICT BEHAV, V79, P45, DOI 10.1016/j.addbeh.2017.12.002; Rycroft N, 2007, PSYCHOPHARMACOLOGY, V195, P245, DOI 10.1007/s00213-007-0885-x; Sattler S, 2013, SUBST USE MISUSE, V48, P220, DOI 10.3109/10826084.2012.751426; Schelle KJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00010; Schmitt KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025790; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Singh I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105969; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Soussan C, 2016, INT J DRUG POLICY, V32, P77, DOI 10.1016/j.drugpo.2016.03.007; Topp N. W., 2002, J SCI EDUC TECHNOL, V11, P173, DOI [10.1023/A:1014669514367, DOI 10.1023/A:1014669514367]; Walsh JK, 2004, SLEEP, V27, P434, DOI 10.1093/sleep/27.3.434; Winstock AR, 2011, ADDICTION, V106, P154, DOI 10.1111/j.1360-0443.2010.03130.x; Wood S, 2014, PHARMACOL REV, V66, P193, DOI 10.1124/pr.112.007054; Wu P, 2008, INTERN MED J, V38, P677, DOI 10.1111/j.1445-5994.2008.01710.x; Young-Powell A, 2014, GUARDIAN	67	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227818	10.1371/journal.pone.0227818	http://dx.doi.org/10.1371/journal.pone.0227818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9FN	32023288	gold, Green Published, Green Accepted			2022-12-26	WOS:000534621500023
J	Hsu, BE; Roy, J; Mouhanna, J; Rayes, RF; Ramsay, L; Tabaries, S; Annis, MG; Watson, IR; Spicer, JD; Costantino, S; Siegel, PM				Hsu, Brian E.; Roy, Joannie; Mouhanna, Jack; Rayes, Roni F.; Ramsay, LeeAnn; Tabaries, Sebastien; Annis, Matthew G.; Watson, Ian R.; Spicer, Jonathan D.; Costantino, Santiago; Siegel, Peter M.			C3a elicits unique migratory responses in immature low-density neutrophils	ONCOGENE			English	Article							PARTICLE TRACKING; CHEMOTAXIS; C5A; RECEPTOR; ANAPHYLATOXIN; ANTAGONIST; EXPRESSION; LEUKOCYTES; LTB4	Neutrophils represent the immune system's first line of defense and are rapidly recruited into inflamed tissue. In cancer associated inflammation, phenotypic heterogeneity has been ascribed to this cell type, whereby neutrophils can manifest anti- or pro-metastatic functions depending on the cellular/micro-environmental context. Here, we demonstrate that pro-metastatic immature low-density neutrophils (iLDNs) more efficiently accumulate in the livers of mice bearing metastatic lesions compared with anti-metastatic mature high-density neutrophils (HDNs). Transcriptomic analyses reveal enrichment of a migration signature in iLDNs relative to HDNs. We find that conditioned media derived from liver-metastatic breast cancer cells, but not lung-metastatic variants, specifically induces chemotaxis of iLDNs and not HDNs. Chemotactic responses are due to increased surface expression of C3aR in iLDNs relative to HDNs. In addition, we detect elevated secretion of cancer-cell derived C3a from liver-metastatic versus lung-metastatic breast cancer cells. Perturbation of C3a/C3aR signaling axis with either a small molecule inhibitor, SB290157, or reducing the levels of secreted C3a from liver-metastatic breast cancer cells by short hairpin RNAs, can abrogate the chemotactic response of iLDNs both in vitro and in vivo, respectively. Together, these data reveal novel mechanisms through which iLDNs prefentially accumulate in liver tissue harboring metastases in response to tumor-derived C3a secreted from the liver-aggressive 4T1 breast cancer cells.	[Hsu, Brian E.; Ramsay, LeeAnn; Tabaries, Sebastien; Annis, Matthew G.; Watson, Ian R.; Siegel, Peter M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Hsu, Brian E.; Siegel, Peter M.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Roy, Joannie; Costantino, Santiago] Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H1T 2M4, Canada; [Roy, Joannie; Costantino, Santiago] Univ Montreal, Inst Biomed Engn, Montreal, PQ H3C 3T5, Canada; [Mouhanna, Jack; Rayes, Roni F.; Spicer, Jonathan D.] McGill Univ, Ctr Hlth, Res Inst, Dept Surg, Montreal, PQ H4A 3J1, Canada; [Watson, Ian R.; Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; McGill University; McGill University	Siegel, PM (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.; Siegel, PM (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada.; Siegel, PM (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.	peter.siegel@mcgill.ca	Costantino, Santiago/ABD-5472-2020	Costantino, Santiago/0000-0002-2454-2635; Watson, Ian/0000-0002-6025-3080; Rayes, Roni/0000-0001-7508-020X; Annis, Matthew/0000-0002-8776-004X	Cancer Research Society; Terry Fox Research Institute [242122]; Quebec Breast Cancer Foundation [242122]; NSERC; Genome Canada; FRQS; AATS; MGH foundation; Charlotte and Leo Karassik Foundation PhD Fellowship; Rolande and Marcel Gosselin Graduate Studentship	Cancer Research Society; Terry Fox Research Institute; Quebec Breast Cancer Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); FRQS; AATS; MGH foundation; Charlotte and Leo Karassik Foundation PhD Fellowship; Rolande and Marcel Gosselin Graduate Studentship	We acknowledge the Goodman Cancer Research Centre histology core facility (McGill University) for routine histological services, the Cell Vision Core Facility (McGill University) for providing routine cell sorting service and the Genetics Perturbation Service for shRNAs (McGill University). We thank Anie Monast and Cynthia Lavoie for technical support and members of the Siegel laboratory for their thoughtful discussions and critical reading of the manuscript. This work was supported by an operating grant to P.M.S. from the Cancer Research Society and the Terry Fox Research Institute and Quebec Breast Cancer Foundation (Grant #: 242122). S.C. acknowledges funding support from NSERC and Genome Canada and salary awarded from FRQS. J.D.S acknowledges funding support from AATS, MGH foundation and FRQS. BEH acknowledges support from the Charlotte and Leo Karassik Foundation PhD Fellowship and the Rolande and Marcel Gosselin Graduate Studentship. PMS is a McGill University William Dawson Scholar.	Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Banda NK, 2012, J IMMUNOL, V188, P1469, DOI 10.4049/jimmunol.1102310; Bautsch W, 2000, J IMMUNOL, V165, P5401, DOI 10.4049/jimmunol.165.10.5401; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; DAFFERN PJ, 1995, J EXP MED, V181, P2119, DOI 10.1084/jem.181.6.2119; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Guglietta S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11037; Hartmann K, 1997, BLOOD, V89, P2863, DOI 10.1182/blood.V89.8.2863; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit Bryan, 2003, Sci STKE, V2003, pPL5, DOI 10.1126/stke.2003.170.pl5; Hsu BE, 2019, CELL REP, V27, P3902, DOI 10.1016/j.celrep.2019.05.091; Hutamekalin P, 2010, J PHARMACOL SCI, V112, P56, DOI 10.1254/jphs.09180FP; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; KRAUSS AHP, 1994, J LEUKOCYTE BIOL, V55, P201, DOI 10.1002/jlb.55.2.201; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052666; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Lohman RJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00414-w; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Majumdar R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002336; MARDER SR, 1985, J IMMUNOL, V134, P3325; Mazzaferri J, 2015, BIOINFORMATICS, V31, P1279, DOI 10.1093/bioinformatics/btu793; Mishalian I, 2017, IMMUNOBIOLOGY, V222, P82, DOI 10.1016/j.imbio.2016.02.001; Mizutani N, 2009, J IMMUNOL, V183, P4039, DOI 10.4049/jimmunol.0901468; Mollnes TE, 2002, BLOOD, V100, P1869; NELSON RD, 1975, J IMMUNOL, V115, P1650; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PALMBLAD J, 1981, BLOOD, V58, P658; Quell KM, 2017, J IMMUNOL, V199, P688, DOI 10.4049/jimmunol.1700318; Rink I, 2015, J IMMUNOL, V194, P5549, DOI 10.4049/jimmunol.1500148; Roy J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02993-6; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Saha P, 2017, J IMMUNOL, V198, P4293, DOI 10.4049/jimmunol.1700261; Saunders CA, 2019, METHOD CELL BIOL, V149, P31, DOI 10.1016/bs.mcb.2018.09.002; Subramanian BC, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217422; Tabaries S, 2011, ONCOGENE, V30, P1318, DOI 10.1038/onc.2010.518; Tabaries S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0558-3; Takabayashi T, 1996, J IMMUNOL, V156, P3455; Talbot J, 2015, ARTHRITIS RHEUMATOL, V67, P1751, DOI 10.1002/art.39117; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Wu MCL, 2013, P NATL ACAD SCI USA, V110, P9439, DOI 10.1073/pnas.1218815110	48	13	13	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2612	2623		10.1038/s41388-020-1169-8	http://dx.doi.org/10.1038/s41388-020-1169-8		FEB 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	32020055				2022-12-26	WOS:000511084200001
J	Kazek, M; Kaczmarek, A; Wronska, AK; Bogus, MI				Kazek, Michalina; Kaczmarek, Agata; Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena			Conidiobolus coronatus induces oxidative stress and autophagy response in Galleria mellonella larvae	PLOS ONE			English	Article							GREATER WAX MOTH; CELLULAR DEFENSE RESPONSE; ENTOMOPATHOGENIC FUNGI; ANTIOXIDANT DEFENSE; BEAUVERIA-BASSIANA; GLUTATHIONE; HEMOCYTES; MIDGUT; DEATH; MORPHOLOGY	Cell homeostasis requires the correct levels of reactive oxygen species (ROS) to be maintained as these regulate the proliferation and differentiation of cells, and control the immune response and inflammation. High levels of ROS can cause oxidative stress, leading to protein, lipid and DNA damage, or even cell death. Under physiological conditions, the rate of autophagy remains stable; however, it can be accelerated by a number of exogenous stimuli such as oxidative stress, starvation or hypoxia, leading to cell death. The present paper examines the effect of Conidiobolus coronatus infection on the immune response, oxidative stress processes and autophagy in the greater wax moth, Galleria mellonella. Fungal infection was found to result in the disorganization of the cytoskeleton of the larval immune cells and the enhancement of oxidative defense processes. Lipid peroxidation and autophagy were also induced in the hemocytes. Our findings show that G. mellonella is an ideal model for exploring immune mechanisms.	[Kazek, Michalina; Kaczmarek, Agata; Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland; [Bogus, Mieczyslawa Irena] BIOMIBO, Warsaw, Poland	Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences	Kazek, M (corresponding author), Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland.	m.kamut@twarda.pan.pl	Wrońska, Anna/HHZ-6185-2022; Wrońska, Anna/AAN-8684-2020; Kaczmarek, Agata/ABG-3240-2020; Kaczmarek, Agata/ABG-3202-2020	Wrońska, Anna/0000-0001-5171-0828; Kaczmarek, Agata/0000-0001-7319-7973; Kaczmarek, Agata/0000-0001-7319-7973; Bogus, Mieczyslawa/0000-0003-4357-2335; Michalina, Kazek/0000-0003-4119-9434	National Centre for Research and Development [POIG.01.04.00-14-019/12]	National Centre for Research and Development	This work was partly supported by National Centre for Research and Development grant number POIG.01.04.00-14-019/12. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Accorsi A, 2015, J INSECT PHYSIOL, V76, P17, DOI 10.1016/j.jinsphys.2015.03.007; AHMAD S, 1990, PHOTOCHEM PHOTOBIOL, V51, P305, DOI 10.1111/j.1751-1097.1990.tb01715.x; AHMAD S, 1992, BIOCHEM SYST ECOL, V20, P269, DOI 10.1016/0305-1978(92)90040-K; Blanco LAA, 2017, CELL TISSUE RES, V370, P153, DOI 10.1007/s00441-017-2653-5; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Babu MN, 2013, THESIS; Bania J, 2006, ARCH INSECT BIOCHEM, V62, P186, DOI 10.1002/arch.20134; Betteridge DJ, 2000, METABOLISM, V49, P3, DOI 10.1016/S0026-0495(00)80077-3; Bogus MI, 2017, B ENTOMOL RES, V107, P66, DOI 10.1017/S0007485316000638; Bogus MI, 2002, ACTA PARASITOL, V47, P66; Bogus MI, 2000, ACTA PARASITOL, V45, P48; Bogus MI, 2018, PHYSIOL ENTOMOL, V43, P214, DOI 10.1111/phen.12246; Bryant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025502; Callaghan AA, 1969, T BRIT MYCOLOGICAL S, P53; Chaurasia A, 2016, PESTIC BIOCHEM PHYS, V127, P28, DOI 10.1016/j.pestbp.2015.09.002; Chen PW, 2014, AUTOPHAGY, V10, P192, DOI 10.4161/auto.26927; Cohen H J, 1993, Prog Clin Biol Res, V380, P191; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Dolphin D., 1990, GLUTATHIONE CHEM BIO, V3; Dromph KM, 2001, J INVERTEBR PATHOL, V78, P226, DOI 10.1006/jipa.2002.5077; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gaschler MM, 2017, BIOCHEM BIOPH RES CO, V482, P419, DOI 10.1016/j.bbrc.2016.10.086; Hall AG, 1999, ADV EXP MED BIOL, V457, P199; HUNG SY, 1992, J INVERTEBR PATHOL, V60, P152, DOI 10.1016/0022-2011(92)90089-M; HUNG SY, 1993, J INVERTEBR PATHOL, V61, P179, DOI 10.1006/jipa.1993.1032; Jung HS, 2010, ANN NY ACAD SCI, V1201, P79, DOI 10.1111/j.1749-6632.2010.05614.x; Kaczmarek A., 2018, THESIS; Kazek M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211697; Khoa DB, 2012, INSECT MOL BIOL, V21, P473, DOI 10.1111/j.1365-2583.2012.01152.x; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Krishnan N, 2006, J INSECT PHYSIOL, V52, P11, DOI 10.1016/j.jinsphys.2005.08.009; Lee CY, 2002, DEV BIOL, V250, P101, DOI 10.1006/dbio.2002.0784; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Mane-Padros D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045019; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Mizerska-Dudka M, 2014, J BASIC MICROB, V54, P232, DOI 10.1002/jobm.201200273; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Monastryska I, 2004, FEBS LETT, V568, P135, DOI 10.1016/j.febslet.2004.05.018; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Pallardo FV, 2010, BIOGERONTOLOGY, V11, P401, DOI 10.1007/s10522-010-9269-4; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Pippneger CE, 1998, METHOD MOL BIOL, P108; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Rosales C ., 2017, INSECT PHYSL ECOLOGY, DOI [10.5772/67107, DOI 10.5772/67107]; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; SEHNAL F, 1966, Z WISS ZOOL ABT A, V174, P53; Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8; Sheehan G, 2018, VIRULENCE, V9, P1625, DOI 10.1080/21505594.2018.1526531; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Uwo MF, 2002, CELL TISSUE RES, V308, P319, DOI 10.1007/s00441-002-0515-1; Vilcinskas A, 1997, J INSECT PHYSIOL, V43, P1149, DOI 10.1016/S0022-1910(97)00066-8; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Wieloch W., 2005, PESTICIDES, V4, P133; Wieloch W, 2011, TOXICON, V58, P369, DOI 10.1016/j.toxicon.2011.07.007; Wu GQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34996; Xu JA, 2017, REDOX BIOL, V12, P198, DOI 10.1016/j.redox.2017.02.017; Zemanova M, 2016, J INSECT PHYSIOL, V91-92, P39, DOI 10.1016/j.jinsphys.2016.06.010; ZUG R, 2015, FRONT MICROBIOL, V6, DOI DOI 10.3389/FMICB.2015.00006	64	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228407	10.1371/journal.pone.0228407	http://dx.doi.org/10.1371/journal.pone.0228407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012188	Green Published, gold			2022-12-26	WOS:000534615800034
J	Manyanga, T; Barnes, JD; Chaput, JP; Dubois, L; Katzmarzyk, PT; Mire, EF; Prista, A; Tremblay, MS				Manyanga, Taru; Barnes, Joel D.; Chaput, Jean-Philippe; Dubois, Lise; Katzmarzyk, Peter T.; Mire, Emily F.; Prista, Antonio; Tremblay, Mark S.			Prevalence and correlates of objectively measured weight status among urban and rural Mozambican primary schoolchildren: A cross-sectional study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; BODY-MASS INDEX; PHYSICAL-ACTIVITY; NUTRITIONAL-STATUS; PROTECTIVE FACTORS; CHILDHOOD OBESITY; SEDENTARY TIME; LIFE-STYLE; CHILDREN; ASSOCIATIONS	Background The coexistence of undernutrition (thinness) and overnutrition (overweight/obesity) among children and adolescents is a public health concern in low-middle-income countries. Accurate prevalence estimates of thinness and overweight/obesity among children and adolescents are unavailable in many low-middle-income countries due to lack of data. Here we describe the prevalences and examine correlates of objectively measured weight status among urban and rural schoolchildren in Mozambique. Methods A cross-sectional study design was applied to recruit 9-11-year-old schoolchildren (n = 683) from 17 urban and rural primary schools in Mozambique. Body mass index (BMI) was computed from objectively measured height and weight and participants' weight categories were determined using the World Health Organization cut-points. Actigraph GT3X + accelerometers were worn 24 hours per day for 7 days to assess movement behaviours. Multilevel multivariable modelling was conducted to estimate odds ratios and confidence intervals. Results Combined prevalence of overweight/obesity (11.4%) was significantly higher among urban participants compared to rural participants (5.7%; chi(2) = 7.1; p = 0.008). Conversely, thinness was more prevalent among rural (6.3%) compared to urban (4.2%) participants. Passive school commute, not meeting daily moderate- to vigorous-intensity physical activity (MVPA) guidelines, and maternal BMI > 25 kg/m(2) were associated with overweight/obesity while possessing one or more functional cars at home, maternal BMI > 25 kg/m(2) and being an older participant were associated with thinness in the present sample. The proportion of total variance in the prevalences of obesity and/or thinness occurring at the school level was 8.7% and 8.3%, respectively. Conclusion Prevalences of thinness, overweight/obesity and other key variables differ between urban and rural schoolchildren in Mozambique. MVPA, active transport and mother's BMI are important modifiable correlates of weight status among Mozambican schoolchildren. Results from this study demonstrate important differences between urban and rural schoolchildren that should not be ignored when designing interventions to manage malnutrition, formulating public health strategies, and interpreting findings. Conclusion Prevalences of thinness, overweight/obesity and other key variables differ between urban and rural schoolchildren in Mozambique. MVPA, active transport and mother's BMI are important modifiable correlates of weight status among Mozambican schoolchildren. Results from this study demonstrate important differences between urban and rural schoolchildren that should not be ignored when designing interventions to manage malnutrition, formulating public health strategies, and interpreting findings.	[Manyanga, Taru; Barnes, Joel D.; Chaput, Jean-Philippe; Tremblay, Mark S.] CHEO Res Inst, Hlth Act Living & Obes Res Grp, Ottawa, ON, Canada; [Manyanga, Taru; Chaput, Jean-Philippe; Dubois, Lise; Tremblay, Mark S.] Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Katzmarzyk, Peter T.; Mire, Emily F.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Prista, Antonio] Univ Pedagog, Res Grp Phys Act & Hlth CIDAF FEFD, Maputo, Mozambique	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Tremblay, MS (corresponding author), CHEO Res Inst, Hlth Act Living & Obes Res Grp, Ottawa, ON, Canada.; Tremblay, MS (corresponding author), Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	mtremblay@cheo.on.ca	Prista, António/ABE-7056-2020; Manyanga, Taru/GQY-7863-2022; Tremblay, Mark/ABI-5477-2020; Chaput, Jean-Philippe/ABE-6307-2020	Manyanga, Taru/0000-0001-5461-5981; Chaput, Jean-Philippe/0000-0002-5607-5736; Prista, Antonio/0000-0002-3652-7205; Mire, Emily/0000-0002-3232-5534	International Development Research Centre (IDRC); Canadian Institutes of Health Research (CIHR)	International Development Research Centre (IDRC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Data collection for this study was partially funded by a doctoral award from the International Development Research Centre (IDRC). TM is supported by a Canadian Institutes of Health Research (CIHR) doctoral fellowship for allied health professionals. Study sponsors had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript.	Aiga H, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7013-9; [Anonymous], 2013, NIGERIAN J CLIN PRAC; [Anonymous], 2007, STRENGTHENING REPORT; [Anonymous], 1995, WHO TECH REP SER, DOI [10.1002/(sici)1520-6300(1996)8:63.0.co;2-i, DOI 10.1002/(SICI)1520-6300(1996)8:63.0.CO;2-I]; Ayogu RNB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5479-5; Barreira TV, 2015, MED SCI SPORT EXER, V47, P937, DOI 10.1249/MSS.0000000000000486; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown V, 2017, PREV MED, V96, P49, DOI 10.1016/j.ypmed.2016.12.020; Caleyachetty R, 2018, AM J CLIN NUTR, V108, P414, DOI 10.1093/ajcn/nqy105; Candler T, 2017, J ADOLESCENT HEALTH, V60, P447, DOI 10.1016/j.jadohealth.2016.11.003; Cheung PC, 2016, CHILD OBES, V12, P1, DOI 10.1089/chi.2015.0055; Davison K K, 2001, Obes Rev, V2, P159, DOI 10.1046/j.1467-789x.2001.00036.x; De Bourdeaudhuij I, 2013, PEDIATR OBES, V8, P367, DOI 10.1111/j.2047-6310.2012.00117.x; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; dos Santos FK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114068; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Ford ND, 2017, ANNU REV PUBL HEALTH, V38, P145, DOI 10.1146/annurev-publhealth-031816-044604; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Freedman DS, 2018, OBESITY, V26, P1197, DOI 10.1002/oby.22199; Gomes A, 2010, OBES REV, V11, P627, DOI 10.1111/j.1467-789X.2010.00739.x; Haines J, 2007, OBESITY, V15, P2748, DOI 10.1038/oby.2007.327; Herman KM, 2009, INT J PEDIATR OBES, V4, P281, DOI 10.3109/17477160802596171; Heude B, 2005, INT J OBESITY, V29, P1222, DOI 10.1038/sj.ijo.0802920; Jaacks LM, 2015, PEDIAT OBES, DOI [10.1111/ijpo, DOI 10.1111/IJPO]; Jeannot E., 2015, SOCIODEMOGRAPHIC EC, V6, P39, DOI DOI 10.4103/2008-7802.156836; Katzmarzyk PT, 2015, MED SCI SPORT EXER, V47, P2062, DOI 10.1249/MSS.0000000000000649; Katzmarzyk PT, 2015, OBESITY, V23, P1696, DOI 10.1002/oby.21152; Katzmarzyk PT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-900; Katzmarzyk PT, 2009, J PHYS ACT HEALTH, V6, P269, DOI 10.1123/jpah.6.3.269; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943; Larouche R, 2014, J PHYS ACT HEALTH, V11, P206, DOI 10.1123/jpah.2011-0345; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lobstein T, 2015, LANCET, V385, P2510, DOI 10.1016/S0140-6736(14)61746-3; Martins VJB, 2011, INT J ENV RES PUB HE, V8, P1817, DOI 10.3390/ijerph8061817; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mushtaq MU, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-790; MUTHURI SK, 2014, BMC PUBLIC HEALTH, V14, DOI DOI 10.1186/1471-2458-14-14; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nhantumbo L, 2013, AM J HUM BIOL, V25, P516, DOI 10.1002/ajhb.22403; Olaya B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1809-z; Prista A, 2016, J PHYS ACT HEALTH, V13, pS213, DOI 10.1123/jpah.2016-0526; Prista A, 2009, PEDIATR EXERC SCI, V21, P384, DOI 10.1123/pes.21.4.384; Regis MF, 2016, EINSTEIN-SAO PAULO, V14, P461, DOI [10.1590/S1679-45082016AO3788, 10.1590/s1679-45082016ao3788]; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Sarmiento O L, 2015, Int J Obes Suppl, V5, pS107, DOI 10.1038/ijosup.2015.27; Shahraki SH, 2016, ECOL FOOD NUTR, V55, P473, DOI 10.1080/03670244.2016.1212710; Stephens S, 2018, RHEUM DIS CLIN N AM, V44, P317, DOI 10.1016/j.rdc.2018.01.012; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Swanton S, 2017, OBES SCI PRACT, V3, P127, DOI 10.1002/osp4.90; Tabachnick B. G., 2013, USING MULTIVARIATE S; Tudor-Locke C, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0172-x; Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210; Van Buuren S., 2018, FLEXIBLE IMPUTATION; van Buuren S, 2011, J STAT SOFTW, V45, P1; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; WHO, 2016, REP COMM END CHILDH; Wilkie HJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010677; World Health Organization, BOD MASS IND BMI; World Health Organization, 2018, WHO LIB; World Health Organization, 2007, BMI FOR AG GROWTH RE	63	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228592	10.1371/journal.pone.0228592	http://dx.doi.org/10.1371/journal.pone.0228592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9DJ	32012187	Green Published, gold			2022-12-26	WOS:000534615800041
J	Alcacer, A; Epifanio, I; Ibanez, MV; Simo, A; Ballester, A				Alcacer, Aleix; Epifanio, Irene; Victoria Ibanez, M.; Simo, Amelia; Ballester, Alfredo			A data-driven classification of 3D foot types by archetypal shapes based on landmarks	PLOS ONE			English	Article							SEX-RELATED DIFFERENCES; GENDER-DIFFERENCES; BODY SHAPES; MULTIVARIATE; SOMATOTYPE	The taxonomy of foot shapes or other parts of the body is important, especially for design purposes. We propose a methodology based on archetypoid analysis (ADA) that overcomes the weaknesses of previous methodologies used to establish typologies. ADA is an objective, data-driven methodology that seeks extreme patterns, the archetypal profiles in the data. ADA also explains the data as percentages of the archetypal patterns, which makes this technique understandable and accessible even for non-experts. Clustering techniques are usually considered for establishing taxonomies, but we will show that finding the purest or most extreme patterns is more appropriate than using the central points returned by clustering techniques. We apply the methodology to an anthropometric database of 775 3D right foot scans representing the Spanish adult female and male population for footwear design. Each foot is described by a 5626 x 3 configuration matrix of landmarks. No multivariate features are used for establishing the taxonomy, but all the information gathered from the 3D scanning is employed. We use ADA for shapes described by landmarks. Women's and men's feet are analyzed separately. We have analyzed 3 archetypal feet for both men and women. These archetypal feet could not have been recovered using multivariate techniques.	[Alcacer, Aleix; Epifanio, Irene; Victoria Ibanez, M.; Simo, Amelia] Univ Jaume 1, Dept Matemat, Castellon de La Plana, Spain; [Epifanio, Irene; Victoria Ibanez, M.; Simo, Amelia] Univ Jaume 1, Inst Matemat & Aplicac Castello, Castellon de La Plana, Spain; [Ballester, Alfredo] Inst Biomecan Valencia, Valencia, Spain	Universitat Jaume I; Universitat Jaume I; Instituto de Biomecanica de Valencia (IBV)	Epifanio, I (corresponding author), Univ Jaume 1, Dept Matemat, Castellon de La Plana, Spain.; Epifanio, I (corresponding author), Univ Jaume 1, Inst Matemat & Aplicac Castello, Castellon de La Plana, Spain.	epifanio@uji.es	Gual, Maria Victoria Ibáñez/AAG-1438-2020; Epifanio, Irene/B-7285-2015; Simo, Amelia/D-6321-2017	Gual, Maria Victoria Ibáñez/0000-0001-7043-8233; Epifanio, Irene/0000-0002-6973-311X; Simo, Amelia/0000-0001-5507-2907; Alcacer, Aleix/0000-0003-3566-0204	Spanish Ministry of Science, Innovation and Universities (AEI/FEDER, EU) [DPI2017-87333-R]; Universitat Jaume I [UJI-B2017-13]	Spanish Ministry of Science, Innovation and Universities (AEI/FEDER, EU); Universitat Jaume I	This work is supported by the following grants: DPI2017-87333-R from the Spanish Ministry of Science, Innovation and Universities (AEI/FEDER, EU) and UJI-B2017-13 from Universitat Jaume I. There was no additional external funding received for this study The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcacer A, 2019, P 12 SCI M CLASS DAT, P26; Alcacer A, 2019, P 17 SPAN BIOM C 7 I, P24; Alemany S, 2010, P 2010 INT C 3D BOD, P1; Allen B, 2003, ACM T GRAPHIC, V22, P587, DOI 10.1145/882262.882311; [Anonymous], 2008, 725012008 ISO; [Anonymous], 2015, D521915 ASTM; Bauckhage C, 2015, WORKSH NEW CHALL NEU; Bittner AC, 1987, TRENDS ERGONOMICS HU, P733; Boguslawski M, 2011, INT J LEGAL MED, V125, P301, DOI [10.1007/s00414-010-0446-4, DOI 10.1007/S00414-010-0446-4]; Braga J, 2019, J HUM EVOL, V130, P21, DOI 10.1016/j.jhevol.2019.01.009; Buffa R, 2007, GERONTOLOGY, V53, P200, DOI 10.1159/000100486; Cabero I, 2019, IMAGE ANAL STEREOL, V38, P151, DOI 10.5566/ias.2052; Canhasi E, 2014, EXPERT SYST APPL, V41, P535, DOI 10.1016/j.eswa.2013.07.079; Chen Y., 2014, CVPR 2014; CUTLER A, 1994, TECHNOMETRICS, V36, P338, DOI 10.2307/1269949; D'Esposito Maria R., 2012, Statistical Analysis and Data Mining, V5, P321, DOI 10.1002/sam.11140; Davis T, 2010, PSYCHOL SCI, V21, P234, DOI 10.1177/0956797609357712; Delgado-Abellan L, 2014, ERGONOMICS, V57, P787, DOI 10.1080/00140139.2014.895055; Devarajan P., 2004, J TEXTILE APPAREL TE, V4, P1; Dryden I. L., 2016, R WILEY SERIES PROBA, V2nd; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Epifanio I, 2013, COMPUT IND ENG, V64, P757, DOI 10.1016/j.cie.2012.12.011; Epifanio I, 2020, AM STAT, V74, P169, DOI 10.1080/00031305.2018.1545700; Epifanio I, 2018, ADV DATA ANAL CLASSI, V12, P705, DOI 10.1007/s11634-017-0297-7; Epifanio I, 2016, COMPUT STAT DATA AN, V104, P24, DOI 10.1016/j.csda.2016.06.007; Eugster MJA, 2012, INT J PERF ANAL SPOR, V12, P166, DOI 10.1080/24748668.2012.11868592; Friess, 2005, SAE TECHNICAL PAPER; Friess M, 2003, P SAE 2003; Fuentes-Hurtado F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211314; Goonetilleke R.S., 2012, SCI FOOTWEAR; Gordon C.C., 1989, 1988 ANTHROPOMETRIC; Hinrich JL, 2016, IEEE J-STSP, V10, P1160, DOI 10.1109/JSTSP.2016.2595103; Hong YL, 2011, SPORT BIOMECH, V10, P85, DOI 10.1080/14763141.2011.569567; Hudson JA, 1998, HUM FAC ERG SOC P, P722; ISO 8559-1, 2017, 855912017 ISO; Jee SC, 2016, INT J IND ERGONOM, V53, P10, DOI 10.1016/j.ergon.2015.10.004; Kim K, 2004, J INT SOC RESP PROTE, V21, P125; Kim Namsoon, 2014, [Journal of the Korean Society of Clothing and Textiles, 한국의류학회지], V38, P305; Koleva M, 2002, Rev Environ Health, V17, P65; Korem Y, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004224; Kouchi M, 2011, APPL ERGON, V42, P518, DOI 10.1016/j.apergo.2010.09.011; Krauss I, 2008, ERGONOMICS, V51, P1693, DOI 10.1080/00140130802376026; Krauss I, 2011, ERGONOMICS, V54, P294, DOI 10.1080/00140139.2010.547605; Lee YC, 2015, ERGONOMICS, V58, P513, DOI 10.1080/00140139.2014.974683; Lin YL, 1999, ERGONOMICS, V42, P1311, DOI 10.1080/001401399184965; Loeffler-Wirth H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186881; Loffler-Wirth H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159887; Luximon A., 2013, HDB FOOTWEAR DESIGN; MacLeod N., 2015, P 3 INT S BIOL SHAP, P156; Mair S, 2017, PR MACH LEARN RES, V70; Malousaris GG, 2008, J SCI MED SPORT, V11, P337, DOI 10.1016/j.jsams.2006.11.008; Mickle KJ, 2010, FOOTWEAR SCI, V2, P131, DOI 10.1080/19424280.2010.487053; Millan-Roures L, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/5129735; Mochimaru M, 2000, ERGONOMICS, V43, P1301, DOI 10.1080/001401300421752; Moliner J, 2019, PHYSICA A, V519, P195, DOI 10.1016/j.physa.2018.12.036; Moroney L.W. F., 1972, EMPIRICAL REDUCTION; Morup M, 2012, NEUROCOMPUTING, V80, P54, DOI 10.1016/j.neucom.2011.06.033; Nikolaidou M., 2006, FOOT, V16, P82, DOI [DOI 10.1016/J.F00T.2006.02.001, 10.1016/j.foot.2006.02.001]; Porzio GC, 2008, APPL STOCH MODEL BUS, V24, P419, DOI 10.1002/asmb.727; R Core Team, 2021, R LANGUAGE ENV STAT; Ragozini G, 2017, STAT ANAL DATA MIN, V10, P6, DOI 10.1002/sam.11325; Ramiro J., 1995, GUIA RECOMENDACIONES, P135; Robinette K., 1981, ALTERNATIVE PERCENTI; Robinson J.C., 1992, USERS GUIDE ANTHROPO; Rodrigo AS, 2012, COMPUT AIDED DESIGN, V44, P48, DOI 10.1016/j.cad.2011.01.005; Rossi W.A., 2013, PROFESSIONAL SHOE FI; Ryan-Stewart H, 2018, PLOS ONE, V13, P1, DOI [10.1371/journal.pone.0197761, DOI 10.1371/journal.pone.0197761]; Saghazadeh M, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0087-4; Sarakon P, 2014, 7 2014 BIOM ENG INT, P1, DOI DOI 10.1109/BMEICON.2014.7017382; Singh SP, 2007, ANTHROPOLOGIST, V3, P251; Sterkowicz-Przybycien K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211533; Sun WW, 2017, ISPRS J PHOTOGRAMM, V131, P147, DOI 10.1016/j.isprsjprs.2017.08.001; Sun WW, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9080841; Thogersen JC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-279; Tomassoni D, 2014, MATURITAS, V79, P421, DOI 10.1016/j.maturitas.2014.07.019; Tsanousa A, 2015, EXPERT SYST APPL, V42, P8454, DOI 10.1016/j.eswa.2015.06.058; Vinue G, 2017, DATA MIN KNOWL DISC, V31, P1643, DOI 10.1007/s10618-017-0514-1; Vinue G, 2019, STAT ANAL DATA MIN, V12, P534, DOI 10.1002/sam.11436; Vinue G, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i06; Vinue G, 2015, COMPUT STAT DATA AN, V87, P102, DOI 10.1016/j.csda.2015.01.018; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Vuruskan A, 2011, INT J CLOTH SCI TECH, V23, P46, DOI 10.1108/09556221111096732; Wu C, 2016, 2016 IEEE 19TH INTERNATIONAL CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS (ITSC), P1384, DOI 10.1109/ITSC.2016.7795738; Wunderlich RE, 2001, MED SCI SPORT EXER, V33, P605; Zehner G.F., 1993, MULTIVARIATE ANTHROP	85	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228016	10.1371/journal.pone.0228016	http://dx.doi.org/10.1371/journal.pone.0228016			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999749	gold, Green Published			2022-12-26	WOS:000534612400043
J	Cawley, NX; Sojka, C; Cougnoux, A; Lyons, AT; Nicoli, ER; Wassif, CA; Porter, FD				Cawley, Niamh X.; Sojka, Caitlin; Cougnoux, Antony; Lyons, Anna T.; Nicoli, Elena-Raluca; Wassif, Christopher A.; Porter, Forbes D.			Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology	PLOS ONE			English	Article							PROTEIN-DEFICIENT; MOUSE MODELS; CHOLESTEROL; NPC1; ACCUMULATION; LYSOSOMES; BINDING; DOMAIN	A hallmark of Niemann-Pick disease, type C (NPC) is the progressive degeneration of Purkinje neurons in the cerebellum caused by the accumulation of free cholesterol and glycosphingolipids in the lysosome. Recent studies suggest that the state of glycosylation of lysosomal membrane proteins may play a role in disease progression. Our study has identified the presence of a highly glycosylated form of Lysosome Associated Membrane Protein 1 (LAMP1) that correlated spatiotemporally with Purkinje neuron loss. This form of LAMP1 was predominantly localized to activated microglia; showing a similar to 5-fold increase in surface labeling by FACS analysis. This suggests a potential role for LAMP1 in the neuro-inflammatory process in these mice during disease progression. Analysis of other mouse models of neurodegeneration that exhibit neuro-inflammation showed little or no presence of this glycosylated form of LAMP1, suggesting this observation for LAMP1 is specific to NPC disease. Furthermore, early treatment of Npc1(-/-) mice with 2-hydroxypropyl-beta-cyclodextrin (HP beta CD), significantly prevented the appearance of the glycosylated LAMP1 in the cerebellum of Npc1(-/-) mice at 7 weeks, consistent with the prevention of neuro-inflammation in mice treated with this drug. Treatment of Npc1(-/-) mice with HP beta CD at 7 weeks, after disease onset, did not reverse or prevent further appearance of the hyperglycosylated LAMP1, demonstrating that once this aspect of neuro-inflammation began, it continued despite the HP beta CD treatment. Analysis of LAMP1 in cerebellar tissue of NPC1 patients showed a small level of hyperglycosylated LAMP1 in the tissue, however, this was not seen in the CSF of patients.	[Cawley, Niamh X.; Sojka, Caitlin; Cougnoux, Antony; Lyons, Anna T.; Wassif, Christopher A.; Porter, Forbes D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Dysmorphol, Div Translat Med, Dept Hlth & Human Serv,NIH, Bethesda, MD 20892 USA; [Nicoli, Elena-Raluca] NHGRI, Dept Hlth & Human Serv, Pediat Undiagnosed Dis Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Porter, FD (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Dysmorphol, Div Translat Med, Dept Hlth & Human Serv,NIH, Bethesda, MD 20892 USA.	fdporter@mail.nih.gov	Nicoli, Elena-Raluca/F-3968-2011	Nicoli, Elena-Raluca/0000-0002-5545-630X; Sojka, Caitlin/0000-0003-0902-8694; Lyons, Anna/0000-0001-6441-4104	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this work was from the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development	Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; [Anonymous], 2016, ELIFE; Caporali P, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0370-z; CARLSSON SR, 1992, ARCH BIOCHEM BIOPHYS, V296, P630, DOI 10.1016/0003-9861(92)90619-8; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Chua CC, 2010, J NEUROCHEM, V112, P1619, DOI 10.1111/j.1471-4159.2010.06586.x; Chung C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006042; Cologna SM, 2014, J INHERIT METAB DIS, V37, P83, DOI 10.1007/s10545-013-9610-6; Cougnoux A, 2018, HUM MOL GENET, V27, P2076, DOI 10.1093/hmg/ddy112; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Klein A, 2006, HEPATOLOGY, V43, P126, DOI 10.1002/hep.20985; Kosicek M, 2018, MOL CELL PROTEOMICS, V17, P631, DOI 10.1074/mcp.RA117.000129; Krishnan V, 2005, CLIN EXP METASTAS, V22, P11, DOI 10.1007/s10585-005-2036-2; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Li DQ, 2008, J IMMUNOL, V180, P3158, DOI 10.4049/jimmunol.180.5.3158; Li J, 2015, P NATL ACAD SCI USA, V112, P14876, DOI 10.1073/pnas.1520490112; Liao GH, 2010, BRAIN RES, V1325, P128, DOI 10.1016/j.brainres.2010.02.019; Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011; Micsenyi MC, 2009, J NEUROPATH EXP NEUR, V68, P125, DOI 10.1097/NEN.0b013e3181942cf0; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Rothaug M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-014-0182-y; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sarafian V, 1998, INT J CANCER, V75, P105, DOI 10.1002/(SICI)1097-0215(19980105)75:1<105::AID-IJC16>3.3.CO;2-L; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Singhal A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1056-1; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Yoshida Y, 2014, IMMUNITY, V40, P187, DOI 10.1016/j.immuni.2013.11.022; Yu T, 2011, HUM MOL GENET, V20, P4440, DOI 10.1093/hmg/ddr372	42	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227829	10.1371/journal.pone.0227829	http://dx.doi.org/10.1371/journal.pone.0227829			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999726	Green Published, gold			2022-12-26	WOS:000534612400033
J	Rincon, LJG; Alencar, GP; Cardoso, MA; Narvai, PC; Frazao, P				Garcia Rincon, Laura Jackeline; Alencar, Gizelton Pereira; Cardoso, Marly Augusto; Narvai, Paulo Capel; Frazao, Paulo			Effect of birth weight and nutritional status on transverse maxillary growth: Implications for maternal and infant health	PLOS ONE			English	Article							BREAST-FEEDING DURATION; NONNUTRITIVE SUCKING; CHILDHOOD; OCCLUSION; CHILDREN; PRETERM; HABITS	We analyzed the association between birthweight, nutritional status and transverse maxillary growth in 7- to 9-year-old schoolchildren. We undertook a cross-sectional survey nested in a population-based cohort study of 158 schoolchildren. The participants lived in the urban area of a small town within the Western Brazilian Amazon. The outcome was represented by the upper intermolar distance given in millimeters (mm), as an indicator of the degree of maxillary bone growth in its transverse dimension. The exposures were sex, birthweight, the bottle-feeding pattern operationalized by a scale corresponding to the age of introduction of the bottle and Body Mass Index-for-age z-score (BAZ) at 4 to 6 ys. Path analysis was employed to estimate standardized direct, indirect and total effects of exposures on the outcome using structural equations model (SEM) supported by Mplus 7 program. The values of standardized coefficients (SC) showed significant direct positive effects of sex (SC = 0.203; p = 0.006), birth weight (SC = 0.155; p = 0.030) and BAZ (SC = 0.165; p = 0.014) on transverse maxillary growth. The indirect effects (SC = 0.057; p = 0.012) and the total effect (SC = 0.261; p<0.001) of sex on the outcome were statistically significant. The indirect effects of birth weight on the outcome were not significant (SC = 0.018; p = 0.488), however, the total effect was significant (SC = 0.174; p = 0.011). In conclusion, sex, birthweight, bottle beginning age and BAZ showed association with the transverse growth of the maxillary bone. In addition to contributing to an adequate birth weight of the child, policies and programs that favor prenatal care and conditions to guarantee a full-term birth can positively affect transverse growth of the maxilla. From a Public Health Surveillance point of view, children with reduced birthweight, inadequate breastfeeding pattern and nutritional deficit for age may be more likely to develop atrophy of the jaws which, depending on the severity, may result in malocclusion with an important impact on quality of life.	[Garcia Rincon, Laura Jackeline; Narvai, Paulo Capel; Frazao, Paulo] Univ Sao Paulo, Sch Publ Hlth, Dept Polit Management & Hlth, Sao Paulo, Brazil; [Alencar, Gizelton Pereira] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil; [Cardoso, Marly Augusto] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Rincon, LJG (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Polit Management & Hlth, Sao Paulo, Brazil.	lajita25_5@usp.br	Alencar, Gizelton P/H-1248-2014; Cardoso, Marly Augusto/B-8010-2013; Frazao, Paulo/G-2261-2012	Alencar, Gizelton P/0000-0002-2354-9050; Cardoso, Marly Augusto/0000-0003-0973-3908; Frazao, Paulo/0000-0002-3224-0020; Garcia Rincon, Laura/0000-0001-7462-5781; Narvai, Paulo Capel/0000-0003-4769-6896	Brazilian Council for Scientific and Technological Development [CNPq 402260/2008-2]	Brazilian Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian Council for Scientific and Technological Development (CNPq 402260/2008-2). The author who received the award was PCN. URL: www.cnpq.br.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaran N, 2009, AM J ORTHOD DENTOFAC, V135, P649, DOI 10.1016/j.ajodo.2007.05.023; Araujo Adriano Marotta, 2004, Rev. Dent. Press Ortodon. Ortop. Facial, V9, P122, DOI 10.1590/S1415-54192004000300013; Azad MB, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1092; Aznar T, 2006, ANGLE ORTHOD, V76, P441; Baccetti T, 2005, ANGLE ORTHOD, V75, P510; Barros H, 1996, J PUBLIC HEALTH MED, V18, P321, DOI 10.1093/oxfordjournals.pubmed.a024513; Belluzzo Regina Helena Lourenço, 2012, Dental Press J. Orthod., V17, P1; Boshari T, 2013, PAEDIATR PERINAT EP, V27, P118, DOI 10.1111/ppe.12038; Cardoso MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036341; Carrascoza Karina Camillo, 2006, J. Pediatr. (Rio J.), V82, P395, DOI [10.1590/S0021-75572006000600015, 10.2223/JPED.1536]; Chen XX, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0364-1; D'Onofrio L, 2019, ORTHOD CRANIOFAC RES, V22, P43, DOI 10.1111/ocr.12277; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; FEARNE JM, 1993, EARLY HUM DEV, V33, P81, DOI 10.1016/0378-3782(93)90203-7; Frazao P, 2014, NUTR SAUDE COLETIVA, P303; Frazão Paulo, 2002, Cad. Saúde Pública, V18, P1197, DOI 10.1590/S0102-311X2002000500012; Frazao P, 2006, AM J ORTHOD DENTOFAC, V129, P809, DOI 10.1016/j.ajodo.2004.10.016; Frazao P, 2014, EUR J ORAL SCI, V122, P210, DOI 10.1111/eos.12124; GARN SM, 1979, AM J PHYS ANTHROPOL, V51, P665, DOI 10.1002/ajpa.1330510416; Jogahara YO, 2012, PRIMATES, V53, P193, DOI 10.1007/s10329-011-0286-y; Kuh Diana, 2007, LIFE COURSE APPROACH; Lourenco BH, 2015, MATERN CHILD NUTR, V11, P240, DOI 10.1111/mcn.12005; Lourenco BH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-265; Maia-Nader M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-743; Mayoral J, 1983, ORTODONCIA PRINCIPIO; McNamara JA, 2000, AM J ORTHOD DENTOFAC, V117, P567, DOI 10.1016/S0889-5406(00)70202-2; Muniz PT, 2007, CAD SAUDE PUBLICA, V23, P1283, DOI 10.1590/S0102-311X2007000600004; Muthen LK, 2012, MPLUS USERS GUIDE, P379; Paolantonio EG, 2019, EUR J PAEDIATR DENT, V20, P204, DOI 10.23804/ejpd.2019.20.03.07; Peabody JW, 1998, HEALTH POLICY, V43, P1, DOI 10.1016/S0168-8510(97)00085-7; Peres KG, 2015, ACTA PAEDIATR, V104, P54, DOI 10.1111/apa.13103; Peres MA, 2013, FUNDAMENTOS ODONTOLO, P415; Proffit W., 2008, ORTODONTIA CONT; Rousset M. M., 2001, RECHERCHE SCI STOMAT, V43, P53; Rousset Monique-Marie, 2003, J Dent Child (Chic), V70, P208; Sanchez-Molins M, 2010, EUR J PAEDIATR DENT, V11, P87; Seow WK, 2005, PEDIATR DENT, V27, P374; SIRIWAT PP, 1985, ANGLE ORTHOD, V55, P127; Viggiano D, 2004, ARCH DIS CHILD, V89, P1121, DOI 10.1136/adc.2003.029728; WHO, 2006, ACTA PAEDIATR, P76, DOI DOI 10.1111/J.1651-2227.2006.TB02378.X; Zhu YY, 2015, J EPIDEMIOL COMMUN H, V69, P632, DOI 10.1136/jech-2014-204794	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228375	10.1371/journal.pone.0228375	http://dx.doi.org/10.1371/journal.pone.0228375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999780	Green Published, gold			2022-12-26	WOS:000534612400074
J	Hofmanova, J; Slavik, J; Ovesna, P; Tylichova, Z; Dusek, L; Strakova, N; Vaculova, AH; Ciganek, M; Kala, Z; Jira, M; Penka, I; Kyclova, J; Kolar, Z; Kozubik, A; Machala, M; Vondracek, J				Hofmanova, Jirina; Slavik, Josef; Ovesna, Petra; Tylichova, Zuzana; Dusek, Ladislav; Strakova, Nicol; Vaculova, Alena Hyrslova; Ciganek, Miroslav; Kala, Zdenek; Jira, Miroslav; Penka, Igor; Kyclova, Jitka; Kolar, Zdenek; Kozubik, Alois; Machala, Miroslav; Vondracek, Jan			Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: Phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; FATTY-ACID; ADENOMA; PHOSPHATIDYLCHOLINE; PROTEIN; DIFFERENTIATION; ADENOCARCINOMA; PROLIFERATION; ABNORMALITIES; INVOLVEMENT	Identification of changes of phospholipid (PL) composition occurring during colorectal cancer (CRC) development may help us to better understand their roles in CRC cells. Here, we used LC-MS/MS-based PL profiling of cell lines derived from normal colon mucosa, or isolated at distinct stages of CRC development, in order to study alterations of PL species potentially linked with cell transformation. We found that a detailed evaluation of phosphatidylinositol (PI) and phosphatidylserine (PS) classes allowed us to cluster the studied epithelial cell lines according to their origin: i) cells originally derived from normal colon tissue (NCM460, FHC); ii) cell lines derived from colon adenoma or less advanced differentiating adenocarcinoma cells (AA/C1, HT-29); or, iii) cells obtained by in vitro transformation of adenoma cells and advanced colon adenocarcinoma cells (HCT-116, AA/C1/SB10, SW480, SW620). Although we tentatively identified several PS and PI species contributing to cell line clustering, full PI and PS profiles appeared to be a key to the successful cell line discrimination. In parallel, we compared PL composition of primary epithelial (EpCAM-positive) cells, isolated from tumor and adjacent non-tumor tissues of colon cancer patients, with PL profiles of cell lines derived from normal colon mucosa (NCM460) and from colon adenocarcinoma (HCT-116, SW480) cells, respectively. In general, higher total levels of all PL classes were observed in tumor cells. The overall PL profiles of the cell lines, when compared with the respective patient-derived cells, exhibited similarities. Nevertheless, there were also some notable differences in levels of individual PL species. This indicated that epithelial cell lines, derived either from normal colon tissue or from CRC cells, could be employed as models for functional lipidomic analyses of colon cells, albeit with some caution. The biological significance of the observed PL deregulation, or their potential links with specific CRC stages, deserve further investigation.	[Hofmanova, Jirina; Ovesna, Petra; Tylichova, Zuzana; Strakova, Nicol; Vaculova, Alena Hyrslova; Vondracek, Jan] Czech Acad Sci, Inst Biophys, Dept Cytokinet, Brno, Czech Republic; [Slavik, Josef; Ciganek, Miroslav; Machala, Miroslav] Vet Res Inst, Brno, Czech Republic; [Ovesna, Petra; Dusek, Ladislav] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic; [Kala, Zdenek; Penka, Igor] Univ Hosp Brno, Dept Surg, Brno, Czech Republic; [Jira, Miroslav] Univ Hosp Brno, Dept Anesthesiol Resuscitat & Intens Care, Brno, Czech Republic; [Kyclova, Jitka] Univ Hosp Brno, Dept Pathol, Brno, Czech Republic; [Kolar, Zdenek] Palacky Univ Olomouc, Fac Med & Dent, Dept Clin & Mol Pathol, Olomouc, Czech Republic; [Kozubik, Alois] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Czech Veterinary Research Institute; Institute of Biostatistics & Analyses; Masaryk University Brno; University Hospital Brno; University Hospital Brno; University Hospital Brno; Palacky University Olomouc; Masaryk University Brno	Vondracek, J (corresponding author), Czech Acad Sci, Inst Biophys, Dept Cytokinet, Brno, Czech Republic.; Machala, M (corresponding author), Vet Res Inst, Brno, Czech Republic.	machala@vri.cz; vondracek@ibp.cz	Straková, Nicol/E-9685-2019; Kolar, Zdenek/A-4597-2008; Vondracek, Jan/J-3037-2012; Tylichova, Zuzana/AAX-9085-2021	Straková, Nicol/0000-0003-3874-3777; Kolar, Zdenek/0000-0003-1838-5925; Vondracek, Jan/0000-0003-4071-1969; Hyrslova Vaculova, Alena/0000-0002-0445-8807; Dusek, Ladislav/0000-0002-8589-4378	Czech Health Research Council [15-30585A]; Ministry of Education, Youth and Sports of the Czech Republic [CZ.02.1.01/0.0/0.0/15_003/0000495]	Czech Health Research Council; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Czech Health Research Council (URL: http://www.azvcr.cz/en), project no. 15-30585A to A.K. and the Ministry of Education, Youth and Sports of the Czech Republic (URL: http://www.msmt.cz/research-and-development-1), project OPVVV PO1 "FIT"(Pharmacology, Immunotherapy, nanoToxicolgy) CZ.02.1.01/0.0/0.0/15_003/0000495 to M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Azordegan N, 2013, MOL CELL BIOCHEM, V374, P223, DOI 10.1007/s11010-012-1523-4; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Bandu R, 2018, MASS SPECTROM REV, V37, P107, DOI 10.1002/mas.21510; Baro L, 1998, BRIT J CANCER, V77, P1978, DOI 10.1038/bjc.1998.328; BENNETT A, 1987, GUT, V28, P315, DOI 10.1136/gut.28.3.315; Berstad P, 2012, J ONCOL, V2012, DOI 10.1155/2012/254801; Bestard-Escalas J, 2016, BBA-MOL CELL BIOL L, V1861, P1942, DOI 10.1016/j.bbalip.2016.09.013; BROWNE SJ, 1994, INT J CANCER, V59, P56, DOI 10.1002/ijc.2910590113; Chen PJ, 2017, FREE RADICAL BIO MED, V104, P280, DOI 10.1016/j.freeradbiomed.2017.01.033; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Doria ML, 2014, FASEB J, V28, P4247, DOI 10.1096/fj.14-249672; Dueck DA, 1996, MOL CELL BIOCHEM, V162, P97; FernandezBanares F, 1996, GUT, V38, P254, DOI 10.1136/gut.38.2.254; Fernandis AZ, 2009, J CHROMATOGR B, V877, P2830, DOI 10.1016/j.jchromb.2009.06.015; Fhaner CJ, 2012, ANAL CHEM, V84, P8917, DOI 10.1021/ac302154g; Goto T, 2015, PROSTATE, V75, P1821, DOI 10.1002/pros.23088; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Greenhough A, 2010, ONCOGENE, V29, P3398, DOI 10.1038/onc.2010.94; Guo S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05959; HAGUE A, 1992, INT J ONCOL, V1, P201; Hofmanova J, 2017, EUR J NUTR, V56, P1493, DOI 10.1007/s00394-016-1196-y; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Johnson CH, 2017, CANCER METAB, V5, DOI 10.1186/s40170-017-0171-2; Kawashima M, 2013, CANCER SCI, V104, P1372, DOI 10.1111/cas.12229; Kim HY, 2016, ONCOTARGET, V7, P67111, DOI 10.18632/oncotarget.11560; Knutsen T, 2010, GENE CHROMOSOME CANC, V49, P204, DOI 10.1002/gcc.20730; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Kurabe N, 2013, CANCER SCI, V104, P1295, DOI 10.1111/cas.12221; Lee HK, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42891; Leyssens C, 2015, J STEROID BIOCHEM, V148, P172, DOI 10.1016/j.jsbmb.2015.01.018; Li F, 2013, RAPID COMMUN MASS SP, V27, P24, DOI 10.1002/rcm.6420; Li Shi-Yong, 2004, Hepatobiliary Pancreat Dis Int, V3, P411; Doria ML, 2013, J CELL PHYSIOL, V228, P457, DOI 10.1002/jcp.24152; Doria ML, 2012, BREAST CANCER RES TR, V133, P635, DOI 10.1007/s10549-011-1823-5; Luo XJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0646-3; Marien E, 2015, INT J CANCER, V137, P1539, DOI 10.1002/ijc.29517; Minoo P, 2007, J PATHOL, V212, P124, DOI 10.1002/path.2160; Mirnezami R, 2014, MOL ONCOL, V8, P39, DOI 10.1016/j.molonc.2013.08.010; NEOPTOLEMOS JP, 1991, GUT, V32, P278, DOI 10.1136/gut.32.3.278; Oraldi M, 2009, J ONCOL, V2009, DOI 10.1155/2009/867915; Pakiet A, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-0977-8; PARASKEVA C, 1989, CANCER RES, V49, P1282; Peng W, 2018, ONCOL REP, V40, P1026, DOI 10.3892/or.2018.6510; Perrotti F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121992; Pot GK, 2008, INT J CANCER, V123, P1974, DOI 10.1002/ijc.23729; Rakheja D, 2005, MED HYPOTHESES, V65, P1120, DOI 10.1016/j.mehy.2005.05.045; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Soucek K, 2010, CANCER GENET CYTOGEN, V197, P107, DOI 10.1016/j.cancergencyto.2009.11.009; Szachowicz-Petelska B, 2007, MOL CELL BIOCHEM, V294, P237, DOI 10.1007/s11010-006-9264-x; Thomas A, 2013, ANAL CHEM, V85, P2860, DOI 10.1021/ac3034294; Tylichova Z, 2017, J NUTR BIOCHEM, V39, P145, DOI 10.1016/j.jnutbio.2016.09.006; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; WILLIAMS AC, 1990, CANCER RES, V50, P4724; WILLIAMS AC, 1994, ONCOGENE, V9, P1479; Yan GF, 2016, ONCOTARGET, V7, P33429, DOI 10.18632/oncotarget.7960; Yaqoob P, 2010, CURR OPIN CLIN NUTR, V13, P156, DOI 10.1097/MCO.0b013e328335725b; Zhang JJ, 2013, PROSTAG LEUKOTR ESS, V88, P355, DOI 10.1016/j.plefa.2013.02.005	62	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228010	10.1371/journal.pone.0228010	http://dx.doi.org/10.1371/journal.pone.0228010			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999740	gold, Green Published, Green Submitted			2022-12-26	WOS:000534612400041
J	Tobin, GJ; Tobin, JK; Gaidamakova, EK; Wiggins, TJ; Bushnell, RV; Lee, WM; Matrosova, VY; Dollery, SJ; Meeks, HN; Kouiavskaia, D; Chumakov, K; Daly, MJ				Tobin, Gregory J.; Tobin, John K.; Gaidamakova, Elena K.; Wiggins, Taralyn J.; Bushnell, Ruth V.; Lee, Wai-Ming; Matrosova, Vera Y.; Dollery, Stephen J.; Meeks, Heather N.; Kouiavskaia, Diana; Chumakov, Konstantin; Daly, Michael J.			A novel gamma radiation-inactivated sabin-based polio vaccine	PLOS ONE			English	Article							MN2+-PEPTIDE COMPLEX; ENDGAME; POLIOMYELITIS; FORMALDEHYDE; RESISTANCE; CHALLENGE; POTENCY	A concerted action on the part of international agencies and national governments has resulted in the near-eradication of poliomyelitis. However, both the oral polio vaccine (OPV) and the inactivated polio vaccine (IPV) have deficiencies which make them suboptimal for use after global eradication. OPV is composed of attenuated Sabin strains and stimulates robust immunity, but may revert to neurovirulent forms in the intestine which can be shed and infect susceptible contacts. The majority of IPV products are manufactured using pathogenic strains inactivated with formalin. Upon eradication, the production of large quantities of pathogenic virus will present an increased biosecurity hazard. A logical ideal endgame vaccine would be an inactivated form of an attenuated strain that could afford protective immunity while safely producing larger numbers of doses per unit of virus stock than current vaccines. We report here the development of an ionizing radiation (IR)-inactivated Sabinbased vaccine using a reconstituted Mn-decapeptide (MDP) antioxidant complex derived from the radioresistant bacterium Deinococcus radiodurans. In bacteria, Mn2+- peptide anti-oxidants protect proteins from oxidative damage caused by extreme radiation exposure. Here we show for the first time, that MDP can protect immunogenic neutralizing epitopes in picornaviruses. MDP protects epitopes in Polio Virus 1 and 2 Sabin strains (PV1-S and PV2-S, respectively), but viral genomic RNA is not protected during supralethal irradiation. IR-inactivated Sabin viruses stimulated equivalent or improved neutralizing antibody responses in Wistar rats compared to the commercially used IPV products. Our approach reduces the biosecurity risk of the current PV vaccine production method by utilizing the Sabin strains instead of the wild type neurovirulent strains. Additionally, the IR-inactivation approach could provide a simpler, faster and less costly process for producing a more immunogenic IPV. Gamma-irradiation is a well-known method of virus inactivation and this vaccine approach could be adapted to any pathogen of interest.	[Tobin, Gregory J.; Tobin, John K.; Wiggins, Taralyn J.; Bushnell, Ruth V.; Lee, Wai-Ming; Dollery, Stephen J.] Biol Mimet Inc, Ft Detrick, MD 21702 USA; [Gaidamakova, Elena K.; Matrosova, Vera Y.; Daly, Michael J.] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Gaidamakova, Elena K.; Matrosova, Vera Y.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Meeks, Heather N.] Def Threat Reduct Agcy, Ft Belvoir, VA USA; [Kouiavskaia, Diana; Chumakov, Konstantin] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA	Uniformed Services University of the Health Sciences - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; Defense Threat Reduction Agency; US Food & Drug Administration (FDA)	Tobin, GJ (corresponding author), Biol Mimet Inc, Ft Detrick, MD 21702 USA.	tobin@bmi-md.com	Matrosova, Vera/AAX-4125-2020	Dollery, Steve/0000-0002-1712-3811	Defense Threat Reduction Agency, Department of Defense STTR Phase 1 [HDTRA115-P-0034]; National Institutes of Health, Department of Health and Human services SBIR Phase 1 [1R43AI120260-01]; USUHS; DTRA	Defense Threat Reduction Agency, Department of Defense STTR Phase 1; National Institutes of Health, Department of Health and Human services SBIR Phase 1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USUHS; DTRA(United States Department of DefenseDefense Threat Reduction Agency)	Two awards funding this study were granted to Biological Mimetics Inc. as follows. Defense Threat Reduction Agency, Department of Defense STTR Phase 1 contract award HDTRA115-P-0034 https://www.dtra.mil/National Institutes of Health, Department of Health and Human services SBIR Phase 1 grant award 1R43AI120260-01 https://sbir.nih.gov/One of the two funding organizations (DTRA) is an agency of the Department of Defense. Two co-authors are employed by the Department of Defense. MJD is a Professor at the Uniformed Services University Health Sciences. Dr. Daly participated in all aspects of the project but he and his University have no control over funding. HNM is a Program Officer at one of the two funding agencies, DTRA. Dr. Meeks played a role in the conceptualization of the overarching research aims, in the analysis and interpretation of the data, and in manuscript editing. Dr. Meeks has no role in decisions regarding funding these types of applications that are submitted to DTRA. The two funding agencies provided support in the form of salaries for all authors with the exception of MJD who is a fullyfunded Professor at USUHS and HNM who is a fully-funded employee at DTRA. The specific roles of these authors are articulated in the `author contributions' section.	Aly HAA, 2015, WHO TECH REP SER, V994, P1; Bockstal V, 2018, VACCINE, V36, P2917, DOI 10.1016/j.vaccine.2018.04.024; BROWN F, 1993, DEV BIOL STAND, V81, P103; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Duizer E, 2016, EUROSURVEILLANCE, V21, P16, DOI 10.2807/1560-7917.ES.2016.21.11.30169; FDA, 2016, FOOD IRRADIATION; Food and Drug Administration, 2016, FOOD IRR WHAT YOU NE; Furuya Y, 2012, IMMUNOL CELL BIOL, V90, P571, DOI 10.1038/icb.2011.70; Gaidamakova EK, 2012, CELL HOST MICROBE, V12, P117, DOI 10.1016/j.chom.2012.05.011; Garon J, 2016, EXPERT REV VACCINES, V15, P693, DOI 10.1586/14760584.2016.1140041; Garon JR, 2015, INFECT DIS CLIN N AM, V29, P651, DOI 10.1016/j.idc.2015.07.003; Gayen M, 2017, VACCINE, V35, P3672, DOI 10.1016/j.vaccine.2017.05.016; Global Polio Eradication Initiative, 2019, AFF IPV DEV AFF IN P; Global Polio Iradication Initiative, 2013, POL ER ENDG PLAN 201; Kangro HO, 1996, VIROLOGY METHODS MAN; Kersten G, 1999, VACCINE, V17, P2059, DOI 10.1016/S0264-410X(98)00409-5; Lee WM, 2015, METHODS MOL BIOL, V1221, P49, DOI 10.1007/978-1-4939-1571-2_5; Lewis I, 2017, J INFECT DIS, V216, pS33, DOI 10.1093/infdis/jiw550; Lopalco PL, 2017, EPIDEMIOL INFECT, V145, P413, DOI [10.1017/S0950268816002569, 10.1017/s0950268816002569]; Martin SS, 2010, VACCINE, V28, P1031, DOI 10.1016/j.vaccine.2009.10.126; Minor P, 2001, Dev Biol (Basel), V105, P75; Minor PD, 2005, J MED VIROL, V75, P153, DOI 10.1002/jmv.20250; Minor PD, 2016, METHODS MOL BIOL, V1387, P1, DOI 10.1007/978-1-4939-3292-4_1; NATHANSON N, 1995, AM J EPIDEMIOL, V142, P109, DOI 10.1093/oxfordjournals.aje.a117611; Nathanson N, 1963, AM J EPIDEMIOL, V142, P7, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A117611; Okayasu H, 2014, J INFECT DIS, V210, pS459, DOI 10.1093/infdis/jiu128; Patel M, 2015, EXPERT REV VACCINES, V14, P749, DOI 10.1586/14760584.2015.1001750; Peana M, 2016, J INORG BIOCHEM, V164, P49, DOI 10.1016/j.jinorgbio.2016.08.012; Peetermans J, 1996, DEV BIOL STAND, V87, P97; Rezapkin G, 2005, BIOLOGICALS, V33, P29, DOI 10.1016/j.biologicals.2004.11.001; Rezapkin G, 2005, BIOLOGICALS, V33, P17, DOI 10.1016/j.biologicals.2004.11.003; SALK JE, 1960, ANN NY ACAD SCI, V83, P609, DOI 10.1111/j.1749-6632.1960.tb40933.x; Schubert RD, 2019, NAT MED, V25, P1748, DOI 10.1038/s41591-019-0613-1; Seo HS, 2015, CLIN EXP VACCINE RES, V4, P145, DOI 10.7774/cevr.2015.4.2.145; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Swift GH, 2000, BIOTECHNIQUES, V28, P524, DOI 10.2144/00283rr01; Tano Y, 2007, VACCINE, V25, P7041, DOI 10.1016/j.vaccine.2007.07.060; VANSTEENIS G, 1981, DEV BIOL STAND, V47, P119; Vidor E, 2012, VACCINES; Weaver SC, 1999, AM J TROP MED HYG, V60, P441, DOI 10.4269/ajtmh.1999.60.441	42	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228006	10.1371/journal.pone.0228006	http://dx.doi.org/10.1371/journal.pone.0228006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999745	Green Submitted, gold, Green Published			2022-12-26	WOS:000534612400039
J	Toldi, V; Szabo, A; Sahin-Toth, M				Toldi, Vanda; Szabo, Andras; Sahin-Toth, Miklos			Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreas; protease; protease inhibitor; trypsin; trypsinogen; chymotrypsin C; mesotrypsin	CATIONIC TRYPSINOGEN; PANCREATITIS; PROTEINS; PROTEASE; AUTOACTIVATION; DETERMINANTS; PURIFICATION; EXPRESSION; CLEAVAGE; AFFINITY	Mesotrypsin is an unusual human trypsin isoform with inhibitor resistance and the ability to degrade trypsin inhibitors. Degradation of the protective serine protease inhibitor Kazal type 1 (SPINK1) by mesotrypsin in the pancreas may contribute to the pathogenesis of pancreatitis. Here we tested the hypothesis that the regulatory digestive protease chymotrypsin C (CTRC) mitigates the harmful effects of mesotrypsin by cleaving the autolysis loop. As human trypsins are post-translationally sulfated in the autolysis loop, we also assessed the effect of this modification. We found that mesotrypsin cleaved in the autolysis loop by CTRC exhibited catalytic impairment on short peptides due to a 10-fold increase in K-m, it digested ?-casein poorly and bound soybean trypsin inhibitor with 10-fold decreased affinity. Importantly, CTRC-cleaved mesotrypsin degraded SPINK1 with markedly reduced efficiency. Sulfation increased mesotrypsin activity but accelerated CTRC-mediated cleavage of the autolysis loop and did not protect against the detrimental effect of CTRC cleavage. The observations indicate that CTRC-mediated cleavage of the autolysis loop in mesotrypsin decreases protease activity and thereby protects the pancreas against unwanted SPINK1 degradation. The findings expand the role of CTRC as a key defense mechanism against pancreatitis through regulation of intrapancreatic trypsin activity.	[Toldi, Vanda; Szabo, Andras] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Egyet Ter 1,Life Sci Bldg 3-109, H-4032 Debrecen, Hungary; [Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Dept Mol & Cell Biol, Ctr Exocrine Disorders, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Sahin-Toth, Miklos] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA	University of Debrecen; Boston University; University of California System; University of California Los Angeles	Szabo, A (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Egyet Ter 1,Life Sci Bldg 3-109, H-4032 Debrecen, Hungary.; Sahin-Toth, M (corresponding author), MacDonald Res Labs, 675 Charles E Young Dr South,Rm 2220, Los Angeles, CA 90095 USA.	andrasszabo@med.unideb.hu; msahintoth@mednet.ucla.edu		Sahin-Toth, Miklos/0000-0003-4513-9922; Toldi, Vanda/0000-0002-0446-027X; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01 DK058088]; National Research, Development and Innovation Office of Hungary [PD120960, FK127942]; European Union; European Social Fund; University of Debrecen OTKA Bridge Fund; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences [BO/00514/19/5];  [EFOP-3.6.3-VEKOP-16-2017-00009]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research, Development and Innovation Office of Hungary; European Union(European Commission); European Social Fund(European Social Fund (ESF)); University of Debrecen OTKA Bridge Fund; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); 	This work was supported by National Institutes of Health Grant R01 DK058088 (to M. S.-T.), National Research, Development and Innovation Office of Hungary Grants PD120960 and FK127942, EFOP-3.6.3-VEKOP-16-2017-00009 project co-financed by the European Union and the European Social Fund, the University of Debrecen OTKA Bridge Fund, and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences Grant BO/00514/19/5 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alloy AP, 2015, J BIOL CHEM, V290, P21523, DOI 10.1074/jbc.M115.662429; Beer S, 2013, GUT, V62, P1616, DOI 10.1136/gutjnl-2012-303090; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chen JM, 2000, PANCREAS, V21, P57, DOI 10.1097/00006676-200007000-00052; GUILLIN MC, 1992, SEMIN THROMB HEMOST, V18, P224, DOI 10.1055/s-2007-1002428; GUY O, 1978, BIOCHEMISTRY-US, V17, P1669, DOI 10.1021/bi00602a014; Hegyi E, 2017, DIGEST DIS SCI, V62, P1692, DOI 10.1007/s10620-017-4601-3; Jancso Z, 2016, J BIOL CHEM, V291, P12897, DOI 10.1074/jbc.M116.725374; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Lasher D, 2019, AM J GASTROENTEROL, V114, P974, DOI 10.14309/ajg.0000000000000051; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; RINDERKNECHT H, 1979, GUT, V20, P886, DOI 10.1136/gut.20.10.886; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; RINDERKNECHT H, 1985, DIGEST DIS SCI, V30, P65, DOI 10.1007/BF01318373; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Ronai Z, 2009, BIOCHEM J, V418, P155, DOI 10.1042/BJ20081848; Sabharwal AK, 1997, J BIOL CHEM, V272, P22037, DOI 10.1074/jbc.272.35.22037; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2006, FEBS J, V273, P5044, DOI 10.1111/j.1742-4658.2006.05501.x; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh Moh'd A, 2013, Int J Biochem Mol Biol, V4, P129; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; Szabo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102063; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104	35	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3447	3455		10.1074/jbc.RA120.012526	http://dx.doi.org/10.1074/jbc.RA120.012526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32014997	Green Published, hybrid			2022-12-26	WOS:000527725300007
J	Belviso, S; Lebegue, B; Ramonet, M; Kazan, V; Pison, I; Berchet, A; Delmotte, M; Yver-Kwok, C; Montagne, D; Ciais, P				Belviso, Sauveur; Lebegue, Benjamin; Ramonet, Michel; Kazan, Victor; Pison, Isabelle; Berchet, Antoine; Delmotte, Marc; Yver-Kwok, Camille; Montagne, David; Ciais, Philippe			A top-down approach of sources and non-photosynthetic sinks of carbonyl sulfide from atmospheric measurements over multiple years in the Paris region (France)	PLOS ONE			English	Article							COS; EXCHANGE; PHOTOSYNTHESIS; TRANSPIRATION; FLUXES; MODEL	Carbonyl sulfide (COS) has been proposed as a proxy for carbon dioxide (CO2) taken up by plants at the leaf and ecosystem scales. However, several additional production and removal processes have been identified which could complicate its use at larger scales, among which are soil uptake, dark uptake by plants, and soil and anthropogenic emissions. This study evaluates the significance of these processes at the regional scale through a top-down approach based on atmospheric COS measurements at Gif-sur-Yvette (GIF), a suburban site near Paris (France). Over a period of four and a half years, hourly measurements at 7 m above ground level were performed by gas chromatography and combined with (222)Radon measurements to calculate nocturnal COS fluxes using the Radon-Tracer Method. In addition, the vertical distribution of COS was investigated at a second site, 2 km away from GIF, where a fast gas analyzer deployed on a 100 m tower for several months during winter 2015-2016 recorded mixing ratios at 3 heights (15, 60 and 100 m). COS appears to be homogeneously distributed both horizontally and vertically in the sampling area. The main finding is that the area is a persistent COS sink even during wintertime episodes of strong pollution. Nighttime net uptake rates ranged from -1.5 to -32.8 pmol m(-2) s(-1), with an average of -7.3 +/- 4.5 pmol m(-2) s(-1) (n = 253). However, episodes of biogenic emissions happened each year in June-July (11.9 +/- 6.2 pmol m(-2) s(-1), n = 24). Preliminary analyses of simulated footprints of source areas influencing the recorded COS data suggest that long-range transport of COS from anthropogenic sources located in Benelux, Eastern France and Germany occasionally impacts the Paris area during wintertime. These production and removal processes may limit the use of COS to assess regional-scale CO2 uptake in Europe by plants through inverse modeling.	[Belviso, Sauveur; Lebegue, Benjamin; Ramonet, Michel; Kazan, Victor; Pison, Isabelle; Berchet, Antoine; Delmotte, Marc; Yver-Kwok, Camille; Ciais, Philippe] Univ Paris Saclay, UVSQ, CNRS, Lab Sci Climat & Environm,CEA,UMR8212, Gif Sur Yvette, France; [Montagne, David] Univ Paris Saclay, AgroParisTech, INRA, UMR ECOSYS, Thiverval Grignon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Belviso, S (corresponding author), Univ Paris Saclay, UVSQ, CNRS, Lab Sci Climat & Environm,CEA,UMR8212, Gif Sur Yvette, France.	sauveur.belviso@lsce.ipsl.fr	Kwok, Camille Yver/ABC-7008-2020; Ciais, Philippe/A-6840-2011	Kwok, Camille Yver/0000-0002-2181-2863; Ciais, Philippe/0000-0001-8560-4943; Belviso, Sauveur/0000-0001-8539-5133				[Anonymous], 2015, INFORMES RECURSOS MU; Asaf D, 2013, NATURE GEOSCIENCE, P6; Belviso S, 2016, ATMOS CHEM PHYS, V16, P14909, DOI 10.5194/acp-16-14909-2016; Belviso S, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.20719; Berkelhammer M, 2014, GLOBAL BIOGEOCHEMICA; Billesbach DP, 2014, AGR FOREST METEOROL, P184, DOI [10.1016/j, DOI 10.1016/J]; Bloem E, 2012, J AGR FOOD CHEM, V60, P7588, DOI 10.1021/jf301912h; Bunk R, 2017, J GEOPHYS RES-BIOGEO, P122; Campbell JE, 2017, EOS, P98; Commane R, 2015, P NATL ACAD SCI USA, V112, P14162, DOI 10.1073/pnas.1504131112; Kaisermann A, 2018, ATMOS CHEM PHYS, V18, P9425, DOI 10.5194/acp-18-9425-2018; Kitz F, 2017, OECOLOGIA, V183, P851, DOI 10.1007/s00442-016-3805-0; Kooijmans LMJ, 2017, ATMOS CHEM PHYS, V17, P11453, DOI 10.5194/acp-17-11453-2017; Kooijmans LMJ, 2016, ATMOS MEAS TECH, V9, P5293, DOI 10.5194/amt-9-5293-2016; Kuhn U, 1999, ATMOS ENVIRON, V33, P995, DOI 10.1016/S1352-2310(98)00211-8; Kwok CY, 2015, ATMOS MEAS TECH, V8, P3867, DOI 10.5194/amt-8-3867-2015; Launois T, 2015, ATMOS CHEM PHYS, V15, P9285, DOI 10.5194/acp-15-9285-2015; Lebegue B, 2016, ATMOS MEAS TECH, V9, P1221, DOI 10.5194/amt-9-1221-2016; Lopez M, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017703; Mallik C, 2016, SCI TOTAL ENVIRON, V551, P725, DOI 10.1016/j.scitotenv.2016.02.014; Maseyk K, 2014, P NATL ACAD SCI USA, P111; Meredith LK, 2018, SOIL SYST, V2, DOI 10.3390/soilsystems2030037; Montzka SA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007665; Owens R., 2018, ECMWF FORECAST USER, DOI DOI 10.21957/M1CS7H; Pal S, 2015, J GEOPHYS RES-ATMOS, V120, P623, DOI 10.1002/2014JD022322; Petit JE, 2017, ATMOS ENVIRON, P155; Seibt U, 2010, BIOGEOSCIENCES, V7, P333, DOI 10.5194/bg-7-333-2010; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Stimler K, 2010, NEW PHYTOL, V186, P869, DOI 10.1111/j.1469-8137.2010.03218.x; Stohl A, 2005, ATMOS CHEM PHYS, V5, P2461, DOI 10.5194/acp-5-2461-2005; Whelan M. E., 2017, BIOGEOSCIENCES DISCU, V15, DOI [10.5194/bg-2017-427, DOI 10.5194/BG-2017-427]; Whelan ME, 2016, ATMOS CHEM PHYS, V16, P3711, DOI 10.5194/acp-16-3711-2016; Whittlestone S, 1998, J GEOPHYS RES-ATMOS, V103, P16743, DOI 10.1029/98JD00687; Wohlfahrt G, 2012, PLANT CELL ENVIRON, V35, P657, DOI 10.1111/j.1365-3040.2011.02451.x; Yver C, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012122; Zumkehr A, 2018, ATMOS ENVIRON, P183	36	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228419	10.1371/journal.pone.0228419	http://dx.doi.org/10.1371/journal.pone.0228419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040521	Green Submitted, Green Published, gold			2022-12-26	WOS:000534629400021
J	Mulcahy, G; Atwood, B; Kuznetsov, A				Mulcahy, Garrett; Atwood, Brady; Kuznetsov, Alexey			Basal ganglia role in learning rewarded actions and executing previously learned choices: Healthy and diseased states	PLOS ONE			English	Article							GLOBUS-PALLIDUS; NEURONAL-ACTIVITY; DOPAMINERGIC MODULATION; COGNITIVE DEFICITS; MOVEMENT-DISORDERS; INDIRECT PATHWAY; ACTION SELECTION; GABA(A) IPSCS; PLASTICITY; LESIONS	The basal ganglia (BG) is a collection of nuclei located deep beneath the cerebral cortex that is involved in learning and selection of rewarded actions. Here, we analyzed BG mechanisms that enable these functions. We implemented a rate model of a BG-thalamo-cortical loop and simulated its performance in a standard action selection task. We have shown that potentiation of corticostriatal synapses enables learning of a rewarded option. However, these synapses became redundant later as direct connections between prefrontal and premotor cortices (PFC-PMC) were potentiated by Hebbian learning. After we switched the reward to the previously unrewarded option (reversal), the BG was again responsible for switching to the new option. Due to the potentiated direct cortical connections, the system was biased to the previously rewarded choice, and establishing the new choice required a greater number of trials. Guided by physiological research, we then modified our model to reproduce pathological states of mild Parkinson's and Huntington's diseases. We found that in the Parkinsonian state PMC activity levels become extremely variable, which is caused by oscillations arising in the BG-thalamo-cortical loop. The model reproduced severe impairment of learning and predicted that this is caused by these oscillations as well as a reduced reward prediction signal. In the Huntington state, the potentiation of the PFC-PMC connections produced better learning, but altered BG output disrupted expression of the rewarded choices. This resulted in random switching between rewarded and unrewarded choices resembling an exploratory phase that never ended. Along with other computational studies, our results further reconcile the apparent contradiction between the critical involvement of the BG in execution of previously learned actions and yet no impairment of these actions after BG output is ablated by lesions or deep brain stimulation. We predict that the cortico-BG-thalamo-cortical loop conforms to previously learned choice in healthy conditions, but impedes those choices in disease states.	[Mulcahy, Garrett] Purdue Univ, Dept Math, W Lafayette, IN 47907 USA; [Atwood, Brady] IUSM, Dept Psychiat, Indianapolis, IN USA; [Atwood, Brady] IUSM, Dept Pharmacol & Toxicol, Indianapolis, IN USA; [Atwood, Brady; Kuznetsov, Alexey] IUSM, Indiana Alcohol Res Ctr, Indianapolis, IN 46202 USA; [Kuznetsov, Alexey] IUPUI, Dept Math Sci, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis	Kuznetsov, A (corresponding author), IUSM, Indiana Alcohol Res Ctr, Indianapolis, IN 46202 USA.; Kuznetsov, A (corresponding author), IUPUI, Dept Math Sci, Indianapolis, IN 46202 USA.	askuznet@iupui.edu	Atwood, Brady/AAJ-6852-2021; Atwood, Brady/AAA-4400-2021	Atwood, Brady/0000-0002-7441-2724; 	NIAAA NIH HHS [R01 AA027214] Funding Source: Medline	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; An J, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0178-19.2019; Baladron J, 2019, EUR J NEUROSCI, V49, P754, DOI 10.1111/ejn.13666; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Bamford NS, 2018, NEURON, V97, P494, DOI 10.1016/j.neuron.2018.01.006; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; Best J, 2007, J COMPUT NEUROSCI, V23, P217, DOI 10.1007/s10827-007-0029-7; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Brown P, 2008, MOVEMENT DISORD, V23, P12, DOI 10.1002/mds.21796; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Cohen JD, 2007, PUBLIC HEALTH AND HU, P362; Cools R, 2006, NEUROPSYCHOLOGIA, V44, P1663, DOI 10.1016/j.neuropsychologia.2006.03.030; Cooper AJ, 2001, NEUROPHARMACOLOGY, V41, P62, DOI 10.1016/S0028-3908(01)00038-7; Cozac V.V, 2016, PARKINSONS DIS-US, V2016, P1; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Damodaran S, 2014, J NEUROPHYSIOL, V111, P836, DOI 10.1152/jn.00382.2013; DeLong M. R., 1987, BASAL GANGLIA, P415, DOI 10.1007/978-1-4684-5347-8_29; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dostrovsky JO, 2002, NEUROSCIENTIST, V8, P284; DOUDET DJ, 1990, EXP BRAIN RES, V80, P177; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; Fisher SD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00394-x; Floran B, 2004, EUR J PHARMACOL, V498, P97, DOI 10.1016/j.ejphar.2004.07.078; Foerde K, 2011, NEUROBIOL LEARN MEM, V96, P624, DOI 10.1016/j.nlm.2011.08.006; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Galvan A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00005; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Graybiel AM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021691; Grillner S, 2013, J PHYSIOL-LONDON, V591, P5425, DOI 10.1113/jphysiol.2012.246660; Grospe GM, 2018, NEUROSCIENCE, V374, P80, DOI 10.1016/j.neuroscience.2018.01.032; Gurney K, 2001, BIOL CYBERN, V84, P401, DOI 10.1007/PL00007984; Gurney KN, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002034; Gutierrez-Garralda JM, 2013, EUR J NEUROSCI; Hassani OK, 1996, NEUROSCIENCE, V72, P105, DOI 10.1016/0306-4522(95)00535-8; HEINDEL WC, 1988, BEHAV NEUROSCI, V102, P141, DOI 10.1037/0735-7044.102.1.141; Hogarth L, 2013, ANN NY ACAD SCI, V1282, P12, DOI 10.1111/j.1749-6632.2012.06768.x; Hopf FW, 2014, ALCOHOL, V48, P253, DOI 10.1016/j.alcohol.2014.03.001; Hulse SH, 1980, MCGRAW HILL SERIES P; Humphries M., 2009, FRONT COMPUT NEUROSC, P3, DOI [10.3389/neuro.10.026.2009/abstract, DOI 10.3389/NEURO.10.026.2009/ABSTRACT]; Humphries MD, 2018, J NEUROL NEUROSUR PS, V89, P1181, DOI 10.1136/jnnp-2017-315922; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; HUTCHISON WD, 1994, NEUROREPORT, V5, P1533, DOI 10.1097/00001756-199407000-00031; Izquierdo A, 2006, BEHAV BRAIN RES, V171, P181, DOI 10.1016/j.bbr.2006.03.029; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Keiflin R, 2015, NEURON, V88, P247, DOI 10.1016/j.neuron.2015.08.037; Kim Y, 2019, ACQUE SOTTER, V8, P31, DOI 10.7343/as-2019-381; Kita H, 2011, FRONT SYST NEUROSCI, P5, DOI [10.3389/fnsys.2011.00042/abstract, DOI 10.3389/FNSYS.2011.00042/ABSTRACT]; Klaus A, 2017, NEURON, V95, P1171, DOI 10.1016/j.neuron.2017.08.015; Koch C., 2001, METHODS NEURONAL MOD; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lanciego JL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009621; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; Lindahl M, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0156-16.2016; Linden J, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0229-17.2018; London TD, 2018, J NEUROSCI, V38, P3547, DOI 10.1523/JNEUROSCI.2693-17.2018; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Markowitz JE, 2018, CELL, V174, P44, DOI 10.1016/j.cell.2018.04.019; MARSDEN CD, 1994, BRAIN, V117, P877, DOI 10.1093/brain/117.4.877; Marsh BT, 2015, J NEUROSCI, V35, P7374, DOI 10.1523/JNEUROSCI.1802-14.2015; Moyer JT, 2007, J NEUROPHYSIOL, V98, P3731, DOI 10.1152/jn.00335.2007; Munhoz RP, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00065; Nelson AB, 2014, ANNU REV NEUROSCI, V37, P117, DOI 10.1146/annurev-neuro-071013-013916; Neymotin SA, 2013, NEURAL COMPUT, V25, P3263, DOI 10.1162/NECO_a_00521; Ogura M, 2000, J NEUROPHYSIOL, V83, P3366, DOI 10.1152/jn.2000.83.6.3366; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; PAN HS, 1988, SYNAPSE, V2, P650, DOI 10.1002/syn.890020612; Park C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042901; Pavlides A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004609; Peterson DA, 2009, NEUROSCIENCE, V163, P1092, DOI 10.1016/j.neuroscience.2009.07.033; Piron C, 2016, MOVEMENT DISORD, V31, P1146, DOI 10.1002/mds.26542; Prescott TJ, 2007, PHILOS T R SOC B, V362, P1521, DOI 10.1098/rstb.2007.2050; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Reed MC, 2009, BIOSCI HYPOTHESES, V2, P240; Reiner A, 2011, INT REV NEUROBIOL, V98, P325, DOI [10.1016/B978-0-12-387003-2.00014-8, 10.1016/B978-0-12-381328-2.00014-6]; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rikhye RV, 2018, ANNU REV NEUROSCI, V41, P163, DOI 10.1146/annurev-neuro-080317-062144; Rommelfanger KS, 2010, FRONT NEUROANAT, P4, DOI [10.3389/fnana.2010.00139/abstract, DOI 10.3389/FNANA.2010.00139/ABSTRACT]; Rubin JE, 2017, CURR OPIN NEUROBIOL, V46, P127, DOI 10.1016/j.conb.2017.08.011; Schapira AHV, 2009, TRENDS PHARMACOL SCI, V30, P41, DOI 10.1016/j.tips.2008.10.005; Schroll H, 2016, MOVEMENT DISORD, V31, P1591, DOI 10.1002/mds.26719; Schroll H, 2015, EUR J NEUROSCI, V41, P1227, DOI 10.1111/ejn.12868; Schroll H, 2014, EUR J NEUROSCI, V39, P688, DOI 10.1111/ejn.12434; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Sharp AH, 1996, NEUROBIOL DIS, V3, P3, DOI 10.1006/nbdi.1996.0002; Shen KZ, 2000, J PHYSIOL-LONDON, V525, P331, DOI 10.1111/j.1469-7793.2000.00331.x; Shen KZ, 2003, EUR J NEUROSCI, V18, P2967, DOI 10.1046/j.1460-9568.2003.03058.x; Shindou T, 2019, EUR J NEUROSCI, V49, P726, DOI 10.1111/ejn.13921; SOIKKELI R, 1991, ELECTROEN CLIN NEURO, V79, P159, DOI 10.1016/0013-4694(91)90134-P; Stanford IM, 1999, J NEUROSCI, V19, P4796; STERIO D, 1994, ANN NEUROL, V35, P586, DOI 10.1002/ana.410350512; Surmeier DJ, 2009, CURR OPIN NEUROBIOL, V19, P621, DOI 10.1016/j.conb.2009.10.003; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Takahashi Y, 2008, FRONT NEUROSCI-SWITZ, V2, P86, DOI 10.3389/neuro.01.014.2008; Topalidou M, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0339-17.2018; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Albada SJ, 2009, J THEOR BIOL, V257, P664, DOI 10.1016/j.jtbi.2008.12.013; Wei W, 2015, J NEUROSCI, V35, P4052, DOI 10.1523/JNEUROSCI.3611-14.2015; Wichmann T, 1999, EXP BRAIN RES, V125, P397, DOI 10.1007/s002210050696; Wojtecki L, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030038; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	107	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228081	10.1371/journal.pone.0228081	http://dx.doi.org/10.1371/journal.pone.0228081			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9IO	32040519	Green Submitted, Green Published, gold			2022-12-26	WOS:000534629400014
J	Chen, PZ; Duan, XH; Li, XG; Li, JQ; Ba, Q; Wang, H				Chen, Peizhan; Duan, Xiaohua; Li, Xiaoguang; Li, Jingquan; Ba, Qian; Wang, Hui			HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1 alpha	ONCOGENE			English	Article							PROTEIN; APOPTOSIS; GENE; P53; PHOSPHORYLATION; IDENTIFICATION; EPIDEMIOLOGY; CONTRIBUTES; METASTASIS; STABILITY	Aberrant angiogenesis of hepatocellular carcinoma (HCC) leads to tumor growth and local or distant metastasis. Uncovering the underlying mechanisms for the neoangiogenesis of HCC can provide novel potential therapeutic targets in the clinic. Here, we reported that serine/threonine homeodomain-interacting protein kinase 2 (HIPK2) was frequently downregulated in HCC tissues compared with the adjacent normal tissues, and patients with lower HIPK2 protein expression were associated with worse overall survival. Both in vitro and in vivo, HIPK2 inhibited the migration of HCC cells, as well as tumor growth and metastasis in xenograft and orthotopic syngeneic HCC mouse models. Furthermore, HIPK2 inhibited the angiogenesis in HCC tumors. Under the hypoxic condition, HIPK2 knockdown enhanced the angiogenesis and the key regulator, HIF-1 alpha signaling pathway; however, HIPK2 overexpression downregulated the tumoral angiogenesis and HIF-1 alpha signaling. In HCC cells, HIPK2 could directly bind to HIF-1 alpha and stimulate the ubiquitination of HIF-1 alpha for proteasomal degradation. HIF-1 alpha knockout partially rescued the promoting effect of HIPK2 depletion on angiogenesis and tumor growth. In conclusion, the downregulation of HIPK2 could enhance the angiogenesis in HCC through inducing the HIF-1 alpha pathway, and further contribute to tumor growth and metastasis, which may provide a novel therapeutic strategy for HCC.	[Chen, Peizhan; Li, Xiaoguang; Li, Jingquan; Ba, Qian; Wang, Hui] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, State Key Lab Oncogenes & Related Genes,Ctr Singl, Shanghai 200025, Peoples R China; [Chen, Peizhan; Duan, Xiaohua; Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS	Ba, Q; Wang, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, State Key Lab Oncogenes & Related Genes,Ctr Singl, Shanghai 200025, Peoples R China.; Wang, H (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai 200031, Peoples R China.	qba@shsmu.edu.cn; huiwang@shsmu.edu.cn	Ba, Qian/AAZ-2623-2021	Ba, Qian/0000-0002-7253-7566	National Key R&D Program of China [2018YFC2000700, 2018ZX10302205, 2017YFC0907001]; National Natural Science Foundation of China [81630086, 81573161, 81973078, 81427805]; Science and Technology Commission of Shanghai Municipality [16391903700]; Shanghai Municipality Health Commission [20164Y0250, 2017YQ0059]; Major Science and Technology Innovation Program of Shanghai Municipal Education Commission [2019-01-07-00-01-E00059]; Chinese Academy of Sciences [ZDRW-ZS-2017-1]; Science and Technology Commission of Jiading Distinct [JDKW-2017-W09]; Shanghai Jiao Tong University [YG2017MS85]; Shanghai Municipal Human Resources and Social Security Bureau [2018060]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipality Health Commission; Major Science and Technology Innovation Program of Shanghai Municipal Education Commission; Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Jiading Distinct; Shanghai Jiao Tong University; Shanghai Municipal Human Resources and Social Security Bureau	This work was supported by grants from the National Key R&D Program of China (2018YFC2000700, 2018ZX10302205, and 2017YFC0907001), the National Natural Science Foundation of China (81630086, 81573161, 81973078, and 81427805), the Science and Technology Commission of Shanghai Municipality (16391903700), the Shanghai Municipality Health Commission (20164Y0250 and 2017YQ0059), the Major Science and Technology Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-01-E00059), the Key Research Program (ZDRW-ZS-2017-1) of the Chinese Academy of Sciences, Shanghai Municipal Human Resources and Social Security Bureau (2018060), Science and Technology Commission of Jiading Distinct (JDKW-2017-W09), and Shanghai Jiao Tong University (YG2017MS85).	Ba Q, 2017, J MOL CELL BIOL, V9, P209, DOI 10.1093/jmcb/mjx019; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cai JL, 2017, EBIOMEDICINE, V19, P18, DOI 10.1016/j.ebiom.2017.04.014; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Choi JR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16489-w; Clark T, 2015, CURR PROBL DIAGN RAD, V44, P479, DOI 10.1067/j.cpradiol.2015.04.004; Di Stefana V, 2005, FEBS LETT, V579, P5473, DOI 10.1016/j.febslet.2005.09.008; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; Fang JM, 2001, CANCER RES, V61, P5731; Feng YY, 2017, ONCOTARGET, V8, P20452, DOI 10.18632/oncotarget.14723; Garufi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048342; Guan Yong-Song, 2012, ISRN Gastroenterol, V2012, P480650, DOI 10.5402/2012/480650; Hofmann TG, 2000, BIOCHIMIE, V82, P1123, DOI 10.1016/S0300-9084(00)01196-2; Hu HY, 2019, INT J BIOL MACROMOL, V132, P470, DOI 10.1016/j.ijbiomac.2019.03.221; Kim CJ, 2004, ONCOGENE, V23, P8591, DOI 10.1038/sj.onc.1208113; Kim EJ, 2002, J BIOL CHEM, V277, P32020, DOI 10.1074/jbc.M200153200; Lazzari C, 2011, ONCOGENE, V30, P4802, DOI 10.1038/onc.2011.182; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Lin JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094040; Liu SP, 2012, J HEPATOL, V56, P389, DOI 10.1016/j.jhep.2011.08.008; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Moehlenbrink J, 2010, CANCER LETT, V292, P119, DOI 10.1016/j.canlet.2009.11.016; Morse MA, 2019, CLIN CANCER RES, V25, P912, DOI 10.1158/1078-0432.CCR-18-1254; Nardinocchi L, 2011, AGING-US, V3, P33, DOI 10.18632/aging.100254; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Nardinocchi L, 2009, BBA-MOL CELL RES, V1793, P368, DOI 10.1016/j.bbamcr.2008.10.013; Puca R, 2008, GYNECOL ONCOL, V109, P403, DOI 10.1016/j.ygyno.2008.02.018; Qin Y, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12603; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Tan MY, 2014, J CELL BIOCHEM, V115, P1762, DOI 10.1002/jcb.24842; Tan XY, 2018, J CELL BIOCHEM, V119, P5153, DOI 10.1002/jcb.26542; Upadhyay M, 2016, BIOCHEM BIOPH RES CO, V472, P580, DOI 10.1016/j.bbrc.2016.03.035; Wang SY, 2012, CLIN CANCER RES, V18, P2987, DOI 10.1158/1078-0432.CCR-11-2863; Wang Y, 2001, BMC Mol Biol, V2, P8, DOI 10.1186/1471-2199-2-8; Zhang N, 2018, J GENET, V97, P47, DOI 10.1007/s12041-018-0881-4; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102; Zhang Z, 2018, EXP THER MED, V15, P1113, DOI 10.3892/etm.2017.5468; Zhou LH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-747; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30	44	17	17	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2863	2876		10.1038/s41388-020-1190-y	http://dx.doi.org/10.1038/s41388-020-1190-y		FEB 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32034309				2022-12-26	WOS:000511752600002
J	Kovacs, E; Sahin-Toth, J; Tothpal, A; van der Linden, M; Tirczka, T; Dobay, O				Kovacs, Eszter; Sahin-Toth, Judit; Tothpal, Adrienn; van der Linden, Mark; Tirczka, Tamas; Dobay, Orsolya			Co-carriage of Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among three different age categories of children in Hungary	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; LEVEL MUPIROCIN RESISTANCE; NASOPHARYNGEAL CARRIAGE; NASAL CARRIAGE; HEALTHY-CHILDREN; CHANGING EPIDEMIOLOGY; MULTIPLEX PCR; RISK-FACTORS; COLONIZATION; REPLACEMENT	Background The nasopharynx can from time to time accommodate otherwise pathogenic bacteria. This phenomenon is called asymptomatic carriage. However, in case of decreased immunity, viral infection or any other enhancing factors, severe disease can develop. Our aim in this study was to survey the nasal carriage rates of four important respiratory pathogens in three different age groups of children attending nurseries, day-care centres and primary schools. This is the first study from Hungary about the asymptomatic carriage of H. influenzae and M. catarrhalis. Methods Altogether 580 asymptomatic children were screened in three Hungarian cities. Samples were collected from both nostrils with cotton swabs. The identification was based on both colony morphology and species-specific PCRs. Serotyping was performed for S. pneumoniae, H. influenzae and M. catarrhalis. Antibiotic susceptibility was determined with agar dilution, according to the EUCAST guidelines. Clonality was examined by PFGE. Results and conclusions Whereas the carriage rates of S. pneumoniae, H. influenzae and M. catarrhalis clearly decreased with age, that of S. aureus showed an opposite tendency. Multiple carriage was least prevalent if S. aureus was one of the participants. The negative association between this bacterium and the others was statistically significant. For pneumococcus, the overall carriage rate was lower compared to earlier years, and PCV13 serotypes were present in only 6.2% of the children. The majority of H. influenzae isolates was non-typeable and no type b was detected; serotype A was dominant among M. catarrhalis. All four bacteria were more sensitive to antibiotics compared to clinical isolates. No MRSAs were detected, but we found three mupirocin resistant strains. The positive effect of Hib- and PCV-vaccination is undoubted. Continued surveillance of these pathogens is required.	[Kovacs, Eszter; Sahin-Toth, Judit; Tothpal, Adrienn; Dobay, Orsolya] Semmelweis Univ, Inst Med Microbiol, Budapest, Hungary; [van der Linden, Mark] Univ Hosp RWTH Aachen, German Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany; [Tirczka, Tamas] Natl Publ Hlth Ctr, Budapest, Hungary	Semmelweis University; RWTH Aachen University; RWTH Aachen University Hospital	Dobay, O (corresponding author), Semmelweis Univ, Inst Med Microbiol, Budapest, Hungary.	dobay.orsolya@med.semmelweis-univ.hu	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313; Tothpal, Adrienn/0000-0002-5204-9450; Dobay, Orsolya/0000-0001-7094-2288	National Research, Development and Innovation Office/Hungarian Scientific Research Fund [K108631]	National Research, Development and Innovation Office/Hungarian Scientific Research Fund(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by the National Research, Development and Innovation Office/Hungarian Scientific Research Fund [grant number K108631], awarded to O.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, VACCINE, V28, P4073, DOI 10.1016/j.vaccine.2010.03.075; [Anonymous], 2018, ELETKORHOZ KOTOTT KO; Anthony RM, 1999, EUR J CLIN MICROBIOL, V18, P30, DOI 10.1007/s100960050222; Antonio M, 2002, ANTIMICROB AGENTS CH, V46, P438, DOI 10.1128/AAC.46.2.438-442.2002; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Blakeway LV, 2017, MICROBIOL-SGM, V163, P1371, DOI 10.1099/mic.0.000523; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bosch AATM, 2016, VACCINE, V34, P531, DOI 10.1016/j.vaccine.2015.11.060; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Camilli R, 2015, VACCINE, V33, P4559, DOI 10.1016/j.vaccine.2015.07.009; Centers for Disease Control and Prevention, 2014, LIST OL PRIM US 41 C; Davis S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S21; de Waroux OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086136; Drayss M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212052; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; Edwards KJ, 2005, J CLIN MICROBIOL, V43, P6139, DOI 10.1128/JCM.43.12.6139-6143.2005; European Centre for Disease Prevention and Control, 2016, ECDC ANN EP REP 2016; FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994; Ghaffar F, 2000, CLIN INFECT DIS, V31, P875, DOI 10.1086/318160; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935; Gunnarsson RK, 1998, SCAND J PRIM HEALTH, V16, P13; Hendolin PH, 2000, J CLIN MICROBIOL, V38, P125; HOBSON RP, 1995, EPIDEMIOL INFECT, V114, P93, DOI 10.1017/S0950268800051943; John TJ, 1998, LSHTM PUBL HEAL FOR, P12; Kovacs E, 2019, VACCINE, V37, P99, DOI 10.1016/j.vaccine.2018.11.026; Laub K, 2018, ACTA MICROBIOL IMM H, V65, P59, DOI 10.1556/030.65.2018.001; Laub K, 2017, ACTA MICROBIOL IMM H, V64, P51, DOI 10.1556/030.64.2017.001; Lee AS, 2011, J HOSP INFECT, V77, P360, DOI 10.1016/j.jhin.2010.11.002; Lee GC, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-96; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Marrs CF, 2001, FRONT BIOSCI-LANDMRK, V6, pE41, DOI 10.2741/Marrs; Menyhart-Laub K., 2017, THESIS, DOI [10.1086/313981, DOI 10.1086/313981]; Mertz D, 2009, ARCH INTERN MED, V169, P172, DOI 10.1001/archinternmed.2008.536; Miller LG, 2009, INFECT DIS CLIN N AM, V23, P35, DOI 10.1016/j.idc.2008.10.002; Mollema FPN, 2010, J CLIN MICROBIOL, V48, P202, DOI 10.1128/JCM.01499-09; MOREILLON P, 1994, J CHEMOTHERAPY, V6, P51; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Nagai K, 2001, J ANTIMICROB CHEMOTH, V48, P915, DOI 10.1093/jac/48.6.915; National Bacteriological Surveillance Management Team, 2015, NBS ANN REP; National Center for Epidemiology, 2000, EPINFO, V8; National Center for Epidemiology, 2009, EPINFO, V16, P141; National Center for Epidemiology, 2009, EPINFO, V16, P487; National Center for Epidemiology, 2012, EPINFO, V19, P521; National Center for Epidemiology, 2014, EPINFO, V21; NOBLE WC, 1964, J CLIN PATHOL, V17, P79, DOI 10.1136/jcp.17.1.79; Oguzkaya-Artan M, 2007, JPN J INFECT DIS, V60, P179; Oikawa J, 2014, J INFECT CHEMOTHER, V20, P146, DOI 10.1016/j.jiac.2013.10.007; PARR TR, 1984, ANTIMICROB AGENTS CH, V25, P747, DOI 10.1128/AAC.25.6.747; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Principi N, 1999, PEDIATR INFECT DIS J, V18, P517, DOI 10.1097/00006454-199906000-00008; Reddinger RM, 2018, MBIO, V9, DOI 10.1128/mBio.02089-17; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Revai K, 2006, PEDIATRICS, V117, P1823, DOI 10.1542/peds.2005-1983; Saito M, 1999, J CLIN MICROBIOL, V37, P2142, DOI 10.1128/JCM.37.7.2142-2147.1999; Skramm I, 2011, APMIS, V119, P522, DOI 10.1111/j.1600-0463.2011.02758.x; Sollid JUE, 2014, INFECT GENET EVOL, V21, P531, DOI 10.1016/j.meegid.2013.03.020; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Szabo J, 2009, EUR J CLIN MICROBIOL, V28, P129, DOI 10.1007/s10096-008-0588-1; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The European Committee on Antimicrobial Susceptibility Testing, 2019, BREAKP TABL INT MICS, DOI [10.1007/s100960050222, DOI 10.1007/S100960050222]; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; Torun MM, 2009, INDIAN J MED MICROBI, V27, P86; Tothpal A, 2016, EPIDEMIOL INFECT, V144, P1563, DOI 10.1017/S0950268815002757; Tothpal A, 2015, EUR J PEDIATR, V174, P373, DOI 10.1007/s00431-014-2408-1; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Varon E, 2000, CLIN INFECT DIS, V31, P477, DOI 10.1086/313981; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wouters I, 2018, VACCINE, V36, P15, DOI 10.1016/j.vaccine.2017.11.052; Zemlickova H, 2006, EPIDEMIOL INFECT, V134, P1179, DOI 10.1017/S0950268806006157	73	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0229021	10.1371/journal.pone.0229021	http://dx.doi.org/10.1371/journal.pone.0229021			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032364	Green Published, gold			2022-12-26	WOS:000534626100035
J	Rajbhandari-Thapa, J; Ingels, J; Thapa, K; Davis, M; Corso, P				Rajbhandari-Thapa, Janani; Ingels, Justin; Thapa, Kiran; Davis, Marsha; Corso, Phaedra			Longitudinal evaluation of the impact of school characteristics on changes in physical activity opportunities	PLOS ONE			English	Article							OBESITY PREVALENCE; CHILDREN; HEALTHY; TRENDS	Background Even as many states adopt physical activity policies to promote physical activity and prevent childhood obesity, little is known about differences in policy implementation based on school characteristics. We studied association of school characteristics and changes in physical activity opportunities at the school level during the implementation of a statewide physical activity policy in the state of Georgia. Methods A web-based school survey was administered to elementary schools at two time points (before and during policy execution). Matched respondents (289 classroom teachers, 234 administrators) reported the frequency and duration of recess and integrated physical activity time. We used paired t-test to assess changes in physical activity opportunities and chisquare tests to assess the association of change in physical activity opportunities with school characteristics. We then constructed a multiple linear regression model following a change score method to identify school-level factors that predict the magnitude of change in physical activity opportunities. Results There was an overall significant increase in total physical activity opportunities across time; however, schools with higher poverty showed a decrease in physical activity time by 5.3 minutes per day (95% CI: -9.2, -1.3). Further, the changes in physical activity time for schools in suburban Georgia were smaller (-5.7, 95% CI: -9.5, -1.9) compared to schools located in towns. Conclusions The change in physical activity opportunities was not the same across schools and school characteristics predicted the magnitude of change. Additional efforts at the local level might be needed for equitable policy implementation based on schools' geographical location and poverty level of the student population.	[Rajbhandari-Thapa, Janani; Ingels, Justin; Thapa, Kiran] Univ Georgia, Dept Hlth Policy & Management, Coll Publ Hlth, Athens, GA 30602 USA; [Davis, Marsha] Univ Georgia, Dept Hlth Promot & Behav, Coll Publ Hlth, Athens, GA 30602 USA; [Corso, Phaedra] Kennesaw State Univ, Kennesaw, GA 30144 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; Kennesaw State University	Rajbhandari-Thapa, J (corresponding author), Univ Georgia, Dept Hlth Policy & Management, Coll Publ Hlth, Athens, GA 30602 USA.	jrthapa@uga.edu			National Institute of Health [1R01HD087411-01A1]; Georgia Department of Public Health; Georgia Department of Education; Power Up for 30 Data Committee	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Department of Public Health; Georgia Department of Education; Power Up for 30 Data Committee	Funding for this study was received from the National Institute of Health [Grant number: 1R01HD087411-01A1]. The funding source was not involved in the writing of this manuscript.; The authors acknowledge the Georgia Department of Public Health, Georgia Department of Education and the Power Up for 30 Data Committee for providing data and their support throughout the project.	Allison PD, 2006, SOCIOL METHODOL, V20, P93; Barrett-Williams SL, 2017, PUBLIC HEALTH REP, V132, p81S, DOI 10.1177/0033354917726328; Barrett-Williams SL, 2017, PUBLIC HLTH REP; Benjamin RM, 2010, PUBLIC HEALTH REP, V125, P514, DOI 10.1177/003335491012500402; Castelli DM, 2007, J SPORT EXERC PSYCHO; Cheung P, 2019, J SCI MED SPORT; Cheung P, 2019, J SCI MED SPORT, V22, P191, DOI 10.1016/j.jsams.2018.07.015; Cheung PC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210444; Chin JJ, 2013, AM J PUBLIC HEALTH, V103, P1229, DOI 10.2105/AJPH.2012.301132; Committee on Accelerating Progress in Obesity Prevention, 2012, ACCELERATING PROGR O; Daniels SR, CIRCULATION, V111; Drewnowski A, 2009, HEAL PLACE; Fink DB, 2018, J SCHOOL HEALTH, V88, P928, DOI 10.1111/josh.12704; Finkelstein EA, 2014, PEDIATRICS, V133, P854, DOI 10.1542/peds.2014-0063; Geverdt D., 2019, 2018115 NCES US DEP; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Heelan KA, 2015, CHILD OBES, V11, P600, DOI 10.1089/chi.2015.0005; Institute of Medicine, 2013, J SCH HLTH; Jelalian E, 2012, AM J LIFESTYLE MED, V6, P505, DOI 10.1177/1559827612458633; Joens-Matre RR, 2008, J RURAL HEAL; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Kumanyika SK, 2019, AM J PUBLIC HLTH; Lounsbery MAF, 2013, ANN BEHAV MED S1, V45; Lyn RS, 2017, PUBLIC HEALTH REP, V132, p9S, DOI 10.1177/0033354917719705; McMurray RG, 1999, J RURAL HEAL; National Center for Education Statistics, 2018, FAST FACTS; Nobari TZ, 2018, CHILD OBES, V14, P248, DOI 10.1089/chi.2017.0264; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Richmond TK, 2008, OBESITY; Robert Wood Johnson Foundation, 2018, NAT STAT STAT OB RAT; SHAPE America, 2016, SHAP NAT STAT PHYS E; Skinner AC, 2016, OBESITY, V24, P1116, DOI 10.1002/oby.21497; Slater SJ, 2012, ARCH PEDIAT ADOLESC; Stewart JA, 2004, J SCHOOL HEALTH, V74, P397, DOI 10.1111/j.1746-1561.2004.tb06605.x; Story M, 2009, MILBANK Q, V87, P71, DOI 10.1111/j.1468-0009.2009.00548.x; U.S. Department of Health and Human Services, 2018, PHYS ACT GUID AM; Vall EA, 1974, PUBLIC HLTH REPORTS; Wechsler H, 2000, PREV MED; White House Task Force on Childhood Obesity, 2010, SOLV PROBL CHILDH OB; Young DR, 2007, J SCH HLTH	41	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228716	10.1371/journal.pone.0228716	http://dx.doi.org/10.1371/journal.pone.0228716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9GK	32027725	Green Published, gold			2022-12-26	WOS:000534623800068
J	Ruscitto, A; Morel, MM; Shawber, CJ; Reeve, G; Lecholop, MK; Bonthius, D; Yao, H; Embree, MC				Ruscitto, Angela; Morel, Mallory M.; Shawber, Carrie J.; Reeve, Gwendolyn; Lecholop, Michael K.; Bonthius, Daniel; Yao, Hai; Embree, Mildred C.			Evidence of vasculature and chondrocyte to osteoblast transdifferentiation in craniofacial synovial joints: Implications for osteoarthritis diagnosis and therapy	FASEB JOURNAL			English	Article						angiogenesis; cartilage; chondrogenesis; miniature pigs; osteoarthritis; osteogenesis; temporomandibular joint; transdifferentiation	TEMPOROMANDIBULAR-JOINT; CONDYLAR CARTILAGE; ENDOTHELIAL-CELL; ARTICULAR-CARTILAGE; GROWTH-FACTOR; MIDDLE-EAR; PATHOGENESIS; EXPRESSION; MOUSE; DIFFERENTIATION	Temporomandibular joint osteoarthritis (TMJ OA) leads to permanent cartilage destruction, jaw dysfunction, and compromises the quality of life. However, the pathological mechanisms governing TMJ OA are poorly understood. Unlike appendicular articular cartilage, the TMJ has two distinct functions as the synovial joint of the craniofacial complex and also as the site for endochondral jaw bone growth. The established dogma of endochondral bone ossification is that hypertrophic chondrocytes undergo apoptosis, while invading vasculature with osteoprogenitors replace cartilage with bone. However, contemporary murine genetic studies support the direct differentiation of chondrocytes into osteoblasts and osteocytes in the TMJ. Here we sought to characterize putative vasculature and cartilage to bone transdifferentiation using healthy and diseased TMJ tissues from miniature pigs and humans. During endochondral ossification, the presence of fully formed vasculature expressing CD31(+) endothelial cells and alpha-SMA(+) vascular smooth muscle cells were detected within all cellular zones in growing miniature pigs. Arterial, endothelial, venous, angiogenic, and mural cell markers were significantly upregulated in miniature pig TMJ tissues relative to donor matched knee meniscus fibrocartilage tissue. Upon surgically creating TMJ OA in miniature pigs, we discovered increased vasculature and putative chondrocyte to osteoblast transformation dually marked by COL2 and BSP or RUNX2 within the vascular bundles. Pathological human TMJ tissues also exhibited increased vasculature, while isolated diseased human TMJ cells exhibited marked increased in vasculature markers relative to control 293T cells. Our study provides evidence to suggest that the TMJ in higher order species are in fact vascularized. There have been no reports of cartilage to bone transdifferentiation or vasculature in human-relevant TMJ OA large animal models or in human TMJ tissues and cells. Therefore, these findings may potentially alter the clinical management of TMJ OA by defining new drugs that target angiogenesis or block the cartilage to bone transformation.	[Ruscitto, Angela; Morel, Mallory M.; Embree, Mildred C.] Columbia Univ, Coll Dent Med, Cartilage Biol & Regenerat Med Lab, Irving Med Ctr, New York, NY 10027 USA; [Shawber, Carrie J.] Columbia Univ, Coll Phys & Surg, Dept OB GYN, Div Reprod Sci,Irving Med Ctr, New York, NY USA; [Reeve, Gwendolyn] New York Presbyterian Weill Cornell Med Ctr, Div Oral & Maxillofacial Surg, New York, NY USA; [Lecholop, Michael K.] Med Univ South Carolina, Dept Oral & Maxillofacial Surg, Coll Dent Med, Charleston, SC 29425 USA; [Bonthius, Daniel; Yao, Hai] Clemson Univ, Clemson MUSC Bioengn Program, Dept Bioengn, Greenville, SC USA; [Yao, Hai] Med Univ South Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Medical University of South Carolina; Clemson University; Medical University of South Carolina; Medical University of South Carolina	Embree, MC (corresponding author), Columbia Univ, Coll Dent Med, Cartilage Biol & Regenerat Med Lab, Irving Med Ctr, New York, NY 10027 USA.	mce2123@cumc.columbia.edu			NIH [5R00DE0220660, R01DE021134, P20GM121342]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: 5R00DE0220660, R01DE021134 and P20GM121342	Aigner T, 2002, CURR OPIN RHEUMATOL, V14, P578, DOI 10.1097/00002281-200209000-00018; Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534; Almarza AJ, 2018, TISSUE ENG PART B-RE, V24, P171, DOI [10.1089/ten.teb.2017.0341, 10.1089/ten.TEB.2017.0341]; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Anthwal N, 2013, J ANAT, V222, P147, DOI 10.1111/j.1469-7580.2012.01526.x; ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205; ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305; Aurich M, 2005, ARTHRITIS RHEUM-US, V52, P112, DOI 10.1002/art.20740; BENJAMIN M, 1990, J ANAT, V171, P1; Berendsen AD, 2015, BONE, V80, P14, DOI 10.1016/j.bone.2015.04.035; BERMEJO A, 1993, ORAL SURG ORAL MED O, V75, P18, DOI 10.1016/0030-4220(93)90399-O; Bharathi SC, 2014, J INT SOC PREV COMMU, V4, P67, DOI 10.4103/2231-0762.127853; BORA FW, 1987, HAND CLIN, V3, P325; de Moraes LOC, 2015, EUR J HISTOCHEM, V59, P263, DOI 10.4081/ejh.2015.2569; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Decker RS, 2014, MATRIX BIOL, V39, P5, DOI 10.1016/j.matbio.2014.08.006; Delaire J., 1998, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V99, P3; Di Giancamillo A, 2017, J CELL MOL MED, V21, P3066, DOI 10.1111/jcmm.13218; DONES M, 1959, Oral Surg Oral Med Oral Pathol, V12, P1433, DOI 10.1016/0030-4220(59)90262-2; Duan XC, 2016, MATRIX BIOL, V52-54, P127, DOI 10.1016/j.matbio.2016.02.005; DURKIN JF, 1973, ORAL SCI REV, V2, P29; Eisenmann D. R., 1980, ORAL HISTOLOGY DEV S, P194; EISENSTEIN R, 1973, AM J PATHOL, V73, P765; Embree MC, 2015, OSTEOARTHR CARTILAGE, V23, P629, DOI 10.1016/j.joca.2014.12.015; Embree MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13073; Embree MC, 2010, AM J PATHOL, V176, P812, DOI 10.2353/ajpath.2010.090450; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Gill M, 2001, CIRC RES, V88, P167; Gray JC, 1999, J ORTHOP SPORT PHYS, V29, P23, DOI 10.2519/jospt.1999.29.1.23; Gu SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101000; Hall AC, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0837-6; Heinemeier KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8335; Herring SW, 2002, ANAT RECORD, V266, P152, DOI 10.1002/ar.10049; HERRING SW, 1976, ARCH ORAL BIOL, V21, P473, DOI 10.1016/0003-9969(76)90105-9; Hinton RJ, 2017, J DENT RES, V96, P23, DOI 10.1177/0022034516668321; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hu DP, 2017, DEVELOPMENT, V144, P221, DOI 10.1242/dev.130807; Huang GTJ, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P1, DOI 10.1002/9781118498026; Ji Q, 2009, SCIENCE, V326, P278, DOI 10.1126/science.1178501; Jing Y, 2015, J DENT RES, V94, P1668, DOI 10.1177/0022034515598135; Jing Y, 2018, INT J BIOL SCI, V14, P1, DOI 10.7150/ijbs.23165; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KERMACK KA, 1972, P ROY SOC MED, V65, P389, DOI 10.1177/003591577206500439; KESSEL L J, 1969, British Journal of Oral Surgery, V7, P124; Kim YH, 2008, DEVELOPMENT, V135, P3755, DOI 10.1242/dev.022475; Kobayashi T, 2014, METHODS MOL BIOL, V1130, P3, DOI 10.1007/978-1-62703-989-5_1; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Kronenberg HM, 2007, ANN NY ACAD SCI, V1116, P59, DOI 10.1196/annals.1402.059; Kume T, 2010, HISTOL HISTOPATHOL, V25, P637, DOI 10.14670/HH-25.637; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lamy S, 2010, VASC PHARMACOL, V53, P200, DOI 10.1016/j.vph.2010.08.002; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Lautenschlager S, 2018, NATURE, V561, P533, DOI 10.1038/s41586-018-0521-4; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lin AW, 2018, J COMP PATHOL, V161, P55, DOI 10.1016/j.jcpa.2018.05.001; Long FX, 1998, DEVELOPMENT, V125, P1067; Mair KH, 2014, DEV COMP IMMUNOL, V45, P321, DOI 10.1016/j.dci.2014.03.022; Mei H, 2014, J BIOL CHEM, V289, P20836, DOI 10.1074/jbc.M114.557454; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miyake T, 1997, J ANAT, V190, P239, DOI 10.1046/j.1469-7580.1997.19020239.x; MORIMOTO K, 1987, J PROSTHET DENT, V57, P723, DOI 10.1016/0022-3913(87)90372-6; Nathan J, 2018, J DENT RES, V97, P329, DOI 10.1177/0022034517735094; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Owtad P, 2013, J DENT RES, V92, P315, DOI 10.1177/0022034513476302; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Park J, 2015, BIOL OPEN, V4, P608, DOI 10.1242/bio.201411031; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Poole A R, 1993, Agents Actions Suppl, V39, P3; Purcell P, 2012, J DENT RES, V91, P387, DOI 10.1177/0022034512438401; Purcell P, 2009, P NATL ACAD SCI USA, V106, P18297, DOI 10.1073/pnas.0908836106; Rotter A, 2017, J DTSCH DERMATOL GES, V15, P1185, DOI 10.1111/ddg.13365; Schneider RA, 2015, CURR TOP DEV BIOL, V115, P271, DOI 10.1016/bs.ctdb.2015.08.002; Schomberg DT, 2016, TOXICOL PATHOL, V44, P299, DOI 10.1177/0192623315618292; Scrivani SJ, 2008, NEW ENGL J MED, V359, P2693, DOI 10.1056/NEJMra0802472; Shen G, 2005, Orthod Craniofac Res, V8, P114; Shen G, 2006, ARCH ORAL BIOL, V51, P315, DOI 10.1016/j.archoralbio.2005.08.004; Shen G, 2005, J DENT RES, V84, P691, DOI 10.1177/154405910508400802; Sherwood J, 2019, OSTEOARTHR CARTILAGE, V27, P365, DOI 10.1016/j.joca.2018.10.005; Shibata S, 2008, J ANAT, V213, P274, DOI 10.1111/j.1469-7580.2008.00934.x; Shibukawa Y, 2007, DEV DYNAM, V236, P426, DOI 10.1002/dvdy.21036; Sindelar BJ, 2005, CELLS TISSUES ORGANS, V180, P36, DOI 10.1159/000086197; Singh P, 2019, ANN NY ACAD SCI, V1442, P17, DOI 10.1111/nyas.13930; Squires GR, 2003, ARTHRITIS RHEUM-US, V48, P1261, DOI 10.1002/art.10976; STROM D, 1986, ARCH ORAL BIOL, V31, P763, DOI 10.1016/0003-9969(86)90009-9; Sun ZY, 2002, ARCH ORAL BIOL, V47, P293, DOI 10.1016/S0003-9969(02)00004-3; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tripathi Tulika, 2019, J Clin Orthod, V53, P29; Vapniarsky N, 2017, TISSUE ENG PART C-ME, V23, P700, DOI [10.1089/ten.tec.2017.0149, 10.1089/ten.TEC.2017.0149]; Wadhwa S, 2005, OSTEOARTHR CARTILAGE, V13, P817, DOI 10.1016/j.joca.2005.04.016; Wang XD, 2015, J DENT RES, V94, P666, DOI 10.1177/0022034515574770; Wang Y, 2011, DEV DYNAM, V240, P2466, DOI 10.1002/dvdy.22748; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820; Zou HX, 2013, CARDIOVASC PATHOL, V22, P203, DOI 10.1016/j.carpath.2012.10.001	96	17	17	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4445	4461		10.1096/fj.201902287R	http://dx.doi.org/10.1096/fj.201902287R		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030828	Green Accepted, hybrid			2022-12-26	WOS:000512333200001
J	Sabir, JSM; El Omri, A; Banaganapalli, B; Aljuaid, N; Omar, AMS; Altaf, A; Hajrah, NH; Zrelli, H; Arfaoui, L; Elango, R; Alharbi, MG; Alhebshi, AM; Jansen, RK; Shaik, NA; Khan, M				Sabir, Jamal Sabir M.; El Omri, Abdelfatteh; Banaganapalli, Babajan; Aljuaid, Nada; Omar, Abdulkader M. Shaikh; Altaf, Abdulmalik; Hajrah, Nahid H.; Zrelli, Houda; Arfaoui, Leila; Elango, Ramu; Alharbi, Mona G.; Alhebshi, Alawiah M.; Jansen, Robert K.; Shaik, Noor A.; Khan, Muhummadh			Unraveling the role of salt-sensitivity genes in obesity with integrated network biology and co-expression analysis	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; HYPERTENSION; EXPRESSION; POTASSIUM; SODIUM; MODELS; LEVEL; SCALE	Obesity is a multifactorial disease caused by complex interactions between genes and dietary factors. Salt-rich diet is related to the development and progression of several chronic diseases including obesity. However, the molecular basis of how salt sensitivity genes (SSG) contribute to adiposity in obesity patients remains unexplored. In this study, we used the microarray expression data of visceral adipose tissue samples and constructed a complex protein-interaction network of salt sensitivity genes and their co-expressed genes to trace the molecular pathways connected to obesity. The Salt Sensitivity Protein Interaction Network (SSPIN) of 2691 differentially expressed genes and their 15474 interactions has shown that adipose tissues are enriched with the expression of 23 SSGs, 16 hubs and 84 bottlenecks (p = 2.52 x 10-16) involved in diverse molecular pathways connected to adiposity. Fifteen of these 23 SSGs along with 8 other SSGs showed a co-expression with enriched obesity-related genes (r >= 0.8). These SSGs and their co-expression partners are involved in diverse metabolic pathways including adipogenesis, adipocytokine signaling pathway, renin-angiotensin system, etc. This study concludes that SSGs could act as molecular signatures for tracing the basis of adipogenesis among obese patients. Integrated network centered methods may accelerate the identification of new molecular targets from the complex obesity genomics data.	[Sabir, Jamal Sabir M.; El Omri, Abdelfatteh; Hajrah, Nahid H.; Zrelli, Houda; Jansen, Robert K.; Khan, Muhummadh] King Abdulaziz Univ, Ctr Excellence Bionanosci Res, Jeddah, Saudi Arabia; [Sabir, Jamal Sabir M.; El Omri, Abdelfatteh; Aljuaid, Nada; Hajrah, Nahid H.; Zrelli, Houda; Khan, Muhummadh] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Genom & Biotechnol Sect & Res Grp, Jeddah, Saudi Arabia; [Banaganapalli, Babajan; Elango, Ramu; Shaik, Noor A.] King Abdulaziz Univ, Fac Med, Dept Genet Med, Jeddah, Saudi Arabia; [Banaganapalli, Babajan; Elango, Ramu; Shaik, Noor A.] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah, Saudi Arabia; [Omar, Abdulkader M. Shaikh; Alharbi, Mona G.; Alhebshi, Alawiah M.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Biol, Jeddah, Saudi Arabia; [Altaf, Abdulmalik] King Abdulaziz Univ, Fac Med, Dept Surg, Jeddah, Saudi Arabia; [Arfaoui, Leila] King Abdulaziz Univ, Fac Appl Med Sci, Clin Nutr Dept, Jeddah, Saudi Arabia; [Jansen, Robert K.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; University of Texas System; University of Texas Austin	Khan, M (corresponding author), King Abdulaziz Univ, Ctr Excellence Bionanosci Res, Jeddah, Saudi Arabia.; Khan, M (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Genom & Biotechnol Sect & Res Grp, Jeddah, Saudi Arabia.	mkmkhan@kau.edu.sa	Elango, Ramu/C-7684-2014; Khan, Mohammad/M-3146-2019; Alhebshi, Alawiah M/AAD-4587-2019; Hajrah, Nahid/AAY-3196-2020; Banaganapalli, Babajan/A-6282-2013; Hajrah, Nahid/AAT-2659-2021; Shaik, Noor ahmad/ABE-4084-2020	Elango, Ramu/0000-0003-4264-2135; Khan, Mohammad/0000-0001-9523-6638; Banaganapalli, Babajan/0000-0001-8089-2210; Hajrah, Nahid/0000-0001-6404-1627; Shaik, Noor ahmad/0000-0002-7133-656X; Arfaoui, Leila/0000-0001-7830-8652; Alhebshi, Alawiah/0000-0002-1751-8944; Omer, Suleymen/0000-0001-7565-5851; Alharbi, Mona G./0000-0001-9738-4175	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, KSA [HiCi-63-130-35]; DSR; Deanship of Scientific Research (DSR) at King Abdulaziz University [HiCi-63-130-35]	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, KSA; DSR; Deanship of Scientific Research (DSR) at King Abdulaziz University	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, KSA, under grant no. HiCi-63-130-35. The authors are thankful to DSR for the technical and the financial support.; This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, under grant no. HiCi-63-130-35. The authors are thankful to DSR for the technical and the financial support.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Araujo TF, 2018, LIFE SCI, V209, P274, DOI 10.1016/j.lfs.2018.08.024; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader S, 2008, FEBS LETT, V582, P1220, DOI 10.1016/j.febslet.2008.02.015; Benton MC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0569-x; BROWN L, 1967, ANN MATH STAT, V38, P1068, DOI 10.1214/aoms/1177698776; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Citterio L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019620; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Ding L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95687; Dunner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075440; Eap CB, 2007, CLIN PHARMACOL THER, V81, P719, DOI 10.1038/sj.clpt.6100120; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Freitas SRS, 2017, AM J HYPERTENS, V30, P554, DOI 10.1093/ajh/hpx039; Gabrielli AP, 2017, OBESITY, V25, P1136, DOI 10.1002/oby.21847; Gao J, 2014, CLIN SCI, V127, P135, DOI 10.1042/CS20130396; George G, 2019, GENE, V697, P67, DOI 10.1016/j.gene.2019.02.026; Ghazalpour A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r59; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; Hadchouel J, 2005, M S-MED SCI, V21, P55, DOI 10.1051/medsci/200521155; Holmes Roger S, 2017, J Data Mining Genomics Proteomics, V8, DOI 10.4172/2153-0602.1000211; Hoorn EJ, 2011, J AM SOC NEPHROL, V22, P605, DOI 10.1681/ASN.2010080827; Hsu CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13295; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Jousheghany F, 2016, BBA CLIN, V6, P45, DOI 10.1016/j.bbacli.2016.04.005; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Khosravi P, 2014, COMPUT BIOL MED, V54, P24, DOI 10.1016/j.compbiomed.2014.08.020; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; Lahiri C, 2014, J THEOR BIOL, V363, P188, DOI 10.1016/j.jtbi.2014.08.013; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mishra S, 2018, INDIAN HEART J, V70, P556, DOI 10.1016/j.ihj.2017.10.006; Naour N, 2010, J CLIN ENDOCR METAB, V95, P1861, DOI 10.1210/jc.2009-1894; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rakshit H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103047; Rassler B, 2010, PHARMACEUTICALS-BASE, V3, P940, DOI 10.3390/ph3040940; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rohart F, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1553-8; Sabir JSM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214337; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sanada H, 2011, CURR HYPERTENS REP, V13, P55, DOI 10.1007/s11906-010-0167-6; Schweda F, 2015, PFLUG ARCH EUR J PHY, V467, P565, DOI 10.1007/s00424-014-1668-y; Shaik NA, 2018, J CELL BIOCHEM, V119, P8233, DOI 10.1002/jcb.26834; Shaik NA, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00168; Shaik NA, 2019, SAUDI J BIOL SCI, V26, P439, DOI 10.1016/j.sjbs.2018.05.026; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Takahashi N, 2015, INT J OBESITY, V39, P747, DOI 10.1038/ijo.2014.208; Tanti JF., 2012, FRONT ENDOCRINOL, V3, P181, DOI [DOI 10.3389/FENDO.2012.00181, 10.3389/fendo.2012.00181]; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533	52	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228400	10.1371/journal.pone.0228400	http://dx.doi.org/10.1371/journal.pone.0228400			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027667	gold, Green Published, Green Submitted			2022-12-26	WOS:000534623800027
J	Schwenk, G; Jochinke, B; Muller, KR				Schwenk, Guido; Jochinke, Ben; Mueller, Klaus-Robert			Features spaces and a learning system for structural-temporal data, and their application on a use case of real-time communication network validation data	PLOS ONE			English	Article							PREDICTION	The service quality and system dependability of real-time communication networks strongly depends on the analysis of monitored data, to identify concrete problems and their causes. Many of these can be described by either their structural or temporal properties, or a combination of both. As current research is short of approaches sufficiently addressing both properties simultaneously, we propose a new feature space specifically suited for this task, which we analyze for its theoretical properties and its practical relevance. We evaluate its classification performance when used on real-world data sets of structural-temporal mobile communication data, and compare it to the performance achieved of feature representations used in related work. For this purpose we propose a system which allows the automatic detection and prediction of classes of pre-defined sequence behavior, greatly reducing costs caused by the otherwise required manual analysis. With our proposed feature spaces this system achieves a precision of more than 93% at recall values of 100%, with an up to 6.7% higher effective recall than otherwise similarly performing alternatives, notably outperforming alternative deep learning, kernel learning and ensemble learning approaches of related work. Furthermore the supported system calibration allows separating reliable from unreliable predictions more effectively, which is highly relevant for any practical application.	[Schwenk, Guido; Mueller, Klaus-Robert] Tech Univ Berlin, Machine Learning Grp, Berlin, Germany; [Jochinke, Ben] P3 Grp, Aachen, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mueller, Klaus-Robert] Max Planck Inst Informat, Stuhlsatzenhausweg, Saarbrucken, Germany	Technical University of Berlin; Korea University; Max Planck Society	Schwenk, G; Muller, KR (corresponding author), Tech Univ Berlin, Machine Learning Grp, Berlin, Germany.; Muller, KR (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.; Muller, KR (corresponding author), Max Planck Inst Informat, Stuhlsatzenhausweg, Saarbrucken, Germany.	guido.schwenk@gmail.com; klaus-robert.mueller@tu-berlin.de	Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685	P3 communications GmbH; Federal Ministry for Education and Research (BMBF); Deutsche Forschungsgesellschaft (DFG); German Ministry for Education and Research (BMBF) [01IS14013A-E, 01GQ1115, 01GQ0850]; German Research Foundation (DFG) under Grant Math+ [EXC 2046/1, 390685689]; Institute for Information & Communications Technology Planning & Evaluation (IITP) - Korea government [2017-0-01779]	P3 communications GmbH; Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) under Grant Math+(German Research Foundation (DFG)); Institute for Information & Communications Technology Planning & Evaluation (IITP) - Korea government(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea)	Guido Schwenk received funding from P3 communications GmbH and partial support by the Federal Ministry for Education and Research (BMBF) and the Deutsche Forschungsgesellschaft (DFG). Ben Jochinke is employee of P3 communications GmbH. Klaus-Robert Muller was partly supported by the German Ministry for Education and Research (BMBF) under Grants 01IS14013A-E, 01GQ1115 and 01GQ0850; the German Research Foundation (DFG) under Grant Math+, EXC 2046/1, Project ID 390685689 and by the Institute for Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (No. 2017-0-01779). The commercial affiliation P3 communications GmbH played a role in our study, as it (in person of Ben Jochinke) collected the raw data used in our research, and provided it to us. Additionally the expertise of Ben Jochinke with this data helped defining the further processing (filtering, selection of relevant properties) of this data.	Abadi M., 2016, TENSORFLOW LARGE SCA; Brants T., 2007, P 2007 JOINT C EMP M, P858; Braun ML, 2008, J MACH LEARN RES, V9, P1875; Caballero J, 2007, CCS'07: PROCEEDINGS OF THE 14TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P317; Ceci M, 2014, LECT NOTES ARTIF INT, V8777, P49, DOI 10.1007/978-3-319-11812-3_5; Chin WH, 2014, IEEE WIREL COMMUN, V21, P106, DOI 10.1109/MWC.2014.6812298; Collins M, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P1; Comparetti PM, 2009, P IEEE S SECUR PRIV, P110, DOI 10.1109/SP.2009.14; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cui W., 2006, NDSS, V4, P279; Cui WD, 2008, CCS'08: PROCEEDINGS OF THE 15TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P391; Dai Andrew M., 2015, ADV NEURAL INFORM PR, P3079; Dietterich T. G., 2002, Structural, Syntactic, and Statistical Pattern Recognition. Joint IAPR International Workshops SSPR 2002 and SPR 2002 (Lecture Notes in Computer Science Vol. 2396), P15; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Evermann J, 2017, LECT NOTES BUS INF P, V281, P327, DOI 10.1007/978-3-319-58457-7_24; Ghiassi M, 2013, EXPERT SYST APPL, V40, P6266, DOI 10.1016/j.eswa.2013.05.057; Graves A, 2012, STUD COMPUT INTELL, V385, P37; He ZB, 2018, IEEE T VEH TECHNOL, V67, P665, DOI 10.1109/TVT.2017.2738018; Henaff M., 2015, ARXIV150605163; Keogh E, 2005, KNOWL INF SYST, V7, P358, DOI 10.1007/s10115-004-0154-9; Kingma D.P., 2014, AUTO ENCODING VARIAT, V1050, P10; Knapp E.D., 2014, IND NETWORK SECURITY; Krueger T., 2012, PROC 5 ACM WORKSHOP, P37, DOI DOI 10.1145/2381896.2381904; Lafferty John, 2001, P INT C MACH LEARN, P282; Lai SW, 2015, AAAI CONF ARTIF INTE, P2267; Lakshmanan GT, 2015, KNOWL INF SYST, V42, P97, DOI 10.1007/s10115-013-0697-8; Laskov P, 2011, 27TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE (ACSAC 2011), P373; Le M., 2012, SGAI 2012, P179, DOI [10.1007/978-1-4471-4739-8-13, DOI 10.1007/978-1-4471-4739-8-13]; Leitner P, 2010, LECT NOTES COMPUT SC, V6275, P176; Leontjeva A, 2015, LECT NOTES COMPUT SC, V9253, P297, DOI 10.1007/978-3-319-23063-4_21; Li M, 2005, TOOLA ART INT 2005 I; Lin Z., 2008, NDSS, V8, P1; Lodhi H, 2001, ADV NEUR IN, V13, P563; Maggi FM, 2014, LECT NOTES COMPUT SC, V8484, P457, DOI 10.1007/978-3-319-07881-6_31; Metzger A, 2015, IEEE T SYST MAN CY-S, V45, P276, DOI 10.1109/TSMC.2014.2347265; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Navarin N, 2017, 2017 IEEE SYMPOSIUM SERIES ON COMPUTATIONAL INTELLIGENCE (SSCI), P3474; Newsome J, 2006, P 13 ACM C COMP COMM, P311, DOI DOI 10.1145/1180405.1180444; Oza A, 2014, COMPUT SECUR, V45, P242, DOI 10.1016/j.cose.2014.06.002; Pandey S, 2011, COLLABORATECOM, P382, DOI 10.4108/icst.collaboratecom.2011.247129; Pelemans J, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P1433; Perdisci R, 2009, COMPUT NETW, V53, P864, DOI 10.1016/j.comnet.2008.11.011; Polato M., 2018, COMPUTING, P1; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rieck K., 2009, MACHINE LEARNING APP; Rieck K, 2010, 26TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE (ACSAC 2010), P31; Rieck K, 2011, J COMPUT SECUR, V19, P639, DOI 10.3233/JCS-2010-0410; Sauter M., 2010, GSM LTE INTRO MOBILE; Schwenk G, 2014, ARXIV14098035; Schwenk K, 2012, WEB3D 2012, P93; Shawe-Taylor J, 2004, KERNEL METHODS PATTE; She Rong, 2003, P 9 ACM SIGKDD INT C, P436, DOI DOI 10.1145/956750.956800; Sonnenburg S, 2005, LECT NOTES COMPUT SC, V3500, P389; Sonnenburg S., 2005, P 22 INT C MACH LEAR, P848, DOI DOI 10.1145/1102351.1102458; Tax N, 2017, LECT NOTES COMPUT SC, V10253, P477, DOI 10.1007/978-3-319-59536-8_30; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Unuvar M, 2016, KNOWL INF SYST, V47, P433, DOI 10.1007/s10115-015-0842-7; van der Aalst W, 2012, LECT NOTES BUS INF P, V99, P169; Wang K, 2004, LECT NOTES COMPUT SC, V3224, P203; Wang K, 2006, LECT NOTES COMPUT SC, V4219, P226; Wang S. I., 2012, P 50 ANN M ASS COMP, V2, P90; Wondracek G., 2008, NDSS, V8, P1; Xing Z., 2010, ACM SIGKDD EXPLOR NE, V12, P40, DOI DOI 10.1145/1882471.1882478; Yang Z, 2016, PR MACH LEARN RES, V48	65	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228434	10.1371/journal.pone.0228434	http://dx.doi.org/10.1371/journal.pone.0228434			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027668	Green Published, gold			2022-12-26	WOS:000534623800033
J	Cobb, SE; Sellers, WI				Cobb, Savannah Elizabeth; Sellers, William, I			Inferring lifestyle for Aves and Theropoda: A model based on curvatures of extant avian ungual bones	PLOS ONE			English	Article							TROODONTID THEROPOD; LONG FEATHERS; DINOSAUR; BIRD; EVOLUTION; ARCHAEOPTERYX; ORIGIN; FLIGHT; CHINA; CLAWS	Claws are involved in a number of behaviours including locomotion and prey capture, and as a result animals evolve claw morphologies that enable these functions. Past authors have found geometry of the keratinous sheath of the claw to correlate with mode of life for extant birds and squamates; this relationship has frequently been cited to infer lifestyles for Mesozoic theropods including Archaeopteryx. However, many fossil claws lack keratinous sheaths and thus cannot be analysed using current methods. As the ungual phalanx within the claw is more commonly preserved in the fossil record, geometry of this bone may provide a more useful metric for paleontological analysis. In this study, ungual bones of 108 birds and 5 squamates were imaged using X-ray techniques and a relationship was found between curvatures of the ungual bone within the claw of pedal digit III and four modes of life; ground-dwelling, perching, predatory, and scansorial; using linear discriminant analysis with weighted accuracy equal to 0.79. Our model predicts arboreal lifestyles for Archaeopteryx and Microraptor and a predatory ecology for Confuciusornis. These findings demonstrate the utility of our model in answering questions of palaeoecology, the theropod-bird transition, and the evolution of avian flight. Though the metric exhibits a strong correlation with lifestyle, morphospaces for PD-III curvatures overlap and so this metric should be considered alongside additional evidence.	[Cobb, Savannah Elizabeth; Sellers, William, I] Univ Manchester, Sch Earth & Environm Sci, Manchester, Lancs, England	University of Manchester	Cobb, SE (corresponding author), Univ Manchester, Sch Earth & Environm Sci, Manchester, Lancs, England.	savannah.cobb@postgrad.manchester.ac.uk	Sellers, William/Q-3843-2019	Sellers, William/0000-0002-2913-5406	University of Manchester [P121568 - P: EAZ PGR CONSUMABLES 1718 CT]; NERC [NE/R011168/1]	University of Manchester; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SEC received funding from the University of Manchester under grant number P121568 -P: EAZ PGR CONSUMABLES 1718 CT. SEC and WIS also received funding from NERC (NE/R011168/1). https://www.manchester.ac.uk/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DE, 2010, P NATL ACAD SCI USA, V107, P2972, DOI 10.1073/pnas.0911852107; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Bell A, 2011, J SYST PALAEONTOL, V9, P119, DOI 10.1080/14772019.2010.525536; BIEWENER AA, 1983, J EXP BIOL, V103, P131; Birn-Jeffery AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050555; Bock W.J., 1959, AM MUS NOVIT; Burnham DA, 2007, NEUES JAHRB GEOL P-A, V245, P33, DOI 10.1127/0077-7749/2007/0245-0033; Burnham DA, 2011, J SYST PALAEONTOL, V9, P103, DOI 10.1080/14772019.2010.522201; Cartmill M., 1985, FUNCT VERTEBR MORPHO; Cau A, 2017, NATURE, V552, P395, DOI 10.1038/nature24679; Chatterjee S, 2004, LIFE O PAST, P251; Chatterjee S, 2015, RISE OF BIRDS: 225 MILLION YEARS OF EVOLUTION, 2ND EDITION, P1; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Chiappe L.M., 2007, GLORIFIED DINOSAURS; Chiappe LM, 2001, MESOZOIC BIRDS; Chiappe LM, 1997, RESPONSE YALDEN ARCH, V15, P109; Crandell KE, 2014, ZOOLOGY, V117, P363, DOI 10.1016/j.zool.2014.05.001; Csermely D, 2012, ITAL J ZOOL, V79, P410, DOI 10.1080/11250003.2012.663003; Dalsatt J, 2006, NATURWISSENSCHAFTEN, V93, P444, DOI 10.1007/s00114-006-0125-y; Dececchi TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022292; Del Hoyo, 1997, HDB BIRDS WORLD SAND; del Hoyo J., 1996, HDB BIRDS WORLD, V3; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Del Hoyo J., 2007, HDB BIRDS WORLD, V12; del Hoyo J, 2013, HDB BIRDS WORLD; Del Hoyo J, 2002, HDB BIRDS WORLD, V7; del Hoyo J., 2003, HDB BIRDS WORLD, V8; del Hoyo J, 2006, HDB BIRDS WORLD VOL, V11; del Hoyo J., 2008, HDB BIRDS WORLD, V13; Del Hoyo J, 1999, HDB BIRDS WORLD, V5; Del Hoyo J, 2005, HDB BIRDS WORLD, V10; DELHOYO J, 2004, HDB BIRDS WORLD, V9; Dunning JB Jr, 2009, CRC HDB AVIAN BODY M; Fain MG, 2004, EVOLUTION, V58, P2558; Falk AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167284; FEDUCCIA A, 1993, SCIENCE, V259, P790, DOI 10.1126/science.259.5096.790; FENN R, 2001, GEOMETRY; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028964; Fowler DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007999; Glen CL, 2007, CURR BIOL, V17, pR911, DOI 10.1016/j.cub.2007.09.026; Godefroit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2389; Hamrick MW, 2001, EVOL DEV, V3, P355, DOI 10.1046/j.1525-142X.2001.01032.x; Han G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5382; Hone DWE, 2014, J ZOOL, V292, P260, DOI 10.1111/jzo.12114; Hou LH, 1999, NATURE, V399, P679, DOI 10.1038/21411; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; LAUDER GV, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P1; Lefevre U, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1496-y; Lefevre U, 2014, BIOL J LINN SOC, V113, P790, DOI 10.1111/bij.12343; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; Makdissi J, 2016, DENTOMAXILLOFAC RAD, V45, DOI 10.1259/dmfr.20150245; Mann S, 1994, MEDIA LAB PERCEPTUAL, V1, P2; Manning PL, 2006, BIOL LETTERS, V2, P110, DOI 10.1098/rsbl.2005.0395; Manning PL, 2009, ANAT REC, V292, P1397, DOI 10.1002/ar.20986; Mayr G, 2007, AUK, V124, P1450, DOI 10.1642/0004-8038(2007)124[1450:TFOART]2.0.CO;2; Moyer AE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1997; O'Connor J, 2013, P NATL ACAD SCI USA, V110, P17404, DOI 10.1073/pnas.1316979110; O'Connor J, 2011, P NATL ACAD SCI USA, V108, P19662, DOI 10.1073/pnas.1117727108; O'Connor JK, 2019, PALAEOGEOGR PALAEOCL, V513, P178, DOI 10.1016/j.palaeo.2018.03.006; Osmo lska H., 1987, ACTA PALAEONTOL POL, V32; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Pei R., 2017, B AM MUS NAT HIST, V411, P1, DOI [10.1206/0003-0090-411.1.1, DOI 10.1206/0003-0090-411.1.1]; Pei R, 2014, AM MUS NOVIT, P1; Peters Dieter Stefan, 1992, Natural History Museum of Los Angeles County Science Series, V36, P29; Pike AVL, 2004, J ZOOL, V262, P73, DOI 10.1017/S0952836903004382; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Rauhut OWM, 2018, PEERJ, V6, DOI 10.7717/peerj.4191; RCore Team, 2020, R LANG ENV STAT COMP; Spielmann Justin A., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P365; Tinius A, 2017, J MORPHOL, V278, P150, DOI 10.1002/jmor.20625; Tsuihiji T, 2016, HIST BIOL, V28, P128, DOI 10.1080/08912963.2015.1005086; Tulli MJ, 2011, J EVOLUTION BIOL, V24, P843, DOI 10.1111/j.1420-9101.2010.02218.x; Tulli MJ, 2009, ZOOLOGY, V112, P379, DOI 10.1016/j.zool.2009.02.001; Turner AH, 2012, B AM MUS NAT HIST, P5; Wang M, 2018, VERTEBR PALASIAT, V10; Wang M, 2014, J VERTEBR PALEONTOL, V34, P657, DOI 10.1080/02724634.2013.812101; Wang XL, 2014, BIOL J LINN SOC, V113, P805, DOI 10.1111/bij.12313; Wang YD, 2006, PROG NAT SCI-MATER, V16, P222; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; White C.M., 1994, NEW WORLD VULTURES G; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Xing LD, 2013, EVOLUTION, V67, P2441, DOI 10.1111/evo.12119; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Yalden D .W., 1985, P91; Yalden D.W., 1997, Archaeopteryx, V15, P107; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x; Zanno LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024487; Zhang YG, 2014, PEERJ, V2, DOI 10.7717/peerj.407; Zhou ZH, 2002, NATURWISSENSCHAFTEN, V89, P34, DOI 10.1007/s00114-001-0276-9; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZH, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P237; Zinoviev AV, 2009, PALEONTOL J+, V43, P444, DOI 10.1134/S0031030109040145	96	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0211173	10.1371/journal.pone.0211173	http://dx.doi.org/10.1371/journal.pone.0211173			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023255	Green Submitted, Green Published, gold			2022-12-26	WOS:000534621500001
J	Garcia, CD; Lamas, CJE; Urso-Guimaraes, MV				Garcia, Carolina De Almeida; Einicker Lamas, Carlos Jose; Urso-Guimaraes, Maria Virginia			Cladistic analysis of the genus Bruggmanniella Tavares (Diptera, Cecicomyiidae, Asphondyliini) with evolutionary inferences on the gall inducer-host plant association and description of a new Brazilian species	PLOS ONE			English	Article							MIDGES DIPTERA; CECIDOMYIIDAE; LAURACEAE; PHYLOGENY	In this study, we present a phylogenetic analysis of the genus Bruggmanniella Tavares based on morphological features. Cladistic analyses were conducted using 57 characters from 26 species. All species of Bruggmanniella except for B. byrsonimae were selected as ingroup and the genera Asphondylia Loew, Bruggmannia Tavares, Illiciomyia Tokuda, Parazalepidota Maia, Pseudasphondylia Monzen, Schizomyia Kieffer, and Lopesia Rubsaamen as outgroup. We used characters from larvae, pupae, adults, and galls. The results of this study supported Bruggmanniella as the sister group of Pseudasphondylia. Bruggmanniella actinodaphnes Tokuda and Yukawa and B. cinnamomi Tokuda and Yukawa have been moved to genus Pseudasphondylia (Pseudasphondylia actinodaphnes (Tokuda and Yukawa) comb. nov. and Pseudasphondylia cinnamomi (Tokuda and Yukawa) comb. nov.). The new genus Odontokeros gen. nov. has been erected for the single species Odontokeros brevipes (Lin, Yang & Tokuda) comb. nov. In addition, we described a new Brazilian species, Bruggmanniella miconia Garcia, Lamas and Urso-Guimaraes sp. nov. Identification keys to the New World species of Bruggmanniella are presented.	[Garcia, Carolina De Almeida; Einicker Lamas, Carlos Jose] Univ Sao Paulo, Museu Zool, Lab Diptera, Sao Paulo, SP, Brazil; [Urso-Guimaraes, Maria Virginia] Univ Fed Sao Carlos, Lab Sistemat Diptera, Dept Biol, Sorocaba, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos	Garcia, CD (corresponding author), Univ Sao Paulo, Museu Zool, Lab Diptera, Sao Paulo, SP, Brazil.	carolina_garcia@usp.br	Lamas, Carlos José/D-1053-2012; Garcia, Carolina/AAW-5781-2021; Maria Virginia Urso-Guimaraes, M.V. Urso-Guimarães/I-2730-2013; Urso-Guimarães, Maria Virginia/AAC-5220-2020	Lamas, Carlos José/0000-0002-7750-590X; Garcia, Carolina/0000-0002-3098-9361; Maria Virginia Urso-Guimaraes, M.V. Urso-Guimarães/0000-0003-3657-9379; Urso-Guimarães, Maria Virginia/0000-0003-3657-9379	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - 2016/19010-4]; "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil" (CAPES) [001]; FAPESP; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil" (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CAG was supported by grants from "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP - 2016/19010-4) (http://www.fapesp.br/) and "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil" (CAPES - Finance Code 001) (https://www.capes.gov.br/).All authors thank FAPESP and CAPES for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim DD, 2007, ZOOTAXA, P1; Bacci LF, 2016, PHYTOTAXA, V271, P1, DOI 10.11646/phytotaxa.271.1.1; Borkent A, 2018, ZOOTAXA, V4402, P53, DOI 10.11646/zootaxa.4402.1.3; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brown BV, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0022-x; Cumming Jeffrey M., 2009, P9; Dorchin N, 2019, MOL PHYLOGENET EVOL, V140, DOI 10.1016/j.ympev.2019.106602; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gagne RJ, 2004, P ENTOMOL SOC WASH, V106, P547; Gagne RJ, 2017, CATALOG CECIDOMYIIDA; Gagne RJ, 1994, GALL MIDGES NEOTROPI; Goldenberg R, 2013, PHYTOTAXA, V106, P1, DOI 10.11646/phytotaxa.106.1.1; Goloboff PA, TNT TREE ANAL USING; Goloboff P, 2008, CLADISTICS, V24, P91; Hebert PD, 2016, PHILOS T R SOC B, V371; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kovalev O.V., 1964, ENTOMOL REV, V43, P215; Lin SF, 2019, J ASIA-PAC ENTOMOL, V22, P203, DOI 10.1016/j.aspen.2018.12.012; Maia Valeria Cid, 2001, Revista Brasileira de Zoologia, V18, P1, DOI 10.1590/S0101-81752001000500001; Maia Valeria Cid, 1992, Revista Brasileira de Entomologia, V36, P653; Mani MS., 1964, ECOLOGY PLANT GALLS, DOI [10.1007/978-94-017-6230-4, DOI 10.1007/978-94-017-6230-4]; Mohn E, 1961, SENCKENBERG BIOL, V42, P131; MOHN E., 1963, SERIE NATURAIS, V32, P3; OOSTERBROEK P, 1995, ZOOL J LINN SOC-LOND, V115, P267, DOI 10.1111/j.1096-3642.1995.tb02462.x; PRICE PW, 1987, ENVIRON ENTOMOL, V16, P15, DOI 10.1093/ee/16.1.15; Sevcik J, 2016, PEERJ, V4, DOI 10.7717/peerj.2563; Sikora T, 2019, ZOOL J LINN SOC-LOND, V185, P98, DOI 10.1093/zoolinnean/zly029; Tavares JS, 1909, BROTERIA Z, V8, P5; THIELE K, 1993, CLADISTICS, V9, P275, DOI 10.1111/j.1096-0031.1993.tb00226.x; Tokuda M, 2005, ANN ENTOMOL SOC AM, V98, P259, DOI 10.1603/0013-8746(2005)098[0259:TNATKJ]2.0.CO;2; Tokuda M, 2008, ZOOL SCI, V25, P533, DOI 10.2108/zsj.25.533; Tokuda M, 2007, ORIENT INSECTS, V41, P121, DOI 10.1080/00305316.2007.10417502; Tokuda M, 2006, ANN ENTOMOL SOC AM, V99, P629, DOI 10.1603/0013-8746(2006)99[629:FROGBD]2.0.CO;2; Tokuda Makoto, 2002, Esakia, P11; Tokuda Makoto, 2004, Esakia, V44, P1; Urso-Guimarães M. V., 2006, Braz. J. Biol., V66, P357, DOI 10.1590/S1519-69842006000200018; URSO-GUIMARAES M.V., 2005, STUDIA DIPTEROLOGICA, V11, P429; Wood D.M., 1989, Agriculture Canada Monograph, P1333; YUKAWA J, 1971, Memoirs of the Faculty of Agriculture Kagoshima University, V8, P1; Yukawa Junichi, 2005, P273	42	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227853	10.1371/journal.pone.0227853	http://dx.doi.org/10.1371/journal.pone.0227853			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023290	gold, Green Published			2022-12-26	WOS:000534621500027
J	Franquesa-Soler, M; Jorge-Sales, L; Aristizabal, JF; Moreno-Casasola, P; Serio-Silva, JC				Franquesa-Soler, Montserrat; Jorge-Sales, Lucia; Aristizabal, John F.; Moreno-Casasola, Patricia; Carlos Serio-Silva, Juan			Evidence-based conservation education in Mexican communities: Connecting arts and science	PLOS ONE			English	Article							ENVIRONMENTAL-EDUCATION; FOREST; KNOWLEDGE; PROGRAM; CULTURE; IMPACT	Several studies suggest that 63% of primate species are currently threatened due to deforestation, pet-trade, and bushmeat hunting. Successful primate conservation strategies require effective educational programs capable of enhancing critical system-thinking and responsible behavior towards these species. Arts-based conservation education can simultaneously foster cognitive and emotional processes. In this paper, we evaluate an arts-based educational program focused on the conservation of black howler monkeys (Alouatta pigra). Our goals were to determine (1) whether children's knowledge changed with our educational techniques, (2) if there was a particular educational technique that better improved the children's learning, and (3) the children's emotional feedback regarding the whole program. A total of 229 children from communities located in primate-habitat areas, both inside and outside protected areas, participated in the study. Different educational techniques were tested (storytelling, theater and shadow puppets), contrasted with a control group, and evaluated through an analysis of drawings. Our results showed that children's knowledge increase with each art-based technique, with storytelling being the most effective for children's learning. Specific drawings indicators also revealed the increase of children's knowledge and a decrease of misconceptions between pre and post evaluations. Finally, a satisfaction survey about the program showed a high positive feedback. The study highlights the value of designing multidisciplinary projects, where arts-based education program (grounded in scientific information) has shown to be a successful way to communicate animal knowledge and promote conservation.	[Franquesa-Soler, Montserrat; Aristizabal, John F.; Carlos Serio-Silva, Juan] Inst Ecol AC, Red Biol & Conservac Vertebrados, Xalapa, Veracruz, Mexico; [Franquesa-Soler, Montserrat; Jorge-Sales, Lucia; Aristizabal, John F.] Miku Conservac AC, Primate Conservat & Sustainable Dev, Xalapa, Veracruz, Mexico; [Moreno-Casasola, Patricia] Inst Ecol AC, Red Ecol Func, Xalapa, Veracruz, Mexico; [Franquesa-Soler, Montserrat] Univ Autonoma Mexico IIES UNAM, Inst Invest Ecosistemas & Sustentabilidad, Lab Interacc Planta Anim, Morelia, Michoacan, Mexico	Instituto de Ecologia - Mexico; Instituto de Ecologia - Mexico	Franquesa-Soler, M (corresponding author), Inst Ecol AC, Red Biol & Conservac Vertebrados, Xalapa, Veracruz, Mexico.; Franquesa-Soler, M (corresponding author), Miku Conservac AC, Primate Conservat & Sustainable Dev, Xalapa, Veracruz, Mexico.; Franquesa-Soler, M (corresponding author), Univ Autonoma Mexico IIES UNAM, Inst Invest Ecosistemas & Sustentabilidad, Lab Interacc Planta Anim, Morelia, Michoacan, Mexico.	franquesamontse@gmail.com	Aristizabal, John Fredy/E-9273-2011; Franquesa-Soler, Montserrat/M-2769-2013; Serio-Silva, Juan Carlos/R-4437-2018	Aristizabal, John Fredy/0000-0001-7158-4881; Franquesa-Soler, Montserrat/0000-0002-3577-8942; Serio-Silva, Juan Carlos/0000-0002-0582-2041	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) [556384]	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We thank Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) for offering the scholarship to MFS (No 556384), Instituto de Ecologia, A.C (INECOL, A.C, Mexico), DGAPAUNAM Postdoctoral Fellowship, and to Juan Carlos Serio-Silva for financial support.; The authors are grateful to the participating schools and the rest of the communities. We would like to express our deepest gratitude to Erin P. Riley and Maria Lay for their valuable suggestions to the structure of the manuscript, language editing, and proofreading. Thank you to Ellen Andresen, Sergi Lo ' pez-Torres and Denise Spaan for English language editing and valuable comments. Thanks to Esther Castro, Laura Jayme for their support during fieldwork and artistic activities, and Adriana Sandoval-Comte who helped with mapping. We also thank Jeffrey Sayer and another anonymous reviewer for their contributions to improve this manuscript.	Acosta A, 2015, POLITICA SOC, V52, P299, DOI 10.5209/rev_POSO.2015.v52.n2.45203; Adcock L, 2007, AUST J ENVIRON EDUC, V23, P31, DOI 10.1017/S0814062600000690; Bamford A., 2006, WOW FACTOR GLOBAL RE; BARANES R, 1989, COGNITION INSTRUCT, V6, P287, DOI 10.1207/s1532690xci0604_1; BARBE WB, 1981, EDUC LEADERSHIP, V38, P378; Barraza L, 2011, TEMAS CONSERVACION V, P321; Barraza L., 2006, EDUCACION CONSERVACI, P255; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bennett NJ, 2016, CONSERV BIOL, V30, P582, DOI 10.1111/cobi.12681; Bettinger TL, 2010, AM J PRIMATOL, V72, P445, DOI 10.1002/ajp.20735; Bolker BM, 2015, ECOLOGICAL STAT CONT, P228; Borchers C, 2014, INT J SCI EDUC PART, V4, P240, DOI 10.1080/21548455.2013.803632; Bosco EB, 2011, LIMITES ESCUELA EDUC; Bowen-Jones E, 2002, ORYX, V36, P189, DOI 10.1017/S0030605302000261; Breuer T, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22692; Brewer C, 2006, CONSERV BIOL, V20, P689, DOI 10.1111/j.1523-1739.2006.00467.x; Caduto MJ, 1997, KEEPERS ANIMALS NATI; Carbonneau KJ, 2013, J EDUC PSYCHOL, V105, P380, DOI 10.1037/a0031084; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Coltman, 1974, SCI ED PSYCHOL CHILD; Cotton A, 2016, INTRODUCTION TO PRIMATE CONSERVATION, P31, DOI 10.1093/acprof:oso/9780198703389.003.0003; Cushing D.F., 2007, ENV ED RES, DOI [10.1080/13504620701581539, DOI 10.1080/13504620701581539]; Dahlstrom MF, 2014, P NATL ACAD SCI USA, V111, P13614, DOI 10.1073/pnas.1320645111; Dolins FL, 2010, AM J PRIMATOL, V72, P391, DOI 10.1002/ajp.20779; Dore K. M., 2017, ETHNOPRIMATOLOGY PRA; Dunn R., 1978, TEACHING STUDENTS TH; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946; Evely AC, 2011, CONSERV LETT, V4, P116, DOI 10.1111/j.1755-263X.2010.00152.x; Fashing PJ, 2000, AM J PRIMATOL, V50, P139, DOI 10.1002/(SICI)1098-2345(200002)50:2&lt;139::AID-AJP4&gt;3.0.CO;2-N; Fernandez A., 2003, CUADERNOS INTERAMERI, V2, P87, DOI DOI 10.22201/2002.7322; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; FORTMANN L, 1990, RURAL SOCIOL, V55, P214, DOI 10.1111/j.1549-0831.1990.tb00681.x; Franquesa-Soler M., 2019, SUSTAINABILITY J REC, V12, P109, DOI DOI 10.1089/SUS.2018.0034; Franquesa-Soler M, 2019, J EDUC RES, V112, P28, DOI 10.1080/00220671.2018.1427038; Franquesa-Soler M, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22723; Instituto Nacional de Estadistica Geografia e Informatica (INEGI), 2013, CENS POBL VIV 2013 I; Jacobson SK, 2015, CONSERVATION ED OUTR, DOI [10.1111/emr.12251, DOI 10.1111/EMR.12251]; Jacobson SK, 2007, CONSERV BIOL, V21, P7, DOI 10.1111/j.1523-1739.2006.00596.x; Kals E., 2002, PSYCHOL SUSTAINABLE, P97, DOI DOI 10.1007/978-1-4615-0995-0_6; Keane A, 2011, CONSERV LETT, V4, P55, DOI 10.1111/j.1755-263X.2010.00144.x; Kennedy EH, 2009, RURAL SOCIOL, V74, P309, DOI 10.1526/003601109789037268; Kling KJ, 2015, AM J PRIMATOL, V77, P434, DOI 10.1002/ajp.22359; KORMINOURI R, 1994, MEM COGNITION, V22, P723, DOI 10.3758/BF03209257; Kuhar CW, 2010, AM J PRIMATOL, V72, P407, DOI 10.1002/ajp.20726; Leeds A, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22673; Lehner PN, 1998, HDB ETHOLOGICAL METH, DOI [10.1086/420284, DOI 10.1086/420284]; LOWE GD, 1982, RURAL SOCIOL, V47, P114; MacDonald MR, 2013, TRADITIONAL STORYTEL; Martinez-Conde S, 2017, P NATL ACAD SCI USA, V114, P8127, DOI 10.1073/pnas.1711790114; Masten AS, 1998, AM PSYCHOL, V53, P205, DOI 10.1037/0003-066X.53.2.205; Montessori M., 1964, MONTESSORI METHOD; Morton Gomez VE, 2001, APROXIMACION EDUCACI; Mulder MB, 2009, BIOL CONSERV, V142, P879, DOI 10.1016/j.biocon.2008.12.021; Nations JD, 2006, MAYA TROP FOR PEOPL; Pavelka MSM, 2004, PRIMATES, V45, P105, DOI 10.1007/s10329-003-0072-6; Pearce JC, 1993, EVOLUTIONS END CLAIM; Pellier AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103005; Pepper C, 2005, AUST J ENVIRON EDUC, V21, P131, DOI 10.1017/S0814062600001026; R Core Team, 2021, R LANGUAGE ENV STAT; Rakotomamonjy SN, 2015, ANIM CONSERV, V18, P157, DOI 10.1111/acv.12153; Richards SA, 2015, ECOLOGICAL STATISTICS: CONTEMPORARY THEORY AND APPLICATION, P58; Rickinson M., 2004, REV RES OUTDOOR LEAR; Sanchez L, 2011, J SOCIOLING, V15, P422, DOI 10.1111/j.1467-9841.2011.00498.x; Saphores JDM, 2006, ENVIRON BEHAV, V38, P183, DOI 10.1177/0013916505279045; Schmelkes S., 2013, REV INT ESTADISTICA, V4, P5; Smith MD, 2000, RURAL SOCIOL, V65, P396, DOI 10.1111/j.1549-0831.2000.tb00036.x; Stern MJ, 2014, ENVIRON EDUC RES, V20, P581, DOI 10.1080/13504622.2013.838749; Teed R., 2004, GAME BASED LEARNING; Tourinan-Lopez JM, 2011, REV ESE ESTUDIOS ED, V21, P61; Turkka J, 2017, INT J SCI EDUC, V39, P1403, DOI 10.1080/09500693.2017.1333656; Tyagi N, 2017, INT FOREST REV, V19, P234; van Boeckel J, 2009, METAMORPHOSES CHILDR, P145; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wright JH, 2010, AM J PRIMATOL, V72, P462, DOI 10.1002/ajp.20749; Zelezny L. C., 1999, J ENVIRON EDUC, V31, P5, DOI DOI 10.1080/00958969909598627	76	6	6	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228382	10.1371/journal.pone.0228382	http://dx.doi.org/10.1371/journal.pone.0228382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9EF	32017779	Green Published, gold			2022-12-26	WOS:000534618100021
J	Luo, ZF; Farnham, PJ				Luo, Zhifei; Farnham, Peggy J.			Genome-wide analysis of HOXC4 and HOXC6 regulated genes and binding sites in prostate cancer cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; TRANSCRIPTION FACTORS; EXPRESSION; HOXB13; MORTALITY; FAMILY; E2F	Aberrant expression of HOXC6 and HOXC4 is commonly detected in prostate cancer. The high expression of these transcription factors is associated with aggressive prostate cancer and can predict cancer recurrence after treatment. Thus, HOXC4 and HOXC6 are clinically relevant biomarkers of aggressive prostate cancer. However, the molecular mechanisms by which these HOXC genes contribute to prostate cancer is not yet understood. To begin to address the role of HOXC4 and HOXC6 in prostate cancer, we performed RNA-seq analyses before and after siRNA-mediated knockdown of HOXC4 and/or HOXC6 and also performed ChIP-seq to identify genomic binding sites for both of these transcription factors. Our studies demonstrate that HOXC4 and HOXC6 co-localize with HOXB13, FOXA1 and AR, three transcription factors previously shown to contribute to the development of prostate cancer. We suggest that the aberrantly upregulated HOXC4 and HOXC6 proteins may compete with HOXB13 for binding sites, thus altering the prostate transcriptome. This competition model may be applicable to many different human cancers that display increased expression of a HOX transcription factor.	[Luo, Zhifei; Farnham, Peggy J.] Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA 90007 USA; [Luo, Zhifei; Farnham, Peggy J.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California	Farnham, PJ (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA 90007 USA.	peggy.farnham@med.usc.edu		Luo, Zhifei/0000-0002-4691-8074; Farnham, Peggy/0000-0003-4469-7914	National Institutes of Health [R01CA136924, P30CA014089]; Harold Brown Ph.D. Fellowship Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold Brown Ph.D. Fellowship Award	Funding was provided by the National Institutes of Health grant R01CA136924 (PJF) and P30CA014089 [USC Norris Cancer Center Support Grant]. ZL was supported, in part, by the Harold Brown Ph.D. Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 1995, TRANSCRIPTIONAL CONT, P79; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bhatlekar S, 2014, J MOL MED, V92, P811, DOI 10.1007/s00109-014-1181-y; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carnesecchi J, 2018, INT J DEV BIOL, V62, P723, DOI 10.1387/ijdb.180294il; Chen J, 2013, CANCER LETT, V330, P217, DOI 10.1016/j.canlet.2012.11.051; Chen Z, 2018, P NATL ACAD SCI USA, V115, P6810, DOI 10.1073/pnas.1718811115; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; FARNHAM PJ, 1993, BIOCHIM BIOPHYS ACTA, V1155, P125, DOI 10.1016/0304-419X(93)90001-S; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Guo Y, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1531-0; Huang LW, 2007, ENDOCRINOLOGY, V148, P1235, DOI 10.1210/en.2006-1250; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Kim SD, 2010, ANAT CELL BIOL, V43, P284, DOI 10.5115/acb.2010.43.4.284; Kron KJ, 2017, NAT GENET, V49, P1336, DOI 10.1038/ng.3930; Leyten GHJM, 2015, CLIN CANCER RES, V21, P3061, DOI 10.1158/1078-0432.CCR-14-3334; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Luo ZF, 2019, CANCERS, V11, DOI 10.3390/cancers11030323; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Ramachandran S, 2005, ONCOGENE, V24, P188, DOI 10.1038/sj.onc.1207906; Rhie SK, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0102-4; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shukla S, 2017, CANCER CELL, V32, P792, DOI 10.1016/j.ccell.2017.10.008; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stelloo S, 2018, ONCOGENE, V37, P313, DOI 10.1038/onc.2017.330; Sun YQ, 2018, CANCER CELL, V34, P643, DOI 10.1016/j.ccell.2018.08.018; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	42	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228590	10.1371/journal.pone.0228590	http://dx.doi.org/10.1371/journal.pone.0228590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012197	gold, Green Submitted, Green Published			2022-12-26	WOS:000534615800040
J	Watson, J; Cumming, O; Aunger, R; Deola, C; Chase, RP; Dreibelbis, R				Watson, Julie; Cumming, Oliver; Aunger, Robert; Deola, Claudio; Chase, Rachel P.; Dreibelbis, Robert			Child handwashing in an internally displaced persons camp in Northern Iraq: A qualitative multi-method exploration of motivational drivers and other handwashing determinants	PLOS ONE			English	Article							HYGIENE BEHAVIOR; HAND HYGIENE; INTERVIEWS; EMERGENCIES; DISEASES; IMPACT	Background Children in humanitarian situations are particularly vulnerable to diseases such as diarrhoea. Handwashing with soap can greatly reduce transmission but handwashing rates are often low and traditional interventions ineffective. To aid future intervention design, this study aims to understand the determinants of child handwashing and the key motivational drivers of children's behaviour within a specific humanitarian setting. Methods In an internally displaced persons camp in Northern Iraq we conducted a series of 36 friendship-paired interviews with children aged 7-12 years, six semi-structured caregiver interviews, and three semi-structured hygiene promoter interviews. Perceived determinants of child handwashing were explored qualitatively, and motivational drivers were explored quantitatively with children in a rating exercise. Qualitative data were analysed thematically, using an inductive approach, and logistic regression analyses of motive rating data were performed to determine the predicted probabilities of motives being rated as important. Results Access to soap and water was perceived to be high across all participant groups. Children, caregivers and hygiene promoters all perceive the determinants of child handwashing to be associated with familial role, environmental factors pertaining to location and quality of handwashing materials and facilities, and level of exposure to hygiene promotion, and children also attribute their handwashing to social norms. We find that children in this context are motived most by play and nurture. Conclusions Provision of soap and water alone is not sufficient to encourage children to practice hand-washing with soap in a humanitarian context. Our findings suggest that equal consideration should be given to the quality and location of handwashing materials and facilities and social norms could be leveraged to promote and enhance child handwashing. Motive-based interventions targeting play or nurture may be a promising approach and are likely most effective when used in conjunction, along with other motivational drivers such as affiliation and love.	[Watson, Julie; Cumming, Oliver; Aunger, Robert; Dreibelbis, Robert] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Deola, Claudio] Save Children, Humanitarian Dept, London, England	University of London; London School of Hygiene & Tropical Medicine; Save the Children	Watson, J (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.	julie.watson@lshtm.ac.uk		Watson, Julie/0000-0003-1487-2443; Chase, Rachel/0000-0002-1503-4954; Cumming, Oliver/0000-0002-5074-8709	Humanitarian Innovation Fund [82603245]	Humanitarian Innovation Fund	JW, OC and CD received financial support from the Humanitarian Innovation Fund, under Grant No. 82603245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; [Anonymous], 2018, DETAILS OMITTED DOUB; Aunger R., 2014, APPL EVOLUTIONARY AN, P271; Aunger R, 2016, HEALTH PSYCHOL REV, V10, P425, DOI 10.1080/17437199.2016.1219673; Aunger R, 2010, SOC SCI MED, V70, P383, DOI 10.1016/j.socscimed.2009.10.038; Behailu Besha, 2016, Epidemiology: Open Access, V6, P247; Biran A, 2014, LANCET GLOB HEALTH, V2, pE145, DOI 10.1016/S2214-109X(13)70160-8; Biran A, 2012, TROP MED INT HEALTH, V17, P1133, DOI 10.1111/j.1365-3156.2012.03045.x; Biran A, 2009, TROP MED INT HEALTH, V14, P1303, DOI 10.1111/j.1365-3156.2009.02373.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chittleborough CR, 2012, HEALTH EDUC RES, V27, P1055, DOI 10.1093/her/cys061; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Curtis V, 2001, J INFECTION, V43, P75, DOI 10.1016/S0163-4453(01)90862-X; Curtis V, 2011, LANCET INFECT DIS, V11, P312, DOI 10.1016/S1473-3099(10)70224-3; Curtis VA, 2009, HEALTH EDUC RES, V24, P655, DOI 10.1093/her/cyp002; De Buck E., 2017, CAMPBELL SYST REV, V13, P1, DOI DOI 10.4073/CSR.2017.7; Dickie R, 2018, PSYCHOL HEALTH MED, V23, P154, DOI 10.1080/13548506.2017.1338736; Ejemot-Nwadiaro RI, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub3; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Greenland K, 2016, LANCET GLOB HEALTH, V4, pE966, DOI 10.1016/s2214-109x(16)30262-5; Grimes JET, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004515, 10.1371/journal.pntd.0005236]; Grover E, 2018, AM J TROP MED HYG, V99, P934, DOI 10.4269/ajtmh.17-0903; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hirai M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090868; Houssart J, 2011, INT J RES METHOD EDU, V34, P63, DOI 10.1080/1743727X.2011.552337; Hulland KRS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-877; Karabakh, 2020, REF IDPS AZ BRIEF IN; Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/ERI.11.155, 10.1586/eri.11.155]; Mariwah S, 2012, TROP MED INT HEALTH, V17, P447, DOI 10.1111/j.1365-3156.2011.02950.x; McMichael C, 2016, SOC SCI MED, V163, P28, DOI 10.1016/j.socscimed.2016.06.051; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nandrup-Bus I, 2009, AM J INFECT CONTROL, V37, P820, DOI 10.1016/j.ajic.2009.06.012; Phillips RM, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0065-2; QSR International Pty Ltd, 2017, DW1000 DAT SHEET; Schmidt WP, 2009, TROP MED INT HEALTH, V14, P1534, DOI 10.1111/j.1365-3156.2009.02404.x; Seimetz Elisabeth, 2017, BMC Res Notes, V10, P280, DOI 10.1186/s13104-017-2599-4; Sphere Association, 2018, SPHER HDB HUM CHART; StataCorp, 2015, STAT STAT SOFTW REL; Stocks ME, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001605; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Talaat M, 2011, EMERG INFECT DIS, V17, P619, DOI 10.3201/eid1704.101353; Vujcic J, 2015, J WATER SANIT HYG DE, V5, P574, DOI 10.2166/washdev.2015.009; Watson J, 2019, INT J HYG ENVIR HEAL, V222, P177, DOI 10.1016/j.ijheh.2018.09.002; Willmott M, 2016, ARCH DIS CHILD, V101, P42, DOI 10.1136/archdischild-2015-308875; Wilson AD, 2016, QUAL REP, V21, P1549	46	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228482	10.1371/journal.pone.0228482	http://dx.doi.org/10.1371/journal.pone.0228482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9DJ	32012206	gold, Green Published, Green Submitted			2022-12-26	WOS:000534615800037
J	Lee, PC; Chen, ST; Kuo, TC; Lino, TC; Lin, MC; Huang, J; Hung, JS; Hsu, CL; Juan, HF; Lee, PH; Huang, MC				Lee, Po-Chu; Chen, Syue-Ting; Kuo, Ting-Chun; Lino, Tzu-Chi; Lin, Mei-Chun; Huang, John; Hung, Ji-Shiang; Hsu, Chia-Lang; Juan, Hsueh-Fen; Lee, Po-Huang; Huang, Min-Chuan			C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; O-GLYCOSYLATION; RECEPTORS; MET; BIOMARKERS; LIGANDS; TARGETS; GROWTH	C1GALT1 controls the crucial step of GalNAc-type O-glycosylation and is associated with both physiologic and pathologic conditions, including cancers. EPH receptors comprise the largest family of receptor tyrosine kinases (RTKs) and modulate a diverse range of developmental processes and human diseases. However, the role of C1GALT1 in the signaling of EPH receptors remains largely overlooked. Here, we showed that C1GALT1 high expression in gastric adenocarcinomas correlated with adverse clinicopathologic features and is an independent prognostic factor for poor overall survival. Silencing or loss of C1GALT1 inhibited cell viability, migration, invasion, tumor growth and metastasis, as well as increased apoptosis and cytotoxicity of 5-fluorouracil in AGS and MKN45 cells. Phospho-RTK array and western blot analysis showed that C1GALT1 depletion suppressed tyrosine phosphorylation of EPHA2 induced by soluble Ephrin A1-Fc. O-glycans on EPHA2 were modified by C1GALT1 and both S277A and T429A mutants, which are O-glycosites on EPHA2, dramatically enhanced phosphorylation of Y588, suggesting that not only overall O-glycan structures but also site-specific O-glycosylation can regulate EPHA2 activity. Furthermore, depletion of C1GALT1 decreased Ephrin A1-Fc induced migration and reduced Ephrin A1 binding to cell surfaces. The effects of C1GALT1 knockdown or knockout on cell invasiveness in vitro and in vivo were phenocopied by EPHA2 knockdown in gastric cancer cells. These results suggest that C1GALT1 promotes phosphorylation of EPHA2 and enhances soluble Ephrin A1-mediated migration primarily by modifying EPHA2 O-glycosylation. Our study highlights the importance of GalNAc-type O-glycosylation in EPH receptor-regulated diseases and identifies C1GALT1 as a potential therapeutic target for gastric cancer.	[Lee, Po-Chu; Kuo, Ting-Chun; Huang, John; Hung, Ji-Shiang; Lee, Po-Huang] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Lee, Po-Chu; Kuo, Ting-Chun] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Lee, Po-Chu] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Syue-Ting; Kuo, Ting-Chun; Lino, Tzu-Chi; Huang, Min-Chuan] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei, Taiwan; [Lin, Mei-Chun] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Hsu, Chia-Lang] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Lee, Po-Huang] E DA Hosp, Dept Surg, Kaohsiung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; E-Da Hospital	Huang, MC (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei, Taiwan.	mchuang@ntu.edu.tw	Hsu, Chia-Lang/O-1458-2013	Hsu, Chia-Lang/0000-0002-7447-8045; LEE, PO-HUANG/0000-0001-5831-035X; KUO, TING-CHUN/0000-0003-1960-1423; HUANG, MIN-CHUAN/0000-0002-0704-3447; Hung, Ji-Shiang/0000-0001-7392-5694; LEE, PO-CHU/0000-0001-5053-1895; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Taiwan University Hospital [109-049]; Ministry of Science and Technology, Taiwan [108-2320-B-002-064-MY3]	National Taiwan University Hospital(National Taiwan University); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank Dr Shu-Yun Tung (Academia Sinica, Taiwan) for performing global gene expression analysis and Dr Chiung-Nien Chen and Dr I-Rue Lai (National Taiwan University Hospital, Taiwan) for providing gastric cancer cell lines. This study was supported by National Taiwan University Hospital (109-049) to PCL, and Ministry of Science and Technology, Taiwan (108-2320-B-002-064-MY3) to MCH.	Alford S, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-41; Beauchamp A, 2012, SEMIN CELL DEV BIOL, V23, P109, DOI 10.1016/j.semcdb.2011.10.019; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Bradley CA, 2017, NAT REV CLIN ONCOL, V14, P562, DOI 10.1038/nrclinonc.2017.40; Campos D, 2015, MOL CELL PROTEOMICS, V14, P1616, DOI 10.1074/mcp.M114.046862; Chou CH, 2015, ONCOTARGET, V6, P6123, DOI 10.18632/oncotarget.3045; Chu ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19788-y; Cui XD, 2010, INT J CANCER, V126, P940, DOI 10.1002/ijc.24798; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Duarte HO, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6030033; Fife CM, 2014, BRIT J PHARMACOL, V171, P5507, DOI 10.1111/bph.12704; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; GOSEKI N, 1992, GUT, V33, P606, DOI 10.1136/gut.33.5.606; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Ho WL, 2014, ONCOTARGET, V5, P12247, DOI 10.18632/oncotarget.2627; Huang J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3875-3; Huang MJ, 2015, ONCOTARGET, V6, P5650, DOI 10.18632/oncotarget.3117; Hung JS, 2014, ONCOTARGET, V5, P2096, DOI 10.18632/oncotarget.1815; Ieguchi K, 2014, ONCOGENE, V33, P2179, DOI 10.1038/onc.2013.180; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Kudo T, 2013, BLOOD, V122, P1649, DOI 10.1182/blood-2012-12-471102; Lin MC, 2018, ONCOGENE, V37, P5780, DOI 10.1038/s41388-018-0375-0; Lisle JE, 2013, BBA-REV CANCER, V1835, P243, DOI 10.1016/j.bbcan.2013.01.003; Liu SY, 2016, ONCOTARGET, V7, P11251, DOI 10.18632/oncotarget.7081; Nakamura R, 2005, CANCER SCI, V96, P42, DOI 10.1111/j.1349-7006.2005.00007.x; Neill T, 2016, J CELL BIOL, V215, P687, DOI 10.1083/jcb.201603079; Ohtsu A, 2003, J CLIN ONCOL, V21, P54, DOI 10.1200/JCO.2003.04.130; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Peng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092924, 10.1371/journal.pone.0084502, 10.1371/journal.pone.0085663]; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sierra JC, 2018, GUT, V67, P1247, DOI 10.1136/gutjnl-2016-312888; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Tran Phu N, 2017, Gastrointest Cancer, V7, P1, DOI 10.2147/GICTT.S113525; Uchida Y, 2013, CANCER BIOL THER, V14, P127, DOI 10.4161/cbt.22634; Vaught D, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2207; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wen QC, 2017, ONCOTARGET, V8, P47998, DOI 10.18632/oncotarget.18208; Wu J, 2016, ONCOTARGET, V7, P25315, DOI 10.18632/oncotarget.8287; Wu YM, 2013, CANCER RES, V73, P5580, DOI 10.1158/0008-5472.CAN-13-0869; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Xi HQ, 2012, J CELL MOL MED, V16, P2894, DOI 10.1111/j.1582-4934.2012.01612.x; Yao HP, 2013, NAT REV CANCER, V13, P466, DOI 10.1038/nrc3545; Yuan W, 2012, NEOPLASMA, V59, P105, DOI 10.4149/neo_2012_014; Yuan WJ, 2009, DIGEST DIS SCI, V54, P2410, DOI 10.1007/s10620-008-0649-4	51	17	17	1	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2724	2740		10.1038/s41388-020-1178-7	http://dx.doi.org/10.1038/s41388-020-1178-7		JAN 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32005975	hybrid, Green Published			2022-12-26	WOS:000510346700005
J	Hayes, JA; Hilbert, BJ; Gaubitz, C; Stone, NP; Kelch, BA				Hayes, Janelle A.; Hilbert, Brendan J.; Gaubitz, Christl; Stone, Nicholas P.; Kelch, Brian A.			A thermophilic phage uses a small terminase protein with a fixed helix?turn?helix geometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cryo-EM; bacteriophage; DNA-binding protein; molecular motor; thermophile; DNA packaging; DNA recognition; helix?turn?helix domain; small terminase; viral motor	CRYSTAL-STRUCTURE; DNA-RECOGNITION; LARGE SUBUNIT; INITIATION; ATPASE; BACTERIOPHAGE-P22; COMPONENT; SEQUENCE; FEATURES; COMPLEX	Tailed bacteriophages use a DNA-packaging motor to encapsulate their genome during viral particle assembly. The small terminase (TerS) component of this DNA-packaging machinery acts as a molecular matchmaker that recognizes both the viral genome and the main motor component, the large terminase (TerL). However, how TerS binds DNA and the TerL protein remains unclear. Here we identified gp83 of the thermophilic bacteriophage P74-26 as the TerS protein. We found that TerS(P76-26) oligomerizes into a nonamer that binds DNA, stimulates TerL ATPase activity, and inhibits TerL nuclease activity. A cryo-EM structure of TerS(P76-26) revealed that it forms a ring with a wide central pore and radially arrayed helix?turn?helix domains. The structure further showed that these helix?turn?helix domains, which are thought to bind DNA by wrapping the double helix around the ring, are rigidly held in an orientation distinct from that seen in other TerS proteins. This rigid arrangement of the putative DNA-binding domain imposed strong constraints on how TerS(P76-26) can bind DNA. Finally, the TerS(P76-26) structure lacked the conserved C-terminal ?-barrel domain used by other TerS proteins for binding TerL. This suggests that a well-ordered C-terminal ?-barrel domain is not required for TerS(P76-26) to carry out its matchmaking function. Our work highlights a thermophilic system for studying the role of small terminase proteins in viral maturation and presents the structure of TerS(P76-26), revealing key differences between this thermophilic phage and its mesophilic counterparts.	[Hayes, Janelle A.; Hilbert, Brendan J.; Gaubitz, Christl; Stone, Nicholas P.; Kelch, Brian A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Kelch, BA (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.	brian.kelch@umassmed.edu		Gaubitz, Christl/0000-0002-6047-9282	Pew Charitable Trusts [00027337]; National Science Foundation [1817338]	Pew Charitable Trusts; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Pew Charitable Trusts Grant 00027337 (to B. A. K.) and the National Science Foundation Grant 1817338 (to B. A. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Zahrani AS, 2009, J BIOL CHEM, V284, P24490, DOI 10.1074/jbc.M109.025007; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; BRENNAN RG, 1990, P NATL ACAD SCI USA, V87, P8165, DOI 10.1073/pnas.87.20.8165; Buttner CR, 2012, P NATL ACAD SCI USA, V109, P811, DOI 10.1073/pnas.1110270109; CASJENS S, 1987, J MOL BIOL, V194, P411, DOI 10.1016/0022-2836(87)90671-1; CASJENS S, 1992, J MOL BIOL, V227, P1086, DOI 10.1016/0022-2836(92)90523-M; CHAI SH, 1995, J MOL BIOL, V252, P386, DOI 10.1006/jmbi.1995.0505; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feiss M, 2012, ADV EXP MED BIOL, V726, P489, DOI 10.1007/978-1-4614-0980-9_22; Gao S, 2016, NUCLEIC ACIDS RES, V44, P4425, DOI 10.1093/nar/gkw184; Gao S, 2011, J BIOL CHEM, V286, P3944, DOI 10.1074/jbc.M110.196907; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383; Greive SJ, 2016, NUCLEIC ACIDS RES, V44, P776, DOI 10.1093/nar/gkv1467; Gual A, 2000, J BIOL CHEM, V275, P35311, DOI 10.1074/jbc.M004309200; Hilbert BJ, 2017, NUCLEIC ACIDS RES, V45, P3591, DOI 10.1093/nar/gkw1356; Hilbert BJ, 2015, P NATL ACAD SCI USA, V112, pE3792, DOI 10.1073/pnas.1506951112; Huang DM, 2000, P NATL ACAD SCI USA, V97, P8324, DOI 10.1073/pnas.120176397; Kelley DS, 2016, MBIO, V7, DOI 10.1128/mBio.01537-16; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leavitt JC, 2013, VIROLOGY, V440, P117, DOI 10.1016/j.virol.2013.02.023; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mastronarde D.N, 2003, MICROSC MICROANAL, V9, P1182, DOI [10.1017/S1431927603445911, DOI 10.1017/S1431927603445911]; McNally R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-3; Minakhin L, 2008, J MOL BIOL, V378, P468, DOI 10.1016/j.jmb.2008.02.018; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Stone NP, 2018, STRUCTURE, V26, P936, DOI 10.1016/j.str.2018.04.008; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; van Duijn E, 2010, J AM SOC MASS SPECTR, V21, P971, DOI 10.1016/j.jasms.2009.12.010; Wu H, 2002, MOL MICROBIOL, V45, P1631, DOI 10.1046/j.1365-2958.2002.03114.x; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000592; Zhao HY, 2012, J MOL BIOL, V423, P413, DOI 10.1016/j.jmb.2012.07.016; Zhao HY, 2010, P NATL ACAD SCI USA, V107, P1971, DOI 10.1073/pnas.0908569107; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	46	2	2	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3783	3793		10.1074/jbc.RA119.012224	http://dx.doi.org/10.1074/jbc.RA119.012224			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32014998	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000527704400006
J	Murugina, NE; Budikhina, AS; Dagil, YA; Maximchik, PV; Balyasova, LS; Murugin, VV; Melnikov, MV; Sharova, VS; Nikolaeva, AM; Chkadua, GZ; Pinegin, BV; Pashenkov, MV				Murugina, Nina E.; Budikhina, Anna S.; Dagil, Yulia A.; Maximchik, Polina, V; Balyasova, Lyudmila S.; Murugin, Vladimir V.; Melnikov, Mikhail, V; Sharova, Viktoriya S.; Nikolaeva, Anna M.; Chkadua, Georgy Z.; Pinegin, Boris, V; Pashenkov, Mikhail, V			Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; dendritic cell; glucose metabolism; Nod-like receptor (NLR); cytokine; unfolded protein response (UPR); 2-deoxy-d-glucose; metabolic reprogramming; NOD1; NOD2; glycolysis; muramyl peptides	P70 S6 KINASE; SUCCINATE-DEHYDROGENASE; DENDRITIC CELL; PROTEIN-KINASE; MESSENGER-RNA; INFLAMMATORY MACROPHAGES; SIGNALING AXIS; METABOLISM; PHOSPHORYLATION; BACTERIAL	Upon activation with pathogen-associated molecular patterns, metabolism of macrophages and dendritic cells is shifted from oxidative phosphorylation to aerobic glycolysis, which is considered important for proinflammatory cytokine production. Fragments of bacterial peptidoglycan (muramyl peptides) activate innate immune cells through nucleotide-binding oligomerization domain (NOD) 1 and/or NOD2 receptors. Here, we show that NOD1 and NOD2 agonists induce early glycolytic reprogramming of human monocyte-derived macrophages (MDM), which is similar to that induced by the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide. This glycolytic reprogramming depends on Akt kinases, independent of mTOR complex 1 and is efficiently inhibited by 2-deoxy-d-glucose (2-DG) or by glucose starvation. 2-DG inhibits proinflammatory cytokine production by MDM and monocyte-derived dendritic cells activated by NOD1 or TLR4 agonists, except for tumor necrosis factor production by MDM, which is inhibited initially, but augmented 4 h after addition of agonists and later. However, 2-DG exerts these effects by inducing unfolded protein response rather than by inhibiting glycolysis. By contrast, glucose starvation does not cause unfolded protein response and, in normoxic conditions, only marginally affects proinflammatory cytokine production triggered through NOD1 or TLR4. In hypoxia mimicked by treating MDM with oligomycin (a mitochondrial ATP synthase inhibitor), both 2-DG and glucose starvation strongly suppress tumor necrosis factor and interleukin-6 production and compromise cell viability. In summary, the requirement of glycolytic reprogramming for proinflammatory cytokine production in normoxia is not obvious, and effects of 2-DG on cytokine responses should be interpreted cautiously. In hypoxia, however, glycolysis becomes critical for cytokine production and cell survival.	[Murugina, Nina E.; Budikhina, Anna S.; Dagil, Yulia A.; Balyasova, Lyudmila S.; Murugin, Vladimir V.; Melnikov, Mikhail, V; Nikolaeva, Anna M.; Pinegin, Boris, V; Pashenkov, Mikhail, V] Fed Med Biol Agcy Russia, Inst Immunol, Lab Clin Immunol, Natl Res Ctr, Kashirskoe Shosse 24, Moscow 115522, Russia; [Maximchik, Polina, V] Lomonosov Moscow State Univ, Fac Fundamental Med, Leninskie Gory 1, Moscow 119991, Russia; [Melnikov, Mikhail, V] Pirogov Russian Natl Res Med Univ, Dept Neurol Neurosurg & Med Genet, Ostrovityanova St 1, Moscow 117997, Russia; [Sharova, Viktoriya S.] Russian Acad Sci, Koltsov Inst Dev Biol, Vavilova St 26, Moscow 119334, Russia; [Nikolaeva, Anna M.] Lomonosov Moscow State Univ, Biol Fac, Leninskie Gory 1, Moscow 119991, Russia; [Chkadua, Georgy Z.] Minist Hlth Russian Federat, NN Blokhin Natl Med Res Ctr Oncol, Lab Expt Diagnost & Biotherapy Tumors, Kashirskoe Shosse 24 Bldg 2, Moscow 115522, Russia	NRC Institute of Immunology FMBA of Russia; Lomonosov Moscow State University; Pirogov Russian National Research Medical University; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Lomonosov Moscow State University; Ministry of Health of the Russian Federation	Pashenkov, MV (corresponding author), Fed Med Biol Agcy Russia, Inst Immunol, Lab Clin Immunol, Natl Res Ctr, Kashirskoe Shosse 24, Moscow 115522, Russia.	mvpashenkov@yandex.ru	Pashenkov, Mikhail/AAU-8034-2020; Melnikov, Mikhail/AAO-4544-2020	Murugina, Nina/0000-0001-7000-5729; Pashenkov, Mikhail/0000-0002-6995-1790	Russian Science Foundation [16-15-10314]; Russian Science Foundation [19-15-13011] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation Grant 16-15-10314 (to N. E. M., A. S. B., Y. A. D., L. S. B., V. V. M., M. V. M., V. S. S., A. M. N., B. V. P., and M. V. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balendran A, 1999, J BIOL CHEM, V274, P37400, DOI 10.1074/jbc.274.52.37400; Boyd S, 2015, J MED CHEM, V58, P3611, DOI 10.1021/acs.jmedchem.5b00352; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Dagil YA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160784; Dietl K, 2010, J IMMUNOL, V184, P1200, DOI 10.4049/jimmunol.0902584; Diskin C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00270; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; Fortin CF, 2013, J LEUKOCYTE BIOL, V94, P693, DOI 10.1189/jlb.0113012; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Hahn EL, 2000, SHOCK, V13, P253, DOI 10.1097/00024382-200004000-00001; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hu K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00426; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Idrovo JP, 2016, J SURG RES, V200, P242, DOI 10.1016/j.jss.2015.06.059; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jiang H, 2016, J IMMUNOL, V197, P2880, DOI 10.4049/jimmunol.1600474; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Kager L, 2010, THER CLIN RISK MANAG, V6, P279; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim S, 2015, J IMMUNOL, V194, P4498, DOI 10.4049/jimmunol.1401399; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lee PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014399; Liu ZY, 2015, MOL MED, V21, P937, DOI 10.2119/molmed.2015.00198; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Maximchik P, 2018, FEBS J, V285, P4590, DOI 10.1111/febs.14687; Meiser J, 2016, J BIOL CHEM, V291, P3932, DOI 10.1074/jbc.M115.676817; Meshcheryakova E, 2007, VACCINE, V25, P4515, DOI 10.1016/j.vaccine.2007.04.006; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; MILLER ES, 1993, BRAIN BEHAV IMMUN, V7, P317, DOI 10.1006/brbi.1993.1031; Millet P, 2016, J IMMUNOL, V196, P2541, DOI 10.4049/jimmunol.1501345; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Na YR, 2016, J IMMUNOL, V197, P4101, DOI 10.4049/jimmunol.1600745; Novellasdemunt L, 2013, BIOCHEM J, V452, P531, DOI 10.1042/BJ20121886; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Pashenkov MV, 2017, J IMMUNOL, V198, P1638, DOI 10.4049/jimmunol.1600467; Pashenkov MV, 2010, INT IMMUNOPHARMACOL, V10, P875, DOI 10.1016/j.intimp.2010.04.025; Rogatzki MJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00022; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Smith JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00422; Stienstra R, 2017, CELL METAB, V26, P142, DOI 10.1016/j.cmet.2017.06.001; Tan YH, 2019, CELL, V177, P384, DOI 10.1016/j.cell.2019.01.039; Tang GM, 2017, ONCOTARGET, V8, P97977, DOI 10.18632/oncotarget.20105; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tawakol A, 2015, ARTERIOSCL THROM VAS, V35, P1463, DOI 10.1161/ATVBAHA.115.305551; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Tokuda H, 2003, AM J PHYSIOL-ENDOC M, V284, pE1202, DOI 10.1152/ajpendo.00300.2002; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wang XM, 1997, BIOCHEM BIOPH RES CO, V238, P207, DOI 10.1006/bbrc.1997.7273; Wlodarski P, 2005, CANCER RES, V65, P7800, DOI 10.1158/0008-5472.CAN-04-4180; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Xi HB, 2014, IUBMB LIFE, V66, P110, DOI 10.1002/iub.1251; Yen YT, 2013, SURGERY, V153, P689, DOI 10.1016/j.surg.2012.11.021; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	77	9	11	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3099	3114		10.1074/jbc.RA119.010589	http://dx.doi.org/10.1074/jbc.RA119.010589			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005665	hybrid, Green Published			2022-12-26	WOS:000519597300018
J	Fehling, MK; Grosch, F; Schuster, ME; Schick, B; Lohscheller, J				Fehling, Mona Kirstin; Grosch, Fabian; Schuster, Maria Elke; Schick, Bernhard; Lohscheller, Joerg			Fully automatic segmentation of glottis and vocal folds in endoscopic laryngeal high-speed videos using a deep Convolutional LSTM Network	PLOS ONE			English	Article							IMAGE SEGMENTATION; VIBRATIONS; PARAMETERS; MODEL; CLASSIFICATION; KYMOGRAPHY; COVER; COLOR	The objective investigation of the dynamic properties of vocal fold vibrations demands the recording and further quantitative analysis of laryngeal high-speed video (HSV). Quantification of the vocal fold vibration patterns requires as a first step the segmentation of the glottal area within each video frame from which the vibrating edges of the vocal folds are usually derived. Consequently, the outcome of any further vibration analysis depends on the quality of this initial segmentation process. In this work we propose for the first time a procedure to fully automatically segment not only the time-varying glottal area but also the vocal fold tissue directly from laryngeal high-speed video (HSV) using a deep Convolutional Neural Network (CNN) approach. Eighteen different Convolutional Neural Network (CNN) network configurations were trained and evaluated on totally 13,000 high-speed video (HSV) frames obtained from 56 healthy and 74 pathologic subjects. The segmentation quality of the best performing Convolutional Neural Network (CNN) model, which uses Long Short-Term Memory (LSTM) cells to take also the temporal context into account, was intensely investigated on 15 test video sequences comprising 100 consecutive images each. As performance measures the Dice Coefficient (DC) as well as the precisions of four anatomical landmark positions were used. Over all test data a mean Dice Coefficient (DC) of 0.85 was obtained for the glottis and 0.91 and 0.90 for the right and left vocal fold (VF) respectively. The grand average precision of the identified landmarks amounts 2.2 pixels and is in the same range as comparable manual expert segmentations which can be regarded as Gold Standard. The method proposed here requires no user interaction and overcomes the limitations of current semiautomatic or computational expensive approaches. Thus, it allows also for the analysis of long high-speed video (HSV)-sequences and holds the promise to facilitate the objective analysis of vocal fold vibrations in clinical routine. The here used dataset including the ground truth will be provided freely for all scientific groups to allow a quantitative benchmarking of segmentation approaches in future.	[Fehling, Mona Kirstin; Grosch, Fabian; Lohscheller, Joerg] Trier Univ Appl Sci, Dept Comp Sci, Trier, Germany; [Schuster, Maria Elke] Univ Munich, Dept Otorhinolaryngol & Head & Neck Surg, Campus Grosshadern, Munich, Germany; [Schick, Bernhard] Saarland Univ Hosp, Dept Otorhinolaryngol, Homburg, Germany	University of Munich; Universitatsklinikum des Saarlandes	Fehling, MK (corresponding author), Trier Univ Appl Sci, Dept Comp Sci, Trier, Germany.	M.Fehling@hochschule-trier.de		Grosch, Fabian/0000-0003-4993-4085; Fehling, Mona Kirstin/0000-0002-3592-5025	German Research Foundation (DFG) [LO-1413/2-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG), LO-1413/2-2. Computational resources were provided by the High Performance Compute Cluster `Elwetritsch' at the University of Kaiserslautern, which is part of the `Alliance of High Performance Computing Rheinland-Pfalz' (AHRP). We kindly acknowledge the support.	Abadi M., 2016, TENSORFLOW LARGE SCA; Alipour F, 2000, J ACOUST SOC AM, V108, P3003, DOI 10.1121/1.1324678; Allin S, 2004, 2004 2 IEEE INT S BI; Alom MZ, 2019, J MED IMAGING, V6, DOI 10.1117/1.JMI.6.1.014006; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2015, ARXIV PREPRINT ARXIV; Arbelle A, 2019, I S BIOMED IMAGING, P1008, DOI 10.1109/ISBI.2019.8759447; Ba J.L., 2016, LAYER NORMALIZATION; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; BARTKO JJ, 1991, SCHIZOPHRENIA BULL, V17, P483, DOI 10.1093/schbul/17.3.483; Caelles S, 2017, PROC CVPR IEEE, P5320, DOI 10.1109/CVPR.2017.565; Chen J., 2016, ARXIV160901006, P3036; Cheng HD, 2001, PATTERN RECOGN, V34, P2259, DOI 10.1016/S0031-3203(00)00149-7; Cho K., 2014, C EMPIRICAL METHODS, P1724; Clevert DA, 2015, INT C LEARN REPR 201; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; Deliyski DD, 2008, FOLIA PHONIATR LOGO, V60, P33, DOI 10.1159/000111802; Deliyski DD, 2010, CURR OPIN OTOLARYNGO, V18, P147, DOI 10.1097/MOO.0b013e3283395dd4; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dollinger M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187486; Dollinger M, 2003, METHOD INFORM MED, V42, P271; Echternach M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175865; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Eysholdt U, 2003, EUR ARCH OTO-RHINO-L, V260, P412, DOI 10.1007/s00405-003-0606-y; Eysholdt U, 1996, FOLIA PHONIATR LOGO, V48, P163, DOI 10.1159/000266404; Gao Y, 2018, I S BIOMED IMAGING, P1104; Gertych A., 2018, AMIA ANN S P, P1140; Gibson E, 2018, COMPUT METH PROG BIO, V158, P113, DOI 10.1016/j.cmpb.2018.01.025; Gloger O, 2015, IEEE T BIO-MED ENG, V62, P795, DOI 10.1109/TBME.2014.2364862; Glorot X., 2010, P 13 INT C ARTIFICIA, V9, P249, DOI DOI 10.1.1/207.2059; He K, 1350, P IEEE INT C COMP VI, DOI [10.1038/s41591-018-0107-6, DOI 10.1038/S41591-018-0107-6]; Henrich N, 2004, J ACOUST SOC AM, V115, P1321, DOI 10.1121/1.1646401; Hertegard Stellan, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P152, DOI 10.1097/01.moo.0000163451.98079.ba; HIROSE H, 1988, ACTA OTO-LARYNGOL, P151; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kamnitsas K, 2018, LECT NOTES COMPUT SC, V10670, P450, DOI 10.1007/978-3-319-75238-9_38; Kayalibay Baris, 2017, ARXIV170103056; Kendall Katherine A, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P135, DOI 10.1097/01.moo.0000162262.26868.df; Kingma DP., 2014, ADAM METHOD STOCHAST; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Larsson H, 2000, LARYNGOSCOPE, V110, P2117, DOI 10.1097/00005537-200012000-00028; Laves MH, 2019, INT J COMPUT ASS RAD, V14, P483, DOI 10.1007/s11548-018-01910-0; Le Q. V., 2012, P 29 INT C MACH LEAR; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Li HW, 2018, NEUROIMAGE, V183, P650, DOI 10.1016/j.neuroimage.2018.07.005; Lin JY, 2019, IEEE T BIO-MED ENG, V66, P1127, DOI 10.1109/TBME.2018.2867636; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Lohscheller J, 2008, LARYNGOSCOPE, V118, P753, DOI 10.1097/MLG.0b013e318161f9e1; Lohscheller J, 2008, IEEE T MED IMAGING, V27, P300, DOI 10.1109/TMI.2007.903690; Lohscheller J, 2007, MED IMAGE ANAL, V11, P400, DOI 10.1016/j.media.2007.04.005; Lohscheller J, 2013, LOGOP PHONIATR VOCO, V38, P182, DOI 10.3109/14015439.2012.731083; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Marendic B, 2001, P 2001 INT C IM PROC; Mehta DD, 2012, CURR OPIN OTOLARYNGO, V20, P429, DOI 10.1097/MOO.0b013e3283585f04; Mehta DD, 2011, J SPEECH LANG HEAR R, V54, P47, DOI 10.1044/1092-4388(2010/10-0026); Neubauer J, 2001, J ACOUST SOC AM, V110, P3179, DOI 10.1121/1.1406498; Ng CB, 2013, 2013 FIRST INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, MODELLING AND SIMULATION (AIMS 2013), P29, DOI 10.1109/AIMS.2013.13; Novozamsky A, 2015, IEEE IMAGE PROC, P78, DOI 10.1109/ICIP.2015.7350763; Oktay O., 2018, ARXIV180403999; Osma-Ruiz V, 2008, COMPUT MED IMAG GRAP, V32, P193, DOI 10.1016/j.compmedimag.2007.12.003; Patel RR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154586; Patel RR, 2011, ANN OTO RHINOL LARYN, V120, P21, DOI 10.1177/000348941112000104; Rahman AIA, 2014, INT J COMINF ENG, V8, P306; Rao MVA, 2018, INTERSPEECH, P3007; Reddy KS, 2017, 2017 2ND IEEE INTERNATIONAL CONFERENCE ON RECENT TRENDS IN ELECTRONICS, INFORMATION & COMMUNICATION TECHNOLOGY (RTEICT), P2001; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; SATALOFF RT, 1991, ANN OTO RHINOL LARYN, V100, P725; Schenk F., 2015, ANN BMVA, V2015, P1; Schlegel P, 2019, J VOICE, V33, DOI 10.1016/j.jvoice.2018.04.011; Schulz H, 2011, P DAGM WORKSH NEW CH, P58; Shelhamer E., 2016, ARXIV160506211; Shi XS, 2015, 2015 IEEE ADVANCED INFORMATION TECHNOLOGY, ELECTRONIC AND AUTOMATION CONTROL CONFERENCE (IAEAC), P802, DOI 10.1109/IAEAC.2015.7428667; Stollenga M. F., 2015, ADV NEURAL INFORM PR, P2998; STORY BH, 1995, J ACOUST SOC AM, V97, P1249, DOI 10.1121/1.412234; Szegedy C., 2015, P IEEE C COMP VIS PA, P1; Szegedy C, 2013, ADV NEURAL INFORM PR, P2553, DOI DOI 10.5555/2999792.2999897; Takefuta Y, 1972, P 7 INT C PHON SCI M, P1035; Tao C, 2007, IEEE T BIO-MED ENG, V54, P794, DOI 10.1109/TBME.2006.889182; Titze I. R., 2000, PRINCIPLES VOICE PRO; Tsutsumi M, 2017, J VOICE, V31, P282, DOI 10.1016/j.jvoice.2016.09.026; Ulyanov D., 2016, ARXIV160708022; Unger J, 2016, ARTIF INTELL MED, V66, P15, DOI 10.1016/j.artmed.2015.10.002; Unger J, 2014, IEEE T BIO-MED ENG, V61, P2422, DOI 10.1109/TBME.2014.2318774; Verikas A, 2009, EUR ARCH OTO-RHINO-L, V266, P1509, DOI 10.1007/s00405-009-1050-4; Wang GT, 2018, IEEE T MED IMAGING, V37, P1562, DOI 10.1109/TMI.2018.2791721; Warhurst S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101128; Wittenberg T, 1995, MACH VISION APPL, V8, P399, DOI 10.1007/s001380050021; Wittenberg T, 2000, J VOICE, V14, P422, DOI 10.1016/S0892-1997(00)80087-9; Wu YX, 2018, LECT NOTES COMPUT SC, V11217, P3, DOI 10.1007/978-3-030-01261-8_1; Xu X, 2018, 22 C MED IM UND AN 2; Yan Y, 2005, 2005 IEEE ENG MED BI, DOI [10.1109/TBME.2006.889182, DOI 10.1109/TBME.2006.889182]; Yan YL, 2005, J VOICE, V19, P161, DOI 10.1016/j.jvoice.2004.04.006; Yan YL, 2006, IEEE T BIO-MED ENG, V53, P1394, DOI 10.1109/TBME.2006.873751; Yu F, 2017, C COMP VIS PATT REC; Zhang K, 2006, J ACOUST SOC AM, V119, P1050, DOI 10.1121/1.2159433; Zhang Y, 2007, CHAOS, V17, DOI 10.1063/1.2784384; Zhou XY, 2019, IEEE ROBOT AUTOM LET, V4, P1792, DOI 10.1109/LRA.2019.2896518; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	102	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0227791	10.1371/journal.pone.0227791	http://dx.doi.org/10.1371/journal.pone.0227791			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9IO	32040514	Green Published, gold			2022-12-26	WOS:000534629400010
J	Wieclaw, H; Kalinka, A; Koopman, J				Wieclaw, Helena; Kalinka, Anna; Koopman, Jacob			Chromosome numbers of Carex (Cyperaceae) and their taxonomic implications	PLOS ONE			English	Article							HOLOCENTRIC CHROMOSOMES; SECTION PHAESTOGLOCHIN; NORTH-AFRICAN; GENOME SIZE; GENUS CAREX; EVOLUTION; SPIROSTACHYAE; PHYLOGENY; SPECIATION; SEQUENCES	Counting chromosomes is the first step towards a better understanding of the karyotype evolution and the role of chromosome evolution in species diversification within Carex; however, the chromosome count is not known yet for numerous sedges. In this paper chromosome counts were performed for 23 Carex taxa from Armenia, Austria, the Czech Republic, and Poland. Chromosome numbers were determined for the first time in three species (Carex cilicica, 2n = 54; C. phyllostachys, 2n = 56; C. randalpina, 2n = 78), two subspecies (C. muricata subsp. ashokae, 2n = 58; C. nigra subsp. transcaucasica, 2n = 84) and two hybrids (C. xdecolorans, 2n = 74; C. xwalasii, 2n = 108). Among the taxa whose number of chromosomes had been known before, the largest difference was found in C. hartmaniorum (here 2n = 52) and C. aterrima subsp. medwedewii (here 2n = 52). A difference in the chromosome count was demonstrated for C. cilicica (2n = 54) versus the species of the section Aulocystis (2n = 30 to 40) and for C. tomentosa (2n = 48) versus the species of the section Acrocystis (2n = 18 to 38). The results of this study indicate that the position of C. cilicica in Aulocystis section may raise doubts. Attention was paid to the relationship between C. phyllostachys and taxa of the subgenus Carex section Gynobasidae.	[Wieclaw, Helena] Univ Szczecin, Inst Marine & Environm Sci, Szczecin, Poland; [Kalinka, Anna] Univ Szczecin, Inst Biol, Szczecin, Poland; [Kalinka, Anna] Univ Szczecin, Mol Biol & Biotechnol Ctr, Szczecin, Poland; [Koopman, Jacob] Ul Kochanowskiego 27, Choszczno, Poland	University of Szczecin; University of Szczecin; University of Szczecin	Wieclaw, H (corresponding author), Univ Szczecin, Inst Marine & Environm Sci, Szczecin, Poland.	helena.wieclaw@usz.edu.pl	Koopman, Jacob/ABB-8760-2020	Kalinka, Anna/0000-0003-3067-5060; Wieclaw, Helena/0000-0002-8165-6532				[Anonymous], 2002, FLORA N AM N MEXICO; Bures P, 2014, EVOLUTION, V68, P2412, DOI 10.1111/evo.12437; Buttler KP, 2017, BERICHTE BOT ARBEITS, V8, P33; CAYOUETTE J, 1985, CAN J BOT, V63, P1957, DOI 10.1139/b85-276; CAYOUETTE J, 1986, CYTOLOGIA, V51, P857, DOI 10.1508/cytologia.51.857; CAYOUETTE J, 1992, BOT REV, V58, P351, DOI 10.1007/BF02858773; Chater A.O., 1980, FLORA EUROPAEA, V5, P290; Crins W.J., 2002, FLORA N AM N MEXICO, V23, P558; DAVIES ELIZABETH W., 1956, WATSONIA, V3, P242; De Storme N, 2014, CURR PLANT BIOL, V1, P10, DOI 10.1016/j.cpb.2014.09.002; Dietrich J., DOCUMENTED CHROMOSOM; Druskovic B., 1995, NEWSLETT INT ORG PL, V24, P11; Egorova T.V., 1999, SEDGES CAREX L RUSSI; Escudero M, 2010, MOL PHYLOGENET EVOL, V57, P353, DOI 10.1016/j.ympev.2010.07.009; Escudero M, 2007, ORG DIVERS EVOL, V7, P271, DOI 10.1016/j.ode.2006.08.006; Escudero M, 2016, AM J BOT, V103, P1529, DOI 10.3732/ajb.1600051; Escudero M, 2015, AM J BOT, V102, P233, DOI 10.3732/ajb.1400433; Escudero M, 2009, PLANT SYST EVOL, V279, P163, DOI 10.1007/s00606-009-0156-x; FAULKNER JS, 1972, BOT J LINN SOC, V65, P271, DOI 10.1111/j.1095-8339.1972.tb00120.x; Favarger C, 1979, NAT MONSP BOT, V29, P1; GOKHMAN V.E., 2006, ENTOMOL REV, V86, P352, DOI [DOI 10.1134/S0013873806030110, 10.1134/s0013873806030110]; Gvinianidze Z. I., 1982, AN GSSR, V106, P577; HALKKA L, 1992, NORD J BOT, V12, P651, DOI 10.1111/j.1756-1051.1992.tb01841.x; Harmaja H, 2005, ANN BOT FENN, V42, P221; HARMAJA H, 1986, ANN BOT FENN, V23, P147; HARTVIG P, 1986, SYMB BOT UPSAL, V27, P127; Hayirlioglu-Ayaz S, 2001, BIOLOGIA, V56, P381; Heilborn O, 1924, HEREDITAS, V5, P129; Heilborn O, 1939, HEREDITAS, V25, P224; Hendrichs M, 2004, PLANT SYST EVOL, V246, P89, DOI 10.1007/s00606-004-0128-0; Hess HE, 1967, PTERIDOPHYTE BIS CAR, VI; Hipp Andrew L., 2007, Aliso, V23, P193; Hipp AL, 2007, EVOLUTION, V61, P2175, DOI 10.1111/j.1558-5646.2007.00183.x; Hipp AL, 2009, BOT REV, V75, P96, DOI 10.1007/s12229-008-9022-8; Jimenez-Mejias P, 2016, SYST BOT, V41, P500, DOI 10.1600/036364416X692497; Jimenez-Mejias P, 2015, PHYTOTAXA, V219, P183, DOI 10.11646/phytotaxa.219.2.8; Jimenez-Mejias P, 2012, SYST BOT, V37, P382, DOI 10.1600/036364412X635449; Knaf JF, 1847, FLORA, V30, P181; Kolodin P, 2018, PLANT SYST EVOL, V304, P1289, DOI 10.1007/s00606-018-1546-8; Koopman J, 2018, THESIS; Koopman J., 2015, ACCEPTED NAMES HYBRI; Koopman J, 2016, ACTA SOC BOT POL, V85, DOI 10.5586/asbp.3512; KOZHEVNIKOV AE, 1986, IZV SIBIRSK OTD A BN, V2, P57; Kukenthal G., 1909, PFLANZENREICH; Lipnerova I, 2013, ANN BOT-LONDON, V111, P79, DOI 10.1093/aob/mcs239; Love A., 1981, TAXON, V30, P845; LOVE A, 1961, OPERA BOTANICA LUND, V5, P1; LUCENO M, 1994, CAN J BOT, V72, P587, DOI 10.1139/b94-078; LUCENO M, 1993, BOT J LINN SOC, V112, P335; LUCENO M, 1991, PLANT SYST EVOL, V177, P149, DOI 10.1007/BF00937952; Luceno M, 1996, CARYOLOGIA, V49, P301, DOI 10.1080/00087114.1996.10797374; Luceno M., 1992, Willdenowia, V22, P149; Luceno Modesto, 1993, Cytologia (Tokyo), V58, P321, DOI 10.1508/cytologia.58.321; MAKINEN YRJO, 1965, ANN BOT FENNICI, V2, P19; Mehra P. N., 1972, TAXON, V21, P333; Melters DP, 2012, CHROMOSOME RES, V20, P579, DOI 10.1007/s10577-012-9292-1; Mola LM, 2006, BAG-J BASIC APPL GEN, V17, P17; Molina A, 2008, SYST BOT, V33, P237, DOI 10.1600/036364408784571563; Molina A, 2008, BOT J LINN SOC, V156, P385, DOI 10.1111/j.1095-8339.2007.00760.x; Nilsson O., 1985, FLORA TURKEY E AEGEA, V9, P73; Panzera F, 1996, MEM I OSWALDO CRUZ, V91, P515, DOI 10.1590/S0074-02761996000400021; PROBATOVA N S, 1981, Botanicheskii Zhurnal (St. Petersburg), V66, P1584; Reznicek AA, 2001, NOVON, V11, P454, DOI 10.2307/3393160; Roalson EH, 2001, SYST BOT, V26, P318; Roalson Eric H., 2007, Aliso, V23, P62; Roalson EH, 2008, BOT REV, V74, P209, DOI 10.1007/s12229-008-9011-y; Rotreklova O, 2011, PRESLIA, V83, P25; SCHMID B, 1982, Feddes Repertorium, V93, P23; SELVI F, 1997, FLORA MEDITERRANEA, V7, P163; Starr JR, 1999, AM J BOT, V86, P563, DOI 10.2307/2656818; Stoeva Milka P., 1993, Fragmenta Floristica et Geobotanica, V38, P29; Stoeva Milka P., 1992, Fitologiya, V43, P77; Stoeva MP, 2000, FLORA MEDITERRANEA, V10, P423; Szelag Zbigniew, 2001, Polish Botanical Journal, V46, P75; TANAKA N, 1942, MED BIOL, V2, P215; Tanaka N., 1948, BIOL CONTRIBUTION JA, V4, P136; TANAKA N, 1942, MED BIOL, V2, P421; Tarnavschi I. T., 1948, B JARD MUS BOT U C S, V28, P1; Vogt R, 2009, TAXON, V58, P1281, DOI 10.1002/tax.584017; Wallnofer B, 1992, LINZER BIOLOGISCHE B, V24, P829; WHITKUS R, 1988, SYST BOT, V13, P146, DOI 10.2307/2419251; Zedek F, 2018, ANN BOT-LONDON, V121, P9, DOI 10.1093/aob/mcx118; Zedek F, 2016, ANN BOT-LONDON, V118, P1347, DOI 10.1093/aob/mcw186	83	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228353	10.1371/journal.pone.0228353	http://dx.doi.org/10.1371/journal.pone.0228353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040511	gold, Green Published			2022-12-26	WOS:000534629400019
J	Ainsworth, A; Drake, DR				Ainsworth, Alison; Drake, Donald R.			Classifying Hawaiian plant species along a habitat generalist-specialist continuum: Implications for species conservation under climate change	PLOS ONE			English	Article							METROSIDEROS-POLYMORPHA; SEED DISPERSAL; NICHE BREADTH; COMMUNITIES; PATTERNS; DISTRIBUTIONS; CONVERGENCE; POPULATIONS; MECHANISMS; STRATEGIES	Plant communities on tropical high islands, such as the Hawaiian Islands, are predicted to experience rapid climate change, resulting in novel climates. If increased temperature and/or drought exceed plant species' current tolerances, species that are unable to adapt or shift ranges risk extinction. By definition, habitat generalists have a wide niche breadth and thrive in a variety of habitats, whereas habitat specialists have a narrow niche breadth, and typically thrive under more specific climatic characteristics (e.g., cold). The objectives of this study were to: (1) classify plant species in the Hawaiian Islands along a habitat generalist-specialist continuum; (2) independently test the validity of species rankings, using environmental and biogeographic ranges; and (3) identify species' life-history traits that predict species location along the continuum. We quantified specialization for 170 plant species using species co-occurrence data from over one thousand plots to rank species' realized habitat niche breadth using the Jaccard index. The distribution of species along this continuum differed by species biogeographic origin, with endemic plant species ranked on the specialist end and non-native plant species ranked on the generalist end. Habitat specialization rankings also differed for four of nine tested variables (while controlling for biogeographic origin): number of habitat moisture types, minimum elevation, number of Hawaiian Islands, and life form. Life form was the only trait tested that differed across the continuum, with woody species ranked as stronger generalists than herbaceous species; this pattern was particularly evident for non-native species. This indirect method of estimating species' potential climatic flexibility uses increasingly available large plant community data sets with output rankings which represent species' realized habitat niches. Identifying species and plant communities that are on the habitat specialist end of the continuum allows for their prioritization in conservation planning, as globally the loss of specialists is an indication of degradation.	[Ainsworth, Alison; Drake, Donald R.] Univ Hawaii Manoa, Sch Life Sci, Honolulu, HI 96822 USA; [Ainsworth, Alison] Natl Pk Serv, Pacific Isl Network Inventory & Monitoring Progra, Volcano, HI 96718 USA; [Ainsworth, Alison] Death Valley Natl Pk, Div Resources Management, Death Valley, CA 92328 USA	University of Hawaii System; University of Hawaii Manoa; United States Department of the Interior	Ainsworth, A (corresponding author), Univ Hawaii Manoa, Sch Life Sci, Honolulu, HI 96822 USA.; Ainsworth, A (corresponding author), Natl Pk Serv, Pacific Isl Network Inventory & Monitoring Progra, Volcano, HI 96718 USA.; Ainsworth, A (corresponding author), Death Valley Natl Pk, Div Resources Management, Death Valley, CA 92328 USA.	aliainsworth@hotmail.com		Ainsworth, Alison/0000-0002-0684-3311	University of Hawai'i at Manoa Botany Department; National Park Service Albright-Wirth grant; Pacific Islands Climate Adaptation Science Center	University of Hawai'i at Manoa Botany Department; National Park Service Albright-Wirth grant; Pacific Islands Climate Adaptation Science Center	AA received support for this research from the Pacific Islands Climate Adaptation Science Center (http://pi-casc.soest.hawaii.edu/index.php), the University of Hawai`i at Manoa Botany Department (http://www.botany.hawaii.edu/), and the National Park Service Albright-Wirth grant (https://www.nps.gov/training/hoalstmagrant.htm).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Alexander JM, 2011, P NATL ACAD SCI USA, V108, P656, DOI 10.1073/pnas.1013136108; Baldwin BG, 2010, ANN BOT-LONDON, V105, P849, DOI 10.1093/aob/mcq052; Banko PC, 1996, HCSU046 U HAW HIL HA; Banko PC, 2014, 046 HAW COOP STUD UN, P493; Barton KE, 2014, OECOLOGIA, V174, P1273, DOI 10.1007/s00442-013-2836-z; Benitez DM, 2012, 179 HAW PAC ISL COOP, P120; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Blonder B, 2016, J ECOL, V104, P219, DOI 10.1111/1365-2745.12497; Boulangeat I, 2012, J BIOGEOGR, V39, P204, DOI 10.1111/j.1365-2699.2011.02581.x; Buchi L, 2014, AM NAT, V183, P612, DOI 10.1086/675756; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Carlquist S, 1980, HAWAII NATURAL HIST; Chu PS, 2005, J CLIMATE, V18, P4796, DOI 10.1175/JCLI3578.1; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Compagnoni A, 2009, ECOGRAPHY, V32, P449, DOI 10.1111/j.1600-0587.2008.05739.x; Cornwell WK, 2007, FUNCT ECOL, V21, P1063, DOI 10.1111/j.1365-2435.2007.01323.x; Daehler CC, 2005, PERSPECT PLANT ECOL, V7, P203, DOI 10.1016/j.ppees.2005.08.002; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Deenik J., 2007, SOIL CROP MANAGEMENT, V20, P1; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; DeWalt SJ, 2004, AM J BOT, V91, P1155, DOI 10.3732/ajb.91.8.1155; Diaz HF, 2011, GLOBAL PLANET CHANGE, V77, P21, DOI 10.1016/j.gloplacha.2011.02.007; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; DRAKE DR, 1992, AM J BOT, V79, P1224, DOI 10.2307/2445048; Fischer M, 2010, J PLANT ECOL, V3, P149, DOI 10.1093/jpe/rtq013; FORTINI LB, 2013, HCSU044 TR; Fortini LB, 2018, REG ENVIRON CHANGE, V18, P2391, DOI 10.1007/s10113-018-1342-6; Fortini LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140389; Fraser LH, 2016, PLANT ECOL, V217, P1297, DOI 10.1007/s11258-016-0628-3; Fridley JD, 2007, J ECOL, V95, P707, DOI 10.1111/j.1365-2745.2007.01236.x; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Gagnu W.C., 1990, MANUAL FLOWERING PLA, V1, P45; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Giambelluca T. W., 2014, EVAPOTRANSPIRA UNPUB; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Green K, 2014, NPSPACNNRR2014819, P230; Green K, 2015, NPSPACNNRR2015966, P316; Green K, 2015, NPSPACNNRR2015986, P297; Grime J. P., 1979, Plant strategies and vegetation processes.; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jansen F, 2020, CONSERV LETT, V13, DOI 10.1111/conl.12674; Keddy P. A., 1990, Perspectives on plant competition., P265; KIRCH PV, 1982, PAC SCI, V36, P1; Kitayama K, 1996, J VEG SCI, V7, P879, DOI 10.2307/3236463; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Krushelnycky PD, 2013, GLOBAL CHANGE BIOL, V19, P911, DOI 10.1111/gcb.12111; Kueffer C, 2009, 166 U HAW PAC COOP S, P50; Kueffer C, 2010, PERSPECT PLANT ECOL, V12, P145, DOI 10.1016/j.ppees.2009.06.002; Leuschner C, 2000, ECOLOGY, V81, P1425, DOI 10.1890/0012-9658(2000)081[1425:AHEITM]2.0.CO;2; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Manthey M, 2009, J ECOL, V97, P18, DOI 10.1111/j.1365-2745.2008.01450.x; Marinsek A, 2015, PLANT ECOL, V216, P1469, DOI 10.1007/s11258-015-0527-z; Marvier M, 2004, RISK ANAL, V24, P869, DOI 10.1111/j.0272-4332.2004.00485.x; Maxwell SL, 2019, DIVERS DISTRIB, V25, P613, DOI 10.1111/ddi.12878; McDougall KL, 2011, DIVERS DISTRIB, V17, P103, DOI 10.1111/j.1472-4642.2010.00713.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Moll RJ, 2016, J ZOOL, V300, P177, DOI 10.1111/jzo.12369; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Mueller-Dombois D, 1998, VEGETATION TROPICAL; Mueller-Dombois D., 1974, AIMS METHODS VEGETAT; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Ostertag R, 2015, J APPL ECOL, V52, P805, DOI 10.1111/1365-2664.12413; PALMER DD, 2003, HAWAIIS FERNS FERN A; Pax DL, 1997, AM J BOT, V84, P72, DOI 10.2307/2445884; Petitpierre B, 2017, GLOBAL ECOL BIOGEOGR, V26, P275, DOI 10.1111/geb.12530; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Pottier J, 2013, GLOBAL ECOL BIOGEOGR, V22, P52, DOI 10.1111/j.1466-8238.2012.00790.x; Price JP, 2018, J SYST EVOL, V56, P600, DOI 10.1111/jse.12465; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Pysek P, 2011, P NATL ACAD SCI USA, V108, P439, DOI 10.1073/pnas.1017682108; R Core Team, 2021, R LANGUAGE ENV STAT; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Sakai AK, 2002, SYST BIOL, V51, P276, DOI 10.1080/10635150252899770; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Shipley B, 2016, OECOLOGIA, V180, P923, DOI 10.1007/s00442-016-3549-x; Timm O, 2009, J CLIMATE, V22, P4261, DOI 10.1175/2009JCLI2833.1; Tosi J, 2002, LIFE ZONE MAPS HAWAI; Trujillo E. E., 1985, Proceedings of the VI International Symposium on Biological Control of Weeds., P661; Urban MC, 2016, SCIENCE, V353, P1113, DOI 10.1126/science.aad8466; USDA, 2015, WEB SOIL SURV; USDA, 2008, NATL RESOURCES CONSE; Vimal R, 2015, ECOL INDIC, V50, P1, DOI 10.1016/j.ecolind.2014.10.024; Vitousek, 2004, NUTR CYCLING LIMITAT; Wagner WL, 2012, HAWAIIAN VASCULAR PL; Wagner WL, 1999, MANUAL FLOWERING PLA, V1; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Warshauer FR, 2009, 014 HAW COOP STUD UN, P108; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; WHITTAKER RH, 1973, AM NAT, V107, P321, DOI 10.1086/282837; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; 2008, AM J PREV MED, V35	108	8	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228573	10.1371/journal.pone.0228573	http://dx.doi.org/10.1371/journal.pone.0228573			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KO3ID	32032387	Green Published, gold			2022-12-26	WOS:000515441200001
J	Posocco, B; Buzzo, M; Poetto, AS; Orleni, M; Gagno, S; Zanchetta, M; Iacuzzi, V; Guardascione, M; Puglisi, F; Basile, D; Pelizzari, G; Marangon, E; Toffoli, G				Posocco, Bianca; Buzzo, Mauro; Poetto, Ariana Soledad; Orleni, Marco; Gagno, Sara; Zanchetta, Martina; Iacuzzi, Valentina; Guardascione, Michela; Puglisi, Fabio; Basile, Debora; Pelizzari, Giacomo; Marangon, Elena; Toffoli, Giuseppe			Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application	PLOS ONE			English	Article							KINASE 4/6 INHIBITOR; BREAST-CANCER; PHASE-I; VALIDATION; ASSAY	A novel LC-MS/MS method was developed for the quantification of the new cyclin dependent kinase inhibitors (CDKIs) palbociclib and ribociclib and the aromatase inhibitor letrozole used in combinatory regimen. The proposed method is appropriate to be applied in clinical practice due to the simple and fast sample preparation based on protein precipitation, the low amount of patient sample necessary for the analysis (10 mu L) and the total run time of 6.5 min. It was fully validated according to FDA and EMA guidelines on bioanalytical method validation. The linearity was assessed (R-2 within 0.9992-0.9983) over the concentration ranges of 0.3-250 ng/mL for palbociclib, 10-10000 ng/mL for ribociclib and 0.5-500 ng/mL for letrozole that properly cover the therapeutic plasma concentrations. A specific strategy was implemented to reduce the carryover phenomenon, formerly known for these CDKIs. This method was applied to quantify the C-min of palbociclib, ribociclib and letrozole in plasma samples from patients enrolled in a clinical study. The same set of study samples was analysed twice in separate runs to assess the reproducibility of the method by means of the incurred samples reanalysis. The results corroborated the reliability of the analyte concentrations obtained with the bioanalytical method, already proved by the validation process. The percentage differences were always within +/- 10% for all the analytes and the R-2 of the correlation graph between the two quantifications was equal to 0.9994.	[Posocco, Bianca; Buzzo, Mauro; Poetto, Ariana Soledad; Orleni, Marco; Gagno, Sara; Zanchetta, Martina; Iacuzzi, Valentina; Guardascione, Michela; Marangon, Elena; Toffoli, Giuseppe] Ctr Riferimento Oncol Aviano CRO IRCCS, Expt & Clin Pharmacol Unit, Aviano, Italy; [Poetto, Ariana Soledad] Univ Padua, Doctoral Sch Pharmacol Sci, Padua, Italy; [Zanchetta, Martina] Univ Trieste, Dept Chem & Pharmaceut Sci, Trieste, Italy; [Iacuzzi, Valentina] Univ Trieste, Doctoral Sch Nanotechnol, Trieste, Italy; [Puglisi, Fabio; Basile, Debora; Pelizzari, Giacomo] Univ Udine, Dept Med DAME, Udine, Italy; [Puglisi, Fabio; Basile, Debora; Pelizzari, Giacomo] Ctr Riferimento Oncol Aviano CRO IRCCS, Dept Med Oncol, Aviano, Italy	University of Padua; University of Trieste; University of Trieste; University of Udine	Posocco, B (corresponding author), Ctr Riferimento Oncol Aviano CRO IRCCS, Expt & Clin Pharmacol Unit, Aviano, Italy.	bposocco@cro.it	Posocco, Bianca/AAX-6323-2020; IACUZZI, VALENTINA/AAZ-6569-2020; Zanchetta, Martina/AAX-6274-2020; Puglisi, Fabio/N-3863-2017; Gagno, Sara/AAX-6330-2020; Toffoli, Giuseppe/F-6642-2018; Poetto, Ariana Soledad/ABD-8748-2020	Posocco, Bianca/0000-0002-3424-8827; IACUZZI, VALENTINA/0000-0003-1708-336X; Zanchetta, Martina/0000-0002-5018-7032; Puglisi, Fabio/0000-0003-0573-4938; Gagno, Sara/0000-0003-4877-6900; Toffoli, Giuseppe/0000-0002-5323-4762; Poetto, Ariana Soledad/0000-0001-9069-7523; Pelizzari, Giacomo/0000-0003-1224-9906	Ministero della Salute Ricerca Corrente	Ministero della Salute Ricerca Corrente(Ministry of Health, Italy)	We warmly thank the patients for their participation in the clinical study and Dr. Sara Colo for her valuable assistance in revising English language. We also thank the "Ministero della Salute Ricerca Corrente" for its support.	Bao X, 2019, J PHARMACEUT BIOMED, V166, P197, DOI 10.1016/j.jpba.2019.01.017; Beer B, 2010, ANAL BIOANAL CHEM, V398, P1791, DOI 10.1007/s00216-010-4075-z; CDER, 2018, BIOAN METH VAL GUID; Chavan BB, 2018, J PHARMACEUT BIOMED, V157, P59, DOI 10.1016/j.jpba.2018.05.008; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Desta Z, 2011, CLIN PHARMACOL THER, V90, P693, DOI 10.1038/clpt.2011.174; European Medicines Agency, 2011, GUIDELINE BIOANALYTI; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Food and Drug Administration. Center for Drug Evaluationand Research, 2014, PALB CLIN PHARM BIOP; Gorijavolu V, 2017, J CHEM PHARM RES, V9; Groenland SL, 2019, CLIN PHARMACOKINET, V58, P299, DOI 10.1007/s40262-018-0683-0; Hortobagyi GN, 2018, ANN ONCOL, V29, P1541, DOI 10.1093/annonc/mdy155; Infante JR, 2016, CLIN CANCER RES, V22, P5696, DOI 10.1158/1078-0432.CCR-16-1248; Kala A, 2017, J CHROMATOGR B, V1057, P110, DOI 10.1016/j.jchromb.2017.05.002; Kumar Pal T., 2017, J ANAL PHARM RES, V4; Marangon E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118194; Martinez-Chavez A, 2019, ANAL BIOANAL CHEM, V411, P5331, DOI 10.1007/s00216-019-01932-w; Mondal N, 2009, ACTA POL PHARM, V66, P11; Nalanda RB, 2018, INT J PHARM SCI RES, V9, P3883, DOI 10.13040/IJPSR.0975-8232.9(9).3883-88; Platova AI, 2014, PHARM CHEM J+, V48, P292, DOI 10.1007/s11094-014-1097-4; Posocco B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193500; Precht JC, 2012, ANAL BIOANAL CHEM, V403, P301, DOI 10.1007/s00216-012-5813-1; Samant TS, 2018, CLIN PHARMACOL THER, V104, P374, DOI 10.1002/cpt.940; Shao R, 2016, BIOMED CHROMATOGR, V30, P632, DOI 10.1002/bmc.3607; Spring LM, 2017, ONCOLOGIST, V22, P1039, DOI 10.1634/theoncologist.2017-0142; Tamura K, 2016, CANCER SCI, V107, P755, DOI 10.1111/cas.12932; Vanol PG, 2016, J PHARM ANAL, V6, P276, DOI 10.1016/j.jpha.2016.05.004; Verheijen RB, 2017, CLIN PHARMACOL THER, V102, P765, DOI 10.1002/cpt.787; Williams JS, 2012, BIOANALYSIS, V4, P1025, DOI [10.4155/BIO.12.76, 10.4155/bio.12.76]	29	13	13	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228822	10.1371/journal.pone.0228822	http://dx.doi.org/10.1371/journal.pone.0228822			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032379	Green Published, gold			2022-12-26	WOS:000534626100030
J	Hoppstadter, J; Perez, JVV; Linnenberger, R; Dahlem, C; Legroux, TM; Hecksteden, A; Tse, WKF; Flamini, S; Andreas, A; Herrmann, J; Herr, C; Muller, R; Meyer, T; Bals, R; Riccardi, C; Bruscoli, S; Kiemer, AK				Hoppstaedter, Jessica; Perez, Jenny Vanessa Valbuena; Linnenberger, Rebecca; Dahlem, Charlotte; Legroux, Thierry M.; Hecksteden, Anne; Tse, William K. F.; Flamini, Sara; Andreas, Anastasia; Herrmann, Jennifer; Herr, Christian; Mueller, Rolf; Meyer, Tim; Bals, Robert; Riccardi, Carlo; Bruscoli, Stefano; Kiemer, Alexandra K.			The glucocorticoid-induced leucine zipper mediates statin-induced muscle damage	FASEB JOURNAL			English	Article						flexor digitorum brevis; HMG-CoA; muscle wasting; statin-associated muscle symptoms; Tsc22d3	MYOBLAST CELLS; GILZ; PROTEIN; DIFFERENTIATION; SIMVASTATIN; INHIBITION; PATHWAY; RAT; GERANYLGERANYLATION; MYOTOXICITY	Statins, the most prescribed class of drugs for the treatment of hypercholesterolemia, can cause muscle-related adverse effects. It has been shown that the glucocorticoid-induced leucine zipper (GILZ) plays a key role in the anti-myogenic action of dexamethasone. In the present study, we aimed to evaluate the role of GILZ in statin-induced myopathy. Statins induced GILZ expression in C2C12 cells, primary murine myoblasts/myotubes, primary human myoblasts, and in vivo in zebrafish embryos and human quadriceps femoris muscle. Gilz induction was mediated by FOXO3 activation and binding to the Gilz promoter, and could be reversed by the addition of geranylgeranyl, but not farnesyl, pyrophosphate. Atorvastatin decreased Akt phosphorylation and increased cleaved caspase-3 levels in myoblasts. This effect was reversed in myoblasts from GILZ knockout mice. Similarly, myofibers isolated from knockout animals were more resistant toward statin-induced cell death than their wild-type counterparts. Statins also impaired myoblast differentiation, and this effect was accompanied by GILZ induction. The in vivo relevance of our findings was supported by the observation that gilz overexpression in zebrafish embryos led to impaired embryonic muscle development. Taken together, our data point toward GILZ as an essential mediator of the molecular mechanisms leading to statin-induced muscle damage.	[Hoppstaedter, Jessica; Perez, Jenny Vanessa Valbuena; Linnenberger, Rebecca; Dahlem, Charlotte; Legroux, Thierry M.; Kiemer, Alexandra K.] Saarland Univ, Dept Pharm, Pharmaceut Biol, Saarbrucken, Germany; [Hoppstaedter, Jessica; Flamini, Sara; Riccardi, Carlo; Bruscoli, Stefano] Univ Perugia, Dept Med, Sect Pharmacol, Perugia, Italy; [Hecksteden, Anne; Meyer, Tim] Saarland Univ, Inst Sports & Prevent Med, Saarbrucken, Germany; [Tse, William K. F.] Kyushu Univ, Fac Agr, Ctr Promot Int Educ & Res, Fukuoka, Japan; [Andreas, Anastasia; Herrmann, Jennifer; Mueller, Rolf] Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, Saarbrucken, Germany; [Herr, Christian; Bals, Robert] Saarland Univ, Dept Internal Med Pulmonol Allergol & Crit Care 5, Homburg, Germany	Saarland University; University of Perugia; Saarland University; Kyushu University; Helmholtz Association; Universitatsklinikum des Saarlandes	Kiemer, AK (corresponding author), Saarland Univ, Pharmaceut Biol, D-66123 Saarbrucken, Germany.	pharm.bio.kiemer@mx.uni-saarland.de	TSE, KA FAI WILLIAM/C-9384-2012; Hoppstädter, Jessica/AAM-2548-2020; Herr, Christian/AAH-5291-2021; Dahlem, Charlotte/Z-3729-2019; Kiemer, Alexandra K./I-9300-2012; Muller, Rolf/B-1559-2008	TSE, KA FAI WILLIAM/0000-0002-3738-0460; Dahlem, Charlotte/0000-0001-9983-0802; Kiemer, Alexandra K./0000-0002-7224-9900; Herrmann, Jennifer/0000-0003-3398-9938; Herr, Christian/0000-0001-9422-6569; Hoppstadter, Jessica/0000-0001-8758-1554; Riccardi, Carlo/0000-0001-9257-3997; Muller, Rolf/0000-0002-1042-5665				Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Asfour HA, 2018, EXP BIOL MED, V243, P118, DOI 10.1177/1535370217749494; Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Baba TT, 2008, J MUSCLE RES CELL M, V29, P127, DOI 10.1007/s10974-008-9146-9; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bereshchenko O, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00308; Bonifacio A, 2015, BBA-MOL CELL RES, V1853, P1841, DOI 10.1016/j.bbamcr.2015.04.010; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bruscoli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01720; Bruscoli S, 2012, J BIOL CHEM, V287, P1242, DOI 10.1074/jbc.M111.316372; Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136; Campos LM, 2016, EXP BIOL MED, V241, P1950, DOI 10.1177/1535370216659944; Campos LM, 2015, J HISTOCHEM CYTOCHEM, V63, P427, DOI 10.1369/0022155415580396; Cannarile L, 2001, CELL DEATH DIFFER, V8, P201, DOI 10.1038/sj.cdd.4400798; Cao PR, 2009, FASEB J, V23, P2844, DOI 10.1096/fj.08-128843; Czepukojc B, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00179; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; du Souich P, 2017, PHARMACOL THERAPEUT, V175, P1, DOI 10.1016/j.pharmthera.2017.02.029; Espinasse MA, 2016, J INNATE IMMUN, V8, P81, DOI 10.1159/000439052; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Heller DJ, 2017, CIRCULATION, V136, P1087, DOI 10.1161/CIRCULATIONAHA.117.027067; Hoppstadter J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01634; Hoppstadter J, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03111; Hoppstadter J, 2016, J BIOL CHEM, V291, P22949, DOI 10.1074/jbc.M116.733253; Joha S, 2012, ONCOGENE, V31, P1419, DOI 10.1038/onc.2011.328; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Keire Paul, 2013, Methods Mol Biol, V946, P431, DOI 10.1007/978-1-62703-128-8_28; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Laufs U, 2017, ATHEROSCLEROSIS SUPP, V26, P45, DOI 10.1016/S1567-5688(17)30024-7; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mosshammer D, 2014, BRIT J CLIN PHARMACO, V78, P454, DOI 10.1111/bcp.12360; Needham M, 2014, NEUROMUSCULAR DISORD, V24, P4, DOI 10.1016/j.nmd.2013.09.011; Nolte Ellen, 2011, Rand Health Q, V1, P4; Ogura Takeharu, 2007, Journal of Toxicological Sciences, V32, P57, DOI 10.2131/jts.32.57; Osaki Y, 2015, BIOCHEM BIOPH RES CO, V466, P536, DOI 10.1016/j.bbrc.2015.09.065; Park KH, 2014, JOVE-J VIS EXP, DOI 10.3791/50898; Pasha R, 2017, ENVIRON TOXICOL PHAR, V52, P150, DOI 10.1016/j.etap.2017.03.021; Rashmi P, 2017, KIDNEY INT, V91, P1159, DOI 10.1016/j.kint.2016.10.038; Ravenscroft G, 2007, CELL MOTIL CYTOSKEL, V64, P727, DOI 10.1002/cm.20223; Sakamoto K, 2007, FASEB J, V21, P4087, DOI 10.1096/fj.07-8713com; Sakamoto K, 2013, J PHARMACOL SCI, V123, P289, DOI 10.1254/jphs.13R06CP; Sakamoto K, 2011, J PHARMACOL EXP THER, V338, P62, DOI 10.1124/jpet.111.179762; Salami JA, 2017, JAMA CARDIOL, V2, P56, DOI 10.1001/jamacardio.2016.4700; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schirris TJJ, 2015, CELL METAB, V22, P399, DOI 10.1016/j.cmet.2015.08.002; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Sirtori CR, 2014, PHARMACOL RES, V88, P3, DOI 10.1016/j.phrs.2014.03.002; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Trapani L, 2012, J CELL BIOCHEM, V113, P2057, DOI 10.1002/jcb.24077; Tse WKF, 2013, BBA-GEN SUBJECTS, V1830, P4584, DOI 10.1016/j.bbagen.2013.05.006; Vancheri F, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010500; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; Ward NC, 2019, CIRC RES, V124, P328, DOI 10.1161/CIRCRESAHA.118.312782; Xie XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024469; Zhou JX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019798, 10.1371/journal.pone.0014752, 10.1371/journal.pone.0024340]	64	16	17	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4684	4701		10.1096/fj.201902557RRR	http://dx.doi.org/10.1096/fj.201902557RRR		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030813	Green Published, hybrid			2022-12-26	WOS:000512334100001
J	Kang, K; Quan, KT; Byun, HS; Lee, SR; Piao, X; Ju, E; Park, KA; Sohn, KC; Shen, HM; Na, M; Hur, GM				Kang, Kidong; Quan, Khong Trong; Byun, Hee Sun; Lee, So-Ra; Piao, Xuezhe; Ju, Eunjin; Park, Kyeong Ah; Sohn, Kyung-Cheol; Shen, Han-Ming; Na, MinKyun; Hur, Gang Min			3-O-acetylrubianol C (3AR-C) induces RIPK1-dependent programmed cell death by selective inhibition of IKK beta	FASEB JOURNAL			English	Article						apoptosis; IKK beta; necroptosis; phosphorylation; RIPK1; TNF; 3AR-C	NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; TNF; KINASE; ACTIVATION; ALPHA; RIPK1; UBIQUITINATION; INFLAMMATION; APOPTOSIS	In tumor necrosis factor (TNF) signaling, phosphorylation and activation of receptor interacting protein kinase 1 (RIPK1) by upstream kinases is an essential checkpoint in the suppression of TNF-induced cell death. Thus, discovery of pharmacological agents targeting RIPK1 may provide new strategies for improving the therapeutic efficacy of TNF. In this study, we found that 3-O-acetylrubianol C (3AR-C), an arborinane triterpenoid isolated from Rubia philippinesis, promoted TNF-induced apoptotic and necroptotic cell death. To identify the molecular mechanism, we found that in mouse embryonic fibroblasts, 3AR-C drastically upregulated RIPK1 kinase activity by selectively inhibiting IKK beta. Notably, 3AR-C did not interfere with IKK alpha or affect the formation of the TNF receptor1 (TNFR1) complex-I. Moreover, in human cancer cells, 3AR-C was only sufficient to sensitize TNF-induced cell death when c-FLIPL expression was downregulated to facilitate the formation of TNFR1 complex-II and necrosome. Taken together, our study identified a novel arborinane triterpenoid 3AR-C as a potent activator of TNF-induced cell death via inhibition of IKK beta phosphorylation and promotion of the cytotoxic potential of RIPK1, thus providing a rationale for further development of 3AR-C as a selective IKK beta inhibitor to overcome TNF resistance in cancer therpay.	[Kang, Kidong; Byun, Hee Sun; Lee, So-Ra; Piao, Xuezhe; Ju, Eunjin; Park, Kyeong Ah; Sohn, Kyung-Cheol; Hur, Gang Min] Chungnam Natl Univ, Dept Pharmacol, Coll Med, 266 Munhwa Ro, Daejeon 35015, South Korea; [Kang, Kidong; Byun, Hee Sun; Lee, So-Ra; Piao, Xuezhe; Ju, Eunjin; Park, Kyeong Ah; Sohn, Kyung-Cheol; Hur, Gang Min] Chungnam Natl Univ, Dept Med Sci, Coll Med, 266 Munhwa Ro, Daejeon 35015, South Korea; [Quan, Khong Trong; Na, MinKyun] Chungnam Natl Univ, Coll Pharm, Daejeon 34134, South Korea; [Shen, Han-Ming] Univ Macau, Fac Hlth Sci, Macau, Peoples R China; [Shen, Han-Ming] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore, Singapore	Chungnam National University; Chungnam National University; Chungnam National University; University of Macau; National University of Singapore	Hur, GM (corresponding author), Chungnam Natl Univ, Dept Pharmacol, Coll Med, 266 Munhwa Ro, Daejeon 35015, South Korea.; Hur, GM (corresponding author), Chungnam Natl Univ, Dept Med Sci, Coll Med, 266 Munhwa Ro, Daejeon 35015, South Korea.; Na, M (corresponding author), Chungnam Natl Univ, Coll Pharm, Daejeon 34134, South Korea.	mkna@cnu.ac.kr; gmhur@cnu.ac.kr	Hur, Gang-min/ABF-9263-2021	Hur, Gang-min/0000-0003-4870-6574; Khong, Quan T./0000-0003-2630-1031; Shen, Han-Ming/0000-0001-7369-5227	National Research Foundation of Korea (NRF) [2017R1A2A1A05001225, 2017R1A5A2015385, 2017R1A2A2A05001340]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2017R1A2A1A05001225, 2017R1A5A2015385 and 2017R1A2A2A05001340	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Annibaldi A, 2018, TRENDS MOL MED, V24, P49, DOI 10.1016/j.molmed.2017.11.002; Bajpai VK, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2253-2; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Carafa V, 2018, CLIN CANCER RES, V24, P2886, DOI 10.1158/1078-0432.CCR-17-3081; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dillon CP, 2016, CYTOKINE, V78, P47, DOI 10.1016/j.cyto.2015.10.014; Dondelinger Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09690-0; Dondelinger Y, 2017, NAT CELL BIOL, V19, P1237, DOI 10.1038/ncb3608; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fritsch J, 2017, BBA-MOL CELL RES, V1864, P2138, DOI 10.1016/j.bbamcr.2017.07.017; Fritsch J, 2014, MOL CELL BIOL, V34, P3214, DOI 10.1128/MCB.00048-14; Geng JF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00406-w; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gill BS, 2016, MOL BIOL REP, V43, P881, DOI 10.1007/s11033-016-4032-9; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Quan KT, 2016, J NAT PROD, V79, P2559, DOI 10.1021/acs.jnatprod.6b00489; Klingbeil O, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.271; Lafont E, 2018, NAT CELL BIOL, V20, P1389, DOI 10.1038/s41556-018-0229-6; Li CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-73; Li QT, 2000, GENE DEV, V14, P1729; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Liu X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.197; Menon MB, 2018, TRENDS BIOCHEM SCI, V43, P170, DOI 10.1016/j.tibs.2017.12.002; Menon MB, 2017, NAT CELL BIOL, V19, P1248, DOI 10.1038/ncb3614; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Newton K, 2015, TRENDS CELL BIOL, V25, P347, DOI 10.1016/j.tcb.2015.01.001; Pannicke U, 2013, NEW ENGL J MED, V369, P2504, DOI 10.1056/NEJMoa1309199; Patlolla JMR, 2012, CURR PHARM BIOTECHNO, V13, P147; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Pratheeshkumar P, 2011, J ENVIRON PATHOL TOX, V30, P21, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i1.30; Salvador JAR, 2017, EUR J MED CHEM, V142, P95, DOI 10.1016/j.ejmech.2017.07.013; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Shi JH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01849; Silke J, 2011, CURR OPIN IMMUNOL, V23, P620, DOI 10.1016/j.coi.2011.08.002; Smart Brian A, 2014, Pediatrics, V134 Suppl 3, pS181, DOI 10.1542/peds.2014-1817EEEE; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Ting AT, 2016, TRENDS IMMUNOL, V37, P535, DOI 10.1016/j.it.2016.06.002; Totzke J, 2017, CELL CHEM BIOL, V24, P1029, DOI 10.1016/j.chembiol.2017.07.011; Vlantis K, 2016, IMMUNITY, V44, P553, DOI 10.1016/j.immuni.2016.02.020; Walczak H, 2011, IMMUNOL REV, V244, P9, DOI 10.1111/j.1600-065X.2011.01066.x; Wegner KW, 2017, TRENDS PHARMACOL SCI, V38, P202, DOI 10.1016/j.tips.2016.12.005; Wertz IE, 2014, CURR OPIN CHEM BIOL, V23, P71, DOI 10.1016/j.cbpa.2014.10.011; Won M, 2016, ARCH PHARM RES, V39, P1075, DOI 10.1007/s12272-016-0772-2; Yan J, 2013, CELL, V152, P304, DOI 10.1016/j.cell.2012.12.021; Yao WL, 2015, ONCOTARGET, V6, P34669, DOI 10.18632/oncotarget.5785; Zhang DW, 2011, CELL RES, V21, P368, DOI 10.1038/cr.2011.3; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444; Zhang YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14329	57	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4369	4383		10.1096/fj.201902547R	http://dx.doi.org/10.1096/fj.201902547R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32027418				2022-12-26	WOS:000512081500001
J	Pro, G; Zaller, N				Pro, George; Zaller, Nick			Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in US healthcare settings	PLOS ONE			English	Article							OPIOID USE DISORDER; MEDICATION-ASSISTED TREATMENT; ETHNIC-DIFFERENCES; PERCEIVED DISCRIMINATION; POSITIVE OUTCOMES; MENTAL-HEALTH; DRUG-USERS; GENDER; ABUSE; STIGMA	Background Disparities in methadone maintenance therapy (MMT) outcomes have received limited attention, but there are important negative outcomes associated with MMT that warrant investigation. Racial discrimination is common in healthcare settings and affects opioid use disorder (OUD) treatment and comorbidities. However, race/ethnicity alone may not fully explain experiences of discrimination. MMT remains highly stigmatized and may compound the effect of race/ethnicity on discrimination in healthcare settings. We sought to quantify differential associations between MMT and experiences of racial discrimination between racial/ethnic groups in a U.S. national sample. Methods We used the National Epidemiologic Survey on Alcohol and Related Conditions-III (2012-2013) to identify a subset of individuals with a lifetime OUD who had ever used MMT (survey n = 766; weighted population n = 5,276,507). We used multivariable logistic regression to model past-year experience of racial discrimination in a healthcare setting. We included an interaction term between race/ethnicity and MMT status to identify the odds of discrimination (MMT vs. no MMT [referent]) within racial/ethnic groups. We used survey procedures with weights to account for the parent study's complex survey design. Findings Twenty-two percent of our sample experienced racial discrimination in a healthcare setting in the past year. Discrimination was more common among those who had ever used MMT (x(2) = 10.00, p = 0.001) and racial/ethnic minorities (x(2) = 23.15, p<0.001). The interaction effect was much stronger than the main effects of race/ethnicity and MMT status. MMT status (versus no MMT) was positively associated with discrimination among Blacks (aOR = 3.93, 95% CI = 3.87-3.98, p<0.001), Whites (aOR = 2.25, 95% CI = 2.23-2.27, p<0.001), and Latino/Latinas (aOR = 1.59, 95% CI = 1.55-1.62, p<0.001). Among American Indian/Alaska Natives (AI/AN), those who had used MMT had over thirty times the odds of racial discrimination, compared to their non-MMT counterparts (aOR = 32.78, 95% CI = 31.16-34.48, p<0.001). Conclusion Race/ethnicity alone did not sufficiently account for racial discrimination in healthcare settings among those with a lifetime OUD. MMT status was strongly associated with racial discrimination among AI/AN. Our strong interaction effect is indicative of an additional barrier to health services utilization among AI/AN, which has important implications for OUD treatment outcomes and comorbidities. Health promotion programs aimed at increased adoption of MMT are promising, but should be considered in the context of racial/ethnic disparities, drug use and MMT stigma, and implicit biases in clinical settings.	[Pro, George] No Arizona Univ, Ctr Hlth Equ Res, Flagstaff, AZ 86011 USA; [Zaller, Nick] Univ Arkansas Med Sci, Coll Publ Hlth, Little Rock, AR 72205 USA	Northern Arizona University; University of Arkansas System; University of Arkansas Medical Sciences	Pro, G (corresponding author), No Arizona Univ, Ctr Hlth Equ Res, Flagstaff, AZ 86011 USA.	george.pro@nau.edu						Abraham AJ, 2017, AM J PUBLIC HEALTH, V107, P31, DOI 10.2105/AJPH.2016.303558; Alderks C.E., 2017, TRENDS USE METHADONE; Anstice S, 2009, SUBST USE MISUSE, V44, P794, DOI 10.1080/10826080802483936; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Becker WC, 2008, DRUG ALCOHOL DEPEN, V94, P38, DOI 10.1016/j.drugalcdep.2007.09.018; Boutwell Amy E, 2007, J Opioid Manag, V3, P328; Burgess DJ, 2008, J HEALTH CARE POOR U, V19, P894, DOI 10.1353/hpu.0.0063; Chou R, 2016, TECHNICAL BRIEFS AGE, V28; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Conner KO, 2008, J SOC WORK PRACT ADD, V8, P244, DOI 10.1080/15332560802157065; Connery HS, 2015, HARVARD REV PSYCHIAT, V23, P63, DOI 10.1097/HRP.0000000000000075; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; Corsi KF, 2009, J SUBST ABUSE TREAT, V37, P120, DOI 10.1016/j.jsat.2008.11.004; Corsi KF, 2002, J DRUG ISSUES, V32, P999, DOI 10.1177/002204260203200316; D'Aunno T, 2002, JAMA-J AM MED ASSOC, V288, P850, DOI 10.1001/jama.288.7.850; Darke S, 2009, DRUG ALCOHOL REV, V28, P243, DOI 10.1111/j.1465-3362.2008.00024.x; Duvivier H, 2017, J AM PHARM ASSOC, V57, pS135, DOI 10.1016/j.japh.2017.01.005; Earnshaw V, 2013, INT J MENT HEALTH AD, V11, P110, DOI 10.1007/s11469-012-9402-5; Evans E, 2015, DRUG ALCOHOL DEPEN, V155, P228, DOI 10.1016/j.drugalcdep.2015.07.010; FitzGerald C, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0179-8; Friedman J, 2019, JAMA INTERNAL MED; Grant B.F., 2014, SOURCE ACCURACY STAT; Hansen H., 2012, CRIT PERSPECT, P79, DOI [10.1108/S1057-6290(2012)0000014008, DOI 10.1108/S1057-6290(2012)0000014008]; Hansen H, 2016, DRUG ALCOHOL DEPEN, V164, P14, DOI 10.1016/j.drugalcdep.2016.03.028; Henry J. Kaiser Family Foundation, 2017, OP OV DEATHS RAC ETH; Hosmer D. W., 2013, APPL LOGISTIC REGRES; HSER YI, 1991, INT J ADDICT, V25, P1295, DOI 10.3109/10826089009068465; Jernigan VBB, 2015, AM J PUBLIC HEALTH, V105, pS376, DOI 10.2105/AJPH.2014.302447; Jimenez-Trevino L, 2011, ADDICT BEHAV, V36, P1184, DOI 10.1016/j.addbeh.2011.07.019; Jones CM, 2015, MMWR-MORBID MORTAL W, V64, P719; Kelly SM, 2011, DRUG ALCOHOL DEPEN, V117, P170, DOI 10.1016/j.drugalcdep.2011.01.008; Keyes KM, 2014, AM J PUBLIC HEALTH, V104, pE52, DOI 10.2105/AJPH.2013.301709; Krawczyk N, 2017, DRUG ALCOHOL DEPEN, V178, P512, DOI 10.1016/j.drugalcdep.2017.06.009; Lagisetty P, 2019, JAMA PSYCHIAT, DOI [10.1016/j.drugalcdep.2011.01.008, DOI 10.1016/J.DRUGALCDEP.2011.01.008]; Lee C, 2009, ETHNIC DIS, V19, P330; Lundgren LM, 2001, J SUBST ABUSE TREAT, V21, P145, DOI 10.1016/S0740-5472(01)00197-0; Maglione MA, 2018, J SUBST ABUSE TREAT, V89, P28, DOI 10.1016/j.jsat.2018.03.001; Martinez-Luna N, 2018, ADICCIONES, V30, P197, DOI 10.20882/adicciones.897; Martins SS, 2015, DRUG ALCOHOL DEPEN, V151, P278, DOI 10.1016/j.drugalcdep.2015.03.020; McKnight C, 2017, J ETHN SUBST ABUSE, V16, P404, DOI 10.1080/15332640.2017.1292418; Minnesota Department of Health, 2019, RAC RAT DISP DRUG OV; Ngo H, 2011, J PSYCHOPHARMACOLOGY, V25; Novins DK, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-63; Olsen Y, 2014, JAMA-J AM MED ASSOC, V311, P1393, DOI 10.1001/jama.2014.2147; Pollack HA, 2008, HEALTH SERV RES, V43, P2143, DOI 10.1111/j.1475-6773.2008.00870.x; Redden SM, 2013, QUAL HEALTH RES, V23, P951, DOI 10.1177/1049732313487802; Rieckmann T, 2011, SUBST ABUS, V32, P180, DOI 10.1080/08897077.2011.600122; Rigg KK, 2015, INT J DRUG POLICY, V26, P484, DOI 10.1016/j.drugpo.2014.10.001; Roncero C, 2016, PSYCHIAT RES, V243, P174, DOI 10.1016/j.psychres.2016.06.024; Rowan-Szal GA, 2000, J SUBST ABUSE TREAT, V19, P7, DOI 10.1016/S0740-5472(99)00091-4; Rudd RA, 2014, MMWR-MORBID MORTAL W, V63, P849; Serdarevic M, 2017, CURR OPIN PSYCHIATR, V30, P238, DOI 10.1097/YCO.0000000000000337; Smye V, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-17; Tipps RT, 2018, J LAW MED ETHICS, V46, P422, DOI 10.1177/1073110518782950; Venner KL, 2018, ADDICT BEHAV, V86, P111, DOI 10.1016/j.addbeh.2018.05.017; Volkow ND, 2019, JAMA PSYCHIAT, V76, P208, DOI 10.1001/jamapsychiatry.2018.3126; Wakeman Sarah E, 2017, AMA J Ethics, V19, P922, DOI 10.1001/journalofethics.2017.19.9.stas1-1709; Walls ML, 2006, COMMUNITY MENT HLT J, V42, P521, DOI 10.1007/s10597-006-9054-7; Walls ML, 2015, J AM BOARD FAM MED, V28, P231, DOI 10.3122/jabfm.2015.02.140194; Williams DR, 2015, JAMA-J AM MED ASSOC, V314, P555, DOI 10.1001/jama.2015.9260	60	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228755	10.1371/journal.pone.0228755	http://dx.doi.org/10.1371/journal.pone.0228755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9GK	32027723	gold, Green Published			2022-12-26	WOS:000534623800072
J	Wang, HG; Zhang, S; Song, LY; Qu, M; Zou, ZH				Wang, Hongge; Zhang, Shan; Song, Liyan; Qu, Meng; Zou, Zhihua			Synergistic lethality between PARP-trapping and alantolactone-induced oxidative DNA damage in homologous recombination-proficient cancer cells	ONCOGENE			English	Article							REPAIR DEFECT; HISTONE H2AX; LUNG-CANCER; INHIBITION; STABILITY; APOPTOSIS; STRESS; METABOLISM; RESISTANCE; BRCA1	PARP1 and PARP2 play critical roles in regulating DNA repair and PARP inhibitors have been approved for the treatment of BRCA1/2-mutated ovarian and breast cancers. It has long been known that PARP inhibition sensitizes cancer cells to DNA-damaging cytotoxic agents independent of BRCA status, however, clinical use of PARP inhibitors in combination with DNA-damaging chemotherapy is limited by the more-than-additive cytotoxicity. The natural compound alantolactone (ATL) inhibits the thioredoxin reductase to induce ROS accumulation and oxidative DNA damage selectively in cancer cells. Here, we showed that nontoxic doses of ATL markedly synergized with the PARP inhibitor olaparib to result in synthetic lethality irrespective of homologous recombination status. Synergistic cytotoxicity was seen in cancer but not noncancerous cells and was reduced by the ROS inhibitor NAC or knockdown of OGG1, demonstrating that the cytotoxicity resulted from the repair of ATL-induced oxidative DNA damage. PARP1 knockdown suppressed the synergistic lethality and olaparib was much more toxic than veliparib when combined with ATL, suggesting PARP-trapping as the primary inducer of cytotoxicity. Consistently, combined use of ATL and olaparib caused intense signs of replication stress and formation of double strand DNA breaks, leading to S and G(2) arrest followed by apoptosis. In vivo, the combination effectively induced regression of tumor xenografts, while either agent alone had no effect. Hence, PARP trapping combined with specific pro-oxidative agents may provide safe and effective ways to broaden the therapeutic potential of PARP inhibitors.	[Wang, Hongge; Zhang, Shan; Song, Liyan; Qu, Meng; Zou, Zhihua] Jilin Univ, Sch Life Sci, Key Lab Mol Enzymol & Engn,Minist Educ, Dept Cell Biol & Biophys,Natl Engn Lab Aids Vacci, Changchun, Peoples R China	Jilin University	Zou, ZH (corresponding author), Jilin Univ, Sch Life Sci, Key Lab Mol Enzymol & Engn,Minist Educ, Dept Cell Biol & Biophys,Natl Engn Lab Aids Vacci, Changchun, Peoples R China.	zouzh@jlu.edu.cn	wang, hg/AAE-2324-2021		Key Research and Development Program of Jilin Province [20170204025YY]; Natural Science Foundation of Jilin Province [20180101237JC]	Key Research and Development Program of Jilin Province; Natural Science Foundation of Jilin Province	This work was supported by grants from the Key Research and Development Program of Jilin Province (20170204025YY) and the Natural Science Foundation of Jilin Province (20180101237JC).	Abbotts R, 2017, FREE RADICAL BIO MED, V107, P228, DOI 10.1016/j.freeradbiomed.2016.11.039; AbdulSalam SF, 2016, BIOCHEMISTRY-US, V55, P5341, DOI 10.1021/acs.biochem.6b00703; Brown JS, 2017, CANCER DISCOV, V7, P20, DOI 10.1158/2159-8290.CD-16-0860; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Chou T-C., 2018, SYNERGIE, V7, P49, DOI [DOI 10.1016/J.SYNRES.2018.04.001, 10.1016/j.synres.2018.04.001]; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Davalli P, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2389523; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Deben C, 2016, CANCER LETT, V375, P313, DOI 10.1016/j.canlet.2016.03.017; Ding YS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040558; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hanzlikova H, 2019, TRENDS GENET, V35, P412, DOI 10.1016/j.tig.2019.03.008; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; He W, 2019, FREE RADICAL RES, V53, P104, DOI 10.1080/10715762.2018.1558448; Hsu PC, 2019, ONCOGENE, V38, P1166, DOI 10.1038/s41388-018-0506-7; Huang XM, 2016, CANCER CELL, V30, P940, DOI 10.1016/j.ccell.2016.11.006; Konstantinopoulos PA, 2015, CANCER DISCOV, V5, P1137, DOI 10.1158/2159-8290.CD-15-0714; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Lee JY, 2016, BIOPHARM DRUG DISPOS, V37, P156, DOI 10.1002/bdd.2005; Liu JL, 2018, INT J MOL MED, V42, P1847, DOI 10.3892/ijmm.2018.3751; Liu Q, 2018, ONCOGENE, V37, P2793, DOI 10.1038/s41388-018-0130-6; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Marcar L, 2019, CELL REP, V27, P3422, DOI 10.1016/j.celrep.2019.05.058; Markkanen E, 2017, DNA REPAIR, V59, P82, DOI 10.1016/j.dnarep.2017.09.007; Marzo T, 2017, ACS MED CHEM LETT, V8, P997, DOI 10.1021/acsmedchemlett.7b00162; Michels J, 2013, CANCER RES, V73, P2271, DOI 10.1158/0008-5472.CAN-12-3000; Moloney JN, 2018, SEMIN CELL DEV BIOL, V80, P50, DOI 10.1016/j.semcdb.2017.05.023; Murai J, 2014, J PHARMACOL EXP THER, V349, P408, DOI 10.1124/jpet.113.210146; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nickoloff JA, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx059; PG P, 2019, CLIN CANCER RES, V25, P3759, DOI [10.1158/1078-0432.CCR-18-0968, DOI 10.1158/1078-0432.CCR-18-0968]; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pilie PG, 2019, NAT REV CLIN ONCOL, V16, P81, DOI 10.1038/s41571-018-0114-z; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Pommier Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9246; Pulliam N, 2018, CLIN CANCER RES, V24, P3163, DOI 10.1158/1078-0432.CCR-18-0204; Reynolds P, 2015, NUCLEIC ACIDS RES, V43, P4028, DOI 10.1093/nar/gkv250; Ronson GE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03159-2; Saikolappan S, 2019, CANCER LETT, V452, P132, DOI 10.1016/j.canlet.2019.03.020; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Venkitaraman AR, 2014, SCIENCE, V343, P1470, DOI 10.1126/science.1252230; Wang K, 2019, TRENDS BIOCHEM SCI, V44, P401, DOI 10.1016/j.tibs.2019.01.001; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Woodhouse BC, 2008, DNA REPAIR, V7, P932, DOI 10.1016/j.dnarep.2008.03.017; Xu XG, 2019, LIFE SCI, V227, P153, DOI 10.1016/j.lfs.2019.04.034; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491; Yap Timothy A, 2019, Am Soc Clin Oncol Educ Book, V39, P185, DOI 10.1200/EDBK_238473; Yin CT, 2019, J CELL MOL MED, V23, P2194, DOI 10.1111/jcmm.14139; Zhang JM, 2016, BIOCHEM PHARMACOL, V102, P34, DOI 10.1016/j.bcp.2015.12.004; Zhao P, 2015, J BIOCHEM MOL TOXIC, V29, P199, DOI 10.1002/jbt.21685; Zhou BL, 2018, J CHROMATOGR B, V1072, P370, DOI 10.1016/j.jchromb.2017.11.039	67	29	29	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2905	2920		10.1038/s41388-020-1191-x	http://dx.doi.org/10.1038/s41388-020-1191-x		FEB 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32029902	hybrid, Green Published			2022-12-26	WOS:000511540800002
J	Lin, WR; Wang, YH; Hung, YM				Lin, Wan-Rung; Wang, Yi-Hsien; Hung, Yi-Min			Analyzing the factors influencing adoption intention of internet banking: Applying DEMATEL-ANP-SEM approach	PLOS ONE			English	Article							MODEL COMBINING DEMATEL; ONLINE BANKING; PERCEIVED RISK; EXTENDING UTAUT2; CUSTOMER LOYALTY; MOBILE BANKING; TRUST; SATISFACTION; PERCEPTIONS; ACCEPTANCE	The main purpose of this study is to propose a research model to explore the key factors affecting consumers' willingness to use online banking. There are two stages in this research. Firstly, the decision making trial and evaluation laboratory (DEMATEL) and analytic network process (ANP) were used to explore the key factors of companies in operation of online banking. Secondly, the structural equation modeling (SEM) was used to explore the key factors of consumers' actual use of online banking. The results showed differences in the factors that companies and consumers adopted. Based on the findings, companies can adjust their business strategies and improve the consumers' willingness of online banking usage. The primary factor valued by both companies and consumers is trust. Hence, in the business of internet banking, the companies must strengthen areas such as liquidity monitoring, information security, and compliance with financial regulations, in order to reduce risks and gain customers' trust.	[Lin, Wan-Rung; Wang, Yi-Hsien; Hung, Yi-Min] Chinese Culture Univ, Dept Banking & Finance, Taipei, Taiwan	Chinese Culture University	Lin, WR (corresponding author), Chinese Culture Univ, Dept Banking & Finance, Taipei, Taiwan.	linyumiko@gmail.com	Wang, Yi-Hsien/U-6102-2019	Wang, Yi-Hsien/0000-0002-5755-9089				Aboobucker I., 2018, J HIGH TECHNOLOGY MA, V29, P109, DOI DOI 10.1016/J.HITECH.2018.04.010; Abubakar A. A., 2012, INT J LATEST TREND F, V2, P80; Al-Somali SA, 2009, TECHNOVATION, V29, P130, DOI 10.1016/j.technovation.2008.07.004; Alalwan AA, 2018, J RETAIL CONSUM SERV, V40, P125, DOI 10.1016/j.jretconser.2017.08.026; Alalwan AA, 2017, INT J INFORM MANAGE, V37, P99, DOI 10.1016/j.ijinfomgt.2017.01.002; Aldas-Manzano J, 2011, SERV IND J, V31, P1165, DOI 10.1080/02642060903433997; Angelakopoulos G, 2011, ELECTRON COMMER RES, V11, P297, DOI 10.1007/s10660-011-9076-2; Bigne E., 2003, INT J RETAIL DISTRIB, V31, P574, DOI DOI 10.1108/09590550310503302; Bollen K.A., 1993, TESTING STRUCTURAL E, DOI DOI 10.1093/SF/73.3.1161; Casalo LV, 2008, INT J BANK MARK, V26, P399, DOI 10.1108/02652320810902433; Chandio FH, 2013, BEHAV INFORM TECHNOL, V32, P668, DOI 10.1080/0144929X.2013.806593; Chau VS, 2010, J SERV MARK, V24, P42, DOI 10.1108/08876041011017880; Chen FH, 2011, INT J HOSP MANAG, V30, P908, DOI 10.1016/j.ijhm.2011.02.001; Chen RF, 2012, TOTAL QUAL MANAG BUS, V23, P749, DOI 10.1080/14783363.2012.704284; Chiou JS, 2012, BEHAV INFORM TECHNOL, V31, P859, DOI 10.1080/0144929X.2010.549509; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; Deng LQ, 2010, EUR J INFORM SYST, V19, P60, DOI 10.1057/ejis.2009.50; Phan DHB, 2020, PAC-BASIN FINANC J, V62, DOI 10.1016/j.pacfin.2019.101210; Estrella-Ramon A, 2016, INTERNET RES, V26, P1072, DOI 10.1108/IntR-03-2015-0092; Featherman MS, 2003, INT J HUM-COMPUT ST, V59, P451, DOI 10.1016/S1071-5819(03)00111-3; Flavian C, 2006, INFORM MANAGE-AMSTER, V43, P1, DOI 10.1016/j.im.2005.01.002; Gabus A., 1973, PERCEPTIONS WORLD PR; George A, 2018, IIMB MANAG REV, V30, P357, DOI 10.1016/j.iimb.2018.05.007; Hair J.F., 1995, MULTIVARIATE DATA AN, V4th; Hamidi H, 2019, TELEMAT INFORM, V38, P166, DOI 10.1016/j.tele.2018.09.008; Hanafizadeh P, 2012, ELECTRON COMMER RES, V12, P151, DOI 10.1007/s10660-012-9090-z; Hernandez-Perlines F, 2016, J BUS RES, V69, P5383, DOI 10.1016/j.jbusres.2016.04.142; Hong SJ, 2006, DECIS SUPPORT SYST, V42, P1819, DOI 10.1016/j.dss.2006.03.009; Hu K. H., 2014, J TEST EVAL, V43, P1395; Hung YH, 2011, DECIS SUPPORT SYST, V51, P270, DOI 10.1016/j.dss.2010.11.021; Igbaria M., 1995, Journal of Management Information Systems, V11, P87; Kassim NM, 2006, INT J BANK MARK, V24, P424, DOI 10.1108/02652320610701744; Khalfan A., 2006, INT J FINANCIAL SERV, V1, P155, DOI DOI 10.1504/IJFSM.2006.009623; King Brett, 2013, BANK 3 0 WHY BANKING; Lee GY, 2011, SOC BEHAV PERSONAL, V39, P1127, DOI 10.2224/sbp.2011.39.8.1127; Lee HS, 2013, APPL MATH MODEL, V37, P6746, DOI 10.1016/j.apm.2013.01.016; Lee MKO, 2001, INT J ELECTRON COMM, V6, P75, DOI 10.1080/10864415.2001.11044227; Liang C. C., 2010, J FORMOSA U, V29, P81; Liang CC, 2015, TOTAL QUAL MANAG BUS, V26, P550, DOI 10.1080/14783363.2013.856546; Liao CC, 2016, SOC BEHAV PERSONAL, V44, P1443, DOI 10.2224/sbp.2016.44.9.1443; Liebermann Y., 2002, QUALITATIVE MARKET R, V5, P291, DOI DOI 10.1108/13522750210443245; Likert R, 1932, ARCH PSYCHOL, V22, P55, DOI DOI 10.4135/9781412961288.N454; Lin FT, 2015, INF SYST E-BUS MANAG, V13, P267, DOI 10.1007/s10257-014-0268-x; Lin WB, 2008, EXPERT SYST APPL, V34, P977, DOI 10.1016/j.eswa.2006.10.042; Liou JJH, 2011, APPL SOFT COMPUT, V11, P3515, DOI 10.1016/j.asoc.2011.01.024; Littler D, 2006, J RETAIL CONSUM SERV, V13, P431, DOI 10.1016/j.jretconser.2006.02.006; Lu MT, 2013, DECIS SUPPORT SYST, V56, P259, DOI 10.1016/j.dss.2013.06.006; Martins C, 2014, INT J INFORM MANAGE, V34, P1, DOI 10.1016/j.ijinfomgt.2013.06.002; Merhi M, 2019, TECHNOL SOC, V59, DOI 10.1016/j.techsoc.2019.101151; Montazemi AR, 2015, INFORM MANAGE-AMSTER, V52, P210, DOI 10.1016/j.im.2014.11.002; MORGAN RM, 1994, J MARKETING, V58, P20, DOI 10.2307/1252308; Mukherjee A., 2003, INT J BANK MARK, V21, P5, DOI DOI 10.1108/02652320310457767; Nel J, 2014, S AFR J ECON MANAG S, V17, P624, DOI 10.4102/sajems.v17i5.775; OLIVER RL, 1981, J RETAILING, V57, P25; Ooi KB, 2016, EXPERT SYST APPL, V59, P33, DOI 10.1016/j.eswa.2016.04.015; Oruc OE, 2017, COMPUT HUM BEHAV, V66, P232, DOI 10.1016/j.chb.2016.09.059; Pavlou PA, 2003, INT J ELECTRON COMM, V7, P101, DOI 10.1080/10864415.2003.11044275; Pourahmad A, 2015, TECHNOL ECON DEV ECO, V21, P773, DOI 10.3846/20294913.2015.1056279; Rahi S, 2019, TECHNOL SOC, V58, DOI 10.1016/j.techsoc.2019.03.003; Saaty T. L., 2004, Journal of Systems Science and Systems Engineering, V13, P1, DOI 10.1007/s11518-006-0151-5; Saaty T.L., 1996, DECISION MAKING DEPE, VVolume 4922; Saaty T. L., 1996, ANAL NETWORKS PROCES; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Saaty TL, 2006, INT SER OPER RES MAN, V95, P1; Saaty TL, 2003, EUR J OPER RES, V145, P85, DOI 10.1016/S0377-2217(02)00227-8; Shih KH, 2010, INT J MOB COMMUN, V8, P689, DOI 10.1504/IJMC.2010.035484; Suh B., 2002, ELECTRON COMMER R A, V1, P247, DOI DOI 10.1016/S1567-4223(02)00017-0; Susanto A, 2016, IND MANAGE DATA SYST, V116, P508, DOI 10.1108/IMDS-05-2015-0195; TANAKA JS, 1987, CHILD DEV, V58, P134, DOI 10.1111/j.1467-8624.1987.tb03495.x; Tsai HT, 2014, ELECTRON COMMER RES, V14, P137, DOI 10.1007/s10660-014-9136-5; Vatanasombut B, 2004, COMMUN ACM, V47, P65, DOI 10.1145/990680.990682; Wang YL, 2012, EXPERT SYST APPL, V39, P5600, DOI 10.1016/j.eswa.2011.11.057; Warrington TB., 2000, INT BUSINESS J INCOR, V10, P160, DOI [DOI 10.1108/EB046409, 10.1108/eb046409]; Wu IL, 2005, INT J HUM-COMPUT ST, V62, P784, DOI 10.1016/j.ijhcs.2005.03.003; Yang JL, 2011, EXPERT SYST APPL, V38, P1417, DOI 10.1016/j.eswa.2010.07.048; Yiga C., 2014, INFORM DEV, V32, P622; Yoon HS, 2013, COMPUT HUM BEHAV, V29, P1133, DOI 10.1016/j.chb.2012.10.005; Yousafzai SY, 2003, TECHNOVATION, V23, P847, DOI 10.1016/S0166-4972(03)00130-5; Yu PL, 2015, IND MANAGE DATA SYST, V115, P235, DOI 10.1108/IMDS-09-2014-0262; Zahid N., 2010, EUROPEAN J EC FINANC, V27, P44	80	23	24	9	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227852	10.1371/journal.pone.0227852	http://dx.doi.org/10.1371/journal.pone.0227852			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9FN	32023278	Green Published, gold			2022-12-26	WOS:000534621500026
J	Bahr, KD; Tran, T; Jury, CP; Toonen, RJ				Bahr, Keisha D.; Tran, Tiana; Jury, Christopher P.; Toonen, Robert J.			Abundance, size, and survival of recruits of the reef coral Pocillopora acuta under ocean warming and acidification	PLOS ONE			English	Article							CARBONATE-ION CONCENTRATION; CLIMATE-CHANGE; SATURATION STATE; COMPARATIVE SENSITIVITY; MARINE ORGANISMS; JUVENILE CORALS; CALCIFICATION; SETTLEMENT; TEMPERATURE; DIOXIDE	Ocean warming and acidification are among the greatest threats to coral reefs. Massive coral bleaching events are becoming increasingly common and are predicted to be more severe and frequent in the near future, putting corals reefs in danger of ecological collapse. This study quantified the abundance, size, and survival of the coral Pocillopora acuta under future projections of ocean warming and acidification. Flow-through mesocosms were exposed to current and future projections of ocean warming and acidification in a factorial design for 22 months. Neither ocean warming or acidification, nor their combination, influenced the size or abundance of P. acuta recruits, but heating impacted subsequent health and survival of the recruits. During annual maximum temperatures, coral recruits in heated tanks experienced higher levels of bleaching and subsequent mortality. Results of this study indicate that P. acuta is able to recruit under projected levels of ocean warming and acidification but are susceptible to bleaching and mortality during the warmest months.	[Bahr, Keisha D.] Texas A&M Univ Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA; [Tran, Tiana; Jury, Christopher P.; Toonen, Robert J.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA	Texas A&M University System; Texas A&M University Corpus Christi; University of Hawaii System; University of Hawaii Manoa	Bahr, KD (corresponding author), Texas A&M Univ Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA.	Keisha.Bahr@tamucc.edu	Bahr, Keisha/HHS-1584-2022		National Science Foundation [1416889]; National Oceanic and Atmospheric Administration - University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce [R/IR-23, R/IR-32, NA09OAR4170060, NA14OAR4170071]	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration - University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce	This paper is funded in part by the National Science Foundation (OA no. 1416889), and by the National Oceanic and Atmospheric Administration, Project R/IR-23, R/IR-32, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional grant no. NA09OAR4170060, NA14OAR4170071 from NOAA Office of Sea Grant, Department of Commerce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Albright R, 2008, CORAL REEFS, V27, P485, DOI 10.1007/s00338-008-0392-5; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Bramanti L, 2016, CORAL REEFS, V35, P543, DOI 10.1007/s00338-016-1413-4; Cohen AL, 2009, WHY CORALS CARE OCEA; COLES SL, 1976, PAC SCI, V30, P159; de Putron SJ, 2011, CORAL REEFS, V30, P321, DOI 10.1007/s00338-010-0697-z; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Drenkard EJ, 2013, CORAL REEFS, V32, P727, DOI 10.1007/s00338-013-1021-5; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius KE, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1536; Foster T, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501130; Frieler K., 2012, NAT CLIM CHANGE, DOI DOI 10.1038/NCLIMATE1674; Gattuso J-P, 2011, OCEAN ACIDIFICATION; Gattuso JP, 1999, AM ZOOL, V39, P160; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hughes TP, 2019, NATURE, V568, P387, DOI 10.1038/s41586-019-1081-y; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Januar HI, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12415; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; JOKIEL PL, 1974, PAC SCI, V28, P1; JOKIEL PL, 1978, B MAR SCI, V28, P786; Jokiel PL, 2014, LIMNOLOGY OCEANOGRAP; Jury CP, 2013, WATER-SUI, V5, P1303, DOI 10.3390/w5031303; Kleypas J. A., 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 2005, REPORT WORKSHOP HELD; Kornder NA, 2018, GLOBAL CHANGE BIOL, V24, P5084, DOI 10.1111/gcb.14431; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Lacis AA, 2010, SCIENCE, V330, P356, DOI 10.1126/science.1190653; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Lukoschek V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065363; Marubini F, 2003, P ROY SOC B-BIOL SCI, V270, P179, DOI 10.1098/rspb.2002.2212; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Mehrbach C., 1973, MEASUREMENT APPARENT; MIDDAUGH DP, 1977, B ENVIRON CONTAM TOX, V17, P645, DOI 10.1007/BF01685947; MOORE SF, 1974, WATER RES, V8, P819, DOI 10.1016/0043-1354(74)90028-1; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Muller A, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002112; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Oporto-Guerrero T, 2018, MAR BIODIVERS, V48, P703, DOI 10.1007/s12526-016-0546-6; Oprandi A, 2019, ESTUAR COAST SHELF S, V217, P158, DOI 10.1016/j.ecss.2018.11.017; RICHMOND RH, 1984, B MAR SCI, V34, P280; Richmond Robert H., 1997, P175; RINGWOOD AH, 1992, ARCH ENVIRON CON TOX, V22, P288; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schmidt-Roach S, 2012, CORAL REEFS, V32, P1; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; SMITH SV, 1992, ANNU REV ECOL SYST, V23, P89, DOI 10.1146/annurev.es.23.110192.000513; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Wallace D, 2006, MS EXCEL PROGRAM DEV; Webster NS, 2013, GLOBAL CHANGE BIOL, V19, P303, DOI 10.1111/gcb.12008; Webster NS, 2011, ISME J, V5, P759, DOI 10.1038/ismej.2010.152	64	14	14	14	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228168	10.1371/journal.pone.0228168	http://dx.doi.org/10.1371/journal.pone.0228168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017776	Green Published, gold			2022-12-26	WOS:000534618100015
J	Johnson, MD; Fox, MD; Kelly, ELA; Zgliczynski, BJ; Sandin, SA; Smith, JE				Johnson, Maggie D.; Fox, Michael D.; Kelly, Emily L. A.; Zgliczynski, Brian J.; Sandin, Stuart A.; Smith, Jennifer E.			Ecophysiology of coral reef primary producers across an upwelling gradient in the tropical central Pacific	PLOS ONE			English	Article							PRIMARY PRODUCTIVITY; FRESH-WATER; PHOTOSYNTHETIC RATES; MACROCYSTIS-PYRIFERA; NITROGEN LIMITATION; NUTRIENT LIMITATION; FLORIDA-KEYS; CONCH REEF; MARINE; GROWTH	Upwelling is an important source of inorganic nutrients in marine systems, yet little is known about how gradients in upwelling affect primary producers on coral reefs. The Southern Line Islands span a natural gradient of inorganic nutrient concentrations across the equatorial upwelling region in the central Pacific. We used this gradient to test the hypothesis that benthic autotroph ecophysiology is enhanced on nutrient-enriched reefs. We measured metabolism and photophysiology of common benthic taxa, including the algae Porolithon, Avrainvillea, and Halimeda, and the corals Pocillopora and Montipora. We found that temperature (27.2-28.7 degrees C) was inversely related to dissolved inorganic nitrogen (0.46-4.63 mu M) and surface chlorophyll a concentrations (0.108-0.147 mg m(-3)), which increased near the equator. Contrary to our prediction, ecophysiology did not consistently track these patterns in all taxa. Though metabolic rates were generally variable, Porolithon and Avrainvillea photosynthesis was highest at the most productive and equatorial island (northernmost). Porolithon photosynthetic rates also generally increased with proximity to the equator. Photophysiology (maximum quantum yield) increased near the equator and was highest at northern islands in all taxa. Photosynthetic pigments also were variable, but chlorophyll a and carotenoids in Avrainvillea and Montipora were highest at the northern islands. Phycobilin pigments of Porolithon responded most consistently across the upwelling gradient, with higher phycoerythrin concentrations closer to the equator. Our findings demonstrate that the effects of in situ nutrient enrichment on benthic autotrophs may be more complex than laboratory experiments indicate. While upwelling is an important feature in some reef ecosystems, ancillary factors may regulate the associated consequences of nutrient enrichment on benthic reef organisms.	[Johnson, Maggie D.; Fox, Michael D.; Kelly, Emily L. A.; Zgliczynski, Brian J.; Sandin, Stuart A.; Smith, Jennifer E.] Univ Calif San Diego, Ctr Marine Biodivers & Conservat, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Johnson, Maggie D.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Fox, Michael D.] Woods Hole Oceanog Inst, Geol & Geophys Dept, Woods Hole, MA 02543 USA; [Kelly, Emily L. A.] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; Stanford University	Johnson, MD (corresponding author), Univ Calif San Diego, Ctr Marine Biodivers & Conservat, Scripps Inst Oceanog, San Diego, CA 92103 USA.; Johnson, MD (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	magjohnson@whoi.edu			Moore Family Foundation; Gordon and Betty Moore Foundation; Scripps family	Moore Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Scripps family	This work was supported by funding from the Moore Family Foundation, the Gordon and Betty Moore Foundation, the Scripps family, and anonymous donors. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.; We are grateful to the Environment and Conservation Division of the Republic of Kiribati for allowing us to conduct research in the Southern Line Islands. We thank the captain and crew of the M/Y Hanse Explorer for logistical support and field assist. We also thank U. Abeysekera, A. Emanuel, E. Jacobs, E. Juhlin, J. Le, and A. Vawter for assistance in the lab, as well as A. Andersson, J. Kohn, and J. Leichter for feedback on an earlier draft of the manuscript. We are grateful to the support and assistance of F. Rohwer during the cruise and for his contributions to an earlier draft of the manuscript. We thank the Moore Family Foundation, the Gordon and Betty Moore Foundation, the Scripps family, and the anonymous donors who helped make this research possible with their financial support.	ANDREWS JC, 1982, MAR ECOL PROG SER, V8, P257, DOI 10.3354/meps008257; BARBER RT, 1991, LIMNOL OCEANOGR, V36, P1803, DOI 10.4319/lo.1991.36.8.1803; Barkley HC, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0183-7; Beach K, 2003, J PHYCOL, V39, P633, DOI 10.1046/j.1529-8817.2003.02147.x; BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; Beer S, 1998, MAR ECOL PROG SER, V174, P293, DOI 10.3354/meps174293; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; Berry J. A., 1982, Photosynthesis. Volume II. Development, carbon metabolism, and productivity, P263; BUNT JS, 1973, HUM ECOL, V1, P333, DOI 10.1007/BF01536730; Chai F, 1996, DEEP-SEA RES PT II, V43, P1031, DOI 10.1016/0967-0645(96)00029-X; CHAPMAN ARO, 1977, MAR BIOL, V40, P197, DOI 10.1007/BF00390875; CHAVEZ FP, 1987, DEEP-SEA RES, V34, P1229, DOI 10.1016/0198-0149(87)90073-2; Cooper TF, 2012, MAR POLLUT BULL, V65, P333, DOI 10.1016/j.marpolbul.2011.07.019; CROMWELL T, 1953, J MAR RES, V12, P196; CULLEN JJ, 1992, ENVIR SCI R, V43, P69; CULLEN JJ, 1981, MAR BIOL, V62, P81, DOI 10.1007/BF00388169; Dailer ML, 2012, HARMFUL ALGAE, V17, P111, DOI 10.1016/j.hal.2012.03.008; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; Diaz-Pulido G, 2002, BOT MAR, V45, P284, DOI 10.1515/BOT.2002.028; DUARTE CM, 1995, OPHELIA, V41, P87, DOI 10.1080/00785236.1995.10422039; Edwards CB, 2014, P ROY SOC B, V281, P1774; Eidens C, 2014, PEERJ, V2, DOI 10.7717/peerj.554; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Enriquez S, 2010, DEVEL APPL PHYCOL, V4, P187, DOI 10.1007/978-90-481-9268-7_9; ENTSCH B, 1983, MAR BIOL, V73, P17, DOI 10.1007/BF00396281; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fong P, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P241, DOI 10.1007/978-94-007-0114-4_17; Fox MD, 2018, CURR BIOL, V28, P3355, DOI 10.1016/j.cub.2018.08.057; FROSTCHRISTENSEN H, 1992, OECOLOGIA, V91, P377, DOI 10.1007/BF00317627; Gove JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10581; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; HATCHER BG, 1988, TRENDS ECOL EVOL, V3, P106, DOI 10.1016/0169-5347(88)90117-6; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; Jacox MG, 2018, J GEOPHYS RES-OCEANS, V123, P7332, DOI 10.1029/2018JC014187; Jakob T, 2005, PHOTOSYNTH RES, V83, P343, DOI 10.1007/s11120-005-1329-2; Johnson MD, 2017, CORAL REEFS, V36, P1059, DOI 10.1007/s00338-017-1597-2; Kelly LW, 2014, P NATL ACAD SCI USA, V111, P10227, DOI 10.1073/pnas.1403319111; Kleypas JA, 1999, AM ZOOL, V39, P146; Koblents-Mishke OI., 1965, OCEANOLOGY+, V5, P104; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; KURSAR TA, 1983, PLANT PHYSIOL, V72, P409, DOI 10.1104/pp.72.2.409; LAPOINTE BE, 1979, BOT MAR, V22, P529, DOI 10.1515/botm.1979.22.8.529; Leichter JJ, 1996, LIMNOL OCEANOGR, V41, P1490, DOI 10.4319/lo.1996.41.7.1490; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Levy O, 2004, MAR ECOL PROG SER, V268, P105, DOI 10.3354/meps268105; LITTLER MM, 1988, CORAL REEFS, V6, P219, DOI 10.1007/BF00302018; Mann K.H., 2005, DYNAMICS MARINE ECOS, V3rd ed., P163; MARSH JA, 1970, ECOLOGY, V51, P254; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Marubini F., 1996, THESIS; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Novozhilov AV, 1992, ATOLL RES B, V366, P1; Parnell PE, 2010, LIMNOL OCEANOGR, V55, P2686, DOI 10.4319/lo.2010.55.6.2686; Payri CE, 2001, J PHYCOL, V37, P223, DOI 10.1046/j.1529-8817.2001.037002223.x; Pennington JT, 2006, PROG OCEANOGR, V69, P285, DOI 10.1016/j.pocean.2006.03.012; Persson L, 1996, PRODUCTIVITY CONSUME; PORTER JW, 1976, AM NAT, V110, P731, DOI 10.1086/283100; R Core Team, 2018, R LANG ENV STAT COMP; Raven JA, 1997, ADV BOT RES, V27, P85; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; ROSENBERG G, 1982, MAR ECOL PROG SER, V8, P233, DOI 10.3354/meps008233; Smit AJ, 2002, BOT MAR, V45, P196, DOI 10.1515/BOT.2002.019; Smith JE, 2016, P ROY SOC B, V283, P1822; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; Steeman Nielsen E., 1975, MARINE PHOTOSYNTHESI; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; THAYER GW, 1974, OECOLOGIA, V14, P75, DOI 10.1007/BF00344899; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; WHEELER PA, 1980, J PHYCOL, V16, P577, DOI 10.1111/j.0022-3646.1980.00577.x; Williams GJ, 2015, ECOGRAPHY, V38, P751, DOI 10.1111/ecog.01353; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516; WYRTKI K, 1981, J PHYS OCEANOGR, V11, P1205, DOI 10.1175/1520-0485(1981)011<1205:AEOEUI>2.0.CO;2; Yeakel KL, 2015, P NATL ACAD SCI USA, V112, P14512, DOI 10.1073/pnas.1507021112	82	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228448	10.1371/journal.pone.0228448	http://dx.doi.org/10.1371/journal.pone.0228448			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017799	Green Published, gold			2022-12-26	WOS:000534618100025
J	Spence, MA; Bannister, HJ; Ball, JE; Dolder, PJ; Griffiths, CA; Thorpe, RB				Spence, Michael A.; Bannister, Hayley J.; Ball, Johnathan E.; Dolder, Paul J.; Griffiths, Christopher A.; Thorpe, Robert B.			LeMaRns: A Length-based Multi-species analysis by numerical simulation in R	PLOS ONE			English	Article							WEIGHT RELATIONSHIPS; COMMUNITY RESPONSES; SIZE; MODELS; UNCERTAINTY; MANAGEMENT; FISHERIES	Fish stocks interact through predation and competition for resources, yet stocks are typically managed independently on a stock-by-stock basis. The need to take account of multispecies interactions is widely acknowledged. However, examples of the application of multi-species models to support management decisions are limited as they are often seen as too complex and lacking transparency. Thus there is a need for simple and transparent methods to address stock interactions in a way that supports managers. Here we introduce LeMaRns, a new R-package of a general length-structured fish community model, LeMans, that characterises fishing using fleets that can have different gears and species catch preferences. We describe the model, package implementation, and give three examples of use: determination of multi-species reference points; modelling of mixed-fishery interactions; and examination of the response of community indicators to dynamical changes in fleet effort within a mixed-fishery. LeMaRns offers a diverse array of options for parameterisation. This, along with the speed, comprehensive documentation, and open source nature of the package makes LeMans newly accessible, transparent, and easy to use, which we hope will lead to increased uptake by the fisheries management community.	[Spence, Michael A.; Bannister, Hayley J.; Ball, Johnathan E.; Dolder, Paul J.; Griffiths, Christopher A.; Thorpe, Robert B.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England	Centre for Environment Fisheries & Aquaculture Science	Spence, MA (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England.	michael.spence@cefas.co.uk	Griffiths, Christopher/AAG-9251-2019; Dolder, Paul/AAA-2926-2021	Griffiths, Christopher/0000-0001-7203-0426; Dolder, Paul/0000-0002-4179-712X	European Union's Horizon 2020 research and innovation programme [773713]	European Union's Horizon 2020 research and innovation programme	MAS, HJB, JEB, PJD, CAG and RBT were all funded by the European Union's Horizon 2020 research and innovation programme under Grant Agreement No 773713 (PANDORA). No the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the European Union's Horizon 2020 research and innovation programme under Grant Agreement No 773713 (PANDORA). We would also like to thank Gary Saggers, Finlay Scott, Sean M. Lucey and Athanassios C. Tsikiras for invaluable comments on an earlier version of the paper.	Andersen KH, 2016, CAN J FISH AQUAT SCI, V73, P575, DOI 10.1139/cjfas-2015-0230; Beverton R.J.H., 1957, FISH INVEST SER, P19; Blanchard JL, 2014, J APPL ECOL, V51, P612, DOI 10.1111/1365-2664.12238; Connor L, 2017, BIOL ENVIRON, V117B, P65, DOI 10.3318/BIOE.2017.07; Datta S, 2016, CAN J FISH AQUAT SCI, V73, P598, DOI 10.1139/cjfas-2015-0468; Froese R, 2014, J APPL ICHTHYOL, V30, P78, DOI 10.1111/jai.12299; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Hall SJ, 2006, CAN J FISH AQUAT SCI, V63, P1344, DOI 10.1139/F06-039; Heymans JJ, 2016, ECOL MODEL, V331, P173, DOI 10.1016/j.ecolmodel.2015.12.007; Hollowed AB, 2000, ICES J MAR SCI, V57, P707, DOI 10.1006/jmsc.2000.0734; Hyder K, 2015, MAR POLICY, V61, P291, DOI 10.1016/j.marpol.2015.07.015; Jennings S, 2001, J ANIM ECOL, V70, P934, DOI 10.1046/j.0021-8790.2001.00552.x; LEWY P, 2004, FF20133 ICES CM, V20, P1; Mesnil B, 2012, MAR POLICY, V36, P473, DOI 10.1016/j.marpol.2011.08.006; MMO, 2018, STAT GUID MIN CONS R; Mueter FJ, 2006, FISH RES, V81, P189, DOI 10.1016/j.fishres.2006.07.010; Ogle D. H., 2016, T AM FISH SOC, DOI DOI 10.1577/1548-8659(2001)1302.0.CO;2; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rochet MJ, 2011, CAN J FISH AQUAT SCI, V68, P469, DOI 10.1139/F10-159; Scott F, 2014, METHODS ECOL EVOL, V5, P1121, DOI 10.1111/2041-210X.12256; Spence MA, 2018, FISH FISH, V19, P1031, DOI 10.1111/faf.12310; Spence MA, 2016, CAN J FISH AQUAT SCI, V73, P589, DOI 10.1139/cjfas-2015-0022; Thorpe RB, 2019, ICES J MAR SCI, V76, P813, DOI 10.1093/icesjms/fsz015; Thorpe RB, 2017, ICES J MAR SCI, V74, P2097, DOI 10.1093/icesjms/fsx062; Thorpe RB, 2015, METHODS ECOL EVOL, V6, P49, DOI 10.1111/2041-210X.12292; Thorpe RB, 2016, ICES J MAR SCI, V73, P1503, DOI 10.1093/icesjms/fsw028; Thorson JT, 2017, ECOL APPL, V27, P2262, DOI 10.1002/eap.1606; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Walker ND, 2017, ICES J MAR SCI, V74, P1448, DOI 10.1093/icesjms/fsw250; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	30	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0227767	10.1371/journal.pone.0227767	http://dx.doi.org/10.1371/journal.pone.0227767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012167	gold, Green Published, Green Accepted			2022-12-26	WOS:000534615800012
J	Morales-McDevitt, ME; Shi, DW; Knap, AH; Quigg, A; Sweet, ST; Sericano, JL; Wade, TL				Morales-McDevitt, Maya E.; Shi, Dawei; Knap, Anthony H.; Quigg, Antonietta; Sweet, Stephen T.; Sericano, Jose L.; Wade, Terry L.			Mesocosm experiments to better understand hydrocarbon half-lives for oil and oil dispersant mixtures	PLOS ONE			English	Article							CRUDE-OIL; AROMATIC-HYDROCARBONS; FUEL-OIL; DEGRADATION; BIODEGRADATION; SPILL; MACONDO; QUANTITATION; ECOSYSTEMS; FRACTIONS	Concerns on the timing and processes associated with petroleum degradation were raised after the use of Corexit during the Deepwater Horizon oil spill. There is a lack of understanding of the removal of oil associated with flocculate materials to the sediment. Mesocosm studies employing coastal and open-ocean seawater from the Gulf of Mexico were undertaken to examine changes in oil concentration and composition with time. The water accommodated fractions (WAF) and chemically enhanced WAF (CEWAF) produced using Macondo surrogate oil and Corexit were followed over 3-4 days in controlled environmental conditions. Environmental half-lives of estimated oil equivalents (EOE), polycyclic aromatic hydrocarbons (PAH), n-alkanes (C10-C35), isoprenoids pristane and phytane, and total petroleum hydrocarbons (TPH) were determined. EOE and PAH concentrations decreased exponentially following first-order decay rate kinetics. WAF, CEWAF and DCEWAF (a 10X CEWAF dilution) treatments half-lives ranged from 0.9 to 3.2 days for EOE and 0.5 to 3.3 days for PAH, agreeing with estimates from previous mesocosm and field studies. The aliphatic half-lives for CEWAF and DECWAF treatments ranged from 0.8 to 2.0 days, but no half-life for WAF could be calculated as concentrations were below the detection limits. Biodegradation occurred in all treatments based on the temporal decrease of the nC17/pristane and nC18/phytane ratios. The heterogeneity observed in all treatments was likely due to the hydrophobicity of oil and weathering processes occurring at different rates and times. The presence of dispersant did not dramatically change the half-lives of oil. Comparing degradation of oil alone as well as with dispersant present is critical to determine the fate and transport of these materials in the ocean.	[Morales-McDevitt, Maya E.; Shi, Dawei; Knap, Anthony H.; Sweet, Stephen T.; Sericano, Jose L.; Wade, Terry L.] Texas A&M Univ, Geochem & Environm Res Grp, College Stn, TX 77843 USA; [Morales-McDevitt, Maya E.; Knap, Anthony H.; Quigg, Antonietta; Wade, Terry L.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Morales-McDevitt, Maya E.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; University of Rhode Island	Morales-McDevitt, ME (corresponding author), Texas A&M Univ, Geochem & Environm Res Grp, College Stn, TX 77843 USA.; Morales-McDevitt, ME (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.; Morales-McDevitt, ME (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	memdevitt@uri.edu		Sweet, Stephen/0000-0002-1441-8198	Gulf of Mexico Research Initiative [SA15-22]	Gulf of Mexico Research Initiative	This research was supported by a grant (SA15-22) from the Gulf of Mexico Research Initiative to support consortium research entitled ADDOMEx (Aggregation and Degradation of Dispersants and Oil by Microbial Exopolymers). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloulou F, 2010, ENVIRON EARTH SCI, V61, P1, DOI 10.1007/s12665-009-0315-y; [Anonymous], [No title captured]; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; Bagby SC, 2017, P NATL ACAD SCI USA, V114, pE9, DOI 10.1073/pnas.1610110114; Ballou TG, 1989, OIL DISPERSANTS NEW, P229; Bejarano AC, 2014, ENVIRON TOXICOL CHEM, V33, P732, DOI 10.1002/etc.2501; Bera G, 2018, ENV TOXICOLOGY CHEM; Brakstad OG, 2018, MAR POLLUT BULL, V135, P346, DOI 10.1016/j.marpolbul.2018.07.028; Bretherton L, 2018, J PHYCOL, V54, P317, DOI 10.1111/jpy.12625; Budzinski H, 1998, ORG GEOCHEM, V28, P337, DOI 10.1016/S0146-6380(98)00002-3; Capello S, 2010, HDB HYDROCARBON LIPI; Daly KL, 2016, ANTHROPOCENE, V13, P18, DOI 10.1016/j.ancene.2016.01.006; Douglas GS, 1996, ENVIRON SCI TECHNOL, V30, P2332, DOI 10.1021/es950751e; Doyle SM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00689; Edwards BR, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035301; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; El Nemr A, 2016, EGYPTIAN J AQUATIC R; FEDORAK PM, 1981, WATER AIR SOIL POLL, V16, P367, DOI 10.1007/BF01046917; Fingas MF, 2005, INT OIL SPILL C P, P2659, DOI [DOI 10.7901/2169-3358-1999-1-281, 10.7901/2169-3358-1999-1-281]; Fu J, 2014, ENVIRON SCI TECHNOL, V48, P14392, DOI 10.1021/es5042157; GEARING PJ, 1980, ENVIRON SCI TECHNOL, V14, P1129, DOI 10.1021/es60169a011; GEARING PJ, 1982, MAR ENVIRON RES, V6, P115, DOI 10.1016/0141-1136(82)90025-3; Gros J, 2014, ENVIRON SCI TECHNOL, V48, P1628, DOI 10.1021/es4042836; Guillard R, 1996, CAN J MICROBIOL, V8, P229; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; JACKSON JBC, 1989, SCIENCE, V243, P37, DOI 10.1126/science.243.4887.37; King SM, 2014, CHEMOSPHERE, V95, P415, DOI 10.1016/j.chemosphere.2013.09.060; Knap A., 1983, OIL PETROCHEM POLLUT, V1, P157, DOI DOI 10.1016/S0143-7127(83)90134-5; KNAP AH, 1987, MAR POLLUT BULL, V18, P119, DOI 10.1016/0025-326X(87)90131-7; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Lee K, 2013, MARINE POLLUTION B, DOI [10.1016/j.marpolbul.2013.06.005, DOI 10.1016/J.MARP0LBUL.2013.06.005]; LEE RF, 1977, B MAR SCI, V27, P127; Lessard RR, 2000, SPILL SCI TECHNOL B, V6, P59, DOI 10.1016/S1353-2561(99)00061-4; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; Murray J, 2016, 8123 NISTIR; ODUM EP, 1984, BIOSCIENCE, V34, P558, DOI 10.2307/1309598; Ohwada K, 2003, MAR POLLUT BULL, V47, P78, DOI 10.1016/S0025-326X(03)00112-7; Olson GM, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00269; Overton EB, 2016, OCEANOGRAPHY, V29, P50, DOI 10.5670/oceanog.2016.62; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Passow U., 2014, FORMATION RAPIDLY SI; Passow U, 2017, MAR POLLUT BULL, V125, P139, DOI 10.1016/j.marpolbul.2017.08.015; Prince RC, 2017, ENVIRON SCI TECHNOL, V51, P1278, DOI 10.1021/acs.est.6b03207; Prince RC, 2013, CHEMOSPHERE, V90, P521, DOI 10.1016/j.chemosphere.2012.08.020; Quigg A, 2016, LIMNOL OCEANOGR LETT, V1, P3, DOI 10.1002/lol2.10030; READMAN JW, 1984, FRESEN Z ANAL CHEM, V319, P126, DOI 10.1007/BF00584673; Roling WFM, 2002, APPL ENVIRON MICROB, V68, P5537, DOI 10.1128/AEM.68.11.5537-5548.2002; Romero I, 2015, PLOS ONE, DOI [10.1371/journal.pone.0128371, DOI 10.1371/J0URNAL.P0NE.0128371]; Ryerson TB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046726; Schwehr KA, 2018, MARINE CHEM; Seo JS, 2009, INT J ENV RES PUB HE, V6, P278, DOI 10.3390/ijerph6010278; Singer MM, 2000, MAR POLLUT BULL, V40, P1007, DOI 10.1016/S0025-326X(00)00045-X; Singh AK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00160; Stout S, 2016, MARINE POLLUTION B, DOI [10.1016/j.marpolbul.2016.07.036, DOI 10.1016/J.MARP0LBUL.2016.07.036]; Tarr MA, 2016, OCEANOGRAPHY, V29, P126, DOI 10.5670/oceanog.2016.77; Tissot B.P., 1984, PETROLEUM FORMATION, DOI 10.1007/978-3-642-96446-6; Turner E, 2014, MARINE POLLUTION B, DOI [10.1016/j.marpolbul.2014.07.003, DOI 10.1016/J.MARP0LBUL.2014.07.003]; Turner E, 2014, MARINE POLLUTION B, DOI [10.1016/j.marpolbul.2014.08.011, DOI 10.1016/J.MARP0LBUL.2014.08.011]; Wade TL, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00419; Wade TL, 2016, MAR POLLUT BULL, V103, P286, DOI 10.1016/j.marpolbul.2015.12.002; Wade TL, 1980, INCORPORATION DISTRI; Wade TL, 2011, GEOPHYS MONOGRAPH SE; Wang J, 2016, SCI TOTAL ENV; WANG ZD, 1995, ENVIRON SCI TECHNOL, V29, P2622, DOI 10.1021/es00010a025; WANG ZD, 1994, J CHROMATOGR SCI, V32, P361, DOI 10.1093/chromsci/32.9.361; Worton DR, 2015, ENVIRON SCI TECHNOL, V49, P13130, DOI 10.1021/acs.est.5b03472; Wozniak AS, 2019, ENVIRON SCI TECHNOL, V53, P3441, DOI 10.1021/acs.est.8b06532; Xu C, 2018, MAR CHEM, V206, P52, DOI 10.1016/j.marchem.2018.09.005; Xu C, 2018, MAR CHEM, V206, P34, DOI 10.1016/j.marchem.2018.09.002; Yamada M, 2003, STUDY FATE PETRO LEU; Ziervogel K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00188	71	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228554	10.1371/journal.pone.0228554	http://dx.doi.org/10.1371/journal.pone.0228554			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004358	gold, Green Published			2022-12-26	WOS:000534614600041
J	Santiago, F; Doscher, E; Kim, J; Camps, M; Meza, J; Sindi, S; Barlow, M				Santiago, Fabian; Doscher, Evin; Kim, Jay; Camps, Manel; Meza, Juan; Sindi, Suzanne; Barlow, Miriam			Growth rate assays reveal fitness consequences of beta-lactamases	PLOS ONE			English	Article							CTX-M; RESISTANCE; EVOLUTION; GENES	Antibiotic resistance is a powerful model for studying evolutionary biology and population genetics. For the purpose of these evolutionary studies, fitness data have been approximated through susceptibility testing methods designed for clinical use in providing appropriate antibiotic therapies. An alternative approach for measuring fitness of microbes has experienced growing popularity: growth rates are a highly sensitive approach for measuring the fitness effects of antibiotics and resistance genes, but they differ from susceptibility testing in that a single concentration of antibiotic is used for the assay. Here we show that despite this key difference, the results of growth rates correlate well with clinical determination of resistance by minimum inhibitory concentration (MIC), while providing the sensitivity required for direct input as fitness values into mathematical models. This means that growth rates at a single sublethal inhibitory concentration can help us understand the fitness effects that result in clinical antibiotic resistance. By measuring the growth rates of sequenced clinical isolates obtained from Dignity Health Mercy Medical Center, we detected the fitness effects of individual resistance genes on bacteria exposed to different antibiotics. In our study, the CTX-M-15 gene conferred the highest fitness in assays with cephalosporins. These results show the strong fitness benefit conferred by CTX-M-15.	[Santiago, Fabian; Meza, Juan; Sindi, Suzanne] Univ Calif Merced, Dept Appl Math, Merced, CA 95343 USA; [Doscher, Evin; Barlow, Miriam] Univ Calif Merced, Dept Mol & Cellular Biol, Merced, CA USA; [Kim, Jay; Camps, Manel] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Kim, Jay] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Sindi, S (corresponding author), Univ Calif Merced, Dept Appl Math, Merced, CA 95343 USA.	ssindi@ucmerced.edu		Santiago, Fabian/0000-0002-5369-4128; Camps, Manel/0000-0002-0467-4032; Meza, Juan/0000-0003-4543-0349; Kim, Jay/0000-0002-7879-0108				Barlow M, 2003, GENETICS, V163, P1237; Barlow M, 2002, J MOL EVOL, V55, P314, DOI 10.1007/s00239-002-2328-y; BARTHOLOMEW JW, 1952, BACTERIOL REV, V16, P1; Baym M, 2016, SCIENCE, V353, P1147, DOI 10.1126/science.aag0822; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Dellus-Gur E, 2015, J MOL BIOL, V427, P2396, DOI 10.1016/j.jmb.2015.05.011; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Goulart CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056040; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Hall BG, 2004, NAT REV MICROBIOL, V2, P430, DOI 10.1038/nrmicro888; Leflon-Guibout V, 2004, ANTIMICROB AGENTS CH, V48, P3736, DOI 10.1128/AAC.48.10.3736-3742.2004; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Maalej SM, 2011, LETT APPL MICROBIOL, V53, P546, DOI 10.1111/j.1472-765X.2011.03145.x; Naas T, 1999, CURR PHARM DESIGN, V5, P865; Package T, 2015, PACKAGE MOMENTS; Pena-Miller R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1035; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Scalzi M, 2001, BIOREMED SER, V6, P23; Seigal A, 2017, B MATH BIOL, V79, P191, DOI 10.1007/s11538-016-0232-7; Team RC, 2016, R LANG ENV STAT COMP; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Zowawi HM, 2015, NAT REV UROL, V12, P570, DOI 10.1038/nrurol.2015.199	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228240	10.1371/journal.pone.0228240	http://dx.doi.org/10.1371/journal.pone.0228240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004340	Green Published, gold			2022-12-26	WOS:000534614600028
J	Durant, S; Zanker, JM				Durant, Szonya; Zanker, Johannes M.			The combined effect of eye movements improve head centred local motion information during walking	PLOS ONE			English	Article							OPTIC-FLOW; SELF-MOTION; DIRECTION; REAL; STATISTICS; PERCEPTION; ROTATION; TASK	Eye movements play multiple roles in human behaviour-small stabilizing movements are important for keeping the image of the scene steady during locomotion, whilst large scanning movements search for relevant information. It has been proposed that eye movement induced retinal motion interferes with the estimation of self-motion based on optic flow. We investigated the effect of eye movements on retinal motion information during walking. Observers walked towards a target, wearing eye tracking glasses that simultaneously recorded the scene ahead and tracked the movements of both eyes. By realigning the frames of the recording from the scene ahead, relative to the centre of gaze, we could mimic the input received by the retina (retinocentric coordinates) and compare this to the input received by the scene camera (head centred coordinates). We asked which of these coordinate frames resulted in the least noisy motion information. Motion noise was calculated by finding the error in between the optic flow signal and a noise-free motion expansion pattern. We found that eye movements improved the optic flow information available, even when large diversions away from target were made.	[Durant, Szonya; Zanker, Johannes M.] Univ London, Dept Psychol, Egham, Surrey, England	University of London; Royal Holloway University London	Durant, S (corresponding author), Univ London, Dept Psychol, Egham, Surrey, England.	szonya.durant@rhul.ac.uk						Banks MS, 1996, VISION RES, V36, P431, DOI 10.1016/0042-6989(95)00122-0; Bernardin D, 2012, EXP BRAIN RES, V223, P65, DOI 10.1007/s00221-012-3241-2; Beurskens R, 2013, HUM MOVEMENT SCI, V32, P1456, DOI 10.1016/j.humov.2013.07.013; Bock O, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-27; Burr DC, 1998, VISION RES, V38, P1731, DOI 10.1016/S0042-6989(97)00346-5; Calow D, 2007, NETWORK-COMP NEURAL, V18, P343, DOI 10.1080/09548980701642277; Crane BT, 1997, J NEUROPHYSIOL, V78, P2129, DOI 10.1152/jn.1997.78.4.2129; Dakin SC, 2005, VISION RES, V45, P3027, DOI 10.1016/j.visres.2005.07.037; Duffy CJ, 1997, EXP BRAIN RES, V114, P472, DOI 10.1007/PL00005656; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Durant S, 2006, BIOL LETTERS, V2, P101, DOI 10.1098/rsbl.2005.0379; Durant S, 2012, NEURAL COMPUT, V24, P1781, DOI 10.1162/NECO_a_00294; Freeman TCA, 1998, VISION RES, V38, P941, DOI 10.1016/S0042-6989(97)00395-7; Grasso R, 1998, NEUROSCI LETT, V253, P115, DOI 10.1016/S0304-3940(98)00625-9; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; Imai T, 2001, EXP BRAIN RES, V136, P1, DOI 10.1007/s002210000533; Jovancevic-Misic J, 2009, J NEUROSCI, V29, P6234, DOI 10.1523/JNEUROSCI.5570-08.2009; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; Land M., 2009, LOOKING ACTING VISIO; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; LAPPE M, 1993, NEURAL COMPUT, V5, P374, DOI 10.1162/neco.1993.5.3.374; Li L, 2000, VISION RES, V40, P3873, DOI 10.1016/S0042-6989(00)00196-6; LONGUETHIGGINS HC, 1980, PROC R SOC SER B-BIO, V208, P385, DOI 10.1098/rspb.1980.0057; Matthis JS, 2018, CURR BIOL, V28, P1224, DOI 10.1016/j.cub.2018.03.008; Meiry J.L., 1971, CONTROL EYE MOVEMENT, P483; Moore ST, 2001, ANN NY ACAD SCI, V942, P139; Muller K, 2018, J VIS, V18, P1059; PRIEST HF, 1985, SCIENCE, V227, P1063, DOI 10.1126/science.3975603; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; 't Hart BM, 2012, EXP BRAIN RES, V223, P233, DOI 10.1007/s00221-012-3254-x; Turano KA, 2005, VISION RES, V45, P3117, DOI 10.1016/j.visres.2005.06.017; Wann JP, 2000, NAT NEUROSCI, V3, P647, DOI 10.1038/76602; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1990, J OPT SOC AM A, V7, P160, DOI 10.1364/JOSAA.7.000160; Zanker JM, 2005, NETWORK-COMP NEURAL, V16, P357, DOI 10.1080/09548980500497758	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228345	10.1371/journal.pone.0228345	http://dx.doi.org/10.1371/journal.pone.0228345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999777	Green Published, gold			2022-12-26	WOS:000534612400070
J	Liu, CC; Wang, JC; Gao, CD; Wang, ZT; Zhou, XH; Tang, MY; Yu, K; Deng, YW				Liu, Congcong; Wang, Jingcheng; Gao, Chengde; Wang, Zhenting; Zhou, Xiaohua; Tang, Mingying; Yu, Kun; Deng, Youwen			Enhanced osteoinductivity and corrosion resistance of dopamine/gelatin/rhBMP-2-coated beta-TCP/Mg-Zn orthopedic implants: An in vitro and in vivo study	PLOS ONE			English	Article							BIODEGRADABLE MAGNESIUM ALLOYS; BONE MORPHOGENETIC PROTEIN-2; CALCIUM-PHOSPHATE COATINGS; MESENCHYMAL STEM-CELLS; MECHANICAL-PROPERTIES; INTERMEDIATE LAYER; BEHAVIOR; DEGRADATION; GELATIN; SCAFFOLDS	Magnesium-based biomaterials are attracting increasingly more attention for orthopedic applications based on their appropriate mechanical properties, biodegradability, and favorable biocompatibility. However, the high corrosion rate of these materials remains to be addressed. In this study, porous beta-Ca-3(PO4)(2)/Mg-Zn (beta-TCP/Mg-Zn) composites were fabricated via a powder metallurgy method. The beta-TCP/Mg-Zn composites with 6% porosity exhibited optimal mechanical properties, and thus, they were selected for surface modification. A novel dopamine/gelatin/recombinant human bone morphogenetic protein-2 (rhBMP-2) coating with demonstrated stability was prepared to further improve the corrosion resistance of the composite and enhance early osteoinductivity. The homogeneously coated beta-TCP/Mg-Zn composite showed significantly improved corrosion resistance according to electrochemical and immersion tests. In addition, extracts from the dopamine/ gelatin/rhBMP-2-coated beta-TCP/Mg-Zn composite not only facilitated cell proliferation but also significantly enhanced the osteogenic differentiation of Sprague-Dawley rat bone marrow-derived mesenchymal stem cells in vitro. Furthermore, in vivo experiments were performed to evaluate the biodegradation, histocompatibility, and osteoinductive potential of the coated composite. No obvious pathological changes in the vital visceral organs were observed after implantation, and radiography and hematoxylin-eosin staining showed strong promotion of new bone formation, matched composite degradation and bone regeneration rates, and complete absorption of the released hydrogen gas. Collectively, these results indicate that the dopamine/gelatin/rhBMP-2-coated beta-TCP/Mg-Zn composite offers improved corrosion resistance, favorable biocompatibility, and enhanced osteoinductive potential for use in the fabrication of orthopedic implants.	[Liu, Congcong; Wang, Jingcheng] Cent South Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China; [Liu, Congcong; Zhou, Xiaohua; Tang, Mingying; Deng, Youwen] Cent South Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha, Hunan, Peoples R China; [Gao, Chengde] Cent South Univ, Coll Mech & Elect Engn, State Key Lab High Performance Complex Mfg, Changsha, Hunan, Peoples R China; [Wang, Zhenting] Cent South Univ, Xiangya Hosp 2, Dept Spine Surg, Changsha, Hunan, Peoples R China; [Yu, Kun] Cent South Univ, Sch Mat Sci & Engn, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University	Deng, YW (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha, Hunan, Peoples R China.; Yu, K (corresponding author), Cent South Univ, Sch Mat Sci & Engn, Changsha, Hunan, Peoples R China.	yukun2010@csu.edu.cn; drywdeng@csu.edu.cn			National Natural Science Foundation of China [81472058]; Science and Technology Innovation Plan of Hunan [2018SK2105]; Science and Technology Innovation Plan of Changsha [KQ1606001]; Fundamental Research Funds for the Central Universities of Central South University [2019ZZTS809]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Plan of Hunan; Science and Technology Innovation Plan of Changsha; Fundamental Research Funds for the Central Universities of Central South University	(1) National Natural Science Foundation of China (No. 81472058); (2) Science and Technology Innovation Plan of Hunan (No. 2018SK2105); (3) Science and Technology Innovation Plan of Changsha (No. KQ1606001); (4) The Fundamental Research Funds for the Central Universities of Central South University (No. 2019ZZTS809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2016, MAT SCI ENG C-MATER, V68, P948, DOI 10.1016/j.msec.2016.06.020; [Anonymous], 2009, 1099352009E ISO; Brown A, 2015, ACTA BIOMATER, V11, P543, DOI 10.1016/j.actbio.2014.09.008; Cai SH, 2012, MAT SCI ENG C-MATER, V32, P2570, DOI 10.1016/j.msec.2012.07.042; Chen DY, 2012, J TISSUE ENG REGEN M, V6, P822, DOI 10.1002/term.489; Chen YQ, 2015, CORROS SCI, V96, P67, DOI 10.1016/j.corsci.2015.03.020; Cui W, 2013, ACTA BIOMATER, V9, P8650, DOI 10.1016/j.actbio.2013.06.031; de Jonge LT, 2010, BIOMATERIALS, V31, P2461, DOI 10.1016/j.biomaterials.2009.11.114; Ding YF, 2014, J MATER CHEM B, V2, P1912, DOI 10.1039/c3tb21746a; Dziuba D, 2013, ACTA BIOMATER, V9, P8548, DOI 10.1016/j.actbio.2012.08.028; Echave MC, 2017, CURR PHARM DESIGN, V23, P3567, DOI 10.2174/0929867324666170511123101; Edward G, 2010, CORROSION RESISTANCE; Feyerabend F, 2006, TISSUE ENG, V12, P3545, DOI 10.1089/ten.2006.12.3545; Fischer J, 2011, MATER SCI ENG B-ADV, V176, P830, DOI 10.1016/j.mseb.2011.04.008; Fischerauer SF, 2013, ACTA BIOMATER, V9, P5411, DOI 10.1016/j.actbio.2012.09.017; Florian L, 2007, METHOD ENZYMOL, P209; Fu YM, 2012, PHARMAZIE, V67, P299, DOI 10.1691/ph.2012.1649; Gao CA, 2011, J POROUS MAT, V18, P139, DOI 10.1007/s10934-010-9364-6; Heise S, 2016, J BIOMED MATER RES A, V104, P2628, DOI 10.1002/jbm.a.35776; Hiromoto S, 2015, ACTA BIOMATER, V11, P520, DOI 10.1016/j.actbio.2014.09.026; Hohn S, 2019, APPL SURF SCI, V464, P212, DOI 10.1016/j.apsusc.2018.08.173; Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012; Horynova M, 2019, J AM CERAM SOC, V102, P123, DOI 10.1111/jace.15888; Hughes-Fulford M, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-8; Kim S, 2012, ACTA BIOMATER, V8, P1768, DOI 10.1016/j.actbio.2012.01.009; Kim YH, 2014, J BIOMATER APPL, V29, P386, DOI 10.1177/0885328214530483; Lai YX, 2019, BIOMATERIALS, V197, P207, DOI 10.1016/j.biomaterials.2019.01.013; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Li H, 2018, BIOMATER SCI-UK, V6, P1846, DOI 10.1039/c8bm00298c; Li X, 2016, ACTA BIOMATER, V45, P2, DOI 10.1016/j.actbio.2016.09.005; Lin BP, 2015, SURF COAT TECH, V281, P82, DOI 10.1016/j.surfcoat.2015.09.033; Lin X, 2013, MAT SCI ENG C-MATER, V33, P3881, DOI 10.1016/j.msec.2013.05.023; Marie PJ, 2002, HISTOL HISTOPATHOL, V17, P877, DOI 10.14670/HH-17.877; Narayan R, 2012, ASM HDB MAT MED DEVI, P136; Barud HGO, 2015, CARBOHYD POLYM, V128, P41, DOI 10.1016/j.carbpol.2015.04.007; Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042; Popescu S, 2014, PROG ORG COAT, V77, P1890, DOI 10.1016/j.porgcoat.2014.06.023; Qi HF, 2019, ACS APPL MATER INTER, V11, P8625, DOI 10.1021/acsami.9b01227; Razavi M, 2018, J MATER SCI-MATER M, V29, DOI 10.1007/s10856-018-6170-1; Razavi M, 2015, MAT SCI ENG C-MATER, V48, P21, DOI 10.1016/j.msec.2014.11.020; Saidin S, 2013, MAT SCI ENG C-MATER, V33, P4715, DOI 10.1016/j.msec.2013.07.026; Schaller B, 2016, J CRANIO MAXILL SURG, V44, P309, DOI 10.1016/j.jcms.2015.12.009; Seyedraoufi ZS, 2013, J MECH BEHAV BIOMED, V21, P1, DOI 10.1016/j.jmbbm.2013.01.023; Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016; Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N; Song GL, 1998, CORROS SCI, V40, P1769, DOI 10.1016/S0010-938X(98)00078-X; Song YW, 2012, CORROS SCI, V65, P322, DOI 10.1016/j.corsci.2012.08.037; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Sun W, 2016, MAT SCI ENG C-MATER, V63, P506, DOI 10.1016/j.msec.2016.03.016; Tang J, 2013, J ORTHOP TRANSL, V1, P41, DOI 10.1016/j.jot.2013.06.003; Thormann U, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/943603; Tie D, 2016, ACTA BIOMATER, V29, P455, DOI 10.1016/j.actbio.2015.11.014; Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4; Walker J, 2014, J BIOMED MATER RES B, V102, P1316, DOI 10.1002/jbm.b.33113; Wang CM, 2017, CORROS SCI, V122, P32, DOI 10.1016/j.corsci.2017.03.021; Wang HA, 2012, BIOMATERIALS, V33, P8695, DOI 10.1016/j.biomaterials.2012.08.024; Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707; Waterman J, 2011, MATER SCI ENG B-ADV, V176, P1756, DOI 10.1016/j.mseb.2011.06.021; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027; Wong HM, 2013, BIOMATERIALS, V34, P7016, DOI 10.1016/j.biomaterials.2013.05.062; Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111; Wu GS, 2013, SURF COAT TECH, V233, P2, DOI 10.1016/j.surfcoat.2012.10.009; Xia P, 2019, ARTIF CELL NANOMED B, V47, P1662, DOI 10.1080/21691401.2019.1594852; Xu TT, 2019, J MATER CHEM B, V7, P5648, DOI 10.1039/c9tb01162e; Yan Y, 2018, J MATER ENG PERFORM, V27, P970, DOI 10.1007/s11665-018-3189-x; Yan Y, 2017, MAT SCI ENG C-MATER, V74, P582, DOI 10.1016/j.msec.2016.12.132; Yang SS, 2019, COLLOID SURFACE B, V181, P549, DOI 10.1016/j.colsurfb.2019.05.058; Yoshizawa S, 2014, ACTA BIOMATER, V10, P2834, DOI 10.1016/j.actbio.2014.02.002; Yu K, 2012, ACTA BIOMATER, V8, P2845, DOI 10.1016/j.actbio.2012.04.009; Yu WL, 2017, COLLOID SURFACE B, V149, P330, DOI 10.1016/j.colsurfb.2016.10.037; Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035; Zhang LC, 2019, AM J TRANSL RES, V11, P3707; Zhang YF, 2016, NAT MED, V22, P1160, DOI 10.1038/nm.4162; Zhang ZH, 2017, J COAT TECHNOL RES, V14, P1083, DOI 10.1007/s11998-016-9897-y; Zhou XH, 2019, SURF COAT TECH, V374, P152, DOI 10.1016/j.surfcoat.2019.05.046; Zhu LP, 2011, COLLOID SURFACE B, V86, P111, DOI 10.1016/j.colsurfb.2011.03.027; Zhuang HY, 2008, MAT SCI ENG C-BIO S, V28, P1462, DOI 10.1016/j.msec.2008.04.001; Zwingenberger S, 2016, J BIOMED MATER RES A, V104, P2126, DOI 10.1002/jbm.a.35744	79	10	11	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228247	10.1371/journal.pone.0228247	http://dx.doi.org/10.1371/journal.pone.0228247			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KW0TY	31999748	Green Published, gold			2022-12-26	WOS:000520887300001
J	Mcbride-Henry, K; Miller, C; Trenholm, A; Officer, TN				Mcbride-Henry, Karen; Miller, Charissa; Trenholm, Adrian; Officer, Tara N.			Occupying 'in-hospitable' spaces: Parental/primary-caregiver perceptions of the impact of repeated hospitalisation in children under two years of age	PLOS ONE			English	Article							CRITICALLY-ILL CHILDREN; PARENTS; FAMILIES; HEALTH; NEEDS; EXPERIENCES; MODELS	The experience of having a child hospitalised is stressful and disrupts families in myriad ways; however, the experiences of parents/caregivers who encounter repeated admissions of a child with acute lower respiratory infections are under-researched. This project aims to explore these experiences, from a qualitative perspective, using the philosophical tenets of reflective lifeworld research. The research included 14 face-to-face interviews with parents, grandparents, or primary caregivers, of children who, whilst under two years of age, were admitted to hospital multiple times with a lower respiratory infection diagnosis. Many of the participants were from Maori or Samoan ethnic backgrounds. The findings of this single site study revealed that these parents/caregivers' experiences were characterised by feelings of powerlessness, offering descriptions of hospitals as harsh and difficult places to reside, they are 'in-hospitable'. The findings suggest that repeated hospitalisations created a cycle of stressful experiences that impacted both familial relationships and interactions with society. This study draws attention to this previously obscured population group, and calls health care practitioners and policy advisors to engage differently over issues involving families in similar positions.	[Mcbride-Henry, Karen; Miller, Charissa] Victoria Univ Wellington, Fac Hlth, Sch Nursing Midwifery & Hlth Practice, Wellington, New Zealand; [Mcbride-Henry, Karen; Officer, Tara N.] Victoria Univ Wellington, Fac Hlth, Hlth Serv Res Ctr, Wellington, New Zealand; [Miller, Charissa; Trenholm, Adrian] Counties Manukau Dist Hlth Board, Kidz First Hosp, Auckland, New Zealand	Victoria University Wellington; Victoria University Wellington	Mcbride-Henry, K (corresponding author), Victoria Univ Wellington, Fac Hlth, Sch Nursing Midwifery & Hlth Practice, Wellington, New Zealand.; Mcbride-Henry, K (corresponding author), Victoria Univ Wellington, Fac Hlth, Hlth Serv Res Ctr, Wellington, New Zealand.	karen.mcbride-henry@vuw.ac.nz	McBride-Henry, Karen/F-5429-2018	McBride-Henry, Karen/0000-0003-4426-2574	Victoria University of Wellington [101514]	Victoria University of Wellington	KMH. Grant number: 101514. Funder name: Victoria University of Wellington, https://www.victoria.ac.nz/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benner P, 1994, INTERPRETIVE PHENOME; Benner P., 2000, NURS PHILOS, V1, P5, DOI DOI 10.1046/J.1466-769X.2000.00014.X; Burke S O, 1991, Image J Nurs Sch, V23, P39; Byrnes C, 2019, THORAX; Case RJL, 2015, J PAEDIATR CHILD H, V51, P1097, DOI 10.1111/jpc.12949; Chisholm E, 2020, HEALTH PROMOT J AUST, V31, P7, DOI 10.1002/hpja.247; Colville Gillian, 2009, Intensive Crit Care Nurs, V25, P72, DOI 10.1016/j.iccn.2008.10.002; Crowley C., 2002, INT J SOC RES METHOD, V5, P193, DOI DOI 10.1080/13645570210146258; Curtis K, 2016, J PEDIATR NURS, V31, P330, DOI 10.1016/j.pedn.2015.11.009; Dahlberg K, 1997, J Holist Nurs, V15, P303; Dahlberg K., 2001, REFLECTIVE LIFEWORLD; Dahlberg K., 2007, REFLECTIVE LIFEWORLD; Foley D, 2019, J PAEDIATR CHILD H, V55, P528, DOI 10.1111/jpc.14234; Foster K, 2017, INJURY, V48, P114, DOI 10.1016/j.injury.2016.09.034; Freshwater Dawn, 2004, Nurs Philos, V5, P4, DOI 10.1111/j.1466-769X.2004.00151.x; Gadamer HG, 1989, TRUTH METHOD; Greenwood ML, 2012, PAED CHILD HEALT-CAN, V17, P381, DOI 10.1093/pch/17.7.381; Health Quality & Safety Commission New Zealand, 2019, HE MAT KI KOUNG HAU; Heidegger Martin, 1962, SEIN ZEIT; Hopia H, 2005, J CLIN NURS, V14, P212, DOI 10.1111/j.1365-2702.2004.01041.x; Hudson SM, 2014, COMPR CHILD ADOLES N, V37, P61, DOI 10.3109/01460862.2013.855844; Inwood Michael, 1999, HEIDEGGER DICT; Ironside PM, 1997, PRESERVING READING W; Jackson, 2008, HLTH STATUS CHILDREN; JOHNSTON IDA, 1985, BRIT MED J, V290, P1636, DOI 10.1136/bmj.290.6482.1636; Kai J, 1996, BRIT MED J, V313, P983; Karron RA, 1999, J INFECT DIS, V180, P41, DOI 10.1086/314841; Landolt MA, 2012, J CHILD PSYCHOL PSYC, V53, P767, DOI 10.1111/j.1469-7610.2011.02520.x; Manguy AM, 2018, J PEDIATR NURS, V38, P46, DOI 10.1016/j.pedn.2017.10.014; Mast TC, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-11; Merleau-Ponty M, 1981, PHENOMENOLOGY PERCEP; Mumford V, 2018, J PAEDIATR CHILD H, V54, P987, DOI 10.1111/jpc.13923; Noyes J, 1999, J ADV NURS, V29, P427, DOI 10.1046/j.1365-2648.1999.00906.x; Palmer Richard E., 1969, HERMENEUTICS INTERPR; Price J, 2016, J PEDIATR PSYCHOL, V41, P86, DOI 10.1093/jpepsy/jsv074; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P371, DOI 10.1002/nur.4770180411; Seguin L, 2005, J EPIDEMIOL COMMUN H, V59, P42, DOI 10.1136/jech.2004.020438; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Simpson J, 2014, DETERMINANTS HLTH CH; Singleton RJ, 2003, PEDIATRICS, V112, P285, DOI 10.1542/peds.112.2.285; Smythe E., 1998, BEING SAFE CHILDBIRT; Trenholme A, 2012, NZ MED J, V125; Trenholme AA, 2013, PEDIATR PULM, V48, P772, DOI 10.1002/ppul.22661; Valery PC, 2004, PEDIATR INFECT DIS J, V23, P902, DOI 10.1097/01.inf.0000142508.33623.2f	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228354	10.1371/journal.pone.0228354	http://dx.doi.org/10.1371/journal.pone.0228354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999770	gold, Green Published			2022-12-26	WOS:000534612400071
J	Scrivner, O; Nguyen, T; Simon, K; Middaugh, EP; Taska, B; Borner, K				Scrivner, Olga; Nguyen, Thuy; Simon, Kosali; Middaugh, Esme Prime; Taska, Bledi; Borner, Katy			Job postings in the substance use disorder treatment related sector during the first five years of Medicaid expansion	PLOS ONE			English	Article							OPIOID USE DISORDERS; ABUSE TREATMENT; DRUG-USE; HEALTH; WORKFORCE; BUPRENORPHINE; INSURANCE; ADDRESS; DISEASE; BURDEN	Background Effective treatment strategies exist for substance use disorder (SUD), however severe hurdles remain in ensuring adequacy of the SUD treatment (SUDT) workforce as well as improving SUDT affordability, access and stigma. Although evidence shows recent increases in SUD medication access from expanding Medicaid availability under the Affordable Care Act, it is yet unknown whether these policies also led to a growth in hiring in the SUDT related workforce, partly due to poor data availability. Our study uses novel data to shed light on recent trends in a fast-evolving and policy-relevant labor market, and contributes to understanding data sources to track the SUDT related workforce and the effect of recent state healthcare policies on the supply side of this sector. Methods and data We examine hiring attempts in the SUDT and related behavioral health sector over 20102018 to estimate the causal effect of the 2014-and-beyond state Medicaid expansions on these outcomes through "difference-in-difference" econometric models. We use Burning Glass Technologies (BGT) data covering virtually all U.S. job postings by employers. Findings Nationally, we find little growth in the sector's hiring attempts in 2010-2018 relative to the rest of the economy or to health care as a whole. However, this masks heterogeneity in the bimodal trend in SUDT job postings, with some increases in most years but a decrease in 2014 and in 2017, as well as a shift in emphasis between different occupational categories. Medicaid expansion, however, is not associated with any statistically significant change in overall hiring attempts in the SUDT related sector during this time period, although there is moderate evidence of increases among primary care physicians. Conclusions Although hiring attempts in the SUDT related sector as measured by the number of job advertisements have not grown substantially over time, there was a shift in the hiring landscape. Many national factors including reimbursement policy may play a role in incentivizing demand for the SUDT related workforce, but our research does not show that recent state Medicaid expansion was one such statistically detectable factor. Future research is needed to understand how aggregate labor demand signals translate into actual increases in SUDT workforce and availability.	[Scrivner, Olga; Middaugh, Esme Prime; Borner, Katy] Indiana Univ, Luddy Sch Informat Comp & Engn, Bloomington, IN 47405 USA; [Nguyen, Thuy; Simon, Kosali] Indiana Univ, ONeill Sch Publ & Environm Affairs, Bloomington, IN USA; [Simon, Kosali] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Taska, Bledi] Burning Glass Technol, Boston, MA USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Bureau of Economic Research	Scrivner, O (corresponding author), Indiana Univ, Luddy Sch Informat Comp & Engn, Bloomington, IN 47405 USA.	obscrivn@indiana.edu	Nguyen, Thuy/ABF-9610-2020	Nguyen, Thuy/0000-0003-3790-6925	Indiana University Responding to the Addictions Crisis Grand Challenge Grant; NIH [1R01LM012832-01A1]; NSF [1U01CA198934-01]	Indiana University Responding to the Addictions Crisis Grand Challenge Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	KS,OS,KB, EM, TN No number the Indiana University Responding to the Addictions Crisis Grand Challenge Grant url -https://addictions.iu.edu/responding-to-crisis/grandchallenge.html KB NIH 1R01LM012832-01A1 MyAura URL: https://projectreporter.nih.gov/project_info_description.cfm?projectnumber= 1R01LM012832-01A1 1U01CA198934-01 NSF HSD URL: https://projectreporter.nih.gov/project_ description.cfm?projectnumber=1U01CA19893401 1713567 AISL https://www.nsf.gov/awardsearch/showAward?AWD_ID=1713567 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Burning Glass Technologies provided support in the form of data access but did not play a role in the study design, analysis, and decision to publish. Bledi Taska is a Chief Economist in Burning Glass Technologies who provided role in revising data collection quality and query design. The specific role of this author is articulated in the `author contributions' section. Other authors were not funded by the BGT.	Bouchery E., 2018, SUBSTANCE USE DISORD; Bureau of Labor Statistics, 2019, EMPL HLTH CAR SOC AS; Bureau of Labor Statistics, 2019, EMPL LEV; Carnevale AP, 2014, UNDERSTANDING ONLINE; CDC, 2019, OP PRESCR RAT MAPS; Christie C, 2017, PRESIDENTS COMMISSIO; Cicero TJ, 2017, ADDICT BEHAV, V74, P63, DOI 10.1016/j.addbeh.2017.05.030; Clemens J, 2018, DROPOUTS NEED NOT AP; Dall TM, 2013, HEALTH AFFAIR, V32, P2013, DOI 10.1377/hlthaff.2013.0714; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Deming D, 2018, J LABOR ECON, V36, pS337, DOI 10.1086/694106; Flynn PM, 2008, J SUBST ABUSE TREAT, V34, P36, DOI 10.1016/j.jsat.2006.11.013; Ghosh A, 2019, J HEALTH ECON, V63, P64, DOI 10.1016/j.jhealeco.2018.11.002; Haffajee RL, 2018, AM J PREV MED, V54, pS230, DOI 10.1016/j.amepre.2017.12.022; Hershbein B, 2018, AM ECON REV, V108, P1737, DOI 10.1257/aer.20161570; Hoge MA, 2013, HEALTH AFFAIR, V32, P2005, DOI 10.1377/hlthaff.2013.0541; Kaiser Family Foundation, 2019, STAT STAT ACT MED EX; Kamal Rabah, 2017, JAMA, V318, P415, DOI 10.1001/jama.2017.8558; Kleinberg J, 2003, DATA MIN KNOWL DISC, V7, P373, DOI 10.1023/A:1024940629314; Maclean JC, 2019, J POLICY ANAL MANAG, V38, P366, DOI 10.1002/pam.22112; Mojtabai R, 2019, HEALTH AFFAIR, V38, P14, DOI 10.1377/hlthaff.2018.05162; Morgan P, 2017, MED CARE RES REV, V74, P109, DOI 10.1177/1077558715627555; Orgera K., 2019, OPIOID EPIDEMIC MED; Rossen Lauren M., 2019, DRUG POISONING MORTA; Saloner B, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1588; Saloner B, 2015, JAMA-J AM MED ASSOC, V314, P1515, DOI 10.1001/jama.2015.10345; Schuckit MA, 2016, NEW ENGL J MED, V375, P357, DOI 10.1056/NEJMra1604339; Sci2 Team, 2009, SCI SCI SCI2 TOOL; Sharp A, 2018, AM J PUBLIC HEALTH, V108, P642, DOI 10.2105/AJPH.2018.304338; Stubbs BA, 2017, VALUE REAL TIME LABO; Substance Abuse and Mental Health Services Administration, 2018, DAT SUBST AB TREATM; Substance Abuse and Mental Health Services Administration, 2018, NAT SURV SUBST AB TR; Substance Abuse & Mental Health Services Administration, 2017, IMPL MHPAEA; U S Census Bureau, 2018, 2016 COUNT BUS PATT; Wen HF, 2017, MED CARE, V55, P336, DOI 10.1097/MLR.0000000000000703; Wherry LR, 2016, ANN INTERN MED, V164, P795, DOI 10.7326/M15-2234	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228394	10.1371/journal.pone.0228394	http://dx.doi.org/10.1371/journal.pone.0228394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999764	gold, Green Submitted, Green Published			2022-12-26	WOS:000534612400076
J	Hartman, Z; Geldenhuys, WJ; Agazie, YM				Hartman, Zachary; Geldenhuys, Werner J.; Agazie, Yehenew M.			A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; receptor tyrosine kinase; breast cancer; phosphatase; inhibitor; EGF signaling; EGFR; HER2; Peptide inhibitor; SHP2	PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR; MOLECULAR-MECHANISM; AUTOMATED DOCKING; SH2 DOMAINS; INHIBITION; BREAST; CELLS; KINASE; TARGET	The Src homology phosphatase 2 (SHP2) is a cytoplasmic enzyme that mediates signaling induced by multiple receptor tyrosine kinases, including signaling by the epidermal growth factor receptor (EGFR) family (EGFR1?4 or the human homologs HER1?4). In EGFR (HER1) and EGFR2 (HER2) signaling, SHP2 increases the half-life of activated Ras by blocking recruitment of Ras GTPase-activating protein (RasGAP) to the plasma membrane through dephosphorylation of docking sites on the receptors. However, it is unclear how SHP2 selectively recognizes RasGAP-binding sites on EGFR and HER2. In this report, we show that SHP2-targeted pTyr residues exist in a specific amino acid context that allows selective binding. More specifically, we show that acidic residues N-terminal to the substrate pTyr in EGFR and HER2 mediate specific binding by the SHP2 active site, leading to blockade of RasGAP binding and optimal signaling by the two receptors. Molecular modeling studies revealed that a peptide derived from the region of pTyr(992)-EGFR packs well and makes stronger interactions with the SHP2 active site than with the SHP1 active site, suggesting a built-in mechanism that enables selective substrate recognition by SHP2. A phosphorylated form of this peptide inhibits SHP2 activity in vitro and EGFR and HER2 signaling in cells, suggesting inhibition of SHP2 protein tyrosine phosphatase activity by this peptide. Although we do not expect this peptide to be a strong inhibitor by itself, we foresee that the insights into SHP2 selectivity described here will be useful in future development of active-site small molecule-based inhibitors.	[Hartman, Zachary; Agazie, Yehenew M.] West Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA; [Geldenhuys, Werner J.] West Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Agazie, Yehenew M.] West Virginia Univ, Sch Med, WVU Canc Inst, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Agazie, YM (corresponding author), West Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA.; Agazie, YM (corresponding author), West Virginia Univ, Sch Med, WVU Canc Inst, Morgantown, WV 26506 USA.	yagazie@hsc.wvu.edu			NCI, National Institute of Health [CA213996]; DOD-CDMRP (Department of Defense - Congressionally Directed Medical Research Program) Breast Cancer Research Program	NCI, National Institute of Health; DOD-CDMRP (Department of Defense - Congressionally Directed Medical Research Program) Breast Cancer Research Program(United States Department of Defense)	This work was supported by NCI, National Institute of Health Grant CA213996 (to Y. M. A.). This work was also supported in part by a predoctoral fellowship (to Z. H.) from the DOD-CDMRP (Department of Defense - Congressionally Directed Medical Research Program) Breast Cancer Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Agazie YM, 2003, J BIOL CHEM, V278, P13952, DOI 10.1074/jbc.M210670200; Ahmed Z, 2010, CELL SIGNAL, V22, P23, DOI 10.1016/j.cellsig.2009.08.011; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Borrelli A, 2018, MOLECULES, V23, DOI 10.3390/molecules23020295; Cao M, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152621; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Chen LW, 2010, BIOCHEM PHARMACOL, V80, P801, DOI 10.1016/j.bcp.2010.05.019; Cleghon V, 1998, MOL CELL, V2, P719, DOI 10.1016/S1097-2765(00)80287-7; Dardaei L, 2018, NAT MED, V24, P512, DOI 10.1038/nm.4497; Della Corte CM, 2019, EBIOMEDICINE, V39, P5, DOI 10.1016/j.ebiom.2018.12.008; FENG GS, 1994, TRENDS GENET, V10, P54, DOI 10.1016/0168-9525(94)90149-X; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hanafusa H, 2004, J BIOL CHEM, V279, P22992, DOI 10.1074/jbc.M312498200; Hartman Z, 2013, ONCOGENE, V32, P4169, DOI 10.1038/onc.2012.418; Hartman ZR, 2013, MOL CANCER RES, V11, P651, DOI 10.1158/1541-7786.MCR-12-0578; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Li J, 2009, EXP CELL RES, V315, P2284, DOI 10.1016/j.yexcr.2009.04.011; Matalkah F, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0659-z; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Morris GM, 2013, J CHEM INF MODEL, V53, P898, DOI 10.1021/ci300545a; O'Reilly AM, 1998, MOL CELL BIOL, V18, P161, DOI 10.1128/MCB.18.1.161; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; Sun X, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020395; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Vermeulen NPE, 2004, DRUG METAB REV, V36, P15; Wong GS, 2018, NAT MED, V24, P968, DOI 10.1038/s41591-018-0022-x; Wu JH, 2006, J BIOL CHEM, V281, P37758, DOI 10.1074/jbc.M605756200; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Yu ZH, 2011, BIOORG MED CHEM LETT, V21, P4238, DOI 10.1016/j.bmcl.2011.05.078; Zhang X, 2010, J MED CHEM, V53, P2482, DOI 10.1021/jm901645u; Zhao H, 2019, ONCOGENE, V38, P2275, DOI 10.1038/s41388-018-0574-8; Zhao H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1131-2; Zhou X, 2008, HISTOPATHOLOGY, V53, P389, DOI 10.1111/j.1365-2559.2008.03103.x; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54; Zhou XD, 2009, J BIOL CHEM, V284, P12226, DOI 10.1074/jbc.M900020200	46	12	11	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3563	3575		10.1074/jbc.RA119.011422	http://dx.doi.org/10.1074/jbc.RA119.011422			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32024694	Green Published, hybrid			2022-12-26	WOS:000527725300016
J	Kumari, R; Kumar, R; Kumar, S; Singh, AK; Hanpude, P; Jangir, D; Maiti, TK				Kumari, Raniki; Kumar, Roshan; Kumar, Sanjay; Singh, Abhishek Kumar; Hanpude, Pranita; Jangir, Deepak; Maiti, Tushar Kanti			Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodegeneration; Parkinson's disease; amyloid; protein aggregation; protein misfolding; Lewy body; neurotoxicity; OTU deubiquitinase ubiquitin aldehyde-binding 1 (OTUB1); otubain-1; pS129; alpha-synuclein	ALPHA-SYNUCLEIN; MITOCHONDRIAL DYSFUNCTION; COMPLEX-I; NEURONAL APOPTOSIS; CYSTEINE PROTEASES; SYNAPTIC DAMAGE; BINDING; BETA; UBIQUITINATION; ROTENONE	Parkinson's disease (PD) is a multifactorial malady and the second most common neurodegenerative disorder, characterized by loss of dopaminergic neurons in the midbrain. A hallmark of PD pathology is the formation of intracellular protein inclusions, termed Lewy bodies (LBs). Recent MS studies have shown that OTU deubiquitinase ubiquitin aldehyde-binding 1 (OTUB1), a deubiquitinating enzyme of the OTU family, is enriched together with ?-synuclein in LBs from individuals with PD and is also present in amyloid plaques associated with Alzheimer's disease. In the present study, using mammalian cell cultures and a PD mouse model, along with CD spectroscopy, atomic force microscopy, immunofluorescence-based imaging, and various biochemical assays, we demonstrate that after heat-induced protein aggregation, OTUB1 reacts strongly with both anti-A11 and anti-osteocalcin antibodies, detecting oligomeric, prefibrillar structures or fibrillar species of amyloidogenic proteins, respectively. Further, recombinant OTUB1 exhibited high thioflavin-T and Congo red binding and increased ?-sheet formation upon heat induction. The oligomeric OTUB1 aggregates were highly cytotoxic, characteristic of many amyloid proteins. OTUB1 formed inclusions in neuronal cells and co-localized with thioflavin S and with ?-synuclein during rotenone-induced stress. It also co-localized with the disease-associated variant pS129-?-synuclein in rotenone-exposed mouse brains. Interestingly, OTUB1 aggregates were also associated with severe cytoskeleton damage, rapid internalization inside the neuronal cells, and mitochondrial damage, all of which contribute to neurotoxicity. In conclusion, the results of our study indicate that OTUB1 may contribute to LB pathology through its amyloidogenic properties.	[Kumari, Raniki; Kumar, Roshan; Kumar, Sanjay; Singh, Abhishek Kumar; Hanpude, Pranita; Jangir, Deepak; Maiti, Tushar Kanti] NCR Biotech Sci Cluster, Funct Prote Lab, RCB, Faridabad 121001, India; [Kumari, Raniki] KIIT, Bhubaneswar 751024, Odisha, India; [Kumar, Roshan; Kumar, Sanjay] Manipal Acad Higher Educ, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Kalinga Institute of Industrial Technology (KIIT); Manipal Academy of Higher Education (MAHE)	Maiti, TK (corresponding author), NCR Biotech Sci Cluster, Funct Prote Lab, RCB, Faridabad 121001, India.	tkmaiti@rcb.res.in	Kumar, Sanjay/HGA-4133-2022; Kumari, Raniki/AAU-2541-2020	Kumar, Sanjay/0000-0002-6101-2334; Hanpude, Pranita/0000-0002-0103-2835; Kumari, Raniki/0000-0001-8902-1729; Maiti, Tushar/0000-0003-4721-827X; Jangir, Deepak Kumar/0000-0001-8838-3859	Regional Center for Biotechnology (Faridabad, India)	Regional Center for Biotechnology (Faridabad, India)	This work was supported by the core funding of the Regional Center for Biotechnology (Faridabad, India). The authors declare that they have no conflicts of interest with the contents of this article.	Alexopoulou Z, 2016, P NATL ACAD SCI USA, V113, pE4688, DOI 10.1073/pnas.1523597113; [Anonymous], 2018, MEDICINE, DOI DOI 10.1097/MD.0000000000010983; Arawaka S, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0452-6; Avidan-Shpalter C, 2006, AMYLOID, V13, P216, DOI 10.1080/13506120600960643; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Ball N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00218; Boncompagni S, 2012, J BIOL CHEM, V287, P20534, DOI 10.1074/jbc.M112.359588; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Bridi JC, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00080; Canerina-Amaro A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00382; Chanez-Cardenas Maria Elena, 2012, J Biophys, V2012, P606172, DOI 10.1155/2012/606172; Chen YX, 2017, ONCOTARGET, V8, P11053, DOI 10.18632/oncotarget.14278; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Engelhardt Eliasz, 2017, Dement. neuropsychol., V11, P198, DOI 10.1590/1980-57642016dn11-020012; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Follmer C, 2015, J BIOL CHEM, V290, P27660, DOI 10.1074/jbc.M115.686584; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Fujikake N, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00255; Galdiero S, 2012, CURR PROTEIN PEPT SC, V13, P843, DOI 10.2174/138920312804871120; Ghosh S, 2017, CELL DEATH DIFFER, V24, P1784, DOI 10.1038/cdd.2017.105; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; Hadley KC, 2015, ELIFE, V4, DOI 10.7554/eLife.09579; Halliday M, 2014, J BIOL CHEM, V289, P19862, DOI 10.1074/jbc.R114.568477; Han XJ, 2017, MOL MED REP, V16, P4521, DOI 10.3892/mmr.2017.7203; Herhaus L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3519; Huseby CJ, 2019, J BIOL CHEM, V294, P4728, DOI 10.1074/jbc.RA118.006943; Inden M, 2011, BIOL PHARM BULL, V34, P92, DOI 10.1248/bpb.34.92; Jin S, 2016, J BIOL CHEM, V291, P19590, DOI 10.1074/jbc.M115.691840; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Julien C, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0634-x; Karpowicz RJ, 2017, J BIOL CHEM, V292, P13482, DOI 10.1074/jbc.M117.780296; Karunarathna U, 2016, ONCOGENE, V35, P1433, DOI 10.1038/onc.2015.208; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kevenaar JT, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00044; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kumar R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44558; Lee SJ, 2012, METHODS MOL BIOL, V849, P347, DOI 10.1007/978-1-61779-551-0_23; Li JQ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-47; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Lipscomb IP, 2007, J GEN VIROL, V88, P2619, DOI 10.1099/vir.0.82228-0; Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749; Magrinelli F, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/9832839; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Mokhtar Sara H, 2013, Int J Alzheimers Dis, V2013, P910502, DOI 10.1155/2013/910502; Montoliu-Gaya L, 2018, MOL CELL NEUROSCI, V89, P49, DOI 10.1016/j.mcn.2018.03.015; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Nakamura T, 2013, NEURON, V78, P596, DOI 10.1016/j.neuron.2013.05.005; Nakamura T, 2012, EXP NEUROL, V238, P12, DOI 10.1016/j.expneurol.2012.06.032; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Ordonez DG, 2018, NEURON, V97, P108, DOI 10.1016/j.neuron.2017.11.036; Pasupala N, 2018, J BIOL CHEM, V293, P18285, DOI 10.1074/jbc.RA118.004677; Patke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064974; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Relini A, 2014, BIOMOLECULES, V4, P20, DOI 10.3390/biom4010020; Rodriguez EE, 2016, J BIOL INORG CHEM, V21, P691, DOI 10.1007/s00775-016-1376-5; Rui YF, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0261-z; Shafrir Y, 2010, PROTEINS, V78, P3458, DOI 10.1002/prot.22832; Singh SK, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7361613; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Sousa VL, 2009, MOL BIOL CELL, V20, P3725, DOI 10.1091/mbc.E08-03-0302; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stanisic V, 2009, J BIOL CHEM, V284, P16135, DOI 10.1074/jbc.M109.007484; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Takahashi H, 2001, NEUROPATHOLOGY, V21, P315, DOI 10.1046/j.1440-1789.2001.00403.x; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Toussi DN, 2016, MICROBES INFECT, V18, P627, DOI 10.1016/j.micinf.2016.06.001; Walsh I, 2014, NUCLEIC ACIDS RES, V42, pW301, DOI 10.1093/nar/gku399; Wang P, 2017, ACTA NEUROPATHOL, V133, P731, DOI 10.1007/s00401-016-1663-9; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu C, 2012, BIOPHYS J, V103, P550, DOI 10.1016/j.bpj.2012.07.008; Xia QW, 2008, FRONT BIOSCI-LANDMRK, V13, P3850; Xie LL, 2016, MOL CELL BIOCHEM, V422, P171, DOI 10.1007/s11010-016-2817-8; Xu L, 2017, NEUROPATHOLOGY, V37, P217, DOI 10.1111/neup.12366; Xu LJ, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/1720621; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Zhao J, 2012, BBA-BIOMEMBRANES, V1818, P3121, DOI 10.1016/j.bbamem.2012.08.012; Zhou HH, 2018, ONCOGENE, V37, P3356, DOI 10.1038/s41388-018-0224-1	91	11	11	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3466	3484		10.1074/jbc.RA119.009546	http://dx.doi.org/10.1074/jbc.RA119.009546			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32005664	Green Published, hybrid			2022-12-26	WOS:000527725300009
J	Luo, Y; Zhang, JX; Chen, L; Chen, SR; Chen, H; Zhang, GF; Pan, HL				Luo, Yi; Zhang, Jixiang; Chen, Lin; Chen, Shao-Rui; Chen, Hong; Zhang, Guangfen; Pan, Hui-Lin			Histone methyltransferase G9a diminishes expression of cannabinoid CB1 receptors in primary sensory neurons in neuropathic pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pain; neurobiology; neurophysiology; neuroscience; synapse; dorsal root ganglion	MECHANICALLY EVOKED-RESPONSES; SPINAL NEURONS; RAT MODEL; METHYLATION; TRANSMISSION; ACTIVATION; INHIBITION; ANALGESIA; PROTEIN; PLASTICITY	Type 1 cannabinoid receptors (CB(1)Rs) are expressed in the dorsal root ganglion (DRG) and contribute to the analgesic effect of cannabinoids. However, the epigenetic mechanism regulating the expression of CB(1)Rs in neuropathic pain is unknown. G9a (encoded by the Ehmt2 gene), a histone 3 at lysine 9 methyltransferase, is a key chromatin regulator responsible for gene silencing. In this study, we determined G9a's role in regulating CB1R expression in the DRG and in CB1R-mediated analgesic effects in an animal model of neuropathic pain. We show that nerve injury profoundly reduced mRNA levels of CB(1)Rs but increased the expression of CB2 receptors in the rat DRG. ChIP results indicated increased enrichment of histone 3 at lysine 9 dimethylation, a G9a-catalyzed repressive histone mark, at the promoter regions of the CB1R genes. G9a inhibition in nerve-injured rats not only up-regulated the CB1R expression level in the DRG but also potentiated the analgesic effect of a CB1R agonist on nerve injury-induced pain hypersensitivity. Furthermore, in mice lacking Ehmt2 in DRG neurons, nerve injury failed to reduce CB1R expression in the DRG and to decrease the analgesic effect of the CB1R agonist. Moreover, nerve injury diminished the inhibitory effect of the CB1R agonist on synaptic glutamate release from primary afferent nerves to spinal cord dorsal horn neurons in WT mice but not in mice lacking Ehmt2 in DRG neurons. Our findings reveal that nerve injury diminishes the analgesic effect of CB1R agonists through G9a-mediated CB1R down-regulation in primary sensory neurons.	[Luo, Yi; Zhang, Jixiang; Chen, Lin; Chen, Shao-Rui; Chen, Hong; Zhang, Guangfen; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Luo, Yi] Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Wuhan 430071, Hubei, Peoples R China; [Chen, Lin] Jianghan Univ, Sch Phys Educ, Wuhan 430056, Hubei, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Wuhan University; Jianghan University	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110,1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Zhang, Jixiang/0000-0002-1641-8650	National Institutes on Drug Abuse [DA041711]; National Institutes of Health [NS101880]; N. G. and Helen T. Hawkins Endowment	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment	This study was supported by National Institutes on Drug Abuse Grant DA041711 (to H.-L. P.), National Institutes of Health Grant NS101880, and by the N. G. and Helen T. Hawkins Endowment. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Berman JS, 2004, PAIN, V112, P299, DOI 10.1016/j.pain.2004.09.013; Bridges D, 2001, BRIT J PHARMACOL, V133, P586, DOI 10.1038/sj.bjp.0704110; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; Chen SR, 2014, J PHYSIOL-LONDON, V592, P215, DOI 10.1113/jphysiol.2013.263814; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; D'Addario C, 2013, FEBS J, V280, P1905, DOI 10.1111/febs.12125; Deng MC, 2019, CELL MOL LIFE SCI, V76, P1889, DOI 10.1007/s00018-019-03047-y; Fox A, 2001, PAIN, V92, P91, DOI 10.1016/S0304-3959(00)00474-7; Garriga J, 2018, J NEUROSCI, V38, P6090, DOI 10.1523/JNEUROSCI.2616-17.2018; Gutierrez T, 2011, PAIN, V152, P1976, DOI 10.1016/j.pain.2011.03.038; Hauser W, 2018, EUR J PAIN, V22, P455, DOI 10.1002/ejp.1118; Herre M, 2019, CURR OPIN NEUROBIOL, V59, P79, DOI 10.1016/j.conb.2019.04.006; Herzberg U, 1997, NEUROSCI LETT, V221, P157, DOI 10.1016/S0304-3940(96)13308-5; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Jones MR, 2015, AM J CLIN EXP UROL, V3, P28; Karst M, 2003, JAMA-J AM MED ASSOC, V290, P1757, DOI 10.1001/jama.290.13.1757; Kelly S, 2003, EUR J NEUROSCI, V18, P2239, DOI 10.1046/j.1460-9568.2003.02957.x; Kelly S, 2003, EUR J PHARMACOL, V474, P209, DOI 10.1016/S0014-2999(03)02085-5; Kelly S, 2001, J NEUROPHYSIOL, V86, P3061, DOI 10.1152/jn.2001.86.6.3061; Khasabova IA, 2004, J NEUROSCI, V24, P1744, DOI 10.1523/JNEUROSCI.4298-03.2004; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Laedermann CJ, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-19; Laprairie RB, 2012, BRIT J PHARMACOL, V167, P1583, DOI 10.1111/j.1476-5381.2012.02175.x; Laumet G, 2015, NAT NEUROSCI, V18, P1746, DOI 10.1038/nn.4165; Lotsch J, 2018, EUR J PAIN, V22, P471, DOI 10.1002/ejp.1148; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Morisset V, 2001, J NEUROPHYSIOL, V86, P40, DOI 10.1152/jn.2001.86.1.40; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nugent SM, 2017, ANN INTERN MED, V167, P319, DOI 10.7326/M17-0155; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Petrov RR, 2013, EUR J MED CHEM, V69, P881, DOI 10.1016/j.ejmech.2013.09.038; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Salio C, 2002, NEUROSCIENCE, V110, P755, DOI 10.1016/S0306-4522(01)00584-X; Stockings E, 2018, PAIN, V159, P1932, DOI 10.1097/j.pain.0000000000001293; Sun J, 2019, J PHYSIOL-LONDON, V597, P1661, DOI 10.1113/JP277428; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Twitchell W, 1997, J NEUROPHYSIOL, V78, P43, DOI 10.1152/jn.1997.78.1.43; Veress G, 2013, BRAIN STRUCT FUNCT, V218, P733, DOI 10.1007/s00429-012-0425-2; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wotherspoon G, 2005, NEUROSCIENCE, V135, P235, DOI 10.1016/j.neuroscience.2005.06.009; Xiong W, 2012, J EXP MED, V209, P1121, DOI 10.1084/jem.20120242; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zhang J., 2018, EPIGENETICS CHRONIC, P85; Zhang JX, 2018, J BIOL CHEM, V293, P19078, DOI 10.1074/jbc.RA118.005846; Zhang YH, 2016, J BIOL CHEM, V291, P8475, DOI 10.1074/jbc.M115.711812; Zhou HY, 2008, J PHARMACOL EXP THER, V327, P375, DOI 10.1124/jpet.108.141226; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	63	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3553	3562		10.1074/jbc.RA119.011053	http://dx.doi.org/10.1074/jbc.RA119.011053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32024693	Green Published, hybrid			2022-12-26	WOS:000527725300015
J	Hrusa, G; Spigt, M; Dejene, T; Shiferaw, S				Hrusa, Gili; Spigt, Mark; Dejene, Tariku; Shiferaw, Solomon			Quality of Family Planning Counseling in Ethiopia: Trends and determinants of information received by female modern contraceptive users, evidence from national survey data, (2014-2018)	PLOS ONE			English	Article							OF-CARE; ADDIS-ABABA; CONTINUATION	Background Family planning counseling is critical for women to make informed reproductive and sexual health decisions. Despite Ethiopia's success in expanding access to family planning services, information on the quality of family planning counseling is limited. The objectives of this study were to assess whether the quality of counseling from the female client ' s perspective has changed over time (2014 to 2018) and to investigate determinants associated with the quality of counseling to provide a more nuanced understanding of disparities in sexual and reproductive health outcomes in Ethiopia. Methods Data were obtained from five rounds of the Ethiopian Performance Monitoring and Accountability 2020 female survey questionnaire. Quality of counseling was categorized into four levels based on the responses of the questions that compose the Method Information Index, a core Family Planning 2020 indicator that serves as a proxy for quality of counseling and reflects the extent to which women are informed about side effects and alternate methods. The proportion of female contraceptive users that received good counseling were examined over time by each region, demographic characteristics, and contraception method type and source. Ordinal logistic regression was applied to the last survey round (2018) to investigate determinants associated with counseling quality. Results The proportion of female contraception users that reported receiving information on all three questions did not significantly change over the period 2014 to 2018. Overall quality of counseling on family planning was low, with only 30% of women reporting receiving sufficient information during counseling. The likelihood of good quality counseling was the least among those who had no formal schooling when compared to those who had higher educational attainment (OR = 0.70, 95% CI: 0.50, 0.97). Women from the wealthiest quintile were 1.72 times more likely (95% CI: 1.10, 2.69) to receive good quality counseling when compared to women in the lower wealth quintile. Women from rural areas were 1.51 times more likely to have received good counseling when compared to those in urban areas (95% CI: 1.04, 2.18). Amhara residents were less likely to receive good counseling when compared to the SNNPR (OR: 0.51, 95% CI: 0.32, 0.81). Women who acquired their method from the private sector had worse counseling (OR: 0.31, 95% CI: 0.23, 0.41) when compared to the public sector. Those using short-acting methods were more at risk of receiving lesser quality counseling when compared to users of long-acting methods (OR: 0.58, 95% CI: 0.46, 0.72). Conclusion The results of this analysis indicated that Ethiopia's overall progress in modern contraceptive use has not been accompanied by a corresponding increase in the quality of family planning counseling. Improving the quality of contraception counseling for women across all demographics, including wealth quintiles and education, is a crucial strategy to support positive reproductive health outcomes with a rights-based focus. Based on the findings of this study, it is essential to emphasize the need to do proper counseling for all methods including short-acting methods especially for those working the private sector and some of the regions which have lower prevalence of good counseling. Further community-based participatory and qualitative research should focus on understanding the root causes and barriers to the delivery of high-quality counseling in Ethiopia.	[Hrusa, Gili; Spigt, Mark] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Family Med, Maastricht, Netherlands; [Spigt, Mark] Arctic Univ Norway, Gen Practice Res Unit, Dept Community Med, Tromso, Norway; [Dejene, Tariku] Addis Ababa Univ, Coll Dev Studies, Ctr Populat Studies, Addis Ababa, Ethiopia; [Shiferaw, Solomon] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia	Maastricht University; UiT The Arctic University of Tromso; Addis Ababa University; Addis Ababa University	Hrusa, G (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Dept Family Med, Maastricht, Netherlands.	gilihrusa91@gmail.com			Bill and Melinda Gates Foundation through the Bill and Melinda Gates Institute for Population and Reproductive Health at the Bloomberg School of Public Health, Johns Hopkins University	Bill and Melinda Gates Foundation through the Bill and Melinda Gates Institute for Population and Reproductive Health at the Bloomberg School of Public Health, Johns Hopkins University	PMA2020/Ethiopia is made possible by generous support from the Bill and Melinda Gates Foundation through the Bill and Melinda Gates Institute for Population and Reproductive Health at the Bloomberg School of Public Health, Johns Hopkins University. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Backman T, 2002, OBSTET GYNECOL, V99, P608, DOI 10.1016/S0029-7844(01)01764-1; Bitzer J, 2016, EUR J CONTRACEP REPR, V21, P417, DOI 10.1080/13625187.2016.1237629; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Both R, 2015, REPROD HEALTH MATTER, V23, P58, DOI 10.1016/j.rhm.2015.06.005; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Brown W, 2014, STUD FAMILY PLANN, V45, P73, DOI 10.1111/j.1728-4465.2014.00377.x; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; Chang KT, 2019, STUD FAMILY PLANN, V50, P25, DOI 10.1111/sifp.12081; Chin-Quee DS, 2007, CONTRACEPTION, V76, P377, DOI 10.1016/j.contraception.2007.07.003; De Cetina TEC, 2001, CONTRACEPTION, V63, P143, DOI 10.1016/S0010-7824(01)00181-0; Dehlendorf C, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.173; Ethiopia Ministry of Health, 2016, COST IMPL PLAN FAM P; Fruhauf T, 2018, HEALTH POLICY PLANN, V33, P828, DOI 10.1093/heapol/czy058; Gillespie DG, 2004, INT FAM PLAN PERSPEC, V30, P34, DOI 10.1363/3003404; Government of Ethiopia, 2017, FP2020 REV COMM SUMM; Hardee K, 2014, STUD FAMILY PLANN, V45, P1, DOI 10.1111/j.1728-4465.2014.00373.x; Hounton S, 2015, GLOBAL HEALTH ACTION, V8, P53, DOI 10.3402/gha.v8.29737; Jadhav A, 2018, J BIOSOC SCI, V50, P823, DOI 10.1017/S0021932017000621; Jain AK, 2017, J BIOSOC SCI, V49, P798, DOI 10.1017/S0021932016000602; Jain AK, 2016, INT PERSPECT SEX R H, V42, P131, DOI 10.1363/42e1616; Karim AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065160; Koenig MA, 1997, STUD FAMILY PLANN, V28, P278, DOI 10.2307/2137859; Lee JK, 2011, J GEN INTERN MED, V26, P731, DOI 10.1007/s11606-011-1647-3; Leisher SH, 2015, QUALITY MEASUREMENT; McMahon SA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-268; Olson DJ, 2013, STUD FAMILY PLANN, V44, P445, DOI 10.1111/j.1728-4465.2013.00369.x; Pitchforth E, 2010, SOC SCI MED, V71, P1739, DOI 10.1016/j.socscimed.2010.08.001; Riley C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192522; Rimon JG, 2018, GLOB HEALTH-SCI PRAC, V6, P626, DOI 10.9745/GHSP-D-18-00483; Shiferaw S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192258; Tafese F, 2013, ETHIOP J HEALTH SCI, V23, P245, DOI 10.4314/ejhs.v23i3.7; Teferra AS., 2015, SCI J PUBLIC HLTH, V3, P143, DOI DOI 10.11648/J.SJPH; Teshome A, 2017, INT J GYNECOL OBSTET, V137, P174, DOI 10.1002/ijgo.12110; Townsend J, 2018, PROPOSED METRICS MEA; United Nations Population Fund, 1994, PROGR ACT INT C POP; Wado YD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209602; Wako G, 2000, ETHIOPIAN J HLTH DEV, V14; Worku AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116525; World Health Organization, 2017, QUAL CAR CONTR INF S; Yakob B, 2019, INT J QUAL HEALTH C, V1, P816; Zimmerman L, 2017, STUD FAMILY PLANN, V48, P293, DOI 10.1111/sifp.12031	41	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228714	10.1371/journal.pone.0228714	http://dx.doi.org/10.1371/journal.pone.0228714			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9IO	32040485	gold, Green Published			2022-12-26	WOS:000534629400037
J	Iwu, CD; Okoh, AI				Iwu, Chidozie Declan; Okoh, Anthony Ifeanyi			Characterization of antibiogram fingerprints in Listeria monocytogenes recovered from irrigation water and agricultural soil samples	PLOS ONE			English	Article							HIGH-RISK SOURCES; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; FECAL CONTAMINATION; GENETIC DIVERSITY; VIRULENCE GENES; FOOD-PRODUCTS; EASTERN CAPE; DAIRY-COWS; RAW-MILK	Listeria monocytogenes (L. monocytogenes) is a foodborne pathogen and the etiologic agent of listeriosis, which can be disseminated within the agricultural environment particularly soil and irrigation water, contaminate farm produce and cause high mortality and morbidity among vulnerable individuals. This study assessed the incidence and antibiogram of L. monocytogenes recovered from irrigation water and agricultural soil samples collected from Chris Hani and Amathole District Municipalities (DMs) in Eastern Cape Province, South Africa. The distribution of presumptive L. monocytogenes in irrigation water and agricultural soil samples was done using the standard plate count method, while polymerase chain reaction (PCR) was used to identify the isolates. The confirmed isolates were screened for 9 key virulence markers using PCR after which they were subjected to antibiotic susceptibility testing against 18 antibiotics used for the alleviation of listeriosis using the disk diffusion method. Relevant putative antibiotic resistance genes in the resistant variants were screened for using PCR. The distribution of L. monocytogenes in irrigation water samples was statistically significant (P < 0.05) and ranged from log(10) 1.00 CFU/100ml to log(10) 3.75 CFU/100 ml. In agricultural soil samples, the distribution ranged significantly (P <= 0.05) from log(10) 2.10 CFU/g to log(10) 3.51 CFU/g. Of the 117 presumptive L. monocytogenes recovered from irrigation water samples and 183 presumptive L. monocytogenes isolated from agricultural soil samples, 8 (6.8%) and 12 (6.6%) isolates were confirmed respectively. Nine virulence genes including in/A, in/B, in/C, inIJ, actA, hlyA, plcA, plcB, and lap were detected in all the isolates. The proportion of the isolates exhibiting phenotypic resistance against the test antimicrobials followed the order: tetracycline (90%), doxycycline (85%), cefotaxime (80%), penicillin (80%), chloramphenicol (70%), linezolid (65%), erythromycin (60%) and trimethoprim/sulfamethoxazole (55%). The isolates exhibited multiple antibiotic resistance against 3 or more antibiotics and the MAR indices of all the multidrug isolates were >= 0.2. The isolates harboured antibiotic resistance genes including tetA, tetB, tetC, sun, sulll, aadA, aac(3)-IIa and ESBLs including bla(TEM), bla(CTX-M) group 9, blav(EB) as well as AmpC. None of the isolates harboured the carbapenemases. We conclude that irrigation water and agricultural soil collected from Chris Hani and Amathole District Municipalities (DMs) in Eastern Cape Province of South Africa are reservoirs and potential transmission routes of multidrug-resistant L. monocytogenes to the food web and consequently threat to public health.	[Iwu, Chidozie Declan; Okoh, Anthony Ifeanyi] Univ Ft Hare, SAMRC Microbial Water Qual Monitoring Ctr, Alice, South Africa; [Iwu, Chidozie Declan; Okoh, Anthony Ifeanyi] Univ Ft Hare, Dept Biochem & Microbiol, Appl & Environm Microbiol Res Grp, Alice, South Africa	University of Fort Hare; University of Fort Hare	Iwu, CD (corresponding author), Univ Ft Hare, SAMRC Microbial Water Qual Monitoring Ctr, Alice, South Africa.; Iwu, CD (corresponding author), Univ Ft Hare, Dept Biochem & Microbiol, Appl & Environm Microbiol Res Grp, Alice, South Africa.	chidoziedeclan@gmail.com	Iwu, Chidozie/H-8285-2018	Iwu, Chidozie/0000-0001-5721-6425; Okoh, Anthony/0000-0002-9770-085X	South African medical Research Council; National Research Foundation	South African medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation	This work was supported by South African medical Research Council http://www.mrc.ac.za/ and the National Research Foundation, https://www.nrf.ac.za/. The funders did not play any role in the study design.	Aarestrup F, 2012, NATURE, V486, P465, DOI 10.1038/486465a; Abdollahzadeh E, 2016, MICROB PATHOGENESIS, V100, P70, DOI 10.1016/j.micpath.2016.09.012; Abriouel H, 2008, INT J FOOD MICROBIOL, V123, P38, DOI 10.1016/j.ijfoodmicro.2007.11.067; Adefisoye MA, 2016, MICROBIOLOGYOPEN, V5, P143, DOI 10.1002/mbo3.319; Allen KJ, 2016, FOOD MICROBIOL, V54, P178, DOI 10.1016/j.fm.2014.08.006; [Anonymous], 1997, 1129011997 ISO; Bae D, 2014, FOOD RES INT, V64, P656, DOI 10.1016/j.foodres.2014.07.049; Bertsch D, 2014, MICROBIOLOGYOPEN, V3, P118, DOI 10.1002/mbo3.155; Boehme S, 2004, MOL NUTR FOOD RES, V48, P522, DOI 10.1002/mnfr.200400030; Bonazzi M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003087; Castro H, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02000-17; CDC, 2015, MULT OUTBR LIST LINK; CDC, 2011, MULT OUTBR LIST LINK; Chao GX, 2007, FOODBORNE PATHOG DIS, V4, P277, DOI 10.1089/fpd.2007.0088; Charpentier E, 1999, ANTIMICROB AGENTS CH, V43, P2103, DOI 10.1128/AAC.43.9.2103; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V1st, DOI [10.1017/cbo9780511543470, DOI 10.1017/CBO9780511543470]; Chen MT, 2014, FOOD CONTROL, V38, P1, DOI 10.1016/j.foodcont.2013.09.061; CLSI, 2022, CLIN LAB STAND I PER; Conter M, 2009, INT J FOOD MICROBIOL, V128, P497, DOI 10.1016/j.ijfoodmicro.2008.10.018; Coroneo V, 2016, J FOOD SCI, V81, pM114, DOI 10.1111/1750-3841.13173; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Du XJ, 2017, FOOD CONTROL, V74, P9, DOI 10.1016/j.foodcont.2016.11.024; Durso LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048325; DWAF Department of Water Affairs and Forestry, 2012, DOMEST WATER USE, V1, P1; Gaul LK, 2013, CLIN INFECT DIS, V56, P20, DOI 10.1093/cid/cis817; Gohar S, 2017, MATRIX SCI MED, V1, P10, DOI [10.26480/msm.01.2017.10.14, DOI 10.26480/MSM.01.2017.10.14]; Hamelin K, 2006, APPL ENVIRON MICROB, V72, P4200, DOI 10.1128/AEM.00137-06; Haubert L, 2016, LETT APPL MICROBIOL, V62, P23, DOI 10.1111/lam.12516; Ho AJ, 2007, PREV VET MED, V80, P287, DOI 10.1016/j.prevetmed.2007.03.005; Hof H, 2004, EXPERT OPIN PHARMACO, V5, P1727, DOI 10.1517/14656566.5.8.1727; Iwu CD, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224407; Jamali H, 2013, FOOD CONTROL, V34, P121, DOI 10.1016/j.foodcont.2013.04.023; Jami S, 2010, IRAN J VET RES, V11, P363; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Komora N, 2017, INT J FOOD MICROBIOL, V245, P79, DOI 10.1016/j.ijfoodmicro.2017.01.013; Korsak D, 2012, INT J FOOD MICROBIOL, V158, P203, DOI 10.1016/j.ijfoodmicro.2012.07.016; KRUMPERMAN PH, 1983, APPL ENVIRON MICROB, V46, P165, DOI 10.1128/AEM.46.1.165-170.1983; Livermore DM, 1996, SCAND J INFECT DIS, P33; Lomonaco S, 2012, INT J FOOD MICROBIOL, V160, P76, DOI 10.1016/j.ijfoodmicro.2012.09.011; Lopez-Saucedo C, 2003, EMERG INFECT DIS, V9, P127, DOI 10.3201/eid0901.010507; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; Maugeri TL, 2004, J APPL MICROBIOL, V97, P354, DOI 10.1111/j.1365-2672.2004.02303.x; Meldrum RJ, 2009, FOOD MICROBIOL, V26, P573, DOI 10.1016/j.fm.2009.03.013; Morvan A, 2010, ANTIMICROB AGENTS CH, V54, P2728, DOI 10.1128/AAC.01557-09; NICD (National Institute for Communicable Diseases), 2017, ANN REV; Noll M, 2018, J INFECT PUBLIC HEAL, V11, P572, DOI 10.1016/j.jiph.2017.12.007; Obaidat MM, 2015, LETT APPL MICROBIOL, V60, P609, DOI 10.1111/lam.12420; Odjadjare EEO, 2010, WORLD J MICROB BIOT, V26, P297, DOI 10.1007/s11274-009-0174-4; Ogunmwonyi IN, 2008, SCI RES ESSAYS, V3, P120; Olaniran AO, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0570-x; Pereira SA, 2018, IMPACT ENV STRESSES, P89, DOI [10.5772/57353, DOI 10.5772/57353]; Pesavento G, 2010, FOOD CONTROL, V21, P708, DOI 10.1016/j.foodcont.2009.10.012; Poimenidou SV, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01103; Popowska M, 2012, ANTIMICROB AGENTS CH, V56, P1434, DOI 10.1128/AAC.05766-11; POYARTSALMERON C, 1990, LANCET, V335, P1422, DOI 10.1016/0140-6736(90)91447-I; Rodriguez C, 2006, APPL ENVIRON MICROB, V72, P5870, DOI 10.1128/AEM.00963-06; Safdar A, 2003, J CLIN MICROBIOL, V41, P483, DOI 10.1128/JCM.41.1.483-485.2003; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SCHLECH WF, 1983, NEW ENGL J MED, V308, P203, DOI 10.1056/NEJM198301273080407; Srinivasan V, 2007, VET MICROBIOL, V124, P319, DOI 10.1016/j.vetmic.2007.04.040; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Titilawo Y, 2015, ENVIRON SCI POLLUT R, V22, P10969, DOI 10.1007/s11356-014-3887-3; Titilawo Y, 2015, SCI TOTAL ENVIRON, V523, P82, DOI 10.1016/j.scitotenv.2015.03.095; Unnerstad H, 2000, ACTA VET SCAND, V41, P167; Vasilev V, 2009, EPIDEMIOL INFECT, V137, P577, DOI 10.1017/S0950268808001179; VENKATESWARAN K, 1989, APPL ENVIRON MICROB, V55, P1591, DOI 10.1128/AEM.55.6.1591-1598.1989; Vijayakumar PP, 2017, FOODS, V6, DOI 10.3390/foods6030022; Wang GY, 2015, FOOD CONTROL, V50, P202, DOI 10.1016/j.foodcont.2014.07.057; Wang XM, 2013, FOOD CONTROL, V32, P153, DOI 10.1016/j.foodcont.2012.11.032; Wu S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00168; Wu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136682; Zhu Q, 2017, FOODS, V6, DOI 10.3390/foods6030021	72	21	23	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228956	10.1371/journal.pone.0228956	http://dx.doi.org/10.1371/journal.pone.0228956			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040533	gold, Green Published, Green Submitted			2022-12-26	WOS:000534629400059
J	Morbey, RA; Charlett, A; Lake, I; Mapstone, J; Pebody, R; Sedgwick, J; Smith, GE; Elliot, AJ				Morbey, Roger A.; Charlett, Andre; Lake, Iain; Mapstone, James; Pebody, Richard; Sedgwick, James; Smith, Gillian E.; Elliot, Alex J.			Can syndromic surveillance help forecast winter hospital bed pressures in England?	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; ADMISSIONS; INFLUENZA; SYSTEM; SEASONALITY; ONTARIO	Background Health care planners need to predict demand for hospital beds to avoid deterioration in health care. Seasonal demand can be affected by respiratory illnesses which in England are monitored using syndromic surveillance systems. Therefore, we investigated the relationship between syndromic data and daily emergency hospital admissions. Methods We compared the timing of peaks in syndromic respiratory indicators and emergency hospital admissions, between 2013 and 2018. Furthermore, we created forecasts for daily admissions and investigated their accuracy when real-time syndromic data were included. Results We found that syndromic indicators were sensitive to changes in the timing of peaks in seasonal disease, especially influenza. However, each year, peak demand for hospital beds occurred on either 29th or 30th December, irrespective of the timing of syndromic peaks. Most forecast models using syndromic indicators explained over 70% of the seasonal variation in admissions (adjusted R square value). Forecast errors were reduced when syndromic data were included. For example, peak admissions for December 2014 and 2017 were underestimated when syndromic data were not used in models. Conclusion Due to the lack of variability in the timing of the highest seasonal peak in hospital admissions, syndromic surveillance data do not provide additional early warning of timing. However, during atypical seasons syndromic data did improve the accuracy of forecast intensity.	[Morbey, Roger A.; Smith, Gillian E.; Elliot, Alex J.] Publ Hlth England, Natl Infect Serv, Birmingham, W Midlands, England; [Charlett, Andre] Publ Hlth England, Stat & Modelling Econ Dept, London, England; [Lake, Iain] Univ East Anglia, Sch Environm Sci, Norwich, England; [Mapstone, James] Publ Hlth England, Bristol, Avon, England; [Pebody, Richard] Publ Hlth England, Natl Infect Serv, London, England; [Sedgwick, James] Publ Hlth England, Natl Infect Serv, Ashford, Kent, England	Public Health England; Public Health England; University of East Anglia; Public Health England; Public Health England	Morbey, RA (corresponding author), Publ Hlth England, Natl Infect Serv, Birmingham, W Midlands, England.	roger.morbey@phe.gov.uk		Pebody, Richard/0000-0002-9069-2885; Morbey, Roger/0000-0001-8543-477X; Elliot, Alex/0000-0002-6414-3065	NHS Digital; NHS [111]; Royal College of Emergency Medicine emergency departments participating in the Emergency Department Syndromic Surveillance System (EDSSS); EMIS Health; L2S2 Ltd	NHS Digital; NHS; Royal College of Emergency Medicine emergency departments participating in the Emergency Department Syndromic Surveillance System (EDSSS); EMIS Health; L2S2 Ltd	We acknowledge support from NHS Digital and NHS 111; Royal College of Emergency Medicine emergency departments participating in the Emergency Department Syndromic Surveillance System (EDSSS); EMIS Health and L2S2 Ltd; out-of-hours providers submitting data to General Practitioners Out-of-Hours and Advanced; The Phoenix Partnership (TPP), and participating SystemOne practices and University of Oxford, ClinRisk, EMIS Health, and EMIS practices submitting data to the QSurveillance database.	Boyle J, 2012, EMERG MED J, V29, P358, DOI 10.1136/emj.2010.103531; Buckingham-Jeffery E, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4372-y; BURMAN P, 1989, BIOMETRIKA, V76, P503, DOI 10.2307/2336116; Chakraborty P, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005964; Chan EH, 2011, J BIOMED INFORM, V44, P221, DOI 10.1016/j.jbi.2010.10.001; Dembek Zygmunt F, 2004, MMWR Suppl, V53, P50; Elliot AJ, 2008, J PUBLIC HEALTH-UK, V30, P91, DOI 10.1093/pubmed/fdn003; Elliot AJ, 2012, EMERG MED J, V29, P954, DOI 10.1136/emermed-2011-200684; Fleming D, 2003, Commun Dis Public Health, V6, P231; Fuhrman C, 2011, RESP MED, V105, P595, DOI 10.1016/j.rmed.2010.11.014; Hadler James L, 2005, MMWR Suppl, V54, P169; Harcourt SE, 2017, J PUBLIC HEALTH-UK, V39, P184, DOI 10.1093/pubmed/fdw013; Harcourt SE, 2012, EPIDEMIOL INFECT, V140, P2152, DOI 10.1017/S0950268812001781; Harcourt SE, 2012, EPIDEMIOL INFECT, V140, P100, DOI 10.1017/S095026881100046X; Hughes HE, 2016, EPIDEMIOL INFECT, V144, P1052, DOI 10.1017/S0950268815002125; Lesesne SB, 2010, CHARACTERISTICS GEOG; Morbey RA, 2018, EPIDEMIOL INFECT, V146, P1389, DOI 10.1017/S0950268818000262; Morbey RA, 2017, EPIDEMIOL INFECT, V145, P1922, DOI 10.1017/S095026881700070X; Nguyen-Van-Tam JS, 2001, EPIDEMIOL INFECT, V126, P71, DOI 10.1017/S0950268801005076; Public Health England, 2019, ANN FLU REP; Smith S, 2017, EMERG INFECT DIS, V23, P1834, DOI 10.3201/eid2311.161632; Soyiri IN, 2013, CHRON RESP DIS, V10, P85, DOI 10.1177/1479972313482847; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Upshur REG, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-13; Wargon M, 2018, EUR J EMERG MED, V25, P250, DOI 10.1097/MEJ.0000000000000451	26	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228804	10.1371/journal.pone.0228804	http://dx.doi.org/10.1371/journal.pone.0228804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040541	Green Accepted, Green Published, gold			2022-12-26	WOS:000534629400043
J	Reggiani, F; Carraro, M; Belligoli, A; Sanna, M; dal Pra, C; Favaretto, F; Ferrari, C; Vettor, R; Tosatto, SCE				Reggiani, Francesco; Carraro, Marco; Belligoli, Anna; Sanna, Marta; dal Pra, Chiara; Favaretto, Francesca; Ferrari, Carlo; Vettor, Roberto; Tosatto, Silvio C. E.			In silico prediction of blood cholesterol levels from genotype data	PLOS ONE			English	Article							HYPERCHOLESTEROLEMIA	In this work we present a framework for blood cholesterol levels prediction from genotype data. The predictor is based on an algorithm for cholesterol metabolism simulation available in literature, implemented and optimized by our group in the R language. The main weakness of the former simulation algorithm was the need of experimental data to simulate mutations in genes altering the cholesterol metabolism. This caveat strongly limited the application of the model in the clinical practice. In this work we present how this limitation could be bypassed thanks to an optimization of model parameters based on patient cholesterol levels retrieved from literature. Prediction performance has been assessed taking into consideration several scoring indices currently used for performance evaluation of machine learning methods. Our assessment shows how the optimization phase improved model performance, compared to the original version available in literature.	[Reggiani, Francesco; Carraro, Marco; Tosatto, Silvio C. E.] Univ Padua, Dept Biomed Sci, Padua, Italy; [Reggiani, Francesco; Ferrari, Carlo] Univ Padua, Dept Informat Engn, Padua, Italy; [Belligoli, Anna; Sanna, Marta; dal Pra, Chiara; Favaretto, Francesca; Vettor, Roberto] Univ Padua, Sch Med, Dept Med DIMED, Clin Med 3, Padua, Italy; [Tosatto, Silvio C. E.] CNR, Inst Neurosci, Padua, Italy	University of Padua; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Tosatto, SCE (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.; Tosatto, SCE (corresponding author), CNR, Inst Neurosci, Padua, Italy.	silvio.tosatto@unipd.it	Ferrari, Carlo/AAU-8107-2021; Reggiani, Francesco/AAG-4589-2021; VETTOR, ROBERTO/K-7121-2016; Tosatto, Silvio/B-2840-2009	Tosatto, Silvio/0000-0003-4525-7793; reggiani, francesco/0000-0003-4144-4292	Italian Ministry of Health [GR-2011-02346845]	Italian Ministry of Health(Ministry of Health, Italy)	The project was supported by the Italian Ministry of Health grant GR-2011-02346845. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canty A., 2017, PACKAGE BOOT BOOTSTR; Carraro M, 2017, HUM MUTAT, V38, P1042, DOI 10.1002/humu.23235; Cazzaniga P, 2014, METABOLITES, V4, P1034, DOI 10.3390/metabo4041034; Daneshjou R, 2017, HUM MUTAT, V38, P1182, DOI 10.1002/humu.23280; Davison AC, 1997, BOOTSTRAP METHODS TH; Elzhov T.V., 2016, R INTERFACE LEVENBER, P14; Gidding SS, 2015, CIRCULATION, V132, P2167, DOI 10.1161/CIR.0000000000000297; Golan D.E., 2012, PRINCIPLES PHARM PAT; Guo JY, 2019, ATHEROSCLEROSIS, V281, P1, DOI 10.1016/j.atherosclerosis.2018.12.003; Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977; Marduel M, 2013, HUM MUTAT, V34, P83, DOI 10.1002/humu.22215; Monzon AM, 2019, HUM MUTAT, V40, P1474, DOI 10.1002/humu.23856; Paalvast Y, 2015, BBA-MOL CELL BIOL L, V1851, P1360, DOI 10.1016/j.bbalip.2015.05.008; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; R Core Team, 2013, R LANG ENV STAT COMP; Ramos-Lopez O, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/4283078; Shapiro MD, 2000, ENDOTEXT; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Spiliopoulou A, 2015, HUM MOL GENET, V24, P4167, DOI 10.1093/hmg/ddv145; van de Pas NCA, 2012, J LIPID RES, V53, P2734, DOI 10.1194/jlr.M031930; van de Pas NCA, 2010, BBA-MOL CELL BIOL L, V1801, P646, DOI 10.1016/j.bbalip.2010.02.009; Verbeek R, 2015, EUR J PHARMACOL, V763, P38, DOI 10.1016/j.ejphar.2015.03.099; White A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005227; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yu HW, 2000, HUM MOL GENET, V9, P1385, DOI 10.1093/hmg/9.9.1385	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0227191	10.1371/journal.pone.0227191	http://dx.doi.org/10.1371/journal.pone.0227191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040480	gold, Green Published, Green Submitted			2022-12-26	WOS:000534629400008
J	Tachibana, RO; Kanno, K; Okabe, S; Kobayasi, KI; Okanoya, K				Tachibana, Ryosuke O.; Kanno, Kouta; Okabe, Shota; Kobayasi, Kohta I.; Okanoya, Kazuo			USVSEG: A robust method for segmentation of ultrasonic vocalizations in rodents	PLOS ONE			English	Article							INDUCED DEFENSE BEHAVIOR; DEVELOPMENTAL-CHANGES; MATERNAL-BEHAVIOR; RATTUS-NORVEGICUS; MONGOLIAN GERBIL; ANIMAL-MODELS; MOUSE MODEL; RATS; COMMUNICATION; CLASSIFICATION	Rodents' ultrasonic vocalizations (USVs) provide useful information for assessing their social behaviors. Despite previous efforts in classifying subcategories of time-frequency patterns of USV syllables to study their functional relevance, methods for detecting vocal elements from continuously recorded data have remained sub-optimal. Here, we propose a novel procedure for detecting USV segments in continuous sound data containing background noise recorded during the observation of social behavior. The proposed procedure utilizes a stable version of the sound spectrogram and additional signal processing for better separation of vocal signals by reducing the variation of the background noise. Our procedure also provides precise time tracking of spectral peaks within each syllable. We demonstrated that this procedure can be applied to a variety of USVs obtained from several rodent species. Performance tests showed this method had greater accuracy in detecting USV syllables than conventional detection methods.	[Tachibana, Ryosuke O.; Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts Sci, Dept Life Sci, Tokyo, Japan; [Kanno, Kouta] Kagoshima Univ, Fac Law Econ & Humanities, Dept Humanities, Lab Neurosci,Course Psychol, Kagoshima, Japan; [Okabe, Shota] Jichi Med Univ, Dept Physiol, Div Brain & Neurophysiol, Shimotsuke, Tochigi, Japan; [Kobayasi, Kohta I.] Doshisha Univ, Grad Sch Life & Med Sci, Kyoto, Japan	University of Tokyo; Kagoshima University; Jichi Medical University; Doshisha University	Tachibana, RO (corresponding author), Univ Tokyo, Grad Sch Arts Sci, Dept Life Sci, Tokyo, Japan.	rtachi@gmail.com	Kanno, Kouta/AGO-0087-2022	Kanno, Kouta/0000-0003-0061-6158; Tachibana, Ryosuke/0000-0002-4766-4504; Okabe, Shota/0000-0003-3448-3584	MEXT/JSPS KAKENHI [14J09362, 16H06528, 18K13371, 19H04912, 17H05956, 18H05089, 17H06380]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI Grant No. 14J09362 to ROT, 16H06528, 18K13371 and 19H04912 to KK, 17H05956 to SO, 18H05089 to KIK, and 17H06380 to KO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaba A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00231; Beckett SRG, 1996, PSYCHOPHARMACOLOGY, V127, P384, DOI 10.1007/s002130050102; Beckett SRG, 1997, BRAIN RES BULL, V42, P421, DOI 10.1016/S0361-9230(96)00332-2; BLANCHARD DC, 1991, ADV PHAR SC, P117; Borta A, 2006, BEHAV BRAIN RES, V166, P271, DOI 10.1016/j.bbr.2005.08.009; Bowers JM, 2013, J NEUROSCI, V33, P3276, DOI 10.1523/JNEUROSCI.0425-12.2013; BROOM DM, 1977, J ZOOL, V183, P281; Brudzynski SM, 2015, CURR NEUROPHARMACOL, V13, P180, DOI 10.2174/1570159X13999150210141444; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Burkett ZD, 2015, SCI REP-UK, V5, DOI 10.1038/srep10237; Chabout J, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00197; Chabout J, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00076, 10.3389/fnbh.2015.00076]; Coffey KR, 2019, NEUROPSYCHOPHARMACOL, V44, P859, DOI 10.1038/s41386-018-0303-6; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; DEGHETT VJ, 1974, DEV PSYCHOBIOL, V7, P267, DOI 10.1002/dev.420070311; Egnor SER, 2016, CURR OPIN NEUROBIOL, V38, P1, DOI 10.1016/j.conb.2015.12.009; ELWOOD RW, 1975, ANIM BEHAV, V23, P766, DOI 10.1016/0003-3472(75)90104-9; Ey E, 2013, BEHAV BRAIN RES, V256, P677, DOI 10.1016/j.bbr.2013.08.031; Farrell WJ, 2002, J COMP PSYCHOL, V116, P297, DOI 10.1037//0735-7036.116.3.297; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; FRANCIS RL, 1977, NATURE, V265, P236, DOI 10.1038/265236a0; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Ishiyama S, 2016, SCIENCE, V354, P757, DOI 10.1126/science.aah5114; Jelen P, 2003, BEHAV BRAIN RES, V141, P63, DOI 10.1016/S0166-4328(02)00321-2; Kanno K, 2018, ZOOL SCI, V35, P208, DOI 10.2108/zs170175; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Kobayasi KI, 2014, J ETHOL, V32, P7, DOI 10.1007/s10164-013-0387-8; Kobayasi KI, 2013, NEUROSCI LETT, V534, P24, DOI 10.1016/j.neulet.2012.10.056; Kobayasi KI, 2012, J ACOUST SOC AM, V131, P1622, DOI 10.1121/1.3672693; Konopka G, 2016, BIOL PSYCHIAT, V79, P53, DOI 10.1016/j.biopsych.2015.07.001; Lahvis GP, 2011, GENES BRAIN BEHAV, V10, P4, DOI 10.1111/j.1601-183X.2010.00603.x; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Marlin BJ, 2015, NATURE, V520, P499, DOI 10.1038/nature14402; Matsumoto YK, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180378; Matsumoto YK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147102; McGinnis MY, 2003, PHYSIOL BEHAV, V80, P81, DOI 10.1016/S0031-9384(03)00227-0; Mogi K, 2017, BEHAV BRAIN RES, V325, P138, DOI 10.1016/j.bbr.2016.08.044; nee Sewell G.D.S., 2009, J ZOOL, V168, P149; Nishiyama K, 2011, J ACOUST SOC AM, V130, P4148, DOI 10.1121/1.3651815; NYBY J, 1983, BEHAV NEURAL BIOL, V39, P128, DOI 10.1016/S0163-1047(83)90722-7; NYBY J, 1976, BEHAV BIOL, V18, P285, DOI 10.1016/S0091-6773(76)92198-2; Okabe S, 2013, BEHAV NEUROSCI, V127, P432, DOI 10.1037/a0032395; Okabe S, 2012, ANIM SCI J, V83, P446, DOI 10.1111/j.1740-0929.2012.01014.x; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Portfors CV, 2014, CURR OPIN NEUROBIOL, V28, P115, DOI 10.1016/j.conb.2014.07.002; Riede T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170976; Saito Y, 2016, BEHAV PROCESS, V132, P5, DOI 10.1016/j.beproc.2016.08.005; SALES GD, 1979, AM ZOOL, V19, P513; Sales GD, 2010, HBK BEHAV NEUROSCI, V19, P77, DOI 10.1016/B978-0-12-374593-4.00009-7; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Sugimoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022093; Tachibana RO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092584; Takahashi T, 2016, MOL PSYCHIATR, V21, P1208, DOI 10.1038/mp.2015.190; Ter-Mikaelian M, 2012, BEHAVIOUR, V149, P461, DOI 10.1163/156853912X639778; THOMAS DA, 1982, BEHAV NEURAL BIOL, V36, P403, DOI 10.1016/S0163-1047(82)90802-0; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Van Segbroeck M, 2017, NEURON, V94, P465, DOI 10.1016/j.neuron.2017.04.005; Wohr M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001365; Wright JM, 2010, PSYCHOPHARMACOLOGY, V211, P1, DOI 10.1007/s00213-010-1859-y; Zala SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181200; Zimmerberg B, 2003, DEV PSYCHOBIOL, V42, P52, DOI 10.1002/dev.10086	63	21	21	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228907	10.1371/journal.pone.0228907	http://dx.doi.org/10.1371/journal.pone.0228907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9IO	32040540	gold, Green Published			2022-12-26	WOS:000534629400053
J	Hills, SP; Radcliffe, JN; Barwood, MJ; Arent, SM; Cooke, CB; Russell, M				Hills, Samuel P.; Radcliffe, Jon N.; Barwood, Martin J.; Arent, Shawn M.; Cooke, Carlton B.; Russell, Mark			Practitioner perceptions regarding the practices of soccer substitutes	PLOS ONE			English	Article							WARM-UP STRATEGIES; PLAYER SUBSTITUTIONS; 120 MIN; MATCH; FATIGUE; PERFORMANCE; TIME; INJURY; SPORT; PREVENTION	Despite empirical observations suggesting that practitioners value the use of substitutions during soccer match-play, limited research has sought to substantiate such claims. This study used online surveys to assess the perceptions of practitioners within professional soccer about the use and practices of substitutes. Thirty-three practitioners completed one of two surveys (each requiring both open and closed questions to be answered), depending upon whether their primary role related mostly to tactical ('tactical practitioners'; n = 7) or physical ('physical practitioners'; n = 26) aspects of player/team management. Thematic content analysis of responses identified four higher-order themes: 'impact of substitutions', 'planning and communication', 'player preparation and recovery' and 'regulations'. Eighty-five percent of practitioners believed that substitutes are important in determining success during soccer match-play, with the primary justification being the perceived ability of such players to provide a physical and/or tactical impact. However, contextual factors such as the match situation, timing of introduction, and players undergoing adequate pre-pitch-entry preparation, may be important for realising such aims. Although many practitioners believed that there was a need for substitutes to engage in bespoke non-match-day preparations and recovery strategies that differ from starting players, logistical considerations, such as scarcity of resources, often limit their scope. Notwithstanding, 96% of respondents indicated that substitutes frequently perform extra conditioning sessions to account for deficits in highspeed running loads compared with players exposed to a longer period of match-play. Substitutes' pre-match warm-ups are typically led by team staff, however practitioners reported providing varying levels of input with regards to the practices adopted between kick-off and pitch-entry. Uncertainty exists as to the efficacy of current pre-pitch-entry practices, and 100% of practitioners highlighted 'preparatory strategies' as at least a 'moderately important' direction for future research. This study presents novel insights and highlights areas that are considered future research priorities amongst those working in the field.	[Hills, Samuel P.; Radcliffe, Jon N.; Barwood, Martin J.; Cooke, Carlton B.; Russell, Mark] Leeds Trinity Univ, Sch Social & Hlth Sci, Leeds, W Yorkshire, England; [Arent, Shawn M.] Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Russell, M (corresponding author), Leeds Trinity Univ, Sch Social & Hlth Sci, Leeds, W Yorkshire, England.	m.russell@leedstrinity.ac.uk	Russell, Mark/M-1652-2019	Russell, Mark/0000-0002-7305-1090; Radcliffe, Jon/0000-0001-5409-4338; Hills, Samuel/0000-0002-8622-4333				Akenhead R, 2016, INT J SPORT PHYSIOL, V11, P587, DOI 10.1123/ijspp.2015-0331; Association FIdF, 2018, FIFA LAWS GAM ZUR; Bangsbo J, 1994, Acta Physiol Scand Suppl, V619, P1; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; Bangsbo J, 2007, INT J SPORT PHYSIOL, V2, P111, DOI 10.1123/ijspp.2.2.111; Bishop D, 2008, SPORTS MED, V38, P253, DOI 10.2165/00007256-200838030-00005; Bixler B, 1992, Fam Pract Res J, V12, P131; Bradley PS, 2018, INT J SPORT PHYSIOL, V13, P656, DOI 10.1123/ijspp.2017-0433; Bradley PS, 2014, INT J SPORT PHYSIOL, V9, P415, DOI [10.1123/ijspp.2013-0304, 10.1123/IJSPP.2013-0304]; Bradley PS, 2013, J SPORT SCI, V31, P1261, DOI 10.1080/02640414.2013.786185; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buckthorpe M, 2019, BRIT J SPORT MED, V53, P449, DOI 10.1136/bjsports-2018-099616; Carling C, 2010, J SCI MED SPORT, V13, P253, DOI 10.1016/j.jsams.2009.02.012; Colby MJ, 2018, INT J SPORT PHYSIOL, V13, P1130, DOI 10.1123/ijspp.2017-0696; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Crowther RG, 2017, SPORTS, V5, DOI 10.3390/sports5020027; Del Corral J, 2008, J SPORT ECON, V9, P160, DOI 10.1177/1527002507308309; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; Drust B, 2013, J SPORT SCI, V31, P1377, DOI 10.1080/02640414.2013.828544; Duhig S, 2016, BRIT J SPORT MED, V50, P1536, DOI 10.1136/bjsports-2015-095679; Fradkin AJ, 2006, J SCI MED SPORT, V9, P214, DOI 10.1016/j.jsams.2006.03.026; Gai Y, 2019, INT J PERF ANAL SPOR, V19, P878, DOI 10.1080/24748668.2019.1669356; Gomez MA, 2016, INT J PERF ANAL SPOR, V16, P553, DOI 10.1080/24748668.2016.11868908; Goodall S, 2017, EUR J APPL PHYSIOL, V117, P687, DOI 10.1007/s00421-017-3561-9; Harper LD, 2017, INT J SPORT PHYSIOL, V12, P990, DOI 10.1123/ijspp.2017-0081; Harper LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157687; Harper LD, 2016, J SCI MED SPORT, V19, P509, DOI 10.1016/j.jsams.2015.06.009; Harper LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110995; Hills SP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211563; Hills SP, 2018, SPORTS MED, V48, P2255, DOI 10.1007/s40279-018-0962-9; Krustrup P, 2006, MED SCI SPORT EXER, V38, P1165, DOI 10.1249/01.mss.0000222845.89262.cd; Lovell R, 2013, SCAND J MED SCI SPOR, V23, P105, DOI 10.1111/j.1600-0838.2011.01353.x; Mazzetti SA, 2000, MED SCI SPORT EXER, V32, P1175, DOI 10.1097/00005768-200006000-00023; McCall A, 2015, BRIT J SPORT MED, V49, P603, DOI 10.1136/bjsports-2015-094747; McCall A, 2014, BRIT J SPORT MED, V48, P1352, DOI 10.1136/bjsports-2014-093439; McGowan CJ, 2015, SPORTS MED, V45, P1523, DOI 10.1007/s40279-015-0376-x; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Mohr M, 2004, SCAND J MED SCI SPOR, V14, P156, DOI 10.1111/j.1600-0838.2004.00349.x; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Morgans R, 2018, INT J SPORT PHYSIOL, V13, P665, DOI 10.1123/ijspp.2016-0412; Myers BR, 2012, J QUANT ANAL SPORTS, V8, DOI 10.1515/1559-0410.1349; Padron-Cabo A, 2018, J HUM KINET, V65, P165, DOI 10.2478/hukin-2018-0025; Rampinini E, 2011, MED SCI SPORT EXER, V43, P2161, DOI 10.1249/MSS.0b013e31821e9c5c; Rampinini E, 2009, J SCI MED SPORT, V12, P227, DOI 10.1016/j.jsams.2007.10.002; Reilly T, 2009, J SPORT SCI, V27, P575, DOI 10.1080/02640410902729741; Rey E, 2015, INT J PERF ANAL SPOR, V15, P840, DOI 10.1080/24748668.2015.11868835; Russell M, 2018, J SCI MED SPORT, V21, P327, DOI 10.1016/j.jsams.2017.06.005; Russell M, 2015, J SPORT SCI, V33, P2133, DOI 10.1080/02640414.2015.1064153; Russell M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119374; Russell M, 2012, J SCI MED SPORT, V15, P348, DOI 10.1016/j.jsams.2011.12.006; Russell M, 2011, INT J SPORT PHYSIOL, V6, P221, DOI 10.1123/ijspp.6.2.221; SAFRAN MR, 1988, AM J SPORT MED, V16, P123, DOI 10.1177/036354658801600206; Shi L, 2019, DYNAM SYST APPL, V28, P1, DOI 10.12732/dsa.v28i1.1; Silva JR, 2011, J STRENGTH COND RES, V25, P2729, DOI 10.1519/JSC.0b013e31820da078; Silva LM, 2018, SPORTS MED, V48, P2285, DOI 10.1007/s40279-018-0958-5; Stevenson EJ, 2017, EUR J APPL PHYSIOL, V117, P2321, DOI 10.1007/s00421-017-3719-5; Stolen T, 2005, SPORTS MED, V35, P501; Towlson C, 2013, J SPORT SCI, V31, P1393, DOI 10.1080/02640414.2013.792946; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; West DJ, 2013, J SCI MED SPORT, V16, P172, DOI 10.1016/j.jsams.2012.06.002; Woods B, 2009, SPORT PSYCHOL, V23, P451, DOI 10.1123/tsp.23.4.451; Woods K, 2007, SPORTS MED, V37, P1089, DOI 10.2165/00007256-200737120-00006	62	10	10	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228790	10.1371/journal.pone.0228790	http://dx.doi.org/10.1371/journal.pone.0228790			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032369	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000534626100025
J	Haderski, GJ; Kander, BM; Brackett, CM; Toshkov, IM; Johnson, CP; Paszkiewicz, GM; Natarajan, V; Gleiberman, AS; Gudkov, AV; Burdelya, LG				Haderski, Gary J.; Kander, Bojidar M.; Brackett, Craig M.; Toshkov, Ilia M.; Johnson, Christopher P.; Paszkiewicz, Geraldine M.; Natarajan, Venkatesh; Gleiberman, Anatoli S.; Gudkov, Andrei, V; Burdelya, Lyudmila G.			TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ISOLATED HEPATIC PERFUSION; TOLL-LIKE RECEPTORS; FACTOR-ALPHA; PROTECTS MICE; PROGRESSION; CELLS; LPS; ANTICANCER; ACTIVATION	Tumor necrosis factor alpha (TNF) is capable of inducing regression of solid tumors. However, TNF released in response to Toll-like receptor 4 (TLR4) activation by bacterial lipopolysaccharide (LPS) is the key mediator of cytokine storm and septic shock that can cause severe tissue damage limiting anticancer applications of this cytokine. In our previous studies, we demonstrated that activation of another Toll-like receptor, TLR5, could protect from tissue damage caused by a variety of stresses including radiation, chemotherapy, Fas-activating antibody and ischemia-reperfusion. In this study, we tested whether entolimod could counteract TNF-induced toxicity in mouse models. We found that entolimod pretreatment effectively protects livers and lungs from LPS- and TNF-induced toxicity and prevents mortality caused by combining either of these agents with the sensitizer, D-galactosamine. While LPS and TNF induced significant activation of apoptotic caspase 3/7, lipid tissue peroxidation and serum ALT accumulation in mice without entolimod treatment, these indicators of toxicity were reduced by entolimod pretreatment to the levels of untreated control mice. Entolimod was effective when injected 0.5-48 hours prior to, but not when injected simultaneously or after LPS or TNF. Using chimeric mice with hematopoiesis differing in its TLR5 status from the rest of tissues, we showed that this protective activity was dependent on TLR5 expression by non-hematopoietic cells. Gene expression analysis identified multiple genes upregulated by entolimod in the liver and cultured hepatocytes as possible mediators of its protective activity. Entolimod did not interfere with the antitumor activity of TNF in mouse hepatocellular and colorectal tumor models. These results support further development of TLR5 agonists to increase tissue resistance to cytotoxic cytokines, reduce the risk of septic shock and enable safe systemic application of TNF as an anticancer therapy.	[Haderski, Gary J.; Kander, Bojidar M.; Brackett, Craig M.; Johnson, Christopher P.; Paszkiewicz, Geraldine M.; Natarajan, Venkatesh; Gudkov, Andrei, V; Burdelya, Lyudmila G.] Roswell Park Comprehens Canc Ctr, Dept Cell Stress Biol, Buffalo, NY 14203 USA; [Toshkov, Ilia M.; Gleiberman, Anatoli S.] Genome Protect Inc, Buffalo, NY USA; [Natarajan, Venkatesh] Univ Southern Calif, Dept Med, Los Angeles, CA 90007 USA	University of Southern California	Gudkov, AV; Burdelya, LG (corresponding author), Roswell Park Comprehens Canc Ctr, Dept Cell Stress Biol, Buffalo, NY 14203 USA.	Andrei.Gudkov@RoswellPark.org; Lyudmila.Burdelya@RoswellPark.org		gleiberman, anatoli/0000-0001-8491-0826; Burdelya, Lyudmila/0000-0001-8632-9154	American Cancer Society [02-197-04]; Roswell Park Comprehensive Cancer Center; National Cancer Institute [P30CA016056]; National Institutes of Health (US) [R21CA22646301A1]	American Cancer Society(American Cancer Society); Roswell Park Comprehensive Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported, in part, by the American Cancer Society Institutional Research Grant 02-197-04 to L.G.B. and by the Roswell Park Comprehensive Cancer Center and National Cancer Institute grant P30CA016056 and National Institutes of Health (US) grant R21CA22646301A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Al-Alwan LA, 2013, J IMMUNOL, V191, P2731, DOI 10.4049/jimmunol.1203421; Andrades ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10334; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Ballesteros-Martinez C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01323; Baston-Bust DM, 2013, CYTOKINE, V64, P79, DOI 10.1016/j.cyto.2013.07.023; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Beutler B, 2001, DRUG METAB DISPOS, V29, P474; Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004; Brackett CM, 2016, P NATL ACAD SCI USA, V113, pE874, DOI 10.1073/pnas.1521359113; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Burdelya LG, 2012, INT J RADIAT ONCOL, V83, P228, DOI 10.1016/j.ijrobp.2011.05.055; Cai ZY, 2011, CANCER RES, V71, P2466, DOI 10.1158/0008-5472.CAN-10-1993; Carvalho FA, 2011, MUCOSAL IMMUNOL, V4, P102, DOI 10.1038/mi.2010.57; Cavaillon JM, 2018, TOXICON, V149, P45, DOI 10.1016/j.toxicon.2017.10.016; Chen XP, 2008, CURR HYPERTENS REV, V4, P245, DOI 10.2174/157340208786241336; Cherix S, 2008, J SURG ONCOL, V98, P148, DOI 10.1002/jso.21081; Dang DM, 2018, ONCOL LETT, V16, P1425, DOI 10.3892/ol.2018.8847; Delano MJ, 2016, IMMUNOL REV, V274, P330, DOI 10.1111/imr.12499; Eggermont Alexander M M, 2003, Curr Oncol Rep, V5, P79, DOI 10.1007/s11912-003-0091-x; Facy O, 2014, J VISC SURG, V151, pS25, DOI 10.1016/j.jviscsurg.2013.12.006; Fougere-Deschatrette C, 2006, STEM CELLS, V24, P2098, DOI 10.1634/stemcells.2006-0009; Fukuzawa N, 2011, J IMMUNOL, V187, P3831, DOI 10.4049/jimmunol.1003238; Guo JS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-21; Jones A, 2008, SURG ONCOL CLIN N AM, V17, P857, DOI 10.1016/j.soc.2008.04.011; Josephs SF, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1611-7; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; Kocijancic D, 2017, ONCOTARGET, V8, P36492, DOI 10.18632/oncotarget.16906; Kojouharov BM, 2014, ONCOTARGET, V5, P802, DOI 10.18632/oncotarget.1773; Kono K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.207; Krivokrysenko VI, 2012, J PHARMACOL EXP THER, V343, P497, DOI 10.1124/jpet.112.196071; KUEI JH, 1989, CHEST, V96, P334, DOI 10.1378/chest.96.2.334; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Li M, 2018, INT J MOL MED, V42, P1756, DOI 10.3892/ijmm.2018.3747; Mahar M, 2018, NAT REV NEUROSCI, V19, P323, DOI 10.1038/s41583-018-0001-8; Mignon A, 1999, AM J RESP CRIT CARE, V159, P1308, DOI 10.1164/ajrccm.159.4.9712012; NOWAK M, 2000, AM J PHYSIOL-REG I, V278, pR120, DOI DOI 10.1152/AJPREGU.2000.278.5.R1202; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Pelus LM, 2006, EXP HEMATOL, V34, P1010, DOI 10.1016/j.exphem.2006.04.004; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Riad A, 2008, EUR J HEART FAIL, V10, P233, DOI 10.1016/j.ejheart.2008.01.004; Roberts NJ, 2011, ONCOTARGET, V2, P739; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Steeland S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051442; Toshkov IA, 2017, RADIAT RES, V187, P570, DOI 10.1667/RR14514.1; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Vijay-Kumar M, 2008, INFECT IMMUN, V76, P1276, DOI 10.1128/IAI.01491-07; Wu ZF, 2018, ONCOL LETT, V15, P9599, DOI 10.3892/ol.2018.8583; Yan F, 2017, ONCOTARGET, V8, P47020, DOI 10.18632/oncotarget.16638; Yi PS, 2019, J CELL PHYSIOL, V234, P21479, DOI 10.1002/jcp.28877; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Zhang T, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0529-x; Zhao X, 2016, CLIN RES HEPATOL GAS, V40, P730, DOI 10.1016/j.clinre.2016.04.003	58	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0227940	10.1371/journal.pone.0227940	http://dx.doi.org/10.1371/journal.pone.0227940			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027657	gold, Green Published			2022-12-26	WOS:000534623800013
J	Maguire, M; Larsen, MC; Vezina, CM; Quadro, L; Kim, YK; Tanumihardjo, SA; Jefcoate, CR				Maguire, Meghan; Larsen, Michele Campaigne; Vezina, Chad M.; Quadro, Loredana; Kim, Youn-Kyung; Tanumihardjo, Sherry A.; Jefcoate, Colin R.			Cyp1b1 directs Srebp-mediated cholesterol and retinoid synthesis in perinatal liver; Association with retinoic acid activity during fetal development	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; DEHYDROGENASE 10; LIPID-METABOLISM; EXPRESSION; TISSUE; CELLS; ACTIVATION; REGULATOR; HOXB1; HOMEOSTASIS	Background Cytochrome P450 1b1 (Cyp1b1) deletion and dietary retinol deficiency during pregnancy (GVAD) affect perinatal liver functions regulated by Srebp. Cyp1b1 is not expressed in perinatal liver but appears in the E9.5 embryo, close to sites of retinoic acid (RA) signaling. Hypothesis Parallel effects of Cyp1b1 and retinol on postnatal Srebp derive from effects in the developing liver or systemic signaling. Approach Cluster postnatal increases in hepatic genes in relation to effects of GVAD or Cyp1b1 deletion. Sort expression changes in relation to genes regulated by Srebp1 and Srebp2.Test these treatments on embryos at E9.5, examining changes at the site of liver initiation. Use in situ hybridization to resolve effects on mRNA distributions of Aldh1a2 and Cyp26a1 (RA homeostasis); Hoxb1 and Pax6 (RA targets). Assess mice lacking Lrat and Rbp4 (DKO mice) that severely limits retinol supply to embryos. Results At birth, GVAD and Cyp1b1 deletion stimulate gene markers of hepatic stellate cell (HSC) activation but also suppress Hamp. These treatments then selectively prevent the postnatal onset of genes that synthesize cholesterol (Hmgcr, Sqle) and fatty acids (Fasn, Scd1), but also direct cholesterol transport (Ldlr, Pcsk9, Stard4) and retinoid synthesis (Aldh1a1, Rdh11). Extensive support by Cyp1b1 is implicated, but with distinct GVAD interventions for Srebp1 and Srebp2. At E9.5, Cyp1b1 is expressed in the septum transversum mesenchyme (STM) with beta-carotene oxygenase (Bco1) that generates retinaldehyde. STM provides progenitors for the HSC and supports liver expansion. GVAD and Cyp1b1-/- do not affect RA-dependent Hoxb1 and Pax6. In DKO embryos, RA-dependent Cyp26a1 is lost but Hoxb1 is sustained with Cyp1b1 at multiple sites. Conclusion Cyp1b1-/- suppresses genes supported by Srebp. GVAD effects distinguish Srebp1 and Srebp2 mediation. Srebp regulation overlaps appreciably in cholesterol and retinoid homeostasis. Bco1/Cyp1b1 partnership in the STM may contribute to this later liver regulation.	[Maguire, Meghan] Univ Wisconsin, Endocrinol & Reprod Physiol Program, Madison, WI USA; [Maguire, Meghan; Larsen, Michele Campaigne; Jefcoate, Colin R.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53705 USA; [Vezina, Chad M.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA; [Quadro, Loredana; Kim, Youn-Kyung] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ USA; [Quadro, Loredana; Kim, Youn-Kyung] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ USA; [Tanumihardjo, Sherry A.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Wisconsin System; University of Wisconsin Madison	Jefcoate, CR (corresponding author), Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53705 USA.	jefcoate@wisc.edu	Vezina, Chad/GRO-2299-2022	Larsen, Michele/0000-0001-7497-1510; Jefcoate, Colin/0000-0002-1739-6211; Kim, Youn-kyung/0000-0003-3916-8444; Vezina, Chad/0000-0001-7058-5399	National Institutes of Health [R01 DK090249, T32 HD041921, NIH U54DK104310, R01ES001332, R01DK099328, R01HD083331, R01EY027405]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from the National Institutes of Health: R01 DK090249 (CRJ), T32 HD041921 (MM), NIH U54DK104310 (CV), R01ES001332 (CV), R01DK099328 (CV), R01HD083331 (LQ), R01EY027405 (LQ) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Alexander DL, 1998, J CELL SCI, V111, P3311; Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049; Ang HL, 1999, EUR J BIOCHEM, V260, P227, DOI 10.1046/j.1432-1327.1999.00139.x; Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Belyaeva OV, 2018, J BIOL CHEM, V293, P6996, DOI 10.1074/jbc.RA117.001646; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; BLESS EP, 2016, ENEURO, V3, DOI DOI 10.1038/SREP23459; Brown NA, 1990, POSTIMPLANTATION MAM, P93; Bushkofsky JR, 2016, ARCH BIOCHEM BIOPHYS, V597, P30, DOI 10.1016/j.abb.2016.03.030; Chambers D, 2007, DEVELOPMENT, V134, P1369, DOI 10.1242/dev.02815; Chen H, 2000, DRUG METAB DISPOS, V28, P315; Cho YC, 2005, ARCH BIOCHEM BIOPHYS, V439, P139, DOI 10.1016/j.abb.2005.04.025; Choe SK, 2011, DEV BIOL, V358, P356, DOI 10.1016/j.ydbio.2011.05.676; Choudhary D, 2003, ARCH BIOCHEM BIOPHYS, V414, P91, DOI 10.1016/S0003-9861(03)00174-7; Cunningham TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137894; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; de Lera AR, 2016, CHEMMEDCHEM, V11, P1027, DOI 10.1002/cmdc.201600105; Dempsie Y, 2013, CARDIOVASC RES, V99, P24, DOI 10.1093/cvr/cvt064; Deng X, 2015, BBA-MOL CELL BIOL L, V1851, P1521, DOI 10.1016/j.bbalip.2015.08.007; Dong QM, 2020, MOL CELL BIOCHEM, V463, P13, DOI 10.1007/s11010-019-03625-5; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Grindheim JM, 2019, GASTROENTEROLOGY, V156, P1834, DOI 10.1053/j.gastro.2019.01.041; Grindheim JM, 2019, GASTROENTEROLOGY; Guo LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32093; Han YM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08585-4; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Huang DY, 2002, DEV DYNAM, V223, P353, DOI 10.1002/dvdy.10057; Huq MDM, 2006, EMBO J, V25, P3203, DOI 10.1038/sj.emboj.7601181; Iaea DB, 2017, MOL BIOL CELL, V28, P1111, DOI 10.1091/mbc.E16-07-0499; Kamarudin TA, 2018, STEM CELLS, V36, P337, DOI 10.1002/stem.2750; Kayam G, 2013, DEVELOPMENT, V140, P2190, DOI 10.1242/dev.089136; Keil KP, 2012, DIFFERENTIATION, V84, P232, DOI 10.1016/j.diff.2012.07.005; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Kim YK, 2015, ARCH BIOCHEM BIOPHYS, V572, P11, DOI 10.1016/j.abb.2015.01.002; Kim YK, 2011, FASEB J, V25, P1641, DOI 10.1096/fj.10-175448; Kolterud A, 2004, GENE EXPR PATTERNS, V4, P521, DOI 10.1016/j.modgep.2004.03.001; Larsen MC, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.245; Larsen MC, 2015, ARCH BIOCHEM BIOPHYS, V571, P21, DOI 10.1016/j.abb.2015.02.010; Lefevre L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7801; Li F, 2017, PHARMACOL THERAPEUT, V178, P18, DOI 10.1016/j.pharmthera.2017.03.007; Libby RT, 2003, SCIENCE, V299, P1578, DOI 10.1126/science.1080095; Liu ZK, 2019, J BIOL CHEM, V294, P3137, DOI 10.1074/jbc.RA118.005761; Maguire M, 2017, MOL CELL ENDOCRINOL, V454, P50, DOI 10.1016/j.mce.2017.05.037; Maguire M, 2017, J NUTR BIOCHEM, V47, P63, DOI 10.1016/j.jnutbio.2017.04.009; Maiers JL, 2019, SEMIN LIVER DIS, V39, P235, DOI 10.1055/s-0039-1681032; McLennan R, 2010, DEV DYNAM, V239, P1664, DOI 10.1002/dvdy.22303; Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Molotkov A, 2003, J BIOL CHEM, V278, P36085, DOI 10.1074/jbc.M303709200; Napoli JL, 2017, PHARMACOL THERAPEUT, V173, P19, DOI 10.1016/j.pharmthera.2017.01.004; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nicholls HT, 2017, AM J PHYSIOL-GASTR L, V313, pG50, DOI 10.1152/ajpgi.00379.2016; Ohshiro T, 2015, J PHARMACOL EXP THER, V355, P297, DOI 10.1124/jpet.115.227348; Palaria A, 2018, HEPATOLOGY, V68, P274, DOI 10.1002/hep.29769; Palenski TL, 2013, AM J PHYSIOL-CELL PH, V305, pC1170, DOI 10.1152/ajpcell.00139.2013; Pang XY, 2017, ARCH BIOCHEM BIOPHYS, V633, P93, DOI 10.1016/j.abb.2017.09.009; Pingili AK, 2017, HYPERTENSION, V69, P1104, DOI 10.1161/HYPERTENSIONAHA.117.09175; Piscaglia F, 1999, BIOCHEM PHARMACOL, V58, P157, DOI 10.1016/S0006-2952(99)00066-0; POTTENGER LH, 1990, CARCINOGENESIS, V11, P321, DOI 10.1093/carcin/11.2.321; Rabanal-Ruiz Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030818; Rasband W.S., 1997, IMAGEJ; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ribes V, 2007, DEV BIOL, V303, P66, DOI 10.1016/j.ydbio.2006.10.032; Romani P, 2019, NAT CELL BIOL, V21, P338, DOI 10.1038/s41556-018-0270-5; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Rossel M, 1999, DEVELOPMENT, V126, P5027; Rouschop SH, 2019, J LIPID RES, V60, P1250, DOI 10.1194/jlr.M092593; Roux M, 2015, DEV BIOL, V406, P247, DOI 10.1016/j.ydbio.2015.08.015; Saito K, 2016, SCI REP-UK, V6, DOI 10.1038/srep23459; SATRE MA, 1992, BIOL REPROD, V46, P802, DOI 10.1095/biolreprod46.5.802; SAVAS U, 1994, J BIOL CHEM, V269, P14905; Seo K, 2017, TOX RESEARCH, V33, P219, DOI 10.5487/TR.2017.33.3.219; Seok SH, 2018, J BIOL CHEM, V293, P1994, DOI 10.1074/jbc.RA117.000631; Shen K, 2018, P NATL ACAD SCI USA, V115, P9545, DOI 10.1073/pnas.1811727115; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Soccio RE, 2005, J BIOL CHEM, V280, P19410, DOI 10.1074/jbc.M501778200; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; Studer M, 1998, DEVELOPMENT, V125, P1025; Su L, 2019, EMBO J, V38, DOI 10.15252/embj.2018100156; Tang YX, 2010, AM J PHYSIOL-CELL PH, V298, pC665, DOI 10.1152/ajpcell.00153.2009; Thomas SE, 2016, J LIPID RES, V57, P1865, DOI 10.1194/jlr.M070193; Uehara M, 2007, DEV BIOL, V302, P399, DOI 10.1016/j.ydbio.2006.09.045; Vollrath AL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-280; Wang JK, 2015, DEV DYNAM, V244, P431, DOI 10.1002/dvdy.24215; Williams AL, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20235; Xu GQ, 2015, ONCOTARGET, V6, P33636, DOI 10.18632/oncotarget.5602; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zaret KS, 2016, CURR TOP DEV BIOL, V117, P647, DOI 10.1016/bs.ctdb.2015.12.015; Zhao Yun, 2015, J Ophthalmic Vis Res, V10, P60, DOI 10.4103/2008-322X.156116; Zhao Y, 2013, MOL CELL BIOL, V33, P4225, DOI 10.1128/MCB.00856-13; Zheng WC, 2013, ARCH BIOCHEM BIOPHYS, V532, P1, DOI 10.1016/j.abb.2013.01.007; Ziaoli AM, 2019, J BIOL CHEM, V294, P12743, DOI [10.1074/jbc.RA119.009644, DOI 10.1074/JBC.RA119.009644]	97	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228436	10.1371/journal.pone.0228436	http://dx.doi.org/10.1371/journal.pone.0228436			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027669	Green Published, gold			2022-12-26	WOS:000534623800034
J	Chao, JQ; Huang, ZJ; Yang, SG; Deng, XM; Tian, WM				Chao, Jinquan; Huang, Zhejun; Yang, Shuguang; Deng, Xiaomin; Tian, Weimin			Genome-wide identification and expression analysis of the phosphatase 2A family in rubber tree (Hevea brasiliensis)	PLOS ONE			English	Article							1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID SYNTHASE; PROTEIN-KINASE; GENE FAMILIES; ARABIDOPSIS; ETHYLENE; PHOSPHORYLATION; PP2A-B'GAMMA; HOLOENZYME; CDPK	The protein phosphatase 2As (PP2As) play a key role in manipulating protein phosphorylation. Although a number of proteins in the latex of laticifers are phosphorylated during latex regeneration in rubber tree, information about the PP2A family is limited. In the present study, 36 members of the HbPP2A family were genome-wide identified. They were clustered into five subgroups: the subgroup HbPP2AA (4), HbPP2AB' (14), HbPP2AB '' (6), HbPP2AB55 (4), and HbPP2AC (8). The members within the same subgroup shared highly conserved gene structures and protein motifs. Most of HbPP2As possessed ethylene- and wounding-responsive cis-acting elements. The transcripts of 29 genes could be detected in latex by using published high-throughput sequencing data. Of the 29 genes, seventeen genes were significantly down-regulated while HbPP2AA1-1 and HbPP2AB55 alpha/B alpha-1 were up-regulated by tapping. Of the 17 genes, 14 genes were further significantly down-regulated by ethrel application. The down-regulated expression of a large number of HbPP2As may attribute to the enhanced phosphorylation of the proteins in latex from the tapped trees and the trees treated with ethrel application.	[Chao, Jinquan; Yang, Shuguang; Deng, Xiaomin; Tian, Weimin] Chinese Acad Trop Agr Sci, State Key Lab Breeding Base Cultivat & Physiol Tr, Key Lab Biol & Genet Resources Rubber Tree, Rubber Res Inst,Minist Agr & Rural Affairs, Haikou, Hainan, Peoples R China; [Huang, Zhejun] Hainan Univ, Coll Foresty, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hainan University	Tian, WM (corresponding author), Chinese Acad Trop Agr Sci, State Key Lab Breeding Base Cultivat & Physiol Tr, Key Lab Biol & Genet Resources Rubber Tree, Rubber Res Inst,Minist Agr & Rural Affairs, Haikou, Hainan, Peoples R China.	wmtian@163.com			National Key R&D Program of China [2018YFD1000502]; Modern Agro-industry Technology Research System [CARS-33-YZ1]; National Natural Science Foundation of China [31700601]	National Key R&D Program of China; Modern Agro-industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was partially supported by the National Key R&D Program of China (2018YFD1000502) and Modern Agro-industry Technology Research System (CARS-33-YZ1) awarded to WM.T. This research was also partially supported by the National Natural Science Foundation of China (31700601) awarded to J.C.	Arsova B, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01168; Booker MA, 2017, PLANT PHYSIOL, V173, P1283, DOI 10.1104/pp.16.01768; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chao JQ, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00372; Chao JQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01904; Chao JQ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0488-3; Chen J, 2014, PLANT PHYSIOL, V166, P1519, DOI 10.1104/pp.114.250563; Creighton MT, 2017, PLANT CELL ENVIRON, V40, P2347, DOI 10.1111/pce.13038; Deng XM, 2018, J EXP BOT, V69, P3559, DOI 10.1093/jxb/ery169; Durian G, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00812; Habib MAH, 2018, BIOCHEM CELL BIOL, V96, P818, DOI 10.1139/bcb-2018-0020; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Jin X, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100261; Jung HW, 2005, PLANTA, V221, P361, DOI 10.1007/s00425-004-1461-9; Kamiyoshihara Y, 2010, PLANT J, V64, P140, DOI 10.1111/j.1365-313X.2010.04316.x; Kataya ARA, 2015, PLANT PHYSIOL, V167, P493, DOI 10.1104/pp.114.254409; KONZE JR, 1981, PLANTA, V151, P327, DOI 10.1007/BF00393286; Leivar P, 2011, PLANT CELL, V23, P1494, DOI 10.1105/tpc.110.074278; Li SC, 2014, NEW PHYTOL, V202, P145, DOI 10.1111/nph.12622; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Garcia MNM, 2017, PLANT MOL BIOL, V93, P227, DOI 10.1007/s11103-016-0555-7; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Rahikainen M, 2017, PLANT J, V89, P112, DOI 10.1111/tpj.13326; Rawat R, 2005, PLANT MOL BIOL, V57, P629, DOI 10.1007/s11103-005-0954-7; Sebastia CH, 2004, ARCH BIOCHEM BIOPHYS, V428, P81, DOI 10.1016/j.abb.2004.04.025; Shi MJ, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-018-1617-6; Skottke KR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001370; Tang CR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.73, 10.1038/nplants.2016.73]; Tsugama D, 2018, BIOCHEM BIOPH RES CO, V505, P176, DOI 10.1016/j.bbrc.2018.09.088; Wang S, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8100362; Wang XC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13778; Wei MM, 2018, FORESTS, V9, DOI 10.3390/f9060304; Xiao XH, 2017, FEBS OPEN BIO, V7, P4, DOI 10.1002/2211-5463.12163; ZHANG HF, 2017, PLOS ONE, V12; Zhu LP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040947; Zou Z, 2017, PLANTA, V246, P999, DOI 10.1007/s00425-017-2739-z; Zou Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148243	37	2	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228219	10.1371/journal.pone.0228219	http://dx.doi.org/10.1371/journal.pone.0228219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023282	Green Published, gold			2022-12-26	WOS:000534621500043
J	Eck, A; Rutten, NBMM; Singendonk, MMJ; Rijkers, GT; Savelkoul, PHM; Meijssen, CB; Crijns, CE; Oudshoorn, JH; Budding, AE; Vlieger, AM				Eck, Anat; Rutten, Nicole B. M. M.; Singendonk, Maartje M. J.; Rijkers, Ger T.; Savelkoul, Paul H. M.; Meijssen, Clemens B.; Crijns, Clarissa E.; Oudshoorn, Johanna H.; Budding, Andries E.; Vlieger, Arine M.			Neonatal microbiota development and the effect of early life antibiotics are determined by two distinct settler types	PLOS ONE			English	Article							INFANT GUT MICROBIOTA; BREAST-FED INFANTS; INTESTINAL MICROBIOTA; PRETERM INFANTS; IMMUNE-SYSTEM; DELIVERY MODE; 1ST YEAR; DIVERSITY; EXPOSURE; RISK	The neonatal period, during which the initial gut microbiota is acquired, is a critical phase. The healthy development of the infant's microbiome can be interrupted by external perturbations, like antibiotics, which are associated with profound effects on the gut microbiome and various disorders later in life. The aim of this study was to investigate the development of intestinal microbiota and the effect of antibiotic exposure during the first three months of life in term infants. Fecal samples were collected from healthy infants and infants who received antibiotics in the first week of life at one week, one month, and three months after birth. Microbial composition was analyzed using IS-pro and compared between antibiotics-treated and untreated infants. In total, 98 infants, divided into four groups based on feeding type and delivery mode, were analyzed. At one week of age, samples clustered into two distinct groups, which were termed "settler types", based on their Bacteroidetes abundance. Caesarean-born infants belonged to the low-Bacteroidetes settler type, but vaginally-born infants were divided between the two groups. The antibiotics effect was assessed within a subgroup of 45 infants, vaginally-born and exclusively breastfed, to minimize the effect of other confounders. Antibiotics administration resulted in lower Bacteroidetes diversity and/or a delay in Bacteroidetes colonization, which persisted for three months, and in a differential development of the microbiota. Antibiotics resulted in pronounced effects on the Bacteroidetes composition and dynamics. Finally, we hypothesize that stratification of children's cohorts based on settler types may reveal group effects that might otherwise be masked.	[Eck, Anat; Savelkoul, Paul H. M.; Budding, Andries E.] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Amsterdam UMC, Amsterdam, Netherlands; [Rutten, Nicole B. M. M.; Vlieger, Arine M.] St Antonius Hosp, Dept Pediat, Nieuwegein, Netherlands; [Singendonk, Maartje M. J.] Univ Amsterdam, Emma Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Amsterdam UMC, Amsterdam, Netherlands; [Rijkers, Ger T.] Univ Coll Roosevelt Acad, Dept Sci, Middelburg, Netherlands; [Savelkoul, Paul H. M.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Dept Med Microbiol, Med Ctr, Maastricht, Netherlands; [Meijssen, Clemens B.] Meander Med Ctr, Dept Pediat, Amersfoort, Netherlands; [Crijns, Clarissa E.] Tergooi Hosp, Dept Pediat, Blaricum, Netherlands; [Oudshoorn, Johanna H.] Gelre Hosp, Dept Pediat, Apeldoorn, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; St. Antonius Hospital Utrecht; Emma Children's Hospital; University of Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC); Meander Medisch Centrum; Tergooi Blaricum; Gelre Hospitals	Vlieger, AM (corresponding author), St Antonius Hosp, Dept Pediat, Nieuwegein, Netherlands.	a.vlieger@antoniusziekenhuis.nl	vlieger, arine/ABE-8079-2020	Budding, Andries/0000-0001-5128-5411; Rijkers, Ger/0000-0001-6948-6123	RVO [FND-06015]; Nutricia Netherlands B.V./Danone Research, Zoetermeer, the Netherlands; Netherlands Organization for Health Research and Development (ZonMw) [95103009]	RVO; Nutricia Netherlands B.V./Danone Research, Zoetermeer, the Netherlands(Netherlands Government); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Enterprise Agency (Agentschap NL), nowadays RVO (https://www.rvo.nl/) [FND-06015] and Nutricia Netherlands B.V./Danone Research, Zoetermeer, the Netherlands (https://www.nutricia.com/).AE was supported by the Netherlands Organization for Health Research and Development (ZonMw, https://www.zonmw.nl/nl/) [95103009]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Abrahamsson TR, 2014, CLIN EXP ALLERGY, V44, P842, DOI 10.1111/cea.12253; Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Adlerberth I, 2008, NESTLE NUTR WORKS SE, V62, P13, DOI 10.1159/000146245; Alm B, 2008, PEDIATRICS, V121, P697, DOI 10.1542/peds.2007-1232; Azad MB, 2017, NESTLE NUTR WORKS SE, V88, P67, DOI 10.1159/000455216; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Bennet R, 2002, INFECTION, V30, P158, DOI 10.1007/s15010-002-2140-z; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Budding AE, 2010, FASEB J, V24, P4556, DOI 10.1096/fj.10-156190; Chang JY, 2011, J PEDIATR GASTR NUTR, V53, P512, DOI 10.1097/MPG.0b013e318227e518; de Meij TGJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197649; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Fooladi Abbas Ali Imani, 2013, Inflammation & Allergy Drug Targets, V12, P410; Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]; Greenwood C, 2014, J PEDIATR-US, V165, P23, DOI 10.1016/j.jpeds.2014.01.010; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; Hussey Seamus, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/130574; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Li M, 2014, SEMIN REPROD MED, V32, P74, DOI 10.1055/s-0033-1361825; Mangin I, 2010, ANAEROBE, V16, P433, DOI 10.1016/j.anaerobe.2010.06.005; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Martinez I, 2018, ELIFE, V7, DOI 10.7554/eLife.36521; Mohan R, 2006, J CLIN MICROBIOL, V44, P4025, DOI 10.1128/JCM.00767-06; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Echarri PP, 2011, EARLY HUM DEV, V87, P511, DOI 10.1016/j.earlhumdev.2011.03.013; Rouge C, 2010, ANAEROBE, V16, P362, DOI 10.1016/j.anaerobe.2010.06.002; Russell ARB, 2006, BJOG-INT J OBSTET GY, V113, P758, DOI 10.1111/j.1471-0528.2006.00952.x; Saari A, 2015, PEDIATRICS, V135, P617, DOI 10.1542/peds.2014-3407; Savino F, 2011, ACTA PAEDIATR, V100, P75, DOI 10.1111/j.1651-2227.2010.01988.x; Sommer F, 2017, NAT REV MICROBIOL, V15, P630, DOI 10.1038/nrmicro.2017.58; Stark CM, 2019, GUT, V68, P62, DOI 10.1136/gutjnl-2017-314971; Tanaka S, 2009, FEMS IMMUNOL MED MIC, V56, P80, DOI 10.1111/j.1574-695X.2009.00553.x; Tapiainen T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46964-5; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Vangay P, 2015, CELL HOST MICROBE, V17, P553, DOI 10.1016/j.chom.2015.04.006; Verhulst SL, 2008, J ASTHMA, V45, P828, DOI 10.1080/02770900802339734; Walker AW, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0087-4; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	48	23	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228133	10.1371/journal.pone.0228133	http://dx.doi.org/10.1371/journal.pone.0228133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023276	Green Submitted, gold, Green Published			2022-12-26	WOS:000534621500038
J	Kim, S; Park, I; Yoon, B				Kim, Sunhye; Park, Inchae; Yoon, Byungun			SAO2Vec: Development of an algorithm for embedding the subject-action-object (SAO) structure using Doc2Vec	PLOS ONE			English	Article							PATENT INFORMATION; TECHNOLOGY; IDENTIFICATION; VISUALIZATION; LANGUAGE; NETWORK	In natural-language processing, the subject-action-object (SAO) structure is used to convert unstructured textual data into structured textual data comprising subjects, actions, and objects. This structure is suitable for analyzing the key elements of technology, as well as the relationships between these elements. However, analysis using the existing SAO structure requires a substantial number of manual processes because this structure does not represent the context of the sentences. Thus, we introduce the concept of SAO2Vec, in which SAO is used to embed the vectors of sentences and documents, for use in text mining in the analysis of technical documents. First, the technical documents of interest are collected, and SAO structures are extracted from them. Then, sentence vectors are extracted through the Doc2Vec algorithm and are updated using word vectors in the SAO structure. Finally, SAO vectors are drawn using an updated sentence vector with the same SAO structure. In addition, document vectors are derived from the document's SAO vectors. The results of an experiment in the Internet of things field indicate that the SAO2Vec method produces 3.1% better accuracy than the Doc2Vec method and 115.0% better accuracy than SAO frequency alone. This proves that the proposed SAO2Vec algorithm can be used to improve grouping and similarity analysis by including both the meanings and the contexts of technical elements.	[Kim, Sunhye; Park, Inchae; Yoon, Byungun] Dongguk Univ, Dept Ind Syst Engn, Coll Engn, Seoul, South Korea; [Park, Inchae] Hansung Univ, Coll IT Engn, Seoul, South Korea	Dongguk University; Hansung University	Yoon, B (corresponding author), Dongguk Univ, Dept Ind Syst Engn, Coll Engn, Seoul, South Korea.	postman3@dongguk.edu		Yoon, Byungun/0000-0002-1110-4011	National Research Foundation of Korea [NRF-2019R1A2C1085388]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF-2019R1A2C1085388, by Byungun Yoon, http://nrf.re.kr/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2017, IEEE ACCESS, V5, P12344, DOI 10.1109/ACCESS.2017.2718038; Altshuller G., 1996, SUDDENLY INVENTOR AP; Amancio DR, 2015, EPL-EUROPHYS LETT, V110, DOI 10.1209/0295-5075/110/68001; Amancio DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118394; Bhattacharya S, 1998, SCIENTOMETRICS, V43, P359, DOI 10.1007/BF02457404; Bojanowski Piotr, 2017, T ASSOC COMPUT LING, V5, P135, DOI 10.1162/tacl_a_00051; Bouazizi M, 2017, IEEE ACCESS, V5, P20617, DOI 10.1109/ACCESS.2017.2740982; Cascini G, 2004, LECT NOTES COMPUT SC, V3163, P508; Cascini G, 2008, INT FED INFO PROC, V277, P31; Chen L., 2003, P ACL 2003 WORKSH PA, V20, P1, DOI DOI 10.3115/1119303.1119304; Choi S, 2012, EXPERT SYST APPL, V39, P11443, DOI 10.1016/j.eswa.2012.04.014; Choi S, 2011, SCIENTOMETRICS, V88, P863, DOI 10.1007/s11192-011-0420-z; de Vos S, 2015, HAEMATOLOGICA, V100, P4; Devlin J., 2018, ARXIV181004805; Euisok Chung, 2016, KIISE Transactions on Computing Practices, V22, P315, DOI 10.5626/KTCP.2016.22.7.315; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Huang L, 2015, PORTL INT CONF MANAG, P2313, DOI 10.1109/PICMET.2015.7273128; IFI CLAIMS Patent Services, 2017, 2017 TRENDS INS; Jiang ZC, 2016, IEEE ACM T COMPUT BI, V13, P634, DOI 10.1109/TCBB.2015.2478467; Kalchbrenner N, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P655, DOI 10.3115/v1/p14-1062; Kim H. B., 2012, 2012 IEEE 6th International Conference on Management of Innovation & Technology (ICMIT 2012), P510, DOI 10.1109/ICMIT.2012.6225858; Kim Yoon, 2014, P 2014 C EMPIRICAL M, P1746, DOI [DOI 10.3115/V1/D14-1181, 10.3115/v1/D14-1181]; Kim YG, 2008, EXPERT SYST APPL, V34, P1804, DOI 10.1016/j.eswa.2007.01.033; Klein D, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P423, DOI 10.3115/1075096.1075150; Korea Basic Science Institute, 2016, DEV REAL TIME IOT DE; Kroeger P. R, 2005, ANAL GRAMMAR INTRO; Kuang S, 2018, INT CONF BIG DATA, P390, DOI 10.1109/BigComp.2018.00064; Kuznets S., 1962, RATE DIRECTION INVEN, P19; Lee B, 2008, SCIENTOMETRICS, V77, P3, DOI 10.1007/s11192-007-1819-4; Lee DL, 1997, IEEE SOFTWARE, V14, P67, DOI 10.1109/52.582976; Lee SY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219389; Lee S, 2008, R&D MANAGE, V38, P169, DOI 10.1111/j.1467-9310.2008.00509.x; Liu ZG, 2015, SCIENTOMETRICS, V103, P135, DOI 10.1007/s11192-014-1517-y; Martincic-Ipsic S, 2016, PHYSICA A, V457, P117, DOI 10.1016/j.physa.2016.03.082; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Moehrle M. G., 2014, R&D MANAGE, V35, P513; Morris S, 2002, COMPUT IND ENG, V43, P841, DOI 10.1016/S0360-8352(02)00143-2; Naili M, 2017, PROCEDIA COMPUT SCI, V112, P340, DOI 10.1016/j.procs.2017.08.009; Norton MJ, 2001, INTRO CONCEPTS INFOR; Park H, 2012, SCIENTOMETRICS, V90, P515, DOI 10.1007/s11192-011-0522-7; Pennington J., 2014, P 2014 C EMPIRICAL M, P1532, DOI DOI 10.3115/V1/D14-1162; Le Q, 2014, PR MACH LEARN RES, V32, P1188; Radford Alec, 2018, TECHNICAL REPORT, DOI 10.48550/ARXIV.1802.05365; Research Variant Market, 2017, INT THINGS IOT MARK; Tan A.H., 1999, P PAKDD 1999 WORKSH, V8, P65; Tseng YH, 2007, INFORM PROCESS MANAG, V43, P1216, DOI 10.1016/j.ipm.2006.11.011; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang XF, 2015, TECHNOL FORECAST SOC, V98, P24, DOI 10.1016/j.techfore.2015.05.014; Wilson B.J., 2015, ARXIV151002675; Yang C, 2016, I C SOFTWARE KNOWL I, P67, DOI 10.1109/SKIMA.2016.7916199; Yang C, 2015, INT CONF KNOWL SYS, P222, DOI 10.1109/ISKE.2015.43; Yang H., 2015, LECT NOTES COMPUTER, V9077; Yoon J, 2011, SCIENTOMETRICS, V86, P687, DOI 10.1007/s11192-010-0303-8	54	10	10	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227930	10.1371/journal.pone.0227930	http://dx.doi.org/10.1371/journal.pone.0227930			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LK4GF	32023289	gold, Green Published			2022-12-26	WOS:000530818200001
J	Singh, S; McDonald, JT; Ilie, G; Adisesh, A				Singh, Smriti; McDonald, James Ted; Ilie, Gabriela; Adisesh, Anil			An examination of the association between lifetime history of prostate and pancreatic cancer diagnosis and occupation in a population sample of Canadians	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; HIGH-RISK; SURVIVAL; ADENOCARCINOMA; SURVEILLANCE; RADIOTHERAPY; METAANALYSIS; CENSUS; HEALTH; COHORT	Background Occupation was assessed as possible risk factors for prostate (PCa) and pancreatic cancer in a large Canadian worker cohort. Methods The Canadian Census Health and Environment Cohort (CanCHEC) was derived from linking the 1991 Canadian Census Cohort to the Canadian Cancer Database (1969-2010), Canadian Mortality Database (1991-2011), and Tax Summary Files (1981-2011). From the total sample of 1,931,110 persons, we identified and derived two samples of 28,610 men and 3,220 men and women with a past history of PCa and pancreatic cancer diagnoses, respectively. Cox proportional hazards models were used to estimate hazards ratios and 95% confidence intervals for occupation. Results In Canadian men aged 24-64 years, the highest elevated risks of PCa were observed for library clerks (HR = 2.36, 95% CI:1.12-4.97), medical radiation technologists (HR = 1.66, 95% CI:1.04-2.65), telecommunications and line cable workers (HR = 1.62, 95% CI: 1.22-3.16) and commissioned police officers (HR = 1.54, 95% CI: 1.10-2.16. The highest elevated risk for pancreatic cancer were observed for commissioned police officers (HR = 4.34, 95% CI: 1.85-10.21), photographic and film processors (HR = 3.97, 95% CI:1.69-9.34), railway and motor transport labourers (HR = 3.94, 95% CI: 1.67-9.29), and computer engineers (HR = 3.82, 95%CI: 1.52-9.61). Conclusion These findings emphasize the need for further study of job-related exposures and the potential influence of non-occupational factors such as screening practices.	[Singh, Smriti] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [McDonald, James Ted] Univ New Brunswick, Fredericton, NB, Canada; [Ilie, Gabriela] Dalhousie Univ, Fac Med, Dept Community Hlth & Epidemiol Urol & Radiat Onc, Halifax, NS, Canada; [Adisesh, Anil] Univ Toronto, Dept Med, Toronto, ON, Canada	Dalhousie University; University of New Brunswick; Dalhousie University; University of Toronto	Ilie, G (corresponding author), Dalhousie Univ, Fac Med, Dept Community Hlth & Epidemiol Urol & Radiat Onc, Halifax, NS, Canada.	Gabriela.Ilie@dal.ca	Ilie, Gabriela/AAM-9122-2021; Adisesh, Anil/AAK-7552-2020; Ilie, Gabriela/J-6066-2014	Adisesh, Anil/0000-0002-4973-8474; Ilie, Gabriela/0000-0002-1602-6374	SSHRC [840-2016-0001]; CIHR [RDC 144721]; CFI [35500]; Dalhousie University; DMRF Soillse Fund; Research Nova Scotia Establishment Grant Project [2215-2019]	SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC)); CIHR(Canadian Institutes of Health Research (CIHR)); CFI(Canada Foundation for Innovation); Dalhousie University; DMRF Soillse Fund; Research Nova Scotia Establishment Grant Project	Data Centre located at the University of New Brunswick in Fredericton, New Brunswick are made possible by the financial or in-kind support of the SSHRC Project Number 840-2016-0001 (TM), the CIHR Project number RDC 144721 (TM), the CFI Project Number 35500 (TM), Dalhousie University, DMRF Soillse Fund (GI), Research Nova Scotia Establishment Grant Project number 2215-2019 (GI). The views expressed in this paper do not necessarily represent the CRDCN's or that of its partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data Centre located at the University of New Brunswick in Fredericton, New Brunswick are made possible by the financial or in-kind support of the SSHRC Project Number 840-2016-0001 (TM), the CIHR Project number RDC 144721 (TM), the CFI Project Number 35500 (TM), Dalhousie University, DMRF Soillse Fund (GI), Research Nova Scotia Establishment Grant 2215-2019 (GI). The views expressed in this paper do not necessarily represent the CRDCN's or that of its partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti G, 2012, MOL CARCINOG, V51, P2012; [Anonymous], 2018, CAN CANC STAT 2018 S; Bashir Muhammad Naeem, 2015, Asian Pac J Cancer Prev, V16, P5137; Becker AE, 2014, WORLD J GASTROENTERO, V20, P11182, DOI 10.3748/wjg.v20.i32.11182; Berndt SI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7889; Block S, 2011, GAP RACIALIZED WORKE; Canada Statistics, 2016, CANC SOC, V2014, P1; Canadian Cancer Society, 2017, CAN CANC STAT SPEC T; Canadian Cancer Society, RISK FACT PROST CANC; Canadian Cancer Society, 2017, TREATM PROST CANC; Canadian Research Data Centre Network, 2018, CANCHEC CAN CENS HLT; Clapp RW, 2009, ENV OCCUPATIONAL CAU, V6, P247; Crouch J, 2015, J GENET COUNS, V24, P67, DOI 10.1007/s10897-014-9738-z; Dennis LK, 2002, EPIDEMIOLOGY, V13, P72, DOI 10.1097/00001648-200201000-00012; Doolan G, 2014, ASIAN PAC J CANCER P, V15, P501, DOI 10.7314/APJCP.2014.15.2.501; Frey AU, 2014, J SEX MED, V11, P374, DOI 10.1111/jsm.12403; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gann Peter H, 2002, Rev Urol, V4 Suppl 5, pS3; Gathirua-Mwangi WG, 2014, EUR J CANCER PREV, V23, P96, DOI 10.1097/CEJ.0b013e3283647394; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gu XB, 2018, CANCER MANAG RES, V10, P1061, DOI 10.2147/CMAR.S157442; Haque R, 2014, OBES RES CLIN PRACT, V8, pE374, DOI 10.1016/j.orcp.2013.06.002; Hart AR, 2008, CLIN GASTROENTEROL H, V6, P275, DOI 10.1016/j.cgh.2007.12.041; Hoffman RM, 2018, SCREENING PROSTATE C; Howlader N, 2014, SEER CANC STAT REV; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Isbarn H, 2010, BJU INT, V106, P37, DOI 10.1111/j.1464-410X.2009.09134.x; Kachuri L, 2017, BMC CANCER, V17, P1; Kanji ZS, 2013, CAN MED ASSOC J, V185, P1219, DOI 10.1503/cmaj.121368; Kpelitse K, 2014, EFFECT INCOME OBESIT, V519, P36; Leitzmann Michael F, 2012, Clin Epidemiol, V4, P1, DOI 10.2147/CLEP.S16747; Litwin MS, 2002, CANCER, V95, P54, DOI 10.1002/cncr.10651; Luckett BG, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/180186; Maisonneuve P, 2007, GUT, V56, P1327, DOI 10.1136/gut.2007.125278; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; Martin RM, 2018, JAMA-J AM MED ASSOC, V319, P883, DOI 10.1001/jama.2018.0154; Matthew AG, 2018, J PSYCHOSOC ONCOL, V36, P159, DOI 10.1080/07347332.2017.1342733; Moller H, 2015, INT J CANCER, V136, P1940, DOI 10.1002/ijc.29238; Moore SP, 2015, LANCET ONCOL, V16, P1483, DOI 10.1016/S1470-2045(15)00232-6; Navaneelan T, 2015, HLTH GLACE; Nguyen LN, 1998, UROLOGY, V51, P991, DOI 10.1016/S0090-4295(98)00028-4; *OCC CANC RES CTR, 2019, BURD OCC CANC CAN MA; Ojajarvi A, 2001, AM J EPIDEMIOL, V153, P841, DOI 10.1093/aje/153.9.841; Parent ME, 2001, EPIDEMIOL REV, V23, P138, DOI 10.1093/oxfordjournals.epirev.a000779; Reid JL, 2010, CAN J PUBLIC HEALTH, V101, P73, DOI 10.1007/BF03405567; Santibanez M, 2010, EUR J EPIDEMIOL, V25, P721, DOI 10.1007/s10654-010-9490-0; Sauve JF, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0185-1; Skinner HG, 2003, CANCER EPIDEM BIOMAR, V12, P433; Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983; Sritharan J, 2018, CANCER MED-US, V7, P1468, DOI 10.1002/cam4.1358; Sritharan J, 2017, CANCER EPIDEMIOL, V48, P96, DOI 10.1016/j.canep.2017.04.006; Vaccarella S., 2019, INT AGENCY RES CANC; Vasen HFA, 2000, INT J CANCER, V87, P809, DOI 10.1002/1097-0215(20000915)87:6<809::AID-IJC8>3.3.CO;2-L; Wilcox SW, 2015, J MED IMAG RADIAT ON, V59, P125, DOI 10.1111/1754-9485.12275; Xie L, 2015, Health Promot Chronic Dis Prev Can, V35 Suppl 1, P2	55	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227622	10.1371/journal.pone.0227622	http://dx.doi.org/10.1371/journal.pone.0227622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023280	Green Published, gold, Green Submitted			2022-12-26	WOS:000534621500019
J	Estep, RD; Govindan, AN; Manoharan, M; Li, H; Fei, SS; Park, BS; Axthelm, MK; Wong, SW				Estep, Ryan Douglas; Govindan, Aparna N.; Manoharan, Minsha; Li, He; Fei, Suzanne S.; Park, Byung S.; Axthelm, Michael K.; Wong, Scott W.			Molecular analysis of lymphoid tissue from rhesus macaque rhadinovirus-infected monkeys identifies alterations in host genes associated with oncogenesis	PLOS ONE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; INDUCED CYTIDINE DEAMINASE; INTERFERON REGULATORY FACTORS; KAPOSIS-SARCOMA; OXIDATIVE STRESS; FUNCTIONAL HOMOLOG; SOMATIC MUTATIONS; DOWN-REGULATION; AID EXPRESSION; B-LYMPHOCYTES	Rhesus macaque (RM) rhadinovirus (RRV) is a simian gamma-2 herpesvirus closely related to human Kaposi's sarcoma-associated herpesvirus (KSHV). RRV is associated with the development of diseases in simian immunodeficiency virus (SIV) co-infected RM that resemble KSHV-associated pathologies observed in HIV-infected humans, including B cell lymphoproliferative disorders (LPD) and lymphoma. Importantly, how de novo KSHV infection affects the expression of host genes in humans, and how these alterations in gene expression affect viral replication, latency, and disease is unknown. The utility of the RRV/RM infection model provides a novel approach to address these questions in vivo, and utilizing the RRV bacterial artificial chromosome (BAC) system, the effects of specific viral genes on host gene expression patterns can also be explored. To gain insight into the effects of RRV infection on global host gene expression patterns in vivo, and to simultaneously assess the contributions of the immune inhibitory viral CD200 (vCD200) molecule to host gene regulation, RNA-seq was performed on pre- and post-infection lymph node (LN) biopsy samples from RM infected with either BAC-derived WT (n = 4) or vCD200 mutant RRV (n = 4). A variety of genes were identified as being altered in LN tissue samples due to RRV infection, including cancer-associated genes activation-induced cytidine deaminase (AICDA), glypican-1 (GPC1), CX3C chemokine receptor 1 (CX3CR1), and Ras dexamethasone-induced 1 (RasD1). Further analyses also indicate that GPC1 may be associated with lymphomagenesis. Finally, comparison of infection groups identified the differential expression of host gene thioredoxin interacting protein (TXNIP), suggesting a possible mechanism by which vCD200 negatively affects RRV viral loads in vivo.	[Estep, Ryan Douglas; Govindan, Aparna N.; Manoharan, Minsha; Li, He; Axthelm, Michael K.; Wong, Scott W.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA; [Fei, Suzanne S.; Wong, Scott W.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Bioinformat & Biostat Core, Beaverton, OR 97239 USA; [Park, Byung S.] Oregon Hlth & Sci Univ, Portland State Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Park, Byung S.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Axthelm, Michael K.] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA; [Wong, Scott W.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Portland State University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Estep, RD; Wong, SW (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA.; Wong, SW (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Bioinformat & Biostat Core, Beaverton, OR 97239 USA.; Wong, SW (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	estepr@ohsu.edu; Wongs@ohsu.edu		Estep, Ryan/0000-0001-7785-8564; Fei, Suzanne/0000-0002-9688-2890	Office of The Director, National Institutes of Health (OD) [P51-OD011092, OD023038]; National Cancer Institute at the National Institutes of Health [CA075922, CA206404]	Office of The Director, National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	S.W.W P51-OD011092 Office of The Director, National Institutes of Health (OD) https://www.nih.gov/institutes-nih/nih-office-director S.W. WCA075922 National Cancer Institute at the National Institutes of Health https://www.cancer.gov/S.W.W.CA206404 National Cancer Institute at the National Institutes of Health https://www.cancer.gov/M.K.A.OD023038 Office of The Director, National Institutes of Health (OD) https://www.nih.gov/institutes-nih/nih-officedirector The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the scientific investigators at the Vaccine and Gene Therapy Institute and members of the Wong Laboratory for their helpful discussions. We also thank Dr. Robert Searles and the OHSU Massively Parallel Sequencing Shared Resource for cDNA library construction and RNA-sequencing, and Dr. Sathya Srinivasan and the ONPRC Imaging and Morphology Support Core for assistance with our microscopy needs.	Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Andreasson U, 2008, CANCER LETT, V259, P138, DOI 10.1016/j.canlet.2007.10.031; Andrews S., 2010, FASTQC QUALITY CONTR; Bekerman E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003748; Bergquam EP, 1999, J VIROL, V73, P7874, DOI 10.1128/JVI.73.9.7874-7876.1999; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cameron CM, 2005, J VIROL, V79, P6052, DOI 10.1128/JVI.79.10.6052-6067.2005; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chen Z, 2011, LEUKEMIA, V25, P440, DOI 10.1038/leu.2010.286; Corcione A, 2012, J LEUKOCYTE BIOL, V92, P51, DOI 10.1189/jlb.0112035; Corcione A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008485; de Yebenes VG, 2006, TRENDS MOL MED, V12, P432, DOI 10.1016/j.molmed.2006.07.001; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Epeldegui M, 2007, MOL IMMUNOL, V44, P934, DOI 10.1016/j.molimm.2006.03.018; Erkeland SJ, 2009, LEUKEMIA RES, V33, P1367, DOI 10.1016/j.leukres.2009.02.027; Ersing I, 2017, CELL REP, V19, P1479, DOI 10.1016/j.celrep.2017.04.062; Estep RD, 2003, J VIROL, V77, P1738, DOI 10.1128/JVI.77.3.1738-1746.2003; Estep RD, 2014, J VIROL, V88, P10635, DOI 10.1128/JVI.01276-14; Ferretti E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/480941; Foster-Cuevas M, 2004, J VIROL, V78, P7667, DOI 10.1128/JVI.78.14.7667-7676.2004; Foster-Cuevas M, 2011, J VIROL, V85, P6055, DOI 10.1128/JVI.00064-11; Gil Y, 2007, MOL IMMUNOL, V44, P494, DOI 10.1016/j.molimm.2006.02.012; Gu XW, 2012, CURR OPIN HEMATOL, V19, P292, DOI 10.1097/MOH.0b013e328353da3a; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; He ZL, 2017, ONCOL LETT, V14, P1323, DOI 10.3892/ol.2017.6296; Heath E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002697; Hong K, 2016, J BIOL CHEM, V291, P8428, DOI 10.1074/jbc.M115.698365; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kalchschmidt JS, 2016, J EXP MED, V213, P921, DOI 10.1084/jem.20160120; Kaleeba JAR, 1999, J VIROL, V73, P6177, DOI 10.1128/JVI.73.7.6177-6181.1999; Kim JH, 2013, LEUKEMIA LYMPHOMA, V54, P2035, DOI 10.3109/10428194.2013.769218; Kim MJ, 2017, CELL SIGNAL, V34, P110, DOI 10.1016/j.cellsig.2017.03.007; Kwon HJ, 2010, J IMMUNOL, V185, P3980, DOI 10.4049/jimmunol.1000990; Kwong LS, 2016, J GEN VIROL, V97, P179, DOI 10.1099/jgv.0.000335; Lane T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00050; Langlals CL, 2006, J VIROL, V80, P3098, DOI 10.1128/JVI.80.6.3098-3103.2006; Li J, 2017, J CELL MOL MED, V21, P838, DOI 10.1111/jcmm.12941; Lindsey JW, 2007, INT IMMUNOL, V19, P583, DOI 10.1093/intimm/dxm023; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Misstear K, 2012, J VIROL, V86, P6246, DOI 10.1128/JVI.07168-11; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nasoohi S, 2018, MOL NEUROBIOL, V55, P7900, DOI 10.1007/s12035-018-0917-z; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Orzechowska BU, 2008, BLOOD, V112, P4227, DOI 10.1182/blood-2008-04-151498; Park JW, 2018, BIOCHEM BIOPH RES CO, V498, P566, DOI 10.1016/j.bbrc.2018.03.020; Pratt CL, 2005, J VIROL, V79, P3878, DOI 10.1128/JVI.79.6.3878-3882.2005; Qin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029141; Rezaee SAR, 2005, AIDS, V19, P1907, DOI 10.1097/01.aids.0000189849.75699.46; Robinson BA, 2012, J VIROL, V86, P2769, DOI 10.1128/JVI.05657-11; Robinson BA, 2012, J VIROL, V86, P2197, DOI 10.1128/JVI.05047-11; Sanchez R, 2015, CURR HYPERTENS REV, V11, P7, DOI 10.2174/157340211101150617154123; Shair KHY, 2012, MBIO, V3, DOI 10.1128/mBio.00288-12; Shao Y, 2010, IMMUNOL LETT, V129, P78, DOI 10.1016/j.imlet.2010.02.002; Shiratori I, 2005, J IMMUNOL, V175, P4441, DOI 10.4049/jimmunol.175.7.4441; Thielen L, 2018, CURR OPIN ENDOCRINOL, V25, P75, DOI 10.1097/MED.0000000000000391; Tobollik S, 2006, BLOOD, V108, P3859, DOI 10.1182/blood-2006-05-021303; Tome ME, 2005, BLOOD, V106, P3594, DOI 10.1182/blood-2005-02-0487; Vaidyanathan G, 2004, ONCOGENE, V23, P5858, DOI 10.1038/sj.onc.1207774; Wang LW, 2019, CELL METAB, V30, P539, DOI 10.1016/j.cmet.2019.06.003; Wang S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00614; Wong SW, 1999, J EXP MED, V190, P827, DOI 10.1084/jem.190.6.827; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Zan H, 2013, AUTOIMMUNITY, V46, P83, DOI 10.3109/08916934.2012.749244; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786; Zhou JB, 2013, MITOCHONDRION, V13, P163, DOI 10.1016/j.mito.2012.06.004; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20	74	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228484	10.1371/journal.pone.0228484	http://dx.doi.org/10.1371/journal.pone.0228484			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017809	gold, Green Published			2022-12-26	WOS:000534618100027
J	Fanshawe, TR; Glogowska, M; Edwards, G; Turner, PJ; Smith, I; Steele, R; Croxson, C; Bowen, JST; Hayward, GN				Fanshawe, Thomas R.; Glogowska, Margaret; Edwards, George; Turner, Philip J.; Smith, Ian; Steele, Rosie; Croxson, Caroline; Bowen, Jordan S. T.; Hayward, Gail N.			Pre-analytical error for three point of care venous blood testing platforms in acute ambulatory settings: A mixed methods service evaluation	PLOS ONE			English	Article							MEDICAL ERRORS; PREVENTION; QUALITY	Introduction Point of care blood testing to aid diagnosis is becoming increasingly common in acute ambulatory settings and enables timely investigation of a range of diagnostic markers. However, this testing allows scope for errors in the pre-analytical phase, which depends on the operator handling and transferring specimens correctly. The extent and nature of these pre-analytical errors in clinical settings has not been widely reported. Methods We carried out a convergent parallel mixed-methods service evaluation to investigate preanalytical errors leading to a machine error reports in a large acute hospital trust in the UK. The quantitative component comprised a retrospective analysis of all recorded error codes from Abbott Point of Care i-STAT 1, i-STAT Alinity and Abbott Rapid Diagnostics Afinion devices to summarise the error frequencies and reasons for error, focusing on those attributable to the operator. The qualitative component included a prospective ethnographic study and a secondary analysis of an existing ethnographic dataset, based in hospital-based ambulatory care and community ambulatory care respectively. Results The i-STAT had the highest usage (113,266 tests, January 2016-December 2018). As a percentage of all tests attempted, its device-recorded overall error rate was 6.8% (95% confidence interval 6.6% to 6.9%), and in the period when reliable data could be obtained, the operator-attributable error rate was 2.3% (2.2% to 2.4%). Staff identified that the most difficult step was the filling of cartridges, but that this could be improved through practice, with a perception that cartridge wastage through errors was rare. Conclusions In the observed settings, the rate of errors attributable to operators of the primary point of care device was less than 1 in 40. In some cases, errors may lead to a small increase in resource use or time required so adequate staff training is necessary to prevent adverse impact on patient care.	[Fanshawe, Thomas R.; Glogowska, Margaret; Edwards, George; Turner, Philip J.; Hayward, Gail N.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Smith, Ian; Steele, Rosie; Bowen, Jordan S. T.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Croxson, Caroline] Univ Oxford, Oxford, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Fanshawe, TR (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	thomas.fanshawe@phc.ox.ac.uk	Edwards, George/HGB-4007-2022	Edwards, George/0000-0002-0048-4178; Turner, Philip/0000-0001-7299-8939; Hayward, Gail/0000-0003-0852-627X	National Institute for Health Research (NIHR) Community Healthcare MedTech and In Vitro Diagnostics Cooperative at Oxford Health NHS Foundation Trust; Becton, Dickinson and Company	National Institute for Health Research (NIHR) Community Healthcare MedTech and In Vitro Diagnostics Cooperative at Oxford Health NHS Foundation Trust; Becton, Dickinson and Company	This research was funded by the National Institute for Health Research (NIHR) Community Healthcare MedTech and In Vitro Diagnostics Cooperative at Oxford Health NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The project was also supported by a grant from Becton, Dickinson and Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott, 2019, I STAT SYST PROD SER; Abbott, 2019, I STAT AL SYST; Abbott, 2018, I STAT AL SYST OP MA; Abbott, 2019, AF 2; Abbott, 2019, AL AF AS100 AN; Abbott, 2019, I STAT SYST TEST CAR; Auvet A, 2016, ANN INTENSIVE CARE, V6, P1, DOI 10.1186/s13613-016-0152-6; Bonini P, 2002, CLIN CHEM, V48, P691; Carraro P, 2007, CLIN CHEM, V53, P1338, DOI 10.1373/clinchem.2007.088344; Jones CHD, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1834-3; Kost GJ, 2001, ARCH PATHOL LAB MED, V125, P1307; Long-Sutehall T, 2011, J RES NURS, V16, P335, DOI 10.1177/1744987110381553; Luppa PB, 2011, TRAC-TREND ANAL CHEM, V30, P887, DOI 10.1016/j.trac.2011.01.019; Meier FA, 2005, ARCH PATHOL LAB MED, V129, P1262; Nichols JH, 2005, LAB MED, V36, P275, DOI 10.1309/NXXWJ31PWFHT7L1Q; O'Kane MJ, 2011, CLIN CHEM, V57, P1267, DOI 10.1373/clinchem.2011.164517; O'Neill J., 2016, REV ANTIMICROBIAL RE; Plebani M, 2010, ANN CLIN BIOCHEM, V47, P101, DOI 10.1258/acb.2009.009222; Plebani M, 2009, CLIN CHIM ACTA, V404, P59, DOI 10.1016/j.cca.2009.03.014; R Core Team, 2018, R LANG ENV STAT COMP; Radiometer, 2019, BLOOD GAS TEST; Schimke I, 2009, ANAL BIOANAL CHEM, V393, P1499, DOI 10.1007/s00216-008-2349-5; Shaw Julie L V, 2016, Pract Lab Med, V4, P22, DOI 10.1016/j.plabm.2015.12.002; Siemens Healthineers, 2019, POCCELERATOR DAT MAN; St John Andrew, 2014, Clin Biochem Rev, V35, P155; Vashist SK, 2015, TRENDS BIOTECHNOL, V33, P692, DOI 10.1016/j.tibtech.2015.09.001	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228687	10.1371/journal.pone.0228687	http://dx.doi.org/10.1371/journal.pone.0228687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012203	Green Published, gold			2022-12-26	WOS:000534615800046
J	Kolanowska, M; Jakubska-Busse, A				Kolanowska, Marta; Jakubska-Busse, Anna			Is the lady's-slipper orchid (Cypripedium calceolus) likely to shortly become extinct in Europe?-Insights based on ecological niche modelling	PLOS ONE			English	Article							CONSERVATION PRIORITIES; HABITAT DISTRIBUTION; CLIMATE-CHANGE; POPULATIONS; POLLINATION; L.; SPECIFICITY; TAXA; DEER; SIZE	Lady's-slipper orchid (Cypripedium calceolus) is considered an endangered species in most countries within its geographical range. The main reason for the decline in the number of populations of this species in Europe is habitat destruction. In this paper the ecological niche modelling approach was used to estimate the effect of future climate change on the area of niches suitable for C. calceolus. Predictions of the extent of the potential range of this species in 2070 were made using climate projections obtained from the Community Climate System Model for four representative concentration pathways: rcp2.6, rcp4.5, rcp6.0 and rcp8.5. According to these analyses all the scenarios of future climate change will result in the total area of niches suitable for C. calceolus decreasing. Considering areas characterized by a suitability of at least 0.4 the loss of habitat will vary between ca. 30% and 63%. The highest habitat loss of ca. 63% is predicted to occur in scenario rcp 8.5. Surprisingly, in the most damaging rcp 8.5 prediction the highest overlap between potential range of C. calceolus and its pollinators will be observed and in all other scenarios some pollinators will be available for this species in various geographical regions. Based on these results at least two approaches should be implemented to improve the chances of survival of C. calceolus. In view of the unavoidable loss of suitable habitats in numerous European regions, conservation activities should be intensified in areas where this species will still have suitable niches in the next 50 years. In addition, for C. calceolus ex-situ activities should be greatly increased so that it can be re-introduced in the remaining suitable areas.	[Kolanowska, Marta] Univ Lodz, Fac Biol & Environm Protect, Dept Geobot & Plant Ecol, Lodz, Poland; [Kolanowska, Marta] Global Change Res Inst AS CR, Dept Biodivers Res, Brno, Czech Republic; [Jakubska-Busse, Anna] Univ Wroclaw, Inst Environm Biol, Dept Bot, Wroclaw, Poland	University of Lodz; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; University of Wroclaw	Kolanowska, M (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Geobot & Plant Ecol, Lodz, Poland.; Kolanowska, M (corresponding author), Global Change Res Inst AS CR, Dept Biodivers Res, Brno, Czech Republic.	martakolanowska@wp.pl	Kolanowska, Marta/AAR-3107-2020; Jakubska-Busse, Anna/D-6149-2016	Kolanowska, Marta/0000-0001-5347-5403; Jakubska-Busse, Anna/0000-0003-4284-9910	Education Youth and Sports (MSMT) [LO1415]	Education Youth and Sports (MSMT)	The research described here was supported by the Education Youth and Sports (MSMT) grant nr LO1415 (MK). https://app.dimensions.ai/details/grant/grant.6884710 The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ECOLOGICAL NICHES GE; [Anonymous], 2006, PRZEWODNIK OZNACZANI; Antonelli A, 2009, NORD J BOT, V27, P1; Ashraf U, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8080722; Balazs Zoltan R., 2016, Contributii Botanice, V51, P43; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; BERGSTROM G, 1992, PHYTOCHEMISTRY, V31, P2315, DOI 10.1016/0031-9422(92)83271-Y; Bilz M., 2014, S IUCN RED LIST THRE, DOI [10.2305/IUCN.UK.2014-1.RLTS.T162021A43316125.en, DOI 10.2305/IUCN.UK.2014-1.RLTS.T162021A43316125.EN]; Blinova I. V., 2002, SELBYANA, V23, P111; Brambilla M, 2014, BIOL CONSERV, V174, P39, DOI 10.1016/j.biocon.2014.03.018; Braunisch V, 2013, ECOGRAPHY, V36, P971, DOI 10.1111/j.1600-0587.2013.00138.x; Briscoe DK, 2014, ENDANGER SPECIES RES, V24, P237, DOI 10.3354/esr00600; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Brzosko E, 2002, BOT J LINN SOC, V139, P67, DOI 10.1046/j.1095-8339.2002.00049.x; CASE MA, 1993, SYST BOT, V18, P663, DOI 10.2307/2419540; Chefaoui RM, 2005, BIOL CONSERV, V122, P327, DOI 10.1016/j.biocon.2004.08.005; Claessens J., 2011, FLOWER EUROPEAN ORCH; DAUMANN E, 1969, OSTERREICHISCHE BOT, V115, P434; Delforge P., 2006, ORCHIDS EUROPE N AFR; Devilliers- Terschuren J., 1999, ACTION PLAN CYPRIPED; Didukh Y, 2009, RED DATA BOOK UKRAIN; Dwyer JG, 2012, J CLIMATE, V25, P6359, DOI 10.1175/JCLI-D-11-00741.1; Edens-Meier R, 2011, TELOPEA, V13, P327; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Erneberg M, 1999, NORD J BOT, V19, P363, DOI 10.1111/j.1756-1051.1999.tb01128.x; Erovsky J., 1995, ENDANGERED PLANTS; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Fay MF, 2009, ANN BOT-LONDON, V104, P517, DOI 10.1093/aob/mcp116; Feng X, 2019, ECOL EVOL, V9, P10365, DOI 10.1002/ece3.5555; Ferraz Katia M.P.M. B., 2012, Cat News, P38; Gale SW, 2018, BOT J LINN SOC, V186, P425, DOI 10.1093/botlinnean/boy003; Gamisch A, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1416-1; Govaerts R, 2009, WORLD CHECKL SEL PLA; Gudzinskas Z, 2006, LIETUVOS GEGUZRAIBIN; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Isaja A., 2003, RIV PIEDMONTESE STOR, V24, P205; Ishmuratova MM, 2006, B MOSC SOC NAT, V110, P40; Kaye TN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210378; Khapugin Anatoliy A., 2017, Lankesteriana, V17, P417, DOI 10.15517/lank.v17i3.31577; Kolanowska M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13088-7; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kull T, 1999, J ECOL, V87, P913, DOI 10.1046/j.1365-2745.1999.00407.x; Kull T, 1998, BOT J LINN SOC, V126, P27, DOI 10.1111/j.1095-8339.1998.tb02513.x; Kull T., 1988, P ACAD SCI ESTONIAN, V37, P195; Lamsal P, 2018, ECOL INFORM, V44, P101, DOI 10.1016/j.ecoinf.2018.02.004; LAZARE J-J, 1986, Anales del Jardin Botanico de Madrid, V43, P375; Limpricht, 1942, FEDDES REPERT BEIH, V131, P126; Limpricht W., 1943, ENGLERS BOT JAHR, V3, P151; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Melnyk V, 2018, Ukrayins'kyi Botanichnyi Zhurnal, V75, P160, DOI 10.15407/ukrbotj75.02.160; Melnyk V. I, 2018, Ukrayins'kyi Botanichnyi Zhurnal, V75, P20, DOI 10.15407/ukrbotj75.01.020; Ferraz KMPMD, 2012, NAT CONSERVACAO, V10, P214, DOI 10.4322/natcon.2012.032; Moss R.H., 2008, IPCC EXPERT M REPORT; Muller H, 1868, VERH NATURHIST VEREI, V25, P1; Muller H, 1873, BEFRUCHTUNG BLUMEN D; Naczk AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143478; Narkiewicz, 2010, PRZYRODA SUDETOW, V13, P43; Oraie H, 2014, ZOOL MIDDLE EAST, V60, P125, DOI 10.1080/09397140.2014.914716; Pedrini P, 2014, LIFE T E NAZIONE A5; Pemberton Robert W., 2013, Lankesteriana, V13, P65; Perazza G., 1995, ANN MUS CIV ROVERETO, V11, P231; Perezza G, 2002, ATTI ACC ROV AGIATI, V252, P129; Petrovic D., 2008, NATURA MONTENEGRINA, V7, P605; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ramsay MM, 1998, BOT J LINN SOC, V126, P173, DOI 10.1006/bojl.1997.0152; Raoomavieius V., 2007, RED DATA BOOK LITHUA; Rasmussen H.N., 2012, EUR J ENVIRON SCI, V1, P69, DOI 10.14712/23361964.2015.49; Robbirt KM, 2014, CURR BIOL, V24, P2845, DOI 10.1016/j.cub.2014.10.033; SEATON P, 2013, LANKESTERIANA, V13, P93, DOI 10.15517/lank.v0i0.11545; Shefferson RP, 2007, EVOLUTION, V61, P1380, DOI 10.1111/j.1558-5646.2007.00112.x; Shefferson RP, 2005, MOL ECOL, V14, P613, DOI 10.1111/j.1365-294X.2005.02424.x; Slater H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032202; sliwinski, 2012, ACTA BOT SILESIACA, V8, P97; Sohel SI, 2017, IFOREST, V10, P154, DOI 10.3832/ifor1608-009; Sony RK, 2018, ECOL ENG, V120, P355, DOI 10.1016/j.ecoleng.2018.06.017; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Teteryuk, 2011, ARBEITSKREIS HEIMISC, V28, P133; Thorn JS, 2009, DIVERS DISTRIB, V15, P289, DOI 10.1111/j.1472-4642.2008.00535.x; Tobena M, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00202; Tsiftsis S., 2016, BOT CHRONIKA, V21, P43; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weyant J., 2009, REPORT 26 VERSUS 29; Xu X, 2017, FORESTS, V8, DOI 10.3390/f8100399; Yanez-Arenas C, 2012, OIKOS, V121, P2081, DOI 10.1111/j.1600-0706.2012.20350.x	88	20	20	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228420	10.1371/journal.pone.0228420	http://dx.doi.org/10.1371/journal.pone.0228420			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004339	Green Published, gold			2022-12-26	WOS:000534614600036
J	Leuker, C; Samartzidis, L; Hertwig, R; Pleskac, TJ				Leuker, Christina; Samartzidis, Lasare; Hertwig, Ralph; Pleskac, Timothy J.			When money talks: Judging risk and coercion in high-paying clinical trials	PLOS ONE			English	Article							HEALTHY-VOLUNTEERS; DECISION-MAKING; PAYMENT; PARTICIPATE	Millions of volunteers take part in clinical trials every year. This is unsurprising, given that clinical trials are often much more lucrative than other types of unskilled work. When clinical trials offer very high pay, however, some people consider them repugnant. To understand why, we asked 1,428 respondents to evaluate a hypothetical medical trial for a new Ebola vaccine offering three different payment amounts. Some respondents (27%) used very high pay (10,000) pound as a cue to infer the potential risks the clinical trial posed. These respondents were also concerned that offering 10,000 pound was coercive-simply too profitable to pass up. Both perceived risk and coercion in high-paying clinical trials shape how people evaluate these trials. This result was robust within and between respondents. The link between risk and repugnance may generalize to other markets in which parties are partially remunerated for the risk they take and contributes to a more complete understanding of why some market transactions appear repugnant.	[Leuker, Christina; Samartzidis, Lasare; Hertwig, Ralph; Pleskac, Timothy J.] Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany; [Pleskac, Timothy J.] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA	Max Planck Society; University of Kansas	Leuker, C (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany.	leuker@mpib.berlin.mpg.de	Hertwig, Ralph/B-3468-2015	Hertwig, Ralph/0000-0002-9908-9556; Samartzidis, Lasare/0000-0001-5685-8485; Leuker, Christina/0000-0003-2337-3785	MaxNetAging Research School at the Max Planck Institute for Demographic Research in Rostock, Germany	MaxNetAging Research School at the Max Planck Institute for Demographic Research in Rostock, Germany	C.L. was supported by a fellowship from the MaxNetAging Research School at the Max Planck Institute for Demographic Research in Rostock, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFP, 2016, GUARDIAN; Ambuehl S., 2017, SSRN ELECT J; Ambuehl S, 2015, AM ECON REV, V105, P357, DOI 10.1257/aer.p20151034; [Anonymous], 2016, RSTANARM VERSION 2 9; Bentley JP, 2004, J MED ETHICS, V30, P293, DOI 10.1136/jme.2002.001594; Bigorra J, 1990, EUROPEAN J CLIN PHAR; Casarett D, 2002, J GEN INTERN MED, V17, P650; Cokely ET, 2012, JUDGM DECIS MAK, V7, P25; Cryder CE, 2010, SOC SCI MED, V70, P455, DOI 10.1016/j.socscimed.2009.10.047; Czarny MJ, 2010, CLIN PHARMACOL THER, V87, P286, DOI 10.1038/clpt.2009.222; Dickert N, 2002, ANN INTERN MED, V136, P368, DOI 10.7326/0003-4819-136-5-200203050-00009; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Elias JJ, 2016, NBER WORKING PAPER S; Fric C., 2016, STATUTORY MINIMUM WA; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694; Kruschke JK, 2014, DOING BAYESIAN DATA, P2; Largent E. A., 2017, YALE J HLTH POLICY L, V17, P61; Leuker C, 2018, COGNITION, V175, P186, DOI 10.1016/j.cognition.2018.02.019; Mantzari E, 2014, SOC SCI MED, V106, P75, DOI 10.1016/j.socscimed.2014.01.020; McNeill P, 1997, BIOETHICS, V11, P390, DOI 10.1111/1467-8519.00079; Nussbaum MC, 1998, J LEGAL STUD, V27, P693, DOI 10.1086/468040; Pike ER, 2012, AM J LAW MED, V38, P7, DOI 10.1177/009885881203800101; Pleskac TJ, 2014, J EXP PSYCHOL GEN, V143, P2000, DOI 10.1037/xge0000013; Roth AE, 2007, J ECON PERSPECT, V21, P37, DOI 10.1257/jep.21.3.37; VANGELDEREN CEM, 1993, EUR J CLIN PHARMACOL, V45, P15, DOI 10.1007/BF00315344; Wilkinson M, 1997, BIOETHICS, V11, P373, DOI 10.1111/1467-8519.00078	27	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0227898	10.1371/journal.pone.0227898	http://dx.doi.org/10.1371/journal.pone.0227898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CX	32005037	Green Published, Green Submitted, gold			2022-12-26	WOS:000534614600009
J	Nizamis, K; Schutte, W; Grutters, JJ; Goseling, J; Rijken, NHM; Koopman, BFJM				Nizamis, Kostas; Schutte, Wouter; Grutters, Jan J.; Goseling, Jasper; Rijken, Noortje H. M.; Koopman, Bart F. J. M.			Evaluation of the cognitive-motor performance of adults with Duchenne Muscular Dystrophy in a hand-related task	PLOS ONE			English	Article							UPPER-LIMB FUNCTION; WORKLOAD	Duchenne muscular Dystrophy (DMD) is a progressive degenerative muscle disease, affecting, among others, the upper extremities. Effective hand rehabilitation can improve the hand function of people with DMD. To reach this goal, we first need to gain more insight into the hand cognitive-motor performance of people with DMD. This is the first study employing a systematic analysis on multi-finger, cognitive-motor performance of people with DMD. For this purpose, we propose an active dynamic visuo-motor task. The task employed six visual stimuli, a subset of which was activated at each trial. The stimuli were activated with a frequency of 1, 2, 3 and 4 Hz. Eight healthy participants and three participants with DMD performed the task. Additionally, the healthy participants performed seven sessions, and we assessed the training effects. Task-related cognitive-motor performance was evaluated using information transfer rate (ITR) and perceived workload. Regarding ITR, healthy participants performed significantly better than DMD participants; however, this was more evident for trials involving more than three fingers. Workload showed no difference between the healthy and the DMD groups. Healthy participants significantly improved their performance during training. Our results suggest that hand rehabilitation of people with DMD should consider multi-finger dynamic training. However, additional research with more people with DMD is needed for further generalization of our conclusions.	[Nizamis, Kostas; Schutte, Wouter; Grutters, Jan J.; Koopman, Bart F. J. M.] Univ Twente, Tech Med Ctr, Dept Biomech Engn, Enschede, Netherlands; [Goseling, Jasper] Univ Twente, Stochast Operat Grp, Enschede, Netherlands; [Goseling, Jasper] Univ Twente, Data Sci Grp, Enschede, Netherlands; [Rijken, Noortje H. M.] Radboud Univ Nijmegen, Dept Rehabil, Donders Inst Brain Cognit & Behav, Med Ctr, Gc Nijmegen, Netherlands	University of Twente; University of Twente; University of Twente; Radboud University Nijmegen	Nizamis, K (corresponding author), Univ Twente, Tech Med Ctr, Dept Biomech Engn, Enschede, Netherlands.	k.nizamis@utwente.nl	Nizamis, Konstantinos/I-2830-2019	Nizamis, Konstantinos/0000-0002-6965-0242; Koopman, Bart/0000-0001-5091-1724	Flextension Foundation through the Netherlands Organisation for Scientific Research (NWO); Duchenne Parent Project; Hankamp Rehab; Spieren voor Spieren; TMSi; Festo; Pontes Medical [13525]	Flextension Foundation through the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Duchenne Parent Project; Hankamp Rehab; Spieren voor Spieren; TMSi; Festo; Pontes Medical	This work was supported by the Flextension Foundation (http://www.flextension.nl/en/) through the Netherlands Organisation for Scientific Research (NWO https://www.nwo.nl/en), the Duchenne Parent Project (https://duchenne.nl/), Hankamp Rehab (http://www.hankamprehab.nl/), Spieren voor Spieren (https://www.spierenvoorspieren.nl/), TMSi (https://www.tmsi.com/), Festo (https://www.festo.com) and Pontes Medical (https://www.pontesmedical.com/), all awarded to BFJMK. Grant Number: 13525. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirabdollahian F, 2014, ROBOTICA, V32, P1331, DOI 10.1017/S0263574714002288; Bartels B, 2011, J REHABIL MED, V43, P770, DOI 10.2340/16501977-0841; Bergsma A, 2016, NEUROMUSCULAR DISORD, V26, P386, DOI 10.1016/j.nmd.2016.04.005; Bushby K., 2010, DIAGNOSIS MANAGEME 1, P77; Bushby K., 2010, DIAGNOSIS MANAGEME 2; Crawford J. R., 2009, COMP SINGLE CASE CON, P2690; Ehrgott M., 2006, MULTICRITERIA OPTIMI, V5; Feix T, 2016, IEEE T HUM-MACH SYST, V46, P66, DOI 10.1109/THMS.2015.2470657; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; Heutinck Lotte, 2018, J Neuromuscul Dis, V5, P359, DOI 10.3233/JND-180307; HILL SG, 1992, HUM FACTORS, V34, P429, DOI 10.1177/001872089203400405; Jansen M, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-55; Janssen MMHP, 2014, J NEUROL, V261, P1269, DOI 10.1007/s00415-014-7316-9; KLEMMER ET, 1969, J MOTOR BEHAV, V1, P135, DOI 10.1080/00222895.1969.10734841; MacKay D. J. C., 2003, INFORM THEORY INFERE; Malheiros S., 2015, INT ARCH MED, V8; Mattar FL, 2008, NEUROMUSCULAR DISORD, V18, P193, DOI 10.1016/j.nmd.2007.11.004; Mendell JR, 2013, MUSCLE NERVE, V48, P21, DOI 10.1002/mus.23810; Nizamis K, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103230; Nizamis K, 2017, INT C REHAB ROBOT, P1227, DOI 10.1109/ICORR.2017.8009417; Malheiros SRP, 2016, NEUROPSYCH DIS TREAT, V12, P41, DOI 10.2147/NDT.S87735; Tan HZ, 2010, IEEE T HAPTICS, V3, P98, DOI 10.1109/ToH.2009.46; Ueda Y, 2017, BRAIN DEV-JPN, V39, P225, DOI 10.1016/j.braindev.2016.10.005; Uetter Robert A. C., 2002, CHILDRENS OMNI SCALE; van den Bergen JC, 2013, NEUROMUSCULAR DISORD, V23, P775, DOI 10.1016/j.nmd.2013.06.489; Verwey WB, 1996, J EXP PSYCHOL-APPL, V2, P270, DOI 10.1037/1076-898X.2.3.270; Vicari S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191164; VIDULICH MA, 1986, APPL ERGON, V17, P291, DOI 10.1016/0003-6870(86)90132-8; Wagner KR, 2007, BBA-MOL BASIS DIS, V1772, P229, DOI 10.1016/j.bbadis.2006.06.009; WAGNER MB, 1989, MUSCLE NERVE, V12, P236, DOI 10.1002/mus.880120313; Weichbrodt J., DISABILITY REHABILIT, P1	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228128	10.1371/journal.pone.0228128	http://dx.doi.org/10.1371/journal.pone.0228128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CX	32004329	Green Published, gold			2022-12-26	WOS:000534614600018
J	Chiumiento, IR; Ituarte, S; Sun, J; Qiu, JW; Heras, H; Dreon, MS				Rafael Chiumiento, Ignacio; Ituarte, Santiago; Sun, Jin; Qiu, Jian Wen; Heras, Horacio; Sebastian Dreon, Marcos			Hemocyanin of the caenogastropod Pomacea canaliculata exhibits evolutionary differences among gastropod clades	PLOS ONE			English	Article							CONCHOLEPAS HEMOCYANIN; CDNA SEQUENCE; MOLLUSCAN; ORGANIZATION; PROTEINS; SUBUNIT; REVEAL; GENES; MODEL	Structural knowledge of gastropod hemocyanins is scarce. To better understand their evolution and diversity we studied the hemocyanin of a caenogastropod, Pomacea canaliculata (PcH). Through a proteomic and genomic approach, we identified 4 PcH subunit isoforms, in contrast with other gastropods that usually have 2 or 3. Each isoform has the typical Keyhole limpet-type hemocyanin architecture, comprising a string of eight globular functional units (FUs). Correspondingly, genes are organized in eight FUs coding regions. All FUs in the 4 genes are encoded by more than one exon, a feature not found in non-caenogastropods. Transmission electron microscopy images of PcH showed a cylindrical structure organized in di, tri and tetra-decamers with an internal collar structure, being the di and tridecameric cylinders the most abundant ones. PcH is N-glycosylated with high mannose and hybrid-type structures, and complex-type N-linked glycans, with absence of sialic acid. Terminal beta-N-GlcNAc residues and nonreducing terminal alpha-GalNAc are also present. The molecule lacks O-linked glycosylation but presents the T-antigen (Gal-beta 1,3-GalNAc). Using an anti-PcH polyclonal antibody, no cross-immunoreactivity was observed against other gastropod hemocyanins, highlighting the presence of clade-specific structural differences among gastropod hemocyanins. This is, to the best of our knowledge, the first gene structure study of a Caenogastropoda hemocyanin.	[Rafael Chiumiento, Ignacio; Ituarte, Santiago; Heras, Horacio; Sebastian Dreon, Marcos] Univ Nacl La Plata UNLP, CONICET, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Argentina; [Sun, Jin] Hong Kong Univ Sci & Technol, Dept Ocean Sci, Hong Kong, Peoples R China; [Qiu, Jian Wen] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Peoples R China; [Heras, Horacio] UNLP, Fac Ciencias Nat & Museo, Catedra Quim Biol, La Plata, Argentina; [Sebastian Dreon, Marcos] UNLP, Fac Ciencias Med, Catedra Bioquim & Biol Mol, La Plata, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Hong Kong University of Science & Technology; Hong Kong Baptist University; National University of La Plata; Museo La Plata; National University of La Plata	Dreon, MS (corresponding author), Univ Nacl La Plata UNLP, CONICET, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Argentina.; Dreon, MS (corresponding author), UNLP, Fac Ciencias Med, Catedra Bioquim & Biol Mol, La Plata, Argentina.	msdreon@gmail.com	Sun, Jin/C-1458-2010; Heras, Horacio/R-9555-2018	Sun, Jin/0000-0001-8002-6881; Heras, Horacio/0000-0003-3379-0216; Ituarte, Santiago/0000-0002-3670-2843	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2017-1815, PICT 2015-0661]; Subsidio Institucional para Investigadores CIC [N 305/17]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Subsidio Institucional para Investigadores CIC	Financial support for this work: HH: Agencia Nacional de Promocion Cientifica y Tecnologica, PICT 2017-1815, http://www.agencia.mincyt.gob.ar; MSD:Agencia Nacional de Promocion Cientifica y Tecnologica, PICT 2015-0661, http://www.agencia.mincyt.gob.ar; MSD: Subsidio Institucional para Investigadores CIC (Resolucion N 305/17), http://www.cic.gba.gob.ar.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhein B, 2002, GENE, V301, P53, DOI 10.1016/S0378-1119(02)01081-8; [Anonymous], 2011, GUIDE CARE USE LAB A, DOI [10.17226/11385, DOI 10.17226/11385]; Arancibia S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087240, 10.1371/journal.pone.0101786]; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; BARROS RMF, 1993, COMP BIOCHEM PHYS B, V105, P725, DOI 10.1016/0305-0491(93)90112-I; Becker MI, 2009, INT IMMUNOPHARMACOL, V9, P330, DOI 10.1016/j.intimp.2008.12.011; Bergmann S, 2006, J MOL EVOL, V62, P362, DOI 10.1007/s00239-005-0160-x; Bergmann S, 2007, J MOL EVOL, V64, P500, DOI 10.1007/s00239-006-0036-8; Coates CJ, 2013, FOOD CHEM, V140, P361, DOI 10.1016/j.foodchem.2013.02.072; De Ioannes P, 2004, J BIOL CHEM, V279, P26134, DOI 10.1074/jbc.M400903200; de Jong-Brink M., 1983, P297; De Smet L, 2011, GENE, V487, P118, DOI 10.1016/j.gene.2011.07.030; Gai ZQ, 2015, STRUCTURE, V23, P2204, DOI 10.1016/j.str.2015.09.008; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gatsogiannis C, 2015, STRUCTURE, V23, P93, DOI 10.1016/j.str.2014.10.013; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gesheva V, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0034-3; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; Ip JCH, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4553-9; Jaenicke E, 2010, BIOCHEM J, V426, P373, DOI 10.1042/BJ20091501; Kato S, 2017, BIOPHYSICAL REV, P1878; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lieb B, 2000, J BIOL CHEM, V275, P5675, DOI 10.1074/jbc.275.8.5675; Lieb B, 2001, P NATL ACAD SCI USA, V98, P4546, DOI 10.1073/pnas.071049998; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Lieb B, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-14; Lowe S., 2000, ENCY BIOL INVASIONS; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000520; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Matsukura K, 2013, BIOL INVASIONS, V15, P2039, DOI 10.1007/s10530-013-0431-1; Miller KI, 1998, J MOL BIOL, V278, P827, DOI 10.1006/jmbi.1998.1648; Moltedo B, 2006, J UROLOGY, V176, P2690, DOI 10.1016/j.juro.2006.07.136; Mu HW, 2018, J PROTEOMICS, V172, P36, DOI 10.1016/j.jprot.2017.11.002; Orr J., 1991, ANAL FATS OILS LIPOP, P525; Pena JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168665; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ponder WF, 2008, PHYLOGENY EVOLUTION; Schaefer GG, 2019, MOL PHYLOGENET EVOL, V130, P99, DOI 10.1016/j.ympev.2018.10.014; Siddiqui NI, 2007, BIOCHEM BIOPH RES CO, V361, P705, DOI 10.1016/j.bbrc.2007.07.098; Sun J., 2019, MATH PROBL ENG, V2019, P1, DOI [10.1093/molbev/msy239, DOI 10.1093/MOLBEV/MSY239]; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Yao T, 2019, INT J BIOL MACROMOL, V129, P538, DOI 10.1016/j.ijbiomac.2019.02.013; Zhang QF, 2013, STRUCTURE, V21, P604, DOI 10.1016/j.str.2013.02.018	48	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228325	10.1371/journal.pone.0228325	http://dx.doi.org/10.1371/journal.pone.0228325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999773	gold, Green Published			2022-12-26	WOS:000534612400068
J	Spani, F; Morigi, MP; Bettuzzi, M; Scalici, M; Carosi, M				Spani, Federica; Morigi, Maria Pia; Bettuzzi, Matteo; Scalici, Massimiliano; Carosi, Monica			A 3D journey on virtual surfaces and inner structure of ossa genitalia in Primates by means of a non-invasive imaging tool	PLOS ONE			English	Article							COPULATORY-BEHAVIOR; MICRO-CT; MAMMALIAN BACULUM; EVOLUTION; MORPHOLOGY; LENGTH	Novel bio-imaging techniques such as micro-Computed Tomography provide an opportunity to investigate animal anatomy and morphology by overcoming limitations imposed by traditional anatomical drawings. The primate genital bones are complex anatomical structures whose occurrence in both male penis (baculum) and female clitoris (baubellum) may be difficult to assess in individual cadavers. We tested a 3-step methodological protocol, including different techniques ranging from inexpensive/simple to more expensive/sophisticated ones, by applying it to a sample of primate species, and resulting in different levels of data complexity: (1) presence/absence manual palpation method; (2) 2D X-ray plates; 3) 3D micro-CT scans. Manual palpation failed on 2 out of 23 specimens by detecting 1 false negative and 1 false positive; radiography failed once confirming the false positive, however firmly disproved by micro-CT; micro-CT analysis reported the presence of 9 bacula out of 11 male specimens and 1 baubellum out of 12 female specimens. A different baculum position was identified between strepsirrhine and haplorrhine species. We also aim to assess microCT as a non-invasive technique providing updated anatomical descriptions of primate ossa genitalia. Micro-CT 3D volumes showed the surface of some bones as rough, with a jagged appearance, whereas in others the surface appeared very smooth and coherent. In addition, four main types of bone internal structure were identified: 1) totally hollow; 2) hollow epiphyses and solid diaphysis with few or several channels inside; 3) totally solid with intricate Haversian channels; 4) totally solid with some channels (structure of single baubellum scanned). Ossa genitalia appeared as a living tissue having its own Haversian-like channels. The high resolution of micro-CT 3D-images of primate genital bones disclosed additional form variability to that available from genital bone 2D images of previous studies, and showed for the first time new internal and external morphological characters. Moreover, micro-CT non-invasive approach proved appropriate to recover much of scientific knowledge still hidden and often neglected in both museum specimens and primate cadavers only destined to necropsy.	[Spani, Federica; Scalici, Massimiliano; Carosi, Monica] Roma Tre Univ, Dept Sci, Rome, Italy; [Morigi, Maria Pia; Bettuzzi, Matteo] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Morigi, Maria Pia; Bettuzzi, Matteo] Hist Museum Phys, Rome, Italy; [Morigi, Maria Pia; Bettuzzi, Matteo] Enrico Fermi Study & Res Ctr, Rome, Italy; [Morigi, Maria Pia; Bettuzzi, Matteo] Natl Inst Nucl Phys, Rome, Italy	Italfarmaco; Roma Tre University; University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN)	Spani, F (corresponding author), Roma Tre Univ, Dept Sci, Rome, Italy.	federica.spani@uniroma3.it	Carosi, Monica/C-9683-2014	Carosi, Monica/0000-0003-1377-2942; Spani, Federica/0000-0001-9577-8875; SCALICI, Massimiliano/0000-0002-5677-8837	Roma Tre University	Roma Tre University	This work was supported by Roma Tre University doctoral funds granted to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2000, INT J PRIMATOL, V21, P815, DOI 10.1023/A:1005542609002; Andre GI, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1086; Brassey CA, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1473; Brassey CA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0823; Brindle M, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1736; Carosi M., 2001, Folia Primatologica, V72, P149; Carosi M., 2017, INT ENCY PRIMATOLOGY, P1; Carosi M, 2017, INT ENCY PRIMATOLOGY, DOI [10.1002/9781119179313.wbprim0215, DOI 10.1002/9781119179313.WBPRIM0215]; Clark DP, 2014, PHYS MEDICA, V30, P619, DOI 10.1016/j.ejmp.2014.05.011; DIXSON AF, 1987, AM J PRIMATOL, V13, P51, DOI 10.1002/ajp.1350130107; Dixson AF, 2012, PRIMATE SEXUALITY: COMPARATIVE STUDIES OF THE PROSIMIANS, MONKEYS, APES, AND HUMANS, 2ND EDITION, P1, DOI 10.1093/acprof:osobl/9780199544646.001.0001; DIXSON AF, 1987, J ZOOL, V213, P423, DOI 10.1111/j.1469-7998.1987.tb03718.x; DIXSON AF, 1995, J ZOOL, V235, P67, DOI 10.1111/j.1469-7998.1995.tb05128.x; Dixson Alan, 2004, Acta Zoologica Sinica, V50, P490; Faot F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46452; Gardiner JD, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1305-z; GEISSMANN T, 1994, RAFFLES B ZOOL, V42, P775; Gerhardt Ulrich, 1909, Anatomischer Anzeiger, V35; GLUCKSMA.A, 1972, J ANAT, V112, P223; Grandidier A., 1875, HIST PHYS NATURELLE; Grandidier A., 1871, CR HEBD ACAD SCI, V72, P231; Harms JW, 1956, PRIMATOLOGIA HDB PRI, V1; Herdina AN, 2015, J MORPHOL, V276, P695, DOI 10.1002/jmor.20372; Herdina AN, 2015, J ANAT, V226, P229, DOI 10.1111/joa.12274; Hershkovitz P., 1977, LIVING NEW WORLD MON, P112; Hershkovitz Philip, 1993, Fieldiana Zoology, V73, P1; Hill PWC, 1953, PRIMATES COMP ANATOM; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Ioannou J. M., 1971, P131; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Lariviere S, 2002, MAMMAL REV, V32, P283, DOI 10.1046/j.1365-2907.2002.00112.x; LAYNE JN, 1954, J MAMMAL, V35, P357, DOI 10.2307/1375960; LONG CA, 1968, J MAMMAL, V49, P32, DOI 10.2307/1377725; Maggiano IS, 2016, J ANAT, V228, P719, DOI 10.1111/joa.12430; Morigi MP, 2010, APPL PHYS A-MATER, V100, P653, DOI 10.1007/s00339-010-5648-6; Morigi MP, 2018, HDB XRAY IMAGING PHY, P1181, DOI DOI 10.1002/MP.14041; Museyko O, 2015, COMPUT METHOD BIOMEC, V18, P1658, DOI 10.1080/10255842.2014.941824; Panmekiate S, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140322; Parsa A, 2015, CLIN ORAL IMPLAN RES, V26, pE1, DOI 10.1111/clr.12315; PATTERSON BD, 1983, J MAMMAL, V64, P496, DOI 10.2307/1380362; Pehrson V. T., 1914, ANAT ANZEIGER, V46, P161; Piras P, 2015, J MORPHOL, V276, P1157, DOI 10.1002/jmor.20405; Pocock RI, 1918, P ZOOL SOC LOND, V1918, P19; Pocock RI, 1920, P ZOOL SOC LOND, V1920, P91; Pocock RI, 1925, P ZOOL SOC LOND, V95, P1479, DOI DOI 10.1111/J.1469-7998.1925.TB07446.X; Pohl von L., 1928, ANAT EMBRYOL, V86, P71; Pohl von L., 1910, ANAT ANZEIGER, V37, P225; Romer AS, 1988, ANATOMIA COMP VERTEB; Ruth EB, 1934, ANAT REC, V60, P231, DOI 10.1002/ar.1090600209; Scalici M, 2016, AQUAT LIVING RESOUR, V29, DOI 10.1051/alr/2016019; Schultz NG, 2017, JOVE-J VIS EXP, DOI 10.3791/55342; Schultz NG, 2016, INTEGR COMP BIOL, V56, P644, DOI 10.1093/icb/icw034; Schultz NG, 2016, G3-GENES GENOM GENET, V6, P1141, DOI 10.1534/g3.116.027888; Sharir A, 2011, J STRUCT BIOL, V175, P451, DOI 10.1016/j.jsb.2011.06.006; Shehab D, 2002, J NUCL MED, V43, P346; Simmons LW, 2014, EVOLUTION, V68, P276, DOI 10.1111/evo.12229; Smirnov DG, 2003, ACTA CHIROPTEROL, V5, P117, DOI 10.3161/001.005.0111; Spani F, 2017, FOLIA PRIMATOL, V88, P200; Stockley P, 2012, CURR BIOL, V22, pR1032, DOI 10.1016/j.cub.2012.11.001; Veracini C., 2010, Atti della Societa Toscana di Scienze Naturali Residente in Pisa Memorie Serie B, V117, P51; WISLOCKI GEORGE B., 1936, HUMAN BIOL, V8, P309	61	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228131	10.1371/journal.pone.0228131	http://dx.doi.org/10.1371/journal.pone.0228131			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999734	Green Published, gold			2022-12-26	WOS:000534612400050
J	Stanly, TA; Fritzsche, M; Banerji, S; Shrestha, D; Schneider, F; Eggeling, C; Jackson, DG				Stanly, Tess A.; Fritzsche, Marco; Banerji, Suneale; Shrestha, Dilip; Schneider, Falk; Eggeling, Christian; Jackson, David G.			The cortical actin network regulates avidity-dependent binding of hyaluronan by the lymphatic vessel endothelial receptor LYVE-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; fluorescence recovery after photobleaching (FRAP); fluorescence correlation spectroscopy (FCS); confocal microscopy; membrane biophysics; leukocyte; hyaluronan; endothelial cell; dendritic cell; receptor; stimulated emission depletion (STED) microscopy; immune system; membrane receptor dynamics; STED-FCS; lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1); sFCS	PLASMA-MEMBRANE; CD44; CELLS; CYTOSKELETON; DIFFUSION; PROTEINS; DYNAMICS; DIFFERENTIATION; POLYMERIZATION; TRANSMIGRATION	Lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) mediates the docking and entry of dendritic cells to lymphatic vessels through selective adhesion to its ligand hyaluronan in the leukocyte surface glycocalyx. To bind hyaluronan efficiently, LYVE-1 must undergo surface clustering, a process that is induced efficiently by the large cross-linked assemblages of glycosaminoglycan present within leukocyte pericellular matrices but is induced poorly by the shorter polymer alone. These properties suggested that LYVE-1 may have limited mobility in the endothelial plasma membrane, but no biophysical investigation of these parameters has been carried out to date. Here, using super-resolution fluorescence microscopy and spectroscopy combined with biochemical analyses of the receptor in primary lymphatic endothelial cells, we provide the first evidence that LYVE-1 dynamics are indeed restricted by the submembranous actin network. We show that actin disruption not only increases LYVE-1 lateral diffusion but also enhances hyaluronan-binding activity. However, unlike the related leukocyte HA receptor CD44, which uses ERM and ankyrin motifs within its cytoplasmic tail to bind actin, LYVE-1 displays little if any direct interaction with actin, as determined by co-immunoprecipitation. Instead, as shown by super-resolution stimulated emission depletion microscopy in combination with fluorescence correlation spectroscopy, LYVE-1 diffusion is restricted by transient entrapment within submembranous actin corrals. These results point to an actin-mediated constraint on LYVE-1 clustering in lymphatic endothelium that tunes the receptor for selective engagement with hyaluronan assemblages in the glycocalyx that are large enough to cross-bridge the corral-bound LYVE-1 molecules and thereby facilitate leukocyte adhesion and transmigration.	[Stanly, Tess A.; Fritzsche, Marco; Banerji, Suneale; Shrestha, Dilip; Schneider, Falk; Eggeling, Christian; Jackson, David G.] Univ Oxford, Weatherall Inst Mol Med, Med Res Council, Human Immunol Unit, Oxford OX3 9DS, England; [Stanly, Tess A.] Univ Oxford, Weatherall Inst Mol Med, Wolfson Imaging Ctr, Oxford OX3 9DS, England; [Fritzsche, Marco] Univ York, Dept Biol, York Biomed Res Inst, York YO10 5DD, N Yorkshire, England; [Eggeling, Christian] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Eggeling, Christian] Leibniz Inst Photon Technol eV, Albert Einstein Str 9, D-07745 Jena, Germany; [Eggeling, Christian] Friedrich Schiller Univ Jena, Inst Appl Opt & Biophys, Max Wien Pl 4, D-07743 Jena, Germany	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; University of Oxford; University of York - UK; University of Oxford; Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena	Eggeling, C; Jackson, DG (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Med Res Council, Human Immunol Unit, Oxford OX3 9DS, England.; Eggeling, C (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England.; Eggeling, C (corresponding author), Leibniz Inst Photon Technol eV, Albert Einstein Str 9, D-07745 Jena, Germany.; Eggeling, C (corresponding author), Friedrich Schiller Univ Jena, Inst Appl Opt & Biophys, Max Wien Pl 4, D-07743 Jena, Germany.	christian.eggeling@rdm.ox.ac.uk; david.jackson@imm.ox.ac.uk		Schneider, Falk/0000-0003-0502-9139; Eggeling, Christian/0000-0002-3698-5599; Fritzsche, Marco/0000-0002-8712-7471	Wolfson Foundation [18272]; Medical Research Council (MRC) [MC_UU_12010, G090-2418, MC_UU_00008/2, MC_UU_12025]; MRC/BBSRC/ESPRC [MR/K01577X/1]; Wellcome Trust [104924/14/Z/14, 100262Z/12/Z, 098274/Z/12/Z, 091911, 107457/Z/15/Z]; Deutsche Forschungsgemeinschaft (Research Unit 1905, Jena Excellence Cluster "Balance of the Microverse") [3162113987-SFB 1278]; Newton-Katip Celebi Institutional Links [352333122]; University of Oxford (EPA Cephalosporin Fund); University of Oxford (John Fell Fund); MRC [MC_UU_00008/2, MC_U137884182, MC_UU_12010/2, MC_UU_00008/9, G0902418] Funding Source: UKRI	Wolfson Foundation; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/BBSRC/ESPRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft (Research Unit 1905, Jena Excellence Cluster "Balance of the Microverse")(German Research Foundation (DFG)); Newton-Katip Celebi Institutional Links; University of Oxford (EPA Cephalosporin Fund); University of Oxford (John Fell Fund); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wolfson Foundation Grant 18272; the Medical Research Council (MRC) (MC_UU_12010/unit programs, G090-2418, MC_UU_00008/2, and MC_UU_12025); MRC/BBSRC/ESPRC Grant MR/K01577X/1; Wellcome Trust Grants 104924/14/Z/14, 100262Z/12/Z, and 098274/Z/12/Z and Strategic Award 091911 (107457/Z/15/Z, Advanced Micron Bioimaging Unit); the Deutsche Forschungsgemeinschaft (Research Unit 1905, Jena Excellence Cluster "Balance of the Microverse," project no. 3162113987-SFB 1278 (project C05)); Newton-Katip Celebi Institutional Links Grant 352333122; and internal University of Oxford funding (EPA Cephalosporin Fund and John Fell Fund). The authors declare that they have no conflicts of interest with the contents of this article.	Andreoli D, 2015, SCI REP-UK, V5, DOI [10.1038/srep10347, 10.1038/srep11454]; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; [Anonymous], [No title captured]; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 2016, J BIOL CHEM, V291, P25004, DOI 10.1074/jbc.M116.736926; Bollyky PL, 2010, CELL MOL IMMUNOL, V7, P211, DOI 10.1038/cmi.2010.9; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Chojnacki J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00515-6; Clarke JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068978; Clausen MP, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa52a1; Clausen MP, 2015, METHODS, V88, P67, DOI 10.1016/j.ymeth.2015.06.017; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Dubacheva GV, 2015, P NATL ACAD SCI USA, V112, P5579, DOI 10.1073/pnas.1500622112; EDIDIN M, 1991, SCIENCE, V254, P1379, DOI 10.1126/science.1835798; EDIDIN M, 1994, P NATL ACAD SCI USA, V91, P3378, DOI 10.1073/pnas.91.8.3378; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Eghiaian F, 2015, BIOPHYS J, V108, P1330, DOI 10.1016/j.bpj.2015.01.016; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Freeman SA, 2018, CELL, V172, P305, DOI 10.1016/j.cell.2017.12.023; Fritzsche M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501337; Fritzsche M, 2015, NAT PROTOC, V10, P660, DOI 10.1038/nprot.2015.042; Fritzsche M, 2013, MOL BIOL CELL, V24, P757, DOI 10.1091/mbc.E12-06-0485; Fujiwara TK, 2016, MOL BIOL CELL, V27, P1101, DOI 10.1091/mbc.E15-04-0186; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hetrick B, 2013, CHEM BIOL, V20, P701, DOI 10.1016/j.chembiol.2013.03.019; Jackson DG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00471; Jackson DG, 2019, MATRIX BIOL, V78-79, P219, DOI 10.1016/j.matbio.2018.02.001; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Johnson LA, 2017, NAT IMMUNOL, V18, P762, DOI 10.1038/ni.3750; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2012, ANNU REV CELL DEV BI, V28, P215, DOI 10.1146/annurev-cellbio-100809-151736; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lawrance W, 2016, J BIOL CHEM, V291, P8014, DOI 10.1074/jbc.M115.708305; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; Lynskey NN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005137; Machan R, 2016, BIOPHYS J, V111, P152, DOI 10.1016/j.bpj.2016.06.001; Mao S Y, 1999, Methods Mol Biol, V115, P35; Mattila PK, 2016, J CELL BIOL, V212, P267, DOI 10.1083/jcb.201504137; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Mueller V, 2011, BIOPHYS J, V101, P1651, DOI 10.1016/j.bpj.2011.09.006; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saka SK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5509; Schneider F, 2018, ACS NANO, V12, P8540, DOI 10.1021/acsnano.8b04080; Schneider F, 2017, MOL BIOL CELL, V28, P1507, DOI 10.1091/mbc.E16-07-0536; Shelby SA, 2013, BIOPHYS J, V105, P2343, DOI 10.1016/j.bpj.2013.09.049; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Staaf E, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aai9200; Stanly TA, 2016, BIOL OPEN, V5, P1343, DOI 10.1242/bio.019943; Torreno-Pina JA, 2016, P NATL ACAD SCI USA, V113, pE772, DOI 10.1073/pnas.1514530113; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Vaahtomeri K, 2017, CELL REP, V19, P902, DOI 10.1016/j.celrep.2017.04.027; Vieira JM, 2018, J CLIN INVEST, V128, P3402, DOI 10.1172/JCI97192; Waithe D, 2018, METHODS, V140, P62, DOI 10.1016/j.ymeth.2017.09.010; Waithe D, 2016, BIOINFORMATICS, V32, P958, DOI 10.1093/bioinformatics/btv687; Wang Y, 2014, J BIOL CHEM, V289, P35159, DOI 10.1074/jbc.M114.600767; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209	68	6	6	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5036	5050		10.1074/jbc.RA119.011992	http://dx.doi.org/10.1074/jbc.RA119.011992			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32034091	Green Published, hybrid			2022-12-26	WOS:000526887000025
J	Lopez-Alvarado, J; Mameli, G; Farris, E; Susanna, A; Filigheddu, R; Garcia-Jacas, N				Lopez-Alvarado, Javier; Mameli, Giulia; Farris, Emmanuele; Susanna, Alfonso; Filigheddu, Rossella; Garcia-Jacas, Nuria			Islands as a crossroad of evolutionary lineages: A case study of Centaurea sect. Centaurea (Compositae) from Sardinia (Mediterranean Basin)	PLOS ONE			English	Article							BIODIVERSITY HOTSPOTS; RETICULATE EVOLUTION; PLANT BIODIVERSITY; NONCODING REGIONS; DNA-SEQUENCES; CONSERVATION; HISTORY; PHYLOGEOGRAPHY; HYBRIDIZATION; PHYLOGENY	The Mediterranean Basin is a biodiversity hotspot, where islands play a key role because of their high biological diversity, degree of endemicity and human pressure. One of these islands, Sardinia, is a good evolutionary laboratory, especially for the study of complex genera, such as Centaurea. In particular, endemic species of Centaurea sect. Centaurea from Sardinia provides an interesting case study of plant evolution on continental islands. We attempted to clarify the processes leading to the diversification of Centaurea species on Sardinia using bi-parentally inherited nuclear markers and maternally inherited plastid markers. Our plastid results revealed the presence of five lineages of sect. Centaurea on the island. Three of them were defined as three species: C. ferulacea, C. filiformis and C. horrida. The other two lineages highlighted the complex evolutionary history of the two polyploids C. corensis and C. magistrorum. Multiple colonization events from the mainland involving the C. deusta and C. paniculata lineages among others, have led to the diversity of sect. Centaurea on Sardinia. One colonization event likely followed a southern path via the land connection between the mainland, the Calabrian Plate and Sardinia. A second pathway likely followed a northern connection, probably through the Tuscan Archipelago. Implications of these findings on conservation efforts for Centaurea endemics on Sardinia are also discussed.	[Lopez-Alvarado, Javier] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Fac Biociencies,Unitat Bot,CSIC, Systemat & Evolut Vasc Plants UAB Associated Unit, Bellaterra, Spain; [Mameli, Giulia; Farris, Emmanuele; Filigheddu, Rossella] Univ Sassari, Dipartimento Chim & Farm, Sassari, Italy; [Susanna, Alfonso; Garcia-Jacas, Nuria] CSIC, ICUB, IBB, Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sassari; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Botanic de Barcelona (ICUB)	Lopez-Alvarado, J (corresponding author), Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Fac Biociencies,Unitat Bot,CSIC, Systemat & Evolut Vasc Plants UAB Associated Unit, Bellaterra, Spain.	javier.lopez.alvarado@uab.cat	Susanna, Alfonso/C-1683-2013	Susanna, Alfonso/0000-0003-4717-9063; Lopez-Alvarado, Javier/0000-0003-0568-4125	Generalitat de Catalunya, Ajuts a Grups de Recerca Consolidats [2014-SGR514-GREB, 2017-SGR1116]; Spanish Ministry of Science and Innovation [CGL2007-60781/BOS, CGL2010-18631/BOS]; Regione Autonoma della Sardegna [LR 7/2007, CRP2_474]	Generalitat de Catalunya, Ajuts a Grups de Recerca Consolidats(Generalitat de Catalunya); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regione Autonoma della Sardegna(Regione Sardegna)	Financial support from the Generalitat de Catalunya, Ajuts a Grups de Recerca Consolidats 2014-SGR514-GREB and 2017-SGR1116 (http://agaur.gencat.cat/en/inici/index.html) and from the Spanish Ministry of Science and Innovation, Projects CGL2007-60781/BOS and CGL2010-18631/BOS (http://www.ciencia.gob.es/portal/site/MICINN/?lang_choosen=en) for A. S. and N. G-J is gratefully acknowledged. This study was also supported by the Regione Autonoma della Sardegna, LR 7/2007 -PO Sardegna FSE 20072013, with the grant no. CRP2_474 for R.F. and E.F (https://www.regione.sardegna.it/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGONI P V, 1972, Webbia, V27, P279; ARRIGONI P V, 1971, Informatore Botanico Italiano, V3, P226; Arrigoni P.V., 2003, PARLATOREA, V6, P49; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bacchetta G, 2012, PLANT BIOSYST, V146, P638, DOI 10.1080/11263504.2011.642417; Baele G, 2013, BIOINFORMATICS, V29, P1970, DOI 10.1093/bioinformatics/btt340; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Barres L, 2013, AM J BOT, V100, P867, DOI 10.3732/ajb.1200058; Blair AC, 2010, EVOL APPL, V3, P40, DOI 10.1111/j.1752-4571.2009.00097.x; Blanca G., 1984, Lazaroa, V6, P169; Blanca G., 1981, LAGASCALIA, V10, P131; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Cogoni D., 2014, Informatore Botanico Italiano, V46, P109; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; CRANDALL KA, 1993, GENETICS, V134, P959; Desole L., 1954, GIORN BOT ITAL, V61, P256, DOI DOI 10.1080/11263505409431564; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duermeijer CE, 1998, TECTONOPHYSICS, V287, P233, DOI 10.1016/S0040-1951(98)80071-1; Duggen S, 2003, NATURE, V422, P602, DOI 10.1038/nature01553; Falchi A, 2009, MOL PHYLOGENET EVOL, V52, P538, DOI 10.1016/j.ympev.2009.04.002; Farris E, 2018, PLANT BIOLOGY, V20, P936, DOI 10.1111/plb.12853; Filigheddu R, 2010, INF BOT ITAL, V42, P558; Filigheddu R, 2014, PHYTOTAXA, V166, P297, DOI 10.11646/phytotaxa.166.4.6; Fromhage L, 2004, MOL PHYLOGENET EVOL, V31, P308, DOI 10.1016/j.ympev.2003.07.009; Ganga M., 2014, Informatore Botanico Italiano, V46, P106; Garcia Jacas Nuria, 1994, Nordic Journal of Botany, V14, P31; Garcia-Jacas N, 2006, ANN BOT-LONDON, V98, P741, DOI 10.1093/aob/mcl157; Garcia-Jacas N, 1998, ANN BOT FENN, V35, P159; Garcia-Jacas N, 2001, ANN BOT-LONDON, V87, P503, DOI 10.1006/anbo.2000.1364; Garcia-Jacas N, 2009, MOL PHYLOGENET EVOL, V52, P377, DOI 10.1016/j.ympev.2009.03.010; Georgiadis T., 1981, ACROLOPHUS COMPOSITA, V102, P321; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Grill A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P273, DOI 10.1007/1-4020-4904-8_10; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halacsy E, 1902, CONSPECTUS FLORAE GR, V2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hershkovitz Mark A, 2006, Gayana Bot., V63, P13; Hilpold A, 2015, PLANT BIOSYST, V149, P1025, DOI 10.1080/11263504.2014.983578; Hilpold A., 2014, Collectanea Botanica (Barcelona), V33, pe001, DOI 10.3989/collectbot.2013.v33.001; Hilpold A, 2014, MOL PHYLOGENET EVOL, V77, P195, DOI 10.1016/j.ympev.2014.04.022; Hmwe SS, 2006, BIOL J LINN SOC, V88, P691, DOI 10.1111/j.1095-8312.2006.00653.x; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ivanov D, 2007, GEOL CARPATH, V58, P367; Jeanmonod D., 2004, Asteraceae - II; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Jordan WC, 1996, AM J BOT, V83, P430, DOI 10.2307/2446212; Ketmaier V, 2010, MALACOLOGIA, V52, P81, DOI 10.4002/040.052.0106; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Liden M, 1997, PLANT SYST EVOL, V206, P411, DOI 10.1007/BF00987960; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Lopez-Alvarado J, 2014, TAXON, V63, P1079, DOI 10.12705/635.6; MADDISON DR, 1991, SYST ZOOL, V40, P315, DOI 10.2307/2992325; Mameli G, 2014, BOT J LINN SOC, V175, P453, DOI 10.1111/boj.12177; Mansion G, 2008, SYST BIOL, V57, P269, DOI 10.1080/10635150802044029; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Medail F, 2017, REG ENVIRON CHANGE, V17, P1775, DOI 10.1007/s10113-017-1123-7; Miller M.A., 2010, P GAT COMP ENV WORKS; Mraz P, 2012, MOL PHYLOGENET EVOL, V62, P612, DOI 10.1016/j.ympev.2011.11.006; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ochsmann Joerg, 1998, Floristische Rundbriefe, V31, P118; Orszag-Sperber F, 1993, ATLAS TETHYS PALEOEN, P237; Papuga G, 2019, PLANT ECOL DIVERS, V12, P51, DOI 10.1080/17550874.2019.1593545; Pau C., 1914, B SOC ARAGONESA CI N, V13, P42; Pisanu S, 2009, PLANT BIOSYST, V143, P275, DOI 10.1080/11263500902722493; Pisanu S, 2011, FOLIA GEOBOT, V46, P69, DOI 10.1007/s12224-010-9085-2; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RAMBAUT A, 2018, SYST BIOL, V67, P901, DOI [10.1093/sysbio/syy032, DOI 10.1093/SYSBIO/SYY032, DOI 10.1093/SYSBI0/SYY032]; Roche C. T., 2010, Collectanea Botanica (Barcelona), V29, P17, DOI 10.3989/collectbot.2010.v29.002; Rosenbaum G., 2002, J VIRTUAL EXPLORER, V8, P107, DOI DOI 10.3809/JVIRTEX.2002.00053; Salvi D, 2016, J BIOGEOGR, V43, P192, DOI 10.1111/jbi.12624; Sanz M, 2014, BOT J LINN SOC, V174, P214, DOI 10.1111/boj.12132; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Signorini, 2003, BOCCONEA, V16, P245; Smissen RD, 2004, PLANT SYST EVOL, V249, P37, DOI 10.1007/s00606-004-0209-0; Speranza F, 2002, TECTONOPHYSICS, V347, P231, DOI 10.1016/S0040-1951(02)00031-8; Suarez-Santiago VN, 2007, MOL PHYLOGENET EVOL, V43, P156, DOI 10.1016/j.ympev.2006.08.006; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Susanna A., 2007, FAMILIES GENERA VASC, P123; Susanna A, 2006, ANN MO BOT GARD, V93, P150, DOI 10.3417/0026-6493(2006)93[150:TCCRIF]2.0.CO;2; Swofford David L., 1990, P411; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 2018, PLANT BIOLOGY, V20, P128, DOI 10.1111/plb.12595; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Thompson JD, 2010, CONSERV BIOL, V24, P236, DOI 10.1111/j.1523-1739.2009.01304.x; Vilatersana R, 2007, MOL PHYLOGENET EVOL, V44, P610, DOI 10.1016/j.ympev.2007.05.008; WAGENITZ G., 1955, FLORA, V142, P213; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	97	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228776	10.1371/journal.pone.0228776	http://dx.doi.org/10.1371/journal.pone.0228776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032368	Green Published, Green Submitted, gold			2022-12-26	WOS:000534626100024
J	Yang, R; Li, XX; Wu, YA; Zhang, GH; Liu, XR; Li, YP; Bao, YH; Yang, WC; Cui, HJ				Yang, Rui; Li, Xiuxiu; Wu, Yanan; Zhang, Guanghui; Liu, Xiaoran; Li, Yanping; Bao, Yonghua; Yang, Wancai; Cui, Hongjuan			EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; THERAPEUTIC TARGET; REDOX HOMEOSTASIS; CELL BIOLOGY; CANCER; ELK-1; RESISTANCE; PROTEIN; GLYCOLYSIS	Cancer metabolism research has recently been revived and its focus expanded from glucose and the Warburg's effects on other nutrients, such as glutamine. The underlying mechanism of oncogenic alterations of glutaminolysis remains unclear. Genetic alterations of EGFR are observed in similar to 50% of glioblastoma (GBM) patients, and have been found to play important roles in the metabolic abnormalities of GBM. In this study, we found that glutamine metabolism was upregulated after EGFR activation in a GDH1 (glutamate dehydrogenase 1)-dependent manner. Knockdown of GDH1 significantly reduced the cell proliferation, colony formation and tumorigenesis abilities of glioblastoma cells. Furthermore, we showed that GDH1-mediated glutaminolysis was involved in EGF-promoted cell proliferation. EGFR triggered the phosphorylation of ELK1 at Ser 383 through activating MEK/ERK signaling. Phosphorylated ELK1 enriched in the promoter of GDH1 to activate the transcription of GDH1, which then promoted glutamine metabolism. In addition, EGFR activation did not accelerate glutaminolysis in ELK1 knockdown or ELK1 Ser383-mutated cells. Collectively, our findings indicate that EGFR phosphorylates ELK1 to activate GDH1 transcription and glutaminolysis through MEK/ERK pathway, providing new insight into oncogenic alterations of glutamine metabolism.	[Yang, Rui; Liu, Xiaoran; Li, Yanping; Bao, Yonghua; Yang, Wancai] Jining Med Univ, Inst Precis Med, Key Lab Precis Oncol Shandong Higher Educ, Jining, Peoples R China; [Yang, Rui; Wu, Yanan; Zhang, Guanghui; Cui, Hongjuan] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Li, Xiuxiu] Second Peoples Hosp Liaocheng, Dept Pharm, Liaocheng, Shandong, Peoples R China; [Zhang, Guanghui; Cui, Hongjuan] Southwest Univ, Engn Res Ctr Canc Biomed & Translat Med, Ctr Canc, Med Res Inst, Chongqing, Peoples R China; [Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL USA	Jining Medical University; Southwest University - China; Southwest University - China; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yang, R (corresponding author), Jining Med Univ, Inst Precis Med, Key Lab Precis Oncol Shandong Higher Educ, Jining, Peoples R China.; Yang, R; Cui, HJ (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.; Cui, HJ (corresponding author), Southwest Univ, Engn Res Ctr Canc Biomed & Translat Med, Ctr Canc, Med Res Inst, Chongqing, Peoples R China.	simply_yang@126.com; hcui@swu.edu.cn	Zhang, Guanghui/HHS-1240-2022	Zhang, Guanghui/0000-0002-6289-4965; Yang, Wancai/0000-0001-7437-9197; Yang, Rui/0000-0002-0525-1728	National Natural Science Foundation of China [81672502, 81872071]; National Natural Science Foundation Cultivation Project of Jining Medical University [600788002]; Jining Medical University [600788001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation Cultivation Project of Jining Medical University; Jining Medical University	This research was supported by the National Natural Science Foundation of China (Nos. 81672502 and 81872071), the grant to the Key Laboratory of Higher Education Institutes of Shandong Province, the National Natural Science Foundation Cultivation Project of Jining Medical University (600788002) and Faculty Startup Fund for RY from Jining Medical University (600788001).	Agnihotri S, 2016, NEURO-ONCOLOGY, V18, P160, DOI 10.1093/neuonc/nov125; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013; Bhutia YD, 2015, CANCER RES, V75, P1782, DOI 10.1158/0008-5472.CAN-14-3745; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Chai YL, 2001, ONCOGENE, V20, P1357, DOI 10.1038/sj.onc.1204256; Craze ML, 2019, BREAST CANCER RES TR, V174, P79, DOI 10.1007/s10549-018-5060-z; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; Felsberg J, 2017, CLIN CANCER RES, V23, P6846, DOI 10.1158/1078-0432.CCR-17-0890; Halatsch ME, 2006, CANCER TREAT REV, V32, P74, DOI 10.1016/j.ctrv.2006.01.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Ji HT, 2016, P NATL ACAD SCI USA, V113, P644, DOI 10.1073/pnas.1517112113; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Jin LT, 2018, MOL CELL, V69, P87, DOI 10.1016/j.molcel.2017.11.025; Jin LT, 2015, CANCER CELL, V27, P257, DOI 10.1016/j.ccell.2014.12.006; KOVACEVIC Z, 1971, BIOCHEM J, V125, P757, DOI 10.1042/bj1250757; Lee JH, 2018, MOL CELL, V70, P197, DOI 10.1016/j.molcel.2018.03.018; Liu F, 2015, MOL CELL, V60, P307, DOI 10.1016/j.molcel.2015.09.002; Ma JL, 2017, CANCER LETT, V411, P117, DOI [10.1016/j.canlet.2017.09.041, 10.1016/j.canlet.2017.10.026]; Mai WX, 2017, NAT MED, V23, P1342, DOI 10.1038/nm.4418; Maicas M, 2013, ONCOGENE, V32, P2069, DOI 10.1038/onc.2012.222; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; Michalak KP, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/964321; Nwosu ZC, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0872-6; Ohguchi H, 2017, LEUKEMIA, V31, P2661, DOI 10.1038/leu.2017.141; Ostrom QT, 2018, NEURO-ONCOLOGY, V20, P1, DOI 10.1093/neuonc/noy131; Shao NS, 1998, ONCOGENE, V17, P527, DOI 10.1038/sj.onc.1201931; Stehle P, 2017, CLIN NUTR ESPEN, V17, P75, DOI 10.1016/j.clnesp.2016.09.007; Tanaka K, 2015, J CLIN INVEST, V125, P1591, DOI 10.1172/JCI78239; Tateishi K, 2016, CLIN CANCER RES, V22, P4452, DOI 10.1158/1078-0432.CCR-15-2274; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang YQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02951-4; Yang R, 2016, MOL CANCER THER, V15, P421, DOI 10.1158/1535-7163.MCT-15-0709; Yeh HY, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-70; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zhang XS, 2013, J BIOL CHEM, V288, P32742, DOI 10.1074/jbc.M113.478016	44	32	32	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2975	2986		10.1038/s41388-020-1199-2	http://dx.doi.org/10.1038/s41388-020-1199-2		FEB 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32034306				2022-12-26	WOS:000511752600006
J	Kikuchi, H; Noda, S; Katsuragi, S; Ikeda, T; Horio, H				Kikuchi, Hitomi; Noda, Shunichi; Katsuragi, Shinji; Ikeda, Tomoaki; Horio, Hiroyuki			Evaluation of 3-tier and 5-tier FHR pattern classifications using umbilical blood pH and base excess at delivery	PLOS ONE			English	Article							FETAL HEART-RATE; GUIDELINES; ACIDEMIA	Objective The relevance between time-series fetal heart rate (FHR) pattern changes during labor and outcomes such as arterial blood gas data at delivery has not been studied. Using 3-tier and 5-tier classification systems, we studied the relationship between time-series FHR pattern changes before delivery and umbilical artery blood gas data at delivery. Methods The subjects were 1,909 low-risk women with vaginal delivery (age: 29.1 +/- 4.4 years, parity: 1.7 +/- 0.8). FHR patterns were classified by a skilled obstetrician based on each 10 min-segment of the last 60 min before delivery from continuous CTG records in an obstetric clinic. Results The relationship between each 10 min-segment FHR pattern classification from 60 minutes before delivery and umbilical artery blood pH and base excess (BE) values at delivery changed with time. In the 3-tier classification, mean pH of Category I group in each 10 min-segment was significantly higher than that of Category II group. For Category I groups in each 10-minute segment, its number decreased and its average pH increased as the delivery time approached. In the 5-tier classification, there was the same tendency. About each level group in 10 min-segment, the higher the level, the lower the blood gas values, and mean pH of higher level groups decreased as the delivery time approached. Conclusions The relationship between classifications and outcomes was clear at any time from 60 min before delivery in 3- and 5-tier classifications, and the 5-tier classification was more relevant.	[Kikuchi, Hitomi] Aino Univ, Dept Med Engn, Ibaraki, Osaka, Japan; [Noda, Shunichi] Noda Clin, Miyakonojo, Miyazaki, Japan; [Katsuragi, Shinji] Sakakibara Heart Inst, Dept Obstet & Gynecol, Fuchu, Tokyo, Japan; [Ikeda, Tomoaki] Mie Univ, Dept Obstet & Gynecol, Grad Sch Med, Tsu, Mie, Japan; [Horio, Hiroyuki] Univ Hyogo, Grad Sch Appl Informat, Kobe, Hyogo, Japan	Mie University; University of Hyogo	Kikuchi, H (corresponding author), Aino Univ, Dept Med Engn, Ibaraki, Osaka, Japan.	h-kikuchi@me-u.aino.ac.jp						Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; American College of Obstetricians and Gynecologists, 2010, OBSTET GYNECOL, V116, P1232, DOI [DOI 10.1097/AOG.0B013E3182004FA9, 10.1097/AOG.0b013e3182004fa9]; Ayres-De-Campos D, 2015, INT J GYNECOL OBSTET, V131, P13, DOI 10.1016/j.ijgo.2015.06.020; Blackwell SC, 2011, AM J OBSTET GYNECOL, V205, P5, DOI 10.1016/j.ajog.2011.02.077; Brocklehurst P, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22090; Cahill AG, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.026; Chen HY, 2011, AM J OBSTET GYNECOL, V204, pS43, DOI 10.1016/j.ajog.2010.10.091; Coletta J, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.014; Dellinger EH, 2000, AM J OBSTET GYNECOL, V182, P214, DOI 10.1016/S0002-9378(00)70515-1; Devane D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005122.pub5; Liston R, 2007, J OBSTET GYNAECOL CA, V29, pS3, DOI 10.1016/S1701-2163(16)32615-9; Macones GA, 2008, OBSTET GYNECOL, V112, P661, DOI 10.1097/AOG.0b013e3181841395; Miller DA, 2012, AM J OBSTET GYNECOL, V207, pE8, DOI 10.1016/j.ajog.2012.07.014; National Collaborating Centre for Women's and Children's Health (UK), 2014, INTR CAR CAR HLTH WO; NICE, 2017, INTR CAR HLTH WOM BA; Okai T, 2010, J OBSTET GYNAECOL RE, V36, P925, DOI 10.1111/j.1447-0756.2010.01342.x; PANETH N, 1993, CLIN INVEST MED, V16, P159; Parer JT, 2006, J MATERN-FETAL NEO M, V19, P289, DOI 10.1080/14767050500526172; Parer JT, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.037; Public Health Agency of Canada, 2009, WHAT MOTH SAY CAN MA; Sadaka A, 2011, J MATERN-FETAL NEO M, V24, P1465, DOI 10.3109/14767058.2011.621999; Sameshima H, 2005, AM J PERINAT, V22, P19, DOI 10.1055/s-2004-837272; Sameshima H, 2004, AM J OBSTET GYNECOL, V190, P118, DOI 10.1016/j.ajog.2003.07.014	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228630	10.1371/journal.pone.0228630	http://dx.doi.org/10.1371/journal.pone.0228630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027690	Green Published, gold			2022-12-26	WOS:000534623800058
J	Lok, TM; Wang, Y; Xu, WK; Xie, SW; Ma, HT; Poon, RYC				Lok, Tsun Ming; Wang, Yang; Xu, Wendy Kaichun; Xie, Siwei; Ma, Hoi Tang; Poon, Randy Y. C.			Mitotic slippage is determined by p31(comet) and the weakening of the spindle-assembly checkpoint	ONCOGENE			English	Article							CELL-CYCLE; AAA-ATPASE; PROTEIN; TRIP13; ACTIVATION; MAD2; MPS1; INACTIVATION; DEGRADATION; INHIBITION	Mitotic slippage involves cells exiting mitosis without proper chromosome segregation. Although degradation of cyclin B1 during prolonged mitotic arrest is believed to trigger mitotic slippage, its upstream regulation remains obscure. Whether mitotic slippage is caused by APC/C-CDC20 activity that is able to escape spindle-assembly checkpoint (SAC)-mediated inhibition, or is actively promoted by a change in SAC activity remains an outstanding issue. We found that a major culprit for mitotic slippage involves reduction of MAD2 at the kinetochores, resulting in a progressive weakening of SAC during mitotic arrest. A further level of control of the timing of mitotic slippage is through p31(comet)-mediated suppression of MAD2 activation. The loss of kinetochore MAD2 was dependent on APC/C-CDC20, indicating a feedback control of APC/C to SAC during prolonged mitotic arrest. The gradual weakening of SAC during mitotic arrest enables APC/C-CDC20 to degrade cyclin B1, cumulating in the cell exiting mitosis by mitotic slippage.	[Lok, Tsun Ming; Wang, Yang; Xu, Wendy Kaichun; Xie, Siwei; Ma, Hoi Tang; Poon, Randy Y. C.] Hong Kong Univ Sci & Technol, Ctr Canc Res, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Lok, Tsun Ming; Wang, Yang; Xu, Wendy Kaichun; Xie, Siwei; Ma, Hoi Tang; Poon, Randy Y. C.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Clear Water Bay, Hong Kong, Peoples R China; [Xu, Wendy Kaichun] Univ Texas Austin, Dept Mol Biosci, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of Texas System; University of Texas Austin	Poon, RYC (corresponding author), Hong Kong Univ Sci & Technol, Ctr Canc Res, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China.; Poon, RYC (corresponding author), Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Clear Water Bay, Hong Kong, Peoples R China.	rycpoon@ust.hk	Xu, Wendy Kaichun/AAO-3471-2021	Xu, Wendy Kaichun/0000-0002-5866-3523; Wang, Yang/0000-0001-5065-7412; MA, Hoi Tang/0000-0001-5876-0107	Research Grants Council [16100017, 16102919]; Health and Medical Research Fund [04153526]; Innovation and Technology Commission [ITCPD/17-9]	Research Grants Council(Hong Kong Research Grants Council); Health and Medical Research Fund; Innovation and Technology Commission	This work was supported in part by grants from the Research Grants Council (16100017 to HTM and 16102919 to RYCP), Health and Medical Research Fund (04153526 to HTM), and Innovation and Technology Commission (ITCPD/17-9 to RYCP).	Ausubel FM, 2012, CURRENT PROTOCOLS MO; Baek KH, 2005, ONCOL RES, V15, P161, DOI 10.3727/096504005776367906; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chow JPH, 2011, MOL CELL BIOL, V31, P1478, DOI 10.1128/MCB.00891-10; Cui YP, 2010, J BIOL CHEM, V285, P32988, DOI 10.1074/jbc.M110.140905; Domenech E, 2015, NAT CELL BIOL, V17, P1304, DOI 10.1038/ncb3231; Eytan E, 2014, P NATL ACAD SCI USA, V111, P12019, DOI 10.1073/pnas.1412901111; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Hashimoto T, 2008, GENES CELLS, V13, P609, DOI 10.1111/j.1365-2443.2008.01192.x; Hashimoto T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018449; Hiruma Y, 2015, SCIENCE, V348, P1264, DOI 10.1126/science.aaa4055; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Hsu SL, 2006, APOPTOSIS, V11, P765, DOI 10.1007/s10495-006-5880-x; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Ji ZJ, 2015, SCIENCE, V348, P1260, DOI 10.1126/science.aaa4029; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Lee K, 2011, MOL BIOL CELL, V22, P2470, DOI 10.1091/mbc.E11-03-0228; Ma HT, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1109; Ma HT, 2018, CELL REP, V22, P1439, DOI 10.1016/j.celrep.2018.01.027; Ma HT, 2017, METHODS MOL BIOL, V1524, P189, DOI 10.1007/978-1-4939-6603-5_12; Ma HT, 2016, CELL REP, V14, P1086, DOI 10.1016/j.celrep.2016.01.001; Ma HT, 2012, J BIOL CHEM, V287, P21561, DOI 10.1074/jbc.M112.364356; Ma HT, 2011, J BIOL CHEM, V286, P13052, DOI 10.1074/jbc.M110.201897; Ma HT, 2009, MOL CELL BIOL, V29, P6500, DOI 10.1128/MCB.00669-09; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Ng LY, 2019, CELL CYCLE, V18, P238, DOI 10.1080/15384101.2018.1563395; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; Riffell JL, 2011, MOL CANCER THER, V10, P839, DOI 10.1158/1535-7163.MCT-10-0909; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Siu WY, 1999, EXP CELL RES, V250, P131, DOI 10.1006/excr.1999.4551; Swe M, 2000, APOPTOSIS, V5, P29, DOI 10.1023/A:1009681408367; Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315; Wong PY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22230; Yam CH, 2000, J BIOL CHEM, V275, P3158, DOI 10.1074/jbc.275.5.3158; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Ye QZ, 2015, ELIFE, V4, DOI 10.7554/eLife.07367; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	46	10	10	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2819	2834		10.1038/s41388-020-1187-6	http://dx.doi.org/10.1038/s41388-020-1187-6		FEB 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32029899	Green Published, hybrid			2022-12-26	WOS:000511540800001
J	Rotoli, BM; Visigalli, R; Barilli, A; Ferrari, F; Bianchi, MG; Di Lascia, M; Riccardi, B; Puccini, P; Dall'Asta, V				Rotoli, Bianca Maria; Visigalli, Rossana; Barilli, Amelia; Ferrari, Francesca; Bianchi, Massimiliano G.; Di Lascia, Maria; Riccardi, Benedetta; Puccini, Paola; Dall'Asta, Valeria			Functional analysis of OCTN2 and ATB(0,+) in normal human airway epithelial cells	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; AMINO-ACID TRANSPORTER; L-CARNITINE; DRUG TRANSPORTERS; LUNG; CALU-3; IPRATROPIUM; EXPRESSION; QUANTIFICATION; MEMBRANE	In human, OCTN2 (SLC22A5) and ATB(0,+) (SLC6A14) transporters mediate the uptake of L-carnitine, essential for the transport of fatty acids into mitochondria and the subsequent degradation by beta-oxidation. Aim of the present study was to characterize L-carnitine transport in EpiAirway (TM), a 3D organotypic in vitro model of primary human tracheal-bronchial epithelial cells that form a fully differentiated, pseudostratified columnar epithelium at air-liquid interface (ALI) condition. In parallel, Calu-3 monolayers grown at ALI for different times (8d or 21d of culture) were used as comparison. OCTN2 transporter was equally expressed in both models and functional at the basolateral side. ATB(0,+) was, instead, highly expressed and active on the apical membrane of EpiAirway (TM) and only in early-cultures of Calu-3 (8d but not 21d ALI). In both cell models, L-carnitine uptake on the apical side was significantly inhibited by the bronchodilators glycopyrrolate and tiotropium, that hence can be considered substrates of ATB(0,+); ipratropium was instead effective on the basolateral side, indicating its interaction with OCTN2. Inflammatory stimuli, such as LPS or TNF alpha, caused an induction of SLC6A14/ATB(0,+) expression in Calu-3 cells, along with a 2-fold increase of L-carnitine uptake only at the apical side; on the contrary SLC22A5/OCTN2 was not affected. As both OCTN2 and ATB(0,+), beyond transporting L-carnitine, have a significant potential as delivery systems for drugs, the identification of these transporters in EpiAirway (TM) can open new fields of investigation in the study of drug inhalation and pulmonary delivery.	[Rotoli, Bianca Maria; Visigalli, Rossana; Barilli, Amelia; Ferrari, Francesca; Bianchi, Massimiliano G.; Dall'Asta, Valeria] Univ Parma, Dept Med & Surg, Lab Gen Pathol, Via Volturno, Parma, Italy; [Di Lascia, Maria; Riccardi, Benedetta; Puccini, Paola] Chiesi Farmaceut, Preclin Pharmacokinet Biochem & Metab Dept, Parma, Italy	University of Parma; Chiesi Pharmaceuticals Inc	Dall'Asta, V (corresponding author), Univ Parma, Dept Med & Surg, Lab Gen Pathol, Via Volturno, Parma, Italy.	valeria.dallasta@unipr.it	Dall'Asta, Valeria/M-6698-2015	Dall'Asta, Valeria/0000-0001-8540-0916	Chiesi Farmaceutici	Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc)	MD, BR, and PP received support in the form of salaries from Chiesi Farmaceutici. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar US, 2010, ENVIRON SCI ENG, P427, DOI 10.1007/978-3-642-12278-1_22; Berg T, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0760-9; BeruBe K, 2010, TOXICOLOGY, V278, P311, DOI 10.1016/j.tox.2010.04.004; Bosquillon C, 2010, J PHARM SCI-US, V99, P2240, DOI 10.1002/jps.21995; Broer S, 2019, COMPR PHYSIOL, V9, P343, DOI 10.1002/cphy.c170041; Bundey RA, 2003, ANAL BIOCHEM, V319, P318, DOI 10.1016/S0003-2697(03)00325-7; Chemuturi NV, 2005, J PHARM SCI-US, V94, P1976, DOI 10.1002/jps.20404; Closs EI, 2004, J NUTR, V134, p2752S, DOI 10.1093/jn/134.10.2752S; Di Paola M, 2017, MBIO, P8; Endter S, 2009, J PHARM PHARMACOL, V61, P583, DOI 10.1211/jpp/61.05.0006; Ferreira GC, 2017, NEUROCHEM RES, V42, P1661, DOI 10.1007/s11064-017-2288-7; Galietta LJV, 1998, AM J PHYSIOL-LUNG C, V275, pL917, DOI 10.1152/ajplung.1998.275.5.L917; GAZZOLA GC, 1981, ANAL BIOCHEM, V115, P368, DOI 10.1016/0003-2697(81)90019-1; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gosens R, 2018, EUR RESPIR J, P52, DOI [10.1016/j.ijpharm.2017.08.112, DOI 10.1016/J.IJPHARM.2017.08.112]; Gulcin I, 2006, LIFE SCI, V78, P803, DOI 10.1016/j.lfs.2005.05.103; Haghi M, 2014, PHARMACOL THERAPEUT, V144, P235, DOI 10.1016/j.pharmthera.2014.05.003; Hatanaka T, 2004, J PHARMACOL EXP THER, V308, P1138, DOI 10.1124/jpet.103.057109; Ingoglia F, 2017, J LEUKOCYTE BIOL, V101, P665, DOI 10.1189/jlb.1A0616-254R; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Kou LF, 2018, EXPERT OPIN THER TAR, V22, P715, DOI 10.1080/14728222.2018.1502273; Kreft ME, 2015, EUR J PHARM SCI, V69, P1, DOI 10.1016/j.ejps.2014.12.017; Li DF, 2019, J SCI COMPUT, V80, P403, DOI 10.1007/s10915-019-00943-0; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; Mathias NR, 2002, J DRUG TARGET, V10, P31, DOI 10.1080/10611860290007504; Mukherjee M, 2017, EUR J PHARM SCI, V106, P62, DOI 10.1016/j.ejps.2017.05.052; Mukherjee M, 2012, INT J PHARMACEUT, V426, P7, DOI 10.1016/j.ijpharm.2011.12.036; Nakamura T, 2010, MOL PHARMACEUT, V7, P187, DOI 10.1021/mp900206j; Nakanishi T, 2001, J PHYSIOL-LONDON, V532, P297, DOI 10.1111/j.1469-7793.2001.0297f.x; Nakanishi T, 2013, J PHARM SCI-US, V102, P3373, DOI 10.1002/jps.23603; Panduga V, 2017, INT J PHARMACEUT, V532, P328, DOI 10.1016/j.ijpharm.2017.08.112; Pochini L, 2019, SLAS DISCOV, V24, P89, DOI 10.1177/2472555218812821; Ribas GS, 2010, MUTAT RES-GEN TOX EN, V702, P123, DOI 10.1016/j.mrgentox.2010.07.008; Rotoli BM, 2020, J CELL MOL MED, V24, P921, DOI 10.1111/jcmm.14801; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Sakamoto A, 2015, J PHARM SCI-US, V104, P3029, DOI 10.1002/jps.24381; Salomon JJ, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11080396; Salomon JJ, 2012, EUR J PHARM BIOPHARM, V81, P351, DOI 10.1016/j.ejpb.2012.03.001; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Wagner CA, 2000, AM J PHYSIOL-RENAL, V279, pF584, DOI 10.1152/ajprenal.2000.279.3.F584; Wu X, 1999, J PHARMACOL EXP THER, V290, P1482	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228568	10.1371/journal.pone.0228568	http://dx.doi.org/10.1371/journal.pone.0228568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027707	Green Submitted, Green Published, gold			2022-12-26	WOS:000534623800050
J	Tran, AK; Hutchison, WD; Asplen, MK				Tran, Anh K.; Hutchison, W. D.; Asplen, Mark K.			Morphometric criteria to differentiate Drosophila suzukii (Diptera: Drosophilidae) seasonal morphs	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; FRUIT PRODUCTION; TRADE-OFFS; SUSCEPTIBILITY; SIZE; CLASSIFICATION; INFESTATION; TEMPERATURE; DYNAMICS; SURVIVAL	Temperate insect species often enter diapause in preparation for overwintering. One such species is the invasive vinegar fly, Drosophila suzukii (Matsumura), which has seasonal polymorphisms, considered winter and summer morphs. To date, the morphs have been differentiated by color and size with winter morphs typically being darker and larger compared to summer morphs. 'Dark' and 'large' are subjective, however, and standardizing an identification process can ensure that the morph of interest is being accurately characterized. The goal of our research was to investigate a quantitative method to distinguish between D. suzukii morphs based on body and wing size. We reared winter and summer morph D. suzukii in the laboratory using standard procedures, and measured wing length, wing width, and hind tibia length. Additionally, we collected field D. suzukii to document the seasonal phenology of the morphs in Minnesota based on our model's cutoff criteria. A classification and regression tree analysis were used to determine which metrics would be best for predicting field-caught D. suzukii morphs. Using laboratory-reared flies as our known morphs for the training data in the classification model we developed classification trees based on wing length and the ratio of wing length to hind tibia length. The frequency of winter and summer morphs present in the field varied based on which classification tree was used. Nevertheless, we suggest ratio of wing length to hind tibia length as the most robust criteria for differentiating D. suzukii morphs because the ratio accounts for the size variability between laboratory-reared and field-caught flies and the error rate of misclassification is reduced to 0.01 for males. The results from this work can aid in future D. suzukii research by allowing scientists to objectively differentiate the morphs, and thereby improve our understanding of the biology and phenology of seasonal morph dynamics.	[Tran, Anh K.; Hutchison, W. D.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Asplen, Mark K.] Metropolitan State Univ, Nat Sci Dept, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Minnesota State Colleges & Universities; Metropolitan State University	Tran, AK (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	aktran@umn.edu		Hutchison, William D./0000-0001-9605-2996; Tran, Anh/0000-0002-7568-0341	Minnesota Invasive Terrestrial Plants and Pests Center (mitppc.umn.edu) through the Minnesota Environment and Natural Resource Trust Fund	Minnesota Invasive Terrestrial Plants and Pests Center (mitppc.umn.edu) through the Minnesota Environment and Natural Resource Trust Fund	This work was funded by grants to WDH from the Minnesota Invasive Terrestrial Plants and Pests Center (mitppc.umn.edu) through the Minnesota Environment and Natural Resource Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT GH, 1993, AM J PHYS ANTHROPOL, V91, P441, DOI 10.1002/ajpa.1330910404; Arno J, 2016, J PEST SCI, V89, P713, DOI 10.1007/s10340-016-0774-3; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Asplen MK, 2009, PHYSIOL ENTOMOL, V34, P350, DOI 10.1111/j.1365-3032.2009.00698.x; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Briem F, 2018, INSECTS, V9, DOI 10.3390/insects9040125; Burrack HJ, 2015, ENVIRON ENTOMOL, V44, P704, DOI 10.1093/ee/nvv022; Burrack HJ, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM12012; Cha DH, 2018, J ECON ENTOMOL, V111, P645, DOI 10.1093/jee/tox369; Cini A, 2012, B INSECTOL, V65, P149; Consoli FL, 2002, ENTOMOL EXP APPL, V102, P135, DOI 10.1023/A:1015895201135; Daane KM, 2016, J PEST SCI, V89, P823, DOI 10.1007/s10340-016-0740-0; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; De Ros G, 2015, J BERRY RES, V5, P89, DOI 10.3233/JBR-150092; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Debat V, 2009, EVOLUTION, V63, P2864, DOI 10.1111/j.1558-5646.2009.00774.x; Ebbenga DN, 2019, J ECON ENTOMOL, V112, P2287, DOI 10.1093/jee/toz143; Fanning PD, 2018, J APPL ENTOMOL, V142, P26, DOI 10.1111/jen.12462; Flockhart DTT, 2017, MOV ECOL, V5, DOI 10.1186/s40462-017-0098-9; Fraimout A, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.166868; Gabarra R, 2015, BIOCONTROL, V60, P331, DOI 10.1007/s10526-014-9646-z; Gareth J., 2013, INTRO STAT LEARNING; Gomez DF, 2018, INSECT SYST DIVER, V2, DOI 10.1093/isd/ixy018; Grassi A., 2011, IOBC/WPRS Bulletin, V70, P121; Grassi A, 2018, ENVIRON ENTOMOL, V47, P166, DOI 10.1093/ee/nvx195; Guedot C, 2018, ENVIRON ENTOMOL, V47, P1365, DOI 10.1093/ee/nvy159; Gwynn DM, 2005, P ROY SOC B-BIOL SCI, V272, P1803, DOI 10.1098/rspb.2005.3089; Hamby KA, 2014, ENVIRON ENTOMOL, V43, P1008, DOI 10.1603/EN13245; Harris AL, 2014, DIPTERISTS DIG, V21; Harris DW, 2014, J ASIA-PAC ENTOMOL, V17, P857, DOI 10.1016/j.aspen.2014.08.006; Haviland DR, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM11034; Jaramillo SL, 2015, PHYSIOL ENTOMOL, V40, P2, DOI 10.1111/phen.12082; Kacar G, 2016, ENVIRON ENTOMOL, V45, P763, DOI 10.1093/ee/nvv182; Kamiyama MT, 2019, J ECON ENTOMOL, V112, P1789, DOI 10.1093/jee/toz102; Kanzawa T., 1939, YAMANASHI AGR EXP ST, V44; Kirkpatrick DM, 2018, ENVIRON ENTOMOL, V47, P700, DOI 10.1093/ee/nvy046; Leach H, 2019, J INSECT SCI, V19, DOI 10.1093/jisesa/iez067; Leach H, 2016, J ECON ENTOMOL, V109, P2151, DOI 10.1093/jee/tow157; Lee JC, 2015, ANN ENTOMOL SOC AM, V108, P117, DOI 10.1093/aesa/sau014; Lee JC, 2013, ENVIRON ENTOMOL, V42, P1348, DOI 10.1603/EN13148; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Lee R., 1991, INSECTS LOW TEMPERAT; Logan David, 2005, New Zealand Entomologist, V28, P37; Mazzi D, 2017, INSECTS, V8, DOI 10.3390/insects8010018; Panel ADC, 2018, INSECTS, V9, DOI 10.3390/insects9040145; R Core Team, 2013, R LANG ENV STAT COMP; R Studio Team, 2018, R STUDIO INTEGRATED; Rogers MA, 2016, J PEST SCI, V89, P851, DOI 10.1007/s10340-016-0772-5; Schmidt JM, 2019, AGR ECOSYST ENVIRON, V272, P86, DOI 10.1016/j.agee.2018.11.014; Shearer PW, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0070-3; Stephens AR, 2015, ENVIRON ENTOMOL, V44, P1619, DOI 10.1093/ee/nvv134; Stewart TJ, 2014, J ECON ENTOMOL, V107, P1771, DOI 10.1603/EC14197; Stockton D, 2019, ENVIRON ENTOMOL, V48, P454, DOI 10.1093/ee/nvy192; Stockton DG, 2018, INSECTS, V9, DOI 10.3390/insects9030105; Tait G, 2018, J PEST SCI, V91, P1213, DOI 10.1007/s10340-018-0985-x; Therneau A, 2018, RPART RECURSIVE PART; Thistlewood HMA, 2018, ENVIRON ENTOMOL, V47, P221, DOI 10.1093/ee/nvx178; Thorne AD, 2006, P ROY SOC B-BIOL SCI, V273, P1099, DOI 10.1098/rspb.2005.3416; Van Timmeren S, 2013, CROP PROT, V54, P126, DOI 10.1016/j.cropro.2013.08.003; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; Wallingford AK, 2016, ENVIRON ENTOMOL, V45, P1081, DOI 10.1093/ee/nvw088; Wallingford AK, 2016, ENTOMOL EXP APPL, V159, P327, DOI 10.1111/eea.12443; Wittkopp PJ, 2011, HEREDITY, V106, P592, DOI 10.1038/hdy.2010.90; Woltz JM, 2015, J APPL ENTOMOL, V139, P759, DOI 10.1111/jen.12200; Xu HJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0489; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zerulla FN, 2015, J BERRY RES, V5, P41, DOI 10.3233/JBR-150089	67	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228780	10.1371/journal.pone.0228780	http://dx.doi.org/10.1371/journal.pone.0228780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027732	gold, Green Published			2022-12-26	WOS:000534623800074
J	White, KE; Brennan, EB; Cavigelli, MA; Smith, RF				White, Kathryn E.; Brennan, Eric B.; Cavigelli, Michel A.; Smith, Richard F.			Winter cover crops increase readily decomposable soil carbon, but compost drives total soil carbon during eight years of intensive, organic vegetable production in California	PLOS ONE			English	Article							PHYSICAL-PROPERTIES; STATISTICAL SIGNIFICANCE; MICROBIAL BIOMASS; MATTER FRACTIONS; COASTAL-PLAIN; SEEDING RATE; NITROGEN; QUALITY; TILLAGE; MANAGEMENT	Maintaining soil organic carbon (SOC) in frequently tilled, intensive organic vegetable production systems is a challenge that is not well understood. Compost and cover crops are often used to add organic matter to the soil in these systems. Compost contributes relatively stabilized carbon (C) while cover crops provide readily degradable (labile) organic matter. Our objectives were to quantify C inputs, and to assess the effects of urban yard-waste compost, winter cover crop frequency and cover crop type on SOC and labile C stocks during eight years of intensive, organic production that usually included two vegetable crops per year in a long-term systems study in Salinas, California. Total C inputs from pelleted fertilizer, compost, vegetable transplant potting mix, vegetable residue and cover crops, including estimates of below ground inputs, ranged from 40 to 108 Mg ha(-1) in the five systems evaluated. Following a rapid decline in SOC stocks in year 1, compost had the largest effect on SOC stocks increasing mean SOC over years 2 to 8 by an average of 9.4 Mg ha(-1,) while increased cover crop frequency (annual vs. quadrennial) led to an additional 3.4 Mg ha(-1) increase. In contrast, cover cropping frequency had the largest effect on permanganate oxidizable labile C (POX-C), increasing POX-C by 26% after 8 years. Labile POX-C was well correlated with microbial biomass C and nitrogen. Compost had the greatest effect on total SOC stocks, while increasing cover crop frequency altered the composition of SOC by increasing the proportion of labile C. These results suggest that frequent winter cover cropping has a greater potential than compost to increase nutrient availability and vegetable yields in high-input, tillage intensive vegetable systems.	[White, Kathryn E.; Cavigelli, Michel A.] ARS, USDA, Sustainable Agr Syst Lab, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA; [Brennan, Eric B.] ARS, USDA, Salinas, CA USA; [Smith, Richard F.] Univ Calif Cooperat Extens, Salinas, CA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of California System	White, KE (corresponding author), ARS, USDA, Sustainable Agr Syst Lab, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA.	kate.white@usda.gov		White, Kathryn/0000-0001-7690-8611				Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Bolinder MA, 2007, AGR ECOSYST ENVIRON, V118, P29, DOI 10.1016/j.agee.2006.05.013; Brennan E.B., 2014, ORGANIC VERSUS CONVE; Brennan EB, 2019, SOIL SCI SOC AM J, V83, P624, DOI 10.2136/sssaj2017.12.0412; Brennan EB, 2018, DATA BRIEF, V21, P212, DOI 10.1016/j.dib.2018.09.013; Brennan EB, 2017, AGRON J, V109, P2199, DOI 10.2134/agronj2016.06.0354; Brennan EB, 2017, SOIL BIOL BIOCHEM, V109, P188, DOI 10.1016/j.soilbio.2017.01.014; Brennan EB, 2013, AGRON J, V105, P171, DOI 10.2134/agronj2012.0258; Brennan EB, 2012, AGRON J, V104, P684, DOI 10.2134/agronj2011.0330; Brennan EB, 2011, AGRON J, V103, P906, DOI 10.2134/agronj2010.0400; Butler DM, 2016, HORTSCIENCE, V51, P1038, DOI 10.21273/HORTSCI.51.8.1038; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P123, DOI 10.2136/sssaj1994.03615995005800010017x; Campbell KG, 2015, AGRON J, V107, P718, DOI 10.2134/agronj14.0167; Cogger CG, 2016, AGRON J, V108, P1142, DOI 10.2134/agronj2015.0335; Culman SW, 2012, SOIL SCI SOC AM J, V76, P494, DOI 10.2136/sssaj2011.0286; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Cumming G, 2017, INTRO NEW STAT ESTIM; Cumming G, 2013, UNDERSTANDING NEW ST; Dao T. H., 2008, J INETGR BIOSCI, V6, P30; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Drummond GB, 2011, CLIN EXP PHARMACOL P, V38, P287, DOI 10.1111/j.1440-1681.2011.05501.x; Evanylo G, 2008, AGR ECOSYST ENVIRON, V127, P50, DOI 10.1016/j.agee.2008.02.014; Ferris H, 2012, APPL SOIL ECOL, V61, P16, DOI 10.1016/j.apsoil.2012.04.006; Fidler F, 2006, CONSERV BIOL, V20, P1539, DOI 10.1111/j.1523-1739.2006.00525.x; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Franzluebbers AJ, 1999, SOIL SCI SOC AM J, V63, P349, DOI 10.2136/sssaj1999.03615995006300020012x; Gan YT, 2009, CAN J PLANT SCI, V89, P883, DOI 10.4141/CJPS08154; Grandy AS, 2007, ECOSYSTEMS, V10, P58, DOI 10.1007/s10021-006-9010-y; Gunapala N, 1998, SOIL BIOL BIOCHEM, V30, P805, DOI 10.1016/S0038-0717(97)00162-4; Haynes RJ, 1999, BIOL FERT SOILS, V28, P259, DOI 10.1007/s003740050491; Hubbard R, 2008, THEOR PSYCHOL, V18, P69, DOI 10.1177/0959354307086923; Hubbard RK, 2013, SOIL TILL RES, V126, P276, DOI 10.1016/j.still.2012.07.009; JACKSON LE, 1993, BIOL AGRIC HORTIC, V9, P273, DOI 10.1080/01448765.1993.9754639; Jackson LE, 2004, AGR ECOSYST ENVIRON, V103, P443, DOI 10.1016/j.agee.2003.11.013; JACKSON LE, 1993, J AGR SCI-CAMBRIDGE, V121, P55, DOI 10.1017/S0021859600076796; Jastrow JD, 1996, SOIL BIOL BIOCHEM, V28, P665, DOI 10.1016/0038-0717(95)00159-X; Jokela WE, 2009, AGRON J, V101, P727, DOI 10.2134/agronj2008.0191; KHALEEL R, 1981, J ENVIRON QUAL, V10, P133, DOI 10.2134/jeq1981.00472425001000020002x; Kuo S, 1997, SOIL SCI SOC AM J, V61, P145, DOI 10.2136/sssaj1997.03615995006100010022x; Lambdin C, 2012, THEOR PSYCHOL, V22, P67, DOI 10.1177/0959354311429854; Lee J, 2009, AGR ECOSYST ENVIRON, V134, P251, DOI 10.1016/j.agee.2009.07.006; Lehtinen T, 2017, ARCH AGRON SOIL SCI, V63, P663, DOI 10.1080/03650340.2016.1235264; Leifeld J, 2002, EUR J SOIL SCI, V53, P299, DOI 10.1046/j.1351-0754.2002.00453.x; Leifeld J, 2010, AMBIO, V39, P585, DOI 10.1007/s13280-010-0082-8; Lucas ST, 2012, AGRON J, V104, P1160, DOI 10.2134/agronj2011.0415; Maltais-Landry G, 2016, AGR ECOSYST ENVIRON, V223, P197, DOI 10.1016/j.agee.2016.03.007; Marriott EE, 2006, SOIL BIOL BIOCHEM, V38, P1527, DOI 10.1016/j.soilbio.2005.11.009; Melero S, 2009, SOIL TILL RES, V104, P292, DOI 10.1016/j.still.2009.04.001; Mirsky SB, 2008, SOIL SCI SOC AM J, V72, P180, DOI 10.2136/sssaj2005.0279; Mitchell J., 1999, California Agriculture, V53, P37, DOI 10.3733/ca.v053n04p37; Mitchell J, 2004, MINIMUM TILLAGE VEGE; Moore EB, 2014, SOIL SCI SOC AM J, V78, P968, DOI 10.2136/sssaj2013.09.0401; Morrow JG, 2016, SOIL SCI SOC AM J, V80, P450, DOI 10.2136/sssaj2015.08.0308; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; PAUSTIAN K, 1992, SOIL SCI SOC AM J, V56, P476, DOI 10.2136/sssaj1992.03615995005600020023x; Poeplau C, 2015, AGR ECOSYST ENVIRON, V200, P33, DOI 10.1016/j.agee.2014.10.024; Poffenbarger HJ, 2015, AGRON J, V107, P2083, DOI 10.2134/agronj15.0065; Sainju UM, 2002, SOIL TILL RES, V63, P167, DOI 10.1016/S0167-1987(01)00244-6; Sainju UM, 2006, J ENVIRON QUAL, V35, P1507, DOI 10.2134/jeq2005.0189; Sharifi M, 2014, NUTR CYCL AGROECOSYS, V100, P135, DOI 10.1007/s10705-014-9633-x; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Smukler SM, 2008, AGR ECOSYST ENVIRON, V126, P168, DOI 10.1016/j.agee.2008.01.028; Steele MK, 2012, SOIL SCI SOC AM J, V76, P2164, DOI 10.2136/sssaj2012.0008; Tautges NE, 2019, GLOBAL CHANGE BIOL, V25, P3753, DOI 10.1111/gcb.14762; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Toonsiri P, 2016, J ENVIRON QUAL, V45, P1812, DOI 10.2134/jeq2015.12.0623; Veum KS, 2014, BIOGEOCHEMISTRY, V117, P81, DOI 10.1007/s10533-013-9868-7; Wang F, 2017, SOIL TILL RES, V165, P247, DOI 10.1016/j.still.2016.08.022; Watson CA, 2002, SOIL USE MANAGE, V18, P239, DOI 10.1079/SUM2002131; Weil R. R., 2003, American Journal of Alternative Agriculture, V18, P3, DOI 10.1079/AJAA2003003; Willekens K, 2014, APPL SOIL ECOL, V82, P61, DOI 10.1016/j.apsoil.2014.05.009; Williams A, 2013, APPL SOIL ECOL, V65, P1, DOI 10.1016/j.apsoil.2012.12.019; Wyland LJ, 1996, AGR ECOSYST ENVIRON, V59, P1, DOI 10.1016/0167-8809(96)01048-1	75	29	29	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228677	10.1371/journal.pone.0228677	http://dx.doi.org/10.1371/journal.pone.0228677			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027701	Green Published, gold			2022-12-26	WOS:000534623800067
J	Gutierrez, JJ; Ruiz, JM; de Gauna, SR; Gonzalez-Otero, DM; Leturiondo, M; Russell, JK; Corcuera, C; Urtusagasti, JF; Daya, MR				Julio Gutierrez, Jose; Maria Ruiz, Jesus; Ruiz de Gauna, Sofia; Maria Gonzalez-Otero, Digna; Leturiondo, Mikel; Russell, James Knox; Corcuera, Carlos; Francisco Urtusagasti, Juan; Daya, Mohamud Ramzan			Modeling the impact of ventilations on the capnogram in out-of-hospital cardiac arrest	PLOS ONE			English	Article							RESUSCITATION COUNCIL GUIDELINES; CHEST COMPRESSION DEPTH; TIDAL CARBON-DIOXIDE; CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; CPR; HYPERVENTILATION; PRESSURE; SURVIVAL; OUTCOMES	Aim Current resuscitation guidelines recommend waveform capnography as an indirect indicator of perfusion during cardiopulmonary resuscitation (CPR). Chest compressions (CCs) and ventilations during CPR have opposing effects on the exhaled carbon dioxide (CO2) concentration, which need to be better characterized. The purpose of this study was to model the impact of ventilations in the exhaled CO2 measured from capnograms collected during out-of-hospital cardiac arrest (OHCA) resuscitation. Methods We retrospectively analyzed OHCA monitor-defibrillator files with concurrent capnogram, compression depth, transthoracic impedance and ECG signals. Segments with CC pauses, two or more ventilations, and with no pulse-generating rhythm were selected. Thus, only ventilations should have caused the decrease in CO2 concentration. The variation in the exhaled CO2 concentration with each ventilation was modeled with an exponential decay function using non-linear-least-squares curve fitting. Results Out of the original 1002 OHCA dataset (one per patient), 377 episodes had the required signals, and 196 segments from 96 patients met the inclusion criteria. Airway type was endotracheal tube in 64.8% of the segments, supraglottic King LT-D (TM) in 30.1%, and unknown in 5.1%. Median (IQR) decay factor of the exhaled CO2 concentration was 10.0% (7.8 - 12.9) with R-2 = 0.98(0.95 - 0.99). Differences in decay factor with airway type were not statistically significant (p = 0.17). From these results, we propose a model for estimating the contribution of CCs to the end-tidal CO2 level between consecutive ventilations and for estimating the end-tidal CO2 variation as a function of ventilation rate. Conclusion We have modeled the decrease in exhaled CO2 concentration with ventilations during chest compression pauses in CPR. This finding allowed us to hypothesize a mathematical model for explaining the effect of chest compressions on ETCO2 compensating for the influence of ventilation rate during CPR. However, further work is required to confirm the validity of this model during ongoing chest compressions.	[Julio Gutierrez, Jose; Maria Ruiz, Jesus; Ruiz de Gauna, Sofia; Maria Gonzalez-Otero, Digna; Leturiondo, Mikel] Univ Basque Country, UPV EHU, Dept Commun Engn, Bilbao, Bizkaia, Spain; [Maria Gonzalez-Otero, Digna] Bexen Cardio, Ermua, Bizkaia, Spain; [Russell, James Knox; Daya, Mohamud Ramzan] Oregon Hlth & Sci Univ OHSU, Dept Emergency Med, Portland, OR USA; [Corcuera, Carlos; Francisco Urtusagasti, Juan] Basque Country Hlth Syst, Emergentziak Osakidetza, Osakidetza, Basque Country, Spain	University of Basque Country; Oregon Health & Science University	de Gauna, SR (corresponding author), Univ Basque Country, UPV EHU, Dept Commun Engn, Bilbao, Bizkaia, Spain.	sofia.ruizdegauna@ehu.eus	Russell, James/AAW-8820-2021; Gutierrez, J. Julio/G-7867-2014	Russell, James/0000-0002-5133-9720; Gonzalez-Otero, Digna Maria/0000-0002-6594-5748; Ruiz de Gauna, Sofia/0000-0002-0414-0946; Gutierrez, J. Julio/0000-0003-3539-0320	Basque Government [IT1087-16]; Spanish Ministry of Economy, Industry and Competitiveness [RTI2018-094396-B-I00]; program Torres Quevedo [PTQ-16-08201];  [PRE-2017-2-0201]	Basque Government(Basque Government); Spanish Ministry of Economy, Industry and Competitiveness; program Torres Quevedo; 	The Basque Government provided support in the form of a grant for research groups (IT1087-16) for authors Jose Julio Gutierrez, Jesus Maria Ruiz, Sofia Ruiz de Gauna, and Mikel Leturiondo; and in the form of a predoctoral grant (PRE-2017-2-0201) for author Mikel Leturiondo (https://www.euskadi.eus).The Spanish Ministry of Economy, Industry and Competitiveness provided support in the form of a grant for research projects (RTI2018-094396-B-I00) for authors Jose Julio Gutierrez, Jesus Maria Ruiz, Sofia Ruiz de Gauna, and Mikel Leturiondo; and in the form of the program Torres Quevedo (PTQ-16-08201) for author Digna Maria Gonzalez-Otero (http://www.ciencia.gob.es/).Bexen Cardio, a Spanish medical device manufacturer, provided support in the form of a salary for author Digna Mari ' a Gonza ' lez-Otero. None of the above funders had any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of each author is articulated in the "author contributions" section. Authors James Knox Russell, Carlos Corcuera, Juan Francisco Urtusagasti, and Mohamud Ramzan Daya received no funding for this work.	Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Babbs CF, 2013, RESUSCITATION, V84, P1297, DOI 10.1016/j.resuscitation.2013.06.005; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Cone DC, 2011, CAPNOGRAPHY, 2ND EDITION, P185; Cordioli RL, 2019, CURR OPIN CRIT CARE, V25, P37, DOI 10.1097/MCC.0000000000000573; Friess SH, 2014, RESUSCITATION, V85, P1298, DOI 10.1016/j.resuscitation.2014.05.040; Gazmuri RJ, 2012, RESUSCITATION, V83, P259, DOI 10.1016/j.resuscitation.2011.07.034; Grmec S, 2003, CRIT CARE, V7, pR139, DOI 10.1186/cc2369; GUDIPATI CV, 1988, CIRCULATION, V77, P234, DOI 10.1161/01.CIR.77.1.234; Idris AH, 2015, CRIT CARE MED, V43, P840, DOI 10.1097/CCM.0000000000000824; Gutierrez JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201565; Leturiondo M, 2018, RESUSCITATION, V124, P63, DOI 10.1016/j.resuscitation.2017.12.013; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; McDannold R, 2018, AM J EMERG MED, V36, P1640, DOI 10.1016/j.ajem.2018.06.057; Meaney PA, 2013, CIRCULATION, V128, P417, DOI 10.1161/CIR.0b013e31829d8654; Murphy RA, 2016, PREHOSP EMERG CARE, V20, P369, DOI 10.3109/10903127.2015.1115929; Paiva EF, 2018, RESUSCITATION, V123, P1, DOI 10.1016/j.resuscitation.2017.12.003; Pantazopoulos C, 2015, HEART LUNG CIRC, V24, P1053, DOI 10.1016/j.hlc.2015.05.013; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Pokorna M, 2010, J EMERG MED, V38, P614, DOI 10.1016/j.jemermed.2009.04.064; Poon KM, 2016, RESUSCITATION, V102, P80, DOI 10.1016/j.resuscitation.2016.02.021; Rognas L, 2014, RESUSCITATION, V85, P332, DOI 10.1016/j.resuscitation.2013.12.009; Ruiz JM, 2018, RESUSCITATION, V128, P158, DOI 10.1016/j.resuscitation.2018.04.036; SANDERS AB, 1985, AM J EMERG MED, V3, P147, DOI 10.1016/0735-6757(85)90039-7; Sandroni C, 2018, RESUSCITATION, V132, P73, DOI 10.1016/j.resuscitation.2018.08.018; Schipke JD, 2003, AM J PHYSIOL-HEART C, V285, pH2510, DOI 10.1152/ajpheart.00604.2003; Sheak KR, 2015, RESUSCITATION, V89, P149, DOI 10.1016/j.resuscitation.2015.01.026; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Steen S, 2003, RESUSCITATION, V58, P249, DOI 10.1016/S0300-9572(03)00265-X; Stiell IG, 2014, CIRCULATION, V130, P1962, DOI 10.1161/CIRCULATIONAHA.114.008671; Sutton RM, 2014, RESUSCITATION, V85, P983, DOI 10.1016/j.resuscitation.2014.04.015; Vadeboncoeur T, 2014, RESUSCITATION, V85, P182, DOI 10.1016/j.resuscitation.2013.10.002; Wang AY, 2016, AM J EMERG MED, V34, P2367, DOI 10.1016/j.ajem.2016.08.052; WEIL MH, 1985, CRIT CARE MED, V13, P907, DOI 10.1097/00003246-198511000-00011	35	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228395	10.1371/journal.pone.0228395	http://dx.doi.org/10.1371/journal.pone.0228395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023298	Green Published, gold			2022-12-26	WOS:000534621500051
J	Jeng, MJ; Sharma, M; Chao, TY; Li, YC; Huang, SF; Chang, LB; Chow, L				Jeng, Ming-Jer; Sharma, Mukta; Chao, Ting-Yu; Li, Ying-Chang; Huang, Shiang-Fu; Chang, Liann-Be; Chow, Lee			Multiclass classification of autofluorescence images of oral cavity lesions based on quantitative analysis	PLOS ONE			English	Article							POTENTIALLY MALIGNANT DISORDERS; FLUORESCENCE SPECTROSCOPY; CANCER; EFFICACY; VISUALIZATION; DIAGNOSIS; TISSUE; VELSCOPE(TM); BENIGN	Background Oral cancer is one of the most common diseases globally. Conventional oral examination and histopathological examination are the two main clinical methods for diagnosing oral cancer early. VELscope is an oral cancer-screening device that exploited autofluorescence. It yields inconsistent results when used to differentiate between normal, premalignant and malignant lesions. We develop a new method to increase the accuracy of differentiation. Materials and methods Five samples (images) of each of 21 normal mucosae, as well as 31 premalignant and 16 malignant lesions of the tongue and buccal mucosa were collected under both white light and autofluorescence (VELscope, 400-460 nm wavelength). The images were developed using an iPod (Apple, Atlanta Georgia, USA). Results The normalized intensity and standard deviation of intensity were calculated to classify image pixels from the region of interest (ROI). Linear discriminant analysis (LDA) and quadratic discriminant analysis (QDA) classifiers were used. The performance of both of the classifiers was evaluated with respect to accuracy, precision, and recall. These parameters were used for multiclass classification. The accuracy rate of LDA with un-normalized data was increased by 2% and 14% and that of QDA was increased by 16% and 25% for the tongue and buccal mucosa, respectively. Conclusion The QDA algorithm outperforms the LDA classifier in the analysis of autofluorescence images with respect to all of the standard evaluation parameters.	[Jeng, Ming-Jer; Sharma, Mukta; Chao, Ting-Yu] Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan; [Jeng, Ming-Jer; Huang, Shiang-Fu; Chang, Liann-Be] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Linkou, Taiwan; [Li, Ying-Chang; Chang, Liann-Be] Chang Gung Univ, Green Technol Res Ctr, Taoyuan, Taiwan; [Huang, Shiang-Fu] Chang Gung Univ, Dept Publ Hlth, Taoyuan, Taiwan; [Chow, Lee] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; State University System of Florida; University of Central Florida	Huang, SF; Chang, LB (corresponding author), Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Linkou, Taiwan.; Chang, LB (corresponding author), Chang Gung Univ, Green Technol Res Ctr, Taoyuan, Taiwan.; Huang, SF (corresponding author), Chang Gung Univ, Dept Publ Hlth, Taoyuan, Taiwan.	shiangfu.huang@gmail.com; liann@mail.cgu.edu.tw	Chow, Lee/A-8106-2009	Chow, Lee/0000-0001-7729-6848	Chang Gung Memorial Hospital [BMRPA52, CMRPD2F0261, CMRPD2G0291, CMRPD2I0061, CMRPG3H0792, CMRPG3J0591, CMRPB53, CMRPG3H0791]; Ministry of Science and Technology, Executive Yuan, Taiwan, ROC [MOST106-2314-B-182-025-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Executive Yuan, Taiwan, ROC	This research was funded by Chang Gung Memorial Hospital (BMRPA52, CMRPD2F0261, CMRPD2G0291, CMRPD2I0061) for study design, data collection and analysis, and preparation of the manuscript, and CMRPG3H0791, CMRPG3H0792, CMRPG3J0591, and CMRPB53 for data collection analysis. This study was also supported by grant MOST106-2314-B-182-025-MY3 from the Ministry of Science and Technology, Executive Yuan, Taiwan, ROC for data collection and analysis.	Allen CT, 2013, HEAD NECK-J SCI SPEC, V35, P1669, DOI 10.1002/hed.23202; [Anonymous], 2007, KNOWLEDGE DISCOVERY; Awan KH, 2011, ORAL ONCOL, V47, P274, DOI 10.1016/j.oraloncology.2011.02.001; Bhatia N, 2013, INT J DENT, V2013, DOI 10.1155/2013/194029; Bhatia N, 2014, ORAL ONCOL, V50, P1012, DOI 10.1016/j.oraloncology.2014.07.002; Burian E, 2017, J CRANIO MAXILL SURG, V45, P1526, DOI 10.1016/j.jcms.2017.05.021; Burzynski N J, 1997, J Cancer Educ, V12, P95; Ciano J, 2015, ANAT REC, V298, P562, DOI 10.1002/ar.23097; Druzhkova IN, 2016, CELL CYCLE, V15, P1257, DOI 10.1080/15384101.2016.1160974; Farah CS, 2012, HEAD NECK-J SCI SPEC, V34, P856, DOI 10.1002/hed.21834; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Ganga RS, 2017, ORAL ONCOL, V75, P67, DOI 10.1016/j.oraloncology.2017.10.023; Gardner-Lubbe S, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0041-9; Gono K, 2003, OPT REV, V10, P211, DOI 10.1007/s10043-003-0211-8; Horner MJ, 2009, SEER CANC STAT REV 1; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang TT, 2017, ORAL ONCOL, V68, P20, DOI 10.1016/j.oraloncology.2017.03.003; Jeng MJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091313; Kanniyappan U, 2016, PHOTODIAGN PHOTODYN, V14, P18, DOI 10.1016/j.pdpdt.2016.02.002; Kordbacheh F, 2016, ORAL DIS, V22, P285, DOI 10.1111/odi.12438; Kumar R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02522-5; Lingen MW, 2008, ORAL ONCOL, V44, P10, DOI 10.1016/j.oraloncology.2007.06.011; Lingen MW, 2017, J AM DENT ASSOC, V148, P712, DOI 10.1016/j.adaj.2017.07.032; Lingen MW, 2016, TAIWANS LEADING CAUS; Liu DJ, 2016, TOHOKU J EXP MED, V238, P165, DOI 10.1620/tjem.238.165; Messadil DV, 2014, INT J ORAL SCI, V6, P162, DOI 10.1038/ijos.2014.39; Mortazavi Hamed, 2014, J Dent Res Dent Clin Dent Prospects, V8, P6, DOI 10.5681/joddd.2014.002; Nagi R, 2016, MED ORAL PATOL ORAL, V21, pE447, DOI 10.4317/medoral.21104; Poh CF, 2006, CLIN CANCER RES, V12, P6716, DOI 10.1158/1078-0432.CCR-06-1317; Reddy SS, 2017, J ORAL PATHOL MED, V46, P454, DOI 10.1111/jop.12508; Rethman MP, 2010, J AM DENT ASSOC, V141, P509, DOI 10.14219/jada.archive.2010.0223; Sawan D, 2015, J INT SOC PREV COMMU, V5, P248, DOI 10.4103/2231-0762.159967; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Siqueira LFS, 2017, CHEMOMETR INTELL LAB, V162, P123, DOI 10.1016/j.chemolab.2017.01.021; Skandarajah A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188440; Song LMWK, 2008, GASTROINTEST ENDOSC, V67, P581, DOI 10.1016/j.gie.2008.01.013; Stewart B, 2018, WORLD CANC REPORT 20; Talmor A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0376; Tosios KI, 2010, HEAD NECK PATHOL, V4, P31, DOI 10.1007/s12105-009-0153-y; Velidandla Surekha, 2014, J Int Oral Health, V6, P33; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; Wu YC, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2362741; Yan YJ, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.4.045007; Yayon N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22489-1	44	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228132	10.1371/journal.pone.0228132	http://dx.doi.org/10.1371/journal.pone.0228132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017775	Green Published, gold			2022-12-26	WOS:000534618100014
J	Thangal, SNM; Donelan, JM				Thangal, Sayed Naseel Mohamed; Donelan, J. Maxwell			Scaling of inertial delays in terrestrial mammals	PLOS ONE			English	Article							BODY-SIZE; STRIDE FREQUENCY; NEURAL-CONTROL; MUSCLE; POSTURE; FORCE; CAT; BIOMECHANICS; MOVEMENT; FEEDBACK	As part of its response to a perturbation, an animal often needs to reposition its body. Inertia acts to oppose the corrective motion, delaying the completion of the movement-we refer to this elapsed time as inertial delay. As animal size increases, muscle moment arms also increase, but muscles are proportionally weaker, and limb inertia is proportionally larger. Consequently, the scaling of inertial delays is complex. Our intent is to determine how quickly different sized animals can produce corrective movements when their muscles act at their force capacity, relative to the time within which those movements need to be performed. Here, we quantify inertial delay using two biomechanical models representing common scenarios in animal locomotion: a distributed mass pendulum approximating swing limb repositioning (swing task), and an inverted pendulum approximating whole body posture recovery (posture task). We parameterized the anatomical, muscular, and inertial properties of these models using literature scaling relationships, then determined inertial delay for each task across a large range of movement magnitudes and the full range of terrestrial mammal sizes. We found that inertial delays scaled with an average of M-0.28 in the swing task and M-0.35 in the posture task across movement magnitudes-larger animals require more absolute time to perform the same movement as small animals. The time available to complete a movement also increases with animal size, but less steeply. Consequently, inertial delays comprise a greater fraction of swing duration and other characteristic movement times in larger animals. We also compared inertial delays to the other component delays within the stimulus-response pathway. As movement magnitude increased, inertial delays exceeded these sensorimotor delays, and this occurred for smaller movements in larger animals. Inertial delays appear to be a challenge for motor control, particularly for bigger movements in larger animals.	[Thangal, Sayed Naseel Mohamed; Donelan, J. Maxwell] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada	Simon Fraser University	Donelan, JM (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.	mdonelan@sfu.ca		mohamed thangal, sayed naseel/0000-0003-2690-2742	Natural Sciences and Engineering Research Council of Canada [RGPIN326825]; Simon Fraser University; Multi Year Funding-Internal award	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Simon Fraser University; Multi Year Funding-Internal award	This work was supported by the Natural Sciences and Engineering Research Council of Canada with a Discovery Grant no: RGPIN326825 to JMD and by Simon Fraser University with a Multi Year Funding-Internal award to SNMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1981, J ZOOL, V194, P539, DOI 10.1111/j.1469-7998.1981.tb04600.x; ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; Alexander RM, 2002, INTEGR COMP BIOL, V42, P158, DOI 10.1093/icb/42.1.158; Alexander RM., 2003, PRINCIPLES ANIMAL LO; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; Brown IE, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P148; BUCHANAN TS, 1995, MED ENG PHYS, V17, P529, DOI 10.1016/1350-4533(95)00005-8; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; Daley MA, 2006, P NATL ACAD SCI USA, V103, P15681, DOI 10.1073/pnas.0601473103; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Garcia M., 2000, ADAPTIVE MOTION ANIM; Gerritsen K G, 1998, Motor Control, V2, P206; GRILLNER S, 1972, ACTA PHYSIOL SCAND, V86, P92, DOI 10.1111/j.1748-1716.1972.tb00227.x; Halliday D., 2010, FUNDAMENTALS PHYS; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; HEGLUND NC, 1988, J EXP BIOL, V138, P301; HOF AL, 1996, GAIT POSTURE, V4, P222; Hooper SL, 2012, CURR BIOL, V22, pR318, DOI 10.1016/j.cub.2012.02.048; Hooper SL, 2009, J NEUROSCI, V29, P4109, DOI 10.1523/JNEUROSCI.5510-08.2009; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Jurgens KD, 2002, J EXP BIOL, V205, P2161; Kilbourne BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078392; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Kuo AD, 2002, MOTOR CONTROL, V6, P129, DOI 10.1123/mcj.6.2.129; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Larramendi A, 2016, ACTA PALAEONTOL POL, V61, P537, DOI 10.4202/app.00136.2014; Lloyd DPC, 1943, J NEUROPHYSIOL, V6, P317, DOI 10.1152/jn.1943.6.4.317; LOEB GE, 1987, J MORPHOL, V191, P1, DOI 10.1002/jmor.1051910102; MATTHEWS PB, 1964, PHYSIOL REV, V44, P219, DOI 10.1152/physrev.1964.44.2.219; MCGEER T, 1990, PROC R SOC SER B-BIO, V240, P107, DOI 10.1098/rspb.1990.0030; MCMAHON TA, 1975, J APPL PHYSIOL, V39, P619, DOI 10.1152/jappl.1975.39.4.619; Medler S, 2002, AM J PHYSIOL-REG I, V283, pR368, DOI 10.1152/ajpregu.00689.2001; MENDEZ J, 1960, METABOLISM, V9, P184; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Milton JG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065005; MOCHON S, 1980, J BIOMECH, V13, P49, DOI 10.1016/0021-9290(80)90007-X; Morl F, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412500856; More HL, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0613; More HL, 2010, P ROY SOC B-BIOL SCI, V277, P3563, DOI 10.1098/rspb.2010.0898; Powell M.J., 1968, FORTRAN SUBROUTINE S; Preacher KJ, 2012, COMMUN METHODS MEAS, V6, P77, DOI 10.1080/19312458.2012.679848; Rajagopal A, 2016, IEEE T BIO-MED ENG, V63, P2068, DOI 10.1109/TBME.2016.2586891; Rao VG, 2001, IEEE CONTR SYST MAG, V21, P86, DOI 10.1109/37.954521; RIOS E, 1992, ANNU REV PHYSIOL, V54, P109, DOI 10.1146/annurev.ph.54.030192.000545; Rospars JP, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160313; RUSHMER DS, 1983, EXP BRAIN RES, V50, P45; Seyfarth A, 2003, J EXP BIOL, V206, P2547, DOI 10.1242/jeb.00463; Srinivasan M, 2011, J R SOC INTERFACE, V8, P74, DOI 10.1098/rsif.2009.0544; Ting LH, 2004, J NEUROPHYSIOL, V92, P808, DOI 10.1152/jn.00773.2003; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Wong JD., 2017, HUMANOID ROBOTICS RE; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1	59	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0217188	10.1371/journal.pone.0217188	http://dx.doi.org/10.1371/journal.pone.0217188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017765	Green Submitted, gold, Green Published			2022-12-26	WOS:000534618100002
J	Pavelka, R; Trebick, V; Fialova, JT; Zdobinsky, A; Coufalova, K; Havlicek, J; Tufano, JJ				Pavelka, Radim; Trebick, Vit; Fialova, Jitka Trebicka; Zdobinsky, Adam; Coufalova, Klara; Havlicek, Jan; Tufano, James J.			Acute fatigue affects reaction times and reaction consistency in Mixed Martial Arts fighters	PLOS ONE			English	Article							CHOICE-REACTION-TIME; PHYSICAL-EXERCISE; MOVEMENT TIME; STRENGTH; IMPACT; AGE	Mixed Martial Arts (MMA) is a multielement combat sport where fighters need to quickly react to an opponent's movements under fatigued conditions. Research indicates that fast reaction time is important in many sports, but the effect of fatigue has shown negative, null, or even positive influences on reaction time. However, few studies have been conducted in a controlled setting, especially using MMA figthers, whose matches are frequently resolved in a split-second. Therefore, this study investigated whether acute neuromuscular fatigue affects reaction and movement times, and their consistency in MMA fighters (N = 45). Before and after an upper-body Wingate test, a simple visual reaction time task was completed. Results showed a significant negative effect of fatigue on the reaction times and their consistency, with longer reactions (1.5% change) and lower consistency (14.7% change) after the Wingate test. Further, greater amounts of fatigue during the Wingate test seemed to negatively affect the consistency of post-Wingate movement time. Due to cumulative fatigue and the dynamic nature of MMA, our data indicate that not only the decrements in aerobic and anaerobic power likely affect a fighter's performance, but their reaction time and motor time may also be compromised during a fight.	[Pavelka, Radim; Trebick, Vit; Zdobinsky, Adam; Coufalova, Klara; Tufano, James J.] Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic; [Trebick, Vit; Fialova, Jitka Trebicka; Havlicek, Jan] Natl Inst Mental Hlth, Klecany, Czech Republic; [Fialova, Jitka Trebicka; Havlicek, Jan] Charles Univ Prague, Fac Sci, Prague, Czech Republic	Charles University Prague; National Institute of Mental Health - Czech Republic; Charles University Prague	Trebick, V (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic.; Trebick, V (corresponding author), Natl Inst Mental Hlth, Klecany, Czech Republic.	vit.trebicky@nudz.cz	Tufano, James/AAD-4416-2019; Fialová, Jitka/E-3125-2018; Pavelka, Radim/GMX-3034-2022; Tufano, James J/O-7363-2017; Trebicky, Vit/P-3115-2016; Coufalova, Klara/V-8808-2017; Havlicek, Jan/F-8985-2011	Tufano, James/0000-0001-8325-0344; Fialová, Jitka/0000-0003-2419-7461; Pavelka, Radim/0000-0001-8148-3160; Tufano, James J/0000-0001-8325-0344; Trebicky, Vit/0000-0003-1440-1772; Coufalova, Klara/0000-0002-8963-8179; Havlicek, Jan/0000-0003-2374-7337	Czech Science Foundation GACR [P407/19/11822S]; Ministry of Education, Youth, and Sports NPU I program [LO1611]; Charles University Centre of Excellence project [UNCE/HUM/032]; Programme of the institutional support for science at Charles University [Q41]	Czech Science Foundation GACR(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports NPU I program; Charles University Centre of Excellence project; Programme of the institutional support for science at Charles University	VT, JTF were supported by Czech Science Foundation GACR P407/19/11822S, VT, JTF and JH were supported by the Ministry of Education, Youth, and Sports NPU I program (No. LO1611), KC was supported by Charles University Centre of Excellence project (UNCE/HUM/032) and by the Programme of the institutional support for science at Charles University Progress, No. Q41.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2013, AMJ SPORTS SCI; [Anonymous], 2019, JAMOVI PROJECT JAMOV; Araki M, 2006, PERCEPT MOTOR SKILL, V102, P736, DOI 10.2466/PMS.102.3.736-746; Balkó Štefan, 2016, Rev. bras. cineantropom. desempenho hum., V18, P391, DOI 10.5007/1980-0037.2016v18n4p391; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Bledsoe GH., 2009, COMBAT SPORTS MED, P323, DOI [10.1007/978-1-84800-354-5, DOI 10.1007/978-1-84800-354-5]; BOILEAU RA, 1977, ORTHOP CLIN N AM, V8, P563; Braswell M., 2010, J STRENGTH COND RES, V24, P1, DOI DOI 10.1097/01.JSC.0000367074.45565.85; Brisswalter J, 1997, PERCEPT MOTOR SKILL, V85, P1019, DOI 10.2466/pms.1997.85.3.1019; Davranche K, 2006, J SPORT SCI, V24, P323, DOI 10.1080/02640410500132165; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Durmic Tijana, 2017, BMJ Open Sport Exerc Med, V3, pe000240, DOI 10.1136/bmjsem-2017-000240; Fight Matrix, 2019, MMA FIGHT OUTCOMES Y; Gallucci M., 2019, GAMLJ GEN ANAL LINEA; Garg Monika, 2013, Indian J Physiol Pharmacol, V57, P138; Gierczuk D., 2012, POLISH J SPORT TOURI, V19, P230, DOI [10.2478/v10197-012-0022-1, DOI 10.2478/V10197-012-0022-1]; Gierczuk D, 2018, J STRENGTH COND RES, V32, P3433, DOI 10.1519/JSC.0000000000002868; Gierczuk D, 2017, PERCEPT MOTOR SKILL, V124, P200, DOI 10.1177/0031512516672126; Heller J, 2002, XXVII FIMS: WORLD CONGRESS OF SPORTS MEDICINE, P47; INBAR O, 1996, HUMAN KINETICS; Jensen P, 2013, SPORT PSYCHOL, V27, P1, DOI 10.1123/tsp.27.1.1; Kahneman D., 1973, ATTENTION EFFORT; Kashihara K, 2005, PERCEPT MOTOR SKILL, V100, P275; Kirk C, 2018, HUMAN MOVEMENT, V19, P46, DOI 10.1007/s11332-016-0270-4; Kirk C., 2016, AGE ANTHROPOMETRIC V, V1, P1, DOI [10.7287/peerj.preprints.2380v2, DOI 10.7287/PEERJ.PREPRINTS.2380V2]; Kirk C., 2016, PEER J PREPRINTS, V4; KROLL W, 1973, J MOTOR BEHAV, V5, P81, DOI 10.1080/00222895.1973.10734953; La Bounty P, 2011, STRENGTH COND J, V33, P56, DOI 10.1519/SSC.0b013e3182044304; Lembo BN, 2002, MIXED MARTIAL ARTS U; Lenetsky S, 2012, STRENGTH COND J, V34, P32, DOI 10.1519/SSC.0b013e3182389f00; LEVITT S, 1971, RES QUART, V42, P405, DOI 10.1080/10671188.1971.10615088; Mala L, 2019, INT J MORPHOL, V37, P568, DOI 10.4067/S0717-95022019000200568; Malhotra V, 2015, J EVOL MED DENT SCI-, V4, P4277, DOI 10.14260/jemds/2015/618; Marinho BF, 2016, SPORT SCI HLTH, V12, P157, DOI DOI 10.1249/JSR.0b013e31821cc952; Mirzaei B, 2011, J HUM SPORT EXERC, V6, P406, DOI 10.4100/jhse.2011.62.21; Mroczek D, 2011, J HUM KINET, V28, P73, DOI 10.2478/v10078-011-0024-y; Murman Daniel L., 2015, Seminars in Hearing, V36, P111, DOI 10.1055/s-0035-1555115; Ong NCH, 2015, INT REV SPORT EXER P, V8, P204, DOI 10.1080/1750984X.2015.1061581; R Core Team, 2015, RSTUDIO INT DEV R; Radovanovic D, 2011, ARCH BUDO, V7, P21; Sabzi A.H., 2012, MIDDLE EAST J SCI RE, V12, P1092, DOI [10.5829/idosi.mejsr.2012.12.8.7113, DOI 10.5829/idosi.mejsr.2012.12.8.7113]; Sant'Ana J, 2017, SPORT BIOMECH, V16, P201, DOI 10.1080/14763141.2016.1217347; Schmidt R. A., 2013, MOTOR LEARNING PERFO; Schmidt R.A, 1991, MOTOR LEARNING PERFO; TOMPOROWSKI PD, 1987, ERGONOMICS, V30, P121, DOI 10.1080/00140138708969682; Trebicky V, 2019, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02740; Tsorbatzoudis H, 1998, PERCEPT MOTOR SKILL, V86, P571, DOI 10.2466/pms.1998.86.2.571; Vaguino de Lima E, 2004, REV BRAS MED ESPORTE, V10, P344, DOI 10.1590/S1517-86922004000500001; Wallace W.A., 2009, COMBAT SPORTS MED, P73, DOI [10.1007/978-1-84800-354-5_5, DOI 10.1007/978-1-84800-354-5_5]; WHITLEY JD, 1992, PERCEPT MOTOR SKILL, V74, P171, DOI 10.2466/PMS.74.1.171-176; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Yoon J, 2002, SPORTS MED, V32, P225, DOI 10.2165/00007256-200232040-00002; Zwierko T., 2014, CENTRAL EUROPEAN J S, V5, P27	54	12	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0227675	10.1371/journal.pone.0227675	http://dx.doi.org/10.1371/journal.pone.0227675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CX	32004350	gold, Green Published			2022-12-26	WOS:000534614600007
J	Ferrando, L; Cirmena, G; Garuti, A; Scabini, S; Grillo, F; Mastracci, L; Isnaldi, E; Marrone, C; Gonella, R; Murialdo, R; Fiocca, R; Romairone, E; Ballestrero, A; Zoppoli, G				Ferrando, Lorenzo; Cirmena, Gabriella; Garuti, Anna; Scabini, Stefano; Grillo, Federica; Mastracci, Luca; Isnaldi, Edoardo; Marrone, Ciro; Gonella, Roberta; Murialdo, Roberto; Fiocca, Roberto; Romairone, Emanuele; Ballestrero, Alberto; Zoppoli, Gabriele			Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma	PLOS ONE			English	Article							CANCER; EXPRESSION; BIOMARKERS; LINC00261; MODELS; TRIAL	Standard treatment for locally advanced rectal adenocarcinoma (LARC) includes a combination of chemotherapy with pyrimidine analogues, such as capecitabine, and radiation therapy, followed by surgery. Currently no clinically useful genomic predictors of benefit from neoadjuvant chemoradiotherapy (nCRT) exist for LARC. In this study we assessed the expression of 8,127 long noncoding RNAs (lncRNAs), poorly studied in LARC, to infer their ability in classifying patients' pathological complete response (pCR). We collected and analyzed, using lncRNA-specific Agilent microarrays a consecutive series of 61 LARC cases undergoing nCRT. Potential lncRNA predictors in responders and non-responders to nCRT were identified with LASSO regression, and a model was optimized using k-fold cross-validation after selection of the three most informative lncRNA. 11 lncRNAs were differentially expressed with false discovery rate < 0.01 between responders and non-responders to NACT. We identified lnc-KLF7-1, lnc-MAB21L2-1, and LINC00324 as the most promising variable subset for classification building. Overall sensitivity and specificity were 0.91 and 0.94 respectively, with an AUC of our ROC curve = 0.93. Our study shows for the first time that lncRNAs can accurately predict response in LARC undergoing nCRT. Our threelncRNA based signature must be independently validated and further analyses must be conducted to fully understand the biological role of the identified signature, but our results suggest lncRNAs may be an ideal biomarker for response prediction in the studied setting.	[Ferrando, Lorenzo; Cirmena, Gabriella; Garuti, Anna; Isnaldi, Edoardo; Gonella, Roberta; Ballestrero, Alberto; Zoppoli, Gabriele] Univ Genoa, Dept Internal Med, Genoa, Italy; [Scabini, Stefano; Grillo, Federica; Mastracci, Luca; Marrone, Ciro; Gonella, Roberta; Murialdo, Roberto; Fiocca, Roberto; Romairone, Emanuele; Ballestrero, Alberto; Zoppoli, Gabriele] IRCSS Osped Policlin San Martino, Genoa, Italy; [Grillo, Federica; Mastracci, Luca; Fiocca, Roberto] Univ Genoa, Dept Integrated Surg & Diagnost Sci, Genoa, Italy	University of Genoa; University of Genoa	Ballestrero, A; Zoppoli, G (corresponding author), Univ Genoa, Dept Internal Med, Genoa, Italy.; Ballestrero, A; Zoppoli, G (corresponding author), IRCSS Osped Policlin San Martino, Genoa, Italy.	aballestrero@unige.it; gabriele.zoppoli@unige.it	Ferrando, Lorenzo/AAA-9281-2022; Fiocca, Roberto/K-9705-2016; Gonella, Roberta/AAA-7517-2021; Ballestrero, Alberto/K-7546-2016; scabini, stefano/AAB-2292-2021	Ferrando, Lorenzo/0000-0002-4025-7930; Fiocca, Roberto/0000-0002-8856-6185; Gonella, Roberta/0000-0001-7897-4102; Ballestrero, Alberto/0000-0002-2601-7711; scabini, stefano/0000-0001-8011-0928; Isnaldi, Edoardo/0000-0002-1055-7254; Cirmena, Gabriella/0000-0002-5794-2766; romairone, emanuele/0000-0002-0370-1481	Associazione Italiana per la Ricerca sul Cancro (AIRC) AB Liberal donations; Associazione Italiana contro la Leucemia, il Linfoma e il Mieloma Multiplo (AIL);  [GZ MFAG 10570]	Associazione Italiana per la Ricerca sul Cancro (AIRC) AB Liberal donations(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana contro la Leucemia, il Linfoma e il Mieloma Multiplo (AIL); 	This work was supported by GZ MFAG 10570, Associazione Italiana per la Ricerca sul Cancro (AIRC) AB Liberal donations, Associazione Italiana contro la Leucemia, il Linfoma e il Mieloma Multiplo (AIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brown DN, 2016, SCI REP-UK, V6, DOI 10.1038/srep19435; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Fang QJ, 2018, CELL BIOCHEM FUNCT, V36, P323, DOI 10.1002/cbf.3352; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Ghadimi BM, 2005, J CLIN ONCOL, V23, P1826, DOI 10.1200/JCO.2005.00.406; Horisberger K, 2008, INT J COLORECTAL DIS, V23, P257, DOI 10.1007/s00384-007-0408-6; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Li N, 2018, J CELL BIOCH; Li Y, 2016, INT J BIOL SCI, V12, P1022, DOI 10.7150/ijbs.15438; Liu Y, 2017, EUR REV MED PHARMACO, V21, P5691, DOI 10.26355/eurrev_201712_14014; Lopes-Ramos CM, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0068-7; Nakao T, 2015, ONCOL REP, V34, P1961, DOI 10.3892/or.2015.4196; Pettit C, 2017, INT J ONCOL, V51, P393, DOI 10.3892/ijo.2017.4045; Pucciarelli S, 2011, ANN SURG, V253, P71, DOI 10.1097/SLA.0b013e3181fcb856; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sanz-Pamplona R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048877; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Scabini S, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-292; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Sha LX, 2017, J OBSTET GYNAECOL RE, V43, P1563, DOI 10.1111/jog.13427; Shi T, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/9085195; Shi W, 2010, NUCLEIC ACIDS RES, V38, P2168, DOI 10.1093/nar/gkp1204; Simon R, 2007, CANCER INFORM, V3, P11; Simon R, 2010, PERS MED, V7, P33, DOI 10.2217/PME.09.49; Sun CC, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.94; Swellengrebel HAM, 2011, BRIT J SURG, V98, P418, DOI 10.1002/bjs.7315; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang ZH, 2017, TRANSPORT RES REC, P11, DOI 10.3141/2612-02; Watanabe T, 2006, CANCER RES, V66, P3370, DOI 10.1158/0008-5472.CAN-05-3834; Wei MM, 2016, GENOM PROTEOM BIOINF, V14, P280, DOI 10.1016/j.gpb.2016.03.007; Wibe A, 2013, COLORECTAL DIS, V15, P1333, DOI 10.1111/codi.12317; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zhang HY, 2018, COGN AFFECT BEHAV NE, V18, P964, DOI 10.3758/s13415-018-0616-2; Zoppoli G, 2012, WORLD J GASTRO SURG, V4, P275, DOI 10.4240/wjgs.v4.i12.275	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0226595	10.1371/journal.pone.0226595	http://dx.doi.org/10.1371/journal.pone.0226595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023246	Green Published, gold			2022-12-26	WOS:000534621500008
J	Cordero, EC; Centeno, D; Todd, AM				Cordero, Eugene C.; Centeno, Diana; Todd, Anne Marie			The role of climate change education on individual lifetime carbon emissions	PLOS ONE			English	Article							PRO-ENVIRONMENTAL BEHAVIOR; OPPORTUNITIES; PERCEPTION; MITIGATION; COMMUNITY; BELIEFS; IMPACT	Strategies to mitigate climate change often center on clean technologies, such as electric vehicles and solar panels, while the mitigation potential of a quality educational experience is rarely discussed. In this paper, we investigate the long-term impact that an intensive one-year university course had on individual carbon emissions by surveying students at least five years after having taken the course. A majority of course graduates reported pro-environmental decisions (i.e., type of car to buy, food choices) that they attributed at least in part to experiences gained in the course. Furthermore, our carbon footprint analysis suggests that for the average course graduate, these decisions reduced their individual carbon emissions by 2.86 tons of CO2 per year. Surveys and focus group interviews identify that course graduates have developed a strong personal connection to climate change solutions, and this is realized in their daily behaviors and through their professional careers. The paper discusses in more detail the specific components of the course that are believed to be most impactful, and the uncertainties associated with this type of research design. Our analysis also demonstrates that if similar education programs were applied at scale, the potential reductions in carbon emissions would be of similar magnitude to other large-scale mitigation strategies, such as rooftop solar or electric vehicles.	[Cordero, Eugene C.; Centeno, Diana] San Jose State Univ, Dept Meteorol & Climate Sci, San Jose, CA 95192 USA; [Todd, Anne Marie] San Jose State Univ, Dept Commun Studies, San Jose, CA 95192 USA	California State University System; San Jose State University; California State University System; San Jose State University	Cordero, EC (corresponding author), San Jose State Univ, Dept Meteorol & Climate Sci, San Jose, CA 95192 USA.	eugene.cordero@sjsu.edu			National Science Foundation [1513332]	National Science Foundation(National Science Foundation (NSF))	The National Science Foundation under grant 1513332 provided support for the partial salary of DC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The commercial company Green Ninja did not provide any financial support related to this research, nor did they have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A, 2012, J ED SUSTAINABLE DEV, V6, P191, DOI [10.1177/0973408212475199, DOI 10.1177/0973408212475199]; [Anonymous], 2018, DRAWDOWN MOST COMPRE; Ardoin NM, 2018, J ENVIRON EDUC, V49, P1, DOI 10.1080/00958964.2017.1366155; Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P14, DOI 10.1016/j.jenvp.2006.12.002; Bray B. J, 2013, INT J INNOVATIVE INT, V2, P27; Breunig M, 2014, ENVIRON EDUC RES, V20, P372, DOI 10.1080/13504622.2013.807326; Buys L, 2012, REG ENVIRON CHANGE, V12, P237, DOI 10.1007/s10113-011-0253-6; California Air Resources Board (CARB), 2018, CAL 2000 2016 GREENH; Chen X, 2011, CLIMATIC CHANGE, V108, P31, DOI 10.1007/s10584-010-0013-5; Cordero EC, 2008, B AM METEOROL SOC, V89, P865, DOI 10.1175/2007BAMS2432.1; Craig CA, 2015, UTIL POLICY, V35, P41, DOI 10.1016/j.jup.2015.06.011; De Leeuw A, 2015, J ENVIRON PSYCHOL, V42, P128, DOI 10.1016/j.jenvp.2015.03.005; Dietz ME, 2004, ENVIRON MANAGE, V34, P684, DOI 10.1007/s00267-003-0238-4; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Feierabend T., 2010, SCI ED INT, V21, P176; Hargreaves T, 2011, J CONSUM CULT, V11, P79, DOI 10.1177/1469540510390500; Heimlich JE, 2008, ENVIRON EDUC RES, V14, P215, DOI 10.1080/13504620802148881; Hungerford H.R., 1990, J ENVIRON EDUC, V21, P8, DOI DOI 10.1080/00958964.1990.10753743; Jackle A, 2008, SURV METHODOL, V34, P105; Johnson B, 2012, ENVIRON EDUC RES, V18, P609, DOI 10.1080/13504622.2011.640748; Jones CM, 2018, URBAN PLAN, V3, P35, DOI 10.17645/up.v3i2.1218; Jones CM, 2011, ENVIRON SCI TECHNOL, V45, P4088, DOI 10.1021/es102221h; Knight CJ, 2018, SPORT PSYCHOLOGY FOR YOUNG ATHLETES, P1; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Laessoe J, 2015, J ED SUSTAINABLE DEV, V9, P27, DOI [10.1177/0973408215569112, DOI 10.1177/0973408215569112]; Lee TM, 2015, NAT CLIM CHANGE, V5, P1014, DOI 10.1038/NCLIMATE2728; Leiserowitz, 2009, GLOBAL WARMINGS 6 AM; Lyons A, 2006, J FINANC COUNS PLAN; MacFall J., 2012, J COLL SCI TEACH, V41, P26; Marcinkowski TJ, 2009, J ENVIRON EDUC, V41, P34, DOI 10.1080/00958960903210015; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; McKenzie-Mohr D, 2000, J SOC ISSUES, V56, P543, DOI 10.1111/0022-4537.00183; Miehe R, 2016, ENVIRON DEV SUSTAIN, V18, P577, DOI 10.1007/s10668-015-9649-7; Mochizuki Y., 2015, J ED SUSTAINABLE DEV, V9, P4, DOI [10.1177/0973408215569109, DOI 10.1177/0973408215569109]; Monroe MC, 2019, ENVIRON EDUC RES, V25, P791, DOI 10.1080/13504622.2017.1360842; Moore L, 2019, SCI SCOPE, V43, P56; National Research Council, 2012, FRAM K 12 SCI ED PRA; Nisbet MC, 2007, PUBLIC OPIN QUART, V71, P444, DOI 10.1093/poq/nfm031; Nyborg K, 2016, SCIENCE, V354, P42, DOI 10.1126/science.aaf8317; Orams M. B., 1997, Progress in Tourism and Hospitality Research, V3, P295, DOI 10.1002/(SICI)1099-1603(199712)3:4<295::AID-PTH85>3.0.CO;2-D; Oversby J, 2015, PROCD SOC BEHV, V167, P23, DOI 10.1016/j.sbspro.2014.12.637; Pooley JA, 2000, ENVIRON BEHAV, V32, P711, DOI 10.1177/0013916500325007; Purnell K, 2004, AUSTR J ENV ED, V20, P81; Ramsey J. M., 1993, J ENVIRON EDUC, V24, P31, DOI DOI 10.1080/00958964.1993.9943501; Robelia BA, 2011, ENVIRON EDUC RES, V17, P553, DOI 10.1080/13504622.2011.565118; Rodriguez M., 2010, PSYECOLOGY, V1, P73, DOI [DOI 10.1174/217119710790709496, 10.1174/217119710790709496]; Rodriguez M, 2011, INT J SCI SOC, V2, P89; Sandoval W, 2014, J LEARN SCI, V23, P18, DOI 10.1080/10508406.2013.778204; Semenza JC, 2008, AM J PREV MED, V35, P479, DOI 10.1016/j.amepre.2008.08.020; Shirley R, 2012, ECOL ECON, V80, P8, DOI 10.1016/j.ecolecon.2012.04.027; Short PC, 2009, J ENVIRON EDUC, V41, P7, DOI 10.1080/00958960903206781; Tabi A, 2013, ENERG POLICY, V63, P972, DOI 10.1016/j.enpol.2013.08.049; United Nations Educational Scientific and Cultural Organization (UNESCO), 2010, UNESCO STRAT 2 UN DE; United Nations Educational Scientific and Cultural Organization (UNESCO), 2015, UIS STAT DAT; United Nations Framework Convention on Climate Change, 1992, UN FRAMEWORK CONVENT; University of California, 2019, COOLCLIMATE NETW HOU; Walsh EM, 2019, ENVIRON EDUC RES, V25, P656, DOI 10.1080/13504622.2019.1569206; Wise S.B., 2010, J GEOSCIENCE ED, V58, P297, DOI [10.5408/1.3559695, DOI 10.5408/1.3559695]; Wolff B., 1993, SUCCESSFUL FOCUS GRO, P118, DOI 10.4135/9781483349008.n8; Wynes S, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7541	60	27	27	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0206266	10.1371/journal.pone.0206266	http://dx.doi.org/10.1371/journal.pone.0206266			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9EF	32017773	gold, Green Submitted, Green Published			2022-12-26	WOS:000534618100001
J	de Souza-Firmino, TS; Alevi, KCC; Itoyama, MM				de Souza-Firmino, Tatiani Seni; Chaboli Alevi, Kaio Cesar; Itoyama, Mary Massumi			Chromosomal divergence and evolutionary inferences in Pentatomomorpha infraorder (Hemiptera, Heteroptera) based on the chromosomal location of ribosomal genes	PLOS ONE			English	Article							HISTONE H3 GENES; 18S RDNA; PHYLOGENETIC-RELATIONSHIPS; PENTATOMIDAE HETEROPTERA; TIGER BEETLES; RNA; HETEROCHROMATIN; COLEOPTERA; NUCLEOLUS; COREIDAE	With the objective of assisting in the understanding of the chromosome evolution of Pentatomomorpha and in the quest to understand how the genome organizes/reorganizes for the chromosomal position of the 45S rDNA in this infraorder, we analyzed 15 species (it has being 12 never studied before by FISH) of Pentatomomorpha with the probe of 18S rDNA. The mapping of the 45S gene in the Coreidae family demonstrated that the species presented markings on the autosomes, with the exception of Acanthocephala parensis and Leptoglossus gonagra that showed markers on m-chromosomes. Most species of the Pentatomidae family showed marking in the autosomes, except for two species that had 45S rDNA on X sex chromosome (Odmalea sp. and Graphosoma lineatum) and two that showed marking on the X and Y sex chromosomes. Species of the Pyrrhocoridae family showed 18S rDNA markers in autosomes, X chromosome as well as in Neo X. The Largidae and Scutelleridae families were represented by only one species that showed marking on the X sex chromosome and on a pair of autosomes, respectively. Based on this, we characterized the arrangement of 45S DNAr in the chromosomes of 12 new species of Heteroptera and discussed the main evolutionary events related to the genomic reorganization of these species during the events of chromosome and karyotype evolution in Pentatomomorpha infraorder.	[de Souza-Firmino, Tatiani Seni; Itoyama, Mary Massumi] Univ Estadual Paulista, Inst Biociencias Letras & Ciencias Exatas, Dept Biol, Campus Sao Jose do Rio Preto, Sao Jose Do Rio Preto, SP, Brazil; [Chaboli Alevi, Kaio Cesar] Univ Estadual Paulista, Fac Ciencias Farmaceut Araraquara, Dept Ciencias Biol, Campus Araraquara, Araraquara, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Alevi, KCC (corresponding author), Univ Estadual Paulista, Fac Ciencias Farmaceut Araraquara, Dept Ciencias Biol, Campus Araraquara, Araraquara, SP, Brazil.	kaiochaboli@hotmail.com			Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES) [001]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/10135-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was carried out with the support of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES) Financing Code 001 (TSSF), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Process number 2016/10135-9) (MMY) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (TSSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardella VB, 2014, GENET MOL RES, V13, P2186, DOI [10.4238/2014.March.26.7, 10.4238/2014.]; Bardella VB, 2016, MOL GENET GENOMICS, V291, P1919, DOI 10.1007/s00438-016-1229-5; Bardella VB, 2013, GENOME, V56, P425, DOI 10.1139/gen-2013-0140; Bargues MD, 1997, MOL BIOL EVOL, V14, P569, DOI 10.1093/oxfordjournals.molbev.a025794; Bressa MJ, 2009, CYTOGENET GENOME RES, V125, P292, DOI 10.1159/000235936; Bressa MJ, 2008, EUR J ENTOMOL, V105, P65, DOI 10.14411/eje.2008.009; Bressa MJ, 2005, GENETICA, V124, P307, DOI 10.1007/s10709-005-4524-3; Cabral-De-Mello DC, 2011, CYTOGENET GENOME RES, V134, P127, DOI 10.1159/000326803; Cabral-de-Mello DC, 2010, HEREDITY, V104, P393, DOI 10.1038/hdy.2009.126; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Cattani MV, 2004, CARYOLOGIA, V57, P267, DOI 10.1080/00087114.2004.10589403; Cattani MV, 2004, HEREDITAS, V140, P105, DOI 10.1111/j.1601-5223.2004.01752.x; Alevi KCC, 2018, AM J TROP MED HYG, V99, P87, DOI 10.4269/ajtmh.17-0166; Dai JB, 2007, MOL CELL, V27, P289, DOI 10.1016/j.molcel.2007.06.010; Fauvel G, 1999, AGR ECOSYST ENVIRON, V74, P275, DOI 10.1016/S0167-8809(99)00039-0; Gabriela Chirino Monica, 2013, Comp Cytogenet, V7, P111, DOI 10.3897/CompCytogen.v7i2.4462; GALIAN J, 1995, HEREDITY, V74, P524, DOI 10.1038/hdy.1995.74; Golub NV, 2015, COMP CYTOGENET, V9, P513, DOI 10.3897/CompCytogen.v9i4.5376; Grazia J, 2008, CLADISTICS, V24, P932, DOI 10.1111/j.1096-0031.2008.00224.x; Grozeva S, 1996, HEREDITAS, V125, P31, DOI 10.1111/j.1601-5223.1996.t01-1-00031.x; Grozeva S, 2011, COMP CYTOGENET, V5, P355, DOI 10.3897/CompCytogen.v5i4.2307; Henking H, 1891, Z F R WISSENSCHAFTLI, V51, P685; Hirai H, 1996, CHROMOSOMA, V105, P190, DOI 10.1007/BF02509500; Jacobs DH, 2004, CHROMOSOME RES, V12, P175, DOI 10.1023/B:CHRO.0000013155.99614.57; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li Xinzheng, 1996, Entomologia Sinica, V3, P283; Mahner Martin, 1993, Zoologica (Stuttgart), V48, P1; MCCONKEY EH, 1964, P NATL ACAD SCI USA, V51, P1197, DOI 10.1073/pnas.51.6.1197; Oliveira J, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028004; Panzera F, 2010, CYTOGENET GENOME RES, V128, P77, DOI 10.1159/000298824; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Papeschi AG, 1996, HEREDITAS, V124, P269, DOI 10.1111/j.1601-5223.1996.00269.x; Papeschi AG, 2003, CHROMOSOME RES, V11, P725, DOI 10.1023/B:CHRO.0000005740.56221.03; Papeschi AG., 2006, RES ADV ENTOMOLOGY, V1, P1; Papeschi Alba Graciela, 2006, Journal of Biological Research (Thessaloniki), V5, P3; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pita S, 2016, INFECT GENET EVOL, V43, P225, DOI 10.1016/j.meegid.2016.05.028; Pita S, 2013, MEM I OSWALDO CRUZ, V108, P376, DOI 10.1590/S0074-02762013000300017; Proenca SJR, 2005, GENET MOL BIOL, V28, P725, DOI 10.1590/S1415-47572005000500012; Rebagliati PJ, 2005, J ZOOL SYST EVOL RES, V43, P199, DOI 10.1111/j.1439-0469.2005.00312.x; RIEGER C, 1976, ZOOMORPHOLOGIE, V83, P109, DOI 10.1007/BF00993483; Roy V, 2005, HEREDITY, V94, P388, DOI 10.1038/sj.hdy.6800612; Schuh RT, 1995, TRUE BUGS WORLD HEMI; Shcherbakov D.E., 2002, HIST INSECTS, P152; Sichova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064520; THOMAS DB, 1987, ANN ENTOMOL SOC AM, V80, P720, DOI 10.1093/aesa/80.6.720; Ueshima N., 1979, Animal Cytogenetics, V3, P1; UESHIMA N, 1966, CHROMOSOMA, V18, P97, DOI 10.1007/BF00326447; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; WHEELER WC, 1993, ENTOMOL SCAND, V24, P121; Wilson EB, 1909, BIOL BULL-US, V16, P199, DOI 10.2307/1536149; Xie Q, 2008, MOL PHYLOGENET EVOL, V47, P463, DOI 10.1016/j.ympev.2008.01.024; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	53	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228631	10.1371/journal.pone.0228631	http://dx.doi.org/10.1371/journal.pone.0228631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017800	Green Published, gold			2022-12-26	WOS:000534618100032
J	Khan, TM; Mehmood, M; Naqvi, SS; Butt, MFU				Khan, Tariq M.; Mehmood, Mehwish; Naqvi, Syed S.; Butt, Muhammad Fasih Uddin			A region growing and local adaptive thresholding-based optic disc detection	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; FUNDUS IMAGES; AUTOMATIC DETECTION; SEGMENTATION; LOCALIZATION	Automatic optic disc (OD) localization and segmentation is not a simple process as the OD appearance and size may significantly vary from person to person. This paper presents a novel approach for OD localization and segmentation which is fast as well as robust. In the proposed method, the image is first enhanced by de-hazing and then cropped around the OD region. The cropped image is converted to HSV domain and then V channel is used for OD detection. The vessels are extracted from the Green channel in the cropped region by multi-scale line detector and then removed by the Laplace Transform. Local adaptive thresholding and region growing are applied for binarization. Furthermore, two region properties, eccentricity, and area are then used to detect the true OD region. Finally, ellipse fitting is used to fill the region. Several datasets are used for testing the proposed method. Test results show that the accuracy and sensitivity of the proposed method are much higher than the existing state-of-the-art methods.	[Khan, Tariq M.; Mehmood, Mehwish; Naqvi, Syed S.; Butt, Muhammad Fasih Uddin] COMSATS Univ, Dept Elect & Comp Engn, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Mehmood, M (corresponding author), COMSATS Univ, Dept Elect & Comp Engn, Islamabad, Pakistan.	mehwish.mehmood@comsats.edu.pk		Khan, Tariq Mahmood/0000-0002-7477-1591; Mehmood, Mehwish/0000-0003-3985-8699				Abdullah M, 2016, PEERJ, V4, DOI 10.7717/peerj.2003; Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; [Anonymous], 2008, MESS DIG RET IM FRAN; Basit A, 2015, APPL OPTICS, V54, P3440, DOI 10.1364/AO.54.003440; Berman D, 2016, PROC CVPR IEEE, P1674, DOI 10.1109/CVPR.2016.185; Decenciere E, 2014, IMAGE ANAL STEREOL, V33, P231, DOI 10.5566/ias.1155; Fan Z, 2018, IEEE J BIOMED HEALTH, V22, P224, DOI 10.1109/JBHI.2017.2723678; Faust O, 2012, J MED SYST, V36, P145, DOI 10.1007/s10916-010-9454-7; Huelva U., 2012, EXPERT SYSTEM EARLY; Joshi GD, 2008, P INT EURASIP C BIOS; Kande GB, 2008, SIXTH INDIAN CONFERENCE ON COMPUTER VISION, GRAPHICS & IMAGE PROCESSING ICVGIP 2008, P535; LINDEBERG T, 1990, IEEE T PATTERN ANAL, V12, P234, DOI 10.1109/34.49051; Liu Z, 1997, P ANN INT IEEE EMBS, V19, P524, DOI 10.1109/IEMBS.1997.757661; Lowell J, 2004, IEEE T MED IMAGING, V23, P256, DOI 10.1109/TMI.2003.823261; Lu SJ, 2011, IEEE T MED IMAGING, V30, P2126, DOI 10.1109/TMI.2011.2164261; Morales S, 2013, IEEE T MED IMAGING, V32, P786, DOI 10.1109/TMI.2013.2238244; Nguyen UTV, 2013, PATTERN RECOGN, V46, P703, DOI 10.1016/j.patcog.2012.08.009; Osareh A, 2002, INT C PATT RECOG, P743, DOI 10.1109/ICPR.2002.1044865; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Pinz A, 1998, IEEE T MED IMAGING, V17, P606, DOI 10.1109/42.730405; Sinthanayothin C, 1999, BRIT J OPHTHALMOL, V83, P902, DOI 10.1136/bjo.83.8.902; Soomro TA, 2016, 2016 INTERNATIONAL CONFERENCE ON DIGITAL IMAGE COMPUTING: TECHNIQUES AND APPLICATIONS (DICTA), P113; Soomro TA, 2017, PATTERN ANAL APPL, V20, P927, DOI 10.1007/s10044-017-0630-y; Soomro T, 2017, SIGNAL IMAGE VIDEO P, V11, P1509, DOI 10.1007/s11760-017-1114-7; Sopharak A, 2008, COMPUT MED IMAG GRAP, V32, P720, DOI 10.1016/j.compmedimag.2008.08.009; Stapor K, 2004, LECT NOTES COMPUT SC, V3039, P41; TAMURA S, 1988, PATTERN RECOGN, V21, P227, DOI 10.1016/0031-3203(88)90057-X; Walter T, 2002, IEEE T MED IMAGING, V21, P1236, DOI 10.1109/TMI.2002.806290; Welfer D, 2013, PATTERN RECOGN LETT, V34, P476, DOI 10.1016/j.patrec.2012.12.011; Welfer D, 2010, COMPUT BIOL MED, V40, P124, DOI 10.1016/j.compbiomed.2009.11.009; Ying HJ, 2007, P ANN INT IEEE EMBS, P4139, DOI 10.1109/IEMBS.2007.4353247; Zhang M, 2007, IM PROC 2007 ICIP 20, V4; Zhang Z, 2009, IEEE ENG MED BIO, P1441, DOI 10.1109/IEMBS.2009.5332913	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227566	10.1371/journal.pone.0227566	http://dx.doi.org/10.1371/journal.pone.0227566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999720	gold, Green Published			2022-12-26	WOS:000534612400021
J	Zhong, XT; Jagarlapudi, S; Weng, Y; Ly, M; Rouse, JC; McClure, K; Ishino, T; Zhang, Y; Sousa, E; Cohen, J; Tzvetkova, B; Cote, K; Scarcelli, JJ; Johnson, K; Palandra, J; Apgar, JR; Yaddanapudi, S; Gonzalez-Villalobos, RA; Opsahl, AC; Lam, K; Yao, Q; Duan, WL; Sievers, A; Zhou, J; Ferguson, D; D'Antona, A; Zollner, R; Zhu, HL; Kriz, R; Lin, L; Clerin, V				Zhong, Xiaotian; Jagarlapudi, Srinath; Weng, Yan; Ly, Mellisa; Rouse, Jason C.; McClure, Kim; Ishino, Tetsuya; Zhang, Yan; Sousa, Eric; Cohen, Justin; Tzvetkova, Boriana; Cote, Kaffa; Scarcelli, John J.; Johnson, Keith; Palandra, Joe; Apgar, James R.; Yaddanapudi, Suma; Gonzalez-Villalobos, Romer A.; Opsahl, Alan C.; Lam, Khetemenee; Yao, Qing; Duan, Weili; Sievers, Annette; Zhou, Jing; Ferguson, Darren; D'Antona, Aaron; Zollner, Richard; Zhu, Hongli L.; Kriz, Ron; Lin, Laura; Clerin, Valerie			Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast growth factor receptor (FGFR); signal transduction; glycosidase; glycosylation; sialic acid; pharmacokinetics; acute kidney injury; Klotho; LacdiNAc; mammalian cell expression	CHINESE-HAMSTER OVARY; GROWTH-FACTOR 23; ALPHA-KLOTHO; N-ACETYLGALACTOSAMINE; MOLECULAR-CLONING; GLYCOSYLATION; RECEPTOR; LACDINAC; FGF23; BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE	The fortuitously discovered antiaging membrane protein ?Klotho (Klotho) is highly expressed in the kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to that of chronic kidney disease (CKD). Klotho functions as a co-receptor for fibroblast growth factor 23 (FGF23) signaling, whereas its shed extracellular domain, soluble Klotho (sKlotho), carrying glycosidase activity, is a humoral factor that regulates renal health. Low sKlotho in CKD is associated with disease progression, and sKlotho supplementation has emerged as a potential therapeutic strategy for managing CKD. Here, we explored the structure-function relationship and post-translational modifications of sKlotho variants to guide the future design of sKlotho-based therapeutics. Chinese hamster ovary (CHO)- and human embryonic kidney (HEK)-derived WT sKlotho proteins had varied activities in FGF23 co-receptor and ?-glucuronidase assays in vitro and distinct properties in vivo. Sialidase treatment of heavily sialylated CHO-sKlotho increased its co-receptor activity 3-fold, yet it remained less active than hyposialylated HEK-sKlotho. MS and glycopeptide-mapping analyses revealed that HEK-sKlotho is uniquely modified with an unusual N-glycan structure consisting of N,N?-di-N-acetyllactose diamine at multiple N-linked sites, one of which at Asn-126 was adjacent to a putative GalNAc transfer motif. Site-directed mutagenesis and structural modeling analyses directly implicated N-glycans in Klotho's protein folding and function. Moreover, the introduction of two catalytic glutamate residues conserved across glycosidases into sKlotho enhanced its glucuronidase activity but decreased its FGF23 co-receptor activity, suggesting that these two functions might be structurally divergent. These findings open up opportunities for rational engineering of pharmacologically enhanced sKlotho therapeutics for managing kidney disease.	[Zhong, Xiaotian; Weng, Yan; Ishino, Tetsuya; Zhang, Yan; Sousa, Eric; Cohen, Justin; Palandra, Joe; Apgar, James R.; Lam, Khetemenee; Yao, Qing; Duan, Weili; Sievers, Annette; Zhou, Jing; Ferguson, Darren; D'Antona, Aaron; Zollner, Richard; Zhu, Hongli L.; Kriz, Ron; Lin, Laura] Pfizer Worldwide Res, BioMed Design, Cambridge, MA 02139 USA; [Jagarlapudi, Srinath; McClure, Kim; Yaddanapudi, Suma; Gonzalez-Villalobos, Romer A.; Opsahl, Alan C.; Clerin, Valerie] Pfizer Worldwide Res, Internal Med, Cambridge, MA 02139 USA; [Ly, Mellisa; Rouse, Jason C.; Tzvetkova, Boriana; Cote, Kaffa; Johnson, Keith] Pfizer Inc, Analyt Res & Dev, Andover, MA 01810 USA; [Scarcelli, John J.] Pfizer Inc, Cell Line Dev Biotherapeut Pharmaceut Sci, Andover, MA 01810 USA; [Gonzalez-Villalobos, Romer A.] Janssen Res & Dev LLC, Cardiovasc & Metab Discovery, 4 Blackfan Circle, Boston, MA 02115 USA	Pfizer; Pfizer; Pfizer; Pfizer; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Zhong, XT; Clerin, V (corresponding author), Pfizer Worldwide R&D, 610 Main St, Cambridge, MA 02139 USA.	Xiaotian.Zhong@pfizer.com; Valerie.Clerin@pfizer.com		Apgar, James/0000-0002-4669-0188; Rouse, Jason/0000-0002-2721-7264				Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Bonar D, 2014, J BIOL CHEM, V289, P29677, DOI 10.1074/jbc.M114.596049; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen GZ, 2018, NATURE, V553, P461, DOI 10.1038/nature25451; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; Dalton GD, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00323; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Erben RG, 2017, BONE, V100, P62, DOI 10.1016/j.bone.2016.09.010; Erben RG, 2016, MOL CELL ENDOCRINOL, V432, P66, DOI 10.1016/j.mce.2016.05.008; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete D, 2007, J BIOL CHEM, V282, P1873, DOI 10.1074/jbc.M606455200; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; Grabner A, 2016, CURR OPIN NEPHROL HY, V25, P314, DOI 10.1097/MNH.0000000000000231; Grams ME, 2011, AM J KIDNEY DIS, V57, P44, DOI 10.1053/j.ajkd.2010.05.013; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hu MC, 2017, KIDNEY INT, V91, P1104, DOI 10.1016/j.kint.2016.10.034; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Hu MC, 2014, CURR OPIN NEPHROL HY, V23, P331, DOI 10.1097/01.mnh.0000447024.97464.a3; Hu MC, 2013, CONTRIB NEPHROL, V180, P47, DOI 10.1159/000346778; Hu MC, 2013, SEMIN NEPHROL, V33, P118, DOI 10.1016/j.semnephrol.2012.12.013; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Kim HR, 2013, AM J KIDNEY DIS, V61, P899, DOI 10.1053/j.ajkd.2013.01.024; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuro-o M, 2017, CLIN EXP NEPHROL, V21, P64, DOI 10.1007/s10157-016-1357-6; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Lu X, 2017, KIDNEY DIS-BASEL, V3, P15, DOI 10.1159/000452880; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Manzella SM, 1997, J BIOL CHEM, V272, P4775, DOI 10.1074/jbc.272.8.4775; Mencke R, 2017, ADV DRUG DELIVER REV, V121, P85, DOI 10.1016/j.addr.2017.07.009; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Mi YL, 2014, J BIOL CHEM, V289, P12157, DOI 10.1074/jbc.M113.544973; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nimtz M, 2004, BBA-GEN SUBJECTS, V1675, P71, DOI 10.1016/j.bbagen.2004.08.007; Palandra J, 2013, ANAL CHEM, V85, P5522, DOI 10.1021/ac4006765; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Radhakrishnan J, 2014, KIDNEY INT, V86, P246, DOI 10.1038/ki.2014.190; Rouse J.C., 2017, LC GC ONLINE, V15, P6; Sakan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086301; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Shang TQ, 2014, J PHARM SCI-US, V103, P1967, DOI 10.1002/jps.24004; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; Stenvinkel P, 2013, AM J KIDNEY DIS, V62, P339, DOI 10.1053/j.ajkd.2012.11.051; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Varki A., 2017, ESSENTIALS GLYCOBIOL; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang MM, 2015, J BIOSCI BIOENG, V119, P657, DOI 10.1016/j.jbiosc.2014.11.008; WONGMADDEN ST, 1995, GLYCOBIOLOGY, V5, P19, DOI 10.1093/glycob/5.1.19; Xie J, 2015, J AM SOC NEPHROL, V26, P1150, DOI 10.1681/ASN.2014040325; Yang K, 2015, J AM SOC NEPHROL, V26, P2434, DOI 10.1681/ASN.2014060543; Zhong XT, 2019, BIOTECHNOL PROGR, V35, DOI 10.1002/btpr.2724; Zhong Xiaotian, 2013, Int J Cell Biol, V2013, P273086, DOI 10.1155/2013/273086; Zhong XT, 2013, J BIOL CHEM, V288, P1409, DOI 10.1074/jbc.M112.417717; Zhong XT, 2012, BIOTECHNOL BIOENG, V109, P1723, DOI 10.1002/bit.24448	70	7	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3115	3133		10.1074/jbc.RA119.012144	http://dx.doi.org/10.1074/jbc.RA119.012144			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005658	Green Published, hybrid			2022-12-26	WOS:000519597300019
J	An, JH; Li, Q; Ryu, MO; Nam, AR; Bhang, DH; Jung, YC; Song, WJ; Youn, HY				An, Ju-Hyun; Li, Qiang; Ryu, Min-Ok; Nam, A-Ryung; Bhang, Dong-Ha; Jung, Yun-Chan; Song, Woo-Jin; Youn, Hwa-Young			TSG-6 in extracellular vesicles from canine mesenchymal stem/stromal is a major factor in relieving DSS-induced colitis	PLOS ONE			English	Article							REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; MACROPHAGE POLARIZATION; INTESTINAL HOMEOSTASIS; TNF-ALPHA; EXPRESSION; INTERLEUKIN-10; PATHOGENESIS; TOLERANCE; FOXP3	Adipose tissue derived mesenchymal stem/stromal cell (ASC)-derived extracellular vesicles (EV) have been reported to be beneficial against dextran sulfate sodium (DSS)-induced colitis in mice. However, the underlying mechanisms have not been fully elucidated. We hypothesize that the tumor necrosis factor-alpha-stimulated gene/protein 6 (TSG-6) in EVs is a key factor influencing the alleviation of colitis symptoms. DSS-induced colitis mice (C57BL/6, male, Naive = 6, Sham = 8, PBS = 8 EV = 8, CTL-EV = 8, TSG-6 depleted EV = 8) were intraperitoneally administered EVs (100 ug/mice) on day 1, 3, and 5; colon tissues were collected on day 10 for histopathological, RT-qPCR, western blot and immunofluorescence analyses. In mice injected with EV, inflammation was alleviated. Indeed, EVs regulated the levels of pro-and anti-inflammatory cytokines, such as TNF-alpha, IL-1 beta, IFN-gamma, IL-6, and IL-10 in inflamed colons. However, when injected with TSG-6 depleted EV, the degree of inflammatory relief was reduced. Furthermore, TSG-6 in EVs plays a key role in increasing regulatory T cells (Tregs) and polarizing macrophage from M1 to M2 in the colon. In conclusion, this study shows that TSG-6 in EVs is a major factor in the relief of DSS-induced colitis, by increasing the number of Tregs and macrophage polarization from M1 to M2 in the colon.	[An, Ju-Hyun; Li, Qiang; Ryu, Min-Ok; Nam, A-Ryung; Song, Woo-Jin; Youn, Hwa-Young] Seoul Natl Univ, Coll Vet Med, Dept Vet Clin Sci, Lab Vet Internal Med, Seoul, South Korea; [Bhang, Dong-Ha] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon, Gyeonggi Do, South Korea; [Jung, Yun-Chan] Chaon Corp, Seongnam Si, Gyeonggi Do, South Korea; [Li, Qiang] YanBian Univ, Dept Vet Med, Coll Agr, Yanji, Jilin, Peoples R China	Seoul National University (SNU); Sungkyunkwan University (SKKU); Yanbian University	Song, WJ; Youn, HY (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Vet Clin Sci, Lab Vet Internal Med, Seoul, South Korea.	woogin1988@snu.ac.kr; hyyoun@snu.ac.kr		Youn, Hwa-Young/0000-0002-0283-1348	Research Institute for Veterinary Science, Seoul National University; Basic Science Research Program of the National Research Foundation of Korea; Chaon Corporation	Research Institute for Veterinary Science, Seoul National University; Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Chaon Corporation	This study received support from the Research Institute for Veterinary Science, Seoul National University and Basic Science Research Program of the National Research Foundation of Korea. Author YCJ receives support in the form of salary from the commercial company the Chaon Corporation. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of YCJ are articulated in the `author contributions' section.	An JH, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1684-9; Arseneau Kristen O, 2007, Curr Gastroenterol Rep, V9, P508, DOI 10.1007/s11894-007-0067-3; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Atri C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061801; Bai LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04559-y; Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192; Banz A, 2003, EUR J IMMUNOL, V33, P2419, DOI 10.1002/eji.200324205; Becker C, 2006, CYTOKINE GROWTH F R, V17, P97, DOI 10.1016/j.cytogfr.2005.09.004; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Biller BJ, 2007, VET IMMUNOL IMMUNOP, V116, P69, DOI 10.1016/j.vetimm.2006.12.002; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Bruno S, 2015, IMMUNOL LETT, V168, P154, DOI 10.1016/j.imlet.2015.06.007; Burrello J, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00083; Cerquetella M, 2010, WORLD J GASTROENTERO, V16, P1050, DOI 10.3748/wjg.v16.i9.1050; Chae HK, 2017, VET IMMUNOL IMMUNOP, V191, P22, DOI 10.1016/j.vetimm.2017.07.013; Ciorba MA, 2013, CURR OPIN GASTROEN, V29, P146, DOI 10.1097/MOG.0b013e32835c9cb3; Coelho LP, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0450-3; Cook MD, 2016, IMMUNOL CELL BIOL, V94, P158, DOI 10.1038/icb.2015.108; Coquerelle C, 2009, GUT, V58, P1363, DOI 10.1136/gut.2008.162842; Hartjes TA, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6010007; Isidro RA, 2016, AM J PHYSIOL-GASTR L, V311, pG59, DOI 10.1152/ajpgi.00123.2016; Jo H, 2018, GUT LIVER, V12, P664, DOI 10.5009/gnl18072; Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373; Lee KS, 2013, ASIAN AUSTRAL J ANIM, V26, P588, DOI 10.5713/ajas.2012.12488; Lee RH, 2014, P NATL ACAD SCI USA, V111, P16766, DOI 10.1073/pnas.1416121111; Li Q, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1009-8; Liu H, 2019, EXOSOMES MESENCHYMAL; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Maloney J, 2015, MICROBES INFECT, V17, P462, DOI 10.1016/j.micinf.2015.03.006; Manning K, 2010, CYTOKINE, V50, P297, DOI 10.1016/j.cyto.2010.01.010; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Monk JM, 2012, BRIT J NUTR, V107, P1249, DOI 10.1017/S0007114511004399; Mowat AM, 2011, J INNATE IMMUN, V3, P550, DOI 10.1159/000329099; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Qian XJ, 2016, STEM CELL TRANSL MED, V5, P1190, DOI 10.5966/sctm.2015-0348; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sartor RB, 1997, AM J GASTROENTEROLOG, V92; Schmitz S, 2012, VET IMMUNOL IMMUNOP, V146, P87, DOI 10.1016/j.vetimm.2012.01.013; Soleymaninejadian E, 2012, AM J REPROD IMMUNOL, V67, P1, DOI 10.1111/j.1600-0897.2011.01069.x; Song WJ, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0841-1; Song WJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04766-7; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Vazquez-Baeza Y, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.177, 10.1038/nmicrobiol.2016.177]; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; Wang XF, 2014, CELL IMMUNOL, V289, P42, DOI 10.1016/j.cellimm.2014.02.005; Wu YB, 2018, AM J TRANSL RES, V10, P2026; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xiao Q, 2012, CELL BIOCHEM BIOPHYS, V62, P409, DOI 10.1007/s12013-011-9317-y; Xie LL, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2730472; Yamada A, 2016, WORLD J GASTROENTERO, V22, P2195, DOI 10.3748/wjg.v22.i7.2195; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Yang HM, 2018, RES VET SCI, V119, P19, DOI 10.1016/j.rvsc.2018.05.011; Yi Z, 2014, DIABETES; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479; Zhang F, 2016, ONCOTARGET, V7, P52294, DOI 10.18632/oncotarget.10561	57	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0220756	10.1371/journal.pone.0220756	http://dx.doi.org/10.1371/journal.pone.0220756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040478	Green Published, Green Submitted, gold			2022-12-26	WOS:000534629400003
J	Potilinski, MC; Ortiz, GA; Salica, JP; Lopez, ES; Acquier, MF; Chuluyan, E; Gallo, JE				Constanza Potilinski, Maria; Ortiz, Gustavo A.; Salica, Juan P.; Lopez, Emiliano S.; Fernandez Acquier, Mariano; Chuluyan, Eduardo; Gallo, Juan E.			Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy	PLOS ONE			English	Article							SIGNALING PATHWAY; MESENCHYMAL TRANSITION; GLUT1 EXPRESSION; OXIDATIVE STRESS; DOWN-REGULATION; GROWTH-FACTOR; DEFICIENCY; CATENIN; PROLIFERATION; SUPPRESSION	Background Alpha-1-antitrypsin is a protein involved in avoidance of different processes that are seen in diabetic retinopathy pathogenesis. These processes include apoptosis, extracellular matrix remodeling and damage of vessel walls and capillaries. Furthermore, because of its anti-inflammatory effects, alpha-1-antitrypsin has been proposed as a possible therapeutic approach for diabetic retinopathy. Our group tested alpha-1-antitrypsin in a type 1 diabetes mouse model and observed a reduction of inflammation and retinal neurodegeneration. Thus, shedding light on the mechanism of action of alpha-1-antitrypsin at molecular level may explain how it works in the diabetic retinopathy context and show its potential for use in other retinal diseases. Methods In this work, we evaluated alpha-1-antitrypsin in an ARPE-19 human cell line exposed to high glucose. We explored the expression of different mediators on signaling pathways related to pro-inflammatory cytokines production, glucose metabolism, epithelial-mesenchymal transition and other proteins involved in the normal function of retinal pigment epithelium by RT-qPCR and Western Blot. Results We obtained different expression patterns for evaluated mediators altered with high glucose exposure and corrected with the use of alpha-1-antitrypsin. Conclusions The expression profile obtained in vitro for the evaluated proteins and mRNA allowed us to explain our previous results obtained on mouse models and to hypothesize how alpha-1-antitrypsin hinder diabetic retinopathy progression on a complex network between different signaling pathways. General significance This network helps to understand the way alpha-1-antitrypsin works in diabetic retinopathy and its scope of action.	[Constanza Potilinski, Maria; Ortiz, Gustavo A.; Salica, Juan P.; Lopez, Emiliano S.; Gallo, Juan E.] Univ Austral, Inst Invest Med Traslac, Consejo Nacl Invest Ciencia & Tecnol CONICET, Nanomed & Vis Grp,Fac Ciencias Biomed, Pilar, Buenos Aires, Argentina; [Salica, Juan P.; Lopez, Emiliano S.; Gallo, Juan E.] Hosp Univ Austral, Dept Ophthalmol, Pilar, Buenos Aires, Argentina; [Fernandez Acquier, Mariano] Hosp Cetrangolo, Serv Neumonol, Vicente Lopez, Buenos Aires, Argentina; [Chuluyan, Eduardo] Univ Buenos Aires, Fac Med, Ctr Estudios Farmacol & Bot, CONICET CEFYBO, Buenos Aires, DF, Argentina	Austral University; Austral University; Hospital Universitario Austral; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Gallo, JE (corresponding author), Univ Austral, Inst Invest Med Traslac, Consejo Nacl Invest Ciencia & Tecnol CONICET, Nanomed & Vis Grp,Fac Ciencias Biomed, Pilar, Buenos Aires, Argentina.; Gallo, JE (corresponding author), Hosp Univ Austral, Dept Ophthalmol, Pilar, Buenos Aires, Argentina.	jgallo06@gmail.com		Ortiz, Gustavo/0000-0002-0186-6530; Chuluyan, Eduardo/0000-0003-3084-2500; Potilinski, Constanza/0000-0003-4116-5875	Agencia Nacional de Promocion Cientifica y Tecnologica [PICTO 2016-0105]; Universidad Austral [O05-PDISR073]; Grifols S.A.	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Austral; Grifols S.A.	This work was funded by Agencia Nacional de Promocion Cientifica y Tecnologica, JEG MCP (PICTO 2016-0105), and Universidad Austral, MCP (grant number O05-PDISR073). JEG obtained a Sponsored Investigator Research Grant from Grifols S.A. in October 2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr GA, 2000, DIABETES, V49, P1016, DOI 10.2337/diabetes.49.6.1016; Bathina S, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0809-2; Bayardo M, 2012, CLIN EXP IMMUNOL, V168, P95, DOI 10.1111/j.1365-2249.2011.04545.x; Bhanushali D, 2016, INVEST OPHTH VIS SCI, V57, pOCT519, DOI 10.1167/iovs.15-18901; Boroughs LK, 2014, J BIOL CHEM, V289, P10115, DOI 10.1074/jbc.M113.464693; Burke JM, 2000, INVEST OPHTH VIS SCI, V41, P1945; Calado SM, 2016, MOL VIS, V22, P761; Cao YL, 2018, EUR REV MED PHARMACO, V22, P4427, DOI 10.26355/eurrev_201807_15493; Chen CY, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00338; Chen GJ, 2007, J CELL BIOCHEM, V101, P1492, DOI 10.1002/jcb.21265; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; Chen QQ, 2019, FREE RADICAL BIO MED, V130, P48, DOI 10.1016/j.freeradbiomed.2018.10.419; Chen X, 2014, CURR MOL MED, V14, P523, DOI 10.2174/1566524014666140331230411; CIVAN MM, 1994, J MEMBRANE BIOL, V139, P1; Curjuric I, 2018, ATHEROSCLEROSIS, V270, P166, DOI 10.1016/j.atherosclerosis.2018.01.042; Ding YH, 2019, BIOCHEM BIOPH RES CO, V509, P633, DOI 10.1016/j.bbrc.2018.12.024; Faber C, 2019, INVEST OPHTH VIS SCI, V60, P192, DOI 10.1167/iovs.18-25721; Fang PH, 2017, MOL CELL ENDOCRINOL, V448, P77, DOI 10.1016/j.mce.2017.03.027; Farnoodian M, 2016, AM J PHYSIOL-CELL PH, V311, pC418, DOI 10.1152/ajpcell.00001.2016; Galli E, 2019, CELL TRANSPLANT, V28, P413, DOI 10.1177/0963689719827943; Gao JR, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/4650906; Garcia-Ramirez M, 2011, MEASURING PERMEABILI, P179, DOI [10.1007/978-1-61779-191-8_12, DOI 10.1007/978-1-61779-191-8_12]; Gong LL, 2018, P NATL ACAD SCI USA, V115, pE3987, DOI 10.1073/pnas.1715237115; Grassi MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160504; Hazari YM, 2017, MUTAT RES-REV MUTAT, V773, P14, DOI 10.1016/j.mrrev.2017.03.001; Hojlund K, 2014, DAN MED J, V61; Huang TS, 2015, STEM CELLS, V33, P1419, DOI 10.1002/stem.1944; Jain S, 2017, CANCER INVEST, V35, P473, DOI 10.1080/07357907.2017.1337783; Jang SY, 2019, LASER MED SCI, V34, P179, DOI 10.1007/s10103-018-2680-9; Kim DI, 2007, LIFE SCI, V80, P626, DOI 10.1016/J.LFS.2006.10.026; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kowluru RA, 2017, VISION RES, V139, P30, DOI 10.1016/j.visres.2017.02.011; Lavin DP, 2016, DIABETOLOGIA, V59, P2280, DOI 10.1007/s00125-016-4072-7; Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2; Leontieva OV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.178; Lin CY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-87; Liu HW, 2018, EUR REV MED PHARMACO, V22, P5063, DOI 10.26355/eurrev_201808_15698; Liu NN, 2015, IUBMB LIFE, V67, P446, DOI 10.1002/iub.1382; Liu XM, 2018, MOL CELL BIOCHEM, V439, P213, DOI 10.1007/s11010-017-3149-z; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; lvarez JA, 2016, FRONT PHYSIOL, V7, P450, DOI [10.3389/fphys.2016.00450, DOI 10.3389/FPHYS.2016.00450]; Maria Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146033; Mo FF, 2019, IRAN J BASIC MED SCI, V22, P262, DOI 10.22038/ijbms.2019.30246.7294; Moriishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086629; Mugisho OO, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122567; Nandipati KC, 2017, MOL CELL BIOCHEM, V426, P27, DOI 10.1007/s11010-016-2878-8; Nezir Ayca Ece, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7020024; Nisr RB, 2019, CELL MOL LIFE SCI, V76, P4887, DOI 10.1007/s00018-019-03148-8; Ortiz G, 2018, EXP EYE RES, V174, P29, DOI 10.1016/j.exer.2018.05.013; Ortiz G, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-58; Pocrnich CE, 2012, GRAEF ARCH CLIN EXP, V250, P515, DOI 10.1007/s00417-011-1871-x; Puddu Alessandra, 2013, Mediators Inflamm, V2013, P317120, DOI 10.1155/2013/317120; Qian C, 2019, RNA BIOL, V16, P1461, DOI 10.1080/15476286.2019.1637696; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Ruimi N, 2010, MOL BIOL REP, V37, P3801, DOI 10.1007/s11033-010-0035-0; Salahuddin P, 2010, CURR PROTEIN PEPT SC, V11, P101, DOI 10.2174/138920310790848368; Samuels IS, 2015, J NEUROPHYSIOL, V113, P1085, DOI 10.1152/jn.00761.2014; Santangelo S, 2017, CURR MED CHEM, V24, P65, DOI 10.2174/0929867324666161118125827; Serban KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176073; Simao S, 2017, ANGIOGENESIS, V20, P175, DOI 10.1007/s10456-016-9526-5; Simo R, 2015, PROG RETIN EYE RES, V48, P160, DOI 10.1016/j.preteyeres.2015.04.003; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Swarup A, 2019, AM J PHYSIOL-CELL PH, V316, pC121, DOI 10.1152/ajpcell.00410.2018; Tan X, 2017, CURR MOL MED, V17, P189, DOI 10.2174/1566524017666170619113435; Tarchick MJ, 2019, EXP EYE RES, V180, P63, DOI 10.1016/j.exer.2018.11.020; Tian CY, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4393529; Usui-Ouchi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158043; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Viswanath K, 2003, Community Eye Health, V16, P21; Walker RJ, 2012, MOL VIS, V18, P271; Wang C, 2018, J BIOL CHEM, V293, P14839, DOI 10.1074/jbc.RA118.002907; Wang JJ, 2017, DIABETES, V66, P970, DOI 10.2337/db16-1036; Wang T, 2018, EXP THER MED, V15, P3197, DOI 10.3892/etm.2018.5853; WHO, 2017, DIABETES; Xia T, 2017, VISION RES, V139, P72, DOI 10.1016/j.visres.2017.02.006; Yin ZJ, 2015, BEHAV BRAIN RES, V292, P288, DOI 10.1016/j.bbr.2015.06.024; Zhang ZW, 2017, CELL PHYSIOL BIOCHEM, V41, P1777, DOI 10.1159/000471870	78	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228895	10.1371/journal.pone.0228895	http://dx.doi.org/10.1371/journal.pone.0228895			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032388	Green Published, gold			2022-12-26	WOS:000534626100033
J	Yu, IC; Fang, JT; Tsai, YF				Yu, I-Chen; Fang, Ji-Tseng; Tsai, Yun-Fang			Exploring demands of hemodialysis patients in Taiwan: A two-step cluster analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; STAGE RENAL-FAILURE; PERITONEAL-DIALYSIS; HOPE; DEPRESSION; DISEASE; SYMPTOMS; SUPPORT; HEALTH; PREVALENCE	Aims and objectives To classify hemodialysis patients into subgroups via cluster analysis according to the Somatic Symptoms Disturbance Index, Taiwanese Depression Scale, and Herth Hope Index scores. Patient demands in each cluster were also examined. Background Overall patient demands among hemodialysis patients have been demonstrated in numerous reports; however, variables among subgroups have not been explored. Methods Data were analyzed from a cross-sectional survey of 114 hemodialysis patients recruited from dialysis centers in Northern Taiwan. Hope, depression, and symptom disturbance were used as parameters for clustering because they have been shown to be important factors affecting patient demands. A two-step cluster analysis was performed to classify participants into clusters. Patient demands in each cluster were analyzed. Results Among the 114 participants, there was a negative correlation between hope and depression as well as between hope and symptom disturbance; there was a positive correlation between depression and symptom disturbance. Two clusters were identified: Cluster 1 (n = 49) included patients with moderate levels of hope and symptom disturbance, and high levels of depression; and Cluster 2 (n = 65) included patients with low levels of depression and symptom disturbance and high levels of hope. Demographic profiles differed between the two clusters. Regarding patient demands, medical demand showed the highest average score; whereas, occupational demand exhibited the lowest average score. Psychological and occupational demands differed significantly between the two clusters. The two clusters were defined as subgroups: Cluster 1 was labeled "resting"; Cluster 2 was labeled "active". Conclusions Cluster analysis may further classify hemodialysis patients into distinct subgroups base on their specific patient demands. A better understanding of patient demands may help health professionals to provide a holistic individualized treatment to improve patients' outcomes.	[Yu, I-Chen; Tsai, Yun-Fang] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan; [Yu, I-Chen; Fang, Ji-Tseng] Chang Gung Mem Hosp, Dept Nephrol, Taoyuan, Taiwan; [Fang, Ji-Tseng; Tsai, Yun-Fang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Tsai, Yun-Fang] Chang Gung Univ, Coll Med, Sch Nursing, Taoyuan, Taiwan; [Tsai, Yun-Fang] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Psychiat, Keelung, Taiwan	Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Tsai, YF (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan.; Tsai, YF (corresponding author), Chang Gung Univ, Coll Med, Sch Nursing, Taoyuan, Taiwan.; Tsai, YF (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Psychiat, Keelung, Taiwan.	yftsai@mail.cgu.edu.tw	Tsai, Yun-Fang/J-6505-2019	Tsai, Yun-Fang/0000-0002-2148-314X	Chang Gung Memorial Hospital [CMRPF190021]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The study was supported by a research grant from Chang Gung Memorial Hospital (grant number: CMRPF190021) to I-Chen Yu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Kader K, 2009, CLIN J AM SOC NEPHRO, V4, P1057, DOI 10.2215/CJN.00430109; Alberto J, 2008, APPL NURS RES, V21, P212, DOI 10.1016/j.apnr.2006.12.005; Alvarez-Ude F, 2001, NEFROLOGIA, V21, P191; Garcia RSA, 2017, ARTIF ORGANS, V41, P1121, DOI 10.1111/aor.12938; Bao YJ, 2017, PSYCHO-ONCOLOGY, V26, P262, DOI 10.1002/pon.4128; Billington E, 2008, BRIT J HEALTH PSYCH, V13, P683, DOI 10.1348/135910707X248959; Cha J, 2017, J KOREAN ACAD NURS, V47, P14, DOI 10.4040/jkan.2017.47.1.14; Chan LL, 2017, BLOOD PURIFICAT, V43, P226, DOI 10.1159/000452750; Chan MF, 2010, J CLIN NURS, V19, P649, DOI 10.1111/j.1365-2702.2009.03103.x; Chan MF, 2004, NURS EDUC TODAY, V24, P202, DOI 10.1016/j.nedt.2003.11.009; Chen IM, 2018, J AFFECT DISORDERS, V227, P7, DOI 10.1016/j.jad.2017.10.020; Cukor D, 2007, J AM SOC NEPHROL, V18, P3042, DOI 10.1681/ASN.2007030345; Dancey CP, 2007, STAT MATHS PSYCHOL, V4th; Davis MP, 2017, AM J HOSP PALLIAT ME, V34, P223, DOI 10.1177/1049909115627772; Gerogianni S, 2016, INT J CARING SCI, V9, P122; Gorsuch R., 1983, FACTOR ANAL; Hassanein KAAM, 2001, BRIT J ORAL MAX SURG, V39, P340, DOI 10.1054/bjom.2001.0652; Hawamdeh S, 2017, INT J NEPHROL RENOV, V10, P183, DOI 10.2147/IJNRD.S139652; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Huang HM., 2003, INVESTIGATION STRESS; Kao TW, 2003, J FORMOS MED ASSOC, V102, P127; Kao TW, 2009, ARTIF ORGANS, V33, P61, DOI 10.1111/j.1525-1594.2008.00675.x; Kimmel PL, 2005, SEMIN DIALYSIS, V18, P91, DOI 10.1111/j.1525-139X.2005.18209.x; Lee Y, 2000, Chang Gung Med J, V23, P688; Lilympaki Ioanna, 2016, Mater Sociomed, V28, P361, DOI 10.5455/msm.2016.28.361-365; Lin C.C., 2004, J TAIWAN NEPHROLOGY, V3, P17; Liu XD, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1294-2; Lu SC, 2010, J NURSING HEALTHCARE, V6, P33; Luo YY, 2010, LEADERSHIP NURSING, V11, P16; Murillo-Zamora Efren, 2016, Rev Med Inst Mex Seguro Soc, V54, P429; Orlandi Fabiana de Souza, 2012, Rev. esc. enferm. USP, V46, P900; Ottaviani AC, 2014, REV LAT-AM ENFERM, V22, P248, DOI 10.1590/0104-1169.3323.2409; Rahimipour Meisam, 2015, Iran J Nurs Midwifery Res, V20, P694, DOI 10.4103/1735-9066.170007; Rawdin B, 2013, J PALLIAT MED, V16, P167, DOI 10.1089/jpm.2012.0223; Shahgholian Nahid, 2012, Iran J Nurs Midwifery Res, V17, pS85; Sugisawa H, 2016, INT J NEPHROL RENOV, V9, P171, DOI 10.2147/IJNRD.S107031; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Weisbord SD, 2005, J AM SOC NEPHROL, V16, P2487, DOI 10.1681/ASN.2005020157; Xhulia Dhima, 2015, Glob J Health Sci, V8, P109, DOI 10.5539/gjhs.v8n6p109; Yu IC, 2012, APPL NURS RES, V25, P190, DOI 10.1016/j.apnr.2010.11.002	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228259	10.1371/journal.pone.0228259	http://dx.doi.org/10.1371/journal.pone.0228259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9HH	32032397	Green Published, gold, Green Submitted			2022-12-26	WOS:000534626100011
J	Iguchi, A; Nishijima, M; Yoshioka, Y; Miyagi, A; Miwa, R; Tanaka, Y; Kato, S; Matsui, T; Igarashi, Y; Okamoto, N; Suzuki, A				Iguchi, Akira; Nishijima, Miyuki; Yoshioka, Yuki; Miyagi, Aika; Miwa, Ryuichi; Tanaka, Yuichiro; Kato, Shogo; Matsui, Takaaki; Igarashi, Yoshiaki; Okamoto, Nobuyuki; Suzuki, Atsushi			Deep-sea amphipods around cobalt-rich ferromanganese crusts: Taxonomic diversity and selection of candidate species for connectivity analysis	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; POPULATION-GENETICS; RATES	The aim of this study was to select a candidate deep-sea amphipod species suitable for connectivity analyses in areas around cobalt-rich ferromanganese crusts (CRCs). We applied DNA barcoding based on the mitochondrial protein-coding gene, cytochrome c oxidase subunit I (COI), to specimens collected from the Xufu Guyot (the JA06 Seamount) off southeastern Minami-Torishima Island in the North Pacific, where CRCs are distributed. We used baited traps to collect 37 specimens. Comparison of COI sequences with public reference databases (GenBank, BOLD) showed that almost all of the specimens belonged to the superfamily Lysianassoidea, which is known to be ubiquitous in deep-sea areas. In a molecular taxonomic analysis of these sequences, we detected 11 clades. One of these clades (group 9) composed of 18 sequences and was identified by DNA barcoding as a putative species belonging to Abyssorchomene, which has been reported from the New Hebrides Trench in the South Pacific. We considered this species to be a candidate for connectivity analysis and analyzed its genome by restriction site-associated DNA sequencing. The results showed that the genetic variation in this species is adequate for analyzing connectivity patterns in CRC areas in the future.	[Iguchi, Akira; Tanaka, Yuichiro; Suzuki, Atsushi] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki, Japan; [Iguchi, Akira; Yoshioka, Yuki; Miyagi, Aika] Natl Inst Technol, Okinawa Coll, Dept Bioresources Engn, Nago City, Okinawa, Japan; [Nishijima, Miyuki; Miwa, Ryuichi] Kaiyo Engn Co Ltd, Taito Ku, Tokyo, Japan; [Kato, Shogo; Matsui, Takaaki; Igarashi, Yoshiaki; Okamoto, Nobuyuki] Japan Oil Gas & Met Natl Corp JOGMEC, Minato Ku, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Oil, Gas and Metals National Corporation (JOGMEC)	Iguchi, A (corresponding author), Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki, Japan.; Iguchi, A (corresponding author), Natl Inst Technol, Okinawa Coll, Dept Bioresources Engn, Nago City, Okinawa, Japan.	iguchi.a@aist.go.jp	Yoshioka, Yuki/AAO-5382-2020; Iguchi, Akira/I-3180-2016; Suzuki, Atsushi/L-6120-2018	Yoshioka, Yuki/0000-0001-6348-4629; Iguchi, Akira/0000-0002-8894-1977; Suzuki, Atsushi/0000-0002-0266-5765	Kaiyo Engineering; Japan Oil, Gas and Metals National Corporation JOGMEC	Kaiyo Engineering; Japan Oil, Gas and Metals National Corporation JOGMEC(Japan Oil, Gas and Metals National Corporation (JOGMEC))	Kaiyo Engineering provided support in the form of salaries for authors MN and RM, and Japan Oil, Gas and Metals National Corporation JOGMEC) provided support in the form of salaries for authors SK, TM, YI, and NO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aronesty E., 2011, EA UTILS COMMAND LIN; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Baco AR, 2016, MOL ECOL, V25, P3276, DOI 10.1111/mec.13689; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clement M., 2002, P 16 INT PARALLEL DI, P7; Fujii T, 2013, MAR ECOL PROG SER, V492, P125, DOI 10.3354/meps10489; Glover AG, 2018, ELIFE, V7, DOI 10.7554/eLife.41319; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; ISA, 2015, ISA TECHN STUD; ISA, 2019, REC GUID CONTR ASS P; Kiel S, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.2337; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kishimoto K, 2017, GEOL SURV JAPAN MISC, V33; Knapp I., 2016, EZRAD ACCESSIBLE NEX, DOI [10.17504/protocols.io.e9pbh5n, DOI 10.17504/PROTOCOLS.IO.E9PBH5N]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mitarai S, 2016, P NATL ACAD SCI USA, V113, P2976, DOI 10.1073/pnas.1518395113; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ritchie H, 2017, DEEP-SEA RES PT I, V119, P50, DOI 10.1016/j.dsr.2016.11.006; Ritchie H, 2015, DEEP-SEA RES PT I, V105, P119, DOI 10.1016/j.dsr.2015.08.014; Ritchie H, 2016, J HERED, V107, P367, DOI 10.1093/jhered/esw019; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor ML, 2017, MOL ECOL, V26, P4872, DOI 10.1111/mec.14237; Toonen RJ, 2013, PEERJ, V1, DOI 10.7717/peerj.203; Watanabe H, 2005, MAR ECOL PROG SER, V288, P233, DOI 10.3354/meps288233; Yahagi T, 2015, MAR ECOL PROG SER, V529, P159, DOI 10.3354/meps11267; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	40	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228483	10.1371/journal.pone.0228483	http://dx.doi.org/10.1371/journal.pone.0228483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027722	Green Published, Green Submitted, gold			2022-12-26	WOS:000534623800041
J	Qi, X; Fu, Z; Xiong, J; Zha, WX				Qi, Xin; Fu, Zhuo; Xiong, Jian; Zha, Weixiong			Multi-start heuristic approaches for one-to-one pickup and delivery problems with shortest-path transport along real-life paths	PLOS ONE			English	Article							LARGE NEIGHBORHOOD SEARCH; VEHICLE-ROUTING PROBLEM; A-RIDE PROBLEM; TRAVELING SALESMAN PROBLEM; TIME WINDOWS; MANY OPERATIONS; SINGLE; ALGORITHM; MULTICOMMODITY; OPTIMIZATION	The One-to-one Pickup and Delivery Problem with Shortest-path Transport along Real-life Paths (OPDPSTRP) is presented in this opaper. It is a variation of the One-to-one Pickup and Delivery Problem (OPDP), which is common in daily life, such as the Passenger Train Operation Plans (PTOP) and partial Taxi-sharing Problem. Unlike the classical OPDP, in the OPDPSTRP, (1) each demand must be transported along the shortest path according to passengers/shippers requirements, and (2) each vehicle should travel along a real-life path. First, six route structure rules are proposed for the OPDPSTRP, and a kind of Mixed-Integer Programming (MIP) models is formulated for it. Second, A Variable Neighborhood Descent (VND), a Variable Neighborhood Research (VNS), a Multi-Start VND (MS_VND) and a Multi-Start VNS (MS_VNS) with five neighborhood operators has been developed to solve the problem. Finally, The Gurobi solver, the VND, the VNS, the MS_VND and the MS_VNS have been compared with each other by 84 random instances partitioned in small size connected graphs, medium size connected graphs and large size connected graphs. From the test results we found that solutions generated by these approaches are often comparable with those found by the Gurobi solver, and the solutions found by these approaches are better than the solutions found by the Gurobi solver when solving instances with larger numbers of demands. In almost all instances, the MS_VND significantly outperforms the VND and the VNS in terms of solution quality, and outperforms the MS_VNS both in terms of solution quality and CPU time. In the instances with large numbers of demands, the MS_VND is still able to generate good feasible solutions in a reasonable CPU time, which is of vital practical significance for real-life instances.	[Qi, Xin; Fu, Zhuo; Xiong, Jian] Cent South Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Qi, Xin; Xiong, Jian; Zha, Weixiong] East China Jiao Tong Univ, Sch Transportat & Logist, Nanchang, Jiangxi, Peoples R China	Central South University; East China Jiaotong University	Qi, X (corresponding author), Cent South Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.; Qi, X (corresponding author), East China Jiao Tong Univ, Sch Transportat & Logist, Nanchang, Jiangxi, Peoples R China.	qixin@ecjtu.edu.cn			National Natural Science Foundation of China [71271220]; Research Project of Humanities and Social Sciences in the Universities of Jiangxi Province [JC18213, JC19207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Project of Humanities and Social Sciences in the Universities of Jiangxi Province	This research was supported by the National Natural Science Foundation of China (ZF) (Grant: 71271220), the Research Project of Humanities and Social Sciences in the Universities of Jiangxi Province (XQ) (Grant No. JC18213), and the Research Project of Humanities and Social Sciences in the Universities of Jiangxi Province (JX) (Grant No. JC19207). All other authors received no specific funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatz N, 2012, EUR J OPER RES, V223, P295, DOI 10.1016/j.ejor.2012.05.028; Aksen D, 2014, EUR J OPER RES, V239, P413, DOI 10.1016/j.ejor.2014.05.043; Fuentes GEA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201868; Aragao MP, 2006, COMPUTERS OPERATIONS, V33, P1823; Berbeglia G, 2007, TOP, V15, P1, DOI 10.1007/s11750-007-0009-0; Berbeglia G, 2010, EUR J OPER RES, V202, P8, DOI 10.1016/j.ejor.2009.04.024; Brimberg J, 2010, 4OR-Q J OPER RES, V8, P181, DOI 10.1007/s10288-009-0108-x; Chen HK, 2015, TOP, V23, P220, DOI 10.1007/s11750-014-0335-y; Cordeau JF, 2008, OPER RES COMPUT SCI, V43, P327, DOI 10.1007/978-0-387-77778-8_15; CORNUEJOLS G, 1985, MATH PROGRAM, V33, P1, DOI 10.1007/BF01582008; de Camargo RS, 2013, APPL MATH MODEL, V37, P7465, DOI 10.1016/j.apm.2013.02.035; Desrosiers J., 1986, American Journal of Mathematical and Management Sciences, V6, P301; Detti P, 2017, OMEGA-INT J MANAGE S, V70, P1, DOI 10.1016/j.omega.2016.08.008; Factorovich P, 2020, COMPUT OPER RES, V113, DOI 10.1016/j.cor.2019.104805; FLEISCHMANN B, 1985, EUR J OPER RES, V21, P307, DOI 10.1016/0377-2217(85)90151-1; Furuhata M, 2013, TRANSPORT RES B-METH, V57, P28, DOI 10.1016/j.trb.2013.08.012; Gribkovskaia I, 2008, OPER RES COMPUT SCI, V43, P359, DOI 10.1007/978-0-387-77778-8_16; Grimault A, 2017, COMPUT OPER RES, V88, P1, DOI 10.1016/j.cor.2017.06.012; Hernandez-Perez H, 2009, EUR J OPER RES, V196, P987, DOI 10.1016/j.ejor.2008.05.009; Ho SC, 2018, TRANSPORT RES B-METH, V111, P395, DOI 10.1016/j.trb.2018.02.001; Hosni H, 2014, TRANSPORT RES B-METH, V70, P303, DOI 10.1016/j.trb.2014.09.011; Koc C, 2018, COMPUT OPER RES, V91, P79, DOI 10.1016/j.cor.2017.11.003; Letchford AN, 2014, COMPUT OPER RES, V51, P331, DOI 10.1016/j.cor.2014.06.022; Li BX, 2014, EUR J OPER RES, V238, P31, DOI 10.1016/j.ejor.2014.03.003; Li J, 2015, EXPERT SYST APPL, V42, P3551, DOI 10.1016/j.eswa.2014.12.004; Li Y, 2016, EUR J OPER RES, V252, P27, DOI 10.1016/j.ejor.2015.12.032; Lin YQ, 2012, PROCD SOC BEHV, V43, P494, DOI 10.1016/j.sbspro.2012.04.122; Ma S, 2015, IEEE T KNOWL DATA EN, V27, P1782, DOI 10.1109/TKDE.2014.2334313; Mahmoudi M, 2016, TRANSPORT RES B-METH, V89, P19, DOI 10.1016/j.trb.2016.03.009; Miao K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215107; Mitra S, 2008, J OPER RES SOC, V59, P1532, DOI 10.1057/palgrave.jors.2602500; Mladenovic N, 1997, COMPUT OPER RES, V24, P1097, DOI 10.1016/S0305-0548(97)00031-2; Muelas S, 2015, TRANSPORT RES C-EMER, V54, P110, DOI 10.1016/j.trc.2015.02.024; Naoum-Sawaya J, 2015, TRANSPORT RES B-METH, V80, P173, DOI 10.1016/j.trb.2015.07.001; Nowak M, 2008, TRANSPORT SCI, V42, P32, DOI 10.1287/trsc.1070.0207; Parragh S.N., 2008, J F R BETR, V58, P81, DOI [10.1007/s11301-008-0036-4, DOI 10.1007/S11301-008-0036-4]; Parragh S.N, 2008, J BETRIEBSWIRTSCHAFT, V58, P81, DOI DOI 10.1007/S11301-008-0036-4; Pisinger D, 2007, COMPUT OPER RES, V34, P2403, DOI 10.1016/j.cor.2005.09.012; POTVIN JY, 1993, EUR J OPER RES, V66, P331, DOI 10.1016/0377-2217(93)90221-8; Prins C., 2009, BIOINSPIRED ALGORITH, V161, P35, DOI DOI 10.1007/978-3-540-85152-3; Psaraftis HN, 2011, EUR J OPER RES, V215, P572, DOI 10.1016/j.ejor.2011.06.038; PSARAFTIS HN, 1983, TRANSPORT RES B-METH, V17, P133, DOI 10.1016/0191-2615(83)90041-3; PSARAFTIS HN, 1983, TRANSPORT SCI, V17, P351, DOI 10.1287/trsc.17.3.351; Qiu XQ, 2017, EUR J OPER RES, V259, P155, DOI 10.1016/j.ejor.2016.10.010; Ribeiro GM, 2012, COMPUT OPER RES, V39, P728, DOI 10.1016/j.cor.2011.05.005; Rieck J, 2014, EUR J OPER RES, V236, P863, DOI 10.1016/j.ejor.2013.12.021; Rivera JC, 2015, COMPUT OPTIM APPL, V61, P159, DOI 10.1007/s10589-014-9713-5; Rodriguez-Martin I, 2012, J HEURISTICS, V18, P849, DOI 10.1007/s10732-012-9210-x; Ropke S, 2006, TRANSPORT SCI, V40, P455, DOI 10.1287/trsc.1050.0135; Sahin M, 2013, TRANSPORT RES C-EMER, V27, P169, DOI 10.1016/j.trc.2012.04.014; Salehipour A, 2011, 4OR-Q J OPER RES, V9, P189, DOI 10.1007/s10288-011-0153-0; Santos DO, 2015, EXPERT SYST APPL, V42, P6728, DOI 10.1016/j.eswa.2015.04.060; SEXTON TR, 1985, TRANSPORT SCI, V19, P411, DOI 10.1287/trsc.19.4.411; SEXTON TR, 1985, TRANSPORT SCI, V19, P378, DOI 10.1287/trsc.19.4.378; Shaw P, 1998, LECT NOTES COMPUT SC, V1520, P417; Shaw P., 1997, NEW LOCAL SEARCH ALG; Soysal M, 2018, J CLEAN PROD, V174, P1664, DOI 10.1016/j.jclepro.2017.11.040; STECKLOV G, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0130224; Urra E, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/707056; Wang YZ, 2018, COMPUT ENVIRON URBAN, V69, P124, DOI 10.1016/j.compenvurbsys.2018.01.006; Xia YK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195457; Zhu ZX, 2016, INFORM SCIENCES, V329, P73, DOI 10.1016/j.ins.2015.09.006	62	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0227702	10.1371/journal.pone.0227702	http://dx.doi.org/10.1371/journal.pone.0227702			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9GK	32027655	gold, Green Published			2022-12-26	WOS:000534623800011
J	Shao, AW; Lang, Y; Wang, MD; Qin, C; Kuang, Y; Mei, YD; Lin, DG; Zhang, S; Tang, J				Shao, Anwen; Lang, Yue; Wang, Mengdong; Qin, Chao; Kuang, Yu; Mei, Yide; Lin, Degui; Zhang, Shuo; Tang, Jun			Bclaf1 is a direct target of HIF-1 and critically regulates the stability of HIF-1 alpha under hypoxia	ONCOGENE			English	Article							INDUCIBLE FACTORS; MESSENGER-RNA; PROTEINS; ALPHA; DEATH; CELLS; DESTABILIZATION; TRANSCRIPTION; DEGRADATION; METABOLISM	Hypoxic stress is intimately connected with tumor progression, with hypoxia-inducible factor-1 alpha (HIF-1 alpha) being a critical regulator in this process. HIF-1 alpha is stabilized in response to hypoxia, which is required for the induction of gene transcriptions important for hypoxic adaptation. Bclaf1 is a multifunctional protein involved in tumorigenesis, however, its role in this process is not well characterized. Here we report Bclaf1 is a direct transcriptional target of HIF-1 and upregulated in multiple cell lines during hypoxia. Importantly, we found Bclaf1 is involved in the stabilization of HIF-1 alpha during long-term hypoxic treatments. Compared with the control cells, the protein level and stability of HIF-1 alpha in Bclaf1 knockdown or knockout cells is greatly compromised after long-term hypoxic treatments, concomitant with the impaired inductions of HIF-1 target gene transcription. Bclaf1 knockout HeLa cells exhibit a reduced tumor growth in mice xenografts, in which the expressions of HIF-1 alpha and its target genes are also decreased. Bclaf1 binds to HIF-1 alpha in the nucleus, and this interaction is required for Bclaf1 to stabilize HIF-1 alpha in hypoxic condition. These results uncover a positive feedback loop, HIF-1-Bclaf1, that sustains HIF-1 activity during long-term hypoxic conditions by binding to and protecting HIF-1 alpha from degradation, and suggest that Bclaf1 may promote tumor progression by enhancing HIF-1 alpha stability.	[Shao, Anwen; Lang, Yue; Wang, Mengdong; Qin, Chao; Kuang, Yu; Tang, Jun] China Agr Univ, Coll Vet Med, Dept Basic Vet Med, Beijing 100193, Peoples R China; [Mei, Yide] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Lin, Degui; Zhang, Shuo] China Agr Univ, Coll Vet Med, Dept Clin Vet Med, Beijing 100193, Peoples R China	China Agricultural University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; China Agricultural University	Tang, J (corresponding author), China Agr Univ, Coll Vet Med, Dept Basic Vet Med, Beijing 100193, Peoples R China.	jtang@cau.edu.cn	Mei, Yide/M-4468-2013		National Natural Science Foundation of China [31671488, 31872834]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31671488 and 31872834).	Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bracken CP, 2008, CANCER RES, V68, P7621, DOI 10.1158/0008-5472.CAN-08-1217; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Cavadas MAS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17851; Chamboredon S, 2011, MOL BIOL CELL, V22, P3366, DOI 10.1091/mbc.E10-07-0617; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10347; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Lee SH, 2012, P NATL ACAD SCI USA, V109, P9575, DOI 10.1073/pnas.1207496109; Lee YY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.76; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Liu J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01947-w; Luo WB, 2018, CELL MOL LIFE SCI, V75, P1043, DOI 10.1007/s00018-017-2684-9; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; McPherson JP, 2009, CELL DEATH DIFFER, V16, P331, DOI 10.1038/cdd.2008.167; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Qin C, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007559; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Savage KI, 2014, MOL CELL, V54, P445, DOI 10.1016/j.molcel.2014.03.021; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shao AW, 2016, CELL DEATH DIFFER, V23, P865, DOI 10.1038/cdd.2015.150; Shih JW, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0358-4; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Vohhodina J, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1046; Wen Y, 2019, ONCOGENE, V38, P1845, DOI 10.1038/s41388-018-0552-1; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Zhou XX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5581; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	41	6	7	3	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2807	2818		10.1038/s41388-020-1185-8	http://dx.doi.org/10.1038/s41388-020-1185-8		FEB 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32029898				2022-12-26	WOS:000511540800003
J	Shim, S; Soh, SH; Im, YB; Ahn, C; Park, HT; Park, HE; Park, WB; Kim, S; Yoo, HS				Shim, Soojin; Soh, Sang Hee; Im, Young Bin; Ahn, Choonghyun; Park, Hong-Tae; Park, Hyun-Eui; Park, Woo Bin; Kim, Suji; Yoo, Han Sang			Induction of systemic immunity through nasal-associated lymphoid tissue (NALT) of mice intranasally immunized with Brucella abortus malate dehydrogenase-loaded chitosan nanoparticles	PLOS ONE			English	Article							CELLS; DIFFERENTIATION; PROTECTION; REVEALS; PATTERN; VIVO	Infection with Brucella abortus causes contagious zoonosis, brucellosis, and leads to abortion in animals and chronic illness in humans. Chitosan nanoparticles (CNs), biocompatible and nontoxic polymers, acts as a mucosal adjuvant. In our previous study, B. abortus malate dehydrogenase (Mdh) was loaded in CNs, and it induced high production of pro-inflammatory cytokines in THP-1 cells and systemic IgA in BALB/C mice. In this study, the time-series gene expression analysis of nasal-associated lymphoid tissue (NALT) was performed to identify the mechanism by which Mdh affect the target site of nasal immunization. We showed that intranasal immunization of CNs-Mdh reduced cell viability of epithelial cells and muscle cells at first 1 h, then induced cellular movement of immune cells such as granulocytes, neutrophils and lymphocytes at 6h, and activated IL-6 signaling pathway at 12h within NALT. These activation of immune cells also promoted signaling pathway for high-mobility group box 1 protein (HMGB1), followed by the maturation of DCs required for mucosal immunity. The CNs also triggered the response to other organism and inflammatory response, showing it is immune-enhancing adjuvant. The ELISA showed that significant production of specific IgA was detected in the fecal excretions and genital secretions from the CNs-Mdh-immunized group after 2 weeks-post immunization. Collectively, these results suggest that B. abortus Mdh-loaded CNs triggers activation of HMGB1, IL-6 and DCs maturation signaling within NALT and induce production of systemic IgG and IgA.	[Shim, Soojin; Soh, Sang Hee; Im, Young Bin; Park, Hong-Tae; Park, Hyun-Eui; Park, Woo Bin; Kim, Suji; Yoo, Han Sang] Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea; [Ahn, Choonghyun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Yoo, Han Sang] Seoul Natl Univ, BioMax N Bio Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Yoo, HS (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea.; Yoo, HS (corresponding author), Seoul Natl Univ, BioMax N Bio Inst, Seoul, South Korea.	yoohs@snu.ac.kr		Soh, Sang Hee/0000-0002-4675-3556; Shim, Soojin/0000-0002-1769-0293; Kim, Suji/0000-0001-8901-0085; YOO, HAN SANG/0000-0003-0548-0835	Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs [918020-4]; Korea Health Industry Development Institute (KHIDI) [HI16C2130]; Brain Korea (BK) 21 PLUS program for Creative Veterinary Science Research, Seoul National University, Republic of Korea; Research Institute of Veterinary Science, Seoul National University, Republic of Korea	Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs; Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Brain Korea (BK) 21 PLUS program for Creative Veterinary Science Research, Seoul National University, Republic of Korea; Research Institute of Veterinary Science, Seoul National University, Republic of Korea	This work was supported by the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs (No. 918020-4), Korea Health Industry Development Institute (KHIDI) (No. HI16C2130) and the Brain Korea (BK) 21 PLUS program for Creative Veterinary Science Research and the Research Institute of Veterinary Science, Seoul National University, Republic of Korea.	ARAYA LN, 1990, INFECT IMMUN, V58, P254, DOI 10.1128/IAI.58.1.254-256.1990; Asanuma H, 1997, J IMMUNOL METHODS, V202, P123, DOI 10.1016/S0022-1759(96)00243-8; Bemark M, 2012, ANN NY ACAD SCI, V1247, P97, DOI 10.1111/j.1749-6632.2011.06378.x; Bin Im Y, 2018, MICROB PATHOGENESIS, V122, P7, DOI 10.1016/j.micpath.2018.06.007; Brandtzaeg P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00222; Carvalho TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166582; Chew JL, 2003, VACCINE, V21, P2720, DOI 10.1016/S0264-410X(03)00228-7; Date Y, 2017, INT IMMUNOL, V29, P471, DOI 10.1093/intimm/dxx064; des Rieux A, 2006, J CONTROL RELEASE, V116, P1, DOI 10.1016/j.jconrel.2006.08.013; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dorneles EMS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136696; Gan Q, 2005, COLLOID SURFACE B, V44, P65, DOI 10.1016/j.colsurfb.2005.06.001; Golding B, 2001, MICROBES INFECT, V3, P43, DOI 10.1016/S1286-4579(00)01350-2; Gwida M, 2010, CROAT MED J, V51, P289, DOI 10.3325/cmj.2010.51.289; Hiroi T, 1998, EUR J IMMUNOL, V28, P3346, DOI 10.1002/(SICI)1521-4141(199810)28:10<3346::AID-IMMU3346>3.0.CO;2-P; Hop HT, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00431-19; Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5; Im YB, 2017, MICROB PATHOGENESIS, V110, P7, DOI 10.1016/j.micpath.2017.06.019; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Kim DY, 2011, J IMMUNOL, V186, P4253, DOI 10.4049/jimmunol.0903794; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Konkel JE, 2011, TRENDS MOL MED, V17, P668, DOI 10.1016/j.molmed.2011.07.002; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lamichhane A, 2014, VACCINE, V32, P6711, DOI 10.1016/j.vaccine.2014.08.089; Li HS, 2016, J CONTROL RELEASE, V233, P114, DOI 10.1016/j.jconrel.2016.05.032; Lowry JE, 2010, VET MICROBIOL, V142, P367, DOI 10.1016/j.vetmic.2009.10.010; Lowry JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017425; Moller W, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-10; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; Niu HX, 2016, J LEUKOCYTE BIOL, V99, P797, DOI 10.1189/jlb.2HI0415-146RR; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Shimizu S, 2016, AM J RHINOL ALLERGY, V30, P167, DOI 10.2500/ajra.2016.30.4300; Soh SH, 2019, VACCINE, V37, P1554, DOI 10.1016/j.vaccine.2019.02.005; Takaki H, 2018, J INNATE IMMUN, V10, P515, DOI 10.1159/000489405; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Wakabayashi A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0665-z; Zhang F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/257930; Zhu XM, 2009, J INTERF CYTOK RES, V29, P677, DOI 10.1089/jir.2008.0104; Zuercher AW, 2002, J IMMUNOL, V168, P1796, DOI 10.4049/jimmunol.168.4.1796	44	7	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228463	10.1371/journal.pone.0228463	http://dx.doi.org/10.1371/journal.pone.0228463			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027689	gold, Green Submitted, Green Published			2022-12-26	WOS:000534623800039
J	Qu, YZ; Wu, PH; Ren, JJ; Liu, ZH; Tang, JH; Lubberstedt, T; Li, HC; Chen, SJ				Qu, Yanzhi; Wu, Penghao; Ren, Jiaojiao; Liu, Zonghua; Tang, Jihua; Lubberstedt, Thomas; Li, Haochuan; Chen, Shaojiang			Mapping of QTL for kernel abortion caused by in vivo haploid induction in maize (Zea mays L.)	PLOS ONE			English	Article							CHROMOSOME ELIMINATION; MATERNAL HAPLOIDS; SEED DEVELOPMENT; GENE; ENCODES; PHOSPHOLIPASE; ENDOSPERM; PROTEIN; CELL; GYNOGENESIS	Kernel abortion is common phenomenon in vivo haploid induction and closely linked with haploid induction rate, but little information of kernel abortion is available and its genetic basis still unclear. We used two mapping populations including 186 and 263 F-2.3 family lines to analyze the different degree of kernel abortion and identify quantitative trait loci (QTL) responsible for kernel abortion during haploid induction. In total 62 putative QTL, accounting for 3.27-14.70% of the phenotypic variation in kernel abortion traits, were detected across all 10 chromosomes. Ten QTL with over 10% contribution to phenotypic variation were affecting the fifth level of endosperm abortion (EnA5th), endosperm abortion (EnA) and total abortion (TA). Co-localization among kernel abortion traits QTL was observed in both populations and among different kernel abortion types. Five overlaps were indentified in the QTL for kernel abortion traits and HIR traits. Maize chromosome bins 3.01-3.02, 3.04-3.06, 4.05-4.06, 5.03-5.04, 8.06 were QTL hotspots for three or four traits related to the kernel abortion during haploid induction. Total kernel abortion rate (TAR) and HIR showed highly significant positive correlation. These findings may help to reveal haploid induction mechanisms and improve haploid production efficiency.	[Qu, Yanzhi; Liu, Zonghua; Tang, Jihua; Li, Haochuan] Henan Agr Univ, Coll Agron, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Wu, Penghao; Ren, Jiaojiao; Li, Haochuan; Chen, Shaojiang] China Agr Univ, Natl Maize Improvement Ctr, Beijing, Peoples R China; [Wu, Penghao; Ren, Jiaojiao] Xinjiang Agr Univ, Coll Agron, Urumqi, Peoples R China; [Lubberstedt, Thomas] Iowa State Univ, Dept Agron, Ames, IA USA	Henan Agricultural University; China Agricultural University; Xinjiang Agricultural University; Iowa State University	Li, HC (corresponding author), Henan Agr Univ, Coll Agron, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China.; Li, HC; Chen, SJ (corresponding author), China Agr Univ, Natl Maize Improvement Ctr, Beijing, Peoples R China.	lihaochuan1220@163.com; shaoj@cau.edu.cn	Zhang, Lu/HGB-5048-2022	Lubberstedt, Thomas/0000-0002-0526-0798	National Key Research and Development Program of China [2016YFD0101205]; National Maize Industrial Technology System [CARS-02-09]; National Natural Science Foundation of China [31560392, U1204316]; Science and Technology Assistance Xinjiang Program [2019E0209, 2018E02032]	National Key Research and Development Program of China; National Maize Industrial Technology System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Assistance Xinjiang Program	This study was supported by The National Key Research and Development Program of China (2016YFD0101205) and the National Maize Industrial Technology System (CARS-02-09) to Shaojiang Chen; National Natural Science Foundation of China (31560392), Science and Technology Assistance Xinjiang Program (2019E0209, 2018E02032) to Penghao Wu and National Natural Science Foundation of China (CN) (U1204316) to Haochuan Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barret P, 2008, THEOR APPL GENET, V117, P581, DOI 10.1007/s00122-008-0803-6; Basten C.J., 1997, QTL CARTOGRAPHER REF; Bylich V. G., 1996, Maize Genetics Cooperation Newsletter, P33; Cande WZ, 2011, GENETICS, V188, P491, DOI 10.1534/genetics.111.130039; Chalyk ST, 2003, MAIZE GENETICS COOPE, V77, P29; CLARK JK, 1991, PLANT CELL, V3, P935, DOI 10.1105/tpc.3.9.935; De La Fuente, 2018, CROP SCI; Dong X, 2013, THEOR APPL GENET, V126, P1713, DOI 10.1007/s00122-013-2086-9; Evans MMS, 2007, PLANT CELL, V19, P46, DOI 10.1105/tpc.106.047506; Fu SN, 2002, PLANT CELL, V14, P3119, DOI 10.1105/tpc.006726; Geiger HH, 2009, MAYDICA, V54, P485; Gilles LM, 2017, EMBO J, V36, P707, DOI 10.15252/embj.201796603; Gutierrez-Marcos JF, 2007, PLANT CELL, V19, P196, DOI 10.1105/tpc.105.039594; Gutierrez-Marcos JF, 2006, GENETICS, V174, P317, DOI 10.1534/genetics.106.059709; Hoisington D, 1994, LAB PROTOCOLS; Kelliher T, 2017, NATURE, V542, P105, DOI 10.1038/nature20827; KERMICLE JL, 1971, AM J BOT, V58, P1, DOI 10.2307/2441299; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li Liang, 2012, Journal of China Agricultural University, V17, P1; Li L, 2009, PLANTA, V230, P367, DOI 10.1007/s00425-009-0943-1; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; LIN BY, 1984, GENETICS, V107, P103; Lincoln S, 1992, CONSTRUCING GENETIC, V3rd; Liu CX, 2017, MOL PLANT, V10, P520, DOI 10.1016/j.molp.2017.01.011; Liu J, 2017, PLANT PHYSIOL, V175, P774, DOI 10.1104/pp.17.00708; Liu LW, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1422-2; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; Miranda JB., 1981, QUANTITATIVE GENETIC; Neuffer M. G., 1987, Maize Genetics Cooperation Newsletter, P50; Poethig S., 1989, Maize Genetics Cooperation News Letter, P101; Prigge V, 2012, GENETICS, V190, P781, DOI 10.1534/genetics.111.133066; SARKAR KR, 1966, GENETICS, V54, P453; Scanlon MJ, 1998, PLANT MOL BIOL, V37, P483, DOI 10.1023/A:1005998830723; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; SENIOR ML, 1993, GENOME, V36, P884, DOI 10.1139/g93-116; SHERIDAN WF, 1982, J HERED, V73, P318, DOI 10.1093/oxfordjournals.jhered.a109662; Sheridan WF, 1978, MAIZE GENET COOP NEW, V52, P88; Sosso D, 2015, NAT GENET, V47, P1489, DOI 10.1038/ng.3422; Tian Q, 2007, PLANT CELL, V19, P3127, DOI 10.1105/tpc.106.048868; Tian XL, 2018, J EXP BOT, V69, P4689, DOI 10.1093/jxb/ery177; Wedzony M, 2002, CHROMOSOME ELIMINATI; Wu PH, 2014, EUPHYTICA, V196, P413, DOI 10.1007/s10681-013-1043-7; Xie GN, 2018, PLANT BIOTECHNOL J, V16, P234, DOI 10.1111/pbi.12763; Xu XW, 2013, J EXP BOT, V64, P1083, DOI 10.1093/jxb/ers393; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang ZL, 2008, PLANT CELL REP, V27, P1851, DOI 10.1007/s00299-008-0601-2; Zhao X, 2013, PLANT PHYSIOL, V163, P721, DOI 10.1104/pp.113.223982	47	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228411	10.1371/journal.pone.0228411	http://dx.doi.org/10.1371/journal.pone.0228411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023320	gold, Green Published			2022-12-26	WOS:000534621500052
J	Yang, PC; Wu, TH; Yu, M; Chen, F; Wang, CC; Yuan, J; Xu, JM; Zhang, G				Yang, Pengcheng; Wu, Taihu; Yu, Ming; Chen, Feng; Wang, Chunchen; Yuan, Jing; Xu, Jiameng; Zhang, Guang			A new method for identifying the acute respiratory distress syndrome disease based on noninvasive physiological parameters	PLOS ONE			English	Article							SPO(2)/FIO(2) RATIO; PAO(2)/FIO(2) RATIO; OXYGENATION INDEX; FEATURE-SELECTION; OUTCOMES; VALIDATION; MORTALITY; RISK	Early diagnosis and prevention play a crucial role in the treatment of patients with ARDS. The definition of ARDS requires an arterial blood gas to define the ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (PaO2/FiO(2) ratio). However, many patients with ARDS do not have a blood gas measured, which may result in under-diagnosis of the condition. Using data from MIMIC-III Database, we propose an algorithm based on patient non-invasive physiological parameters to estimate P/F levels to aid in the diagnosis of ARDS disease. The machine learning algorithm was combined with the filter feature selection method to study the correlation of various noninvasive parameters from patients to identify the ARDS disease. Cross-validation techniques are used to verify the performance of algorithms for different feature subsets. XGBoost using the optimal feature subset had the best performance of ARDS identification with the sensitivity of 84.03%, the specificity of 87.75% and the AUC of 0.9128. For the four machine learning algorithms, reducing a certain number of features, AUC can still above 0.8. Compared to Rice Linear Model, this method has the advantages of high reliability and continually monitoring the development of patients with ARDS.	[Yang, Pengcheng; Wu, Taihu; Yu, Ming; Chen, Feng; Yuan, Jing; Xu, Jiameng; Zhang, Guang] Acad Mil Med Sci, Inst Med Support, Tianjin, Peoples R China; [Wang, Chunchen] Air Force Mil Med Univ, Dept Aerosp Med, Xian, Peoples R China	Academy of Military Medical Sciences - China	Zhang, G (corresponding author), Acad Mil Med Sci, Inst Med Support, Tianjin, Peoples R China.	zhangguang01@hotmail.com			National Key Research and Development Program of China [:2017YFC0806406, 2017YFC0806402]; Tianjin Science and Technology Program [18ZXJMTG00060]; logistics scientific research foundation program at the Military Medical Innovation Project [16CXZ034]	National Key Research and Development Program of China; Tianjin Science and Technology Program; logistics scientific research foundation program at the Military Medical Innovation Project	This study was supported by the National Key Research and Development Program of China (Grant Number: 2017YFC0806402) and Tianjin Science and Technology Program (Grant Number: 18ZXJMTG00060). The work was also funded in part by logistics scientific research foundation program at the Military Medical Innovation Project (Grant Number: 16CXZ034). The National Key Research and Development Program of China (Grant Number:2017YFC0806406).	Ahmed A, 2009, NETH J MED, V67, P268; Alonso-Atienza F, 2014, IEEE T BIO-MED ENG, V61, P832, DOI 10.1109/TBME.2013.2290800; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Bos LD, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0107-2017; Bouaguel W, 2015, NEW WAY COMBINING FI, DOI [10.1007/978-81-322-2538-6_43, DOI 10.1007/978-81-322-2538-6_43]; Brown LM, 2016, CHEST, V150, P3, DOI 10.1016/j.chest.2016.03.034; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cheifetz IM, 2016, RESP CARE, V61, P980, DOI 10.4187/respcare.05017; Chen T, 2016, P 22 ACM SIGKDD INT, DOI DOI 10.1145/2939672.2939785; Dechert RE, 2014, J TRAUMA ACUTE CARE, V76, P469, DOI 10.1097/TA.0b013e3182ab0d27; DesPrez K, 2017, CHEST, V152, P1151, DOI 10.1016/j.chest.2017.08.002; Festic E, 2015, J INTENSIVE CARE MED, V30, P209, DOI 10.1177/0885066613516411; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Hammond BG, 2017, RESP CARE, V62, P1249, DOI 10.4187/respcare.05092; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; Horhat FG, 2017, BIOCHEM GENET, V55, P204, DOI 10.1007/s10528-016-9787-0; Ishikawa Tomokazu, 2012, Proceedings of the International Conference on Computer Graphics Theory and Applications (GRAPP 2012) and International Conference on Information Visualization Theory and Applications (IVAPP 2012), P319; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Jonsson P, 2004, 10TH INTERNATIONAL SYMPOSIUM ON SOFTWARE METRICS, PROCEEDINGS, P108, DOI 10.1109/METRIC.2004.1357895; Khemani RG, 2012, CRIT CARE MED, V40, P1309, DOI 10.1097/CCM.0b013e31823bc61b; Lemaitre G, 2016, IMBALANCED LEARN PYT, P18; Li JD, 2018, ACM COMPUT SURV, V50, DOI 10.1145/3136625; Liu H, 1995, PROC INT C TOOLS ART, P388, DOI 10.1109/TAI.1995.479783; Ng A.Y., 2004, P 21 INT C MACH LEAR, P78, DOI [10.1145/1015330.1015435, DOI 10.1145/1015330.1015435]; NUSS A, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0159654; Pandharipande PP, 2009, CRIT CARE MED, V37, P1317, DOI 10.1097/CCM.0b013e31819cefa9; Pisani L, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0327-9; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ray S, 2017, PEDIATR CRIT CARE ME, V18, pE131, DOI 10.1097/PCC.0000000000001075; Rezoagli E, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.62; Rice TW, 2007, CHEST, V132, P410, DOI 10.1378/chest.07-0617; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Simon RM, 2011, BRIEF BIOINFORM, V12, P203, DOI 10.1093/bib/bbr001; Zimmerman JJ, 2009, PEDIATRICS, V124, P87, DOI 10.1542/peds.2007-2462	35	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0226962	10.1371/journal.pone.0226962	http://dx.doi.org/10.1371/journal.pone.0226962			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023257	Green Published, gold			2022-12-26	WOS:000534621500013
J	Ellmann, S; Wenkel, E; Dietzel, M; Bielowski, C; Vesal, S; Maier, A; Hammon, M; Janka, R; Fasching, PA; Beckmann, MW; Wendtland, RS; Uder, M; Bauerle, T				Ellmann, Stephan; Wenkel, Evelyn; Dietzel, Matthias; Bielowski, Christian; Vesal, Sulaiman; Maier, Andreas; Hammon, Matthias; Janka, Rolf; Fasching, Peter A.; Beckmann, Matthias W.; Wendtland, Ruediger Schulz; Uder, Michael; Baeuerle, Tobias			Implementation of machine learning into clinical breast MRI: Potential for objective and accurate decision-making in suspicious breast masses	PLOS ONE			English	Article							NEURAL-NETWORKS; LESIONS; CLASSIFICATION; BENIGN; DIFFERENTIATION; MAMMOGRAPHY; EXPERIENCE; TOOL	We investigated whether the integration of machine learning (ML) into MRI interpretation can provide accurate decision rules for the management of suspicious breast masses. A total of 173 consecutive patients with suspicious breast masses upon complementary assessment (BI-RADS IV/V: n = 100/76) received standardized breast MRI prior to histological verification. MRI findings were independently assessed by two observers (R1/R2: 5 years of experience/no experience in breast MRI) using six (semi-)quantitative imaging parameters. Interobserver variability was studied by ICC (intraclass correlation coefficient). A polynomial kernel function support vector machine was trained to differentiate between benign and malignant lesions based on the six imaging parameters and patient age. Tenfold cross-validation was applied to prevent overfitting. Overall diagnostic accuracy and decision rules (rule-out criteria) to accurately exclude malignancy were evaluated. Results were integrated into a web application and published online. Malignant lesions were present in 107 patients (60.8%). Imaging features showed excellent interobserver variability (ICC: 0.81-0.98) with variable diagnostic accuracy (AUC: 0.65-0.82). Overall performance of the ML algorithm was high (AUC = 90.1%; BI-RADS IV: AUC = 91.6%). The ML algorithm provided decision rules to accurately rule-out malignancy with a false negative rate <1% in 31.3% of the BI-RADS IV cases. Thus, integration of ML into MRI interpretation can provide objective and accurate decision rules for the management of suspicious breast masses, and could help to reduce the number of potentially unnecessary biopsies.	[Ellmann, Stephan; Wenkel, Evelyn; Dietzel, Matthias; Bielowski, Christian; Hammon, Matthias; Janka, Rolf; Wendtland, Ruediger Schulz; Uder, Michael; Baeuerle, Tobias] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Radiol, Erlangen, Germany; [Vesal, Sulaiman; Maier, Andreas] Friedrich Alexander Univ Erlangen Nurnberg, Dept Comp Sci, Pattern Recognit Lab, Erlangen, Germany; [Fasching, Peter A.; Beckmann, Matthias W.] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Comprehens Canc Ctr Erlangen EMW, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Ellmann, S (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Radiol, Erlangen, Germany.	stephan.ellmann@uk-erlangen.de	Maier, Andreas/AAV-6505-2021; Fasching, Peter A/ABH-9912-2020; Ellmann, Stephan/P-3824-2016	Maier, Andreas/0000-0002-9550-5284; Fasching, Peter A/0000-0003-4885-8471; Ellmann, Stephan/0000-0003-2737-5526; Bauerle, Tobias/0000-0002-0206-6199; Vesal, Sulaiman/0000-0001-6156-9338	Emerging Fields Initiative (EFI) "Big Thera", University of Erlangen-Nunberg [3_Med_05]	Emerging Fields Initiative (EFI) "Big Thera", University of Erlangen-Nunberg	This study has received funding by the Emerging Fields Initiative (EFI) "Big Thera", University of Erlangen-Nunberg to T.B., grant number 3_Med_05. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.	Ballesio L, 2009, EUR J RADIOL, V71, P96, DOI 10.1016/j.ejrad.2008.03.025; Baltzer A, 2016, EUR RADIOL, V26, P884, DOI 10.1007/s00330-015-3886-x; Baltzer P, 2020, EUR RADIOL, V30, P1436, DOI 10.1007/s00330-019-06510-3; Baltzer PAT, 2015, EUR J RADIOL, V84, P86, DOI 10.1016/j.ejrad.2014.10.023; Baltzer PAT, 2013, EUR RADIOL, V23, P2051, DOI 10.1007/s00330-013-2804-3; Baltzer PAT, 2012, TECHNOL CANCER RES T, V11, P553, DOI 10.7785/tcrt.2012.500266; Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Baum F, 2002, EUR RADIOL, V12, P1087, DOI 10.1007/s00330-001-1213-1; Bennani-Baiti B, 2017, RADIOLOGY, V283, P691, DOI 10.1148/radiol.2016161106; Bennani-Baiti B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160346; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bruno Paul, 2011, J Can Chiropr Assoc, V55, P69; Cao LJ, 2003, NEUROCOMPUTING, V51, P321, DOI 10.1016/S0925-2312(02)00577-5; Chang W, 2016, SHINY WEB APPL FRAME; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Clauser P, 2018, EUR RADIOL, V28, P1909, DOI 10.1007/s00330-017-5121-4; Davidson M, 2002, AUST J PHYSIOTHER, V48, P227, DOI 10.1016/S0004-9514(14)60228-2; Dietzel M, 2018, INSIGHTS IMAGING, V9, P325, DOI 10.1007/s13244-018-0611-8; Dietzel M, 2012, EUR J RADIOL, V81, P1508, DOI 10.1016/j.ejrad.2011.03.024; Dietzel M, 2010, ACTA RADIOL, V51, P851, DOI 10.3109/02841851.2010.498444; Fox MJ, 2016, J MAGN RESON IMAGING, V43, P903, DOI 10.1002/jmri.25057; Gallego-Ortiz C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187501; Grimm LJ, 2015, AM J ROENTGENOL, V204, P1120, DOI 10.2214/AJR.14.13047; Hamidinekoo A, 2018, MED IMAGE ANAL, V47, P45, DOI 10.1016/j.media.2018.03.006; Huang SJ, 2018, CANCER GENOM PROTEOM, V15, P41, DOI 10.21873/cgp.20063; Janka R, 2014, ROFO-FORTSCHR RONTG, V186, P130, DOI 10.1055/s-0033-1350298; Kapetas P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22065-7; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft Deutsche Krebshilfe AWMF), 2018, S3 LEITL FRUH DIAGN; Liberman L, 2006, AM J ROENTGENOL, V186, P426, DOI 10.2214/AJR.04.1707; Liu HX, 2003, J CHEM INF COMP SCI, V43, P900, DOI 10.1021/ci0256438; Malich A, 2005, AM J ROENTGENOL, V185, P964, DOI 10.2214/AJR.04.1073; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Marino MA, 2016, EUR RADIOL, V26, P2529, DOI 10.1007/s00330-015-4075-7; Morris E.A., 2013, ACR BI RADS ATLAS BR; Partridge SC, 2017, J MAGN RESON IMAGING, V45, P337, DOI 10.1002/jmri.25479; Rstudio Team, 2015, RSTUDIO INT DEV R; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Spick C, 2015, EUR J RADIOL, V84, P61, DOI 10.1016/j.ejrad.2014.10.005; Truhn D, 2019, RADIOLOGY, V290, P290, DOI 10.1148/radiol.2018181352	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228446	10.1371/journal.pone.0228446	http://dx.doi.org/10.1371/journal.pone.0228446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999755	Green Published, gold			2022-12-26	WOS:000534612400086
J	Wang, XF; Chen, XJ; Wang, L				Wang, Xiaofeng; Chen, Xiaojie; Wang, Long			Evolution of egalitarian social norm by resource management	PLOS ONE			English	Article							ULTIMATUM GAME; FAIRNESS; CHIMPANZEES; ALTRUISM; DYNAMICS; COEVOLUTION; INEQUITY; BEHAVIOR; MOTIVES; CULTURE	Social organizations, especially human society, rely on egalitarian social norm, which can be characterized by high levels of fairness, empathy and collective conformity. Nevertheless, the evolution of egalitarian social norm remains a conundrum, as it suffers the persistent challenge from individual self-interest. To address this issue, we construct an evolutionary game theoretical model by employing the Ultimatum Game, in which rational individuals are able to perform resource management. We show that resource management drives a population evolving into an oscillatory state with high equilibrium degrees of fairness, empathy and collective conformity and thus constitutes a key mechanism for the evolution of egalitarian social norm in social dilemma situations. Specifically, it results in (1) the formation of egalitarian social norm from diverse individual norms, (2) the emergence of egalitarian social norm in a selfish and unfair world, and (3) the maintenance of egalitarian social norm despite the presence of norm violators. The constructive role of resource management is explained by a mean-field analysis revealing that resource management can effectively enlarge the attraction basin of egalitarian norms or even change the dynamical property of the mini Ultimatum Game from bistability between egalitarian norms and less egalitarian norms to complete-dominance of egalitarian norms over less egalitarian norms. Furthermore, we find that the capacity of resource management can be evolutionarily selected by a coevolution between egalitarian social norm and resource management. Our study suggests that efficiency and equity are linked to each other.	[Wang, Xiaofeng] Donghua Univ, Sch Informat Sci & Technol, Dept Automat, Shanghai, Peoples R China; [Wang, Xiaofeng] Donghua Univ, Minist Educ, Engn Res Ctr Digitized Text & Apparel Technol, Shanghai, Peoples R China; [Chen, Xiaojie] Univ Elect Sci & Technol China, Sch Math Sci, Chengdu, Peoples R China; [Wang, Long] Peking Univ, Ctr Syst & Control, Beijing, Peoples R China	Donghua University; Donghua University; University of Electronic Science & Technology of China; Peking University	Wang, XF (corresponding author), Donghua Univ, Sch Informat Sci & Technol, Dept Automat, Shanghai, Peoples R China.; Wang, XF (corresponding author), Donghua Univ, Minist Educ, Engn Res Ctr Digitized Text & Apparel Technol, Shanghai, Peoples R China.; Wang, L (corresponding author), Peking Univ, Ctr Syst & Control, Beijing, Peoples R China.	rokywang1987@gmail.com; longwang@pku.edu.cn		Wang, Xiaofeng/0000-0002-8134-0917	NSFC [61903077]; Shanghai Sailing Program [19YF1402500]; Fundamental Research Funds for the Central Universities [2232019D3-56, 2232018G-09]	NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	X. W. acknowledges gratefully financial support from NSFC (Grants No. 61903077), the Shanghai Sailing Program (Grants No. 19YF1402500) as well as the Fundamental Research Funds for the Central Universities (Grants No. 2232019D3-56 and 2232018G-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, EVOLUTIONARY GAME TH; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bethwaite J, 1996, J ECON PSYCHOL, V17, P259, DOI 10.1016/0167-4870(96)00006-2; Bicchieri C., 2006, GRAMMAR SOC; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Brosnan S.F., 2006, SOC JUSTICE RES, V19, P153, DOI [10.1007/s11211-006-0002-z, DOI 10.1007/S11211-006-0002-Z]; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Chu C, 2019, NEW J PHYS, V21, DOI 10.1088/1367-2630/ab0999; Chu C, 2019, CHAOS, V29, DOI 10.1063/1.5059360; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Debove S, 2016, EVOL HUM BEHAV, V37, P245, DOI 10.1016/j.evolhumbehav.2016.01.001; Ehrlich PR, 2005, PLOS BIOL, V3, P943, DOI 10.1371/journal.pbio.0030194; Elster J., 1989, CEMENT SOC STUDY SOC; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046707; GALE J, 1995, GAME ECON BEHAV, V8, P56, DOI 10.1016/S0899-8256(05)80017-X; Gintis H, 2003, J THEOR BIOL, V220, P407, DOI 10.1006/jtbi.2003.3104; Guth W, 2014, J ECON BEHAV ORGAN, V108, P396, DOI 10.1016/j.jebo.2014.06.006; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; GUTH W, 1990, J ECON PSYCHOL, V11, P417, DOI 10.1016/0167-4870(90)90021-Z; Hechter M., 2001, SOCIAL NORMS; Hechter M., 2003, THEORIES SOCIAL ORDE; Helbing D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012530; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J., 2005, FDN HUMAN SOCIALITY; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Huck S, 1999, GAME ECON BEHAV, V28, P13, DOI 10.1006/game.1998.0691; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Jiang LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14657; Kaiser I, 2012, BIOL LETTERS, V8, P942, DOI 10.1098/rsbl.2012.0519; Killingback T, 2001, P ROY SOC B-BIOL SCI, V268, P1797, DOI 10.1098/rspb.2001.1697; KIRCHSTEIGER G, 1994, J ECON BEHAV ORGAN, V25, P373, DOI 10.1016/0167-2681(94)90106-6; Liu C, 2019, APPL MATH COMPUT, V342, P247, DOI 10.1016/j.amc.2018.09.034; Maynard Smith J., 1982, pi; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, PHILOS T R SOC B, V365, P19, DOI 10.1098/rstb.2009.0215; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Page KM, 2002, B MATH BIOL, V64, P1101, DOI 10.1006/bulm.2002.0321; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Proctor D, 2013, P NATL ACAD SCI USA, V110, P2070, DOI 10.1073/pnas.1220806110; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Richerson P. J., 2008, NOT GENES ALONE CULT; Roca CP, 2011, P NATL ACAD SCI USA, V108, P11370, DOI 10.1073/pnas.1101044108; ROTH AE, 1991, AM ECON REV, V81, P1068; RUBINSTEIN A, 1982, ECONOMETRICA, V50, P97, DOI 10.2307/1912531; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Schmidt MFH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023223; Selten R., 1975, International Journal of Game Theory, V4, P25, DOI 10.1007/BF01766400; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Skyrms Brian., 2004, STAG HUNT EVOLUTION; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/28005; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; THALER RH, 1988, J ECON PERSPECT, V2, P195, DOI 10.1257/jep.2.4.195; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang Q, 2018, APPL MATH COMPUT, V328, P162, DOI 10.1016/j.amc.2018.01.045; Wang XF, 2014, SCI REP-UK, V4, DOI 10.1038/srep04534; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01550; Zhang YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196524	79	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227902	10.1371/journal.pone.0227902	http://dx.doi.org/10.1371/journal.pone.0227902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999744	Green Published, Green Submitted, gold			2022-12-26	WOS:000534612400036
J	Wegmuller, R; Bentil, H; Wirth, JP; Petry, N; Tanumihardjo, SA; Allen, L; Williams, TN; Selenje, L; Mahama, A; Amoaful, E; Steiner-Asiedu, M; Adu-Afarwuah, S; Rohner, F				Wegmuller, Rita; Bentil, Helena; Wirth, James P.; Petry, Nicolai; Tanumihardjo, Sherry A.; Allen, Lindsay; Williams, Thomas N.; Selenje, Lilian; Mahama, Abraham; Amoaful, Esi; Steiner-Asiedu, Matilda; Adu-Afarwuah, Seth; Rohner, Fabian			Anemia, micronutrient deficiencies, malaria, hemoglobinopathies and malnutrition in young children and non-pregnant women in Ghana: Findings from a national survey	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; SYSTEMATIC ANALYSIS; PREVALENCE; BURDEN; IRON; FORTIFICATION; DETERMINANTS; INFLAMMATION; FERRITIN; DISEASE	Nationally representative data on the micronutrient status of Ghanaian women and children are very scarce. We aimed to document the current national prevalence of micronutrient deficiencies, anemia, malaria, inflammation, alpha-thalassemia, sickle cell disease and trait, and under-and over-nutrition in Ghana. In 2017, a two-stage cross-sectional design was applied to enroll pre-school children (6-59 months) and non-pregnant women (15-49 years) from three strata in Ghana: Northern, Middle and Southern Belt. Household and individual questionnaire data were collected along with blood samples. In total, 2123 households completed the household interviews, 1165 children and 973 women provided blood samples. Nationally, 35.6% (95%CI: 31.7,39.6) of children had anemia, 21.5% (18.4,25.0) had iron deficiency, 12.2% (10.1,14.7) had iron deficiency anemia, and 20.8% (18.1,23.9) had vitamin A deficiency; 20.3%(15.2,26.6) tested positive for malaria, 13.9% (11.1,17.3) for sickle trait plus disease, and 30.7% (27.5,34.2) for alpha-thalassemia. Anemia and micronutrient deficiencies were more prevalent in rural areas, poor households and in the Northern Belt. Stunting and wasting affected 21.4% (18.0,25.2) and 7.0% (5.1,9.5) of children, respectively. Stunting was more common in rural areas and in poor households. Among non-pregnant women, 21.7% (18.7,25.1) were anemic, 13.7% (11.2,16.6) iron deficient, 8.9% (6.7,11.7) had iron deficiency anemia, and 1.5% (0.8,2.9) were vitamin A deficient, 53.8% (47.6,60.0) were folate deficient, and 6.9% (4.8,9.8) were vitamin B12 deficient. Malaria parasitemia in women [8.4% (5.7,12.2)] was lower than in children, but the prevalence of sickle cell disease or trait and a-thalassemia were similar. Overweight [24.7% (21.0,28.8)] and obesity [14.3% (11.5,17.7)] were more common in wealthier, older, and urban women. Our findings demonstrate that anemia and several micronutrient deficiencies are highly present in Ghana calling for the strengthening of Ghana's food fortification program while overweight and obesity in women are constantly increasing and need to be addressed urgently through governmental policies and programs.	[Wegmuller, Rita; Wirth, James P.; Petry, Nicolai; Rohner, Fabian] GroundWork, Flasch, Switzerland; [Bentil, Helena; Steiner-Asiedu, Matilda; Adu-Afarwuah, Seth] Univ Ghana, Dept Nutr & Food Sci, Legon, Ghana; [Tanumihardjo, Sherry A.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Allen, Lindsay] USDA ARS, Western Human Nutr Res Ctr, Davis, CA USA; [Williams, Thomas N.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Selenje, Lilian; Mahama, Abraham] UNICEF, Accra, Ghana; [Amoaful, Esi] Ghana Hlth Serv, Accra, Ghana	University of Ghana; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); Ghana Health Service	Rohner, F (corresponding author), GroundWork, Flasch, Switzerland.	fabian@groundworkhealth.org	Adu-Afarwuah, Seth/GWZ-2033-2022	Adu-Afarwuah, Seth/0000-0002-2720-5474; Bentil, Helena/0000-0001-8728-6715	UNICEF; Canada's Ministry of Foreign Affairs, Trade and Development [43210308]; Wellcome Trust [202800]; GroundWork	UNICEF; Canada's Ministry of Foreign Affairs, Trade and Development; Wellcome Trust(Wellcome TrustEuropean Commission); GroundWork	Funding for data collection, laboratory analysis, and reporting were provided by UNICEF and Canada's Ministry of Foreign Affairs, Trade and Development through a grant between UNICEF Ghana and the University of Ghana (#43210308). TNW was funded through a fellowship from the Wellcome Trust (#202800). Funding for the development of this manuscript was provided by GroundWork, and page charges were borne by UNICEF.	Abarca-Gomez L, 2017, WORLDWIDE TRENDS BOD; Allen L, 2006, GUIDELINES FOOD FORT; Atkinson SH, 2006, PLOS MED, V3, P652, DOI 10.1371/journal.pmed.0030172; Bartier PM, 1996, COMPUT GEOSCI, V22, P795, DOI 10.1016/0098-3004(96)00021-0; Beaton GH, 1993, 13 ACCSCN; Castillo-Lancellotti C, 2013, PUBLIC HEALTH NUTR, V16, P901, DOI 10.1017/S1368980012003576; Chong SS, 2000, BLOOD, V95, P360; Cogill B, 2003, ANTHROPOMETRIC INDIC; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; De-Regil Luz Maria, 2015, Cochrane Database Syst Rev, pCD007950, DOI 10.1002/14651858.CD007950.pub3; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Engle-Stone R, 2017, J NUTR, V147, P1426, DOI 10.3945/jn.116.245076; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Food And Nutrition Technical Assistance, 2003, ANTHROPOMETRIC INDIC; Ghana Statistical Service, 2013, 2010 POP HOUS CENS N; Ghana Statistical Service, 2014, GHAN DEM HLTH SURV 2, DOI [10.15171/ijhpm.2016.42, DOI 10.15171/IJHPM.2016.42]; Global Alliance for Improved Nutrition Ghana Health Service UNICEF, 2017, NAT IOD SURV REP GHA; Jones AD, 2016, J NUTR, V146, P1257, DOI 10.3945/jn.115.226654; Karakochuk CD, 2019, ANN NY ACAD SCI, V1450, P126, DOI 10.1111/nyas.14003; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Larson LM, 2017, AM J CLIN NUTR, V106, p390S, DOI 10.3945/ajcn.116.142166; Lartey A, 2000, J NUTR, V130, P199, DOI 10.1093/jn/130.2.199; Nyumuah RO, 2012, FOOD NUTR BULL, V33, pS293, DOI 10.1177/15648265120334S305; Onyango AW, 2013, MATERN CHILD NUTR, V9, P1, DOI 10.1111/mcn.12092; Petry N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110693; Quarshie K, 1998, P WORKSH DISS FIND V; Saydah S, 2014, OBESITY, V22, P1888, DOI 10.1002/oby.20761; Shetty P S, 1994, FAO Food Nutr Pap, V56, P1; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Tanumihardjo SA, 2016, J NUTR, V146, P1816, DOI 10.3945/jn.115.229708; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Waterfall CM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.23.e119; WHO, 2011, SER RET CONC DET PRE, P3; WHO, 2011, WHONMHNHDMNM111; WHO/UNICEF, 2010, IND ASS INF YOUNG 2; WHO/UNICEF Joint Monitoring Programme for Water Supply Sanitation and Hygiene (JMP), JMP METH 2017 UPD SD; Wirth JP, 2015, PLOS ONE; World Health Organization, 2011, HAEM CONC DIAGN AN A; Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129	42	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228258	10.1371/journal.pone.0228258	http://dx.doi.org/10.1371/journal.pone.0228258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999737	Green Published, gold			2022-12-26	WOS:000534612400060
J	Ullah, K; Chen, SP; Lu, JQ; Wang, XH; Liu, Q; Zhang, Y; Long, YQ; Hu, ZH; Xu, GQ				Ullah, Kifayat; Chen, Suping; Lu, Jiaqi; Wang, XiaoHui; Liu, Qing; Zhang, Yang; Long, Yaqiu; Hu, Zhanhong; Xu, Guoqiang			The E3 ubiquitin ligase STUB1 attenuates cell senescence by promoting the ubiquitination and degradation of the core circadian regulator BMAL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; senescence; ubiquitylation (ubiquitination); protein degradation; hydrogen peroxide; brain and muscle ARNT-like 1 (BMAL1; ARNTL; MOP3); cell cycle regulation; circadian clock; proteasome; STIP1 homology and U-box-containing protein 1 (STUB1)	HUMAN FIBROBLASTS; CHIP CONTROLS; PROTEIN; TRANSCRIPTION; CLOCK; P53; COMPONENT; CANCER; UBIQUITYLATION; PROTEASOME	Cell senescence is one of the most important processes determining cell fate and is involved in many pathophysiological conditions, including cancer, neurodegenerative diseases, and other aging-associated diseases. It has recently been discovered that the E3 ubiquitin ligase STIP1 homology and U-box?containing protein 1 (STUB1 or CHIP) is up-regulated during the senescence of human fibroblasts and modulates cell senescence. However, the molecular mechanism underlying STUB1-controlled senescence is not clear. Here, using affinity purification and MS-based analysis, we discovered that STUB1 binds to brain and muscle ARNT-like 1 (BMAL1, also called aryl hydrocarbon receptor nuclear translocator?like protein 1 (ARNTL)). Through biochemical experiments, we confirmed the STUB1-BMAL1 interaction, identified their interaction domains, and revealed that STUB1 overexpression down-regulates BMAL1 protein levels through STUB1's enzymatic activity and that STUB1 knockdown increases BMAL1 levels. Further experiments disclosed that STUB1 enhances BMAL1 degradation, which is abolished upon proteasome inhibition. Moreover, we found that STUB1 promotes the formation of Lys-48?linked polyubiquitin chains on BMAL1, facilitating its proteasomal degradation. Interestingly, we also discovered that oxidative stress promotes STUB1 nuclear translocation and enhances its co-localization with BMAL1. STUB1 expression attenuates hydrogen peroxide?induced cell senescence, indicated by a reduced signal in senescence-associated ?-gal staining and decreased protein levels of two cell senescence markers, p53 and p21. BMAL1 knockdown diminishes this effect, and BMAL1 overexpression abolishes STUB1's effect on cell senescence. In summary, the results of our work reveal that the E3 ubiquitin ligase STUB1 ubiquitinates and degrades its substrate BMAL1 and thereby alleviates hydrogen peroxide?induced cell senescence.	[Ullah, Kifayat; Chen, Suping; Lu, Jiaqi; Wang, XiaoHui; Liu, Qing; Zhang, Yang; Long, Yaqiu; Xu, Guoqiang] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Ullah, Kifayat; Chen, Suping; Lu, Jiaqi; Wang, XiaoHui; Liu, Qing; Zhang, Yang; Long, Yaqiu; Xu, Guoqiang] Soochow Univ, Coll Pharmaceut Sci, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Hu, Zhanhong] Soochow Univ, Affiliated Hosp 2, Dept Pharm, Suzhou 215004, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Hu, ZH (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Pharm, Suzhou 215004, Jiangsu, Peoples R China.; Xu, GQ (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Suzhou 215123, Jiangsu, Peoples R China.	sdfeyhzh@163.com; gux2002@suda.edu.cn	Xiaohui, Wang/AFS-7746-2022	Xu, Guoqiang/0000-0002-4753-4769	National Key R&D Program of China [2019YFA0800400]; National Natural Science Foundation of China [31670833, 31700722]; Suzhou Bureau of Science and Technology (Basic Research in Medical and Health Sciences) [SYS201718]; Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX17_2040]; Jiangsu Key Laboratory of Neuropsychiatric Diseases [BM2013003]; National Center for International Research Grant [2017B01012]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Bureau of Science and Technology (Basic Research in Medical and Health Sciences); Postgraduate Research and Practice Innovation Program of Jiangsu Province; Jiangsu Key Laboratory of Neuropsychiatric Diseases; National Center for International Research Grant; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by National Key R&D Program of China Grant 2019YFA0800400, National Natural Science Foundation of China Grants 31670833 and 31700722, Suzhou Bureau of Science and Technology (Basic Research in Medical and Health Sciences) Grant SYS201718, Postgraduate Research and Practice Innovation Program of Jiangsu Province Grant KYCX17_2040, Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant BM2013003, National Center for International Research Grant 2017B01012, and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Chen SP, 2018, FEBS J, V285, P2987, DOI 10.1111/febs.14595; Chen SP, 2018, J BIOL CHEM, V293, P11296, DOI 10.1074/jbc.RA117.001432; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Choppara S, 2018, J BIOL CHEM, V293, P16291, DOI 10.1074/jbc.RA118.005354; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Fang LM, 2017, ACTA PHARMACOL SIN, V38, P1305, DOI 10.1038/aps.2017.25; Gossan NC, 2014, NUCLEIC ACIDS RES, V42, P5765, DOI 10.1093/nar/gku225; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Hou XO, 2015, ACTA PHARMACOL SIN, V36, P1300, DOI 10.1038/aps.2015.54; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang WL, 2016, CANCER LETT, V371, P314, DOI 10.1016/j.canlet.2015.12.002; Khapre RV, 2011, CELL CYCLE, V10, P4162, DOI 10.4161/cc.10.23.18381; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee JS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.181; Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002; Liu BY, 2019, ONCOGENE, V38, P2501, DOI 10.1038/s41388-018-0605-5; Ma Q, 2015, ACTA PHARMACOL SIN, V36, P966, DOI 10.1038/aps.2015.48; Mavrogonatou E, 2020, SEMIN CANCER BIOL, V62, P182, DOI 10.1016/j.semcancer.2019.06.018; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Mullenders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004798; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nakahata Y, 2018, CHRONOBIOL INT, V35, P730, DOI 10.1080/07420528.2018.1430038; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Rhinn M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.151837; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Seo J, 2016, NAT CELL BIOL, V18, P291, DOI 10.1038/ncb3314; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shang Y, 2014, BIOCHEM BIOPH RES CO, V446, P387, DOI 10.1016/j.bbrc.2014.02.124; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shi GS, 2016, CELL REP, V14, P823, DOI 10.1016/j.celrep.2015.12.076; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Sisoula C, 2011, MECH AGEING DEV, V132, P269, DOI 10.1016/j.mad.2011.04.003; Sisoula C, 2011, FREE RADICAL BIO MED, V50, P157, DOI 10.1016/j.freeradbiomed.2010.10.701; VanPelt J, 2017, BBA-PROTEINS PROTEOM, V1865, P133, DOI 10.1016/j.bbapap.2016.11.005; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Xu GQ, 2013, CURR PHARM DESIGN, V19, P3315, DOI 10.2174/13816128113199990305; Zhang QQ, 2015, ACTA PHARMACOL SIN, V36, P1113, DOI 10.1038/aps.2015.36; Zhang Y, 2018, BIOCHEM J, V475, P1507, DOI 10.1042/BCJ20180005; Zhang Y, 2011, ACTA PHARMACOL SIN, V32, P1199, DOI 10.1038/aps.2011.108; Zhou YQ, 2016, J PROTEOMICS, V148, P94, DOI 10.1016/j.jprot.2016.07.015	52	16	17	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4696	4708		10.1074/jbc.RA119.011280	http://dx.doi.org/10.1074/jbc.RA119.011280			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32041778	hybrid, Green Published			2022-12-26	WOS:000524499700027
J	Li, HY; Zhang, WX; Zhao, KM; Zhao, D; Zheng, SL; Hu, Y				Li Huayi; Zhang Wenxin; Zhao Kunming; Zhao Dong; Zheng Shanliang; Hu Ying			A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; NF-?B (NF-?B); senescence; interleukin 6 (IL-6); cancer therapy; iASPP; inhibitor of senescence-associated secretion phenotype	NF-KAPPA-B; ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; SECRETORY PHENOTYPE; DNA-DAMAGE; TUMOR-SUPPRESSOR; P53; PROMOTES; PROTEIN; NRF2	Cellular senescence is terminal cell cycle arrest that represents a prominent response to numerous anticancer therapies. The oncogene inhibitor of the apoptosis-stimulating protein of p53 (iASPP) plays essential roles in regulating cellular drug response by inhibiting apoptosis. However, whether or not it regulates chemotherapy-induced senescence (TIS) in cancer cells remains unclear. Here, using two commonly used cancer cell lines, HCT 116 and MCF-7, along with the xenograft mouse model, we found that iASPP inhibits senescence and also influences the senescence-associated secretory phenotype (SASP), which confers anticancer drug resistance independently of apoptosis. Mechanistically, iASPP is transcriptionally elevated by the p65 subunit of NF-?B in senescent cells and then translocates to the nucleus, where it binds p53 and NF-?Bp65. This binding inhibits their transcriptional activities toward p21 and the key SASP factors interleukin (IL)-6/IL-8, respectively, and subsequently prevents senescence. Of note, we observed that iASPP knockdown sensitizes apoptosis-resistant cancers to doxorubicin treatment by promoting senescence both in vitro and in vivo. We conclude that iASPP integrates the NF-?Bp65- and p53-signaling pathways and thereby regulates cell fate in response to TIS, leading to chemotherapy resistance. These findings suggest that iASPP inhibition might be a strategy that could help restore senescence in cancer cells and improve outcomes of chemotherapy-based therapies.	[Li Huayi; Zhang Wenxin; Zhao Kunming; Zhao Dong; Zheng Shanliang; Hu Ying] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China; [Hu Ying] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; University Town of Shenzhen	Hu, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China.; Hu, Y (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China.	huying@hit.edu.cn	Hu, Ying/ABG-2935-2021	Hu, Ying/0000-0003-2469-5604; Li, Huayi/0000-0002-0732-3246; Zhao, Dong/0000-0001-7214-6947	National Natural Science Foundation of China [31871389, 31301131, 31741084]; Basic Science Foundation of Science and Technology Innovation Commission in Shenzhen Grant [JCYJ20170811154452255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Science Foundation of Science and Technology Innovation Commission in Shenzhen Grant	This work was supported by National Natural Science Foundation of China Grants 31871389, 31301131, and 31741084 and Basic Science Foundation of Science and Technology Innovation Commission in Shenzhen Grant JCYJ20170811154452255. The authors declare that they have no conflicts of interest with the contents of this article.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Falik-Zaccai TC, 2017, EMBO MOL MED, V9, P319, DOI 10.15252/emmm.201606523; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Ge WJ, 2017, CANCER CELL, V32, P561, DOI 10.1016/j.ccell.2017.09.008; Gunaratna RT, 2019, ONCOGENE, V38, P3535, DOI 10.1038/s41388-018-0630-4; Hainaut P, 2009, LANCET ONCOL, V10, P913, DOI 10.1016/S1470-2045(09)70198-6; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Herron BJ, 2005, HUM MOL GENET, V14, P667, DOI 10.1093/hmg/ddi063; Hu Y, 2015, ONCOTARGET, V6, P42478, DOI 10.18632/oncotarget.6478; Hussain S, 2019, J CELL BIOCHEM, V120, P14213, DOI 10.1002/jcb.28782; Jia YJ, 2014, FASEB J, V28, P2816, DOI 10.1096/fj.13-244632; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15208; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Laska MJ, 2010, BBA-GEN SUBJECTS, V1800, P1231, DOI 10.1016/j.bbagen.2010.09.002; Li GL, 2011, MOL CELL BIOCHEM, V350, P193, DOI 10.1007/s11010-010-0698-9; Li Y, 2015, CELL MOL BIOL, V61, P2; Lu B, 2010, GASTROENTEROLOGY, V139, P2183, DOI 10.1053/j.gastro.2010.06.049; Lu M, 2016, CANCER CELL, V30, P822, DOI 10.1016/j.ccell.2016.09.019; Lu M, 2014, CELL, V157, P1130, DOI 10.1016/j.cell.2014.05.006; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mohan S, 2018, BIOMED PHARMACOTHER, V108, P1866, DOI 10.1016/j.biopha.2018.10.019; Morris EV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.442; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Notari M, 2011, P NATL ACAD SCI USA, V108, P16645, DOI 10.1073/pnas.1102292108; Oronsky B, 2019, MOL PHARMACEUT, V16, P2929, DOI 10.1021/acs.molpharmaceut.9b00150; Ortiz-Montero P, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0172-3; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Rao SG, 2016, TRENDS CANCER, V2, P676, DOI 10.1016/j.trecan.2016.10.001; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; te Poele RH, 2002, CANCER RES, V62, P1876; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008; Xiong Y, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0520-6; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	55	7	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4049	4063		10.1074/jbc.RA119.011411	http://dx.doi.org/10.1074/jbc.RA119.011411			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32005663	Green Published, hybrid			2022-12-26	WOS:000527704400028
J	Venkatesh, J; Sekhar, SC; Cheriyan, VT; Muthu, M; Meister, P; Levi, E; Dzinic, S; Gauld, JW; Polin, LA; Rishi, AK				Venkatesh, Jaganathan; Sekhar, Sreeja C.; Cheriyan, Vino T.; Muthu, Magesh; Meister, Paul; Levi, Edi; Dzinic, Sijana; Gauld, James W.; Polin, Lisa A.; Rishi, Arun K.			Antagonizing binding of cell cycle and apoptosis regulatory protein 1 (CARP-1) to the NEMO/IKK? protein enhances the anticancer effect of chemotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-?B transcription factor; high-throughput screening (HTS); small molecule; breast cancer; cytokine; CARP-1; CCAR1; NEMO; IKK?; p65; RelA	NF-KAPPA-B; ESSENTIAL MODULATOR NEMO; IKK-GAMMA; ACTIVATION; COMPLEX; GROWTH; IDENTIFICATION; INHIBITION; CCAR1; REQUIREMENT	NF-?B is a pro-inflammatory transcription factor that critically regulates immune responses and other distinct cellular pathways. However, many NF-?B?mediated pathways for cell survival and apoptosis signaling in cancer remain to be elucidated. Cell cycle and apoptosis regulatory protein 1 (CARP-1 or CCAR1) is a perinuclear phosphoprotein that regulates signaling induced by anticancer chemotherapy and growth factors. Although previous studies have reported that CARP-1 is a part of the NF-?B proteome, regulation of NF-?B signaling by CARP-1 and the molecular mechanism(s) involved are unclear. Here, we report that CARP-1 directly binds the NF-?B?activating kinase I?B kinase subunit ? (NEMO or NF-?B essential modulator) and regulates the chemotherapy-activated canonical NF-?B pathway. Importantly, blockade of NEMO?CARP-1 binding diminished NF-?B activation, indicated by reduced phosphorylation of its subunit p65/RelA by the chemotherapeutic agent adriamycin (ADR), but not NF-?B activation induced by tumor necrosis factor ? (TNF?), interleukin (IL)-1?, or epidermal growth factor. High-throughput screening of a chemical library yielded a small molecule inhibitor of NEMO?CARP-1 binding, termed selective NF-?B inhibitor 1 (SNI)-1). We noted that SNI-1 enhances chemotherapy-dependent growth inhibition of a variety of cancer cells, including human triple-negative breast cancer (TNBC) and patient-derived TNBC cells in vitro, and attenuates chemotherapy-induced secretion of the pro-inflammatory cytokines TNF?, IL-1?, and IL-8. SNI-1 also enhanced ADR or cisplatin inhibition of murine TNBC tumors in vivo and reduced systemic levels of pro-inflammatory cytokines. We conclude that inhibition of NEMO?CARP-1 binding enhances responses of cancer cells to chemotherapy.	[Venkatesh, Jaganathan; Sekhar, Sreeja C.; Cheriyan, Vino T.; Muthu, Magesh; Levi, Edi; Rishi, Arun K.] Wayne State Univ, John D Dingell Vet Affairs Med Ctr, Detroit, MI 48201 USA; [Venkatesh, Jaganathan; Sekhar, Sreeja C.; Cheriyan, Vino T.; Muthu, Magesh; Dzinic, Sijana; Polin, Lisa A.; Rishi, Arun K.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Venkatesh, Jaganathan; Sekhar, Sreeja C.; Cheriyan, Vino T.; Muthu, Magesh; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI 48201 USA; [Levi, Edi] Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA; [Meister, Paul; Gauld, James W.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada; [Sekhar, Sreeja C.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Cheriyan, Vino T.] LA State Univ Hlth Sci Ctr, Dept Biochem, Shreveport, LA 71103 USA; [Muthu, Magesh] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; University of Windsor; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Umea University	Rishi, AK (corresponding author), VAMC, Rm B4334,4646 John R, Detroit, MI 48201 USA.	Rishia@Karmanos.org	muthu, magesh/N-6987-2017	muthu, magesh/0000-0003-3311-8120; sekhar, sreeja/0000-0002-9827-5349	Department of Veterans Affairs; Wayne State University Molecular Therapeutics Seed Money Grant	Department of Veterans Affairs(US Department of Veterans Affairs); Wayne State University Molecular Therapeutics Seed Money Grant	This work was supported by a Department of Veterans Affairs merit review grant (to A. K. R.) and Wayne State University Molecular Therapeutics Seed Money Grant (to A. K. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agou F, 2004, J BIOL CHEM, V279, P54248, DOI 10.1074/jbc.M406423200; Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Case DA, 2014, AMBER 14; Cheriyan VT, 2017, ONCOTARGET, V8, P104928, DOI 10.18632/oncotarget.20650; Cheriyan VT, 2016, ONCOTARGET, V7, P73370, DOI 10.18632/oncotarget.12333; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Fang R, 2017, J IMMUNOL, V199, P3222, DOI 10.4049/jimmunol.1700699; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; Francois S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043335; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Hervy Martial, 2010, Genes Cancer, V1, P506; Heyninck K, 2014, BIOCHEM PHARMACOL, V91, P501, DOI 10.1016/j.bcp.2014.08.004; Hooper C, 2014, J BIOL CHEM, V289, P33161, DOI 10.1074/jbc.M114.582478; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hwang B, 2015, J BIOL CHEM, V290, P17967, DOI 10.1074/jbc.M115.645960; Jackson SS, 2015, EXP CELL RES, V331, P58, DOI 10.1016/j.yexcr.2014.09.034; Jiang Yan, 2010, J Mol Signal, V5, P7, DOI 10.1186/1750-2187-5-7; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Lu CK, 2012, BIOCHEM BIOPH RES CO, V418, P307, DOI 10.1016/j.bbrc.2012.01.016; Martin AG, 2009, AGING-US, V1, P335, DOI 10.18632/aging.100026; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Muthu M, 2015, J BIOMED NANOTECHNOL, V11, P1608, DOI 10.1166/jbn.2015.2099; Muthu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102567; Ou CY, 2014, J BIOL CHEM, V289, P17078, DOI 10.1074/jbc.M114.548081; Ou CY, 2009, J BIOL CHEM, V284, P20629, DOI 10.1074/jbc.M109.014332; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Picco Vincent, 2013, Genes Cancer, V4, P360, DOI 10.1177/1947601913486347; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Rocha CRR, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e478s; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Sekhar SC, 2019, CANCERS, V11, DOI 10.3390/cancers11020221; Shou Y, 2002, J NEUROCHEM, V81, P842, DOI 10.1046/j.1471-4159.2002.00880.x; van Raam BJ, 2013, CELL DEATH DIFFER, V20, P86, DOI 10.1038/cdd.2012.98; Vincendeau M, 2016, SCI REP-UK, V6, DOI 10.1038/srep18934; Vyas D, 2014, ONCOTARGETS THER, V7, P1015, DOI 10.2147/OTT.S60114; Wang Wei, 2017, J Cancer Metastasis Treat, V3, P45, DOI 10.20517/2394-4722.2017.03; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wen SH, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0625-9; Wu GY, 2018, CANCER RES, V78, P6399, DOI 10.1158/0008-5472.CAN-18-2063; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012	59	4	4	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3532	3552		10.1074/jbc.RA119.009898	http://dx.doi.org/10.1074/jbc.RA119.009898			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32024692	Green Published, hybrid			2022-12-26	WOS:000527725300014
J	Wu, XY; Schnitzler, GR; Gao, GF; Diamond, B; Baker, AR; Kaplan, B; Williamson, K; Westlake, L; Lorrey, S; Lewis, TA; Garvie, CW; Lange, M; Hayat, S; Seidel, H; Doench, J; Cherniack, AD; Kopitz, C; Meyerson, M; Greulich, H				Wu, Xiaoyun; Schnitzler, Gavin R.; Gao, Galen F.; Diamond, Brett; Baker, Andrew R.; Kaplan, Bethany; Williamson, Kaylyn; Westlake, Lindsay; Lorrey, Selena; Lewis, Timothy A.; Garvie, Colin W.; Lange, Martin; Hayat, Sikander; Seidel, Henrik; Doench, John; Cherniack, Andrew D.; Kopitz, Charlotte; Meyerson, Matthew; Greulich, Heidi			Mechanistic insights into cancer cell killing through interaction of phosphodiesterase 3A and schlafen family member 12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; cancer biology; cell death; phosphodiesterases; biomarker; AIP; DNMDP; PDE3A; PDE3B; SLFN12; protein-protein interaction; chaperone	WEB TOOL; PDE3A; PHOSPHORYLATION; EXPRESSION; CHOPCHOP; ISOFORMS; REGION; AIP	Cytotoxic molecules can kill cancer cells by disrupting critical cellular processes or by inducing novel activities. 6-(4-(Diethylamino)-3-nitrophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one (DNMDP) is a small molecule that kills cancer cells by generation of novel activity. DNMDP induces complex formation between phosphodiesterase 3A (PDE3A) and schlafen family member 12 (SLFN12) and specifically kills cancer cells expressing elevated levels of these two proteins. Here, we examined the characteristics and covariates of the cancer cell response to DNMDP. On average, the sensitivity of human cancer cell lines to DNMDP is correlated with PDE3A expression levels. However, DNMDP could also bind the related protein, PDE3B, and PDE3B supported DNMDP sensitivity in the absence of PDE3A expression. Although inhibition of PDE3A catalytic activity did not account for DNMDP sensitivity, we found that expression of the catalytic domain of PDE3A in cancer cells lacking PDE3A is sufficient to confer sensitivity to DNMDP, and substitutions in the PDE3A active site abolish compound binding. Moreover, a genome-wide CRISPR screen identified the aryl hydrocarbon receptor?interacting protein (AIP), a co-chaperone protein, as required for response to DNMDP. We determined that AIP is also required for PDE3A-SLFN12 complex formation. Our results provide mechanistic insights into how DNMDP induces PDE3A-SLFN12 complex formation, thereby killing cancer cells with high levels of PDE3A and SLFN12 expression.	[Wu, Xiaoyun; Schnitzler, Gavin R.; Gao, Galen F.; Diamond, Brett; Baker, Andrew R.; Kaplan, Bethany; Williamson, Kaylyn; Westlake, Lindsay; Lorrey, Selena; Cherniack, Andrew D.; Meyerson, Matthew; Greulich, Heidi] Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Lewis, Timothy A.; Garvie, Colin W.] Broad Inst, Ctr Dev Therapeut, Cambridge, MA 02142 USA; [Doench, John] Broad Inst, Genet Perturbat Platform, Cambridge, MA 02142 USA; [Lange, Martin; Hayat, Sikander; Seidel, Henrik; Kopitz, Charlotte] Bayer AG, Res & Dev, Pharmaceut, D-13342 Berlin, Germany; [Cherniack, Andrew D.; Meyerson, Matthew; Greulich, Heidi] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Bayer AG; Harvard University; Dana-Farber Cancer Institute	Greulich, H (corresponding author), Broad Inst, 415 Main St, Cambridge, MA 02142 USA.	heidig@broadinstitute.org	Doench, John/ABE-6251-2020; Doench, John G/HCI-9570-2022; Cherniack, Andrew D./AAY-8132-2020	Doench, John/0000-0002-3707-9889; Doench, John G/0000-0002-3707-9889; Cherniack, Andrew D./0000-0003-0470-0111; Lorrey, Selena/0000-0001-5567-2830; Seidel, Henrik/0000-0001-7804-5143; Williamson, Kaylyn/0000-0002-3252-5050; Gao, Galen/0000-0003-3143-9270; Meyerson, Matthew/0000-0002-9133-8108; Hayat, Sikander/0000-0001-5919-8371	Bayer AG	Bayer AG(Bayer AG)	We thank Alex Burgin and Jon Goldstein for critical reading of the manuscript. This work was supported by funding from Bayer AG.	Ahmad F, 2015, J BIOL CHEM, V290, P6763, DOI 10.1074/jbc.M115.638585; An R, 2019, AM J CANCER RES, V9, P1905; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basson MD, 2018, CELL PHYSIOL BIOCHEM, V48, P1274, DOI 10.1159/000492019; Berrisch S, 2017, N-S ARCH PHARMACOL, V390, P269, DOI 10.1007/s00210-016-1328-1; Cartledge DM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00042; de Waal L, 2016, NAT CHEM BIOL, V12, P102, DOI [10.1038/NCHEMBIO.1984, 10.1038/nchembio.1984]; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Fryknas M, 2006, J BIOMOL SCREEN, V11, P457, DOI 10.1177/1087057106288048; Hambleton R, 2005, J BIOL CHEM, V280, P39168, DOI 10.1074/jbc.M506760200; Hernandez-Ramirez LC, 2016, J CLIN ENDOCR METAB, V101, P3144, DOI 10.1210/jc.2016-1307; Hung SH, 2006, J BIOL CHEM, V281, P29236, DOI 10.1074/jbc.M606558200; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Kenan Y, 2000, J BIOL CHEM, V275, P12331, DOI 10.1074/jbc.275.16.12331; Kovalenko PL, 2014, J SURG RES, V190, P177, DOI 10.1016/j.jss.2014.03.069; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Li DR, 2019, MOL CELL, V75, P1103, DOI 10.1016/j.molcel.2019.06.040; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nazir M, 2017, EXP CELL RES, V361, P308, DOI 10.1016/j.yexcr.2017.10.032; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Puck A, 2017, EUR J IMMUNOL, V47, P193, DOI 10.1002/eji.201646405; Pulkka OP, 2019, CLIN CANCER RES, V25, P1676, DOI 10.1158/1078-0432.CCR-18-0815; Rhead B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206511; Sanson KR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07901-8; Scapin G, 2004, BIOCHEMISTRY-US, V43, P6091, DOI 10.1021/bi049868i; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sun LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090627; Suzuki Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni103; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; Vandenberghe P, 2017, ONCOTARGET, V8, P41026, DOI 10.18632/oncotarget.17010; Vandeput F, 2013, P NATL ACAD SCI USA, V110, P19778, DOI 10.1073/pnas.1305427110; Wechsler J, 2002, J BIOL CHEM, V277, P38072, DOI 10.1074/jbc.M203647200; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522	36	8	9	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3431	3446		10.1074/jbc.RA119.011191	http://dx.doi.org/10.1074/jbc.RA119.011191			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32005668	hybrid, Green Published			2022-12-26	WOS:000527725300006
J	Yang, H; Xiang, SY; Kazi, A; Sebti, SM				Yang, Hua; Xiang, Shengyan; Kazi, Aslamuzzaman; Sebti, Said M.			The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; GTPase Kras (KRAS); reactive oxygen species (ROS); redox signaling; RalB; TBK1	NF-KAPPA-B; NRF2; MECHANISMS; KINASE; PHOSPHORYLATION; CYTOTOXICITY; ASSOCIATION; EXPRESSION; BINDING; REDOX	In human cancer cells that harbor mutant KRAS and WT p53 (p53), KRAS contributes to the maintenance of low p53 levels. Moreover, KRAS depletion stabilizes and reactivates p53 and thereby inhibits malignant transformation. However, the mechanism by which KRAS regulates p53 is largely unknown. Recently, we showed that KRAS depletion leads to p53 Ser-15 phosphorylation (P-p53) and increases the levels of p53 and its target p21/WT p53-activated fragment 1 (WAF1)/CIP1. Here, using several human lung cancer cell lines, siRNA-mediated gene silencing, immunoblotting, quantitative RT-PCR, promoter?reporter assays, and reactive oxygen species (ROS) assays, we demonstrate that KRAS maintains low p53 levels by activating the NRF2 (NFE2-related factor 2)?regulated antioxidant defense system. We found that KRAS depletion led to down-regulation of NRF2 and its targets NQO1 (NAD(P)H quinone dehydrogenase 1) and SLC7A11 (solute carrier family 7 member 11), decreased the GSH/GSSG ratio, and increased ROS levels. We noted that the increase in ROS is required for increased P-p53, p53, and p21(Waf1/cip1) levels following KRAS depletion. Downstream of KRAS, depletion of RalB (RAS-like proto-oncogene B) and I?B kinase?related TANK-binding kinase 1 (TBK1) activated p53 in a ROS- and NRF2-dependent manner. Consistent with this, the I?B kinase inhibitor BAY11-7085 and dominant-negative mutant I?B?M inhibited NF-?B activity and increased P-p53, p53, and p21(Waf1/cip1) levels in a ROS-dependent manner. In conclusion, our findings uncover an important role for the NRF2-regulated antioxidant system in KRAS-mediated p53 suppression.	H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Sebti, SM (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA.; Sebti, SM (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA.	Said.Sebti@vcuhealth.org			Molecular Genomics Facility at Moffitt Cancer Center, an National Cancer Institute Comprehensive Cancer Center [P30-CA076292]	Molecular Genomics Facility at Moffitt Cancer Center, an National Cancer Institute Comprehensive Cancer Center	This work was supported in part by the Molecular Genomics Facility at Moffitt Cancer Center, an National Cancer Institute Comprehensive Cancer Center (P30-CA076292). We thank Gina DeNicola (Moffitt Cancer Center) for critical reading of this manuscript and Rasa Hamilton for editorial assistance.	Adler E.M., 2011, SCI SIGNAL, V4, pec24; Atia A., 2014, J APPL PHARM SCI, V4, P118, DOI [DOI 10.7324/JAPS.2014.41220, 10.7324/JAPS.2014.41220]; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Berger N, 2007, EXP HEMATOL, V35, P1495, DOI 10.1016/j.exphem.2007.07.006; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen CG, 1996, MOL IMMUNOL, V33, P57, DOI 10.1016/0161-5890(95)00128-X; Chien YC, 2008, METHOD ENZYMOL, V438, P321, DOI 10.1016/S0076-6879(07)38022-1; Cruz VH, 2018, J CELL COMMUN SIGNAL, V12, P83, DOI 10.1007/s12079-017-0438-y; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Durand JK, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090139; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Joerger AC, 2016, ANNU REV BIOCHEM, V85, P375, DOI 10.1146/annurev-biochem-060815-014710; Jung BJ, 2018, BIOMOL THER, V26, P57, DOI 10.4062/biomolther.2017.195; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kitamura H, 2018, CANCER SCI, V109, P900, DOI 10.1111/cas.13537; Kong B, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00246; Koppula P, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0288-x; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Tecleab A, 2014, J BIOL CHEM, V289, P31296, DOI 10.1074/jbc.M114.565796	35	14	14	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3055	3063		10.1074/jbc.RA119.011930	http://dx.doi.org/10.1074/jbc.RA119.011930			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32001619	hybrid, Green Published			2022-12-26	WOS:000519597300015
J	Chang, XB; Shi, XB; Zhang, XZ; Chen, J; Fan, XM; Yang, YH; Wang, L; Wang, AP; Deng, RG; Zhou, EM; Zhang, GP				Chang, Xiaobo; Shi, Xibao; Zhang, Xiaozhuan; Chen, Jing; Fan, Xiaomin; Yang, Yuanhao; Wang, Li; Wang, Aiping; Deng, Ruiguang; Zhou, Enmin; Zhang, Gaiping			miR-382-5p promotes porcine reproductive and respiratory syndrome virus (PRRSV) replication by negatively regulating the induction of type I interferon	FASEB JOURNAL			English	Article						antiviral protein; HSP60; MAVS	ANTIVIRAL INNATE IMMUNITY; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; MICRORNA; MAVS; PATHOGENESIS; MACROPHAGES; RECOGNITION; SUPPRESSOR; COMPLEX	Previous studies have indicated that inhibition of type I interferon production may be an important reason for porcine reproductive and respiratory syndrome virus (PRRSV) to achieve immune escape, revealing the mechanism of inhibiting the production of type I interferon will help design novel strategies for controlling PRRS. Here, we found that PRRSV infection upregulated the expression of miR-382-5p, which in turn inhibited polyI:C-induced the production of type I interferon by targeting heat shock protein 60 (HSP60), thus facilitating PRRSV replication in MARC-145 cells. Furthermore, we found that HSP60 could interact with mitochondrial antiviral signaling protein (MAVS), an important signal transduction protein for inducing production of type I interferon, and promote polyI:C-mediated the production of type I interferon in a MAVS-dependent manner. Finally, we also found that HSP60 could inhibit PRRSV replication in a MAVS-dependent manner, which indicated that HSP60 was a novel antiviral protein against PRRSV replication. In conclusion, the study demonstrated that miR-382-5p was upregulated during PRRSV infection and may promote PRRSV replication by negatively regulating the production of type I interferon, which also indicated that miR-382-5p and HSP60 might be the potential therapeutic targets for anti-PRRSV.	[Chang, Xiaobo; Shi, Xibao; Wang, Li; Deng, Ruiguang; Zhang, Gaiping] Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, 116 Huayuan Rd, Zhengzhou 450002, Henan, Peoples R China; [Chang, Xiaobo; Zhou, Enmin; Zhang, Gaiping] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Shi, Xibao; Zhang, Xiaozhuan; Fan, Xiaomin; Yang, Yuanhao] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China; [Chen, Jing; Zhang, Gaiping] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Wang, Aiping; Zhang, Gaiping] Zhengzhou Univ, Dept Bioengn, Zhengzhou, Peoples R China	Henan Academy of Agricultural Sciences; Northwest A&F University - China; Henan Normal University; Henan Agricultural University; Zhengzhou University	Zhang, GP (corresponding author), Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, 116 Huayuan Rd, Zhengzhou 450002, Henan, Peoples R China.	zhanggaiping2003@163.com			National Natural Science Fund [31490600]; Henan Natural Science Foundation [182300410077]; Henan Normal University Outstanding Youth Science Fund [20170031]; Henan Province Animal Immunology Key Laboratory Open Project [PKLAI20170605]; Key Scientific Research Projects of Henan Provincial Institution of Higher Education [17A180006]; National Foundation of China [31472177]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Henan Natural Science Foundation; Henan Normal University Outstanding Youth Science Fund; Henan Province Animal Immunology Key Laboratory Open Project; Key Scientific Research Projects of Henan Provincial Institution of Higher Education; National Foundation of China	National Natural Science Fund, Grant/Award Number: 31490600; Henan Natural Science Foundation, Grant/Award Number: 182300410077; Henan Normal University Outstanding Youth Science Fund, Grant/Award Number: 20170031; Henan Province Animal Immunology Key Laboratory Open Project, Grant/Award Number: PKLAI20170605; Key Scientific Research Projects of Henan Provincial Institution of Higher Education, Grant/Award Number: 17A180006; National Foundation of China, Grant/Award Number: 31472177	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; [Anonymous], CELL MOL IMMUNOL, DOI DOI 10.1099/vir.0.030213-0; [Anonymous], FRONT VET SCI; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beura LK, 2010, J VIROL, V84, P1574, DOI 10.1128/JVI.01326-09; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Catalfamo M, 2018, CELL MOL IMMUNOL, V15, P402, DOI 10.1038/cmi.2017.80; Chang XB, 2018, VET RES, V49, DOI 10.1186/s13567-018-0571-5; Chen J, 2017, J VIROL, V91, DOI 10.1128/JVI.01311-16; Chen LQ, 2016, J BIOL CHEM, V291, P14706, DOI 10.1074/jbc.M115.700252; Chen NH, 2019, INFECT GENET EVOL, V68, P127, DOI 10.1016/j.meegid.2018.12.011; Chen YN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003248; Chun JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009422; Dey R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28279; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Gammazza AM, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120224; Gomez-Laguna J, 2013, VET J, V195, P148, DOI 10.1016/j.tvjl.2012.11.012; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Hanada K, 2005, MOL BIOL EVOL, V22, P1024, DOI 10.1093/molbev/msi089; He X, 2018, EXP CELL RES, V369, P197, DOI 10.1016/j.yexcr.2018.05.019; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jang SI, 2019, EBIOMEDICINE, V48, P526, DOI 10.1016/j.ebiom.2019.09.010; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Leelarasamee N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006947; Li AM, 2013, INT J BIOCHEM CELL B, V45, P858, DOI 10.1016/j.biocel.2013.01.008; Lin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114874; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu BY, 2018, CURR OPIN IMMUNOL, V50, P75, DOI 10.1016/j.coi.2017.12.002; Liu BY, 2017, NAT IMMUNOL, V18, P214, DOI 10.1038/ni.3641; Liuyu TZ, 2019, CELL RES, V29, P67, DOI 10.1038/s41422-018-0107-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunney JK, 2016, ANNU REV ANIM BIOSCI, V4, P129, DOI 10.1146/annurev-animal-022114-111025; Luo R, 2008, MOL IMMUNOL, V45, P2839, DOI 10.1016/j.molimm.2008.01.028; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Milani A, 2019, IMMUNOTHERAPY-UK, V11, P215, DOI 10.2217/imt-2018-0105; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Overend C, 2007, J GEN VIROL, V88, P925, DOI 10.1099/vir.0.82585-0; Padwad YS, 2009, IMMUNOBIOLOGY, V214, P422, DOI 10.1016/j.imbio.2008.11.010; Parissi V, 2001, J VIROL, V75, P11344, DOI 10.1128/JVI.75.23.11344-11353.2001; Park SG, 2001, J VIROL, V75, P6962, DOI 10.1128/JVI.75.15.6962-6968.2001; Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saliminejad K, 2019, J CELL PHYSIOL, V234, P5451, DOI 10.1002/jcp.27486; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi X, 2016, ACTA VIROL, V60, P290, DOI 10.4149/av_2016_03_290; Shi XB, 2010, VIRUS RES, V153, P151, DOI 10.1016/j.virusres.2010.07.028; Smith S, 2017, J AUTOIMMUN, V79, P105, DOI 10.1016/j.jaut.2017.03.003; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tanaka Y, 2004, BIOCHEM BIOPH RES CO, V318, P461, DOI 10.1016/j.bbrc.2004.04.046; VanReeth K, 1996, VET MICROBIOL, V48, P325, DOI 10.1016/0378-1135(95)00145-X; Vilasi S, 2018, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00099; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wu JM, 2017, TRENDS PHARMACOL SCI, V38, P226, DOI 10.1016/j.tips.2016.11.009; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang F, 2017, J HEALTHC ENG, V2017, DOI 10.1155/2017/4620732; Younis S, 2018, P NATL ACAD SCI USA, V115, pE3808, DOI 10.1073/pnas.1722333115; Zhang FM, 2019, BIOMED PHARMACOTHER, V111, P740, DOI 10.1016/j.biopha.2018.12.103; Zhang SM, 2005, ARCH VIROL, V150, P1579, DOI 10.1007/s00705-005-0521-1; Zheng HQ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113381; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19	71	11	11	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4497	4511		10.1096/fj.201902031RRR	http://dx.doi.org/10.1096/fj.201902031RRR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32037657				2022-12-26	WOS:000512569700001
J	Mathison, A; De Assuncao, TM; Dsouza, NR; Williams, M; Zimmermann, MT; Urrutia, R; Lomberk, G				Mathison, Angela; De Assuncao, Thiago Milech; Dsouza, Nikita R.; Williams, Monique; Zimmermann, Michael T.; Urrutia, Raul; Lomberk, Gwen			Discovery, expression, cellular localization, and molecular properties of a novel, alternative spliced HP1 gamma isoform, lacking the chromoshadow domain	PLOS ONE			English	Article							HETEROCHROMATIN PROTEIN 1-GAMMA; DNA-DAMAGE RESPONSE; CHROMOSOMAL-PROTEIN; HISTONE H3; LYSINE 9; HP1; CELLS; OVEREXPRESSION; RECOGNITION; METHYLATION	By reading the H3K9Me3 mark through their N-terminal chromodomain (CD), HP1 proteins play a significant role in cancer-associated processes, including cell proliferation, differentiation, chromosomal stability, and DNA repair. Here, we used a combination of bioinformatics-based methodologies, as well as experimentally-derived datasets, that reveal the existence of a novel short HP1 gamma (CBX3) isoform, named here sHP1 gamma, generated by alternative splicing of the CBX3 locus. The sHP1 gamma mRNA encodes a protein composed of 101 residues and lacks the C-terminal chromoshadow domain (CSD) that is required for dimerization and heterodimerization in the previously described 183 a. a HP1. protein. Fold recognition, order-to-disorder calculations, threading, homology-based molecular modeling, docking, and molecular dynamic simulations show that the sHP1 gamma is comprised of a CD flanked by intrinsically disordered regions (IDRs) with an IDR-CD-IDR domain organization and likely retains the ability to bind to the H3K9Me3. Both qPCR analyses and mRNA-seq data derived from large-scale studies confirmed that sHP1 gamma mRNA is expressed in the majority of human tissues at approximately constant ratios with the chromoshadow domain containing isoform. However, sHP1 gamma mRNA levels appear to be dysregulated in different cancer types. Thus, our data supports the notion that, due to the existence of functionally different isoforms, the regulation of HP1.-mediated functions is more complex than previously anticipated.	[Mathison, Angela; De Assuncao, Thiago Milech; Urrutia, Raul; Lomberk, Gwen] Med Coll Wisconsin, Genom & Precis Med Ctr GSPMC, Milwaukee, WI 53226 USA; [Mathison, Angela; De Assuncao, Thiago Milech; Urrutia, Raul; Lomberk, Gwen] Med Coll Wisconsin, Dept Surg, Div Res, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Dsouza, Nikita R.; Zimmermann, Michael T.] Med Coll Wisconsin, Genom & Precis Med Ctr GSPMC, Bioinformat Res & Dev Lab, Milwaukee, WI 53226 USA; [Dsouza, Nikita R.; Zimmermann, Michael T.] Med Coll Wisconsin, Genom & Precis Med Ctr GSPMC, Precis Med Simulat Unit, Milwaukee, WI 53226 USA; [Williams, Monique] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Zimmermann, Michael T.] Med Coll Wisconsin, Clin & Translat Sci Inst, Milwaukee, WI 53226 USA; [Urrutia, Raul] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Lomberk, Gwen] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Duke University; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Lomberk, G (corresponding author), Med Coll Wisconsin, Genom & Precis Med Ctr GSPMC, Milwaukee, WI 53226 USA.; Lomberk, G (corresponding author), Med Coll Wisconsin, Dept Surg, Div Res, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.; Lomberk, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	glomberk@mcw.edu	Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X; Mathison, Angela/0000-0002-6763-2710	National Institutes of Health [R01 CA178627, R01 DK52913]; Advancing a Healthier Wisconsin Endowment; Linda T. and John A. Mellowes Endowed Innovation and Discovery Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advancing a Healthier Wisconsin Endowment; Linda T. and John A. Mellowes Endowed Innovation and Discovery Fund	This work was supported by National Institutes of Health Grants R01 CA178627 (to G.L.) and R01 DK52913 (to R.U.), the Advancing a Healthier Wisconsin Endowment (to each G.L. and R.U.) and The Linda T. and John A. Mellowes Endowed Innovation and Discovery Fund (to R.U.).	Abe K, 2011, BIOL REPROD, V85, P1013, DOI 10.1095/biolreprod.111.091512; Akaike Y, 2015, ONCOGENE, V34, P3463, DOI 10.1038/onc.2014.278; Alam H, 2018, CANCER RES, V78, P3834, DOI 10.1158/0008-5472.CAN-17-3571; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bartkova J, 2011, INT J ANDROL, V34, pE103, DOI 10.1111/j.1365-2605.2010.01096.x; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Bot C, 2017, J CELL SCI, V130, P1134, DOI 10.1242/jcs.197236; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Caillier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015507; Canudas S, 2011, GENE DEV, V25, P1807, DOI 10.1101/gad.17325211; Chang C, 2018, ONCOGENE, V37, P415, DOI 10.1038/onc.2017.332; Charo NL, 2018, BBA-MOL CELL RES, V1865, P432, DOI 10.1016/j.bbamcr.2017.11.015; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gouw M, 2018, NUCLEIC ACIDS RES, V46, pD428, DOI 10.1093/nar/gkx1077; Grzenda A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-21; Huang CY, 2017, GENE DEV, V31, P241, DOI 10.1101/gad.292169.116; Imanishi S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01166; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kim H, 2016, CANCER RES TREAT, V48, P322, DOI 10.4143/crt.2014.294; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Kuwano Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101638; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Leonard PH, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0073-x; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Liu M, 2015, CANCER RES, V75, P4593, DOI 10.1158/0008-5472.CAN-14-3735; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Lomberk G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04383-6; Lomberk GA, 2016, EPIGENOMICS-UK, V8, P831, DOI 10.2217/epi-2015-0016; Lomberk GA, 2015, SURG CLIN N AM, V95, P935, DOI 10.1016/j.suc.2015.05.011; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Morikawa K, 2013, BIOCHEM BIOPH RES CO, V431, P225, DOI 10.1016/j.bbrc.2012.12.128; Nielsen PR, 2004, METHOD ENZYMOL, V376, P148; Oka Y, 2011, BIOCHEM BIOPH RES CO, V411, P762, DOI 10.1016/j.bbrc.2011.07.021; Park JW, 2018, BIOCHEM BIOPH RES CO, V505, P67, DOI 10.1016/j.bbrc.2018.09.099; Ruan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035376; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Silverman BD, 2001, P NATL ACAD SCI USA, V98, P4996, DOI 10.1073/pnas.081086198; Sun M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42888; Takanashi M, 2009, AM J PATHOL, V174, P309, DOI 10.2353/ajpath.2009.080148; Tress ML, 2017, TRENDS BIOCHEM SCI, V42, P98, DOI 10.1016/j.tibs.2016.08.008; VELEZ G, 2013, MED EPIGENET, V1, P100, DOI DOI 10.1159/000355978; Velez G, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-015-2874-z; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wu SJ, 2000, J BIOL CHEM, V275, P7351, DOI 10.1074/jbc.275.10.7351; Wu WW, 2016, CANCER SCI, V107, P1406, DOI 10.1111/cas.13008; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001; Zhang HY, 2018, EXP THER MED, V15, P4271, DOI 10.3892/etm.2018.5969; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhong XP, 2019, AGING-US, V11, P5483, DOI 10.18632/aging.102132; Zhou J, 2014, TUMOR BIOL, V35, P9777, DOI 10.1007/s13277-014-2182-8	61	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0217452	10.1371/journal.pone.0217452	http://dx.doi.org/10.1371/journal.pone.0217452			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027651	Green Submitted, Green Published, gold			2022-12-26	WOS:000534623800002
J	Betjes, MGH; Litjens, NHR				Betjes, Michiel G. H.; Litjens, Nicolle H. R.			High numbers of differentiated CD28null CD8(+) T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation	PLOS ONE			English	Article							MEMORY; PROLIFERATION; AGE	Background The hypothesis was tested that parameters of an aged T-cell compartment associate with the risk for late rejection after kidney transplantation. Methods Recipients of a kidney transplant in the period 2007-2013 were (N = 365) were included. T cells were characterized prior to transplantation by flow cytometry as naive (CD45RO(-)CCR7(+)), central-memory (CD45RO(+)CCR7(+)), effector-memory (CD45RO(-)CCR7(-)) or terminally differentiated CD8(+) Temra (CD45RO(-)/CCR7(-)/CD28(-)) cells. T cell telomere length and thymic output were assessed prior to transplantation in 202 recipients. Follow-up was until December 2018. The date of the first time of biopsy-proven late rejection (> 6 months after transplantation) was used to calculate the rejection-free survival time. Results Fifty cases of biopsy-proven rejection were recorded. Thymic output and T cell telomere length did not associate with late rejection-free survival. However, the percentage and absolute numbers of CD8(+)Temra and CD28null CD8(+) T cells were significantly lower in patients with late rejection. Specifically, in the highest tertile of percentages of CD28null CD8(+) T cells, the cumulative incidence of late rejection at 5 and 10 years was only 5% and 8% compared to 16% and 20% in the middle to lowest tertile (p = 0.002). Multivariate proportional hazard analysis showed that percentage and absolute number of CD28null CD8(+) T cells remained significantly associated with late rejection and rejection-related graft loss. Conclusion High numbers of differentiated CD28null CD8(+) T cells decrease the risk for late rejection and rejection-related graft loss after kidney transplantation.	[Betjes, Michiel G. H.; Litjens, Nicolle H. R.] Univ Med Ctr, Dept Internal Med, Sect Nephrol & Transplantat, Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Betjes, MGH (corresponding author), Univ Med Ctr, Dept Internal Med, Sect Nephrol & Transplantat, Erasmus MC, Rotterdam, Netherlands.	m.g.h.betjes@erasmusmc.nl			Dutch Kidney Foundation [KSPB.10.12]	Dutch Kidney Foundation	This study was supported by a grant (KSPB.10.12) of the Dutch Kidney Foundation (http://www.nierstichting.nl/) awarded to Dr Betjes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betjes MGH, 2008, KIDNEY INT, V74, P760, DOI 10.1038/ki.2008.301; Betjes MGH, 2016, TRANSPL INT, V29, P274, DOI 10.1111/tri.12658; Betjes MGH, 2014, CURR UROL REP, V16, DOI 10.1007/s11934-014-0471-9; Betjes MGH, 2013, NAT REV NEPHROL, V9, P255, DOI 10.1038/nrneph.2013.44; Betjes MGH, 2012, TRANSPLANTATION, V94, P63, DOI 10.1097/TP.0b013e31825306ff; Betjes MGH, 2011, KIDNEY INT, V80, P209, DOI 10.1038/ki.2011.110; Bottomley MJ, 2016, J AM SOC NEPHROL, V27, P1505, DOI 10.1681/ASN.2015030250; Chiu YL, 2018, IMMUN AGEING, V15, DOI 10.1186/s12979-018-0131-x; Dedeoglu B, 2018, AM J TRANSPLANT, V18, P341, DOI 10.1111/ajt.14480; Dedeoglu B, 2017, CLIN EXP IMMUNOL, V188, P299, DOI 10.1111/cei.12934; Dedeoglu B, 2016, AM J TRANSPLANT, V16, P2324, DOI 10.1111/ajt.13759; Dedeoglu B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01416; Dedeoglu B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150826; Echeverria A, 2015, J LEUKOCYTE BIOL, V98, P373, DOI 10.1189/jlb.1A0514-276RR; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Huang L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01826; Huang L, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0055-7; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; Krenzien F, 2015, TRANSPLANTATION, V99, P2258, DOI 10.1097/TP.0000000000000842; Litjens NHR, 2008, J AM SOC NEPHROL, V19, P1483, DOI 10.1681/ASN.2007090971; Meijers RWJ, 2015, AM J TRANSPLANT, V15, P3143, DOI 10.1111/ajt.13396; Meijers RWJ, 2014, TRANSPL INT, V27, P1272, DOI 10.1111/tri.12416; Meijers RWJ, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-19; Naesens M, 2014, TRANSPLANTATION, V98, P427, DOI 10.1097/TP.0000000000000183; Riley JL, 2005, BLOOD, V105, P13, DOI 10.1182/blood-2004-04-1596; Sablik KA, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1385-z; Traitanon O, 2014, AM J TRANSPLANT, V14, P1277, DOI 10.1111/ajt.12719; Trzonkowski P, 2008, AM J TRANSPLANT, V8, P338, DOI 10.1111/j.1600-6143.2007.02078.x; Tullius SG, 2010, ANN SURG, V252, P662, DOI 10.1097/SLA.0b013e3181f65c7d; Vallejo AN, 1999, J IMMUNOL, V162, P6572	31	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228096	10.1371/journal.pone.0228096	http://dx.doi.org/10.1371/journal.pone.0228096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023273	Green Published, gold			2022-12-26	WOS:000534621500036
J	Charpier, S; Pidoux, M; Mahon, S				Charpier, Stephane; Pidoux, Morgane; Mahon, Severine			Converging sensory and motor cortical inputs onto the same striatal neurons: An in vivo intracellular investigation	PLOS ONE			English	Article							NEOSTRIATAL PROJECTION NEURONS; RAT BARREL CORTEX; CORTICOSTRIATAL PROJECTIONS; VIBRISSAL REPRESENTATIONS; FIRING PATTERNS; RESPONSES; ORGANIZATION; INTEGRATION; INHIBITION; WHISKING	The striatum is involved in the completion and optimization of sensorimotor tasks. In rodents, its dorsolateral part receives converging glutamatergic corticostriatal (CS) inputs from whisker-related primary somatosensory (S1) and motor (M1) cortical areas, which are interconnected at the cortical level. Although it has been demonstrated that the medium-spiny neurons (MSNs) from the dorsolateral striatum process sensory information from the whiskers via the S1 CS pathway, the functional impact of the corresponding M1 CS inputs onto the same striatal neurons remained unknown. Here, by combining in vivo S1 electrocorticogram with intracellular recordings from somatosensory MSNs in the rat, we first confirmed the heterogeneity of striatal responsiveness to whisker stimuli, encompassing MSNs responding exclusively by subthreshold synaptic depolarizations, MSNs exhibiting sub- and suprathreshold responses over successive stimulations, and non-responding cells. All recorded MSNs also exhibited clear-cut monosynaptic depolarizing potentials in response to electrical stimulations of the corresponding ipsilateral M1 cortex, which were efficient to fire striatal cells. Since M1-evoked responses in MSNs could result from the intra-cortical recruitment of S1 CS neurons, we performed intracellular recordings of S1 pyramidal neurons and compared their firing latency following M1 stimuli to the latency of striatal synaptic responses. We found that the onset of M1-evoked synaptic responses in MSNs significantly preceded the firing of S1 neurons, demonstrating a direct synaptic excitation of MSNs by M1. However, the firing of MSNs seemed to require the combined excitatory effects of S1 and M1 CS inputs. This study directly demonstrates that the same somatosensory MSNs can process excitatory synaptic inputs from two functionally-related sensory and motor cortical regions converging into the same striatal sector. The effectiveness of these convergent cortical inputs in eliciting action potentials in MSNs may represent a key mechanism of striatum-related sensorimotor behaviors.	[Charpier, Stephane; Pidoux, Morgane; Mahon, Severine] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, ICM, INSERM UMRS 1127,CNRS UMR 7225, Paris, France; [Charpier, Stephane] UPMC Univ Paris 06, Sorbonne Univ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Charpier, S (corresponding author), Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, ICM, INSERM UMRS 1127,CNRS UMR 7225, Paris, France.; Charpier, S (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Paris, France.	stephane.charpier@upmc.fr	mahon, severine/AAG-9225-2021	mahon, severine/0000-0001-8339-9034	Fondation de France; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche [ANR-16-CE37-0021 2016]; program 'Investissements d'avenir' [ANR-10-IAIHU-06]	Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); program 'Investissements d'avenir'(French National Research Agency (ANR))	This research was funded by the Fondation de France, the Fondation pour la Recherche Medicale, the Agence Nationale de la Recherche (Grant Number: ANR-16-CE37-0021 2016) and the program 'Investissements d'avenir' ANR-10-IAIHU-06.	Ahrens KF, 2004, J NEUROPHYSIOL, V92, P1700, DOI 10.1152/jn.00020.2004; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alloway KD, 2000, J COMP NEUROL, V426, P51, DOI 10.1002/1096-9861(20001009)426:1<51::AID-CNE4>3.0.CO;2-N; Alloway KD, 1999, J NEUROSCI, V19, P10908, DOI 10.1523/JNEUROSCI.19-24-10908.1999; Alloway KD, 2006, J COMP NEUROL, V499, P33, DOI 10.1002/cne.21039; Alloway KD, 2009, J COMP NEUROL, V515, P548, DOI 10.1002/cne.22073; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; Brown LL, 1996, NEUROSCIENCE, V75, P717, DOI 10.1016/0306-4522(96)00310-7; Chakraibarti S, 2006, J COMP NEUROL, V498, P624, DOI 10.1002/cne.21052; CHANG HT, 1982, J COMP NEUROL, V208, P107, DOI 10.1002/cne.902080202; Charpier S, 1999, NEUROSCIENCE, V91, P1209, DOI 10.1016/S0306-4522(98)00719-2; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Deniau JM, 1996, NEUROSCIENCE, V73, P761, DOI 10.1016/0306-4522(96)00088-7; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FLAHERTY AW, 1993, J NEUROSCI, V13, P1120; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Hintiryan H, 2016, NAT NEUROSCI, V19, P1100, DOI 10.1038/nn.4332; Hoffer ZS, 2001, J COMP NEUROL, V439, P87, DOI 10.1002/cne.1337; Hooks BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05780-7; Kincaid AE, 1998, J NEUROSCI, V18, P4722, DOI 10.1523/jneurosci.18-12-04722.1998; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Lee CR, 2019, CURR BIOL, V29, P1313, DOI 10.1016/j.cub.2019.03.028; Mahon S, 2001, CEREB CORTEX, V11, P360, DOI 10.1093/cercor/11.4.360; Mahon S, 2003, J PHYSIOL-PARIS, V97, P557, DOI 10.1016/j.jphysparis.2004.01.013; Mahon S, 2004, TRENDS NEUROSCI, V27, P460, DOI 10.1016/j.tins.2004.06.010; Mahon S, 2012, J NEUROSCI, V32, P11377, DOI 10.1523/JNEUROSCI.0415-12.2012; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; NISENBAUM ES, 1995, J NEUROSCI, V15, P4449; Paxinos G, 2014, BRAIN STEREOTAXIC CO; Pidoux M, 2012, FRONT NEUROSCI, P139; Pidoux M, 2011, J PHYSIOL-LONDON, V589, P263, DOI 10.1113/jphysiol.2010.199646; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Reig R, 2016, CEREB CORTEX, V26, P4405, DOI 10.1093/cercor/bhw268; Reig R, 2014, NEURON, V83, P1200, DOI 10.1016/j.neuron.2014.07.033; Robbe D, 2018, CURR OPIN NEUROBIOL, V52, P123, DOI 10.1016/j.conb.2018.04.009; Sippy T, 2015, NEURON, V88, P298, DOI 10.1016/j.neuron.2015.08.039; Slaght S, 2004, J NEUROSCI, V24, P6816, DOI 10.1523/JNEUROSCI.1449-04.2004; Smith Y, 1998, NEUROSCIENCE, V86, P353; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; Wickens JR, 1998, J NEUROPHYSIOL, V79, P2358, DOI 10.1152/jn.1998.79.5.2358; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Wilson C., 1995, MODELS INFORMATION P, V1, P29; Wilson C. J., 1992, SINGLE NEURON COMPUT, P141, DOI [10.1016/B978-0-12-484815-3.50012-8, DOI 10.1016/B978-0-12-484815-3.50012-8]; Wilson CJ, 2007, PROG BRAIN RES, V160, P91, DOI 10.1016/S0079-6123(06)60006-X; WILSON CJ, 1993, PROG BRAIN RES, V99, P277; WILSON CJ, 1986, BRAIN RES, V367, P201, DOI 10.1016/0006-8993(86)91593-3; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wright AK, 2001, NEUROSCIENCE, V103, P87, DOI 10.1016/S0306-4522(00)00564-9; 2010, HIST COMMUN, P1	53	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228260	10.1371/journal.pone.0228260	http://dx.doi.org/10.1371/journal.pone.0228260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023274	Green Published, gold			2022-12-26	WOS:000534621500044
J	Gagne, TO; Reygondeau, G; Jenkins, CN; Sexton, JO; Bograd, SJ; Hazen, EL; Van Houtan, KS				Gagne, Tyler O.; Reygondeau, Gabriel; Jenkins, Clinton N.; Sexton, Joseph O.; Bograd, Steven J.; Hazen, Elliott L.; Van Houtan, Kyle S.			Towards a global understanding of the drivers of marine and terrestrial biodiversity	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; PATTERNS; MODELS; SENSITIVITY; PERFORMANCE; DIVERSITY; GRADIENTS; RICHNESS	Understanding the distribution of life's variety has driven naturalists and scientists for centuries, yet this has been constrained both by the available data and the models needed for their analysis. Here we compiled data for over 67,000 marine and terrestrial species and used artificial neural networks to model species richness with the state and variability of climate, productivity, and multiple other environmental variables. We find terrestrial diversity is better predicted by the available environmental drivers than is marine diversity, and that marine diversity can be predicted with a smaller set of variables. Ecological mechanisms such as geographic isolation and structural complexity appear to explain model residuals and also identify regions and processes that deserve further attention at the global scale. Improving estimates of the relationships between the patterns of global biodiversity, and the environmental mechanisms that support them, should help in efforts to mitigate the impacts of climate change and provide guidance for adapting to life in the Anthropocene.	[Gagne, Tyler O.; Van Houtan, Kyle S.] Monterey Bay Aquarium, Monterey, CA 93940 USA; [Reygondeau, Gabriel] Univ British Columbia, Inst Oceans & Fisheries, Nereus Program, Nippon Fdn, Vancouver, BC, Canada; [Reygondeau, Gabriel] Univ British Columbia, Inst Oceans & Fisheries, Changing Ocean Res Unit, Vancouver, BC, Canada; [Jenkins, Clinton N.] IPE, Nazare Paulista, SP, Brazil; [Sexton, Joseph O.] TerraPulse Inc, Rockville, MD USA; [Bograd, Steven J.; Hazen, Elliott L.] NOAA, Environm Res Div, Southwest Fisheries Sci Ctr, Monterey, CA USA; [Van Houtan, Kyle S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Monterey Bay Aquarium Research Institute; University of British Columbia; University of British Columbia; National Oceanic Atmospheric Admin (NOAA) - USA; Duke University	Van Houtan, KS (corresponding author), Monterey Bay Aquarium, Monterey, CA 93940 USA.; Van Houtan, KS (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	kvanhoutan@mbayaq.org	Van Houtan, Kyle S/GRY-0874-2022; Van Houtan, Kyle Schuyler/A-4695-2008; Bograd, Steven/AAA-4824-2021; Hazen, Elliott/G-4149-2014; Jenkins, Clinton/D-6134-2011	Hazen, Elliott/0000-0002-0412-7178; Jenkins, Clinton/0000-0003-2198-0637; Gagne, Tyler/0000-0002-8584-6368; Van Houtan, Kyle/0000-0001-5725-1773	Presidential Early Career Award for Scientists and Engineers (PECASE); terraPulse Inc., an incorporated research services company	Presidential Early Career Award for Scientists and Engineers (PECASE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); terraPulse Inc., an incorporated research services company	This work was supported by a Presidential Early Career Award for Scientists and Engineers (PECASE) to KV and by generous contributions to the Monterey Bay Aquarium a nonprofit, 501(c)(3) tax-exempt organization. terraPulse Inc., an incorporated research services company, provided support in the form of salaries for JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the Author Contributions section.	Adobe, 2018, AD ILL 23 1 1; Akusok A, 2015, IEEE ACCESS, V3, P1011, DOI 10.1109/ACCESS.2015.2450498; Amatulli G, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.40; [Anonymous], 2017, BIRD SPEC DISTR MAPS; [Anonymous], 2013, F1000RESEARCH, DOI DOI 10.1186/2193-1801-2-576; [Anonymous], 1878, TROPICAL NATURE OTHE; Ascani F, 2016, GLOBAL CHANGE BIOL, V22, P3529, DOI 10.1111/gcb.13331; Asch RG, 2017, MAR POLICY, DOI [10.1016/j.marpol.2017.08.014, DOI 10.1016/J.MARPOL.2017.08.014]; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Brodie SJ, 2020, ECOGRAPHY, V43, P11, DOI 10.1111/ecog.04707; Bukata R.P., 2018, OPTICAL PROPERTIES R; Chen T, ARXIV2015151201274; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Costello MJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01121-2; Costello MJ, 2017, CURR BIOL, V27, pR511, DOI 10.1016/j.cub.2017.04.060; Costello MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051629; Cramer W, 1999, GLOBAL CHANGE BIOL, V5, P1, DOI 10.1046/j.1365-2486.1999.00009.x; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Demarcq H, 2012, REMOTE SENS ENVIRON, V117, P211, DOI 10.1016/j.rse.2011.09.019; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Feng M, 2010, MAR FRESHWATER RES, V61, P1259, DOI 10.1071/MF09275; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Forster J. R., 1778, OBSERVATIONS MADE VO; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Grady JM, 2019, SCIENCE, V363, P366, DOI 10.1126/science.aat4220; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Gubbi J, 2013, FUTURE GENER COMP SY, V29, P1645, DOI 10.1016/j.future.2013.01.010; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Halley JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203124; Harcourt R, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00326; HASTIE T, 1990, BIOMETRICS, V46, P1005, DOI 10.2307/2532444; Hazen EL, 2012, MAR ECOL PROG SER, V457, P221, DOI 10.3354/meps09857; Hazen EL, 2009, MAR ECOL PROG SER, V395, P75, DOI 10.3354/meps08108; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jenkins CN, 2015, P NATL ACAD SCI USA, V112, P5081, DOI 10.1073/pnas.1418034112; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jobbagy EG, 2002, ECOLOGY, V83, P307, DOI 10.1890/0012-9658(2002)083[0307:PACOPP]2.0.CO;2; Kato S, 2013, J CLIMATE, V26, P2719, DOI 10.1175/JCLI-D-12-00436.1; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Kuhn I, 2012, J BIOGEOGR, V39, P995, DOI 10.1111/j.1365-2699.2012.02707.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pinsky ML, 2018, SCIENCE, V360, P1189, DOI 10.1126/science.aat2360; Rabosky DL, 2015, AM NAT, V185, P572, DOI 10.1086/680850; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Reisenbichler KR, 2016, OCEANS 2016 MTS/IEEE MONTEREY, DOI 10.1109/OCEANS.2016.7761499; Reygondeau G, NATURE; Reygondeau G, 2019, PREDICTING FUTURE OCEANS: SUSTAINABILITY OF OCEAN AND HUMAN SYSTEMS AMIDST GLOBAL ENVIRONMENTAL CHANGE, P87, DOI 10.1016/B978-0-12-817945-1.00009-5; Reygondeau G, 2018, J BIOGEOGR, V45, P500, DOI 10.1111/jbi.13149; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x; Seddon AWR, 2016, NATURE, V531, P229, DOI 10.1038/nature16986; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Tillotson MD, 2018, BIOL CONSERV, V220, P1, DOI 10.1016/j.biocon.2018.01.030; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Toledo-Aceves T, 2014, TROP CONSERV SCI, V7, P240; Urban MC, 2016, SCIENCE, V353, P1113, DOI 10.1126/science.aad8466; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Weatherall P, 2015, EARTH SPACE SCI, V2, P331, DOI 10.1002/2015EA000107; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu C, 2012, ENVIRON MONIT ASSESS, V184, P1275, DOI 10.1007/s10661-011-2039-1	70	26	27	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228065	10.1371/journal.pone.0228065	http://dx.doi.org/10.1371/journal.pone.0228065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023269	gold, Green Published			2022-12-26	WOS:000534621500033
J	Gersak, G; Drnovsek, J				Gersak, Gregor; Drnovsek, Janko			Electrodermal activity patient simulator	PLOS ONE			English	Article							SYMPTOMS	Electrodermal activity (EDA) is an electrical property of the human skin, correlated with person's psychological arousal. Nowadays, different types of EDA measuring devices are used in highly versatile fields-from research, health-care and education to entertainment industry. But despite their universal use the quality of their measuring function (their accuracy) is questioned or investigated very seldom. In this paper, we propose a concept of an EDA patient simulator a device enabling metrological testing of EDA devices by means of a variable resistance. EDA simulator was designed based on a programmable light-controlled resistor with a wide resistance range, capable of simulating skin conductance levels (SCL) and responses (SCR) and was equipped with an artificial hand. The hand included electrically conductive fingers for attachment of EDA device electrodes. A minimal set of tests for evaluating an EDA device was identified, the simulator's functionality discussed and some testing results presented.	[Gersak, Gregor; Drnovsek, Janko] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia	University of Ljubljana	Gersak, G (corresponding author), Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia.	gregor.gersak@fe.uni-lj.si			Slovenian Research Agency [P2-0225]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge the financial support from the Slovenian Research Agency (research core funding No. P2-0225). http://www.arrs.si/en/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoore JN, 2000, BLOOD PRESS MONIT, V5, P81; Amoore JN, 2006, BLOOD PRESS MONIT, V11, P63, DOI 10.1097/01.mbp.0000200482.72410.e2; [Anonymous], SHIELD ZELL RS COND; Boucsein W, 2012, PSYCHOPHYSIOLOGY, V49, P1017, DOI 10.1111/j.1469-8986.2012.01384.x; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Braithwaite J. J., 2013, PSYCHOPHYSIOLOGY, V49, P1017, DOI DOI 10.1111/J.1469-8986.2012.01384.X; Burke MJ, 2001, J MED ENG TECHNOL, V25, P97, DOI 10.1080/03091900110051640; Christopoulos GI, 2019, ORGAN RES METHODS, V22, P394, DOI 10.1177/1094428116681073; Dawson ME, 2002, SCHIZOPHR RES, V54, P87, DOI 10.1016/S0920-9964(01)00355-3; de Wijk RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093823; Ekman I., 2010, INNOVATION; Figner B., 2011, HDB PROCESS TRACING; Flor H, 1997, PAIN, V73, P413, DOI 10.1016/S0304-3959(97)00137-1; Gersak G, 2020, MULTIMED TOOLS APPL, V79, P14491, DOI 10.1007/s11042-018-6969-2; Gersak G, 2009, MED BIOL ENG COMPUT, V47, P1221, DOI 10.1007/s11517-009-0532-2; Gersak V., 2012, P 20 IMEKO WORLD C 2, VVolume 2, P788; Gersak V, 2020, COMPUT COMMUN, V150, P581, DOI 10.1016/j.comcom.2019.12.019; Grillon C, 2002, BIOL PSYCHIAT, V51, P851, DOI 10.1016/S0006-3223(01)01370-1; Hamann S, 2002, NEUROPSYCHOLOGIA, V40, P1187, DOI 10.1016/S0028-3932(01)00223-8; He W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00110; Iaboni F, 1997, PSYCHOPHYSIOLOGY, V34, P116, DOI 10.1111/j.1469-8986.1997.tb02422.x; Kasos K, 2018, APPL PSYCHOPHYS BIOF, V43, P203, DOI 10.1007/s10484-018-9398-0; Kleckner I. R., 2015, PSYCHOL CONSTRUCTION, P265; Kleckner IR, 2019, PSYARXIV, DOI [10.31234/osf.io/a9ju4, DOI 10.31234/OSF.IO/A9JU4]; Kleeberg J, 2004, ANN NEUROL, V56, P787, DOI 10.1002/ana.20277; Kushki A, 2011, PHYSIOL MEAS, V32, P1529, DOI 10.1088/0967-3334/32/10/002; Mandryk RL, 2007, INT J HUM-COMPUT ST, V65, P329, DOI 10.1016/j.ijhcs.2006.11.011; Nacke LE, 2010, INTERACT COMPUT, V22, P336, DOI 10.1016/j.intcom.2010.04.005; Nourbakhsh N, 2012, P 24 AUSTR COMP HUM, P420, DOI DOI 10.1145/2414536.2414602; Ogorevc J, 2013, MEASUREMENT, V46, P2993, DOI 10.1016/j.measurement.2013.06.024; Pabst O, 2017, PSYCHOPHYSIOLOGY, V54, P374, DOI 10.1111/psyp.12803; Picard RW, 2016, EMOT REV, V8, P62, DOI 10.1177/1754073914565517; Poh MZ, 2010, IEEE T BIO-MED ENG, V57, P1243, DOI 10.1109/TBME.2009.2038487; Pope GC, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19112450; Romine W, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19061417; Roth WT, 1998, PSYCHIAT RES, V80, P155, DOI 10.1016/S0165-1781(98)00066-3; Savic M, 2015, MEASUREMENT, V59, P192, DOI 10.1016/j.measurement.2014.09.010; Schell AM, 2005, PSYCHOPHYSIOLOGY, V42, P483, DOI 10.1111/j.1469-8986.2005.00300.x; Setz C, 2010, IEEE T INF TECHNOL B, V14, P410, DOI 10.1109/TITB.2009.2036164; Wendt J, 2008, PSYCHOPHYSIOLOGY, V45, P205, DOI 10.1111/j.1469-8986.2007.00620.x; Wolfe Glen, 2006, Biomed Instrum Technol, V40, P363, DOI 10.2345/i0899-8205-40-5-363.1	41	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228949	10.1371/journal.pone.0228949	http://dx.doi.org/10.1371/journal.pone.0228949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9FN	32023317	Green Published, gold			2022-12-26	WOS:000534621500074
J	Li, TG; Gong, H; Yuan, QC; Du, M; Ren, FZ; Mao, XY				Li, Tiange; Gong, Han; Yuan, Qichen; Du, Min; Ren, Fazheng; Mao, Xueying			Supplementation of polar lipids-enriched milk fat globule membrane in high-fat diet-fed rats during pregnancy and lactation promotes brown/beige adipocyte development and prevents obesity in male offspring	FASEB JOURNAL			English	Article						beige adipogenesis; maternal obesity; polar lipids-enriched milk fat globule membrane; thermogenesis; uncoupling protein 1	BROWN ADIPOSE-TISSUE; UNCOUPLING PROTEIN-1 EXPRESSION; UNTIL 12 MO; MATERNAL OBESITY; BODY-FAT; RESVERATROL SUPPLEMENTATION; ENDOCANNABINOID SYSTEM; ENERGY-EXPENDITURE; GUT MICROBIOTA; CHOLINE INTAKE	Promoting brown adipose tissue (BAT) function or browning of white adipose tissue (WAT) provides a defense against obesity. The aim of the study was to investigate whether maternal polar lipids-enriched milk fat globule membrane (MFGM-PL) supplementation to high-fat diet (HFD) rats during pregnancy and lactation could promote brown/beige adipogenesis and protect against HFD-induced adiposity in offspring. Female SD rats were fed a HFD for 8 weeks to induce obesity and, then, fed a HFD during pregnancy and lactation with or without MFGM-PL. Male offspring were weaned at postnatal Day 21 and then fed a HFD for 9 weeks. MFGM-PL treatment to HFD dams decreased the body weight gain and WAT mass as well as lowered the serum levels of insulin and triglycerides in male offspring at weaning. MFGM-PL+HFD offspring showed promoted thermogenic function in BAT and inguinal WAT through the upregulation of UCP1 and other thermogenic genes. In adulthood, maternal MFGM-PL supplementation reduced adiposity and increased oxygen consumption, respiratory exchange ratio, and heat production in male offspring. The enhancement of energy expenditure was correlated with elevated BAT activity and inguinal WAT thermogenic program. In conclusion, maternal MFGM-PL treatment activated thermogenesis in offspring, which exerted long-term beneficial effects against HFD-induced obesity in later life.	[Li, Tiange; Gong, Han; Yuan, Qichen; Ren, Fazheng; Mao, Xueying] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Key Lab Funct Dairy, Beijing, Peoples R China; [Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	China Agricultural University; Washington State University	Mao, XY (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100083, Peoples R China.	maoxueying@cau.edu.cn	Du, Min/H-4311-2011	Du, Min/0000-0002-7232-072X; Yuan, Qichen/0000-0001-9588-0968; Li, Tiange/0000-0002-5601-9224	NSFC; National Natural Science Foundation of China [31871806]; Beijing Dairy Industry Innovation Team [BAIC06-2020]	NSFC(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Dairy Industry Innovation Team	NSFC vertical bar National Natural Science Foundation of China, Grant/Award Number: 31871806; Beijing Dairy Industry Innovation Team, Grant/Award Number: BAIC06-2020	Al-Makdissy N, 2003, CELL SIGNAL, V15, P1019, DOI 10.1016/S0898-6568(03)00070-6; Alfaradhi MZ, 2016, ENDOCRINOLOGY, V157, P4246, DOI 10.1210/en.2016-1314; Almeida MM, 2017, BRIT J NUTR, V118, P788, DOI 10.1017/S0007114517002884; Baars A, 2016, BRIT J NUTR, V115, P1930, DOI 10.1017/S0007114516001082; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Beals E, 2019, J NUTR SCI, V8, DOI 10.1017/jns.2019.11; Blackmore HL, 2014, ENDOCRINOLOGY, V155, P3970, DOI 10.1210/en.2014-1383; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Butruille L, 2019, INT J OBESITY, V43, P2381, DOI 10.1038/s41366-018-0310-z; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Carobbio S, 2019, BBA-MOL CELL BIOL L, V1864, P37, DOI 10.1016/j.bbalip.2018.05.013; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; CHAO CK, 1988, BIOCHEM J, V254, P33, DOI 10.1042/bj2540033; Chondronikola M, 2019, BBA-MOL CELL BIOL L, V1864, P91, DOI 10.1016/j.bbalip.2018.05.014; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; del Bas JM, 2015, INT J OBESITY, V39, P7, DOI 10.1038/ijo.2014.159; Dias-Rocha CP, 2018, J NUTR BIOCHEM, V51, P56, DOI 10.1016/j.jnutbio.2017.09.019; Fischer LM, 2010, AM J CLIN NUTR, V92, P336, DOI 10.3945/ajcn.2010.29459; Franco JG, 2012, J PHYSIOL-LONDON, V590, P5503, DOI 10.1113/jphysiol.2012.240655; Gil-Sanchez A, 2010, AM J CLIN NUTR, V92, P115, DOI 10.3945/ajcn.2010.29589; Haramizu S, 2014, AM J PHYSIOL-REG I, V307, pR1009, DOI 10.1152/ajpregu.00004.2014; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hari S, 2015, BIOSCI BIOTECH BIOCH, V79, P1172, DOI 10.1080/09168451.2015.1012150; He X, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36292-5; Hernell O, 2016, J PEDIATR-US, V173, pS60, DOI 10.1016/j.jpeds.2016.02.077; Jeremic N, 2017, J CELL PHYSIOL, V232, P61, DOI 10.1002/jcp.25450; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kruse M, 2013, ENDOCRINOLOGY, V154, P3565, DOI 10.1210/en.2012-1877; Lamothe S, 2008, J DAIRY RES, V75, P439, DOI 10.1017/S002202990800349X; Lecoutre S, 2014, ADIPOCYTE, V3, P256, DOI 10.4161/adip.29806; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Li TE, 2018, J FUNCT FOODS, V47, P56, DOI 10.1016/j.jff.2018.05.038; Li TG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030331; Liang XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34345; Liang XW, 2016, J PHYSIOL-LONDON, V594, P4453, DOI 10.1113/JP272123; Lo KA, 2013, BIOSCIENCE REP, V33, P711, DOI 10.1042/BSR20130046; Markworth JF, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0161-y; McNamara JP, 2018, ANNU REV ANIM BIOSCI, V6, P177, DOI 10.1146/annurev-animal-030117-014720; Merkestein M, 2014, MAMM GENOME, V25, P413, DOI 10.1007/s00335-014-9528-9; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Nestel PJ, 2014, AM J CLIN NUTR, V99, P46, DOI 10.3945/ajcn.113.071712; Norris GH, 2017, J NUTR BIOCHEM, V40, P36, DOI 10.1016/j.jnutbio.2016.09.017; Norris GH, 2016, J NUTR BIOCHEM, V30, P93, DOI 10.1016/j.jnutbio.2015.12.003; Ohta T, 2017, ANIM SCI J, V88, P149, DOI 10.1111/asj.12606; Reis MG, 2013, J AGR FOOD CHEM, V61, P2729, DOI 10.1021/jf303795b; Roberts VHJ, 2014, FASEB J, V28, P2466, DOI 10.1096/fj.13-245472; Saito M, 2013, DIABETES METAB J, V37, P22, DOI 10.4093/dmj.2013.37.1.22; Scholler M, 2012, J CLIN ENDOCR METAB, V97, P2466, DOI 10.1210/jc.2011-2969; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Segovia SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07108-9; Sellayah D, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121832; Symonds ME, 2012, DIABETOLOGIA, V55, P1597, DOI 10.1007/s00125-012-2505-5; Symonds ME, 2003, J ENDOCRINOL, V179, P293, DOI 10.1677/joe.0.1790293; Taylor PD, 2014, ACTA PHYSIOL, V210, P508, DOI 10.1111/apha.12223; Timby N, 2014, PEDIATR RES, V76, P394, DOI 10.1038/pr.2014.110; Timby N, 2014, AM J CLIN NUTR, V99, P860, DOI 10.3945/ajcn.113.064295; Uhl O, 2015, DIABETES RES CLIN PR, V109, P364, DOI 10.1016/j.diabres.2015.05.032; Wang B, 2017, EBIOMEDICINE, V18, P288, DOI 10.1016/j.ebiom.2017.03.041; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wankhade UD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175675; Wat E, 2009, ATHEROSCLEROSIS, V205, P144, DOI 10.1016/j.atherosclerosis.2008.12.004; Wiedeman AM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101513; Zhang X, 2016, INT J OBESITY, V40, P1841, DOI 10.1038/ijo.2016.108; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493; Zou TD, 2017, J PHYSIOL-LONDON, V595, P1547, DOI 10.1113/JP273478	68	16	16	5	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4619	4634		10.1096/fj.201901867RRR	http://dx.doi.org/10.1096/fj.201901867RRR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32020679				2022-12-26	WOS:000512309000001
J	Ray, A; Song, Y; Du, T; Chauhan, D; Anderson, KC				Ray, Arghya; Song, Yan; Du, Ting; Chauhan, Dharminder; Anderson, Kenneth C.			Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma	ONCOGENE			English	Article							DRUG-RESISTANCE; IMMUNE; INHIBITOR; THERAPIES; HYPOXIA; CELLS; CYTOTOXICITY; GROWTH; OXYGEN; MODEL	Bone marrow plasmacytoid dendritic cells (pDCs) in patients with multiple myeloma (MM) promote tumor growth, survival, drug resistance, and immune suppression. Understanding the molecular signaling crosstalk among the tumor cells, pDCs and immune cells will identify novel therapeutic approaches to enhance anti-MM immunity. Using oligonucleotide arrays, we found that pDC-MM interactions induce metabolic enzyme Alpha-Enolase (ENO1) in both pDCs and MM cells. Analysis of MM patient gene expression profiling database showed that ENO1 expression inversely correlates with overall survival. Protein expression analysis showed that ENO1 is expressed in pDC and MM cells; and importantly, that pDC-MM coculture further increases ENO1 expression in both MM cells and pDCs. Using our coculture models of patient autologous pDC-T-NK-MM cells, we examined whether targeting ENO1 can enhance anti-MM immunity. Biochemical inhibition of ENO1 with ENO1 inhibitor (ENO1i) activates pDCs, as well as increases pDC-induced MM-specific CD8(+) CTL and NK cell activity against autologous tumor cells. Combination of ENO1i and anti-PD-L1 Ab or HDAC6i ACY-241 enhances autologous MM-specific CD8(+) CTL activity. Our preclinical data therefore provide the basis for novel immune-based therapeutic approaches targeting ENO1, alone or in combination with anti-PD-L1 Ab or ACY241, to restore anti-MM immunity, enhance MM cytotoxicity, and improve patient outcome.	[Ray, Arghya; Song, Yan; Du, Ting; Chauhan, Dharminder; Anderson, Kenneth C.] Harvard Med Sch, Dept Med Oncol, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA; [Ray, Arghya; Song, Yan; Du, Ting; Chauhan, Dharminder; Anderson, Kenneth C.] Harvard Med Sch, Jerome Lipper Myeloma Ctr, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Chauhan, D; Anderson, KC (corresponding author), Harvard Med Sch, Dept Med Oncol, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA.; Chauhan, D; Anderson, KC (corresponding author), Harvard Med Sch, Jerome Lipper Myeloma Ctr, Dana Farber Canc Inst, Boston, MA 02115 USA.	Dharminder_Chauhan@dfci.harvard.edu; Kenneth_Anderson@dfci.harvard.edu			Dr. Miriam and Sheldon Adelson Medical Research Foundation; National Institutes of Health Specialized Programs of Research Excellence (SPORE) grant [P50100707, R01CA207237, R01 CA050947]	Dr. Miriam and Sheldon Adelson Medical Research Foundation; National Institutes of Health Specialized Programs of Research Excellence (SPORE) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The grant supports for this investigation were provided by "Dr. Miriam and Sheldon Adelson Medical Research Foundation", and by the National Institutes of Health Specialized Programs of Research Excellence (SPORE) grant P50100707, R01CA207237, and R01 CA050947. KCA is an American Cancer Society Clinical Research Professor.	Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Anderson KC, 2018, J ONCOL PRACT, V14, P411, DOI 10.1200/JOP.18.00311; Anderson KC, 2013, J NATL COMPR CANC NE, V11, P676, DOI 10.6004/jnccn.2013.0199; Anderson KC, 2012, J CLIN ONCOL, V30, P445, DOI 10.1200/JCO.2011.37.8919; Bae J, 2018, LEUKEMIA, V32, P1932, DOI 10.1038/s41375-018-0062-8; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Bi EG, 2018, J CLIN INVEST, V128, P4821, DOI 10.1172/JCI121421; Cappello P, 2017, FRONT BIOSCI-LANDMRK, V22, P944, DOI 10.2741/4526; Cappello P, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1112940; Chauhan D, 2003, BLOOD, V101, P3606, DOI 10.1182/blood-2002-10-3146; Chauhan D, 2009, CANCER CELL, V16, P309, DOI 10.1016/j.ccr.2009.08.019; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; de Broek IV, 2006, HAEMATOL-HEMATOL J, V91, P200; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Granchi C, 2014, BIOORG MED CHEM LETT, V24, P4915, DOI 10.1016/j.bmcl.2014.09.041; Gu ZM, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0392-4; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heuck CJ, 2014, LEUKEMIA, V28, P2410, DOI 10.1038/leu.2014.232; Ikeda S, 2018, BLOOD ADV, V2, P323, DOI 10.1182/bloodadvances.2017008847; Jung DW, 2013, ACS CHEM BIOL, V8, P1271, DOI 10.1021/cb300687k; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Li WB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071616; Liberti MV, 2016, NAT CHEM BIOL, V12, P577, DOI 10.1038/nchembio.2133; Lu CC, 2014, J CHROMATOGR A, V1372, P34, DOI 10.1016/j.chroma.2014.10.098; Maiso P, 2015, CANCER RES, V75, P2071, DOI 10.1158/0008-5472.CAN-14-3400; Manasanch EE, 2019, BLOOD ADV, V3, P2400, DOI 10.1182/bloodadvances.2019000300; Milosevic A, 2004, SEMIN RADIAT ONCOL, V14, P249, DOI 10.1016/j.semradonc.2004.04.006; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Pacella I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01889; Qorraj M, 2017, LEUKEMIA, V31, P470, DOI 10.1038/leu.2016.214; Ray A, 2018, LEUKEMIA, V32, P843, DOI 10.1038/leu.2017.322; Ray A, 2015, LEUKEMIA, V29, P1441, DOI 10.1038/leu.2015.11; Ray A, 2014, LEUKEMIA, V28, P1716, DOI 10.1038/leu.2014.46; Ray A, 2020, LEUKEMIA, V34, P567, DOI 10.1038/s41375-019-0558-x; Ryans K, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0212-1; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shin YC, 2008, CANCER RES, V68, P1751, DOI 10.1158/0008-5472.CAN-07-2766; Stessman HAF, 2013, MOL CANCER THER, V12, P1140, DOI 10.1158/1535-7163.MCT-12-1151; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Zhao MY, 2015, ONCOTARGET, V6, P15610, DOI 10.18632/oncotarget.3639; Zhu XH, 2015, EXP CELL RES, V335, P216, DOI 10.1016/j.yexcr.2015.05.020	41	17	19	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2786	2796		10.1038/s41388-020-1172-0	http://dx.doi.org/10.1038/s41388-020-1172-0		FEB 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32024967	Green Accepted			2022-12-26	WOS:000511273600001
J	Al-Fasih, MY; Kueh, ABH; Ibrahim, MHW				Al-Fasih, M. Y.; Kueh, A. B. H.; Ibrahim, M. H. W.			Failure behavior of sandwich honeycomb composite beam containing crack at the skin	PLOS ONE			English	Article							ENERGY-RELEASE RATE; SHEAR PROPERTIES; FRACTURE; STRENGTH; PROPAGATION; CORE	Skin crack defects can develop in sandwich honeycomb composite structures during service life due to static and impact loads. In this study, the fracture behavior of sandwich honeycomb composite (SHC) beams containing crack at the skin was investigated experimentally and numerically under four-point loading. Three different arrangements of unidirectional (UD) carbon fiber composite and the triaxially woven (TW) fabric were considered for the skins. The presence of a 10 mm crack at mid-span of the top skin, mid-span of the bottom skin, and mid-way between load and support of the top skin, respectively, were considered. Failure load equations of the load initiating the skin crack extension were analytically derived and then numerically developed using the J-integral approach. The crack extension failure mode dominated all cracked specimens except those with low-stiffness skin which were controlled by the compressive skin debonding and core shear failures.	[Al-Fasih, M. Y.; Ibrahim, M. H. W.] Univ Tun Hussein Onn Malaysia, Fac Civil Engn & Built Environm, Jamilus Res Ctr, Pant Raja, Johor, Malaysia; [Al-Fasih, M. Y.] Off Educ Sanaa, Sanaa, Yemen; [Kueh, A. B. H.] Univ Malaysia Sarawak, Fac Engn, Dept Civil Engn, Sarawak, Malaysia	University of Malaysia Sarawak	Al-Fasih, MY; Ibrahim, MHW (corresponding author), Univ Tun Hussein Onn Malaysia, Fac Civil Engn & Built Environm, Jamilus Res Ctr, Pant Raja, Johor, Malaysia.; Al-Fasih, MY (corresponding author), Off Educ Sanaa, Sanaa, Yemen.	alfaseeh500@gmail.com; haziman@uthm.edu.my	Kueh, Ahmad/Z-2045-2019; Ibrahim, Mohd/GQH-0781-2022; Ibrahim, Mohd Haziman Wan/ABA-5502-2020	Kueh, Ahmad/0000-0002-3011-8611; Ibrahim, Mohd Haziman Wan/0000-0002-0793-1612; Al-Fasih, Mohammed/0000-0002-7193-4543				ABAQUS, 2013, ABAQUS US THEOR MAN; Allen HG., 2013, ANAL DESIGN STRUCTUR, pp 300; ASTM International, 2018, STANDARD TEST METHOD; Balaban AC, 2019, THEOR APPL FRACT MEC, V101, P191, DOI 10.1016/j.tafmec.2019.03.001; Berggreen C, 2007, J COMPOS MATER, V41, P493, DOI 10.1177/0021998306065285; Caner FC, 2009, COMPOS PART B-ENG, V40, P337, DOI 10.1016/j.compositesb.2009.03.005; Caprino G, 1989, SANDWICH STRUCTURES; Cook R.D., 1989, CONCEPTS APPL FINITE; Funari MF, 2019, FRAT INTEGRITA STRUT, P277, DOI 10.3221/IGF-ESIS.47.21; Ivanez I, 2013, COMPOS STRUCT, V106, P716, DOI 10.1016/j.compstruct.2013.07.025; Maleki FK, 2019, MATER RES EXPRESS, V6, DOI 10.1088/2053-1591/aafc02; Mansourinik M, 2020, J SANDW STRUCT MATER, V22, P1132, DOI 10.1177/1099636218781981; Meraghni F, 1999, COMPOS PART A-APPL S, V30, P767, DOI 10.1016/S1359-835X(98)00182-1; Mouritz AP, 1999, COMPOS STRUCT, V44, P263, DOI 10.1016/S0263-8223(98)00133-0; Pan SD, 2008, MATER LETT, V62, P523, DOI 10.1016/j.matlet.2007.05.084; Petras A, 2000, COMPOS STRUCT, V50, P311, DOI 10.1016/S0263-8223(00)00122-7; Petras A, 1999, DESIGN SANDWICH STRU; Rizov VI, 2012, J THEOR APPL MECH-BU, V42, P3, DOI 10.2478/v10254-012-0006-z; Shah OR, 2017, COMPOS PART B-ENG, V111, P134, DOI 10.1016/j.compositesb.2016.11.044; Spadea S, 2017, COMPOS STRUCT, V176, P244, DOI 10.1016/j.compstruct.2017.05.032; Thomson RS, 1998, COMPOS STRUCT, V42, P107, DOI 10.1016/S0263-8223(98)00058-0; Triantafillou TC, 1989, MATER STRUCT, V22, P64; Ural A, 2003, ENG FRACT MECH, V70, P93, DOI 10.1016/S0013-7944(02)00024-3; Zenkert D, 2005, COMPOS SCI TECHNOL, V65, P2597, DOI 10.1016/j.compscitech.2005.05.026; ZENKERT D, 1990, COMPOS STRUCT, V15, P279, DOI 10.1016/0263-8223(90)90018-A; ZENKERT D, 1991, COMPOS STRUCT, V17, P331, DOI 10.1016/0263-8223(91)90025-T	26	4	4	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0227895	10.1371/journal.pone.0227895	http://dx.doi.org/10.1371/journal.pone.0227895			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012168	Green Published, gold			2022-12-26	WOS:000534615800014
J	Liu, SY; Wang, S; Wu, SW; Wu, YD; Yang, YH				Liu, Shaoyan; Wang, Shuo; Wu, Shuwen; Wu, Yidong; Yang, Yihua			Proteolysis activation of Cry1Ac and Cry2Ab protoxins by larval midgut juice proteases from Helicoverpa armigera	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; DELTA-ENDOTOXIN; BT CROPS; INSECT RESISTANCE; TOXIN; GENE; COTTON; LEPIDOPTERA; BINDING	Proteolytic processing of Bacillus thuringiensis (Bt) Cry protoxins by insect midgut proteases is critical to their insecticidal activities against target insects. Although transgenic Bt cotton expressing Cry1Ac and Cry2Ab proteins have been widely used for control of the cotton bollworm (Helicoverpa armigera) in the field, the proteolytic cleavage sites in the two protoxins targeted by H. armigera midgut proteases are still not clear. In this study, the proteolysis of Cry1Ac and Cry2Ab protoxins by midgut juice prepared from midgut tissue of H. armigera larvae was investigated. Cleavage of Cry1Ac protoxin by midgut proteases formed a major protein fragment of similar to 65 kDa, and N-terminal sequencing revealed that cleavage occurred at Arg28 in the fore-end of helix alpha-1 in domain I of Cry1Ac. Cleavage of Cry2Ab protoxin by midgut juice proteases produced a major protein fragment of similar to 50 kDa, and the cleavage occurred at Arg139 between helices alpha-3 and alpha-4 in domain I of Cry2Ab. The amino acids Arg28 of Cry1Ac and Arg139 of Cry2Ab were predicted as putative trypsin cleavage sites. Bioassay data showed that the toxicities (LC(50)s) of Cry1Ac and Cry2Ab protoxins were equivalent to those of their respective midgut juice-activated toxins in the susceptible SCD strain of H. armigera. Identification of the exact sites of N-terminal activation of Cry1Ac and Cry2Ab protoxins will provide a basis for a better understanding of the mode of action and resistance mechanisms based on aberrant activation of these protoxins in H. armigera.	[Liu, Shaoyan; Wang, Shuo; Wu, Shuwen; Wu, Yidong; Yang, Yihua] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, YH (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	yhyang@njau.edu.cn	Wu, Yidong/E-9720-2012	Wu, Yidong/0000-0003-3456-3373; Yang, Yihua/0000-0002-5561-1269	Ministry of Agriculture and Rural Affairs of China [2016ZX08011002]	Ministry of Agriculture and Rural Affairs of China	Work presented in the report was supported by the grant from Ministry of Agriculture and Rural Affairs of China to YY(grant number 2016ZX08011002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audtho M, 1999, APPL ENVIRON MICROB, V65, P4601; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2002, J BIOL CHEM, V277, P23985, DOI 10.1074/jbc.C200263200; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; CHOMA CT, 1990, EUR J BIOCHEM, V189, P523, DOI 10.1111/j.1432-1033.1990.tb15518.x; CHRISTELLER JT, 1992, INSECT BIOCHEM MOLEC, V22, P735, DOI 10.1016/0965-1748(92)90052-G; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Jones CM, 2019, ANNU REV ENTOMOL, V64, P277, DOI 10.1146/annurev-ento-011118-111959; Karumbaiah L, 2007, COMP BIOCHEM PHYS B, V146, P139, DOI 10.1016/j.cbpb.2006.10.104; Keller M, 1996, INSECT BIOCHEM MOLEC, V26, P365, DOI 10.1016/0965-1748(95)00102-6; LIANG Y, 1994, MOL MICROBIOL, V13, P569, DOI 10.1111/j.1365-2958.1994.tb00451.x; Lightwood DJ, 2000, APPL ENVIRON MICROB, V66, P5174, DOI 10.1128/AEM.66.12.5174-5181.2000; Liu CX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07219; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; MILNE R, 1993, INSECT BIOCHEM MOLEC, V23, P663, DOI 10.1016/0965-1748(93)90040-Y; Morse RJ, 2001, STRUCTURE, V9, P409, DOI 10.1016/S0969-2126(01)00601-3; OGIWARA K, 1992, J INVERTEBR PATHOL, V60, P121, DOI 10.1016/0022-2011(92)90084-H; Ohsawa M, 2012, APPL ENVIRON MICROB, V78, P4755, DOI 10.1128/AEM.07123-11; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Oppert B, 1999, ARCH INSECT BIOCHEM, V42, P1, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;1::AID-ARCH2&gt;3.0.CO;2-#; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Rajagopal R, 2009, BIOCHEM J, V419, P309, DOI 10.1042/BJ20081152; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Software LeOra, 2002, POLO PLUS USERS GUID; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tay WT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005534; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; TOJO A, 1983, APPL ENVIRON MICROB, V45, P576, DOI 10.1128/AEM.45.2.576-580.1983; Wang J, 2017, INSECT BIOCHEM MOLEC, V87, P147, DOI 10.1016/j.ibmb.2017.07.002; Welch KL, 2015, J INVERTEBR PATHOL, V132, P149, DOI 10.1016/j.jip.2015.10.003; Wu KM, 2003, J ECON ENTOMOL, V96, P1322, DOI 10.1603/0022-0493-96.4.1322; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Xu L, 2016, J AGR FOOD CHEM, V64, P7195, DOI 10.1021/acs.jafc.6b03111; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YH, 2009, B ENTOMOL RES, V99, P175, DOI 10.1017/S0007485308006226; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	43	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228159	10.1371/journal.pone.0228159	http://dx.doi.org/10.1371/journal.pone.0228159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004347	Green Published, gold			2022-12-26	WOS:000534614600021
J	Sterzel, T; Ludeke, MKB; Walther, C; Kok, MT; Sietz, D; Lucas, PL				Sterzel, Till; Luedeke, Matthias K. B.; Walther, Carsten; Kok, Marcel T.; Sietz, Diana; Lucas, Paul L.			Typology of coastal urban vulnerability under rapid urbanization	PLOS ONE			English	Article							CLIMATE-CHANGE; FLOOD RISK; ADAPTATION; CITIES; 21ST-CENTURY; PROJECTIONS; PHILIPPINES; POPULATION; RESILIENCE; VALIDATION	Coastal areas are urbanizing at unprecedented rates, particularly in low- and middle-income countries. Combinations of long-standing and emerging problems in these urban areas generate vulnerability for human well-being and ecosystems alike. This baseline study provides a spatially explicit global systematization of these problems into typical urban vulnerability profiles for the year 2000 using largely sub-national data. Using 11 indicator datasets for urban expansion, urban population growth, marginalization of poor populations, government effectiveness, exposures and damages to climate-related extreme events, low-lying settlement, and wetlands prevalence, a cluster analysis reveals a global typology of seven clearly distinguishable clusters, or urban profiles of vulnerability. Each profile is characterized by a specific data-value combination of indicators representing mechanisms that generate vulnerability. Using 21 studies for testing the plausibility, we identify seven key profile-based vulnerabilities for urban populations, which are relevant in the context of global urbanization, expansion, and climate change. We show which urban coasts are similar in this regard. Sensitivity and exposure to extreme climate-related events, and government effectiveness, are the most important factors for the huge asymmetries of vulnerability between profiles. Against the background of underlying global trends we propose entry points for profile-based vulnerability reduction. The study provides a baseline for further pattern analysis in the rapidly urbanizing coastal fringe as data availability increases. We propose to explore socio-ecologically similar coastal urban areas as a basis for sharing experience and vulnerability-reducing measures among them.	[Sterzel, Till] Climate Babel, Beelitz, Germany; [Luedeke, Matthias K. B.; Walther, Carsten; Sietz, Diana] Potsdam Inst Climate Impact Res, Res Domain Climate Resilience 2, Potsdam, Germany; [Kok, Marcel T.; Lucas, Paul L.] PBL Netherlands Environm Assessment Agcy, Ah Bilthoven, Netherlands	Potsdam Institut fur Klimafolgenforschung	Sterzel, T (corresponding author), Climate Babel, Beelitz, Germany.	till@climate-babel.org	Lüdeke, Matthias/ABG-3798-2021	Lucas, Paul/0000-0003-0292-7830; Sietz, Diana/0000-0002-2309-2134	Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany; Netherlands Environmental Assessment Agency (PBL) [E555075]	Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany; Netherlands Environmental Assessment Agency (PBL)	The authors acknowledge the financial support from the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany who supports this work within the framework of the International Climate Protection Initiative; https://www.bmub.bund.de/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was funded in part by the Netherlands Environmental Assessment Agency (PBL) Project E555075, http://www.pbl.nl/en/contact.; The authors acknowledge the financial support from the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany who supports this work within the framework of the International Climate Protection Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded in part by the Netherlands Environmental Assessment Agency (PBL) Project E555075. We thank Henk Hilderink for helpful discussions on the methodology. We also thank Steffen Kriewald for valuable support in comparing different global digital elevation models.	Adelekan IO, 2010, ENVIRON URBAN, V22, P433, DOI 10.1177/0956247810380141; Alam M, 2007, ENVIRON URBAN, V19, P81, DOI 10.1177/0956247807076911; Allen SK, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P3; AMAP, 2017, SNOW WAT IC PERM SUM; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; Awuor CB, 2008, ENVIRON URBAN, V20, P231, DOI 10.1177/0956247808089158; Baird RC, 2009, MANAG ENVIRON QUAL, V20, P371, DOI 10.1108/14777830910963726; Birkmann J., 2013, MEASURING VULNERABIL; Birkmann J, 2016, NATURE, V537, P605, DOI 10.1038/537605a; Birkmann J, 2010, SUSTAIN SCI, V5, P171, DOI 10.1007/s11625-010-0108-y; Bloom DE, 2011, SCIENCE, V333, P562, DOI 10.1126/science.1209290; Bravo de Guenni L, 2005, MILLENIUM ECOSYSTEM, V1; Brecht H., 2013, POLICY RES WORKING P; Bull-Kamanga L, 2003, ENVIRON URBAN, V15, P193, DOI 10.1177/095624780301500109; Button C, 2013, LOCAL ENVIRON, V18, P705, DOI 10.1080/13549839.2013.798632; Carcellar N, 2011, ENVIRON URBAN, V23, P365, DOI 10.1177/0956247811415581; Cardona OD, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P65; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Center for International Earth Science Information Network (CIESIN) & NASA Socioeconomic Data and Applications Center (SEDAC), 2016, GRIDD POP WORLD VERS; Chatterjee M, 2010, MITIG ADAPT STRAT GL, V15, P337, DOI 10.1007/s11027-010-9221-6; Cohen B, 2006, TECHNOL SOC, V28, P63, DOI 10.1016/j.techsoc.2005.10.005; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; de Sherbinin A, 2007, ENVIRON URBAN, V19, P39, DOI 10.1177/0956247807076725; Dilley M, 2005, DISAST RISK MANAGE, P1; Dodman D, 2011, CIT CLIM CHANG GLOB; Douglas I, 2008, ENVIRON URBAN, V20, P187, DOI 10.1177/0956247808089156; El-Raey M., 2009, ARAB ENV CLIM CHANG, P47; Fraiman R, 2008, J AM STAT ASSOC, V103, P1294, DOI 10.1198/016214508000000544; Frazier TG, 2010, APPL GEOGR, V30, P490, DOI 10.1016/j.apgeog.2010.05.005; Garschagen M, 2015, CLIMATIC CHANGE, V133, P37, DOI 10.1007/s10584-013-0812-6; German Advisory Council on Global Change (WBGU), 2016, HUM MOV UNL TRANSF M; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Group C40 Cities Climate Leadership, 2016, CLIM CHANG AD DELT C; Grubler A., 2012, GLOBAL ENERGY ASSESS, P1307, DOI DOI 10.1017/CBO9780511793677.024; Guneralp B, 2015, GLOBAL ENVIRON CHANG, V31, P217, DOI 10.1016/j.gloenvcha.2015.01.002; Gupta K.A., 2010, J GEOGRAPHY REGIONAL, V3, P365; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Handmer J., 2007, HDB DISASTER EMERGEN; Handmer J, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P231; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; Hardoy J.E., 2001, ENV PROBLEMS URBANIZ; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Hoornweg D, 2011, URB DEV SER, P1, DOI 10.1596/978-0-8213-8493-0; Huq S, 2007, ENVIRON URBAN, V19, P3, DOI 10.1177/0956247807078058; Janssen P., 2012, CLUSTER ANAL UNDERST; Jarvis A, 2008, HOLE FILLED SRTM GLO; Kaufmann D, 2010, POLICY RES WORKING P, V18; Kit O, 2013, ISPRS J PHOTOGRAMM, V83, P130, DOI 10.1016/j.isprsjprs.2013.06.009; Kit O, 2011, LOCAL SUSTAIN, V1, P35, DOI 10.1007/978-94-007-0785-6_4; Klose CD, 2011, ENVIRON RES LETT, V6, DOI [10.1088/1748-9326/6/4/044015, DOI 10.1088/1748-9326/6/4/044015]; Klose CD, 2010, NATURE PRECEDINGS, DOI [10.1038/npre.2010.4737.1, DOI 10.1038/NPRE.2010.4737.1]; Kok M. T. J., 2010, QUANTITATIVE ANAL PA; Kok M, 2016, REG ENVIRON CHANGE, V16, P229, DOI 10.1007/s10113-014-0746-1; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Ludeke M, 2014, UNDERSTANDING CHANGE; Luque A, 2013, LOCAL ENVIRON, V18, P738, DOI 10.1080/13549839.2012.716414; Ma CH, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201903243; McCarney P., 2011, 1 ASSESSMENT REPORT, P249, DOI [DOI 10.3168/JDS.2011-4174, 10.3168/jds.2011-4174]; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Mondal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048191; Muis S, 2015, SCI TOTAL ENVIRON, V538, P445, DOI 10.1016/j.scitotenv.2015.08.068; Mukheibir P, 2007, ENVIRON URBAN, V19, P143, DOI 10.1177/0956247807076912; Nicholls R.J., 2007, OECD ENV WORKING PAP; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P69, DOI 10.1016/j.gloenvcha.2003.10.007; Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103; O'Brien K, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P437; Prasad N, 2009, CLIMATE RESILIENT CITIES: A PRIMER ON REDUCING VULNERABILITIES TO DISASTERS, P1, DOI 10.1596/978-0-8213-7766-6; Ranger N, 2011, CLIMATIC CHANGE, V104, P139, DOI 10.1007/s10584-010-9979-2; Rayos Co J., 2010, HUMAN SETTLEMENTS WO; Revi A, 2008, ENVIRON URBAN, V20, P207, DOI 10.1177/0956247808089157; Revi A, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P535; Romero Lankao P., 2007, HUMAN SETTLEMENTS DI; Rosenzweig C., 2018, CLIMATE CHANGE CITIE; Saab N, 2009, ARAB ENV CLIMATE CHA; Satterthwaite D, 2009, ENVIRON URBAN, V21, P545, DOI 10.1177/0956247809344361; Schroter D., 2005, Mitigation and Adaptation Strategies for Global Change, V10, P573, DOI 10.1007/s11027-005-6135-9; Schroter D., 2008, ASSESSING VULNERABIL; Seto K.C., 2012, P NATL ACAD SCI USA, V109, P1; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Sietz D, 2014, GLOBAL ENVIRON CHANG, V25, P173, DOI 10.1016/j.gloenvcha.2014.01.010; Sietz D, 2012, REG ENVIRON CHANGE, V12, P489, DOI 10.1007/s10113-011-0246-5; Sietz D, 2011, GLOBAL ENVIRON CHANG, V21, P431, DOI 10.1016/j.gloenvcha.2010.11.005; Stehfest E., 2014, INTEGRATED ASSESSMEN; Sterzel T, 2014, REG ENVIRON CHANGE, V14, P1419, DOI 10.1007/s10113-013-0553-0; Tacoli C., 2008, NEW GLOBAL FRONTIER, P37; Tanner T, INTRO DEV STUDIES WO; Tornqvist TE, 2008, NAT GEOSCI, V1, P805, DOI 10.1038/ngeo365; UN HABITAT, 2011, CIT CLIM CHANG GLOB; UN-HABITAT, 2007, GLOB REP HUM SETTL E; UN-Habitat (United Nations Human Settlements Programme), 2008, STAT WORLD CIT 2008; UNDESA (United Nations Department of Economic and Social Affairs), 2008, WORLD URB PROSP 2007; UNISDR, 2009, GLOBAL ASSESSMENT RE; UNISDR, 2011, GLOB ASS REP DIS RIS; UNSTAT, 2005, NAT ACC MAIN AGGR DA; Wilbanks T, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P357; *WORLD BANK, 2006, WORLD DEV IND	98	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0220936	10.1371/journal.pone.0220936	http://dx.doi.org/10.1371/journal.pone.0220936			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CX	32004319	Green Published, gold			2022-12-26	WOS:000534614600002
J	Afshar, N; English, DR; Blakely, T; Thursfield, V; Farrugia, H; Giles, GG; Milne, RL				Afshar, Nina; English, Dallas R.; Blakely, Tony; Thursfield, Vicky; Farrugia, Helen; Giles, Graham G.; Milne, Roger L.			Differences in cancer survival by area-level socio-economic disadvantage: A population-based study using cancer registry data	PLOS ONE			English	Article							NEW-SOUTH-WALES; NEW-ZEALAND; INEQUALITIES; IMPACT; TRENDS; DISPARITIES; MORTALITY	Despite overall improvements in cancer survival due to earlier diagnosis and better treatment, socio-economically disadvantaged people have lower cancer survival than more advantaged people. We aimed to examine differences in cancer survival by area-level socio-economic disadvantage in Victoria, Australia and assess whether these inequalities varied by year of diagnosis, age at diagnosis, time since diagnosis and sex. Cases diagnosed with a first primary cancer in 2001-2015 were identified using the Victorian Cancer Registry and followed to the end of 2016. Five-year net survival and the excess risk of death due to a cancer diagnosis were estimated. People living in more disadvantaged areas had lower five-year survival than residents of less disadvantaged regions for 21 of 29 cancer types: head and neck, oesophagus, stomach, colorectum, anus/anal canal, liver, gallbladder/biliary tract, pancreas, lung, melanoma, connective/soft tissue, female breast, ovary, prostate, kidney, bladder, brain and central nervous system, unknown primary, non-Hodgkin lymphoma, multiple myeloma and leukemia. The observed lower survival in more deprived regions persisted over time, except head and neck cancer, for which the gap in survival has widened. Socio-economic inequalities in survival decreased with increasing age at diagnosis for cancers of connective/soft tissue, bladder and unknown primary. For colorectal cancer, the observed survival disadvantage in lower socio-economic regions was greater for men than for women, while for brain and central nervous system tumours, it was larger for women. Cancer survival is generally lower for residents of more socio-economically disadvantaged areas. Identifying the underlying reasons for these inequalities is important and may help to identify effective interventions to increase survival for underprivileged cancer patients.	[Afshar, Nina; English, Dallas R.; Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia; [Afshar, Nina; English, Dallas R.; Blakely, Tony; Giles, Graham G.; Milne, Roger L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Thursfield, Vicky; Farrugia, Helen] Canc Council Victoria, Victorian Canc Registry, Melbourne, Vic, Australia; [Giles, Graham G.; Milne, Roger L.] Monash Univ, Monash Hlth, Sch Clin Sci, Precis Med, Clayton, Vic, Australia	Cancer Council Victoria; University of Melbourne; Cancer Council Victoria; Monash University	Afshar, N (corresponding author), Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia.; Afshar, N (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia.	Nina.Afshar@cancervic.org.au	Afshar, Nina/GSN-0396-2022; Afshar, Nina/ADZ-4359-2022	Afshar, Nina/0000-0001-5587-9540	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. N.A. is the recipient of an Australian Government Research Training Program Scholarship.	Afshar N, 2018, CANCER CAUSE CONTROL, V29, P1059, DOI 10.1007/s10552-018-1079-z; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Australian Bureau of Statistics, 2018, LIF TABL STAT TERR A; Australian Bureau of Statistics, 2016, MAIN STRUCT GREAT CA, V1; Australian Bureau of Statistics, 2011, INF PAP CENS DICT; Australian Bureau of Statistics, 2016, TECHNICAL PAPER SOCI; Australian Institute of Health and Welfare, 2018, AUSTR I HLTH WELF CA; Australian Institute of Health and Welfare, 2019, CANC SER, V119; Beckmann KR, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1263-3; Blakely T, 2012, INT J CANCER, V131, pE974, DOI 10.1002/ijc.27531; Cervical, CERV SCREEN AUSTR 20; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; Coviello E, 2015, STATA J, V15, P173, DOI 10.1177/1536867X1501500111; Dabbikeh Andrew, 2017, CMAJ Open, V5, pE682, DOI 10.9778/cmajo.20170025; Dalton SO, 2019, ACTA ONCOL, V58, P737, DOI 10.1080/0284186X.2019.1566772; Dickman PW, 2015, STATA J, V15, P186, DOI 10.1177/1536867X1501500112; Ederer F., 1959, INSTRUCTIONS IBM 650; Ellison L F, 2001, Health Rep, V13, P23; Ellison LF, 2016, HEALTH REP, V27, P19; Jeffreys M, 2009, CANCER EPIDEM BIOMAR, V18, P915, DOI 10.1158/1055-9965.EPI-08-0685; KOGEVINAS M, 1991, J EPIDEMIOL COMMUN H, V45, P216, DOI 10.1136/jech.45.3.216; Micheli A, 2009, EUR J CANCER, V45, P1017, DOI 10.1016/j.ejca.2008.11.008; Moser Elizabeth Charlotte, 2014, EJC Suppl, V12, P1, DOI 10.1016/j.ejcsup.2014.03.001; Nair-Shalliker V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22589-y; Nur U, 2015, CANCER EPIDEMIOL, V39, P641, DOI 10.1016/j.canep.2015.05.006; Pathirana T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022457; Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x; Radkiewicz C, 2017, EUR J CANCER, V84, P130, DOI 10.1016/j.ejca.2017.07.013; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Shack LG, 2007, BRIT J CANCER, V97, P999, DOI 10.1038/sj.bjc.6603980; Sharrocks K, 2014, BRIT J CANCER, V111, P1684, DOI 10.1038/bjc.2014.108; Singh GK, 2017, J ENVIRON PUBLIC HEA, V2017, P1, DOI 10.1155/2017/2819372; Smyth GK, 2003, INST MATH S, V40, P115; Soeberg M, 2015, CANCER EPIDEMIOL, V39, P860, DOI 10.1016/j.canep.2015.10.018; Stanbury JF, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2065-z; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Tervonen HE, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4692-y; Vaccarella S, 2018, CA-CANCER J CLIN, V68, P324, DOI 10.3322/caac.21463; VanderWeele T J, 2014, Epidemiol Methods, V2, P95; Woods LM, 2016, INT J CANCER, V138, P2396, DOI 10.1002/ijc.29983; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; Yu XQ, 2008, CANCER CAUSE CONTROL, V19, P1383, DOI 10.1007/s10552-008-9210-1	43	19	19	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228551	10.1371/journal.pone.0228551	http://dx.doi.org/10.1371/journal.pone.0228551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999795	Green Published, gold			2022-12-26	WOS:000534612400094
J	Gestin, M; Helmfors, H; Falato, L; Lorenzon, N; Michalakis, FI; Langel, U				Gestin, Maxime; Helmfors, Henrik; Falato, Luca; Lorenzon, Nicola; Michalakis, Filip Ilias; Langel, Ulo			Effect of small molecule signaling in PepFect14 transfection	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDE; RECEPTOR-MEDIATED UPTAKE; ANTISENSE OLIGONUCLEOTIDES; ESTROGEN-RECEPTORS; RNA INTERFERENCE; DELIVERY; POTENT; SIRNA; NANOCOMPLEXES; EXPRESSION	Cell-penetrating peptides can be used to deliver oligonucleotide-based cargoes into cells. Previous studies have shown that the use of small molecule drugs could be an efficient method to increase the efficacy of delivery of oligonucleotides by cell-penetrating peptides either as targeting agents that can be used in formulation with the cell-penetrating peptide and its cargo or as cell signaling modulators that facilitates the cellular uptake of the treatment. This study presents two aims. The first aim is the identification of small molecule drugs that would induce a synergic effect on the transfection of splice correcting oligonucleotides assisted by PepFect14. The second aim is to identify the mechanisms behind the effect of small molecule drugs modulation of cell-penetrating peptide assisted transfection of oligonucleotides. Through an optimized, high-throughput luciferase assay for short oligonucleotide delivery using cell-penetrating peptides, and the simultaneous addition of a small molecule drug library, we show that three small molecule drugs (MPEP, VU0357121 and Ciproxifan) induced an increase in the transfection efficacy of PepFect14 in complex with a short single-stranded oligonucleotide in HeLa pLuc705 cells. These three drugs are described in the literature to be highly specific for their respective target receptors. However, none of those receptors are expressed in our cell line, indicating a yet non-described pathway of action for these small molecules. We show that the indicated small molecules, without interfering with the particles formed by PepFect14 and the oligonucleotide, interfere via still unidentified interactions in cell signaling, leading to an up-regulation of endocytosis and a higher efficacy in the delivery of short splice correcting oligonucleotides in complex with PepFect14.	[Gestin, Maxime; Helmfors, Henrik; Falato, Luca; Lorenzon, Nicola; Michalakis, Filip Ilias; Langel, Ulo] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden; [Langel, Ulo] Univ Tartu, Inst Technol, Lab Mol Biotechnol, Tartu, Estonia	Stockholm University; University of Tartu	Gestin, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden.	maxime.gestin@dbb.su.se		Gestin, Maxime/0000-0002-4164-166X; Lorenzon, Nicola/0000-0003-4128-011X; Langel, Ulo/0000-0001-6107-0844	Swedish Research Council [VR 521-2011-2461, VR 2017-03691]; IMI-COMPACT; Innovative Medicines Initiative Joint Undertaking [115363]; European Union; EFPIA companies; Swedish Cancer Foundation [CAN 2014/259]; European Regional Development Fund through the Center of Excellence in Molecular Cell Engineering [2014-2020.4.01.15-0013]; Estonian Research Council [IUT20-26]	Swedish Research Council(Swedish Research CouncilEuropean Commission); IMI-COMPACT; Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA companies; Swedish Cancer Foundation; European Regional Development Fund through the Center of Excellence in Molecular Cell Engineering; Estonian Research Council(Estonian Research Council)	This work was supported by the Swedish Research Council (VR 521-2011-2461 to UL and VR 2017-03691 to UL) (https://www.vr.se/english.html), and from IMI-COMPACT (https://www.imi.europa.eu), the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115363 resources of which are composed of financial contribution from the European Union's Seventh Framework Program (https://ec.europa.eu/research/fp7/index_en.cfm) (FP7/2007-2013) (IMI) and EFPIA companies in kind contribution, the Swedish Cancer Foundation (CAN 2014/259 toUL) (https://www.cancerfonden.se), and from the European Regional Development Fund through the Center of Excellence in Molecular Cell Engineering (2014-2020.4.01.15-0013 to UL) (https://ec.europa.eu/regional_policy/en/funding/erdf/), and by the Estonian Research Council (IUT20-26 to UL) (https://www.etag.ee/en/).The funders had no role in study design, data collection and analysis, decision to publish,	Astriab-Fisher A, 2002, PHARMACEUT RES, V19, P744, DOI 10.1023/A:1016136328329; Cervia LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171699; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Dowaidar M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12747-z; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ezzat K, 2015, NANO LETT, V15, P4364, DOI 10.1021/acs.nanolett.5b00490; Ezzat K, 2012, J CONTROL RELEASE, V162, P1, DOI 10.1016/j.jconrel.2012.06.006; Ezzat K, 2012, FASEB J, V26, P1172, DOI 10.1096/fj.11-191536; Ezzat K, 2011, NUCLEIC ACIDS RES, V39, P5284, DOI 10.1093/nar/gkr072; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Grove-Strawser D, 2010, NEUROSCIENCE, V170, P1045, DOI 10.1016/j.neuroscience.2010.08.012; Hagenow S, 2017, SCI REP, P7; Hammond AS, 2010, ACS CHEM NEUROSCI, V1, P702, DOI 10.1021/cn100051m; Helmfors H, 2015, ANAL BIOCHEM, V484, P136, DOI 10.1016/j.ab.2015.05.023; Ivanova GD, 2008, NUCLEIC ACIDS RES, V36, P6418, DOI 10.1093/nar/gkn671; Jarver P, 2015, NUCLEIC ACID THER, V25, P65, DOI 10.1089/nat.2014.0511; Kang SH, 1998, BIOCHEMISTRY-US, V37, P6235, DOI 10.1021/bi980300h; Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Kurrikoff K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17316-y; Kurrikoff K, 2016, EXPERT OPIN DRUG DEL, V13, P373, DOI 10.1517/17425247.2016.1125879; Lehto T, 2012, EXPERT OPIN DRUG DEL, V9, P823, DOI 10.1517/17425247.2012.689285; Lehto T, 2017, BIOCONJUGATE CHEM, V28, P782, DOI 10.1021/acs.bioconjchem.6b00680; Ligneau X, 1998, J PHARMACOL EXP THER, V287, P658; Lindberg S, 2015, J CONTROL RELEASE, V206, P58, DOI 10.1016/j.jconrel.2015.03.009; Lindberg S, 2013, INT J PHARMACEUT, V441, P242, DOI 10.1016/j.ijpharm.2012.11.037; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lo SL, 2008, BIOMATERIALS, V29, P2408, DOI 10.1016/j.biomaterials.2008.01.031; Meszaros M, 2018, EUR J PHARM SCI, V123, P228, DOI 10.1016/j.ejps.2018.07.042; Monje P, 2002, J CELL BIOCHEM, V86, P136, DOI 10.1002/jcb.10193; Niidome T, 1999, J PEPT RES, V54, P361, DOI 10.1034/j.1399-3011.1999.00122.x; O'Connor TP, 2006, NAT REV GENET, V7, P261, DOI 10.1038/nrg1829; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pleyer L, 2015, DRUG METAB REV, V47, P252, DOI 10.3109/03602532.2014.995379; Rago V, 2004, ANAT REC A; Song XN, 2018, BIOMATERIALS, V180, P78, DOI 10.1016/j.biomaterials.2018.07.006; Tam YYC, 2013, NANOMED-NANOTECHNOL, V9, P665, DOI 10.1016/j.nano.2012.11.006; Tanaka G, 2012, CHEM BIOL, V19, P1437, DOI 10.1016/j.chembiol.2012.09.011; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Tonges L, 2006, RNA, V12, P1431, DOI 10.1261/rna.2252206; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Veiman KL, 2013, MOL PHARMACEUT, V10, P199, DOI 10.1021/mp3003557; Yang Nicole J, 2015, Methods Mol Biol, V1266, P29, DOI 10.1007/978-1-4939-2272-7_3; Zhang ZP, 2006, MOL ENDOCRINOL, V20, P1547, DOI 10.1210/me.2005-0252	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228189	10.1371/journal.pone.0228189	http://dx.doi.org/10.1371/journal.pone.0228189			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999754	Green Published, Green Submitted, gold			2022-12-26	WOS:000534612400054
J	Niemann, U; Boecking, B; Brueggemann, P; Mebus, W; Mazurek, B; Spiliopoulou, M				Niemann, Uli; Boecking, Benjamin; Brueggemann, Petra; Mebus, Wilhelm; Mazurek, Birgit; Spiliopoulou, Myra			Tinnitus-related distress after multimodal treatment can be characterized using a key subset of baseline variables	PLOS ONE			English	Article							DEPRESSION; SEVERITY; QUESTIONNAIRE; ASSOCIATION; VALIDATION; THERAPY; ANXIETY	Background Chronic tinnitus is a complex condition that can be associated with considerable distress. Whilst cognitive-behavioral treatment (CBT) approaches have been shown to be effective, not all patients benefit from psychological or psychologically anchored multimodal therapies. Determinants of tinnitus-related distress thus provide valuable information about tinnitus characterization and therapy planning. Objective The study aimed to develop machine learning models that use variables (or "features") obtained before treatment to characterize patients' tinnitus-related distress status after treatment. Whilst initially all available variables were considered for model training, the final model was required to achieve highest predictive performance using only a small number of features. Methods 1,416 tinnitus patients (decompensated tinnitus: 32%) who completed a 7-day multimodal treatment encompassing tinnitus-specific components, CBT, physiotherapy and informational counseling were included in the analysis. At baseline, patients were assessed using 205 features from 10 questionnaires comprising sociodemographic and clinical information. A data-driven workflow was developed consisting of (a) an initial exploratory correlation analysis, (b) supervised machine learning to predict tinnitus-related distress after treatment (T1) using baseline data only (T0), and (c) post-hoc analysis of the best model to facilitate model inspection and understanding. Classification methods were embedded in a feature elimination wrapper that iteratively learned on features found to be important for the model in the preceding iteration, in order to keep the performance stable while successively reducing the model complexity. 10-fold cross-validation with area under the curve (AUC) as performance measure was implemented for model generalization error estimation. Results The best machine learning classifier (gradient boosted trees) can predict tinnitus-related distress in T1 with AUC = 0.890 using 26 features. Subjectively perceived tinnitus-related impairment, depressivity, sleep problems, physical health-related impairments in quality of life, time spent to complete questionnaires and educational level exhibited a high attribution towards model prediction. Conclusions Machine learning can reliably identify baseline features recorded prior to treatment commencement that characterize tinnitus-related distress after treatment. The identification of key features can contribute to an improved understanding of multifactorial contributors to tinnitus-related distress and thereon based multimodal treatment strategies.	[Niemann, Uli; Spiliopoulou, Myra] Otto von Guericke Univ, Fac Comp Sci, Univ Pl 2, Magdeburg, Germany; [Boecking, Benjamin; Brueggemann, Petra; Mebus, Wilhelm; Mazurek, Birgit] Charite Univ Med Berlin, Tinnitus Ctr, Charitepl 1, Berlin, Germany	Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Niemann, U (corresponding author), Otto von Guericke Univ, Fac Comp Sci, Univ Pl 2, Magdeburg, Germany.	uli.niemann@ovgu.de		Niemann, Uli/0000-0001-9634-2248				Andersson G, 2002, CLIN PSYCHOL REV, V22, P977, DOI 10.1016/S0272-7358(01)00124-6; Andersson G, 1999, BRIT J AUDIOL, V33, P201, DOI 10.3109/03005369909090101; [Anonymous], 1992, VERHALTENSTHERAPIE, DOI DOI 10.1159/000258202; [Anonymous], 2008, GESUNDHEITSOKONOMISC; Bischl B, 2016, J MACH LEARN RES, V17; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bruggemann P, 2018, HNO, V66, pS34, DOI 10.1007/s00106-017-0463-4; Bruggemann P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00341; Cima RFF, 2014, J AM ACAD AUDIOL, V25, P29, DOI 10.3766/jaaa.25.1.4; Cima RFF, 2012, LANCET, V379, P1951, DOI 10.1016/S0140-6736(12)60469-3; Ding BY, 2005, J COMPUT GRAPH STAT, V14, P280, DOI 10.1198/106186005X47697; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Folmer RL, 1999, OTOLARYNG HEAD NECK, V121, P48, DOI 10.1016/S0194-5998(99)70123-3; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Goebel G, 1998, TINNITUS FRAGEBOGEN; HALFORD JBS, 1991, J PSYCHOSOM RES, V35, P383, DOI 10.1016/0022-3999(91)90033-K; Hautzinger M., 2003, ADS ALLGEMEINE DEPRE; Hechenbichler K., 2004, SONDERFORSCHUNGSBERE, V386, P1, DOI DOI 10.5282/UBM/EPUB.1769; Hielscher T, 2018, EXPERT SYST APPL, V113, P147, DOI 10.1016/j.eswa.2018.07.003; Hiller W, 1997, J PSYCHOSOM RES, V43, P613, DOI 10.1016/S0022-3999(97)00188-8; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Horhold M, 1997, PSYCHOTHER PSYCH MED, V47, P156; HORHOLD M, 1993, Z MED PSYCHOL, V2, P27; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Lundberg SM, 2017, ADV NEUR IN, V30; Lundberg SM, 2019, EXPLAINABLE TREES LO; Martines F, 2010, EUR ARCH OTO-RHINO-L, V267, P1685, DOI 10.1007/s00405-010-1302-3; McCormack A, 2016, HEARING RES, V337, P70, DOI 10.1016/j.heares.2016.05.009; McCormack A, 2015, INT J AUDIOL, V54, P599, DOI 10.3109/14992027.2015.1014577; Quinlan R, 1993, C4 5 PROGRAMS MACHIN; R Core Team, 2021, R LANGUAGE ENV STAT; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rudin C., 2018, ARXIV180101489; Scholler G, 1999, PSYCHOTHER PSYCH MED, V49, P275; Trevis KJ, 2018, CLIN PSYCHOL REV, V60, P62, DOI 10.1016/j.cpr.2017.12.006; Venables WN., 2002, MODERN APPL STAT S, V4; Wallhausser-Franke E, 2013, SLEEP MED REV, V17, P65, DOI 10.1016/j.smrv.2012.04.003; Zirke N, 2013, QUAL LIFE RES, V22, P2095, DOI 10.1007/s11136-012-0338-9; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228037	10.1371/journal.pone.0228037	http://dx.doi.org/10.1371/journal.pone.0228037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999776	Green Published, Green Submitted, gold			2022-12-26	WOS:000534612400044
J	Martin, ER; Barbieri, A; Ford, RC; Robinson, RC				Martin, Eleanor R.; Barbieri, Alessandro; Ford, Robert C.; Robinson, Robert C.			In vivo crystals reveal critical features of the interaction between cystic fibrosis transmembrane conductance regulator (CFTR) and the PDZ2 domain of Na+/H+ exchange cofactor NHERF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PDZ domain; X-ray crystallography; molecular modeling; protein complex; protein crystallization; crystal structure; cystic fibrosis transmembrane conductance regulator (CFTR); cystic fibrosis; ion channel; protein-protein interaction	SOLVATED INTERACTION ENERGY; FUNCTIONAL EXPRESSION; PROTEIN INTERACTIONS; BINDING AFFINITIES; STRUCTURAL BASIS; KINASE; PHOSPHORYLATION; COMPLEX; ACTIN; AUTOINHIBITION	Crystallization of recombinant proteins has been fundamental to our understanding of protein function, dysfunction, and molecular recognition. However, this information has often been gleaned under extremely nonphysiological protein, salt, and H+ concentrations. Here, we describe the development of a robust Inka1-Box (iBox)?PAK4cat system that spontaneously crystallizes in several mammalian cell types. The semi-quantitative assay described here allows the measurement of in vivo protein-protein interactions using a novel GFP-linked reporter system that produces fluorescent readouts from protein crystals. We combined this assay with in vitro X-ray crystallography and molecular dynamics studies to characterize the molecular determinants of the interaction between the PDZ2 domain of Na+/H+ exchange regulatory cofactor NHE-RF1 (NHERF1) and cystic fibrosis transmembrane conductance regulator (CFTR), a protein complex pertinent to the genetic disease cystic fibrosis. These experiments revealed the crystal structure of the extended PDZ domain of NHERF1 and indicated, contrary to what has been previously reported, that residue selection at positions ?1 and ?3 of the PDZ-binding motif influences the affinity and specificity of the NHERF1 PDZ2-CFTR interaction. Our results suggest that this system could be utilized to screen additional protein-protein interactions, provided they can be accommodated within the spacious iBox-PAK4cat lattice.	[Martin, Eleanor R.; Barbieri, Alessandro; Ford, Robert C.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Michael Smith Bldg, Manchester M13 9PL, Lancs, England; [Martin, Eleanor R.; Robinson, Robert C.] ASTAR, Inst Mol & Cell Biol, Biopolis 138673, Singapore; [Barbieri, Alessandro] ASTAR, Bioinformat Inst BII, Biopolis 138671, Singapore; [Robinson, Robert C.] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Rayong 21210, Thailand; [Robinson, Robert C.] Okayama Univ, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan; [Martin, Eleanor R.] Luxembourg Inst Hlth, 1A-B,Rue Thomas Edison, L-1445 Luxembourg, Luxembourg	University of Manchester; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Vidyasirimedhi Institute of Science & Technology; Okayama University; Luxembourg Institute of Health	Robinson, RC (corresponding author), ASTAR, Inst Mol & Cell Biol, Biopolis 138673, Singapore.; Robinson, RC (corresponding author), Okayama Univ, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan.	br.okayama.u@gmail.com	robinson, robert/G-9702-2011	robinson, robert/0000-0001-6367-6903; Martin, Eleanor/0000-0003-4707-697X; Barbieri, Alessandro/0000-0002-0135-9977; Ford, Robert/0000-0002-0958-1505	University of Manchester, United Kingdom; Agency for Science, Technology and Research (A*STAR), Singapore; Vidyasirimedhi Institute of Science and Technology (VISTEC)	University of Manchester, United Kingdom; Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Vidyasirimedhi Institute of Science and Technology (VISTEC)	This work was supported by the University of Manchester, United Kingdom, the Agency for Science, Technology and Research (A*STAR), Singapore and by Vidyasirimedhi Institute of Science and Technology (VISTEC). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alewine C, 2006, MOL BIOL CELL, V17, P4200, DOI 10.1091/mbc.E06-02-0129; [Anonymous], [No title captured]; Arora K, 2014, BIOCHEMISTRY-US, V53, P4169, DOI 10.1021/bi401263h; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Baskaran Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9681; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; Breton S, 2000, J BIOL CHEM, V275, P18219, DOI 10.1074/jbc.M909857199; Case DA, 2014, AMBER 14; Cau Y, 2015, J CHEM INF MODEL, V55, P2611, DOI 10.1021/acs.jcim.5b00452; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Chumnarnsilpa S, 2009, P NATL ACAD SCI USA, V106, P13719, DOI 10.1073/pnas.0812383106; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elkins JM, 2007, PROTEIN SCI, V16, P683, DOI 10.1110/ps.062657507; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Holcomb J, 2014, BIOCHEM BIOPH RES CO, V448, P169, DOI 10.1016/j.bbrc.2014.04.085; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Houslay MD, 2009, BRIT J PHARMACOL, V158, P483, DOI 10.1111/j.1476-5381.2009.00359.x; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Kim JY, 2004, J BIOL CHEM, V279, P10389, DOI 10.1074/jbc.M312871200; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Loureiro CA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1580; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mamonova T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129554; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Monterisi S, 2012, J CELL SCI, V125, P1106, DOI 10.1242/jcs.089086; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Ostedgaard LS, 2003, P NATL ACAD SCI USA, V100, P1937, DOI 10.1073/pnas.2627982100; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Poli G, 2018, J ENZYM INHIB MED CH, V33, P956, DOI 10.1080/14756366.2018.1469017; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schrodinger L.L.C., 2015, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S13398-014-0173-7.2; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Southern KW, 2007, J CYST FIBROS, V6, P57, DOI 10.1016/j.jcf.2006.05.008; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	64	4	4	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4464	4476		10.1074/jbc.RA119.012015	http://dx.doi.org/10.1074/jbc.RA119.012015			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32014995	Green Published, hybrid			2022-12-26	WOS:000524499700009
J	Dahl, S; Pettersson, M; Eisfeldt, J; Schroder, AK; Wickstrom, R; Fahnehjelm, KT; Anderlid, BM; Lindstrand, A				Dahl, Sara; Pettersson, Maria; Eisfeldt, Jesper; Schroder, Anna Katharina; Wickstrom, Ronny; Fahnehjelm, Kristina Tear; Anderlid, Britt-Marie; Lindstrand, Anna			Whole genome sequencing unveils genetic heterogeneity in optic nerve hypoplasia	PLOS ONE			English	Article							COL4A1 MUTATIONS; DYSPLASIA; VARIABILITY; PHENOTYPE; STANDARDS; VARIANTS; CHILDREN; SPECTRUM; SOX5	Optic nerve hypoplasia (ONH) is a congenital malformation with a reduced number of retinal ganglion cell axons in a thin optic nerve. It is a common cause of visual impairment in children and ONH is associated with neurodevelopmental disorders, pituitary hormone deficiencies, and brain malformations. In most cases, the aetiology is unknown, but both environmental factors and genetic causes have been described. This study aimed to identify genetic variants underlying ONH in a well-characterised cohort of individuals with ONH. We performed array comparative genomic hybridization and whole genome sequencing in 29 individuals with ONH. Rare variants were verified by Sanger sequencing and inheritance was assessed in parental samples. We identified 11 rare single nucleotide variants (SNVs) in ten individuals, including a homozygous variant in KIF7 (previously associated with Joubert syndrome), a heterozygous de novo variant in COL4A1 (previously described in an individual with porencephaly), and a homozygous variant in COL4A2. In addition, one individual harboured a heterozygous variant in OPA1 and a heterozygous variant in COL4A1, both were inherited and assessed as variants of unknown clinical significance. Finally, a heterozygous deletion of 341 kb involving exons 7-18 of SOX5 (associated with Lamb-Schaffer syndrome) was identified in one individual. The overall diagnostic yield of pathogenic or likely pathogenic variants in individuals with ONH using whole genome sequencing was 4/29 (14%). Our results show that there is a genetic heterogeneity in ONH and indicate that genetic causes of ONH are not rare. We conclude that genetic testing is valuable in a substantial proportion of the individuals with ONH, especially in cases with non-isolated ONH.	[Dahl, Sara; Wickstrom, Ronny] Karolinska Inst, Neuropediatr Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Pettersson, Maria; Eisfeldt, Jesper; Schroder, Anna Katharina; Anderlid, Britt-Marie; Lindstrand, Anna] Karolinska Inst, Ctr Mol Med, Dept Mol Med & Surg, Stockholm, Sweden; [Eisfeldt, Jesper] Karolinska Inst, Sci Life Lab, Sci Pk, Stockholm, Sweden; [Fahnehjelm, Kristina Tear] St Erik Eye Hosp, Dept Paediat Ophthalmol, Stockholm, Sweden; [Fahnehjelm, Kristina Tear] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Anderlid, Britt-Marie; Lindstrand, Anna] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Dahl, S (corresponding author), Karolinska Inst, Neuropediatr Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden.	sara.dahl@ki.se	Lindstrand, Anna/J-3566-2012; Lindstrand, Anna/AAT-9969-2021; Teär Fahnehjelm, Kristina/HCI-1836-2022	Lindstrand, Anna/0000-0003-0806-5602; Lindstrand, Anna/0000-0003-0806-5602; Pettersson, Maria/0000-0003-3120-1625; Tear Fahnehjelm, Kristina/0000-0003-4165-0731	Swedish Research Council [2013-2603]; Swedish Society for Medical Research; Marianne and Marcus Wallenberg Foundation [2014.0084]; Stockholm County Council; Swedish Brain Foundation; SciLifeLab National projects; Linnea och Josef Carlsson Foundation; Sunnerdahl's Handicap Foundation; Sallskapet Barnavard; Frimurare barnhuset Foundation; HRH Crown Princess Lovisa and Axel Tielman's Foundation; Sigvard och Marianne Bernadotte Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Marianne and Marcus Wallenberg Foundation; Stockholm County Council(Stockholm County Council); Swedish Brain Foundation; SciLifeLab National projects; Linnea och Josef Carlsson Foundation; Sunnerdahl's Handicap Foundation; Sallskapet Barnavard; Frimurare barnhuset Foundation; HRH Crown Princess Lovisa and Axel Tielman's Foundation; Sigvard och Marianne Bernadotte Foundation	This research was supported by the Swedish Research Council [2013-2603] (AL), the Swedish Society for Medical Research (AL), Marianne and Marcus Wallenberg Foundation [2014.0084] (AL), Stockholm County Council (AL), the Swedish Brain Foundation (AL), SciLifeLab National projects (AL), Linnea och Josef Carlsson Foundation (SD, BMA), Sunnerdahl's Handicap Foundation (SD, RW), Sa<spacing diaeresis>llskapet Barnavard (SD), Frimurare barnhuset Foundation (SD, BMA), HRH Crown Princess Lovisa and Axel Tielman's Foundation (BMA), and Sigvard och Marianne Bernadotte Foundation (KTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ameur A, 2017, EUR J HUM GENET, V25, P1253, DOI 10.1038/ejhg.2017.130; Asadollahi R, 2018, EUR J HUM GENET, V26, P197, DOI 10.1038/s41431-017-0019-9; Atapattu N, 2012, HORM RES PAEDIAT, V78, P81, DOI 10.1159/000341148; Bachmann-Gagescu R, 2015, J MED GENET, V52, P514, DOI 10.1136/jmedgenet-2015-103087; Barboni P, 2010, OPHTHALMOLOGY, V117, P1547, DOI 10.1016/j.ophtha.2009.12.042; Bonneau D, 2014, BRAIN, V137, DOI 10.1093/brain/awu184; Chen CA, 2017, J MED GENET, V54, P441, DOI 10.1136/jmedgenet-2017-104626; Cidis M B, 1997, J Am Optom Assoc, V68, P325; Dahl S, 2019, ACTA PAEDIATR, V108, P1677, DOI 10.1111/apa.14751; Dahl S, 2018, ACTA PAEDIATR, V107, P484, DOI 10.1111/apa.14163; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Eisfeldt Jesper, 2017, F1000Res, V6, P664, DOI 10.12688/f1000research.11168.1; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Fahnehjelm KT, 2014, ACTA OPHTHALMOL, V92, P563, DOI 10.1111/aos.12270; Flex E, 2013, J MED GENET, V50, P493, DOI 10.1136/jmedgenet-2012-101405; Garcia-Filion P, 2013, CURR TREAT OPTION NE, V15, P78, DOI 10.1007/s11940-012-0209-2; Garcia-Filion P, 2010, ACTA OPHTHALMOL, V88, P527, DOI 10.1111/j.1755-3768.2008.01450.x; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gould DB, 2007, HUM MOL GENET, V16, P798, DOI 10.1093/hmg/ddm024; Gunda B, 2014, J NEUROL, V261, P500, DOI 10.1007/s00415-013-7224-4; Jeanne M, 2012, AM J HUM GENET, V90, P91, DOI 10.1016/j.ajhg.2011.11.022; Kahn BM, 2017, DIS MODEL MECH, V10, P29, DOI 10.1242/dmm.026195; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kim MR, 2006, JPN J OPHTHALMOL, V50, P250, DOI 10.1007/s10384-006-0310-8; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuo DS, 2014, HUM MOL GENET, V23, P1709, DOI 10.1093/hmg/ddt560; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Lee RWY, 2013, PEDIATR NEUROL, V48, P317, DOI 10.1016/j.pediatrneurol.2012.12.013; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lubinsky MS, 1997, AM J MED GENET, V69, P235, DOI 10.1002/(SICI)1096-8628(19970331)69:3<235::AID-AJMG4>3.3.CO;2-5; MARGALITH D, 1984, DEV MED CHILD NEUROL, V26, P311, DOI 10.1111/j.1469-8749.1984.tb04447.x; McCabe MJ, 2011, BEST PRACT RES CL EN, V25, P115, DOI 10.1016/j.beem.2010.06.008; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mcnay DEG, 2007, J CLIN ENDOCR METAB, V92, P691, DOI 10.1210/jc.2006-1609; Meire F, 2011, MOL VIS, V17, P2072; Meuwissen MEC, 2015, GENET MED, V17, P843, DOI 10.1038/gim.2014.210; Nesbitt A, 2015, AM J MED GENET A, V167, P2548, DOI 10.1002/ajmg.a.37221; Patel L, 2006, J PEDIATR-US, V148, P85, DOI 10.1016/j.jpeds.2005.07.031; Pettersson M, 2017, J CLIN ENDOCR METAB, V102, P3029, DOI 10.1210/jc.2017-00565; Plaisier E, 2007, NEW ENGL J MED, V357, P2687, DOI 10.1056/NEJMoa071906; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ruat M, 2012, DIFFERENTIATION, V83, pS97, DOI 10.1016/j.diff.2011.11.011; Sanchez-Ferrero E, 2013, CLIN GENET, V83, P257, DOI 10.1111/j.1399-0004.2012.01896.x; Schaaf CP, 2011, MOL GENET METAB, V103, P383, DOI 10.1016/j.ymgme.2011.04.018; Schimpf S, 2008, HUM MUTAT, V29, P106, DOI 10.1002/humu.20607; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Verbeek E, 2012, EUR J HUM GENET, V20, P844, DOI 10.1038/ejhg.2012.20; Yoneda Y, 2013, ANN NEUROL, V73, P48, DOI 10.1002/ana.23736; Yoneda Y, 2012, AM J HUM GENET, V90, P86, DOI 10.1016/j.ajhg.2011.11.016	56	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228622	10.1371/journal.pone.0228622	http://dx.doi.org/10.1371/journal.pone.0228622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040484	gold, Green Published			2022-12-26	WOS:000534629400031
J	Matias, AM; Coelho, PM; Marques, VB; dos Santos, L; de Assis, ALEM; Nogueira, BV; Lima-Leopoldo, AP; Leopoldo, AS				Matias, Amanda Martins; Coelho, Priscila Murucci; Marques, Vinicius Bermond; dos Santos, Leonardo; Evangelista Monteiro de Assis, Aricia Leone; Nogueira, Breno Valentim; Lima-Leopoldo, Ana Paula; Leopoldo, Andre Soares			Hypercaloric diet models do not develop heart failure, but the excess sucrose promotes contractility dysfunction	PLOS ONE			English	Article							HIGH-FAT; CARDIOMYOCYTE DYSFUNCTION; MYOCARDIAL-INFARCTION; BRAZILIAN GUIDELINES; INSULIN-RESISTANCE; DIASTOLIC FUNCTION; BLOOD-PRESSURE; RAT MODEL; OBESITY; CARBOHYDRATE	Several diseases are associated with excess of adipose tissue, and obesity is considered an independent risk factor for the development of cardiac remodeling and heart failure. Dietary aspects have been studied to elucidate the mechanisms involved in these processes. Thus, the purpose was the development and characterization of an obesity experimental model from hypercaloric diets, which resulted in cardiac remodeling and predisposition to heart failure. Thirty-day-old male Wistar rats (n = 52) were randomized into four groups: control (C), high sucrose (HS), high-fat (HF) and high-fat and sucrose (HFHS) for 20 weeks. General characteristics, comorbidities, weights of the heart, left (LV) and right ventricles, atrium, and relationships with the tibia length were evaluated. The LV myocyte cross sectional area and fraction of interstitial collagen were assayed. Cardiac function was determined by hemodynamic analysis and the contractility by cardiomyocyte contractile function. Heart failure was analyzed by pulmonary congestion, right ventricular hypertrophy, and hemodynamic parameters. HF and HFHS models led to obesity by increase in adiposity index (C = 8.3 +/- 0.2% vs. HF = 10.9 +/- 0.5%, HFHS = 10.2 +/- 0.3%). There was no change in the morphological parameters and heart failure signals. HF and HFHS caused a reduction in times to 50% relaxation without cardiomyocyte contractile damage. The HS model presented cardiomyocyte contractile dysfunction visualized by lower shortening (C: 8.34 +/- 0.32% vs. HS: 6.91 +/- 0.28), as well as the Ca2+ transient amplitude was also increased when compared to HFHS. In conclusion, the experimental diets based on high amounts of sugar, lard or a combination of both did not promote cardiac remodeling with predisposition to heart failure under conditions of obesity or excess sucrose. Nevertheless, excess sucrose causes cardiomyocyte contractility dysfunction associated with alterations in the myocyte sensitivity to intracellular Ca2+.	[Matias, Amanda Martins; Coelho, Priscila Murucci; Lima-Leopoldo, Ana Paula; Leopoldo, Andre Soares] Univ Fed Espirito Santo, Ctr Hlth Sci, Postgrad Program Nutr & Hlth, Vitoria, ES, Brazil; [Marques, Vinicius Bermond; dos Santos, Leonardo] Univ Fed Espirito Santo, Ctr Hlth Sci, Dept Physiol Sci, Vitoria, ES, Brazil; [Evangelista Monteiro de Assis, Aricia Leone; Nogueira, Breno Valentim] Univ Fed Espirito Santo, Ctr Hlth Sci, Dept Morphol, Vitoria, ES, Brazil; [Lima-Leopoldo, Ana Paula; Leopoldo, Andre Soares] Univ Fed Espirito Santo, Ctr Phys Educ & Sports, Dept Sports, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Leopoldo, AS (corresponding author), Univ Fed Espirito Santo, Ctr Hlth Sci, Postgrad Program Nutr & Hlth, Vitoria, ES, Brazil.; Leopoldo, AS (corresponding author), Univ Fed Espirito Santo, Ctr Phys Educ & Sports, Dept Sports, Vitoria, ES, Brazil.	andre.leopoldo@ufes.br	dos Santos, Leonardo/B-6509-2013; Leopoldo, André Soares/F-9924-2012; Coelho, Paulo Marcos Zech/ABE-6169-2021	dos Santos, Leonardo/0000-0002-4340-6364; Coelho, Paulo Marcos Zech/0000-0002-2443-8897; Bermond Marques, Vinicius/0000-0002-3522-3867; Leopoldo, Andre Soares/0000-0001-5999-2671	Brazilian National Council for Scientific and Technological Development - CNPq [402090/2016-0]; FAPES [590/2019]	Brazilian National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPES(Fundacao de Amparo a Pesquisa do Estado de Espiritu Santo (FAPES))	This study was supported by the Brazilian National Council for Scientific and Technological Development - CNPq (grant number: 402090/2016-0) to ASL and FAPES (grant number: 590/2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Alfarano C, 2015, INT J OBESITY, V39, P312, DOI 10.1038/ijo.2014.122; Alpert MA, 2016, CURR OBES REP, V5, P424, DOI 10.1007/s13679-016-0235-6; Alpert MA, 2014, TRANSL RES, V164, P345, DOI 10.1016/j.trsl.2014.04.010; Balderas-Villalobos J, 2013, AM J PHYSIOL-HEART C, V305, pH1344, DOI 10.1152/ajpheart.00211.2013; Barnes MJ, 2003, BRAIN RES BULL, V61, P511, DOI 10.1016/S0361-9230(03)00188-6; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Bocchi EA, 2009, ARQ BRAS CARDIOL, V93, P1, DOI 10.1590/S0066-782X2009002000001; Carbone S, 2015, INT J CARDIOL, V198, P66, DOI 10.1016/j.ijcard.2015.06.136; Carvajal K, 2014, CELL CALCIUM, V56, P408, DOI 10.1016/j.ceca.2014.08.003; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Clark AL, 2014, PROG CARDIOVASC DIS, V56, P409, DOI 10.1016/j.pcad.2013.10.004; Davidoff AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE718, DOI 10.1152/ajpendo.00358.2003; De Schutter A, 2014, PROG CARDIOVASC DIS, V56, P401, DOI 10.1016/j.pcad.2013.08.003; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Fauconnier J, 2007, DIABETES, V56, P1136, DOI 10.2337/db06-0739; Francis J, 2001, AM J PHYSIOL-REG I, V281, pR1734, DOI 10.1152/ajpregu.2001.281.5.R1734; Gonsolin D, 2007, MOL CELL BIOCHEM, V295, P217, DOI 10.1007/s11010-006-9291-7; HILL DJ, 1985, PEDIATR RES, V19, P879, DOI 10.1203/00006450-198509000-00001; Leopoldo AS, 2011, J CELL PHYSIOL, V226, P2934, DOI 10.1002/jcp.22643; Leopoldo AS, 2010, CAN J CARDIOL, V26, P423, DOI 10.1016/S0828-282X(10)70440-2; Lima-Leopoldo AP, 2014, J APPL PHYSIOL, V117, P669, DOI 10.1152/japplphysiol.00088.2014; Liu J, 2013, NUTR RES, V33, P311, DOI 10.1016/j.nutres.2013.02.005; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Martins F, 2015, ARQ BRAS CARDIOL, V105, P479, DOI 10.5935/abc.20150095; Matias AM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081071; Pang XF, 2008, J ETHNOPHARMACOL, V117, P325, DOI 10.1016/j.jep.2008.02.002; Pereira RB, 2005, J PHARMACOL EXP THER, V312, P1321, DOI 10.1124/jpet.104.077701; Phillips RA, 1998, J CLIN ENDOCR METAB, V83, P4284, DOI 10.1210/jc.83.12.4284; Polegato BF, 2016, ARQ BRAS CARDIOL, V106, P105, DOI 10.5935/abc.20160015; Poudyal H, 2012, AM J PHYSIOL-ENDOC M, V302, pE1472, DOI 10.1152/ajpendo.00102.2012; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Rosini TC, 2012, REV ASSOC MED BRAS, V58, P383; Salie R, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0109-8; Santos RD, 2012, ARQ BRAS CARDIOL, V99, P1, DOI [10.5935/abc.20120202, 10.1590/S0066-782X2013000900001]; Sharma N, 2007, CARDIOVASC RES, V73, P257, DOI 10.1016/j.cardiores.2006.11.007; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; STRAUS DS, 1984, ENDOCR REV, V5, P356, DOI 10.1210/edrv-5-2-356; Teerlink JR, 1993, J AM COLL CARDIOL, V22, P615, DOI 10.1016/0735-1097(93)90073-A; Tucci PJF, 2011, ARQ BRAS CARDIOL, V96, P420, DOI 10.1590/S0066-782X2011005000049; Vasanji Z, 2006, AM J PHYSIOL-CELL PH, V291, pC772, DOI 10.1152/ajpcell.00086.2005	41	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228860	10.1371/journal.pone.0228860	http://dx.doi.org/10.1371/journal.pone.0228860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032383	Green Published, gold			2022-12-26	WOS:000534626100031
J	Gromboni, JGG; de Oliveira, HC; Marques, DBD; Garcia, AAP; Farias, RV; Gromboni, CF; Souza, TM; Wenceslau, AA				Gonzaga Gromboni, Juliana Gracielle; de Oliveira, Haniel Cedraz; Diniz Marques, Daniele Botelho; Pinto Garcia Junior, Antonio Amandio; Farias Filho, Ronaldo Vasconcelos; Gromboni, Caio Fernando; Souza, Teillor Machado; Wenceslau, Amauri Arias			Influence of heat stress on reference genes stability in heart and liver of two chickens genotypes	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; RT-PCR; EXPRESSION; SELECTION; NORMALIZATION; VALIDATION; PITUITARY	Introduction Real-time polymerase chain reaction (RT-qPCR) is an important tool for analyzing gene expression. However, before analyzing the expression of target genes, it is crucial to normalize the reference genes, in order to find the most stable gene to be used as an endogenous control. A gene that remains stable in all samples under different treatments is considered a suitable normalizer. In this sense, we aimed to identify stable reference genes for normalization of target genes in the heart and liver tissues from two genetically divergent groups of chickens (Cobb 500 (R) commercial line and Peloco backyard chickens) under comfort and acute heat stress environmental conditions. Eight reference genes (ACTB, HPRT1, RPL5, EEF1, MRPS27, MRPS30, TFRC and LDHA) were analyzed for expression stability. The samples were obtained from 24 chickens, 12 from the backyard Peloco and 12 from the Cobb 500 (R) line, exposed to two environmental conditions (comfort and heat stress). Comfort temperature was 23 degrees C and heat stress temperature was 39.5 degrees C for one hour. Subsequently, the animals were euthanized, and heart and liver tissue fragments were collected for RNA extraction and amplification. To determine the stability rate of gene expression, three different statistical algorithms were applied: BestKeeper, geNorm and NormFinder, and to obtain an aggregated stability list, the RankAgregg package of R software was used. Results The most stable genes using BestKeeper tool, including the two factors (genetic group and environmental condition), were LDHA, RPL5 and MRPS27 for heart tissue, and TFRC, RPL5 and EEF1 for liver tissue. Applying geNorm algorithm, the best reference genes were RPL5, EEF1 and MRPS30 for heart tissue and LDHA, EEF1 and RPL5 for liver. Using the NormFinder algorithm, the best normalizer genes were EEF1, RPL5 and LDHA in heart, and EEF1, RPL5 and ACTB in liver tissue. In the overall ranking obtained by RankAggreg package, considering the three algorithms, the RPL5, EEF1 and LDHA genes were the most stable for heart tissue, whereas RPL5, EEF1 and ACTB were the most stable for liver tissue. Conclusion According to the RankAggreg tool classification based on the three different algorithms (BestKeeper, geNorm and NormFinder), the most stable genes were RPL5, EEF1 and LDHA for heart tissue and RPL5, EEF1 and ACTB for liver tissue of chickens subjected to comfort and acute heat stress environmental conditions. However, the best reference genes may vary depending on the experimental conditions of each study, such as different breeds, environmental stressors, and tissues analyzed. Therefore, the need to perform priori studies to assay the best reference genes at the outset of each study is emphasized.	[Gonzaga Gromboni, Juliana Gracielle] Univ Estadual Santa CruzUESC, Pos Grad Program Anim Sci, Ilheus, BA, Brazil; [de Oliveira, Haniel Cedraz; Diniz Marques, Daniele Botelho] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Pinto Garcia Junior, Antonio Amandio; Farias Filho, Ronaldo Vasconcelos] Univ Estadual Sudoeste Bahia, Dept Rural & Anim Technol, Itapetinga, BA, Brazil; [Gromboni, Caio Fernando] Inst Fed Educ Ciencia & Tecnol Bahia IFBA, Ilheus, BA, Brazil; [Souza, Teillor Machado] Univ Estadual Santa Cruz UESC, Vet Med, Ilheus, BA, Brazil; [Wenceslau, Amauri Arias] Univ Estadual Santa Cruz UESC, Dept Agr & Environm Sci, Ilheus, BA, Brazil	Universidade Federal de Vicosa; Universidade Estadual do Sudoeste da Bahia; Instituto Federal da Bahia (IFBA); Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz	Gromboni, JGG (corresponding author), Univ Estadual Santa CruzUESC, Pos Grad Program Anim Sci, Ilheus, BA, Brazil.	jugracielle@hotmail.com		Botelho Diniz Marques, Daniele/0000-0001-7080-7465	Fundacao de Amparo a Pesquisa no Estado da Bahia (FAPESB); Universidade Estadual de Santa Cruz (UESC); Universidade Estadual do Sudoeste da Bahia (UESB)	Fundacao de Amparo a Pesquisa no Estado da Bahia (FAPESB); Universidade Estadual de Santa Cruz (UESC); Universidade Estadual do Sudoeste da Bahia (UESB)	This study was financially supported by Fundacao de Amparo a Pesquisa no Estado da Bahia (FAPESB), Universidade Estadual de Santa Cruz (UESC) and Universidade Estadual do Sudoeste da Bahia (UESB).	Ahn K, 2011, GENES GENOM, V33, P245, DOI 10.1007/s13258-010-0114-6; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2013, SEMIN CIENC BIOL SAU, DOI DOI 10.5433/1679-0367.2013v34n2p125; Bages S, 2015, GENE, V561, P82, DOI 10.1016/j.gene.2015.02.016; Bentz AB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52312-4; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Capitelli Raffaella, 2013, Vet Clin North Am Exot Anim Pract, V16, P71, DOI 10.1016/j.cvex.2012.10.002; Caracausi M, 2017, MOL MED REP, V16, P2397, DOI 10.3892/mmr.2017.6944; de Oliveira HC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176402; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Hassanpour H, 2018, POULTRY SCI, V97, P4048, DOI 10.3382/ps/pey258; Hawkins MG, 2006, VET CLIN PATH, V35, P219, DOI 10.1111/j.1939-165X.2006.tb00118.x; Jemiolo B, 2004, BIOCHEM BIOPH RES CO, V320, P1043, DOI 10.1016/j.bbrc.2004.05.223; Kishore A, 2013, MOL CELL PROBE, V27, P140, DOI 10.1016/j.mcp.2013.02.003; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Laine VN, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6043-0; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Martinez-Giner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066023; Mengmeng L, 2017, GENE, V620, P30, DOI [10.1016/j.gene.2017.04.006, DOI 10.1016/J.GENE.2017.04.006]; Najafpanah MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083041; Nascimento CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127935; Nerren JR, 2010, VET IMMUNOL IMMUNOP, V136, P151, DOI 10.1016/j.vetimm.2010.02.017; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rostagno H. S., 2011, COMPOSICAO ALIMENTOS; Staines K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160173; Team RC, 2015, LANG ENV STAT COMP; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weber R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/198582; Yang CG, 2013, GENE, V527, P183, DOI 10.1016/j.gene.2013.06.013; Zang R, 2011, ASIAN J ANIM VET ADV, V6, P789, DOI 10.3923/ajava.2011.789.804; Zhang J, 2018, ITAL J ANIM SCI, V17, P540, DOI [10.1080/1828051X.2017.1365633, 10.1080/1828051x.2017.1365633]; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zinzow-Kramer WM, 2014, HORM BEHAV, V66, P267, DOI 10.1016/j.yhbeh.2014.04.011	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228314	10.1371/journal.pone.0228314	http://dx.doi.org/10.1371/journal.pone.0228314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027666	Green Published, gold			2022-12-26	WOS:000534623800021
J	Maudsley-Barton, S; Yap, MH; Bukowski, A; Mills, R; McPhee, J				Maudsley-Barton, Sean; Yap, Moi Hoon; Bukowski, Anthony; Mills, Richard; McPhee, Jamie			A new process to measure postural sway using a Kinect depth camera during a Sensory Organisation Test	PLOS ONE			English	Article							MICROSOFT KINECT; HUMAN BALANCE; AGE; NONFALLERS; VALIDITY; FALLERS	Posturography provides quantitative, objective measurements of human balance and postural control for research and clinical use. However, it usually requires access to specialist equipment to measure ground reaction forces, which are not widely available in practice, due to their size or cost. In this study, we propose an alternative approach to posturography. It uses the skeletal output of an inexpensive Kinect depth camera to localise the Centre of Mass (CoM) of an upright individual. We demonstrate a pipeline which is able to measure postural sway directly from CoM trajectories, obtained from tracking the relative position of three key joints. In addition, we present the results of a pilot study that compares this method of measuring postural sway to the output of a NeuroCom SMART Balance Master. 15 healthy individuals (age: 42.3 +/- 20.4 yrs, height: 172 +/- 11 cm, weight: 75.1 +/- 14.2 kg, male = 11), completed 25 Sensory Organisation Test (SOT) on a NeuroCom SMART Balance Master. Simultaneously, the sessions were recorded using custom software developed for this study (CoM path recorder). Postural sway was calculated from the output of both methods and the level of agreement determined, using Bland-Altman plots. Good agreement was found for eyes open tasks with a firm support, the agreement decreased as the SOT tasks became more challenging. The reasons for this discrepancy may lie in the different approaches that each method takes to calculate CoM. This discrepancy warrants further study with a larger cohort, including fall-prone individuals, cross-referenced with a marker-based system. However, this pilot study lays the foundation for the development of a portable device, which could be used to assess postural control, more cost-effectively than existing equipment.	[Maudsley-Barton, Sean; Yap, Moi Hoon; Bukowski, Anthony] Manchester Metropolitan Univ, Dept Comp & Math, Manchester, Lancs, England; [Mills, Richard; McPhee, Jamie] Manchester Metropolitan Univ, Dept Sport & Exercise Sci, Manchester, Lancs, England	Manchester Metropolitan University; Manchester Metropolitan University	Maudsley-Barton, S (corresponding author), Manchester Metropolitan Univ, Dept Comp & Math, Manchester, Lancs, England.	s.maudsley-barton@mmu.ac.uk		Maudsley-Barton, Sean/0000-0003-0289-0783; McPhee, Jamie/0000-0002-3659-0773; Yap, Moi Hoon/0000-0001-7681-4287; Mills, Richard/0000-0002-3249-7539	Manchester Metropolitan University	Manchester Metropolitan University	This work was funded by the Manchester Metropolitan University.; This work was funded by the Manchester Metropolitan University.	Abrahamova D, 2008, PHYSIOL RES, V57, P957, DOI 10.33549/physiolres.931238; Benda B. J., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P3, DOI 10.1109/86.296348; BLACK FO, 1982, AM J OTOLARYNG, V3, P309, DOI 10.1016/S0196-0709(82)80002-1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bogaerts A, 2007, GAIT POSTURE, V26, P309, DOI 10.1016/j.gaitpost.2006.09.078; Buatois S, 2006, GERONTOLOGY, V52, P345, DOI 10.1159/000094983; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; Craig CE, 2016, NEUROSCIENCE, V322, P251, DOI 10.1016/j.neuroscience.2016.02.036; Cretual A, 2015, NEUROPHYSIOL CLIN, V45, P285, DOI 10.1016/j.neucli.2015.07.004; Galna B, 2014, GAIT POSTURE, V39, P1062, DOI 10.1016/j.gaitpost.2014.01.008; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Halvarsson A, 2013, OSTEOPOROSIS INT, V24, P1853, DOI 10.1007/s00198-012-2197-1; HASSELKUS BR, 1975, J GERONTOL, V30, P661, DOI 10.1093/geronj/30.6.661; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Kapteyn T S, 1983, Agressologie, V24, P321; Lafond D, 2004, J BIOMECH, V37, P1421, DOI 10.1016/S0021-9290(03)00251-3; Leightley D, 2016, J AGING PHYS ACTIV, V25, P1; Leightley D, 2017, IEEE J BIOMED HEALTH, V21, P939, DOI 10.1109/JBHI.2016.2558540; Leightley D, 2015, ASIAPAC SIGN INFO PR, P1, DOI 10.1109/APSIPA.2015.7415438; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; McPhee JS, 2016, BIOGERONTOLOGY, V17, P567, DOI 10.1007/s10522-016-9641-0; Monsell EM, 1997, OTOLARYNG HEAD NECK, V117, P394, DOI 10.1016/S0194-5998(97)70132-3; Morasso PG, 1999, HUM MOVEMENT SCI, V18, P759, DOI 10.1016/S0167-9457(99)00039-1; Mujdeci B, 2012, BRAZ J OTORHINOLAR, V78, P104, DOI 10.5935/1808-8694.20120016; MULLER B, 2017, PLOS ONE, V12, P17, DOI DOI 10.1017/S1743921317002575; Narayanan MR, 2010, IEEE T BIO-MED ENG, V57, P534, DOI 10.1109/TBME.2009.2033038; Nardone A, 2010, EUR J PHYS REHAB MED, V46, P221; NASHNER LM, 1982, J NEUROSCI, V2, P536; NICE,, 2013, FALLS OLD PEOPL ASS; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Roller M, 2009, BALANCE MANAGER CLIN; Shih MC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0185-y; Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Tideiksaar R., 1998, FALLS OLDER PEOPLE R; Vemulapalli R, 2014, PROC CVPR IEEE, P588, DOI 10.1109/CVPR.2014.82; Visser JE, 2008, CLIN UTILITY POSTURO; Wallmann HW, 2001, J GERONTOL A-BIOL, V56, pM580, DOI 10.1093/gerona/56.9.M580; Wang Q, 2015, EVALUATION POSE TRAC; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter D. A., 2009, BIOMECHANICS MOTOR C, DOI DOI 10.1002/9780470549148; Yeung LF, 2014, GAIT POSTURE, V40, P532, DOI 10.1016/j.gaitpost.2014.06.012	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227485	10.1371/journal.pone.0227485	http://dx.doi.org/10.1371/journal.pone.0227485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023256	gold, Green Published, Green Accepted			2022-12-26	WOS:000534621500015
J	Messerli, M; Aaldijk, D; Haberthur, D; Ross, H; Garcia-Poyatos, C; Sande-Melon, M; Khoma, OZ; Wieland, FAM; Fark, S; Djonov, V				Messerli, Matthias; Aaldijk, Dea; Haberthur, David; Ross, Helena; Garcia-Poyatos, Carolina; Sande-Melon, Marcos; Khoma, Oleksiy-Zakhar; Wieland, Fluri A. M.; Fark, Sarya; Djonov, Valentin			Adaptation mechanism of the adult zebrafish respiratory organ to endurance training	PLOS ONE			English	Article							COMPENSATORY LUNG GROWTH; EXERCISE; MUSCLE; OXYGEN; HYPOXIA; VOLUME; FISH	In order to study the adaptation scope of the fish respiratory organ and the O-2 metabolism due to endurance training, we subjected adult zebrafish (Danio rerio) to endurance exercise for 5 weeks. After the training period, the swimmer group showed a significant increase in swimming performance, body weight and length. In scanning electron microscopy of the gills, the average length of centrally located primary filaments appeared significantly longer in the swimmer than in the non-trained control group (+6.1%, 1639 mu m vs. 1545 mu m, p = 0.00043) and the average number of secondary filaments increased significantly (+7.7%, 49.27 vs. 45.73, p = 9e-09). Micro-computed tomography indicated a significant increase in the gill volume (p = 0.048) by 11.8% from 0.490 mm(3) to 0.549 mm(3). The space-filling complexity dropped significantly (p = 0.0088) by 8.2% from 38.8% to 35.9%., i.e. making the gills of the swimmers less compact. Respirometry after 5 weeks showed a significantly higher oxygen consumption (+30.4%, p = 0.0081) of trained fish during exercise compared to controls. Scanning electron microscopy revealed different stages of new secondary filament budding, which happened at the tip of the primary lamellae. Using BrdU we could confirm that the growth of the secondary filaments took place mainly in the distal half and the tip and for primary filaments mainly at the tip. We conclude that the zebrafish respiratory organ-unlike the mammalian lung-has a high plasticity, and after endurance training increases its volume and changes its structure in order to facilitate O-2 uptake.	[Messerli, Matthias; Aaldijk, Dea; Haberthur, David; Ross, Helena; Khoma, Oleksiy-Zakhar; Wieland, Fluri A. M.; Fark, Sarya; Djonov, Valentin] Univ Bern, Inst Anat, Topog & Clin Anat, CH-3012 Bern, Switzerland; [Garcia-Poyatos, Carolina; Sande-Melon, Marcos] Univ Bern, Inst Anat, Dev Biol & Regenerat, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Djonov, V (corresponding author), Univ Bern, Inst Anat, Topog & Clin Anat, CH-3012 Bern, Switzerland.	djonov@ana.unibe.ch	Poyatos, Carolina García/ABI-2282-2020; Haberthür, David/K-2105-2014	Poyatos, Carolina García/0000-0003-0918-5403; Haberthür, David/0000-0003-3388-9187; Djonov, Valentin/0000-0002-5062-1169; Sande, Marcos/0000-0003-3844-0143; Messerli, Matthias/0000-0003-0247-9732	Swiss National Foundation [31003A_176038]; Swiss Cancer Research [KFS-4281-08-2017]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss Cancer Research	The present work was supported by the Swiss National Foundation (31003A_176038) and Swiss Cancer Research (KFS-4281-08-2017) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; ARMOUR J, 1993, EUR RESPIR J, V6, P237; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Baum O, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.171819; BaxterJones ADG, 1996, PEDIATR EXERC SCI, V8, P310, DOI 10.1123/pes.8.4.310; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012; BOESGAARD L, 1993, COMP BIOCHEM PHYS A, V106, P641, DOI 10.1016/0300-9629(93)90373-C; Bovard JM, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13816; Butler JP, 2012, NEW ENGL J MED, V367, P244, DOI 10.1056/NEJMoa1203983; Courteix D, 1997, EUR J APPL PHYSIOL O, V76, P264, DOI 10.1007/s004210050246; Fagard RH, 1996, INT J SPORTS MED, V17, pS140, DOI 10.1055/s-2007-972915; Fu SJ, 2011, J EXP BIOL, V214, P2080, DOI 10.1242/jeb.053132; Gilbert MJH, 2014, EXP GERONTOL, V50, P106, DOI 10.1016/j.exger.2013.11.013; Glenet S, 2017, J THORAC DIS, V9, P3938, DOI 10.21037/jtd.2017.08.135; Haberthur D., 2019, HABI ZEBRA FISH GILL; Heinicke K, 2001, INT J SPORTS MED, V22, P504, DOI 10.1055/s-2001-17613; Herring MJ, 2014, AM J PHYSIOL-LUNG C, V307, pL338, DOI 10.1152/ajplung.00094.2014; HOCHACHKA P, 1961, CAN J ZOOLOG, V39, P767, DOI 10.1139/z61-073; Jenjan HBB, 2018, ECOL FRESHW FISH, V27, P732, DOI 10.1111/eff.12388; KAPPAGODA CT, 1979, Q J EXP PHYSIOL CMS, V64, P205, DOI 10.1113/expphysiol.1979.sp002473; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Levene H., 1960, CONTRIB PROBAB STAT, P278; McClelland GB, 2006, J PHYSIOL-LONDON, V577, P739, DOI 10.1113/jphysiol.2006.119032; Montero D, 2017, AM J PHYSIOL-REG I, V312, pR894, DOI 10.1152/ajpregu.00012.2017; Nilsson GE, 2007, J EXP BIOL, V210, P2403, DOI 10.1242/jeb.000281; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palstra AP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1136; Palstra AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014483; Pelster B, 2003, AM J PHYSIOL-REG I, V285, pR339, DOI 10.1152/ajpregu.00110.2003; Rovira M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01362; SALTIN B, 1985, AM J CARDIOL, V55, pD42, DOI 10.1016/0002-9149(85)91054-9; SANGER AM, 1992, J FISH BIOL, V40, P637, DOI 10.1111/j.1095-8649.1992.tb02611.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sollid J, 2003, J EXP BIOL, V206, P3667, DOI 10.1242/jeb.00594; Sollid J, 2006, RESP PHYSIOL NEUROBI, V154, P241, DOI 10.1016/j.resp.2006.02.006; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; van der Meer DLM, 2005, AM J PHYSIOL-REG I, V289, pR1512, DOI 10.1152/ajpregu.00089.2005; Voswinckel R, 2004, EUR RESPIR J, V24, P524, DOI 10.1183/09031936.04.10004904; Wang W, 2013, AM J RESP CELL MOL, V49, P697, DOI 10.1165/rcmb.2012-0332MA; WEIBEL ER, 1992, RESP PHYSIOL, V87, P325, DOI 10.1016/0034-5687(92)90015-O; WOODWARD JJ, 1985, J FISH BIOL, V26, P435, DOI 10.1111/j.1095-8649.1985.tb04283.x	45	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228333	10.1371/journal.pone.0228333	http://dx.doi.org/10.1371/journal.pone.0228333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023296	gold, Green Published, Green Submitted			2022-12-26	WOS:000534621500048
J	Riahi, P; Kazemnejad, A; Mostafaei, S; Meguro, A; Mizuki, N; Ashraf-Ganjouei, A; Javinani, A; Faezi, ST; Shahram, F; Mahmoudi, M				Riahi, Parisa; Kazemnejad, Anoshirvan; Mostafaei, Shayan; Meguro, Akira; Mizuki, Nobuhisa; Ashraf-Ganjouei, Amir; Javinani, Ali; Faezi, Seyedeh Tahereh; Shahram, Farhad; Mahmoudi, Mahdi			ERAP1 polymorphisms interactions and their association with Behcet's disease susceptibly: Application of Model-Based Multifactor Dimension Reduction Algorithm (MB-MDR)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MHC CLASS-I; EPISTASIS; RISK; AMINOPEPTIDASE; IDENTIFICATION; IL23R-IL12RB2; PROTEIN; LOCI; IL10	Background Behcet's disease (BD) is a chronic multi-systemic vasculitis with a considerable prevalence in Asian countries. There are many genes associated with a higher risk of developing BD, one of which is endoplasmic reticulum aminopeptidase-1 (ERAP1). In this study, we aimed to investigate the interactions of ERAP1 single nucleotide polymorphisms (SNPs) using a novel data mining method called Model-based multifactor dimensionality reduction (MB-MDR). Methods We have included 748 BD patients and 776 healthy controls. A peripheral blood sample was collected, and eleven SNPs were assessed. Furthermore, we have applied the MB-MDR method to evaluate the interactions of ERAP1 gene polymorphisms. Results The TT genotype of rs1065407 had a synergistic effect on BD susceptibility, considering the significant main effect. In the second order of interactions, CC genotype of rs2287987 and GG genotype of rs1065407 had the most prominent synergistic effect (beta = 12.74). The mentioned genotypes also had significant interactions with CC genotype of rs26653 and TT genotype of rs30187 in the third-order (beta = 12.74 and beta = 12.73, respectively). Conclusion To the best of our knowledge, this is the first study investigating the interaction of a particular gene's SNPs in BD patients by applying a novel data mining method. However, future studies investigating the interactions of various genes could clarify this issue.	[Riahi, Parisa; Kazemnejad, Anoshirvan] Tarbiat Modares Univ, Fac Med Sci, Dept Biostat, Tehran, Iran; [Mostafaei, Shayan] Kermanshah Univ Med Sci, Hlth Technol Inst, Med Biol Res Ctr, Kermanshah, Iran; [Meguro, Akira; Mizuki, Nobuhisa] Yokohama City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Yokohama, Kanagawa, Japan; [Ashraf-Ganjouei, Amir; Javinani, Ali; Faezi, Seyedeh Tahereh; Shahram, Farhad; Mahmoudi, Mahdi] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran; [Mahmoudi, Mahdi] Univ Tehran Med Sci, Inflammat Res Ctr, Tehran, Iran	Tarbiat Modares University; Kermanshah University of Medical Sciences; Yokohama City University; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Kazemnejad, A (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Biostat, Tehran, Iran.; Mahmoudi, M (corresponding author), Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran.; Mahmoudi, M (corresponding author), Univ Tehran Med Sci, Inflammat Res Ctr, Tehran, Iran.	kazem_an@modares.ac.ir; mahmoudim@tums.ac.ir	Javinani, Ali/AAH-2212-2020; Mostafaei, Shayan/AAU-2895-2020	Javinani, Ali/0000-0003-4056-1585; Mostafaei, Shayan/0000-0002-1966-1306; Meguro, Akira/0000-0002-9797-0948; Mahmoudi, Mahdi/0000-0002-8164-8831				Calle M.L., 2008, MB MDR MODEL BASED M; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cattaert T, 2011, ANN HUM GENET, V75, P78, DOI 10.1111/j.1469-1809.2010.00604.x; Conde-Jaldon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102100; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Davatchi F, 2014, J EUR ACAD DERMATOL, V28, P338, DOI 10.1111/jdv.12107; Davatchi F, 2019, MOD RHEUMATOL, V29, P1023, DOI 10.1080/14397595.2018.1558752; Davatchi F, 2017, EXPERT REV CLIN IMMU, V13, P57, DOI 10.1080/1744666X.2016.1205486; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; John JMM, 2011, EUR J HUM GENET, V19, P696, DOI 10.1038/ejhg.2011.17; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Calle ML, 2010, BIOINFORMATICS, V26, P2198, DOI 10.1093/bioinformatics/btq352; Mahmoudi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35700-0; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Sousa I, 2015, ARTHRITIS RHEUMATOL, V67, P2742, DOI 10.1002/art.39240; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Takeuchi M, 2016, ANN RHEUM DIS, V75, P2208, DOI 10.1136/annrheumdis-2015-209059; Tong BN, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00665; Yazici H, 2007, NAT CLIN PRACT RHEUM, V3, P148, DOI 10.1038/ncprheum0436; Zhang LJ, 2015, INVEST OPHTH VIS SCI, V56, P6029, DOI 10.1167/iovs.15-17544; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227997	10.1371/journal.pone.0227997	http://dx.doi.org/10.1371/journal.pone.0227997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023277	Green Published, gold			2022-12-26	WOS:000534621500031
J	de Koeijer, AA; Hagenaars, TJ; van Leuken, JPG; Swart, AN; Boender, GJ				de Koeijer, Aline A.; Hagenaars, Thomas J.; van Leuken, Jeroen P. G.; Swart, Arno N.; Boender, Gert Jan			Spatial transmission risk during the 2007-2010 Q fever epidemic in The Netherlands: Analysis of the farm-to-farm and farm-to-resident transmission	PLOS ONE			English	Article							COXIELLA-BURNETII DNA; DAIRY GOAT; SHEEP; OUTBREAK; HISTORY; SAMPLES	Between 2007 and 2010 a Q fever epidemic in Dutch dairy goat farms caused a large Q fever outbreak in human residents in the southern part of the Netherlands. Here we characterize the transmission of Coxiella burnetii, the aetiological agent of Q fever, between infected and susceptible dairy goat farms by estimating a spatial transmission kernel. In addition, we characterize the zoonotic transmission of C. burnetii by estimating the spatial kernel for transmission from infected farms to neighbouring residents. Whereas the range of between-farm transmission is comparable to the scale of the Netherlands, likely due to long-range between-farm contacts such as animal transport, the transmission risk from farms to humans is more localized, although still extending to 10 km and beyond. Within a range of about 10 km, the transmission risk from an infected goat farm to a single resident is of the same order of magnitude as the farm-to-farm transmission risk per animal in a receiving farm. We illustrate how, based on the estimated kernels, spatial patterns of transmission risks between farms and from farms to residents can be calculated and visualized by means of risk maps, offering further insight relevant to policy making in a one-health context.	[de Koeijer, Aline A.; Hagenaars, Thomas J.; Boender, Gert Jan] Wageningen Biovet Res, Dept Bacteriol & Epidemiol, Lelystad, Netherlands; [van Leuken, Jeroen P. G.; Swart, Arno N.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Boender, GJ (corresponding author), Wageningen Biovet Res, Dept Bacteriol & Epidemiol, Lelystad, Netherlands.	gertjan.boender@wur.nl			ZonMW [50-51800-98-035]	ZonMW(Netherlands Organization for Health Research and Development)	The study was financially supported through a research grant of ZonMW (project number 50-51800-98-035) (www.zonmw.nl).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Astobiza I, 2011, RES VET SCI, V91, pE58, DOI 10.1016/j.rvsc.2010.11.014; Boender GJ, 2007, PREV VET MED, V82, P90, DOI 10.1016/j.prevetmed.2007.05.016; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Boender GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095278; Boender GJ, 2010, EPIDEMICS-NETH, V2, P36, DOI 10.1016/j.epidem.2010.03.001; Brooke RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-488; Commandeur M, 2014, INT J ENVIRON HEAL R, V24, P137, DOI 10.1080/09603123.2013.800963; de Bruin A, 2012, APPL ENVIRON MICROB, V78, P1652, DOI 10.1128/AEM.07323-11; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Gilsdorf A, 2008, EPIDEMIOL INFECT, V136, P1084, DOI 10.1017/S0950268807009533; Hawker J I, 1998, Commun Dis Public Health, V1, P180; Hogerwerf L, 2012, APPL ENVIRON MICROB, V78, P5410, DOI 10.1128/AEM.00677-12; Hogerwerf L, 2011, EMERG INFECT DIS, V17, P379, DOI 10.3201/eid1703.101157; Klous G, 2018, ENVIRON INT, V115, P150, DOI 10.1016/j.envint.2018.03.020; MARRIE TJ, 1990, CAN VET J, V31, P555; Nassuato C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062878; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Schimmer B, 2008, EUROSURVEILLANCE B E, V13; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; Smit LAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038843; Ster IC, 2009, EPIDEMICS-NETH, V1, P21, DOI 10.1016/j.epidem.2008.09.001; van den Brom R, 2012, VET REC, V170, P310, DOI 10.1136/vr.100304; Van den Brom R, 2009, SMALL RUMINANT RES, V86, P74, DOI 10.1016/j.smallrumres.2009.09.022; Van Leuken JPG, 2016, ONE HEALTH, V2, P77, DOI 10.1016/j.onehlt.2016.03.004; WELSH HH, 1958, ANN NY ACAD SCI, V70, P528, DOI 10.1111/j.1749-6632.1958.tb35409.x; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001	30	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0227491	10.1371/journal.pone.0227491	http://dx.doi.org/10.1371/journal.pone.0227491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017771	gold, Green Published			2022-12-26	WOS:000534618100011
J	Ogrodowicz, P; Kuczynska, A; Mikolajczak, K; Adamski, T; Surma, M; Krajewski, P; Cwiek-Kupczynska, H; Kempa, M; Rokicki, M; Jasinska, D				Ogrodowicz, Piotr; Kuczynska, Anetta; Mikolajczak, Krzysztof; Adamski, Tadeusz; Surma, Maria; Krajewski, Pawel; Cwiek-Kupczynska, Hanna; Kempa, Michal; Rokicki, Michal; Jasinska, Dorota			Mapping of quantitative trait loci for traits linked to fusarium head blight in barley	PLOS ONE			English	Article							YIELD-RELATED TRAITS; SMALL-GRAIN CEREALS; DEOXYNIVALENOL ACCUMULATION; UDP-GLUCOSYLTRANSFERASE; PLANT HEIGHT; EAR BLIGHT; RESISTANCE; WHEAT; GRAMINEARUM; POPULATION	Fusarium head blight (FHB) is a devastating disease occurring in small grain cereals worldwide. The disease results in the reduction of grain yield, and mycotoxins accumulated in grain are also harmful to both humans and animals. It has been reported that response to pathogen infection may be associated with the morphological and developmental traits of the host plant, e.g. earliness and plant height. Despite many studies, effective markers for selection of barley genotypes with increased resistance to FHB have not been developed. In the present study, we investigated 100 recombinant inbred lines (RIL) of spring barley. Plants were examined in field conditions (three locations) in a completely randomized design with three replications. Barley genotypes were artificially infected with spores of Fusarium culmorum before heading. Apart from the main phenotypic traits (plant height, spike characteristic, grain yield), infected kernels were visually scored and the content of deoxynivalenol (DON) mycotoxin was investigated. A set of 70 Quantitative Trait Loci (QTLs) were detected through phenotyping of the mapping population in field conditions and genotyping using a barley Ilumina 9K iSelect platform. Six loci were detected for the FHB index on chromosomes 2H, 3H, 5H, and 7H. A region on the short arm of chromosome 2H was detected in which many QTLs associated with FHB- and yield-related traits were found. This study confirms that agromorphological traits are tightly related to FHB and should be taken into consideration when breeding barley plants for FHB resistance.	[Ogrodowicz, Piotr; Kuczynska, Anetta; Mikolajczak, Krzysztof; Adamski, Tadeusz; Surma, Maria; Krajewski, Pawel; Cwiek-Kupczynska, Hanna; Kempa, Michal] Acad Sci, Inst Plant Genet, Poznan, Poland; [Rokicki, Michal; Jasinska, Dorota] Poznan Plant Breeding Stn, Kasztanowa, Tulce, Poland	Polish Academy of Sciences	Kuczynska, A (corresponding author), Acad Sci, Inst Plant Genet, Poznan, Poland.	akuc@igr.poznan.pl	Kuczynska, Anetta/AAG-2610-2022; Ogrodowicz, Piotr/ABG-2508-2020; Ćwiek-Kupczyńska, Hanna/W-1810-2018; Kuczynska, Anetta/AFK-3837-2022; Mikołajczak, Krzysztof/AAP-8992-2020	Ćwiek-Kupczyńska, Hanna/0000-0001-9113-567X; Mikołajczak, Krzysztof/0000-0003-3821-4461; Kempa, Michal/0000-0001-5368-5953; Ogrodowicz, Piotr/0000-0002-9044-8137; , Anetta/0000-0003-0203-3458; Krajewski, Pawel/0000-0001-5318-9896	Polish Ministry of Agriculture and Rural Development [HOR hn-501-19/15 Task 88]	Polish Ministry of Agriculture and Rural Development	This work was financially supported by Polish Ministry of Agriculture and Rural Development (grant no HOR hn-501-19/15 Task 88).	Alshannaq A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060632; BAI GH, 1994, PLANT DIS, V78, P760, DOI 10.1094/PD-78-0760; Bayer MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01792; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger G, 2014, PLANT DIS, V98, P599, DOI 10.1094/PDIS-05-13-0479-RE; Bernhoft A, 2012, FOOD ADDIT CONTAM A, V29, P1129, DOI 10.1080/19440049.2012.672476; Bottalico A, 2002, EUR J PLANT PATHOL, V108, P611, DOI 10.1023/A:1020635214971; Buerstmayr M, 2012, THEOR APPL GENET, V125, P1751, DOI 10.1007/s00122-012-1951-2; Buerstmayr M, 2011, THEOR APPL GENET, V123, P293, DOI 10.1007/s00122-011-1584-x; CAI X, 2008, P 11 INT WHEAT GEN S; Cantalapiedra CP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0253-1; Caputi L, 2012, PLANT J, V69, P1030, DOI 10.1111/j.1365-313X.2011.04853.x; Champeil A, 2004, PLANT SCI, V166, P1389, DOI 10.1016/j.plantsci.2004.02.004; Chelkowski J, 2000, J PHYTOPATHOL, V148, P433, DOI 10.1046/j.1439-0434.2000.00538.x; Choo TM, 2004, PHYTOPATHOLOGY, V94, P1145, DOI 10.1094/PHYTO.2004.94.10.1145; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Dahleen LS, 2003, THEOR APPL GENET, V108, P95, DOI 10.1007/s00122-003-1409-7; Dahleen LS, 2012, PLANT BREEDING, V131, P237, DOI 10.1111/j.1439-0523.2012.01952.x; de la Pena RC, 1999, THEOR APPL GENET, V99, P561, DOI 10.1007/s001220051269; Dhariwal R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010019; Edwards SG, 2001, APPL ENVIRON MICROB, V67, P1575, DOI 10.1128/AEM.67.4.1575-1580.2001; Eslami M, 2015, TOXIN REV, V34, P125, DOI 10.3109/15569543.2015.1074925; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gahlaut V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182857; Geddes J, 2008, PROTEOMICS, V8, P545, DOI 10.1002/pmic.200700115; Gorny AG, 2001, EUPHYTICA, V117, P59, DOI 10.1023/A:1004061709964; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; He XY, 2015, CAN J PLANT SCI, V95, P923, DOI 10.4141/CJPS-2015-062; Hill NS, 2008, CROP SCI, V48, P1389, DOI 10.2135/cropsci2007.05.0266; Hope R, 2005, LETT APPL MICROBIOL, V40, P295, DOI 10.1111/j.1472-765X.2005.01674.x; Hori K, 2005, THEOR APPL GENET, V111, P1661, DOI 10.1007/s00122-005-0102-4; Horsley RD, 2006, CROP SCI, V46, P145, DOI 10.2135/cropsci2005.0247; Huang YD, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01260; Huang YD, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2716-0; Hunt CW, 1996, ANIM FEED SCI TECH, V62, P37, DOI 10.1016/S0377-8401(96)01004-8; Ji F, 2011, TOXINS, V3, P968, DOI 10.3390/toxins3080968; Knutsen HK, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4718; Kuczynska A, 2014, ELECTRON J BIOTECHN, V17, P217, DOI 10.1016/j.ejbt.2014.07.005; Kuczynska A, 2013, J APPL GENET, V54, P381, DOI 10.1007/s13353-013-0165-x; Lacey J, 1999, ANN APPL BIOL, V134, P277, DOI 10.1111/j.1744-7348.1999.tb05265.x; Langevin F, 2004, EUR J PLANT PATHOL, V110, P735, DOI 10.1023/B:EJPP.0000041568.31778.ad; Lemmens M, 2004, J PHYTOPATHOL, V152, P1, DOI 10.1046/j.1439-0434.2003.00791.x; Levasseur-Garcia C, 2018, TOXINS, V10, DOI 10.3390/toxins10010038; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li XX, 2017, PEST MANAG SCI, V73, P1402, DOI 10.1002/ps.4469; Ma ZQ, 2007, MOL GENET GENOMICS, V277, P31, DOI 10.1007/s00438-006-0166-0; Ma ZQ, 2000, PHYTOPATHOLOGY, V90, P1079, DOI 10.1094/PHYTO.2000.90.10.1079; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malosetti M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00044; Mamo BE, 2015, CROP SCI, V55, P1494, DOI 10.2135/cropsci2014.06.0428; Mansour E, 2014, MOL BREEDING, V33, P249, DOI 10.1007/s11032-013-9946-5; Mao SL, 2010, EUPHYTICA, V174, P343, DOI 10.1007/s10681-010-0128-9; Massman J, 2011, MOL BREEDING, V27, P439, DOI 10.1007/s11032-010-9442-0; Mesfin A, 2003, CROP SCI, V43, P307, DOI 10.2135/cropsci2003.0307; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; Miedaner T, 2004, EUPHYTICA, V139, P123, DOI 10.1007/s10681-004-2489-4; Mikolajczak K, 2017, J APPL GENET, V58, P23, DOI 10.1007/s13353-016-0358-1; Mikolajczak K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155938; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Nadolska-Orczyk A, 2017, THEOR APPL GENET, V130, P1081, DOI 10.1007/s00122-017-2880-x; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Nduulu LM, 2007, THEOR APPL GENET, V115, P561, DOI 10.1007/s00122-007-0590-5; Nita M, 2005, P NAT FUS HEAD BLIGH, P125; Nopsa JFH, 2012, CAN J PLANT PATHOL, V34, P380, DOI 10.1080/07060661.2012.695751; Ogrodowicz P, 2017, J APPL GENET, V58, P49, DOI 10.1007/s13353-016-0363-4; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Paul PA, 2005, PHYTOPATHOLOGY, V95, P1225, DOI 10.1094/PHYTO-95-1225; Paul PA, 2004, PHYTOPATHOLOGY, V94, P1342, DOI 10.1094/PHYTO.2004.94.12.1342; Pereira VL, 2014, TRENDS FOOD SCI TECH, V36, P96, DOI 10.1016/j.tifs.2014.01.005; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Rant JC, 2013, MOL PLANT PATHOL, V14, P828, DOI 10.1111/mpp.12043; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Rudd JC, 2001, CROP SCI, V41, P620, DOI 10.2135/cropsci2001.413620x; Saisho D, 2011, PLANT CELL PHYSIOL, V52, P724, DOI 10.1093/pcp/pcr049; Savi GD, 2014, FOOD ADDIT CONTAM B, V7, P232, DOI 10.1080/19393210.2014.898337; Saxena RK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01535-4; Schoneberg T, 2018, EUR J PLANT PATHOL, V151, P975, DOI 10.1007/s10658-018-1434-7; Schulte D, 2009, PLANT PHYSIOL, V149, P142, DOI 10.1104/pp.108.128967; Shah L, 2018, PLANT PATHOL, V67, P532, DOI 10.1111/ppa.12785; Shi W, 2017, TOXINS, V9, DOI 10.3390/toxins9010006; Slikova S, 2009, EUR J PLANT PATHOL, V124, P163, DOI 10.1007/s10658-008-9403-1; Sobrova Pavlina, 2010, Interdiscip Toxicol, V3, P94, DOI 10.2478/v10102-010-0019-x; Steffenson B. J., 1996, P 7 INT BARL GEN S; Steffenson BJ, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P241; Surma M, 2019, J AGRON CROP SCI, V205, P295, DOI 10.1111/jac.12324; Surma M, 2016, CZECH J GENET PLANT, V52, P132, DOI 10.17221/86/2016-CJGPB; Tekauz A, 2000, CAN J PLANT PATHOL, V22, P9, DOI 10.1080/07060660009501156; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Turner NW, 2009, ANAL CHIM ACTA, V632, P168, DOI 10.1016/j.aca.2008.11.010; Ullrich SE, 1993, P 5 INT OAT C 7 BARL, P141; Urrea CA, 2002, CROP SCI, V42, P1404, DOI 10.2135/cropsci2002.1404; Van Ooijen JW, 2006, SOFTWARE CALCULATION; Vigier B, 1997, CAN J PLANT PATHOL, V19, P60, DOI 10.1080/07060669709500574; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; VSN International, 2015, GENSTAT WINDOWS, V18th; Wagacha JM, 2007, CROP PROT, V26, P877, DOI 10.1016/j.cropro.2006.09.003; Wang JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090144; Wang N, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00856, 10.3389/fpls.2016.00338, 10.3359/fpls.2016.00338]; WANG YZ, 1988, J PHYTOPATHOL, V122, P118, DOI 10.1111/j.1439-0434.1988.tb00998.x; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Wisniewska H, 2016, BREEDING SCI, V66, P281, DOI 10.1270/jsbbs.66.281; Xing LP, 2018, PLANT GROWTH REGUL, V84, P561, DOI 10.1007/s10725-017-0361-5; Xue AG, 2006, PHYTOPROTECTION, V87, P55, DOI 10.7202/013973ar; Yoshida M, 2005, EUPHYTICA, V141, P217, DOI 10.1007/s10681-005-7008-8; Yoshida M, 2007, PHYTOPATHOLOGY, V97, P1054, DOI 10.1094/PHYTO-97-9-1054; Yu JB, 2008, PHYTOPATHOLOGY, V98, P87, DOI 10.1094/PHYTO-98-1-0087; Zhang JX, 2008, CROP SCI, V48, P223, DOI 10.2135/cropsci2007.02.0116; Zhao LF, 2018, PLANT CELL REP, V37, P641, DOI 10.1007/s00299-018-2257-x; Zhu H, 1999, THEOR APPL GENET, V99, P1221, DOI 10.1007/s001220051328	111	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0222375	10.1371/journal.pone.0222375	http://dx.doi.org/10.1371/journal.pone.0222375			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017768	Green Published, gold			2022-12-26	WOS:000534618100006
J	Gao, P; Wang, JZ; Wen, JB				Gao, Peng; Wang, Jingzhen; Wen, Junbao			Selection of reference genes for tissue/organ samples of adults of Eucryptorrhynchus scrobiculatus	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DIFFERENT DEVELOPMENTAL-STAGES; RT-PCR NORMALIZATION; REAL-TIME PCR; QRT-PCR; BIOLOGICAL-CONTROL; EXPRESSION; VALIDATION; TISSUES	Eucryptorrhynchus scrobiculatus is an important wood-boring pest of Ailanthus altissima in China, where it causes a large number of these trees to weaken or even die. To identify genes related to economic traits or specific cellular processes in E. scrobiculatus, gene expression in multiple tissue/organ samples is commonly surveyed, and reference genes are required in this process as a control for normalization. In the present study, 18 candidate reference genes from E. scrobiculatus were identified, and the expression levels of these reference genes were estimated through quantitative real-time PCR. Differences in expression levels were analyzed with four algorithms (geNorm, NormFinder, BestKeeper and delta Ct) and comprehensively with RefFinder. With the most stable levels of expression in different tissues, RPL13, RPS3 and RPL36 were determined to be suitable for use as candidate reference genes. Moreover, the expression profile of one target gene (glycoside hydrolase family 45, GH45) confirmed the reliability of the selected candidate reference genes. This study provides the first set of suitable candidate reference genes for gene expression studies in E. scrobiculatus, and the findings will facilitate subsequent transcriptomics and functional gene research on this pest.	[Gao, Peng; Wang, Jingzhen; Wen, Junbao] Beijing Forestry Univ, Beijing Key Lab Forest Pest Control, Beijing, Peoples R China	Beijing Forestry University	Wen, JB (corresponding author), Beijing Forestry Univ, Beijing Key Lab Forest Pest Control, Beijing, Peoples R China.	wenjb@bjfu.edu.cn	WANG, JINGYI/GSJ-1241-2022; Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022		National Key R&D Program of China [2018YFC1200400]; National Natural Sciences Foundation of China [31770691]	National Key R&D Program of China; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China (2018YFC1200400) and National Natural Sciences Foundation of China (Grant No. 31770691).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Busch A, 2018, INSECT MOL BIOL, V27, P633, DOI 10.1111/imb.12500; Bustin SA, 2013, REAL-TIME PCR: ADVANCED TECHNOLOGIES AND APPLICATIONS, P51; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dheda K, 2004, BIOTECHNOLOGY, V37; Ding JQ, 2006, BIOL INVASIONS, V8, P1439, DOI 10.1007/s10530-005-5833-2; Ding JQ, 2006, BIOCONTROL SCI TECHN, V16, P547, DOI 10.1080/09583150500531909; Dzaki N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43618; Fischer R, 2013, ADV BIOCHEM ENG BIOT, V136, P51, DOI 10.1007/10_2013_206; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Gao XK, 2017, GENE, V637, P211, DOI 10.1016/j.gene.2017.09.057; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ibanez F, 2016, INSECT MOL BIOL, V25, P227, DOI 10.1111/imb.12219; Ji YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09659-3; Kang ZW, 2017, INSECT SCI, V24, P222, DOI 10.1111/1744-7917.12310; Koramutla MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25883; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Liu ZK, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YM, 2013, J SPECTROSC, V2013, P1, DOI 10.1155/2013/797232; Lu YH, 2015, J ASIA-PAC ENTOMOL, V18, P669, DOI 10.1016/j.aspen.2015.08.002; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Petriccione M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16961; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Qu C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192521; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rodrigues TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109825; Shakeel M, 2018, BIOTECHNOL LETT, V40, P227, DOI 10.1007/s10529-017-2465-4; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059; Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tan Y, 2017, B ENTOMOL RES, V107, P359, DOI 10.1017/S0007485316000948; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GH, 2018, ARCH INSECT BIOCHEM, V98, DOI 10.1002/arch.21458; Xu J, 2017, J ECON ENTOMOL, V110, P683, DOI 10.1093/jee/tow297; Yang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120833; Yang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110454; Yuan M., 2014, PLOS ONE, V9, P1, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; Zhai YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106800; Zhang QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37549; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	53	10	10	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228308	10.1371/journal.pone.0228308	http://dx.doi.org/10.1371/journal.pone.0228308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012184	Green Published, gold			2022-12-26	WOS:000534615800027
J	Nguyen, TH; Tang, FHM; Maggi, F				Thu Ha Nguyen; Tang, Fiona H. M.; Maggi, Federico			Sinking of microbial-associated microplastics in natural waters	PLOS ONE			English	Article							SUSPENDED PARTICULATE MATTER; SETTLING VELOCITY; RESIN PELLETS; MARINE SNOW; PARTICLES; SEDIMENTS; SEA; RATES; RIVER; SIZE	Degraded plastic debris has been found in nearly all waters within and nearby urban developments as well as in the open oceans. Natural removal of suspended microplastics (MPs) by deposition is often limited by their excess buoyancy relative to water, but this can change with the attachment of biological matter. The extent to which the attached biological ballast affects MP dynamics is still not well characterised. Here, we experimentally demonstrate using a novel OMCEC (Optical Measurement of CEll colonisation) system that the biological fraction of MP aggregates has substantial control over their size, shape and, most importantly, their settling velocity. Polyurethane MP aggregates made of 80% biological ballast had an average size almost twice of those containing 5% biological ballast, and sank about two times slower. Based on our experiments, we introduce a settling velocity equation that accounts for different biological content as well as the irregular fractal structure of MP aggregates. This equation can capture the settling velocity of both virgin MPs and microbial-associated MP aggregates in our experiment with 7% error and can be used as a preliminary tool to estimate the vertical transport of MP aggregates made of different polymers and types of microbial ballast.	[Thu Ha Nguyen; Tang, Fiona H. M.; Maggi, Federico] Univ Sydney, Sch Civil Engn, Lab Adv Environm Engn Res, Sydney, NSW, Australia	University of Sydney	Nguyen, TH (corresponding author), Univ Sydney, Sch Civil Engn, Lab Adv Environm Engn Res, Sydney, NSW, Australia.	thuha.nguyen@sydney.edu.au	Maggi, Federico/ABG-8100-2020; Tang, Fiona/AAN-6872-2021	Maggi, Federico/0000-0002-7878-8112; Tang, Fiona/0000-0002-8119-4016; Nguyen, Thu Ha/0000-0001-9464-6491	Australia Awards Scholarship; Australia Department of Foreign Affair and Trade; SREI2020 Envirosphere, The University of Sydney; SOAR, The University of Sydney	Australia Awards Scholarship; Australia Department of Foreign Affair and Trade; SREI2020 Envirosphere, The University of Sydney; SOAR, The University of Sydney	THN: Australia Awards Scholarship. Funder: Australia Department of Foreign Affair and Trade. (https://dfat.gov.au).F.M and F.H.M.T: SREI2020 Envirosphere, The University of Sydney. (https://sydney.edu.au/).F.M - SOAR, The University of Sydney (https://sydney.edu.au/).Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript? NO.	Ahrens JP, 2000, J WATERW PORT C-ASCE, V126, P99, DOI 10.1061/(ASCE)0733-950X(2000)126:2(99); ALLDREDGE AL, 1989, DEEP-SEA RES, V36, P159, DOI 10.1016/0198-0149(89)90131-3; ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; AZETSUSCOTT K, 1992, DEEP-SEA RES, V39, P1057, DOI 10.1016/0198-0149(92)90039-V; Bagaev A, 2017, SCI TOTAL ENVIRON, V599, P560, DOI 10.1016/j.scitotenv.2017.04.185; Basset AB, 1988, TREATISE HYDRODYNAMI, V2; Boussinesq J., 1885, CR HEBD ACAD SCI, V100, P935; Brenner J., 1982, 82010 CR NAV CIV ENG, P55; Browne MA, 2007, INTEGR ENVIRON ASSES, V3, P559, DOI 10.1002/ieam.5630030412; Chapalain M, 2019, OCEAN DYNAM, V69, P59, DOI 10.1007/s10236-018-1229-6; Chubarenko I, 2016, MAR POLLUT BULL, V108, P105, DOI 10.1016/j.marpolbul.2016.04.048; Chubarenko I, 2018, MICROPLASTIC CONTAMINATION IN AQUATIC ENVIRONMENTS: AN EMERGING MATTER OF ENVIRONMENTAL URGENCY, P175, DOI 10.1016/B978-0-12-813747-5.00006-0; Cole M, 2016, ENVIRON SCI TECHNOL, V50, P3239, DOI 10.1021/acs.est.5b05905; DIETRICH WE, 1982, WATER RESOUR RES, V18, P1615, DOI 10.1029/WR018i006p01615; Doherty J.E., 2015, WATERMARK NUMERICAL; Endo S, 2005, MAR POLLUT BULL, V50, P1103, DOI 10.1016/j.marpolbul.2005.04.030; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; European Commission, 2018, EUR STRAT PLAST CIRC; FENNESSY MJ, 1994, MAR GEOL, V117, P107, DOI 10.1016/0025-3227(94)90009-4; G7, 2018, OC PLAST CHART; Galloway TS, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0116; Giacovelli C., 2018, SINGLE USE PLASTICS; Graca B, 2017, ENVIRON SCI POLLUT R, V24, P7650, DOI 10.1007/s11356-017-8419-5; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Howard GT, 2002, INT BIODETER BIODEGR, V49, P245, DOI 10.1016/S0964-8305(02)00051-3; Iversen MH, 2010, BIOGEOSCIENCES, V7, P2613, DOI 10.5194/bg-7-2613-2010; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Kaiser D, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8e8b; Kelbaliyev GI, 2011, THEOR FOUND CHEM EN+, V45, P248, DOI 10.1134/S0040579511020084; Khatmullina L, 2017, MAR POLLUT BULL, V114, P871, DOI 10.1016/j.marpolbul.2016.11.024; Kiorboe T, 2001, SCI MAR, V65, P57, DOI 10.3989/scimar.2001.65s257; Kowalski N, 2016, MAR POLLUT BULL, V109, P310, DOI 10.1016/j.marpolbul.2016.05.064; Lagarde F, 2016, ENVIRON POLLUT, V215, P331, DOI 10.1016/j.envpol.2016.05.006; Lahens L, 2018, ENVIRON POLLUT, V236, P661, DOI 10.1016/j.envpol.2018.02.005; Lebreton LCM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15611; LEE BJ, 2017, WATER-SUI, V9, DOI DOI 10.3390/W9050335; Long M, 2015, MAR CHEM, V175, P39, DOI 10.1016/j.marchem.2015.04.003; MacDonald IT, 2013, J GEOPHYS RES-OCEANS, V118, P2581, DOI 10.1002/jgrc.20197; Maggi F, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011405; Maggi F, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003951; Maggi F, 2015, MAR GEOL, V363, P102, DOI 10.1016/j.margeo.2015.01.017; Maggi F, 2013, J GEOPHYS RES-OCEANS, V118, P2118, DOI 10.1002/jgrc.20086; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; McMinn A, 2004, ALCHERINGA, V28, P505, DOI 10.1080/03115510408619299; Michels J, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1203; Munari C, 2017, MAR POLLUT BULL, V122, P161, DOI 10.1016/j.marpolbul.2017.06.039; NOAA Marine Debris Program, 2011, INF MAR DEBR; Peng GY, 2017, ENVIRON POLLUT, V225, P283, DOI 10.1016/j.envpol.2016.12.064; PlasticsEurope, 2018, PLAST FACTS 2018 AN; Porter A, 2018, ENVIRON SCI TECHNOL, V52, P7111, DOI 10.1021/acs.est.8b01000; Rochman CM, 2016, ECOLOGY, V97, P302, DOI 10.1890/14-2070.1; Romera-Castillo C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03798-5; Rubey WW, 1933, AM J SCI, V25, P325; Russell JR, 2011, APPL ENVIRON MICROB, V77, P6076, DOI 10.1128/AEM.00521-11; Setala O, 2014, ENVIRON POLLUT, V185, P77, DOI 10.1016/j.envpol.2013.10.013; Shang QQ, 2014, INT J SEDIMENT RES, V29, P471, DOI 10.1016/S1001-6279(14)60060-3; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Song ZY, 2008, WATER SCI ENG, V1, P37, DOI 10.3882/j.issn.1674-2370.2008.01.005; Stokes GG., 1851, T CAMBRIDGE PHILOS S, V9; Tang F., 2016, THESIS; Tang FHM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03479-1; Tang FHM, 2016, WATER RES, V89, P76, DOI 10.1016/j.watres.2015.11.033; Teuten EL, 2007, ENVIRON SCI TECHNOL, V41, P7759, DOI 10.1021/es071737s; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Thompson RC, 2009, PHILOS T R SOC B, V364, P1973, DOI 10.1098/rstb.2009.0054; Nguyen TH, 2017, J GEOPHYS RES-EARTH, V122, P1794, DOI 10.1002/2017JF004263; Tran D, 2017, CONT SHELF RES, V138, P81, DOI 10.1016/j.csr.2017.02.011; UN Environment, 2017, COMB MAR PLAST LITT; United Kingdom Department for Environment Food Rural Affairs, 2016, MICR BAN ANN PROT SE; Van Cauwenberghe L, 2013, ENVIRON POLLUT, V182, P495, DOI 10.1016/j.envpol.2013.08.013; Vianello A, 2013, ESTUAR COAST SHELF S, V130, P54, DOI 10.1016/j.ecss.2013.03.022; Xanthos D, 2017, MAR POLLUT BULL, V118, P17, DOI 10.1016/j.marpolbul.2017.02.048	73	37	37	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228209	10.1371/journal.pone.0228209	http://dx.doi.org/10.1371/journal.pone.0228209			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012181	Green Published, gold			2022-12-26	WOS:000534615800023
J	Nasipuri, P; Herschend, J; Brejnrod, AD; Madsen, JS; Espersen, R; Svensson, B; Burmolle, M; Jacquiod, S; Sorensen, SJ				Nasipuri, Poonam; Herschend, Jakob; Brejnrod, Asker D.; Madsen, Jonas S.; Espersen, Roall; Svensson, Birte; Burmolle, Mette; Jacquiod, Samuel; Sorensen, Soren J.			Community-intrinsic properties enhance keratin degradation from bacterial consortia	PLOS ONE			English	Article							ENGINEERING MICROBIAL CONSORTIA; BIOFILM FORMATION; PURIFICATION; ENZYMES; METALLOPROTEASE; IDENTIFICATION; DECOMPOSITION; ENRICHMENT; PROTEASES; FEATHERS	Although organic matter may accumulate sometimes (e.g. lignocellulose in peat bog), most natural biodegradation processes are completed until full mineralization. Such transformations are often achieved by the concerted action of communities of interacting microbes, involving different species each performing specific tasks. These interactions can give rise to novel "community-intrinsic" properties, through e.g. activation of so-called "silent genetic pathways" or synergistic interplay between microbial activities and functions. Here we studied the microbial community-based degradation of keratin, a recalcitrant biological material, by four soil isolates, which have previously been shown to display synergistic interactions during biofilm formation; Stenotrophomonas rhizophila, Xanthomonas retroflexus, Microbacterium oxydans and Paenibacillus amylolyticus. We observed enhanced keratin weight loss in cultures with X. retroflexus, both in dual and four-species co-cultures, as compared to expected keratin degradation by X. retroflexus alone. Additional community intrinsic properties included accelerated keratin degradation rates and increased biofilm formation on keratin particles. Comparison of secretome profiles of X. retroflexus mono-cultures to co-cultures revealed that certain proteases (e.g. serine protease S08) were significantly more abundant in mono-cultures, whereas co-cultures had an increased abundance of proteins related to maintaining the redox environment, e.g. glutathione peroxidase. Hence, one of the mechanisms related to the community intrinsic properties, leading to enhanced degradation from co-cultures, might be related to a switch from sulfitolytic to proteolytic functions between mono- and co-cultures, respectively.	[Nasipuri, Poonam; Herschend, Jakob; Madsen, Jonas S.; Burmolle, Mette; Jacquiod, Samuel; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Sect Microbiol, Copenhagen, Denmark; [Brejnrod, Asker D.] Univ Copenhagen, Novo Nordic Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Espersen, Roall; Svensson, Birte] Tech Univ Denmark, Dept Biotechnol & Biomed, DTU Bioengn, Lyngby, Denmark; [Jacquiod, Samuel] Univ Bourgogne Franche Comte, INRA Ctr Dijon, Agroecol, Dijon, France	University of Copenhagen; University of Copenhagen; Technical University of Denmark; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Sorensen, SJ (corresponding author), Univ Copenhagen, Dept Biol, Sect Microbiol, Copenhagen, Denmark.	sjs@bio.ku.dk	Sørensen, Søren Johannes/N-2120-2019; Jacquiod, Samuel/M-2259-2014	Sørensen, Søren Johannes/0000-0001-6227-9906; Jacquiod, Samuel/0000-0002-0713-7996; Madsen, Jonas Stenlokke/0000-0003-4830-1796; Svensson, Birte/0000-0002-2993-8196	Danish Council for Strategic Research, The Programme Commission on Health, Food and Welfare	Danish Council for Strategic Research, The Programme Commission on Health, Food and Welfare	The projected was funded by SJS as part the Keratin2Protein grant from The Danish Council for Strategic Research, The Programme Commission on Health, Food and Welfare. There was no additional external funding received for this study.	Ahuja SK, 2004, CRIT REV BIOTECHNOL, V24, P125, DOI 10.1080/07388550490493726; Albers P, 2018, MICROBIOLOGYOPEN, V7, DOI 10.1002/mbo3.559; Allpress JD, 2002, LETT APPL MICROBIOL, V34, P337, DOI 10.1046/j.1472-765X.2002.01093.x; Azeredo LAI, 2006, J APPL MICROBIOL, V100, P641, DOI 10.1111/j.1365-2672.2005.02791.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bach E, 2015, INT BIODETER BIODEGR, V104, P136, DOI 10.1016/j.ibiod.2015.06.001; Bach E, 2012, PROCESS BIOCHEM, V47, P2455, DOI 10.1016/j.procbio.2012.10.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandelli A, 2010, APPL MICROBIOL BIOT, V85, P1735, DOI 10.1007/s00253-009-2398-5; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Burmolle M, 2014, TRENDS MICROBIOL, V22, P84, DOI 10.1016/j.tim.2013.12.004; Cai CG, 2008, J ZHEJIANG UNIV-SC B, V9, P60, DOI 10.1631/jzus.B061620; Cavaliere M, 2017, ENVIRON MICROBIOL, V19, P2949, DOI 10.1111/1462-2920.13767; Chaturvedi V, 2014, J WASTE MANAGE, V2014, P1, DOI [10.1155/2014/928618, DOI 10.1155/2014/928618]; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daroit DJ, 2014, CRIT REV BIOTECHNOL, V34, P372, DOI 10.3109/07388551.2013.794768; de la Cruz-Perera CI, 2013, FEMS MICROBIOL LETT, V338, P95, DOI [10.1111/1574-6968., 10.1111/1574-6968.12036]; De Toni CH, 2002, CAN J MICROBIOL, V48, P342, DOI 10.1139/w02-027; Deng YJ, 2016, J MICROBIOL, V54, P23, DOI 10.1007/s12275-016-5461-9; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Gessesse A, 2003, ENZYME MICROB TECH, V32, P519, DOI 10.1016/S0141-0229(02)00324-1; Ghasemi Y, 2012, ANN MICROBIOL, V62, P737, DOI 10.1007/s13213-011-0313-7; Grumbt M, 2013, J INVEST DERMATOL, V133, P1550, DOI 10.1038/jid.2013.41; Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8; Herschend J, 2018, IN VITRO COMMUNITY S, DOI [10.1128/AEM.01450-18, DOI 10.1128/AEM.01450-18]; Herschend J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16633-6; Herzog B, 2016, SYST APPL MICROBIOL, V39, P49, DOI 10.1016/j.syapm.2015.10.004; Istrate D, 2013, POLYM DEGRAD STABIL, V98, P542, DOI 10.1016/j.polymdegradstab.2012.12.001; Jahan Z., 2010, Bangladesh Journal of Scientific and Industrial Research, V45, P261, DOI 10.3329/bjsir.v45i3.6535; Kang DR, 2018, BIORESOURCE TECHNOL, V270, P303, DOI 10.1016/j.biortech.2018.09.006; Kappler U, 2011, BBA-BIOENERGETICS, V1807, P1, DOI 10.1016/j.bbabio.2010.09.004; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Kornillowicz-Kowalska T, 2011, WASTE MANAGE, V31, P1689, DOI 10.1016/j.wasman.2011.03.024; Kuddus M., 2017, KERATIN DEGRADING MI, V5, P4, DOI [10.15406/jmen.2017.05.00154, DOI 10.15406/JMEN.2017.05.00154]; KUNERT J, 1972, EXPERIENTIA, V28, P1025, DOI 10.1007/BF01918649; Laba W., 2013, Acta Scientiarum Polonorum - Biotechnologia, V12, P29; Lange L, 2016, APPL MICROBIOL BIOT, V100, P2083, DOI 10.1007/s00253-015-7262-1; Leewis MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22145; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; LIN XA, 1992, APPL ENVIRON MICROB, V58, P3271, DOI 10.1128/AEM.58.10.3271-3275.1992; Lindemann SR, 2016, ISME J, V10, P2077, DOI 10.1038/ismej.2016.26; Liu WZ, 2018, ISME J, V12, P1940, DOI 10.1038/s41396-018-0112-2; Liu WZ, 2017, ENVIRON MICROBIOL, V19, P2893, DOI 10.1111/1462-2920.13816; Madsen JS, 2016, ENVIRON MICROBIOL, V18, P2565, DOI 10.1111/1462-2920.13335; Madsen JS, 2018, CURR OPIN MICROBIOL, V42, P104, DOI 10.1016/j.mib.2017.11.018; Monod M, 2005, MICROBIOL-SGM, V151, P145, DOI 10.1099/mic.0.27484-0; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Navone L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202608; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Onifade AA, 1998, BIORESOURCE TECHNOL, V66, P1, DOI 10.1016/S0960-8524(98)00033-9; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; PAPADOPOULOS MC, 1986, ANIM FEED SCI TECH, V14, P279, DOI 10.1016/0377-8401(86)90100-8; PAPADOPOULOS MC, 1985, AGR WASTES, V14, P275, DOI 10.1016/S0141-4607(85)80009-3; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; Prakash P, 2010, APPL MICROBIOL BIOT, V87, P625, DOI 10.1007/s00253-010-2499-1; Rahayu S, 2012, BIOCATAL AGR BIOTECH, V1, P152, DOI 10.1016/j.bcab.2012.02.001; Ramnani P, 2005, CAN J MICROBIOL, V51, P191, DOI 10.1139/W04-123; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rawlings ND, 1999, NUCLEIC ACIDS RES, V27, P325, DOI 10.1093/nar/27.1.325; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Ren DW, 2015, ISME J, V9, P81, DOI 10.1038/ismej.2014.96; Ren DW, 2014, MICROB ECOL, V68, P146, DOI 10.1007/s00248-013-0315-z; Riffel A, 2003, ARCH MICROBIOL, V179, P258, DOI 10.1007/s00203-003-0525-8; Riffel A, 2007, J BIOTECHNOL, V128, P693, DOI 10.1016/j.jbiotec.2006.11.007; Sangali S, 2000, APPL BIOCHEM BIOTECH, V87, P17, DOI 10.1385/ABAB:87:1:17; Sharma S, 2016, BRAZ ARCH BIOL TECHN, V59, DOI 10.1590/1678-4324-2016150684; Silveira ST, 2012, J MICROBIOL BIOTECHN, V22, P818, DOI 10.4014/jmb.1111.11048; Thys RCS, 2006, J APPL MICROBIOL, V101, P1259, DOI 10.1111/j.1365-2672.2006.03050.x; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Verma A, 2017, CRIT REV BIOTECHNOL, V37, P476, DOI 10.1080/07388551.2016.1185388; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLIAMS CM, 1990, APPL ENVIRON MICROB, V56, P1509, DOI 10.1128/AEM.56.6.1509-1515.1990; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Wongwilaiwalin S, 2013, APPL MICROBIOL BIOT, V97, P8941, DOI 10.1007/s00253-013-4699-y; Yamamura S, 2002, BIOCHEM BIOPH RES CO, V294, P1138, DOI 10.1016/S0006-291X(02)00580-6; Yamamura S, 2002, J BIOSCI BIOENG, V93, P595, DOI 10.1263/jbb.93.595	81	11	12	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228108	10.1371/journal.pone.0228108	http://dx.doi.org/10.1371/journal.pone.0228108			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004342	Green Published, gold			2022-12-26	WOS:000534614600017
J	Cao, Z; Wang, GD; Hui, WP; Liu, B; Liu, ZY; Sun, JM				Cao, Zhong; Wang, Guodong; Hui, Wenpeng; Liu, Bo; Liu, Zhiyong; Sun, Jianmin			Percutaneous kyphoplasty for osteoporotic vertebral compression fractures improves spino-pelvic alignment and global sagittal balance maximally in the thoracolumbar region	PLOS ONE			English	Article							GRAVITY LINE; END-PLATE; BACK-PAIN; DEFORMITY; PARAMETERS; IMBALANCE; KYPHOSIS; FORCES; VALUES	Background Osteoporotic vertebral compression fractures (OVCFs) often cause local kyphosis. Percutaneous kyphoplasty (PKP) is a common method for the treatment of local kyphosis. However, the influence of kyphoplasty on spino-pelvic alignment and global sagittal balance when performed at specific treatment sites in the spine remains unclear. The purpose of the study is to investigate the influence of different fracture sites and PKP treatment on the spino-pelvic alignment and global sagittal balance in patients with OVCFs. Methods 90 patients with OVCF who underwent PKP were included in the retrospective study. According to the site of the fractured vertebrae, all the cases were divided into 3 groups: Main thoracic (MT) group (T1 to T9), Thoracolumbar (TL) group (T10 to L2) and Lumbar (LU) group (L3 to L5). 26 healthy elderly volunteers (aged over 59) were enrolled as the control group. Sagittal spino-pelvic parameters were measured on the full-spine radiographs preoperatively and postoperatively. Information of sagittal spino-pelvic parameters and global sagittal balance was gathered. Results Compared with the Control group, TL group showed significant differences in almost all parameters, except pelvic incidence (PI) and lumbar lordosis (LL). While only local sagittal parameters (Thoracic kyphosis (TK), Thoracolumbar kyphosis (TLK), LL) were significantly different in MT group. There was no significant difference in almost all of the parameters except for PT and TPA in LU group. Correspondingly, the sagittal parameters of TL group improved best after PKP, except for thoracic kyphosis (TK) and sagittal vertical axis (SVA). In MT group, only TLK was significantly decreased, while in LU group, only local kyphosis Cobb angle and SSA were improved. Conclusions OVCF mainly occurs in the thoracolumbar region. Compared with MT group and LU group, OVCF occurred in the thoracolumbar region had greater influence on the spino-pelvic alignment and global sagittal balance. When PKP was performed, the improvement of sagittal balance parameters of TL group was the best in the three groups.	[Cao, Zhong; Hui, Wenpeng; Liu, Bo; Liu, Zhiyong] Shandong Univ, Shandong Prov ENT Hosp, Dept Orthopaed Surg, Jinan, Peoples R China; [Wang, Guodong; Sun, Jianmin] Shandong Univ, Shandong Prov Hosp, Dept Spine Surg, Jinan, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Sun, JM (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Spine Surg, Jinan, Peoples R China.	sunjmsunjmsd@163.com		Cao, Zhong/0000-0002-6283-4014				[Anonymous], 1996, BONE, V18, pS179, DOI [10.1016/8756-3282(95)00499-8, DOI 10.1016/8756-3282(95)00499-8]; Aota Y, 2009, SPINE, V34, P808, DOI 10.1097/BRS.0b013e31819e2191; Barrey Cedric, 2011, Eur Spine J, V20 Suppl 5, P626, DOI 10.1007/s00586-011-1930-3; Berthonnaud E, 2005, J SPINAL DISORD TECH, V18, P40, DOI 10.1097/01.bsd.0000117542.88865.77; Boulay C, 2006, EUR SPINE J, V15, P415, DOI 10.1007/s00586-005-0984-5; Cogniet A, 2016, EUR SPINE J, V25, P2657, DOI 10.1007/s00586-016-4424-5; Diebo BG, 2015, CLIN NEUROL NEUROSUR, V139, P295, DOI 10.1016/j.clineuro.2015.10.024; Duval-Beaup?re G., 2004, REV RHUM, V71, P105, DOI [10.1016/j.rhum.2003.09.018, DOI 10.1016/J.RHUM.2003.09.018]; Friedrich HC, 2011, CENT EUR NEUROSURG, V72, P176, DOI 10.1055/s-0031-1284415; Guigui P, 2003, REV CHIR ORTHOP, V89, P496; Hasegawa K, 2017, J ANAT, V230, P619, DOI 10.1111/joa.12586; Hu ZS, 2018, ARCH OSTEOPOROS, V13, DOI 10.1007/s11657-018-0512-y; Ismail AA, 1999, OSTEOPOROSIS INT, V9, P206, DOI 10.1007/s001980050138; Jackson RP, 2000, SPINE, V25, P575, DOI 10.1097/00007632-200003010-00008; Jean L, 2014, EUR SPINE J, V23, P1394, DOI 10.1007/s00586-014-3207-0; Kanayama M, 2015, INT ORTHOP, V39, P1137, DOI 10.1007/s00264-015-2737-3; Kondo Kimi L, 2008, Semin Intervent Radiol, V25, P413, DOI 10.1055/s-0028-1103000; Kong LD., 2014, EUR J ORTHOP SURG TR, V24, pS201, DOI [DOI 10.1007/s00590-013-1374-z, 10.1007/s00590-013-1374-z, DOI 10.1007/S00590-013-1374-Z]; Lafage V, 2008, SPINE, V33, P1572, DOI 10.1097/BRS.0b013e31817886a2; Lamartina C, 2014, EUR SPINE J, V23, P1177, DOI 10.1007/s00586-014-3227-9; Lamartina C, 2012, EUR SPINE J, V21, pS27, DOI 10.1007/s00586-012-2236-9; Le Huec J C, 2011, Eur Spine J, V20 Suppl 5, P564, DOI 10.1007/s00586-011-1940-1; Le Huec JC, 2012, EUR SPINE J, V21, P1896, DOI 10.1007/s00586-012-2474-x; Lee TO, 2007, J KOREAN NEUROSURG S, V42, P271, DOI 10.3340/jkns.2007.42.4.271; Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038; Liu T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007216; Lunt M, 2003, BONE, V33, P505, DOI 10.1016/S8756-3282(03)00248-5; Mac-Thiong JM, 2010, SPINE, V35, pE1193, DOI 10.1097/BRS.0b013e3181e50808; Mac-Thiong JM, 2003, SPINE, V28, P1404, DOI 10.1097/01.BRS.0000067118.60199.D1; Marks M, 2009, SPINE, V34, P949, DOI 10.1097/BRS.0b013e318199650a; Muratore M, 2018, EUR SPINE J, V27, P2565, DOI 10.1007/s00586-017-5340-z; Ould-Slimane M, 2012, EUR SPINE J, V21, P1200, DOI 10.1007/s00586-011-2124-8; Pradhan BB, 2006, SPINE, V31, P435, DOI 10.1097/01.brs.0000200036.08679.1e; Protopsaltis T, 2014, J BONE JOINT SURG AM, V96A, P1631, DOI 10.2106/JBJS.M.01459; Qian J, 2016, EUR SPINE J, V25, P3715, DOI 10.1007/s00586-016-4486-4; Roussouly P., 2011, EUR SPINE J, V20, P609, DOI 10.1007/s00586-011-1928-x; Roussouly P, 2006, SPINE, V31, pE320, DOI 10.1097/01.brs.0000218263.58642.ff; Roussouly P, 2010, EUR SPINE J, V19, P1824, DOI 10.1007/s00586-010-1476-9; Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4; Sutipornpalangkul Werasak, 2016, Journal of the Medical Association of Thailand, V99, P1025; Trout AT, 2006, J BONE MINER RES, V21, P1797, DOI 10.1359/JBMR.060723; Trout AT, 2006, AM J NEURORADIOL, V27, P217; Vaz G, 2002, EUR SPINE J, V11, P80, DOI 10.1007/s005860000224; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043; Yokoyama K, 2015, EUR SPINE J, V24, P744, DOI 10.1007/s00586-014-3678-z; Yu CW, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-3; Zhang YL, 2017, ORTHOPADE, V46, P249, DOI 10.1007/s00132-016-3359-1; Zhao FD, 2009, BONE, V44, P372, DOI 10.1016/j.bone.2008.10.048	48	19	22	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228341	10.1371/journal.pone.0228341	http://dx.doi.org/10.1371/journal.pone.0228341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999783	Green Published, gold			2022-12-26	WOS:000534612400069
J	Spangler, D; Kish, D; Beigel, B; Morgan, J; Gruszynski, K; Naikare, H; Nahar, VK; Coarsey, MD; Verma, A				Spangler, Dawn; Kish, Daniel; Beigel, Brittney; Morgan, Joey; Gruszynski, Karen; Naikare, Hemant; Nahar, Vinayak K.; Coarsey, Michele D.; Verma, Ashutosh			Leptospiral shedding and seropositivity in shelter dogs in the Cumberland Gap Region of Southeastern Appalachia	PLOS ONE			English	Article							CHAIN-REACTION ASSAY; UNITED-STATES; CANINE LEPTOSPIROSIS; RISK-FACTORS; INFECTION; PREVALENCE; ANTIBODIES; MAMMALS; CATS; AREA	Background Leptospirosis, caused by pathogenic Leptospira spp., is a zoonotic infection that affects humans, dogs and many other mammalian species. Virtually any mammalian species can act as asymptomatic reservoir, characterized by chronic renal carriage and shedding of a host-adapted leptospiral serovar. Environmental contamination by chronic shedders results in acquisition of infection by humans and susceptible animals. Methods In this study, we investigated if clinically normal shelter dogs and cats harbor leptospires in their kidneys by screening urine samples for the presence of leptospiral DNA by a TaqMan based-quantitative PCR (qPCR) that targets pathogen-associated lipl32 gene. To identify the infecting leptospiral species, a fragment of leptospiral rpoB gene was PCR amplified and sequenced. Additionally, we measured Leptospira-specific serum antibodies using the microscopic agglutination test (MAT), a gold standard in leptospiral serology. Results A total of 269 shelter animals (219 dogs and 50 cats) from seven shelters located in the tristate area of western Virginia, eastern Tennessee, and southeastern Kentucky were included in this study. All cats tested negative by both qPCR and MAT. Of the 219 dogs tested in the study, 26/198 (13.1%, 95% CI: 8.4-17.8%) were positive for leptospiral DNA in urine by qPCR and 38/211 (18.0%, 95% CI: 12.8-23.2%) were seropositive by MAT. Twelve dogs were positive for both qPCR and MAT. Fourteen dogs were positive by qPCR but not by MAT. Additionally, leptospiral rpoB gene sequencing from a sub-set of qPCR-positive urine samples (n = 21) revealed L. interrogans to be the leptospiral species shed by dogs. Conclusions These findings have significant implications regarding animal and public health in the Cumberland Gap Region and possibly outside where these animals may be adopted.	[Spangler, Dawn; Kish, Daniel; Beigel, Brittney; Morgan, Joey; Verma, Ashutosh] Lincoln Mem Univ, Coll Vet Med, Harrogate, TN USA; [Spangler, Dawn; Verma, Ashutosh] Ctr Infect Zoonot & Vector Borne Dis, Harrogate, TN USA; [Gruszynski, Karen] Lincoln Mem Univ, Ctr Human & Anim Hlth Appalachia, Harrogate, TN USA; [Naikare, Hemant; Coarsey, Michele D.] Univ Georgia, Coll Vet Med, Tifton Vet Diagnost & Invest Lab, Tifton, GA USA; [Nahar, Vinayak K.] Univ Mississippi, Med Ctr, Dept Dermatol, Sch Med, Jackson, MS 39216 USA; [Nahar, Vinayak K.] Univ Mississippi, Med Ctr, Sch Med, Dept Prevent Med,John D Bower Sch Populat Hlth, Jackson, MS 39216 USA	University System of Georgia; University of Georgia; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Verma, A (corresponding author), Lincoln Mem Univ, Coll Vet Med, Harrogate, TN USA.; Verma, A (corresponding author), Ctr Infect Zoonot & Vector Borne Dis, Harrogate, TN USA.	ashutosh.verma@lmunet.edu			Lincoln Memorial University-College of Veterinary Medicine's Intramural Grant Program [17DS001]	Lincoln Memorial University-College of Veterinary Medicine's Intramural Grant Program	Please note the funding for this study was provided by Lincoln Memorial University-College of Veterinary Medicine's Intramural Grant Program to Dawn Spangler and Ashutosh Verma (Grant#17DS001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Boey K, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007499; Brown CA, 1996, J AM VET MED ASSOC, V209, P1265; Calderon A, 2014, TROP ANIM HEALTH PRO, V46, P427, DOI 10.1007/s11250-013-0508-y; Clifton M., RECORD LOW SHELTER K; Delaude A, 2017, PREV VET MED, V141, P48, DOI 10.1016/j.prevetmed.2017.04.008; DICKESON D, 1993, AUST VET J, V70, P389, DOI 10.1111/j.1751-0813.1993.tb00823.x; Dietrich M, 2014, MOL ECOL, V23, P2783, DOI 10.1111/mec.12777; dos Santos LF, 2017, TROP ANIM HEALTH PRO, V49, P1715, DOI 10.1007/s11250-017-1382-9; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Ford R, 2017, 2017 AM ANIMAL HOSP; Gautam R, 2010, PREV VET MED, V96, P122, DOI 10.1016/j.prevetmed.2010.05.017; Gay N, 2014, INT J ENV RES PUB HE, V11, P4316, DOI 10.3390/ijerph110404316; Glickman LT, 2006, VECTOR-BORNE ZOONOT, V6, P14, DOI 10.1089/vbz.2006.6.14; Greene CE, 2012, INFECT DIS DOG CAT, P431, DOI DOI 10.1016/J.PREVETMED.2017.04.008; Harkin KR, 2003, J AM VET MED ASSOC, V222, P1230, DOI 10.2460/javma.2003.222.1230; Harkin KR, 2003, J AM VET MED ASSOC, V222, P1224, DOI 10.2460/javma.2003.222.1224; Hennebelle JH, 2013, JAVMA-J AM VET MED A, V242, P941, DOI 10.2460/javma.242.7.941; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x; Lapointe C, 2013, CAN VET J, V54, P497; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Llewellyn JR, 2016, BERL MUNCH TIERARZTL, V129, P251, DOI 10.2376/0005-9366-129-15061; Lopez MC, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02373; Miotto BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200384; Miotto BA, 2016, ACTA TROP, V162, P1, DOI 10.1016/j.actatropica.2016.06.007; Moore GE, 2006, EMERG INFECT DIS, V12, P501, DOI 10.3201/eid1203.050809; Nelson RW, 2003, SMALL ANIMAL MED; Oliveira ST, 2012, ACTA SCI VET, V40; da Cunha CEP, 2016, AM J TROP MED HYG, V94, P519, DOI 10.4269/ajtmh.15-0505; Rodriguez J, 2014, J VET INTERN MED, V28, P284, DOI 10.1111/jvim.12287; Rojas P, 2010, EUR J CLIN MICROBIOL, V29, P1305, DOI 10.1007/s10096-010-0991-2; Rowan A, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8050068; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SanT'Anna R, 2017, EPIDEMIOL INFECT, V145, P1852, DOI 10.1017/S0950268817000632; Schuller S, 2015, J SMALL ANIM PRACT, V56, P159, DOI 10.1111/jsap.12328; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Verma A, PLOS NEGL TROP DIS; Vinetz Joseph M., 2005, EcoHealth, V2, P291, DOI 10.1007/s10393-005-8638-y; Ward MP, 2002, J AM VET MED ASSOC, V220, P53, DOI 10.2460/javma.2002.220.53; Ward MP, 2002, PREV VET MED, V56, P215, DOI 10.1016/S0167-5877(02)00160-5; Weis S, 2017, J FELINE MED SURG, V19, P470, DOI 10.1177/1098612X16634389; White AM, 2017, VET J, V222, P29, DOI 10.1016/j.tvjl.2017.02.009; Zaidi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197068; Zakeri S, 2010, INFECT GENET EVOL, V10, P273, DOI 10.1016/j.meegid.2010.01.001; Zhang CC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007513	49	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228038	10.1371/journal.pone.0228038	http://dx.doi.org/10.1371/journal.pone.0228038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999733	Green Published, gold			2022-12-26	WOS:000534612400045
J	Yakhelef, N; Audibert, M; Ferlazzo, G; Sitienei, J; Wanjala, S; Varaine, F; Bonnet, M; Huerga, H				Yakhelef, Nadia; Audibert, Martine; Ferlazzo, Gabriella; Sitienei, Joseph; Wanjala, Steve; Varaine, Francis; Bonnet, Maryline; Huerga, Helena			Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; UNCERTAINTY; DISEASE; PEOPLE; BURDEN	Background Tuberculosis (TB) is the leading cause of death among HIV-positive patients. We assessed the cost-effectiveness of including lateral-flow urine lipoarabinomannan (LF-LAM) in TB diagnostic algorithms for severely ill or immunosuppressed HIV-positive patients with symptoms of TB in Kenya. Methods From a decision-analysis tree, ten diagnostic algorithms were elaborated and compared. All algorithms included clinical exam. The costs of each algorithm were calculated using a `micro-costing' method. The efficacy was estimated through a prospective study that included severely ill or immunosuppressed (CD4< 200cells/mu L) HIV-positive adults with symptoms of TB. The cost-effectiveness analysis was performed using the disabilityadjusted life year (DALY) averted as effectiveness outcome. A 4% discount rate was applied. Results The algorithm that added LF-LAM alone to the clinical exam lead to the least average cost per TB case detected (_ 47) and was the most cost-effective with a cost/DALY averted of (sic)4.6. The algorithms including LF-LAM, microscopy and X-ray, and LF-LAM and Xpert in sputum, detected a high number of TB cases with a cost/DALY averted of (sic)6.1 for each of them. In the comparisons of the algorithms two by two, using LF-LAM instead of microscopy (clinic&LAM vs clinic&microscopy) and using LF-LAM along with GeneXpert in instead of GeneXpert in urine along with GeneXpert in sputum, (clinic&LAM&Xpert_sputum vs clinic&Xpert_sputum&Xpert_urine) led to the highest increase in the cost-effectiveness ratios (ICERs): (sic)- 7.2 and (sic)- 12.6 respectively. In these two comparisons, using LF-LAM increased the number of TB patients detected while reducing costs. Adding LF-LAM to smear microscopy alone or to smear microscopy and Xray led to the highest increase in the additional number of TB cases detected (31 and 25 respectively) with an incremental efficiency estimated at 134 and 344 DALYs respectively. The ICERs were (sic)22.0 and (sic)8.6 respectively. Conclusion Including LF-LAM in TB diagnostic algorithms is cost-effective for severely ill or immunosuppressed HIV-positive patients.	[Yakhelef, Nadia; Bonnet, Maryline; Huerga, Helena] Epicentre, Paris, France; [Audibert, Martine] Univ Clermont Auvergne, CNRS, CERDI, Clermont Ferrand, France; [Ferlazzo, Gabriella; Varaine, Francis] Med Sans Frontieres, Paris, France; [Sitienei, Joseph] Minist Hlth, Div Natl Strateg Hlth Programs, Nairobi, Kenya; [Sitienei, Joseph] Med Sans Frontieres, Nairobi, Kenya; [Wanjala, Steve; Bonnet, Maryline] IRD UMI 233 TransVIHMI UM INSERM U1175, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Doctors Without Borders; Institut National de la Sante et de la Recherche Medicale (Inserm)	Yakhelef, N (corresponding author), Epicentre, Paris, France.	nadiayakhelef@hotmail.com			Kenyan Ministry of Health; National TB Control Program	Kenyan Ministry of Health; National TB Control Program	We are grateful to the patients who participated in this study, and to the Medecins Sans Frontieres and Ministry of Health staff teams who provided care to the patients and contributed to this study. We would like to thank the Kenyan Ministry of Health and National TB Control Program for their support.	[Anonymous], 2012, GLOB TUB REP 2012; BLACK WC, 1990, MED DECIS MAKING, V10, P212, DOI 10.1177/0272989X9001000308; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Cohen DJ, 2008, J AM COLL CARDIOL, V52, P2119, DOI 10.1016/j.jacc.2008.09.018; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Dowdy DW, 2008, INT J TUBERC LUNG D, V12, P1021; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Glick H A, 2001, Expert Rev Pharmacoecon Outcomes Res, V1, P25, DOI 10.1586/14737167.1.1.25; Haute Autorite de Sante, 2003, CHOIX METH EV EC EC; Huerga H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170976; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241; National AIDS Control Council, 2018, KEN HIV EST REP 2018; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; O'Brien BJ, 2002, STAT METHODS MED RES, V11, P455, DOI 10.1191/0962280202sm304ra; Organization WH, 2014, CHOOS INT AR COST EF; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Reddy KP, 2019, LANCET GLOBAL HLTH; Sabur NF, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2914-7; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sekandi JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117009; Shah M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011420.pub2; Shah M, 2014, AIDS, V28, P1307, DOI 10.1097/QAD.0000000000000264; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Sun D, 2013, INT J TUBERC LUNG D, V17, P552, DOI 10.5588/ijtld.12.0627; The National Tuberculosis Leprosy and Lung Disease Program, 2016, KEN TUB PREV SURV 20; Tuberculosis Coalition for Technical Assistance, 2006, INT STAND TUB CAR IS; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Bank, 2013, GNI PER CAP KEN CURR; World Health Organization, 2013, WHO GUIDE COST EFFEC; World Health Organization, 2016, CHEST RAD TUB DET SU; World Health Organization, LIF TABL COUNTR; World Health Organization, 2016, TUB DIAGN LAT FLOW U; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Yakhelef N, 2014, INT J TUBERC LUNG D, V18, P541, DOI 10.5588/ijtld.13.0630	41	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227138	10.1371/journal.pone.0227138	http://dx.doi.org/10.1371/journal.pone.0227138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999746	gold, Green Published			2022-12-26	WOS:000534612400013
J	Gomez, AC; Rodriguez-Fernandez, P; Villar-Hernandez, R; Gibert, I; Muriel-Moreno, B; Lacoma, A; Prat-Aymerich, C; Dominguez, J				Gomez, Andromeda-Celeste; Rodriguez-Fernandez, Pablo; Villar-Hernandez, Raquel; Gibert, Isidre; Muriel-Moreno, Beatriz; Lacoma, Alicia; Prat-Aymerich, Cristina; Dominguez, Jose			E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis	PLOS ONE			English	Article							ELECTRONIC CIGARETTE; SMOKE EXPOSURE; VAPOR EXTRACT; IN-VITRO; SUSCEPTIBILITY; MACROPHAGES; EXPRESSION; VIRULENCE; IMMUNITY; RELEASE	Cigarette smoking and tuberculosis are a significant cause of death worldwide. Several epidemiological studies have demonstrated cigarette smoking is a risk factor for tuberculosis. Electronic cigarettes have recently appeared as a healthier alternative to conventional smoking, although their impact in tuberculosis is not well understood. The aim of this study was to explore the effect of electronic cigarettes in phagocytosis of Mycobacterium tuberculosis and cytokines production. In vitro infection was carried out by exposing THP-1 macrophages to four electronic vapor extracts and the intracellular burden of M. tuberculosis was determined. The percentage of infection was evaluated by confocal microscopy and the cytokine production by Luminex. A reduction of intracellular M. tuberculosis burden in THP1 macrophages was found after its exposure to electronic vapor extract; the same trend was observed by confocal microscopy when Mycobacterium bovis BCG-GFP strain was used. Electronic cigarettes stimulate a pro-inflammatory cytokine response. We conclude that electronic cigarettes impair the phagocytic function and the cytokine response to M. tuberculosis.	[Gomez, Andromeda-Celeste; Rodriguez-Fernandez, Pablo; Villar-Hernandez, Raquel; Muriel-Moreno, Beatriz; Lacoma, Alicia; Prat-Aymerich, Cristina; Dominguez, Jose] Hosp Badalona Germans Trias & Pujol, Inst Invest Ciencies Salut Germans Trias & Pujol, CIBER Enfermedades Resp CIBERES, Serv Microbiol, Badalona, Catalonia, Spain; [Gomez, Andromeda-Celeste; Rodriguez-Fernandez, Pablo; Gibert, Isidre] Univ Autonoma Barcelona UAB, Inst Biotecnol Biomedi IBB, Barcelona, Catalonia, Spain; [Gomez, Andromeda-Celeste; Rodriguez-Fernandez, Pablo; Villar-Hernandez, Raquel; Gibert, Isidre; Prat-Aymerich, Cristina; Dominguez, Jose] Univ Autonoma Barcelona UAB, Dept Genet & Microbiol, Barcelona, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Dominguez, J (corresponding author), Hosp Badalona Germans Trias & Pujol, Inst Invest Ciencies Salut Germans Trias & Pujol, CIBER Enfermedades Resp CIBERES, Serv Microbiol, Badalona, Catalonia, Spain.; Dominguez, J (corresponding author), Univ Autonoma Barcelona UAB, Dept Genet & Microbiol, Barcelona, Catalonia, Spain.	jadominguez@igtp.cat	Villar-Hernández, Raquel/AGD-6666-2022; Gómez, Andromeda/AAI-8082-2020; Villar Hernández, Raquel/AFN-3894-2022; Gibert, Isidre/L-9834-2014; Lacoma, Alicia/H-8516-2017; PRAT AYMERICH, CRISTINA/R-3484-2016	Villar-Hernández, Raquel/0000-0002-2249-0579; Gómez, Andromeda/0000-0002-0075-6903; Villar Hernández, Raquel/0000-0002-2249-0579; Gibert, Isidre/0000-0003-1442-2258; Lacoma, Alicia/0000-0002-2049-3872; Dominguez, Jose/0000-0001-7888-0309; PRAT AYMERICH, CRISTINA/0000-0001-6974-9165	SEPAR (Spanish Society for Pulmonology and Thoracic Surgery; Extraordinary Call for Research PII Smoking, Research) [16/024]; European Respiratory Society Long-Term Research Fellowship [LTRF-2015-5934]; Instituto de Salud Carlos III [PI16/1912, PI17/01139]; Instituto de Salud Carlos III (ISCIII); Instituto de Salud Carlos III (European Regional Development Fund); CERCA Programme/Generalitat de Catalunya; Spanish Ministry of Science, Innovation and Universities, as a part of the Program Training of University Staff [FPU14/01854]	SEPAR (Spanish Society for Pulmonology and Thoracic Surgery; Extraordinary Call for Research PII Smoking, Research); European Respiratory Society Long-Term Research Fellowship; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (European Regional Development Fund)(Instituto de Salud Carlos IIIEuropean Commission); CERCA Programme/Generalitat de Catalunya; Spanish Ministry of Science, Innovation and Universities, as a part of the Program Training of University Staff	This work was supported by: SEPAR (Spanish Society for Pulmonology and Thoracic Surgery; Extraordinary Call for Research PII Smoking, Research Project no :16/024); European Respiratory Society Long-Term Research Fellowship (LTRF-2015-5934); Instituto de Salud Carlos III (PI16/1912 y PI17/01139 projects, integrated in the National Plan R+D+I and funded by the ISCIII and the European Regional Development Fund.) and the CERCA Programme/Generalitat de Catalunya. Jose Dominguez is an investigator of the Program Miguel Servet from Instituto de Salud Carlos III and Pablo Rodriguez-Fernandez is the recipient of a fellowship from the Spanish Ministry of Science, Innovation and Universities , as a part of the Program Training of University Staff (FPU14/01854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altet N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182998; Aryanpur M, 2016, IRAN J ALLERGY ASTHM, V15, P174; Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Bai XY, 2017, AM J RESP CELL MOL, V57, P324, DOI 10.1165/rcmb.2016-0270OC; Bals R, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01151-2018; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; Bengalli R, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101254; Besaratinia A, 2017, CANCER CAUSE CONTROL, V28, P1167, DOI 10.1007/s10552-017-0952-5; Bishwakarma R, 2015, RESPIROLOGY, V20, P556, DOI 10.1111/resp.12515; Cervellati F, 2014, TOXICOL IN VITRO, V28, P999, DOI 10.1016/j.tiv.2014.04.012; Chan ED, 2014, TUBERCULOSIS, V94, P544, DOI 10.1016/j.tube.2014.08.010; Cooke A, 2015, J ALLER CL IMM-PRACT, V3, P498, DOI 10.1016/j.jaip.2015.05.022; Dacie RL, 2016, THORAX, V71, pA72, DOI 10.1136/thoraxjnl-2016-209333.129; Domingo-Gonzalez R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0018-2016; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-68; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Ghosh A, 2018, AM J RESP CRIT CARE, V198, P67, DOI 10.1164/rccm.201710-2033OC; Gomez A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26221; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Han S, 2017, RESP RES, V18, DOI 10.1186/s12931-016-0485-6; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hwang JH, 2016, J MOL MED, V94, P667, DOI 10.1007/s00109-016-1378-3; Kent L, 2008, CYTOKINE, V42, P205, DOI 10.1016/j.cyto.2008.02.001; Kosmider L, 2016, THORAX, V71, P376, DOI 10.1136/thoraxjnl-2015-207895; Leigh NJ, 2016, TOB CONTROL, V25, pii81, DOI 10.1136/tobaccocontrol-2016-053205; Lerner CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116732; Lopez-Hernandez Y, 2018, EXP LUNG RES, V44, P113, DOI 10.1080/01902148.2018.1444824; Margham J, 2016, CHEM RES TOXICOL, V29, P1662, DOI 10.1021/acs.chemrestox.6b00188; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; McEachern EK, 2015, INFECT IMMUN, V83, P2443, DOI 10.1128/IAI.00303-15; Minematsu N, 2011, AM J RESP CELL MOL, V44, P474, DOI 10.1165/rcmb.2009-0463OC; Muthumalage T, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01130; O'Leary SM, 2014, AM J RESP CRIT CARE, V190, P1430, DOI 10.1164/rccm.201407-1385OC; Ouyang Y, 2000, J ALLERGY CLIN IMMUN, V106, P280, DOI 10.1067/mai.2000.107751; Queval CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02284; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Rodriguez-Fernandez P, 2018, ARCH BRONCONEUMOL; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott A, 2018, THORAX; Scott A, 2016, THORAX S3, V71, pA288; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Sitas F, 2004, TOB CONTROL, V13, P396, DOI 10.1136/tc.2004.007682; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; Sussan TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116861; van Zyl-Smit RN, 2014, THORAX, V69, P363, DOI 10.1136/thoraxjnl-2013-204229; Ween MP, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13370; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization, 2017, WHO REP GLOB TOB EP; Wu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108342; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Zhao JW, 2017, INT J IMMUNOPATH PH, V30, P315, DOI 10.1177/0394632017716370	55	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228919	10.1371/journal.pone.0228919	http://dx.doi.org/10.1371/journal.pone.0228919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040536	Green Published, gold			2022-12-26	WOS:000534629400054
J	Ide, M; Sonoda, N; Inoue, T; Kimura, S; Minami, Y; Makimura, H; Hayashida, E; Hyodo, F; Yamato, M; Takayanagi, R; Inoguchi, T				Ide, Makoto; Sonoda, Noriyuki; Inoue, Tomoaki; Kimura, Shinichiro; Minami, Yohei; Makimura, Hiroaki; Hayashida, Eiichi; Hyodo, Fuminori; Yamato, Mayumi; Takayanagi, Ryoichi; Inoguchi, Toyoshi			The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation	PLOS ONE			English	Article							BRAIN MITOCHONDRIAL-FUNCTION; IN-VITRO; MRI	Objective Accumulating epidemiological studies have demonstrated that diabetes is an important risk factor for dementia. However, the underlying pathological and molecular mechanisms, and effective treatment, have not been fully elucidated. Herein, we investigated the effect of the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, on diabetes-related cognitive impairment. Method Streptozotocin (STZ)-induced diabetic mice were treated with linagliptin (3 mg/kg/24 h) for 17 weeks. The radial arm water maze test was performed, followed by evaluation of oxidative stress using DNP-MRI and the expression of NAD(P)H oxidase components and proinflammatory cytokines and of microglial activity. Results Administration of linagliptin did not affect the plasma glucose and body weight of diabetic mice; however, it improved cognitive impairment. Additionally, linagliptin reduced oxidative stress and the mRNA expression of NAD(P)H oxidase component and TNF-alpha, and the number and body area of microglia, all of which were significantly increased in diabetic mice. Conclusions Linagliptin may have a beneficial effect on diabetes-related dementia by inhibiting oxidative stress and microglial activation, independently of glucose-lowering.	[Ide, Makoto; Sonoda, Noriyuki; Inoue, Tomoaki; Kimura, Shinichiro; Minami, Yohei; Makimura, Hiroaki; Hayashida, Eiichi; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Internal Med & Bioregulatory Sci, Fukuoka, Japan; [Sonoda, Noriyuki; Hyodo, Fuminori; Yamato, Mayumi; Inoguchi, Toyoshi] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka, Japan; [Inoguchi, Toyoshi] Fukuoka City Hlth Promot Support Ctr, Fukuoka, Japan	Kyushu University; Kyushu University	Sonoda, N (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Internal Med & Bioregulatory Sci, Fukuoka, Japan.; Sonoda, N (corresponding author), Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka, Japan.	noriyuki@intmed3.med.kyushu-u.ac.jp		Inoguchi, Toyoshi/0000-0002-7344-6199	Special Coordination Funds for Promoting Science and Technology (SCF funding program "Innovation Center for Medical Redox Navigation")	Special Coordination Funds for Promoting Science and Technology (SCF funding program "Innovation Center for Medical Redox Navigation")	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology (SCF funding program "Innovation Center for Medical Redox Navigation"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054; [Anonymous], 2005, ACTA ENDOCRINOL-COP, V5, P9, DOI [10.4183/aeb.2019.9, DOI 10.4183/AEB.2019.9]; Bae CS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112493; Biessels GJ, 2019, DIABETES CARE, V42, P1930, DOI 10.2337/dc19-0783; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bogush M, 2017, J NEUROIMMUNE PHARM, V12, P593, DOI 10.1007/s11481-017-9752-7; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Faivre E, 2012, EUR J PHARMACOL, V674, P294, DOI 10.1016/j.ejphar.2011.11.007; Fetler L, 2005, SCIENCE, V309, P392, DOI 10.1126/science.1114852; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hanyu H, 2019, ADV EXP MED BIOL, V1128, P147, DOI 10.1007/978-981-13-3540-2_8; Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008; Hutch CR, 2019, DIABETOLOGIA, V62, P1928, DOI 10.1007/s00125-019-4963-5; Hyodo F, 2008, J CEREBR BLOOD F MET, V28, P1165, DOI 10.1038/jcbfm.2008.5; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Kato TA, 2011, SCHIZOPHR RES, V129, P172, DOI 10.1016/j.schres.2011.03.019; Kimura S, 2016, METABOLISM, V65, P138, DOI 10.1016/j.metabol.2015.10.030; Kodama Y, 2019, KIDNEY INT, V96, P787, DOI 10.1016/j.kint.2019.04.034; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; dos Santos JAL, 2019, J NANOMATER, V2019, DOI 10.1155/2019/2796746; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; Minami Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21426-6; Nakaoku Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102539; Nauck MA, 2011, AM J MED, V124, pS19, DOI 10.1016/j.amjmed.2010.11.002; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588; Pintana H, 2013, J ENDOCRINOL, V218, P1, DOI 10.1530/JOE-12-0521; Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088; Sano H, 2000, FREE RADICAL BIO MED, V28, P959, DOI 10.1016/S0891-5849(00)00184-2; Selvarajah Dinesh, 2006, Curr Diab Rep, V6, P431, DOI 10.1007/s11892-006-0075-y; Spencer NY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200249; Spielman LJ, 2017, EUR J CELL BIOL, V96, P240, DOI 10.1016/j.ejcb.2017.03.004; Terawaki Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0154-3; Utsumi H, 2006, P NATL ACAD SCI USA, V103, P1463, DOI 10.1073/pnas.0510670103; Yagi K, 1998, Methods Mol Biol, V108, P101; Yamada J, 2011, NEUROSCI LETT, V504, P295, DOI 10.1016/j.neulet.2011.09.051; Yamato M, 2009, J CEREBR BLOOD F MET, V29, P1655, DOI 10.1038/jcbfm.2009.84	40	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228750	10.1371/journal.pone.0228750	http://dx.doi.org/10.1371/journal.pone.0228750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032367	gold, Green Published			2022-12-26	WOS:000534626100023
J	He, LQ; Long, J; Zhou, XH; Liu, YH; Li, TJ; Wu, X				He, Liuqin; Long, Jing; Zhou, Xihong; Liu, Yonghui; Li, Tiejun; Wu, Xin			Serine is required for the maintenance of redox balance and proliferation in the intestine under oxidative stress	FASEB JOURNAL			English	Article						apoptosis; cell growth; glutathione; reactive oxygen species	GLUTATHIONE SYNTHESIS; METABOLISM; AMPK; PATHOGENESIS; PROTEIN; CYCLE; MTOR; ACID	Serine has critical roles in maintaining cell growth and redox balance in cancer cells. However, the role of exogenous serine played in oxidative response and proliferation in normal mammalian intestine need to be further elucidated. We used a mouse model and intestinal porcine epithelial cells (IPEC-J2) to reveal that exogenous serine deficiency did not lead to redox imbalance and inhibition of proliferation in the intestine. However, serine deficiency exacerbated oxidative stress, mitochondrial dysfunction, apoptosis, and inhibition of proliferation in IPEC-J2 cells challenged by hydrogen peroxide, while serine supplementation rescued redox imbalance and those proliferation defects. Importantly, serine supplementation restored the glutathione content and decreased the accumulation of reactive oxygen species, while no such effects were observed when glutathione synthesis was inhibited. Additionally, serine supplementation increased nuclear nrf2 expression in IPEC-J2 cells. These results suggested that serine alleviates oxidative stress through supporting glutathione synthesis and activating nrf2 signaling. We further found that serine supplementation activated the mTOR pathway, while inhibition of mTOR diminished the effects of serine on promoting proliferation, suggesting critical roles of the mTOR pathway in this context. Taken together, our study underlines the importance of serine in the maintenance of redox status and proliferation in the intestine and reveals a novel potential mechanism that mediates these effects.	[He, Liuqin; Long, Jing; Zhou, Xihong; Liu, Yonghui; Li, Tiejun; Wu, Xin] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, 644,Yuanda 2nd Rd, Changsha 410125, Hunan, Peoples R China; [He, Liuqin; Long, Jing; Liu, Yonghui] Hunan Normal Univ, Coll Life Sci, Hunan Int Joint Lab Anim Intestinal Ecol & Hlth, Lab Anim Nutr & Human Hlth, Changsha, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Hunan Normal University	Zhou, XH (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, 644,Yuanda 2nd Rd, Changsha 410125, Hunan, Peoples R China.	xhzhou@isa.ac.cn	Liu, Yong/GWQ-6163-2022		National Natural Science Foundation of China (NSFC) [31702125]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31702125	AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4; Bauchart-Thevret C, 2010, AM J PHYSIOL-ENDOC M, V299, pE899, DOI 10.1152/ajpendo.00068.2010; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chua PJ, 2009, EXP BIOL MED, V234, P1086, DOI 10.3181/0903-RM-98; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; FELL DA, 1988, BIOCHEM J, V256, P97, DOI 10.1042/bj2560097; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; He LQ, 2018, J AGR FOOD CHEM, V66, P11273, DOI 10.1021/acs.jafc.8b04470; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim M, 2015, INT J MOL MED, V35, P755, DOI 10.3892/ijmm.2014.2046; Lucas S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800036; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Minton DR, 2018, MOL CELL, V69, P610, DOI 10.1016/j.molcel.2018.01.024; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Park SY, 2002, NUTR RES, V22, P283, DOI 10.1016/S0271-5317(01)00398-0; Parker SJ, 2016, MOL CELL, V61, P185, DOI 10.1016/j.molcel.2016.01.006; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Wu HM, 2009, ECOTOX ENVIRON SAFE, V72, P572, DOI 10.1016/j.ecoenv.2008.03.001; Wyant GA, 2017, CELL, V171, P642, DOI 10.1016/j.cell.2017.09.046; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yin J, 2017, ONCOTARGET, V8, P3124, DOI 10.18632/oncotarget.13844; Zhang HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03062; Zhang T, 2018, MOL NEUROBIOL, V55, P7025, DOI 10.1007/s12035-017-0840-8; Zhou XH, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700262; Zhou XH, 2018, BBA-MOL BASIS DIS, V1864, P488, DOI 10.1016/j.bbadis.2017.11.009; Zhou XH, 2017, J FUNCT FOODS, V39, P225, DOI 10.1016/j.jff.2017.10.026; Zhou XH, 2014, J PHYSIOL BIOCHEM, V70, P547, DOI 10.1007/s13105-014-0334-3	36	20	22	16	43	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4702	4717		10.1096/fj.201902690R	http://dx.doi.org/10.1096/fj.201902690R		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030825	Bronze			2022-12-26	WOS:000512333800001
J	Kluber, LA; Johnston, ER; Allen, SA; Hendershot, JN; Hanson, PJ; Schadt, CW				Kluber, Laurel A.; Johnston, Eric R.; Allen, Samantha A.; Hendershot, J. Nicholas; Hanson, Paul J.; Schadt, Christopher W.			Constraints on microbial communities, decomposition and methane production in deep peat deposits	PLOS ONE			English	Article							MARCELL EXPERIMENTAL FOREST; 16S RIBOSOMAL-RNA; TEMPERATURE SENSITIVITY; ANAEROBIC-DIGESTION; SOIL CARBON; ORGANIC-MATTER; OXIDATION; CO2; BOG; CH4	Peatlands play outsized roles in the global carbon cycle. Despite occupying a rather small fraction of the terrestrial biosphere (similar to 3%), these ecosystems account for roughly one third of the global soil carbon pool. This carbon is largely comprised of undecomposed deposits of plant material (peat) that may be meters thick. The fate of this deep carbon stockpile with ongoing and future climate change is thus of great interest and has large potential to induce positive feedback to climate warming. Recent in situ warming of an ombrotrophic peatland indicated that the deep peat microbial communities and decomposition rates were resistant to elevated temperatures. In this experiment, we sought to understand how nutrient and pH limitations may interact with temperature to limit microbial activity and community composition. Anaerobic microcosms of peat collected from 1.5 to 2 meters in depth were incubated at 6 degrees C and 15 degrees C with elevated pH, nitrogen (NH4Cl), and/or phosphorus (KH2PO4) in a full factorial design. The production of CO2 and CH4 was significantly greater in microcosms incubated at 15 degrees C, although the structure of the microbial community did not differ between the two temperatures. Increasing the pH from similar to 3.5 to similar to 5.5 altered microbial community structure, however increases in CH4 production were non-significant. Contrary to expectations, N and P additions did not increase CO2 and CH4 production, indicating that nutrient availability was not a primary constraint in microbial decomposition of deep peat. Our findings indicate that temperature is a key factor limiting the decomposition of deep peat, however other factors such as the availability of O-2 or alternative electron donors and high concentrations of phenolic compounds, may also exert constraints. Continued experimental peat warming studies will be necessary to assess if the deep peat carbon bank is susceptible to increased temperatures over the longer time scales.	[Kluber, Laurel A.; Johnston, Eric R.; Allen, Samantha A.; Hendershot, J. Nicholas; Schadt, Christopher W.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA; [Kluber, Laurel A.; Johnston, Eric R.; Allen, Samantha A.; Hendershot, J. Nicholas; Hanson, Paul J.; Schadt, Christopher W.] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37830 USA; [Hanson, Paul J.] Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA; [Schadt, Christopher W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Kluber, Laurel A.] Novozymes Inc, Salem, VA USA; [Allen, Samantha A.] Tennessee Technol Univ, Sch Environm Studies, Cookeville, TN 38505 USA; [Hendershot, J. Nicholas] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; Tennessee Technological University; Stanford University	Schadt, CW (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA.; Schadt, CW (corresponding author), Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37830 USA.; Schadt, CW (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	schadtcw@ornl.gov	Hanson, Paul James/D-8069-2011; Hendershot, J Nicholas/AAO-9686-2021; Johnston, Eric R/J-1051-2019; Schadt, Christopher/B-7143-2008	Hanson, Paul James/0000-0001-7293-3561; Hendershot, J Nicholas/0000-0001-9570-8447; Johnston, Eric R/0000-0002-3217-7711; Allen, Samantha/0000-0001-6663-2834; Schadt, Christopher/0000-0001-8759-2448	US Department of Energy, Office of Science, Office of Biological and Environmental Research as part of the SPRUCE project; U.S. Department of Energy [DE-AC05-00OR22725]	US Department of Energy, Office of Science, Office of Biological and Environmental Research as part of the SPRUCE project(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research as part of the SPRUCE project (http://mnspruce.ornl.gov). Oak Ridge National Laboratory is managed by UTBattelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725 (to CWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Taniya Roy Chowhury and Jana Phillips for assistance in implementing the experiment, as well as Zamin Yang, Melissa Cregger, and Allison Veach for assistance with the sequencing and bioinformatic analysis. Further, we thank the USDA Forest Service, Northern Research Station for enabling access to and use of the S1-Bog of the Marcell Experimental Forest. This work was supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research as part of the SPRUCE project (http://mnspruce.ornl.gov). Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, OECOLOGIA, V146, P652, DOI 10.1007/s00442-005-0247-5; Aerts R, 1999, OIKOS, V84, P44, DOI 10.2307/3546865; AMADOR JA, 1993, SOIL BIOL BIOCHEM, V25, P793, DOI 10.1016/0038-0717(93)90125-U; ARMENTANO TV, 1986, J ECOL, V74, P755, DOI 10.2307/2260396; Blankinship JC, 2011, OECOLOGIA, V165, P553, DOI 10.1007/s00442-011-1909-0; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bragazza L, 2006, P NATL ACAD SCI USA, V103, P19386, DOI 10.1073/pnas.0606629104; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Bubier JL, 2007, GLOBAL CHANGE BIOL, V13, P1168, DOI 10.1111/j.1365-2486.2007.01346.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chowdhury TR, 2015, GLOBAL CHANGE BIOL, V21, P722, DOI 10.1111/gcb.12762; Cleveland CC, 2014, OECOLOGIA, V174, P283, DOI 10.1007/s00442-013-2758-9; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Cregger MA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0413-8; DeAngelis KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00104; Deslippe JR, 2012, FEMS MICROBIOL ECOL, V82, P303, DOI 10.1111/j.1574-6941.2012.01350.x; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Freitag TE, 2010, FEMS MICROBIOL ECOL, V73, P157, DOI 10.1111/j.1574-6941.2010.00871.x; GOODWIN S, 1987, APPL ENVIRON MICROB, V53, P57, DOI 10.1128/AEM.53.1.57-64.1987; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Griffiths NA, 2017, SOIL SCI SOC AM J, V81, P1668, DOI 10.2136/sssaj2016.12.0422; Griffiths NA, 2016, WETLANDS, V36, P1119, DOI 10.1007/s13157-016-0829-5; Gupta V, 2013, ENVIRON SCI TECHNOL, V47, P8273, DOI 10.1021/es400484t; Hanson PJ, 2016, BIOGEOCHEMISTRY, V129, P255, DOI 10.1007/s10533-016-0230-8; Hanson PJ, 2017, BIOGEOSCIENCES, V14, P861, DOI 10.5194/bg-14-861-2017; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Hill BH, 2014, BIOGEOCHEMISTRY, V120, P203, DOI 10.1007/s10533-014-9991-0; Hodgkins SB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06050-2; Ise T, 2008, NAT GEOSCI, V1, P763, DOI 10.1038/ngeo331; Iversen C. M., 2014, SPRUCE PEAT PHYS CHE, DOI [10.3334/CDIAC/spruce.005, DOI 10.3334/CDIAC/SPRUCE.005]; Johnston ER, 2019, P NATL ACAD SCI USA, V116, P15096, DOI 10.1073/pnas.1901307116; KANG H, 2018, NATURE COMMUNICATION, V9, DOI DOI 10.1038/S41467-018-02843-7; Karhu K, 2014, NATURE, V513, P81, DOI 10.1038/nature13604; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Kolka RK, 2011, PEATLAND BIOGEOCHEMISTRY AND WATERSHED HYDROLOGY AT THE MARCELL EXPERIMENTAL FOREST, P1; Kostka JE, 2016, NEW PHYTOL, V211, P57, DOI 10.1111/nph.13993; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lin X, 2012, APPL ENVIRON MICROB, V78, P7023, DOI 10.1128/AEM.01750-12; Lin XJ, 2014, APPL ENVIRON MICROB, V80, P3518, DOI 10.1128/AEM.00205-14; Lin X, 2014, APPL ENVIRON MICROB, V80, P3531, DOI 10.1128/AEM.00206-14; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McKenzie C, 1998, CLIMATIC CHANGE, V40, P247, DOI 10.1023/A:1005416903368; Melillo JM, 2017, SCIENCE, V358, P101, DOI 10.1126/science.aan2874; Melton JR, 2013, BIOGEOSCIENCES, V10, P753, DOI 10.5194/bg-10-753-2013; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Norby RJ, 2019, ECOL EVOL, V9, P12571, DOI 10.1002/ece3.5722; Oksanen J., 2020, VEGAN COMMUNITY ECOL; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Preston MD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00070; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Puglisi E, 2014, BIOL FERT SOILS, V50, P815, DOI 10.1007/s00374-014-0902-2; Putkinen A, 2014, FEMS MICROBIOL ECOL, V88, P596, DOI 10.1111/1574-6941.12327; Putkinen A, 2009, FEMS MICROBIOL ECOL, V70, P87, DOI 10.1111/j.1574-6941.2009.00738.x; R Core Team, 2021, R LANGUAGE ENV STAT; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Segarra KEA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8477; Shi Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep40848; Smemo KA, 2011, BIOGEOSCIENCES, V8, P779, DOI 10.5194/bg-8-779-2011; Smemo KA, 2007, GEOMICROBIOL J, V24, P583, DOI 10.1080/01490450701672083; Steinweg JM, 2018, SOIL BIOL BIOCHEM, V125, P244, DOI 10.1016/j.soilbio.2018.07.001; Tfaily MM, 2014, J GEOPHYS RES-BIOGEO, V119, P661, DOI 10.1002/2013JG002492; Treat CC, 2015, GLOBAL CHANGE BIOL, V21, P2787, DOI 10.1111/gcb.12875; Turunen J, 2002, HOLOCENE, V12, P69, DOI 10.1191/0959683602hl522rp; Updegraff K, 2001, ECOL APPL, V11, P311; van Winden JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039614; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLIAMS RT, 1984, APPL ENVIRON MICROB, V47, P1266, DOI 10.1128/AEM.47.6.1266-1271.1984; Wilson RM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13723; YAVITT JB, 1987, BIOGEOCHEMISTRY, V4, P141, DOI 10.1007/BF02180152; Ye RZ, 2012, SOIL BIOL BIOCHEM, V54, P36, DOI 10.1016/j.soilbio.2012.05.015; Yenigun O, 2013, PROCESS BIOCHEM, V48, P901, DOI 10.1016/j.procbio.2013.04.012; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhu BL, 2012, APPL ENVIRON MICROB, V78, P8657, DOI 10.1128/AEM.02102-12; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	87	6	6	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0223744	10.1371/journal.pone.0223744	http://dx.doi.org/10.1371/journal.pone.0223744			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027653	Green Submitted, Green Published, gold			2022-12-26	WOS:000534623800006
J	Loehfelm, A; Elder, MK; Boucsein, A; Jones, PP; Williams, JM; Tups, A				Loehfelm, Aline; Elder, Megan K.; Boucsein, Alisa; Jones, Peter P.; Williams, Joanna M.; Tups, Alexander			Docosahexaenoic acid prevents palmitate-induced insulin-dependent impairments of neuronal health	FASEB JOURNAL			English	Article						cortex; cytoskeleton; fatty acids; high-fat diet; hippocampus; synaptic innervation	HIGH-FAT DIET; BETA/NF-KAPPA-B; HYPOTHALAMIC NEURONS; RESISTANCE; BRAIN; STRESS; ACTIVATION; INHIBITION; APOPTOSIS; LOCALIZATION	The importance of fatty acids (FAs) for healthy brain development and function has become more evident in the past decades. However, most studies focus on the hypothalamus as an important FA-sensing brain region involved in energy homeostasis. Less work has been done to evaluate the effects of FAs on brain regions such as the hippocampus or cortex, two important centres of learning, memory formation, and cognition. Furthermore, the mechanisms of how FAs modulate the neuronal development and function are incompletely understood. Therefore, this study examined the effects of the saturated FA palmitic acid (PA) and the polyunsaturated FA docosahexaenoic acid (DHA) on primary hippocampal and cortical cultures isolated from P0/P1 Sprague Dawley rat pups. Exposure to PA, but not DHA, resulted in severe morphological changes in primary neurons such as cell body swelling, axonal and dendritic blebbing, and a reduction in synaptic innervation, compromising healthy cell function and excitability. Pharmacological assessment revealed that the PA-mediated alterations were caused by overactivation of neuronal insulin signaling, demonstrated by insulin stimulation and phosphoinositide 3-kinase inhibition. Remarkably, co-exposure to DHA prevented all PA-induced morphological changes. This work provides new insights into how FAs can affect the cytoskeletal rearrangements and neuronal function via modulation of insulin signaling.	[Loehfelm, Aline; Boucsein, Alisa; Tups, Alexander] Univ Otago, Ctr Neuroendocrinol, Sch Med Sci, Dept Physiol, Dunedin, New Zealand; [Loehfelm, Aline; Boucsein, Alisa; Tups, Alexander] Univ Otago, Brain Hlth Res Ctr, POB 56, Dunedin 9054, New Zealand; [Elder, Megan K.; Williams, Joanna M.] Univ Otago, Brain Hlth Res Ctr, Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Jones, Peter P.] Univ Otago, Sch Med Sci, Dept Physiol & HeartOtago, Dunedin, New Zealand; [Elder, Megan K.] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Otago; University of Otago; University of Otago; University of Otago; New York University	Tups, A (corresponding author), Univ Otago, Brain Hlth Res Ctr, POB 56, Dunedin 9054, New Zealand.; Tups, A (corresponding author), Univ Otago, Dept Physiol, Ctr Neuroendocrinol, POB 56, Dunedin 9054, New Zealand.	alexander.tups@otago.ac.nz		Elder, Megan/0000-0002-9111-3152; Jones, Pete/0000-0001-7977-1737; Boucsein, Alisa/0000-0002-6266-8802	Royal Society of New Zealand \ Marsden Fund (Royal Society of New Zealand Marsden Fund); University of Otago (Te Whare Wananga o Otago)	Royal Society of New Zealand \ Marsden Fund (Royal Society of New Zealand Marsden Fund); University of Otago (Te Whare Wananga o Otago)	Royal Society of New Zealand vertical bar Marsden Fund (Royal Society of New Zealand Marsden Fund); University of Otago (Te Whare Wananga o Otago)	Antollini SS, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00573; Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Benzler J, 2015, DIABETES, V64, P2015, DOI 10.2337/db14-0093; Benzler M, 2019, J COMP PHYSIOL B, V189, P413, DOI 10.1007/s00360-019-01220-0; Caires R, 2017, CELL REP, V21, P246, DOI 10.1016/j.celrep.2017.09.029; Calvo-Ochoa E, 2014, J CEREBR BLOOD F MET, V34, P1001, DOI 10.1038/jcbfm.2014.48; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Cordner ZA, 2015, PHYSIOL BEHAV, V152, P363, DOI 10.1016/j.physbeh.2015.06.008; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; da Silva-Santi LG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091277; Dalvi PS, 2017, INT J OBESITY, V41, P149, DOI 10.1038/ijo.2016.183; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Dieck ST, 2015, NAT METHODS, V12, P411, DOI [10.1038/nmeth.3319, 10.1038/NMETH.3319]; Dubey J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00343; Egnatchik RA, 2014, METABOLISM, V63, P283, DOI 10.1016/j.metabol.2013.10.009; Fogarty MJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00153; Fonteh AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100519; Guest J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-79; Guixa-Gonzalez R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19839; Gupta S, 2012, J NEUROCHEM, V120, P1060, DOI 10.1111/j.1471-4159.2012.07660.x; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hall E, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-103; Honen BN, 2003, J MEMBRANE BIOL, V196, P95, DOI 10.1007/s00232-003-0628-9; Hou QM, 2008, MOL CELL NEUROSCI, V38, P213, DOI 10.1016/j.mcn.2008.02.010; Hsiao YH, 2014, INT J MOL SCI, V15, P20876, DOI 10.3390/ijms151120876; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jembrek MJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/346783; Jia D, 2014, NEUROSCIENCE, V258, P228, DOI 10.1016/j.neuroscience.2013.11.016; Karmi A, 2010, DIABETES, V59, P2171, DOI 10.2337/db09-0138; Khazen T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48800-2; Kim J, 2011, BRAIN RES, V1418, P42, DOI 10.1016/j.brainres.2011.08.059; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; Kuda O, 2017, BIOCHIMIE, V136, P12, DOI 10.1016/j.biochi.2017.01.002; Kwon B, 2014, BBA-MOL CELL RES, V1843, P1402, DOI 10.1016/j.bbamcr.2014.04.004; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Larrieu T, 2012, J PHYSIOL BIOCHEM, V68, P671, DOI 10.1007/s13105-012-0179-6; Lauritzen L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010006; Laws SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09577-4; Martinez-Garcia C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142291; Maulik M, 2019, J FUNCT FOODS, V53, P306, DOI 10.1016/j.jff.2018.12.028; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; McLean FH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30265-4; Morselli E, 2014, CELL REP, V9, P633, DOI 10.1016/j.celrep.2014.09.025; Nasaruddin ML, 2016, AM J TRANSL RES, V8, P154; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; OISHI K, 1990, J BIOL CHEM, V265, P70; Orr SK, 2013, J NEUROCHEM, V127, P378, DOI 10.1111/jnc.12392; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Piro S, 2010, ENDOCRINOLOGY, V151, P4197, DOI 10.1210/en.2009-1472; Rapoport SI, 2001, J LIPID RES, V42, P678; Rodriguez-Navas C, 2016, MOL METAB, V5, P680, DOI 10.1016/j.molmet.2016.06.014; Sargsyan E, 2016, BBA-MOL CELL BIOL L, V1861, P1151, DOI 10.1016/j.bbalip.2016.06.012; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Stillwell W., 2006, Scandinavian Journal of Food & Nutrition, V50, P107, DOI 10.1080/17482970601066165; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Tewari KP, 2000, AM J PHYSIOL-CELL PH, V279, pC40, DOI 10.1152/ajpcell.2000.279.1.C40; Tups A, 2010, J NEUROENDOCRINOL, V22, P534, DOI 10.1111/j.1365-2826.2010.01975.x; Vreugdenhil M, 1996, P NATL ACAD SCI USA, V93, P12559, DOI 10.1073/pnas.93.22.12559; Watkins PA, 2001, J MOL NEUROSCI, V16, P87, DOI 10.1385/JMN:16:2-3:87; Weilinger NL, 2016, NAT NEUROSCI, V19, P432, DOI 10.1038/nn.4236; World Health Organization, 2018, OB OV FACT SHEET 311; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X	73	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4635	4652		10.1096/fj.201902517R	http://dx.doi.org/10.1096/fj.201902517R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030816	Bronze			2022-12-26	WOS:000512332900001
J	Ye, ZC; Wu, YG; Muhammad, ZU; Yan, WP; Yu, J; Zhang, JF; Yao, GL; Hu, XW				Ye, Zhouchen; Wu, Yougen; Muhammad, Zeeshan Ul Haq; Yan, Wuping; Yu, Jing; Zhang, Junfeng; Yao, Guanglong; Hu, Xinwen			Complementary transcriptome and proteome profiling in the mature seeds of Camellia oleifera from Hainan Island	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; COA-ACP TRANSACYLASE; STREPTOMYCES-COELICOLOR; CRUCIAL ROLES; OIL; ABEL.; CAKE; POLYSACCHARIDES; QUALITY; BINDING	Camellia oleifera Abel. (C. oleifera), as an important woody tree species producing edible oils in China, has attracted enormous attention due to its abundant unsaturated fatty acids and their associated benefits to human health. To reveal novel insights into the characters during the maturation period of this plant as well as the molecular basis of fatty acid biosynthesis and degradation, we conducted a conjoint analysis of the transcriptome and proteome of C. oleifera seeds from Hainan Island. Using RNA sequencing (RNA-seq) technology and shotgun proteomic method, 59,391 transcripts and 40,500 unigenes were obtained by TIGR Gene Indices Clustering Tools (TGICL), while 1691 protein species were identified from Mass Spectrometry (MS). Subsequently, all genes and proteins were employed in euKaryotic Orthologous Groups (KOG) classification, Gene Ontology (GO) annotation, and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis to investigate their essential functions. The results indicated that the most abundant pathways were biological metabolic processes. There were 946 unigenes associated with lipid metabolism at the transcriptome level, with 116 proteins at the proteome level; among these, 38 specific proteins were involved in protein-protein interactions, with the majority being related to fatty acid catabolic process. The expression levels of 21 candidate unigenes encoding target proteins were further detected by quantitative real-time polymerase chain reaction (qRT-PCR). Finally, Gas Chromatography Mass Spectrometry (GC-MS) was carried out to determine the fatty acid composition of C. oleifera oil. These findings not only deepened our understanding about the molecular mechanisms of fatty acid metabolism but also offered new evidence concerning the roles of relevant proteins in oilbearing crops. Furthermore, the lipid-associated proteins recognized in this research might be helpful in providing a reference for the synthetic regulation of C. oleifera oil quality by genetic engineering techniques, thus resulting in potential application in agriculture.	[Ye, Zhouchen; Wu, Yougen; Muhammad, Zeeshan Ul Haq; Yan, Wuping; Yu, Jing; Zhang, Junfeng; Yao, Guanglong; Hu, Xinwen] Hainan Univ, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China	Hainan University	Wu, YG (corresponding author), Hainan Univ, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China.	wygeng2003@163.com			Major Science & Technology project of Hainan Province [ZDKJ2017004]; Key Research & Development project of Hainan Province [ZDYF2016157]	Major Science & Technology project of Hainan Province; Key Research & Development project of Hainan Province	This research was supported in part by grant from the Major Science & Technology project of Hainan Province (No. ZDKJ2017004) and the Key Research & Development project of Hainan Province (No. ZDYF2016157).	Abdullayev I, 2013, EXP CELL RES, V319, P1187, DOI 10.1016/j.yexcr.2013.02.013; Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; Ang CS, 2011, J PROTEOME RES, V10, P5059, DOI 10.1021/pr200516d; Arthur CJ, 2009, ACS CHEM BIOL, V4, P625, DOI 10.1021/cb900099e; Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613; Boeglin WE, 2008, LIPIDS, V43, P979, DOI 10.1007/s11745-008-3230-1; Bork CS, 2019, PROSTAG LEUKOTR ESS, V141, P1, DOI 10.1016/j.plefa.2018.12.001; Chen HM, 2015, ENERG CONVERS MANAGE, V89, P955, DOI 10.1016/j.enconman.2014.11.003; Chen JM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3570-4; Chen SC, 2017, ECOGRAPHY, V40, P531, DOI 10.1111/ecog.02010; Das A, 2012, PLANT MOL BIOL REP, V30, P1088, DOI 10.1007/s11105-012-0422-x; Dreier J, 2001, BIOCHEMISTRY-US, V40, P12407, DOI 10.1021/bi011108+; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Gao DF, 2011, FOOD CHEM, V124, P432, DOI 10.1016/j.foodchem.2010.06.048; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He Y, 2016, GENES GENOM, V38, P1031, DOI 10.1007/s13258-016-0447-x; Huang Q, 2019, FOOD CHEM, V272, P549, DOI 10.1016/j.foodchem.2018.07.116; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Ji JL, 2018, J PROTEOMICS, V179, P80, DOI 10.1016/j.jprot.2018.03.003; Jiang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062315; Jin XC, 2012, CARBOHYD POLYM, V87, P2198, DOI 10.1016/j.carbpol.2011.10.047; Koncitikova R, 2015, BIOCHEM J, V468, P109, DOI 10.1042/BJ20150009; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Laibach N, 2018, PLANT J, V93, P1045, DOI 10.1111/tpj.13829; Lee CP, 2007, FOOD CHEM TOXICOL, V45, P888, DOI 10.1016/j.fct.2006.11.007; Lee CP, 2006, J AGR FOOD CHEM, V54, P779, DOI 10.1021/jf052325a; Li H, 2011, J MED PLANTS RES, V5, P485; Li TT, 2019, INT J BIOL MACROMOL, V136, P284, DOI 10.1016/j.ijbiomac.2019.06.054; Lin CY, 2011, FUEL, V90, P2240, DOI 10.1016/j.fuel.2011.02.020; Lin P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Fan, 2012, Acta Agriculturae Universitatis Jiangxiensis, V34, P87; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Mahadevan C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00785; Mikulska-Ruminska K, 2019, J CHEM INF MODEL, V59, P2496, DOI 10.1021/acs.jcim.9b00006; Mukhopadhyay M, 2016, PLANT CELL REP, V35, P255, DOI 10.1007/s00299-015-1884-8; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Qi BY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0201-y; Qizhi L, 2008, EUR J LIPID SCI TECH, V110, P768, DOI 10.1002/ejlt.200700271; Sasser M, 2009, MICROBIAL IDENTIFICA; Seo Hogyun, 2018, Biodesign, V6, P46; Srivastava S, 2015, CHEM BIOL, V22, P1577, DOI 10.1016/j.chembiol.2015.10.009; Su MH, 2014, FOOD CHEM, V156, P369, DOI 10.1016/j.foodchem.2014.02.016; [谭晓风 Tan Xiaofeng], 2014, [植物生理学报, Plant Physiology Journal], V50, P1845; Vekiari SA, 2010, GRASAS ACEITES, V61, P221, DOI 10.3989/gya.108709; Wang D, 2018, J PROTEOMICS, V182, P53, DOI 10.1016/j.jprot.2018.05.002; [王建勇 Wang Jianyong], 2016, [分子植物育种, Molecular Plant Breeding], V14, P1410; Wang LM, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0071-8; Wang QT, 2021, PLANT SOIL, V458, P277, DOI [10.1007/s11104-019-04156-0, 10.1145/3361242.3361254]; Wang XC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13778; Wang XC, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-35; Wang ZW, 2014, GENE, V538, P1, DOI 10.1016/j.gene.2014.01.035; Wen Y, 2019, FORESTS, V10, DOI 10.3390/f10070563; Wu B, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1792-7; Xia EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104150; Xu M, 2017, J PHYTOPATHOL, V165, P380, DOI 10.1111/jph.12571; Yang L.R., 2018, NONWOOD RES, V2, P69, DOI [10.29011/2638-0013.100013, DOI 10.29011/2638-0013.100013, DOI 10.14067/J.CNKI.1003-8981.2018.03.011]; Yao GL, 2019, INT J FOOD PROP, V22, P1283, DOI 10.1080/10942912.2019.1642355; Yao GL, 2019, J FOOD QUALITY, DOI 10.1155/2019/7364213; Yao Xiao-hua, 2013, Forest Research, V26, P533; Yi XP, 2014, J PROTEOMICS, V99, P84, DOI 10.1016/j.jprot.2014.01.017; You L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208289; Yuan JJ, 2013, FOOD CHEM, V138, P1657, DOI 10.1016/j.foodchem.2012.11.096; [袁军 Yuan Jun], 2014, [植物遗传资源学报, Journal of Plant Genetic Resources], V15, P1380; [曾艳玲 Zeng Yanling], 2014, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V29, P26; Zhang CW, 2016, J PROTEOMICS, V144, P1, DOI 10.1016/j.jprot.2016.05.022; Zhang DQ, 2007, NONWOOD FOREST RES, V25, P5, DOI [10.14067/j.cnki.1003-8981.2007.02.004, DOI 10.14067/J.CNKI.1003-8981.2007.02.004]; Zhang J., 2019, DEGRADATIONS TANNIN, P652560, DOI [10.1101/652560, DOI 10.1101/652560]; Zhang JF, 2018, PROTEIN EXPRES PURIF, V152, P13, DOI 10.1016/j.pep.2018.07.004; Zhang LL, 2010, J MED PLANTS RES, V4, P1420; Zhang SY, 2019, FOOD SCI NUTR, V7, P1004, DOI 10.1002/fsn3.924; Zhang S, 2015, CARBOHYD POLYM, V115, P38, DOI 10.1016/j.carbpol.2014.08.059; Zhang W, 2019, PEERJ, V7, DOI 10.7717/peerj.7210; Zhang W, 2017, MITOCHONDRIAL DNA B, V2, P843, DOI 10.1080/23802359.2017.1407687; [张智敏 Zhang Zhimin], 2013, [食品科学, Food Science], V34, P268; Zhao JV, 2019, AM J CLIN NUTR, V110, P685, DOI 10.1093/ajcn/nqz130; Zhou X, 2019, J PROTEOMICS, V204, DOI 10.1016/j.jprot.2019.103395; Zhu GF, 2020, FOOD REV INT, V36, P319, DOI 10.1080/87559129.2019.1649688	78	11	11	9	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0226888	10.1371/journal.pone.0226888	http://dx.doi.org/10.1371/journal.pone.0226888			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027663	Green Published, gold			2022-12-26	WOS:000534623800008
J	Crawford, CK; Akins, JD; Vardarli, E; Wolfe, AS; Coyle, EF				Crawford, Charles K.; Akins, John D.; Vardarli, Emre; Wolfe, Anthony S.; Coyle, Edward F.			Prolonged standing reduces fasting plasma triglyceride but does not influence postprandial metabolism compared to prolonged sitting	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; TRIACYLGLYCEROL CONCENTRATIONS; PHYSICAL INACTIVITY; ENDURANCE EXERCISE; INTENSITY EXERCISE; MODERATE EXERCISE; TIME; MORTALITY; HEALTHY; LIPEMIA	Prolonged periods of sedentary behavior are linked to cardiometabolic disease independent of exercise and physical activity. This study examined the effects of posture by comparing one day of sitting (14.4 +/- 0.3 h) to one day of standing (12.2 +/- 0.1 h) on postprandial metabolism the following day. Eighteen subjects (9 men, 9 women; 24 +/- 1 y) completed two trials (sit or stand) in a crossover design. The day after prolonged sitting or standing the subjects completed a postprandial high fat/glucose tolerance test, during which blood and expired gas was collected immediately before and hourly for 6 h after the ingestion of the test meal. Indirect calorimetry was used to measure substrate oxidation while plasma samples were analyzed for triglyceride, glucose, and insulin concentrations. Standing resulted in a lower fasting plasma triglyceride concentration (p = 0.021) which was primarily responsible for an 11.3% reduction in total area under the curve (p = 0.022) compared to sitting. However, no difference between trials in incremental area under the curve for plasma triglycerides was detected (p>0.05). There were no differences in substrate oxidation, plasma glucose concentration, or plasma insulin concentration (all p>0.05). These data demonstrate that 12 h of standing compared to 14 h of sitting has a small effect the next day by lowering fasting plasma triglyceride concentration, and this contributed to a 11.3% reduction in postprandial plasma triglyceride total area under the curve (p = 0.022) compared to sitting.	[Crawford, Charles K.; Akins, John D.; Vardarli, Emre; Wolfe, Anthony S.; Coyle, Edward F.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Human Performance Lab, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Coyle, EF (corresponding author), Univ Texas Austin, Dept Kinesiol & Hlth Educ, Human Performance Lab, Austin, TX 78712 USA.	coyle@austin.utexas.edu	Akins, John/GVN-2915-2022	Crawford, Charles/0000-0002-1872-1469				Akins JD, 2019, J APPL PHYSIOL, V126, P1088, DOI 10.1152/japplphysiol.00968.2018; Altena TS, 2004, MED SCI SPORT EXER, V36, P1364, DOI 10.1249/01.MSS.0000135793.43808.6C; Bailey DP, 2015, J SCI MED SPORT, V18, P294, DOI 10.1016/j.jsams.2014.03.008; Bergouignan A, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010027; Bergouignan A, 2009, DIABETES, V58, P367, DOI 10.2337/db08-0263; Betts JA, 2019, MED SCI SPORT EXER, V51, P726, DOI 10.1249/MSS.0000000000001841; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Camhi SM, 2011, PREV MED, V52, P358, DOI 10.1016/j.ypmed.2011.01.030; Carstensen M, 2003, METABOLISM, V52, P1034, DOI 10.1016/S0026-0495(03)00155-0; Dekker B, 2018, SPINAL CORD, V56, P1008, DOI 10.1038/s41393-018-0167-y; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Freese EC, 2014, J APPL PHYSIOL, V116, P67, DOI 10.1152/japplphysiol.00623.2013; Gill JMR, 2001, CLIN SCI, V100, P517, DOI 10.1042/CS20000258; Gupta N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121159; Hallman DM, 2015, INT J ENV RES PUB HE, V12, P14811, DOI 10.3390/ijerph121114811; Hamilton MT, 1998, AM J PHYSIOL-ENDOC M, V275, pE1016, DOI 10.1152/ajpendo.1998.275.6.E1016; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Henson J, 2016, DIABETES CARE, V39, P130, DOI 10.2337/dc15-1240; Herd SL, 2001, METABOLISM, V50, P756, DOI 10.1053/meta.2001.24199; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; HOLLOSZY JO, 1964, AM J CARDIOL, V14, P753, DOI 10.1016/0002-9149(64)90004-9; Howard B, 2015, MED SCI SPORT EXER, V47, P2093, DOI 10.1249/MSS.0000000000000631; Judice PB, 2016, EUR J APPL PHYSIOL, V116, P263, DOI 10.1007/s00421-015-3279-5; Kim IY, 2016, AM J PHYSIOL-ENDOC M, V311, pE891, DOI 10.1152/ajpendo.00287.2016; Kim IY, 2014, MED SCI SPORT EXER, V46, P1882, DOI 10.1249/MSS.0000000000000324; LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172; Magkos F, 2006, AM J PHYSIOL-ENDOC M, V291, pE1243, DOI 10.1152/ajpendo.00246.2006; Malkova D, 1999, METABOLISM, V48, P245, DOI 10.1016/S0026-0495(99)90042-2; McArdle W.D., 2006, ESSENTIALS EXERCISE; Miyashita M, 2008, INT J OBESITY, V32, P1271, DOI 10.1038/ijo.2008.73; Miyashita M, 2008, AM J CLIN NUTR, V88, P1225, DOI 10.3945/ajcn.2008.26493; National Heart L and Blood Institute, 2018, HIGH BLOOD TRIGL; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Olsen RH, 2008, JAMA-J AM MED ASSOC, V299, P1261, DOI 10.1001/jama.299.11.1259; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Popp CJ, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00049; Restaino RM, 2016, AM J PHYSIOL-HEART C, V310, pH648, DOI 10.1152/ajpheart.00943.2015; Sacchetti M, 2002, J PHYSIOL-LONDON, V540, P387, DOI 10.1113/jphysiol.2001.013912; Saunders TJ, 2018, SPORTS MED, V48, P2347, DOI 10.1007/s40279-018-0963-8; Thorp AA, 2014, MED SCI SPORT EXER, V46, P2053, DOI 10.1249/MSS.0000000000000337; Thosar SS, 2015, MED SCI SPORT EXER, V47, P843, DOI 10.1249/MSS.0000000000000479; Trombold JR, 2013, J APPL PHYSIOL, V114, P792, DOI 10.1152/japplphysiol.01028.2012; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Yates T, 2020, J GERONTOL A-BIOL, V75, P139, DOI 10.1093/gerona/gly252	46	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228297	10.1371/journal.pone.0228297	http://dx.doi.org/10.1371/journal.pone.0228297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023313	Green Published, gold, Green Submitted			2022-12-26	WOS:000534621500047
J	Khrunin, AV; Khvorykh, GV; Fedorov, AN; Limborska, SA				Khrunin, Andrey, V; Khvorykh, Gennady, V; Fedorov, Alexei N.; Limborska, Svetlana A.			Genomic landscape of the signals of positive natural selection in populations of Northern Eurasia: A view from Northern Russia	PLOS ONE			English	Article							SYSTEMIC VASCULITIS; WIDE ASSOCIATION; MIGRATION; ADMIXTURE; HISTORY; DISEASE; SET	Natural selection of beneficial genetic variants played a critical role in human adaptation to a wide range of environmental conditions. Northern Eurasia, despite its severe climate, is home to lots of ethnically diverse populations. The genetic variants associated with the survival of these populations have hardly been analyzed. We searched for the genomic signatures of positive selection in (1) the genome-wide microarray data of 432 people from eight different northern Russian populations and (2) the whole-genome sequences of 250 people from Northern Eurasia from a public repository through testing the extended haplotype homozigosity (EHH) and direct comparison of allele frequency, respectively. The 20 loci with the strongest selection signals were characterized in detail. Among the top EHH hits were the NRG3 and NBEA genes, which are involved in the development and functioning of the neural system, the PTPRM gene, which mediates cell cell interactions and adhesion, and a region on chromosome 4 (chr4:28.7-28.9 Mb) that contained several loci affiliated with different classes of non-coding RNAs (RN7SL101P, M1R4275, MESTP3, and L1NCO2364). NBEA and the region on chromosome 4 were novel selection targets that were identified for the first time in Western Siberian populations. Cross-population comparisons of EHH profiles suggested a particular role for the chr4:28.7-28.9 Mb region in the local adaptation of Western Siberians. The strongest selection signal identified in Siberian sequenced genomes was formed by six SNPs on chromosome 11 (chr11:124.9-125.2 Mb). This region included well-known genes SLC37A2 and PKNOX2. SLC37A2 is most-highly expressed in the gut. Its expression is regulated by vitamin D, which is often deficient in northern regions. The PKNOX2 gene is a transcription factor of the homeobox family that is expressed in the brain and many other tissues. This gene is associated with alcohol addiction, which is widespread in many Northern Eurasian populations.	[Khrunin, Andrey, V; Khvorykh, Gennady, V; Fedorov, Alexei N.; Limborska, Svetlana A.] Russian Acad Sci, Dept Mol Bases Human Genet, Inst Mol Genet, Moscow, Russia; [Fedorov, Alexei N.] Univ Toledo, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA	Russian Academy of Sciences; University System of Ohio; University of Toledo	Khrunin, AV (corresponding author), Russian Acad Sci, Dept Mol Bases Human Genet, Inst Mol Genet, Moscow, Russia.	khrunin@img.ras.ru		Khvorykh, Gennady/0000-0001-8927-5921	Russian Foundation for Basic Research [16-04-00635, 20-04-00824]; Program `Fundamental Researches for Biomedical Technologies' of the Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program `Fundamental Researches for Biomedical Technologies' of the Russian Academy of Sciences	This research was supported by grants of the Russian Foundation for Basic Research (project numbers 16-04-00635, 20-04-00824) to Andrey V. Khrunin. Svetlana A. Limborska was supported by The Program `Fundamental Researches for Biomedical Technologies' of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2018, LANG ENV STAT COMP; Avramopoulos D, 2018, AM J MED GENET B, V177, P257, DOI 10.1002/ajmg.b.32552; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Blair LM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0239-3; Cardona A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098076; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chen G, 2017, ADDICT BIOL, V22, P1475, DOI 10.1111/adb.12402; Chen XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016002; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Fan SH, 2016, SCIENCE, V354, P54, DOI 10.1126/science.aaf5098; Gatenby PA, 2012, INTERN MED J, V42, P1066, DOI 10.1111/j.1445-5994.2012.02891.x; Gautier M, 2017, MOL ECOL RESOUR, V17, P78, DOI 10.1111/1755-0998.12634; Granka JM, 2012, GENETICS, V192, P1049, DOI 10.1534/genetics.112.144071; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Guo J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04191-y; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hallmark B, 2019, MOL BIOL EVOL, V36, P315, DOI 10.1093/molbev/msy211; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hsieh P, 2017, MOL BIOL EVOL, V34, P2913, DOI 10.1093/molbev/msx226; Hudjashov G, 2017, MOL BIOL EVOL, V34, P2439, DOI 10.1093/molbev/msx196; Jobling M, 2014, HUMAN EVOLUTIONARY GENETICS, SECOND EDITION, P1; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Kelley JM, 2011, P NATL ACAD SCI USA, V108, P20736, DOI 10.1073/pnas.1109227109; Khrunin AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058552; Kobayashi S, 2013, CLIN EXP NEPHROL, V17, P611, DOI 10.1007/s10157-013-0813-9; Kovalenko TF, 2018, BIOCHEMISTRY-MOSCOW+, V83, P1332, DOI 10.1134/S0006297918110044; Lam TH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16972; Liu XY, 2017, EUR J HUM GENET, V25, P499, DOI 10.1038/ejhg.2016.181; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Milligan B, 1998, MOL GENETIC ANAL POP, P29; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Mulhern MS, 2018, ANN NEUROL, V84, P788, DOI 10.1002/ana.25350; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Norman PJ, 2017, GENOME RES, V27, P813, DOI 10.1101/gr.213538.116; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Saksa N, 2015, J STEROID BIOCHEM, V148, P275, DOI 10.1016/j.jsbmb.2014.11.012; Scheinfeldt LB, 2019, P NATL ACAD SCI USA, V116, P4166, DOI 10.1073/pnas.1817678116; Skoglund P, 2017, CELL, V171, P59, DOI 10.1016/j.cell.2017.08.049; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Sohail M, 2019, ELIFE, V8, DOI 10.7554/eLife.39702; Su XM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46259; Sudhir PR, 2015, SCI REP-UK, V5, DOI 10.1038/srep09633; Sun PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050183; Tekola-Ayele F, 2015, EUR J HUM GENET, V23, P1085, DOI 10.1038/ejhg.2014.233; Tennekes M, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i06; Triska P, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0578-3; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Volders K, 2011, CURR MOL MED, V11, P204, DOI 10.2174/156652411795243432; Wagh K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044751; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Wang KS, 2011, J PSYCHIATR RES, V45, P1419, DOI 10.1016/j.jpsychires.2011.06.005; Watts RA, 2001, ANN RHEUM DIS, V60, P170, DOI 10.1136/ard.60.2.170; Wong ENM, 2017, GENOME RES, V27, P1, DOI 10.1101/gr.202945.115; Wu Q, 2014, PROTEIN CELL, V5, P99, DOI 10.1007/s13238-013-0004-1; Yamada Y, 2017, ONCOTARGET, V8, P39296, DOI 10.18632/oncotarget.16945; Yu FL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121644; Zhang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06637-9; Zuo LJ, 2014, AM J ADDICTION, V23, P526, DOI 10.1111/j.1521-0391.2014.12147.x	70	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228778	10.1371/journal.pone.0228778	http://dx.doi.org/10.1371/journal.pone.0228778			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023328	Green Published, gold			2022-12-26	WOS:000534621500071
J	Siebert, C; Villers, C; Pavlou, G; Touquet, B; Yakandawala, N; Tardieux, I; Renesto, P				Siebert, Claire; Villers, Corinne; Pavlou, Georgios; Touquet, Bastien; Yakandawala, Nandadeva; Tardieux, Isabelle; Renesto, Patricia			Francisella novicida and F. philomiragia biofilm features conditionning fitness in spring water and in presence of antibiotics	PLOS ONE			English	Article							BACTERIAL BIOFILMS; STAPHYLOCOCCUS-EPIDERMIDIS; PNEUMONIC TULAREMIA; SUSCEPTIBILITY; TULARENSIS; EPIDEMIOLOGY; BACTEREMIA; INFECTION; OUTBREAK; ASSAY	Biofilms are currently considered as a predominant lifestyle of many bacteria in nature. While they promote survival of microbes, biofilms also potentially increase the threats to animal and public health in case of pathogenic species. They not only facilitate bacteria transmission and persistence, but also promote spreading of antibiotic resistance leading to chronic infections. In the case of Francisella tularensis, the causative agent of tularemia, biofilms have remained largely enigmatic. Here, applying live and static confocal microscopy, we report growth and ultrastructural organization of the biofilms formed in vitro by these microorganisms over the early transition from coccobacillary into coccoid shape during biofilm assembly. Using selective dispersing agents, we provided evidence for extracellular DNA (eDNA) being a major and conserved structural component of mature biofilms formed by both F. subsp. novicida and a human clinical isolate of F. philomiragia. We also observed a higher physical robustness of F. novicida biofilm as compared to F. philomiragia one, a feature likely promoted by specific polysaccharides. Further, F. novicida biofilms resisted significantly better to ciprofloxacin than their planktonic counterparts. Importantly, when grown in biofilms, both Francisella species survived longer in cold water as compared to free-living bacteria, a trait possibly associated with a gain in fitness in the natural aquatic environment. Overall, this study provides information on survival of Francisella when embedded with biofilms that should improve both the future management of biofilm-related infections and the design of effective strategies to tackle down the problematic issue of bacteria persistence in aquatic ecosystems.	[Siebert, Claire; Villers, Corinne; Renesto, Patricia] TIMC IMAG UMR 5525 UGA CNRS, Grenoble 9, France; [Villers, Corinne] Univ Caen Normandie, EA4655 U2RM, Caen, France; [Pavlou, Georgios; Touquet, Bastien; Tardieux, Isabelle] Univ Grenoble Alpes, Inst Adv Biosci IAB, Team Membrane Dynam Parasite Host Cell Interact, CNRS,UMR 5309,INSERM,U1209, Grenoble, France; [Yakandawala, Nandadeva] Kane Biotech Inc, Winnipeg, MB, Canada	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Renesto, P (corresponding author), TIMC IMAG UMR 5525 UGA CNRS, Grenoble 9, France.	patricia.renesto@univ-grenoble-alpes.fr	; Tardieux, Isabelle/G-4733-2014	Renesto, Patricia/0000-0002-6749-7862; Tardieux, Isabelle/0000-0002-5677-7463	FINOVI Foundation [AO12-02]; ANR ASTRID [ANR-17-ASTR-0024]	FINOVI Foundation; ANR ASTRID(French National Research Agency (ANR))	This work was supported by the FINOVI Foundation (Grant AO12-02) and by the ANR ASTRID (grant ANR-17-ASTR-0024). NY Yakandawala was employed by the company Kane Biotech, Inc. (Winnipeg, Canada). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimana C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00034; Azeredo J, 2017, CRIT REV MICROBIOL, V43, P313, DOI 10.1080/1040841X.2016.1208146; Backman S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07793; Balcazar JL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01216; Barry AL, 1999, METHODS DETERMINING; Belfield K, 2017, J ANTIMICROB CHEMOTH, V72, P2531, DOI 10.1093/jac/dkx192; Berrada ZL, 2011, ARCH MICROBIOL, V193, P223, DOI 10.1007/s00203-010-0655-8; Boisset S, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00040; Brett M, 2012, J CLIN MICROBIOL, V50, P2826, DOI 10.1128/JCM.00995-12; Brett ME, 2014, CLIN INFECT DIS, V59, P826, DOI 10.1093/cid/ciu430; Broman T, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/851946; Cavaliere R, 2014, MICROBIOLOGYOPEN, V3, P557, DOI 10.1002/mbo3.187; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; Champion AE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48697-x; Chung MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093119; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Das T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091935; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dean RE, 2009, MICROBIOL-SGM, V155, P4104, DOI 10.1099/mic.0.031021-0; Dean SN, 2015, APPL ENVIRON MICROB, V81, P7057, DOI 10.1128/AEM.02165-15; Durham-Colleran MW, 2010, MICROB ECOL, V59, P457, DOI 10.1007/s00248-009-9586-9; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Flemming HC, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4040041; Foerster S, 2017, J ANTIMICROB CHEMOTH, V72, P1961, DOI 10.1093/jac/dkx113; Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hennebique A, 2019, EMERG MICROBES INFEC, V8, P1027, DOI 10.1080/22221751.2019.1638734; Heriot M, 2019, INT J BIOL MACROMOL, V121, P390, DOI 10.1016/j.ijbiomac.2018.10.025; Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Kingry LC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00035; Koo H, 2017, NAT REV MICROBIOL, V15, P740, DOI 10.1038/nrmicro.2017.99; Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0; Kreitmann L, 2015, EMERG INFECT DIS, V21, P2260, DOI 10.3201/eid2112.150615; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Margolis JJ, 2010, APPL ENVIRON MICROB, V76, P596, DOI 10.1128/AEM.02037-09; Maurin M, 2016, LANCET INFECT DIS, V16, P113, DOI 10.1016/S1473-3099(15)00355-2; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Milton ME, 2017, MOL MICROBIOL, V106, P223, DOI 10.1111/mmi.13759; Okuda K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00182; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Petersen JM, 2009, LETT APPL MICROBIOL, V48, P663, DOI 10.1111/j.1472-765X.2009.02589.x; Pettit RK, 2005, ANTIMICROB AGENTS CH, V49, P2612, DOI 10.1128/AAC.49.7.2612-2617.2005; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Schmitt DM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00093; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siebert C, 2019, EMERG MICROBES INFEC, V8, DOI 10.1080/22221751.2019.1615848; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Solano C, 2014, CURR OPIN MICROBIOL, V18, P96, DOI 10.1016/j.mib.2014.02.008; Sugimoto S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20485-z; Telford SR, 2020, ANNU REV ENTOMOL, V65, P351, DOI 10.1146/annurev-ento-011019-025134; TEUTSCH SM, 1979, NEW ENGL J MED, V301, P826, DOI 10.1056/NEJM197910113011507; Thelaus J, 2014, MICROB ECOL, V67, P96, DOI 10.1007/s00248-013-0285-1; van Hoek ML, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00198; van Hoek ML, 2013, VIRULENCE, V4, P833, DOI 10.4161/viru.27023; Verhoeven AB, 2010, BIOL BULL-US, V219, P178, DOI 10.1086/BBLv219n2p178; Whitehouse CA, 2012, LETT APPL MICROBIOL, V54, P313, DOI 10.1111/j.1472-765X.2012.03214.x; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Ziveri J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00889-7; Zogaj X, 2012, INFECT IMMUN, V80, P4239, DOI 10.1128/IAI.00702-12	63	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228591	10.1371/journal.pone.0228591	http://dx.doi.org/10.1371/journal.pone.0228591			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023304	Green Published, gold			2022-12-26	WOS:000534621500063
J	Wong, B; Leal, I; Feau, N; Dale, A; Uzunovic, A; Hamelin, RC				Wong, Barbara; Leal, Isabel; Feau, Nicolas; Dale, Angela; Uzunovic, Adnan; Hamelin, Richard C.			Molecular assays to detect the presence and viability of Phytophthora ramorum and Grosmannia clavigera	PLOS ONE			English	Article							REVERSE-TRANSCRIPTION-PCR; POLYMERASE-CHAIN-REACTION; MOUNTAIN PINE-BEETLE; PLANT-TISSUES RICH; MESSENGER-RNA; RT-PCR; GENOME SEQUENCES; FUNCTIONAL RNA; PATHOGEN; INDICATOR	Wood and wood products can harbor microorganisms that can raise phytosanitary concerns in countries importing or exporting these products. To evaluate the efficacy of wood treatment on the survival of microorganisms of phytosanitary concern the method of choice is to grow microbes in petri dishes for subsequent identification. However, some plant pathogens are difficult or impossible to grow in axenic cultures. A molecular methodology capable of detecting living fungi and fungus-like organisms in situ can provide a solution. RNA represents the transcription of genes and can become rapidly unstable after cell death, providing a proxy measure of viability. We designed and used RNA-based molecular diagnostic assays targeting genes essential to vital processes and assessed their presence in wood colonized by fungi and oomycetes through reverse transcription and real-time polymerase chain reaction (PCR). A stability analysis was conducted by comparing the ratio of mRNA to gDNA over time following heat treatment of mycelial cultures of the Oomycete Phytophthora ramorum and the fungus Grosmannia clavigera. The real-time PCR results indicated that the DNA remained stable over a period of 10 days post treatment in heat-treated samples, whereas mRNA could not be detected after 24 hours for P. ramorum or 96 hours for G. clavigera. Therefore, this method provides a reliable way to evaluate the viability of these pathogens and offers a potential way to assess the effectiveness of existing and emerging wood treatments. This can have important phytosanitary impacts on assessing both timber and non-timber forest products of commercial value in international wood trade.	[Wong, Barbara; Hamelin, Richard C.] Univ Laval, IBIS, Fac Foresterie & Geomat, Quebec City, PQ, Canada; [Wong, Barbara; Feau, Nicolas; Dale, Angela; Hamelin, Richard C.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC, Canada; [Leal, Isabel] Nat Resources Canada, Pacific Forestry Ctr, Victoria, BC, Canada; [Dale, Angela; Uzunovic, Adnan] FPInnovat, Vancouver, BC, Canada	Laval University; University of British Columbia; Natural Resources Canada	Hamelin, RC (corresponding author), Univ Laval, IBIS, Fac Foresterie & Geomat, Quebec City, PQ, Canada.; Hamelin, RC (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC, Canada.	richard.hamelin@ubc.ca	Hamelin, Richard/F-7006-2010	Hamelin, Richard/0000-0003-4006-532X	Genome Canada [10106]; Genomic Research and Development (GRDI) initiative; Natural Sciences and Engineering Research Council of Canada (NSERC) TRIA-Net [NETGP-434810-12]	Genome Canada(Genome Canada); Genomic Research and Development (GRDI) initiative; Natural Sciences and Engineering Research Council of Canada (NSERC) TRIA-Net(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by: Grant from Genome Canada (10106) to RCH; Grant from the Genomic Research and Development (GRDI) initiative to IL; Natural Sciences and Engineering Research Council of Canada (NSERC) TRIA-Net (NETGP-434810-12).	Aarthi P, 2012, CURR EYE RES, V37, P1114, DOI 10.3109/02713683.2012.704476; Alamouti SM, 2011, MOL ECOL, V20, P2581, DOI 10.1111/j.1365-294X.2011.05109.x; Alayon DIO, 2017, MOL ECOL, V26, P2077, DOI 10.1111/mec.14074; ALIFANO P, 1994, GENETICA, V94, P157, DOI 10.1007/BF01443430; Allen E, 2017, BIOL INVASIONS, V19, P3365, DOI 10.1007/s10530-017-1515-0; Alum A, 2012, INT J INFECT DIS, V16, pE350, DOI 10.1016/j.ijid.2012.01.004; Baque RH, 2011, WATER RES, V45, P3175, DOI 10.1016/j.watres.2011.03.032; Bergin PF, 2010, J BONE JOINT SURG AM, V92A, P654, DOI 10.2106/JBJS.I.00400; Bilodeau GJ, 2007, PHYTOPATHOLOGY, V97, P632, DOI 10.1094/PHYTO-97-5-0632; Bilodeau P, 2019, J PEST SCI, V92, P71, DOI 10.1007/s10340-018-1001-1; Bleve G, 2003, APPL ENVIRON MICROB, V69, P4116, DOI 10.1128/AEM.69.7.4116-4122.2003; Brasier C, 2010, NATURE, V466, P824, DOI 10.1038/466824a; Brown AV, 2007, PLANT PATHOL, V56, P227, DOI 10.1111/j.1365-3059.2006.01511.x; Cai LP, 2011, DRY TECHNOL, V29, P729, DOI 10.1080/07373937.2010.535131; Callan B. E., 2018, Bulletin OEPP, V48, P245, DOI 10.1111/epp.12476; Caro A, 1999, APPL ENVIRON MICROB, V65, P3229; Chimento A, 2012, FOREST PATHOL, V42, P14, DOI 10.1111/j.1439-0329.2011.00717.x; Coffey M, 2019, TLS-TIMES LIT SUPPL, P6; Cuomo CA, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00446-14; Dale AL, 2019, MBIO, V10, DOI [10.1128/mBio.02452-18, 10.1128/mbio.02452-18]; Davis GL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002404; Dickson AM, 2009, ELS; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; Feau N, 2019, PLANT PATHOL, V68, P878, DOI 10.1111/ppa.13015; Feau N, 2018, PEERJ, V6, DOI 10.7717/peerj.4392; Feau N, 2016, GENOM DATA, V10, P85, DOI 10.1016/j.gdata.2016.09.013; Feau N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018803; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Food and Agriculture Organization of the United Nations (FAO), 2017, REG WOOD PACK MAT IN; Forgetta Vincenzo, 2013, J Biomol Tech, V24, P39, DOI 10.7171/jbt.12-2401-005; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Haridas S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-373; Heise J, 2016, J MICROBIOL METH, V121, P11, DOI 10.1016/j.mimet.2015.12.002; Hellyer TJ, 1999, J CLIN MICROBIOL, V37, P290, DOI 10.1128/JCM.37.2.290-295.1999; Hesse-Orce U, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-536; Humble LM, 2006, CAN J PLANT PATHOL, V28, pS256, DOI 10.1080/07060660609507383; Jeffers S., 2015, LAB PROTOCOLS PHYTOP, P1, DOI DOI 10.1094/9780890544969.07.11.1; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kasuga T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2717-z; Kasuga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034728; Kiefer E, 2000, PLANT MOL BIOL REP, V18, P33, DOI 10.1007/BF02825291; Le Provost G, 2007, BIOL RES, V40, P291, DOI [10.4067/S0716-97602007000400003, /S0716-97602007000400003]; Leal I, 2015, FOREST PATHOL, V45, P134, DOI 10.1111/efp.12149; Leal I, 2013, FOREST PATHOL, V43, P104, DOI 10.1111/efp.12003; Leal I, 2010, PHYTOSANITARY RISKS; Lee S, 2005, MYCOL RES, V109, P1162, DOI 10.1017/S0953756205003588; Li L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00258; Lim YW, 2004, FEMS MICROBIOL LETT, V237, P89, DOI 10.1111/j.1574-6968.2004.tb09682.x; Marthey S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-456; Martin FN, 2007, CURR GENET, V51, P285, DOI 10.1007/s00294-007-0121-6; Martin RR, 2000, ANNU REV PHYTOPATHOL, V38, P207, DOI 10.1146/annurev.phyto.38.1.207; Menzel W, 2002, J VIROL METHODS, V99, P81, DOI 10.1016/S0166-0934(01)00381-0; Miles TD, 2017, PLANT DIS, V101, P1162, DOI 10.1094/PDIS-09-16-1224-RE; Oliveira L, 2012, DRY TECHNOL, V30, P1792, DOI 10.1080/07373937.2012.708003; Overbergh L, 2003, J Biomol Tech, V14, P33; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Parke JL, 2007, PHYTOPATHOLOGY, V97, P1558, DOI 10.1094/PHYTO-97-12-1558; Parke J.L., 2008, PLANT HLTH INSTRUCTO; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Puspita ID, 2012, MICROBES ENVIRON, V27, P356, DOI 10.1264/jsme2.ME12092; Ramsfield TD, 2010, CAN J PLANT PATHOL, V32, P368, DOI 10.1080/07060661.2010.499269; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Roe AD, 2019, J PEST SCI, V92, P51, DOI 10.1007/s10340-018-1027-4; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Salzman RA, 1999, PLANT MOL BIOL REP, V17, P11, DOI 10.1023/A:1007520314478; SCHNEIDERBAUER A, 1991, ANAL BIOCHEM, V197, P91, DOI 10.1016/0003-2697(91)90360-6; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sheridan GEC, 1998, APPL ENVIRON MICROB, V64, P1313; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Taylor DL, 2003, MYCORRHIZAL ECOLOGY, P375; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Tooley PW, 2006, PHYTOPATHOLOGY, V96, P336, DOI 10.1094/PHYTO-96-0336; TSAO PH, 1971, PHYTOPATHOLOGY, V61, P1412, DOI 10.1094/Phyto-61-1412; Tubajika KM, 2007, P SUDD OAK DEATH 3 S, P477; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Villarino A, 2003, EUR J BIOCHEM, V270, P2689, DOI 10.1046/j.1432-1033.2003.03652.x; White R., 2000, GENE TRANSCRIPTION M	78	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0221742	10.1371/journal.pone.0221742	http://dx.doi.org/10.1371/journal.pone.0221742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023247	gold, Green Submitted, Green Published			2022-12-26	WOS:000534621500003
J	Sarkar, A; Ghosh, S; Shaw, R; Patra, MM; Calcuttawala, F; Mukherjee, N; Das Gupta, SK				Sarkar, Apurba; Ghosh, Shreya; Shaw, Rahul; Patra, Madhu Manti; Calcuttawala, Fatema; Mukherjee, Noyonika; Das Gupta, Sujoy K.			Mycobacterium tuberculosis thymidylate synthase (ThyX) is a target for plumbagin, a natural product with antimycobacterial activity	PLOS ONE			English	Article							DRUG-RESISTANCE; CELL-GROWTH; MECHANISM; ASSAY; TB	Plumbagin derived from the plant Plumbago indica, known as Chitrak in India, is an example of a medicinal compound used traditionally to cure a variety of ailments. Previous reports have indicated that it can inhibit the growth of Mycobacterium tuberculosis (Mtb), the causative agent of the deadly disease TB. In this investigation, we provide an insight into its mode of action. We show here that a significant mycobacterial target that is inhibited by plumbagin is the enzyme ThyX, a form of thymidylate synthase, that is responsible for the synthesis of dTMP from dUMP in various bacterial pathogens, including Mtb. Using a purified preparation of the recombinant version of Mtb ThyX, we demonstrate that plumbagin, a 2,4 napthoquinone, but not lawsone, a structurally related medicinal compound, inhibits its activity in vitro. We also show that the intracellular [dTTP]/[dATP] ratio in Mycobacterium smegmatis (Msm) cells decrease upon treatment with plumbagin, and this, in turn, leads to cell death. Such a conclusion is supported by the observation that over-expression of thyx in the plumbagin treated Msm cells leads to the restoration of viability. The results of our investigation indicate that plumbagin kills mycobacterial cells primarily by targeting ThyX, a vital enzyme required for their survival.	[Sarkar, Apurba; Ghosh, Shreya; Shaw, Rahul; Patra, Madhu Manti; Calcuttawala, Fatema; Mukherjee, Noyonika; Das Gupta, Sujoy K.] Bose Inst, Dept Microbiol, Kolkata, India	Department of Science & Technology (India); Bose Institute	Das Gupta, SK (corresponding author), Bose Inst, Dept Microbiol, Kolkata, India.	sujoy@jcbose.ac.in		Das Gupta, Sujoy K/0000-0002-7200-3652; Ghosh, Shreya/0000-0002-1709-8011	Science & Engineering Research Board, India [EMR/2016/006505]; Bose Institute, UGC, Govt. of India; CSIR, Govt. of India; DBT, Ministry of Science Technology	Science & Engineering Research Board, India; Bose Institute, UGC, Govt. of India; CSIR, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); DBT, Ministry of Science Technology	Author-SDG Grant No.-EMR/2016/006505 FUNDER'S Name-Science & Engineering Research Board, India URL-http://www.serb.gov.in/home.php The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Mycobacterium tuberculosis Ra (Mtb Ra) is a kind gift from Manikuntala Kundu and Joyoti Basu. We thank Mr. P. Halder for technical assistance. We would like to thank Mr. Souvik Roy for his assistance in acquiring and processing mass spectrometry data. A.S, R.S, M.P and F.C thank Bose Institute, UGC, Govt. of India,CSIR, Govt. of India, and DBT, Ministry of Science & Technology respectively for funding their fellowship.	Alexander DC, 2003, ANTIMICROB AGENTS CH, V47, P3208, DOI 10.1128/AAC.47.10.3208-3213.2003; BAPAT V R, 1947, Antiseptic, V44, P672; Basta T, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120120; Bhattacharya B, 2008, FEMS MICROBIOL LETT, V280, P64, DOI 10.1111/j.1574-6968.2007.01047.x; Billo NE, 2016, INT J TUBERC LUNG D, V20, P427, DOI 10.5588/ijtld.16.0104; Bonev B, 2008, J ANTIMICROB CHEMOTH, V61, P1295, DOI 10.1093/jac/dkn090; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Cholden LS, 1944, J BACTERIOL, V47, P402, DOI 10.1128/JB.47.4.402-403.1944; Chopra T, 2014, MOL CELL PROTEOMICS, V13, P3014, DOI 10.1074/mcp.M113.034082; Dey D, 2014, PHYTOTHER RES, V28, P1014, DOI 10.1002/ptr.5090; Djaout K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27792; Dookie N, 2018, J ANTIMICROB CHEMOTH, V73, P1138, DOI 10.1093/jac/dkx506; Fivian-Hughes AS, 2012, MICROBIOL-SGM, V158, P308, DOI 10.1099/mic.0.053983-0; Ghosh S, 2016, J BACTERIOL, V198, P352, DOI 10.1128/JB.00669-15; Griffin J, 2005, J BIOL CHEM, V280, P5456, DOI 10.1074/jbc.M412415200; Uc-Cachon AH, 2014, PULM PHARMACOL THER, V27, P114, DOI 10.1016/j.pupt.2013.08.001; Hunter JH, 2008, KINETICS LIGAND BIND; Li J, 2012, ACTA PHARMACOL SIN, V33, P242, DOI 10.1038/aps.2011.152; Mathew R, 2010, CHEM BIOL DRUG DES, V76, P34, DOI 10.1111/j.1747-0285.2010.00987.x; MATHEWS II, 2013, J BIOTERROR BIOD S12; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Nguta JM, 2015, INT J MYCOBACT, V4, P116, DOI 10.1016/j.ijmyco.2015.02.003; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Projan S, 2004, NAT BIOTECHNOL, V22, P167, DOI 10.1038/nbt0204-167; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; SHARMA VK, 1990, TUBERCLE, V71, P293, DOI 10.1016/0041-3879(90)90044-9; Skouloubris S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150015; Taneja NK, 2007, J ANTIMICROB CHEMOTH, V60, P288, DOI 10.1093/jac/dkm207; Tyagi P, 2015, FREE RADICAL BIO MED, V84, P344, DOI 10.1016/j.freeradbiomed.2015.03.008; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Yan W, 2014, ACTA PHARMACOL SIN, V35, P124, DOI 10.1038/aps.2013.152	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228657	10.1371/journal.pone.0228657	http://dx.doi.org/10.1371/journal.pone.0228657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017790	Green Published, Green Submitted, gold			2022-12-26	WOS:000534618100036
J	Tung, YC; Tu, HP; Wu, MK; Kuo, KL; Su, YF; Lu, YY; Lin, CL; Wu, CH				Tung, Yi-Ching; Tu, Hung-Pin; Wu, Ming-Kung; Kuo, Keng-Liang; Su, Yu-Feng; Lu, Ying-Yi; Lin, Chih-Lung; Wu, Chieh-Hsin			Higher risk of herpes zoster in stroke patients	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; RHEUMATOID-ARTHRITIS; MAJOR DEPRESSION; VIRUS; VACCINE; CARE; EPIDEMIOLOGY; PATHOGENESIS; INFLAMMATION; POSTSTROKE	Background Stroke is a leading cause of death, morbidity and disability worldwide. Infection is a common complication in the acute phase after stroke. Herpes zoster is a common viral disease, in which the most debilitating complication is post-herpetic neuralgia, which can have a very large negative impact on quality of life. The aim of this study was to investigate whether stroke increases the risk of herpes zoster. Methods This cohort study compared patients who had herpes zoster with and without a first incident of stroke. The Taiwan National Health Insurance Research Database was utilized to identify 20,551 stroke patients and 20,551 controls matched for age, gender, age categories and Charlson Comorbidity Index (CCI) score categories at a one-to-one ratio. Cox proportional-hazards regression models were employed to estimate herpes zoster risk in the stroke group relative to general population. Results Compared to the control group, the stroke group had a greater risk for herpes zoster, especially within 1 year after stroke (adjust HR = 25.27). Both hemorrhagic stroke and ischemic stroke were significantly associated with herpes zoster (hemorrhagic type (IRR = 2.31, 95% CI, 1.67-3.20); ischemic type (IRR = 2.51, 95% CI 2.09-3.02)). However, the hemorrhagic stroke patients had a higher risk of herpes zoster ophthalmicus (IRR = 12.46, 95% CI 4.00-38.76) whereas the ischemic stroke patients had a higher risk of post-herpetic neuralgia (IRR = 2.24, 95% CI 1.56-3.20). Conclusion Physicians should know about that adults with stroke have a higher than normal risk of herpes zoster. Thus, physicians must be acquainted with proper antiviral therapy and pain control to bring down the morbidity that ensues from herpes zoster. Use of herpes zoster vaccine may be considered in stroke patients.	[Tung, Yi-Ching; Tu, Hung-Pin] Kaohsiung Med Univ, Coll Med, Dept Publ Hlth & Environm Med, Kaohsiung, Taiwan; [Wu, Ming-Kung] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Wu, Ming-Kung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Kuo, Keng-Liang; Su, Yu-Feng; Lu, Ying-Yi; Lin, Chih-Lung; Wu, Chieh-Hsin] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Kuo, Keng-Liang; Su, Yu-Feng; Lin, Chih-Lung; Wu, Chieh-Hsin] Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan; [Su, Yu-Feng; Lin, Chih-Lung; Wu, Chieh-Hsin] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan; [Lu, Ying-Yi] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan	Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Veterans General Hospital	Lin, CL; Wu, CH (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.; Lin, CL; Wu, CH (corresponding author), Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan.; Lin, CL; Wu, CH (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan.	chilung1@yahoo.com; wujoeys@gmail.com		Tu, Hung-Pin/0000-0003-1044-2673; Su, Yu-feng/0000-0003-0355-3981	Taiwan Ministry of Science and Technology [MOST105-2314-B-037-003]; Kaohsiung Medical University Hospital [KMUH-1044R16, KMUH106-6T09, KMU-Q108029, KMUH108-8M23]	Taiwan Ministry of Science and Technology; Kaohsiung Medical University Hospital	This research work was supported by grants from the Taiwan Ministry of Science and Technology (MOST105-2314-B-037-003), and Kaohsiung Medical University Hospital (KMUH-1044R16, KMUH106-6T09, KMU-Q108029 and KMUH108-8M23). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 2014, FRANCIS B VICK SER, P223; ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; Ayerbe L, 2011, STROKE, V42, P1907, DOI 10.1161/STROKEAHA.110.605808; Cai PY, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00107; CAMACHO TC, 1991, AM J EPIDEMIOL, V134, P220, DOI 10.1093/oxfordjournals.aje.a116074; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chen HH, 2011, CLINICS, V66, P1177, DOI 10.1590/S1807-59322011000700009; Chiu HF, 2013, J EPIDEMIOL, V23, P205, DOI 10.2188/jea.JE20120155; Creutzfeldt CJ, 2012, J GEN INTERN MED, V27, P853, DOI 10.1007/s11606-011-1966-4; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; El Husseini N, 2012, STROKE, V43, P1609, DOI 10.1161/STROKEAHA.111.643130; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Gelenberg AJ, 2007, AM J MED, V120, P105, DOI 10.1016/j.amjmed.2006.05.059; Gilden DH, 2003, VIRAL IMMUNOL, V16, P243, DOI 10.1089/088282403322396073; Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-6; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X; Irwin M, 1998, J INFECT DIS, V178, pS104, DOI 10.1086/514272; Irwin MR, 2013, CLIN INFECT DIS, V56, P1085, DOI 10.1093/cid/cis1208; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Joesoef RM, 2012, MAYO CLIN PROC, V87, P961, DOI 10.1016/j.mayocp.2012.05.021; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Ke CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146750; Lewin-Richter A, 2015, J NUTR HEALTH AGING, V19, P754, DOI 10.1007/s12603-015-0540-x; Liao CH, 2015, J CLIN PSYCHIAT, V76, pE1099, DOI 10.4088/JCP.14m09311; Liesz A, 2015, J NEUROSCI, V35, P583, DOI 10.1523/JNEUROSCI.2439-14.2015; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Mackay J., 2004, The atlas of heart disease and stroke; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Neumann S, 2015, INT J MOL SCI, V16, P29029, DOI 10.3390/ijms161226141; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Patten SB, 2009, PSYCHOSOM MED, V71, P273, DOI 10.1097/PSY.0b013e3181988e5f; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Schmader K, 1998, J INFECT DIS, V178, pS67, DOI 10.1086/514254; Schmidt SAJ, 2018, AM J EPIDEMIOL, V187, P1019, DOI 10.1093/aje/kwx338; Shimbo D, 2005, AM J CARDIOL, V96, P1016, DOI 10.1016/j.amjcard.2005.05.064; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Thomas SL, 2006, INT J EPIDEMIOL, V35, P307, DOI 10.1093/ije/dyi270; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Veetil BMA, 2013, ARTHRIT CARE RES, V65, P854, DOI 10.1002/acr.21928; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wilson JF, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-3-201102010-01002; Wu PH, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040547; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Yawn BP, 2009, MAYO CLIN PROC, V84, P787, DOI [10.4065/84.9.787, 10.1016/S0025-6196(11)60488-6]; Zerboni L, 2014, NAT REV MICROBIOL, V12, P197, DOI 10.1038/nrmicro3215; Zisman D, 2016, ANN RHEUM DIS, V75, P131, DOI 10.1136/annrheumdis-2013-205148; Zorrilla EP, 2001, BRAIN BEHAV IMMUN, V15, P199, DOI 10.1006/brbi.2000.0597	56	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228409	10.1371/journal.pone.0228409	http://dx.doi.org/10.1371/journal.pone.0228409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017810	Green Published, gold			2022-12-26	WOS:000534618100023
J	Belzunce, I; Belmonte-Mateos, C; Pujades, C				Belzunce, Ivan; Belmonte-Mateos, Carla; Pujades, Cristina			The interplay of atoh1 genes in the lower rhombic lip during hindbrain morphogenesis	PLOS ONE			English	Article							ZEBRAFISH; EXPRESSION; BRAIN; NEUROGENESIS; BOUNDARIES; STEM; POPULATIONS; DIVERSITY; EVOLUTION; DIVISION	The Lower Rhombic Lip (LRL) is a transient neuroepithelial structure of the dorsal hindbrain, which expands from r2 to r7, and gives rise to deep nuclei of the brainstem, such as the vestibular and auditory nuclei and most posteriorly the precerebellar nuclei. Although there is information about the contribution of specific proneural-progenitor populations to specific deep nuclei, and the distinct rhombomeric contribution, little is known about how progenitor cells from the LRL behave during neurogenesis and how their transition into differentiation is regulated. In this work, we investigated the atoh1 gene regulatory network operating in the specification of LRL cells, and the kinetics of cell proliferation and behavior of atoh1a-derivatives by using complementary strategies in the zebrafish embryo. We unveiled that atoh1a is necessary and sufficient for specification of LRL cells by activating atoh1b, which worked as a differentiation gene to transition progenitor cells towards neuron differentiation in a Notch-dependent manner. This cell state transition involved the release of atoh1a-derivatives from the LRL: atoh1a progenitors contributed first to atoh1b cells, which are committed non-proliferative precursors, and to the lhx2b-neuronal lineage as demonstrated by cell fate studies and functional analyses. Using in vivo cell lineage approaches we revealed that the proliferative cell capacity, as well as the mode of division, relied on the position of the atoh1a progenitors within the dorsoventral axis. We showed that atoh1a may behave as the cell fate selector gene, whereas atoh1b functions as a neuronal differentiation gene, contributing to the lhx2b neuronal population. atoh1a-progenitor cell dynamics (cell proliferation, cell differentiation, and neuronal migration) relies on their position, demonstrating the challenges that progenitor cells face in computing positional information from a dynamic two-dimensional grid in order to generate the stereotyped neuronal structures in the embryonic hindbrain.	[Belzunce, Ivan; Belmonte-Mateos, Carla; Pujades, Cristina] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Pompeu Fabra University	Pujades, C (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain.	cristina.pujades@upf.edu	Pujades, Cristina/F-7908-2014	Pujades, Cristina/0000-0001-6423-7451; Belzunce, Ivan/0000-0003-4235-2226	Unidad de Excelencia Maria de Maetzu [MDM2014-0370, AEI-CEX2018-000792-M]; Generalitat de Catalunya (FI); Spanish Ministry of Economy, Industry and Competitiveness (FPI); ICREA Academia award (Generalitat de Catalunya).; MINECO-FEDER [BFU201681887-REDT/AEI]; MICIU [AEI-PGC2018-095663-B-I00 FEDER/UE]	Unidad de Excelencia Maria de Maetzu; Generalitat de Catalunya (FI)(Generalitat de Catalunya); Spanish Ministry of Economy, Industry and Competitiveness (FPI); ICREA Academia award (Generalitat de Catalunya).(ICREA); MINECO-FEDER; MICIU	This work was supported by BFU201681887-REDT/AEI (MINECO-FEDER), and AEI-PGC2018-095663-B-I00 FEDER/UE (MICIU) to CP, and Unidad de Excelencia Mari ' a de Maetzu MDM2014-0370 and AEI-CEX2018-000792-M to DCEXS-UPF. IB and CBM were recipients of predoctoral fellowships from the Generalitat de Catalunya (FI) and the Spanish Ministry of Economy, Industry and Competitiveness (FPI), respectively. CP is a recipient of ICREA Academia award (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDE ML, 1994, DEV BIOL, V166, P509, DOI 10.1006/dbio.1994.1334; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Calzolari S, 2014, EMBO J, V33, P686, DOI 10.1002/embj.201386003; Chitnis AB, 1999, CURR OPIN NEUROBIOL, V9, P18, DOI 10.1016/S0959-4388(99)80003-8; Clark BS, 2012, DEVELOPMENT, V139, P1599, DOI 10.1242/dev.078097; Dale RM, 2011, DEV BIOL, V357, P518, DOI 10.1016/j.ydbio.2011.06.020; Distel M, 2010, J CELL BIOL, V191, P1412, DOI 10.1083/jcb.20100415420101108c; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Fujiyama T, 2009, DEVELOPMENT, V136, P2049, DOI 10.1242/dev.033480; Gonzalez-Quevedo R, 2010, DEV CELL, V18, P136, DOI 10.1016/j.devcel.2009.11.010; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; Hernandez-Miranda LR, 2017, DEV BIOL, V432, P34, DOI 10.1016/j.ydbio.2016.10.008; Hibi M, 2017, DEV GROWTH DIFFER, V59, P228, DOI 10.1111/dgd.12349; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2; Iulianella A, 2019, DEV DYNAM, V248, P506, DOI 10.1002/dvdy.64; Jimenez-Guri E, 2011, EVOL DEV, V13, P38, DOI 10.1111/j.1525-142X.2010.00454.x; Jimenez-Guri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010112; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Kawauchi D, 2008, DEV BIOL, V322, P345, DOI 10.1016/j.ydbio.2008.08.005; Kicheva A, 2014, SCIENCE, V345, P1577, DOI 10.1126/science.1254927; Kicheva A, 2012, SCIENCE, V338, P210, DOI 10.1126/science.1225182; Kidwell CU, 2018, DEV BIOL, V438, P44, DOI 10.1016/j.ydbio.2018.03.004; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Kratochwil CF, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00033; Le Dreau G, 2018, ELIFE, V7, DOI 10.7554/eLife.37267; Le Dreau G, 2014, J CELL BIOL, V204, P591, DOI 10.1083/jcb.201307031; Letelier J, 2018, P NATL ACAD SCI USA, V115, pE3731, DOI 10.1073/pnas.1719885115; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Murakami Y, 2005, DEV BIOL, V280, P249, DOI 10.1016/j.ydbio.2005.02.008; Nikolaou N, 2009, DEVELOPMENT, V136, P2523, DOI 10.1242/dev.034736; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Park SH, 2003, BIOCHEM BIOPH RES CO, V308, P184, DOI 10.1016/S0006-291X(03)01353-6; Peretz Y, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0277-y; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Saade M, 2013, CELL REP, V4, P492, DOI 10.1016/j.celrep.2013.06.038; Satou C, 2013, DEVELOPMENT, V140, P3927, DOI 10.1242/dev.099531; Terriente J, 2012, DEVELOPMENT, V139, P2978, DOI 10.1242/dev.080135; THISSE C, 1993, DEVELOPMENT, V119, P1203; Volkmann K, 2008, DEV BIOL, V313, P167, DOI 10.1016/j.ydbio.2007.10.024; Volkmann K, 2010, J COMP NEUROL, V518, P2794, DOI 10.1002/cne.22364; Voltes A, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.176735; Wolff C, 2018, ELIFE, V7, DOI 10.7554/eLife.34410	48	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228225	10.1371/journal.pone.0228225	http://dx.doi.org/10.1371/journal.pone.0228225			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KO3IF	32012186	Green Published, Green Submitted, gold			2022-12-26	WOS:000515441400001
J	Liu, YY; Yang, G; Xu, Y; Peng, F; Wang, LQ				Liu, Ying-Yuan; Yang, Gang; Xu, Ying; Peng, Fan; Wang, Le-Qin			Effect of space diffuser on flow characteristics of a centrifugal pump by computational fluid dynamic analysis	PLOS ONE			English	Article							COMPRESSOR DIFFUSERS; FIELD CONDITIONS; DESIGN METHOD; PERFORMANCE; EFFICIENCY	Achieving an optimal configuration of the diffuser is indispensable for high pump performances. In this work, a numerical study on diffuser configuration is conducted for a high pump performance using a computational fluid dynamics code, and the effects of the wrap angle and the relative position of the diffuser vane to the impeller on pump performances are included. The results indicate that the modified diffuser with a suitable wrap angle may improve the pump hydraulic efficiency and the head by approximately 4% and 8%, respectively, while a suitable position of the diffuser vane can enhance the pump head by more than 4%. Meanwhile, the pressure recovery coefficient and the local Euler head of the diffuser are adopted to evaluate the diffuser performance. For a high pump performance, the local Euler head of the diffuser has a peak value at the leading edge with the change rate of zero along the meridian streamline, meaning that no blade loading at the leading edge of the diffuser guarantees a better match between the impeller and the diffuser.	[Liu, Ying-Yuan; Yang, Gang; Xu, Ying; Peng, Fan] Shanghai Normal Univ, Coll Informat Mech & Elect Engn, Shanghai, Peoples R China; [Wang, Le-Qin] Zhejiang Univ, Inst Proc Equipment, Hangzhou, Peoples R China	Shanghai Normal University; Zhejiang University	Liu, YY (corresponding author), Shanghai Normal Univ, Coll Informat Mech & Elect Engn, Shanghai, Peoples R China.	yyliu@shnu.edu.cn			National Natural Science Foundation of China [51806145]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (Grants No. 51806145).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, ANSYS CFX THEORY GUI; Bai L, 2019, PROCESSES, V7, DOI 10.3390/pr7060354; Bai L, 2019, SHOCK VIB, V2019, DOI 10.1155/2019/2057031; Boncinelli P, 2008, J TURBOMACH, V130, DOI 10.1115/1.2777182; Deniz S, 2000, J TURBOMACH, V122, P11, DOI 10.1115/1.555424; Derakhshan S, 2008, EXP THERM FLUID SCI, V32, P800, DOI 10.1016/j.expthermflusci.2007.10.004; Filipenco VG, 2000, J TURBOMACH, V122, P1, DOI 10.1115/1.555418; Karanth K.V., 2017, INT J APPL ENG ING R, V12, P4415; Karanth KV, 2019, PROCEDIA MANUF, V35, P1102, DOI 10.1016/j.promfg.2019.06.063; Kim JW, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016676680; Madhwesh N, 2018, J FLUID ENG-T ASME, V140, DOI 10.1115/1.4039413; Scheit C, 2012, J SOUND VIB, V331, P996, DOI 10.1016/j.jsv.2011.10.014; van Esch BPM, 2001, J FLUID ENG-T ASME, V123, P256, DOI 10.1115/1.1365121; Wang C, 2017, APPL ENERG, V187, P10, DOI 10.1016/j.apenergy.2016.11.046; WANG L, 2019, WATER-SUI, V11, DOI [DOI 10.3390/W11091777, DOI 10.3390/w11091777]; Wu DZ, 2015, J FLUID ENG-T ASME, V137, DOI 10.1115/1.4030488; Yang SS, 2012, J FLUID ENG-T ASME, V134, DOI 10.1115/1.4006677; Zangeneh M, 1999, P I MECH ENG C-J MEC, V213, P27, DOI 10.1243/0954406991522167; ZANGENEH M, 1991, INT J NUMER METH FL, V13, P599, DOI 10.1002/fld.1650130505; Zhou WJ, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161059; Zhu BS, 2015, RENEW ENERG, V81, P366, DOI 10.1016/j.renene.2015.03.050	22	3	3	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228051	10.1371/journal.pone.0228051	http://dx.doi.org/10.1371/journal.pone.0228051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012173	gold, Green Published			2022-12-26	WOS:000534615800017
J	Bashiri, G; Nigon, LV; Jirgis, ENM; Ho, NAT; Stanborough, T; Dawes, SS; Baker, EN; Bulloch, EMM; Johnston, JM				Bashiri, Ghader; Nigon, Laura V.; Jirgis, Ehab N. M.; Ho, Ngoc Anh Thu; Stanborough, Tamsyn; Dawes, Stephanie S.; Baker, Edward N.; Bulloch, Esther M. M.; Johnston, Jodie M.			Allosteric regulation of menaquinone (vitamin K-2) biosynthesis in the human pathogen Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; allosteric regulation; cooperativity; structural biology; vitamin K; feedback inhibition; 1; 4-dihydroxy-2-naphthoic acid (DHNA); menaquinone (vitamin K-2) biosynthesis; drug target; pyruvate oxidase (POX) enzymes; SEPHCHC synthase (MenD); thiamine diphosphate (ThDP)-dependent enzymes; allostery	ESCHERICHIA-COLI; MEND; DECARBOXYLASE; INHIBITORS; DISCOVERY; SYSTEM; 1,4-DIHYDROXY-2-NAPHTHOATE; IDENTIFICATION; THIOESTERASE; UBIQUINONE	Menaquinone (vitamin K-2) plays a vital role in energy generation and environmental adaptation in many bacteria, including the human pathogen Mycobacterium tuberculosis (Mtb). Although menaquinone levels are known to be tightly linked to the cellular redox/energy status of the cell, the regulatory mechanisms underpinning this phenomenon are unclear. The first committed step in menaquinone biosynthesis is catalyzed by MenD, a thiamine diphosphate?dependent enzyme comprising three domains. Domains I and III form the MenD active site, but no function has yet been ascribed to domain II. Here, we show that the last cytosolic metabolite in the menaquinone biosynthesis pathway, 1,4-dihydroxy-2-naphthoic acid (DHNA), binds to domain II of Mtb-MenD and inhibits its activity. Using X-ray crystallography of four apo- and cofactor-bound Mtb-MenD structures, along with several spectroscopy assays, we identified three arginine residues (Arg-97, Arg-277, and Arg-303) that are important for both enzyme activity and the feedback inhibition by DHNA. Among these residues, Arg-277 appeared to be particularly important for signal propagation from the allosteric site to the active site. This is the first evidence of feedback regulation of the menaquinone biosynthesis pathway in bacteria, identifying a protein-level regulatory mechanism that controls menaquinone levels within the cell and may therefore represent a good target for disrupting menaquinone biosynthesis in M. tuberculosis.	[Bashiri, Ghader; Nigon, Laura V.; Jirgis, Ehab N. M.; Dawes, Stephanie S.; Baker, Edward N.; Bulloch, Esther M. M.] Univ Auckland, Struct Biol Lab, Sch Biol Sci, Private Bag 92019, Auckland 1010, New Zealand; [Bashiri, Ghader; Nigon, Laura V.; Jirgis, Ehab N. M.; Dawes, Stephanie S.; Baker, Edward N.; Bulloch, Esther M. M.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1010, New Zealand; [Ho, Ngoc Anh Thu; Stanborough, Tamsyn; Johnston, Jodie M.] Univ Canterbury, Sch Phys & Chem Sci, BIC, Christchurch 8041, New Zealand; [Ho, Ngoc Anh Thu; Stanborough, Tamsyn; Johnston, Jodie M.] Univ Canterbury, Maurice Wilkins Ctr Mol Biodiscovery, Christchurch 8041, New Zealand	University of Auckland; University of Auckland; University of Canterbury; University of Canterbury	Johnston, JM (corresponding author), Univ Canterbury, Sch Phys & Chem Sci, BIC, Christchurch 8041, New Zealand.; Johnston, JM (corresponding author), Univ Canterbury, Maurice Wilkins Ctr Mol Biodiscovery, Christchurch 8041, New Zealand.	jodie.johnston@canterbury.ac.nz	; Bashiri, Ghader/R-4957-2017	Nigon, Laura/0000-0003-0577-2918; Bashiri, Ghader/0000-0002-5092-3749; Baker, Edward/0000-0003-2456-7661; Stanborough, Tamsyn/0000-0001-5945-2536; Ho, Thu/0000-0001-9291-8860; Bulloch, Esther/0000-0002-4262-1791	Marsden Fund grant from the Royal Society Te Aparangi [M1208]; Auckland Medical Research Foundation; Canterbury Medical Research Foundation; Biomolecular Interaction Centre	Marsden Fund grant from the Royal Society Te Aparangi; Auckland Medical Research Foundation; Canterbury Medical Research Foundation; Biomolecular Interaction Centre	This work was primarily supported by a Marsden Fund grant from the Royal Society Te Aparangi (M1208, to J. M. J., G. B., and E. M. M. B.), with additional funding support from the Auckland Medical Research Foundation (to L. V. N. and J. M. J.), the Canterbury Medical Research Foundation (to T. S. and J. M. J.), and the Biomolecular Interaction Centre (to J. M. J. and N. A. T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Magid Ahmed F, 2015, ACS Med Chem Lett, V6, P104, DOI 10.1021/ml5005365; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; Balakrishnan A, 2013, J BIOL CHEM, V288, P21688, DOI 10.1074/jbc.M113.465419; Barak Z, 2012, ARCH BIOCHEM BIOPHYS, V519, P167, DOI 10.1016/j.abb.2011.11.025; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Chen GY, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12762; Chen GY, 2017, MBIO, V8, DOI 10.1128/mBio.00119-17; Chen MJ, 2013, J BACTERIOL, V195, P2768, DOI 10.1128/JB.00141-13; Dawson A, 2010, J MOL BIOL, V401, P253, DOI 10.1016/j.jmb.2010.06.025; Dawson A, 2008, J MOL BIOL, V384, P1353, DOI 10.1016/j.jmb.2008.10.048; Debnath J, 2012, J MED CHEM, V55, P3739, DOI 10.1021/jm201608g; Dhiman RK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214958; Dhiman RK, 2009, MOL MICROBIOL, V72, P85, DOI 10.1111/j.1365-2958.2009.06625.x; Duggleby RG, 2006, ACCOUNTS CHEM RES, V39, P550, DOI 10.1021/ar068022z; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fang MH, 2010, BIOCHEMISTRY-US, V49, P2672, DOI 10.1021/bi901432d; Frank RAW, 2007, CELL MOL LIFE SCI, V64, P892, DOI 10.1007/s00018-007-6423-5; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jirgis ENM, 2016, STRUCTURE, V24, P1167, DOI 10.1016/j.str.2016.04.018; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Koehn JT, 2018, ACS OMEGA, V3, P14889, DOI 10.1021/acsomega.8b02620; Konig S, 2009, J MOL CATAL B-ENZYM, V61, P100, DOI 10.1016/j.molcatb.2009.02.010; KONIG S, 1993, EUR BIOPHYS J BIOPHY, V22, P185; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kurosu M, 2007, J MED CHEM, V50, P3973, DOI 10.1021/jm070638m; Kurosu M, 2009, MED CHEM, V5, P197, DOI 10.2174/157340609787582882; Kutter S, 2009, J BIOL CHEM, V284, P12136, DOI 10.1074/jbc.M806228200; LINDQVIST Y, 1993, CURR OPIN STRUC BIOL, V3, P896, DOI 10.1016/0959-440X(93)90153-C; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mishra A, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708038; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Amit P, 2009, BIOCHEM BIOPH RES CO, V380, P797, DOI 10.1016/j.bbrc.2009.01.168; Puffal J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03145; Qin MM, 2018, BIOCHEM J, V475, P3651, DOI 10.1042/BCJ20180548; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rozewicki J, 2019, NUCLEIC ACIDS RES, V47, pW5, DOI 10.1093/nar/gkz342; Sogi KM, 2016, ACS INFECT DIS, V2, P800, DOI 10.1021/acsinfecdis.6b00106; Sukheja P, 2017, MBIO, V8, DOI 10.1128/mBio.02022-16; Upadhyay A, 2015, ACS CENTRAL SCI, V1, P292, DOI 10.1021/acscentsci.5b00212; van Beilen JWA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01339; Versees W, 2007, J BIOL CHEM, V282, P35269, DOI 10.1074/jbc.M706048200; Versees W, 2007, FEBS J, V274, P2363, DOI 10.1111/j.1742-4658.2007.05771.x; Vogel C, 2014, PROTEINS, V82, P2523, DOI 10.1002/prot.24615; Vogel C, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-24; Wagner T, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav9504; Wagner T, 2011, CHEM BIOL, V18, P1011, DOI 10.1016/j.chembiol.2011.06.004; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; Ward MJ, 2004, APPL MICROBIOL BIOT, V63, P571, DOI 10.1007/s00253-003-1407-3; Wellington S, 2017, NAT CHEM BIOL, V13, P943, DOI [10.1038/NCHEMBIO.2420, 10.1038/nchembio.2420]; Werther T, 2010, FEBS J, V277, P2628, DOI [10.1111/j.1742-4658.2010.07673.x, 10.1111/j.1742-464X.2010.07673.x]; Widhalm JR, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.46; Widhalm JR, 2009, P NATL ACAD SCI USA, V106, P5599, DOI 10.1073/pnas.0900738106; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	60	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3759	3770		10.1074/jbc.RA119.012158	http://dx.doi.org/10.1074/jbc.RA119.012158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32029475	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000527704400003
J	Doruk, YU; Yarparvar, D; Akyel, YK; Gul, S; Taskin, AC; Yilmaz, F; Baris, I; Ozturk, N; Turkay, M; Ozturk, N; Okyar, A; Kavakli, IH				Doruk, Yagmur Umay; Yarparvar, Darya; Akyel, Yasemin Kubra; Gul, Seref; Taskin, Ali Cihan; Yilmaz, Fatma; Baris, Ibrahim; Ozturk, Nuri; Turkay, Metin; Ozturk, Narin; Okyar, Alper; Kavakli, Ibrahim Halil			A CLOCK-binding small molecule disrupts the interaction between CLOCK and BMAL1 and enhances circadian rhythm amplitude	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug design; circadian clock; gene expression; protein expression; drug development; transcription; transcription coregulator; brain and muscle Arnt-like protein-1 (BMAL1); circadian locomotor output cycles kaput (CLOCK); circadian regulation; circadian rhythm amplitude; gene regulation	DRUG; PROTEINS; INHIBITORS; ACTIVATORS; PACEMAKER; MICE	Proper function of many physiological processes requires a robust circadian clock. Disruptions of the circadian clock can result in metabolic diseases, mood disorders, and accelerated aging. Therefore, identifying small molecules that specifically modulate regulatory core clock proteins may potentially enable better management of these disorders. In this study, we applied a structure-based molecular-docking approach to find small molecules that specifically bind to the core circadian regulator, the transcription factor circadian locomotor output cycles kaput (CLOCK). We identified 100 candidate molecules by virtual screening of ?2 million small molecules for those predicted to bind closely to the interface in CLOCK that interacts with its transcriptional co-regulator, Brain and muscle Arnt-like protein-1 (BMAL1). Using a mammalian two-hybrid system, real-time monitoring of circadian rhythm in U2OS cells, and various biochemical assays, we tested these compounds experimentally and found one, named CLK8, that specifically bound to and interfered with CLOCK activity. We show that CLK8 disrupts the interaction between CLOCK and BMAL1 and interferes with nuclear translocation of CLOCK both in vivo and in vitro. Results from further experiments indicated that CLK8 enhances the amplitude of the cellular circadian rhythm by stabilizing the negative arm of the transcription/translation feedback loop without affecting period length. Our results reveal CLK8 as a tool for further studies of CLOCK's role in circadian rhythm amplitude regulation and as a potential candidate for therapeutic development to manage disorders associated with dampened circadian rhythms.	[Doruk, Yagmur Umay; Baris, Ibrahim; Kavakli, Ibrahim Halil] Koc Univ, Dept Mol Biol & Genet, Rumelifeneri Yolu, Istanbul, Turkey; [Yarparvar, Darya; Gul, Seref; Kavakli, Ibrahim Halil] Koc Univ, Dept Chem & Biol Engn, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey; [Turkay, Metin] Koc Univ, Dept Ind Engn, Rumelifeneri Yolu, Istanbul, Turkey; [Akyel, Yasemin Kubra; Ozturk, Narin; Okyar, Alper] Istanbul Univ, Dept Pharmacol, Fac Pharm, TR-34116 Istanbul, Turkey; [Taskin, Ali Cihan] Koc Univ, Embryo Manipulat Lab, Anim Res Facil, Res Ctr Translat Med, Rumelifeneri yolu, Istanbul, Turkey; [Yilmaz, Fatma; Ozturk, Nuri] Gebze Tech Univ, Dept Mol Biol & Genet, Kocaeli, Turkey	Koc University; Koc University; Koc University; Istanbul University; Koc University; Gebze Technical University	Kavakli, IH (corresponding author), Koc Univ, Dept Chem & Biol Engn, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey.; Kavakli, IH (corresponding author), Koc Univ, Dept Mol Biol, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey.; Kavakli, IH (corresponding author), Koc Univ, Dept Genet, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey.	hkavakli@ku.edu.tr	GUL, SEREF/AAR-3289-2020; Ozturk, Nuri/F-4140-2011; Turkay, Metin/F-9769-2011	GUL, SEREF/0000-0002-5613-1339; Ozturk, Nuri/0000-0001-5206-4127; Turkay, Metin/0000-0003-4769-6714; Doruk Polcyn, Yagmur Umay/0000-0002-3388-7803; Taskin, Ali Cihan/0000-0003-3196-821X; Kavakli, Ibrahim/0000-0001-6624-3505	Scientific and Technological Research Council of Turkey (TUBITAK KBAG) [118Z140]	Scientific and Technological Research Council of Turkey (TUBITAK KBAG)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK KBAG) Grant 118Z140 (to I. H. K). The authors declare that they have no conflicts of interest with the contents of this article.	Antoch MP, 2009, MUTAT RES-GEN TOX EN, V680, P109, DOI 10.1016/j.mrgentox.2009.07.015; Armutlu P, 2009, LETT DRUG DES DISCOV, V6, P337, DOI 10.2174/1570180810906050337; Brown SA, 2011, GERONTOLOGY, V57, P427, DOI 10.1159/000320673; Cakir B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031787; Chen Z, 2013, CELL MOL LIFE SCI, V70, P2985, DOI 10.1007/s00018-012-1207-y; Chun SK, 2014, ACS CHEM BIOL, V9, P1213, DOI 10.1021/cb5002872; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gaddameedhi S, 2012, CELL CYCLE, V11, P3481, DOI 10.4161/cc.21771; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gloston GF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00100; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; Hirano A, 2016, NAT STRUCT MOL BIOL, V23, P1053, DOI 10.1038/nsmb.3326; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Hirota T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000559; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hu Y, 2011, ONCOTARGET, V2, P1279; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Kavakli IH, 2017, PHOTOCHEM PHOTOBIOL, V93, P93, DOI 10.1111/php.12669; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Korkmaz T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34433-4; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee Y, 2011, J BIOL CHEM, V286, P7033, DOI 10.1074/jbc.M110.207217; Li Y, 2016, BIOCHEM BIOPH RES CO, V472, P531, DOI 10.1016/j.bbrc.2016.03.010; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Manoogian ENC, 2017, AGEING RES REV, V39, P59, DOI 10.1016/j.arr.2016.12.006; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nishide S, 2008, EUR J NEUROSCI, V27, P2686, DOI 10.1111/j.1460-9568.2008.06231.x; Nohara K, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00035; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Schroeder AM, 2013, TRENDS PHARMACOL SCI, V34, P605, DOI 10.1016/j.tips.2013.09.002; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TUREK FW, 1995, NEUROSCI BIOBEHAV R, V19, P53, DOI 10.1016/0149-7634(94)00030-5; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Yagita K, 2009, ACTA HISTOCHEM CYTOC, V42, P89, DOI 10.1267/ahc.09015; Yoshitane H, 2012, EMBO REP, V13, P455, DOI 10.1038/embor.2012.37; Zee Phyllis C, 2013, Continuum (Minneap Minn), V19, P132, DOI 10.1212/01.CON.0000427209.21177.aa	46	23	24	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3518	3531		10.1074/jbc.RA119.011332	http://dx.doi.org/10.1074/jbc.RA119.011332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32019867	Green Published, hybrid			2022-12-26	WOS:000527725300013
J	Petrlova, J; Petruk, G; Huber, RG; McBurnie, EW; van der Plas, MJA; Bond, PJ; Puthia, M; Schmidtchen, A				Petrlova, Jitka; Petruk, Ganna; Huber, Roland G.; McBurnie, Eilish W.; van der Plas, Mariena J. A.; Bond, Peter J.; Puthia, Manoj; Schmidtchen, Artur			Thrombin-derived C-terminal fragments aggregate and scavenge bacteria and their proinflammatory products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); innate immunity; aggregation; thrombin; lipopolysaccharide (LPS); peptides; bacteria; endotoxin; Toll-like receptor (TLR); inflammation; host defense; thrombin-derived C-terminal peptide (TCP)	TOLL-LIKE RECEPTORS; ANTIMICROBIAL PEPTIDES; MICROBIOLOGY; PATHOGENESIS; PH	Thrombin-derived C-terminal peptides (TCPs), including a major 11-kDa fragment (TCP96), are produced through cleavage by human neutrophil elastase and aggregate lipopolysaccharide (LPS) and the Gram-negative bacterium Escherichia coli. However, the physiological roles of TCP96 in controlling bacterial infections and reducing LPS-induced inflammation are unclear. Here, using various biophysical methods, in silico molecular modeling, microbiological and cellular assays, and animal models, we examined the structural features and functional roles of recombinant TCP96 (rTCP96) in the aggregation of multiple bacteria and the Toll-like receptor (TLR) agonists they produce. We found that rTCP96 aggregates both Gram-negative and Gram-positive bacteria, including Staphylococcus aureus and Pseudomonas aeruginosa, and their cell-wall components LPS, lipid A, and lipoteichoic acid (LTA). The Gram-negative bacteria E. coli and P. aeruginosa were particularly sensitive to aggregation-induced bacterial permeabilization and killing. As a proof of concept, we show that rTCP96 reduces LPS-induced NF-?B activation in human monocytes, as well as in mouse models of LPS-induced subcutaneous inflammation. Moreover, in a mouse model of subcutaneous inoculation with P. aeruginosa, rTCP96 reduced bacterial levels. Together, these results link TCP-mediated aggregation of endotoxins and bacteria in vitro to attenuation of inflammation and bacterial levels in vivo.	[Petrlova, Jitka; Petruk, Ganna; van der Plas, Mariena J. A.; Puthia, Manoj; Schmidtchen, Artur] Lund Univ, Div Dermatol & Venereol, Dept Clin Sci, SE-22184 Lund, Sweden; [Huber, Roland G.; McBurnie, Eilish W.; Bond, Peter J.] Bioinformat Inst A STAR, SG-138671 Singapore, Singapore; [McBurnie, Eilish W.] Univ Southampton, Dept Chem, Southampton SO17 1BJ, Hants, England; [van der Plas, Mariena J. A.] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen, Denmark; [Bond, Peter J.] Natl Univ Singapore, Dept Biol Sci, SG-117558 Singapore, Singapore; [Schmidtchen, Artur] Univ Copenhagen, Bispebjerg Hosp, Dept Biomed Sci, Copenhagen Wound Healing Ctr, DK-2400 Copenhagen, Denmark	Lund University; University of Southampton; University of Copenhagen; National University of Singapore; University of Copenhagen; Bispebjerg Hospital	Petrlova, J (corresponding author), Lund Univ, Div Dermatol & Venereol, Dept Clin Sci, SE-22184 Lund, Sweden.	jitka.petrlova@med.lu.se	van der Plas, Mariena/GYV-3702-2022; Petruk, Ganna/AAH-8559-2020; Huber, Roland G/AAG-6353-2019; Petruk, Ganna/AAE-8378-2022	Huber, Roland G/0000-0001-5093-5988; Petrlova, Jitka/0000-0002-7554-3945; Puthia, Manoj/0000-0001-6048-7234; Schmidtchen, Artur/0000-0001-9209-3141; van der Plas, Mariena/0000-0002-3233-2881; Bond, Peter/0000-0003-2900-098X	Swedish Research Council [2012-1883, 2017-02341]; Welander-Finsen Foundation; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Swedish Government Funds for Clinical Research (ALF); Lund University; Crafoord 2018-2019 Foundation; Osterlund Foundation; Johanssons Foundation; Soderberg 2019 Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Welander-Finsen Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Government Funds for Clinical Research (ALF); Lund University; Crafoord 2018-2019 Foundation; Osterlund Foundation; Johanssons Foundation; Soderberg 2019 Foundation	This work was supported by Swedish Research Council Projects 2012-1883 ative bacteria and the products LPS, lipid A, and LTA. Finally, and 2017-02341, the Welander-Finsen, Crafoord 2018-2019, Osterlund, Johanssons, and Soderberg 2019 Foundations, the Swedish Foundation for Strategic Research 2018-2020, the Knut and Alice Wallenberg Foundation, The Swedish Government Funds for Clinical Research (ALF), and Lund University 2019-2020. A. S. is a founder of in2cure AB, a company developing therapies based on thrombin-derived host defense peptides. The peptide GKY25 and variants are patent-protected.	Berendsen H. J. C. P., 1981, INTERMOLECULAR FORCE, V14, P341; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Dancer SJ, 2015, J HOSP INFECT, V91, P292, DOI 10.1016/j.jhin.2015.08.017; GRINSTEIN S, 1991, CLIN BIOCHEM, V24, P241, DOI 10.1016/0009-9120(91)80014-T; Hansen FC, 2015, J IMMUNOL, V194, P5397, DOI 10.4049/jimmunol.1403009; Holdbrook DA, 2018, BBA-BIOMEMBRANES, V1860, P2374, DOI 10.1016/j.bbamem.2018.06.002; Huber RG, 2018, STRUCTURE, V26, P1151, DOI 10.1016/j.str.2018.04.007; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kalle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051313; Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10; Kumar KVSH, 2009, ENDOCR PRACT, V15, P6, DOI 10.4158/EP.15.1.6; Laupland KB, 2014, CLIN MICROBIOL REV, V27, P647, DOI 10.1128/CMR.00002-14; Levine BG, 2011, J COMPUT PHYS, V230, P3556, DOI 10.1016/j.jcp.2011.01.048; Llewelyn MJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3418; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; Nekoofar MH, 2009, INT ENDOD J, V42, P534, DOI 10.1111/j.1365-2591.2009.01550.x; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Petrlova J, 2017, P NATL ACAD SCI USA, V114, pE4213, DOI 10.1073/pnas.1619609114; Petrlova J, 2014, PROTEIN SCI, V23, P1559, DOI 10.1002/pro.2534; Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883; Puthia M, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax6601; Risselada HJ, 2008, J PHYS CHEM B, V112, P7438, DOI 10.1021/jp0758519; Saleh K, 2015, DERMATOL SURG, V41, P537, DOI 10.1097/DSS.0000000000000364; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spitzer P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32228; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Torrent M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003005; Tsujimoto H, 2008, SHOCK, V29, P315, DOI [10.1097/shk.0b013e318157ee55, 10.1097/SHK.0b013e318157ee55]; van der Plas MJA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11567; Wennberg CL, 2015, J CHEM THEORY COMPUT, V11, P5737, DOI 10.1021/acs.jctc.5b00726; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3417	3430		10.1074/jbc.RA120.012741	http://dx.doi.org/10.1074/jbc.RA120.012741			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32034093	hybrid, Green Published			2022-12-26	WOS:000527725300005
J	Arons, E; Zhou, H; Sokolsky, M; Gorelik, D; Potocka, K; Davies, S; Fykes, E; Still, K; Edelman, DC; Wang, YH; Meltzer, PS; Raffeld, M; Wiestner, A; Xi, LQ; Wang, HW; Stetler-Stevenson, M; Yuan, C; Kreitman, RJ				Arons, Evgeny; Zhou, Hong; Sokolsky, Mark; Gorelik, Daniel; Potocka, Katherine; Davies, Sarah; Fykes, Erin; Still, Katherine; Edelman, Daniel C.; Wang, Yonghong; Meltzer, Paul S.; Raffeld, Mark; Wiestner, Adrian; Xi, Liqiang; Wang, Hao-Wei; Stetler-Stevenson, Maryalice; Yuan, Constance; Kreitman, Robert J.			Expression of the muscle-associated gene MYF6 in hairy cell leukemia	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ANNEXIN A1; VARIANT; DIAGNOSIS; METHYLATION; CLADRIBINE; SIGNATURE; MUTATION; DISTINCT; CLUSTER	Hairy cell leukemia (HCL) is a purine analog-responsive B-cell malignancy containing the BRAF V600E mutation, expressing CD22, CD11c, CD103, tartrate resistant acid phosphatase (TRAP) CD25, CD123, and annexin 1A. BRAF V600E and the latter 4 markers are usually absent in the more aggressive and chemoresistant variant HCLv. To evaluate differences between HCL and HCLv, expression microarrays comparing HCL with HCLv were performed for 24694 genes using 47323 probes. Microarray data from 35 HCL and 27 HCLv purified samples showed the greatest HCL-HCLv difference in the muscle-associated gene MYF6, expressed by its 2 probes 18.5- and 10.8-fold higher in HCL than HCLv (p< 0.0001). By real-time quantitative PCR (RQ-PCR), 100% of 152 classic HCL samples were MYF6-positive, vs 5 (6%) of 90 blood donors. MYF6-expression was also detected in 18 (35%) of 51 with HCLv, 11 (92%) of 12 with HCL expressing unmutated IGHV4-34, 35 (73%) of 48 with chronic lymphocytic leukemia (CLL), and 1 (8%) of 12 with mantle cell lymphoma. Hypomethylation status of MYF6 supported expression in HCL more than HCLv. Post0treatment blood samples becoming negative by flow cytometry remained MYF6+ by RQ-PCR in 42 (48%) of 87 HCL patients, and MYF6 RQ-PCR could detect 1 HCL in 10(5) normal cells. MYF6, universally expressed in HCL and in most CLL samples, may be a useful biomarker for these leukemias. Further studies are underway to determine the role of MYF6 in HCL.	[Arons, Evgeny; Zhou, Hong; Sokolsky, Mark; Gorelik, Daniel; Potocka, Katherine; Davies, Sarah; Fykes, Erin; Still, Katherine; Kreitman, Robert J.] NCI, Mol Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA; [Edelman, Daniel C.; Wang, Yonghong; Meltzer, Paul S.] NCI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Raffeld, Mark; Xi, Liqiang; Wang, Hao-Wei; Stetler-Stevenson, Maryalice; Yuan, Constance] NCI, Pathol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Wiestner, Adrian] NHLBI, Lab Lymphoid Malignancies, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kreitman, RJ (corresponding author), NCI, Mol Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA.	kreitmar@mail.nih.gov	Stetler-Stevenson, Maryalice/AAV-7393-2020	Wang, Hao-Wei/0000-0002-5408-9253; Fykes, Erin/0000-0001-9161-6270; Gorelik, Daniel/0000-0001-7998-6949	National Cancer Institute	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute, Intramural program. All authors were working for and receiving salary from the National Institutes of Health (NIH).	ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Arons E, 2006, CLIN CANCER RES, V12, P2804, DOI 10.1158/1078-0432.CCR-05-2315; Arons E, 2009, BLOOD, V114, P4687, DOI 10.1182/blood-2009-01-201731; Basso K, 2004, J EXP MED, V199, P59, DOI 10.1084/jem.20031175; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; CAWLEY JC, 1980, LEUKEMIA RES, V4, P547, DOI 10.1016/0145-2126(80)90066-1; CLARK J, 1991, BRIT J CANCER, V64, P1039, DOI 10.1038/bjc.1991.461; Cupelli L, 1996, CYTOGENET CELL GENET, V72, P250, DOI 10.1159/000134201; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Durham BH, 2017, BLOOD, V130, P1644, DOI [10.1182/blood-2017-01765107, 10.1182/blood-2017-01-765107]; Falini B, 2004, LANCET, V363, P1869, DOI 10.1016/S0140-6736(04)16356-3; Goodman GR, 2003, BEST PRACT RES CL HA, V16, P101, DOI 10.1016/S1521-6926(02)00089-0; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hockley SL, 2011, LEUKEMIA, V25, P1189, DOI 10.1038/leu.2011.47; Hosoyama Tohru, 2010, Genes Cancer, V1, P388; Jain P, 2016, J CLIN ONCOL, V34, pE57, DOI 10.1200/JCO.2013.50.9661; Kreitman RJ, 2013, CLIN CANCER RES, V19, P6873, DOI 10.1158/1078-0432.CCR-13-1752; Mason EF, 2017, LEUKEMIA LYMPHOMA, V58, P233, DOI 10.1080/10428194.2016.1185786; Matutes E, 2006, HEMATOL ONCOL CLIN N, V20, P1051, DOI 10.1016/j.hoc.2006.06.012; Ott German, 2009, J Hematop, V2, P77, DOI 10.1007/s12308-009-0037-9; Perrot A, 2018, BLOOD, V132, P2456, DOI 10.1182/blood-2018-06-858613; Porpaczy E, 2009, EUR J CLIN INVEST, V39, P568, DOI 10.1111/j.1365-2362.2009.02146.x; Robak T, 2011, CANCER TREAT REV, V37, P3, DOI 10.1016/j.ctrv.2010.05.003; Sasaki M, 2009, ACTA HAEMATOL-BASEL, V121, P63, DOI 10.1159/000210064; Strati P, 2015, BLOOD, V126, P454, DOI 10.1182/blood-2015-02-585059; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tiacci E, 2012, BLOOD, V119, P192, DOI 10.1182/blood-2011-08-371179; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Waterfall JJ, 2014, NAT GENET, V46, P8, DOI 10.1038/ng.2828; Weston-Bell NJ, 2013, LEUKEMIA, V27, P241, DOI 10.1038/leu.2012.163; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xi LQ, 2012, BLOOD, V119, P3330, DOI 10.1182/blood-2011-09-379339; Zhao YX, 2013, ONCOL LETT, V5, P1211, DOI 10.3892/ol.2013.1161	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0227586	10.1371/journal.pone.0227586	http://dx.doi.org/10.1371/journal.pone.0227586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040482	Green Published, gold			2022-12-26	WOS:000534629400009
J	Kwon, J; Kim, B; Lee, C; Joung, H; Kim, BK; Choi, IS; Hyun, CK				Kwon, Jeonghyeon; Kim, Bobae; Lee, Chungho; Joung, Hyunchae; Kim, Byoung-Kook; Choi, In Suk; Hyun, Chang-Kee			Comprehensive amelioration of high-fat diet-induced metabolic dysfunctions through activation of the PGC-1 alpha pathway by probiotics treatment in mice	PLOS ONE			English	Article							GUT MICROBIOTA; ACID-METABOLISM; ADIPOSE-TISSUE; BILE-ACIDS; OBESITY; ADIPONECTIN; LIVER; MITOCHONDRIA; PROTECTS; BENEFITS	Although the beneficial effects of probiotics in the prevention or treatment of metabolic disorders have been extensively researched, the precise mechanisms by which probiotics improve metabolic homeostasis are still not clear. Given that probiotics usually exert a comprehensive effect on multiple metabolic disorders, defining a concurrent mechanism underlying the multiple effects is critical to understand the function of probiotics. In this study, we identified the SIRT1-dependent or independent PGC-1 alpha pathways in multiple organs that mediate the protective effects of a strain of Lactobacillus plantarum against high-fat diet-induced adiposity, glucose intolerance, and dyslipidemia. L. plantarum treatment significantly enhanced the expression of SIRT1, PPAR alpha, and PGC-1 alpha in the liver and adipose tissues under HFD-fed condition. L. plantarum treated mice also exhibited significantly increased expressions of genes involved in bile acid synthesis and reverse cholesterol transport in the liver, browning and thermogenesis of adipose tissue, and fatty acid oxidation in the liver and adipose tissue. Additionally, L. plantarum treatment significantly upregulated the expressions of adiponectin in adipose tissue, irisin in skeletal muscle and subcutaneous adipose tissue (SAT), and FGF21 in SAT. These beneficial changes were associated with a significantly improved HFD-induced alteration of gut microbiota. Our findings suggest that the PGC-1 alpha- mediated pathway could be regarded as a potential target in the development of probiotics-based therapies for the prevention and treatment of metabolic disorders.	[Kwon, Jeonghyeon; Kim, Bobae; Lee, Chungho; Hyun, Chang-Kee] Handong Global Univ, Sch Life Sci, Pohang, Gyungbuk, South Korea; [Joung, Hyunchae; Kim, Byoung-Kook; Choi, In Suk] Chong Kun Dang Bio Res Inst, Ansan, Gyeonggi, South Korea	Handong Global University	Hyun, CK (corresponding author), Handong Global Univ, Sch Life Sci, Pohang, Gyungbuk, South Korea.	ckhyun@handong.edu			Chong Kun Dang Bio Research Institute, Ansan, South Korea [HGU20190075]	Chong Kun Dang Bio Research Institute, Ansan, South Korea	This work was supported by Chong Kun Dang Bio Research Institute, Ansan, South Korea (HGU20190075). There was no additional external or internal funding received for this study.	Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; Afonso MS, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060760; Amplicon PCR, 2013, CLEAN UP PCR INDEX P; Arhire LL, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00524; Bagarolli RA, 2017, J NUTR BIOCHEM, V50, P16, DOI 10.1016/j.jnutbio.2017.08.006; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boutant M, 2015, MOL METAB, V4, P118, DOI 10.1016/j.molmet.2014.12.008; Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; Canfora EE, 2019, NAT REV ENDOCRINOL, V15, P261, DOI 10.1038/s41574-019-0156-z; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Clarke SF, 2012, GUT MICROBES, V3, P186, DOI 10.4161/gmic.20168; Cuevas-Ramos D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00037; Dalby MJ, 2017, CELL REP, V21, P1521, DOI 10.1016/j.celrep.2017.10.056; Danic M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01382; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Elibol B, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00614; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Fillmore N, 2010, J APPL PHYSIOL, V109, P511, DOI 10.1152/japplphysiol.00126.2010; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Flynn CR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8715; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; He MQ, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0183-1; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Just S, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0510-8; Kim B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210120; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lee SM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02236; Lim SD, 2011, KOREAN J FOOD SCI AN, V31, P513, DOI 10.5851/kosfa.2011.31.4.513; Liu HX, 2016, J HEPATOL, V64, P641, DOI 10.1016/j.jhep.2015.09.022; Liu SS, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.7015.01092, 10.3389/fmicb.2015.01092]; Marlatt KL, 2017, CURR OBES REP, V6, P389, DOI 10.1007/s13679-017-0283-6; Marques LR, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00526; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Paolella G, 2014, WORLD J GASTROENTERO, V20, P15518, DOI 10.3748/wjg.v20.i42.15518; Pierre JF, 2016, AM J PHYSIOL-GASTR L, V311, pG286, DOI 10.1152/ajpgi.00202.2016; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Reynes B, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01908; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Ruan H, 2016, J MOL CELL BIOL, V8, P101, DOI 10.1093/jmcb/mjw014; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Thushara RM, 2016, FOOD FUNCT, V7, P632, DOI [10.1039/c5fo01190f, 10.1039/C5FO01190F]; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Velazquez-Villegas LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02068-0; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178868; You M, 2009, EXP BIOL MED, V234, P850, DOI 10.3181/0902-MR-61; Zeng HW, 2016, J NUTR BIOCHEM, V35, P30, DOI 10.1016/j.jnutbio.2016.05.015; Zhang Y, 2016, AM J PHYSIOL-ENDOC M, V311, pE530, DOI 10.1152/ajpendo.00094.2016; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zhao XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030696	66	15	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228932	10.1371/journal.pone.0228932	http://dx.doi.org/10.1371/journal.pone.0228932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040532	gold, Green Published			2022-12-26	WOS:000534629400055
J	Singh, RK; Gorantla, R				Singh, Rajeev Kumar; Gorantla, Rohan			DMENet: Diabetic Macular Edema diagnosis using Hierarchical Ensemble of CNNs	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; RETINOPATHY; MIXTURES; EXPERTS; SYSTEM	Diabetic Macular Edema (DME) is an advanced stage of Diabetic Retinopathy (DR) and can lead to permanent vision loss. Currently, it affects 26.7 million people globally and on account of such a huge number of DME cases and the limited number of ophthalmologists, it is desirable to automate the diagnosis process. Computer-assisted, deep learning based diagnosis could help in early detection, following which precision medication can help to mitigate the vision loss. Method: In order to automate the screening of DME, we propose a novel DMENet Algorithm which is built on the pillars of Convolutional Neural Networks (CNNs). DMENet analyses the preprocessed color fundus images and passes it through a two-stage pipeline. The first stage detects the presence or absence of DME whereas the second stage takes only the positive cases and grades the images based on severity. In both the stages, we use a novel Hierarchical Ensemble of CNNs (HE-CNN). This paper uses two of the popular publicly available datasets IDRiD and MESSIDOR for classification. Preprocessing on the images is performed using morphological opening and gaussian kernel. The dataset is augmented to solve the class imbalance problem for better performance of the proposed model. Results: The proposed methodology achieved an average Accuracy of 96.12%, Sensitivity of 96.32%, Specificity of 95.84%, and F-1 score of 0.9609 on MESSIDOR and IDRiD datasets. Conclusion: These excellent results establish the validity of the proposed methodology for use in DME screening and solidifies the applicability of the HECNN classification technique in the domain of biomedical imaging.	[Singh, Rajeev Kumar; Gorantla, Rohan] Shiv Nadar Univ, Dept Comp Sci, Noida, UP, India	Shiv Nadar University	Singh, RK (corresponding author), Shiv Nadar Univ, Dept Comp Sci, Noida, UP, India.	rajeev.kumar@snu.edu.in	Gorantla, Rohan/AAR-9818-2020	Gorantla, Rohan/0000-0003-4344-0383; Singh, Rajeev Kumar/0000-0003-1369-5377				Abramoff MD, 2008, DIABETES CARE, V31, P193, DOI 10.2337/dc07-1312; Al-Bander B., 2016, DIABETIC MACULAR EDE; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2013, ARXIV PREPRINT ARXIV; Bi L, 2017, ARXIV PREPRINT ARXIV; Boureau Y-L., 2010, P 27 INT C MACH LEAR, P111, DOI DOI 10.5555/3104322.3104338; Bridle John S, 1990, NEUROCOMPUTING, P227, DOI DOI 10.1007/978-3-642-76153-9_28; Buyssens Pierre, 2013, Computer Vision - ACCV 2012. 11th Asian Conference on Computer Vision. Revised Selected Papers, P342, DOI 10.1007/978-3-642-37444-9_27; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dailey MN, 1999, NEURAL NETWORKS, V12, P1053, DOI 10.1016/S0893-6080(99)00050-7; DASARATHY BV, 1979, P IEEE, V67, P708, DOI 10.1109/PROC.1979.11321; Davidson JA, 2007, ENDOCRINE, V32, P107, DOI 10.1007/s12020-007-0040-9; de Brebisson Alexandre, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P20, DOI 10.1109/CVPRW.2015.7301312; De Souza N, 2012, INDIAN J OPHTHALMOL, V60, P401, DOI 10.4103/0301-4738.100534; Decenciere E, 2014, IMAGE ANAL STEREOL, V33, P231, DOI 10.5566/ias.1155; Deepak KS, 2012, IEEE T MED IMAGING, V31, P766, DOI 10.1109/TMI.2011.2178856; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Graham B, 2015, KAGGLE DIABETIC RETI; Gu JX, 2018, PATTERN RECOGN, V77, P354, DOI 10.1016/j.patcog.2017.10.013; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; He XD, 2019, LECT NOTES COMPUT SC, V11764, P788, DOI 10.1007/978-3-030-32239-7_87; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Hu J., 2018, CVPR, P7132, DOI [10.1109/CVPR.2018.00745, DOI 10.1109/CVPR.2018.00745]; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Jaafar HF, 2011, EUR SIGNAL PR CONF, P66; JORDAN MI, 1994, NEURAL COMPUT, V6, P181, DOI 10.1162/neco.1994.6.2.181; Keutzer K, 2016, ARXIV160207360; King H, 1999, B WORLD HEALTH ORGAN, V77, P954; Kingma DP., 2014, ADAM METHOD STOCHAST; Kori A, 2018, ARXIV180904228; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kumar A, 2017, IEEE J BIOMED HEALTH, V21, P31, DOI 10.1109/JBHI.2016.2635663; Kunwar A, 2015, 2015 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P2285, DOI 10.1109/ICACCI.2015.7275958; Li X, 2019, ARXIV191101376; Lim S. T., 2011, 2011 IEEE Colloquium on Humanities, Science and Engineering (CHUSER 2011), P265, DOI 10.1109/CHUSER.2011.6163730; Lo SCB, 1995, IEEE T MED IMAGING, V14, P711, DOI 10.1109/42.476112; Masoudnia S, 2014, ARTIF INTELL REV, V42, P275, DOI 10.1007/s10462-012-9338-y; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Najarian K., 2005, BIOMEDICAL SIGNAL IM; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Porwal P, 2018, DATA, V3, DOI 10.3390/data3030025; Rasti R, 2018, IEEE T MED IMAGING, V37, P1024, DOI 10.1109/TMI.2017.2780115; Rasti R, 2017, PATTERN RECOGN, V72, P381, DOI 10.1016/j.patcog.2017.08.004; Sasaki Y., 2007, TEACH TUTOR MATER; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Siddalingaswamy P. C., 2010, 2010 International Conference on Systems in Medicine and Biology (ICSMB), P331, DOI 10.1109/ICSMB.2010.5735398; Sivaprasad S, 2016, CLIN OPHTHALMOL, V10, P939, DOI 10.2147/OPTH.S100168; Song YY, 2015, IEEE T BIO-MED ENG, V62, P2421, DOI 10.1109/TBME.2015.2430895; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Tariq A, 2012, CAIRO INT BIOM ENG, P31, DOI 10.1109/CIBEC.2012.6473318; Thomas R, 2005, SURV OPHTHALMOL, V50, P85, DOI 10.1016/j.survophthal.2004.10.008; Wang T, 2012, INT C PATT RECOG, P3304; Wijnhoven R.G.J., 2010, 2010 20 INT C PATT R, P424, DOI DOI 10.1109/ICPR.2010.112; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Yosinski Jason, 2014, NIPS, DOI DOI 10.1109/IJCNN.2016.7727519; ZHANG W, 1994, MED PHYS, V21, P517, DOI 10.1118/1.597177; Zhang XW, 2014, MED IMAGE ANAL, V18, P1026, DOI 10.1016/j.media.2014.05.004; Zheng Yingfeng, 2012, Indian J Ophthalmol, V60, P428, DOI 10.4103/0301-4738.100542	62	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0220677	10.1371/journal.pone.0220677	http://dx.doi.org/10.1371/journal.pone.0220677			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040475	Green Submitted, gold, Green Published			2022-12-26	WOS:000534629400002
J	Drews, K; Calgi, MP; Harrison, WC; Drews, CM; Costa-Pinheiro, P; Shaw, JJP; Jobe, KA; Han, JD; Fox, TE; White, JM; Kester, M				Drews, Kelly; Calgi, Michael P.; Harrison, William Casey; Drews, Camille M.; Costa-Pinheiro, Pedro; Shaw, Jeremy Joseph Porter; Jobe, Kendra A.; Han, John D.; Fox, Todd E.; White, Judith M.; Kester, Mark			Glucosylceramide synthase maintains influenza virus entry and infection	PLOS ONE			English	Article							MEASLES-VIRUS; CELL; SPHINGOMYELINASE; CERAMIDE; PROTEIN; FUSION; RNA; CANCER; HEMAGGLUTININ; DETERMINANT	Influenza virus is an enveloped virus wrapped in a lipid bilayer derived from the host cell plasma membrane. Infection by influenza virus is dependent on these host cell lipids, which include sphingolipids. Here we examined the role of the sphingolipid, glucosylceramide, in influenza virus infection by knocking out the enzyme responsible for its synthesis, glucosylceramide synthase (UGCG). We observed diminished influenza virus infection in HEK 293 and A549 UGCG knockout cells and demonstrated that this is attributed to impaired viral entry. We also observed that entry mediated by the glycoproteins of other enveloped viruses that enter cells by endocytosis is also impaired in UGCG knockout cells, suggesting a broader role for UGCG in viral entry by endocytosis.	[Drews, Kelly; Drews, Camille M.; Costa-Pinheiro, Pedro; Shaw, Jeremy Joseph Porter; Kester, Mark] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Calgi, Michael P.; Harrison, William Casey; Kester, Mark] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22904 USA; [Jobe, Kendra A.] Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA; [Han, John D.] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Fox, Todd E.; Kester, Mark] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [White, Judith M.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA; [White, Judith M.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Harrison, William Casey] Eli Lilly, Indianapolis, IN USA; [Jobe, Kendra A.] Univ Pittsburgh, Pittsburgh, PA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; Eli Lilly; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kester, M (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.; Kester, M (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22904 USA.; Kester, M (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	mkester@virginia.edu	Kester, Mark/ABG-4615-2020		NIH [AI114776, T32 GM008715]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by grants from the NIH: AI114776 (JMW) http://grantome.com/grant/NIH/R01-AI114776-02 and T32 GM008715 (KD) grantome.com/grant/NIH/T32-GM008715-17 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068450; Bar S, 2006, J VIROL, V80, P2815, DOI 10.1128/JVI.80.6.2815-2822.2006; Batishchev OV, 2016, J VIROL, V90, P575, DOI 10.1128/JVI.01539-15; Braune EB, 2016, DISCOV MED, V21, P189; Cros JF, 2003, VIRUS RES, V95, P3, DOI 10.1016/S0168-1702(03)00159-X; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Drake MJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006316; Dreschers S, 2007, CELL PHYSIOL BIOCHEM, V20, P241, DOI 10.1159/000104170; Drews K, 2019, J VIROL, V93, DOI 10.1128/JVI.00017-19; Finnegan CM, 2007, J VIROL, V81, P5294, DOI 10.1128/JVI.02553-06; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; GOTOH B, 1992, FEBS LETT, V296, P274, DOI 10.1016/0014-5793(92)80303-X; GOTOH B, 1990, EMBO J, V9, P4189, DOI 10.1002/j.1460-2075.1990.tb07643.x; Grassme H, 2005, J BIOL CHEM, V280, P26256, DOI 10.1074/jbc.M500835200; Grazide S, 2004, J BIOL CHEM, V279, P18256, DOI 10.1074/jbc.M314105200; Hankins JL, 2011, J BIOL CHEM, V286, P44357, DOI 10.1074/jbc.M111.264010; Hufford MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047659; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; Jan JT, 2000, J VIROL, V74, P6425, DOI 10.1128/JVI.74.14.6425-6432.2000; Kanj SS, 2006, VIROLOGY, V345, P280, DOI 10.1016/j.virol.2005.09.060; Konan KV, 2014, CURR OPIN VIROL, V9, P45, DOI 10.1016/j.coviro.2014.09.005; Li S, 2014, BIOPHYS J, V106, P1447, DOI 10.1016/j.bpj.2014.02.018; Libersou S, 2010, J CELL BIOL, V191, P199, DOI 10.1083/jcb.201006116; Marvin SA, 2017, J VIROL, V91, DOI 10.1128/JVI.01417-16; Miller ME, 2012, J VIROL, V86, P7473, DOI 10.1128/JVI.00136-12; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Puri A, 2004, AIDS, V18, P849, DOI 10.1097/00002030-200404090-00002; Rasbach A, 2013, J VIROL, V87, P6246, DOI 10.1128/JVI.03298-12; Rawat SS, 2004, J VIROL, V78, P7360, DOI 10.1128/JVI.78.14.7360-7368.2004; Ryland LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084648; Seo Y-J, 2013, PLOS ONE, P8, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Seo YJ, 2010, J VIROL, V84, P8124, DOI 10.1128/JVI.00510-10; Shaw J, 2018, ADV CANCER RES, V140, P327, DOI 10.1016/bs.acr.2018.04.016; Shivanna V, 2015, VIROLOGY, V483, P218, DOI 10.1016/j.virol.2015.04.022; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sillence DJ, 2002, J LIPID RES, V43, P1837, DOI 10.1194/jlr.M200232-JLR200; Soudani N, 2019, J VIROL, V93, DOI 10.1128/JVI.00053-19; Sun XJ, 2010, J VIROL, V84, P8683, DOI 10.1128/JVI.00797-10; Tafesse FG, 2013, P NATL ACAD SCI USA, V110, P6406, DOI 10.1073/pnas.1219909110; Tani H, 2010, J VIROL, V84, P2798, DOI 10.1128/JVI.02499-09; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Tatsuo H, 2000, J VIROL, V74, P4139, DOI 10.1128/JVI.74.9.4139-4145.2000; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tscherne DM, 2010, J VIROL METHODS, V163, P336, DOI 10.1016/j.jviromet.2009.10.020; Turakova K, 2014, ACTA CHIM SLOVACA, V7, P99, DOI 10.2478/acs-2014-0017; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; Wegner MS, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4084-4; Weng LY, 2010, J VIROL, V84, P11761, DOI 10.1128/JVI.00638-10; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Whitt MA, 2010, J VIROL METHODS, V169, P365, DOI 10.1016/j.jviromet.2010.08.006; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537	52	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228735	10.1371/journal.pone.0228735	http://dx.doi.org/10.1371/journal.pone.0228735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032363	Green Published, gold			2022-12-26	WOS:000534626100022
J	Jauregui, A; Salvo, D; Medina, C; Barquera, S; Hammond, D				Jauregui, Alejandra; Salvo, Deborah; Medina, Catalina; Barquera, Simon; Hammond, David			Understanding the contribution of public- and restricted-access places to overall and domain-specific physical activity among Mexican adults: A cross-sectional study	PLOS ONE			English	Article								Latin Americans engage in physical activity (PA) in unique ways and use a wider range of places for PA than those commonly studied in high-income settings. We examined the contribution of a variety of places and domains of PA to meeting PA recommendations among a sample of adults (18-65 y) from all over Mexico. This was a cross-sectional study conducted in 2017 (n = 3 686). Overall and domain-specific PA was measured using the Global Physical Activity Questionnaire. Use of places for PA was self-reported. Places were classified as private or public. In 2018, associations between specific places and meeting PA recommendations (>= 150 mins/week) were estimated using multivariate logistic regression models. In total 72.1% met PA recommendations. The proportion meeting recommendations through domain-specific PA was highest for leisure-time PA (50.0%), followed by travel-related (39.1%) and work-related (24.9%) PA. The most commonly reported places for PA were home (43%), parks (40.7%) and streets (39.4%) (public). Use of most public places was positively associated with meeting PA recommendations, mainly through travel-related PA (Streets OR 2.05 [95% CI 1.71-2.45]; Cycling paths OR 1.91 [1.37-2.68]). Using private places was more strongly associated with PA, mainly leisure-time PA (Gyms OR 9.66 [7.34-12.70]); Sports facilities OR 5.03 [3.27-7.74]). In conclusion, public and private places were important contributors to PA. While public places may be a powerful setting for PA promotion, increasing the equitable access for all to private places may also represent an effective strategy to increase PA among Mexican adults.	[Jauregui, Alejandra; Salvo, Deborah; Medina, Catalina; Barquera, Simon] Natl Inst Publ Hlth, Ctr Nutr & Hlth Res, Cuernavaca, Morelos, Mexico; [Salvo, Deborah] Washington Univ, Brown Sch, Prevent Res Ctr, St Louis, MO 63110 USA; [Salvo, Deborah] Washington Univ, Brown Sch, Ctr Diabet Translat Res, St Louis, MO 63110 USA; [Hammond, David] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada	Instituto Nacional de Salud Publica; Washington University (WUSTL); Washington University (WUSTL); University of Waterloo	Jauregui, A (corresponding author), Natl Inst Publ Hlth, Ctr Nutr & Hlth Res, Cuernavaca, Morelos, Mexico.	alejandra.jauregui@insp.mx	Medina, Catalina/AAT-6316-2020	Jauregui, Alejandra/0000-0001-9158-2007; Salvo, Deborah/0000-0002-9726-0882	Canadian Institutes of Health Research (CIHR); International Health Grant; Public Health Agency of Canada (PHAC); CIHR - PHAC Applied Public Health Chair	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International Health Grant; Public Health Agency of Canada (PHAC); CIHR - PHAC Applied Public Health Chair(Canadian Institutes of Health Research (CIHR))	Funding for this project was provided by a Canadian Institutes of Health Research (CIHR) Project Grant, with additional support from an International Health Grant, the Public Health Agency of Canada (PHAC), and a CIHR -PHAC Applied Public Health Chair (Hammond).	Adopcion de las TIC y usos de internet en Mexico, 2018, IMP CAR SOC US; [Anonymous], 2000, WORLD HEAL ORGAN TEC; [Anonymous], 2012, SURV POP DEP PREV NO, DOI [10.1016/S0140-6736(12)60736-3, DOI 10.1016/S0140-6736(12)60736-3]; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Farren L, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150027; Guthold R, 2018, LANCET GLOB HEALTH, V6, pE1077, DOI [10.1016/s2214-109x(18)30357-7, 10.1016/S2214-109X(18)30357-7]; Hammond D., 2018, INT FOOD POLICY STUD; Hoos T, 2012, J PHYS ACT HEALTH, V9, P698, DOI 10.1123/jpah.9.5.698; INEGI, 2010, CENS POBL VIV 2010; Instituto Nacional de Salud Publica, 2016, ENC NAC SAL NUTR MED, DOI [10.21149/8593, DOI 10.21149/8593]; Jauregui A, 2017, PREV MED, V103, pS21, DOI 10.1016/j.ypmed.2016.11.014; Leppe J., 2012, J SCI MED SPORT, V15, pS297, DOI [DOI 10.1016/J.JSAMS.2012.11, 10.1016/j.jsams.2012.11.723, DOI 10.1016/J.JSAMS.2012.11.723]; Litwin H, 2009, GERONTOLOGIST, V49, P397, DOI 10.1093/geront/gnp036; Loprinzi PD, 2015, AM J HEALTH PROMOT, V29, P277, DOI 10.4278/ajhp.130709-QUAN-354; Medina C, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16101685; Medina C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1063; Moreira Alexandra Dias, 2017, Rev. bras. epidemiol., V20, P136, DOI 10.1590/1980-5497201700010012; Perez Lopez R, 2017, REV TRANSPORTE Y TER, V16, P220, DOI DOI 10.34096/RTT.I16.3611; Pratt M, 2016, ENVIRON BEHAV, V48, P37, DOI 10.1177/0013916515609668; Reis RS, 2016, LANCET, V388, P1337, DOI 10.1016/S0140-6736(16)30728-0; Salvo D, 2020, J PEDIAT-BRAZIL, V96, P4, DOI 10.1016/j.jped.2018.12.006; Salvo D, 2017, PREV MED, V103, pS27, DOI 10.1016/j.ypmed.2016.09.007; Salvo D, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0243-z; Salvo D, 2014, PREV MED, V69, pS86, DOI 10.1016/j.ypmed.2014.10.014; Sarmiento OL, 2017, PREV MED, V103, pS34, DOI 10.1016/j.ypmed.2016.07.028; World Health Organization, 2018, GLOBAL ACTION PLAN P, DOI DOI 10.1016/J.JPOLMOD.2006.06.007	26	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228491	10.1371/journal.pone.0228491	http://dx.doi.org/10.1371/journal.pone.0228491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9HH	32032390	Green Published, gold			2022-12-26	WOS:000534626100017
J	Zhang, H; Guo, SD; Qian, YB; Liu, Y; Lu, CP				Zhang, Hua; Guo, Sidai; Qian, Yubing; Liu, Yan; Lu, Chengpeng			Dynamic analysis of agricultural carbon emissions efficiency in Chinese provinces along the Belt and Road	PLOS ONE			English	Article							DATA ENVELOPMENT ANALYSIS; GREENHOUSE-GAS EMISSIONS; ECONOMIC-GROWTH; CLIMATE-CHANGE; RENEWABLE ENERGY; CO2 EMISSIONS; SOIL; FOOTPRINT; MITIGATION; REDUCTION	To better understand the agricultural resources and environmental problems of the provinces along The Belt and Road in China, it is critical to investigate their agricultural carbon emission efficiency and evolutionary trends. Based on the panel data of 18 key provinces and cities between 2006 and 2015, this paper evaluated the agricultural carbon emission efficiency with the data envelopment analysis-Malmquist model and further explored their dynamic evolutionary trends. There were several main findings. First, the efficiency levels of agricultural carbon emissions showed significant regional differentiation among the areas, with that along the 21st-Century Maritime Silk Road being much higher than that along the Silk Road Economic Belt. Second, technical efficiency was the key factor that restricted the improvement of the comprehensive efficiency of agricultural carbon. Third, most provinces invested in too many redundant and unreasonably allocated resources, showing a trend of diminishing returns to scale. Last, According to dynamic evolution analysis, the total productivity still demonstrated a diminishing trend. This paper provides some suggestions for effectively improve the efficiency of agricultural carbon emissions in China, such as optimize the agricultural industrial structure, increasing the investment of carbon emission reduction technology, and implementing a carbon emission quota clearing system. This paper contributes to the improvement of the environment in China.	[Zhang, Hua; Guo, Sidai; Qian, Yubing; Liu, Yan] Southwest Univ Sci & Technol, Sichuan Circular Econ Res Ctr, Mianyang, Sichuan, Peoples R China; [Liu, Yan] Univ Elect Sci & Technol China, Sch Publ Adm, Chengdu, Peoples R China; [Lu, Chengpeng] Lanzhou Univ, Inst Cty Econ Dev & Rural Revitalizat Strategy, Lanzhou, Peoples R China; [Lu, Chengpeng] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang, Peoples R China; [Lu, Chengpeng] Key Lab Environm Computat & Sustainabil Liaoning, Shenyang, Peoples R China	Southwest University of Science & Technology - China; University of Electronic Science & Technology of China; Lanzhou University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Lu, CP (corresponding author), Lanzhou Univ, Inst Cty Econ Dev & Rural Revitalizat Strategy, Lanzhou, Peoples R China.; Lu, CP (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang, Peoples R China.; Lu, CP (corresponding author), Key Lab Environm Computat & Sustainabil Liaoning, Shenyang, Peoples R China.	lcp@lzu.edu.cn	Sidai, Guo/GLV-2648-2022; Lu, Chengpeng/GWC-4535-2022	Lu, Chengpeng/0000-0002-2035-2295	National Natural Science Foundation of China [41701142, 71774026, 41471116]; Soft Science Project of Science and Technology Department of Sichuan [18RX0986]; Research Center of Sichuan Rural Development [CR1813]; Project for Serving Gansu Province's Economic and Social Development of Lanzhou University [2019-FWZX-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Soft Science Project of Science and Technology Department of Sichuan; Research Center of Sichuan Rural Development; Project for Serving Gansu Province's Economic and Social Development of Lanzhou University	This study is sponsored by the National Natural Science Foundation of China (No. 41701142, 71774026, and 41471116), Soft Science Project of Science and Technology Department of Sichuan (No. 18RX0986), Research Center of Sichuan Rural Development (No. CR1813) and Project for Serving Gansu Province's Economic and Social Development of Lanzhou University (No. 2019-FWZX-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian D, 2015, J OPTIM, V2015, DOI 10.1155/2015/594727; Ali S.S., 2019, ASSESSING SUSTAINABI; [Anonymous], 2007, CHINESE RURAL STAT Y; Arevalo CBM, 2011, AGR ECOSYST ENVIRON, V141, P342, DOI 10.1016/j.agee.2011.03.013; Asumadu-Sarkodie S, 2016, ENVIRON SCI POLLUT R, V23, P10968, DOI 10.1007/s11356-016-6252-x; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; Ben Jebli M, 2017, ECOL INDIC, V74, P295, DOI 10.1016/j.ecolind.2016.11.032; Ben Jebli M, 2017, INT J SUST DEV WORLD, V24, P149, DOI 10.1080/13504509.2016.1196467; CAVES DW, 1982, ECON J, V92, P73, DOI 10.2307/2232257; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; CHENG K, 2014, J AGR SCI, V153, P422; Cheng K, 2011, AGR ECOSYST ENVIRON, V142, P231, DOI 10.1016/j.agee.2011.05.012; Dogan E, 2016, ENERG POLICY, V95, P370, DOI 10.1016/j.enpol.2016.05.018; FARE R, 1994, AM ECON REV, V84, P66; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fei RL, 2017, ECOL INDIC, V73, P653, DOI 10.1016/j.ecolind.2016.10.021; Fisher I., 1922, MAKING INDEX NUMBERS, P526; Flachowsky Gerhard, 2012, Animals (Basel), V2, P108, DOI 10.3390/ani2020108; Guo XD, 2011, ENERG POLICY, V39, P2352, DOI 10.1016/j.enpol.2011.01.055; Guzman I, 2008, APPL ECON, V40, P2033, DOI 10.1080/00036840600949413; Hillier J, 2012, GLOBAL CHANGE BIOL, V18, P1880, DOI 10.1111/j.1365-2486.2012.02671.x; International Panel on Climate Change (IPCC), 2007, CLIM CHANG 2007 4 AS; Ke SF, 2015, INT FOREST REV, V17, P469, DOI 10.1505/146554815817476413; Khoshnevisan B, 2013, ENERGY, V58, P588, DOI 10.1016/j.energy.2013.06.030; Kindler R, 2011, GLOBAL CHANGE BIOL, V17, P1167, DOI 10.1111/j.1365-2486.2010.02282.x; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Li JY, 2018, LAND DEGRAD DEV, V29, P4061, DOI 10.1002/ldr.3175; Liu X, 2017, J CLEAN PROD, V164, P1239, DOI 10.1016/j.jclepro.2017.07.086; Lu CP, 2017, P I CIVIL ENG-ENG SU, V170, P133, DOI 10.1680/jensu.16.00002; Lu CP, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8101058; Luo YS, 2017, J CLEAN PROD, V159, P220, DOI 10.1016/j.jclepro.2017.05.076; Nayak D, 2015, AGR ECOSYST ENVIRON, V209, P108, DOI 10.1016/j.agee.2015.04.035; Oke AE, 2017, ENRGY PROCED, V142, P2371, DOI 10.1016/j.egypro.2017.12.169; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Perez K, 2017, ENERG ECON, V66, P290, DOI 10.1016/j.eneco.2017.05.022; Rafiq S, 2016, AUST J AGR RESOUR EC, V60, P348, DOI 10.1111/1467-8489.12131; Ramirez-Villegas J, 2012, CLIMATIC CHANGE, V115, P611, DOI 10.1007/s10584-012-0500-y; Rebolledo-Leiva R, 2017, SCI TOTAL ENVIRON, V593, P36, DOI 10.1016/j.scitotenv.2017.03.147; Rotz CA, 2010, J DAIRY SCI, V93, P1266, DOI 10.3168/jds.2009-2162; Sebri M, 2012, ENERG POLICY, V48, P711, DOI 10.1016/j.enpol.2012.06.006; Seiford LM, 2002, EUR J OPER RES, V142, P16, DOI 10.1016/S0377-2217(01)00293-4; Shao S, 2016, RENEW SUST ENERG REV, V55, P516, DOI 10.1016/j.rser.2015.10.081; Tian Y, 2014, J INTEGR AGR, V13, P1393, DOI 10.1016/S2095-3119(13)60624-3; Tian Yun, 2011, Research of Agricultural Modernization, V32, P752; Verge Xavier P C, 2012, Animals (Basel), V2, P437, DOI 10.3390/ani2030437; Wang W, 2018, RESOUR CONSERV RECY, V128, P489, DOI 10.1016/j.resconrec.2016.09.005; Wang W, 2014, GLOBAL ENVIRON CHANG, V26, P53, DOI 10.1016/j.gloenvcha.2014.03.008; Wang X., 2003, ECOLOGICAL ENV, V12, P379; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; Wu Fen-lin, 2007, Shengtaixue Zazhi, V26, P2035; Xiong CH, 2016, POL J ENVIRON STUD, V25, P2187, DOI 10.15244/pjoes/63038; Xue B, 2015, SCIENCE, V348, P872, DOI 10.1126/science.348.6237.872-a; Yan D, 2017, J CLEAN PROD, V156, P518, DOI 10.1016/j.jclepro.2017.04.063; Yue Q, 2017, J CLEAN PROD, V149, P1011, DOI 10.1016/j.jclepro.2017.02.172; Zhang J., 2015, J CLEAN PROD, V163, P202, DOI DOI 10.1016/j.jclepro.2015.06.111; Zhang ZY., 2016, ADV EC BUS, V4, P117, DOI 10.13189/aeb.2016.040301; Zhu S, 2017, J CLEAN PROD, V148, P665, DOI 10.1016/j.jclepro.2017.01.159	57	13	15	14	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228223	10.1371/journal.pone.0228223	http://dx.doi.org/10.1371/journal.pone.0228223			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9HH	32032386	gold, Green Published			2022-12-26	WOS:000534626100010
J	Ngu, L; Winters, JN; Nguyen, K; Ramos, KE; DeLateur, NA; Makowski, L; Whitford, PC; Ondrechen, MJ; Beuning, PJ				Ngu, Lisa; Winters, Jenifer N.; Nguyen, Kien; Ramos, Kevin E.; DeLateur, Nicholas A.; Makowski, Lee; Whitford, Paul C.; Ondrechen, Mary Jo; Beuning, Penny J.			Probing remote residues important for catalysis in Escherichia coli ornithine transcarbamoylase	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; CRYSTAL-STRUCTURE; COLORIMETRIC DETERMINATION; SUBSTRATE-BINDING; SINGLE-CRYSTALS; ACTIVE-SITES; ARGF-GENE; DYNAMICS; MUTATIONS; DEFICIENCY	Understanding how enzymes achieve their tremendous catalytic power is a major question in biochemistry. Greater understanding is also needed for enzyme engineering applications. In many cases, enzyme efficiency and specificity depend on residues not in direct contact with the substrate, termed remote residues. This work focuses on Escherichia coli ornithine transcarbamoylase (OTC), which plays a central role in amino acid metabolism. OTC has been reported to undergo an induced-fit conformational change upon binding its first substrate, carbamoyl phosphate (CP), and several residues important for activity have been identified. Using computational methods based on the computed chemical properties from theoretical titration curves, sequence-based scores derived from evolutionary history, and protein surface topology, residues important for catalytic activity were predicted. The roles of these residues in OTC activity were tested by constructing mutations at predicted positions, followed by steady-state kinetics assays and substrate binding studies with the variants. First-layer mutations R57A and D231A, second-layer mutation H272L, and thirdlayer mutation E299Q, result in 57- to 450-fold reductions in k(cat)/K-M with respect to CP and 44- to 580-fold reductions with respect to ornithine. Second-layer mutations D140N and Y160S also reduce activity with respect to ornithine. Most variants had decreased stability relative to wild-type OTC, with variants H272L, H272N, and E299Q having the greatest decreases. Variants H272L, E299Q, and R57A also show compromised CP binding. In addition to direct effects on catalytic activity, effects on overall protein stability and substrate binding were observed that reveal the intricacies of how these residues contribute to catalysis.	[Ngu, Lisa; Winters, Jenifer N.; Ramos, Kevin E.; DeLateur, Nicholas A.; Makowski, Lee; Ondrechen, Mary Jo; Beuning, Penny J.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Nguyen, Kien; Whitford, Paul C.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Makowski, Lee] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA; [Ramos, Kevin E.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [DeLateur, Nicholas A.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Northeastern University; Northeastern University; Northeastern University; Yeshiva University; Albert Einstein College of Medicine; Massachusetts Institute of Technology (MIT)	Ondrechen, MJ; Beuning, PJ (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA.	mjo@neu.edu; pbeuning@neu.edu		Ondrechen, Mary Jo/0000-0003-2456-4313	National Science Foundation [MCB-1158176, MCB-1517290, CHE-1905214, MCB-1350312]; LSAMP Program at Northeastern; McNair Scholars Program at Suffolk University; REU program at Northeastern - NSF [CHE-1262734]; NSF [DMR1829070]; NIGMS [1-P30-GM12416601A1]; NYSTAR	National Science Foundation(National Science Foundation (NSF)); LSAMP Program at Northeastern; McNair Scholars Program at Suffolk University; REU program at Northeastern - NSF; NSF(National Science Foundation (NSF)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NYSTAR	This research was supported by the National Science Foundation (MCB-1158176 and MCB-1517290 to M.J.O. and P.J.B., CHE-1905214 to M.J.O. and P.J.B., and MCB-1350312 to P.C. W.). K.E.R. was supported by the LSAMP Program at Northeastern, the McNair Scholars Program at Suffolk University, and the REU program at Northeastern funded by NSF CHE-1262734. CHEXS is supported by the NSF award DMR1829070, and the MacCHESS resource is supported by NIGMS award 1-P30-GM12416601A1 and NYSTAR.	Ah Mew N., 1993, GENEREVIEWS R; Arranz JA, 2007, J INHERIT METAB DIS, V30, P217, DOI 10.1007/s10545-007-0429-x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOYDE TRC, 1980, ANAL BIOCHEM, V107, P424, DOI 10.1016/0003-2697(80)90404-2; Brassier A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0266-1; Brodkin HR, 2015, PROTEIN SCI, V24, P762, DOI 10.1002/pro.2648; Brodkin HR, 2011, BIOCHEMISTRY-US, V50, P4923, DOI 10.1021/bi101761e; Caldovic L, 2015, J GENET GENOMICS, V42, P181, DOI 10.1016/j.jgg.2015.04.003; Calvas P, 1998, HUM MUTAT, pS81; Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585; CERIOTTI G, 1965, CLIN CHIM ACTA, V11, P519, DOI 10.1016/0009-8981(65)90007-0; COULOMBE JJ, 1963, CLIN CHEM, V9, P102; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fearon WR, 1939, BIOCHEM J, V33, P902, DOI 10.1042/bj0330902; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Genet S, 2000, J INHERIT METAB DIS, V23, P669, DOI 10.1023/A:1005614409241; GilbertDussardier B, 1996, HUM MUTAT, V8, P74, DOI 10.1002/(SICI)1098-1004(1996)8:1<74::AID-HUMU11>3.0.CO;2-O; GOLDSMITH JO, 1991, J BIOL CHEM, V266, P18626; GOLDSMITH JO, 1993, J BIOL CHEM, V268, P18481; GOLDSMITH JO, 1993, J BIOL CHEM, V268, P18485; GROMPE M, 1991, AM J HUM GENET, V48, P212; Gunner MR, 2011, PROTEINS, V79, P3306, DOI 10.1002/prot.23124; Ha Y, 1997, P NATL ACAD SCI USA, V94, P9550, DOI 10.1073/pnas.94.18.9550; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson J, 2015, INT J MOL SCI, V16, P6868, DOI 10.3390/ijms16046868; Jin L, 1997, NAT STRUCT BIOL, V4, P622, DOI 10.1038/nsb0897-622; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; KUO LC, 1989, J BIOL CHEM, V264, P16246; KUO LC, 1990, J MOL BIOL, V211, P271, DOI 10.1016/0022-2836(90)90026-I; KUO LC, 1988, BIOCHEMISTRY-US, V27, P8823, DOI 10.1021/bi00424a021; KUO LC, 1989, SCIENCE, V245, P522, DOI 10.1126/science.2667139; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Langley DB, 2000, J BIOL CHEM, V275, P20012, DOI 10.1074/jbc.M000585200; LEGRAIN C, 1976, EUR J BIOCHEM, V63, P289, DOI 10.1111/j.1432-1033.1976.tb10230.x; Leibundgut EO, 1996, HUM MUTAT, V8, P333, DOI 10.1002/(SICI)1098-1004(1996)8:4<333::AID-HUMU6>3.3.CO;2-N; Lichter-Konecki U, 1993, GENEREVIEWS R; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; MILLER AW, 1990, J BIOL CHEM, V265, P15023; Murata LB, 1996, PROTEIN SCI, V5, P709; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Noel JK, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004794; Noel JK, 2012, J PHYS CHEM B, V116, P8692, DOI 10.1021/jp300852d; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Parasuram R, 2018, BIOCHEMISTRY-US, V57, P1063, DOI 10.1021/acs.biochem.7b01004; Parasuram R, 2010, J BIOINFORM COMPUT B, V8, P1, DOI 10.1142/S0219720010005166; PARRINELLO M, 1982, J CHEM PHYS, V76, P2662, DOI 10.1063/1.443248; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIETTE J, 1982, EMBO J, V1, P853, DOI 10.1002/j.1460-2075.1982.tb01259.x; RAHMATULLAH M, 1980, CLIN CHIM ACTA, V107, P3, DOI 10.1016/0009-8981(80)90407-6; Ringe D, 2004, CELL MOL LIFE SCI, V61, P387, DOI 10.1007/s00018-003-3291-5; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Sankararaman S, 2009, NUCLEIC ACIDS RES, V37, pW390, DOI 10.1093/nar/gkp339; Shehadi IA, 2002, MOL BIOL REP, V29, P329, DOI 10.1023/A:1021220208562; SHEN WH, 1993, BIOCHEMISTRY-US, V32, P13925, DOI 10.1021/bi00213a023; Shi DS, 1998, J BIOL CHEM, V273, P34247, DOI 10.1074/jbc.273.51.34247; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Somarowthu S, 2012, BIOINFORMATICS, V28, P2078, DOI 10.1093/bioinformatics/bts321; Somarowthu S, 2011, BIOCHEMISTRY-US, V50, P9283, DOI 10.1021/bi201089v; Somarowthu S, 2011, BIOPOLYMERS, V95, P390, DOI 10.1002/bip.21589; Song YF, 2011, PROTEINS, V79, P3356, DOI 10.1002/prot.23146; Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tong WX, 2008, PROTEIN SCI, V17, P333, DOI 10.1110/ps.073213608; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Tuchman M, 1996, HUM GENET, V97, P274, DOI 10.1007/BF02185751; Tuchman M, 1997, J INHERIT METAB DIS, V20, P525, DOI 10.1023/A:1005301513465; Tuchman M, 2002, HUM MUTAT, V19, P93, DOI 10.1002/humu.10035; VANVLIET F, 1984, NUCLEIC ACIDS RES, V12, P6277, DOI 10.1093/nar/12.15.6277; VILLERET V, 1995, P NATL ACAD SCI USA, V92, P10762, DOI 10.1073/pnas.92.23.10762; Walsh JM, 2012, ENVIRON MOL MUTAGEN, V53, P766, DOI 10.1002/em.21730; Wei Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-119; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; WILLEJORGENSEN P, 1983, ARCH SURG-CHICAGO, V118, P926; Wraith JE, 2001, ARCH DIS CHILD, V84, P84, DOI 10.1136/adc.84.1.84; Yamaguchi S, 2006, HUM MUTAT, V27, P626, DOI 10.1002/humu.20339	91	3	3	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228487	10.1371/journal.pone.0228487	http://dx.doi.org/10.1371/journal.pone.0228487			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027716	gold, Green Published			2022-12-26	WOS:000534623800042
J	Amendola, A; Sberna, G; Forbici, F; Abbate, I; Lorenzini, P; Pinnetti, C; Antinori, A; Capobianchi, LMR				Amendola, Alessandra; Sberna, Giuseppe; Forbici, Federica; Abbate, Isabella; Lorenzini, Patrizia; Pinnetti, Carmela; Antinori, Andrea; Capobianchi, Maria Rosaria L.			The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?	PLOS ONE			English	Article							QUANT DX ASSAY; REALTIME HIV-1; ANTIRETROVIRAL THERAPY; RNA; QUANTIFICATION; PROVIRUSES; QUANTITATION; PLASMA; V2.0	New methods of HIV-1 RNA quantification based on dual-target detection are increasingly used in HIV viral load monitoring, but clinical implications and impact of dual-target detection on HIV-1 infection management are not established. Aptima HIV-1 Quant Dx assay is a last generation HIV viral load method, that uses pol and LTR as simultaneous target, providing quantitative results based mainly on pol target, while LTR target is used to report the results when pol signal is absent. In our laboratory, about 6% of results of all HIV-1 viral load tests performed with this platform in one year period resulted from LTR signal. Interestingly, LTR-based viremia (sometimes exceeding 1,000 copies/mL) was observed in a small proportion (up to 1%) of patients under ART, considered for long time virologically suppressed on the basis of a single target (pol-based) assay. Male gender, >700 vs <200 CD4 cell/mL and dual therapy including NRTI plus either NNRTI, or PI/b or INSTI were independently associated with increased risk of LTR-based HIV-1 viral load detection by multivariable logistic regression. A significant linear correlation was observed between LTR-based HIV-1 RNA levels and PBMC-associated proviral DNA. Moreover, in a small group of patients with HIV-1 RNA levels >200 copies/mL, longitudinal assessments showed parallel kinetics between plasma viremia and proviral DNA. Sequencing of pol region for drug resistance assessment in patients with LTR-based viremia failed on plasma HIV-1 RNA, while it was successful on proviral DNA. The detection/quantification of HIV-1 viremia based only on LTR signal with a dual target assay in samples resulting undetectable with the more conventional target pol needs accurate evaluation; unravelling the biological basis of this phenomenon, here described for the first time, is mandatory to establish relevance and implication by both pathogenetic (i.e. infectivity of LTR-detected viruses, reservoir turnover, immune activation, etc.) and clinical standpoint.	[Amendola, Alessandra; Sberna, Giuseppe; Forbici, Federica; Abbate, Isabella; Capobianchi, Maria Rosaria L.] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Lab Virol, Rome, Italy; [Lorenzini, Patrizia; Pinnetti, Carmela; Antinori, Andrea] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Amendola, A (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Lab Virol, Rome, Italy.	alessandra.amendola@inmi.it	Abbate, Isabella/K-6434-2016; Amendola, Alessandra/ABC-2753-2021; Amendola, Alessandra/K-8835-2016	Amendola, Alessandra/0000-0002-7063-0222; Amendola, Alessandra/0000-0002-7063-0222; Antinori, Andrea/0000-0003-2121-4684; Sberna, Giuseppe/0000-0003-0955-2074	Ricerca Corrente grants; Italian Ministry of Health	Ricerca Corrente grants; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by Ricerca Corrente grants assigned to CMR from the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amendola A, 2016, J MED VIROL, V88, P1535, DOI 10.1002/jmv.24493; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Fleming J, 2019, AIDS, V33, P2005, DOI 10.1097/QAD.0000000000002306; Garcia-Diaz A, 2013, J CLIN VIROL, V57, P66, DOI 10.1016/j.jcv.2013.01.006; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hopkins M, 2015, J CLIN VIROL, V69, P56, DOI 10.1016/j.jcv.2015.05.020; Imamichi H, 2016, P NATL ACAD SCI USA, V113, P8783, DOI 10.1073/pnas.1609057113; Li JZ, 2012, ANTIMICROB AGENTS CH, V56, P5998, DOI 10.1128/AAC.01217-12; Mor O, 2015, J CLIN MICROBIOL, V53, P3458, DOI 10.1128/JCM.01806-15; Rozera G, 2010, J VIROL METHODS, V164, P135, DOI 10.1016/j.jviromet.2009.11.031; Schonning K, 2017, J CLIN VIROL, V92, P14, DOI 10.1016/j.jcv.2017.05.006; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Vardhanabhuti S, 2015, ANTIVIR THER, V20, P73, DOI 10.3851/IMP2772; Wall GR, 2012, J CLIN VIROL, V55, P62, DOI 10.1016/j.jcv.2012.05.014; Williams I, 2014, HIV MED, V15, P1, DOI 10.1111/hiv.12119	15	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228192	10.1371/journal.pone.0228192	http://dx.doi.org/10.1371/journal.pone.0228192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023284	Green Published, gold			2022-12-26	WOS:000534621500041
J	Marchant, E; Todd, C; Stratton, G; Brophy, S				Marchant, Emily; Todd, Charlotte; Stratton, Gareth; Brophy, Sinead			The Daily Mile: Whole-school recommendations for implementation and sustainability. A mixed-methods study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY INTERVENTIONS; CHILDREN; HEALTH; ADOLESCENTS; FITNESS; ASSOCIATIONS; ATTAINMENT; CHILDHOOD; WORKING	Regular physical activity (PA) during childhood is associated with a range of positive health outcomes and higher educational attainment. However, only 2.0% to 14.7% of girls and 9.5% to 34.1% of boys are meeting the current PA guidelines of 60 minutes of moderate to vigorous PA daily. Schools are targeted as a key setting to improve children's PA levels. The Daily Mile (TDM), a teacher-led 15 minute PA intervention was established in 2012 and has been widely adopted globally. However, the dynamic school environment generates challenges for school-based interventions to follow a uniform implementation method resulting in sustainability issues and limited evaluation. The aims of this mixed-methods study were to (1) explore whether whole-school experiences of TDM were related to implementation and (2) examine the association between TDM and CRF in children from high and low socio-economic groups. Focus groups with pupils (n = 6) and interviews with teachers (n = 9) and headteachers (n = 2) were conducted to explore factors associated with successful implementation. Pupils (n = 258 imputed) aged 9-11 from six primary schools in south Wales, United Kingdom participated in CRF assessments (20m shuttle run test) at two time-points (baseline, 6 month follow-up). Thematic analyses of qualitative measures and linear regression analyses of quantitative measures were used to assess the research questions. Qualitative findings identified implementation factors associated with a positive experience of TDM; flexible and adaptable, not replacing current play provision but delivered as an additional playtime, incorporate personal goal setting, teacher participation, whole-school delivery with community support. Both groups demonstrated equal increases in shuttles between baseline and follow-up (deprived: 4.7 +/- 13.4, non-deprived: 4.8 +/- 16.0). There was no significant difference in this increase for deprived compared to non-deprived children adjusted for age and gender. Findings from this study provide a set of recommendations for the future implementation and sustainability of TDM.	[Marchant, Emily; Todd, Charlotte; Brophy, Sinead] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Stratton, Gareth] Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr, Swansea, W Glam, Wales	Swansea University; Swansea University	Marchant, E (corresponding author), Swansea Univ, Sch Med, Swansea, W Glam, Wales.	E.K.Marchant@swansea.ac.uk	Marchant, Emily/AAC-4917-2022	Marchant, Emily/0000-0002-9701-5991; Todd, Charlotte/0000-0002-3183-2403; Brophy, Sinead/0000-0001-7417-2858	Economic and Social Research Council [ES/J500197/1]; National Centre for Population Health and Wellbeing Research	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Centre for Population Health and Wellbeing Research	This work was supported by the Economic and Social Research Council [grant number ES/J500197/1 to EM] https://esrc.ukri.org/and National Centre for Population Health and Wellbeing Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C., 1988, EUROFIT HDB EUROFIT; [Anonymous], 2012, REGEN MED S3, V7, pS14; Atkin AJ, 2016, MED SCI SPORT EXER, V48, P449, DOI 10.1249/MSS.0000000000000786; Banerjee R, 2014, BRIT EDUC RES J, V40, P718, DOI 10.1002/berj.3114; Booth JN, 2014, BRIT J SPORT MED, V48, P265, DOI 10.1136/bjsports-2013-092334; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Burnard P, 1991, Nurse Educ Today, V11, P461, DOI 10.1016/0260-6917(91)90009-Y; Butler H, 2010, HLTH PROMOT PRACT; Chalkley AE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6078-1; Chesham RA, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1336-3; Christian D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1557-0; Cohen DJ, 2008, ANN FAM MED, V6, P331, DOI 10.1370/afm.818; Cooper RN, 2006, J POLICY MODEL, V28, P615, DOI 10.1016/j.jpolmod.2006.06.007; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Creswell W. C., 2011, DESIGNING CONDUCTING; Daly-Smith A, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1335-4; Department of Health and Social Care, 2019, NEW PHYS ACT GUID IS; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Fairhurst A, 2017, PERSPECT PUBLIC HEAL, V137, P83, DOI 10.1177/1757913916685639; Forman S.G., 2009, SCH MENTAL HLTH, V1, P26, DOI [10.1007/s12310-008-9002-5, DOI 10.1007/S12310-008-9002-5, https://doi.org/10.1007/s12310-008-9002-5]; Fossey E, 2002, ANP AUST NZ J PSYCHI; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Gibson F, 2007, J RES NURSING; Greenberg M., 2010, EFFECTIVE ED, V2, P27, DOI [DOI 10.1080/19415531003616862, https://doi.org/10.1080/19415531003616862]; Gutierrez K, 2018, WHY YOU SHOULD USE C; HAWKES N, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2142; he Daily Mile Foundation, 2017, DAILY MILE; Huberty J, 2012, HEALTH EDUC RES, V27, P986, DOI 10.1093/her/cys071; Jaycox LH, 2006, AM J EVAL, V27, P320, DOI 10.1177/1098214006291010; Kohl H.W., 2013, ED STUDENT BODY; Konstabel K, 2014, INT J OBESITY, V38, pS135, DOI 10.1038/ijo.2014.144; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Landsverk J. A., 2012, DISSEMINATION IMPLEM, P225, DOI DOI 10.1093/ACPROF:OSO/9780199751877.001.0001/ACPROF-9780199751877-CHAPTER-12; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Malden S, 2019, BMJ OPEN, V9; Marchant E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212242; Mesa JL, 2006, NUTR METAB CARDIOVAS, V16, P285, DOI 10.1016/j.numecd.2006.02.003; Mindell JS, 2014, P NUTR SOC, V73, P218, DOI 10.1017/S0029665113003820; Morrow JR, 2013, AM J PREV MED, V44, P439, DOI 10.1016/j.amepre.2013.01.008; Naylor PJ, 2015, PREV MED, V72, P95, DOI 10.1016/j.ypmed.2014.12.034; Newell R., 2011, RES EVIDENCE BASED P, V2nd; Pampaka M, 2016, INT J RES METHOD EDU, V39, P19, DOI 10.1080/1743727X.2014.979146; Peralta LR, 2019, J SCHOOL HEALTH, V89, P460, DOI 10.1111/josh.12761; Rafferty R, 2016, INT REV SPORT EXER P, V9, P215, DOI 10.1080/1750984X.2016.1164228; Ruiz JR, 2006, J PUBLIC HLTH; Ryde GC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204988; Seabra AF, 2008, CAD SAUDE PUBLICA, V24, P721, DOI 10.1590/S0102-311X2008000400002; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Statistics for Wales, 2011, WELSH IND MULT DEPR; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; The Daily Mile Foundation, 2016, DAIL MIL; Todd C, 2016, PERSPECT PUBLIC HEAL, V136, P115, DOI 10.1177/1757913916638231; Tomkinson GR, 2019, PEDIATR EXERC SCI, V31, P152, DOI 10.1123/pes.2018-0179; Tyler R, 2016, J PHYS ACT HEALTH, V13, pS330, DOI 10.1123/jpah.2016-0309; Welsh Government, 2018, MY LOCAL SCH; Welsh Government, 2019, DRAFT CURR WAL 2022; Welsh Government, 2015, FDN PHAS FRAM CURR W; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	60	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228149	10.1371/journal.pone.0228149	http://dx.doi.org/10.1371/journal.pone.0228149			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KO3IE	32023297	gold, Green Published			2022-12-26	WOS:000515441300001
J	Petimar, J; Rifas-Shiman, SL; Hivert, MF; Fleisch, AF; Tiemeier, H; Oken, E				Petimar, Joshua; Rifas-Shiman, Sheryl L.; Hivert, Marie-France; Fleisch, Abby F.; Tiemeier, Henning; Oken, Emily			Prenatal and childhood predictors of hair cortisol concentration in mid-childhood and early adolescence	PLOS ONE			English	Article							LONG-TERM CORTISOL; BODY-MASS INDEX; SOCIOECONOMIC-STATUS; BIRTH-WEIGHT; DEVELOPMENTAL ORIGINS; SALIVARY CORTISOL; BLOOD-PRESSURE; SCALP HAIR; STRESS; CHILDREN	Background Hair cortisol concentration (HCC) is an increasingly used measure of systemic cortisol concentration. However, determinants of HCC in children and adolescents are unclear because few prospective studies have been conducted to date. Study design We followed 725 children in Project Viva, a pre-birth cohort study of mothers and children, who provided hair samples at mid-childhood (median age: 7.7 years) or early adolescence (median age: 12.9 years). We examined associations of various factors measured from pregnancy to mid-childhood with HCC in mid-childhood and early adolescence, as well as change in HCC between these time points (Delta HCC). Results There were 426 children with HCC measurements in both mid-childhood and early adolescence, 173 children with measures only in mid-childhood, and 126 with measures only in early adolescence. HCC was lower in mid-childhood (median 1.0pg/mg [interquartile range, IQR: 0.5, 2.4]) than early adolescence (2.2pg/mg [1.1, 4.4]). In multivariable-adjusted regression models, female sex (beta = -0.41, 95% CI: -0.67, -0.15) and birth weight-for-gestational age z-score (beta = -0.19, 95% CI: -0.33, -0.04) were associated with lower mid-childhood HCC, while prenatal smoking was associated with higher mid-childhood HCC (beta = 0.53, 95% CI: 0.04, 1.01). In early adolescence, child age (beta = 0.34 per year, 95% CI: 0.21, 0.46) female sex (beta = 0.33, 95% CI: 0.10, 0.57), and maternal pre-pregnancy body mass index (beta = 0.15 per 5-kg/m(2), 95% CI: 0.01, 0.29) were positively associated with HCC. Child anthropometric measures and biomarker concentrations were not associated with HCC. Conclusion Maternal pre-pregnancy BMI, maternal prenatal smoking, and low birth weight were associated with higher mid-childhood and adolescent HCC. However, few postnatal characteristics were associated with HCC.	[Petimar, Joshua] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Petimar, Joshua; Rifas-Shiman, Sheryl L.; Hivert, Marie-France; Oken, Emily] Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA; [Petimar, Joshua; Rifas-Shiman, Sheryl L.; Hivert, Marie-France; Oken, Emily] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; [Hivert, Marie-France] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Fleisch, Abby F.] Maine Med Ctr, Pediat Endocrinol & Diabet, Portland, ME 04102 USA; [Fleisch, Abby F.] Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA; [Tiemeier, Henning] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Tiemeier, Henning] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Rotterdam, Netherlands; [Oken, Emily] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Massachusetts General Hospital; Maine Medical Center; Maine Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Petimar, J (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Petimar, J (corresponding author), Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA.; Petimar, J (corresponding author), Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA.	jsp778@mail.harvard.edu	Tiemeier, Henning/H-6534-2019; Hivert, Marie-France/GWN-0455-2022	Tiemeier, Henning/0000-0002-4395-1397; 	National Institutes of Health [R01HD034569, UH3OD023286, T32HL098048]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health (R01HD034569 and UH3OD023286 to EO). JP is supported by T32HL098048. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Aas M, 2019, SCHIZOPHR RES, V213, P65, DOI 10.1016/j.schres.2019.01.011; Abraham SB, 2013, OBESITY, V21, pE105, DOI 10.1002/oby.20083; Aris IM, 2018, CURR EPIDEMIOL REP, V5, P293, DOI 10.1007/s40471-018-0161-0; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Camerota M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153800; Centers for Disease Control, CDC GROWTH CHARTS US; Cespedes EM, 2016, OBESITY, V24, P184, DOI 10.1002/oby.21196; Cespedes EM, 2014, OBESITY, V22, P2586, DOI 10.1002/oby.20894; Dajani R, 2018, PSYCHONEUROENDOCRINO, V89, P138, DOI 10.1016/j.psyneuen.2017.12.012; Eiden RD, 2015, DEV PSYCHOBIOL, V57, P212, DOI 10.1002/dev.21284; Elshenawy S, 2016, MOL CELL ENDOCRINOL, V435, P2, DOI 10.1016/j.mce.2016.07.002; Gao W, 2013, J CHROMATOGR B, V928, P1, DOI 10.1016/j.jchromb.2013.03.008; Geiker NRW, 2018, OBES REV, V19, P81, DOI 10.1111/obr.12603; Gerber M, 2017, PSYCHONEUROENDOCRINO, V76, P1, DOI 10.1016/j.psyneuen.2016.11.008; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gray NA, 2018, PSYCHONEUROENDOCRINO, V87, P204, DOI 10.1016/j.psyneuen.2017.10.022; Institute of Medicine, 1990, NUTR PREGN, V1; Karlen J, 2013, PEDIATRICS, V132, pE1333, DOI 10.1542/peds.2013-1178; KIESS W, 1995, PEDIATR RES, V37, P502, DOI 10.1203/00006450-199504000-00020; Knopik VS, 2012, DEV PSYCHOPATHOL, V24, P1377, DOI 10.1017/S0954579412000776; Larsen SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163639; Larsson CA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-16; Loussouarn G, 2001, BRIT J DERMATOL, V145, P294, DOI 10.1046/j.1365-2133.2001.04350.x; Manenschijn L, 2013, J CLIN ENDOCR METAB, V98, P2078, DOI 10.1210/jc.2012-3663; Manenschijn L, 2012, J CLIN ENDOCR METAB, V97, pE1836, DOI 10.1210/jc.2012-1852; Morris MC, 2017, STRESS, V20, P350, DOI 10.1080/10253890.2017.1340450; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Must A, 2006, INT J OBESITY, V30, P590, DOI 10.1038/sj.ijo.0803300; Netherton C, 2004, PSYCHONEUROENDOCRINO, V29, P125, DOI 10.1016/S0306-4530(02)00150-6; Noppe G, 2014, HORM RES PAEDIAT, V82, P97, DOI 10.1159/000362519; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Oken E, 2015, INT J EPIDEMIOL, V44, P37, DOI 10.1093/ije/dyu008; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Phillips DIW, 2005, PAEDIATR PERINAT EP, V19, P294, DOI 10.1111/j.1365-3016.2005.00661.x; Rippe RCA, 2016, PSYCHONEUROENDOCRINO, V66, P56, DOI 10.1016/j.psyneuen.2015.12.016; Ruy CA, 2017, PSYCHONEUROENDOCRINO, V82, P75, DOI 10.1016/j.psyneuen.2017.05.007; Shaheen M, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13271; Stalder T, 2017, PSYCHONEUROENDOCRINO, V77, P261, DOI 10.1016/j.psyneuen.2016.12.017; Sternthal MJ, 2011, DU BOIS REV, V8, P95, DOI 10.1017/S1742058X11000087; Steudte S, 2011, PSYCHONEUROENDOCRINO, V36, P1193, DOI 10.1016/j.psyneuen.2011.02.012; Strait Robert B, 2018, J Child Obes, V3, DOI 10.21767/2572-5394.100048; Ursache A, 2017, PSYCHONEUROENDOCRINO, V78, P142, DOI 10.1016/j.psyneuen.2017.01.020; Vaghri Z, 2013, PSYCHONEUROENDOCRINO, V38, P331, DOI 10.1016/j.psyneuen.2012.06.009; van Montfoort N, 2005, EUR J ENDOCRINOL, V153, P811, DOI 10.1530/eje.1.02050; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; Ward AMV, 2004, J CLIN ENDOCR METAB, V89, P1227, DOI 10.1210/jc.2003-030978; Wennig R, 2000, FORENSIC SCI INT, V107, P5, DOI 10.1016/S0379-0738(99)00146-2; Wester VL, 2017, EUR J ENDOCRINOL, V176, P695, DOI 10.1530/EJE-16-0873; White LO, 2017, J CHILD PSYCHOL PSYC, V58, P998, DOI 10.1111/jcpp.12700; Winchester SB, 2016, RES NURS HEALTH, V39, P15, DOI 10.1002/nur.21707; Wosu AC, 2013, ANN EPIDEMIOL, V23, P797, DOI 10.1016/j.annepidem.2013.09.006	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228769	10.1371/journal.pone.0228769	http://dx.doi.org/10.1371/journal.pone.0228769			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9EF	32017807	Green Published, gold			2022-12-26	WOS:000534618100041
J	Worthington, J; Lew, JB; Feletto, E; Holden, CA; Worthley, DL; Miller, C; Canfell, K				Worthington, Joachim; Lew, Jie-Bin; Feletto, Eleonora; Holden, Carol A.; Worthley, Daniel L.; Miller, Caroline; Canfell, Karen			Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment	PLOS ONE			English	Article							COLORECTAL-CANCER; BLOOD-TEST; SURVIVAL	Background The Australian National Bowel Cancer Screening Program (NBCSP) provides biennial immunochemical faecal occult blood test (iFOBT) screening for people aged 50-74 years. Previous work has quantified the number of colorectal cancer (CRC) deaths prevented by the NBCSP and has shown that it is cost-effective. With a 40% screening participation rate, the NBCSP is currently underutilised and could be improved by increasing program participation, but the maximum appropriate level of spending on effective interventions to increase adherence has not yet been quantified. Objectives To estimate (i) reductions in CRC cases and deaths for 2020-2040 attributable to, and (ii) the threshold for cost-effective investment (TCEI) in, effective future interventions to improve participation in the NBCSP. Methods A comprehensive microsimulation model, Policy1-Bowel, was used to simulate CRC natural history and screening in Australia, considering currently reported NBCSP adherence rates, i.e. iFOBT participation (similar to 40%) and diagnostic colonoscopy assessment rates (similar to 70%). Australian residents aged 40-74 were modelled. We evaluated three scenarios: (1) diagnostic colonoscopy assessment increasing to 90%; (2) iFOBT screening participation increasing to 60% by 2020, 70% by 2030 with diagnostic assessment rates of 90%; and (3) iFOBT screening increasing to 90% by 2020 with diagnostic assessment rates of 90%. In each scenario, we estimated CRC incidence and mortality, colonoscopies, costs, and TCEI given indicative willingness-to-pay thresholds of AUD$10,000-$30,000/LYS. Results By 2040, age-standardised CRC incidence and mortality rates could be reduced from 46.2 and 13.5 per 100,000 persons, respectively, if current participation rates continued, to (1) 44.0 and 12.7, (2) 36.8 and 8.8, and (3) 31.9 and 6.5. In Scenario 2, 23,000 lives would be saved from 2020-2040 vs current participation rates. The estimated scenario-specific TCEI (Australian dollars or AUD$/year) to invest in interventions to increase participation, given a conservative willingness-to-pay threshold of AUD$10,000/LYS, was (1) AUD$14.9M, (2) AUD$72.0M, and (3) AUD$76.5M. Conclusion Significant investment in evidence-based interventions could be used to improve NBCSP adherence and help realise the program's potential. Such interventions might include mass media campaigns to increase program participation, educational or awareness interventions for practitioners, and/or interventions resulting in improvements in referral pathways. Any set of interventions which achieves at least 70% iFOBT screening participation and a 90% diagnostic assessment rate while costing under AUD$72 million annually would be highly cost-effective (<AUD$10,000/LYS) and save 23,000 additional lives from 2020-2040.	[Worthington, Joachim; Lew, Jie-Bin; Feletto, Eleonora; Canfell, Karen] Canc Council NSW, Canc Res Div, Woolloomooloo, Australia; [Lew, Jie-Bin; Canfell, Karen] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Holden, Carol A.; Worthley, Daniel L.; Miller, Caroline] South Australian Hlth & Med Res Inst, North Terrace, Adelaide, SA, Australia; [Miller, Caroline] Univ Adelaide, Adelaide, SA, Australia; [Canfell, Karen] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia	Cancer Council New South Wales; University of New South Wales Sydney; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Sydney	Worthington, J (corresponding author), Canc Council NSW, Canc Res Div, Woolloomooloo, Australia.	joachim.worthington@nswcc.org.au		Canfell, Karen/0000-0002-6443-6618; Worthington, Joachim/0000-0002-8830-0520; Lew, Jie-Bin/0000-0003-2837-3565; Feletto, Eleonora/0000-0001-6192-4694	Medical Research Future Fund (MRFF) Rapid Applied Research Translation Program; Cancer Council NSW; Cancer Institute NSW's Translational Cancer Research Network; MRFF; Commonwealth Department of Health	Medical Research Future Fund (MRFF) Rapid Applied Research Translation Program(Medical Research Future Fund (MRFF)); Cancer Council NSW(Cancer Council New South Wales); Cancer Institute NSW's Translational Cancer Research Network; MRFF(Medical Research Future Fund (MRFF)); Commonwealth Department of Health	This study was supported with funding received for the No Australians Dying of Bowel Cancer Initiative (administered through Health Translation SA) through approved disbursements from the Medical Research Future Fund (MRFF) Rapid Applied Research Translation Program. The Policy1-Bowel model was previously developed with the assistance of a number of funding agencies including Cancer Council NSW and the Cancer Institute NSW's Translational Cancer Research Network.; The authors acknowledge the MRFF and Commonwealth Department of Health in supporting the broader project aim to reduce premature colorectal cancer death in the South Australian population. The authors would like to thank David Goldsbury for his assistance with sourcing costs for the modelling.	ACE Bowel Screening Cluster, 2017, INT INCR BOW SCREEN; Ananda S, 2016, ASIA-PAC J CLIN ONCO, V12, P33, DOI 10.1111/ajco.12350; [Anonymous], 2014, NAT HOSP COST DAT CO; Australian Bureau of Statistics, 2019, 64010 AUSTR BUR STAT; Australian Bureau of Statistics, 2016, 31010 AUSTR BUR STAT; Australian Bureau of Statistics, 32220 AUSTR BUR STAT; Australian Government, 2013, MEDICARE BENEFITS SC; Australian Institute of Health and Welfare, 2018, HLTH EXP AUSTR 2016; Barclay K., 2013, ALGORITHM COLONOSCOP; Cancer Council Australia Colonoscopy Surveillance Working Party, 2011, CLIN PRACT GUID SURV; Cancer Council Victoria, 2018, BOW CANC SCREEN CAMP; Cenin DR, 2014, MED J AUSTRALIA, V201, P456, DOI 10.5694/mja13.00112; Cole SR, 2002, J MED SCREEN, V9, P147, DOI 10.1136/jms.9.4.147; Dawson G, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0610-8; Durkin SJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024267; Gill MD, 2014, BRIT J CANCER, V111, P2076, DOI 10.1038/bjc.2014.498; Greuter MJE, 2014, RISK ANAL, V34, P889, DOI 10.1111/risa.12137; Grogan PB, 2014, MED J AUSTRALIA, V201, P435, DOI 10.5694/mja14.01089; Hall MT, 2019, LANCET PUBLIC HEALTH, V4, pE19, DOI 10.1016/S2468-2667(18)30183-X; He E, 2018, PREV MED, V106, P185, DOI 10.1016/j.ypmed.2017.10.032; Javanparast S, 2012, MED J AUSTRALIA, V196, P521, DOI 10.5694/mja11.10701; JENTSCHURA D, 1994, SURG ENDOSC-ULTRAS, V8, P672, DOI 10.1007/BF00678564; Lew J, 2013, NATL CERVICAL SCREEN; Lew JB, 2019, PUBLIC HEALTH RES PR, V29, DOI 10.17061/phrp2921913; Lew JB, 2018, CANCER EPIDEM BIOMAR, V27, P1450, DOI [10.1158/1055-9965.EPI-18-0128, 10.1158/1055-9965.epi-18-0128]; Lew JB, 2018, INT J CANCER, V143, P269, DOI 10.1002/ijc.31314; Lew JB, 2017, LANCET PUBLIC HEALTH, V2, pE331, DOI 10.1016/S2468-2667(17)30105-6; Medical Services Advisory C, 2009, 39 MSAC, V39; Morris M, 2007, MED J AUSTRALIA, V186, P296, DOI 10.5694/j.1326-5377.2007.tb00904.x; National Health and Medical Research Council, 2001, COMP COSTS BEN EV EC; O'Leary BA, 2004, J GASTROEN HEPATOL, V19, P38, DOI 10.1111/j.1440-1746.2004.03177.x; Pande R, 2013, COLORECTAL DIS, V15, P74, DOI 10.1111/j.1463-1318.2012.03120.x; Parente F, 2015, DIGEST LIVER DIS, V47, P68, DOI 10.1016/j.dld.2014.09.015; Rex DK, 2017, AM J GASTROENTEROL, V112, P1016, DOI 10.1038/ajg.2017.174; Salkeld G, 1996, AUST NZ J PUBL HEAL, V20; Salkeld GP, 2003, ANZ J SURG, V73, P128, DOI 10.1046/j.1445-2197.2003.02650.x; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Simms KT, 2016, LANCET PUBLIC HEALTH, V1, pE66, DOI 10.1016/S2468-2667(16)30019-6; The Pharmaceutical Benefits Advisory Committee, 2016, PBAC GUID; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; von Karsa L, 2012, ENDOSCOPY, V44, pSE1, DOI 10.1055/s-0032-1309822; Whiteman DC, 2015, AUST NZ J PUBL HEAL, V39, P477, DOI 10.1111/1753-6405.12471; World Cancer Research Fund International/American Institute for Cancer Research, 2017, CONT UPD PROJ REP DI; Worthington J, 2020, PUBLIC HEALTH, V179, P90, DOI 10.1016/j.puhe.2019.10.003	44	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0227899	10.1371/journal.pone.0227899	http://dx.doi.org/10.1371/journal.pone.0227899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9DJ	32012174	Green Published, gold			2022-12-26	WOS:000534615800015
J	Li, YM; Zhou, Y; Li, BF; Chen, F; Shen, WY; Lu, YS; Zhong, CL; Zhang, C; Xie, H; Katanaev, VL; Jia, L				Li, Yumei; Zhou, Yu; Li, Bifei; Chen, Fan; Shen, Weiyu; Lu, Yusheng; Zhong, Chunlian; Zhang, Chen; Xie, Huanzhang; Katanaev, Vladimir L.; Jia, Lee			WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5-MDM2-p53 pathway	ONCOGENE			English	Article							NUCLEOLAR AAA-ATPASE; RIBOSOMAL-PROTEINS; P53; GROWTH; PROLIFERATION; BIOGENESIS; MUTATIONS; REGULATOR; CANCER	The key molecules and underlying mechanisms of melanoma metastasis remain poorly understood. Using isobaric tag for relative and absolute quantitation (iTRAQ) proteomic screening, probing of patients' samples, functional verification, and mechanistic validation, we identified the important role of the WD repeat-containing protein 74 (WDR74) in melanoma progression and metastasis. Through gain- and loss-of-function approaches, WDR74 was found to promote cell proliferation, apoptosis resistance, and aggressive behavior in vitro. Moreover, WDR74 contributed to melanoma growth and metastasis in vivo. Mechanistically, WDR74 modulates RPL5 protein levels and consequently regulates MDM2 and insulates the ubiquitination degradation of p53 by MDM2. Our study is the first to reveal the oncogenic role of WDR74 in melanoma progression and the regulatory effect of WDR74 on the RPL5-MDM2-p53 pathway. Collectively, WDR74 can serve as a candidate target for the prevention and treatment of melanoma in the clinic.	[Li, Yumei; Zhou, Yu; Li, Bifei; Chen, Fan; Shen, Weiyu; Jia, Lee] Fuzhou Univ, Coll Chem, Canc Metastasis Alert & Prevent Ctr, Fujian Prov Key Lab Canc Metastasis Chemoprevent, Fuzhou 350116, Fujian, Peoples R China; [Lu, Yusheng; Zhong, Chunlian; Zhang, Chen; Xie, Huanzhang; Katanaev, Vladimir L.; Jia, Lee] Minjiang Univ, Inst Oceanog, Fuzhou 350116, Fujian, Peoples R China; [Katanaev, Vladimir L.] Far Eastern Fed Univ, Sch Biomed, Nat Prod Drug Discovery Lab, Vladivostok, Russia; [Katanaev, Vladimir L.] Univ Geneva, Fac Med, Translat Res Ctr Oncohaematol, Dept Cell Physiol & Metab, Geneva, Switzerland	Fuzhou University; Minjiang University; Far Eastern Federal University; University of Geneva	Jia, L (corresponding author), Fuzhou Univ, Coll Chem, Canc Metastasis Alert & Prevent Ctr, Fujian Prov Key Lab Canc Metastasis Chemoprevent, Fuzhou 350116, Fujian, Peoples R China.; Katanaev, VL; Jia, L (corresponding author), Minjiang Univ, Inst Oceanog, Fuzhou 350116, Fujian, Peoples R China.; Katanaev, VL (corresponding author), Far Eastern Fed Univ, Sch Biomed, Nat Prod Drug Discovery Lab, Vladivostok, Russia.; Katanaev, VL (corresponding author), Univ Geneva, Fac Med, Translat Res Ctr Oncohaematol, Dept Cell Physiol & Metab, Geneva, Switzerland.	Vladimir.Katanaev@unige.ch; cmapcjia1234@163.com	Katanaev, Vladimir/F-9480-2014	Katanaev, Vladimir/0000-0002-7909-5617; Chen, Fan/0000-0003-3873-7094; JIA, LEE/0000-0001-6839-5545; Li, Yumei/0000-0002-7910-6515; Lu, Yusheng/0000-0003-2341-4487; Zhang, Chen/0000-0002-5080-9321	National Natural Science Foundation of China [81961138017, 81773063, U1505225]; Ministry of Science and Technology of China [2015CB931804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the grants from National Natural Science Foundation of China (81961138017, 81773063, U1505225); Ministry of Science and Technology of China (2015CB931804).	Azim HA, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0538-7; Bedrosian I, 2000, ANN SURG ONCOL, V7, P262, DOI 10.1007/s10434-000-0262-z; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Chen XX, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1188-3; Chen XX, 2018, AGING-US, V10, P3421, DOI 10.18632/aging.101656; Cheng YL, 2018, INT J ONCOL, V53, P2590, DOI 10.3892/ijo.2018.4582; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Damsky WE, 2014, ONCOGENE, V33, P2413, DOI 10.1038/onc.2013.194; de Marval PLM, 2011, ONCOTARGET, V2, P234; Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172; Fahraeus R, 2014, ONCOGENE, V33, P4365, DOI 10.1038/onc.2013.410; Han Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.014076; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Hiraishi N, 2018, BIOCHEM BIOPH RES CO, V495, P116, DOI 10.1016/j.bbrc.2017.10.148; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kardos GR, 2014, PIGM CELL MELANOMA R, V27, P801, DOI 10.1111/pcmr.12259; Kitatani K, 2016, ONCOGENE, V35, P2801, DOI 10.1038/onc.2015.330; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Krol M, 2010, J APPL GENET, V51, P37, DOI 10.1007/BF03195709; Li BF, 2019, ONCOTARGETS THER, V12, P3207, DOI 10.2147/OTT.S195703; Liang W, 2018, P NATL ACAD SCI USA, V115, P11060, DOI 10.1073/pnas.1811717115; Lin CP, 2019, ENVIRON TOXICOL, V34, P303, DOI 10.1002/tox.22685; Little EG, 2012, DERMATOL CLIN, V30, P355, DOI 10.1016/j.det.2012.04.001; Liu JQ, 2018, J GENET GENOMICS, V45, P639, DOI 10.1016/j.jgg.2018.08.005; Liu S, 2017, ONCOGENE, V36, P1374, DOI 10.1038/onc.2016.301; Liu Y, 2016, TRENDS CANCER, V2, P191, DOI 10.1016/j.trecan.2016.03.002; Lo YH, 2017, STRUCTURE, V25, P762, DOI 10.1016/j.str.2017.03.008; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; Maserati M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022516; Murphy JF, 2001, FASEB J, V15, P1667, DOI 10.1096/fj.00-0757fje; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ossio R, 2017, NAT REV CANCER, V17, P393, DOI 10.1038/nrc.2017.43; Owens, 2020, NATURE, V515, pS109; Ozdemir E, 2000, EUR UROL, V38, P230, DOI 10.1159/000020284; Paradiso V, 2018, J MOL DIAGN, V20, P836, DOI 10.1016/j.jmoldx.2018.07.003; Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104; Srivastava SK, 2015, BRIT J CANCER, V113, P1694, DOI 10.1038/bjc.2015.400; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; uri Reimand, 2017, CANC RES S, V77, DOI [10.1158/1538-7445.AM2017-385, DOI 10.1158/1538-7445.AM2017-385]; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang SY, 2018, CANCER LETT, V439, P78, DOI 10.1016/j.canlet.2018.09.026; Wang W, 2015, MED RES REV, V35, P225, DOI 10.1002/med.21327; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Yoshikatsu Y, 2015, BIOCHEM BIOPH RES CO, V464, P780, DOI 10.1016/j.bbrc.2015.07.032; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219; Zhang F, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.NONRNA15-PR06; Zhang Q, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1156-5; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zheng N, 2017, MOL CARCINOGEN, V56, P1896, DOI 10.1002/mc.22645; Zheng N, 2017, BIOMED PHARMACOTHER, V90, P339, DOI 10.1016/j.biopha.2017.03.076	52	12	12	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2741	2755		10.1038/s41388-020-1179-6	http://dx.doi.org/10.1038/s41388-020-1179-6		JAN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32005977				2022-12-26	WOS:000510346700002
J	Daly, C; Logan, B; Breeyear, J; Whitaker, K; Ahmed, M; Seals, DF				Daly, Christina; Logan, Brewer; Breeyear, Joseph; Whitaker, Kelley; Ahmed, Maryam; Seals, Darren F.			Tks5 SH3 domains exhibit differential effects on invadopodia development	PLOS ONE			English	Article							PODOSOME FORMATION; SRC; PROTEIN; TRAFFICKING; ACTIVATION; INVASION; FISH	The Src substrate Tks5 helps scaffold matrix-remodeling invadopodia in invasive cancer cells. Focus was directed here on how the five SH3 domains of Tks5 impact that activity. Mutations designed to inhibit protein-protein interactions were created in the individual SH3 domains of Tks5, and the constructs were introduced into the LNCaP prostate carcinoma cell line, a model system with intrinsically low Tks5 expression and which our lab had previously showed the dependence of Src-dependent Tks5 phosphorylation on invadopodia development. In LNCaP cells, acute increases in wild-type Tks5 led to increased gelatin matrix degradation. A similar result was observed when Tks5 was mutated in its 4th or 5th SH3 domains. This was in contrast to the 1st, 2nd, and 3rd SH3 domain mutations of Tks5 where each had a remarkable accentuating effect on gelatin degradation. Conversely, in the invadopodia-competent Src-3T3 model system, mutations in any one of the first three SH3 domains had a dominant negative effect that largely eliminated the presence of invadopodia, inhibited gelatin degradation activity, and redistributed both Src, cortactin, and Tks5 to what are likely endosomal compartments. A hypothesis involving Tks5 conformational states and the regulation of endosomal trafficking is presented as an explanation for these seemingly disparate results.	[Daly, Christina; Logan, Brewer; Breeyear, Joseph; Whitaker, Kelley; Ahmed, Maryam; Seals, Darren F.] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA; [Daly, Christina] St Jude Childrens Res Hosp, Grad Sch Biomed Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Breeyear, Joseph] Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN USA; [Whitaker, Kelley] PRA Hlth Sci, Raleigh, NC USA	University of North Carolina; Appalachian State University; St Jude Children's Research Hospital; Vanderbilt University	Seals, DF (corresponding author), Appalachian State Univ, Dept Biol, Boone, NC 28608 USA.	sealsdf@appstate.edu		Daly, Christina/0000-0001-7470-0454	Appalachian State University; College of Arts and Sciences; Department of Biology; Cratis D. Williams School Of Graduate Studies; Honors College at Appalachian State University; Department of Biology at Appalachian State University; Cratis D. Williams School of Graduate Studies at Appalachian State University; College of Arts and Sciences at Appalachian State University	Appalachian State University; College of Arts and Sciences; Department of Biology; Cratis D. Williams School Of Graduate Studies; Honors College at Appalachian State University; Department of Biology at Appalachian State University; Cratis D. Williams School of Graduate Studies at Appalachian State University; College of Arts and Sciences at Appalachian State University	This work was supported by institutional funds from Appalachian State University, the College of Arts and Sciences, the Department of Biology, and the Cratis D. Williams School Of Graduate Studies.; The authors would like to think the Cratis D. Williams School of Graduate Studies, the College of Arts and Sciences, the Honors College, and the Department of Biology at Appalachian State University for their generous support of this research. Appreciation is also extended to Dr. Sara Courtneidge (Oregon Health and Sciences University, Portland OR) for feedback on a draft version of this manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Blouw B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121003; Burger KL, 2014, PROSTATE, V74, P134, DOI 10.1002/pros.22735; Burger KL, 2011, CYTOSKELETON, V68, P694, DOI 10.1002/cm.20545; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Cejudo-Martin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107674; Crimaldi L, 2009, EXP CELL RES, V315, P2581, DOI 10.1016/j.yexcr.2009.06.012; Destaing O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077956; Diaz B, 2013, J CELL BIOL, V201, P279, DOI 10.1083/jcb.201209151; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Eddy RJ, 2017, TRENDS CELL BIOL, V27, P595, DOI 10.1016/j.tcb.2017.03.003; Foxall E, 2016, EUR J CELL BIOL, V95, P483, DOI 10.1016/j.ejcb.2016.07.002; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Jacob A, 2016, J CELL SCI, V129, P4341, DOI 10.1242/jcs.193904; Jacob A, 2013, J CELL SCI, V126, P4647, DOI 10.1242/jcs.126573; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Martin KH, 2012, JOVE-J VIS EXP, DOI 10.3791/4119; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Reinecke JB, 2014, J CELL SCI, V127, P1684, DOI 10.1242/jcs.133892; Rufer AC, 2009, J MOL BIOL, V390, P939, DOI 10.1016/j.jmb.2009.05.025; Saini P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.203661; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Sharma VP, 2013, CURR BIOL, V23, P2079, DOI 10.1016/j.cub.2013.08.044; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Thompson O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003638; Williams KC, 2014, J CELL SCI, V127, P1712, DOI 10.1242/jcs.134734	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227855	10.1371/journal.pone.0227855	http://dx.doi.org/10.1371/journal.pone.0227855			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999741	Green Published, gold			2022-12-26	WOS:000534612400034
J	Hui, CY; Guo, Y; Liu, LS; Zheng, HQ; Gao, CX; Zhang, W				Hui, Chang-ye; Guo, Yan; Liu, Lisa; Zheng, Hao-qu; Gao, Chao-xian; Zhang, Wen			Construction of a RFP-lacZ alpha bicistronic reporter system and its application in lead biosensing	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN-SYNTHESIS; SENSITIVITY; CODONS	The combination of a fluorescent reporter and enzymatic reporter provides a flexible and versatile way for the study of diverse biological processes, such as the detection of transcription and translation. Thus, there is an urgent need to develop this novel bifunctional reporter system. This study reports the design, construction, and validation of a new dicistronic mCherry-lacZ alpha reporter system by artificial lac operon and pbr operon models in lacZM15-producing E. coli. It allows two reporter genes to be co-transcribed into a dicistronic mRNA strand, followed by coupled expression of mCherry and lacZ alpha. In artificial lac operons, expression of the downstream lacZ alpha was demonstrated to be positively related to expression of the upstream ORF. In artificial pbr operons, compared with the insertion of downstream full-length lacZ, the insertion of downstream lacZ alpha exerted a slight effect on the response from the upstream mCherry. Furthermore, the downstream lacZ alpha reporter showed stronger response to Pb(II) than the downstream full-length lacZ. Importantly, the response sensitivity of downstream lacZ alpha was still higher than that of upstream mCherry in a dual RFP-lacZ alpha reporter construct. The highly efficient expression profile of the reporter lacZ alpha peptide makes it a preferred downstream reporter in polycistronic constructs. This novel bifunctional reporter system offers a robust tool for biological studies.	[Hui, Chang-ye; Gao, Chao-xian; Zhang, Wen] Shenzhen Prevent & Treatment Ctr Occupat Dis, Dept Toxicol & Pathol, Shenzhen, Peoples R China; [Guo, Yan; Zheng, Hao-qu] Shenzhen Prevent & Treatment Ctr Occupat Dis, Dept Sci & Educ, Shenzhen, Peoples R China; [Liu, Lisa] Shenzhen Second Peoples Hosp, Inst Translat Med, Shenzhen, Peoples R China	Second People's Hospital of Shenzhen	Hui, CY (corresponding author), Shenzhen Prevent & Treatment Ctr Occupat Dis, Dept Toxicol & Pathol, Shenzhen, Peoples R China.	hcy_sypu@hotmail.com			Shenzhen Science and Technology Innovation Commission [JCYJ20180306170237563]; Department of Science and Technology of Guangdong Province [2019A1515011989]	Shenzhen Science and Technology Innovation Commission; Department of Science and Technology of Guangdong Province	This research was partly supported by a grant (JCYJ20180306170237563) from Shenzhen Science and Technology Innovation Commission (http://stic.sz.gov.cn/) to Hui CY, and a grant (2019A1515011989) from Department of Science and Technology of Guangdong Province (http://gdstc.gd.gov.cn/) to Guo Y. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereza-Malcolm L, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122174; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Brule CE, 2017, TRENDS GENET, V33, P283, DOI 10.1016/j.tig.2017.02.001; Choi SC, 2008, BIOTECHNOL LETT, V30, P835, DOI 10.1007/s10529-007-9631-z; Chumpolkulwong Namthip, 2006, Journal of Structural and Functional Genomics, V7, P31, DOI 10.1007/s10969-006-9007-y; David HE, 2003, ENVIRON TOXICOL CHEM, V22, P111, DOI [10.1897/1551-5028(2003)022&lt;0111:CAEOAT&gt;2.0.CO;2, 10.1002/etc.5620220114]; de Almeida RA, 2006, J BIOL CHEM, V281, P695, DOI 10.1074/jbc.M511467200; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; Guo Y, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01454; Hennessy RC, 2018, J MICROBIOL METH, V144, P173, DOI 10.1016/j.mimet.2017.11.024; Hui CY, 2019, BIOTECHNOL LETT, V41, P763, DOI 10.1007/s10529-019-02676-4; Hui CY, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0612-5; Hui CY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24134-3; Hwang CN, 2006, BIOTECHNOL LETT, V28, P287, DOI 10.1007/s10529-005-5715-9; Jia B, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160196; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P6268, DOI 10.1093/nar/gki928; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Levin-Karp A, 2013, ACS SYNTH BIOL, V2, P327, DOI 10.1021/sb400002n; Magrisso S, 2008, MICROB BIOTECHNOL, V1, P320, DOI 10.1111/j.1751-7915.2008.00022.x; Mahalik S, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0177-1; Benedetti IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052000; Martin L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007569; Menzella HG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-15; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sambrook J., 2001, MOL CLONING LAB MANU; Silva-Rocha R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034675; Sun WSW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155578; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tauer C, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0150-z; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; Wei W, 2014, ENVIRON SCI TECHNOL, V48, P3363, DOI 10.1021/es4046567; Yang LL, 2013, BIOSENS BIOELECTRON, V48, P49, DOI 10.1016/j.bios.2013.03.078	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228456	10.1371/journal.pone.0228456	http://dx.doi.org/10.1371/journal.pone.0228456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999769	gold, Green Published			2022-12-26	WOS:000534612400087
J	Kim, S; Han, S; Rane, PP; Qian, Y; Zhao, ZY; Suh, HS				Kim, Siin; Han, Sola; Rane, Pratik P.; Qian, Yi; Zhao, Zhongyun; Suh, Hae Sun			Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea	PLOS ONE			English	Article							CARDIOVASCULAR RISK; SERUM-CHOLESTEROL; STATIN THERAPY; ATTAINMENT; DISEASE; ADHERENCE; OUTCOMES	Background It is important to achieve the low-density lipoprotein cholesterol (LDL-C) goal recommended by clinical guidelines in managing the risk of cardiovascular (CV) events, however, the current management of LDL-C in actual clinical settings is suboptimal. We examined the LDL-C level among patients with dyslipidemia against the 2015 Korean guidelines, the crude rates of CV events based on LDL-C goal achievement, and the factors associated with LDL-C goal achievement. Methods This was a retrospective cohort study using the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) database from 2006 to 2013. Patients who had a health examination with LDL-C measurement between January 1, 2007, and December 31, 2011 were identified. Patients were required to have at least one diagnosis of dyslipidemia during the 1 year before the index date, defined as the first date of LDL-C measurement. The 2015 Korean guidelines were used to measure LDL-C goal achievement based on the CV risk level. Crude CV event rates were calculated for total and individual CV events as the number of events divided by person-years (PYs) during the follow-up period. CV events included acute coronary syndrome, ischemic stroke, peripheral artery disease, CV death, and all-cause death. Factors associated with LDL-C goal achievement were assessed using logistic regression. Results In the NHIS-HEALS database, 69,942 patients met the eligibility criteria: 36.7%, 22.5%, 20.1%, and 20.6% were among the very high-, high-, moderate-, and low-risk groups for the CV events, respectively, as defined by the 2015 Korean guidelines. Approximately half of the patients with dyslipidemia (47.6%) achieved their recommended LDL-C goal, but the achievement rates were substantially different across CV risk levels (17.6%, 47.2%, 66.9%, and 82.4% for very high-, high-, moderate-, and low-risk groups, respectively; P<0.0001). The crude event rate of total CV events during the follow-up period in the LDL-C goal non-achievers was higher than that in the LDL-C goal achievers (24.35/100 PYs vs. 11.93/100 PYs; P<0.0001). LDL-C goal achievement was significantly associated with patient characteristics, including age, sex, body mass index, lipid-modifying therapy, and CV risk level. Conclusions In South Korea, LDL-C goal achievement among patients with very high or high CV risk was suboptimal. Patients who did not achieve the goal showed a higher rate of CV events during the follow-up period than patients who achieved the goal. LDL-C management strategies should be highlighted in dyslipidemia patients who are less likely to achieve the goal, such as female, overweight or obese patients, patients not adherent to statin, or patients with very high or high CV risk.	[Kim, Siin; Han, Sola; Suh, Hae Sun] Pusan Natl Univ, Coll Pharm, Busan, South Korea; [Rane, Pratik P.; Qian, Yi; Zhao, Zhongyun] Amgen Inc, Thousand Oaks, CA 91320 USA	Pusan National University; Amgen	Suh, HS (corresponding author), Pusan Natl Univ, Coll Pharm, Busan, South Korea.	haesun.suh@pusan.ac.kr	Han, Sola/ABE-5476-2021	Han, Sola/0000-0002-6269-172X	Amgen, Inc.; National Health Insurance Service (NHIS) [NHIS-2017-2-292]	Amgen, Inc.(Amgen); National Health Insurance Service (NHIS)	This research was funded by Amgen, Inc.; URLs to sponsor's website: https://www.amgen.com/.Qian, Rane are employees of Amgen Inc and own stocks in the company. Zhao was an employee of Amgen Inc at the time this research was performed. The funder provided support in the form of salaries for authors PPR, YQ, and ZZ, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section (Qian, Rane and Zhao contributed in development of study design, analysis, decision to publish and in preparation of the manuscript).; This study used National Health Insurance Service-Health Screening data (NHIS-2017-2-292) made by National Health Insurance Service (NHIS). The authors declare no conflict of interest with NHIS.	Baessler A, 2005, INT J CARDIOL, V101, P293, DOI 10.1016/j.ijcard.2004.03.053; Barkas F, 2015, ANGIOLOGY, V66, P346, DOI 10.1177/0003319714535073; Benner JS, 2005, AM J HEALTH-SYST PH, V62, P1468, DOI 10.2146/ajhp040419; Chang Hoo-Sun, 2012, J Prev Med Public Health, V45, P291, DOI 10.3961/jpmph.2012.45.5.291; Gao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047681; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Jones PH, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001800; Kim BK, 2010, CORONARY ARTERY DIS, V21, P182, DOI 10.1097/MCA.0b013e328337ad09; Kim HS, 2016, J CLIN PHARM THER, V41, P70, DOI 10.1111/jcpt.12350; Kim HS, 2008, CURR MED RES OPIN, V24, P1951, DOI [10.1185/03007990802138731, 10.1185/03007990802138731 ]; Kim KI, 2016, KOREAN CIRC J, V46, P275, DOI 10.4070/kcj.2016.46.3.275; Kimm H, 2012, KOREAN CIRC J, V42, P10, DOI 10.4070/kcj.2012.42.1.10; Kwon JE, 2014, J LIPID ATHEROSCLER, V3, P21, DOI DOI 10.12997/jla.2014.3.1.21; Mitchell S, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0241-3; Park TH, 2016, J CLIN NEUROL, V12, P42, DOI 10.3988/jcn.2016.12.1.42; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; Pirro M, 2011, EUR J INTERN MED, V22, P412, DOI 10.1016/j.ejim.2011.04.007; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Roger VL, 2011, CIRCULATION; Seong SC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016640; Slejko JF, 2014, J MANAGE CARE PHARM, V20, P51, DOI 10.18553/jmcp.2014.20.1.51; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WONG ND, 1991, ANN INTERN MED, V115, P687, DOI 10.7326/0003-4819-115-9-687	25	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228472	10.1371/journal.pone.0228472	http://dx.doi.org/10.1371/journal.pone.0228472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999714	Green Published, gold			2022-12-26	WOS:000534612400090
J	Martinez-Lacoba, R; Pardo-Garcia, I; Amo-Saus, E; Escribano-Sotos, F				Martinez-Lacoba, Roberto; Pardo-Garcia, Isabel; Amo-Saus, Elisa; Escribano-Sotos, Francisco			Social determinants of food group consumption based on Mediterranean diet pyramid: A cross-sectional study of university students	PLOS ONE			English	Article							LIFE-STYLE FACTORS; SOCIOECONOMIC POSITION; YOUNG-ADULTS; HEALTH; QUALITY; ADHERENCE; ADOLESCENTS; HABITS; METAANALYSIS; PATTERNS	Considering food habits as a modifiable risk factor, an early intervention on youth people could avoid future health and social costs. We aim to determine the level of compliance with the recommendations of the Mediterranean diet pyramid according to social determinants in university students and to analyse the association of these social determinants (and their interaction with gender) with different food group consumption. We used the records of an electronic cross-sectional survey on university students (n = 593) from inland Spain. The results show, generally, that university students do not fully comply with the recommendations and that gender is the social determinant with the greatest effect on differences in food group consumption. Women have a lower consumption of dairy products, olives, nuts and seeds, red meat, and processed meat, sweets, eggs, alcoholic drinks and fast food; and a higher consumption of fruit, compared with men. Socioeconomic status, geographic area, and whether students cook for themselves have a limited influence on differences in food group consumption, which is inconsistent with the literature. Policy makers should consider this gender gap if they wish to implement a policy based on healthy diet, considering that other social determinants are also important, and could interact with gender.	[Martinez-Lacoba, Roberto; Pardo-Garcia, Isabel; Amo-Saus, Elisa; Escribano-Sotos, Francisco] Univ Castilla La Mancha UCLM, Fac Ciencias Econ & Empresariales, Plaza Univ, Albacete, Spain; [Martinez-Lacoba, Roberto; Pardo-Garcia, Isabel; Escribano-Sotos, Francisco] Univ Castilla La Mancha UCLM, Ctr Estudios Sociosanitarios CESS, Albacete, Spain; [Martinez-Lacoba, Roberto; Pardo-Garcia, Isabel; Amo-Saus, Elisa; Escribano-Sotos, Francisco] Econ Food & Soc Res Grp, Res Grp Econ Alimentac & Soc, Albacete, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha	Martinez-Lacoba, R (corresponding author), Univ Castilla La Mancha UCLM, Fac Ciencias Econ & Empresariales, Plaza Univ, Albacete, Spain.; Martinez-Lacoba, R (corresponding author), Univ Castilla La Mancha UCLM, Ctr Estudios Sociosanitarios CESS, Albacete, Spain.; Martinez-Lacoba, R (corresponding author), Econ Food & Soc Res Grp, Res Grp Econ Alimentac & Soc, Albacete, Spain.	roberto.mlacoba@uclm.es	Martinez-Lacoba, Roberto/Q-9499-2017; SOTOS, FRANCISCO ESCRIBANO/AAA-5548-2020; SOTOS, FRANCISCO ESCRIBANO/C-3961-2013	Martinez-Lacoba, Roberto/0000-0001-5543-2191; SOTOS, FRANCISCO ESCRIBANO/0000-0002-2747-6725; SOTOS, FRANCISCO ESCRIBANO/0000-0002-2747-6725	University of Castilla-La Mancha Research Group "Economy, Food and Society [2019-GRIN-27194]	University of Castilla-La Mancha Research Group "Economy, Food and Society	This research has been funded by the University of Castilla-La Mancha Research Group "Economy, Food and Society." (Project 2019-GRIN-27194.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.066159; Al-Rethaiaa AS, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-39; Atkins JL, 2015, BRIT J NUTR, V113, P1441, DOI 10.1017/S0007114515000604; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P2274, DOI 10.1017/S1368980011002515; Baldini M, 2009, PUBLIC HEALTH NUTR, V12, P148, DOI 10.1017/S1368980008002759; Beck KL, 2018, EUR J NUTR, V57, P1421, DOI 10.1007/s00394-017-1421-3; Beghin L, 2014, BRIT J NUTR, V111, P1303, DOI 10.1017/S0007114513003796; Bertin M, 2016, J HUM NUTR DIET, V29, P241, DOI 10.1111/jhn.12315; Boylan S, 2011, PUBLIC HEALTH NUTR, V14, P678, DOI 10.1017/S1368980010002570; CEBRIAN F., 2000, PAPELES GEOGRAFIA, V32, P45; Chourdakis M, 2010, APPETITE, V55, P722, DOI 10.1016/j.appet.2010.08.013; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; Samaniego-Vaesken MD, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040392; Bibiloni MD, 2012, PUBLIC HEALTH NUTR, V15, P683, DOI 10.1017/S1368980011002199; Deliens T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-53; Dernini S, 2017, PUBLIC HEALTH NUTR, V20, P1322, DOI 10.1017/S1368980016003177; Deshmukh-Taskar P, 2007, J AM DIET ASSOC, V107, P223, DOI 10.1016/j.jada.2006.11.004; Domingo-Salvany A, 2013, GAC SANIT, V27, P263, DOI 10.1016/j.gaceta.2012.12.009; El Ansari Walid, 2012, Nutr J, V11, P28, DOI 10.1186/1475-2891-11-28; Fransen HP, 2017, EUR J PUBLIC HEALTH, V27, P274, DOI 10.1093/eurpub/ckw190; Fraser LK, 2011, INT J OBESITY, V35, P1325, DOI 10.1038/ijo.2011.120; Freedman LS, 2011, J NATL CANCER I, V103, P1086, DOI 10.1093/jnci/djr189; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Ganzeboom H.B.G., 2010, ISCO08; Cabrera SG, 2015, NUTR HOSP, V32, P2390, DOI 10.3305/nh.2015.32.6.9828; Godos J, 2017, INT J FOOD SCI NUTR, V68, P138, DOI 10.1080/09637486.2016.1221900; Hupkens CLH, 2000, EUR J PUBLIC HEALTH, V10, P108, DOI 10.1093/eurpub/10.2.108; International Labour Organization, 2012, INT STAND CLAS OCC S; Johansen A, 2006, SCAND J PUBLIC HEALT, V34, P32, DOI 10.1080/14034940510032158; Garcia-Meseguer MJ, 2014, APPETITE, V78, P156, DOI 10.1016/j.appet.2014.03.020; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Leon-Munoz LM, 2012, J NUTR, V142, P1843, DOI 10.3945/jn.112.164616; Mangiafico S.S., 2015, R COMPANION HDB BIOL; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Martinez-Lacoba R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6149-3; Martinez-Lacoba R, 2018, EUR J PUBLIC HEALTH, V28, P955, DOI 10.1093/eurpub/cky113; McDonald JH, 2009, HDB BIOL STAT, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; McInerney M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3631-7; Michels N, 2018, EUR J NUTR, V57, P951, DOI 10.1007/s00394-017-1380-8; Microsoft, 2016, EXC 2016; Bernardez MM, 2013, NUTR HOSP, V28, P2099, DOI [10.3305/nh.2013.28.6.6940, 10.3305/nutr hosp.v28in06.6940]; Moreno-Gomez C, 2012, PUBLIC HEALTH NUTR, V15, P2131, DOI 10.1017/S1368980012000080; Nedo E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-60; Nilsen SM, 2010, EUR J PUBLIC HEALTH, V20, P299, DOI 10.1093/eurpub/ckp137; OECD, 2007, GLOSS STAT TERMS; Pedersen AB, 2017, CLIN EPIDEMIOL, V9, P157, DOI 10.2147/CLEP.S129785; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Perez-Gallardo L, 2015, NUTR HOSP, V31, P2230, DOI 10.3305/nh.2015.31.5.8614; Rhee JJ, 2015, AM J EPIDEMIOL, V181, P225, DOI 10.1093/aje/kwu308; Rizo-Baeza MM, 2014, NUTR HOSP, V29, P153, DOI 10.3305/nh.2014.29.1.6761; Rstudio Team, 2015, RSTUDIO INT DEV R; Ryden PJ, 2011, PUBLIC HEALTH NUTR, V14, P1680, DOI 10.1017/S1368980010003642; Schulz W., 2005, ANNU M AM EDUC RES; Sofi F, 2017, INT J FOOD SCI NUTR, V68, P757, DOI 10.1080/09637486.2017.1287884; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169; Stockburger D. W., 2016, MULTIVARIATE STAT CO; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; SurveyMonkey, 2012, SURVEYMONKEY FREE ON; Thorpe MG, 2014, PUBLIC HEALTH NUTR, V17, P1767, DOI 10.1017/S1368980013001924; Urbanos-Garrido RM, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-77; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vathesatogkit P, 2014, J EPIDEMIOL COMMUN H, V68, P375, DOI 10.1136/jech-2013-203053; Vioque J, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-26; Vuille JC, 2001, EUR J PUBLIC HEALTH, V11, P287, DOI 10.1093/eurpub/11.3.287; WHO, 2003, WHO TECH REP SER, V916, P1; Wilkinson R., 2003, Social determinants of health: the solid facts; Willet W., 1998, NUTR EPIDEMIOLOGY, P74, DOI DOI 10.1093/ACPROF:OSO/9780195122978.001.0001; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	70	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227620	10.1371/journal.pone.0227620	http://dx.doi.org/10.1371/journal.pone.0227620			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999722	gold, Green Published			2022-12-26	WOS:000534612400023
J	Naert, T; Dimitrakopoulou, D; Tulkens, D; Demuynck, S; Carron, M; Noelanders, R; Eeckhout, L; Van Isterdael, G; Deforce, D; Vanhove, C; Van Dorpe, J; Creytens, D; Vleminckx, K				Naert, Thomas; Dimitrakopoulou, Dionysia; Tulkens, Dieter; Demuynck, Suzan; Carron, Marjolein; Noelanders, Rivka; Eeckhout, Liza; Van Isterdael, Gert; Deforce, Dieter; Vanhove, Christian; Van Dorpe, Jo; Creytens, David; Vleminckx, Kris			RBL1 (p107) functions as tumor suppressor in glioblastoma and small-cell pancreatic neuroendocrine carcinoma in Xenopus tropicalis	ONCOGENE			English	Article							RETINOBLASTOMA PROTEIN; GENOMIC PROFILES; HIGH-GRADE; BETA-CELL; P53; INACTIVATION; TP53; DELETION; MICE; PRB	Alterations of the retinoblastoma and/or the p53 signaling network are associated with specific cancers such as high-grade astrocytoma/glioblastoma, small-cell lung cancer (SCLC), choroid plexus tumors, and small-cell pancreatic neuroendocrine carcinoma (SC-PaNEC). However, the intricate functional redundancy between RB1 and the related pocket proteins RBL1/p107 and RBL2/p130 in suppressing tumorigenesis remains poorly understood. Here we performed lineage-restricted parallel inactivation of rb1 and rbl1 by multiplex CRISPR/Cas9 genome editing in the true diploid Xenopus tropicalis to gain insight into this in vivo redundancy. We show that while rb1 inactivation is sufficient to induce choroid plexus papilloma, combined rb1 and rbl1 inactivation is required and sufficient to drive SC-PaNEC, retinoblastoma and astrocytoma. Further, using a novel Li-Fraumeni syndrome-mimicking tp53 mutant X. tropicalis line, we demonstrate increased malignancy of rb1/rbl1-mutant glioma towards glioblastoma upon concomitant inactivation of tp53. Interestingly, although clinical SC-PaNEC samples are characterized by abnormal p53 expression or localization, in the current experimental models, the tp53 status had little effect on the establishment and growth of SC-PaNEC, but may rather be essential for maintaining chromosomal stability. SCLC was only rarely observed in our experimental setup, indicating requirement of additional or alternative oncogenic insults. In conclusion, we used CRISPR/Cas9 to delineate the tumor suppressor properties of Rbl1, generating new insights in the functional redundancy within the retinoblastoma protein family in suppressing neuroendocrine pancreatic cancer and glioma/glioblastoma.	[Naert, Thomas; Dimitrakopoulou, Dionysia; Tulkens, Dieter; Demuynck, Suzan; Carron, Marjolein; Noelanders, Rivka; Eeckhout, Liza; Vleminckx, Kris] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Naert, Thomas; Dimitrakopoulou, Dionysia; Tulkens, Dieter; Vanhove, Christian; Van Dorpe, Jo; Creytens, David; Vleminckx, Kris] Canc Res Inst Ghent, Ghent, Belgium; [Carron, Marjolein; Vleminckx, Kris] Univ Ghent, Ctr Med Genet, Ghent, Belgium; [Van Isterdael, Gert] VIB, VIB Ctr Inflammat Res, Ghent, Belgium; [Deforce, Dieter] Univ Ghent, Lab Pharmaceut Biotechnol, Ghent, Belgium; [Vanhove, Christian] Ghent Univ Hosp, Infin Lab, Ghent, Belgium; [Van Dorpe, Jo; Creytens, David] Univ Ghent, Dept Pathol, Ghent, Belgium; [Van Dorpe, Jo; Creytens, David] Ghent Univ Hosp, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital	Vleminckx, K (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.; Vleminckx, K (corresponding author), Canc Res Inst Ghent, Ghent, Belgium.; Vleminckx, K (corresponding author), Univ Ghent, Ctr Med Genet, Ghent, Belgium.	kris.vleminckx@irc.UGent.be	Deforce, Dieter LD/J-4725-2013; Vleminckx, Kris/AAZ-4170-2020	Deforce, Dieter LD/0000-0002-0635-661X; Vanhove, Christian/0000-0002-3988-5980; Tulkens, Dieter/0000-0003-1688-5619	Research Foundation-Flanders (FWO-Vlaanderen) [G0A1515N, G029413N]; Belgian Science Policy (Interuniversity Attraction Poles) [IAP7/07]; Concerted Research Actions from Ghent University [BOF15/GOA/011]; Hercules Foundation, Flanders [AUGE/11/14]; Desmoid Tumor Research Foundation; "Kom op tegen Kanker" (Stand up to Cancer); Flemish cancer society; VLAIO-HERMES; Research Foundation-Flanders (FWO-Vlaanderen); NIH [R24 AI059830]; VIB BioImaging Core	Research Foundation-Flanders (FWO-Vlaanderen)(FWO); Belgian Science Policy (Interuniversity Attraction Poles); Concerted Research Actions from Ghent University; Hercules Foundation, Flanders; Desmoid Tumor Research Foundation; "Kom op tegen Kanker" (Stand up to Cancer); Flemish cancer society; VLAIO-HERMES; Research Foundation-Flanders (FWO-Vlaanderen)(FWO); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VIB BioImaging Core	Research in the authors' laboratory is supported by the Research Foundation-Flanders (FWO-Vlaanderen) (grants G0A1515N and G029413N), by the Belgian Science Policy (Interuniversity Attraction Poles-IAP7/07) and by the Concerted Research Actions from Ghent University (BOF15/GOA/011). Further support was obtained by the Hercules Foundation, Flanders (grant AUGE/11/14) and the Desmoid Tumor Research Foundation. TN is funded by "Kom op tegen Kanker" (Stand up to Cancer), the Flemish cancer society and previously held PhD fellowship with VLAIO-HERMES during the course of this work. DT and MC have a PhD fellowship from the Research Foundation-Flanders (FWO-Vlaanderen). We thank the Xenopus laevis Resource for Immunobiology (Rochester, NY, NIH R24 AI059830) for the kind gift of monoclonal antibody AM20 (10A91, CD8). We are indebted to Tim Deceuninck for animal care, Kelly Lemeire for technical assistance with TUNEL staining. We would like to thank the VIB BioImaging Core, and in particular Chris Guerin, Eef Parthoens, and Anneke Kremer, for access to the instrument park, training, and support.	Abou-El-Ardat K, 2017, NEURO-ONCOLOGY, V19, P546, DOI 10.1093/neuonc/now231; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Basturk O, 2015, AM J SURG PATHOL, V39, P683, DOI 10.1097/PAS.0000000000000408; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Boel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30330; Bougeard G, 2015, J CLIN ONCOL, V33, P2345, DOI 10.1200/JCO.2014.59.5728; Cai EP, 2014, DIABETOLOGIA, V57, P2555, DOI 10.1007/s00125-014-3381-y; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Chow RD, 2017, NAT NEUROSCI, V20, P1329, DOI 10.1038/nn.4620; Costa C, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00307; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eischen CM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026096; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Glenn ST, 2014, ONCOGENE, V33, P5706, DOI 10.1038/onc.2013.514; Hann CL, 2008, ONCOLOGY-NY, V22, P1486; Harb G, 2009, DIABETES, V58, P1852, DOI 10.2337/db08-0759; Ignatius MS, 2018, ELIFE, V7, DOI 10.7554/eLife.37202; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Konukiewitz B, 2017, MODERN PATHOL, V30, P587, DOI 10.1038/modpathol.2016.217; Liu F, 2014, ONCOGENE, V33, P4813, DOI 10.1038/onc.2013.428; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu XD, 2001, MOL CELL BIOL, V21, P6017, DOI 10.1128/MCB.21.17.6017-6030.2001; Manning AL, 2014, ONCOGENE, V33, P2487, DOI 10.1038/onc.2013.201; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Marino S, 2000, GENE DEV, V14, P994; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Naert T, 2019, CRISPR NSID IN VIVO, DOI DOI 10.1101/595769V1; Naert Thomas, 2018, Drug Discov Today Technol, V28, P41, DOI 10.1016/j.ddtec.2018.07.001; Naert T, 2018, METHODS MOL BIOL, V1865, P33, DOI 10.1007/978-1-4939-8784-9_3; Naert T, 2017, GENESIS, V55, DOI 10.1002/dvg.23005; Naert T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35264; Neely HR, 2018, EUR J IMMUNOL, V48, P430, DOI 10.1002/eji.201747260; Pan D, 2017, ONCOTARGET, V8, P4422, DOI 10.18632/oncotarget.12647; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Schmid RS, 2016, NEURO-ONCOLOGY, V18, P962, DOI 10.1093/neuonc/nov321; Shi ZY, 2019, FASEB J, V33, P6962, DOI 10.1096/fj.201802661R; Shim J, 2017, ONCOTARGET, V8, P55280, DOI 10.18632/oncotarget.19424; Solin SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13745; Steed TC, 2016, ONCOTARGET, V7, P24899, DOI 10.18632/oncotarget.8551; Strecker J, 2019, SCIENCE, V365, P48, DOI 10.1126/science.aax9181; Tabori U, 2010, J CLIN ONCOL, V28, P1995, DOI 10.1200/JCO.2009.26.8169; Tong YA, 2015, CANCER CELL, V27, P712, DOI 10.1016/j.ccell.2015.04.005; Vanderluit JL, 2007, J CELL BIOL, V178, P129, DOI 10.1083/jcb.200703176; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANZOEST ID, 1989, GEN COMP ENDOCR, V76, P19, DOI 10.1016/0016-6480(89)90028-2; Vasavada RC, 2007, DIABETES, V56, P57, DOI 10.2337/db06-0517; Vitucci M, 2017, NEURO-ONCOLOGY, V19, P1237, DOI 10.1093/neuonc/nox050; Ward JM, 1999, LAB INVEST, V79, P3; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Wojton J, 2013, MOL THER, V21, P1517, DOI 10.1038/mt.2013.114; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; Yachida S, 2012, AM J SURG PATHOL, V36, P173, DOI 10.1097/PAS.0b013e3182417d36	57	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2692	2706		10.1038/s41388-020-1173-z	http://dx.doi.org/10.1038/s41388-020-1173-z		JAN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32001819	Green Submitted			2022-12-26	WOS:000510328400001
J	Ruder, B; Gunther, C; Sturzl, M; Neurath, MF; Cesarman, E; Ballon, G; Becker, C				Ruder, Barbara; Guenther, Claudia; Stuerzl, Michael; Neurath, Markus Friedrich; Cesarman, Ethel; Ballon, Gianna; Becker, Christoph			Viral FLIP blocks Caspase-8 driven apoptosis in the gut in vivo	PLOS ONE			English	Article							NF-KAPPA-B; CELL-DEATH; C-FLIP; NECROPTOSIS; MODULATION; ACTIVATION; SURVIVAL; SIGNALS; VFLIP; FORM	A strict cell death control in the intestinal epithelium is indispensable to maintain barrier integrity and homeostasis. In order to achieve a balance between cell proliferation and cell death, a tight regulation of Caspase-8, which is a key player in controlling apoptosis, is required. Caspase-8 activity is regulated by cellular FLIP proteins. These proteins are expressed in different isoforms (cFLIP(long) and cFLIP(short)) which determine cell death and survival. Interestingly, several viruses encode FLIP proteins, homologous to cFLIP(short), which are described to regulate Caspase-8 and the host cell death machinery. In the current study a mouse model was generated to show the impact of viral FLIP (vFLIP) from Kaposi's Sarcoma-associated Herpesvirus (KSHV)/ Human Herpesvirus-8 (HHV-8) on cell death regulation in the gut. Our results demonstrate that expression of vFlip in intestinal epithelial cells suppressed cFlip expression, but protected mice from lethality, tissue damage and excessive apoptotic cell death induced by genetic cFlip deletion. Finally, our model shows that vFlip expression decreases cFlip mediated Caspase-8 activation in intestinal epithelial cells. In conclusion, our data suggests that viral FLIP neutralizes and compensates for cellular FLIP, efficiently counteracting host cell death induction and facilitating further propagation in the host organism.	[Ruder, Barbara; Guenther, Claudia; Neurath, Markus Friedrich; Becker, Christoph] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany; [Stuerzl, Michael] Univ Erlangen Nurnberg, Div Mol & Expt Surg, Dept Surg, Erlangen, Germany; [Cesarman, Ethel] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Ballon, Gianna] Cooper Univ Hlth Care, Dept Pathol & Lab Serv, Camden, NY USA	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Cornell University	Becker, C (corresponding author), Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany.	Christoph.becker@uk-erlangen.de	Stürzl, Michael/B-3019-2015; Becker, Christoph/L-2996-2016; Becker, Christoph/A-6694-2008	Stürzl, Michael/0000-0002-9276-2824; Becker, Christoph/0000-0002-1388-1041	DFG [SFB796, SFB1181, TRR241, SPP1656, KFO257, FOR2438, FOR2886, BE3686/2, GU 1431/1-2]; Interdisciplinary Centre for Clinical Research (IZKF) of the University Erlangen-Nurnberg [J78, P056, A75]	DFG(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research (IZKF) of the University Erlangen-Nurnberg	This work received funding from the DFG projects SFB796 (B07, B09) to CB, MS and MFN, SFB1181 (B02, C05) to CB and MFN, TRR241 (A02, A03, A06, C04) to CB, MS, CG, and MFN, SPP1656 to CB, CG, and MFN, KFO257 (TP01, TP05, TP08) to CB, MS, and MFN, the FOR2438 (P2, P5, P8) to CB, MS, and MFN, FOR2886 (A02) to CG and individual grants BE3686/2 to CB and GU 1431/1-2 to CG. Furthermore the work was supported by the Interdisciplinary Centre for Clinical Research (IZKF, J78, P056, A75) of the University Erlangen-Nurnberg to BR and CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Ballon G, 2011, J CLIN INVEST, V121, P1141, DOI 10.1172/JCI44417; Belanger C, 2001, J HUMAN VIROL, V4, P62; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Delgado ME, 2016, FEBS J, V283, P2701, DOI 10.1111/febs.13575; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feoktistova M, 2012, CELL CYCLE, V11, P460, DOI 10.4161/cc.11.3.19060; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Gunther C, 2015, GUT, V64, P601, DOI 10.1136/gutjnl-2014-307226; Gunther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kather A, 2010, J VIROL, V84, P1034, DOI 10.1128/JVI.01409-09; Konrad A, 2009, J VIROL, V83, P2563, DOI 10.1128/JVI.01512-08; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Muller DB, 2004, EUR J IMMUNOL, V34, P941, DOI 10.1002/eji.200324509; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Ruder B, 2018, MUCOSAL IMMUNOL, V11, P1621, DOI 10.1038/s41385-018-0068-6; Sander G, 2008, J VIROL, V82, P1908, DOI 10.1128/JVI.01716-07; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Shindo R, 2016, BIOCHEM BIOPH RES CO, V480, P23, DOI 10.1016/j.bbrc.2016.10.015; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tsuchiya Y, 2015, INT J MOL SCI, V16, P30321, DOI 10.3390/ijms161226232; Tummers B, 2017, IMMUNOL REV, V277, P76, DOI 10.1111/imr.12541; Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349; Wittkopf N, 2013, GASTROENTEROLOGY, V145, P1369, DOI 10.1053/j.gastro.2013.08.059; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9	34	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228441	10.1371/journal.pone.0228441	http://dx.doi.org/10.1371/journal.pone.0228441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999759	Green Published, Green Submitted, gold			2022-12-26	WOS:000534612400084
J	Wen, GP; Eder, K; Ringseis, R				Wen, Gaiping; Eder, Klaus; Ringseis, Robert			1,25-hydroxyvitamin D3 decreases endoplasmic reticulum stress-induced inflammatory response in mammary epithelial cells	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; 1,25-DIHYDROXYVITAMIN D-3; ER STRESS; SYMPORTER EXPRESSION; GENE-EXPRESSION; ACTIVATION; ACID; METABOLISM	Recent studies indicated that intramammary administration of active vitamin D-3 hormone (1,25D(3)) inhibits the inflammatory process associated with mastitis. We hypothesized that attenuation of endoplasmic reticulum (ER) stress by 1,25D(3) in mammary epithelial cells (MECs) is an important cellular mechanism contributing to this beneficial effect of intramammary treatment with 1,25D(3). To test this hypothesis, the effect of 1,25D(3) was studied on induction of ER stress in a transformed human MEC line, MCF-7 cells. Treatment with two different ER stress inducers, thapsigargin (TG) and tunicamycin (TM), caused a dose-dependent induction of ER stress as evident from up-regulation of protein kinase RNA-like ER kinase (PERK), heat shock protein family A (Hsp70) member 5 (HSPA5), activating transcription factor (ATF4), ATF6, DNA damage inducible transcript 3 (DDIT3) and spliced X-box binding protein 1 (sXBP1) and impaired cell viability and decreased expression of vitamin D receptor (VDR) in MCF-7 cells (P < 0.05). Treatment with 1,25D(3) (100 nM) inhibited TG (10 nM)-and TM (1 mu g/mL)-induced mRNA and/or protein levels of ATF4, ATF6, DDIT3 and HSPA5 in MCF-7 cells (P < 0.05). In addition, 1,25D(3) (100 nM) antagonized the effect of TG (10 nM) and TM (1 mu g/mL) on mRNA and protein levels of VDR and mRNA levels of genes involved in production and degradation of 1,25D(3) in MCF-7 cells (P < 0.05). Moreover, 1,25D(3) (100 nM) inhibited nuclear factor-kappa B (NF-kappa B) activation in response to TM (10 nM) and TG (1 mu g/mL) in MCF-7 cells. In conclusion, the present findings show that 1,25D(3) is effective in attenuating ER stress and the NF-kappa B-driven inflammatory response in MCF-7 cells. This indicates that attenuation of ER stress by 1,25D(3) in MECs may contribute to the recently observed inhibitory effect of intramammary treatment of dairy cows with 1,25D(3) on the inflammatory process associated with mastitis.	[Wen, Gaiping; Eder, Klaus; Ringseis, Robert] Justus Liebig Univ Giessen, Inst Anim Nutr & Nutr Physiol, Giessen, Germany	Justus Liebig University Giessen	Ringseis, R (corresponding author), Justus Liebig Univ Giessen, Inst Anim Nutr & Nutr Physiol, Giessen, Germany.	robert.ringseis@ernaehrung.uni-giessen.de	Ringseis, Robert/AAH-1509-2021					Abu el Maaty MA, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0183-6; Akers RM, 2011, J MAMMARY GLAND BIOL, V16, P275, DOI 10.1007/s10911-011-9231-3; Arturi F, 2005, J CLIN ENDOCR METAB, V90, P2321, DOI 10.1210/jc.2004-1562; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Chen J, 2018, FOOD FUNCT, V9, P2386, DOI [10.1039/c7fo01406f, 10.1039/C7FO01406F]; Chiappisi E, 2017, J DAIRY SCI, V100, P6689, DOI 10.3168/jds.2016-12406; Damiano F, 2010, BIOCHEM J, V429, P603, DOI 10.1042/BJ20091827; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; Dhawan P, 2005, MOL CELL BIOL, V25, P472, DOI 10.1128/MCB.25.1.472-487.2005; Diesing D, 2006, ANTICANCER RES, V26, P2755; Doehring C, 2019, PREV VET MED, V165, P63, DOI 10.1016/j.prevetmed.2019.02.004; Fan P, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0012-7; Griesbeck-Zilch B, 2008, J DAIRY SCI, V91, P2215, DOI 10.3168/jds.2007-0752; Gunther J, 2010, VET IMMUNOL IMMUNOP, V135, P152, DOI 10.1016/j.vetimm.2009.11.004; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Haas MJ, 2016, FREE RADICAL BIO MED, V99, P1, DOI 10.1016/j.freeradbiomed.2016.07.020; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Invernizzi G, 2012, J DAIRY SCI, V95, P2562, DOI 10.3168/jds.2011-4806; Invernizzi G, 2010, FUNCT INTEGR GENOMIC, V10, P561, DOI 10.1007/s10142-010-0179-y; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Koc M, 2015, BIOCHEM BIOPH RES CO, V460, P684, DOI 10.1016/j.bbrc.2015.03.090; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee SM, 2015, J BIOL CHEM, V290, P30573, DOI 10.1074/jbc.M115.693614; Leonardi A, 2002, ENDOCRINOLOGY, V143, P2169, DOI 10.1210/en.143.6.2169; Lippolis JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025479; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Mengesdorf T, 2001, BIOCHEM J, V356, P805, DOI 10.1042/0264-6021:3560805; Merriman KE, 2018, J DAIRY SCI, V101, P7593, DOI 10.3168/jds.2017-14143; Merriman KE, 2017, J STEROID BIOCHEM, V173, P33, DOI 10.1016/j.jsbmb.2017.02.006; Merriman KE, 2015, J STEROID BIOCHEM, V154, P120, DOI 10.1016/j.jsbmb.2015.08.002; Moloney JN, 2018, SEMIN CELL DEV BIOL, V80, P50, DOI 10.1016/j.semcdb.2017.05.023; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; Nelson CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015469; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Park K, 2011, J BIOL CHEM, V286, P34121, DOI 10.1074/jbc.M111.250431; Reinhardt TA, 1999, ARCH BIOCHEM BIOPHYS, V368, P244, DOI 10.1006/abbi.1999.1335; Riek AE, 2012, J BIOL CHEM, V287, P38482, DOI 10.1074/jbc.M112.386912; Rillema JA, 2000, AM J PHYSIOL-ENDOC M, V279, pE769, DOI 10.1152/ajpendo.2000.279.4.E769; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Simmons KM, 2015, J CELL BIOCHEM, V116, P1693, DOI 10.1002/jcb.25129; Singh K, 2010, J MAMMARY GLAND BIOL, V15, P101, DOI 10.1007/s10911-010-9164-2; Strandberg Y, 2005, CYTOKINE, V31, P72, DOI 10.1016/j.cyto.2005.02.010; STROM M, 1989, P NATL ACAD SCI USA, V86, P9770, DOI 10.1073/pnas.86.24.9770; Su SY, 2019, INFLAMMOPHARMACOLOGY, V27, P77, DOI 10.1007/s10787-018-0521-x; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Vo DKH, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090503; Wen GP, 2019, J AGR FOOD CHEM, V67, P4493, DOI 10.1021/acs.jafc.9b00673; Wen GP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187561; Yao C, 2015, ONCOL REP, V34, P59, DOI 10.3892/or.2015.3946; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhao X, 2008, J ANIM SCI, V86, P57, DOI 10.2527/jas.2007-0302	61	7	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228945	10.1371/journal.pone.0228945	http://dx.doi.org/10.1371/journal.pone.0228945			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040528	gold, Green Submitted, Green Published			2022-12-26	WOS:000534629400058
J	Giannakakis, E; Hutchings, F; Papasavvas, CA; Han, CE; Weber, B; Zhang, CC; Kaiser, M				Giannakakis, Emmanouil; Hutchings, Frances; Papasavvas, Christoforos A.; Han, Cheol E.; Weber, Bernd; Zhang, Chencheng; Kaiser, Marcus			Computational modelling of the long-term effects of brain stimulation on the local and global structural connectivity of epileptic patients	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; TRANSCRANIAL MAGNETIC STIMULATION; FOCUSED ULTRASOUND; COORDINATED RESET; SEIZURE; INHIBITION; PLASTICITY; TDCS; DISRUPTION; DISEASE	Computational studies of the influence of different network parameters on the dynamic and topological network effects of brain stimulation can enhance our understanding of different outcomes between individuals. In this study, a brain stimulation session along with the subsequent post-stimulation brain activity is simulated for a period of one day using a network of modified Wilson-Cowan oscillators coupled according to diffusion imaging based structural connectivity. We use this computational model to examine how differences in the interregion connectivity and the excitability of stimulated regions at the time of stimulation can affect post-stimulation behaviours. Our findings indicate that the initial inter-region connectivity can heavily affect the changes that stimulation induces in the connectivity of the network. Moreover, differences in the excitability of the stimulated regions seem to lead to different post-stimulation connectivity changes across the model network, including on the internal connectivity of non-stimulated regions.	[Giannakakis, Emmanouil; Hutchings, Frances; Papasavvas, Christoforos A.; Kaiser, Marcus] Newcastle Univ, Sch Comp, Interdisciplinary Comp & Complex BioSyst ICOS Res, Newcastle Upon Tyne, Tyne & Wear, England; [Han, Cheol E.] Korea Univ, Dept Elect & Informat Engn, Sejong, South Korea; [Weber, Bernd] Univ Bonn, Inst Expt Epileptol & Cognit Res, Bonn, Germany; [Zhang, Chencheng; Kaiser, Marcus] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Funct Neurosurg, Shanghai, Peoples R China; [Kaiser, Marcus] Newcastle Univ, Inst Neurosci, Henry Wellcome Bldg, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Korea University; University of Bonn; Shanghai Jiao Tong University; Newcastle University - UK	Giannakakis, E (corresponding author), Newcastle Univ, Sch Comp, Interdisciplinary Comp & Complex BioSyst ICOS Res, Newcastle Upon Tyne, Tyne & Wear, England.	giannakakismanos@gmail.com	Zhang, ChenCheng/AAK-6096-2020; Kaiser, Marcus/A-7166-2008; Han, Cheol/AAR-9212-2021; Weber, Bernd/H-5244-2012	Zhang, ChenCheng/0000-0003-4472-4134; Kaiser, Marcus/0000-0002-4654-3110; Weber, Bernd/0000-0002-7811-9605; Papasavvas, Christoforos/0000-0001-9122-2925; Han, Cheol/0000-0002-9994-6861; Emmanouil, Giannakakis/0000-0001-5636-5824	CANDO project through the Wellcome Trust [102037]; EPSRC [NS/A000026/1]; Portabolomics project through EPSRC [EP/N031962/1]; Guangci Professorship Program of Ruijin Hospital (Shanghai Jiao Tong University); EPSRC [EP/N031962/1] Funding Source: UKRI; MRC [MR/T004347/1] Funding Source: UKRI	CANDO project through the Wellcome Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Portabolomics project through EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Guangci Professorship Program of Ruijin Hospital (Shanghai Jiao Tong University); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MK was supported by the CANDO project (http://www.cando.ac.uk/) funded through the Wellcome Trust (102037) and EPSRC (NS/A000026/1), by the Portabolomics project funded through EPSRC (EP/N031962/1), and funded by the Guangci Professorship Program of Ruijin Hospital (Shanghai Jiao Tong University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Auvichayapat N, 2013, BRAIN STIMUL, V6, P696, DOI 10.1016/j.brs.2013.01.009; Baxter BS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00691; Bojak I, 2010, BRAIN TOPOGR, V23, P139, DOI 10.1007/s10548-010-0140-3; Boon P, 2018, CURR OPIN NEUROL, V31, P198, DOI 10.1097/WCO.0000000000000534; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Chamberland S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00165; Chen KHS, 2019, CLIN PHARMACOL THER, V106, P763, DOI 10.1002/cpt.1542; Chen XY, 2018, NEUROSCI BULL, V34, P921, DOI 10.1007/s12264-018-0256-0; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Denslow S, 2005, BIOL PSYCHIAT, V57, P752, DOI 10.1016/j.biopsych.2004.12.017; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dmochowski JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046011; Dutta A, 2013, 2013 6 INT IEEE EMBS; Einarsson H, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00033; Farisco M, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00585; Fischl B, 2004, CORTEX, DOI [10.1093/cercor/bhg087, DOI 10.1093/CERCOR/BHG087]; Fregni F, 2006, EPILEPSIA, V47, P335, DOI 10.1111/j.1528-1167.2006.00426.x; Grohn H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01260; Gschwind M, 2016, EXPERT REV NEUROTHER, V16, P1427, DOI 10.1080/14737175.2016.1209410; Halassa MM, 2016, TRENDS NEUROSCI, V39, P680, DOI 10.1016/j.tins.2016.08.001; Helmstaedter C, 2004, EPILEPSY BEHAV, V5, pS45, DOI 10.1016/j.yebeh.2003.11.006; Hutchings F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004642; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Karvigh SA, 2017, SEIZURE-EUR J EPILEP, V47, P74, DOI 10.1016/j.seizure.2017.03.005; Lang AE, 2000, ARCH NEUROL-CHICAGO, V57, P1118, DOI 10.1001/archneur.57.8.1118; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liebetanz D, 2006, EPILEPSIA, V47, P1216, DOI 10.1111/j.1528-1167.2006.00539.x; Maschio M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-60; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; Mendonca ME, 2011, J PAIN, V12, P610, DOI 10.1016/j.jpain.2010.12.015; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Molaee-Ardekani B, 2013, BRAIN STIMUL, V6, P25, DOI 10.1016/j.brs.2011.12.006; Mori S, 2002, ANAT REC, V257, P102, DOI [10.1002/(SICI)1097-0185(19990615)257, DOI 10.1002/(SICI)1097-0185(19990615)257]; Nardone R, 2014, J SPINAL CORD MED, V37, P19, DOI 10.1179/2045772313Y.0000000140; Ng Yi Shiau, 2018, Epilepsia Open, V3, P103, DOI 10.1002/epi4.12094; Nonnekes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107731; Papasavvas CA, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032723; Payne DE, 2018, EPILEPSIA, V59, P1027, DOI 10.1111/epi.14065; Paz JT, 2015, NAT NEUROSCI, V18, P351, DOI 10.1038/nn.3950; Regner GG, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00189; San-Juan D, 2017, BRAIN STIMUL, V10, P28, DOI 10.1016/j.brs.2016.08.013; San-Juan D, 2015, BRAIN STIMUL, V8, P455, DOI 10.1016/j.brs.2015.01.001; Schutter DJLG, 2005, J PSYCHIATR NEUROSCI, V30, P91; Sinha N, 2017, BRAIN, V140, P319, DOI 10.1093/brain/aww299; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Susumu MM, 2002, NMR BIOMED, V15, P468, DOI [10.1002/nbm.781, DOI 10.1002/NBM.781]; Tass PA, 2003, BIOL CYBERN, V89, P81, DOI [10.1007/s00422-003-0425-7, 10.1007/S00422-003-0425-7]; Tass PA, 2012, ANN NEUROL, V72, P816, DOI 10.1002/ana.23663; Taylor PN, 2015, NEUROIMAGE-CLIN, V8, P322, DOI 10.1016/j.nicl.2015.02.004; Taylor PN, 2013, BIOL CYBERN, V107, P83, DOI 10.1007/s00422-012-0534-2; Tecchio F, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00044; Tekturk P, 2016, CLIN NEUROL NEUROSUR, V149, P27, DOI 10.1016/j.clineuro.2016.07.014; Urquhart BL, 2009, EUR J CLIN PHARMACOL, V65, P1063, DOI 10.1007/s00228-009-0714-8; van den Heuvel MP, 2015, HUM BRAIN MAPP, V36, P3064, DOI 10.1002/hbm.22828; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Vogels TP, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00119; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Wang M, 2019, WORK AGING RETIRE, V5, P1, DOI 10.1093/workar/way018; Wang R., 2007, DIFFUSION TOOLKIT SO; Woods AJ, 2016, CLIN NEUROPHYSIOL, V127, P1031, DOI 10.1016/j.clinph.2015.11.012; Yook SW, 2011, ANN REHABIL MED-ARM, V35, P579, DOI 10.5535/arm.2011.35.4.579; Yoon HH, 2003, NEUROLOGY, V61, P445, DOI 10.1212/01.WNL.0000081226.51886.5B; Zenke F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003330; Zoghi M, 2016, BRAIN STIMUL, V9, P790, DOI 10.1016/j.brs.2016.05.011	67	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0221380	10.1371/journal.pone.0221380	http://dx.doi.org/10.1371/journal.pone.0221380			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027654	Green Published, Green Submitted, gold			2022-12-26	WOS:000534623800005
J	Hsu, YW; Liang, CS; Lee, JT; Chu, HT; Lee, MS; Tsai, CL; Lin, GY; Lin, YK; Ho, TH; Yang, FC				Hsu, Yu-Wei; Liang, Chih-Sung; Lee, Jiunn-Tay; Chu, Hsuan-Te; Lee, Meei-Shyuan; Tsai, Chia-Lin; Lin, Guan-Yu; Lin, Yu-Kai; Ho, Tsung-Han; Yang, Fu-Chi			Associations between migraine occurrence and the effect of aura, age at onset, family history, and sex: A cross-sectional study	PLOS ONE			English	Article							HEMIPLEGIC MIGRAINE; HOSPITAL ANXIETY; HEADACHE; CHILDREN; DISEASE; METAANALYSIS; PREVALENCE; DISABILITY; MUTATIONS; FREQUENCY	Introduction The relationships between family history, sex, age at onset, and migraine occurrence have been documented. However, the associations between these factors across different sexes and subgroups of patients have yet to be elucidated. This study evaluated the association between family history and migraine in male and female patients experiencing episodic and chronic migraine with and without aura. Methods This cross-sectional, case-control study included 299 headache-free controls and 885 patients receiving outpatient treatment for migraine. Participants were classified into episodic (1-14 days/month) and chronic (>= 15 days/month) migraine groups. Results Positive family history was significantly more frequently observed in the episodic group than in the chronic group (49.5% vs. 26%; P < 0.001) in male patients, particularly in male patients without aura (50.3% vs. 21.9%; P = 0.003); it was less frequently observed (58.7% vs. 73.7%; P = 0.048) in female patients with aura. Family history was correlated with an earlier age at onset (20.7 years vs. 22.8 years; P = 0.002), particularly in patients without aura (21 years vs. 23.7 years; P = 0.002), who were women (20.9 years vs. 23.9 years; P = 0.002). Conclusions Different patterns of association between family history and migraine can be observed between men and women. A positive family history of migraine is correlated with an earlier age at onset, particularly among female patients without aura.	[Hsu, Yu-Wei; Lee, Jiunn-Tay; Tsai, Chia-Lin; Lin, Guan-Yu; Lin, Yu-Kai; Ho, Tsung-Han; Yang, Fu-Chi] Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol, Taipei, Taiwan; [Liang, Chih-Sung; Chu, Hsuan-Te] Triserv Gen Hosp, Natl Def Med Ctr, Dept Psychiat, Beitou Branch, Taipei, Taiwan; [Lee, Meei-Shyuan] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Yang, FC (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol, Taipei, Taiwan.	fuji-yang@yahoo.com.tw	Liang, Chih-Sung/V-6720-2019	Liang, Chih-Sung/0000-0003-1138-5586; Hsu, Yu-Wei/0000-0003-4983-835X; Yang, Fu-Chi/0000-0001-6831-3634	Ministry of Science and Technology of Taiwan [MOST 105-2314-B-016-004-, MOST 106-2314-B-016-007-MY2, MOST 106-2221-E-010-011-, MOST 108-2314-B-0160-23-]; Tri-Service General Hospital, Taiwan [TSGH-C101-159, TSGH-C106-068, TSGH-C107-072, TSGH-C108-100]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, Taiwan	Initials of the authors who received each award: FCY. This project was supported in part by grants from: The Ministry of Science and Technology of Taiwan (MOST 105-2314-B-016-004-, MOST 106-2314-B-016-007-MY2, MOST 106-2221-E-010-011-, MOST 108-2314-B-0160-23-) and Tri-Service General Hospital, Taiwan (TSGH-C101-159, TSGH-C106-068, TSGH-C107-072, TSGH-C108-100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2014, SLEEP MED, V15, P860, DOI 10.1016/j.sleep.2014.03.025; Arnold M, 2018, CEPHALALGIA, V38, P1; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chambers CT, 2002, J PEDIATR PSYCHOL, V27, P293, DOI 10.1093/jpepsy/27.3.293; Chia R, 2018, LANCET NEUROL, V17, P94, DOI 10.1016/S1474-4422(17)30401-5; Chu HT, 2018, HEADACHE, V58, P407, DOI 10.1111/head.13215; Cologno D, 2003, HEADACHE, V43, P231, DOI 10.1046/j.1526-4610.2003.03046.x; Damasio A., 2019, STRANGE ORDER THINGS; de Vries B, 2016, CEPHALALGIA, V36, P604, DOI 10.1177/0333102414566820; Debette S, 2011, NEUROLOGY, V77, P1174, DOI 10.1212/WNL.0b013e31822f03fc; Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007; Eidlitz-Markus T, 2018, J CHILD NEUROL, V33, P92, DOI 10.1177/0883073817739197; Eidlitz-Markus T, 2015, CEPHALALGIA, V35, P722, DOI 10.1177/0333102414554114; Eising E, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-26; Ferrari A, 2007, HEADACHE, V47, P65, DOI 10.1111/j.1526-4610.2006.00629.x; Fisher E, 2014, J PEDIATR PSYCHOL, V39, P763, DOI 10.1093/jpepsy/jsu008; Genizi J, 2016, HEADACHE, V56, P113, DOI 10.1111/head.12741; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; Groholt EK, 2003, EUR J EPIDEMIOL, V18, P965, DOI 10.1023/A:1025889912964; Jen JC, 2004, ARCH NEUROL-CHICAGO, V61, P926, DOI 10.1001/archneur.61.6.926; Kelman L, 2004, CEPHALALGIA, V24, P728, DOI 10.1111/j.1468-2982.2004.00748.x; Kindelan-Calvo P, 2014, PAIN MED, V15, P1619, DOI 10.1111/pme.12505; Koneczny I, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070671; Lemos C, 2009, HEADACHE, V49, P404, DOI 10.1111/j.1526-4610.2008.01177.x; Liao KY-H, 2016, J BEHAV HLTH, V5, P75, DOI [10.5455/jbh.20160204094059, DOI 10.5455/jbh.20160204094059]; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Magalhaes JE, 2019, HEADACHE, V59, P77, DOI 10.1111/head.13460; Martin Ralf Dittrich., 2012, ULTRASOUND SPONTANEO, V1, P250; Montagna P, 2003, NEUROL SCI, V24, pS51; O'Connell C, 2019, CLIN CHILD PSYCHOL P; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; OSBORNE RB, 1989, J PEDIATR PSYCHOL, V14, P43, DOI 10.1093/jpepsy/14.1.43; Papetti L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00092; Pelzer N, 2018, NEUROLOGY, V90, pE575, DOI 10.1212/WNL.0000000000004966; PENG GS, 1996, J MED ULTRASOUND, V4, P174; Roos-Araujo D, 2014, GENE, V543, P1, DOI 10.1016/j.gene.2014.04.001; Russell MB, 1996, BRAIN, V119, P355, DOI 10.1093/brain/119.2.355; RUSSELL MB, 1995, BRIT MED J, V311, P541, DOI 10.1136/bmj.311.7004.541; RUSSELL MB, 1993, NEUROLOGY, V43, P1369, DOI 10.1212/WNL.43.7.1369; Russell MB, 1996, CEPHALALGIA, V16, P305, DOI 10.1046/j.1468-2982.1996.1605305.x; Schwedt TJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1416; Stark RJ, 2013, CEPHALALGIA, V33, P266, DOI 10.1177/0333102412468677; Stewart WF, 1999, NEUROLOGY, V53, P988, DOI 10.1212/WNL.53.5.988; Stewart WF, 2006, NEUROLOGY, V66, P344, DOI 10.1212/01.wnl.0000196640.71600.00; Stewart WF, 2001, NEUROLOGY, V56, pS20, DOI 10.1212/WNL.56.suppl_1.S20; Stovner LJ, 2018, LANCET NEUROL, V17, P954, DOI [10.1016/S1474-4422(18)30322-3, 10.1016/S1474-4422(18)30499-X]; Stovner LJ, 2010, J HEADACHE PAIN, V11, P289, DOI 10.1007/s10194-010-0217-0; Sung YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080675; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Torriero R, 2017, CEPHALALGIA, V37, P947, DOI 10.1177/0333102416660533; Yang CP, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0641-9; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228284	10.1371/journal.pone.0228284	http://dx.doi.org/10.1371/journal.pone.0228284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9FN	32023286	Green Published, gold			2022-12-26	WOS:000534621500046
J	Stinnesbeck, W; Rennie, SR; Olguin, JA; Stinnesbeck, SR; Gonzalez, S; Frank, N; Warken, S; Schorndorf, N; Krengel, T; Morlet, AV; Gonzalez, AG				Stinnesbeck, Wolfgang; Rennie, Samuel R.; Olguin, Jeronimo Aviles; Stinnesbeck, Sarah R.; Gonzalez, Silvia; Frank, Norbert; Warken, Sophie; Schorndorf, Nils; Krengel, Thomas; Morlet, Adriana Velazquez; Gonzalez, Arturo Gonzalez			New evidence for an early settlement of the Yucatan Peninsula, Mexico: The Chan Hol 3 woman and her meaning for the Peopling of the Americas	PLOS ONE			English	Article							SEA-LEVEL RISE; STRONTIUM ISOTOPES; LATE PLEISTOCENE; LAGOA-SANTA; MORPHOLOGY; PALEOAMERICANS; SR-87/SR-86; MOBILITY; HUMANS; HEALTH	Human presence on the Yucatan Peninsula reaches back to the Late Pleistocene. Osteological evidence comes from submerged caves and sinkholes (cenotes) near Tulum in the Mexican state of Quintana Roo. Here we report on a new skeleton discovered by us in the Chan Hol underwater cave, dating to a minimum age of 9.9 +/- 0.1 ky BP based on Th-230/U-dating of flowstone overlying and encrusting human phalanges. This is the third Paleoindian human skeleton with mesocephalic cranial characteristics documented by us in the cave, of which a male individual named Chan Hol 2 described recently is one of the oldest human skeletons found on the American continent. The new discovery emphasizes the importance of the Chan Hol cave and other systems in the Tulum area for understanding the early peopling of the Americas. The new individual, here named Chan Hol 3, is a woman of about 30 years of age with three cranial traumas. There is also evidence for a possible trepanomal bacterial disease that caused severe alteration of the posterior parietal and occipital bones of the cranium. This is the first time that the presence of such disease is reported in a Paleoindian skeleton in the Americas. All ten early skeletons found so far in the submerged caves from the Yucatan Peninsula have mesocephalic cranial morphology, different to the dolicocephalic morphology for Paleoindians from Central Mexico with equivalent dates. This supports the presence of two morphologically different Paleoindian populations for Mexico, coexisting in different geographical areas during the Late Pleistocene-Early Holocene.	[Stinnesbeck, Wolfgang; Frank, Norbert; Warken, Sophie; Schorndorf, Nils; Krengel, Thomas] Heidelberg Univ, Inst Geowissensch, Heidelberg, Germany; [Rennie, Samuel R.; Gonzalez, Silvia] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England; [Rennie, Samuel R.] Bournemouth Univ, Dept Archaeol & Anthropol, Poole, Dorset, England; [Olguin, Jeronimo Aviles; Gonzalez, Arturo Gonzalez] Museo Desierto, Carlos Abedrop Davila Nuevo Ctr Metropolitano Sal, Saltillo, Coahuila, Mexico; [Stinnesbeck, Sarah R.] Staatl Museum Nat Kunde Karlsruhe, Geowissenschaftl Abt, Erbprinzstr, Karlsuhe, Germany; [Frank, Norbert; Warken, Sophie; Krengel, Thomas] Heidelberg Univ, Inst Umweltphys, Heidelberg, Germany; [Morlet, Adriana Velazquez] CINAH Campeche, Inst Nacl Antropol & Hist, Campeche, Campeche, Mexico	Ruprecht Karls University Heidelberg; Liverpool John Moores University; Bournemouth University; Ruprecht Karls University Heidelberg	Stinnesbeck, W (corresponding author), Heidelberg Univ, Inst Geowissensch, Heidelberg, Germany.	wolfgang.stinnesbeck@geow.uni-heidelberg.de	Warken, Sophie/AAJ-1845-2021; Frank, Norbert/D-6486-2016	Warken, Sophie/0000-0003-3293-9074; Frank, Norbert/0000-0002-0416-9546; Schorndorf, Nils/0000-0003-0043-061X; Rennie, Samuel/0000-0002-3333-6809	Internationales Buro of the German Bundesministerium fur Bildung und Forschung (BMBF) [01DN119]; Deutsche Forschungsgemeinschaft (DFG project) [STI 128/28-1, STI 128/28-2]; MC-ICPMS infra-structure [DFG-INST 35_1143-1 FUGG]; BMBF; DFG	Internationales Buro of the German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG project)(German Research Foundation (DFG)); MC-ICPMS infra-structure; BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	Financial support to this project was provided by the Internationales Buro of the German Bundesministerium fur Bildung und Forschung (BMBF project 01DN119) and the Deutsche Forschungsgemeinschaft (DFG project STI 128/28-1 and -2). This work also benefited from the support of MC-ICPMS infra-structure through grant DFG-INST 35_1143-1 FUGG. BMBF and DFG financed our field work in Mexico and provided funds for laboratory work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila Flores Ramiro, 2018, THESIS; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Beddows P. A., 2004, THESIS; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; Blanchon P, 2009, NATURE, V458, P881, DOI 10.1038/nature07933; Brothwell D.R., 1981, DIGGING BONES EXCAVA; Buikstra J, 1994, ARK ARCHEOL, V44; Castro MM, 2016, INT J PALEOPATHOL, V13, P20, DOI 10.1016/j.ijpp.2016.01.002; Chatters JC, 2014, SCIENCE, V344, P750, DOI 10.1126/science.1252619; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Cohen MN, 1984, PALEOPATHOLOGY ORIGI, P585; Collins SV, 2015, QUATERNARY SCI REV, V124, P68, DOI 10.1016/j.quascirev.2015.06.024; Cucina A, 2019, AM J PHYS ANTHROPOL, V170, P246, DOI 10.1002/ajpa.23884; Da-Gloria P, 2014, AM J PHYS ANTHROPOL, V154, P11, DOI 10.1002/ajpa.22467; De Groote I, 2011, J HUM EVOL, V60, P540, DOI 10.1016/j.jhevol.2010.09.009; Freiwald C., 2011, THESIS U WISCONSIN M; GENOVES S, 1967, AM J PHYS ANTHROPOL, V26, P67, DOI 10.1002/ajpa.1330260109; Gerszten PC, 1998, NEUROSURGERY, V42, P1145, DOI 10.1097/00006123-199805000-00114; Gonzalez A.H., 2008, CURR RES PLEISTOCENE, V25, P1; Gonzalez ArturoH., 2013, PALEOAMERICAN ODYSSE, P323; Gonzalez Gonzalez AH, 2008, UNDERWATER MARITIME, P127; Gonzalez S, 2003, J HUM EVOL, V44, P379, DOI 10.1016/S0047-2484(03)00004-6; Gonzalez-Jose R, 2005, AM J PHYS ANTHROPOL, V128, P772, DOI 10.1002/ajpa.20165; Hering F, 2018, J QUATERNARY SCI, V33, P444, DOI 10.1002/jqs.3025; Hodell DA, 2004, J ARCHAEOL SCI, V31, P585, DOI 10.1016/j.jas.2003.10.009; HORWITZ EP, 1992, SOLVENT EXTR ION EXC, V10, P313, DOI 10.1080/07366299208918107; Howells W. W., 1973, PAPERS PEABODY MUSEU; Howells WW, 1996, AM J PHYS ANTHROPOL, V101, P441, DOI 10.1002/ajpa.1331010302; HOWELLS WW, 1989, PAPERS PEABODY MUSEU, V79; Howells WW, 1995, PAPERS PEABODY MUSEU, V82; Hubbe M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138090; Iscan M.Y., 2013, HUMAN SKELETON FOREN, V3rd, P493; Kaufman MH, 1997, J ARCHAEOL SCI, V24, P193, DOI 10.1006/jasc.1995.0104; Kenyhercz MW, 2016, BIOLOGICAL DISTANCE ANALYSIS: FORENSIC AND BIOARCHAEOLOGICAL PERSPECTIVES, P181, DOI 10.1016/B978-0-12-801966-5.00009-3; Khan NS, 2017, QUATERNARY SCI REV, V155, P13, DOI 10.1016/j.quascirev.2016.08.032; Kober B, 2007, CHEM GEOL, V240, P361, DOI 10.1016/j.chemgeo.2007.03.005; Kohn MJ, 1999, GEOCHIM COSMOCHIM AC, V63, P2737, DOI 10.1016/S0016-7037(99)00208-2; LARSEN T, 1991, SCAND J INFECT DIS, V23, P89, DOI 10.3109/00365549109023379; LUDWIG KR, 1994, GEOCHIM COSMOCHIM AC, V58, P5031, DOI 10.1016/0016-7037(94)90229-1; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Moseley GE, 2015, HOLOCENE, V25, P1511, DOI 10.1177/0959683615585832; Nelson SJ, 2014, WHEELERS DENT ANATOM; Neves WA, 2005, P NATL ACAD SCI USA, V102, P18309, DOI 10.1073/pnas.0507185102; Ortega-Munoz A, 2019, J ARCHAEOL SCI-REP, V23, P490, DOI 10.1016/j.jasrep.2018.11.013; Ortner D, 1981, SMITHSONIAN CONTRIBU, P1; Pacheco AR, 2005, RESTOS OSEOS HUMANOS; Price TD, 2008, LAT AM ANTIQ, V19, P167, DOI 10.2307/25478222; Price TD, 2014, J ANTHROPOL ARCHAEOL, V36, P32, DOI 10.1016/j.jaa.2014.02.003; Price TD, 2010, J ANTHROPOL ARCHAEOL, V29, P15, DOI 10.1016/j.jaa.2009.10.001; QRSS. [QRSS] Quintana Roo Speleological Society, 2018, SURV CART UND CAV QU; Ritter SM, 2019, BIOGEOSCIENCES, V16, P2285, DOI 10.5194/bg-16-2285-2019; Sheiham A., 1984, CARIOLOGY TODAY, P33; Larsen CS, 2006, QUATERN INT, V150, P12, DOI 10.1016/j.quaint.2006.01.004; Stinnesbeck SR, 2018, HOLOCENE, V28, P1992, DOI 10.1177/0959683618798124; Stinnesbeck SR, 2017, PALZ, V91, P245, DOI 10.1007/s12542-017-0349-5; Stinnesbeck W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183345; Terrazas Mata A, 2006, 2 S INT HOMBR TEMPR; TILLIER AM, 1995, J HUM EVOL, V29, P189, DOI 10.1006/jhev.1995.1055; Walker PL, 2008, AM J PHYS ANTHROPOL, V136, P39, DOI 10.1002/ajpa.20776; Walker PL, 2005, AM J PHYS ANTHROPOL, V127, P385, DOI 10.1002/ajpa.10422; Wefing AM, 2017, CHEM GEOL, V475, P140, DOI 10.1016/j.chemgeo.2017.10.036	62	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227984	10.1371/journal.pone.0227984	http://dx.doi.org/10.1371/journal.pone.0227984			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9FN	32023279	Green Published, Green Accepted, gold			2022-12-26	WOS:000534621500030
J	Tesfahunegn, GB; Gebru, TA				Tesfahunegn, Gebreyesus Brhane; Gebru, Teklebirhan Arefaine			Variation in soil properties under different cropping and other land-use systems in Dura catchment, Northern Ethiopia	PLOS ONE			English	Article							ORGANIC-MATTER; CARBON STOCKS; QUALITY INDICATORS; MANAGEMENT; NITROGEN; DEGRADATION; HIGHLANDS; KNOWLEDGE; GRADIENT; EROSION	There are limited reports about the impacts of long-term cropping and land-use systems (CLUS) on soil properties and nutrient stocks under smallholder farmers' conditions in developing countries. The objective of this research was to examine variation in soil properties and OC and TN stocks across the different CLUS in Dura sub-catchment, northern Ethiopia. Surveys and discussions on field history were used to identify nine CLUS, namely, tef (Eragrostis tef (Zucc) Trot)) mono-cropping (TM), maize (Zea mays L.) mono-cropping (MM), cauliflower (Brassica oleracea var. botrytis)-maize intercropping (IC1), red beet (Beta Vulgaris)-maize intercropping (IC2), cauliflower-tef-maize rotation (R1), onion (Allium cepa L.)-maize-onion rotation (R2), tr eated gully (TG), untreated gully (UTG), and natural forest system (NF). A total of 27 composite soil samples were randomly collected from the CLUS for soil analysis. Data were subjected to one-way analysis of variance and PCA. The lowest and highest bulk density was determined from NF (1.19 Mg m(-3)) and UTG (1.77 Mg m-3), respectively. Soil pH, EC and CEC varied significantly among the CLUS. The highest CEC (50.3 cmol(c) kg(-1)) was reported under TG followed by NF. The highest soil OC stock (175.3 Mg C ha(-1)) and TN stock (13.6 Mg C ha(-1)) were found from NF. The PCA chosen soil properties explained 87% of the soil quality variability among the CLUS. Such soil properties and nutrient stocks variability among the CLUS suggested that introduction of suitable management practices that sustain the soil system of the CLUS with poor soil properties and nutrient stocks are crucial for the study area conditions.	[Tesfahunegn, Gebreyesus Brhane] Aksum Univ, Coll Agr, Dept Soil Resources & Watershed Management, Shire Campus, Shire, Ethiopia; [Gebru, Teklebirhan Arefaine] Aksum Univ, Sch Water Technol, Dept Water Resource & Irrigat Engn, Shire Campus, Shire, Ethiopia		Tesfahunegn, GB (corresponding author), Aksum Univ, Coll Agr, Dept Soil Resources & Watershed Management, Shire Campus, Shire, Ethiopia.	gebre33@gmail.com		Tesfahunegn, Gebreyesus Brhane/0000-0001-7777-4088	Aksum University [AKU/IG/RCSD/1092/07]; University of Aksum (Ethiopia) [AKU/IG/RCSD/1092/07]; Aksum University	Aksum University; University of Aksum (Ethiopia); Aksum University	Initials of the authors who received each award: Tesfahunegn GB and Gebru TA Grant numbers awarde:AKU/IG/RCSD/1092/07 The full name of each funder: Aksum University Include this sentence at the end of your statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financial supported by University of Aksum (Ethiopia) under the terms of grant no. AKU/IG/RCSD/1092/07. The author gratefully acknowledged the financial support provided by Aksum University to conduct this study. The author also highly appreciated the farmers and development agents who involved in the identification and characterization of the different cropping and land-use systems. The support provided during the soil sample collection by Mr. Kahsu Kidane (Development Agent) is highly appreciated. The assistance offered by the village administration and development agents during all the discussions and data collection processes are also highly acknowledged.	Agoume V., 2009, Tropicultura, V27, P15; Ahukaemere C.M., 2012, INT J FOREST SOIL ER, V2, P175; Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Anderson JM., 1993, TROPICAL SOIL BIOL F, V2nd, DOI DOI 10.1017/S0014479700024832; ANDERSON JPE, 1980, SOIL SCI, V130, P211, DOI 10.1097/00010694-198010000-00008; Andrews SS, 2001, ECOL APPL, V11, P1573, DOI 10.1890/1051-0761(2001)011[1573:DASQAT]2.0.CO;2; [Anonymous], METHODS SOIL ANAL; Appireddy Gopinath K., 2008, Archives of Agronomy and Soil Science, V54, P127, DOI 10.1080/03650340701836808; Arshad M. A., 1996, Methods for assessing soil quality., P123; Arshad MA, 2002, AGR ECOSYST ENVIRON, V88, P153, DOI 10.1016/S0167-8809(01)00252-3; Barrios E, 2003, GEODERMA, V111, P217, DOI 10.1016/S0016-7061(02)00265-3; Batjes NH, 2005, SOIL USE MANAGE, V21, P22, DOI 10.1079/SUM2005286; Behailu M., 2002, THESIS; Bilosova H, 2017, ARCH AGRON SOIL SCI, V63, P1535, DOI 10.1080/03650340.2017.1289373; Bird MI, 2004, GLOBAL CHANGE BIOL, V10, P342, DOI 10.1046/j.1365-2486.2003.00695.x; BLACK C. A., 1965, Methods of Soil Analysis.; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P377; BOWMAN RA, 1990, SOIL SCI, V150, P851, DOI 10.1097/00010694-199012000-00004; Brady NC, 2002, NATURE PROPERTY SOIL, V13; Brejda JJ, 2000, SOIL SCI SOC AM J, V64, P2125, DOI 10.2136/sssaj2000.6462125x; BREMER E, 1994, CAN J SOIL SCI, V74, P131, DOI 10.4141/cjss94-020; Bremner J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P595; Brunner AC, 2008, LAND DEGRAD DEV, V19, P623, DOI 10.1002/ldr.865; Campbell CA, 1996, CAN J SOIL SCI, V76, P395, DOI 10.4141/cjss96-047; Craul P.J., 1999, URBAN SOILS APPL PRA; DALAL RC, 1974, EXP AGR, V10, P219, DOI 10.1017/S0014479700000454; Dile YT, 2013, AGR ECOSYST ENVIRON, V181, P69, DOI 10.1016/j.agee.2013.09.014; Doran JW, 2002, AGR ECOSYST ENVIRON, V88, P119, DOI 10.1016/S0167-8809(01)00246-8; Duff B., 1995, Agricultural sustainability: economic, environmental and statistical considerations., P85; Elbashier M., 2016, UNIVERSAL J AGR RES, V4, P32, DOI [10.13189/ujar.2016.040106, DOI 10.13189/UJAR.2016.040106]; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Evanylo G, 2000, VIRGINIA STATE U PUB; Fantaw A., 2007, 3 INT WORKSH WAT MAN; Feng ZZ, 2005, AGR WATER MANAGE, V71, P131, DOI 10.1016/j.agwat.2004.07.001; Ferreira MT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218168; Fikadu G, 2013, ETHIOPIA N Y SCI J, V5; Food and Agriculture Organization of the United Nations (FAO), 1998, SOIL TERR DAT NORTH; Ge S.F., 2013, OPEN J SOIL SCI, V3, P213, DOI [10.4236/ojss.2013.35025, DOI 10.4236/OJSS.2013.35025]; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Ghaemi M, 2014, J SOIL SCI PLANT NUT, V14, P987; HILL RL, 1990, SOIL SCI SOC AM J, V54, P161, DOI 10.2136/sssaj1990.03615995005400010025x; Hurni H, 2005, MT RES DEV, V25, P147, DOI 10.1659/0276-4741(2005)025[0147:TIOCIP]2.0.CO;2; Iqbal M, 2014, INT J AGRIC BIOL, V16, P242; Jagadamma S, 2008, SOIL TILL RES, V98, P120, DOI 10.1016/j.still.2007.10.008; Jien SH, 2013, CATENA, V110, P225, DOI 10.1016/j.catena.2013.06.021; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Johnson R., 2007, APPL MULTIVARIATE ST; Karlen DL, 1997, SOIL SCI SOC AM J, V61, P4, DOI 10.2136/sssaj1997.03615995006100010001x; Kauffman S., 1998, Soils of tropical forest ecosystems. Characteristics, ecology and management. Proceedings of an International Conference, Balikpapan, Indonesia., P9; Kay B. D, 1999, HDB SOIL SCI; KIRKENDALL DT, 2001, CLIMATE CHANGE 2001, P185; Kujala H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053315; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; LAL R, 1981, GEODERMA, V25, P215, DOI 10.1016/0016-7061(81)90037-9; Landon J.R., 1991, HDB SOIL SURVEY AGR; LARSON WE, 1994, SSSA SPEC PUBL, P37; Lemenih M, 2004, GEODERMA, V123, P177, DOI 10.1016/j.geoderma.2004.02.004; Logsdon SD, 2004, SOIL TILL RES, V78, P143, DOI 10.1016/j.still.2004.02.003; Mairura FS, 2008, LAND DEGRAD DEV, V19, P77, DOI 10.1002/ldr.815; Mairura FS, 2007, GEODERMA, V139, P134, DOI 10.1016/j.geoderma.2007.01.019; Mandal B, 2007, GLOBAL CHANGE BIOL, V13, P357, DOI 10.1111/j.1365-2486.2006.01309.x; Mengistu C., 2017, INT J ENV SCI NAT RE, V4, P68, DOI [10.19080/IJESNR.2017.04.555634, DOI 10.19080/IJESNR.2017.04.555634]; Moges G, 2011, AGR WATER MANAGE, V98, P1215, DOI 10.1016/j.agwat.2011.03.009; Moghadam M. K., 2014, International Journal of Biosciences (IJB), V5, P406; Negasa T, 2017, GEODERMA, V290, P40, DOI 10.1016/j.geoderma.2016.11.021; Nursima KA, 2009, USM R D, V17, P65; Nweke IA, 2014, INT J RES APPL NATUR, V2, P273; Flynn CJ, 2018, SOIL USE MANAGE, V34, P1, DOI 10.1111/sum.12391; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Pieri C.J.M.G., 1992, FERTILITY SOILS FUTU; Reed MS, 2007, LAND DEGRAD DEV, V18, P249, DOI 10.1002/ldr.777; Reeves DW, 1997, SOIL TILL RES, V43, P131, DOI 10.1016/S0167-1987(97)00038-X; Rhoades J. D., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P149; RICHARDS L. A., 1954, Diagnosis and Improvement of Saline and Alkali Soils.; ROMIG DE, 1995, J SOIL WATER CONSERV, V50, P229; Saiz G, 2012, GLOBAL CHANGE BIOL, V18, P1670, DOI 10.1111/j.1365-2486.2012.02657.x; SANCHEZ PA, 1982, GEODERMA, V27, P283, DOI 10.1016/0016-7061(82)90019-2; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Seilsepour M., 2008, Journal of Agricultural and Biological Science, V3, P27; Senjobi B. A., 2011, Journal of Agricultural Biotechnology and Sustainable Development, V3, P7; Serme I., 2016, International Journal of Agricultural Policy and Research, V4, P1; Sharaiha Ramzi K., 2004, Dirasat Agricultural Sciences, V31, P1; Sharma K.L, 2012, RESOURCE MANAGEMENT, P203, DOI DOI 10.5772/45870; Shepherd G, 2000, BIOL FERT SOILS, V31, P348, DOI 10.1007/s003740050667; Shukla MK, 2006, SOIL TILL RES, V87, P194, DOI 10.1016/j.still.2005.03.011; Singh G., 2017, INDIA ANN ADV AGRIC, V1, P43, DOI DOI 10.22606/as.2017.12001; Singh MJ, 2009, ARID LAND RES MANAG, V23, P152, DOI 10.1080/15324980902817147; Sojka RE, 1999, SOIL SCI SOC AM J, V63, P1039, DOI 10.2136/sssaj1999.6351039x; Solomon D, 2002, SOIL SCI SOC AM J, V66, P68, DOI 10.2136/sssaj2002.0068; Solomon D, 2002, SOIL SCI SOC AM J, V66, P969, DOI 10.2136/sssaj2002.0969; Sparling G.P., AUST J SOIL RES, P195; Springob G, 2003, SOIL BIOL BIOCHEM, V35, P629, DOI 10.1016/S0038-0717(03)00052-X; Tamene L., 2005, THESIS; Tesfahunegn GB, 2016, LAND DEGRAD DEV, V27, P120, DOI 10.1002/ldr.2233; Tesfahunegn GB, 2016, LAND DEGRAD DEV, V27, P438, DOI 10.1002/ldr.2245; Tesfahunegn GB, 2011, GEODERMA, V163, P209, DOI 10.1016/j.geoderma.2011.04.016; Thomas G. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P475; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Titilola A.O., 2006, J APPL SCI RES, V2, P1112; Trivedi P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00990; Voundi Nkana JC, 2002, LAND DEGRAD DEV, DOI [10.1002/Idc.519, DOI 10.1002/IDC.519]; Wang XX, 2014, ENVIRON MONIT ASSESS, V186, P6903, DOI 10.1007/s10661-014-3898-z; Wu H.B., 2001, J QUATERNARY SCI, V21, P366; Yeshaneh GT., 2015, INT J ENV BIOREMEDI, V3, P15; Yesilonis I, 2016, FOREST ECOL MANAG, V370, P83, DOI 10.1016/j.foreco.2016.03.046; Yildirim E, 2005, EUR J AGRON, V22, P11, DOI 10.1016/j.eja.2003.11.003; Yimer F, 2007, FOREST ECOL MANAG, V242, P337, DOI 10.1016/j.foreco.2007.01.087; Zhang Chun-hua, 2011, Huanjing Kexue, V32, P1407; Zhao QH, 2014, CATENA, V113, P226, DOI 10.1016/j.catena.2013.08.007	109	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0222476	10.1371/journal.pone.0222476	http://dx.doi.org/10.1371/journal.pone.0222476			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023243	gold, Green Published			2022-12-26	WOS:000534621500005
J	Wang, J; Li, YY; Wang, SY; Liu, F				Wang, Jian; Li, Yangyang; Wang, Shouyu; Liu, Fei			Dynamics of transmissible gastroenteritis virus internalization unraveled by single-virus tracking in live cells	FASEB JOURNAL			English	Article						actin; caveolae; clathrin; dynamin 2; TGEV	GROWTH-FACTOR RECEPTOR; MEDIATED ENDOCYTOSIS; DEPENDENT FUSION; CLATHRIN; ENTRY; CHOLESTEROL; INFECTION; CAVEOLAE	Transmissible gastroenteritis virus (TGEV) is a swine enteropathogenic coronavirus that causes significant economic losses in swine industry. Current studies on TGEV internalization mainly focus on viral receptors, but the internalization mechanism is still unclear. In this study, we used single-virus tracking to obtain the detailed insights into the dynamic events of the TGEV internalization and depict the whole sequential process. We observed that TGEVs could be internalized through clathrin- and caveolae-mediated endocytosis, and the internalization of TGEVs was almost completed within similar to 2 minutes after TGEVs attached to the cell membrane. Furthermore, the interactions of TGEVs with actin and dynamin 2 in real time during the TGEV internalization were visualized. To our knowledge, this is the first report that single-virus tracking technique is used to visualize the entire dynamic process of the TGEV internalization: before the TGEV internalization, with the assistance of actin, clathrin, and caveolin 1 would gather around the virus to form the vesicle containing the TGEV, and after similar to 60 seconds, dynamin 2 would be recruited to promote membrane fission. These results demonstrate that TGEVs enter ST cells via clathrin- and caveolae-mediated endocytic, actin-dependent, and dynamin 2-dependent pathways.	[Wang, Jian; Li, Yangyang; Wang, Shouyu; Liu, Fei] Nanjing Agr Univ, Joint Int Res Lab Anim Hlth & Food Safety, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Jian; Li, Yangyang; Wang, Shouyu; Liu, Fei] Nanjing Agr Univ, Single Mol Nanometry Lab Sinmolab, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Shouyu] Jiangnan Univ, Computat Opt Lab, Sch Sci, Wuxi, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Jiangnan University	Liu, F (corresponding author), Nanjing Agr Univ, Joint Int Res Lab Anim Hlth & Food Safety, Nanjing 210095, Jiangsu, Peoples R China.; Liu, F (corresponding author), Nanjing Agr Univ, Single Mol Nanometry Lab Sinmolab, Nanjing 210095, Jiangsu, Peoples R China.	feiliu24@njau.edu.cn			National Key Research and Development Program [2018YFD0500100]; National Natural Science Foundation of China (NSFC) [31870154, 31522056, 61705092]; Natural Science Foundation of Jiangsu Province of China [BK20170194]; Jiangsu Key Research and Development Program [BE2018709]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Key Research and Development Program; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Jiangsu Key Research and Development Program; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Key Research and Development Program, Grant/Award Number: 2018YFD0500100; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31870154, 31522056 and 61705092; Natural Science Foundation of Jiangsu Province of China, Grant/Award Number: BK20170194; Jiangsu Key Research and Development Program, Grant/Award Number: BE2018709; Priority Academic Program Development of Jiangsu Higher Education Institutions	Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Hansen GH, 1998, J VIROL, V72, P527, DOI 10.1128/JVI.72.1.527-534.1998; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Holla P, 2015, TRAFFIC, V16, P398, DOI 10.1111/tra.12260; Hoornweg TE, 2016, J VIROL, V90, P4745, DOI 10.1128/JVI.03184-15; Hu WW, 2018, VIROLOGY, V521, P33, DOI 10.1016/j.virol.2018.05.009; Hu WW, 2016, ONCOTARGET, V7, P12206, DOI 10.18632/oncotarget.7723; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; LAUDE H, 1990, VET MICROBIOL, V23, P147, DOI 10.1016/0378-1135(90)90144-K; Li Q, 2017, ACS NANO, V11, P3890, DOI 10.1021/acsnano.7b00275; Li Z, 2017, J VIROL, V91, DOI [10.1128/JVI.01083-17, 10.1128/jvi.01083-17]; Liu HB, 2011, J VIROL, V85, P6252, DOI 10.1128/JVI.00109-11; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Ren XF, 2008, VIRUS RES, V137, P220, DOI 10.1016/j.virusres.2008.07.023; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; RUST MJ, 2011, COLD SPRING HARB PRO, V2011, P1042, DOI DOI 10.1101/PDB.T0P065623; Salanueva IJ, 1999, J VIROL, V73, P7952, DOI 10.1128/JVI.73.10.7952-7964.1999; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schwegmann-Wessels C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-435; Sun E, 2013, CURR OPIN VIROL, V3, P34, DOI 10.1016/j.coviro.2013.01.005; Sun EZ, 2017, ACS NANO, V11, P4395, DOI 10.1021/acsnano.6b07853; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Zhang FX, 2018, VIROLOGY, V513, P195, DOI 10.1016/j.virol.2017.09.019; Zhang S, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0283-5; Zhao TT, 2019, VIROLOGY, V529, P160, DOI 10.1016/j.virol.2019.01.009	43	12	12	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4653	4669		10.1096/fj.201902455R	http://dx.doi.org/10.1096/fj.201902455R		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32017270	Green Published, Bronze			2022-12-26	WOS:000511115000001
J	Waters, JC; Jhaveri, D; Biffinger, JC; Lee, K				Waters, Joshua C.; Jhaveri, Deval; Biffinger, Justin C.; Lee, Kwangwon			Quantitative trait loci (QTL) underlying phenotypic variation in bioethanol-related processes in Neurospora crassa	PLOS ONE			English	Article							SYSTEMS-ANALYSIS; DEGRADATION; REVEALS; BIOCONVERSION; RESPONSES; BIOMASS; GENES; YEAST	Bioethanol production from lignocellulosic biomass has received increasing attention over the past decade. Many attempts have been made to reduce the cost of bioethanol production by combining the separate steps of the process into a single-step process known as consolidated bioprocessing. This requires identification of organisms that can efficiently decompose lignocellulose to simple sugars and ferment the pentose and hexose sugars liberated to ethanol. There have been many attempts in engineering laboratory strains by adding new genes or modifying genes to expand the capacity of an industrial microorganism. There has been less attention in improving bioethanol-related processes utilizing natural variation existing in the natural ecotypes. In this study, we sought to identify genomic loci contributing to variation in saccharification of cellulose and fermentation of glucose in the fermenting cellulolytic fungus Neurospora crassa through quantitative trait loci (QTL) analysis. We identified one major QTL contributing to fermentation of glucose and multiple putative QTL's underlying saccharification. Understanding the natural variation of the major QTL gene would provide new insights in developing industrial microbes for bioethanol production.	[Waters, Joshua C.; Lee, Kwangwon] Rutgers State Univ New Jersey Camden, Dept Biol, Camden, NJ 08102 USA; [Waters, Joshua C.; Jhaveri, Deval; Lee, Kwangwon] Rutgers State Univ New Jersey Camden, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA; [Biffinger, Justin C.] Univ Dayton, Dept Chem, Dayton, OH 45469 USA	University of Dayton	Lee, K (corresponding author), Rutgers State Univ New Jersey Camden, Dept Biol, Camden, NJ 08102 USA.; Lee, K (corresponding author), Rutgers State Univ New Jersey Camden, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA.	kwagnwon.lee@rutgers.edu		Lee, Kwangwon/0000-0001-8225-4220; Jhaveri, Deval/0000-0003-1053-8181	Big Data Analytics Grant from Rutgers ORED, Rutgers University-Newark	Big Data Analytics Grant from Rutgers ORED, Rutgers University-Newark	The work was supported by Big Data Analytics Grant from Rutgers ORED, Rutgers University-Newark to KL.	Benocci T, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0841-x; Benz JP, 2014, MOL MICROBIOL, V91, P275, DOI 10.1111/mmi.12459; Cai PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089330; Camassola M, 2012, J ANAL BIOANAL TECH, V01, DOI [10.4172/scientificreports.125, DOI 10.4172/scientificreports.125]; Craig JP, 2015, MBIO, V6, DOI 10.1128/mBio.01452-15; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Dogaris I, 2013, APPL MICROBIOL BIOT, V97, P1457, DOI 10.1007/s00253-012-4655-2; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Favaro L, 2013, BIOENGINEERED, V4, P97, DOI 10.4161/bioe.22268; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Hallauer AR, 2010, HANDB PLANT BREED, V6, P1, DOI 10.1007/978-1-4419-0766-0; Hartman Y, 2013, GENET RESOUR CROP EV, V60, P1487, DOI 10.1007/s10722-012-9937-0; Hildebrand A, 2015, APPL ENVIRON MICROB, V81, P597, DOI 10.1128/AEM.02885-14; Kumar J, 2017, PLANT CELL REP, V36, P1187, DOI 10.1007/s00299-017-2127-y; MARULLO P, 2019, BMC GENOMICS, V20, DOI DOI 10.1186/S12864-018-5319-0; Mattila H, 2017, BIORESOURCE TECHNOL, V225, P254, DOI 10.1016/j.biortech.2016.11.082; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Muranty H, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.60; Qiu XJ, 2017, THEOR APPL GENET, V130, P951, DOI 10.1007/s00122-017-2862-z; Reilly MC, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0297-9; Sakuragi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/416931; Stricker AR, 2008, APPL MICROBIOL BIOT, V78, P211, DOI 10.1007/s00253-007-1322-0; Sun JP, 2012, EUKARYOT CELL, V11, P482, DOI 10.1128/EC.05327-11; Sun JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025654; Tani S, 2014, APPL MICROBIOL BIOT, V98, P4829, DOI 10.1007/s00253-014-5707-6; Tani S, 2012, CURR GENET, V58, P93, DOI 10.1007/s00294-012-0367-5; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Wang Z, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1398-7; Waters JC, 2017, J IND MICROBIOL BIOT, V44, P1137, DOI 10.1007/s10295-017-1941-0; Wu G, 2016, TRENDS BIOTECHNOL, V34, P652, DOI 10.1016/j.tibtech.2016.02.010; Zhang GC, 2017, J IND MICROBIOL BIOT, V44, P387, DOI 10.1007/s10295-016-1899-3	31	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0221737	10.1371/journal.pone.0221737	http://dx.doi.org/10.1371/journal.pone.0221737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017762	Green Submitted, gold, Green Published			2022-12-26	WOS:000534618100005
J	Satinsky, EN; Doran, K; Felton, JW; Kleinman, M; Dean, D; Magidson, JF				Satinsky, Emily N.; Doran, Kelly; Felton, Julia W.; Kleinman, Mary; Dean, Dwayne; Magidson, Jessica F.			Adapting a peer recovery coach-delivered behavioral activation intervention for problematic substance use in a medically underserved community in Baltimore City	PLOS ONE			English	Article							INJECTION-DRUG USERS; USE DISORDERS; MEDICATION ADHERENCE; OPIOID DEPENDENCE; UNITED-STATES; MENTAL-HEALTH; RISK-FACTORS; ALCOHOL; RELIABILITY; DEPRESSION	Low-income, racial/ethnic minority groups have disproportionately high rates of problematic substance use yet face barriers in accessing evidence-based interventions (EBIs). Peer recovery coaches (PRCs), individuals with lived experience with problematic substance use, may provide an effective approach to reaching these individuals. Traditionally PRCs have focused on bridging to other types of care rather than delivering EBIs themselves. The aim of this study was to assess perceptions of the appropriateness of a PRC-delivered adapted behavioral activation (BA) intervention to reduce problematic substance use for individuals not engaged in care. This study was conducted at a community resource center in Baltimore, Maryland serving low-income and homeless clients who have high rates of problematic substance use yet also face barriers to accessing care. Guided by the ADAPT-ITT framework, we conducted semi-structured key informant interviews with clients (n = 30) with past or present problematic substance use, and a focus group with community providers, including staff at the community resource center (n = 5) and PRCs (n = 6) from the community. Thirty percent (n = 9) of clients interviewed reported past problematic substance use and 70% (n = 21) met criteria for current use, most commonly cocaine and opioids. Clients, center staff, and PRCs shared that PRC-delivered BA could be acceptable and appropriate with suggested adaptations, including adding peer-delivered case-management and linkage to care alongside BA, and tailoring BA to include activities that are accessible and feasible in the community. These findings will inform the adaptation of PRC-delivered BA to address problematic substance use in this setting.	[Satinsky, Emily N.; Kleinman, Mary; Magidson, Jessica F.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Doran, Kelly; Dean, Dwayne] Univ Maryland, Dept Nursing, Baltimore, MD 21201 USA; [Felton, Julia W.] Michigan State Univ, Dept Publ Hlth, Flint, MI USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; Michigan State University	Satinsky, EN (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	esatinsk@umd.edu	Satinsky, Emily N./AAD-3114-2022	Satinsky, Emily N./0000-0003-0666-6009	University of Maryland Baltimore-University of Maryland College Park Innovation Seed Grant	University of Maryland Baltimore-University of Maryland College Park Innovation Seed Grant	This study was fully supported by the University of Maryland Baltimore-University of Maryland College Park Innovation Seed Grant, awarded to JF, KD, and JFM. The funding grant had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Rashid R, 2014, INT J DRUG POLICY, V25, P1071, DOI 10.1016/j.drugpo.2014.07.003; Acuff SF, 2019, CLIN PSYCHOL REV, V70, P79, DOI 10.1016/j.cpr.2019.04.003; Ali R, 2002, ADDICTION, V97, P1183; [Anonymous], 2017, INT NSDUH STAT EST; [Anonymous], 2017, COMM HLTH ASS; Asante-Muhammed D., 2017, RACIAL WEALTH DIVIDE; Bassuk EL, 1998, AM J PSYCHIAT, V155, P1561, DOI 10.1176/ajp.155.11.1561; Bassuk EL, 2016, J SUBST ABUSE TREAT, V63, P1, DOI 10.1016/j.jsat.2016.01.003; Bosworth B, 2018, ANNU REV PUBL HEALTH, V39, P237, DOI 10.1146/annurev-publhealth-040617-014615; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Cabral RR, 2011, J COUNS PSYCHOL, V58, P537, DOI 10.1037/a0025266; Carusone SC, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-019-0285-7; Catherine P, 2007, BMJ BOOKS; CDC, 2017, DRUG OV DEATH DAT; CDC, 2018, OV DEATHS INV OP COC; Clark RE, 2015, J SUBST ABUSE TREAT, V57, P75, DOI 10.1016/j.jsat.2015.05.001; Connery HS, 2015, HARVARD REV PSYCHIAT, V23, P63, DOI 10.1097/HRP.0000000000000075; D'Onofrio G, 2015, JAMA-J AM MED ASSOC, V313, P1636, DOI 10.1001/jama.2015.3474; Dara M, 2016, EUR RESPIR J, V48, P808, DOI 10.1183/13993003.00840-2016; Daughters SB, 2017, EFFECT BEHAV ACTIVAT; Daughters SB, 2010, COGNITIVE BEHAV PRAC; Daughters SB, 2018, ADDICTION, V113, P535, DOI 10.1111/add.14049; Daughters SB, 2010, COGN BEHAV PRACT, V17, P309, DOI 10.1016/j.cbpra.2009.12.003; Eddie D, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01052; Ekers D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100100; Ekers D, 2011, BRIT J PSYCHIAT, V198, P66, DOI 10.1192/bjp.bp.110.079111; Flores YN, 2008, AM J GASTROENTEROL, V103, P2231, DOI 10.1111/j.1572-0241.2008.02022.x; Francis JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211322; Genberg BL, 2011, ADDICTION, V106, P1966, DOI 10.1111/j.1360-0443.2011.03501.x; Glasner-Edwards S, 2010, HEALTH POLICY, V97, P93, DOI 10.1016/j.healthpol.2010.05.013; Hammett TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043141; Hogan L, 2017, UNINTENTIONAL DRUG A; IRP, 2018, OP EP SOC DIS; Jack H. E, 2017, SUBST ABUS, V13, P1, DOI DOI 10.1080/08897077.2017.1389; James K, 2018, J LAW MED ETHICS, V46, P404, DOI 10.1177/1073110518782949; KFF, 2017, OP OV DEATH RAT ALL; Laudet AB, 2006, ALCOHOL TREAT Q, V24, P33, DOI 10.1300/J020v24n01_04; Lejuez CW, 2011, BEHAV MODIF, V35, P111, DOI 10.1177/0145445510390929; Liebling EJ, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0082-1; Linehan M.M, 2015, DBT R SKILLS TRAININ, Vsecond; Linton SL, 2013, DRUG ALCOHOL DEPEN, V132, P457, DOI 10.1016/j.drugalcdep.2013.03.009; London K., 2018, RECOVERY COACHES OPI; MACPHILLAMY DJ, 1982, J CONSULT CLIN PSYCH, V50, P363, DOI 10.1037/0022-006X.50.3.363; Magidson JF, 2015, GLOB MENT HEALTH, V2, DOI 10.1017/gmh.2015.22; Magidson J.F., 2017, MASSACHUSETTS GEN HO, P297, DOI 10.1007/978-3-319-29294-6_14; Magidson JF, 2019, INT J DRUG POLICY, V70, P61, DOI 10.1016/j.drugpo.2018.11.004; Magidson JF, 2015, AIDS BEHAV, V19, P34, DOI 10.1007/s10461-014-0802-3; Magidson JF, 2014, COGN BEHAV PRACT, V21, P386, DOI 10.1016/j.cbpra.2013.10.002; Magidson JF, 2011, ADDICT BEHAV, V36, P615, DOI 10.1016/j.addbeh.2011.01.016; Magidson JF, PSYCHOTHERAPY; McGovern MP, 2003, PSYCHIAT CLIN N AM, V26, P991, DOI 10.1016/S0193-953X(03)00073-X; Mimiaga MJ, 2019, PSYCHOL HEALTH MED, V24, P374, DOI 10.1080/13548506.2018.1515492; Mimiaga MJ, 2012, AIDS PATIENT CARE ST, V26, P681, DOI 10.1089/apc.2012.0216; Myers B, 2019, BMJ OPEN, P9; Myers B, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024277; Myers B, 2017, AIDS CARE, V29, P209, DOI 10.1080/09540121.2016.1211242; NIH, 2018, OP SUMM STAT MAR NAT; Office of the Surgeon General, 2016, FAC ADD AM SURG GEN; Papas RK, 2011, ADDICTION, V106, P2156, DOI 10.1111/j.1360-0443.2011.03518.x; Papas RK, 2010, AIDS BEHAV, V14, P669, DOI 10.1007/s10461-009-9647-6; Parry CDH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-500; Patel V, 2017, LANCET, V389, P176, DOI 10.1016/S0140-6736(16)31589-6; Patel V, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-101; Petry NM, 2009, AM J ADDICTION, V17, P408; Raymond D., 2018, PHILADELPHIA INQUIRE; Reif S, 2014, PSYCHIAT SERV, V65, P853, DOI 10.1176/appi.ps.201400047; Resnick B, 2007, GERONTOLOGIST, V47, P69, DOI 10.1093/geront/47.1.69; SAMHSA, 2009, WHAT AR PEER REC SUP; Samuels EA, 2018, J SUBST ABUSE TREAT, V94, P29, DOI 10.1016/j.jsat.2018.07.013; Samuels EA, 2019, ACAD EMERG MED, V26, P160, DOI 10.1111/acem.13545; Sanchez ZV, 2008, REV SAUDE PUBL, V42; Schmidt LA, 2012, J STUD ALCOHOL DRUGS, V73, P413, DOI 10.15288/jsad.2012.73.413; Scott CK, 2018, J SUBST ABUSE TREAT, V86, P30, DOI 10.1016/j.jsat.2017.12.007; Scott CK, 2019, J SUBSTANCE ABUSE TR; Sorsdahl K, 2015, PSYCHOTHER RES, V25, P435, DOI 10.1080/10503307.2014.897770; Tobin KE, 2011, ADDICTION, V106, P366, DOI 10.1111/j.1360-0443.2010.03146.x; van Boekel LC, 2013, DRUG ALCOHOL DEPEN, V131, P23, DOI 10.1016/j.drugalcdep.2013.02.018; Wagner GJ, 2004, AIDS PATIENT CARE ST, V18, P385, DOI 10.1089/1087291041518238; Wakeman SE, 2018, NEW ENGL J MED, V379, P1, DOI 10.1056/NEJMp1802741; Wang DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110728; Watson DP, 2019, J SUBSTANCE ABUSE TR; Williams CT, 2007, AM J PREV MED, V32, pS203, DOI 10.1016/j.amepre.2007.02.006; Wingood GM, 2008, JAIDS-J ACQ IMM DEF, V47, pS40, DOI 10.1097/QAI.0b013e3181605df1; Yang AL, 2008, ARCH INTERN MED, V168, P649, DOI 10.1001/archinte.168.6.649; Zschucke E, 2012, SCI WORLD J, DOI 10.1100/2012/901741	85	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228084	10.1371/journal.pone.0228084	http://dx.doi.org/10.1371/journal.pone.0228084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CX	32004328	Green Published, gold, Green Submitted			2022-12-26	WOS:000534614600014
J	Al-Hanawi, MK; Chirwa, GC; Pemba, LA; Qattan, AMN				Al-Hanawi, Mohammed Khaled; Chirwa, Gowokani Chijere; Pemba, Laeticia Amiss; Qattan, Ameerah M. N.			Does prolonged television viewing affect Body Mass Index? A case of the Kingdom of Saudi Arabia	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; RISK-FACTORS; SEDENTARY BEHAVIOR; OBESITY; HEALTH; OVERWEIGHT; WEIGHT; ASSOCIATION; CHILDREN; BURDEN	Background The rising prevalence of overweight and obesity and their health implications is a major public health concern worldwide. This study set out to understand the relationship between the number of hours spent watching television and Body Mass Index (BMI) in the Kingdom of Saudi Arabia using data from the Saudi Health Interview Survey. Methods The study employed both ordinary least squares and quantile regressions to estimate the mean and distributional association of prolonged television watching and BMI. Results The findings showed that prolonged television viewing is associated with larger BMI values. Additionally, the relationship was found to be greater towards the lower and upper tails of the BMI range and insignificant in the middle of the BMI distribution. Furthermore, the findings also showed that there is a gender gap in BMI levels, where females are likely to have higher BMI values than males. Conclusions The creation of more proactive recreational programs that can act as substitutes to television watching is recommended in order to reduce the amount of time that individuals spend watching television. It is also recommended that such interventions are tailored towards improving females' levels of physical activity. The inclusion of television programs aimed at encouraging physical exercise and healthy diets is also imperative.	[Al-Hanawi, Mohammed Khaled; Qattan, Ameerah M. N.] King Abdulaziz Univ, Fac Econ & Adm, Dept Hlth Serv & Hosp Adm, Jeddah, Saudi Arabia; [Chirwa, Gowokani Chijere] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Chirwa, Gowokani Chijere; Pemba, Laeticia Amiss] Univ Malawi, Econ Dept, Chancellor Coll, Zomba, Malawi	King Abdulaziz University; University of York - UK; University of Malawi	Al-Hanawi, MK (corresponding author), King Abdulaziz Univ, Fac Econ & Adm, Dept Hlth Serv & Hosp Adm, Jeddah, Saudi Arabia.	mkalhanawi@kau.edu.sa	Qattan, Ameerah/AAU-6538-2020; Chirwa, Gowokani Chijere/AAB-3310-2020; Al-Hanawi, Mohammed Khaled/AAB-2455-2020	Qattan, Ameerah/0000-0003-3201-547X; Chirwa, Gowokani Chijere/0000-0003-0199-779X; Al-Hanawi, Mohammed Khaled/0000-0002-8419-2219	Deanship of Scientific Research (DSR) at King Abdulaziz University [D-048-120-1441]; Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah [D-048-120-1441]	Deanship of Scientific Research (DSR) at King Abdulaziz University; Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah	This research was funded by Deanship of Scientific Research (DSR) at King Abdulaziz University, grant number D-048-120-1441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, under grant number D-048-120-1441. The authors, therefore, acknowledge, with thanks, the DSR for its technical and financial support.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Aizawa T, 2017, ECON HUM BIOL, V27, P315, DOI 10.1016/j.ehb.2017.09.005; Al-Ghamdi SH, 2013, J FAM COMMUNITY MED, V20, P83, DOI 10.4103/2230-8229.114767; Al-Hanawi MK, 2020, INT J HEALTH PLAN M, V35, P233, DOI 10.1002/hpm.2899; Al-Hazzaa HM, 2007, PUBLIC HEALTH NUTR, V10, P59, DOI 10.1017/S1368980007184299; Al-Hazzaa HM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-140; Al-Nozha MM, 2007, SAUDI MED J, V28; Albawardi NM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060659; Alghamdi AS, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0467-9; Alharbi NS, 2014, DIABETES RES CLIN PR, V106, pE30, DOI 10.1016/j.diabres.2014.08.019; ALNohair S, 2014, INT J HEALTH SCI-IJH, V8, P79, DOI 10.12816/0006074; Alqarni S.M., 2016, J OBES EAT DISORD, V2, P2, DOI [10.21767/2471-8203.100025, DOI 10.21767/2471-8203.100025]; AlQuaiz AM, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1048-9; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Ballard M, 2009, EAT BEHAV, V10, P161, DOI 10.1016/j.eatbeh.2009.05.001; Bickham DS, 2013, PEDIATRICS, V131, P935, DOI 10.1542/peds.2012-1197; Bowman Shanthy A, 2006, Prev Chronic Dis, V3, pA38; Braithwaite I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074263; Buchinsky M, 1998, J HUM RESOUR, V33, P88, DOI 10.2307/146316; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Chen CY, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015600480; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Costa-Font J, 2009, ECON HUM BIOL, V7, P351, DOI 10.1016/j.ehb.2009.08.003; DeNicola E, 2015, REV ENVIRON HEALTH, V30, P191, DOI 10.1515/reveh-2015-0008; Eisenmann JC, 2008, INT J OBESITY, V32, P613, DOI 10.1038/sj.ijo.0803800; Fanzo J., 2019, 2018 GLOBAL NUTR REP; Firpo S, 2009, ECONOMETRICA, V77, P953, DOI 10.3982/ECTA6822; Ford ND, 2017, ANNU REV PUBL HEALTH, V38, P145, DOI 10.1146/annurev-publhealth-031816-044604; Fortin N, 2011, HBK ECON, V4, P1, DOI 10.1016/S0169-7218(11)00407-2; Fox SI, 2006, HUMAN PHYSL; Goh VHH, 2010, AGING MALE, V13, P265, DOI 10.3109/13685538.2010.489623; Gomez LF, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-41; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Gujarati D., 2009, BASIC ECONOMETRICS; Hauger MS, 2008, ACTA OBSTET GYN SCAN, V87, P953, DOI 10.1080/00016340802303349; Helajarvi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101860; Hossain P, 2009, OBESITY DIABETES DEV; Jones AM, 2015, HEALTH ECON, V24, P1192, DOI 10.1002/hec.3178; Keadle SK, 2015, AM J PREV MED, V49, P811, DOI 10.1016/j.amepre.2015.05.023; Kesavachandran C, 2009, Int J Yoga, V2, P26, DOI 10.4103/0973-6131.53839; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Lim JU, 2017, INT J CHRONIC OBSTR, V12, P2465, DOI 10.2147/COPD.S141295; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mabry R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3642-4; Maher C, 2012, ACTA PAEDIATR, V101, P1170, DOI 10.1111/j.1651-2227.2012.02804.x; Misra A, 2019, NUTR DIABETES, V9, DOI 10.1038/s41387-018-0070-9; Moradi-Lakeh M, 2017, PUBLIC HEALTH NUTR, V20, P1075, DOI [10.1017/S1368980016003141, 10.1017/s1368980016003141]; Moradi-Lakeh M, 2016, PHARMACOEPIDEM DR S, V25, P73, DOI 10.1002/pds.3904; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; Roemling C, 2013, ECON HUM BIOL, V11, P563, DOI 10.1016/j.ehb.2013.07.001; Roemling C, 2012, APPETITE, V58, P1005, DOI 10.1016/j.appet.2012.02.053; Rosiek A, 2015, INT J ENV RES PUB HE, V12, P9408, DOI 10.3390/ijerph120809408; Salmon J, 2006, MED J AUSTRALIA, V184, P64, DOI 10.5694/j.1326-5377.2006.tb00117.x; Singh GP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064893, 10.1371/journal.pone.0065174]; WHO, 2016, NCD COUNTR PROF SAUD; Wilmot EG, 2012, SEDENTARY TIME ADULT; Witoelar F., 2009, WR704 RAND; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	62	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228321	10.1371/journal.pone.0228321	http://dx.doi.org/10.1371/journal.pone.0228321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KV4NY	31999775	Green Published, gold			2022-12-26	WOS:000520460100001
J	Moreno-Lama, L; Galindo-Campos, MA; Martinez, C; Comerma, L; Vazquez, I; Vernet-Tomas, M; Ampurdanes, C; Lutfi, N; Martin-Caballero, J; Dantzer, F; Quintela-Fandino, M; Ali, SO; Jimeno, J; Yelamos, J				Moreno-Lama, Lucia; Galindo-Campos, Miguel A.; Martinez, Carlos; Comerma, Laura; Vazquez, Ivonne; Vernet-Tomas, Maria; Ampurdanes, Coral; Lutfi, Nura; Martin-Caballero, Juan; Dantzer, Francoise; Quintela-Fandino, Miguel; Ali, Syed O.; Jimeno, Jaime; Yelamos, Jose			Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice	ONCOGENE			English	Article							CANCER; EXPRESSION; REVEALS	Poly(ADP-ribose)-polymerase (PARP)-1 and PARP-2 play an essential role in the DNA damage response. Based on this effect of PARP in the tumor cell itself, PARP inhibitors have emerged as new therapeutic tools both approved and in clinical trials. However, the interactome of multiple other cell types, particularly T cells, within the tumor microenvironment are known to either favor or limit tumorigenesis. Here, we bypassed the embryonic lethality of dually PARP-1/PARP-2-deficient mice by using a PARP-1-deficient mouse with a Cd4-promoter-driven deletion of PARP-2 in T cells to investigate the understudied role of these PARPs in the modulation of T cell responses against AT-3-induced breast tumors. We found that dual PARP-1/PARP-2-deficiency in T cells promotes tumor growth while single deficiency of each protein limited tumor progression. Analysis of tumor-infiltrating cells in dual PARP-1/PARP-2-deficiency host-mice revealed a global change in immunological profile and impaired recruitment and activation of T cells. Conversely, single PARP-1 and PARP-2-deficiency tends to produce an environment with an active and partially upregulated immune response. Our findings pinpoint opposite effects of single and dual PARP-1 and PARP-2-deficiency in modulating the antitumor response with an impact on tumor progression, and will have implications for the development of more selective PARP-centered therapies.	[Moreno-Lama, Lucia; Galindo-Campos, Miguel A.; Ampurdanes, Coral; Lutfi, Nura; Yelamos, Jose] Hosp del Mar Med Res Inst IMIM, Canc Res Program, Barcelona, Spain; [Martinez, Carlos] IMIB LAIB Arrixaca, Expt Pathol Unit, Murcia, Spain; [Comerma, Laura; Vazquez, Ivonne; Yelamos, Jose] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Vernet-Tomas, Maria] Hosp del Mar Med Res Inst IMIM, Dept Obstet & Gynecol, Barcelona, Spain; [Martin-Caballero, Juan] Barcelona Biomed Res Pk PRBB, Barcelona, Spain; [Dantzer, Francoise] ESBS, Lab Excellence Medalis, Biotechnol & Cell Signaling, UMR7242 CNRS, Illkirch Graffenstaden, France; [Quintela-Fandino, Miguel] CNIO, Breast Canc Clin Res Unit, Madrid, Spain; [Ali, Syed O.] NHS, Oxford Univ Hosp, Oxford, England; [Jimeno, Jaime] Hosp Univ Marques Valdecilla, Dept Gen Surg, Breast Unit, Santander, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centro Nacional de Investigaciones Oncologicas (CNIO); Oxford University Hospitals NHS Foundation Trust; Hospital Universitario Marques de Valdecilla (HUMV)	Yelamos, J (corresponding author), Hosp del Mar Med Res Inst IMIM, Canc Res Program, Barcelona, Spain.; Yelamos, J (corresponding author), Hosp del Mar, Dept Pathol, Barcelona, Spain.	jyelamos@imim.es	Blesa, Laura Comerma/AAQ-9455-2020; Vernet-Tomas, Maria/AAE-6363-2021; Yelamos, Jose/N-2842-2016; Moreno Lama, Lucia/CAC-3410-2022; Martinez, Carlos M./E-4986-2016	Blesa, Laura Comerma/0000-0002-0249-4636; Moreno Lama, Lucia/0000-0003-3900-1388; Martinez, Carlos M./0000-0003-3307-1326; Vazquez, Ivonne/0000-0002-5305-1560; Galindo Campos, Miguel Alejandro/0000-0002-0650-8660; Yelamos, Jose/0000-0003-1195-1496; Dantzer, Francoise/0000-0003-0945-8483	Spanish Ministerio de Economia, Industria y Competitividad [SAF2017-83565-R]; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC); LABEX, Strasbourg University, CNRS [ANR-10-LABX-0034_Medalis]	Spanish Ministerio de Economia, Industria y Competitividad; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC); LABEX, Strasbourg University, CNRS	We thank Dr. Abrams Scott for giving us the AT-3 cell line, Mary Hensen for assistance with the AT-3 cell line, Gemma Torres-Sotodosos and Laura Regue for technical assistance, and Xavi Duran for statistical assistance. The Yelamos's lab is funded by the Spanish Ministerio de Economia, Industria y Competitividad (grant SAF2017-83565-R) and The Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC). The Dantzer's lab is supported by LABEX ANR-10-LABX-0034_Medalis, Strasbourg University, CNRS.	Ashworth A, 2018, NAT REV CLIN ONCOL, V15, P564, DOI 10.1038/s41571-018-0055-6; Badoual C, 2013, CANCER RES, V73, P128, DOI 10.1158/0008-5472.CAN-12-2606; Bai P, 2015, MOL CELL, V58, P947, DOI 10.1016/j.molcel.2015.01.034; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bock FJ, 2015, MOL CELL, V58, P911, DOI 10.1016/j.molcel.2015.06.012; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Cohen MS, 2018, NAT CHEM BIOL, V14, P236, DOI [10.1038/NCHEMBIO.2568, 10.1038/nchembio.2568]; Dantzer F, 2006, P NATL ACAD SCI USA, V103, P14854, DOI 10.1073/pnas.0604252103; Darvin P, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0191-1; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Farres J, 2015, CELL DEATH DIFFER, V22, P1144, DOI 10.1038/cdd.2014.202; Farres J, 2013, BLOOD, V122, P44, DOI 10.1182/blood-2012-12-472845; Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865; Hinshaw DC, 2019, CANCER RES, V79, P4557, DOI 10.1158/0008-5472.CAN-18-3962; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Lee KM, 2003, J IMMUNOL, V170, P4881, DOI 10.4049/jimmunol.170.10.4881; Luo XR, 2015, J BIOL CHEM, V290, P28675, DOI 10.1074/jbc.M115.661611; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685; Muntasell A, 2019, CLIN CANCER RES, V25, P1535, DOI 10.1158/1078-0432.CCR-18-2365; Navarro J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41962; Nicolas L, 2010, ONCOGENE, V29, P2877, DOI 10.1038/onc.2010.11; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Saenz L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-171; Schalper KA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju435; Silva-Santos B, 2019, NAT REV CANCER, V19, P392, DOI 10.1038/s41568-019-0153-5; Simon S, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1364828; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Stewart RA, 2018, CANCER RES, V78, P6717, DOI 10.1158/0008-5472.CAN-18-2652; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Valdor R, 2008, MOL IMMUNOL, V45, P1863, DOI 10.1016/j.molimm.2007.10.044; Veglia F, 2017, CURR OPIN IMMUNOL, V45, P43, DOI 10.1016/j.coi.2017.01.002; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang BF, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-43; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301; Yelamos J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1065370; Yelamos J, 2011, AM J CANCER RES, V1, P328; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zhang P, 2013, BLOOD, V122, P2224, DOI 10.1182/blood-2013-05-503250	40	13	14	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2835	2843		10.1038/s41388-020-1175-x	http://dx.doi.org/10.1038/s41388-020-1175-x		JAN 2020	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32001817				2022-12-26	WOS:000510328400003
J	Coloma-Garcia, W; Mehaba, N; Llonch, P; Caja, G; Such, X; Salama, AAK				Coloma-Garcia, Wellington; Mehaba, Nabil; Llonch, Pol; Caja, Gerardo; Such, Xavier; Salama, Ahmed A. K.			Prenatal heat stress effects on gestation and postnatal behavior in kid goats	PLOS ONE			English	Article							DRY PERIOD; PHYSIOLOGICAL-RESPONSES; EMOTIONAL REACTIVITY; AMBIENT-TEMPERATURE; DAIRY GOATS; MOTHER; GROWTH; EXPOSURE; ANXIETY; IMPACT	Consequences of heat stress during pregnancy can affect the normal development of the offspring. In the present experiment, 30 Murciano-Granadina dairy goats (41.8 +/- 5.7 kg) were exposed to 2 thermal environments varying in temperature-humidity index (THI) from 12 days before mating to 45 days of gestation. The environmental conditions were: gestation under thermal-neutral (TN; THI = 71 +/- 3); and gestation under heat stress (HS; THI = 85 +/- 3) conditions. At 27 +/- 4 days old, female kids exposed to in utero TN (IUTN; n = 16) or in utero HS (IUHS; n = 10) were subjected to 2 tests: arena test (AT) and novel object test (NOT), the latter was repeated at 3 months of age. Additionally, 8 months after birth, a subset of IUTH and IUHS growing goats (n = 8 each; 16.8 +/- 3.4 kg BW) were exposed to 2 environmental conditions in 2 consecutive periods: a basal thermal-neutral period (THI = 72 +/- 3) for 7 days, and a heat-stress period (THI = 87 +/- 2) for 21 days. In both periods, feeding, resting, posture, and thermally-associated behaviors were recorded. The gestation length was shortened by 3 days in GHS goats. In the AT, IUHS kids showed a lower number of sniffs (P < 0.01) compared to IUTN. In the NOT, IUHS kids also tended to show a lower number of sniffs (P = 0.09). During heat exposure, IUTN and IUHS growing goats spent more time resting and exhibited more heat-stress related behaviors such as panting and drinking (P < 0.001); however, no differences were observed between both groups. In conclusion, heat stress during the first third of pregnancy shortened gestation length and influenced the exploratory behavior of the kids in the early life. However, behavior responses to heat stress during the adulthood were not affected by the in utero thermal treatment.	[Coloma-Garcia, Wellington; Mehaba, Nabil; Caja, Gerardo; Such, Xavier; Salama, Ahmed A. K.] UAB, Dept Anim & Food Sci, Grp Res Ruminants G2R, Barcelona, Spain; [Coloma-Garcia, Wellington] UAE, Fac Med Vet, Guayaquil, Ecuador; [Llonch, Pol] UAB, Dept Anim & Food Sci, Serv Nutr & Anim Welf SNiBA, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Such, X (corresponding author), UAB, Dept Anim & Food Sci, Grp Res Ruminants G2R, Barcelona, Spain.	Xavier.such@uab.cat	Llonch, Pol/M-3597-2014; Salama, Ahmed/O-1367-2013; Caja, Gerardo/AAH-2838-2020; SUCH MARTI, FRANCESC XAVIER/J-4944-2016	Llonch, Pol/0000-0001-5958-861X; Salama, Ahmed/0000-0003-2065-9702; Caja, Gerardo/0000-0001-8606-3587; SUCH MARTI, FRANCESC XAVIER/0000-0002-9712-4477; Coloma Garcia, Wellington/0000-0003-3182-2085; Mehaba, Nabil/0000-0002-1701-5407	Spanish Ministry of Economy and Competitivity (Programa I+D+i orientada a los retos de la sociedad) [AGL2013-44061-R]; Ministry of Science, Innovation and Universities; Agency for Management of University and Research grants (Catalonia, Spain)	Spanish Ministry of Economy and Competitivity (Programa I+D+i orientada a los retos de la sociedad); Ministry of Science, Innovation and Universities; Agency for Management of University and Research grants (Catalonia, Spain)	This work is part of a research project funded by the Spanish Ministry of Economy and Competitivity (Programa I+D+i orientada a los retos de la sociedad; Project AGL2013-44061-R) given to AAKS. The funder name has changed to the Ministry of Science, Innovation and Universities (http://www.ciencia.gob.es/portal/site/MICINN/menuitem.791459a43fdf738d70fd325001432ea0/?vgnextoid=fef9e6f001f01610VgnVCM1000001d 04140aRCRD&vgnextchannel=b24e067c468a4610VgnVCM1000001d04140aRCRD&vgnextfmt= formato2&id3=8a89ed0fd1915610VgnVCM1000 001d04140a____). A pre-doctoral FI grant from the Agency for Management of University and Research grants (Catalonia, Spain) was awarded to NM (http://agaur.gencat.cat/en/inici/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarinejad V, 2017, THERIOGENOLOGY, V99, P69, DOI 10.1016/j.theriogenology.2017.05.018; Battini M, 2016, INT J BIOMETEOROL, V60, P289, DOI 10.1007/s00484-015-1025-7; Breed M., 2010, NATURE ED KNOWLEDGE, V3, P68; Bristow DJ, 2007, PHYSIOL BEHAV, V90, P626, DOI 10.1016/j.physbeh.2006.11.015; BROWN DL, 1988, J DAIRY SCI, V71, P2486, DOI 10.3168/jds.S0022-0302(88)79835-5; Castro-Costa A, 2015, J DAIRY SCI, V98, P4646, DOI 10.3168/jds.2014-8819; Coulon M, 2015, DEV PSYCHOBIOL, V57, P626, DOI 10.1002/dev.21320; Coulon M, 2014, STRESS, V17, P460, DOI 10.3109/10253890.2014.969238; Dahl GE, 2017, J ANIM SCI, V95, P5701, DOI 10.2527/jas2017.2006; Estanislau C, 2005, BEHAV BRAIN RES, V163, P70, DOI 10.1016/j.bbr.2005.04.003; Fabris TF, 2019, J DAIRY SCI, V102, P5647, DOI 10.3168/jds.2018-15721; FORBES JM, 1967, J AGR SCI, V68, P191, DOI 10.1017/S0021859600016221; Hamzaoui S, 2013, J DAIRY SCI, V96, P6355, DOI 10.3168/jds.2013-6665; Herskin MS, 2004, PHYSIOL BEHAV, V83, P411, DOI 10.1016/j.physbeh.2004.08.027; Kaliber M, 2016, ANIMAL, V10, P82, DOI 10.1017/S1751731115001652; Kovacs L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33451-6; Laporta J, 2017, J DAIRY SCI, V100, P2976, DOI 10.3168/jds.2016-11993; Marchlewska-Koj A, 2003, PHYSIOL BEHAV, V79, P671, DOI 10.1016/S0031-9384(03)00168-9; Martin P., 2007, MEASURING BEHAV INTR, V3, DOI [10.1017/CBO9780511810893, DOI 10.1017/CBO9780511810893]; McGeady T.A., 2006, VET EMBRYOLOGY; McGowan PO, 2018, ENDOCRINOLOGY, V159, P69, DOI 10.1210/en.2017-00896; Monteiro APA, 2016, J DAIRY SCI, V99, P3896, DOI 10.3168/jds.2015-10699; NRC, 1971, GUID ENV RES AN; ROMEYER A, 1992, APPL ANIM BEHAV SCI, V34, P93, DOI 10.1016/S0168-1591(05)80060-7; Roussel S, 2005, HORM BEHAV, V47, P256, DOI 10.1016/j.yhbeh.2004.09.010; RUIZMIRANDA CR, 1992, APPL ANIM BEHAV SCI, V33, P277, DOI 10.1016/S0168-1591(05)80015-2; Salama AAK, 2014, SMALL RUMINANT RES, V121, P73, DOI 10.1016/j.smallrumres.2013.11.021; Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6; Schroeder M, 2013, DEV PSYCHOBIOL, V55, P176, DOI 10.1002/dev.21010; Seckl JR, 2001, MOL CELL ENDOCRINOL, V185, P61, DOI 10.1016/S0303-7207(01)00633-5; Shilja S, 2016, INT J BIOMETEOROL, V60, P1311, DOI 10.1007/s00484-015-1124-5; Silanikove N, 2015, SMALL RUMINANT RES, V123, P27, DOI 10.1016/j.smallrumres.2014.11.005; Tao S, 2014, J DAIRY SCI, V97, P897, DOI 10.3168/jds.2013-7323; Tao S, 2013, J DAIRY SCI, V96, P4079, DOI 10.3168/jds.2012-6278; Vallee M, 1997, J NEUROSCI, V17, P2626; Van den Hove DLA, 2014, EUR NEUROPSYCHOPHARM, V24, P595, DOI 10.1016/j.euroneuro.2013.09.006; Viltart O, 2007, THESCIENTIFICWORLDJO, V7, P1493, DOI 10.1100/tsw.2007.204; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Yang CH, 2018, APPL ANIM BEHAV SCI, V202, P7, DOI 10.1016/j.applanim.2018.02.004; Yates DT, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/740408; Zhu MJ, 2007, PLACENTA, V28, P361, DOI 10.1016/j.placenta.2006.04.005	41	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0220221	10.1371/journal.pone.0220221	http://dx.doi.org/10.1371/journal.pone.0220221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040479	Green Published, Green Submitted, gold			2022-12-26	WOS:000534629400001
J	Koo, BJ; Seo, J				Koo, Bon Joo; Seo, Jaehwan			Filtration rates of the manila clam, Ruditapes philippinarum, in tidal flats with different hydrographic regimes	PLOS ONE			English	Article							TEMPERATURE	The manila clam Ruditapes philippinarum is widely distributed in the sandy mud sediments of tidal flats and plays a role in seawater purification by filtering suspended organic matter. This study was designed to evaluate differences in seawater purification based on the filtration rate of the manila clam in terms of particulate organic matter (POM) between two tidal flats with different hydrographic regimes. In situ experiments were carried out at Geunso and Sihwa tidal flats, along the west coast of Korea. The amount of POM removed from the water column by the feeding activity of the clam was measured in the field using a closed circulation chamber. The filtration rate of clams for POM at Sihwa tidal flat (2.86 for POC, 2.29 for PON and 5.46 L h(-1) gDW(-1) for Chl a) was higher than that at Geunso tidal flat (0.61 for POC, 0.89 for PON and 2.54 L h(-1) gDW(-1) for Chl a) which resulted from differences in the hydrographic regime, including tide characteristics, current speed and submergence time, and food quantity and quality. The current speed was much greater at Geunso tidal flat than at Sihwa tidal flat, but the submergence time by tide was longer at the latter site than the former, resulting in different feeding times for clams. The food quantity in terms of chlorophyll a was higher at Sihwa tidal flat than at Geunso tidal flat, and the food quality based on the C/N ratio of POM was better at the former site than the latter, with values of 12.8 and 15.6, respectively. These findings suggest that hydrographic regime could be important in understanding in situ filtration rates of R. philippinarum.	[Koo, Bon Joo; Seo, Jaehwan] Univ Sci & Technol, Sch Ocean Sci, Daejeon, South Korea; [Koo, Bon Joo; Seo, Jaehwan] KIOST, Marine Ecosyst Res Ctr, Busan, South Korea	University of Science & Technology (UST); Korea Institute of Ocean Science & Technology (KIOST)	Koo, BJ (corresponding author), Univ Sci & Technol, Sch Ocean Sci, Daejeon, South Korea.; Koo, BJ (corresponding author), KIOST, Marine Ecosyst Res Ctr, Busan, South Korea.	bjkoo@kiost.ac.kr		Koo, Bon Joo/0000-0002-3078-2942	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2018R1D1A1B07049632, KIOST PN67930]; 'Development and security of mud shellfish resources in the small-sized tidal flat waterways' - Ministry of Oceans and Fisheries, Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; 'Development and security of mud shellfish resources in the small-sized tidal flat waterways' - Ministry of Oceans and Fisheries, Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2018R1D1A1B07049632, KIOST PN67930) and also was supported by a grant from the 'Development and security of mud shellfish resources in the small-sized tidal flat waterways', funded by the Ministry of Oceans and Fisheries, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HS, 2012, BIOCHEM SYST ECOL, V44, P186, DOI 10.1016/j.bse.2012.05.007; Aoyama H, 1997, AICHI FISHERIES RES, V6, P5; BEUKEMA J J, 1976, Netherlands Journal of Sea Research, V10, P236, DOI 10.1016/0077-7579(76)90017-X; Choi J. K., 2011, J COLLOID INTERF SCI, V13, P45; DAME RF, 1986, MAR ECOL PROG SER, V32, P71, DOI 10.3354/meps032071; Defossez JM, 1997, MAR BIOL, V129, P139, DOI 10.1007/s002270050154; GALLAGER SM, 1981, AQUACULTURE, V26, P95, DOI 10.1016/0044-8486(81)90113-7; GOLDMAN JC, 1980, J EXP MAR BIOL ECOL, V46, P29, DOI 10.1016/0022-0981(80)90088-X; Han KN, 2008, AQUACULT INT, V16, P143, DOI 10.1007/s10499-007-9133-y; Jensen AC, 2004, J MAR BIOL ASSOC UK, V84, P1069, DOI 10.1017/S0025315404010446h; KORDI, 2007, ASS FLUX SED WAT BOU; Lee C.I., 2016, P 2016 INT C ADV MAT, P128; Lee S, 2014, INT J REMOTE SENS, V35, P3875, DOI 10.1080/01431161.2014.919680; 신현출, 2003, The Korean Journal of Malacology, V19, P1; MLTMA, 2008, ANN REP PROJ IMPR MA; MLTMA, 2009, ANN REP PROJ IMPR MA; MOMAF, 2005, ANN REP PROJ IMPR MA; Nakamura Y, 2001, J EXP MAR BIOL ECOL, V266, P181, DOI 10.1016/S0022-0981(01)00354-9; Sylvester F, 2005, HYDROBIOLOGIA, V534, P71, DOI 10.1007/s10750-004-1322-3; Widdow J, 1998, ESTUAR COAST SHELF S, V34, P557; WOLFF WJ, 1977, ESTUAR COAST MAR SCI, V5, P1, DOI 10.1016/0302-3524(77)90070-6; Wolff WJ, 1983, ECOSYSTEMS WORLD EST, V26, P152	22	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228873	10.1371/journal.pone.0228873	http://dx.doi.org/10.1371/journal.pone.0228873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040527	gold, Green Published			2022-12-26	WOS:000534629400048
J	Nair, M; Kumar, P; Pandey, S; Kazmi, S; Moreto-Planas, L; Ranjan, A; Burza, S				Nair, Mohit; Kumar, Pragya; Pandey, Sanjay; Kazmi, Shahwar; Moreto-Planas, Laura; Ranjan, Alok; Burza, Sakib			Quality of life perceptions amongst patients co-infected with Visceral Leishmaniasis and HIV: A qualitative study from Bihar, India	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS; COINFECTION; CARE	Background Co-infection with Visceral Leishmaniasis (commonly known as Kala Azar, KA) and Human Immunodeficiency Virus (HIV) is increasingly being diagnosed among patients in Bihar. This qualitative study is the first assessment of self-reported quality of life among patients co-infected with KA-HIV in the Asian context. Methods We conducted semi-structured, in-depth interviews and adopted an inductive thematic analysis to generate evidence on the quality of life of patients co-infected with KA and HIV. Patients were purposively sampled until saturation was attained. Results We found that patients highly valued income or livelihood potential and health as indicators of a good quality life, and routinely went into debt accessing care in the private setup. This was due to perceptions of poor quality of care in the government setup and a lack of knowledge regarding available government services at the district level. KA symptoms were often misdiagnosed in the private sector as seasonal fever, while care providers found it difficult to disentangle the clinical symptoms of KA and HIV; hence, patients presented late to district hospitals. Patients perceived a high level of stigma, largely due to their HIV status, and routinely reported that HIV had "destroyed" their life. Conclusions Inadequate social support and referral pathways that were not conducive to patient needs negatively impacted patients' quality of life. The dual burden of poverty interacting with the severity and chronicity of KA-HIV co-infection means financial support, increased community engagement, and collaborative decision making are crucial for co-infected patients. Increased provider awareness of co-infection and effective stigma-reduction interventions should be integrated to ensure that appropriate and effective access to care is possible for this vulnerable population. A sustainable long-term strategy requires a people-centered approach wherein the perceptions and life circumstances of patients are taken into account in the medical decision making process.	[Nair, Mohit; Kazmi, Shahwar; Burza, Sakib] Med Sans Frontieres, New Delhi, India; [Kumar, Pragya; Pandey, Sanjay; Ranjan, Alok] All India Inst Med Sci, Patna, Bihar, India; [Moreto-Planas, Laura] Med Sans Frontieres, Barcelona, Spain	All India Institute of Medical Sciences (AIIMS) Patna; Doctors Without Borders	Burza, S (corresponding author), Med Sans Frontieres, New Delhi, India.	sakib.burza@barcelona.msf.org	Kazmi, Shahwar/AAZ-7218-2021	Kazmi, Shahwar/0000-0003-1126-9219; Burza, Sakib/0000-0001-7886-8633				Akuffo H, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006375; Alemayehu M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4132-z; Alexander J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00080; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; [Anonymous], 2018, NAT VECT BORN DIS CO; [Anonymous], DIAGNOSIS TREATMENT; [Anonymous], 2015, IND HIV EST 2015 TEC; Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003053; Burza S, 2014, CLIN INFECT DIS, V59, P552, DOI 10.1093/cid/ciu333; Cameron MM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1309-8; Chandan Kumar, 2011, Consilience: The Journal of Sustainable Development, P25; Dilip TR, 2010, HEALTH POLICY PLANN, V25, P437, DOI 10.1093/heapol/czq012; Duggal R, 1994, Health Millions, V2, P10; Ergler CR, 2011, SOC SCI MED, V72, P327, DOI 10.1016/j.socscimed.2010.09.042; Griensven JV, 2018, OPEN FORUM INFECT DI, V5, P1; Hazarika I, 2011, J GLOB INFECT DIS, V3, P19, DOI 10.4103/0974-777X.77291; Jarvis JN, 2013, CURR OPIN INFECT DIS, V26, P1, DOI 10.1097/QCO.0b013e32835c2198; Lindoso JAL, 2018, HIV AIDS-RES PALLIAT, V10, P193, DOI 10.2147/HIV.S143929; Lindoso JAL, 2016, HIV AIDS-RES PALLIAT, V8, P147, DOI 10.2147/HIV.S93789; Lindoso JA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003136; Mahajan R, 2015, CLIN INFECT DIS, V61, P1255, DOI 10.1093/cid/civ530; Mathur P, 2006, J MED MICROBIOL, V55, P919, DOI 10.1099/jmm.0.46574-0; Mock DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002635; Nandi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187904; Pandey A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000926; Pomeroy A, 2010, DHS WORKING PAPERS, V76, P1; Pradhan BK, 2006, SOCIOECONOMIC IMPACT, P1; Rao P., 2012, ASCI J MANAGE, V41, P14; Redhu NS, 2006, AIDS, V20, P1213, DOI 10.1097/01.aids.0000226971.42622.4e; Rezaei Z, 2018, PARASITOL RES, P1; Rijal S, 2006, T ROY SOC TROP MED H, V100, P838, DOI 10.1016/j.trstmh.2005.09.017; Sharma D, 2017, INDIAN J MED RES, V146, P759, DOI 10.4103/ijmr.IJMR_2003_15; Thakur CP, 2000, T ROY SOC TROP MED H, V94, P696, DOI 10.1016/S0035-9203(00)90238-4; Thakur CP, 2003, JAIDS-J ACQ IMM DEF, V32, P572, DOI 10.1097/00126334-200304150-00017; WHO, 2007, 5 CONS M LEISHM HIV, V20; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2017, KEY CONS DIFF ANT TH	38	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0227911	10.1371/journal.pone.0227911	http://dx.doi.org/10.1371/journal.pone.0227911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040525	Green Published, gold			2022-12-26	WOS:000534629400011
J	Acosta, K; Xu, J; Gilbert, S; Denison, E; Brinkman, T; Lebeis, S; Lam, E				Acosta, Kenneth; Xu, Jenny; Gilbert, Sarah; Denison, Elizabeth; Brinkman, Thomas; Lebeis, Sarah; Lam, Eric			Duckweed hosts a taxonomically similar bacterial assemblage as the terrestrial leaf microbiome	PLOS ONE			English	Article							ACINETOBACTER-CALCOACETICUS P23; ARABIDOPSIS-THALIANA; SPIRODELA-POLYRHIZA; PLANT; GROWTH; RHIZOSPHERE; INSIGHTS; FEATURES	Culture-independent characterization of microbial communities associated with popular plant model systems have increased our understanding of the plant microbiome. However, the integration of other model systems, such as duckweed, could facilitate our understanding of plant microbiota assembly and evolution. Duckweeds are floating aquatic plants with many characteristics, including small size and reduced plant architecture, that suggest their use as a facile model system for plant microbiome studies. Here, we investigated the structure and assembly of the duckweed bacterial microbiome. First, a culture-independent survey of the duckweed bacterial microbiome from different locations in New Jersey revealed similar phylogenetic profiles. These studies showed that Proteobacteria is a dominant phylum in the duckweed bacterial microbiome. To observe the assembly dynamics of the duckweed bacterial community, we inoculated quasi-gnotobiotic duckweed with wastewater effluent from a municipal wastewater treatment plant. Our results revealed that duckweed strongly shapes its bacterial microbiome and forms distinct associations with bacterial community members from the initial inoculum. Additionally, these inoculation studies showed the bacterial communities of different duckweed species were similar in taxa composition and abundance. Analysis across the different duckweed bacterial communities collected in this study identified a set of "core" bacterial taxa consistently present on duckweed irrespective of the locale and context. Furthermore, comparison of the duckweed bacterial community to that of rice and Arabidopsis revealed a conserved taxonomic structure between the duckweed microbiome and the terrestrial leaf microbiome. Our results suggest that duckweeds utilize similar bacterial community assembly principles as those found in terrestrial plants and indicate a highly conserved structuring effect of leaf tissue on the plant microbiome.	[Acosta, Kenneth; Xu, Jenny; Gilbert, Sarah; Brinkman, Thomas; Lam, Eric] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08854 USA; [Denison, Elizabeth; Lebeis, Sarah] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	Rutgers State University New Brunswick; University of Tennessee System; University of Tennessee Knoxville	Lam, E (corresponding author), Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08854 USA.	ericl89@hotmail.com		Denison, Elizabeth/0000-0003-3320-8847; Acosta, Kenneth/0000-0001-5309-2760	Department of Energy [DE-SC0018244]; New Jersey Agricultural Experiment Station at Rutgers University [12116]; University of Tennessee, Knoxville	Department of Energy(United States Department of Energy (DOE)); New Jersey Agricultural Experiment Station at Rutgers University; University of Tennessee, Knoxville	Duckweed research in EL laboratory was supported in part by a grant from the Department of Energy (DE-SC0018244) and a Hatch project (#12116) from the New Jersey Agricultural Experiment Station at Rutgers University. SL acknowledges start-up funds provided to her from the University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler MT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002352; Appenroth Klaus J., 2013, Chinese Journal of Applied and Environmental Biology, V19, P1, DOI 10.3724/SP.J.1145.2013.00001; Appenroth KJ, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00483; Bai Y, 2015, NATURE, V528, P364, DOI 10.1038/nature16192; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Borisjuk N, 2015, PLANT BIOLOGY, V17, P42, DOI 10.1111/plb.12229; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canto-Pastor A, 2015, PLANT BIOLOGY, V17, P59, DOI 10.1111/plb.12215; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Dillon M.R., 2019, NAT BIOTECHNOL, V37, P1, DOI [10.1038/nbt.4341, DOI 10.1038/NBT.4341]; Duran P, 2018, CELL, V175, P973, DOI 10.1016/j.cell.2018.10.020; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Finkel OM, 2017, CURR OPIN PLANT BIOL, V38, P155, DOI 10.1016/j.pbi.2017.04.018; Fitzpatrick CR, 2018, P NATL ACAD SCI USA, V115, pE1157, DOI 10.1073/pnas.1717617115; Glick BR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/963401; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Huang W, 2020, HOST SPECIFIC TISSUE; Ishizawa H, 2020, CHEMOSPHERE, V238, DOI 10.1016/j.chemosphere.2019.124682; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Laird RA, 2018, AM J BOT; Lam E, 2 INT C DUCKW RES AP, DOI [10.1111/plb.12184, DOI 10.1111/PLB.12184]; Levy A, 2018, NAT GENET, V50, P138, DOI 10.1038/s41588-017-0012-9; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Michael TP, 2017, PLANT J, V89, P617, DOI 10.1111/tpj.13400; Muller DB, 2016, ANNU REV GENET, V50, P211, DOI 10.1146/annurev-genet-120215-034952; Naylor D, 2017, ISME J, V11, P2691, DOI 10.1038/ismej.2017.118; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Parnell JJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01110; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Robbins C, 2018, PHYTOBIOMES J, V2, P24, DOI 10.1094/PBIOMES-09-17-0042-R; Santos-Medellin C, 2017, MBIO, V8, DOI [10.1128/mbio.00764-17, 10.1128/mBio.00764-17]; Schlaeppi K, 2014, P NATL ACAD SCI USA, V111, P585, DOI 10.1073/pnas.1321597111; Sebastien M, 2015, BIOL CONTROL, V89, P98, DOI 10.1016/j.biocontrol.2015.06.003; Thiergart T, 2019, ROOT MICROBIOTA ASSE; Thomson ELS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080102; Thorsen J, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0208-8; Toyama T, 2017, WATER SCI TECHNOL, V76, P1418, DOI 10.2166/wst.2017.296; Vannier N, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007740; Wang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4311; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Xu JL, 2012, BIOFUELS-UK, V3, P589, DOI 10.4155/BFS.12.31; Xu L, 2018, P NATL ACAD SCI USA, V115, pE4284, DOI 10.1073/pnas.1717308115; Yamaga F, 2010, ENVIRON SCI TECHNOL, V44, P6470, DOI 10.1021/es1007017; Zhang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013527; Ziegler P, 2015, PLANT BIOLOGY, V17, P33, DOI 10.1111/plb.12184	54	14	14	9	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228560	10.1371/journal.pone.0228560	http://dx.doi.org/10.1371/journal.pone.0228560			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027711	gold, Green Published, Green Submitted			2022-12-26	WOS:000534623800048
J	Herbut, A				Herbut, Aneta			Vibration mitigation efficiency of an inclined, curved, open trench	PLOS ONE			English	Article							WAVE-PROPAGATION; BARRIERS	The vibration screening efficiency of a curved, inclined, open trench is investigated in this paper. An elastic, transversely isotropic half-space with hysteretic damping, acted upon by a harmonic vertical excitation, is assumed. Equations of motion with absorbing boundary conditions are presented and numerically integrated using FlexPDE software, based on the finite element method. The barrier efficiency is analysed in terms of the reduction of the vertical and horizontal components of the ground surface vibration. The results are presented for trenches with different geometric features based on the non-dimensional amplitude reduction factor. The trench inclination angle, the shape of the trench surface and the distance between the source of vibration and an obstacle are investigated as factors that can improve the trench reduction ability. It is demonstrated that a better attenuation of vibration is achieved with the proposed inclined trench than with its vertical counterpart. Moreover, the vibration mitigation effect is more significant in the case of a more horizontally located trench than for its vertical counterpart (even up to 5 times smaller displacement amplitudes for the vertical displacement component). Additionally, assuming the same trench depth, the vibration reduction effect is better in the case of a smaller number of rings used. The vibration attenuation efficiency is more visible if the trench is located closer to the vibration source.	[Herbut, Aneta] Wroclaw Univ Sci & Technol, Fac Civil Engn, Inst Geotech & Hydrotech, Wroclaw, Poland	Wroclaw University of Science & Technology	Herbut, A (corresponding author), Wroclaw Univ Sci & Technol, Fac Civil Engn, Inst Geotech & Hydrotech, Wroclaw, Poland.	aneta.herbut@pwr.edu.pl	Herbut, Aneta/G-6467-2018	Herbut, Aneta/0000-0001-7106-9652	WCSS Computer Centre [437]	WCSS Computer Centre	The results of numerical calculations presented in this paper have been obtained with the support of the WCSS Computer Centre, within the frame of Grant No 437. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaoui Y, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa6e21; Alzawi A, 2011, SOIL DYN EARTHQ ENG, V31, P306, DOI 10.1016/j.soildyn.2010.08.010; [Anonymous], 1983, FUNDAMENTALS SOIL DY; Brule S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.133901; Carcione J.M, 2001, WAVE FIELDS REAL MED; Celebi E, 2009, SOIL DYN EARTHQ ENG, V29, P824, DOI 10.1016/j.soildyn.2008.08.007; Chen XJ, 2014, SOIL DYN EARTHQ ENG, V65, P243, DOI 10.1016/j.soildyn.2014.06.019; Deymier PA, 2013, SPRINGER SERIES SOLI; Gao GY, 2006, SOIL DYN EARTHQ ENG, V26, P1015, DOI 10.1016/j.soildyn.2006.02.005; Geng Q, 2018, SOIL DYN EARTHQ ENG, V107, P264, DOI 10.1016/j.soildyn.2018.01.028; Javanmardi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200482; Kattis SE, 1999, SOIL DYN EARTHQ ENG, V18, P1, DOI 10.1016/S0267-7261(98)00032-3; KERNER C, 1989, GEOPHYS J INT, V97, P295, DOI 10.1111/j.1365-246X.1989.tb00502.x; Kramer S.L., 1996, GEOTECHNICAL EARTHQU; Kuznetsov SV, 2011, ACOUST PHYS+, V57, P420, DOI 10.1134/S1063771011030109; Lohunova O, 2018, MATEC WEB CONF, V251, DOI 10.1051/matecconf/201825103063; Lysmer J, 1969, J ENG MECH DIV ASCE, V95, P859, DOI 10.1061/JMCEA3.0001144; Mehrabi MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176480; Oliveira F., 2017, 17 INT MULTIDISCIPLI, P993, DOI [10.5593/sgem2017/12/S02.126, DOI 10.5593/SGEM2017/12/S02.126]; Palermo A, 2018, SOIL DYN EARTHQ ENG, V113, P265, DOI 10.1016/j.soildyn.2018.05.035; Persson P, 2014, SOIL DYN EARTHQ ENG, V60, P31, DOI 10.1016/j.soildyn.2014.01.009; Reinhorn, 2005, ACTIVE HYBRID SEMIAC; Rybak J, 2010, NDE FOR SAFETY: DEFEKTOSKOPIE 2010, P237; Saikia A, 2014, SOIL DYN EARTHQ ENG, V65, P206, DOI 10.1016/j.soildyn.2014.05.012; Shrivastava RK, 2002, SOIL DYN EARTHQ ENG, V22, P695, DOI 10.1016/S0267-7261(02)00060-X; Towhata I, 2008, SPRINGER SER GEOMECH, P3, DOI 10.1007/978-3-540-35783-4_1; Turan A, 2013, SOIL DYN EARTHQ ENG, V55, P225, DOI 10.1016/j.soildyn.2013.09.003; Verruijt A., 2010, INTRO SOIL DYNAMICS, P24; Wang JG, 2009, J SOUND VIB, V321, P492, DOI 10.1016/j.jsv.2008.09.047; Woods RD, 1967, SCREENING ELASTIC SU; Wrana B., 2012, DYNAMIKA GRUNTOWE MO; Xu F.H., 2016, INTELLIGENT VIBRATIO; Xu YL., 2017, SMART CIVIL STRUCTUR	33	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0229010	10.1371/journal.pone.0229010	http://dx.doi.org/10.1371/journal.pone.0229010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027726	Green Submitted, Green Published, gold			2022-12-26	WOS:000534623800079
J	Ludwig, G; Garcia-Garcia, S; Lanaspa, M; Ciruela, P; Esteva, C; de Sevilla, MF; Diaz-Conradi, A; Marti, C; Motje, M; Galles, C; Morta, M; Izquierdo, C; Moraga-Llop, F; Campins, M; Salleras, L; Jane, M; Dominguez, A; Garcia-Garcia, JJ; Munoz-Almagro, C				Ludwig, Guillermo; Garcia-Garcia, Selene; Lanaspa, Miguel; Ciruela, Pilar; Esteva, Cristina; Fernandez de Sevilla, Mariona; Diaz-Conradi, Alvaro; Marti, Carmina; Motje, Montse; Galles, Carme; Morta, Montse; Izquierdo, Conchita; Moraga-Llop, Fernando; Campins, Magda; Salleras, Luis; Jane, Mireia; Dominguez, Angela; Jose Garcia-Garcia, Juan; Munoz-Almagro, Carmen		Catalan Study Grp Invasive Pneumoc	Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain	PLOS ONE			English	Article							CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; 13-VALENT; DISEASE; EMERGENCE; CHILDREN; ENGLAND; WALES; IMMUNOGENICITY; REPLACEMENT	Background The objective of this study is to describe incidence and shifts of serotype and clonal distribution of invasive Streptococcus pneumoniae strains in four different age groups (<5 years, 5-17 years, 18-64 years and >65 years) during a period of intermediate PCV13 vaccination coverage (2011-2016) in Catalonia, Spain. Methods We included all pneumococcal strains systematically sent to the Catalan support laboratory for molecular surveillance of invasive pneumococcal disease (IPD) located at Hospital Sant Joan de Deu, Barcelona. Two study periods were considered: 2011-13, early PCV13 vaccination period (EVP) and 2014-2016, late vaccination period (LVP). Results A total of 2142 strains were included in the study. Five years after intermediate introduction of PCV13 in our population, a significant decrease of overall incidence of IPD in children <5 years was observed (incidence rate ratio 0.5, 95% confidence interval 0.4-0.8). However, in seniors older than 65 years, a significant increase of overall incidence of IPD was observed (IRR 1.4, 95% CI 1.1-1.7). The contribution of PCV13 vaccine serotypes to IPD declined significantly in all age groups: from 59% to 38.1% in <5 years; 82.7% to 59% in 5-17 years, 47.8% to 34.1% in 18-64 years and 48.2% to 37% in >65 years. Results found when comparing both periods were consistent with IRRs observed year by year. In children <5 years, the three major serotypes detected were 1, 24F and 19A in EVP vs 24F, 14 and 10A in LVP. Among patients 5-17 years the first three serotypes were 1, 12F and 14 both in EVP and LVP. Among adults 18-64, the three major serotypes detected were 1, 12F and 8 vs 8, 12F and 3, respectively. Finally, in patients >65 years the most frequently isolated serotypes were 3, 19A and 7F vs 3, 14 and 12F, respectively. Regarding clonal complexes (CCs) expressing mainly PCV13 serotypes, significant decreases of the proportions of CC306, CC191 and CC320 were observed, while CC156 showed a significant increase. As for CCs expressing mostly non-PCV13 serotypes, significant increases in ST989, CC53 and CC404 were showed. Conclusions Despite low vaccine coverage in our setting a significant decrease of incidence of IPD was observed in children younger than 5 years. The modest indirect protection against vaccine serotypes causing IPD in elderly indicate the need for the inclusion of more serotypes in future high-valent PCV and vaccinating old adults should be considered.	[Ludwig, Guillermo; Garcia-Garcia, Selene; Lanaspa, Miguel; Esteva, Cristina; Fernandez de Sevilla, Mariona; Jose Garcia-Garcia, Juan; Munoz-Almagro, Carmen] Hosp St Joan de Deu, Inst Recerca St Joan Deu, Barcelona, Spain; [Lanaspa, Miguel; Ciruela, Pilar; Esteva, Cristina; Fernandez de Sevilla, Mariona; Salleras, Luis; Jane, Mireia; Dominguez, Angela; Jose Garcia-Garcia, Juan; Munoz-Almagro, Carmen] Inst Salud Carlos III, GIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Ciruela, Pilar; Izquierdo, Conchita; Jane, Mireia] Agencia Salut Publ Catalunya ASPCAT, Barcelona, Spain; [Diaz-Conradi, Alvaro] Hosp Nens, Barcelona, Spain; [Marti, Carmina] Hosp Gen Granollers, Granollers, Spain; [Motje, Montse] Hosp Univ Girona Dr Josep Trueta, Girona, Spain; [Galles, Carme] Hosp St Jaume, Calella, Spain; [Morta, Montse] Hosp St Joan de Deu Manresa, Barcelona, Spain; [Moraga-Llop, Fernando; Campins, Magda] Hosp Univ Vall dHebron, Barcelona, Spain; [Campins, Magda] Vall dHebron Inst Recerca, Grup Recerca Epidemiol & Salut PUbl, Barcelona, Spain; [Salleras, Luis; Dominguez, Angela] Univ Barcelona, Dept Med, Barcelona, Spain; [Munoz-Almagro, Carmen] Univ Int Catalunya, Dept Med, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona; Universitat Internacional de Catalunya (UIC)	Munoz-Almagro, C (corresponding author), Hosp St Joan de Deu, Inst Recerca St Joan Deu, Barcelona, Spain.; Munoz-Almagro, C (corresponding author), Inst Salud Carlos III, GIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	cma@sjdhospitalbarcelona.org	Ludwig, Guillermo/E-5390-2018	Ludwig, Guillermo/0000-0001-9465-3085; Esteva Afonso, Cristina/0000-0001-7133-4540	ISCIII Sub-Directorate General for Evaluation and Promotion of Research [PI16/00174, PI17/00337]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2017/SGR 00742, 2017/SGR 1342]; SpIDnet Network, ECDC	ISCIII Sub-Directorate General for Evaluation and Promotion of Research; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); SpIDnet Network, ECDC	This work was supported by the ISCIII Sub-Directorate General for Evaluation and Promotion of Research (Projects CMA: PI16/00174, JJGG: PI17/00337) cofounded by Fondo Europeo de Desarrollo Regional (FEDER) and Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) (Grant CMA: 2017/SGR 00742 and AD: 2017/SGR 1342).; The authors would acknowledge Dr. Savulescu and SpIDnet Network, ECDC-funded project. The authors would also acknowledge the members of Catalan Study Group of Invasive Pneumococcal Disease are: S Broner, Pilar Ciruela, Mireia Jane, Agencia de Salut Publica de Catalunya; J. Llaberia, Hospital de Barcelona; R Cliville, Hospital de Sant Joan Despi Moises Broggi; C Galles and A Puig, Hospital Comarcal Sant Jaume de Calella; E Jou and C Sanjose, Hospital Comarcal de l'Alt Penedes; Hospital Dos de Maig; P Gassiot, Hospital de Figueres; C Marti, Hospital de Granollers; A Garcia, Hospital d'Igualada; A Diaz, Hospital de Nens; J de Batlle andMMotje, Hospital Josep Trueta; MOlsina, Hospital General de Catalunya; S Hernandez, Hospital Sant Joan de Deu de Barcelona; F Gomez, Hospital Joan XXIII; C Alfonso, Hospital General de l'Hospitalet; MMorta, Althaia Xarxa Asistencial Manresa; G Sauca, Consorci Sanitari del Maresme; E Sanfeliu, Hospital Sant Jaume d'Olot; F Ballester and I Pujol, Hospital Sant Joan de Reus; A Gonzalez, Hospital Sant Joan de Deu de Sant Boi; F Corcoy, Hospital Residencia Sant Camil; X Raga, Hospital Sant Pau i Santa Tecla; MO Perez, Hospital Verge de la Cinta; G.Codina, B Vinado, Hospital del Vall d'Hebron; S Noguer, Hospital del Vendrell andM Navarro, Hospital Universitari de Vic (Consorci Hospitalari de Vic).	Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Balsells E, 2018, J INFECTION, V77, P368, DOI 10.1016/j.jinf.2018.06.004; Ben-Shimol S, 2012, VACCINE, V30, P6600, DOI 10.1016/j.vaccine.2012.08.012; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Choi EH, 2016, CLIN VACCINE IMMUNOL, V23, P162, DOI 10.1128/CVI.00591-15; Ciruela P., 2018, EPIDEMIOLOGY INVASIV; Ciruela P, 2018, VACCINE, V36, P7744, DOI 10.1016/j.vaccine.2018.05.026; Cohen C, 2017, LANCET GLOB HEALTH, V5, pE359, DOI 10.1016/S2214-109X(17)30043-8; Corcoran M, 2016, 10 INT S PNEUM PNEUM; Dagan R, 2013, CLIN INFECT DIS, V57, P952, DOI 10.1093/cid/cit428; del Amo E, 2014, CLIN MICROBIOL INFEC, V20, P684, DOI 10.1111/1469-0691.12422; del Amo E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151125; Deng XD, 2016, CLIN INFECT DIS, V62, P1126, DOI 10.1093/cid/ciw050; Dominguez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183191; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Fry N, 2016, 10 INT S PNEUM PNEUM; Garcia E, 1997, MICROB DRUG RESIST, V3, P73, DOI 10.1089/mdr.1997.3.73; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Golden AR, 2018, J ANTIMICROB CHEMOTH, V73, P20, DOI 10.1093/jac/dky157; Hanquet G, 2019, THORAX, V74, P473, DOI 10.1136/thoraxjnl-2018-211767; Horacio AN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01616; Htar MTT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1147-x; Izurieta P, 2018, EXPERT REV VACCINES, V17, P479, DOI 10.1080/14760584.2018.1413354; Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5; Martinon-Torres F, 2017, PEDIATR INFECT DIS J, V36, P326, DOI 10.1097/INF.0000000000001428; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2016, LANCET RESP MED, V4, P399, DOI 10.1016/S2213-2600(16)00052-7; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Moraga-Llop F, 2016, PEDIATR INFECT DIS J, V35, P460, DOI 10.1097/INF.0000000000001041; Morales M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209048; Munoz-Almagro C, 2009, J INFECTION, V59, P75, DOI 10.1016/j.jinf.2009.05.012; Normark BH, 2003, MICROB DRUG RESIST, V9, P337, DOI 10.1089/107662903322762761; Olarte L, 2017, J CLIN MICROBIOL, V55, P724, DOI 10.1128/JCM.01778-16; Pallares R, 2007, CLIN INFECT DIS, V46, P174; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rokney A, 2018, EMERG INFECT DIS, V24, P453, DOI 10.3201/eid2403.170769; Rupp R, 2019, HUM VACC IMMUNOTHER, V15, P549, DOI 10.1080/21645515.2019.1568159; Silva-Costa C, 2018, EMERG INFECT DIS, V24, P1307, DOI 10.3201/eid2407.180029; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; Vanderkooi OG, 2012, PEDIATR INFECT DIS J, V31, P72, DOI 10.1097/INF.0b013e318233049d; Vila-Corcoles A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3096-7; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; World Health Organization, 2008, EST HIB PNEUM DEATHS	46	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228612	10.1371/journal.pone.0228612	http://dx.doi.org/10.1371/journal.pone.0228612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027715	Green Published, gold			2022-12-26	WOS:000534623800056
J	Emiru, AA; Alene, GD; Debelew, GT				Emiru, Amanu Aragaw; Alene, Getu Degu; Debelew, Gurmesa Tura			The role of maternal health care services as predictors of time to modern contraceptive use after childbirth in Northwest Ethiopia: Application of the shared frailty survival analysis	PLOS ONE			English	Article							POSTPARTUM WOMEN; POSTNATAL CARE; MORTALITY	Introduction The first year after birth is an ideal time to offer contraception services, as many women have many opportunities to be in contact with the health care system. Nevertheless, a large number of postpartum women in developing countries do not use the service owing to the interplay of factors operating at various stages. Therefore, this study aimed to assess predictors of modern contraceptive use in the extended postpartum period. Methods A community based retrospective cross-sectional study was done among 1281 women who gave birth within 12 months preceding the survey. Kaplan-Meier plots and log rank tests were used to explore the rate of modern contraceptive use. The Weibull regression survival model with multivariate frailty was employed to identify the predictors of time to contraception. Results Of the respondents, 59.1% (95% CI: 56.8%-62.2%) had started using modern contraceptive methods within 12 months after birth. By the second month after birth, only 11.1 percent of the women surveyed started to use a contraceptive method, which increased steadily to 25.9%, 37.7%, and 59.5% at 6, 9, and 12 months, respectively. The most preferred contraceptive method was injectable (71.5%), followed by implants (21.5%). Women's education (aHR = 1.29; 95%CI: 1.02, 1.66), four or more antenatal care (aHR = 1.59; 95% CI: 1.22, 2.06), early initiation of antenatal care (aHR = 2.03; 95% CI: 1.28, 3.21), and early postnatal checkup (aHR = 1.39; 95% CI: 1.12, 1.73) were statistically significant predictors of earlier initiation of modern contraceptive methods. Conclusions A substantial proportion of women did not use modern contraceptive methods in the first year after birth. Maternal services were found to be the sole predictors in postpartum contraceptive use. Findings suggest the importance of linking postpartum family planning along the continuum of care. The observed heterogeneity at cluster level also urges the need of disaggregating data for decision-making.	[Emiru, Amanu Aragaw] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia; [Alene, Getu Degu] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Bahir Dar, Ethiopia; [Debelew, Gurmesa Tura] Jimma Univ, Fac Publ Hlth, Inst Hlth, Dept Populat & Family Hlth, Jimma, Ethiopia	Bahir Dar University; Bahir Dar University; Jimma University	Emiru, AA (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia.	amanuaragaw@yahoo.com		Debelew, Gurmesa/0000-0002-6216-3804	Bahir Dar University [RCS/252/09]	Bahir Dar University	This manuscript was based on the PhD thesis on the continuum of maternal care, which was conducted with the financial support of Bahir Dar University (URL: https://www.bdu.edu.et).Amanu Aragaw received the award (Research project code No: RCS/252/09). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut P, 2016, J FAM PLAN REPROD H, V42, P107, DOI 10.1136/jfprhc-2015-101271; Alebel A, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0173-x; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Balan TA, 2019, STAT MED; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P3, DOI 10.4314/ejhs.v24i0.2S; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2017, 2016 ETH DEM HLTH SU; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Cleves M., 2008, INTRO SURVIVAL ANAL; Dona A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5981-9; Dzakpasu S, 2014, HEALTH POLICY PLANN, V29, P137, DOI 10.1093/heapol/czs142; Embafrash G, 2019, INT J REPROD MED, V2019; Gebremedhin AY, 2018, CONTRACEP REPROD MED, V3, DOI 10.1186/s40834-017-0054-5; Gejo NG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217167; Gutierrez RG, 2002, STATA J, V2, P22, DOI 10.1177/1536867X0200200102; Hounton S, 2015, GLOBAL HEALTH ACTION, V8, P64, DOI 10.3402/gha.v8.29738; Jalang'o R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4510-6; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kongnyuy EJ, 2009, WOMEN HEALTH ISS, V19, P14, DOI 10.1016/j.whi.2008.09.008; Langlois EV, 2015, B WORLD HEALTH ORGAN, V93, P259, DOI 10.2471/BLT.14.140996; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S6; Mekonnen W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-37; Moore Z, 2015, CONTRACEPTION, V92, P31, DOI 10.1016/j.contraception.2015.03.007; Tran NT, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3199-2; Pasha O, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S11; Rao SR, 2015, OPEN ACCESS J CONTR, V6, P117, DOI 10.2147/OAJC.S55033; Sonalkar S, 2017, INT J GYNECOL OBSTET, V136, P2, DOI 10.1002/ijgo.12003; Tadele A, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-019-0087-z; Tafere Tadese Ejigu, 2018, Contracept Reprod Med, V3, P28, DOI 10.1186/s40834-018-0081-x; Tappis H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139628; Taye EB, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4464-0; Tegegn M, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-017-0048-3; Teka Takele Teshome, 2018, BMC Res Notes, V11, P581, DOI 10.1186/s13104-018-3698-6; Tessema GA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1790-5; TRAN NT, 2018, BMC HEALTH SERV RES, V18, DOI DOI 10.1186/S.12913-018-3199-2; Wang H., 2016, ETHIOPIA HLTH EXTENS; Weitzman A, 2017, SOC SCI MED, V180, P1, DOI 10.1016/j.socscimed.2017.03.004; West Gojjam ZoneHealth Office, 2017, 2016 17 FISC YEAR AN; WHO, 2022, WHO RECOMMENDATIONS; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization, 2013, PROGR STRAT POSTP FA; Zelelew H, 2018, HLTH CARE FINANCING, V20, P20	41	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228678	10.1371/journal.pone.0228678	http://dx.doi.org/10.1371/journal.pone.0228678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9EF	32017797	Green Published, gold, Green Submitted			2022-12-26	WOS:000534618100038
J	Nienhaus, F; Meemken, D; Schoneberg, C; Hartmann, M; Kornhoff, T; May, T; Hess, S; Kreienbrock, L; Wendt, A				Nienhaus, Franziska; Meemken, Diana; Schoneberg, Clara; Hartmann, Maria; Kornhoff, Thomas; May, Thomas; Hess, Sabrina; Kreienbrock, Lothar; Wendt, Anna			Health scores for farmed animals: Screening pig health with register data from public and private databases	PLOS ONE			English	Article							WELFARE QUALITY(R) PROTOCOL; MEAT INSPECTION; HERDS; PREVALENCE; ISSUES	There are growing demands to ensure animal health and, from a broader perspective, animal welfare, especially for farmed animals. In addition to the newly developed welfare assessment protocols, which provide a harmonised method to measure animal health during farm visits, the question has been raised whether data from existing data collections can be used for an assessment without a prior farm visit. Here, we explore the possibilities of developing animal health scores for fattening pig herds using a) official meat inspection results, b) data on antibiotic usage and c) data from the QS (QS Qualitat und Sicherheit GmbH) Salmonella monitoring programme in Germany. The objective is to aggregate and combine these register-like data into animal health scores that allow the comparison and benchmark of participating pig farms according to their health status. As the data combined in the scores have different units of measure and are collected in different abattoirs with possibly varying recording practices, we chose a relative scoring approach using z-transformations of different entrance variables. The final results are aggregated scores in which indicators are combined and weighted based on expert opinion according to their biological significance for animal health. Six scores have been developed to describe different focus areas, such as "Respiratory Health", "External Injuries/Alterations", "Animal Management", "Antibiotic Usage", "Salmonella Status" and "Mortality". These "focus" area scores are finally combined into an "Overall Score". To test the scoring method, existing routine data from 1,747 pig farm units in Germany are used; these farm units are members of the QS Qualitat und Sicherheit GmbH (QS) quality system. In addition, the scores are directly validated for 38 farm units. For these farm units, the farmers and their veterinarians provided their perceptions concerning the actual health status and existing health problems. This process allowed a comparison of the scoring results with actual health information using kappa coefficients as a measure of similarity. The score testing of the focus area scores using real information resulted in normalised data. The results of the validation showed satisfactory agreement between the calculated scores for the project farm units and the actual health information provided by the related farmers and veterinarians. In conclusion, the developed scoring method could become a viable benchmark and risk assessment instrument for animal health on a larger scale under the conditions of the German system.	[Nienhaus, Franziska; Kornhoff, Thomas] Univ Vet Med Hannover, Field Stn Epidemiol Bakum, Zeven, Germany; [Meemken, Diana] Free Univ Berlin, Inst Food Safety & Food Hyg, Working Grp Meat Hyg, Berlin, Germany; [Schoneberg, Clara; Hartmann, Maria; Kreienbrock, Lothar; Wendt, Anna] Univ Vet Med Hannover, Dept Biometry Epidemiol & Informat Proc, Collaborating Ctr Res & Training Hlth Human Anim, WHO, Hannover, Germany; [May, Thomas; Hess, Sabrina] QS Qualitat & Sicherheit GmbH, Bonn, Germany	University of Veterinary Medicine Hannover, Foundation; Free University of Berlin; University of Veterinary Medicine Hannover, Foundation; World Health Organization	Nienhaus, F (corresponding author), Univ Vet Med Hannover, Field Stn Epidemiol Bakum, Zeven, Germany.	franziska.nienhaus@mail.de		Nienhaus, Franziska/0000-0001-6836-751X	Federal Ministry of Food and Agriculture (BMEL) [742849]; Bundesanstalt fur Landwirtschaft und Erna hrung (BLE) [2817204313]; Landwirtschaftliche Rentenbank; BLE	Federal Ministry of Food and Agriculture (BMEL); Bundesanstalt fur Landwirtschaft und Erna hrung (BLE); Landwirtschaftliche Rentenbank; BLE	The project is supported by funds of the Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via "Landwirtschaftliche Rentenbank" under the number 742849 and the "Bundesanstalt fur Landwirtschaft und Erna hrung (BLE)" under the number 2817204313. The University of Veterinary Medicine received funds of the "Landwirtschaftliche Rentenbank" and QS received funds of the "BLE". The funder provided support in the form of salaries for authors [FN, TK, AW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. Funding was available in the specific national innovation funding scheme to support companies working within agriculture with research results. With this support non-public data can be aggregated scientifically and is made available for the public. Beside this general benefit no competing interests can be declared by QS.	ANDREOLETTI O, 2011, EFSA J, V9, DOI DOI 10.2903/J.EFSA; Bockel V., 2008, THESIS; Botner A, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2512; Botreau R, 2009, ANIM WELFARE, V18, P363; Broom DM, 2010, J VET MED EDUC, V37, P83, DOI 10.3138/jvme.37.1.83; Czycholl I, ARCH ANIMAL BREEDING; Dalmau A, 2009, ANIM WELFARE, V18, P497; Dickhaus C-P, 2010, THESIS; Dickhaus CP, 2007, ANIMAL HLTH ANIMAL W, V1; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; EFSA (European Food Safety Authority), 2015, EFSA SUPP PUBL, V12, p884E; Enoe C, 2003, PREV VET MED, V57, P117, DOI 10.1016/S0167-5877(02)00229-5; Forkman B, 2015, INT C PIG WELF 2015; Fraser D, 2009, ZOO BIOL, V28, P507, DOI 10.1002/zoo.20253; Harley S, 2012, IRISH VET J, V65, DOI 10.1186/2046-0481-65-11; Hoischen-Taubner S, 2011, ARCH LEBENSMITTELHYG, V62, P82, DOI 10.2376/0003-925X-62-82; Knage-Rasmussen KM, 2015, ANIMAL, V9, P509, DOI 10.1017/S1751731114002705; Meemken D., 2006, THESIS; Nielsen SS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0109-z; Nielsen SS, 2017, ANIMALS, V7, DOI 10.3390/ani7120094; Nielsen SS, 2014, PREV VET MED, V117, P200, DOI 10.1016/j.prevetmed.2014.08.003; Otten ND, 2016, ANIM WELFARE, V25, P207, DOI 10.7120/09627286.25.2.207; Pandolfi F, 2017, ANIMAL, V11, P1816, DOI 10.1017/S1751731117000246; Petersen HH, 2008, VET REC, V162, P377, DOI 10.1136/vr.162.12.377; QS Qualitat und Sicherheit GmbH, 2016, LEITF BEF SCHWEIND; QS Qualitat und Sicherheit GmbH, 2018, QS REPORT MEAT MEAT, P3; Sandgren CH, 2009, ANIM WELFARE, V18, P523; Schaekel F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182661; Schruff C., 2004, THESIS; Scott EM, 2001, ACTA AGR SCAND A-AN, V51, P5, DOI 10.1080/090647001316922983; Sorensen JT, 2010, LIVEST SCI, V131, P1, DOI 10.1016/j.livsci.2010.02.025; Steinmann T, 2018, BERL MUNCH TIERARZTL, V131, P206, DOI 10.2376/0005-9366-17015; Temple D, 2011, J VET BEHAV, V6, P138, DOI 10.1016/j.jveb.2010.10.003; Verbeke W, 2000, J AGR ENVIRON ETHIC, V12, P141, DOI 10.1023/A:1009538613588; Viera AJ, 2005, FAM MED, V37, P360; Wesselmann S., 2016, THESIS	36	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228497	10.1371/journal.pone.0228497	http://dx.doi.org/10.1371/journal.pone.0228497			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017788	Green Submitted, Green Published, gold			2022-12-26	WOS:000534618100029
J	Saksouk, N; Hajdari, S; Perez, Y; Pratlong, M; Barrachina, C; Graber, C; Gregoire, D; Zavoriti, A; Sarrazin, A; Pirot, N; Noel, JY; Khellaf, L; Fabbrizio, E; Julien, E; Cammas, FM				Saksouk, Nehme; Hajdari, Shefqet; Perez, Yannick; Pratlong, Marine; Barrachina, Celia; Graber, Celine; Gregoire, Damien; Zavoriti, Aliki; Sarrazin, Amelie; Pirot, Nelly; Noel, Jean-Yohan; Khellaf, Lakhdar; Fabbrizio, Eric; Julien, Eric; Cammas, Florence M.			The mouse HP1 proteins are essential for preventing liver tumorigenesis	ONCOGENE			English	Article							HISTONE H3 LYSINE-9; REGULATE GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; HETEROCHROMATIN; METHYLATION; METHYLTRANSFERASE; DEREGULATION; DROSOPHILA; TRIM24; LEADS	Chromatin organization is essential for appropriate interpretation of the genetic information. Here, we demonstrated that the chromatin-associated proteins HP1 are dispensable for hepatocytes survival but are essential within hepatocytes to prevent liver tumor development in mice with HP1 beta being pivotal in these functions. Yet, we found that the loss of HP1 per se is not sufficient to induce cell transformation but renders cells more resistant to specific stress such as the expression of oncogenes and thus in fine, more prone to cell transformation. Molecular characterization of HP1-Triple KO premalignant livers and BMEL cells revealed that HP1 are essential for the maintenance of heterochromatin organization and for the regulation of specific genes with most of them having well characterized functions in liver functions and homeostasis. We further showed that some specific retrotransposons get reactivated upon loss of HP1, correlating with overexpression of genes in their neighborhood. Interestingly, we found that, although HP1-dependent genes are characterized by enrichment H3K9me3, this mark does not require HP1 for its maintenance and is not sufficient to maintain gene repression in absence of HP1. Finally, we demonstrated that the loss of TRIM28 association with HP1 recapitulated several phenotypes induced by the loss of HP1 including the reactivation of some retrotransposons and the increased incidence of liver cancer development. Altogether, our findings indicate that HP1 proteins act as guardians of liver homeostasis to prevent tumor development by modulating multiple chromatin-associated events within both the heterochromatic and euchromatic compartments, partly through regulation of the corepressor TRIM28 activity.	[Saksouk, Nehme; Hajdari, Shefqet; Perez, Yannick; Zavoriti, Aliki; Pirot, Nelly; Noel, Jean-Yohan; Fabbrizio, Eric; Julien, Eric; Cammas, Florence M.] IRCM, F-34298 Montpellier, France; [Saksouk, Nehme; Hajdari, Shefqet; Perez, Yannick; Zavoriti, Aliki; Pirot, Nelly; Noel, Jean-Yohan; Fabbrizio, Eric; Julien, Eric; Cammas, Florence M.] INSERM, U1194, F-34298 Montpellier, France; [Saksouk, Nehme; Hajdari, Shefqet; Perez, Yannick; Zavoriti, Aliki; Pirot, Nelly; Noel, Jean-Yohan; Fabbrizio, Eric; Julien, Eric; Cammas, Florence M.] Univ Montpellier, F-34090 Montpellier, France; [Saksouk, Nehme; Hajdari, Shefqet; Perez, Yannick; Zavoriti, Aliki; Pirot, Nelly; Noel, Jean-Yohan; Khellaf, Lakhdar; Fabbrizio, Eric; Julien, Eric; Cammas, Florence M.] Inst Reg Canc Montpellier, F-34298 Montpellier, France; [Pratlong, Marine; Barrachina, Celia] Univ Montpellier, MGX, Biocampus Montpellier, CNRS,INSERM, Montpellier, France; [Graber, Celine; Sarrazin, Amelie] IGBMC, Illkirch Graffenstaden, France; [Gregoire, Damien; Fabbrizio, Eric; Julien, Eric; Cammas, Florence M.] CNRS, Route Mende, Montpellier, France; [Gregoire, Damien] Univ Montpellier, CNRS, Inst Genet Mol Montpellier, Montpellier, France; [Sarrazin, Amelie] Univ Montpellier, MRI, BioCampus Montpellier, CNRS,INSERM, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Cammas, FM (corresponding author), IRCM, F-34298 Montpellier, France.; Cammas, FM (corresponding author), INSERM, U1194, F-34298 Montpellier, France.; Cammas, FM (corresponding author), Univ Montpellier, F-34090 Montpellier, France.; Cammas, FM (corresponding author), Inst Reg Canc Montpellier, F-34298 Montpellier, France.; Cammas, FM (corresponding author), CNRS, Route Mende, Montpellier, France.	Florence.cammas@inserm.fr	SAKSOUK, NEHME/ABA-4057-2021	SAKSOUK, NEHME/0000-0001-5592-6298; cammas, florence/0000-0003-4117-8182; JULIEN, ERIC/0000-0003-2976-666X	French National Research Agency [ANR-10-INBS-04]; Center National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); University of Montpellier; Institut regional de Cancerologie de Montpellier (ICM); SIRIC Montpellier Cancer [INCa_Inserm_DGOS_12553]; Erasmus Ph.D. fellowship; Ministry of Education, Science and Technology of the Republic of Kosovo; ANR [ANR 2009 BLAN 021 91, ANR-16CE15-0018-03]; INCa [PLBIO13-146]; ARC [PJA20131200357]; La ligue Regionale contre le Cancer [128-R13021FF-RAB13006FFA]	French National Research Agency(French National Research Agency (ANR)); Center National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier; Institut regional de Cancerologie de Montpellier (ICM); SIRIC Montpellier Cancer; Erasmus Ph.D. fellowship; Ministry of Education, Science and Technology of the Republic of Kosovo; ANR(French National Research Agency (ANR)); INCa(Institut National du Cancer (INCA) France); ARC(Australian Research Council); La ligue Regionale contre le Cancer	We thank P. Chambon, C. Sardet, T. Forne, D. Fisher, and C. Grimaud for helpful discussions and critical reading of the paper. We thank F. Bernex and L. LeCam, C. Keime, and B. Jost for fruitful discussions. We thank L. Papon, H. Fontaine, and C. Bonhomme for technical assistance and M. Oulad-Abdelghani and the IGBMC for the anti-HP1 and TRIM28 antibodies. We also thank the RHEM technical facility and particularly J. Simony for histological analysis and the IGBMC/ICS transgenic and animal facility for the initial establishment of the HP1 and TRIM28 mouse models. We thank C. Vincent and the IRCM animal core facility for the day to day care of the animal models. Finally, we thank S. Chamroeun for counting positive cells on TMA. We acknowledge the imaging facility MRI, member of the national infrastructure France-BioImaging and supported by the French National Research Agency (ANR-10-INBS-04, "Investments for the future"). This work was supported by funds from the Center National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the University of Montpellier and the Institut regional de Cancerologie de Montpellier (ICM),) and SIRIC Montpellier Cancer, Grant INCa_Inserm_DGOS_12553. SH was funded by an Erasmus Ph.D. fellowship. We also thank the Ministry of Education, Science and Technology of the Republic of Kosovo for a scholarships to support SH. FC was supported by grants from ANR (ANR 2009 BLAN 021 91; ANR-16CE15-0018-03), INCa (PLBIO13-146), ARC (PJA20131200357), and La ligue Regionale contre le Cancer (128-R13021FF-RAB13006FFA). Sequencing was performed by the MGX facility. Montpellier, France.	Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Bhattacharyya S, 2014, CURR DRUG METAB, V15, P719, DOI 10.2174/1389200215666141125121659; Bishayee A, 2014, ADV EXP MED BIOL, V816, P401, DOI 10.1007/978-3-0348-0837-8_16; Bojkowska K, 2012, HEPATOLOGY, V56, P1279, DOI 10.1002/hep.25767; Bosch-Presegue L, 2017, CELL REP, V21, P2048, DOI 10.1016/j.celrep.2017.10.092; Bregnard C, 2016, EBIOMEDICINE, V8, P184, DOI 10.1016/j.ebiom.2016.05.005; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Brustel J, 2017, EMBO J, V36, P2726, DOI 10.15252/embj.201796541; Camacho OV, 2017, ELIFE, V6, DOI 10.7554/eLife.25293; Cammas F, 2000, DEVELOPMENT, V127, P2955; Cizkova K, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/656428; Del Campo JA, 2018, WORLD J HEPATOL, V10, P1, DOI 10.4254/wjh.v10.i1.1; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Du Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08302-1; Ecco G, 2017, DEVELOPMENT, V144, P2719, DOI 10.1242/dev.132605; Ecco G, 2016, DEV CELL, V36, P611, DOI 10.1016/j.devcel.2016.02.024; EISSENBERG JC, 1992, GENETICS, V131, P345; Eissenberg JC, 2014, TRENDS GENET, V30, P103, DOI 10.1016/j.tig.2014.01.002; Fan DNY, 2013, HEPATOLOGY, V57, P637, DOI 10.1002/hep.26083; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Guengerich FP, 2019, J BIOL CHEM, V294, P1671, DOI 10.1074/jbc.TM118.004144; Hardy T, 2016, GUT, V65, P1895, DOI 10.1136/gutjnl-2015-311292; Herquel B, 2013, NAT STRUCT MOL BIOL, V20, P339, DOI 10.1038/nsmb.2496; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Herzog M, 2011, DEV BIOL, V350, P548, DOI 10.1016/j.ydbio.2010.12.014; Huang CY, 2017, GENE DEV, V31, P241, DOI 10.1101/gad.292169.116; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Janssen A, 2018, ANNU REV CELL DEV BI, V34, P265, DOI 10.1146/annurev-cellbio-100617-062653; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kato M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04132-9; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Koschmann C, 2017, CANCER RES, V77, P227, DOI 10.1158/0008-5472.CAN-16-2301; Kuo LJ, 2008, IN VIVO, V22, P305; Kurinna S, 2011, INT J BIOCHEM CELL B, V43, P189, DOI 10.1016/j.biocel.2010.03.013; Lee DH, 2013, BIOCHEM BIOPH RES CO, V434, P820, DOI 10.1016/j.bbrc.2013.04.020; Lee Young-Ho, 2015, J Nat Sci, V1, pe127; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Mai S, 2019, GENE CHROMOSOME CANC, V58, P462, DOI 10.1002/gcc.22720; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mattout A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0760-8; Mirabella AC, 2016, CHROMOSOMA, V125, P75, DOI 10.1007/s00412-015-0530-0; Nishibuchi G, 2014, J BIOCHEM, V156, P11, DOI 10.1093/jb/mvu032; Niu ZS, 2016, WORLD J GASTROENTERO, V22, P9069, DOI 10.3748/wjg.v22.i41.9069; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Paik YH, 2014, ANTIOXID REDOX SIGN, V20, P2854, DOI 10.1089/ars.2013.5619; Park JW, 2014, BIOCHEM J, V464, P241, DOI 10.1042/BJ20140787; Piacentini L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000670; Pogribny IP, 2006, CARCINOGENESIS, V27, P1180, DOI 10.1093/carcin/bgi364; Pogribny IP, 2014, CANCER LETT, V342, P223, DOI 10.1016/j.canlet.2012.01.038; Poleshko A, 2013, CELL REP, V5, P292, DOI 10.1016/j.celrep.2013.09.024; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Prakash K, 2018, BIOSYSTEMS, V164, P49, DOI 10.1016/j.biosystems.2017.11.005; Schott S, 2006, DEV BIOL, V298, P176, DOI 10.1016/j.ydbio.2006.06.039; Shi S, 2008, NAT CELL BIOL, V10, P491, DOI 10.1038/ncb1713; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Stunnenberg R, 2015, EMBO J, V34, P2789, DOI 10.15252/embj.201591320; Takaki A, 2015, WORLD J HEPATOL, V7, P968, DOI 10.4254/wjh.v7.i7.968; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Vad-Nielsen J, 2015, CANCER BIOL THER, V16, P189, DOI 10.1080/15384047.2014.1001277; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114; Yang P, 2017, TRENDS GENET, V33, P871, DOI 10.1016/j.tig.2017.08.006	67	10	10	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2676	2691		10.1038/s41388-020-1177-8	http://dx.doi.org/10.1038/s41388-020-1177-8		FEB 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32020053	Green Submitted			2022-12-26	WOS:000511084200003
J	Oliveira, JF; Rodrigues, MS; Skalinski, LM; Santos, AES; Costa, LC; Cardim, LL; Paixao, ES; Costa, MDN; Oliveira, WK; Barreto, ML; Teixeira, MG; Andrade, RFS				Oliveira, Juliane F.; Rodrigues, Moreno S.; Skalinski, Lacita M.; Santos, Aline E. S.; Costa, Larissa C.; Cardim, Luciana L.; Paixao, Enny S.; Costa, Maria da Conceicao N.; Oliveira, Wanderson K.; Barreto, Mauricio L.; Teixeira, Maria Gloria; Andrade, Roberto F. S.			Interdependence between confirmed and discarded cases of dengue, chikungunya and Zika viruses in Brazil: A multivariate time-series analysis	PLOS ONE			English	Article								The co-circulation of different arboviruses in the same time and space poses a significant threat to public health given their rapid geographic dispersion and serious health, social, and economic impact. Therefore, it is crucial to have high quality of case registration to estimate the real impact of each arboviruses in the population. In this work, a Vector Autoregressive (VAR) model was developed to investigate the interrelationships between discarded and confirmed cases of dengue, chikungunya, and Zika in Brazil. We used data from the Brazilian National Notifiable Diseases Information System (SINAN) from 2010 to 2017. There were three peaks in the series of dengue notification in this period occurring in 2013, 2015 and in 2016. The series of reported cases of both Zika and chikungunya reached their peak in late 2015 and early 2016. The VAR model shows that the Zika series have a significant impact on the dengue series and vice versa, suggesting that several discarded and confirmed cases of dengue could actually have been cases of Zika. The model also suggests that the series of confirmed and discarded chikungunya cases are almost independent of the cases of Zika, however, affecting the series of dengue. In conclusion, co-circulation of arboviruses with similar symptoms could have lead to misdiagnosed diseases in the surveillance system. We argue that the routinely use of mathematical and statistical models in association with traditional symptom-surveillance could help to decrease such errors and to provide early indication of possible future outbreaks. These findings address the challenges regarding notification biases and shed new light on how to handle reported cases based only in clinical-epidemiological criteria when multiples arboviruses co-circulate in the same population.	[Oliveira, Juliane F.; Rodrigues, Moreno S.; Costa, Larissa C.; Cardim, Luciana L.; Paixao, Enny S.; Barreto, Mauricio L.; Andrade, Roberto F. S.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Ctr Data & Knowledge Integrat Hlth CIDACS, Salvador, BA, Brazil; [Oliveira, Juliane F.] Univ Porto CMUP, Dept Math, Ctr Math, Porto, Portugal; [Rodrigues, Moreno S.] Fundacao Oswaldo Cruz, Porto Velho, Rondonia, Brazil; [Skalinski, Lacita M.] Univ Estadual Santa Cruz, Ilheus, BA, Brazil; [Skalinski, Lacita M.; Santos, Aline E. S.; Costa, Maria da Conceicao N.; Barreto, Mauricio L.; Teixeira, Maria Gloria] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [Paixao, Enny S.] London Sch Hyg & Trop Med, London, England; [Oliveira, Wanderson K.] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil; [Andrade, Roberto F. S.] Univ Fed Bahia, Inst Fis, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade do Porto; Fundacao Oswaldo Cruz; Universidade Estadual de Santa Cruz; Universidade Federal da Bahia; University of London; London School of Hygiene & Tropical Medicine; Universidade Federal da Bahia	Oliveira, JF (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Ctr Data & Knowledge Integrat Hlth CIDACS, Salvador, BA, Brazil.; Oliveira, JF (corresponding author), Univ Porto CMUP, Dept Math, Ctr Math, Porto, Portugal.	julianlanzin@gmail.com	costa, larissa/GRX-4740-2022; de Oliveira, Juliane Fonseca/W-6438-2018; Rodrigues, Moreno/ABD-9852-2020; Teixeira, Maria Gloria L C/G-4808-2012; Oliveira, Juliane/AAX-9476-2020; Oliveira, Wanderson/D-7140-2016; L. Barreto, Mauricio/B-1752-2008	de Oliveira, Juliane Fonseca/0000-0002-7167-8754; Rodrigues, Moreno/0000-0002-1594-2311; Teixeira, Maria Gloria L C/0000-0003-3318-3408; Oliveira, Juliane/0000-0002-7167-8754; Andrade, Roberto/0000-0002-9323-1400; Oliveira, Wanderson/0000-0002-9662-1930; L. Barreto, Mauricio/0000-0002-0215-4930	Center of Data and Knowledge Integration for Health (CIDACS) through theZika Platform-a long-term surveillance platform for the Zika virus and microcephaly, Unified Health System (SUS) - Brazilian Ministry of Health; Wellcome Trust [213589/Z/18/Z]	Center of Data and Knowledge Integration for Health (CIDACS) through theZika Platform-a long-term surveillance platform for the Zika virus and microcephaly, Unified Health System (SUS) - Brazilian Ministry of Health; Wellcome Trust(Wellcome TrustEuropean Commission)	This work is supported by the Center of Data and Knowledge Integration for Health (CIDACS) through the Zika Platform-a long-term surveillance platform for the Zika virus and microcephaly, Unified Health System (SUS) - Brazilian Ministry of Health. ESP is funded by the Wellcome Trust (grant number 213589/Z/18/Z) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 9 PYTH SCI C; Barbosa JR, 2015, EPIDEMIOL SERV SAUDE, V24, P49, DOI 10.5123/S1679-49742015000100006; BRASIL. Ministerio da Saude. Secretaria de Vigilancia em Saude, GUIA VIG EP; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; de Oliveira WK, 2017, LANCET, V390, P861, DOI [10.1016/S0140-6736(17)31368-5, 10.1016/s0140-6736(17)31368-5]; Diggle P, 1990, TIME SERIES BIOSTATI; Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; Lutkepohl H., 2005, NEW INTRO MULTIPLE T, DOI DOI 10.1007/078-3-540-27752-1; Margiotta M.R., 1969, AM J TROP MED HYG, V18, P954, DOI [10.4269/ajtmh.1969.18.954, DOI 10.4269/AJTMH.1969.18.954]; Oliveira JF, MULTIVARIATE TIME SE; Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530; Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5; Siggiridou E, 2016, IEEE T SIGNAL PROCES, V64, P1759, DOI 10.1109/TSP.2015.2500893; Silva MM, 2018, CONCOMITANT TRANSMIS; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727; Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589; Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7; World Health Organization, GLOB STRAT DENG PREV	20	11	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228347	10.1371/journal.pone.0228347	http://dx.doi.org/10.1371/journal.pone.0228347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012191	Green Submitted, Green Published, gold			2022-12-26	WOS:000534615800031
J	Holla, JFM; van den Akker, LE; Dadema, T; de Groot, S; Tieland, M; Weijs, PJM; Deutekom, M				Holla, Jasmijn F. M.; van den Akker, Lizanne E.; Dadema, Tessa; de Groot, Sonja; Tieland, Michael; Weijs, Peter J. M.; Deutekom, Marije		WHEELS-study Grp	Determinants of dietary behaviour in wheelchair users with spinal cord injury or lower limb amputation: Perspectives of rehabilitation professionals and wheelchair users	PLOS ONE			English	Article							BODY-MASS INDEX; LONG-TERM MORTALITY; PHYSICAL-ACTIVITY; HEALTH-PROMOTION; AFTER-DISCHARGE; BARRIERS; PEOPLE; OBESITY; ADULTS; DISABILITY	Objective This study aims to identify determinants of dietary behaviour in wheelchair users with spinal cord injury or lower limb amputation, from the perspectives of both wheelchair users and rehabilitation professionals. The findings should contribute to the field of health promotion programs for wheelchair users. Methods Five focus groups were held with wheelchair users (n = 25), and two with rehabilitation professionals (n = 11). A thematic approach was used for data analysis in which the determinants were categorized using an integrated International Classification of Functioning, Disability and Health and Attitude, Social influence and self-Efficacy model. Results Reported personal factors influencing dietary behaviour in wheelchair users were knowledge, boredom, fatigue, stage of life, habits, appetite, self-control, multiple lifestyle problems, intrinsic motivation, goal setting, monitoring, risk perception, positive experiences, suffering, action planning, health condition, function impairments, attitude and self-efficacy. Reported environmental factors influencing dietary behaviour in wheelchair users were unadjusted kitchens, monitoring difficulties, eating out, costs, unfavourable food supply, nutrition education/counselling, access to simple healthy recipes, eating together, cooking for others, and awareness and support of family and friends. Conclusions Important modifiable determinants of dietary behaviour in wheelchair users that might be influenced in lifestyle interventions are knowledge, fatigue, habits, self-control, intrinsic motivation, risk perception, attitude and self-efficacy. It is recommended to involve relatives, since they appear to significantly influence dietary behaviour.	[Holla, Jasmijn F. M.; van den Akker, Lizanne E.; Deutekom, Marije] Inholland Univ Appl Sci, Fac Hlth Sports & Social Work, Haarlem, Netherlands; [Holla, Jasmijn F. M.; de Groot, Sonja] Amsterdam Rehabil Res Ctr, Amsterdam, Netherlands; [Dadema, Tessa] Amsterdam Univ Appl Sci, Fac Hlth, Amsterdam, Netherlands; [de Groot, Sonja] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Tieland, Michael; Weijs, Peter J. M.; Deutekom, Marije] Amsterdam Univ Appl Sci, Fac Sports & Nutr, Amsterdam, Netherlands; [Weijs, Peter J. M.] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Nutr & Dietet, Amsterdam, Netherlands	University of Groningen; Vrije Universiteit Amsterdam	Deutekom, M (corresponding author), Inholland Univ Appl Sci, Fac Hlth Sports & Social Work, Haarlem, Netherlands.; Deutekom, M (corresponding author), Amsterdam Univ Appl Sci, Fac Sports & Nutr, Amsterdam, Netherlands.	m.deutekom@hva.nl		Weijs, Peter/0000-0001-8281-0426; de Groot, Sonja/0000-0001-8463-2563; Holla, Jasmijn/0000-0002-1204-3134	National Taskforce for Applied Research SIA; Netherlands Organisation for Scientific Research (NWO) [RAAK.PUB03.029]	National Taskforce for Applied Research SIA; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research is co-financed by the National Taskforce for Applied Research SIA (www.regieorgaan-sia.nl), part of the Netherlands Organisation for Scientific Research (NWO), grant number RAAK.PUB03.029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey KA, 2018, HEALTH PSYCHOL OPEN, V5, DOI 10.1177/2055102918798732; Bartholomew LK, 2016, PLANNING HLTH PROMOT; Bigford G, 2017, TOP SPINAL CORD INJ, V23, P188, DOI 10.1310/sci2303-188; Bloemen-Vrencken JHA, 2005, DISABIL REHABIL, V27, P1381, DOI 10.1080/09638280500164685; Boeie H, 2014, ANAL KWALITATIEF OND; Boninger ML, 1999, ARCH PHYS MED REHAB, V80, P910, DOI 10.1016/S0003-9993(99)90082-5; Bragaru M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059881; Bullock VE, 2017, ANN HUM BIOL, V44, P230, DOI 10.1080/03014460.2016.1232749; de Groot S, 2016, APPL PHYSIOL NUTR ME, V41, P1190, DOI 10.1139/apnm-2016-0269; de Groot S, 2010, J REHABIL MED, V42, P922, DOI 10.2340/16501977-0605; de Vries H, 1988, HLTH ED RES, V3, P273, DOI [10.1093/her/3.3.273, DOI 10.1093/HER/3.3.273]; Deliens T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-53; Durkin JL, 2003, J BIOMECH ENG-T ASME, V125, P515, DOI 10.1115/1.1590359; Durstine JL, 2000, SPORTS MED, V30, P207, DOI 10.2165/00007256-200030030-00005; Ejtahed HS, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0298-2; Gater David R Jr, 2007, Phys Med Rehabil Clin N Am, V18, P333, DOI 10.1016/j.pmr.2007.03.004; GATER DR, 2019, J SPINAL CORD MED, V42, P86, DOI DOI 10.1080/10790268.2017.1423266; Gorgey AS, 2014, J SPINAL CORD MED, V37, P693, DOI 10.1179/2045772314Y.0000000245; Gorgey AS, 2014, WORLD J ORTHOP, V5, P158, DOI 10.5312/wjo.v5.i3.158; Green J, 2013, QUALITATIVE METHODS; Greenwood J, 2000, Contemp Nurse, V9, P181; Hall L, 2003, INT J REHABIL RES, V26, P245, DOI 10.1097/00004356-200309000-00013; Hatchett PE, 2016, J SPINAL CORD MED, V39, P421, DOI 10.1080/10790268.2015.1133482; Heath G W, 1997, Exerc Sport Sci Rev, V25, P195; HIMES JH, 1995, J AM DIET ASSOC, V95, P646, DOI 10.1016/S0002-8223(95)00175-1; Krueger R., 1998, DEV QUESTIONS FOCUS; Kulkarni J, 2015, PROSTHET ORTHOT INT, V39, P226, DOI 10.1177/0309364614525186; Laughton GE, 2009, SPINAL CORD, V47, P757, DOI 10.1038/sc.2009.33; Lieberman J, 2014, J SPINAL CORD MED, V37, P751, DOI 10.1179/2045772313Y.0000000180; Littman AJ, 2015, DISABIL HEALTH J, V8, P325, DOI 10.1016/j.dhjo.2014.10.003; Littman AJ, 2019, DISABIL HEALTH J, V12, P43, DOI 10.1016/j.dhjo.2018.08.002; Morgan DL, 1998, PLANNING FOCUS GROUP; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; National Health Services (NHS), 2019, WHAT IS BOD MASS IND; Nevin AN, 2016, SPINAL CORD, V54, P248, DOI 10.1038/sc.2015.193; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nooijen CFJ, 2016, J PHYSIOTHER, V62, P35, DOI 10.1016/j.jphys.2015.11.003; OSTERKAMP LK, 1995, J AM DIET ASSOC, V95, P215, DOI 10.1016/S0002-8223(95)00050-X; Parsons M, 2000, Contemp Nurse, V9, P169; Rimmer JH, 1999, PHYS THER, V79, P495, DOI 10.1093/ptj/79.5.495; Rosenberg DE, 2013, DISABIL REHABIL, V35, P1269, DOI 10.3109/09638288.2012.726690; Seaman JA, 1999, PRESIDENTS COUNCIL P, V3, P1; Singh RK, 2016, PROSTHET ORTHOT INT, V40, P545, DOI 10.1177/0309364615596067; Sniehotta FF, 2005, EUR J SOC PSYCHOL, V35, P565, DOI 10.1002/ejsp.258; Stern JR, 2017, ANN VASC SURG, V42, P322, DOI 10.1016/j.avsg.2016.12.015; Tomey KM, 2005, ARCH PHYS MED REHAB, V86, P664, DOI 10.1016/j.apmr.2004.10.023; van den Akker LE, 2020, DISABIL REHABIL, V42, P1934, DOI 10.1080/09638288.2019.1577503; van der Ploeg HP, 2004, SPORTS MED, V34, P639, DOI 10.2165/00007256-200434100-00002; van Drongelen S, 2006, SPINAL CORD, V44, P152, DOI 10.1038/sj.sc.3101826; Vercambre MN, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-168, 10.1186/1471-2458-9-333]; Vissers M, 2008, J REHABIL MED, V40, P461, DOI 10.2340/16501977-0191; Wadey R, 2018, PSYCHOL SPORT EXERC, V37, P251, DOI 10.1016/j.psychsport.2017.11.005; Weil E, 2002, JAMA-J AM MED ASSOC, V288, P1265, DOI 10.1001/jama.288.10.1265; Westerkamp EA, 2019, PROSTHET ORTHOT INT, V43, P284, DOI 10.1177/0309364618823118; Wong S, 2018, EUR J CLIN NUTR, V72, P1555, DOI 10.1038/s41430-018-0194-y; World Health Organization, 2001, ICF INT CLASFUNCT	56	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228465	10.1371/journal.pone.0228465	http://dx.doi.org/10.1371/journal.pone.0228465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CX	32004359	Green Published, gold			2022-12-26	WOS:000534614600040
J	Pamphlett, R; Satgunaseelan, L; Jew, SK; Doble, PA; Bishop, DP				Pamphlett, Roger; Satgunaseelan, Laveniya; Jew, Stephen Kum; Doble, Philip A.; Bishop, David P.			Elemental bioimaging shows mercury and other toxic metals in normal breast tissue and in breast cancers	PLOS ONE			English	Article							RESISTANCE PROTEIN; ENVIRONMENTAL-POLLUTANTS; ESTROGEN-RECEPTOR; LEAD-EXPOSURE; RISK; CADMIUM; ALUMINUM; WOMEN; AIR; TRANSPORTER	Objective Exposure to toxic metals such as mercury has been proposed to be a risk factor for the development of breast cancer since some metals can promote genetic mutations and epigenetic changes. We sought to find what toxic metals are present in normal breast tissue and in the tumours of women who had mastectomies for invasive ductal breast carcinoma. Materials and methods Formalin-fixed paraffin-embedded blocks from mastectomies for breast carcinoma were examined from 50 women aged 34-69 years. Paraffin blocks selected for elemental analysis were from breast tissue not involved by carcinoma and from the carcinoma itself. Seven micrometer-thick sections were stained with autometallography to demonstrate the presence of mercury, and subjected to laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) to confirm the presence of mercury and to detect other toxic metals. Results Autometallography-detected mercury was seen in intraductal secretions and some luminal epithelial cells of normal breast lobules in 26 (55%) of the 47 samples where lobules were present, and in 10 (23%) of carcinomas from the 44 samples where carcinoma was present. In eight samples ductal carcinoma in situ was present and one of these contained mercury. LA-ICP-MS confirmed the presence of mercury in samples that stained with autometallography, and detected lead, iron, nickel, aluminium, chromium and cadmium in some samples. Conclusions Mercury was present in normal breast lobules in more than half of mastectomy samples that contained an invasive carcinoma, and in a smaller proportion of carcinomas and ductal carcinomas in situ. Other toxic metals that may interact synergistically with mercury could be detected in some samples. These findings do not provide direct evidence that toxic metals such as mercury play a role in the pathogenesis of breast cancer, but suggest that future molecular biological investigations on the role of toxic metals in breast cancer are warranted.	[Pamphlett, Roger; Jew, Stephen Kum] Univ Sydney, Brain & Mind Ctr, Sydney Med Sch, Discipline Pathol, Sydney, NSW, Australia; [Pamphlett, Roger] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia; [Satgunaseelan, Laveniya] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia; [Doble, Philip A.; Bishop, David P.] Univ Technol Sydney, Sch Math & Phys Sci, Elemental Bioimaging Facil, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Technology Sydney	Pamphlett, R (corresponding author), Univ Sydney, Brain & Mind Ctr, Sydney Med Sch, Discipline Pathol, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	roger.pamphlett@sydney.edu.au	; Bishop, David/F-2891-2019	Satgunaseelan, Laveniya/0000-0002-7435-0834; Pamphlett, Roger/0000-0003-3326-7273; Bishop, David/0000-0002-6533-4410	Aimee Stacy Memorial and Ignacy Burnett bequests; Australian Research Council [DE180100194, DP170100036, DP190102361]; USA National Institute of Health R21 Exploratory/Development Grant [1R21AR072950-01A1]	Aimee Stacy Memorial and Ignacy Burnett bequests; Australian Research Council(Australian Research Council); USA National Institute of Health R21 Exploratory/Development Grant	RP is supported by the Aimee Stacy Memorial and Ignacy Burnett bequests, PAD is supported by Australian Research Council Discovery Project Grants DP170100036 and DP190102361, DPB is supported by an Australian Research Council Discovery Early Career Researcher Award DE180100194, and PAD and DPB are both supported by the USA National Institute of Health R21 Exploratory/Development Grant 1R21AR072950-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2016, AM J EPIDEMIOL, V183, P815, DOI 10.1093/aje/kwv285; Alatise OI, 2010, BIOL TRACE ELEM RES, V136, P127, DOI 10.1007/s12011-010-8608-2; Andrade V M, 2017, Adv Neurobiol, V18, P227, DOI 10.1007/978-3-319-60189-2_12; Andreoli V, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010093; Aquino NB, 2012, J ENVIRON SCI HEAL C, V30, P189, DOI 10.1080/10590501.2012.705159; Atashgaran V, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00267; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Bridges CC, 2015, TOXICOL APPL PHARM, V285, P110, DOI 10.1016/j.taap.2015.03.027; Brody JG, 2003, ENVIRON HEALTH PERSP, V111, P1007, DOI 10.1289/ehp.6310; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2667, DOI 10.1002/cncr.22655; Byrne C, 2013, J MAMMARY GLAND BIOL, V18, P63, DOI 10.1007/s10911-013-9273-9; Cherkani-Hassani A, 2019, CRIT REV TOXICOL, V49, P110, DOI 10.1080/10408444.2019.1571010; Cihan YB, 2011, BIOL TRACE ELEM RES, V144, P360, DOI 10.1007/s12011-011-9104-z; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Cobbina SJ, 2015, ENVIRON TOXICOL PHAR, V39, P280, DOI 10.1016/j.etap.2014.11.030; COSTA M, 1991, ROCH S ENV, P255; Crespo-Lopez ME, 2009, PHARMACOL RES, V60, P212, DOI 10.1016/j.phrs.2009.02.011; Danscher G, 2000, J HISTOCHEM CYTOCHEM, V48, P1503, DOI 10.1177/002215540004801107; DANSCHER G, 1994, NEUROPATH APPL NEURO, V20, P454, DOI 10.1111/j.1365-2990.1994.tb00996.x; DANSCHER G, 1986, HISTOCHEM J, V18, P109, DOI 10.1007/BF01675364; Darbre PD, 2011, J INORG BIOCHEM, V105, P1484, DOI 10.1016/j.jinorgbio.2011.07.017; Davis JD, 2011, WORLD J CLIN ONCOL, V2, P329, DOI 10.5306/wjco.v2.i9.329; Eriksen KT, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw204; Exley C, 2007, J INORG BIOCHEM, V101, P1344, DOI 10.1016/j.jinorgbio.2007.06.005; Faneyte IF, 2002, CLIN CANCER RES, V8, P1068; Florea AM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/159619; Gaudet HM, 2018, TOXICOL REP, V5, P579, DOI 10.1016/j.toxrep.2018.05.002; Gaudet MM, 2019, INT J CANCER, V144, P1010, DOI 10.1002/ijc.31805; Hartwig A, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110s5797; Higgins SA, 2005, BREAST CANCER RES, V7, pR1017, DOI 10.1186/bcr1335; House E, 2013, J TRACE ELEM MED BIO, V27, P257, DOI 10.1016/j.jtemb.2013.05.002; Ionescu JG, 2006, NEUROENDOCRINOL LETT, V27, P36; Johnson-Thompson MC, 2000, CANCER, V88, P1224, DOI 10.1002/(SICI)1097-0142(20000301)88:5+<1224::AID-CNCR8>3.0.CO;2-H; Jonker JW, 2005, NAT MED, V11, P127, DOI 10.1038/nm1186; Jouybari L, 2018, CANCER MANAG RES, V10, P69, DOI 10.2147/CMAR.S151324; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Khan F, 2019, J TRACE ELEM MED BIO, V52, P37, DOI 10.1016/j.jtemb.2018.11.006; Khanjani N, 2017, REV ENVIRON HEALTH, V32, P267, DOI 10.1515/reveh-2016-0068; Kolbinger V, 2019, ENVIRON RES, V176, DOI 10.1016/j.envres.2019.05.043; Kresovich JK, 2019, ENVIRON RES, V177, DOI 10.1016/j.envres.2019.108639; Kullmann JAP, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122874; Lappano R, 2017, MOL CELL ENDOCRINOL, V457, P49, DOI 10.1016/j.mce.2016.10.017; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin JB, 2016, CANCER EPIDEMIOL, V42, P101, DOI 10.1016/j.canep.2016.04.002; Liu RL, 2015, EPIDEMIOLOGY, V26, P365, DOI 10.1097/EDE.0000000000000277; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Maliepaard M, 2001, CANCER RES, V61, P3458; Mandriota SJ, 2017, EBIOMEDICINE, V22, P22, DOI 10.1016/j.ebiom.2017.06.025; McElroy JA, 2008, CANCER EPIDEM BIOMAR, V17, P2311, DOI 10.1158/1055-9965.EPI-08-0263; Mohammadi M, 2014, J TOXICOL-US, V2014, DOI 10.1155/2014/413870; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Morales ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151367; Nersesyan A, 2016, MUTAT RES-REV MUTAT, V770, P119, DOI 10.1016/j.mrrev.2016.04.002; Nunes MAG, 2016, ANAL CHIM ACTA, V905, P51, DOI 10.1016/j.aca.2015.11.049; Oskarsson A, 1996, ARCH ENVIRON HEALTH, V51, P234, DOI 10.1080/00039896.1996.9936021; Pamphlett R, 1998, J NEUROPATH EXP NEUR, V57, P360; Pamphlett R, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00419; Pamphlett R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203627; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Ralston NVC, 2010, TOXICOLOGY, V278, P112, DOI 10.1016/j.tox.2010.06.004; Reding KW, 2015, CANCER EPIDEM BIOMAR, V24, P1907, DOI 10.1158/1055-9965.EPI-15-0787; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Streets DG, 2018, SCI TOTAL ENVIRON, V615, P131, DOI 10.1016/j.scitotenv.2017.09.207; Strumylaite L, 2014, BREAST CANCER RES TR, V145, P225, DOI 10.1007/s10549-014-2918-6; Torti Suzy V., 2013, Critical Reviews in Oncogenesis, V18, P435; Van Maele-Fabry G, 2016, ENVIRON INT, V86, P1, DOI 10.1016/j.envint.2015.10.003; Vu V, 2019, GYNECOL ENDOCRINOL, V35, P1099, DOI 10.1080/09513590.2019.1622089; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; White AJ, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1110-7; White AJ, 2018, CURR EPIDEMIOL REP, V5, P92, DOI 10.1007/s40471-018-0143-2; White AJ, 2019, EPIDEMIOLOGY, V30, P20, DOI 10.1097/EDE.0000000000000917; Zhang M, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a027128	74	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228226	10.1371/journal.pone.0228226	http://dx.doi.org/10.1371/journal.pone.0228226			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004334	Green Published, gold			2022-12-26	WOS:000534614600026
J	Zhang, M; Wang, C; O'Connor, A				Zhang, Min; Wang, Chong; O'Connor, Annette			A hierarchical Bayesian latent class mixture model with censorship for detection of linear temporal changes in antibiotic resistance	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; UNITED-STATES; SUSCEPTIBILITY; SURVEILLANCE	Identifying and controlling the emergence of antimicrobial resistance (AMR) is a high priority for researchers and public health officials. One critical component of this control effort is timely detection of emerging or increasing resistance using surveillance programs. Currently, detection of temporal changes in AMR relies mainly on analysis of the proportion of resistant isolates based on the dichotomization of minimum inhibitory concentration (MIC) values. In our work, we developed a hierarchical Bayesian latent class mixture model that incorporates a linear trend for the mean log(2)MIC of the non-resistant population. By introducing latent variables, our model addressed the challenges associated with the AMR MIC values, compensating for the censored nature of the MIC observations as well as the mixed components indicated by the censored MIC distributions. Inclusion of linear regression with time as a covariate in the hierarchical structure allowed modelling of the linear creep of the mean log(2)MIC in the non-resistant population. The hierarchical Bayesian model was accurate and robust as assessed in simulation studies. The proposed approach was illustrated using Salmonella enterica I,4,[5],12:i:- treated with chloramphenicol and ceftiofur in human and veterinary samples, revealing some significant linearly increasing patterns from the applications. Implementation of our approach to the analysis of an AMR MIC dataset would provide surveillance programs with a more complete picture of the changes in AMR over years by exploring the patterns of the mean resistance level in the non-resistant population. Our model could therefore serve as a timely indicator of a need for antibiotic intervention before an outbreak of resistance, highlighting the relevance of this work for public health. Currently, however, due to extreme right censoring on the MIC data, this approach has limited utility for tracking changes in the resistant population.	[Zhang, Min; Wang, Chong] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Wang, Chong; O'Connor, Annette] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA	Iowa State University; Iowa State University	Wang, C (corresponding author), Iowa State Univ, Dept Stat, Ames, IA 50011 USA.; Wang, C (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	chwang@iastate.edu	O'Connor, A/E-5591-2010; O'Connor, A/AFK-8069-2022; Wang, Chong/AAI-3796-2020; O'Connor, Annette/GRX-1453-2022	O'Connor, A/0000-0003-0604-7822; O'Connor, A/0000-0003-0604-7822; Wang, Chong/0000-0003-4489-4344; O'Connor, Annette/0000-0003-0604-7822; Zhang, Min/0000-0002-4745-4662	United States Department of Agriculture National Institution for Food and Agriculture [2018-67030-28361]	United States Department of Agriculture National Institution for Food and Agriculture	This project was supported by funding from United States Department of Agriculture National Institution for Food and Agriculture (https://nifa.usda.gov/).The grant was awarded to Dr. Annette O'Connor and Dr. Chong Wang (Grant Award Number: 2018-67030-28361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts M., 2011, EFSA SUPPORT PUBL, V8, P186, DOI [10.2903/sp.efsa.2011.EN-186, DOI 10.2903/SP.EFSA.2011.EN-186]; Annis DH, 2005, STAT MED, V24, P3631, DOI 10.1002/sim.2207; [Anonymous], 2016, NATL ANTIMICROBIAL R; Craig BA, 2000, DIAGN MICR INFEC DIS, V36, P193, DOI 10.1016/S0732-8893(99)00130-3; Cummings KJ, 2016, AM J VET RES, V77, P505, DOI 10.2460/ajvr.77.5.505; Deckert A, 2010, ZOONOSES PUBLIC HLTH, V57, P71, DOI 10.1111/j.1863-2378.2010.01356.x; Dey D. K., 2000, GEN LINEAR MODELS BA; Gagliotti C, 2011, EUROSURVEILLANCE, V16, P20; HAMILTON MA, 1988, STAT MED, V7, P535, DOI 10.1002/sim.4780070410; Hanon JB, 2015, PREV VET MED, V122, P443, DOI 10.1016/j.prevetmed.2015.09.001; Jaspers S, 2018, BIOMETRICAL J, V60, P7, DOI 10.1002/bimj.201600253; Jaspers S, 2016, ANN APPL STAT, V10, P906, DOI 10.1214/16-AOAS918; Jaspers S, 2016, BIOSTATISTICS, V17, P94, DOI 10.1093/biostatistics/kxv030; Jaspers S, 2014, COMPUT STAT DATA AN, V71, P30, DOI 10.1016/j.csda.2013.01.024; Komarek A, 2009, COMPUT STAT DATA AN, V53, P3932, DOI 10.1016/j.csda.2009.05.006; Mazloom R, 2018, FOODBORNE PATHOG DIS, V15, P44, DOI 10.1089/fpd.2017.2301; Mouton JW, 2002, INT J ANTIMICROB AG, V19, P323, DOI 10.1016/S0924-8579(02)00028-6; Nguyen M, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01260-18; Ruiz J, 2016, CLIN MICROBIOL INFEC, V22, P741, DOI 10.1016/j.cmi.2016.05.007; Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153; van de Kassteele J, 2012, ANTIMICROB AGENTS CH, V56, P1557, DOI 10.1128/AAC.05777-11	21	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0220427	10.1371/journal.pone.0220427	http://dx.doi.org/10.1371/journal.pone.0220427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004341	gold, Green Published, Green Submitted			2022-12-26	WOS:000534614600001
J	Jiang, SM; Huo, DX; You, ZK; Peng, QN; Ma, CC; Chang, HB; Lin, X; Wang, L; Zhang, JC				Jiang, Shuaiming; Huo, Dongxue; You, Zhengkai; Peng, Qiannan; Ma, Chenchen; Chang, Haibo; Lin, Xue; Wang, Lu; Zhang, Jiachao			The distal intestinal microbiome of hybrids of Hainan black goats and Saanen goats	PLOS ONE			English	Article							GENE; METABOLISM; DIGESTION; GENOME; DIETS	Intestinal microbiota performed numerous important functions during digestion. The first filial generation (F1) hybrids of Hainan black goats and Saanen goats had different traits, black goats (BG) and white goats (WG), which also brought different production performance. We explored the difference of gut microbiota between black goats and white goats that both belonged to the first filial generation (F1) hybrids. In general, the alpha diversity of the black goat group was significantly higher than the white goat group. The species richness had no significant difference, while the species evenness of BG was higher than WG. Bacteroides, Oscillospira, Alistipes, Ruminococcus, Clostridium and Oscillibacter, as the core gut microbial genera, all had high abundance in BG and WG group. Only the Bacteroides and Bacteroidaceae 5-7N15 were the different genera between the BG and WG group, of which Bacteroides overlapped with the core genera and enriched in the WG group. Besides, PICRUSt analysis showed that there was a high abundance in the secondary metabolic pathways including membrane transport, replication and repair, carbohydrate metabolism and amino acid metabolism. We found the intestinal microbial species of black goats and white goats were very similar for living in the identical growing environment and feeding conditions, but there was still a slight difference in the content. On the one hand, it was proved that the small effect of genotype and the great effect of diet affected the intestinal microbiota together. On the other hand, it was also proved that these different traits of first filial generation (F1) hybrids may not related to gut microbiota and only because of different genotype. Moreover, characterization of the gut microbiota in BG and WG will be useful in goats gut microbiota research.	[Jiang, Shuaiming; Huo, Dongxue; You, Zhengkai; Peng, Qiannan; Ma, Chenchen; Chang, Haibo; Lin, Xue; Wang, Lu; Zhang, Jiachao] Hainan Univ, Coll Food Sci & Engn, Haikou, Hainan, Peoples R China	Hainan University	Zhang, JC (corresponding author), Hainan Univ, Coll Food Sci & Engn, Haikou, Hainan, Peoples R China.	zhjch321123@163.com	Zhang, jiachao/L-1332-2013	Zhang, jiachao/0000-0001-8099-6749; Jiang, Shuaiming/0000-0002-9384-9200	Key Research and Development Project of Hainan Province [ZDYF2018111]	Key Research and Development Project of Hainan Province	This research was supported by the Key Research and Development Project of Hainan Province (No. ZDYF2018111). This award was granted to JZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asomaning N, 2012, COMPUT STAT DATA AN, V56, P1748, DOI 10.1016/j.csda.2011.10.020; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cummings JH, 1996, BRIT J NUTR, V75, P733, DOI 10.1079/BJN19960177; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; do Rosario VA, 2016, NUTR REV, V74, P444, DOI 10.1093/nutrit/nuw012; Flachowsky G., 2004, ANIM FEED SCI TECH, V113, P253, DOI [10.1016/j.anifeedsci.2003.09.002, DOI 10.1016/J.ANIFEEDSCI.2003.09.002]; Fouhy F, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0738-z; Hu JT, 2016, MITOCHONDRIAL DNA A, V27, P1656, DOI 10.3109/19401736.2014.958715; Jiao JZ, 2014, J SCI FOOD AGR, V94, P1745, DOI 10.1002/jsfa.6485; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Moreno-Indias I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00190; Portune KJ, 2016, TRENDS FOOD SCI TECH, V57, P213, DOI 10.1016/j.tifs.2016.08.011; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ranjan R, 2016, BIOCHEM BIOPH RES CO, V469, P967, DOI 10.1016/j.bbrc.2015.12.083; Rausch P, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0743-1; Rintala Anniina, 2017, J Biomol Tech, V28, P19, DOI 10.7171/jbt.17-2801-003; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Tang YX, 2016, MITOCHONDRIAL DNA A, V27, P224, DOI 10.3109/19401736.2014.880900; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Wang DF, 2017, ITAL J ANIM SCI, V16, P61, DOI 10.1080/1828051X.2016.1263546; Wang DF, 2014, TROP ANIM HEALTH PRO, V46, P783, DOI 10.1007/s11250-014-0565-x; Wang ZX, 2018, FOOD FUNCT, V9, P2320, DOI [10.1039/c7fo01780d, 10.1039/C7FO01780D]; Wu XF, 2014, SMALL RUMINANT RES, V121, P232, DOI 10.1016/j.smallrumres.2014.09.002; Wu XY, 2016, APPL MICROBIOL BIOT, V100, P3577, DOI 10.1007/s00253-015-7257-y; Xu YH, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0877-2; Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103; Zhang H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00032; Zhang JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep32524; Zhang JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05001	34	6	7	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228496	10.1371/journal.pone.0228496	http://dx.doi.org/10.1371/journal.pone.0228496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999767	gold, Green Published			2022-12-26	WOS:000534612400091
J	Minuzzi, CE; Portella, LP; Braunig, P; Sangioni, LA; Ludwig, A; Ramos, LS; Pacheco, L; Silva, CR; Pacheco, FC; Menegolla, IA; Farinha, LB; Kist, PP; Bregano, RM; Nino, BDL; Martins, FDC; Monica, TC; Ferreira, FP; Britto, I; Signori, A; Medici, KC; Freire, RL; Garcia, JL; Navarro, IT; Difante, CM; Vogel, FSF				Minuzzi, Camila E.; Portella, Luiza Pires; Braunig, Patricia; Sangioni, Luis Antonio; Ludwig, Aline; Ramos, Luciane Silva; Pacheco, Liliane; Silva, Camila Ribeiro; Pacheco, Flavia Caselli; Menegolla, Ivone Andreatta; Farinha, Lourdes Bonfleur; Kist, Priscila Pauli; Bregano, Regina Mitsuka; Lima Nino, Beatriz de Souza; Cardoso Martins, Felippe Danyel; Monica, Thais Cabral; Ferreira, Fernanda Pinto; Britto, Isadora; Signori, Ariana; Medici, Kerlei Cristina; Freire, Roberta Lemos; Garcia, Joao Luis; Navarro, Italmar Teodorico; Difante, Cledison Marcio; Flores Vogel, Fernanda Silveira			Isolation and molecular characterization of Toxoplasma gondii from placental tissues of pregnant women who received toxoplasmosis treatment during an outbreak in southern Brazil	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; IDENTIFICATION; GENOTYPES; ANIMALS; HISTORY	Toxoplasma gondii is a protozoan that has great genetic diversity and is prevalent worldwide. In 2018, an outbreak of toxoplasmosis occurred in Santa Maria, Brazil, which was considered the largest outbreak ever described in the world. This paper describes the isolation and molecular characterization of Toxoplasma gondii from the placenta of two pregnant women with acute toxoplasmosis who had live births and were receiving treatment for toxoplasmosis during the outbreak. For this, placental tissue samples from two patients underwent isolation by mice bioassay, conventional PCR and genotyping using PCR-RFLP with twelve markers. Both samples were positive in isolation in mice. The isolate was lethal to mice, suggesting high virulence. In addition, the samples were positive in conventional PCR and isolates submitted to PCR-RFLP genotyping presented an atypical genotype, which had never been described before. This research contributes to the elucidation of this great outbreak in Brazil.	[Minuzzi, Camila E.; Portella, Luiza Pires; Braunig, Patricia; Sangioni, Luis Antonio; Ludwig, Aline; Flores Vogel, Fernanda Silveira] Univ Fed Santa Maria UFSM, Dept Med Vet Prevent, Lab Doencas Parasitarias Ladopar, Santa Maria, RS, Brazil; [Ramos, Luciane Silva; Pacheco, Liliane] Hosp Univ Santa Maria, Santa Maria, RS, Brazil; [Silva, Camila Ribeiro; Pacheco, Flavia Caselli; Menegolla, Ivone Andreatta] Secretaria Saude Estado Rio Grande Sul, CIEVS, DAT, CEVS, Porto Alegre, RS, Brazil; [Farinha, Lourdes Bonfleur] Secretaria Saude, Vigilancia Epidemiol Reg Saude 4, Santa Maria, RS, Brazil; [Kist, Priscila Pauli; Bregano, Regina Mitsuka; Lima Nino, Beatriz de Souza; Cardoso Martins, Felippe Danyel; Monica, Thais Cabral; Ferreira, Fernanda Pinto; Britto, Isadora; Signori, Ariana; Medici, Kerlei Cristina; Freire, Roberta Lemos; Garcia, Joao Luis; Navarro, Italmar Teodorico] Univ Estadual Londrina, Dept Med Vet Prevent, Londrina, Parana, Brazil; [Difante, Cledison Marcio] Secretaria Municipal Saude, Superintendencia Vigilancia Saude, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Estadual de Londrina	Minuzzi, CE (corresponding author), Univ Fed Santa Maria UFSM, Dept Med Vet Prevent, Lab Doencas Parasitarias Ladopar, Santa Maria, RS, Brazil.	camila.minuzzi03@gmail.com	Garcia, Joao Luis/Y-8864-2019; Monica, Thaís Cabral/AAE-1557-2020; Sangioni, Luis Antonio/AAC-3674-2022; Monica, Thais Cabral/AAK-2481-2021	Garcia, Joao Luis/0000-0002-5736-7511; Monica, Thaís Cabral/0000-0001-8418-7359; Sangioni, Luis Antonio/0000-0002-2364-1084; Andreatta Menegolla, Ivone/0000-0002-4789-4430	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 to CEM, PhD Fellow.	Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12; Boughattas S, 2011, TROP BIOMED, V28, P615; Capobiango JD, 2014, BRAZ J INFECT DIS, V18, P364, DOI 10.1016/j.bjid.2013.11.009; Carral L, 2013, MEDICINA-BUENOS AIRE, V73, P238; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Darde ML, 2008, PARASITE, V15, P366, DOI 10.1051/parasite/2008153366; DARDE ML, 1988, AM J TROP MED HYG, V39, P551, DOI 10.4269/ajtmh.1988.39.551; Delhaes L, 2010, PRENATAL DIAG, V30, P902, DOI 10.1002/pd.2563; Dubey JP, 2006, VET CLIN N AM-FOOD A, V22, P645, DOI 10.1016/j.cvfa.2006.08.001; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dubey JP, 2009, MEM I OSWALDO CRUZ, V104, P190, DOI 10.1590/S0074-02762009000200011; Dubey JP, 2008, J EUKARYOT MICROBIOL, V55, P467, DOI 10.1111/j.1550-7408.2008.00345.x; Dubey JP, 1998, VET PARASITOL, V74, P75, DOI 10.1016/S0304-4017(97)00135-0; Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8; Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277; GOVERNO DO ESTADO DO RIO GRANDE DO SUL/CENTRO ESTADUAL DE VIGILA DE, 2018, REL AT SURT; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Pardini L, 2019, PARASITOL INT, V68, P48, DOI 10.1016/j.parint.2018.10.002; Pardini L, 2014, PARASITOL INT, V63, P470, DOI 10.1016/j.parint.2013.10.011; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Ferreira IMR, 2011, EXP PARASITOL, V129, P190, DOI 10.1016/j.exppara.2011.06.002; Ferreira TCR, 2018, REV BRAS PARASITOL V, V27, P384, DOI [10.1590/S1984-296120180028, 10.1590/s1984-296120180028]; Robert-Gangneux F, 2010, PEDIATR INFECT DIS J, V29, P33, DOI 10.1097/INF.0b013e3181b20ed1; Silva LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090237; Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Vielmo A, 2019, PARASITOL RES, V118, P991, DOI 10.1007/s00436-019-06233-w; Weiss LM, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P1047; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004	30	11	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228442	10.1371/journal.pone.0228442	http://dx.doi.org/10.1371/journal.pone.0228442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999785	Green Published, gold			2022-12-26	WOS:000534612400085
J	Watanabe, Y; Tamura, Y; Kakuta, C; Watanabe, S; Endo, T				Watanabe, Yasunori; Tamura, Yasushi; Kakuta, Chika; Watanabe, Seiya; Endo, Toshiya			Structural basis for interorganelle phospholipid transport mediated by VAT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); mitochondria; lipid transport; lipid-protein interaction; X-ray crystallography	INTRAMITOCHONDRIAL TRANSPORT; LIPID TRANSFER; YEAST; PHOSPHATIDYLSERINE; PROTEIN; UPS2-MDM35; MEMBRANES; INSIGHTS; TORPEDO; SUITE	Eukaryotic cells are compartmentalized to form organelles, whose functions rely on proper phospholipid and protein transport. Here we determined the crystal structure of human VAT-1, a cytosolic soluble protein that was suggested to transfer phosphatidylserine, at 2.2 ? resolution. We found that VAT-1 transferred not only phosphatidylserine but also other acidic phospholipids between membranes in vitro. Structure-based mutational analyses showed the presence of a possible lipid-binding cavity at the interface between the two subdomains, and two tyrosine residues in the flexible loops facilitated phospholipid transfer, likely by functioning as a gate to this lipid-binding cavity. We also found that a basic and hydrophobic loop with two tryptophan residues protruded from the molecule and facilitated binding to the acidic-lipid membranes, thereby achieving efficient phospholipid transfer.	[Watanabe, Yasunori; Watanabe, Seiya] Ehime Univ, Grad Sch Agr, Dept Biosci, Matsuyama, Ehime 7908566, Japan; [Watanabe, Yasunori; Kakuta, Chika; Endo, Toshiya] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Endo, Toshiya] Kyoto Sangyo Univ, Res Ctr Prot Dynam, Kita Ku, Kyoto 6038555, Japan; [Tamura, Yasushi] Yamagata Univ, Fac Sci, Dept Mat & Biol Chem, Yamagata 9908560, Japan; [Watanabe, Seiya] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan	Ehime University; Kyoto Sangyo University; Kyoto Sangyo University; Yamagata University; Ehime University	Endo, T (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	tendo@cc.kyoto-su.ac.jp	Tamura, Yasushi/H-8270-2017	Tamura, Yasushi/0000-0002-8462-0607; Watanabe, Yasunori/0000-0002-7846-680X; Watanabe, Seiya/0000-0002-6530-9047	Japan Society of the Promotion of Science KAKENHI [16K21473, 15H05595, 17H06414, 15H05705, 22227003]; Japan Science and Technology Agency (JST) CREST Grant [JPMJCR12M]; Takeda Science Foundation; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society of the Promotion of Science KAKENHI; Japan Science and Technology Agency (JST) CREST Grant; Takeda Science Foundation(Takeda Science Foundation (TSF)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by Japan Society of the Promotion of Science KAKENHI Grants 16K21473 (to Y. W.), 15H05595 and 17H06414 (to Y. T.), and 15H05705 and 22227003 (to T. E.); a Japan Science and Technology Agency (JST) CREST Grant JPMJCR12M (to T. E.); a grant from the Takeda Science Foundation (to T. E.); and funds from the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aaltonen MJ, 2016, J CELL BIOL, V213, P525, DOI 10.1083/jcb.201602007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Faugaret D, 2011, BIOCHEM PHARMACOL, V81, P144, DOI 10.1016/j.bcp.2010.09.014; Guo PC, 2011, J STRUCT BIOL, V176, P112, DOI 10.1016/j.jsb.2011.07.010; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hirabayahi Y, 2017, SCIENCE, V358, P623, DOI 10.1126/science.aan6009; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; Jeong H, 2017, P NATL ACAD SCI USA, V114, pE9502, DOI 10.1073/pnas.1715592114; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Junker M, 2015, TRAFFIC, V16, P1306, DOI 10.1111/tra.12336; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawano S, 2018, J CELL BIOL, V217, P959, DOI 10.1083/jcb.201704119; Kobashigawa Y, 2009, J BIOMOL NMR, V43, P145, DOI 10.1007/s10858-008-9296-5; Kojima R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30777; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lev S, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013300; LINIAL M, 1993, FEBS LETT, V315, P91, DOI 10.1016/0014-5793(93)81140-U; LINIAL M, 1989, NEURON, V2, P1265, DOI 10.1016/0896-6273(89)90311-5; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyata N, 2016, J CELL BIOL, V214, P77, DOI 10.1083/jcb.201601082; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Tamura Y, 2019, J BIOCHEM, V165, P115, DOI 10.1093/jb/mvy088; Tamura Y, 2017, ADV EXP MED BIOL, V997, P121, DOI 10.1007/978-981-10-4567-7_9; Tatsuta T, 2017, BBA-MOL CELL BIOL L, V1862, P81, DOI 10.1016/j.bbalip.2016.08.006; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsujita K, 2010, J BIOL CHEM, V285, P6781, DOI 10.1074/jbc.M109.057018; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Watanabe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8922; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001	40	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3257	3268		10.1074/jbc.RA119.011019	http://dx.doi.org/10.1074/jbc.RA119.011019			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005660	hybrid, Green Published			2022-12-26	WOS:000519597300030
J	Agudelo, CW; Kumley, BK; Area-Gomez, E; Xu, YM; Dabo, AJ; Geraghty, P; Campos, M; Foronjy, R; Garcia-Arcos, I				Agudelo, Christina W.; Kumley, Britta K.; Area-Gomez, Estela; Xu, Yimeng; Dabo, Abdoulaye J.; Geraghty, Patrick; Campos, Michael; Foronjy, Robert; Garcia-Arcos, Itsaso			Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD)	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; FIBROSIS; AIRWAYS; FLUID	Smoke exposure is known to decrease total pulmonary surfactant and alter its composition, but the role of surfactant in chronic obstructive pulmonary disease (COPD) remains unknown. We aimed to analyze the compositional changes in the surfactant lipidome in COPD and identify specific lipids associated with pulmonary function decline. Bronchoalveolar lavage (BAL) fluid was obtained from 12 former smokers with COPD and 5 nonsmoking, non-asthmatic healthy control volunteers. Lipids were extracted and analyzed by liquid chromatography and mass spectrometry. Pulmonary function data were obtained by spirometry, and correlations of lung function with lipid species were determined. Wild-type C57BL/6 mice were exposed to 6 months of second-hand smoke in a full-body chamber. Surfactant lipids were decreased by 60% in subjects with COPD. All phospholipid classes were dramatically decreased, including ether phospholipids, which have not been studied in pulmonary surfactant. Availability of phospholipid, cholesterol, and sphingomyelin in BAL strongly correlated with pulmonary function and this was attributable to specific lipid species of phosphatidylcholine with surface tension reducing properties, and of phosphatidylglycerol with antimicrobial roles, as well as to other less studied lipid species. Mice exposed to smoke for six months recapitulated surfactant lipidomic changes observed in human subjects with COPD. In summary, we show that the surfactant lipidome is substantially altered in subjects with COPD, and decreased availability of phospholipids correlated with decreased pulmonary function. Further investigation of surfactant alterations in COPD would improve our understanding of its physiopathology and reveal new potential therapeutic targets.	[Agudelo, Christina W.; Kumley, Britta K.; Dabo, Abdoulaye J.; Geraghty, Patrick; Foronjy, Robert; Garcia-Arcos, Itsaso] SUNY Downstate Med Ctr, Dept Med, New York, NY 11203 USA; [Area-Gomez, Estela; Xu, Yimeng] Columbia Univ, Dept Neurol, New York, NY USA; [Campos, Michael] Univ Miami, Miller Sch Med, Div Pulm Allergy Crit Care & Sleep Med, Miami, FL 33136 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University; University of Miami	Garcia-Arcos, I (corresponding author), SUNY Downstate Med Ctr, Dept Med, New York, NY 11203 USA.	Itsaso.garcia-arcos@downstate.edu		Geraghty, Patrick/0000-0003-1647-5505; Garcia-Arcos, Itsaso/0000-0002-4190-3252; Area, Estela/0000-0002-0962-1570; Agudelo, Christina/0000-0002-9633-0308	American Heart Association [17GRNT33700252]; Flight Attendant Medical Research Institute [YCSA13005]; National Heart, Lung, And Blood Institute of the National Institutes of Health [R56HL148774]; National Institutes of Health [NO1-HR-96140]	American Heart Association(American Heart Association); Flight Attendant Medical Research Institute; National Heart, Lung, And Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded with grants from American Heart Association 17GRNT33700252 (I. G.A) and from the Flight Attendant Medical Research Institute YCSA13005 (I.G.A), National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R56HL148774 (I.G.A) and National Institutes of Health (NO1-HR-96140) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassandian M, 2013, BBA-MOL CELL BIOL L, V1831, P612, DOI 10.1016/j.bbalip.2012.09.010; Anzueto A, 1997, JAMA-J AM MED ASSOC, V278, P1426; Aoshiba K, 2003, Tob Induc Dis, V1, P219, DOI 10.1186/1617-9625-1-3-219; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brehm A, 2014, FASEB J, V28, P2318, DOI 10.1096/fj.13-246843; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Devendra G, 2002, RESPIR RES, V3, DOI 10.1186/rr168; ENHORNING G, 1995, AM J RESP CRIT CARE, V151, P554, DOI 10.1164/ajrccm.151.2.7842219; Fessler MB, 2016, AM J RESP CELL MOL, V54, P624, DOI 10.1165/rcmb.2016-0011PS; Frohlich E, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00181; FUJIWARA T, 1980, LANCET, V1, P55; Glasser JR, 2012, MICROBES INFECT, V14, P17, DOI 10.1016/j.micinf.2011.08.019; Goss V, 2013, BBA-MOL CELL BIOL L, V1831, P448, DOI 10.1016/j.bbalip.2012.11.009; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x; Griese M, 2019, AM J RESP CRIT CARE, V200, P881, DOI 10.1164/rccm.201901-0086OC; Gunasekara L, 2017, J CYST FIBROS, V16, P565, DOI 10.1016/j.jcf.2017.04.015; Gunther A, 1999, EUR RESPIR J, V14, P565, DOI 10.1034/j.1399-3003.1999.14c14.x; Gunther A, 1996, AM J RESP CRIT CARE, V153, P176; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; Halliday HL, 2008, J PERINATOL, V28, pS47, DOI 10.1038/jp.2008.50; Haslam PL, 1999, EUR RESPIR J, V14, P245, DOI 10.1034/j.1399-3003.1999.14b01.x; HITE RD, 2005, AM J PHYSIOL-LUNG C, V288, pL61, DOI DOI 10.1152/AJPLUNG.00274; Hohlfeld J, 1997, EUR RESPIR J, V10, P482, DOI 10.1183/09031936.97.10020482; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; LEWIS JF, 1993, AM REV RESPIR DIS, V147, P218, DOI 10.1164/ajrccm/147.1.218; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; MASON RJ, 1976, J LIPID RES, V17, P281; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Roth MD, 2006, CHEST, V130, P1334, DOI 10.1378/chest.130.5.1334; Schmidt R, 2001, AM J RESP CRIT CARE, V163, P95, DOI 10.1164/ajrccm.163.1.9903029; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; Seeds MC, 2012, AM J MED SCI, V343, P446, DOI 10.1097/MAJ.0b013e318239c96c; Telenga ED, 2014, AM J RESP CRIT CARE, V190, P155, DOI 10.1164/rccm.201312-2210OC; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Yang R, 2019, METABOLITES, V9, DOI 10.3390/metabo9040080	37	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228279	10.1371/journal.pone.0228279	http://dx.doi.org/10.1371/journal.pone.0228279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027677	gold, Green Published			2022-12-26	WOS:000534623800020
J	Bazzano, AN; Stolow, JA; Duggal, R; Oberhelman, RA; Var, C				Bazzano, Alessandra N.; Stolow, Jeni A.; Duggal, Ryan; Oberhelman, Richard A.; Var, Chivorn			Warming the postpartum body as a form of postnatal care: An ethnographic study of medical injections and traditional health practices in Cambodia	PLOS ONE			English	Article							MATERNITY CARE; WOMENS; INTERVIEWS; PREGNANCY; BELIEFS	Postpartum care is a critical element for ensuring survival and health of mothers and new-borns but is often inadequate in low- and middle-income countries due to barriers to access and resource constraints. Newly delivered mothers and their families often rely on traditional forms of postnatal care rooted in social and cultural customs or may blend modern and traditional forms of care. This ethnographic study sought to explore use of biomedical and traditional forms of postnatal care. Data were collected through unstructured observation and in-depth interviews with 15 mothers. Participants reported embracing traditional understandings of health and illness in the post-partum period centered on heating the body through diet, steaming, and other applications of heat, yet also seeking injections from private health care providers. Thematic analysis explored concepts related to transitioning forms of postnatal care, valuing of care through different lenses, and diverse sources of advice on postnatal care. Mothers also described concurrent use of both traditional medicine and biomedical postnatal care, and the importance of adhering to cultural traditions of postnatal care for future health. Maternal and newborn health are closely associated with postnatal care, so ensuring culturally appropriate and high-quality care must be an important priority for stakeholders including understand health practices that are evolving to include injections.	[Bazzano, Alessandra N.; Stolow, Jeni A.; Oberhelman, Richard A.] Tulane Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70112 USA; [Duggal, Ryan] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Var, Chivorn] Reprod Hlth Assoc Cambodia, Phnom Penh, Cambodia; [Var, Chivorn] Natl Inst Publ Hlth, Phnom Penh, Cambodia	Tulane University; Tulane University	Bazzano, AN (corresponding author), Tulane Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70112 USA.	abazzano@tulane.edu		Bazzano, Alessandra N./0000-0002-8299-2626; Stolow, Jeni/0000-0001-8926-1861	National Institute of Public Health Cambodia; National Academy of Sciences (NAS) - United States Agency for International Development (USAID) [AID-OAAA-A-11-00012]	National Institute of Public Health Cambodia; National Academy of Sciences (NAS) - United States Agency for International Development (USAID)	CV received funding through the National Institute of Public Health Cambodia. The study was funded through a sub-grant award from the National Academy of Sciences (NAS), funded by United States Agency for International Development (USAID) under prime agreement number AID-OAAA-A-11-00012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, MATERN CHILD HLTH J, V20, P854; Bazzano AN, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4040094; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bigdeli M, 2009, B WORLD HEALTH ORGAN, V87, P560, DOI 10.2471/BLT.08.053058; Dingle A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-51; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Health Mo, 2012, HLTH SERV DEL PROF C; Hmong J J., 1995, CLIN NURS RES, V4; Hoban E, 2013, MIDWIFERY, V29, P772, DOI 10.1016/j.midw.2012.06.021; Ith P, 2013, MIDWIFERY, V29, P300, DOI 10.1016/j.midw.2012.01.010; Ith P, 2013, WOMEN BIRTH, V26, P71, DOI 10.1016/j.wombi.2012.05.002; Janssens F., 2012, BIRTH WIND FIRE; Kermode M, 2004, HEALTH PROMOT INT, V19, P95, DOI 10.1093/heapro/dah110; Kikuchi K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198829; Liljestrand J, 2012, REPROD HEALTH MATTER, V20, P62, DOI 10.1016/S0968-8080(12)39620-1; Lundberg PC, 2011, MIDWIFERY, V27, P731, DOI 10.1016/j.midw.2010.02.006; Mallick L., 2016, TRENDS MATERNAL CHIL; Ministry of Health and Family Welfare Bangladesh World Health Organization World Bank, 2015, SUCC FACT WOM CHILDR; Ministry of Health Kingdom of Cambodia, 2010, FAST TRACK IN ROAD M; Montesanti S, 2011, VIS VIS EXPLORATIONS, V11, P90; National Institute of SC Directorate General for HC International ICF, 2015, CAMB DEM HLTH SURV 2; Ozawa S, 2018, PHARMACOECON OPEN; Ozawa S, 2018, HEALTH POLICY PLANN, V33, P1009, DOI 10.1093/heapol/czy080; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Ros B, 2018, HEALTH POLICY PLANN, V33, P9, DOI 10.1093/heapol/czx144; Rouet F, 2018, CLIN INFECT DIS, V66, P1733, DOI 10.1093/cid/cix1071; Salam RA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S3; Sein KK, 2013, MIDWIFERY, V29, P1257, DOI 10.1016/j.midw.2012.11.012; Sharma S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0938-4; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turner C, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1305-9; Vachon M., 2004, THE CAMBODIA DAILY; Var C, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0771-5; Wang WQ, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0101-0; White P., 2010, HEALTH CARE WOMEN IN, V25, P179; White P., 2004, J MIDWIFERY WOM HEAL, V47, P239; White Patrice M, 2004, Health Care Women Int, V25, P179, DOI 10.1080/07399330490267477; White PM, 2002, J MIDWIFERY WOM HEAL, V47, P239, DOI 10.1016/S1526-9523(02)00266-0; Withers M, 2018, MIDWIFERY, V56, P158, DOI 10.1016/j.midw.2017.10.019; Woods J, 2015, INT J GYNECOL OBSTET, V129, P178, DOI 10.1016/j.ijgo.2014.10.034; World Health Organization, 2015, PREGN CHILDB POSTP N; World Health Organization, 2013, POSTN CAR MOTH NEWB	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228529	10.1371/journal.pone.0228529	http://dx.doi.org/10.1371/journal.pone.0228529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9GK	32027688	gold, Green Published			2022-12-26	WOS:000534623800044
J	Sun, Y; Geng, MY; Yuan, YM; Guo, PL; Chen, YC; Yang, D; Petersen, RB; Huang, K; Zheng, L				Sun, Yu; Geng, Mengyuan; Yuan, Yangmian; Guo, Peilian; Chen, Yuchen; Yang, Dong; Petersen, Robert B.; Huang, Kun; Zheng, Ling			Lmo4-resistin signaling contributes to adipose tissue-liver crosstalk upon weight cycling	FASEB JOURNAL			English	Article						adipose tissue-liver crosstalk; diet-induced weight cycling; hepatic inflammation; Lmo4; resistin	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; INSULIN-RESISTANCE; GENE-EXPRESSION; LIM DOMAIN; RISK; GLUCOSE; PATHWAY; INFLAMMATION; HOMEOSTASIS; METABOLISM	Repeated cycles of weight loss and regain, known as weight cycling, is often seen when people try to lose weight. The exact pathophysiological effects and the underlying mechanisms of weight cycling remain largely unclear. Here, we report that weight cycling induced by alternating feeding mice with a low-fat diet or a high-fat diet in a 1-week switch protocol caused further increased epididymal white adipose tissue (eWAT) weight, preadipocyte proliferation, hepatic inflammation, fasting blood glucose level, and glucose intolerance, compared with the continuously HF-fed mice. Combining the secretory protein database with RNA-sequencing and quantitative PCR (qPCR) results in eWAT, the mRNA levels of several adipokines, including Retn (encoding resistin), were found altered by weight cycling. A transcriptional co-factor Lmo4 was found regulated by weight cycling; Lmo4 enhanced preadipocyte proliferation, in vitro adipogenesis, transcription of Retn, and resistin secretion in 3T3-L1 cells. Primary mouse hepatocytes administrated with recombinant mouse resistin (rm-resistin), or exposed to media from Lmo4-overexpressed 3T3-L1 cells, showed increased inflammatory responses and gluconeogenesis. Furthermore, rm-resistin-injected normal chow-fed mice showed upregulated blood glucose level by increasing gluconeogenesis, and upregulated the hepatic inflammatory responses. Together, our results suggest a regulatory role of Lmo4-resistin signaling in weight cycling, indicating a crosstalk between the adipose tissue and liver.	[Sun, Yu; Geng, Mengyuan; Yuan, Yangmian; Guo, Peilian; Zheng, Ling] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China; [Chen, Yuchen; Yang, Dong; Huang, Kun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Sch Pharm, Wuhan 430030, Peoples R China; [Petersen, Robert B.] Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA; [Zheng, Ling] Wuhan Univ, Frontier Sci Ctr Immunol & Metab, Wuhan, Peoples R China	Wuhan University; Huazhong University of Science & Technology; Central Michigan University; Wuhan University	Zheng, L (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China.; Huang, K (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Sch Pharm, Wuhan 430030, Peoples R China.	kunhuang@hust.edu.cn; lzheng@whu.edu.cn		Zheng, Ling/0000-0002-6545-4180	National Natural Science Foundation of China (NSFC) [91957114, 31871381, 31971066]; National Key Research and Development Program of China [2018YFA0800700, 2019YFA0802701]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 91957114, 31871381 & 31971066; National Key Research and Development Program of China, Grant/Award Number: 2018YFA0800700 & 2019YFA0802701	Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; BLACKBURN GL, 1989, AM J CLIN NUTR, V49, P1105, DOI 10.1093/ajcn/49.5.1105; Cai RQ, 2015, FASEB J, V29, P2749, DOI 10.1096/fj.14-265801; Chen H, 2017, J AM SOC NEPHROL, V28, P2695, DOI 10.1681/ASN.2016111210; Cheng CW, 2017, CELL, V168, P775, DOI 10.1016/j.cell.2017.01.040; Chikamoto K, 2016, BIOCHEM BIOPH RES CO, V478, P1310, DOI 10.1016/j.bbrc.2016.08.117; Cho Youngjin, 2011, J Am Coll Cardiol, V57, P99, DOI 10.1016/j.jacc.2010.07.035; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Dankel SN, 2014, AM J PHYSIOL-ENDOC M, V306, pE210, DOI 10.1152/ajpendo.00188.2013; Delahanty LM, 2014, DIABETES CARE, V37, P2738, DOI 10.2337/dc14-0018; Ding Y, 2014, INT J OBESITY, V38, P198, DOI 10.1038/ijo.2013.98; Feve B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62; Haczeyni F, 2018, OBES REV, V19, P406, DOI 10.1111/obr.12646; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Jiao XM, 2014, EUR REV MED PHARMACO, V18, P2025; Kim KH, 2017, CELL RES, V27, P1309, DOI 10.1038/cr.2017.126; Koch CE, 2014, J NEUROENDOCRINOL, V26, P58, DOI 10.1111/jne.12131; Li GL, 2017, CELL METAB, V26, P672, DOI 10.1016/j.cmet.2017.08.019; Li J, 2012, J HEPATOL, V56, P900, DOI 10.1016/j.jhep.2011.10.018; Linden MA, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12071; Liu CY, 2020, DIABETES, V69, P35, DOI 10.2337/db19-0502; Liu SS, 2017, HEPATOLOGY, V66, P631, DOI 10.1002/hep.29202; Liu XR, 2014, CANCER RES, V74, P6623, DOI 10.1158/0008-5472.CAN-14-1279; Maher JJ, 2001, SEMIN LIVER DIS, V21, P417, DOI 10.1055/s-2001-17555; Maiorana Arianna, 2007, Rev Diabet Stud, V4, P134, DOI 10.1900/RDS.2007.4.134; Menegaut L, 2017, CURR OPIN LIPIDOL, V28, P19, DOI 10.1097/MOL.0000000000000370; Menon SS, 2019, CLIN CHIM ACTA, V491, P39, DOI 10.1016/j.cca.2019.01.011; Montani JP, 2015, OBES REV, V16, P7, DOI 10.1111/obr.12251; Mousses S, 2002, CANCER RES, V62, P1256; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Muse ED, 2007, J CLIN INVEST, V117, P1670, DOI 10.1172/JCI30440; Peppler WT, 2019, AM J PHYSIOL-GASTR L, V316, pG166, DOI 10.1152/ajpgi.00097.2018; Rabbitts TH, 1999, CANCER RES, V59, p1798S; Reilly SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7047; Rhee EJ, 2018, DIABETES RES CLIN PR, V139, P230, DOI 10.1016/j.diabres.2018.03.018; Rodriguez-Pacheco F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/479739; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Schofield S, 2017, INT J OBESITY, V41, P402, DOI 10.1038/ijo.2016.193; Schroeder M, 2018, MOL METAB, V9, P176, DOI 10.1016/j.molmet.2018.01.015; Serbulea V, 2018, P NATL ACAD SCI USA, V115, pE6254, DOI 10.1073/pnas.1800544115; Simonds SE, 2018, PHYSIOL BEHAV, V194, P184, DOI 10.1016/j.physbeh.2018.05.026; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Syngal S, 1999, ANN INTERN MED, V130, P471, DOI 10.7326/0003-4819-130-6-199903160-00003; Taniwaki M, 2006, INT J ONCOL, V29, P567; Tsai CJ, 2006, ARCH INTERN MED, V166, P2369, DOI 10.1001/archinte.166.21.2369; Vergnaud AC, 2008, INT J OBESITY, V32, P315, DOI 10.1038/sj.ijo.0803739; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wan DY, 2017, J MOL CELL BIOL, V9, P325, DOI 10.1093/jmcb/mjx027; Wang WJ, 2017, AUTOPHAGY, V13, P941, DOI 10.1080/15548627.2017.1293768; Xu Y, 2017, ONCOTARGET, V8; Yang JL, 2011, CANCER-AM CANCER SOC, V117, P4925, DOI 10.1002/cncr.26116; Yang Y, 2009, BIOMED PHARMACOTHER, V63, P366, DOI 10.1016/j.biopha.2008.06.033; Ying CJ, 2016, ENDOCRINE, V53, P81, DOI 10.1007/s12020-016-0867-z; Yu J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-93; Zhang Y, 2020, CELL DEATH DIFFER, V27, P1243, DOI 10.1038/s41418-019-0412-8; Zhang Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02355-w; Zhao SG, 2019, CELL METAB, V30, P706, DOI 10.1016/j.cmet.2019.08.005	60	11	12	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4732	4748		10.1096/fj.201902708R	http://dx.doi.org/10.1096/fj.201902708R		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030835	Bronze			2022-12-26	WOS:000512334000001
J	Yin, JL; Tu, G; Peng, MX; Zeng, H; Wan, XY; Qiao, YN; Qin, YL; Liu, MR; Luo, HJ				Yin, Jiali; Tu, Gang; Peng, Meixi; Zeng, Huan; Wan, Xueying; Qiao, Yina; Qin, Yilu; Liu, Manran; Luo, Haojun			GPER-regulated lncRNA-Glu promotes glutamate secretion to enhance cellular invasion and metastasis in triple-negative breast cancer	FASEB JOURNAL			English	Article						G protein-coupled estrogen receptor; glutamate N-methyl-D-aspartate receptor; glutamate signaling; triple-negative breast cancer	LONG NONCODING RNAS; TUMOR-GROWTH; ESTROGEN; RECEPTOR; CELLS; TUMORIGENESIS; TRANSLOCATION; INVASIVENESS; ACTIVATION; EXPRESSION	Triple-negative breast cancer (TNBC) is a group of breast cancer with heterogeneity and poor prognosis and effective therapeutic targets are not available currently. TNBC has been recognized as estrogen-independent breast cancer, while the novel estrogen receptor, namely G protein-coupled estrogen receptor (GPER), was claimed to mediate estrogenic actions in TNBC tissues and cell lines. Through mRNA microarrays, lncRNA microarrays, and bioinformatics analysis, we found that GPER is activated by 17 beta-estradiol (E2) and GPER-specific agonist G1, which downregulates a novel lncRNA (termed as lncRNA-Glu). LncRNA-Glu can inhibit glutamate transport activity and transcriptional activity of its target gene VGLUT2 via specific binding. GPER-mediated reduction of lncRNA-Glu promotes glutamate transport activity and transcriptional activity of VGLUT2. Furthermore, GPER-mediated activation of cAMP-PKA signaling contributes to glutamate secretion. LncRNA-Glu-VGLUT2 signaling synergizes with cAMP-PKA signaling to increase autologous glutamate secretion in TNBC cells, which activates glutamate N-methyl-D-aspartate receptor (NMDAR) and its downstream CaMK and MEK-MAPK pathways, thus enhancing cellular invasion and metastasis in vitro and in vivo. Our data provide new insights into GPER-mediated glutamate secretion and its downstream signaling NMDAR-CaMK/MEK-MAPK during TNBC invasion. The mechanisms we discovered may provide new targets for clinical therapy of TNBC.	[Yin, Jiali; Peng, Meixi; Zeng, Huan; Wan, Xueying; Qiao, Yina; Qin, Yilu; Liu, Manran] Chongqing Med Univ, Key Lab Lab Med Diagnost, Chinese Minist Educ, 1 Yi Xue Yuan Rd, Chongqing 400016, Peoples R China; [Tu, Gang] Chongqing Med Univ, Dept Endocrine & Breast Surg, Affiliated Hosp 1, Chongqing, Peoples R China; [Luo, Haojun] Chongqing Med Univ, Dept Thyroid & Breast Surg, Affiliated Hosp 2, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Liu, MR (corresponding author), Chongqing Med Univ, Key Lab Lab Med Diagnost, Chinese Minist Educ, 1 Yi Xue Yuan Rd, Chongqing 400016, Peoples R China.; Luo, HJ (corresponding author), Chongqing Med Univ, Dept Thyroid & Breast Surg, Affiliated Hosp 2, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China.	manranliu@cqmu.edu.cn; luohaojun@hospital.cqmu.edu.cn			National Natural Science Foundation of China (NSFC) [NSFC 81402184, NSFC 81874199, NSFC 31671481]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: NSFC 81402184, NSFC 81874199 and NSFC 31671481	Blesson CS, 2012, MOL CELL ENDOCRINOL, V361, P179, DOI 10.1016/j.mce.2012.04.006; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Cao Y, 2017, THERANOSTICS, V7, P3021, DOI 10.7150/thno.18992; Chen ZJ, 2016, MOL ONCOL, V10, P775, DOI 10.1016/j.molonc.2016.01.002; Denkert C, 2017, LANCET, V389, P2430, DOI 10.1016/S0140-6736(16)32454-0; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; Dornier E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02101-2; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Han BC, 2018, ONCOGENE, V37, P1399, DOI 10.1038/s41388-017-0021-2; Herrero I, 1996, J BIOL CHEM, V271, P30554, DOI 10.1074/jbc.271.48.30554; Iriondo O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04460-w; Jiang YZ, 2019, CANCER CELL, V35, P428, DOI 10.1016/j.ccell.2019.02.001; Jonsson P, 2015, MOL ENDOCRINOL, V29, P1634, DOI 10.1210/me.2015-1153; Jorgensen EM, 2016, FASEB J, V30, P3194, DOI 10.1096/fj.201500089R; KUMAR MS, 1979, CANCER RES, V39, P3515; Lange CA, 2007, ANNU REV PHYSIOL, V69, P171, DOI 10.1146/annurev.physiol.69.031905.160319; Lappano R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00066; Li L, 2018, CANCER CELL, V33, P736, DOI 10.1016/j.ccell.2018.02.011; Li L, 2013, CELL, V153, P86, DOI 10.1016/j.cell.2013.02.051; Luo HJ, 2011, J BREAST CANCER, V14, P185, DOI 10.4048/jbc.2011.14.3.185; Marjon NA, 2014, MOL CANCER RES, V12, P1644, DOI 10.1158/1541-7786.MCR-14-0128-T; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P113, DOI 10.1038/nrclinonc.2017.1; Otters S, 2016, TRENDS ENDOCRIN MET, V27, P177, DOI 10.1016/j.tem.2015.12.004; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Prossnitz ER, 2009, PROSTAG OTH LIPID M, V89, P89, DOI 10.1016/j.prostaglandins.2009.05.001; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P1, DOI 10.1016/j.mce.2009.04.005; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rigiracciolo D, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1056-8; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; TANAKA S, 1989, CELL, V57, P675, DOI 10.1016/0092-8674(89)90136-0; Vivacqua A, 2012, BREAST CANCER RES TR, V133, P1025, DOI 10.1007/s10549-011-1901-8; Wu LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31716; Xiao B, 2019, MOL CARCINOGEN, V58, P1314, DOI 10.1002/mc.23014; Xu FY, 2017, ENVIRON POLLUT, V231, P1609, DOI 10.1016/j.envpol.2017.09.069; Yam C, 2017, ONCOLOGIST, V22, P1086, DOI 10.1634/theoncologist.2017-0095; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yu LMJ, 2017, NEUROPHARMACOLOGY, V115, P193, DOI 10.1016/j.neuropharm.2016.02.011; Yu T, 2017, ONCOGENE, V36, P2131, DOI 10.1038/onc.2016.370; Yu TH, 2014, J STEROID BIOCHEM, V143, P392, DOI 10.1016/j.jsbmb.2014.05.003; Zeng QQ, 2019, NATURE, V573, P526, DOI 10.1038/s41586-019-1576-6; Zhang JW, 2018, HEPATOLOGY, V67, P171, DOI 10.1002/hep.29405; Zhou R, 2018, CANCER RES, V78, P5521, DOI 10.1158/0008-5472.CAN-17-3988	45	8	8	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4557	4572		10.1096/fj.201901384RR	http://dx.doi.org/10.1096/fj.201901384RR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030797	Bronze			2022-12-26	WOS:000512332500001
J	Rayanakorn, A; Katip, W; Goh, BH; Oberdorter, P; Lee, LH				Rayanakorn, Ajaree; Katip, Wasan; Goh, Bey Hing; Oberdorter, Peninnah; Lee, Learn Han			A risk scoring system for predicting Streptococcus suis hearing loss: A 13-year retrospective cohort study	PLOS ONE			English	Article							CLINICAL-MANIFESTATIONS; INFECTION	Background Streptococcus suis (S.suis) is an emerging zoonosis disease with a high prevalence in Southeast Asia. There are over 1,500 cases reported globally in which majority of cases are from Thailand followed by Vietnam. The disease leads to meningitis in human with sensorineural hearing loss (SNHL) as the most common complication suffered by the patients. Early diagnosis and treatment is important to prevent severe neurological complication. In this study, we aim to develop an easy-to-use risk score to promote early diagnosis and detection of S.suis in patients who potentially develop hearing loss. Methods Data from a retrospective review of 13-year S.suis patient records in a tertiary hospital in Chiang Mai, Northern, Thailand was obtained. Univariate and multivariate logistic regressions were employed to develop a predictive model. The clinical risk score was constructed from the coefficients of significant predictors. Area under the receiver operator characteristic curve (AuROC) was identified to verify the model discriminative performance. Bootstrap technique with 1000-fold bootstrapping was used for internal validation. Key Results Among 133 patients, the incidence of hearing loss was 31.6% (n = 42). Significant predictors for S. suis hearing loss were meningitis, raw pork consumption, and vertigo. The predictive score ranged from 0-4 and correctly classified 81.95% patients as being at risk of S.suis hearing loss. The model showed good power of prediction (AuROC: 0.859; 95%CI 0.785-0.933) and calibration (AuROC: 0.860; 95%CI 0.716-0.953). Conclusions To our best knowledge, this is the first risk scoring system development for S.suis hearing loss. We identified meningitis, raw pork consumption and vertigo as the main risk factors of S.suis hearing loss. Future studies are needed to optimize the developed scoring system and investigate its external validity before recommendation for use in clinical practice.	[Rayanakorn, Ajaree; Lee, Learn Han] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Novel Bacteria & Drug Discovery Res Grp NBDD, Microbiome & Bioresource Res Strength, Bandar Sunway, Malaysia; [Katip, Wasan] Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Care, Chiang Mai, Thailand; [Goh, Bey Hing] Monash Univ Malaysia, Sch Pharm, Biofunct Mol Exploratory Res Grp BMEX, Bandar Sunway, Malaysia; [Goh, Bey Hing] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China; [Goh, Bey Hing] Monash Univ Malaysia, Global Asia 21st Century GA21 Platform, Hlth & Well Being Cluster, Bandar Sunway, Malaysia; [Oberdorter, Peninnah] Chiang Mai Univ, Fac Med, Dept Pediat, Div Pediat Infect Dis, Chiang Mai, Thailand	Monash University; Monash University Sunway; Chiang Mai University; Monash University; Monash University Sunway; Zhejiang University; Monash University; Monash University Sunway; Chiang Mai University	Rayanakorn, A; Lee, LH (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Novel Bacteria & Drug Discovery Res Grp NBDD, Microbiome & Bioresource Res Strength, Bandar Sunway, Malaysia.	ajaree.rayanakorn@monash.edu; lee.learn.han@monash.edu	Lee, Learn-Han/HGD-7373-2022; Goh, Bey Hing/ABA-3131-2021; Goh, Bey Hing/I-4880-2015; Katip, Wasan/Q-3892-2019	Lee, Learn-Han/0000-0002-8589-7456; Goh, Bey Hing/0000-0003-1006-3649; Goh, Bey Hing/0000-0003-1006-3649; Katip, Wasan/0000-0001-7665-8819; Rayanakorn, Ajaree/0000-0002-5961-8978	Jeffrey Cheah School of Medicine and Health Sciences Internal Grant; Monash Global Asia in the 21st Century (GA21) research grant [GA-HW-19-L01]	Jeffrey Cheah School of Medicine and Health Sciences Internal Grant; Monash Global Asia in the 21st Century (GA21) research grant	This work was financially supported by Jeffrey Cheah School of Medicine and Health Sciences Internal Grant awarded to LHL and Monash Global Asia in the 21st Century (GA21) research grant GA-HW-19-L01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Brouwer MC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub5; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; KAY R, 1995, QJM-INT J MED, V88, P39; KAY R, 1991, NEUROPATH APPL NEURO, V17, P485, DOI 10.1111/j.1365-2990.1991.tb00751.x; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; Navacharoen N, 2009, J LARYNGOL OTOL, V123, P857, DOI 10.1017/S0022215109004939; Rayanakorn A, 2019, INFECT DRUG RESIST, V12, P3955, DOI 10.2147/IDR.S233326; Rayanakorn A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31598-w; Richardson MP, 1997, ARCH DIS CHILD, V76, P134, DOI 10.1136/adc.76.2.134; Tan JH, 2010, SINGAP MED J, V51, pE30; Huong VTL, 2014, EMERG INFECT DIS, V20, P1105, DOI 10.3201/eid2007.131594; Wangkaew S, 2006, J INFECTION, V52, P455, DOI 10.1016/j.jinf.2005.02.012; Wangsomboonsiri W, 2008, J INFECTION, V57, P392, DOI 10.1016/j.jinf.2008.08.006	17	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228488	10.1371/journal.pone.0228488	http://dx.doi.org/10.1371/journal.pone.0228488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017787	Green Published, Green Submitted, gold			2022-12-26	WOS:000534618100028
J	Melia, P; Casagrandi, R; Di Franco, A; Guidetti, P; Gatto, M				Melia, Paco; Casagrandi, Renato; Di Franco, Antonio; Guidetti, Paolo; Gatto, Marino			Protection reveals density-dependent dynamics in fish populations: A case study in the central Mediterranean	PLOS ONE			English	Article							DIPLODUS-SARGUS; MARINE RESERVES; WHITE SEABREAM; TIME-SERIES; HOME-RANGE; RECRUITMENT; PATTERNS; MORTALITY; FISHERIES; MODELS	Casting light on how the interaction between protection and density dependence affects fish population dynamics is critical for understanding the effectiveness of marine protected areas (MPAs). We developed a framework based on nonparametric statistics, model selection and multi-model inference to contrast alternative hypotheses about the effect of density dependence on demographic dynamics under protected and unprotected conditions. We trialed it using a 12-year long time series of white seabream (Diplodus sargus sargus) population density within the no-take zone of Torre Guaceto MPA (Italy) and at two nearby unprotected locations. Then, we showed how the demographic models obtained can be used to assess the consequences of protection on population viability. Population dynamics were significantly influenced by fish density within the MPA and at one of the unprotected locations, where demography is possibly driven by directional recruitment subsidy from the MPA. The comparison of population growth rates within and outside the MPA suggests that in unprotected conditions the fishery may remove a fraction between 40 and 70% of the population each year. The population viability analysis pointed out that, while the probability that the population becomes depleted (i.e. undergoes a local, temporary quasi-extinction) is high in unprotected locations, it is negligible within the no-take zone of the MPA.	[Melia, Paco; Casagrandi, Renato; Gatto, Marino] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy; [Di Franco, Antonio] Stn Zool Anton Dohrn, Sede Interdipartimentale Sicilia, Dipartimento Ecol Marina Integrate, Palermo, Italy; [Di Franco, Antonio; Guidetti, Paolo] Univ Cote Azur, CNRS, UMR 7035, ECOSEAS, Nice, France; [Guidetti, Paolo] Consorzio Nazl Interuniv Sci Mare, CoNISMa, Rome, Italy	Polytechnic University of Milan; Stazione Zoologica Anton Dohrn di Napoli; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CoNISMa	Melia, P (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy.	paco.melia@polimi.it	Casagrandi, Renato/L-3985-2013; Melià, Paco/E-8844-2012; Gatto, Marino/D-9531-2012; Di Franco, Antonio/A-8796-2010	Casagrandi, Renato/0000-0001-5177-803X; Melià, Paco/0000-0002-7763-9836; Gatto, Marino/0000-0001-8063-9178; Di Franco, Antonio/0000-0003-3411-7015	Italian Ministry of Research (PRIN project) [2008E7KBAE]; European Commission, Directorate General for Maritime Affairs and Fisheries [SI2.721708, MARE/2014/41]; Interreg MED Programme (project "FishMPABlue2" - European Regional Development Fund -ERDF)	Italian Ministry of Research (PRIN project); European Commission, Directorate General for Maritime Affairs and Fisheries; Interreg MED Programme (project "FishMPABlue2" - European Regional Development Fund -ERDF)	This work was supported by the Italian Ministry of Research (PRIN project #2008E7KBAE), the European Commission, Directorate General for Maritime Affairs and Fisheries (grant SI2.721708 "Marine protected areas: network(s) for enhancement of sustainable fisheries in EU Mediterranean waters" (MARE/2014/41)), and the Interreg MED Programme (project "FishMPABlue2" co-financed by the European Regional Development Fund -ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P23; [Anonymous], 2013, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0079889; Aspillaga E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159813; Bennett NJ, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12640; Bevacqua D, 2011, OECOLOGIA, V165, P333, DOI 10.1007/s00442-010-1727-9; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calo A., 2013, ADV OCEANOGR LIMNOL, V4, P150, DOI DOI 10.1080/19475721.2013.840680; Casagrandi R, 1999, NATURE, V400, P560, DOI 10.1038/23020; CHARNOV EL, 1986, OIKOS, V47, P129, DOI 10.2307/3566037; Clark C.W., 2010, MATH BIOECONOMICS MA, V91; Clark F, 2010, METHODS ECOL EVOL, V1, P253, DOI 10.1111/j.2041-210X.2010.00029.x; Coulson T, 2008, ECOLOGY, V89, P1661, DOI 10.1890/07-1099.1; de Valpine P, 2002, B MAR SCI, V70, P455; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Di Franco A, 2013, J SEA RES, V76, P73, DOI 10.1016/j.seares.2012.11.006; Di Franco A, 2018, BIOL CONSERV, V221, P175, DOI 10.1016/j.biocon.2018.03.012; Di Franco A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38135; Di Franco A, 2015, BIOL CONSERV, V192, P361, DOI 10.1016/j.biocon.2015.10.015; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052108; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031681; Di Lorenzo M, 2016, J NAT CONSERV, V32, P62, DOI 10.1016/j.jnc.2016.04.004; Di Lorenzo M, 2014, MAR ECOL PROG SER, V502, P245, DOI 10.3354/meps10723; Di Natale A, 1989, T GUACETO INDAGINI P; Figueiredo M, 2005, FISH RES, V75, P107, DOI 10.1016/j.fishres.2005.04.013; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Froese R., 2016, EXPLOITATION STATUS; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Garcia-Rubies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073922; Gardmark A, 2006, J APPL ECOL, V43, P61, DOI 10.1111/j.1365-2664.2005.01104.x; Gerber LR, 2003, ECOL APPL, V13, pS47; Giacalone VM, 2018, CAH BIOL MAR, V59, P421, DOI 10.21411/CBM.A.7C19C1B8; Giakoumi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08850-w; Gordoa A, 1997, FISH RES, V33, P123, DOI 10.1016/S0165-7836(97)00074-X; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2007, CONSERV BIOL, V21, P540, DOI 10.1111/j.1523-1739.2007.00657.x; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Guidetti P, 2010, CONSERV BIOL, V24, P312, DOI 10.1111/j.1523-1739.2009.01358.x; Jahnke M, 2017, DIVERS DISTRIB, V23, P1423, DOI 10.1111/ddi.12633; Knape J, 2012, ECOL LETT, V15, P17, DOI 10.1111/j.1461-0248.2011.01702.x; Knape J, 2008, ECOLOGY, V89, P2994, DOI 10.1890/08-0071.1; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Legrand T, 2019, MAR ENVIRON RES, V151, DOI 10.1016/j.marenvres.2019.104761; Lenfant P, 2003, CR BIOL, V326, P751, DOI 10.1016/S1631-0691(03)00168-9; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Lloret J, 2019, ICES J MAR SCI, DOI [10.1093/icesimstisz071, DOI 10.1093/ICESIMS/FSZ071]; Lorenzen K, 2002, P ROY SOC LOND B BIO, P269; Lubchenco J, 2010, OCEANOGRAPHY, V23, P115, DOI 10.5670/oceanog.2010.55; Macpherson E, 1997, MAR ECOL PROG SER, V160, P135, DOI 10.3354/meps160135; Mahmoud Hatem H., 2010, Egyptian Journal of Aquatic Research, V36, P123; Melia P, 2017, MANAGEMENT MARINE PR, P125; Melia P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23705; Melia P, 2012, FISH RES, V117, P130, DOI 10.1016/j.fishres.2011.05.011; Myers RA, 2001, ICES J MAR SCI, V58, P937, DOI 10.1006/jmsc.2001.1109; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; Pajuelo JG, 2004, J APPL ICHTHYOL, V20, P15, DOI 10.1046/j.0175-8659.2003.00540.x; Paterno M, 2017, ECOL EVOL, V7, P2463, DOI 10.1002/ece3.2844; Planes S, 1998, OIKOS, V83, P293, DOI 10.2307/3546840; Prato G., 2013, ADV OCEANOGR LIMNOL, V4, P176, DOI DOI 10.1080/19475721.2013.841754; Pujolar JM, 2013, DIVERS DISTRIB, V19, P1531, DOI 10.1111/ddi.12114; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Schiavina M, 2014, MOL ECOL, V23, P5496, DOI 10.1111/mec.12956; Shelton AO, 2011, P NATL ACAD SCI USA, V108, P7075, DOI 10.1073/pnas.1100334108; Sibly RM, 2002, PHILOS TRANS R SOC L, P357; St Mary CM, 2000, B MAR SCI, V66, P675; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379	70	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228604	10.1371/journal.pone.0228604	http://dx.doi.org/10.1371/journal.pone.0228604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012196	gold, Green Published			2022-12-26	WOS:000534615800042
J	Erwin, S; Foster, DM; Jacob, ME; Papich, MG; Lanzas, C				Erwin, Samantha; Foster, Derek M.; Jacob, Megan E.; Papich, Mark G.; Lanzas, Cristina			The effect of enrofloxacin on enteric Escherichia coli: Fitting a mathematical model to in vivo data	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SELECTION; PHARMACOKINETICS; VETERINARY; SALMONELLA; PATHOGENS; CEFTIOFUR; BACTERIA; IMPACTS	Antimicrobial drugs administered systemically may cause the emergence and dissemination of antimicrobial resistance among enteric bacteria. To develop logical, research-based recommendations for food animal veterinarians, we must understand how to maximize antimicrobial drug efficacy while minimizing risk of antimicrobial resistance. Our objective is to evaluate the effect of two approved dosing regimens of enrofloxacin (a single high dose or three low doses) on Escherichia coli in cattle. We look specifically at bacteria above and below the epidemiological cutoff (ECOFF), above which the bacteria are likely to have an acquired or mutational resistance to enrofloxacin. We developed a differential equation model for the antimicrobial drug concentrations in plasma and colon, and bacteria populations in the feces. The model was fit to animal data of drug concentrations in the plasma and colon obtained using ultrafiltration probes. Fecal E. coli counts and minimum inhibitory concentrations were measured for the week after receiving the antimicrobial drug. We predict that the antimicrobial susceptibility of the bacteria above the ECOFF pre-treatment strongly affects the composition of the bacteria following treatment. Faster removal of the antimicrobial drugs from the colon throughout the study leads to improved clearance of bacteria above the ECOFF in the low dose regimen. If we assume a fitness cost is associated with bacteria above the ECOFF, the increased fitness costs leads to reduction of bacteria above the ECOFF in the low dose study. These results suggest the initial E. coli susceptibility is a strong indicator of how steers respond to antimicrobial drug treatment.	[Erwin, Samantha; Foster, Derek M.; Jacob, Megan E.; Lanzas, Cristina] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Papich, Mark G.] North Carolina State Univ, Coll Vet Med, Dept Mol & Biomed Sci, Raleigh, NC USA; [Erwin, Samantha] Oak Ridge Natl Lab, Biomed Sci Engn & Comp Grp, POB 2009, Oak Ridge, TN 37830 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Erwin, S (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.; Erwin, S (corresponding author), Oak Ridge Natl Lab, Biomed Sci Engn & Comp Grp, POB 2009, Oak Ridge, TN 37830 USA.	erwinsh@ornl.gov	Erwin, Samantha/AAK-8865-2021	Erwin, Samantha/0000-0002-5162-4193	U.S. National Institute of Health (NIH) [R01GM117618]; Bayer Animal Health	U.S. National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer Animal Health(Bayer AG)	SE and CL were partially supported by U.S. National Institute of Health (NIH) grant R01GM117618 as part of the joint National Science Foundation-NIH-United States Department of Agriculture Ecology and Evolution of Infectious Disease program. DMF, MGP and MEJ have received research support from Bayer Animal Health, the manufacturer of enrofloxacin. MGP has also performed consulting activities for Bayer	Ahmad A, 2015, ANTIMICROB AGENTS CH, V59, P1639, DOI 10.1128/AAC.03919-14; Alvarez AI, 2008, J PHARM SCI-US, V97, P3483, DOI 10.1002/jps.21233; Aslam M, 2004, LETT APPL MICROBIOL, V39, P523, DOI 10.1111/j.1472-765X.2004.01620.x; Bertrand I, 2018, SENSITIVITY GLOBAL S; Cazer CL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01753; Chantziaras I, 2017, J ANTIMICROB CHEMOTH, V72, P1991, DOI 10.1093/jac/dkx104; Clinical Institute LS, 2018, PERF STAND ANT DISK; Collignon PC, 2016, CLIN INFECT DIS, V63, P1087, DOI 10.1093/cid/ciw475; Daniels JB, 2009, APPL ENVIRON MICROB, V75, P3648, DOI 10.1128/AEM.02435-08; Day T, 2015, TRENDS MICROBIOL, V23, P126, DOI 10.1016/j.tim.2015.01.005; Delyon B, 1999, ANN STAT, V27, P94; Donskey CJ, 2004, ANTIMICROB AGENTS CH, V48, P326, DOI 10.1128/AAC.48.1.326-328.2004; Doyle ME, 2015, FOODBORNE PATHOG DIS, V12, P261, DOI 10.1089/fpd.2014.1865; Ferguson KM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02190; Foster DM, 2016, J VET PHARMACOL THER, V39, P62, DOI 10.1111/jvp.12236; Giguere S, 2013, ANTIMICROBIAL THERAPY IN VETERINARY MEDICINE, 5TH EDITION, P1; Grobbel M, 2007, VET MICROBIOL, V124, P73, DOI 10.1016/j.vetmic.2007.03.017; KAARTINEN L, 1995, J VET PHARMACOL THER, V18, P357, DOI 10.1111/j.1365-2885.1995.tb00604.x; Kariuki S, 2015, VACCINE, V33, pS21, DOI 10.1016/j.vaccine.2015.03.102; Lanzas C, 2011, FOODBORNE PATHOG DIS, V8, P1, DOI 10.1089/fpd.2010.0643; Marcusson LL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000541; Massot M, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/aem.00659-17, 10.1128/AEM.00659-17]; McDermott PF, 2002, J INFECT DIS, V185, P837, DOI 10.1086/339195; Mentre F, 1995, J Biopharm Stat, V5, P141, DOI 10.1080/10543409508835104; Meshkat N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110261; Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007; Riviere J. E., 2018, VET PHARM THERAPEUTI, V10th; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Shryock TR, 2010, ANN NY ACAD SCI, V1213, P92, DOI 10.1111/j.1749-6632.2010.05788.x; Ternent L, 2015, J THEOR BIOL, V372, P1, DOI 10.1016/j.jtbi.2015.02.011; Ternhag A, 2007, CLIN INFECT DIS, V44, P696, DOI 10.1086/509924; Volkova VV, 2016, FOODBORNE PATHOG DIS, V13, P610, DOI 10.1089/fpd.2016.2152; Volkova VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036738; Wiuff C, 2003, RES VET SCI, V75, P185, DOI 10.1016/S0034-5288(03)00112-7	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228138	10.1371/journal.pone.0228138	http://dx.doi.org/10.1371/journal.pone.0228138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004337	Green Published, Green Submitted, gold			2022-12-26	WOS:000534614600020
J	Kwon, MJ; Lee, KY; Ham, WG; Tak, LJ; Agrahari, G; Kim, TY				Kwon, Myung-Ja; Lee, Kyo-Young; Ham, Won-Gug; Tak, Lee-Jung; Agrahari, Gaurav; Kim, Tae-Yoon			Pathologic properties of SOD3 variant R213G in the cardiovascular system through the altered neutrophils function	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; COLONY-STIMULATING FACTOR; BONE-MARROW; EC-SOD; IMMUNE-RESPONSES; G-CSF; INFLAMMATION; INHIBITION; HEPARIN; SERUM	The SOD3 variant, SOD3(R213G), results from substitution of arginine to glycine at amino acid 213 (R213G) in its heparin binding domain (HBD) and is a common genetic variant, reported to be associated with ischemic heart disease. However, little is understood about the role of SOD3(R213G) in innate immune function, and how it leads to dysfunction of the cardiovascular system. We observed pathologic changes in SOD3(R213G) transgenic (Tg) mice, including cystic medial degeneration of the aorta, heart inflammation, and increased circulating and organ infiltrating neutrophils. Interestingly, SOD3(R213G) altered the profile of SOD3 interacting proteins in neutrophils in response to G-CSF. Unexpectedly, we found that G-CSF mediated tyrosine phosphatase, SH-PTP1 was down-regulated in the neutrophils of SOD3(R213G) overexpressing mice. These effects were recovered by reconstitution with Wt SOD3 expressing bone marrow cells. Overall, our study reveals that SOD3(R213G) plays a crucial role in the function of the cardiovascular system by controlling innate immune response and signaling. These results suggest that reconstitution with SOD3 expressing bone marrow cells may be a therapeutic strategy to treat SOD3(R213G) mediated diseases.	[Kwon, Myung-Ja; Ham, Won-Gug; Tak, Lee-Jung; Agrahari, Gaurav; Kim, Tae-Yoon] Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Dept Dermatol, Seoul, South Korea; [Lee, Kyo-Young] Catholic Univ Korea, Coll Med, Dept Hosp Pathol, 222 Banpo Dong, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, TY (corresponding author), Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Dept Dermatol, Seoul, South Korea.	tykimder@catholic.ac.kr		Lee, Kyo-Young/0000-0001-9954-8583	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government, MSIP [NRF-2016M3A9B6903020]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government, MSIP(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	The research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government, MSIP(NRF-2016M3A9B6903020).	Abe T, 1993, Kokyu To Junkan, V41, P308; Adachi T, 1996, BIOCHEM J, V313, P235, DOI 10.1042/bj3130235; ADACHI T, 1992, CLIN CHIM ACTA, V212, P89, DOI 10.1016/0009-8981(92)90176-Q; Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bowler RP, 2004, AM J RESP CELL MOL, V31, P432, DOI 10.1165/rcmb.2004-0057OC; Bowler RP, 2001, AM J RESP CRIT CARE, V164, P290, DOI 10.1164/ajrccm.164.2.2011054; Break TJ, 2012, J IMMUNOL, V188, P3342, DOI 10.4049/jimmunol.1102341; Chu Y, 2005, CIRCULATION, V112, P1047, DOI 10.1161/CIRCULATIONAHA.104.531251; Dong F, 2000, BLOOD, V95, P1656, DOI 10.1182/blood.V95.5.1656.005k29_1656_1662; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FOLZ RJ, 1994, GENOMICS, V22, P162, DOI 10.1006/geno.1994.1357; FOLZ RJ, 1994, HUM MOL GENET, V3, P2251, DOI 10.1093/hmg/3.12.2251; Gaurav R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95072; Hoyer FF, 2017, EUR HEART J, V38, P465, DOI 10.1093/eurheartj/ehx017; Iversen MB, 2016, FREE RADICAL BIO MED, V97, P478, DOI 10.1016/j.freeradbiomed.2016.07.004; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Juul K, 2004, CIRCULATION, V109, P59, DOI 10.1161/01.CIR.0000105720.28086.6C; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KAWAKAMI M, 1990, BLOOD, V76, P1962; Kobylecki CJ, 2015, EBIOMEDICINE, V2, P2010, DOI 10.1016/j.ebiom.2015.11.026; Kwon MJ, 2015, ANTIOXID REDOX SIGN, V23, P985, DOI 10.1089/ars.2014.6035; Kwon MJ, 2012, ANTIOXID REDOX SIGN, V17, P1376, DOI 10.1089/ars.2012.4572; Kwon MJ, 2012, J DERMATOL SCI, V67, P81, DOI 10.1016/j.jdermsci.2012.06.003; Kwon MJ, 2012, ANTIOXID REDOX SIGN, V16, P297, DOI 10.1089/ars.2011.4066; Laukkanen MO, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3612589; LIESCHKE GJ, 1994, BLOOD, V84, P27; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lund DD, 2007, J PHYSIOL-LONDON, V584, P583, DOI 10.1113/jphysiol.2007.140830; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Marklund SL, 1997, J INTERN MED, V242, P5, DOI 10.1046/j.1365-2796.1997.00160.x; MARKLUND SL, 1982, CLIN CHIM ACTA, V126, P41, DOI 10.1016/0009-8981(82)90360-6; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; OURY TD, 1994, LAB INVEST, V70, P889; Oury TD, 1996, FREE RADICAL BIO MED, V20, P957, DOI 10.1016/0891-5849(95)02222-8; Petersen SV, 2005, BIOCHEM J, V385, P427, DOI 10.1042/BJ20041218; Rausch O, 1997, MOL CELL BIOL, V17, P1170, DOI 10.1128/MCB.17.3.1170; SANDSTROM J, 1994, J BIOL CHEM, V269, P19163; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; STRALIN P, 1995, ARTERIOSCL THROM VAS, V15, P2032, DOI 10.1161/01.ATV.15.11.2032; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; Yan B, 2014, J IMMUNOL, V192, P5998, DOI 10.4049/jimmunol.1301645; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0227449	10.1371/journal.pone.0227449	http://dx.doi.org/10.1371/journal.pone.0227449			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004354	gold, Green Published			2022-12-26	WOS:000534614600006
J	Fang, CL; Huang, H; Guo, J; Ferianc, M; Xu, ZJ				Fang, Chuling; Huang, Hui; Guo, Jian; Ferianc, Martin; Xu, Zuojun			Real-world experiences: Efficacy and tolerability of pirfenidone in clinical practice	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; INTERSTITIAL LUNG-DISEASE; BODY-MASS INDEX; NUTRITIONAL-STATUS; CIGARETTE-SMOKING; OPEN-LABEL; HYPERTENSION; SCLERODERMA; SURVIVAL; SAFETY	Background The safety of pirfenidone on pulmonary fibrosis patients with other kinds of interstitial lung diseases (ILDs) in addition to idiopathic pulmonary fibrosis (IPF) is unknown. Furthermore, its effectiveness- related factors on IPF patients are not quite explored. Methods A retrospective study, on patients prescribed pirfenidone for pulmonary fibrosis, was conducted to assess effectiveness on IPF patients and tolerability of all patients with lung fibrosis. The effectiveness of pirfenidone was tested on 110 IPF subjects receiving treatment for >= 3 months by high-resolution computed tomography (HRCT). Response-linked factors and progression-free survival (PFS) were also analyzed. The data about safety outcomes and drug dose adjustments were collected from all included subjects. Results A total of 176 subjects were included: 117 were IPF, 19 connective tissue disease-associated interstitial lung disease (CTD-ILD), and 40 unclassifiable ILD. Out of the 110 IPF subjects, 89 subjects were assessed as stable and 21 as progressive, out of which 10 died of acute exacerbation and 11 progressed. The effectiveness was significantly related to their baseline body mass index (BMI). IPF subjects with BMI> 25kg/m(2) or diffusion capacity of carbon monoxide (DLco)> 30% had higher PFS rate. The most common adverse events were skin-related and gastrointestinal-related. Drug discontinuation owing to adverse events occurred similarly in these three groups. Conclusion Pirfenidone was well tolerated in most of the lung fibrosis patients besides IPF, with a similar pattern of adverse events. Nearly 80% of IPF subjects were assessed as stable. More benefits were seen in IPF patients with higher BMI or mild-to-moderate disease.	[Fang, Chuling; Huang, Hui; Guo, Jian; Xu, Zuojun] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp Med, Beijing, Peoples R China; [Ferianc, Martin] UCL, Elect & Elect Engn Dept, London, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; University of London; University College London	Xu, ZJ (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp Med, Beijing, Peoples R China.	xuzj@hotmail.com			National Key Technologies R&D Program Precision Medicine Research [2016YFC0905700]; National Natural Science Foundation of China [81670061]	National Key Technologies R&D Program Precision Medicine Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research leading to these results has received funding from National Key Technologies R&D Program Precision Medicine Research (No.2016YFC0905700) and the National Natural Science Foundation of China (No.81670061) to ZX. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakhras M, 2007, CHEST, V131, P1448, DOI 10.1378/chest.06-2784; Antoniou KM, 2008, AM J RESP CRIT CARE, V177, P190, DOI 10.1164/rccm.200612-1759OC; Baumgartner KB, 1997, AM J RESP CRIT CARE, V155, P242, DOI 10.1164/ajrccm.155.1.9001319; Castria D, 2012, INT J IMMUNOPATH PH, V25, P681, DOI 10.1177/039463201202500314; Costabel U, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1021-2; Costabel U, 2017, RESPIRATION, V94, P408, DOI 10.1159/000479976; Galli JA, 2017, RESPIROLOGY, V22, P1171, DOI 10.1111/resp.13024; Guler SA, 2018, CURR OPIN PULM MED, V24, P461, DOI 10.1097/MCP.0000000000000509; Huang H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004113; Huang H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001600; Jo HE, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0575-y; Judge EP, 2012, EUR RESPIR J, V40, P93, DOI 10.1183/09031936.00115511; Khanna D, 2016, J RHEUMATOL, V43, P1672, DOI 10.3899/jrheum.151322; Khanna D, 2011, ARTHRITIS RHEUM-US, V63, P3078, DOI 10.1002/art.30467; Kim JH, 2012, TUBERC RESPIR DIS, V73, P162, DOI 10.4046/trd.2012.73.3.162; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kolb M, 2017, RESP MED, V131, P49, DOI 10.1016/j.rmed.2017.07.062; Konstan MW, 2003, J PEDIATR-US, V142, P624, DOI 10.1067/mpd.2003.152; Lancaster L, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2015-000105; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Li T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33226; Miura Y, 2014, SARCOIDOSIS VASC DIF, V31, P235; Miyata S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-42; Nadrous HF, 2005, CHEST, V128, P2393, DOI 10.1378/chest.128.4.2393; Nathan SD, 2019, RESP MED, V153, P44, DOI 10.1016/j.rmed.2019.04.016; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Ogura T, 2015, RESPIR INVESTIG, V53, P232, DOI 10.1016/j.resinv.2015.06.001; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Savino W, 2002, EUR J CLIN NUTR, V56, pS46, DOI 10.1038/sj.ejcn.1601485; Schaefer CJ, 2011, EUR RESPIR REV, V20, P85, DOI 10.1183/09059180.00001111; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Valapour M, 2018, AM J TRANSPLANT, V18, P363, DOI 10.1111/ajt.14562; Ye Q, 2014, CHINESE MED J-PEKING, V127, P469, DOI 10.3760/cma.j.issn.0366-6999.20131684; Yen EH, 2013, J PEDIATR-US, V162, P530, DOI 10.1016/j.jpeds.2012.08.040; Yoon HY, 2019, RESPIRATION, V97, P242, DOI 10.1159/000492937	41	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228390	10.1371/journal.pone.0228390	http://dx.doi.org/10.1371/journal.pone.0228390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999801	Green Published, gold			2022-12-26	WOS:000534612400075
J	Muratore, M; Prather, C; Sun, Y				Muratore, Melani; Prather, Chelse; Sun, Yvonne			The gut bacterial communities across six grasshopper species from a coastal tallgrass prairie	PLOS ONE			English	Review							LARVAE TENEBRIO-MOLITOR; HOST; DIVERSITY; TRANSMISSION; MICROBIOME; SYMBIONTS; PREDATION; DYNAMICS	Insect microbiomes play an important role in the health and fitness of insect hosts by contributing to nutrient absorption, immune health, and overall ecological fitness. As such, research interests in insect microbiomes have focused on agriculturally and industrially important organisms such as honey bees and termites. Orthopterans, on the other hand, have not been well explored for their resident microbial communities. Grasshoppers are an integral part of grassland ecosystems and provide important ecosystem services. Conversely, grasshoppers can be an agricultural pest requiring management with broad spectrum pesticides. However, little is known about the microbiomes of grasshoppers and their potential contribution to grasshopper biology. Here we examine the gut microbiome of six species of grasshoppers (n = 60) from a coastal tallgrass prairie ecosystem to gain a better understanding of the microbial communities present across the orthopteran order in this ecosystem. We found that there are bacterial phyla common to all six grasshopper species: Actinobacteria, Proteobacteria, Firmicutes, and to a lesser degree, Tenericutes. Although the grasshopper species shared a high relative abundance of these groups, there were notable shifts in dominant phyla depending on the grasshopper species. Moreover, measures of alpha diversity revealed a more diverse microbiome in males than females. Our observations support the hypothesis that there is a "core" group of bacterial families in these grasshopper species and factors such as trophic behaviors and the evolution of the host may contribute to the shifts in prevalence among these core microbial groups.	[Muratore, Melani; Prather, Chelse; Sun, Yvonne] Univ Dayton, Dept Biol, Dayton, OH 45469 USA	University of Dayton	Sun, Y (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.	ysun02@udayton.edu			STEM Catalyst Grant; University of Dayton; University of Dayton Graduate Student Summer Fellowship; NSF [1457114, 1724663]	STEM Catalyst Grant; University of Dayton; University of Dayton Graduate Student Summer Fellowship; NSF(National Science Foundation (NSF))	This work was supported by the STEM Catalyst Grant (CP and YS) and the Keck Environmental Fellowship (MM) from the University of Dayton. MMwas also supported by the University of Dayton Graduate Student Summer Fellowship. Grasshoppers were collected from a study funded by NSF to CP (DEB #1457114 and #1724663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar ED, 2011, ARCH MICROBIOL, V193, P35, DOI 10.1007/s00203-010-0637-x; Anjum SI, 2018, SAUDI J BIOL SCI, V25, P388, DOI 10.1016/j.sjbs.2017.05.008; Baldi A, 1997, AGR ECOSYST ENVIRON, V66, P121, DOI 10.1016/S0167-8809(97)00068-6; Branson DH, 2006, BIOSCIENCE, V56, P743, DOI 10.1641/0006-3568(2006)56[743:SMOIHI]2.0.CO;2; Branson DH, 2009, RESTOR ECOL, V17, P89, DOI 10.1111/j.1526-100X.2007.00343.x; Branson DH, 2005, ENVIRON ENTOMOL, V34, P1114, DOI 10.1603/0046-225X(2005)034[1114:DAIEOA]2.0.CO;2; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29505; Chiara M, 2015, GENOME BIOL EVOL, V7, P2154, DOI 10.1093/gbe/evv131; de Vries EJ, 2004, P ROY SOC B-BIOL SCI, V271, P2171, DOI 10.1098/rspb.2004.2817; Dillon R, 2002, RES MICROBIOL, V153, P503, DOI 10.1016/S0923-2508(02)01361-X; Engel P, 2016, MBIO, V7, DOI 10.1128/mBio.02164-15; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gai CS, 2009, J MICROBIOL, V47, P448, DOI 10.1007/s12275-008-0303-z; Grabowski NT, 2017, FOOD SCI TECHNOL INT, V23, P17, DOI 10.1177/1082013216652994; Gupta RS, 2018, ANTON LEEUW INT J G, V111, P1583, DOI 10.1007/s10482-018-1047-3; Hammer TJ, 2017, P NATL ACAD SCI USA, V114, P9641, DOI 10.1073/pnas.1707186114; Hammer TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086995; Hansen AK, 2014, MOL ECOL, V23, P1473, DOI 10.1111/mec.12421; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Heck M, 2018, MSYSTEMS, V3, DOI [10.1128/msystems.00168-17, 10.1128/mSystems.00168-17]; Heys C, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00029; Johnson EL, 2017, J MOL MED, V95, P1, DOI 10.1007/s00109-016-1492-2; Jones JC, 2018, INSECT SOC, V65, P419, DOI 10.1007/s00040-018-0624-9; Kaltenpoth M, 2009, FEMS MICROBIOL ECOL, V69, P373, DOI 10.1111/j.1574-6941.2009.00722.x; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Kochi Y, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw163; Kwong WK, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600513; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Lugli GA, 2018, APPL ENV MICROBIOL, V84; Lukasik P, 2017, MOL ECOL, V26, P3808, DOI 10.1111/mec.14140; Mansfield BE, 2003, CELL MICROBIOL, V5, P901, DOI 10.1046/j.1462-5822.2003.00329.x; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; McLauchlin J., 2014, PROKARYOTES FIRMICUT, P241; Moeller AH, 2018, SCIENCE, V362, P453, DOI 10.1126/science.aat7164; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Nadarasah G, 2011, FEMS MICROBIOL REV, V35, P555, DOI 10.1111/j.1574-6976.2011.00264.x; Ng'ang'a J, 2019, J FOOD SAFETY, V39, DOI 10.1111/jfs.12549; Oksanen J., 2015, MULTIVARIATE ANAL EC; OOI MC, 2017, FEMS MICROBIOL ECOL, V93, DOI DOI 10.1016/J.CELL.2017.09.016; Pandey N, 2013, ENVIRON ENTOMOL, V42, P1257, DOI 10.1603/EN13110; Parfrey LW, 2018, MOL ECOL, V27, P1749, DOI 10.1111/mec.14706; Parker KD, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01598; Pava-Ripoll M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0478-5; Prather C, 2017, SOIL BIOL BIOCHEM, V112, P277, DOI 10.1016/j.soilbio.2017.05.013; Prather CM, 2018, ECOL LETT, V21, P1467, DOI 10.1111/ele.13127; Ravenscraft A, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1346; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Salem H, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2957; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shukla SP, 2018, MOL ECOL, V27, P1980, DOI 10.1111/mec.14269; Simothy L, 2018, AIMS MICROBIOL, V4, P319, DOI 10.3934/microbiol.2018.2.319; Smith CC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00801; Squitier JM, 2002, FLA ENTOMOL, V85, P336, DOI 10.1653/0015-4040(2002)085[0336:HSBGOA]2.0.CO;2; Stoops J, 2016, FOOD MICROBIOL, V53, P122, DOI 10.1016/j.fm.2015.09.010; van Schooten B, 2018, PEERJ, V6, DOI 10.7717/peerj.5502; Vandeweyer D, 2017, INT J FOOD MICROBIOL, V242, P13, DOI 10.1016/j.ijfoodmicro.2016.11.007; Vandeweyer D, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/aem.00255-18, 10.1128/AEM.00255-18]; Voirol LRP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00556; Walker T. J., 2004, FIELD GUIDE GRASSHOP; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Weger BD, 2019, CELL METAB, V29, P362, DOI 10.1016/j.cmet.2018.09.023; Wynants E, 2018, FOOD MICROBIOL, V70, P181, DOI 10.1016/j.fm.2017.09.012; Xia XF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00025; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149; Zhang HL, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-37	70	14	15	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228406	10.1371/journal.pone.0228406	http://dx.doi.org/10.1371/journal.pone.0228406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999781	Green Published, gold			2022-12-26	WOS:000534612400079
J	Shi, J; Zhang, L; Mi, J; Gao, XW				Shi, Jing; Zhang, Lan; Mi, Jia; Gao, Xiwu			Role transformation of fecundity and viability: The leading cause of fitness costs associated with beta-cypermethrin resistance in Musca domestica	PLOS ONE			English	Article							HOUSE-FLY; CROSS-RESISTANCE; INSECTICIDE RESISTANCE; PYRETHROID INSECTICIDES; BACILLUS-THURINGIENSIS; METABOLIC RESISTANCE; LAMBDA-CYHALOTHRIN; DIPTERA; L.; POPULATIONS	Fitness is closely associated with the development of pesticide resistance in insects, which determines the control strategies employed to target species and the risks of toxicity faced by non-target species. After years of selections with beta-cypermethrin in laboratory, a strain of housefly was developed that was 684,521.62-fold resistant (CRR) compared with the susceptible strain (CSS). By constructing <= 21 d and <= 30 d life tables, the differences in life history parameters between CSS and CRR were analyzed. The total production numbers of all the detected development stages in CRR were lower than in CSS. Except for the lower mortality of larvae, all the other detected mortalities in CRR were higher than in CSS. female:male and normal females of CRR were also lower than those of CSS. For CRR, the relative fitness was 0.25 in the <= 21 d life table and 0.24 in the <= 30 d life table, and a lower intrinsic rate of increase (rm) and net reproductive rate (R-o) were detected. Based on phenotype correlation and structural equation model (SEM) analyses, fecundity and viability were the only directly positive fitness components affecting fitness in CRR and CSS, and the other components played indirect roles in fitness. The variations of the relationships among fitness, fecundity and viability seemed to be the core issue resulting in fitness differences between CRR and CSS. The interactions among all the detected fitness components and the mating frequency-time curves appeared to be distinctly different between CRR and CSS. In summary, fecundity and its related factors separately played direct and indirect roles in the fitness costs of a highly beta-cypermethrin-resistant housefly strain.	[Shi, Jing] Shanxi Univ, Coll Environm & Resource Sci, Taiyuan, Peoples R China; [Zhang, Lan] Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China; [Mi, Jia] Shanxi Univ, Inst Loess Plateau, Taiyuan, Peoples R China; [Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing, Peoples R China	Shanxi University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Shanxi University; China Agricultural University	Shi, J (corresponding author), Shanxi Univ, Coll Environm & Resource Sci, Taiyuan, Peoples R China.; Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.	shijing@sxu.edu.cn; gaoxiwu@263.net.cn			Applied Basic Research Project of Shanxi Province [201701D221153]; National Basic Research Program of China [2006CB102003]; National Natural Science Foundation of China [30530530, 30571232]	Applied Basic Research Project of Shanxi Province; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Applied Basic Research Project of Shanxi Province (No. 201701D221153), National Basic Research Program of China (No. 2006CB102003) and National Natural Science Foundation of China (Nos 30530530 and 30571232).	Abbas N, 2016, PARASITOL RES, V115, P2073, DOI 10.1007/s00436-016-4952-2; Abbas N, 2015, PARASITOL RES, V114, P2629, DOI 10.1007/s00436-015-4467-2; Abbas N, 2015, PARASITOL RES, V114, P247, DOI 10.1007/s00436-014-4186-0; Alvarez-Gonzalez LC, 2017, PEST MANAG SCI, V73, P2287, DOI 10.1002/ps.4609; Antoninka A, 2009, GLOBAL CHANGE BIOL, V15, P914, DOI 10.1111/j.1365-2486.2008.01760.x; Arnaud L, 2002, EVOLUTION, V56, P2435, DOI 10.1111/j.0014-3820.2002.tb00169.x; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Belinato TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130719; Bernardi O, 2016, PEST MANAG SCI, V72, P1794, DOI 10.1002/ps.4223; Bryant EH, 1999, CONSERV BIOL, V13, P665, DOI 10.1046/j.1523-1739.1999.97518.x; BRYANT EH, 1969, ECOLOGY, V50, P1049, DOI 10.2307/1936896; Cao GC, 2006, PEST MANAG SCI, V62, P746, DOI 10.1002/ps.1234; Cao GC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05629; Chevillon C, 1999, BIOL J LINN SOC, V68, P147, DOI 10.1111/j.1095-8312.1999.tb01163.x; Crespo ALB, 2010, J ECON ENTOMOL, V103, P1386, DOI 10.1603/EC09158; Fenner K, 2013, SCIENCE, V341, P752, DOI 10.1126/science.1236281; Hasan F, 2016, CHEMOSPHERE, V154, P398, DOI 10.1016/j.chemosphere.2016.03.137; Higginson DM, 2005, EVOLUTION, V59, P915, DOI 10.1111/j.0014-3820.2005.tb01765.x; Ingber DA, 2015, J ECON ENTOMOL, V108, P2421, DOI 10.1093/jee/tov199; Jaramillo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096379; Kuijper B, 2006, J EVOLUTION BIOL, V19, P1795, DOI 10.1111/j.1420-9101.2006.01186.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10875; Meffert LM, 1999, J EVOLUTION BIOL, V12, P859, DOI 10.1046/j.1420-9101.1999.00105.x; Pamilo P, 1998, HEREDITY, V81, P381, DOI 10.1046/j.1365-2540.1998.00395.x; Peck GW, 2014, PEST MANAG SCI, V70, P123, DOI 10.1002/ps.3537; Platt N, 2015, HEREDITY, V115, P243, DOI 10.1038/hdy.2015.33; Reed DH, 2005, CONSERV BIOL, V19, P563, DOI 10.1111/j.1523-1739.2005.00444.x; Reed DH, 2004, J EVOLUTION BIOL, V17, P919, DOI 10.1111/j.1420-9101.2004.00718.x; Reed DH, 2001, ZOO BIOL, V20, P145, DOI 10.1002/zoo.1016; Reed DH, 2000, HEREDITY, V85, P115, DOI 10.1046/j.1365-2540.2000.00737.x; Rinkevich FD, 2007, INSECT BIOCHEM MOLEC, V37, P550, DOI 10.1016/j.ibmb.2007.02.013; Rostant WG, 2017, BEHAV GENET, V47, P449, DOI 10.1007/s10519-017-9850-6; Saeed R, 2018, CHEMOSPHERE, V213, P149, DOI 10.1016/j.chemosphere.2018.09.042; Schumacker RE, 2005, ENCY STAT BEHAV SCI, P1941; Scott JG, 2017, PEST MANAG SCI, V73, P716, DOI 10.1002/ps.4328; SCOTT JG, 1985, J ECON ENTOMOL, V78, P316, DOI 10.1093/jee/78.2.316; Shah RM, 2017, PEST MANAG SCI, V73, P254, DOI 10.1002/ps.4296; Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4; TANAKA T, 1990, JPN J GENET, V65, P417, DOI 10.1266/jjg.65.417; Tarapore D, 2010, BEHAV ECOL SOCIOBIOL, V64, P675, DOI 10.1007/s00265-009-0885-4; Taskin V, 2004, RUSS J GENET+, V40, P377, DOI 10.1023/B:RUGE.0000024974.58424.f9; Teseo S, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0917; Tirello P, 2013, CHEMOSPHERE, V93, P1139, DOI 10.1016/j.chemosphere.2013.06.046; Xu QA, 2006, GENE, V379, P62, DOI 10.1016/j.gene.2006.04.013; Zhang L, 2008, PEST MANAG SCI, V64, P185, DOI 10.1002/ps.1510; Zhang L, 2007, PESTIC BIOCHEM PHYS, V89, P65, DOI 10.1016/j.pestbp.2007.03.001; Zhang L, 2010, COMP BIOCHEM PHYS B, V156, P6, DOI 10.1016/j.cbpb.2010.01.011	48	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228268	10.1371/journal.pone.0228268	http://dx.doi.org/10.1371/journal.pone.0228268			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999782	gold, Green Published			2022-12-26	WOS:000534612400061
J	Li, ZL; Zhang, ZL; Ke, LR; Sun, YS; Li, WX; Feng, X; Zhu, W; Chen, SF				Li, Zilun; Zhang, Zili; Ke, Liangru; Sun, Yanshuang; Li, Wenxue; Feng, Xiang; Zhu, Wei; Chen, Sifan			Resveratrol promotes white adipocytes browning and improves metabolic disorders in Sirt1-dependent manner in mice	FASEB JOURNAL			English	Article						adipose tissues; browning; metabolites; obesity; resveratrol; silent information regulator 1	ADIPOSE-TISSUE THERMOGENESIS; INSULIN-RESISTANCE; FAT; OBESITY; SIRT1; SULFOTRANSFERASES; SUPPLEMENTATION; BIOAVAILABILITY; ABSORPTION; ACTIVATION	Obesity has become an epidemic concern in modern society. The chronic obesity is associated with metabolic disorders, such as hyperglycemia, hyperlipidemia, fatty liver, and cadiovascular disease, which cause high risk for mortality. The novel potential strategy to overcome obesity is to "burn out" the extra fat via "browning" of the white adipose tissues. The phytochemical resveratrol (Res) has attracted substantial attention due to its powerful amelioratory effects in metabolic diseases. However, how Res regulates the browning of adipose tissues remains largely elusive. Our data show that the NAD(+)-dependent deacetylase silent information regulator 1 (Sirt1) mediates Res-induced browning and fat reduction of adipocytes, as well as other Res-improved metabolic phenotypes including hyperglycemina and hyperlipidemia in mice. Interestingly, we found that the major metabolites of Res in vivo (Res-3-O-glucuronide, Res-4 '-O-glucuronide, and Res-3-O-sulfate) were much less potent in promoting browning gene expressions and reducing fat content in comparison to Res itself in mouse and human adipocytes in vitro, suggesting the importance and necessarity to enhance the bioavailability of Res in vivo in consideration of therapeutic application. Taken together, our findings clarify the beneficial effects of Res on excess fat utilization via promotion of browning in a Sirt1-dependent manner, suggesting the potential therapeutic application of Res in the treatment of obesity and related metabolic disorders.	[Li, Zilun] Sun Yat Sen Univ, Affiliated Hosp 1, Div Vasc Surg, Guangzhou, Peoples R China; [Zhang, Zili] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Peoples R China; [Ke, Liangru] Sun Yat Sen Univ, Dept Radiol, Canc Ctr, Guangzhou, Peoples R China; [Sun, Yanshuang; Feng, Xiang] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Peoples R China; [Li, Wenxue; Zhu, Wei] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Peoples R China; [Chen, Sifan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, SF (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China.	chensf26@mail.sysu.edu.cn						Alberdi G, 2013, FOOD CHEM, V141, P1530, DOI 10.1016/j.foodchem.2013.03.085; Andreadi C, 2014, AUTOPHAGY, V10, P524, DOI 10.4161/auto.27593; Arias N, 2017, OBESITY, V25, P111, DOI 10.1002/oby.21706; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Blanchard OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090131; Bohmdorfer M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121347; Borrell LN, 2014, AM J PUBLIC HEALTH, V104, P512, DOI 10.2105/AJPH.2013.301597; Calleri E, 2014, CHEMBIOCHEM, V15, P1154, DOI 10.1002/cbic.201300754; Cercato C, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0468-0; Chen SF, 2018, J NUTR BIOCHEM, V55, P209, DOI 10.1016/j.jnutbio.2018.02.007; Chen SF, 2012, J NUTR BIOCHEM, V23, P1100, DOI 10.1016/j.jnutbio.2011.06.003; Chen SF, 2012, CAN J PHYSIOL PHARM, V90, P237, DOI [10.1139/Y11-123, 10.1139/y11-123]; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Colom H, 2011, PHARM RES-DORDR, V28, P1606, DOI 10.1007/s11095-011-0395-8; Das S, 2008, PHARM RES-DORDR, V25, P2593, DOI 10.1007/s11095-008-9677-1; Chu DT, 2017, BIOCHIMIE, V138, P102, DOI 10.1016/j.biochi.2017.04.017; Dong SZ, 2011, MOL CELL BIOCHEM, V358, P281, DOI 10.1007/s11010-011-0978-z; Eseberri I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063918; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23; Johnson JJ, 2011, MOL NUTR FOOD RES, V55, P1169, DOI 10.1002/mnfr.201100117; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lam YY, 2013, EXP GERONTOL, V48, P1018, DOI 10.1016/j.exger.2013.04.005; Liang L, 2013, PHYTOMEDICINE, V20, P558, DOI 10.1016/j.phymed.2012.12.012; Meldrum DR, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.02.104; Mena P, 2018, J AGR FOOD CHEM, V66, P8221, DOI 10.1021/acs.jafc.8b03249; Miksits M, 2005, XENOBIOTICA, V35, P1101, DOI 10.1080/00498250500354253; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Okla M, 2017, ADV NUTR, V8, P473, DOI 10.3945/an.116.014332; Andrade JMO, 2014, EUR J NUTR, V53, P1503, DOI 10.1007/s00394-014-0655-6; Pan Y, 2013, MOL CELL ENDOCRINOL, V367, P116, DOI 10.1016/j.mce.2012.12.027; Park SY, 2016, ONCOL REP, V35, P3248, DOI 10.3892/or.2016.4716; Patel KR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005870; Piche ME, 2018, PROG CARDIOVASC DIS, V61, P103, DOI 10.1016/j.pcad.2018.06.004; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Silvester AJ, 2019, J NUTR BIOCHEM, V64, P1, DOI 10.1016/j.jnutbio.2018.09.028; Soleas GJ, 2001, METHOD ENZYMOL, V335, P145; Springer M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010143; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Timmers S, 2016, DIABETES CARE, V39, P2211, DOI 10.2337/dc16-0499; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Voloshyna I, 2016, EXP BIOL MED, V241, P1611, DOI 10.1177/1535370216647181; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4; Zou TD, 2017, J PHYSIOL-LONDON, V595, P1547, DOI 10.1113/JP273478	50	16	18	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4527	4539		10.1096/fj.201902222R	http://dx.doi.org/10.1096/fj.201902222R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32003501				2022-12-26	WOS:000519218400072
J	Bhandarkar, NS; Mouatt, P; Goncalves, P; Thomas, T; Brown, L; Panchal, SK				Bhandarkar, Nikhil S.; Mouatt, Peter; Goncalves, Priscila; Thomas, Torsten; Brown, Lindsay; Panchal, Sunil K.			Modulation of gut microbiota by spent coffee grounds attenuates diet-induced metabolic syndrome in rats	FASEB JOURNAL			English	Article						gut microbiota; metabolic syndrome; obesity; rats; spent coffee grounds	CHAIN FATTY-ACIDS; HIGH-CARBOHYDRATE; LIPID PROFILE; GREEN COFFEE; OBESITY; WASTE; HEALTH; INDUSTRY; CANCER; OLIGOSACCHARIDES	Coffee brewing produces spent coffee grounds as waste; few studies have investigated the health benefits of these grounds. This study investigated responses to spent coffee grounds in a diet-induced rat model of metabolic syndrome. Male Wistar rats aged 8-9 weeks were fed either corn starch-rich diet or high-carbohydrate, high-fat diet for 16 weeks, which were supplemented with 5% spent coffee grounds during the last 8 weeks. Rats fed non-supplemented diets were used as controls. High-carbohydrate, high-fat diet-fed rats developed metabolic syndrome including abdominal obesity, impaired glucose tolerance, dyslipidemia, and cardiovascular and liver damage. Body weight, abdominal fat, total body fat mass, systolic blood pressure, and concentrations of plasma triglycerides and non-esterified fatty acids were reduced by spent coffee grounds along with improved glucose tolerance and structure and function of heart and liver. Spent coffee grounds increased the diversity of the gut microbiota and decreased the ratio of Firmicutes to Bacteroidetes. Changes in gut microbiota correlated with the reduction in obesity and improvement in glucose tolerance and systolic blood pressure. These findings indicate that intervention with spent coffee grounds may be useful for managing obesity and metabolic syndrome by altering the gut microbiota, thus increasing the value of this food waste.	[Bhandarkar, Nikhil S.; Brown, Lindsay; Panchal, Sunil K.] Univ Southern Queensland, Funct Foods Res Grp, Toowoomba, Qld, Australia; [Bhandarkar, Nikhil S.; Brown, Lindsay] Univ Southern Queensland, Sch Hlth & Wellbeing, Toowoomba, Qld, Australia; [Mouatt, Peter] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia; [Goncalves, Priscila; Thomas, Torsten] Univ New South Wales, Ctr Marine Sci & Innovat, Sydney, NSW, Australia; [Goncalves, Priscila; Thomas, Torsten] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Panchal, Sunil K.] Western Sydney Univ, Sch Sci, Richmond, NSW 2753, Australia; [Bhandarkar, Nikhil S.] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel	University of Southern Queensland; University of Southern Queensland; Southern Cross University; University of New South Wales Sydney; University of New South Wales Sydney; Western Sydney University; Ben Gurion University	Panchal, SK (corresponding author), Western Sydney Univ, Sch Sci, Richmond, NSW 2753, Australia.	S.Panchal@westernsydney.edu.au	Bhandarkar, Nikhil Suresh/AAV-4263-2020	Bhandarkar, Nikhil Suresh/0000-0001-8790-8940	University of Southern Queensland (USQ) [SRF-09]	University of Southern Queensland (USQ)	University of Southern Queensland (USQ), Grant/Award Number: SRF-09	Bekedam EK, 2008, J AGR FOOD CHEM, V56, P7138, DOI 10.1021/jf800999a; Bhandarkar NS, 2019, J FUNCT FOODS, V57, P141, DOI 10.1016/j.jff.2019.04.003; Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002; Bravo J, 2013, FOOD CHEM TOXICOL, V60, P397, DOI 10.1016/j.fct.2013.08.002; Byrne CS, 2015, INT J OBESITY, V39, P1331, DOI 10.1038/ijo.2015.84; Caligiuri SPB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-232; CAMERON A, 2016, COFFEE GROUND RECOVE; Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012; Candela M, 2014, WORLD J GASTROENTERO, V20, P908, DOI 10.3748/wjg.v20.i4.908; Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723; Cervera-Mata A, 2019, FOOD CHEM, V282, P1, DOI 10.1016/j.foodchem.2018.12.101; Choi B, 2017, FOOD SCI BIOTECHNOL, V26, P921, DOI 10.1007/s10068-017-0144-9; Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Coppo E, 2014, CURR PHARM BIOTECHNO, V15, P380, DOI 10.2174/138920101504140825121142; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eteberria U, 2015, J NUTR BIOCHEM, V26, P651, DOI 10.1016/j.jnutbio.2015.01.002; Fan L, 2000, ACTA BIOTECHNOL, V20, P41, DOI 10.1002/abio.370200108; Fernandes AS, 2017, ECOTOX ENVIRON SAFE, V141, P30, DOI 10.1016/j.ecoenv.2017.03.011; Filosa S, 2018, NEURAL REGEN RES, V13, P2055, DOI 10.4103/1673-5374.241429; Fisgativa H, 2017, J ENVIRON MANAGE, V188, P95, DOI 10.1016/j.jenvman.2016.11.058; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Fu XY, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-3; Garcia-Garcia G, 2019, J CLEAN PROD, V211, P1339, DOI 10.1016/j.jclepro.2018.11.269; Guo Z, 2012, CLIN LIPIDOL, V7, P215, DOI 10.2217/CLP.12.8; Harakeh SM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00095; Rodiguez MH, 2018, J ENVIRON CHEM ENG, V6, P1161, DOI 10.1016/j.jece.2017.12.045; *INT COFF ORG, TOT PROD ALL EXP COU; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Karmee SK, 2018, WASTE MANAGE, V72, P240, DOI 10.1016/j.wasman.2017.10.042; Kim J, 2017, BIORESOURCE TECHNOL, V241, P1182, DOI 10.1016/j.biortech.2017.06.012; Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1; Kourmentza C, 2018, J CLEAN PROD, V172, P980, DOI 10.1016/j.jclepro.2017.10.088; Kwon EE, 2013, BIORESOURCE TECHNOL, V136, P475, DOI 10.1016/j.biortech.2013.03.052; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahboobi S, 2018, ADV PHARM BULL, V8, P565, DOI 10.15171/apb.2018.065; Hernandez-Arriaga AM, 2017, FOOD RES INT, V97, P191, DOI 10.1016/j.foodres.2017.04.004; Lopez-Barrera DM, 2016, FOOD CHEM, V212, P282, DOI 10.1016/j.foodchem.2016.05.175; Martinez I, 2013, APPL ENVIRON MICROB, V79, P516, DOI 10.1128/AEM.03046-12; Martinez-Saez N, 2017, FOOD CHEM, V216, P114, DOI 10.1016/j.foodchem.2016.07.173; MCINTYRE A, 1993, GUT, V34, P386, DOI 10.1136/gut.34.3.386; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Mesias M, 2017, CURR OPIN FOOD SCI, V14, P37, DOI 10.1016/j.cofs.2017.01.007; Mohsin GF, 2018, FOOD CHEM, V245, P761, DOI 10.1016/j.foodchem.2017.11.115; Morales FJ, 2012, AMINO ACIDS, V42, P1097, DOI 10.1007/s00726-010-0774-1; Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f; Murugesan S, 2015, EUR J CLIN MICROBIOL, V34, P1337, DOI 10.1007/s10096-015-2355-4; O'Connor S, 2017, MATURITAS, V104, P11, DOI 10.1016/j.maturitas.2017.07.005; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ooi LG, 2010, INT J MOL SCI, V11, P2499, DOI 10.3390/ijms11062499; Oseguera-Castro KY, 2019, FOOD FUNCT, V10, P4546, DOI [10.1039/C9FO01021A, 10.1039/c9fo01021a]; Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013; Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Passos CP, 2019, CARBOHYD POLYM, V214, P53, DOI 10.1016/j.carbpol.2019.02.094; Paun A, 2016, PEDIATR DIABETES, V17, P469, DOI 10.1111/pedi.12424; Perez-Burillo S, 2019, J AGR FOOD CHEM, V67, P2500, DOI 10.1021/acs.jafc.8b06604; Petrik S, 2014, BIOCHEM ENG J, V90, P307, DOI 10.1016/j.bej.2014.06.025; Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024; Rahim MBHA, 2019, ACTA DIABETOL, V56, P493, DOI 10.1007/s00592-019-01312-x; Ramalakshmi K, 2009, FOOD CHEM, V115, P79, DOI 10.1016/j.foodchem.2008.11.063; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ribeiro H, 2013, EUR J LIPID SCI TECH, V115, P330, DOI 10.1002/ejlt.201200239; Ribeiro JP, 2017, ENVIRON SCI POLLUT R, V24, P15270, DOI 10.1007/s11356-017-9134-y; Sales AL, 2020, FOOD FUNCT, V11, P1410, DOI [10.1039/C9FO02589H, 10.1039/c9fo02589h]; Santos C, 2017, WASTE MANAGE, V59, P37, DOI 10.1016/j.wasman.2016.10.020; Schoeler M, 2019, REV ENDOCR METAB DIS, V20, P461, DOI 10.1007/s11154-019-09512-0; Sekar S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46457; Stylianou M, 2018, ENVIRON SCI POLLUT R, V25, P35776, DOI 10.1007/s11356-018-2359-6; Tagliazucchi D, 2015, AMINO ACIDS, V47, P1077, DOI 10.1007/s00726-015-1951-z; Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715; Tian T, 2017, J AGR FOOD CHEM, V65, P2784, DOI 10.1021/acs.jafc.6b04716; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Vazquez-Sanchez K, 2018, FOOD CHEM, V261, P253, DOI 10.1016/j.foodchem.2018.04.064; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wang LL, 2017, FOOD FUNCT, V8, P1966, DOI [10.1039/c7fo00031f, 10.1039/C7FO00031F]; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Wanyonyi S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111261; Wu LF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15904; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	85	14	14	5	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4783	4797		10.1096/fj.201902416RR	http://dx.doi.org/10.1096/fj.201902416RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32039529				2022-12-26	WOS:000512571500001
J	Coombs, GW; Baines, SL; Howden, BP; Swenson, KM; O'Brien, FG				Coombs, Geoffrey W.; Baines, Sarah L.; Howden, Benjamin P.; Swenson, Krister M.; O'Brien, Frances G.			Diversity of bacteriophages encoding Panton-Valentine leukocidin in temporally and geographically related Staphylococcus aureus	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; EPIDEMIC CLONE; PHAGE; INFECTION; SEVERITY; SEQUENCE; DISEASE; GENOME; USA300; STRAIN	Production of the Panton-Valentine leukocidin (PVL) by Staphylococcus aureus is mediated via the genes lukS-PV and lukF-PV which are carried on bacteriophage phi Sa2. PVL is associated with S. aureus strains that cause serious infections and clones of community-associated methicillin-resistant S. aureus (CA-MRSA) that have additionally disseminated widely. In Western Australia (WA) the original CA-MRSA were PVL negative however, between 2005 and 2008, following the introduction of eight international PVL-positive CA-MRSA, PVL-positive WA CA-MRSA were found. There was concern that PVL bacteriophages from the international clones were transferring into the local clones, therefore a comparative study of PVL-carrying phi Sa2 prophage genomes from historic WA PVL-positive S. aureus and representatives of all PVL-positive CA-MRSA isolated in WA between 2005 and 2008 was performed. The prophages were classified into two genera and three PVL bacteriophage groups and had undergone many recombination events during their evolution. Comparative analysis of mosaic regions of selected bacteriophages using the Alignments of bacteriophage genomes (Alpha) aligner revealed novel recombinations and modules. There was heterogeneity in the chromosomal integration sites, the lysogeny regulation regions, the defence and DNA processing modules, the structural and packaging modules and the lukSF-PV genes. One WA CA-MRSA (WA518751) and one international clone (Korean Clone) have probably acquired PVL-carrying phi Sa2 in WA, however these clones did not disseminate in the community. Genetic heterogeneity made it impossible to trace the source of the PVL prophages in the other WA clones. Against this background of PVL prophage diversity, the sequence of one group, the phi Sa2USA/phi Sa2wa-st93 group, was remarkably stable over at least 20 years and associated with the highly virulent USA300 and ST93-IVa CA-MRSA lineages that have disseminated globally.	[Coombs, Geoffrey W.] Murdoch Univ, Antimicrobial Resistance & Infect Dis Res Lab, Murdoch, WA, Australia; [Coombs, Geoffrey W.] Fiona Stanley Hosp, PathWest Lab Med WA, Murdoch, WA, Australia; [Baines, Sarah L.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Doherty Appl Microbial Genom, Melbourne, Vic, Australia; [Howden, Benjamin P.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Microbiol Diagnost Unit,Publ Hlth Lab, Melbourne, Vic, Australia; [Swenson, Krister M.] Univ Montpellier, CNRS, LIRMM, Montpellier, France; [Swenson, Krister M.] IBC Inst Biol Computat, Montpellier, France; [O'Brien, Frances G.] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [O'Brien, Frances G.] Curtin Univ, Sch Pharm & Biomed Sci, Perth, WA, Australia; [O'Brien, Frances G.] Murdoch Univ, Sch Vet Sci & Life Sci, Australian Collaborating Ctr Enterococcus & Staph, Perth, Australia; [O'Brien, Frances G.] Curtin Univ, Sch Pharm & Biomed Sci, Perth, WA, Australia	Murdoch University; University of Melbourne; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Universite de Montpellier; Curtin University; Curtin University; Murdoch University; Curtin University	Coombs, GW (corresponding author), Murdoch Univ, Antimicrobial Resistance & Infect Dis Res Lab, Murdoch, WA, Australia.; Coombs, GW (corresponding author), Fiona Stanley Hosp, PathWest Lab Med WA, Murdoch, WA, Australia.	Geoffrey.Coombs@health.wa.gov.au	Baines, Sarah/AAV-8684-2021	Baines, Sarah/0000-0002-0557-0518; O'Brien, Frances/0000-0003-2429-5408; Coombs, Geoffrey/0000-0003-1635-6506; Howden, Benjamin/0000-0003-0237-1473	Curtin University; Health Department of Western Australia; Health Department of WA	Curtin University; Health Department of Western Australia; Health Department of WA	This work was funded by Curtin University and the Health Department of Western Australia.; This work was funded by grants from the Health Department of WA and Curtin University. The authors would like to acknowledge Tam Le who performed the bacteriophage PVL gene typing and induction experiments, the scientists of the Australian Collaborating Centre for Enterococcus and Staphylococcus Species (ACCESS) Typing and Research for typing the isolates and provision of epidemiological information and Warren Grubb for critical reading of the manuscript.	Adhikari RP, 2002, J ANTIMICROB CHEMOTH, V50, P825, DOI 10.1093/jac/dkf242; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Berard S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0869-5; Boakes E, 2011, J CLIN MICROBIOL, V49, P684, DOI 10.1128/JCM.01917-10; Boakes E, 2012, J CLIN MICROBIOL, V50, P1773, DOI 10.1128/JCM.06421-11; CARROLL D, 1995, MOL MICROBIOL, V16, P877, DOI 10.1111/j.1365-2958.1995.tb02315.x; Coombs GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043037; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; Coombs GW, 2016, W AUSTR METHICILLIN; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Deghorain M, 2012, VIRUSES-BASEL, V4, P3316, DOI 10.3390/v4123316; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dumitrescu O, 2008, J INFECT DIS, V198, P792, DOI 10.1086/590914; El Haddad L, 2013, APPL ENVIRON MICROB, V79, P2828, DOI 10.1128/AEM.03852-12; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Gutierrez D, 2014, ARCH VIROL, V159, P389, DOI 10.1007/s00705-013-1833-1; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X; Kim ES, 2007, J ANTIMICROB CHEMOTH, V60, P1108, DOI 10.1093/jac/dkm309; Kraushaar B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02175-4; Ma XX, 2008, J CLIN MICROBIOL, V46, P3246, DOI 10.1128/JCM.00136-08; McCarthy AJ, 2014, GENOME BIOL EVOL, V6, P2697, DOI 10.1093/gbe/evu214; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; Monecke S, 2009, CLIN MICROBIOL INFEC, V15, P770, DOI 10.1111/j.1469-0691.2009.02792.x; Monecke Stefan, 2013, BMC Res Notes, V6, P548, DOI 10.1186/1756-0500-6-548; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; O'Brien FG, 2009, J ANTIMICROB CHEMOTH, V64, P684, DOI 10.1093/jac/dkp285; O'Brien FG, 1999, J CLIN MICROBIOL, V37, P2858; O'Brien FG, 2004, J CLIN MICROBIOL, V42, P3185, DOI 10.1128/JCM.42.7.3185-3190.2004; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Otter JA, 2010, CLIN MICROBIOL INFEC, V16, P68, DOI 10.1111/j.1469-0691.2009.02925.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shahmirzadi SV, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01404; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Stegger M, 2014, MBIO, V5, DOI 10.1128/mBio.01044-14; Stinear TP, 2014, GENOME BIOL EVOL, V6, P366, DOI 10.1093/gbe/evu022; Strauss L, 2017, P NATL ACAD SCI USA, V114, pE10596, DOI 10.1073/pnas.1702472114; Swenson KM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S15-S17; Tao LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000888; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; van Hal SJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01453; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wehrhahn MC, 2012, J INFECT DIS, V205, P1840, DOI 10.1093/infdis/jis279; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wolter DJ, 2007, CLIN MICROBIOL INFEC, V13, P827, DOI 10.1111/j.1469-0691.2007.01763.x; Yoong P, 2012, INFECT IMMUN, V80, P2894, DOI 10.1128/IAI.06360-11; Zhang M, 2011, FEMS MICROBIOL LETT, V323, P20, DOI 10.1111/j.1574-6968.2011.02355.x	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228676	10.1371/journal.pone.0228676	http://dx.doi.org/10.1371/journal.pone.0228676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040487	Green Published, gold			2022-12-26	WOS:000534629400034
J	Paes, L; Lima, D; Matsuura, C; de Souza, MD; Cyrino, F; Barbosa, C; Ferrao, F; Bottino, D; Bouskela, E; Farinatti, P				Paes, Lorena; Lima, Daniel; Matsuura, Cristiane; de Souza, Maria das Gracas; Cyrino, Fatima; Barbosa, Carolina; Ferrao, Fernanda; Bottino, Daniel; Bouskela, Eliete; Farinatti, Paulo			Effects of moderate and high intensity isocaloric aerobic training upon microvascular reactivity and myocardial oxidative stress in rats	PLOS ONE			English	Article							ENDOTHELIAL FUNCTION; NITRIC-OXIDE; EXERCISE; INTERVAL; FLOW; MICROCIRCULATION; ADAPTATIONS; DYSFUNCTION; BIOMARKERS; DILATION	Systemic and central cardiovascular adaptations may vary in response to chronic exercise performed with different intensities and volumes. This study compared the effects of aerobic training with different intensities but equivalent volume upon microvascular reactivity in cremaster muscle and myocardial biomarkers of oxidative stress in Wistar rats. After peak oxygen uptake (VO2peak) assessment, rats (n = 24) were assigned into three groups: moderateintensity exercise training (MI); high-intensity exercise training (HI); sedentary control (SC). Treadmill training occurred during 4 weeks, with exercise bouts matched by the energy expenditure (3.0-3.5 Kcal). Microvascular reactivity was assessed in vivo by intravital microscopy in cremaster muscle arterioles, while biomarkers of oxidative stress and eNOS expression were quantified at left ventricle and at aorta, respectively. Similar increasing vs. sedentary control group (SC) occurred in moderate intensity training group (MI) and highintensity training group (HI) for endothelium-dependent vasodilation (10-4 M: MI: 168.7%, HI: 164.6% vs. SC: 146.6%, P = 0.0004). Superoxide dismutase (SOD) (HI: 0.13 U/mg vs. MI: 0.09 U/mg and SC: 0.06 U/mg; P = 0.02), glutathione peroxidase (GPX) (HI: 0.00038 U/mg vs. MI: 0.00034 U/mg and SC: 0.00024 U/mg; P = 0.04), and carbonyl protein content (HI: 0.04 U/mg vs. MI: 0.03 U/mg and SC: 0.01 U/mg; P = 0.003) increased only in HI. No difference across groups was detected for catalase (CAT) (P = 0.12), Thiobarbituric acid reactive substances (TBARS) (P = 0.38) or eNOS expression in aorta (P = 0.44). In conclusion, higher exercise intensity induced greater improvements in myocardium antioxidant defenses, while gains in microvascular reactivity appeared to rely more on exercise volume than intensity.	[Paes, Lorena; de Souza, Maria das Gracas; Cyrino, Fatima; Barbosa, Carolina; Ferrao, Fernanda; Bottino, Daniel; Bouskela, Eliete] Univ Estado Rio De Janeiro, Lab Clin & Expt Res Vasc Biol, Rio De Janeiro, RJ, Brazil; [Lima, Daniel; Matsuura, Cristiane] Univ Estado Rio De Janeiro, Dept Pharmacol & Psychobiol, Rio De Janeiro, RJ, Brazil; [Farinatti, Paulo] Univ Estado Rio De Janeiro, Lab Phys Act & Hlth Promot, Rio De Janeiro, RJ, Brazil; [Farinatti, Paulo] Univ Salgado de Oliveira, Grad Program Sci Phys Act, Niteroi, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Salgado de Oliveira	Farinatti, P (corresponding author), Univ Estado Rio De Janeiro, Lab Phys Act & Hlth Promot, Rio De Janeiro, RJ, Brazil.; Farinatti, P (corresponding author), Univ Salgado de Oliveira, Grad Program Sci Phys Act, Niteroi, RJ, Brazil.	paulofarinatti@labsau.org	Lima, Daniel J M Medeiros/AAC-4741-2021; Farinatti, Paulo/AAG-7505-2019	Lima, Daniel J M Medeiros/0000-0003-4930-0533; Farinatti, Paulo/0000-0003-2463-1280; Matsuura, Cristiane/0000-0002-2317-5781				Abularrage CJ, 2005, J VASC SURG, V42, P574, DOI 10.1016/j.jvs.2005.05.019; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Bagher P, 2011, JOVE-J VIS EXP, DOI [10.3791/28742874, DOI 10.3791/28742874]; Barbosa VA, 2012, INT J CARDIOL, V157, P422, DOI 10.1016/j.ijcard.2012.03.153; Battault S, 2016, HYPERTENS RES, V39, P70, DOI 10.1038/hr.2015.114; Bloomer RJ, 2008, ADV CLIN CHEM, V46, P1, DOI 10.1016/S0065-2423(08)00401-0; de Souza MDC, 2016, CLIN HEMORHEOL MICRO, V64, P645, DOI 10.3233/CH-168018; Costa RRS, 2011, MICROVASC RES, V82, P416, DOI 10.1016/j.mvr.2011.08.007; Cunha FA, 2012, EUR J APPL PHYSIOL, V112, P3019, DOI 10.1007/s00421-011-2275-7; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dawson EA, 2013, J APPL PHYSIOL, V115, P1589, DOI 10.1152/japplphysiol.00450.2013; Di Francescomarino S, 2009, SPORTS MED, V39, P797, DOI 10.2165/11317750-000000000-00000; DRAPER HH, 1993, FREE RADICAL BIO MED, V15, P353, DOI 10.1016/0891-5849(93)90035-S; Durrant JR, 2009, J PHYSIOL-LONDON, V587, P3271, DOI 10.1113/jphysiol.2009.169771; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; Goutianos G, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12293; Hallmark R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085450; Haram PM, 2009, CARDIOVASC RES, V81, P723, DOI 10.1093/cvr/cvn332; Hudlicka O, 2011, MLTJ-MUSCLE LIGAMENT, V1, P3; Jasperse JL, 2006, MED SCI SPORT EXER, V38, P445, DOI 10.1249/01.mss.0000191187.24525.f2; Jasperse JL, 1999, J APPL PHYSIOL, V86, P441, DOI 10.1152/jappl.1999.86.2.441; Johnson BD, 2012, EUR J APPL PHYSIOL, V112, P33, DOI 10.1007/s00421-011-1946-8; Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010; LASH JM, 1992, J APPL PHYSIOL, V72, P2052, DOI 10.1152/jappl.1992.72.6.2052; LAUGHLIN MH, 1990, J APPL PHYSIOL, V68, P2337, DOI 10.1152/jappl.1990.68.6.2337; Leite RD, 2012, MICROVASC RES, V84, P94, DOI 10.1016/j.mvr.2012.03.009; Lennon SL, 2004, ACTA PHYSIOL SCAND, V182, P161, DOI 10.1111/j.1365-201X.2004.01346.x; Leong Xin-Fang, 2015, Biomed Res Int, V2015, P528757, DOI 10.1155/2015/528757; Li XC, 2012, J AGR FOOD CHEM, V60, P6418, DOI 10.1021/jf204970r; Liu JK, 2000, J APPL PHYSIOL, V89, P21; Lu K, 2015, MOL MED REP, V12, P2374, DOI 10.3892/mmr.2015.3669; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; McAllister RM, 2008, APPL PHYSIOL NUTR ME, V33, P173, DOI 10.1139/H07-146; McCullough DJ, 2011, J APPL PHYSIOL, V110, P695, DOI 10.1152/japplphysiol.01084.2010; Padilla J, 2011, PHYSIOLOGY, V26, P132, DOI 10.1152/physiol.00052.2010; Paes LS, 2016, BRAZ J MED BIOL RES, V49, DOI [10.1590/1414-431X20165200, 10.1590/1414-431x20165200]; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; POWERS SK, 1993, AM J PHYSIOL, V265, pH2094, DOI 10.1152/ajpheart.1993.265.6.H2094; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Sarelius I, 2010, ACTA PHYSIOL, V199, P349, DOI 10.1111/j.1748-1716.2010.02129.x; Sawyer BJ, 2016, J APPL PHYSIOL, V121, P279, DOI 10.1152/japplphysiol.00024.2016; Sephro D, 2006, MICROVASCULAR RES BI; Trott DW, 2009, J APPL PHYSIOL, V106, P1925, DOI 10.1152/japplphysiol.91232.2008; Wehr Nancy B, 2013, Methods Mol Biol, V965, P265, DOI 10.1007/978-1-62703-239-1_18; Xiang LS, 2005, AM J PHYSIOL-REG I, V288, pR987, DOI 10.1152/ajpregu.00702.2004	48	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0218228	10.1371/journal.pone.0218228	http://dx.doi.org/10.1371/journal.pone.0218228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032358	Green Submitted, Green Published, gold			2022-12-26	WOS:000534626100001
J	Ding, ML; Asim, M; Li, MJ; Abdelkhalik, S; Manore, D; Li, SX; Zhao, H; Lin, LP				Ding Mingliang; Asim, Muhammad; Li Mingju; Abdelkhalik, Sedhom; Manore, Daniel; Li Shaoxiang; Zhao Hong; Lin Liping			Wheat genetic gains for two distinct management schemes in China: An analysis of elite spring type genotypes	PLOS ONE			English	Article							ENVIRONMENT INTERACTION; YIELD; TRIALS; ADAPTATION; EFFICIENCY; STABILITY	The information collected through multi-environment testing of wheat genotypes not only provides basis to identify promising genotypes but also to ascertain their yield potential and the genetic gains. For this purpose, in the presented study, the data originated from the Yunnan provincial Regional Yield Trials (RYT) conducted during 2006 and 2018 was used. During this period, 107 genotypes were evaluated at 18 locations under Upland Wheat (UW) management scheme, while 116 genotypes were evaluated at 21 locations under Field Wheat (FW) management scheme. By adopting standard statistical approaches and through repeated elimination procedures, 7 genotypes emerged as promising for UW and 11 for FW cultivation. These genotypes have genetic variance > 1 and 44/33% higher average yield than that of UW/FW genotypes. Most of these promising genotypes were tested during 2016 and 2018 cropping seasons. This indicated a good genetic gain of around 0.7 t/ha in recent years from that of base year. These genotypes, however, needs to be further evaluated in diverse environments suitable for spring type wheat cultivation to ascertain the extent of their interaction with wider environmental conditions and possibility of using in local breeding programs of those target environments.	[Ding Mingliang; Asim, Muhammad; Abdelkhalik, Sedhom; Manore, Daniel; Li Shaoxiang; Zhao Hong] Yunnan Acad Agr Sci, Inst Food Crops, Kunming, Yunnan, Peoples R China; [Asim, Muhammad] Pakistan Agr Res Council, Plant Sci Div, Islamabad, Pakistan; [Li Mingju] Yunnan Acad Agr Sci, Inst Agr Environm & Resources, Kunming, Yunnan, Peoples R China; [Abdelkhalik, Sedhom] Agr Res Ctr, Field Crops Res Inst, Kaferelsheikh, Egypt; [Manore, Daniel] Wachemo Univ, Coll Agr, Dept Plant Sci, Hosaena, Ethiopia; [Lin Liping] Seed Management Dept Yunnan Prov, Kunming, Yunnan, Peoples R China	Yunnan Academy of Agricultural Sciences; National Agricultural Research Council - Pakistan; Yunnan Academy of Agricultural Sciences; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Asim, M (corresponding author), Yunnan Acad Agr Sci, Inst Food Crops, Kunming, Yunnan, Peoples R China.; Asim, M (corresponding author), Pakistan Agr Res Council, Plant Sci Div, Islamabad, Pakistan.; Li, MJ (corresponding author), Yunnan Acad Agr Sci, Inst Agr Environm & Resources, Kunming, Yunnan, Peoples R China.	asim.muhamed@gmail.com; limingju1996@hotmail.com	lin, liping/HGE-0871-2022; Asim, Muhammad/D-1905-2013; Li, Mingju/AFP-1561-2022	Asim, Muhammad/0000-0003-1696-5117; 	National Key Research and Development Program of China [2018YFD0200500]	National Key Research and Development Program of China	The financial support by The National Key Research and Development Program of China (2018YFD0200500) is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnston A., NOTES CORRES; COOPER M, 1994, THEOR APPL GENET, V88, P561, DOI 10.1007/BF01240919; Curtis R, 2002, USDA FOR SERV PNW RE, P1; FRANCIS TR, 1978, CAN J PLANT SCI, V58, P1029, DOI 10.4141/cjps78-157; Gauch HG, 2006, CROP SCI, V46, P1488, DOI 10.2135/cropsci2005.07-0193; Ghahderijani M., 2013, African Journal of Agricultural Research, V8, P1929; Hu XY, 2015, FIELD CROP RES, V179, P144, DOI 10.1016/j.fcr.2015.04.023; Kleinknecht K, 2016, CROP SCI, V56, P2237, DOI 10.2135/cropsci2015.07.0405; Mingliang D, 2019, IDENTIFICATION PROMI; Peake AS, 2014, FIELD CROP RES, V158, P1, DOI 10.1016/j.fcr.2013.12.001; Piepho HP, 2016, CROP SCI, V56, P2465, DOI 10.2135/cropsci2015.12.0743; Sa'diyah H, 2016, AGRIC AGRIC SCI PROC, V9, P163, DOI 10.1016/j.aaspro.2016.02.113; SHUKLA GK, 1972, HEREDITY, V29, P237, DOI 10.1038/hdy.1972.87; Stone P., 2000, WHEAT ECOLOGY PHYSL, P3; Trethowan R, 2018, FIELD CROP RES, V219, P192, DOI 10.1016/j.fcr.2018.01.021; Volvo PJL, 2018, FIELD CROPS RES, V221, P314, DOI [10.1016/j.fcr.2017.08.014, DOI 10.1016/J.FCR.2017.08.014]; Whitford R, 2013, J EXP BOT, V64, P5411, DOI 10.1093/jxb/ert333; Xu HC, 2018, J INTEGR AGR, V17, P315, DOI [10.1016/S2095-3119(17)61805-7, 10.1016/s2095-3119(17)61805-7]; Yu Y, 2016, PROCEEDINGS OF THE ASME TURBO EXPO: TURBINE TECHNICAL CONFERENCE AND EXPOSITION, 2016, VOL 6; Zeleke KT, 2016, AGR WATER MANAGE, V166, P139, DOI 10.1016/j.agwat.2015.12.016; Zhang HP, 2013, FIELD CROP RES, V144, P77, DOI 10.1016/j.fcr.2013.01.006	21	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228823	10.1371/journal.pone.0228823	http://dx.doi.org/10.1371/journal.pone.0228823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027705	Green Published, gold			2022-12-26	WOS:000534623800075
J	Easley, D; Patacchini, E; Rojas, C				Easley, David; Patacchini, Eleonora; Rojas, Christopher			Multidimensional diffusion processes in dynamic online networks	PLOS ONE			English	Article								We develop a dynamic matched sample estimation algorithm to distinguish peer influence and homophily effects on item adoption decisions in dynamic networks, with numerous items diffusing simultaneously. We infer preferences using a machine learning algorithm applied to previous adoption decisions, and we match agents using those inferred preferences. We show that ignoring previous adoption decisions leads to significantly overestimating the role of peer influence in the diffusion of information, mistakenly confounding influence-based contagion with diffusion driven by common preferences. Our matching-on-preferences algorithm with machine learning reduces the relative effect of peer influence on item adoption decisions in this network significantly more than matching on earlier adoption decisions, as well other observable characteristics. We also show significant and intuitive heterogeneity in the relative effect of peer influence.	[Easley, David; Patacchini, Eleonora; Rojas, Christopher] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA	Cornell University	Rojas, C (corresponding author), Cornell Univ, Dept Econ, Ithaca, NY 14853 USA.	car332@cornell.edu						Anagnostopoulos A., 2008, P 14 ACM SIGKDD INT, P7, DOI DOI 10.1145/1401890.1401897; [Anonymous], 2012, NETWORKS CROWDS MARK; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Athey S., 2019, ESTIMATING TREATMENT, P190207409; Austin PC, 2014, STAT MED, V33, P4306, DOI 10.1002/sim.6276; Bridgewater A., 2019, IMPACT TECH GIANTS O; Cha Meeyoung, 2010, AAAI C WEBL SOC MED, P14; Kasy M, 2017, RISK MACHINE LEARNIN; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mullainathan S, 2017, J ECON PERSPECT, V31, P87, DOI 10.1257/jep.31.2.87; Rubin DB, 2006, MATCHED SAMPLING FOR CAUSAL EFFECTS, P1, DOI 10.2277/ 0521674360; Sharma A, 2016, DISTINGUISHING PERSO; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; SUNDARARAJAN A, 2008, BE J THEOR ECON, V7, P1; Varian HR, 2014, J ECON PERSPECT, V28, P3, DOI 10.1257/jep.28.2.3; Wager S, 2018, J AM STAT ASSOC, V113, P1228, DOI 10.1080/01621459.2017.1319839	20	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228421	10.1371/journal.pone.0228421	http://dx.doi.org/10.1371/journal.pone.0228421			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9GK	32027659	Green Submitted, Green Published, gold			2022-12-26	WOS:000534623800029
J	Phares, CA; Danquah, A; Atiah, K; Agyei, FK; Michael, OT				Phares, Christian Adler; Danquah, Andrews; Atiah, Kofi; Agyei, Frimpong Kwame; Michael, Osei-Tutu			Antibiotics utilization and farmers' knowledge of its effects on soil ecosystem in the coastal drylands of Ghana	PLOS ONE			English	Article							VETERINARY ANTIBIOTICS; LIVESTOCK MANURE; RESISTANCE GENES; TETRACYCLINE; EXPOSURE; GROWTH	Background There is paucity of information on antibiotics utilization amongst farmers, factors associated with administration of antibiotics and farmers' knowledge of the effects of antibiotics on the soil ecosystem in Ghana. Methods A cross sectional quantitative survey across three coastal regions of Ghana was undertaken amongst poultry and livestock farmers. Six hundred respondents were selected from five districts each across the three regions. Pretested and structured questionnaire were used to collect data through face to face interview. Data were summarized using descriptive statistics and regression analysis. Factors associated with antibiotic administration were determined using binary multiple logistic regression at p <= 0.05. Results Out of the 600 farmers, 95% administered antibiotics and 84% bought antibiotics over-the-counter without prescription. Approximately 9% of antibiotic administration was carried out by veterinary officers, and the remaining, 91% based on farmer's experience. Approximately 93% had access to antibiotics without any difficulty. Withdrawal period was always observed by only 16% of farmers. Majority (74%) of farmers never had education on antibiotics and none of the farmers screened manure for the antibiotic residuals. Years of farming, income status, level of education of farmers, type of animal kept, access to extension services, registration with farmers' association, employing veterinary services, location of farm, system of production, education on antibiotics and access to antibiotics positively and significantly predicted the administration of antibiotics by farmers. Majority of farmers had inadequate knowledge of the effects of antibiotics on soil ecosystem with mean score ranging between 2.87 +/- 0.60 and 2.98 +/- 0.7 on a scale of 5.0. Conclusion The study exposed the poor practices regarding antibiotic use and also inadequate knowledge on its effect on the soil ecosystem amongst farmers in Ghana. This calls for development of strategies to increase awareness on antibiotics because its misuse can negatively impact human, animals, environment and impact food security.	[Phares, Christian Adler; Atiah, Kofi; Agyei, Frimpong Kwame] Univ Cape Coast, Dept Soil Sci, Cape Coast, Ghana; [Danquah, Andrews; Michael, Osei-Tutu] Univ Cape Coast, Dept Mol Biol & Biotechnol, Cape Coast, Ghana	University of Cape Coast; University of Cape Coast	Phares, CA (corresponding author), Univ Cape Coast, Dept Soil Sci, Cape Coast, Ghana.	christian.phares@ucc.edu.gh		Phares, Christian Adler/0000-0001-8602-9776; Danquah, Andrews/0000-0002-5542-5968				Adams F., 2015, Journal of Veterinary Medicine and Animal Health, V7, P193; Agyare Christian, 2018, INTEROPEN BOOK SERIE, P1, DOI [10.5772/INTECHOPEN.79371, DOI 10.5772/INTECHOPEN.79371]; Akimenko Y. V., 2015, American Journal of Applied Sciences, V12, P80; Al-Emran HM, 2016, CLIN INFECT DIS, V62, pS42, DOI 10.1093/cid/civ788; [Anonymous], 2017, WHO GUIDELINES USE M; Armar-Klemesu M, 2000, URBAN AGR POLICY AGE, P183; Boamah VE, PRACTICES FACTORS IN; Call JJ, CATION EXCHANGE PROC; Capita R, 2014, APPL ENVIRON MICROB, V80, P1268, DOI 10.1128/AEM.02283-13; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Chauhan AS, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0354-9; Conley TG, 2000, LEARNING NEW TECHNOL; Cycon M, 2019, FRONTIERS MICROBIOLO, P10; Dahshan H, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4218-3; Darko G, 2017, COGENT CHEM, V3, DOI 10.1080/23312009.2017.1343636; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; DeVries SL, 2016, CURR POLLUT REP, V2, P51, DOI 10.1007/s40726-016-0027-3; Hou J, 2015, ENVIRON SCI POLLUT R, V22, P4545, DOI 10.1007/s11356-014-3632-y; Hu XG, 2010, ENVIRON POLLUT, V158, P2992, DOI 10.1016/j.envpol.2010.05.023; Kumaranayake I, 2000, HEALTH POLICY PLANN, V15, P357, DOI 10.1093/heapol/15.4.357; Kyselkova M, 2015, SOIL BIOL BIOCHEM, V81, P259, DOI 10.1016/j.soilbio.2014.11.018; Li YX, 2013, ENVIRON MONIT ASSESS, V185, P2211, DOI 10.1007/s10661-012-2702-1; Liu F, 2009, ENVIRON POLLUT, V157, P1636, DOI 10.1016/j.envpol.2008.12.021; Marquardt RR, 2018, ANIM FRONT, V8, P30, DOI 10.1093/af/vfy001; Marx MC, 2005, SOIL BIOL BIOCHEM, V37, P35, DOI 10.1016/j.soilbio.2004.05.024; Masse Daniel I, 2014, Animals (Basel), V4, P146, DOI 10.3390/ani4020146; Mathew AG, 2009, FOODBORNE PATHOG DIS, V6, P959, DOI 10.1089/fpd.2009.0263; Migliore L, 2003, CHEMOSPHERE, V52, P1233, DOI 10.1016/S0045-6535(03)00272-8; Msoffe PL, 2009, HDB POULTRY DIS IMPO, V83; Osei Sekyere J., 2014, J VET MED, V2014; Leal RMP, 2012, SCI TOTAL ENVIRON, V432, P344, DOI 10.1016/j.scitotenv.2012.06.002; Pornsukarom S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164621; Ransom JK, 2003, AGR ECON, V29, P299, DOI [10.1016/S0169-5150(03)00057-4, 10.1111/j.1574-0862.2003.tb00166.x]; Rosendahl I, 2012, J ENVIRON QUAL, V41, P1275, DOI 10.2134/jeq2011.0459; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Sommanustweechai A, 2018, B WORLD HEALTH ORGAN, V96, P101, DOI 10.2471/BLT.17.199679; Stockwell VO, 2012, REV SCI TECHNIQUE OF, V31; Su JQ, 2014, ENVIRON INT, V65, P9, DOI 10.1016/j.envint.2013.12.010; Toth JD, 2011, SOIL BIOL BIOCHEM, V43, P2470, DOI 10.1016/j.soilbio.2011.09.004; Turkson PK, 2003, TROP ANIM HEALTH PRO, V35, P321, DOI 10.1023/A:1025141321334; van Bijnen EME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135094; Wegst-Uhrich SR, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-5; Wei X, 2009, J ENVIRON SCI HEAL B, V44, P461, DOI 10.1080/03601230902935139; World Health Organization, 2014, ANT RES GLOB REP SUR; Xu YG, 2016, ECOTOX ENVIRON SAFE, V134, P43, DOI 10.1016/j.ecoenv.2016.06.041; Yevutsey SK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4910-7	46	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228777	10.1371/journal.pone.0228777	http://dx.doi.org/10.1371/journal.pone.0228777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027735	Green Submitted, Green Published, gold			2022-12-26	WOS:000534623800073
J	Yalachkov, Y; Uhlmann, V; Bergmann, J; Soyda, D; Frisch, S; Behrens, M; Foerch, C; Gehrig, J				Yalachkov, Yavor; Uhlmann, Valerie; Bergmann, Johannes; Soyda, Dilara; Frisch, Stefan; Behrens, Marion; Foerch, Christian; Gehrig, Johannes			Patients with chronic autoimmune demyelinating polyneuropathies exhibit cognitive deficits which might be associated with CSF evidence of blood-brain barrier disturbance	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; IMPAIRMENT	Background Chronic autoimmune demyelinating polyneuropathies (CADP) result in impaired sensorimotor function. However, anecdotal clinical observations suggest the development of cognitive deficits during the course of disease. Methods We tested 16 patients with CADP (11 patients with chronic inflammatory demyelinating polyneuropathy, 4 patients with multifocal motor neuropathy and 1 patient with multifocal acquired demyelinating sensory and motor neuropathy) and 40 healthy controls (HC) with a neuropsychological test battery. Blood-brain-barrier dysfunction (BBBd) in patients was assessed retrospectively by analysing the cerebral spinal fluid (CSF) status at the time the diagnosis of CAPD was established. Results CADP patients failed on average in 1.7 out of 9 neuropsychological tests (SD +/- 1.25, min. 0, max. 5). 50% of the CADP patients failed in at least two neuropsychological tests and 44.3% of the patients failed in at least two different cognitive domains. CADP patients exhibiting BBBd at the time of first diagnosis failed in more neuropsychological tests than patients with intact integrity of the BBB (p < 0.05). When compared directly with the HC group, CADP patients performed worse than HC in tests measuring information processing ability and speed as well as phonemic verbal fluency after adjusting for confounding covariates. Conclusions Our results suggest that mild to moderate cognitive deficits might be present in patients with CAPD. One possible tentative explanation, albeit strong evidence is still lacking for this pathophysiological mechanism, refers to the effect of autoimmune antibodies entering the CNS via the dysfunctional blood-brain barrier typically seen in some of the CADP patients.	[Yalachkov, Yavor; Uhlmann, Valerie; Bergmann, Johannes; Soyda, Dilara; Frisch, Stefan; Behrens, Marion; Foerch, Christian; Gehrig, Johannes] Univ Hosp Frankfurt, Dept Neurol, Frankfurt, Germany; [Frisch, Stefan] Goethe Univ, Inst Psychol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Yalachkov, Y (corresponding author), Univ Hosp Frankfurt, Dept Neurol, Frankfurt, Germany.	yavor.yalachkov@kgu.de		Frisch, Stefan/0000-0002-7294-4786				Achiron A, 2003, J NEUROL NEUROSUR PS, V74, P443, DOI 10.1136/jnnp.74.4.443; Achiron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071058; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Broers MC, 2019, NEUROEPIDEMIOLOGY, V52, P161, DOI 10.1159/000494291; Chio A, 2007, J NEUROL NEUROSUR PS, V78, P1349, DOI 10.1136/jnnp.2007.114868; Cochen V, 2005, BRAIN, V128, P2535, DOI 10.1093/brain/awh585; Deloire MSA, 2011, NEUROLOGY, V76, P1161, DOI 10.1212/WNL.0b013e318212a8be; Dorman C, 2013, HAWAII J MED PUBLIC, V72, P49; dos Santos PL, 2014, ARQ NEURO-PSIQUIAT, V72, P179, DOI 10.1590/0004-282X20130232; Eijlers AJC, 2018, BRAIN, V141, P2605, DOI 10.1093/brain/awy202; Eijlers AJC, 2017, NEUROLOGY, V88, P952, DOI 10.1212/WNL.0000000000003689; Geng JL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00129; Gronwall D.M.A., 1997, PACED AUDITORY SERIA; Heaton RK, 1991, COMPREHENSIVE NORMS; Helmstaedter C, 2001, VERBALER LERN MERKFA, V1; Hirohata S, 2018, CLIN EXP RHEUMATOL; Illes Z, 2018, HAND CLINIC, V146, P125, DOI 10.1016/B978-0-12-804279-3.00009-5; Jende JME, 2017, ANN NEUROL, V82, P676, DOI 10.1002/ana.25068; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Latov N, 2004, J PERIPHER NERV SYST, V9, P165, DOI 10.1111/j.1085-9489.2004.09306.x; Meyers JE., 1995, REY COMPLEX FIGURE T; Misawa S, 2008, CLIN NEUROPHYSIOL, V119, P1829, DOI 10.1016/j.clinph.2008.04.010; Querol L, 2017, NAT REV NEUROL, V13, P533, DOI 10.1038/nrneurol.2017.84; Sag S, 2017, ACTA NEUROL BELG, DOI 10.1007/s13760-017-0879-3; Sangroula D, 2017, J CLIN NEUROSCI, V44, P245, DOI 10.1016/j.jocn.2017.06.041; Schmidt KH., 1992, WORTSCHATZTEST; Schwid SR, 2007, J NEUROL SCI, V255, P57, DOI 10.1016/j.jns.2007.01.070; Sepulcre J, 2006, MULT SCLER J, V12, P187, DOI 10.1191/1352458506ms1258oa; Slotwinski K, 2015, J NEUROL SCI, V357, pE345, DOI 10.1016/j.jns.2015.08.1226; Smith A., 2013, SYMBOL DIGIT MODALIT; Sumowski JF, 2018, NEUROLOGY, V90, P278, DOI 10.1212/WNL.0000000000004977; Sumowski JF, 2009, J INT NEUROPSYCH SOC, V15, P606, DOI 10.1017/S1355617709090912; Takechi R, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00399; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x; Warabi Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/847670; Yalachkov Y, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00373	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228679	10.1371/journal.pone.0228679	http://dx.doi.org/10.1371/journal.pone.0228679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017808	Green Published, gold			2022-12-26	WOS:000534618100039
J	Engel, LC; Landmesser, U; Abdelwahed, YS; Jaguszewski, M; Gigengack, K; Wurster, TH; Skurk, C; Manes, C; Schuster, A; Noutsias, M; Hamm, B; Botnar, RM; Makowski, MR; Bigalke, B				Engel, Leif-Christopher; Landmesser, Ulf; Abdelwahed, Youssef S.; Jaguszewski, Milosz; Gigengack, Kevin; Wurster, Thomas-Heinrich; Skurk, Carsten; Manes, Costantina; Schuster, Andreas; Noutsias, Michel; Hamm, Bernd; Botnar, Rene M.; Makowski, Marcus R.; Bigalke, Boris			Comprehensive multimodality characterization of hemodynamically significant and non-significant coronary lesions using invasive and noninvasive measures	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; FRACTIONAL FLOW RESERVE; PLAQUE; STENOSIS; ATHEROSCLEROSIS; THROMBUS	Background There is limited knowledge about morphological molecular-imaging-derived parameters to further characterize hemodynamically relevant coronary lesions. Objective The aim of this study was to describe and differentiate specific parameters between hemodynamically significant and non-significant coronary lesions using various invasive and noninvasive measures. Methods This clinical study analyzed patients with symptoms suggestive of coronary artery disease (CAD) who underwent native T1-weighted CMR and gadofosveset-enhanced CMR as well as invasive coronary angiography. OCT of the culprit vessel to determine the plaque type was performed in a subset of patients. Functional relevance of all lesions was examined using quantitative flow reserve (QFR-angiography). Hemodynamically significant lesions were defined as lesions with a QFR <0.8. Signal intensity (contrast-to-noise ratios; CNRs) on native T1-weighted CMR and gadofosveset-enhanced CMR was defined as a measure for intraplaque hemorrhage and endothelial permeability, respectively. Results Overall 29 coronary segments from 14 patients were examined. Segments containing lesions with a QFR < 0.8 (n = 9) were associated with significantly higher signal enhancement on Gadofosveset-enhanced CMR as compared to segments containing a lesions without significant stenosis (lesion-QFR> 0.8; n = 19) (5.32 (4.47-7.02) vs. 2.42 (1.04-5.11); p = 0.042). No differences in signal enhancement were seen on native T1-weighted CMR (2.2 (0.68-6.75) vs. 2.09 (0.91-6.57), p = 0.412). 66.7% (4 out of 6) of all vulnerable plaque and 33.3% (2 out of 6) of all non-vulnerable plaque (fibroatheroma) as assessed by OCT were hemodynamically significant lesions. Conclusion The findings of this pilot study suggest that signal enhancement on albumin-binding probeenhanced CMR but not on T1-weighted CMR is associated with hemodynamically relevant coronary lesions	[Engel, Leif-Christopher; Landmesser, Ulf; Abdelwahed, Youssef S.; Jaguszewski, Milosz; Gigengack, Kevin; Wurster, Thomas-Heinrich; Skurk, Carsten; Manes, Costantina; Bigalke, Boris] Univ Med Berlin, Klin Kardiol, Charite Campus Benjamin Franklin, Berlin, Germany; [Engel, Leif-Christopher; Landmesser, Ulf] Berlin Inst Hlth BIH, Berlin, Germany; [Engel, Leif-Christopher] Deutsch Herzzentrum Munchen DHM, Klin Kardiovaskulare Erkrankungen, Munich, Germany; [Jaguszewski, Milosz] Med Univ Gdansk, Gdansk, Poland; [Schuster, Andreas] Georg August Univ, Dept Cardiol & Pulmonol, Gottingen, Germany; [Schuster, Andreas] Univ Sydney, Northern Clin Sch, Kolling Inst, Royal North Shore Hosp,Dept Cardiol, 5th Floor,Acute Serv Bldg,Reserve Rd, Sydney, NSW, Australia; [Noutsias, Michel] Martin Luther Univ Halle Wittenberg, Midgerman Heart Ctr, Univ Hosp Halle Wittenberg, Div Cardiol Angiol & Intens Med Care,Dept Interna, Halle, Saale, Germany; [Hamm, Bernd; Makowski, Marcus R.] Univ Med Berlin, Charite Campus Benjamin Franklin, Klin Radiol, Berlin, Germany; [Botnar, Rene M.] Kings Coll London, Div Imaging Sci & Biomed Engn, London, England; [Botnar, Rene M.] Pontificia Univ Catolica Chile, Escuela Ingn, Santiago, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Fahrenheit Universities; Medical University Gdansk; University of Gottingen; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Martin Luther University Halle Wittenberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; King's College London	Engel, LC (corresponding author), Univ Med Berlin, Klin Kardiol, Charite Campus Benjamin Franklin, Berlin, Germany.; Engel, LC (corresponding author), Berlin Inst Hlth BIH, Berlin, Germany.; Engel, LC (corresponding author), Deutsch Herzzentrum Munchen DHM, Klin Kardiovaskulare Erkrankungen, Munich, Germany.	leifengel@hotmail.com	Jaguszewski, Milosz/AAL-3169-2020; Noutsias, Michel/AAM-4006-2021; Botnar, Rene Michael/AAZ-2112-2020; Makowski, Marcus R/Q-7957-2018; Botnar, Rene/E-6875-2012	Botnar, Rene/0000-0003-2811-2509	British Heart Foundation [RG/12/1/29262] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Ahmadi A, 2015, JACC-CARDIOVASC IMAG, V8, P111, DOI 10.1016/j.jcmg.2014.11.010; Aitken AP, 2015, MAGN RESON MED, V74, P756, DOI 10.1002/mrm.25460; Baskaran L, 2017, ATHEROSCLEROSIS, V260, P163, DOI [10.1016/j.atheroscIerosis.2017.02.017, DOI 10.1016/J.ATHER0SCIER0SIS.2017.02.017]; Driessen RS, 2018, J AM COLL CARDIOL, V71, P499, DOI 10.1016/j.jacc.2017.11.054; Engel LC, 2019, JACC-CARDIOVASC IMAG, V12, P297, DOI 10.1016/j.jcmg.2017.10.026; Ferencik M, 2017, ATHEROSCLEROSIS, V260, P150, DOI 10.1016/j.atherosclerosis.2017.03.027; Hoshi T, 2015, EUR HEART J, V36, P1913, DOI 10.1093/eurheartj/ehv187; Jansen CHP, 2011, CIRCULATION, V124, P416, DOI 10.1161/CIRCULATIONAHA.110.965442; Lavi S, 2009, HEART, V95, P1525, DOI 10.1136/hrt.2009.166017; Lobbes MBI, 2010, INVEST RADIOL, V45, P275, DOI 10.1097/RLI.0b013e3181d5466b; Moody AR, 2003, CIRCULATION, V107, P3047, DOI 10.1161/01.CIR.0000074222.61572.44; Nakazato R, 2013, CIRC-CARDIOVASC IMAG, V6, P881, DOI 10.1161/CIRCIMAGING.113.000297; Noguchi T, 2014, J AM COLL CARDIOL, V63, P989, DOI 10.1016/j.jacc.2013.11.034; Phinikaridou A, 2012, CIRCULATION, V126, P707, DOI 10.1161/CIRCULATIONAHA.112.092098; Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Spuentrup E, 2008, EUR RADIOL, V18, P1995, DOI 10.1007/s00330-008-0965-2; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Xu B, 2017, J AM COLL CARDIOL, V70, P3077, DOI 10.1016/j.jacc.2017.10.035	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228292	10.1371/journal.pone.0228292	http://dx.doi.org/10.1371/journal.pone.0228292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004345	Green Published, gold			2022-12-26	WOS:000534614600031
J	He, J; Zhou, MX; Li, XY; Gu, SW; Cao, Y; Xing, TF; Chen, W; Chu, CY; Gu, F; Zhou, J; Jin, YT; Ma, J; Ma, D; Zou, Q				He, Jing; Zhou, Mingxia; Li, Xiaoyan; Gu, Siwen; Cao, Yun; Xing, Tengfei; Chen, Wei; Chu, Chengyu; Gu, Fei; Zhou, Jian; Jin, Yiting; Ma, Jing; Ma, Duan; Zou, Qiang			SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms	ONCOGENE			English	Article							NONSMALL CELL LUNG; COLORECTAL-CANCER; PROTEIN-KINASE; PROLIFERATION; PROGRESSION; METASTASIS; FAMILY	Thyroid cancer is the fastest growing cancer among all solid tumors in recent decades. Papillary thyroid carcinoma (PTC) is the most predominant type of thyroid cancer. Around 30% of PTC patients with distant metastases and local invasion receive poor prognosis. Thus, the identification of new druggable biological targets is of great importance. Accumulating evidence indicates that solute carrier family numbers have emerged as obligate effectors during the progression of multiple malignancies. Here, we uncovered the functional significance, molecular mechanisms, and clinical impact of solute carrier family 34 member A2 (SLC34A2) in PTC. SLC34A2 was markedly overexpressed in PTC tissues at both mRNA and protein levels compared with matched adjacent normal tissues due to promoter hypomethylation mediated by the DNA methyltransferase 3 beta (DNMT3B). Furthermore, a series of in vivo and in vitro gain- or loss-of-functional assays elucidated the role of SLC34A2 in boosting cell proliferation, cell cycle progression, migration, invasion, and adhesion of PTC cells. Using immunoprecipitation and mass spectrometry, we discovered that SLC34A2 bound to the actin-binding repeats domain of Cortactin (CTTN), thereby inducing the invadopodia formation of PTC cells to promote the metastasis potential of PTC cells. Besides, our mechanistic studies, as well as gene set enrichment analysis (GSEA), have pinpointed the PTEN/AKT/FOXO3a pathway as a major signaling functioning downstream of SLC34A2 regulated cell growth. Taken together, our results highlighted that SLC34A2 plays a pivotal oncogenic role during carcinogenesis and metastasis through distinct mechanisms in PTC.	[He, Jing; Li, Xiaoyan; Gu, Siwen; Cao, Yun; Xing, Tengfei; Chen, Wei; Chu, Chengyu; Gu, Fei; Zhou, Jian; Jin, Yiting; Zou, Qiang] Fudan Univ, Huashan Hosp, Dept Gen Surg, 12 Urumqi Middle Rd, Shanghai 200040, Peoples R China; [Zhou, Mingxia] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gastroenterol, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China; [Ma, Jing; Ma, Duan] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, 130 Dongan Rd, Shanghai 200032, Peoples R China; [Ma, Jing; Ma, Duan] Fudan Univ, Inst Biomed Sci, 130 Dongan Rd, Shanghai 200032, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University	Zou, Q (corresponding author), Fudan Univ, Huashan Hosp, Dept Gen Surg, 12 Urumqi Middle Rd, Shanghai 200040, Peoples R China.; Ma, D (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, 130 Dongan Rd, Shanghai 200032, Peoples R China.; Ma, D (corresponding author), Fudan Univ, Inst Biomed Sci, 130 Dongan Rd, Shanghai 200032, Peoples R China.	duanma@fudan.edu.cn; zouqiang_hs@163.com		Li, Xiaoyan/0000-0002-1243-3845	Science and Technology Commission of Shanghai Municipality [15411952503]; National Nature Science Foundation of China [81602326, 81741078, 81801501]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Science and Technology Commission of Shanghai Municipality (No. 15411952503) and National Nature Science Foundation of China (Nos. 81602326, 81741078, and 81801501).	Lacerda-Abreu MA, 2018, BBA-REV CANCER, V1870, P291, DOI 10.1016/j.bbcan.2018.05.001; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cabanillas ME, 2016, LANCET, V388, P2783, DOI 10.1016/S0140-6736(16)30172-6; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chen DR, 2010, ANTICANCER RES, V30, P4135; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Eddy RJ, 2017, TRENDS CELL BIOL, V27, P595, DOI 10.1016/j.tcb.2017.03.003; Fisher KE, 2014, MODERN PATHOL, V27, P222, DOI 10.1038/modpathol.2013.140; Gamble LD, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau1099; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He J, 2018, CANCER SCI, V109, P642, DOI 10.1111/cas.13478; He J, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0378-z; Hernando N, 2018, COMPR PHYSIOL, V8, P1065, DOI 10.1002/cphy.c170024; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Jeannot Pauline, 2020, Small GTPases, V11, P256, DOI 10.1080/21541248.2017.1405773; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Kareva I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051844; Kim S, 2018, ONCOGENE, V37, P2982, DOI 10.1038/s41388-018-0124-4; Li YH, 2016, ONCOL RES, V24, P511, DOI 10.3727/096504016X14719078133483; Li YJ, 2018, CANCER RES, V78, P5216, DOI 10.1158/0008-5472.CAN-18-0003; Lin KD, 2015, CLIN CANCER RES, V21, P5139, DOI 10.1158/1078-0432.CCR-14-3383; Liu XZ, 2017, DNA CELL BIOL, V36, P775, DOI 10.1089/dna.2017.3750; Lv P, 2014, INT J MOL SCI, V15, P5774, DOI 10.3390/ijms15045774; Lv SD, 2018, ONCOGENE, V37, P1354, DOI 10.1038/s41388-017-0026-x; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Neel DS, 2019, CANCER RES, V79, P546, DOI 10.1158/0008-5472.CAN-18-1492; Ramirez-Moya J, 2018, ONCOGENE, V37, P3369, DOI 10.1038/s41388-017-0088-9; Rangel LBA, 2003, ONCOGENE, V22, P7225, DOI 10.1038/sj.onc.1207008; Ricketts CJ, 2012, EPIGENETICS-US, V7, P278, DOI 10.4161/epi.7.3.19103; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Spina A, 2013, J CELL PHYSIOL, V228, P198, DOI 10.1002/jcp.24124; Wagner CA, 2014, PFLUG ARCH EUR J PHY, V466, P139, DOI 10.1007/s00424-013-1418-6; Wang Y, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0158-7; Watkins RJ, 2016, J CLIN ENDOCR METAB, V101, P4551, DOI 10.1210/jc.2016-1932; Weisenberger DJ, 2018, ONCOGENE, V37, P566, DOI 10.1038/onc.2017.374; Wong CC, 2017, ONCOGENE, V36, P3359, DOI 10.1038/onc.2016.485; Wong CC, 2016, GASTROENTEROLOGY, V151, P945, DOI 10.1053/j.gastro.2016.07.011; Yousefi M, 2018, CELL ONCOL, V41, P123, DOI 10.1007/s13402-018-0376-6	41	17	17	1	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2658	2675		10.1038/s41388-020-1181-z	http://dx.doi.org/10.1038/s41388-020-1181-z		JAN 2020	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32005974				2022-12-26	WOS:000510346700004
J	Nielsen, AL; Olsen, CA				Nielsen, Alexander L.; Olsen, Christian A.			Finding the gas pedal on a slow sirtuin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ACTIVATION	The class III histone deacetylase sirtuin 6 (SIRT6) modulates numerous functions in the cell by deacetylating histone lysine residues. Interestingly, SIRT6's efficiency in in vitro experiments is far greater against substrates carrying long-chain fatty acyl modifications such as myristoylated lysine compared with acetylated counterparts, but the deacetylase activity can be stimulated by fatty acids and small-molecule allosteric modulators. A new study helps to explain this puzzling activation using a novel activator, thorough kinetic investigation, and mutagenesis studies. These data help elucidate the molecular requirements for activation of SIRT6 and provide a foundation for development of activators for therapeutic purposes.	[Olsen, Christian A.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Biopharmaceut, Univ Parken 2, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Parken 2, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Olsen, CA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Biopharmaceut, Univ Parken 2, DK-2100 Copenhagen, Denmark.	cao@sund.ku.dk	Nielsen, Alexander Lund/AAJ-4395-2020	Nielsen, Alexander Lund/0000-0003-1195-0143; Olsen, Christian Adam/0000-0002-2953-8942	European Research Council [ERC-CoG-725172-SIRFUNCT]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council Grant ERC-CoG-725172-SIRFUNCT. The authors declare that they have no conflicts of interest with the contents of this article.	Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Huang ZM, 2018, NAT CHEM BIOL, V14, P1118, DOI 10.1038/s41589-018-0150-0; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Klein MA, 2020, J BIOL CHEM, V295, P1385, DOI 10.1074/jbc.RA119.011285; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Tong Z, 2017, ACS CHEM BIOL, V12, P300, DOI 10.1021/acschembio.6b00954; Wang WW, 2019, J AM CHEM SOC, V141, P2462, DOI 10.1021/jacs.8b12083; You WJ, 2017, ANGEW CHEM INT EDIT, V56, P1007, DOI 10.1002/anie.201610082	10	0	0	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1400	1401		10.1074/jbc.H120.012534	http://dx.doi.org/10.1074/jbc.H120.012534			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	32005646	Green Published, hybrid			2022-12-26	WOS:000513822300021
J	Noh, GT; Han, J; Cho, MS; Hur, H; Lee, KY; Kim, NK; Min, BS				Noh, Gyoung Tae; Han, Jeonghee; Cho, Min Soo; Hur, Hyuk; Lee, Kang Young; Kim, Nam Kyu; Min, Byung Soh			The impact of early adjuvant chemotherapy in rectal cancer	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; SHORT-TERM OUTCOMES; COLORECTAL-CANCER; COLON-CANCER; NEOADJUVANT CHEMORADIOTHERAPY; LAPAROSCOPIC SURGERY; OPEN COLECTOMY; STAGE-II; SURVIVAL; FLUOROURACIL	Purposes Although adjuvant chemotherapy (AC) has been established as a standard of treatment for advanced rectal cancer, there is no guideline regarding the timing of AC initiation. In this study, we aimed to evaluate the oncologic outcome of early AC initiation and clarify the ideal time to AC among rectal cancer patients receiving preoperative chemo-radiotherapy (preCRT). Methods The medical records of 719 patients who underwent curative resection followed by AC for rectal cancer were analyzed retrospectively. Data distributions were compared according to the calculated cut-off for AC initiation, survival results, and chemotherapy-induced toxicity. Additionally, patients were divided into two groups according to preCRT status and compared with respect to differences in the optimal time to AC. Results Overall, a cut-off time point of 20 days after surgery for AC initiation was identified as the optimal interval; this yielded a significant difference in disease-free survival but no significant difference in AC toxicity. In the cut-off analysis of patients treated without preCRT, 19 days was identified as the optimal time to AC. However, for patients treated with preCRT, no significant value affected the survival outcome. Conclusions Earlier initiation of AC (within approximately 3 weeks) was associated with better oncological outcomes among patients with rectal cancer. Additionally, the optimal timing of AC was unclear among patients who received preCRT; this might be attributable to an undetermined role of AC after preCRT or the effects of complications such as anastomotic leakage.	[Noh, Gyoung Tae] Ewha Womans Univ, Dept Surg, Coll Med, Seoul, South Korea; [Han, Jeonghee] Hallym Univ, Dept Surg, Coll Med, Seoul, South Korea; [Cho, Min Soo; Hur, Hyuk; Lee, Kang Young; Kim, Nam Kyu; Min, Byung Soh] Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea	Ewha Womans University; Hallym University; Yonsei University; Yonsei University Health System	Min, BS (corresponding author), Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea.	bsmin@yuhs.ac		Hur, Hyuk/0000-0002-9864-7229; Kim, Nam-Kyu/0000-0003-0639-5632				Ahmed S, 2010, DIS COLON RECTUM, V53, P1432, DOI 10.1007/DCR.0b013e3181e78815; Aldo S, 2014, RADIOTHER ONCOL, V113, P223, DOI 10.1016/j.radonc.2014.10.006; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; [Anonymous], 1990, Consens Statement, V8, P1; Bayraktar UD, 2011, CANCER-AM CANCER SOC, V117, P2364, DOI 10.1002/cncr.25720; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Bosset JF, 2014, LANCET ONCOL, V15, P184, DOI 10.1016/S1470-2045(13)70599-0; Breugom AJ, 2015, ANN ONCOL, V26, P696, DOI 10.1093/annonc/mdu560; Cheung WY, 2009, DIS COLON RECTUM, V52, P1054, DOI 10.1007/DCR.0b013e3181a51173; Day AR, 2014, COLORECTAL DIS, V16, P368, DOI 10.1111/codi.12570; Des Guetz G, 2010, EUR J CANCER, V46, P1049, DOI 10.1016/j.ejca.2010.01.020; Edge SB, 2010, AJCC CANC STAGING MA; EGGERMONT AMM, 1987, SURGERY, V102, P71; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Glimelius B, 2013, ANN ONCOL, V24, P81, DOI 10.1093/annonc/mdt240; Glynne-Jones R, 2014, ANN ONCOL, V25, P1356, DOI 10.1093/annonc/mdu147; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; GUNDUZ N, 1979, CANCER RES, V39, P3861; Health UDo Services H. National Cancer Institute, 2013, COMMON TERMINOLOGY C; Hothorn T, 2002, R NEWS, V2, P3; Jeong WK, 2015, ANN SURG TREAT RES, V89, P124, DOI 10.4174/astr.2015.89.3.124; Kang J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001202; Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Kim HJ, 2014, AM J SURG, V207, P840, DOI 10.1016/j.amjsurg.2013.07.047; Kim IY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138720; Klein M, 2015, J SURG ONCOL, V112, P538, DOI 10.1002/jso.24017; Labianca R, 2013, ANN ONCOL, V24, P64, DOI 10.1093/annonc/mdt354; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Lassen K, 2009, ARCH SURG-CHICAGO, V144, P961, DOI 10.1001/archsurg.2009.170; MCCULLOCH P, 1994, LANCET, V344, P402; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; Nachiappan S, 2015, EJSO-EUR J SURG ONC, V41, P1636, DOI 10.1016/j.ejso.2015.09.009; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Network NCC, 2015, NCCN CLIN PRACT GUID; ONO I, 1994, SCAND J PLAST RECONS, V28, P269, DOI 10.3109/02844319409022010; Poulsen LO, 2015, ACTA ONCOL, V54, P437, DOI 10.3109/0284186X.2014.993768; Rayson D, 2012, J ONCOL PRACT, V8, P253, DOI 10.1200/JOP.2012.000578; Spanjersberg WR, 2015, SURG ENDOSC, V29, P3443, DOI 10.1007/s00464-015-4148-3; Spanjersberg WR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007635.pub2; Glasgow SC, 2013, DIS COLON RECTUM, V56, P1339, DOI 10.1097/DCR.0b013e3182a857eb; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; Yu S, 2013, CLIN COLORECTAL CANC, V12, P275, DOI 10.1016/j.clcc.2013.08.002	47	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228060	10.1371/journal.pone.0228060	http://dx.doi.org/10.1371/journal.pone.0228060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004327	Green Published, gold			2022-12-26	WOS:000534614600013
J	Samarghandi, A; Ioachimescu, OC; Qayyum, R				Samarghandi, Arash; Ioachimescu, Octavian C.; Qayyum, Rehan			Association between peak inspiratory flow rate and hand grip muscle strength in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease	PLOS ONE			English	Article							DRY POWDER; COPD; INHALER; DYSFUNCTION; PREVALENCE; RESISTANCE; ENDURANCE; DELIVERY; DEVICES; DISKUS	Rationale Ineffective peak inspiratory flow rate (PIFR) generation in patients using inhalers results in insufficient drug delivery to the lungs and poor clinical outcomes. Low inspiratory muscle strength is associated with suboptimal PIFR. Objective To examine in a prospective study the relationship between PIFR and skeletal muscle strength using hand grip strength (HGS) as a surrogate. Methods Adult patients admitted with acute exacerbation of chronic obstructive pulmonary disease (COPD) were enrolled. PIFR was measured within 48 hours before discharge. PIFR below 60L/min was considered suboptimal. HGS was measured using a handheld dynamometer. Any readmissions and emergency department visit data were collected. The associations between PIFR, HGS, 30 and 90-day COPD and all-cause readmissions were examined, without and with adjustment for age, race and gender. Results Of the 75 enrolled patients, 56% had suboptimal PIFR; they were older (63.9 +/- 9.7 vs. 58.2 +/- 7.7 years) and had significantly lower HGS (24.2 +/- 11.1 vs. 30.9 +/- 10.9 Kg) compared to those with optimal PIFR. There were no significant differences between the two PIFR groups by gender, race, history of coronary artery disease, congestive heart failure, hypertension or functional scores. Each kilogram increase in HGS was associated with 0.50 (95% CI 0.18-0.89, p = 0.003) L/min increase in PIFR. We did not observe an association between PIFR and 30 or 90-day readmission rates. Conclusion We found a significant association between HGS and PIFR in hospitalized patients with acute exacerbations of COPD. Whether interventions aimed at increasing skeletal muscle strength also result in improvement in PIFR remains unclear and need further study.	[Samarghandi, Arash; Ioachimescu, Octavian C.] Emory Univ, Sch Med Crit Care & Sleep Med, Div Pulm, Allergy, Atlanta, GA 30322 USA; [Qayyum, Rehan] Virginia Commonwealth Univ, Sch Med, Div Hosp Med, Richmond, VA USA	Emory University; Virginia Commonwealth University	Samarghandi, A (corresponding author), Emory Univ, Sch Med Crit Care & Sleep Med, Div Pulm, Allergy, Atlanta, GA 30322 USA.	asamarg@emory.edu	Ioachimescu, Octavian Cosmin/AAG-5963-2019	Ioachimescu, Octavian Cosmin/0000-0001-9047-6894	VCU Johnson Center (VJC) - department of pulmonary and critical care at VCU	VCU Johnson Center (VJC) - department of pulmonary and critical care at VCU	Research grant from VCU Johnson Center (VJC) for Critical Care and Pulmonary Research-non for profit source of funding provided by the department of pulmonary and critical care at VCU	Adams V, 1999, J AM COLL CARDIOL, V33, P959, DOI 10.1016/S0735-1097(98)00626-3; Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Al-Showair RAM, 2007, RESP MED, V101, P2395, DOI 10.1016/j.rmed.2007.06.008; [Anonymous], 2018, USER MANUAL JAMAR HY; [Anonymous], 2018, IN CHECK DIAL INH TE; Barnes N, 2014, AGING CLIN EXP RES, V26, P171, DOI 10.1007/s40520-013-0146-2; Bigard AX, 2000, J APPL PHYSIOL, V88, P479, DOI 10.1152/jappl.2000.88.2.479; Braman SS, 2015, CHRON OBSTR PULM DIS, V2, P4, DOI 10.15326/jcopdf.2.1.2015.0130; Broeders MEAC, 2003, INT J PHARMACEUT, V252, P275, DOI 10.1016/S0378-5173(02)00650-6; Bui KL, 2019, CLIN CHEST MED, V40, P367, DOI 10.1016/j.ccm.2019.02.013; Burtin C, 2016, THORAX, V71, P86, DOI 10.1136/thoraxjnl-2015-207451; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chrystyn H, 2003, RESP MED, V97, P181, DOI 10.1053/rmed.2003.1351; Crompton GK, 2006, RESP MED, V100, P1479, DOI 10.1016/j.rmed.2006.01.008; Dal Negro RW, 2015, MULTIDISCIP RESP MED, V10, DOI 10.1186/s40248-015-0012-5; DIFRANCIA M, 1994, AM J RESP CRIT CARE, V150, P1453, DOI 10.1164/ajrccm.150.5.7952575; Dudzinska-Griszek J, 2017, CLIN INTERV AGING, V12, P1151, DOI 10.2147/CIA.S140192; Frohnhofen H, 2011, Z GERONTOL GERIATR, V44, P245, DOI 10.1007/s00391-011-0222-1; Global Initiative for Chronic Obstructive Lung Disease, 2017, GLOB STRAT DIAGN MAN; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Janssens W, 2008, EUR RESPIR J, V31, P78, DOI 10.1183/09031936.00024807; Jeong M, 2017, INT J CHRONIC OBSTR, V12, P2385, DOI 10.2147/COPD.S140915; Kawamatawong T, 2017, J ASTHMA ALLERGY, V10, P17, DOI 10.2147/JAA.S127580; Kim S, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-35; Kovarik M, 2017, INT J CHRONIC OBSTR, V12, P3429, DOI 10.2147/COPD.S144566; lepsen UW, 2019, AM J RESP CELL MOL B; Loh CH, 2017, ANN AM THORAC SOC, V14, P1305, DOI 10.1513/AnnalsATS.201611-903OC; Mahler DA, 2014, J AEROSOL MED PULM D, V27, P103, DOI 10.1089/jamp.2013.1038; Mahler DA, 2013, J AEROSOL MED PULM D, V26, P174, DOI 10.1089/jamp.2012.0987; Malmberg L Pekka, 2010, Int J Chron Obstruct Pulmon Dis, V5, P257; Maltais F, 2014, AM J RESP CRIT CARE, V189, P1121, DOI 10.1164/rccrn.201402-0373ST; Marklund S, 2019, INT J CHRONIC OBSTR, V14, P1825, DOI 10.2147/COPD.S178948; National Heart Lung and Blood Institute, 2012, MORB MORT 2012 CHART; Newman SP, 2003, CURR OPIN PULM MED, V9, pS17, DOI 10.1097/00063198-200304001-00005; Newman Stephen P, 2005, Respir Care, V50, P1177; Nyberg A, 2015, ANN AM THORAC SOC, V12, P1269, DOI 10.1513/AnnalsATS.201505-278PS; ozyemisci-Taskiran o, 2011, EUR RESP J S55, V38, P1247; Pavasini R, 2019, HEART, V105, P834, DOI 10.1136/heartjnl-2018-313816; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Prime D, 1999, J AEROSOL MED, V12, P75, DOI 10.1089/jam.1999.12.75; RENNIE MJ, 1983, CLIN PHYSIOL, V3, P387, DOI 10.1111/j.1475-097X.1983.tb00847.x; Salpeter Shelley R, 2007, Int J Chron Obstruct Pulmon Dis, V2, P11, DOI 10.2147/copd.2007.2.1.11; Schols AMWJ, 1996, THORAX, V51, P819, DOI 10.1136/thx.51.8.819; Shah S, 2013, INDIAN J MED RES, V138, P492; Sharma G, 2017, COPD-J COPD FDN, V4, P217, DOI 10.15326/jcopdf.4.3.2017.0183; Strandkvist VJ, 2016, INT J CHRONIC OBSTR, V11, P2527, DOI 10.2147/COPD.S114154; Vilaro J, 2010, RESP MED, V104, P1896, DOI 10.1016/j.rmed.2010.05.001; Xu Jiaquan, 2016, Natl Vital Stat Rep, V64, P1	48	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0227737	10.1371/journal.pone.0227737	http://dx.doi.org/10.1371/journal.pone.0227737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004333	Green Published, gold			2022-12-26	WOS:000534614600008
J	Skarratt, KK; Gu, B; Lovelace, MD; Milligan, CJ; Stokes, L; Glover, R; Petrou, S; Wiley, JS; Fuller, SJ				Skarratt, Kristen K.; Gu, Ben J.; Lovelace, Michael D.; Milligan, Carol J.; Stokes, Leanne; Glover, Rachel; Petrou, Steven; Wiley, James S.; Fuller, Stephen J.			A P2RX7 single nucleotide polymorphism haplotype promotes exon 7 and 8 skipping and disrupts receptor function	FASEB JOURNAL			English	Article						alternative splicing; heteromer; single nucleotide polymorphism	P2X(7) RECEPTOR; P2X7 RECEPTOR; QUANTITATIVE METHOD; PORE FORMATION; CANCER-CELLS; ATP-BINDING; ION-CHANNEL; C-TERMINUS; ACTIVATION; ALLELE	P2X7 is an ATP-gated membrane ion channel that is expressed by multiple cell types. Brief exposure to ATP induces the opening of a nonselective cation channel; while repeated or prolonged exposure induces formation of a transmembrane pore. This process may be partially regulated by alternative splicing of full-length P2RX7A pre-mRNA, producing isoforms that delete or retain functional domains. Here, we report cloning and expression of a novel P2RX7 splice variant, P2RX7L, that is, characterized by skipping of exons 7 and 8. In HEK 293 cells, expression of P2RX7L produces a protein isoform, P2X7L, that forms a heteromer with P2X7A. A haplotype defined by six single nucleotide polymorphisms (SNPs) (rs208307, rs208306, rs36144485, rs208308, rs208309, and rs373655596) promotes allele-specific alternative splicing, increasing mRNA levels of P2RX7L and another isoform, P2RX7E, which in addition has a truncated C-terminus. Skipping of exons 7 and 8 is predicted to delete critical amino acids in the ATP-binding site. P2X7L-transfected HEK 293 cells have phagocytic but not channel, pore, or membrane-blebbing function, and double-transfected P2X7L and P2X7A cells have reduced pore function. Heteromeric receptor complexes of P2X7A and P2X7L are predicted to have reduced numbers of ATP-binding sites, which potentially alters receptor function compared to homomeric P2X7A complexes.	[Skarratt, Kristen K.; Lovelace, Michael D.; Stokes, Leanne; Glover, Rachel; Fuller, Stephen J.] Univ Sydney, Fac Med & Hlth, Sydney Med Sch Nepean, Dept Med, Kingswood, NSW, Australia; [Gu, Ben J.; Milligan, Carol J.; Petrou, Steven; Wiley, James S.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Stokes, Leanne] Univ East Anglia, Sch Pharm, Norwich Res Pk, Norwich, Norfolk, England	University of Sydney; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of East Anglia	Fuller, SJ (corresponding author), Univ Sydney, Nepean Clin Sch, 62 Derby St, Kingswood, NSW 2747, Australia.	stephen.fuller@sydney.edu.au	Skarratt, Kristy/AAN-1479-2020; Lovelace, Michael D./AAB-5258-2019; Fuller, Stephen/W-6646-2019	Lovelace, Michael D./0000-0003-2066-3031; Fuller, Stephen/0000-0003-4637-7391; Skarratt, Kristy/0000-0003-4971-2773; Wiley, James/0000-0001-9421-4154; Gu, Ben/0000-0001-5500-4453	Sydney Medical School Foundation; Nepean Medical Research Fund	Sydney Medical School Foundation; Nepean Medical Research Fund	Sydney Medical School Foundation, Nepean Medical Research Fund, Grant/Award Number: 2011	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Buell G, 1998, BLOOD, V92, P3521, DOI 10.1182/blood.V92.10.3521.422k50_3521_3528; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chessell IP, 1998, FEBS LETT, V439, P26, DOI 10.1016/S0014-5793(98)01332-5; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Denlinger LC, 2006, CLIN CHEM, V52, P995, DOI 10.1373/clinchem.2005.065425; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; Feng YH, 2006, NUCLEOS NUCLEOT NUCL, V25, P1271, DOI 10.1080/15257770600890921; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Gu BJ, 2014, CYTOM PART A, V85, P313, DOI 10.1002/cyto.a.22400; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Gu BJ, 2009, AM J PHYSIOL-CELL PH, V297, pC430, DOI 10.1152/ajpcell.00079.2009; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2012, FLOW CYTOMETRY RECEN, P185; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Jursik C, 2007, J IMMUNOL METHODS, V325, P67, DOI 10.1016/j.jim.2007.06.002; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khadra A, 2013, BIOPHYS J, V104, P2612, DOI 10.1016/j.bpj.2013.05.006; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Leeson HC, 2019, JOVE-J VIS EXP, DOI 10.3791/59313; Mankus C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028541; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Masin M, 2012, BRIT J PHARMACOL, V165, P978, DOI 10.1111/j.1476-5381.2011.01624.x; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sadovnick AD, 2017, HUM MUTAT, V38, P736, DOI 10.1002/humu.23218; Skarratt KK, 2005, FEBS LETT, V579, P2675, DOI 10.1016/j.febslet.2005.03.091; Skarratt KK, 2014, J MICROBIOL METH, V96, P99, DOI 10.1016/j.mimet.2013.11.011; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Sun CQ, 2010, PURINERG SIGNAL, V6, P31, DOI 10.1007/s11302-009-9168-9; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Trabanelli S, 2012, J IMMUNOL, V189, P1303, DOI 10.4049/jimmunol.1103800; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Wilkinson SM, 2017, ACS CHEM NEUROSCI, V8, P2374, DOI 10.1021/acschemneuro.7b00272; Worthington RA, 2002, FEBS LETT, V512, P43, DOI 10.1016/S0014-5793(01)03311-7	48	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3884	3901		10.1096/fj.201901198RR	http://dx.doi.org/10.1096/fj.201901198RR		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32003498	Green Accepted			2022-12-26	WOS:000510460800001
J	Singh, S; Pilavachi, E; Dudek, A; Bray, TJP; Latifoltojar, A; Rajesparan, K; Punwani, S; Hall-Craggs, MA				Singh, Saurabh; Pilavachi, Elly; Dudek, Alexandra; Bray, Timothy J. P.; Latifoltojar, Arash; Rajesparan, Kannan; Punwani, Shonit; Hall-Craggs, Margaret A.			Whole body MRI in multiple myeloma: Optimising image acquisition and read times	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; GUIDELINES; DIAGNOSIS; CONSENSUS; MANAGEMENT	Objective To identify the whole-body MRI (WB-MRI) image type(s) with the highest value for assessment of multiple myeloma, in order to optimise acquisition protocols and read times. Methods Thirty patients with clinically-suspected MM underwent WB-MRI at 3 Tesla. Unenhanced Dixon images [fat-only (FO) and water-only (WO)], post contrast Dixon [fat-only plus contrast (FOC) and water-only plus contrast (WOC)] and diffusion weighted images (DWI) of the pelvis from all 30 patients were randomised and read by three experienced readers. For each image type, each reader identified and labelled all visible myeloma lesions. Each identified lesion was compared with a composite reference standard achieved by review of a complete imaging dataset by a further experienced consultant radiologist to determine truly positive lesions. Lesion count, true positives, sensitivity, and positive predictive value were determined. Time to read each scan set was recorded. Confidence for a diagnosis of myeloma was scored using a Likert scale. Conspicuity of focal lesions was assessed in terms of percent contrast and contrast to noise ratio (CNR). Results Lesion count, true positives, sensitivity and confidence scores were significantly higher when compared to other image types for DWI (P<0.0001 to 0.003), followed by WOC (significant for sensitivity (P<0.0001 to 0.004), true positives (P = 0.003 to 0.049) and positive predictive value (P<0.0001 to 0.006)). There was no statistically significant difference in these metrics between FO and FOC. Percent contrast was highest for WOC (P = 0.001 to 0.005) and contrast to noise ratio (CNR) was highest for DWI (P = 0.03 to 0.05). Reading times were fastest for DWI across all observers (P<0.0001 to 0.014). Discussion Observers detected more myeloma lesions on DWI images and WOC images when compared to other image types. We suggest that these image types should be read preferentially by radiologists to improve diagnostic accuracy and reporting efficiency.	[Singh, Saurabh; Bray, Timothy J. P.; Latifoltojar, Arash; Punwani, Shonit; Hall-Craggs, Margaret A.] UCL, Div Med, Ctr Med Imaging, London, England; [Pilavachi, Elly; Dudek, Alexandra; Rajesparan, Kannan] Univ Coll Hosp, Dept Radiol, London, England	University of London; University College London; University of London; University College London	Hall-Craggs, MA (corresponding author), UCL, Div Med, Ctr Med Imaging, London, England.	m.hall-craggs@ucl.ac.uk		Bray, Timothy/0000-0001-8886-5356; Singh, Saurabh/0000-0002-8730-524X	Department of Health's the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme; NIHR University College London Hospitals BRC; CRUK/EPSRC KCL/UCL Comprehensive Cancer Imaging Centre	Department of Health's the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme(National Institute for Health Research (NIHR)); NIHR University College London Hospitals BRC; CRUK/EPSRC KCL/UCL Comprehensive Cancer Imaging Centre	This work was undertaken at UCLH/UCL, which receives funding from the Department of Health's the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health. MHC, SP, TJPB and AL are supported by the NIHR University College London Hospitals BRC. This work was supported by CRUK/EPSRC KCL/UCL Comprehensive Cancer Imaging Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MYEL DIAGN MAN GUID; Bauerle T, 2009, RADIOLOGY, V252, P477, DOI 10.1148/radiol.2522081756; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Bourillon C, 2015, RADIOLOGY, V277, P773, DOI 10.1148/radiol.2015141728; Bray TJP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180562; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; Dimopoulos M, 2011, BLOOD, V117, P4701, DOI 10.1182/blood-2010-10-299529; Dimopoulos MA, 2015, J CLIN ONCOL, V33, P657, DOI 10.1200/JCO.2014.57.9961; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Durie Brian G M, 2003, Hematol J, V4, P379; Dutoit JC, 2017, SKELETAL RADIOL, V46, P733, DOI 10.1007/s00256-017-2609-6; Dutoit JC, 2016, EUR J RADIOL, V85, P373, DOI 10.1016/j.ejrad.2015.11.040; Eggers H, DUAL ECHO DIXON IMAG; Giles SL, 2014, RADIOLOGY, V271, P785, DOI 10.1148/radiol.13131529; ISMRM, MR VAL IN; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Latifoltojar A, 2015, ISMRM; Messiou C, 2019, RADIOLOGY, V291, P4, DOI 10.1148/radiol.2019181949; Pawlyn C, 2016, LEUKEMIA, V30, P1446, DOI 10.1038/leu.2015.338; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Sachpekidis C, 2015, AM J NUCL MED MOLEC, V5, P479; Sonneveld P, 2016, BLOOD, V127, P2955, DOI 10.1182/blood-2016-01-631200; Takasu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085931; Takasu M, 2012, EUR RADIOL, V22, P1114, DOI 10.1007/s00330-011-2351-8; Walker R, 2007, J CLIN ONCOL, V25, P1121, DOI 10.1200/JCO.2006.08.5803; Weininger M, 2009, EUR J RADIOL, V69, P339, DOI 10.1016/j.ejrad.2007.10.025	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228424	10.1371/journal.pone.0228424	http://dx.doi.org/10.1371/journal.pone.0228424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999774	Green Published, gold			2022-12-26	WOS:000534612400080
J	Turcotte, C; Archambault, AS; Dumais, E; Martin, C; Blanchet, MR; Bissonnette, E; Ohashi, N; Yamamoto, K; Itoh, T; Laviolette, M; Veilleux, A; Boulet, LP; Di Marzo, V; Flamand, N				Turcotte, Caroline; Archambault, Anne-Sophie; Dumais, Elizabeth; Martin, Cyril; Blanchet, Marie-Renee; Bissonnette, Elyse; Ohashi, Nami; Yamamoto, Keiko; Itoh, Toshimasa; Laviolette, Michel; Veilleux, Alain; Boulet, Louis-Philippe; Di Marzo, Vincenzo; Flamand, Nicolas			Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human myeloid leukocytes	FASEB JOURNAL			English	Article						CB2 receptor; Inflammation; JZL184; MAFP; resolution	COLONY-STIMULATING FACTOR; HUMAN-NEUTROPHILS; LEUKOTRIENE BIOSYNTHESIS; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC-ACID; PHOSPHOLIPASE-D; CB2 RECEPTOR; TRIACSIN-C; 2-ARACHIDONOYLGLYCEROL; INVOLVEMENT	The endocannabinoid (eCB) 2-arachidonoyl-gycerol (2-AG) modulates immune responses by activating cannabinoid receptors or through its multiple metabolites, notably eicosanoids. Thus, 2-AG hydrolysis inhibition might represent an interesting anti-inflammatory strategy that would simultaneously increase the levels of 2-AG and decrease those of eicosanoids. Accordingly, 2-AG hydrolysis inhibition increased 2-AG half-life in neutrophils. Under such setting, neutrophils, eosinophils, and monocytes synthesized large amounts of 2-AG and other monoacylglycerols (MAGs) in response to arachidonic acid (AA) and other unsaturated fatty acids (UFAs). Arachidonic acid and UFAs were ~1000-fold more potent than G protein-coupled receptor (GPCR) agonists. Triascin C and thimerosal, which, respectively, inhibit fatty acyl-CoA synthases and acyl-CoA transferases, prevented the UFA-induced MAG biosynthesis, implying glycerolipid remodeling. 2-AG and other MAG biosynthesis was preceded by that of the corresponding lysophosphatidic acid (LPA). However, we could not directly implicate LPA dephosphorylation in MAG biosynthesis. While GPCR agonists poorly induced 2-AG biosynthesis, they inhibited that induced by AA by 25%-50%, suggesting that 2-AG biosynthesis is decreased when leukocytes are surrounded by a pro-inflammatory entourage. Our data strongly indicate that human leukocytes use AA and UFAs to biosynthesize biologically significant concentrations of 2-AG and other MAGs and that hijacking the immune system with 2-AG hydrolysis inhibitors might diminish inflammation in humans.	[Turcotte, Caroline; Archambault, Anne-Sophie; Dumais, Elizabeth; Martin, Cyril; Blanchet, Marie-Renee; Bissonnette, Elyse; Laviolette, Michel; Boulet, Louis-Philippe; Di Marzo, Vincenzo; Flamand, Nicolas] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Fac Med, Dept Med,Ctr Rech, 2725 Chemin St Foy,Room A2142, Quebec City, PQ G1V 4G5, Canada; [Ohashi, Nami; Yamamoto, Keiko; Itoh, Toshimasa] Showa Pharmaceut Univ, Lab Drug Design & Med Chem, Machida, Tokyo, Japan; [Veilleux, Alain; Di Marzo, Vincenzo] Univ Laval, Fac Sci Agr & Alimentat, Ecole Nutr, Quebec City, PQ, Canada; [Di Marzo, Vincenzo] CNR, Joint Int Unit Natl Res Council CNR Italy & Univ, Pozzuoli, Italy	Laval University; Showa Pharmaceutical University; Laval University; Consiglio Nazionale delle Ricerche (CNR)	Flamand, N (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Fac Med, Dept Med,Ctr Rech, 2725 Chemin St Foy,Room A2142, Quebec City, PQ G1V 4G5, Canada.	Nicolas.Flamand@criucpq.ulaval.ca	Ohashi, Nami/ABH-2782-2020; Veilleux, Alain/I-5028-2019; Flamand, Nicolas/H-5823-2019; Di Marzo, Vincenzo/AAD-7742-2019	Veilleux, Alain/0000-0003-4078-1908; Flamand, Nicolas/0000-0001-5944-7200; Di Marzo, Vincenzo/0000-0002-1490-3070; Itoh, Toshimasa/0000-0003-3446-4447; Archambault, Anne-Sophie/0000-0001-7243-7445; Yamamoto, Keiko/0000-0001-6642-7961				Aaltonen Niina, 2012, BMC Pharmacology, V12, P7, DOI 10.1186/1471-2210-12-7; Archambault AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202424; Berdyshev EV, 2001, FASEB J, V15, P2171, DOI 10.1096/fj.01-0181com; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; Bisogno T, 1999, J NEUROCHEM, V72, P2113, DOI 10.1046/j.1471-4159.1999.0722113.x; BOURGOIN S, 1990, J EXP MED, V172, P767, DOI 10.1084/jem.172.3.767; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Chouinard F, 2013, J LEUKOCYTE BIOL, V93, P267, DOI 10.1189/jlb.0412200; Chouinard F, 2011, J IMMUNOL, V186, P3188, DOI 10.4049/jimmunol.1002853; DePetrocellis L, 1997, BIOCHEM BIOPH RES CO, V231, P82, DOI 10.1006/bbrc.1997.6000; Deutsch DG, 1997, BIOCHEM PHARMACOL, V53, P255, DOI 10.1016/S0006-2952(96)00830-1; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Everard A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08051-7; Fanelli F, 2012, J LIPID RES, V53, P481, DOI 10.1194/jlr.M021378; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Flamand N, 2004, BRIT J PHARMACOL, V141, P552, DOI 10.1038/sj.bjp.0705654; Flamand N, 2000, AM J RESP CRIT CARE, V161, pS88, DOI 10.1164/ajrccm.161.supplement_1.ltta-18; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; HARTMAN EJ, 1989, PROSTAGLANDINS, V37, P655, DOI 10.1016/0090-6980(89)90103-2; Hillard CJ, 2012, NEUROSCIENCE, V204, P207, DOI 10.1016/j.neuroscience.2011.11.020; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; KORCHAK HM, 1994, J BIOL CHEM, V269, P30281; Lankinen M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111785; Larose MC, 2014, J ALLERGY CLIN IMMUN, V133, P1480, DOI 10.1016/j.jaci.2013.12.1081; Li L, 2003, CRIT REV ORAL BIOL M, V14, P100, DOI 10.1177/154411130301400204; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Nakane S, 2002, ARCH BIOCHEM BIOPHYS, V402, P51, DOI 10.1016/S0003-9861(02)00038-3; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; PRESCOTT SM, 1983, J BIOL CHEM, V258, P764; Ramsden CE, 2015, J PAIN, V16, P707, DOI 10.1016/j.jpain.2015.04.007; Simon MF, 2002, J BIOL CHEM, V277, P23131, DOI 10.1074/jbc.M201530200; Smith FL, 1998, PHARMACOL BIOCHEM BE, V60, P183, DOI 10.1016/S0091-3057(97)00583-2; Smyth SS, 2003, J BIOL CHEM, V278, P43214, DOI 10.1074/jbc.M306709200; Staiano RI, 2016, J LEUKOCYTE BIOL, V99, P531, DOI 10.1189/jlb.3HI1214-584R; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Turcotte C, 2019, J LEUKOCYTE BIOL, V106, P1337, DOI 10.1002/JLB.3A0919-049RRR; Turcotte C, 2017, J IMMUNOL, V198, P3255, DOI 10.4049/jimmunol.1601767; Turcotte C, 2016, CELL MOL LIFE SCI, V73, P4449, DOI 10.1007/s00018-016-2300-4; Turcotte C, 2015, J LEUKOCYTE BIOL, V97, P1049, DOI 10.1189/jlb.3RU0115-021R; Wood JT, 2010, J LIPID RES, V51, P1416, DOI 10.1194/jlr.M002436; Yamamoto Y, 2017, ORG BIOMOL CHEM, V15, P8186, DOI 10.1039/c7ob01771e; Zarini S, 2006, J BIOL CHEM, V281, P10134, DOI 10.1074/jbc.M510783200	47	20	20	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4253	4265		10.1096/fj.201902916R	http://dx.doi.org/10.1096/fj.201902916R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32012340	hybrid			2022-12-26	WOS:000519218400055
J	Musaba, MW; Ndeezi, G; Barageine, JK; Weeks, A; Nankabirwa, V; Wamono, F; Semakula, D; Tumwine, JK; Wandabwa, JN				Musaba, Milton W.; Ndeezi, Grace; Barageine, Justus K.; Weeks, Andrew; Nankabirwa, Victoria; Wamono, Felix; Semakula, Daniel; Tumwine, James K.; Wandabwa, Julius N.			Risk factors for obstructed labour in Eastern Uganda: A case control study	PLOS ONE			English	Article							MATERNAL DEATH	Introduction Obstructed labour (OL) is an important clinical and public health problem because of the associated maternal and perinatal morbidity and mortality. Risk factors for OL and its associated obstetric squeal are usually context specific. No epidemiological study has documented the risk factors for OL in Eastern Uganda. This study was conducted to identify the risk factors for OL in Mbale Hospital. Objective To identify the risk factors for OL in Mbale Regional Referral and Teaching Hospital, Eastern Uganda. Methods We conducted a case control study with 270 cases of women with OL and 270 controls of women without OL. We consecutively enrolled eligible cases between July 2018 and February 2019. For each case, we randomly selected one eligible control admitted in the same 24-hour period. Data was collected using face-to-face interviews and a review of patient notes. Logistic regression was used to identify the risk factors for OL. Results The risk factors for OL were, being a referral from a lower health facility (AOR 6.80, 95% CI: 4.20-11.00), prime parity (AOR 2.15 95% CI: 1.26-3.66) and use of herbal medicines in active labour (AOR 2.72 95% CI: 1.49-4.96). Married participants (AOR 0.59 95% CI: 0.35-0.97) with a delivery plan (AOR 0.56 95% CI: 0.35-0.90) and educated partners (AOR 0.57 95% CI: 0.33-0.98) were less likely to have OL. In the adjusted analysis, there was no association between four or more ANC visits and OL, adjusted odds ratio [(AOR) 0.96 95% CI: 0.57-1.63)]. Conclusions Prime parity, use of herbal medicines in labour and being a referral from a lower health facility were identified as risk factors. Being married with a delivery plan and an educated partner were protective of OL. Increased frequency of ANC attendance was not protective against obstructed labour.	[Musaba, Milton W.] Mbale Reg Referral & Teaching Hosp, Dept Obstet & Gynaecol, Mbale, Uganda; [Musaba, Milton W.; Wandabwa, Julius N.] Busitema Univ, Dept Obstet & Gynaecol, Fac Hlth Sci, Mbale, Uganda; [Musaba, Milton W.; Ndeezi, Grace; Tumwine, James K.] Makerere Univ, Sch Med, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda; [Barageine, Justus K.] Makerere Univ, Sch Med, Dept Obstet & Gynaecol, Coll Hlth Sci, Kampala, Uganda; [Barageine, Justus K.; Semakula, Daniel] Makerere Univ, Coll Hlth Sci, Africa Ctr Systemat Reviews & Knowledge Translat, Kampala, Uganda; [Weeks, Andrew] Univ Liverpool, Liverpool Womens Hosp, Sanyu Res Unit, Liverpool, Merseyside, England; [Nankabirwa, Victoria] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Nankabirwa, Victoria] Univ Bergen, Ctr Intervent Sci & Maternal Child Hlth CISMAC, Ctr Int Hlth, Bergen, Norway; [Wamono, Felix] Makerere Univ, Sch Stat & Planning, Coll Business & Management Sci, Kampala, Uganda	Makerere University; Makerere University; Makerere University; University of Liverpool; Makerere University; University of Bergen; Makerere University	Musaba, MW (corresponding author), Mbale Reg Referral & Teaching Hosp, Dept Obstet & Gynaecol, Mbale, Uganda.; Musaba, MW (corresponding author), Busitema Univ, Dept Obstet & Gynaecol, Fac Hlth Sci, Mbale, Uganda.; Musaba, MW (corresponding author), Makerere Univ, Sch Med, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda.	miltonmusaba@gmail.com		Musaba, Milton/0000-0003-4145-4044; Weeks, Andrew/0000-0002-1909-337X	Survival Pluss Project at Makerere University; NORHED under NORAD [UGA-13-0030]	Survival Pluss Project at Makerere University; NORHED under NORAD	Survival Pluss Project at Makerere University. Funded by NORHED under NORAD. UGA-13-0030, Prof. James K. Tumwine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; Abraham W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-256; Alkema L, NATL REGIONAL GLOBAL; [Anonymous], 2014, OBSTET GYNECOL, V123, P693; Bako B, 2018, SAHEL MED J, V21, P117; Barageine JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112299; Benova L, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3546-3; Fantu S, INCIDENCE CAUSES OUT, P145; GREENLAND S, 1986, AM J EPIDEMIOL, V124, P869, DOI 10.1093/oxfordjournals.aje.a114476; Gudina AT, 2016, MAGNITUDE OBSTRUCTED, V4, P12; Gupta R, 2017, J NEONATAL BIOL, V06; Henok A, 2015, J WOMENS HEAL CARE, V4, P1; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Howards PP, 2018, ACTA OBSTET GYN SCAN, V97, P394, DOI 10.1111/aogs.13295; Indra N.U., 2017, INT J REPROD CONTRAC, V6, P439; Kabakyenga JK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-73; Kabakyenga JK, 2011, GLOB HLTH ACTION, V4, P1; Kadowa I, 2010, SINGAP MED J, V51, P35; Kayiga H, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0949-1; Kennedy DA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-355; Wall LL, 2017, INT UROGYNECOL J, V28, P1817, DOI 10.1007/s00192-017-3368-6; Mathew M., 2016, PLOS ONE, V11, P1; Mawoza T, PREVALENCE TRADITION, P1; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; Mhiretie AA, 2015, PREDICTORS OUTCOMES; MoH, 2016, REP UG MIN HLTH ANN; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Raj SS, 2015, INT J HEALTH POLICY, V4, P99, DOI 10.15171/ijhpm.2015.14; Shaikh S, 2013, NEPAL J OBSTET GYNAE, V7, P37; SOGC, 2008, MAN LAB OBSTR LAB, P1; Sullivan KM, 2007, SAMPLE SIZE CROSS SE, P1; Sunday-adeoye I, 2014, WOMENS HLTH CARE OBS, V3, P10; Sunday-Adeoye I., 2014, J WOMENS HLTH CARE, V03, P1; Tetui M, 2012, PAN AFR MED J, V13; UBOS ICF, 2017, UG DEM HLHT SURV 201; Uganda National Council for Science and Technology, 2014, NAT GUID RES INV HUM	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228856	10.1371/journal.pone.0228856	http://dx.doi.org/10.1371/journal.pone.0228856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040542	gold, Green Published			2022-12-26	WOS:000534629400045
J	Tfaily, MA; Nassar, F; Sellam, LS; Amir-Tidadini, ZC; Asselah, F; Bourouba, M; Rihab, N				Tfaily, Mohamad Ali; Nassar, Farah; Sellam, Leila-Sarah; Amir-Tidadini, Zine-Charaf; Asselah, Fatima; Bourouba, Mehdi; Rihab, Nasr			miRNA expression in advanced Algerian breast cancer tissues	PLOS ONE			English	Article							PROTEIN-KINASE CK2; CIRCULATING MICRORNAS; INVASION; CELLS; PROLIFERATION; PROGNOSIS; ETHNICITY; DIAGNOSIS; BIOMARKER; MIR-182	Breast cancer is one of the commonest cancers among Algerian females. Compared to Western populations, the median age of diagnosis of breast cancer is much lower in Algeria. The objective of this study is to explore the expression of several miRNAs reported to be deregulated in breast cancer. The miRNAs miR-21, miR-125b, miR-100, miR-425-5p, miR-200c, miR-183 and miR-182 were studied on tumor and normal adjacent Algerian breast tissues using quantitative reverse transcription real time PCR, and the results were analyzed according to clinical characteristics. Compared to the normal adjacent tissues, miR-21, miR-183, miR-182, miR-425-5p and miR-200c were found to be upregulated while miR-100 and miR-125b were insignificantly deregulated. A positive correlation was noted among miR183, miR-182 and miR-200c and among miR-425-5p, miR-183, miR-200c and miR-21. Further global miRNA microarray profiling studies can aid in finding ethnic specific miRNA biomarkers in the Algerian breast cancer population.	[Tfaily, Mohamad Ali; Nassar, Farah; Rihab, Nasr] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Lebanon, NH USA; [Sellam, Leila-Sarah; Bourouba, Mehdi] Univ Sci & Technol Houari Boumediene USTHB, Fac Biol, Team Cytokines & Nitr Oxide Synth, Dept Cell & Mol Biol, Algiers, Algeria; [Amir-Tidadini, Zine-Charaf; Asselah, Fatima] Mustapha Pacha Hosp, Cent Lab Anatomopathol, Algiers, Algeria	American University of Beirut; University Science & Technology Houari Boumediene	Rihab, N (corresponding author), Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Lebanon, NH USA.; Bourouba, M (corresponding author), Univ Sci & Technol Houari Boumediene USTHB, Fac Biol, Team Cytokines & Nitr Oxide Synth, Dept Cell & Mol Biol, Algiers, Algeria.	mbourouba@usthb.dz; rn03@aub.edu.lb	Nassar, Farah/AAJ-4792-2020; Nasr, Rihab/ABE-4068-2020; Nassar, Farah Jihad/GYA-5024-2022	Nassar, Farah/0000-0002-4092-2531; Nasr, Rihab/0000-0003-1166-4999; Nassar, Farah Jihad/0000-0002-4092-2531				Akhavantabasi S, 2012, CELL STRUCT FUNCT, V37, P27; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; [Anonymous], 2018, EST CANC INC MORT PR; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen DH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004177; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; Chen QH, 2014, TUMOR BIOL, V35, P529, DOI 10.1007/s13277-013-1074-7; Cherbal F, 2010, DIS MARKERS, V28, P377, DOI [10.3233/DMA-2010-0718, 10.1155/2010/585278]; Chiang CH, 2016, AM J CANCER RES, V6, P1785; Chiang Chi-Hsiang, 2012, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbagen.2013.01, DOI 10.1016/J.BBAGEN.2013.01]; Corbex M, 2014, EUR J CANCER, V50, P1808, DOI 10.1016/j.ejca.2014.03.016; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Feliciano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076247; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Font-Porterias N, 2018, ANN HUM BIOL, V45, P98, DOI 10.1080/03014460.2017.1413133; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gebeshuber CA, 2013, ONCOGENE, V32, P3306, DOI 10.1038/onc.2012.372; Gong Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11650; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kawaguchi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16112-y; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0473-z; Li Yu, 2012, Genomics Proteomics & Bioinformatics, V10, P246, DOI 10.1016/j.gpb.2012.07.005; Lowery AJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-502; Luo YW, 2017, ONCOL LETT, V13, P867, DOI 10.3892/ol.2016.5482; Matamala N, 2015, CLIN CHEM, V61, P1098, DOI 10.1373/clinchem.2015.238691; Michael MZ, 2003, MOL CANCER RES, V1, P882; Najjar H, 2010, INT J SURG, V8, P448, DOI 10.1016/j.ijsu.2010.05.012; Nassar FJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16978-y; Nassar FJ, 2017, PHARMACOL THERAPEUT, V172, P34, DOI 10.1016/j.pharmthera.2016.11.012; Nassar FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107566; Ozgun A, 2013, ONKOLOGIE, V36, P115, DOI 10.1159/000348678; Roche, RAIS AW BREAST CANC; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Song CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24502; Song DH, 2000, J BIOL CHEM, V275, P23790, DOI 10.1074/jbc.M909107199; Sun QQ, 2015, INT J CANCER, V136, P1003, DOI 10.1002/ijc.29065; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Tsai HP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191195; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Uhrhammer Nancy, 2008, Int J Med Sci, V5, P197; Wang AX, 2012, GENET MOL RES, V11, P3051, DOI 10.4238/2012.August.31.2; Wang PY, 2013, ONCOL LETT, V6, P1681, DOI 10.3892/ol.2013.1593; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0227928	10.1371/journal.pone.0227928	http://dx.doi.org/10.1371/journal.pone.0227928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040529	Green Published, gold			2022-12-26	WOS:000534629400012
J	Knelange, EB; Lopez-Moliner, J				Knelange, Elisabeth B.; Lopez-Moliner, Joan			Increased error-correction leads to both higher levels of variability and adaptation	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; HITTING MOVING-OBJECTS; MOTOR VARIABILITY; STOCHASTIC RESONANCE; MOVEMENT; FEEDBACK; SPEED; DETERMINES; MODELS; MEMORY	In order to intercept moving objects, we need to predict the spatiotemporal features of the motion of both the object and our hand. Our errors can result in updates of these predictions to benefit interceptions in the future (adaptation). Recent studies claim that task-relevant variability in baseline performance can help adapt to perturbations, because initial variability helps explore the spatial demands of the task. In this study, we examined whether this relationship is also found in interception (temporal domain) by looking at the link between the variability of hand-movement speed during baseline trials, and the adaptation to a temporal perturbation. 17 subjects performed an interception task on a graphic tablet with a stylus. A target moved from left to right or vice versa, with varying speed across trials. Participants were instructed to intercept this target with a straight forward movement of their hand. Their movements were represented by a cursor that was displayed on a screen above the tablet. To prevent online corrections we blocked the hand from view, and a part of the cursor's trajectory was occluded. After a baseline phase of 80 trials, a temporal delay of 100 ms was introduced to the cursor representing the hand (adaptation phase: 80 trials). This delay initially caused participants to miss the target, but they quickly accounted for these errors by adapting to most of the delay of the cursor. We found that variability in baseline movement velocity is a good predictor of temporal adaptation (defined as a combination of the rate of change and the asymptotic level of change after a perturbation), with higher variability during baseline being associated with better adaptation. However, cross-correlation results suggest that the increased variability is the result of increased error correction, rather than exploration.	[Knelange, Elisabeth B.; Lopez-Moliner, Joan] Univ Barcelona, Inst Neurociencies, Vis & Control Act VISCA Grp, Dept Cognit Dev & Psychol Educ, Barcelona, Catalonia, Spain	University of Barcelona	Lopez-Moliner, J (corresponding author), Univ Barcelona, Inst Neurociencies, Vis & Control Act VISCA Grp, Dept Cognit Dev & Psychol Educ, Barcelona, Catalonia, Spain.	j.lopezmoliner@ub.edu		Knelange, Elisabeth/0000-0002-4133-5136; Lopez-Moliner, Joan/0000-0001-5040-8889	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [642961]; AEI/FEDER, UE [PSI2017-83493-R]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa); AEI/FEDER, UE	This work is part of the PACE project, which received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642961. We also received funding from grant PSI2017-83493-R of AEI/FEDER, UE. There were no commercial relationships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; BAIRSTOW PJ, 1987, HUM MOVEMENT SCI, V6, P205, DOI 10.1016/0167-9457(87)90013-3; Murillo DB, 2017, J EXP PSYCHOL HUMAN, V43, P596, DOI 10.1037/xhp0000303; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brenner E, 2015, J VISION, V15, DOI 10.1167/15.3.8; Brouwer AM, 2000, EXP BRAIN RES, V133, P242, DOI 10.1007/s002210000371; Brouwer AM, 2002, EXP BRAIN RES, V143, P198, DOI 10.1007/s00221-001-0980-x; Chaisanguanthum KS, 2014, J NEUROSCI, V34, P12071, DOI 10.1523/JNEUROSCI.3001-13.2014; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cunningham DW, 2001, PSYCHOL SCI, V12, P532, DOI 10.1111/1467-9280.d01-17; de la Malla C, 2014, J VISION, V14, DOI 10.1167/14.12.8; de la Malla C, 2012, J VISION, V12, DOI 10.1167/12.10.4; Dhawale AK, 2017, ANNU REV NEUROSCI, V40, P479, DOI 10.1146/annurev-neuro-072116-031548; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fernandes HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043016; Haar S, 2017, J NEUROSCI, V37, P9076, DOI 10.1523/JNEUROSCI.1650-17.2017; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; He K, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005023; Herzfeld DJ, 2014, SCIENCE, V345, P1349, DOI 10.1126/science.1253138; Herzfeld DJ, 2014, NAT NEUROSCI, V17, P149, DOI 10.1038/nn.3633; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Knelange EB, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00046; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lopez-Moliner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035705; Lopez-Moliner J, 2010, EXP BRAIN RES, V206, P409, DOI 10.1007/s00221-010-2421-1; Mattar AAG, 2010, J NEUROPHYSIOL, V104, P426, DOI 10.1152/jn.00886.2009; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; R Core Team, 2021, R LANGUAGE ENV STAT; Regan D, 1997, J SPORT SCI, V15, P533, DOI 10.1080/026404197366985; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Stacey WC, 2000, J NEUROPHYSIOL, V83, P1394, DOI 10.1152/jn.2000.83.3.1394; Takiyama K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6925; Tan HL, 2016, J NEUROSCI, V36, P1516, DOI 10.1523/JNEUROSCI.3204-15.2016; TEASDALE N, 1993, J MOTOR BEHAV, V25, P97, DOI 10.1080/00222895.1993.9941644; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064332; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Groen O, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006301; van der Vliet R, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0170-18.2018; VERCHER JL, 1992, EXP BRAIN RES, V90, P599; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616; Zhou S, 1998, Electromyogr Clin Neurophysiol, V38, P67	57	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0227913	10.1371/journal.pone.0227913	http://dx.doi.org/10.1371/journal.pone.0227913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9EF	32017774	Green Published, gold			2022-12-26	WOS:000534618100012
J	Su, X; Lu, LY; Li, YS; Zhen, CA; Hu, GL; Jiang, K; Yan, YW; Xu, YB; Wang, G; Shi, MW; Chen, XL; Zhang, BZ				Su, Xu; Lu, Liuyang; Li, Yashe; Zhen, Congai; Hu, Guilei; Jiang, Kun; Yan, Yawei; Xu, Yanbo; Wang, Geng; Shi, Mingwang; Chen, Xiling; Zhang, Baizhong			Reference gene selection for quantitative real-time PCR (qRT-PCR) expression analysis in Galium aparine L.	PLOS ONE			English	Article							HOUSEKEEPING GENES; RT-PCR; NORMALIZATION; RESISTANCE; QUANTIFICATION; IDENTIFICATION; MODEL	To accurately evaluate expression levels of target genes, stable internal reference genes is required for normalization of quantitative real-time PCR (qRT-PCR) data. However, there have been no systematical investigation on the stability of reference genes used in the bed-straw weed, Galium aparine L. (BGA). In this study, the expression profiles of seven traditionally used reference genes, namely 18S, 28S, ACT, GAPDH, EF1 alpha, RPL7 and TBP in BGA were assessed under both biotic (developmental time and tissue), and abiotic (temperature, regions and herbicide) conditions. Four analytical algorithms (geNorm, Normfinder, BestKeeper and the.Ct method) were used to analyze the suitability of these genes as internal reference genes. RefFinder, a comprehensive analytical software, was used to rank the overall stability of the candidate genes. The optimal normalization internal control genes were ranked as: 28S and RPL7 were best for all the different experimental conditions (developmental stages, tissues, temperature, regions and herbicide treatment); 28S and RPL7 for developmental stages; TBP and GAPDH for different tissues; 28S and GAPDH were relatively stable for different temperature; 28S and TBP were suitable for herbicide treatment. A specific set of reference genes were recommended for each experimental condition in BGA.	[Su, Xu; Lu, Liuyang; Li, Yashe; Hu, Guilei; Jiang, Kun; Yan, Yawei; Xu, Yanbo; Wang, Geng; Shi, Mingwang; Chen, Xiling; Zhang, Baizhong] Henan Inst Sci & Technol, Coll Resources & Environm, Xinxiang, Henan, Peoples R China; [Zhen, Congai] Museum Chinese Gardens & Landscape Architecture, Beijing, Peoples R China	Henan Institute of Science & Technology	Zhang, BZ (corresponding author), Henan Inst Sci & Technol, Coll Resources & Environm, Xinxiang, Henan, Peoples R China.	baizhongzhang@hist.edu.cn			National Key Research and Development Program of China [2017YFD0201700]; Key Science and Technology Program of Henan (Agriculture) [182102110053]; Project of Plant Protection Key Discipline of Henan Province [1070202190011005]	National Key Research and Development Program of China; Key Science and Technology Program of Henan (Agriculture); Project of Plant Protection Key Discipline of Henan Province	This work is supported by the National Key Research and Development Program of China (2017YFD0201700) to XC, the Key Science and Technology Program of Henan (Agriculture) (182102110053) to BZ, and Project of Plant Protection Key Discipline of Henan Province (1070202190011005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bagnall NH, 2010, MED VET ENTOMOL, V24, P176, DOI 10.1111/j.1365-2915.2010.00866.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chatham LA, 2015, WEED SCI, V63, P569, DOI 10.1614/WS-D-14-00149.1; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Ciric L, 2010, ACB NEWS, V568, P6; Cruz-Hipolito H, 2011, J AGR FOOD CHEM, V59, P7261, DOI 10.1021/jf201074k; Deng W, 2019, WEED SCI, V67, P183, DOI 10.1017/wsc.2018.70; Duhoux A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063576; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Li R., 2010, CHINESE AGR SCI B, V26, P289; Liang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087514; Liu JJ, 2019, PLANT PROTECT SCI, V55, P61, DOI 10.17221/20/2018-PPS; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Overbergh L, 2003, J Biomol Tech, V14, P33; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; RYAN GF, 1970, WEED SCI, V18, P614, DOI 10.1017/S0043174500034330; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Spiess AN, 2016, SCI REP-UK, V6, DOI 10.1038/srep38951; Sun Jian, 2010, Scientia Agricultura Sinica, V43, P972; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang X, 2015, MOLECULES, V20, P4833, DOI 10.3390/molecules20034833; Wrzesinska B, 2016, WEED RES, V56, P284, DOI 10.1111/wre.12209; Cesare P, 2015, PHYTOCHEMISTRY, V116, P78, DOI 10.1016/j.phytochem.2015.02.024; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038	38	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0226668	10.1371/journal.pone.0226668	http://dx.doi.org/10.1371/journal.pone.0226668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017769	Green Published, gold			2022-12-26	WOS:000534618100007
J	Meegan, JE; Shaver, CM; Putz, ND; Jesse, JJ; Landstreet, SR; Lee, HNR; Sidorova, TN; McNeil, JB; Wynn, JL; Cheung-Flynn, J; Komalavilas, P; Brophy, CM; Ware, LB; Bastarache, JA				Meegan, Jamie E.; Shaver, Ciara M.; Putz, Nathan D.; Jesse, Jordan J.; Landstreet, Stuart R.; Lee, Han Noo Ri; Sidorova, Tatiana N.; McNeil, J. Brennan; Wynn, James L.; Cheung-Flynn, Joyce; Komalavilas, Padmini; Brophy, Colleen M.; Ware, Lorraine B.; Bastarache, Julie A.			Cell-free hemoglobin increases inflammation, lung apoptosis, and microvascular permeability in murine polymicrobial sepsis	PLOS ONE			English	Article							MULTIORGAN DYSFUNCTION SYNDROME; OXIDATIVE STRESS; UNITED-STATES; INJURY; RELAXATION; MORTALITY; THROMBOMODULIN; ENDOTHELIUM; HEMOLYSIS; IMMUNITY	Increased endothelial permeability is central to the pathogenesis of sepsis and leads to organ dysfunction and death but the endogenous mechanisms that drive increased endothelial permeability are not completely understood. We previously reported that cell-free hemoglobin (CFH), elevated in 80% of patients with sepsis, increases lung microvascular permeability in an ex vivo human lung model and cultured endothelial cells. In this study, we augmented a murine model of polymicrobial sepsis with elevated circulating CFH to test the hypothesis that CFH increases microvascular endothelial permeability by inducing endothelial apoptosis. Mice were treated with an intraperitoneal injection of cecal slurry with or without a single intravenous injection of CFH. Severity of illness, mortality, systemic and lung inflammation, endothelial injury and dysfunction and lung apoptosis were measured at selected time points. We found that CFH added to CS increased sepsis mortality, plasma inflammatory cytokines as well as lung apoptosis, edema and inflammation without affecting large vessel reactivity or vascular injury marker concentrations. These results suggest that CFH is an endogenous mediator of increased endothelial permeability and apoptosis in sepsis and may be a promising therapeutic target.	[Meegan, Jamie E.; Shaver, Ciara M.; Putz, Nathan D.; Jesse, Jordan J.; Landstreet, Stuart R.; Lee, Han Noo Ri; Sidorova, Tatiana N.; McNeil, J. Brennan; Ware, Lorraine B.; Bastarache, Julie A.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Wynn, James L.] Univ Florida Hlth, Dept Pediat, Gainesville, FL USA; [Wynn, James L.] Univ Florida Hlth, Dept Pathol, Gainesville, FL USA; [Wynn, James L.] Univ Florida Hlth, Dept Immunol, Gainesville, FL USA; [Wynn, James L.] Univ Florida Hlth, Dept Expt Med, Gainesville, FL USA; [Cheung-Flynn, Joyce; Komalavilas, Padmini; Brophy, Colleen M.] Vanderbilt Univ, Med Ctr, Div Vasc Surg, Nashville, TN USA; [Ware, Lorraine B.; Bastarache, Julie A.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Bastarache, Julie A.] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Vanderbilt University; Vanderbilt University; Vanderbilt University	Bastarache, JA (corresponding author), Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA.; Bastarache, JA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Bastarache, JA (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	julie.bastarache@vumc.org	Ware, Lorraine/AAJ-9307-2021	Ware, Lorraine/0000-0002-9429-4702; McNeil, Joel/0000-0002-9200-1881; Meegan, Jamie/0000-0002-2644-676X; Shaver, Ciara/0000-0002-5677-0288; Wynn, James/0000-0001-7052-4836; Jesse, Jordan/0000-0001-8123-2273	National Institute of Health [HL135849, HL070717, HD089939, GM128452, HL103836, HL094296]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Health HL135849 to LBW, JAB; HL070717 to CMB; HD089939, GM128452 to JLW; HL103836 to LBW; HL094296 to JEM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banathy A, 2016, AM J RESP CELL MOL, V55, P225, DOI 10.1165/rcmb.2015-0139OC; Bastarache JA, 2014, J IMMUNOL METHODS, V408, P13, DOI 10.1016/j.jim.2014.04.006; Bastarache JA, 2012, THORAX, V67, P1032, DOI 10.1136/thoraxjnl-2012-201781; Della Giustina A, 2018, INFLAMMATION, V41, P315, DOI 10.1007/s10753-017-0689-z; Fessel JP, 2002, P NATL ACAD SCI USA, V99, P16713, DOI 10.1073/pnas.252649099; Flynn CR, 2005, J APPL PHYSIOL, V98, P1836, DOI 10.1152/japplphysiol.01043.2004; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gerin F, 2016, INFLAMMATION, V39, P700, DOI 10.1007/s10753-015-0296-9; Gill SE, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0266-7; Gladwin MT, 2012, J CLIN INVEST, V122, P1205, DOI 10.1172/JCI62972; Goldman DW, 1998, AM J PHYSIOL-HEART C, V275, pH1046, DOI 10.1152/ajpheart.1998.275.3.H1046; GORIN AB, 1979, J APPL PHYSIOL, V47, P1315, DOI 10.1152/jappl.1979.47.6.1315; Guo RF, 2007, ANTIOXID REDOX SIGN, V9, P1991, DOI 10.1089/ars.2007.1785; Janz DR, 2013, CRIT CARE, V17, DOI 10.1186/cc13108; Janz DR, 2013, CRIT CARE MED, V41, P784, DOI 10.1097/CCM.0b013e3182741a54; Janz DR, 2014, CRIT CARE MED; Jespersen Brian, 2015, J Vis Exp, P52324, DOI 10.3791/52324; Katayama S, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1815-x; Kato GJ, 2017, J CLIN INVEST, V127, P750, DOI 10.1172/JCI89741; KILBOURN RG, 1994, BIOCHEM BIOPH RES CO, V199, P155, DOI 10.1006/bbrc.1994.1208; Kramer PA, 2015, LAB INVEST, V95, P132, DOI 10.1038/labinvest.2014.144; Kuck JL, 2017, BIOCH BIOPHYS RES CO; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Lax S., 2014, BMJ OPEN RESP RES, V1, P1, DOI DOI 10.1136/; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Lin SM, 2008, CRIT CARE MED, V36, P683, DOI 10.1097/CCM.0B013E31816537D8; Manley MO, 2005, SHOCK, V23, P521, DOI 10.1097/01.shk.0000161386.23817.7f; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mihajlovic DM, 2015, CLIN APPL THROMB-HEM, V21, P469, DOI 10.1177/1076029613508600; Molinaro R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133227; Nakai K, 1996, J CARDIOVASC PHARM, V28, P115, DOI 10.1097/00005344-199607000-00018; O'Mahony DS, 2006, CRIT CARE, V10, DOI 10.1186/cc5050; Razavi HM, 2005, CRIT CARE MED, V33, P1333, DOI 10.1097/01.CCM.0000165445.48350.4F; RIOUX F, 1994, J CARDIOVASC PHARM, V24, P229, DOI 10.1097/00005344-199424020-00006; Roberts J. L., 2003, METHOD PHARMACOL TOX, V1, P33; Shaver CM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98546; Shaver CM, 2016, AM J PHYSIOL-LUNG C, V310, pL532, DOI 10.1152/ajplung.00155.2015; Shaver CM, 2015, AM J RESP CELL MOL, V53, P719, DOI 10.1165/rcmb.2014-0179OC; Stephens RS, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12589; Su G, 2013, CRIT CARE MED, V41, P546, DOI 10.1097/CCM.0b013e3182711b1e; Voskresensky IV, 2014, JAMA SURG, V149, P1176, DOI 10.1001/jamasurg.2014.2029; Wynn JL, 2008, BLOOD, V112, P1750, DOI 10.1182/blood-2008-01-130500; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09	44	22	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228727	10.1371/journal.pone.0228727	http://dx.doi.org/10.1371/journal.pone.0228727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012200	Green Published, gold			2022-12-26	WOS:000534615800047
J	Ibrahim, ST; Chinnadurai, R; Ali, I; Payne, D; Rice, GI; Newman, WG; Algohary, E; Adam, AG; Kalra, PA				Ibrahim, Sara T.; Chinnadurai, Rajkumar; Ali, Ibrahim; Payne, Debbie; Rice, Gillian, I; Newman, William G.; Algohary, Eman; Adam, Ahmed G.; Kalra, Philip A.			Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD	PLOS ONE			English	Article							STAGE RENAL-DISEASE; ALTERNATIVE PATHWAY; MOLECULAR ANALYSIS; ALL-CAUSE; COMPLEMENT; MORTALITY; EPIDEMIOLOGY; ACTIVATION; ALLOTYPES; MORBIDITY	Objectives The R102G variant in complement 3 (C3) results in two allotypic variants: C3 fast (C3F) and C3 slow (C3S). C3F presents at increased frequency in patients with chronic kidney disease (CKD), our aim is to explore its role in CKD progression and mortality. Methods Delta (Delta) eGFR for 2038 patients in the Salford Kidney Study (SKS) was calculated by linear regression; those with <=-3ml/min/1.73m(2) /yr were defined as rapid progressors (RP) and those with Delta eGFR between -0.5 and +1ml/min/1.73m(2)/yr, labelled stable CKD patients (SP).A group of 454 volunteers was used as a control group. In addition, all biopsy-proven glomerulonephritis (GN) patients were studied regardless of their Delta eGFR. R102G was analysed by real-time PCR, and genotypic and allelic frequencies were compared between RP and SP along with the healthy control group. Results There were 255 SP and 259 RP in the final cohort. Median Delta eGFR was 0.07 vs. -4.7 ml/min/1.73m(2)/yr in SP vs. RP. C3F allele frequency was found to be significantly higher in our CKD cohort (25.7%) compared with the healthy control group (20.6%); p = 0.008.However, there was no significant difference in C3F allele frequency between the RP and SP groups. In a subgroup analysis of 37 patients with IgA nephropathy in the CKD cohort (21 RP and 16 SP), there was a significantly higher frequency of C3F in RP 40.5% vs. 9.4% in SP; p = 0.003. In the GN group, Cox regression showed an association between C3F and progression only in those with IgA nephropathy (n = 114);HR = 1.9 (95% CI 1.1-3.1; p = 0.018) for individuals heterozygous for the C3F variant, increased further for individuals homozygous for the variant, HR = 2.8 (95% CI 1.2-6.2; p = 0.014). Conclusion The C3 variant R102G is associated with progression of CKD in patients with IgA nephropathy.	[Ibrahim, Sara T.; Algohary, Eman; Adam, Ahmed G.] Alexandria Univ, Fac Med, Dept Internal Med & Nephrol, Alexandria, Egypt; [Ibrahim, Sara T.; Chinnadurai, Rajkumar; Ali, Ibrahim; Kalra, Philip A.] Salford Royal NHS Fdn Trust, Dept Renal Med, Salford, Lancs, England; [Ibrahim, Sara T.; Chinnadurai, Rajkumar; Ali, Ibrahim; Payne, Debbie; Kalra, Philip A.] Univ Manchester, Manchester, Lancs, England; [Rice, Gillian, I] Manchester Univ NHS Fdn Trust, Manchester Ctr Genom Med, Hlth Innovat Manchester, Manchester, Lancs, England; [Newman, William G.] Univ Manchester, Fac Biol Med & Human Sci, Div Evolut & Genom Sci, Manchester, Lancs, England	Egyptian Knowledge Bank (EKB); Alexandria University; Salford Royal NHS Foundation Trust; University of Manchester; University of Manchester	Ibrahim, ST (corresponding author), Alexandria Univ, Fac Med, Dept Internal Med & Nephrol, Alexandria, Egypt.; Ibrahim, ST (corresponding author), Salford Royal NHS Fdn Trust, Dept Renal Med, Salford, Lancs, England.; Ibrahim, ST (corresponding author), Univ Manchester, Manchester, Lancs, England.	sara.ibrahim@alexmed.edu.eg	Chinnadurai, Rajkumar/AAQ-4808-2020; Ibrahim, Sara T/GLV-0890-2022	Ibrahim, Sara T/0000-0001-7442-7902; Newman, William/0000-0002-6382-4678				Alderson HV, 2016, CLIN J AM SOC NEPHRO, V11, P2141, DOI 10.2215/CJN.02670316; Badve SV, 2016, NEPHROL DIAL TRANSPL, V31, P1425, DOI 10.1093/ndt/gfv269; Bazyar N, 2012, MOL BIOL REP, V39, P8919, DOI 10.1007/s11033-012-1759-9; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; Chang WX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132927; Collins AJ, 2009, CLIN J AM SOC NEPHRO, V4, pS5, DOI 10.2215/CJN.05980809; Delanghe JR, 2014, PATHOLOGY, V46, P1, DOI 10.1097/PAT.0000000000000042; Eftimovska N, 2008, Prilozi, V29, P153; FINN JE, 1994, AM J KIDNEY DIS, V23, P543, DOI 10.1016/S0272-6386(12)80376-3; FINN JE, 1993, CLIN EXP IMMUNOL, V91, P410; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Heurich M, 2011, P NATL ACAD SCI USA, V108, P8761, DOI 10.1073/pnas.1019338108; Hsu JY, 2017, CLIN J AM SOC NEPHRO, V12, P1181, DOI 10.2215/CJN.10301016; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Li YW, 2017, ATHEROSCLEROSIS, V259, P75, DOI 10.1016/j.atherosclerosis.2017.02.003; Lukawska E, 2018, CLIN EXP MED, V18, P297, DOI 10.1007/s10238-018-0491-8; Maillard N, 2015, J AM SOC NEPHROL, V26, P1503, DOI 10.1681/ASN.2014101000; Menon V, 2005, KIDNEY INT, V68, P766, DOI 10.1111/j.1523-1755.2005.00455.x; Murphy B, 2002, AM J KIDNEY DIS, V39, P24, DOI 10.1053/ajkd.2002.29873; Onuigbo M A C, 2014, Indian J Nephrol, V24, P75, DOI 10.4103/0971-4065.127886; Onuigbo MAC, 2010, RENAL FAILURE, V32, P954, DOI 10.3109/0886022X.2010.502608; Parsa A, 2017, J AM SOC NEPHROL, V28, P923, DOI 10.1681/ASN.2015101152; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Persson U, 2013, KIDNEY BLOOD PRESS R, V37, P641, DOI 10.1159/000355744; RAMBAUSEK M, 1987, Nephrology Dialysis Transplantation, V2, P208; REGUEIRO JR, 1984, HUM GENET, V67, P437, DOI 10.1007/BF00291406; Reikes ST, 2000, POSTGRAD MED, V108, P124, DOI 10.3810/pgm.2000.07.1152; Ritchie J, 2013, INT J HYPERTENS, V2013, P1; Ritchie JP, 2014, NEPHRON CLIN PRACT, V128, P22, DOI 10.1159/000362453; Ritz Eberhard, 2005, Kidney Int Suppl, pS66, DOI 10.1111/j.1523-1755.2005.09912.x; Testa A, 2014, CLIN J AM SOC NEPHRO, V9, P1059, DOI 10.2215/CJN.11041013; Thurman JM, 2015, AM J KIDNEY DIS, V65, P156, DOI 10.1053/j.ajkd.2014.06.035; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; WIEME RJ, 1967, NATURE, V214, P1042, DOI 10.1038/2141042a0	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228101	10.1371/journal.pone.0228101	http://dx.doi.org/10.1371/journal.pone.0228101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004338	Green Published, gold			2022-12-26	WOS:000534614600016
J	He, D; Zhang, JR; Zhang, XF; He, SL; Xie, DB; Liu, Y; Li, CM; Wang, Z; Liu, YP				He, Dan; Zhang, Jiaorui; Zhang, Xuefeng; He, Songlin; Xie, Dongbo; Liu, Yang; Li, Chaomei; Wang, Zheng; Liu, Yiping			Development of SSR markers in Paeonia based on De Novo transcriptomic assemblies	PLOS ONE			English	Article							RETICULATE EVOLUTION; TREE PEONY; BIOGEOGRAPHY; DNA	Peony is a famous ornamental and medicinal plant in China, and peony hybrid breeding is an important means of germplasm innovation. However, research on the genome of this species is limited, thereby hindering the genetic and breeding research on peony. In the present study, simple sequence repeat (SSR) locus analysis was performed on expressed sequence tags obtained by the transcriptome sequencing of Paeonia using Microsatellite software. Primers with polymorphism were obtained via polymerase chain reaction amplification and electrophoresis. As a result, a total of 86,195 unigenes were obtained by assembling the transcriptome data of Paeonia. Functional annotations were obtained in seven functional databases including 49,172 (Non-Redundant Protein Sequence Database: 57.05%), 38,352 (Nucleotide Sequence Database: 44.49%), 36,477 (Swiss Prot: 42.32%), 38,905 (Clusters of Orthologous Groups for Eukaryotic Complete Genomes: 45.14%), 37,993 (Kyoto Encyclopedia of Genes and Genomes: 44.08%), 26,832 (Gene Ontology: 31.13%) and 37,758 (Pfam: 43.81%) unigenes. Meanwhile, 21,998 SSR loci were distributed in 17,567 unigenes containing SSR sequences, and the SSR distribution frequency was 25.52%, with an average of one SSR sequence per 4.66 kb. Mononucleotide, dinucleotide, and trinucleotide were the main repeat types, accounting for 55.74%, 25.58%, and 13.21% of the total repeat times, respectively. Forty-five pairs of the 100 pairs of primers selected randomly could amplify clear polymorphic bands. The polymorphic primers of these 45 pairs were used to cluster and analyze 16 species of peony. The new SSR molecular markers can be useful for the study of genetic diversity and marker-assisted breeding of peony.	[He, Dan; Zhang, Jiaorui; Zhang, Xuefeng; He, Songlin; Xie, Dongbo; Li, Chaomei; Wang, Zheng; Liu, Yiping] Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China; [He, Dan] Henan Inst Sci & Technol, Postdoctor Res Base, Xinxiang, Henan, Peoples R China; [He, Dan] Henan Agr Univ, Coll Forestry, Innovat Platform Mol Biol, Zhengzhou, Henan, Peoples R China; [Zhang, Xuefeng] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [He, Songlin] Henan Inst Sci & Technol, Xinxiang, Henan, Peoples R China; [Liu, Yang] Univ Minnesota, Dept Genet Cell Biol & Dev, St Paul, MN 55108 USA	Henan Agricultural University; Henan Institute of Science & Technology; Henan Agricultural University; Nanjing Agricultural University; Henan Institute of Science & Technology; University of Minnesota System; University of Minnesota Twin Cities	He, SL (corresponding author), Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China.; He, SL (corresponding author), Henan Inst Sci & Technol, Xinxiang, Henan, Peoples R China.	hsl213@yeah.net	Wang, Zheng/HGT-7145-2022	Liu, Yang/0000-0001-6045-4969; Songlin, He/0000-0002-3462-4730	National Natural Science Foundation of China [31600568, 31870698]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (http://dx.doi.org/10.13039/501100001809 31600568) to Dan He and National Natural Science Foundation of China (http://dx.doi.org/10.13039/501100001809 31870698) to Professor SongLin He. Author Dongbo Xie received funding in the form of a salary from Henan Longxiang Ecological Landscape Technology Company Limited. The specific role of this author is articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[安宗燕 An Zongyan], 2018, [分子植物育种, Molecular Plant Breeding], V16, P6744; Cai CF, 2015, THESIS, P6; Chen JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184736; Fan HongHong, 2009, Genomics and Applied Biology, V28, P869; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; Guo R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01383; HANFT JM, 1990, J PLANT GROWTH REGUL, V9, P89, DOI 10.1007/BF02041947; He D, 2019, FUNCT PLANT BIOL, V46, P417, DOI [10.1071/fp18163, 10.1071/FP18163]; Hou XG, 2011, AM J BOT, V98, pE303, DOI 10.3732/ajb.1100172; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kang Seonghui, 2013, BMC Res Notes, V6, P478, DOI 10.1186/1756-0500-6-478; Liu CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179219; Liu DG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115128, 10.1371/journal.pone.0086976]; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Liu N, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6036-z; ROHLF FJ, 1992, NTSYS PC NUMERICAL T; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; SANG T, 1995, P NATL ACAD SCI USA, V92, P6813, DOI 10.1073/pnas.92.15.6813; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tsai CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141761; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang SL, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5857-0; Wang XJ, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0194-7; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu J, 2014, MOL BREEDING, V34, P1853, DOI 10.1007/s11032-014-0144-x; Xiao JJ, 2010, THESIS, P6; Yang X, 2018, BASIC APPL ECOL, V32, P53, DOI 10.1016/j.baae.2018.07.002; Zhang HuaLi, 2018, Acta Horticulturae Sinica, V45, P159; Zhang JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119118; [张振 Zhang Zhen], 2015, [林业科学, Scientia Silvae Sinicae], V51, P114; Zheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142542; [郑涛 Zheng Tao], 2017, [分子植物育种, Molecular Plant Breeding], V15, P513	33	10	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227794	10.1371/journal.pone.0227794	http://dx.doi.org/10.1371/journal.pone.0227794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999761	Green Published, gold			2022-12-26	WOS:000534612400031
J	Wambura, M; Nyato, DJ; Makyao, N; Drake, M; Kuringe, E; Casalini, C; Materu, J; Nnko, S; Mbita, G; Shao, A; Komba, A; Changalucha, J; Saidel, T				Wambura, Mwita; Nyato, Daniel Josiah; Makyao, Neema; Drake, Mary; Kuringe, Evodius; Casalini, Caterina; Materu, Jacqueline; Nnko, Soori; Mbita, Gasper; Shao, Amani; Komba, Albert; Changalucha, John; Saidel, Tobi			Programmatic mapping and size estimation of key populations to inform HIV programming in Tanzania	PLOS ONE			English	Article							FEMALE SEX WORKERS; PREVENTION; ENUMERATION; SERVICES; QUALITY; MEN	Introduction A programmatic mapping and size estimation study was conducted in 24 districts in 5 regions of Tanzania to estimate the size and locations of female sex workers (FSW) and men who have sex with men (MSM) to inform the HIV programming for Key Populations. Methodology Data were collected at two levels: first, interviews were conducted with informants to identify venues where FSWs and MSM frequent. Secondly, the size of MSM and FSWs were estimated through interviews with FSWs, MSM and other informants at the venue. The venue estimates were aggregated to generate the ward level estimates. Correction factors were then applied to adjust for MSM/FSW counted twice or more, absent from the venues on the mapping day or remain online and hidden. The ward size estimates for mapped wards were extrapolated to non-mapped wards and aggregated to generate district and regional level estimates. Results A total of 4,557 level I interviews were conducted. Further, 3,098 FSWs and 1,074 other informants at the FSWs venues and 558 MSM and 210 other informants at the MSM venues were interviewed during level II. The mapping survey identified 6,658 FSW, 1,099 FSW and MSM and 50 MSM venues in 75 wards. A total of 118,057 (range: 108,269 to 127,845) FSWs and 23,771 (range: 22,087 to 25,454) MSM were estimated in the study regions after extrapolation and accounting for correction factors. It was estimated that 5.6% and 1.3% of the female and male population of reproductive age (15-49 years old) could be FSWs and MSM in the study regions, respectively. Conclusion This study provides the baseline figures for planning, target setting and monitoring of the HIV intervention services in the study areas and geographic prioritisation of the response by allocating more resources to areas with a large number of FSWs and MSM.	[Wambura, Mwita; Nyato, Daniel Josiah; Kuringe, Evodius; Materu, Jacqueline; Nnko, Soori; Shao, Amani; Changalucha, John] Mwanza Ctr, Natl Inst Med Res, Dept Sexual & Reprod Hlth, Mwanza, Tanzania; [Makyao, Neema] Minist Hlth Community Dev Gender Elderly & Childr, Natl AIDS Control Programme, Dar Es Salaam, Tanzania; [Drake, Mary; Casalini, Caterina; Mbita, Gasper; Komba, Albert] Johns Hopkins Univ, Jhpiego Tanzania, Dar Es Salaam, Tanzania; [Saidel, Tobi] Partnership Epidem Anal PEMA, New Delhi, India	National Institute of Medical Research; Jhpiego	Wambura, M (corresponding author), Mwanza Ctr, Natl Inst Med Res, Dept Sexual & Reprod Hlth, Mwanza, Tanzania.	wmwita@yahoo.com	Nyato, Daniel/J-1682-2019	Nyato, Daniel/0000-0002-2397-1390; Shao, Amani/0000-0003-1995-3031; Materu, Jacqueline/0000-0002-5678-8285; Wambura, Mwita/0000-0001-9079-7057	United States Agency for International Development (USAID) [SOL-621-14-000015]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	AK received a grant from the United States Agency for International Development (USAID) (SOL-621-14-000015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Council P Solutions CR Project S Ministry of Health CD Gender and Children-Reproductive and Child Health Section, 2018, ASS FAM PLANN SAF CO; Delany-Moretlwe S, 2015, J INT AIDS SOC, V18, P29, DOI 10.7448/IAS.18.2.19833; Dutta A., 2014, CONSENSUS ESTIMATES; Geibel S, 2007, AIDS, V21, P1349, DOI 10.1097/QAD.0b013e328017f843; Gibb Jean, 2017, J Clin Res HIV AIDS Prev, V3, DOI 10.14302/issn.2324-7339.jcrhap-17-1468; HIV/AIDS J. U. N. P. O, 2016, GLOB AIDS UPD 2016; HIV/AIDS. JUNPo, 2007, UNAIDS PRACT GUID IN; Ikpeazu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103619; Kerrigan D, 2017, JAIDS-J ACQ IMM DEF, V74, pS60, DOI 10.1097/qai.0000000000001203; Kruse N, 2003, SEX TRANSM DIS, V30, P664, DOI 10.1097/01.OLQ.0000079523.04451.82; Leshabari M, 2013, PREVALENCE HUMAN IMM; Levy ME, 2014, AIDS BEHAV, V18, P972, DOI 10.1007/s10461-014-0719-x; Mmbaga EJ, 2017, SEX TRANSM INFECT SE; Mutagoma M, 2015, INT J STD AIDS, V26, P810, DOI 10.1177/0956462414555931; Muthee V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195362; NASCOP NACC, 2012, GEOGR MAPP MOST RISK; NBS, 2012, 2012 POP HOUS CENS P; NBS OCGS ICAP TACAIDS ZAC, 2017, TANZ HIV IMP SURV TH; Ngugi EN, 2012, SAHARA J-J SOC ASP H, V9, P148, DOI 10.1080/17290376.2012.743825; Nyblade L, 2017, AIDS CARE, V29, P1364, DOI 10.1080/09540121.2017.1307922; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; O'Hagan R, 2017, GLOB HEALTH-SCI PRAC, V5, P367, DOI 10.9745/GHSP-D-17-00177; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Pathack A, 2018, AJAR-AFR J AIDS RES, V17, P129, DOI 10.2989/16085906.2018.1462216; Quaye S, 2015, AIDS BEHAV, V19, pS16, DOI 10.1007/s10461-014-0943-4; Rice B, 2018, JMIR PUBLIC HLTH SUR, V4, P338, DOI 10.2196/publichealth.9344; Ross MW, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2014-006175, 10.1136/bmjopen-2012-001928]; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; TACAIDS ZAC NBS OCGS ICF, 2013, TANZ HIV AIDS MAL IN; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vanwesenbeeck I, 2013, J SEX RES, V50, P11, DOI 10.1080/00224499.2012.696285; Vu L, 2018, AIDS BEHAV, V22, P1113, DOI 10.1007/s10461-017-1992-2; Weir SS, 2004, SEX TRANSM INFECT, V80, P63, DOI 10.1136/sti.2004.012336; Weir SS, 2003, AIDS, V17, P895, DOI 10.1097/00002030-200304110-00015; Whitehead J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146139; WHO; UNAIDS, 2016, EST SIZ KEP POP GUID; Williams ML, 2009, AIDS EDUC PREV, V21, P474, DOI 10.1521/aeap.2009.21.5.474; World Health Organisation, 2021, CONSOLIDATED GUIDELI	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228618	10.1371/journal.pone.0228618	http://dx.doi.org/10.1371/journal.pone.0228618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999810	Green Published, gold			2022-12-26	WOS:000534612400098
J	Byron, MJ; Koester, DC; Edwards, KL; Mozdziak, PE; Farin, CE; Crosier, AE				Byron, Michael J.; Koester, Diana C.; Edwards, Katie L.; Mozdziak, Paul E.; Farin, Charlotte E.; Crosier, Adrienne E.			Immunoglobulin J chain as a non-invasive indicator of pregnancy in the cheetah (Acinonyx jubatus)	PLOS ONE			English	Article							NAMIBIAN CHEETAH; DEMOGRAPHY; INDUCTION; SEMEN; CAT; AGE	The North American cheetah population serves as a reservoir for the species, and acts as a research population to help understand the unique biology of the species. Little is known about the intrauterine physiology of the cheetah, including embryo differentiation, implantation, and the development of the placenta. After mating, cheetah females frequently experience (30-65% of matings) a non-pregnant luteal phase where progestogen metabolite levels match those found in pregnant females for the first similar to 55 days of gestation, but parturition does not occur. Immunoglobulin J chain (IgJ) is a molecule that is involved in the activation of the secretory immune response and has been found to be indicative of pregnancy in the cheetah using fecal monitoring. In this study, western blotting was employed to track IgJ abundance in pooled weekly fecal samples following natural breeding or exogenous stimulation to ovulate, and IgJ levels were compared between individuals undergoing a pregnant (n = 12) and non-pregnant (n = 19) luteal phase. It was revealed that IgJ abundance was increased in pregnant females compared to non-pregnant females at week 4 and week 8 post-breeding, indicating the potential modulation of maternal immunity in response to sensitive events such as implantation and the increased secretory activity of the placenta. IgJ levels also tended to be higher early after breeding in females that were bred naturally with intact males compared to exogenously stimulated females with no exposure to seminal plasma, potentially indicating a response to the act of intromission or the stress of breeding, or possibly demonstrating an immune response resulting in the promotion of maternal tolerance to seminal antigens present upon embryonic implantation. Monitoring fecal IgJ may be a potential method to determine gestational status in the cheetah and will aid future conservation efforts of the species.	[Byron, Michael J.; Edwards, Katie L.; Crosier, Adrienne E.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Byron, Michael J.; Mozdziak, Paul E.; Farin, Charlotte E.] North Carolina State Univ, Coll Agr & Life Sci, Raleigh, NC 27695 USA; [Koester, Diana C.] Cleveland Metroparks Zoo, Conservat & Sci Dept, Cleveland, OH USA; [Edwards, Katie L.] Chester Zoo, North England Zool Soc, Upton By Chester, Cheshire, England	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of North Carolina; North Carolina State University	Byron, MJ (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA.; Byron, MJ (corresponding author), North Carolina State Univ, Coll Agr & Life Sci, Raleigh, NC 27695 USA.	mjbyron@ncsu.edu	Edwards, Katie/K-5559-2015	Edwards, Katie/0000-0001-6736-1183; mozdziak, paul/0000-0002-1575-3123; Byron, Michael/0000-0001-9857-2119	C2S2's Cheetah Sustainability Program; Ferris Family Foundation; William H. Donner Foundation	C2S2's Cheetah Sustainability Program; Ferris Family Foundation; William H. Donner Foundation	This research was supported by C2S2's Cheetah Sustainability Program (AEC and DK), the Ferris Family Foundation (AEC) and the William H. Donner Foundation (AEC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Bauman JE, 2008, ZOO BIOL, V27, P406, DOI 10.1002/zoo.20196; BRANDTZAEG P, 1983, MOL IMMUNOL, V20, P941, DOI 10.1016/0161-5890(83)90036-6; Brown JL, 1996, J REPROD FERTIL, V106, P337, DOI 10.1530/jrf.0.1060337; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Burke HB, 2016, BIOMARKERS CANC, V8; Crosier AE, 2007, REPROD FERT DEVELOP, V19, P370, DOI 10.1071/RD06057; Crosier AE, 2011, BIOL REPROD, V85, P243, DOI 10.1095/biolreprod.110.089417; Curry E, 2012, THERIOGENOLOGY, V78, P308, DOI 10.1016/j.theriogenology.2012.02.004; Dehnhard M, 2012, THERIOGENOLOGY, V77, P1088, DOI 10.1016/j.theriogenology.2011.10.011; DENKER HW, 1978, ANAT EMBRYOL, V154, P39, DOI 10.1007/BF00317953; Durant SM, 2017, P NATL ACAD SCI USA, V114, P528, DOI 10.1073/pnas.1611122114; HALPERN MS, 1970, NATURE, V228, P1276, DOI 10.1038/2281276a0; Howard JG, 1997, BIOL REPROD, V56, P1059, DOI 10.1095/biolreprod56.4.1059; Johansen FE, 2001, J IMMUNOL, V167, P5185, DOI 10.4049/jimmunol.167.9.5185; Johansson M, 2004, IMMUNOLOGY, V112, P290, DOI 10.1111/j.1365-2567.2004.01876.x; Kelly MJ, 1998, J ZOOL, V244, P473, DOI 10.1017/S0952836998004014; Koester DC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188575; Kuribayashi T, 2003, EXP ANIM TOKYO, V52, P377, DOI 10.1538/expanim.52.377; LAURENSON MK, 1992, RES EXPLOR, V8, P64; LEISER R, 1993, J EXP ZOOL, V266, P642, DOI 10.1002/jez.1402660612; Marker LL, 2003, BIOL CONSERV, V114, P413, DOI 10.1016/S0006-3207(03)00069-7; Monteiro RC, 2014, CLIN EXP IMMUNOL, V178, P108, DOI 10.1111/cei.12531; O'Brien SJ, 2017, J HERED, V108, P671, DOI 10.1093/jhered/esx047; Pelican KM, 2006, THERIOGENOLOGY, V66, P37, DOI 10.1016/j.theriogenology.2006.03.013; Robertson SA, 2001, SEMIN IMMUNOL, V13, P243, DOI 10.1006/smim.2000.0320; Senger P.L., 2005, PATHWAYS PREGNANCY P, V2nd ed.; Siemieniuch MJ, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-89; SIITERI PK, 1982, BIOL REPROD, V26, P1, DOI 10.1095/biolreprod26.1.1; Szekeres-Bartho Julia, 2002, Int Rev Immunol, V21, P471, DOI 10.1080/08830180215017; Tsutsui T, 2009, REPROD DOMEST ANIM, V44, P120, DOI 10.1111/j.1439-0531.2009.01452.x; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; WILDT DE, 1993, ZOO BIOL, V12, P45, DOI 10.1002/zoo.1430120107; WILDT DE, 1987, BIOL REPROD, V36, P351, DOI 10.1095/biolreprod36.2.351	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0225354	10.1371/journal.pone.0225354	http://dx.doi.org/10.1371/journal.pone.0225354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040477	Green Published, Green Submitted, gold			2022-12-26	WOS:000534629400004
J	Dampmann, M; Gorgens, A; Mollmann, M; Murke, F; Duhrsen, U; Giebel, B; Durig, J				Dampmann, Maria; Gorgens, Andre; Mollmann, Michael; Murke, Florian; Duhrsen, Ulrich; Giebel, Bernd; Durig, Jan			CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo	PLOS ONE			English	Article							HEMATOPOIETIC STEM; OBLIMERSEN SODIUM; BCL-2 ANTISENSE; PHASE-I; DNA; OLIGONUCLEOTIDE; EXPRESSION; APOPTOSIS; TRIAL	In order to accomplish their physiological functions leukocytes have the capability to migrate. As a prerequisite they need to adopt a polarized cell shape, forming a leading edge at the front and a uropod at rear pole. In this study we explored the capability of chronic lymphocytic leukaemia (CLL) cells to adopt this leukocyte-specific migration phenotype. Furthermore, we studied the impact of the Toll-like receptor 9 (TLR9) agonists CpGs type A, B and C and the antagonist oligodesoxynucleotide (ODN) INH-18 on the cell polarization and migration process of primary human CLL cells. Upon cultivation, a portion of purified CLL cells adopted polarized cell shapes spontaneously (range 10-38%). Stimulation with CpG ODNs type B (ODN 2006) and CpGs type C (ODN 2395) significantly increased the frequency of morphologically polarized CLL cells, while ODN INH-18 was hardly able to act antagonistically. Like in human hematopoietic stem and progenitor cells, in morphologically polarized CLL cells CXCR4 was redistributed to the leading edge and CD50 to the uropod. Coupled to the increased frequencies of morphologically polarized cells, CpGs type B and C stimulated CLL cells showed higher migration activities in vitro and following intravenous injection higher homing frequencies to the bone marrow of immunocompromised NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ (NSG) mice. Thus, presumably independent of TLR-9 signaling, CpGs type B and C promote the cellular polarization process of CLL cells and their ability to migrate in vitro and in vivo.	[Dampmann, Maria; Mollmann, Michael; Duhrsen, Ulrich; Durig, Jan] Univ Duisburg Essen, Univ Hosp, Dept Hematol, Essen, Germany; [Gorgens, Andre] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Gorgens, Andre; Murke, Florian; Giebel, Bernd] Univ Duisburg Essen, Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Durig, Jan] St Josef Hosp, Dept Internal Med, Essen, Germany	University of Duisburg Essen; Karolinska Institutet; University of Duisburg Essen	Durig, J (corresponding author), Univ Duisburg Essen, Univ Hosp, Dept Hematol, Essen, Germany.; Giebel, B (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Transfus Med, Essen, Germany.; Durig, J (corresponding author), St Josef Hosp, Dept Internal Med, Essen, Germany.	bernd.giebel@uk-essen.de; jan.duerig@sjk.uk-essen.de	Görgens, André/C-3835-2016; Giebel, Bernd/AAH-1083-2021	Görgens, André/0000-0001-9198-0857; Giebel, Bernd/0000-0003-2446-948X; Dampmann, Maria/0000-0003-1418-3269	Wiedenfeldstiftung	Wiedenfeldstiftung	Maria Dampmann was supported by the Wiedenfeldstiftung.	Burger JA, 2010, SEMIN CANCER BIOL, V20, P424, DOI 10.1016/j.semcancer.2010.09.005; del Pozo MA, 1998, CELL ADHES COMMUN, V6, P125, DOI 10.3109/15419069809004468; Durig J, 2011, LEUKEMIA, V25, P638, DOI 10.1038/leu.2010.322; Durig J, 2007, CANCER RES, V67, P8653, DOI 10.1158/0008-5472.CAN-07-1198; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Goergens A, 2010, J Stem Cells Regen Med, V6, P74; Gorgens A, 2013, CELL CYCLE, V12, P3478, DOI 10.4161/cc.26900; Gorgens A, 2013, CELL REP, V3, P1539, DOI 10.1016/j.celrep.2013.04.025; Gorgens A, 2012, INT J BIOCHEM CELL B, V44, P1121, DOI 10.1016/j.biocel.2012.03.020; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hutchinson CV, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-7; Jahrsdorfer B, 2001, J LEUKOCYTE BIOL, V69, P81; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; O'Brien SM, 2005, J CLIN ONCOL, V23, P7697, DOI 10.1200/JCO.2005.02.4364; O'Brien S, 2007, J CLIN ONCOL, V25, P1114, DOI 10.1200/JCO.2006.07.1191; Pepper C, 1999, BRIT J HAEMATOL, V107, P611, DOI 10.1046/j.1365-2141.1999.01726.x; Rajendran L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008290; Robertson LE, 1996, LEUKEMIA, V10, P456; Rozkova D, 2010, INT J CANCER, V126, P1132, DOI 10.1002/ijc.24832; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Vestweber D, 2012, CURR OPIN HEMATOL, V19, P212, DOI 10.1097/MOH.0b013e3283523e78; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Zent CS, 2012, LEUKEMIA LYMPHOMA, V53, P211, DOI 10.3109/10428194.2011.608451	26	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228674	10.1371/journal.pone.0228674	http://dx.doi.org/10.1371/journal.pone.0228674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040489	Green Published, gold			2022-12-26	WOS:000534629400033
J	Das Gupta, R; Haider, SS; Hashan, MR; Hasan, M; Sutradhar, I; Sajal, IH; Joshi, H; Haider, MR; Sarker, M				Das Gupta, Rajat; Haider, Shams Shabab; Hashan, Mohammad Rashidul; Hasan, Mehedi; Sutradhar, Ipsita; Sajal, Ibrahim Hossain; Joshi, Hemraj; Haider, Mohammad Rifat; Sarker, Malabika			Association between the frequency of television watching and overweight and obesity among women of reproductive age in Nepal: Analysis of data from the Nepal Demographic and Health Survey 2016	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; URBAN	Background The prevalence of overweight and obesity, particularly among women, is increasing in Nepal. Previous studies in the South Asia have found television watching to be a risk factor for overweight and obesity among women of reproductive age. However, this association had not been studied in the context of Nepal. This study aims to identify the association between frequency of television watching and overweight and obesity among Nepalese women of reproductive age. Methods This cross-sectional study utilized the Nepal Demographic and Health Survey 2016 (NDHS 2016) data. A total weighted sample of 6,031 women were included in the final analyses. The women were 15-49 years of age and were either not pregnant or had not delivered a child within the two months prior to the survey. Body mass index (BMI) was the primary outcome of this study, which was categorized using an Asia-specific cutoff value. Normal and/or underweight was defined as a BMI < 23.0 kg/m(2), overweight was defined as a BMI between 23.0 kg/m(2) and < 27.5 kg/m(2), and obesity was defined as a BMI.27.5 kg/m(2). Frequency of watching television was the main independent variable of this study, which was divided into the following three categories: not watching television at all, watching television less than once a week, and watching television at least once a week. Multilevel ordered logistic regression was conducted to find the factors associated with overweight and obesity. A p-value <0.05 was considered significant in the final model. Results Around 35% of the participants were overweight or obese (overweight: 23.7% and obese: 11.6%). A majority of the study participants was aged between 15 and 24 years (36.5%), and resided in an urban area (63.2%), Province No. 3 (22.3%), and the Terai ecological region (49.5%). Around one-third (34.0%) of the participants received no formal education while an almost similar proportion (35.5%) completed secondary education. Approximately half of the study participants (50.6%) reported watching television at least once a week, whereas more than a quarter (28.7%) of them did not watch television at all. Women who watched television at least once a day had a higher prevalence of overweight and obesity than the other groups (p-value < 0.0001). Women who watched television at least once a week were 1.3 times more likely to be overweight or obese in comparison to women who never watched television (Adjusted Odds Ratio (AOR): 1.3, 95% CI: 1.0-1.7; p-value < 0.05). In the urban areas, women who watched television at least once a week were 40% more likely to be overweight or obese than those who did not watch television at all (AOR: 1.4, 95% CI: 1.1-1.7; p-value < 0.01). No significant association between overweight and obesity and the frequency of viewing television was observed in the rural area. Conclusions Watching television at least once a week is associated with overweight and obesity in women of reproductive age living in the urban areas of Nepal. Public health promotion programs should raise awareness among women regarding harmful health consequences of sedentary lifestyle due to television watching.	[Das Gupta, Rajat; Hasan, Mehedi; Sutradhar, Ipsita; Sarker, Malabika] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Noncommunicable Dis & Nutr, Dhaka, Bangladesh; [Das Gupta, Rajat; Haider, Shams Shabab; Hasan, Mehedi; Sutradhar, Ipsita; Sajal, Ibrahim Hossain; Sarker, Malabika] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Sci Implementat & Scale Up, Dhaka, Bangladesh; [Das Gupta, Rajat] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Hashan, Mohammad Rashidul] Bangladesh Icddr B, Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Sajal, Ibrahim Hossain] Univ Texas Dallas, Sch Nat Sci & Math, Dept Math Sci, Dallas, TX USA; [Joshi, Hemraj] Modern Tech Coll, Dept Publ Hlth, Sanepa, Lalitpur, Nepal; [Haider, Mohammad Rifat] Ohio Univ, Coll Hlth Sci & Profess, Dept Social & Publ Hlth, Athens, OH 45701 USA; [Sarker, Malabika] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	Bangladesh Rural Advancement Committee BRAC; BRAC University; Bangladesh Rural Advancement Committee BRAC; BRAC University; University of South Carolina System; University of South Carolina Columbia; International Centre for Diarrhoeal Disease Research (ICDDR); University of Texas System; University of Texas Dallas; University System of Ohio; Ohio University; Ruprecht Karls University Heidelberg	Das Gupta, R (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Noncommunicable Dis & Nutr, Dhaka, Bangladesh.; Das Gupta, R (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Sci Implementat & Scale Up, Dhaka, Bangladesh.; Das Gupta, R (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA.	rajat89.dasgupta@gmail.com	Gupta, Rajat Das/E-5545-2018; Sutradhar, Ipsita/AAW-6456-2021; Haider, Mohammad Rifat/N-9987-2016; Hasan, Mehedi/HHC-4236-2022; Hasan, Mehedi/J-8056-2019	Gupta, Rajat Das/0000-0002-7680-676X; Sutradhar, Ipsita/0000-0003-4747-7693; Haider, Mohammad Rifat/0000-0002-0690-8242; Hasan, Mehedi/0000-0003-2153-4979				Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7; Bennett GG, 2006, AM J PUBLIC HEALTH, V96, P1681, DOI 10.2105/AJPH.2005.080580; Biswas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181080; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Burke V, 2006, INT J PEDIATR OBES, V1, P248, DOI 10.1080/17477160600984975; Centers for Disease Control and Prevention, DEF AD OV OB; Chen CY, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015600480; Chowdhury MAB, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018468; Council on Communications and Media, 2011, Pediatrics, V128, P201, DOI 10.1542/peds.2011-1066; Das Gupta R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221758; Das Gupta R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024680; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Garg C, 2010, OBES REV, V11, P105, DOI 10.1111/j.1467-789X.2009.00666.x; Ghavamzadeh S, 2013, J HEALTH POPUL NUTR, V31, P334; Ghimire S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6512-z; Ghose B, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017142; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Gouda J, 2014, J HEALTH POPUL NUTR, V32, P79; Hox J.J, 2010, MULTILEVEL ANAL TECH, V2nd ed., DOI [10.4324/9780203852279, DOI 10.4324/9780203852279]; Janjua NZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122314; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kanguru L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188677; Kim SY, 2010, AM J PUBLIC HEALTH, V100, P1047, DOI 10.2105/AJPH.2009.172890; Kutner M, APPL LINEAR STAT MOD, DOI [10.7326/0003-4819-147-8-200710160-00010, DOI 10.7326/0003-4819-147-8-200710160-00010]; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Ministry of Health Nepal New ERA ICF, 2017, NEP HLTH FAC SURV 20; Ministry of Health-MOH/Nepal New ERA/Nepal ICF., 2017, NEP DEM HLTH SURV 20; Piryani S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010335; Pradhan KM, 2017, POLICY IMPLEMENTATIO; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rai A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216644; Rawal LB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205912; Resource Centre for Primary Health Care, 2014, RAP ASS MED COV JUNK; Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z; Sharma SR, 2019, GLOB HEALTH PROMOT, V26, P94, DOI 10.1177/1757975917720800; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Subedi YP, 2017, ASIA PAC J CLIN NUTR, V26, P358, DOI 10.6133/apjcn.112015.10; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Webber L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039589; WHO, 2004, LANCET, V363, P902; Xu F, 2008, PUBLIC HEALTH NUTR, V11, P891, DOI 10.1017/S1368980007001280	43	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228862	10.1371/journal.pone.0228862	http://dx.doi.org/10.1371/journal.pone.0228862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9IO	32040537	Green Published, Green Submitted, gold			2022-12-26	WOS:000534629400047
J	Kudo, S; Shiino, H; Furuta, S; Tamura, Y				Kudo, Shinnosuke; Shiino, Hiroya; Furuta, Shiina; Tamura, Yasushi			Yeast transformation stress, together with loss of Pah1, phosphatidic acid phosphatase, leads to Ty1 retrotransposon insertion into the INO4 gene	FASEB JOURNAL			English	Article						Pah1; Phospholipid; Retrotransposon; Yeast	PHOSPHOLIPID BIOSYNTHETIC GENES; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; EXPRESSION; INOSITOL; METABOLISM; CHOLINE; PHOSPHATIDYLETHANOLAMINE; CARDIOLIPIN; TRANSPORT	Most phospholipids are synthesized via modification reactions of a simple phospholipid phosphatidic acid (PA). PA and its modified phospholipids travel between organelle membranes, for example, the endoplasmic reticulum (ER) and mitochondrial inner membrane, to be converted to the other phospholipids. To gain insight into mechanisms of the phospholipid biosynthetic pathways, we searched for factors whose loss affects the phospholipid synthesis using an in vitro phospholipid transport assay. Among the various factors that were tested, we noticed that a lack of Pah1, which is a phosphatidic acid phosphatase, led to severe defects in phospholipid synthesis, which was not rescued by re-expression of wild-type Pah1. These results indicated other mutations in addition to the deletion of Pah1. Interestingly, we found that stress conditions associated with the yeast transformation process triggered a disruption of the INO4 gene by insertion of the Ty1 retrotransposon in pah1 increment strains. Additionally, we noticed that loss of the diacylglycerol kinase Dgk1, which has an opposing function to Pah1, suppressed the insertional mutation of INO4. These findings suggest that normal Pah1 function is critical for the suppression of insertional mutations by retrotransposon elements.	[Kudo, Shinnosuke; Shiino, Hiroya; Furuta, Shiina; Tamura, Yasushi] Yamagata Univ, Fac Sci, 1-4-12 Kojirakawa Machi, Yamagata, Yamagata 9908560, Japan	Yamagata University	Tamura, Y (corresponding author), Yamagata Univ, Fac Sci, 1-4-12 Kojirakawa Machi, Yamagata, Yamagata 9908560, Japan.	tamura@sci.kj.yamagata-u.ac.jp	Tamura, Yasushi/H-8270-2017	Tamura, Yasushi/0000-0002-8462-0607	Japan Agency for Medical Research and Development (AMED) [JP19gm5910026]; JSPS KAKENHI [15H05595, 17H06414, 19H03174]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19gm5910026; JSPS KAKENHI, Grant/Award Number: 15H05595, 17H06414 and 19H03174	Bachman N, 2004, GENOME RES, V14, P1232, DOI 10.1101/gr.2052904; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Dietz M, 2003, MOL MICROBIOL, V48, P1119, DOI 10.1046/j.1365-2958.2003.03501.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Gulshan K, 2010, MOL BIOL CELL, V21, P443, DOI 10.1091/mbc.E09-06-0519; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Kitamura H, 2002, J BIOL CHEM, V277, P33720, DOI 10.1074/jbc.M205672200; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; Kojima R, 2019, CELL REP, V26, P518, DOI 10.1016/j.celrep.2018.12.070; Kojima R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30777; Kwiatek JM, 2019, BIOCH BIOPHYS ACTA M, V1865, P1; LAMPING E, 1994, GENETICS, V137, P55; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Morillon A, 2002, MOL CELL BIOL, V22, P2078, DOI 10.1128/MCB.22.7.2078-2088.2002; Mularoni L, 2012, GENOME RES, V22, P693, DOI 10.1101/gr.129460.111; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Rahman MA, 2018, FEBS J, V285, P1840, DOI 10.1111/febs.14448; Sakaue H, 2019, MOL CELL, V73, P1044, DOI 10.1016/j.molcel.2019.01.003; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; Servant G, 2012, NUCLEIC ACIDS RES, V40, P5271, DOI 10.1093/nar/gks166; Suzuki K, 2011, DEV CELL, V21, P358, DOI 10.1016/j.devcel.2011.06.023; Tamura Y, 2019, METHODS MOL BIOL, V1949, P57, DOI 10.1007/978-1-4939-9136-5_6; Tamura Y, 2019, J BIOCHEM, V165, P115, DOI 10.1093/jb/mvy088; Tamura Y, 2014, TRAFFIC, V15, P933, DOI 10.1111/tra.12188; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Watanabe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8922	40	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4749	4763		10.1096/fj.201901811RR	http://dx.doi.org/10.1096/fj.201901811RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32037626	hybrid			2022-12-26	WOS:000512570900001
J	Ramos-Robles, M; Vargas-Cardoso, OR; Corona-Lopez, AM; Flores-Palacios, A; Toledo-Hernandez, VH				Ramos-Robles, Michelle; Ricardo Vargas-Cardoso, Orthon; Maria Corona-Lopez, Angelica; Flores-Palacios, Alejandro; Hugo Toledo-Hernandez, Victor			Spatio-temporal variation of Cerambycidae-host tree interaction networks	PLOS ONE			English	Article							TROPICAL DRY FOREST; SAPROXYLIC BEETLES; INSECT HERBIVORES; R-PACKAGE; PATTERNS; CANOPY; WOOD; COLEOPTERA; DIVERSITY; ASSEMBLAGES	Despite its high ecological importance, the commensal interactions at community level are poorly studied. In tropical dry forests (TDF) there is a great diversity of species adapted to the high seasonality that characterizes them; however, little is known regarding how the spatial and temporal availability of resources generates changes in the pattern of commensal interactions. We experimentally studied changes in the diversity, composition, and pattern of interactions in spatio-temporal associations between the saproxylophagous beetles and their host trees in a TDF in Morelos, Mexico. A total of 65 host tree species were selected, from which 16 wood sections were obtained per species. These sections were exposed in the field to allow oviposition by the cerambycids under four different (spatio-temporal) treatments. We analyzed the network structure and generated indices at species level (i.e., specialization, species strength, and effective partners) and those related to physical characteristics of the wood (hardness and degradation rate) and the cerambycids (body size). In total, 1,323 individuals of 57 species of cerambycids emerged. Our results showed that, independently of the space and time, the network presented a nested and modular structure, with a high specialization degree and a high turnover of cerambycid species and their interactions. In general, we found that the cerambycids are mostly associated with softwood species with a lower decomposition rate of wood, as well as with the most abundant host species. The commensalistic interactions between the cerambycids and their host trees are highly specialized but are not spatio-temporally static. The high turnover in the interactions is caused by the emergence patterns of cerambycids, which seem to restrict their use to certain species. The knowledge of the spatio-temporal variation in Cerambycidae-host tree interactions allows us to predict how environmental and structural changes in the habitat can modify the species ensemble, and therefore its interactions.	[Ramos-Robles, Michelle; Ricardo Vargas-Cardoso, Orthon; Maria Corona-Lopez, Angelica; Flores-Palacios, Alejandro; Hugo Toledo-Hernandez, Victor] Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Cuernavaca, Morelos, Mexico; [Ramos-Robles, Michelle] Univ Autonoma Agraria Antonio Narro, Dept Bot, Saltillo, Coahuila, Mexico	Universidad Autonoma del Estado de Morelos	Toledo-Hernandez, VH (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Cuernavaca, Morelos, Mexico.	victor.toledo@uaem.mx	Michelle, Ramos-Robles/S-6567-2019; Flores-Palacios, Alejandro/T-7074-2017	Michelle, Ramos-Robles/0000-0002-0692-5608; Flores-Palacios, Alejandro/0000-0002-2000-9964; Corona-Lopez, Angelica Maria/0000-0003-3445-9306; Vargas Cardoso, Orthon Ricardo/0000-0001-5251-3746; Toledo-Hernandez, Victor H./0000-0002-1119-2189	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [274685]; postdoctoral Programa para el Desarrollo Profesional Docente PRODEP [511-6/17-10976]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); postdoctoral Programa para el Desarrollo Profesional Docente PRODEP	This research was funded by a Consejo Nacional de Ciencia y Tecnologia (CONACyT) (grant 274685) awarded to ORVC, and by the postdoctoral Programa para el Desarrollo Profesional Docente PRODEP (grant 511-6/17-10976) awarded to MRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abundancia Cortes-Anzures B, 2015, DISTRIBUCION EPIFITA; Vergara-Torres CA, 2010, J TROP ECOL, V26, P563, DOI 10.1017/S0266467410000349; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; ASTM, 2007, STAND TEST METH SPEC; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Beckett SJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.140536; Berkov A, 2018, ZOOL MONOGR, V1, P547, DOI 10.1007/978-3-319-75937-1_16; Blick R, 2009, PERSPECT PLANT ECOL, V11, P41, DOI 10.1016/j.ppees.2008.10.002; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bouget C, 2011, FOREST ECOL MANAG, V261, P211, DOI 10.1016/j.foreco.2010.10.007; Brown GE, 2009, PRUNING TREES SHRUBS; Ceccon E, 2006, BRAZ ARCH BIOL TECHN, V49, P305, DOI 10.1590/S1516-89132006000300016; Danks HV, 2007, CAN ENTOMOL, V139, P1, DOI 10.4039/n06-048; Dehling DM, 2014, GLOBAL ECOL BIOGEOGR, V23, P1085, DOI 10.1111/geb.12193; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dormann CF, 2014, METHODS ECOL EVOL, V5, P90, DOI 10.1111/2041-210X.12139; Erwin T. L., 1988, BIODIVERSITY, P123; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gossner MM, 2016, BIOL CONSERV, V201, P92, DOI 10.1016/j.biocon.2016.06.032; Gossner MM, 2013, FOREST ECOL MANAG, V302, P404, DOI 10.1016/j.foreco.2013.03.039; Martinez-Hernandez JG, 2019, PEERJ, V7, DOI 10.7717/peerj.7866; Haack R.A., 1987, P449; Hammond HE, 2001, CAN J FOREST RES, V31, P1175, DOI 10.1139/cjfr-31-7-1175; Hardersen S, 2014, B INSECTOL, V67, P87; Hernandez-Cardenas JA, 2016, ENTOMOLOGIA MEXICANA, V3, P495; Holland JD, 2007, BIODIVERS CONSERV, V16, P2599, DOI 10.1007/s10531-006-9066-1; Hsieh T. C., 2013, INEXT ONLINE INTERPO; Invertebrate Link, 2002, British Journal of Entomology and Natural History, V15, P1; Jacobs JM, 2007, AGR FOREST ENTOMOL, V9, P3, DOI 10.1111/j.1461-9563.2006.00310.x; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janzen D.H., 1988, P130; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kassambara A., 2015, VISUALIZATION OUTPUT; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee CJ, 2014, BIOTROPICA, V46, P302, DOI 10.1111/btp.12101; LIU SS, 1995, ANN ENTOMOL SOC AM, V88, P107, DOI 10.1093/aesa/88.2.107; Lopez-Carretero A, 2016, AM J BOT, V103, P1436, DOI 10.3732/ajb.1600045; Martikainen P, 1999, FOREST ECOL MANAG, V116, P233, DOI 10.1016/S0378-1127(98)00462-9; Naranjo C, 2019, AOB PLANTS, V11, DOI 10.1093/aobpla/plz011; Noguera FA, 2007, PAN-PAC ENTOMOL, V83, P296, DOI 10.3956/2007-14.1; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Olesen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026455; Ospina-Garces SM, 2018, ARTHROPOD STRUCT DEV, V47, P2, DOI 10.1016/j.asd.2017.11.005; Parker Geoffrey G., 1995, P73; Patefield W. M., 1981, APPL STAT, V30, P91, DOI DOI 10.2307/2346669; Poisot T, 2012, ECOL LETT, V15, P1353, DOI 10.1111/ele.12002; Portillo-Quintero C, 2015, REG ENVIRON CHANGE, V15, P1039, DOI 10.1007/s10113-014-0689-6; Quinto J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122141; Quinto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045062; Ramilo P, 2017, J INSECT CONSERV, V21, P607, DOI 10.1007/s10841-017-9999-6; Ramirez-Hernandez A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214920; Ramos-Robles M, 2018, ECOSCIENCE, V25, P209, DOI 10.1080/11956860.2018.1446284; Ramos-Robles M, 2018, SCI NAT-HEIDELBERG, V105, DOI 10.1007/s00114-018-1556-y; RCore Team, 2020, R LANG ENV STAT COMP; Rodriguez-Rodriguez MC, 2017, ECOLOGY, V98, P1266, DOI 10.1002/ecy.1756; Ruiz-Rivera C.A., 2001, SAN ANDRES CAL CULTO; Scherrer S, 2016, BIOTROPICA, V48, P491, DOI 10.1111/btp.12325; Schowalter TD, 2016, INSECT ECOLOGY: AN ECOSYSTEM APPROACH, 4TH EDITION, P1; Seibold S, 2018, FOREST ECOL MANAG, V409, P564, DOI 10.1016/j.foreco.2017.11.052; Seibold S, 2016, J APPL ECOL, V53, P934, DOI 10.1111/1365-2664.12607; Simila M, 2002, BIOL CONSERV, V106, P19, DOI 10.1016/S0006-3207(01)00225-7; Sobek S, 2009, DIVERS DISTRIB, V15, P660, DOI 10.1111/j.1472-4642.2009.00570.x; Song CL, 2017, J ANIM ECOL, V86, P1417, DOI 10.1111/1365-2656.12749; Speight M.C.D., 1989, Council of Europe Nature and Environment Series, P1; Stokland JN, 2012, ECOL BIODIVERS CONS, P248; Tillman PG, 2009, ENVIRON ENTOMOL, V38, P1038, DOI 10.1603/022.038.0411; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Ulyshen MD, 2018, ZOOL MONOGR, V1, P1, DOI 10.1007/978-3-319-75937-1_1; Ulyshen MD, 2011, FOREST ECOL MANAG, V261, P1479, DOI 10.1016/j.foreco.2011.01.033; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Vargas-Cardoso OR, 2018, PAN-PAC ENTOMOL, V94, P91, DOI 10.3956/2018-94.2.91; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; Wardhaugh CW, 2014, BIOL REV, V89, P1021, DOI 10.1111/brv.12094; Wende B, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0198; Wermelinger B, 2007, J APPL ENTOMOL, V131, P104, DOI 10.1111/j.1439-0418.2006.01128.x; White HJ, 2018, ECOGRAPHY, V41, P845, DOI 10.1111/ecog.03111	84	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228880	10.1371/journal.pone.0228880	http://dx.doi.org/10.1371/journal.pone.0228880			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040535	Green Published, gold, Green Submitted			2022-12-26	WOS:000534629400049
J	Levy, HC; Hulvey, D; Adamson-Small, L; Jn-Simon, N; Prima, V; Rivkees, S; Hobbs, JA				Levy, Hazel C.; Hulvey, Danielle; Adamson-Small, Laura; Jn-Simon, Natacha; Prima, Victor; Rivkees, Scott; Hobbs, Jacqueline A.			Improved cell-specificity of adeno-associated viral vectors for medullary thyroid carcinoma using calcitonin gene regulatory elements	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; VIRUS TYPE-2; CANCER; IDENTIFICATION; EXPRESSION; TRANSCRIPTION; MANAGEMENT; THERAPY; DISEASE; BINDING	Targeted gene therapy using recombinant adeno-associated virus (rAAV) vectors is a potential therapeutic strategy for treating cancer, and tissue-specific promoters may help with tissue targeting. Medullary thyroid carcinoma (MTC) is a disease of the calcitonin secreting thyroid C cells, and calcitonin is highly expressed in MTC tumors compared to other cells. To target MTC cells, we evaluated an rAAV serotype 2 vector (rAAV2-pM+104-GFP) containing a modified calcitonin/calcitonin gene related peptide promoter (pM+104) and a green fluorescent protein (GFP) reporter gene. In vitro transduction experiments comparing the MTC TT cell line with non-MTC cell lines demonstrated that rAAV2-pM+104-GFP infection yielded significantly (p < 0.05) higher GFP expression in TT cells than in non-MTC cell lines (HEK293 and HeLa), and significantly higher expression than in TT cells infected with the positive control rAAV2-pCBA-GFP vector. The rAAV2-pCBA-GFP control vector included a well-characterized, ubiquitously expresses control promoter, the chicken beta actin promoter with a cytomegalovirus enhancer (pCBA). In vivo experiments using a TT cell xenograft tumor mouse model showed that tumors directly injected with 2 x 10(10) vg of rAAV2-pM+104-GFP vector resulted in GFP expression detected in 21.7% of cells, 48 hours after the injection. Furthermore, GFP expression was significantly higher for rAAV-pM +104-GFP treatments with a longer vector treatment duration and higher vector dose, with up to 52.6% (q < 0.05) GFP cells detected 72 hours after injecting 1x 10(11) vg/tumor. These data show that we have developed an rAAV vector with improved selectivity for MTC.	[Levy, Hazel C.; Hulvey, Danielle; Adamson-Small, Laura; Jn-Simon, Natacha; Prima, Victor; Rivkees, Scott] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA; [Hobbs, Jacqueline A.] Univ Florida, Dept Psychiat, Coll Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Levy, HC (corresponding author), Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA.	hclevy@ufl.edu		Hobbs, Jacqueline/0000-0002-4488-6304	National Institutes of Health (NIH-NHLBI) [3R01HL90708806S1]; Children's Miracle Network at the University of Florida	National Institutes of Health (NIH-NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Children's Miracle Network at the University of Florida	This work was supported by National Institutes of Health (NIH-NHLBI; https://urldefense.proofpoint.com/v2/url?u=https-3A__www.nhlbi.nih.gov_&d=DwIGaQ&c=sJ6xIWYx-zLMB3EPkv cnVg&r=jilNh6XqfuCP849b8B4l1w&m=ho-Y04Ag ZWsl4vmIiqOxFRqwr0jQJxqpEbAYm6LceRM&s= Fi1OFDrsHN_sd8GqY3IB9ob5zK_4tqgS43k8I1C IoQI&e=) Diversity Supplement 3R01HL90708806S1 (to HCL) and a grant from Children's Miracle Network (https://urldefense.proofpoint.com/v2/url? u=https-3A__childrensmiraclenetworkhospitals.org_about-2Dus_&d=DwIGaQ&c=sJ6xIWYx-zLM B3EPkvcnVg&r=jilNh6XqfuCP849b8B4l1w&m=hoY04AgZWsl4vmIiqOxFRqwr0jQJxqpEbAYm6LceR M&s=beEPsF34w5LGdQlSXB9nOlGn9wrKWEGUi0 Wirndx7BM&e=) at the University of Florida (to JAH and SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adamson LA, 2014, J MED VIROL, V86, P1614, DOI 10.1002/jmv.23852; AMARA SG, 1980, P NATL ACAD SCI-BIOL, V77, P4444, DOI 10.1073/pnas.77.8.4444; [Anonymous], 1986, P 8 INT C PATT REC; BALL DW, 1992, NUCLEIC ACIDS RES, V20, P117, DOI 10.1093/nar/20.1.117; BECKER KL, 1979, ACTA ENDOCRINOL-COP, V92, P746, DOI 10.1530/acta.0.0920746; Bockmann M, 2005, HUM GENE THER, V16, P1267, DOI 10.1089/hum.2005.16.1267; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; Brutsaert EF, 2015, J CLIN ENDOCR METAB, V100, P337, DOI 10.1210/jc.2014-3095; Buning H, 2013, EMBO MOL MED, V5, P1, DOI 10.1002/emmm.201202291; Buning H, 2019, MOL THER-METH CLIN D, V12, P248, DOI 10.1016/j.omtm.2019.01.008; COTE GJ, 1992, NUCLEIC ACIDS RES, V20, P2361, DOI 10.1093/nar/20.9.2361; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; DEBUSTROS A, 1992, BIOCHEM BIOPH RES CO, V189, P1157, DOI 10.1016/0006-291X(92)92325-R; DEBUSTROS A, 1985, J BIOL CHEM, V260, P98; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P682, DOI 10.1210/jc.2007-1714; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Frendo JL, 1998, THYROID, V8, P141, DOI 10.1089/thy.1998.8.141; Frendo JL, 1998, MOL CELL ENDOCRINOL, V139, P37, DOI 10.1016/S0303-7207(98)00075-6; Ghazi AA, 2014, ARCH IRAN MED, V17, P378, DOI 0141705/AIM.0013; Grabowski P, 2012, DRUG TODAY, V48, P723, DOI 10.1358/dot.2012.48.11.1867323; Hedayati M, 2006, Med J Malaysia, V61, P564; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Jiang S, 2001, CANCER GENE THER, V8, P469, DOI 10.1038/sj.cgt.7700327; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Kloos RT, 2009, THYROID, V19, P565, DOI 10.1089/thy.2008.0403; KOTIN RM, 1994, HUM GENE THER, V5, P793, DOI 10.1089/hum.1994.5.7-793; Lisowski L, 2015, CURR OPIN PHARMACOL, V24, P59, DOI 10.1016/j.coph.2015.07.006; Majidi Mahnaz, 2011, J Med Case Rep, V5, P587, DOI 10.1186/1752-1947-5-587; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Messina M, 2000, MOL CELL ENDOCRINOL, V164, P219, DOI 10.1016/S0303-7207(00)00204-5; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mohammadi M, 2017, CELL J, V18, P485; MONIA YT, 1995, MOL ENDOCRINOL, V9, P784; Morandi A, 2011, TRENDS MOL MED, V17, P149, DOI 10.1016/j.molmed.2010.12.007; Muller B, 2001, J CLIN ENDOCR METAB, V86, P396, DOI 10.1210/jc.86.1.396; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; PELEG S, 1990, MOL ENDOCRINOL, V4, P1750, DOI 10.1210/mend-4-11-1750; Rendl G, 2008, CLIN ENDOCRINOL, V69, P497, DOI 10.1111/j.1365-2265.2008.03229.x; Romei C, 2011, CLIN ENDOCRINOL, V74, P241, DOI 10.1111/j.1365-2265.2010.03900.x; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Salehian B, 2013, J CLIN RES PEDIATR E, V5, P70, DOI 10.4274/Jcrpe.870; Schneider AB, 2005, WERNER INGBARS THYRO, P889; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Sippel RS, 2008, ONCOLOGIST, V13, P539, DOI 10.1634/theoncologist.2007-0239; Spitzweg C, 2004, THYROID, V14, P424, DOI 10.1089/105072504323150732; Starenki D, 2017, CANCER BIOL THER, V18, P473, DOI 10.1080/15384047.2017.1323594; Waguespack SG, 2011, NAT REV ENDOCRINOL, V7, P596, DOI 10.1038/nrendo.2011.139; Zhong L, 2006, CURR GENE THER, V6, P683, DOI 10.2174/156652306779010660; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228005	10.1371/journal.pone.0228005	http://dx.doi.org/10.1371/journal.pone.0228005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027681	gold, Green Published			2022-12-26	WOS:000534623800014
J	Machiels, JD; Cremers, AJH; van Bergen-Verkuyten, MCGT; Paardekoper-Strijbosch, SJM; Frijns, KCJ; Wertheim, HFL; Rahamat-Langendoen, J; Melchers, WJG				Machiels, Julian D.; Cremers, Amelieke J. H.; van Bergen-Verkuyten, Muriel C. G. T.; Paardekoper-Strijbosch, Sandra J. M.; Frijns, Kelly C. J.; Wertheim, Heiman F. L.; Rahamat-Langendoen, Janette; Melchers, Willem J. G.			Impact of the BioFire FilmArray gastrointestinal panel on patient care and infection control	PLOS ONE			English	Article							REAL-TIME PCR; CLINICAL MICROBIOLOGY; DIAGNOSIS; GASTROENTERITIS; NETHERLANDS; SAMPLES; TESTS	Objectives Conventional routine PCR testing for gastrointestinal infections is generally based on pathogen related panels specifically requested by clinicians and can be erroneous and time consuming. The BioFire FilmArray gastrointestinal (GI) panel combines 22 pathogens into a single cartridge-based test on a random-access system, thereby reducing the turnaround time to less than 2 hours. We described the clinical impact of implementing the BioFire FilmArray on patients with gastroenteritis in our hospital. Methods Patients attending a Dutch tertiary care center (Radboud University Medical Center), from whom stool samples were obtained, were eligible for inclusion. The clinicians selected one or a combination of different routinely performed PCR panels (bacterial panel, viral panel, clostridium testing, and three parasitic panels) based on clinical history and symptoms. All samples were in parallel tested with the FilmArray. We retrospectively collected patient data regarding infection control and patient management to assess the potential impact of implementing the FilmArray. Results In total 182 patients were included. Routine PCR detected one or more pathogens in 52 (28.6%) patients compared to 72 (39.6%) using the FilmArray. Turnaround time (including transport) decreased from median 53 hours for the routine PCR to 16 hours for the FilmArray. Twenty-six patients could have been removed from isolation 29 hours sooner, 3.6 antibiotic days could have been saved and in five patients additional imaging testing (including colonoscopies) could have been prevented. Conclusion The theoretical implementation of the BioFire FilmArray GI panel in patients with clinical suspicion of gastroenteritis resulted in a significant better patient management.	[Machiels, Julian D.; Cremers, Amelieke J. H.; van Bergen-Verkuyten, Muriel C. G. T.; Paardekoper-Strijbosch, Sandra J. M.; Frijns, Kelly C. J.; Wertheim, Heiman F. L.; Rahamat-Langendoen, Janette; Melchers, Willem J. G.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Machiels, Julian D.; Cremers, Amelieke J. H.; van Bergen-Verkuyten, Muriel C. G. T.; Paardekoper-Strijbosch, Sandra J. M.; Frijns, Kelly C. J.; Wertheim, Heiman F. L.; Rahamat-Langendoen, Janette; Melchers, Willem J. G.] Radboud Univ Nijmegen, Med Ctr, Radboudumc Ctr Infect Dis, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Machiels, JD (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands.	Julian.machiels@radboudumc.nl	Cremers, Amelieke J.H./A-5536-2016; Melchers, Willem/C-8819-2015; Wertheim, Heiman FL/F-3338-2016; Cremers, Amelieke/R-5197-2019	Cremers, Amelieke J.H./0000-0003-4704-4978; Melchers, Willem/0000-0002-5446-2230; Wertheim, Heiman FL/0000-0002-5003-5565; Cremers, Amelieke/0000-0003-4704-4978; Machiels, Julian/0000-0003-2606-8276				Barratt JLN, 2011, GUT MICROBES, V2, P3, DOI 10.4161/gmic.2.1.14755; Beal SG, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.02012-17, 10.1128/JCM.02029-17]; Beersma MFC, 2012, J CLIN MICROBIOL, V50, P3040, DOI 10.1128/JCM.00908-12; Bos J., 2014, SWAB GUIDELINE ANTIM; Buss SN, 2015, J CLIN MICROBIOL, V53, P915, DOI 10.1128/JCM.02674-14; Crobach MJT, 2016, CLIN MICROBIOL INFEC, V22, pS63, DOI 10.1016/j.cmi.2016.03.010; Cybulski Jr R.J., 2018, CLIN INFECT DIS; de Boer RF, 2013, J CLIN MICROBIOL, V51, P253, DOI 10.1128/JCM.01716-12; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; Freeman K, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21230; Friesema IHM, 2012, EUR J CLIN MICROBIOL, V31, P1895, DOI 10.1007/s10096-011-1518-1; Jensen AN, 2005, J APPL MICROBIOL, V99, P292, DOI 10.1111/j.1365-2672.2005.02616.x; Lambertz ST, 2008, APPL ENVIRON MICROB, V74, P6060, DOI 10.1128/AEM.00405-08; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; MATTILA L, 1994, CLIN INFECT DIS, V19, P728, DOI 10.1093/clinids/19.4.728; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/cix1085, 10.1093/cid/ciy149]; Murphy CN, 2017, EUR J CLIN MICROBIOL, V36, P747, DOI 10.1007/s10096-016-2858-7; Pavlovic M, 2010, FOODBORNE PATHOG DIS, V7, P801, DOI 10.1089/fpd.2009.0457; PHE, 2013, UK STAND MICR INV GA; Rand KH, 2015, DIAGN MICR INFEC DIS, V82, P154, DOI 10.1016/j.diagmicrobio.2015.01.007; Riddle MS, 2016, AM J GASTROENTEROL, V111, P602, DOI 10.1038/ajg.2016.126; Schreckenberger PC, 2015, J CLIN MICROBIOL, V53, P3110, DOI 10.1128/JCM.00382-15; Shea S, 2017, J CLIN MICROBIOL, V55, P10, DOI [10.1128/jcm.01624-16, 10.1128/JCM.01624-16]; Stockmann C, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.07.011; Thiem VD, 2004, J CLIN MICROBIOL, V42, P2031, DOI 10.1128/JCM.42.5.2031-2035.2004; van Maarseveen NM, 2010, J CLIN VIROL, V49, P205, DOI 10.1016/j.jcv.2010.07.019; Verweij JJ, 2003, INT J MED MICROBIOL, V293, P199, DOI 10.1078/1438-4221-00252; Verweij JJ, 2004, J CLIN MICROBIOL, V42, P1220, DOI 10.1128/JCM.42.3.1220-1223.2004; Wong YKN, 2019, CLIN INFECT DIS, V68, P711, DOI 10.1093/cid/ciy701	29	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228596	10.1371/journal.pone.0228596	http://dx.doi.org/10.1371/journal.pone.0228596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027698	Green Published, gold			2022-12-26	WOS:000534623800053
J	Park, S; Kyung, G; Yi, J; Choi, D; Lee, S				Park, Sungryul; Kyung, Gyouhyung; Yi, Jihhyeon; Choi, Donghee; Lee, Songil			Curved TVs improved watching experience when display curvature radii approached viewing distances: Effects of display curvature radius, viewing distance, and lateral viewing position on TV watching experience	PLOS ONE			English	Article							VISUAL FATIGUE; LCD-TV; TELEVISION; COMFORT; HOME; PERFORMANCE; LEGIBILITY; DISCOMFORT; EYESTRAIN; SICKNESS	Although watching TV often involves multiple viewing distances and viewers, less attention has been paid to the effects of display curvature radius, viewing distance, and lateral viewing position on TV watching experience. This study examined the effects of four display curvature radii (2300R, 4000R, 6000R, and flat), two viewing distances (2.3 m and 4 m), and five lateral viewing positions (P-1-P-5; 0, 35, 70, 105, and 140 cm off-center) on seven TV watching experience elements (spatial presence, engagement, ecological validity, negative effects, visual comfort, image quality, and user satisfaction). Fifty-six individuals (14 per display curvature radius) were seated in pairs to watch videos, each time at a different viewing position (2 viewing distances x 5 paired lateral viewing positions). The spatial presence and engagement increased when display curvature radius approached a viewing distance and lateral viewing position approached P-1, with 4000R-4m-P-1 (display curvature radius-viewing distance-lateral viewing position) providing the best results. Lateral viewing position alone significantly affected five TV watching experience elements; the spatial presence and engagement decreased at P-3-P-5, and ecological validity, image quality, and user satisfaction decreased at P-4-P-5. However, display curvature radius alone did not appreciably affect TV watching experience, and viewing distance alone significantly affected visual comfort only, with a 4-m viewing distance increasing visual comfort. This study demonstrated that effective display curvature radii for watching TV are viewing distance-dependent, and less off-center lateral viewing positions (P-1-P-2) are recommended for TV watching experience. Finally, among the TV watching experience elements, engagement explained user satisfaction to the greatest degree.	[Park, Sungryul; Kyung, Gyouhyung; Yi, Jihhyeon; Choi, Donghee; Lee, Songil] UNIST, Dept Human Factors Engn, Ulsan, South Korea; [Kyung, Gyouhyung] Hanyang Univ, Div Media Culture & Design Technol, Ansan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Hanyang University	Kyung, G (corresponding author), UNIST, Dept Human Factors Engn, Ulsan, South Korea.; Kyung, G (corresponding author), Hanyang Univ, Div Media Culture & Design Technol, Ansan, South Korea.	ghkyung@gmail.com	Kyung, Gyouhyung/AAN-1328-2021; Kyung, Gyouhyung/F-5342-2010	Kyung, Gyouhyung/0000-0003-3612-1720; Park, Sungryul/0000-0002-4662-6506	National Research Foundation of Korea [NRF-2016R1A2B4010158]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was funded by the National Research Foundation of Korea (NRF-2016R1A2B4010158). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi AJ, 2017, APPL ERGON, V58, P573, DOI 10.1016/j.apergo.2016.04.009; Akelo V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131163; [Anonymous], 2012, BT2022 IR ITU; [Anonymous], BT50013 IR; Ardito M, 1996, IEEE T CONSUM ELECTR, V42, P145, DOI 10.1109/30.485473; Baranowski AM, 2016, DISPLAYS, V44, P53, DOI 10.1016/j.displa.2016.06.004; Biocca F., 1997, J COMPUT-MEDIAT COMM, V3, DOI [10.1111/j.1083-6101.1997.tb00070.x, DOI 10.1111/J.1083-6101.1997.TB00070.X]; Blankenbach K., 2015, SID S, V46, P630; Bracken CC, 2005, MEDIA PSYCHOL, V7, P191, DOI 10.1207/S1532785XMEP0702_4; Bulu ST, 2012, COMPUT EDUC, V58, P154, DOI 10.1016/j.compedu.2011.08.024; Cai HY, 2014, APPL ERGON, V45, P865, DOI 10.1016/j.apergo.2013.11.004; Chang J, 2014, INT J IND ERGONOM, V44, P801, DOI 10.1016/j.ergon.2014.10.005; Chapman D., 1960, DESIGN ETV PLANNING; Chen CX, 2013, DISPLAYS, V34, P81, DOI 10.1016/j.displa.2013.01.002; Choi Bernard C K, 2005, Prev Chronic Dis, V2, pA16; CHOI K, 2015, SID S, V46, P798, DOI DOI 10.1002/SDTP.10315; Christou G, 2014, COMPUT HUM BEHAV, V32, P92, DOI 10.1016/j.chb.2013.11.018; Company EK, 2009, KODAKS ERGONOMIC DES; Fujine T, 2007, JPN J APPL PHYS 1, V46, P1358, DOI 10.1143/JJAP.46.1358; Gausewitz CH, 1964, SPACE AUDIO VISUAL L; Goldmark PC, 1940, P IRE, V28, P343; Hakkinen J, 2008, ELECT IMAGING, V2008; HATADA T, 1980, SMPTE J, V89, P560, DOI 10.5594/J01582; HEDMAN LR, 1984, HUM FACTORS, V26, P357, DOI 10.1177/001872088402600311; Heeter C., 1992, PRESENCE, V1, P262, DOI DOI 10.1162/PRES.1992.1.2.262; Huynh-Thu Q, 2010, IEEE IMAGE PROC, P4025, DOI 10.1109/ICIP.2010.5650571; Iatsun I, 2015, DISPLAYS, V39, P11, DOI 10.1016/j.displa.2015.07.001; Kee Se-Young, 2006, Korean J Ophthalmol, V20, P177; Kim H, 2018, APPL ERGON, V68, P72, DOI 10.1016/j.apergo.2017.11.003; Kim T., 2003, KOREAN J BROADCASTIN, V17, P111; Kim T., 2006, J COMPUT-MEDIAT COMM, V3; Kim T, 2014, IEEE T MULTIMEDIA, V16, P387, DOI 10.1109/TMM.2013.2292592; Kim Taeyong, 2014, [Korean Journal of Broadcasting and Telecommunication Studies, 한국방송학보], V28, P50; Kubota S., 2006, Journal of the Institute of Image Information and Television Engineers, V60, P597, DOI 10.3169/itej.60.597; Kwon JM, 2006, STUDY INFLUENCE MEDI; Lambooij M, 2011, DISPLAYS, V32, P209, DOI 10.1016/j.displa.2011.05.012; Lambooij M, 2011, IEEE T BROADCAST, V57, P432, DOI 10.1109/TBC.2011.2134590; Lambooij M, 2009, J IMAGING SCI TECHN, V53, DOI 10.2352/J.ImagingSci.Technol.2009.53.3.030201; Lee DS, 2012, APPL ERGON, V43, P151, DOI 10.1016/j.apergo.2011.04.007; Lee EC, 2009, IEEE T CONSUM ELECTR, V55, P1447, DOI 10.1109/TCE.2009.5278012; 이옥기, 2006, [Korean Journal of Broadcasting and Telecommunication Studies, 한국방송학보], V20, P197; 권중문, 2007, [Journal of Communication Science, 언론과학연구], V7, P5; Lessiter J, 2001, PRESENCE-TELEOP VIRT, V10, P282, DOI 10.1162/105474601300343612; Lin JJW, 2002, P IEEE VIRT REAL ANN, P164, DOI 10.1109/VR.2002.996519; LOMBARD M, 1995, COMMUN RES, V22, P288, DOI 10.1177/009365095022003002; Lombard M, 2000, HUM COMMUN RES, V26, P75, DOI 10.1111/j.1468-2958.2000.tb00750.x; Lombard M., 1997, J COMPUT-MEDIAT COMM, V3, DOI DOI 10.1111/J.1083-6101.1997.TB00072.X; Maguire M, 2001, INT J HUM-COMPUT ST, V55, P453, DOI 10.1006/ijhc.2001.0486; Maia OB, 2015, COMPUT COMMUN, V57, P1, DOI 10.1016/j.comcom.2014.11.005; Matsumoto T, 2011, J SOC INF DISPLAY, V19, P813, DOI 10.1889/JSID19.11.813; MCVEY GF, 1970, AV COMMUN REV, V18, P277; Moon Jang Ho, 2014, International Journal of Contents, V10, P23, DOI 10.5392/IJoC.2014.10.4.023; Mun S, 2015, OPT ENG, V54, DOI 10.1117/1.OE.54.10.103104; Mustonen T, 2015, HUM FACTORS, V57, P1029, DOI 10.1177/0018720815570090; Na N, 2016, J SOC INF DISPLAY, V24, P21, DOI 10.1002/jsid.411; Na N, 2015, PROC SPIE, V9394, DOI 10.1117/12.2078102; Narita N., 2001, TE J, V55, P773; NATHAN JG, 1985, HUM FACTORS, V27, P467, DOI 10.1177/001872088502700410; Nimako S. G, 2012, EUR J BUS MANAGE, V4, P1; Nojiri Y., 2006, P IBC, V373; Nussbaumer LL., 2013, HUMAN FACTORS BUILT; Oh H, 2016, IEEE T IMAGE PROCESS, V25, P3358, DOI 10.1109/TIP.2016.2567099; Ohtsuka S., 2015, SID S, V46, P1274, DOI [10.1002/sdtp.10089, DOI 10.1002/SDTP.10089]; Ohtsuka S., 2016, SID S, V47, P907; Orlandi L, 2018, APPL ERGON, V69, P74, DOI 10.1016/j.apergo.2018.01.005; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Park J, 2015, IEEE T IMAGE PROCESS, V24, P1101, DOI 10.1109/TIP.2014.2383327; Park S, 2016, SID S, V47, P911, DOI DOI 10.1002/sdtp.10846; Park S, 2014, IMID P, V527; Park S, 2017, APPL ERGON, V60, P183, DOI 10.1016/j.apergo.2016.11.012; Park Y, 2015, J SOC INF DISPLAY, V23, P391, DOI 10.1002/jsid.348; Polonen M, 2013, APPL ERGON, V44, P151, DOI 10.1016/j.apergo.2012.06.006; Reeves B, 1999, MEDIA PSYCHOL, V1, P49, DOI DOI 10.1207/S1532785XMEP0101_4; Kleiner AFR, 2015, APPL ERGON, V50, P147, DOI 10.1016/j.apergo.2015.02.010; Sagawa K, 1999, COLOR RES APPL, V24, P313, DOI 10.1002/(SICI)1520-6378(199910)24:5<313::AID-COL3>3.0.CO;2-B; Saglimbene V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179511; Sakamoto K, 2008, LECT NOTES COMPUT SC, V5068, P232; Sakamoto K, 2014, IEEE I C CONS ELECT, P162, DOI 10.1109/ICCE-Berlin.2014.7034209; Sakamoto Kiyomi, 2012, J Hum Ergol (Tokyo), V41, P17; SCHADE OH, 1987, SMPTE J, V96, P567, DOI 10.5594/J03153; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Tam WJ, 2011, IEEE T BROADCAST, V57, P335, DOI 10.1109/TBC.2011.2125070; TODD JT, 2007, J VISION, V7, P1, DOI DOI 10.1167/7.12.9; Vespa J, 2013, CURRENT POPULATION R, P1; Vishwanath D, 2005, NAT NEUROSCI, V8, P1401, DOI 10.1038/nn1553; Wadsworth R., 1968, ARCHIT REC, V144, P149; Welde B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187111; Wirth W, 2007, MEDIA PSYCHOL, V9, P493, DOI 10.1080/15213260701283079; Wu HC, 2011, ERGONOMICS, V54, P806, DOI 10.1080/00140139.2011.600775; Yang HC, 2012, J BROADCAST ENG, V17, P60, DOI [10.5909/jeb.2012.17.1.60, DOI 10.5909/JEB.2012.17.1.60]; Zannoli M, 2017, ACM T APPL PERCEPT, V15, DOI 10.1145/3106012; Zhang YH, 2015, COMM COM INF SC, V528, P150, DOI 10.1007/978-3-319-21380-4_27; Zhong X, 2014, SID S, V45, P1077; 이옥기, 2009, [Korean Journal of Communication & Information, 한국언론정보학보], V48, P231	94	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228437	10.1371/journal.pone.0228437	http://dx.doi.org/10.1371/journal.pone.0228437			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9GK	32027670	Green Published, gold			2022-12-26	WOS:000534623800035
J	Sato, S; Kiyono, R; Takahashi, N; Yoshida, T; Takeuchi, K; Nakamura, M				Sato, Shigeru; Kiyono, Ryosuke; Takahashi, Nobushige; Yoshida, Tomoichi; Takeuchi, Kosuke; Nakamura, Masatoshi			The acute and prolonged effects of 20-s static stretching on muscle strength and shear elastic modulus	PLOS ONE			English	Article							CONDITIONING PRACTICES; PASSIVE STIFFNESS; MUSCULOTENDINOUS STIFFNESS; LEAGUE STRENGTH; PEAK TORQUE; TIME-COURSE; PERFORMANCE; DURATION; HARDNESS; MOMENT	Introduction Static stretching (SS) is commonly performed as part of warm-up routine. However, only few previous studies have reported on the effects of short-duration SS, which is often used in the sports field. The purpose of this study was to investigate the acute and prolonged effects of 20-s SS on isokinetic contraction muscle strength, range of motion (ROM), and the shear elastic modulus. Method Twenty male volunteers participated in this study. The ROM and both concentric and eccentric contraction muscle strengths were measured using a dynamometer. In addition, the shear elastic modulus of medial gastrocnemius muscle in dominant leg was measured by ultrasonic shear wave elastography. The participants visited the laboratory on four occasions each separated by > 3 days. The first visit was a familiarization trial, and the subsequent three visits included the following experimental conditions in a random order. All measurements were performed prior to and immediately after SS or 5 min and 10 min after 20-s SS. Results The results of this study showed that the ROM was significantly increased SS intervention in all conditions compared with prior to SS intervention. In addition, ROM was significantly higher post SS and 5 min after SS than 10 min after SS. However, there were no significant interaction effects for isokinetic contraction muscle strength and the shear elastic modulus Conclusion In the sports field, from the point of performance, a 20-s SS intervention could be a useful technique before exercise because it increases ROM and does not decrease maximum torque.	[Sato, Shigeru; Kiyono, Ryosuke; Takahashi, Nobushige; Yoshida, Tomoichi; Nakamura, Masatoshi] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata, Japan; [Takeuchi, Kosuke] Kobe Int Univ, Fac Rehabil, Dept Phys Therapy, Kobe, Hyogo, Japan; [Nakamura, Masatoshi] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan	Niigata University; Niigata University	Nakamura, M (corresponding author), Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata, Japan.; Nakamura, M (corresponding author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan.	masatoshi-nakamura@nuhw.ac.jp		Sato, Shigeru/0000-0002-4669-551X				Akagi R, 2014, SCAND J MED SCI SPOR, V24, P950, DOI 10.1111/sms.12111; Akagi R, 2013, MED SCI SPORT EXER, V45, P1348, DOI 10.1249/MSS.0b013e3182850e17; Behm DG, 2016, APPL PHYSIOL NUTR ME, V41, P1, DOI 10.1139/apnm-2015-0235; Behm DG, 2011, EUR J APPL PHYSIOL, V111, P2633, DOI 10.1007/s00421-011-1879-2; Borges PRT, 2017, BRAZ J PHYS THER, V21, P51, DOI 10.1016/j.bjpt.2016.12.004; Cannavan D, 2012, CLIN BIOMECH, V27, P306, DOI 10.1016/j.clinbiomech.2011.10.003; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cramer JT, 2007, J ORTHOP SPORT PHYS, V37, P130, DOI 10.2519/jospt.2007.2389; Duehring MD, 2009, J STRENGTH COND RES, V23, P2188, DOI 10.1519/JSC.0b013e3181bac62d; Ebben WP, 2005, J STRENGTH COND RES, V19, P538; Ebben WP, 2004, J STRENGTH COND RES, V18, P889, DOI 10.1519/00124278-200411000-00036; Ebben WP, 2001, J STRENGTH COND RES, V15, P48; HATANO G, 2019, J SPORT REHABIL, V28, P325, DOI DOI 10.1123/JSR.2017-0203; Hirata K, 2017, EUR J APPL PHYSIOL, V117, P493, DOI 10.1007/s00421-017-3550-z; Hirata K, 2016, EUR J APPL PHYSIOL, V116, P911, DOI 10.1007/s00421-016-3349-3; Kay AD, 2008, EUR J SPORT SCI, V8, P41, DOI 10.1080/17461390701855505; Kay AD, 2012, MED SCI SPORT EXER, V44, P154, DOI 10.1249/MSS.0b013e318225cb27; Kay AD, 2009, J APPL PHYSIOL, V106, P1249, DOI 10.1152/japplphysiol.91476.2008; Knudson D, 2005, EUR J APPL PHYSIOL, V94, P348, DOI 10.1007/s00421-004-1309-9; Mizuno T, 2013, SCAND J MED SCI SPOR, V23, P23, DOI 10.1111/j.1600-0838.2011.01329.x; Mizuno T, 2014, J STRENGTH COND RES, V28, P147, DOI 10.1519/JSC.0b013e3182964220; Nakamura M, 2015, J SPORT REHABIL, V24, P286, DOI [10.1123/jsr.2014-0164, 10-1123/jsr.2014-0164]; Nakamura M, 2014, ULTRASOUND MED BIOL, V40, P1991, DOI 10.1016/j.ultrasmedbio.2014.03.024; Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445; Ryan ED, 2008, J ORTHOP SPORT PHYS, V38, P632, DOI 10.2519/jospt.2008.2843; Ryan ED, 2008, MED SCI SPORT EXER, V40, P1529, DOI 10.1249/MSS.0b013e31817242eb; Siatras TA, 2008, J STRENGTH COND RES, V22, P40, DOI 10.1519/JSC.0b013e31815f970c; Simic L, 2013, SCAND J MED SCI SPOR, V23, P131, DOI 10.1111/j.1600-0838.2012.01444.x; Taniguchi K, 2015, SCAND J MED SCI SPOR, V25, P32, DOI 10.1111/sms.12146; Watsford ML, 2010, AM J SPORT MED, V38, P2058, DOI 10.1177/0363546510370197; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WILSON GJ, 1994, J APPL PHYSIOL, V76, P2714, DOI 10.1152/jappl.1994.76.6.2714	32	27	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228583	10.1371/journal.pone.0228583	http://dx.doi.org/10.1371/journal.pone.0228583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027694	gold, Green Published			2022-12-26	WOS:000534623800051
J	Yau, D; Laver, TW; Dastamani, A; Senniappan, S; Houghton, JAL; Shaikh, G; Cheetham, T; Mushtaq, T; Kapoor, RR; Randell, T; Ellard, S; Shah, P; Banerjee, I; Flanagan, SE				Yau, Daphne; Laver, Thomas W.; Dastamani, Antonia; Senniappan, Senthil; Houghton, Jayne A. L.; Shaikh, Guftar; Cheetham, Tim; Mushtaq, Talat; Kapoor, Ritika R.; Randell, Tabitha; Ellard, Sian; Shah, Pratik; Banerjee, Indraneel; Flanagan, Sarah E.			Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389	PLOS ONE			English	Article							HYPOGLYCEMIA; INFANCY	Congenital hyperinsulinism (CHI) is a significant cause of hypoglycaemia in neonates and infants with the potential for permanent neurologic injury. Accurate calculations of the incidence of rare diseases such as CHI are important as they inform health care planning and can aid interpretation of genetic testing results when assessing the frequency of variants in large-scale, unselected sequencing databases. Whilst minimal incidence rates have been calculated for four European countries, the incidence of CHI in the UK is not known. In this study we have used referral rates to a central laboratory for genetic testing and annual birth rates from census data to calculate the minimal incidence of CHI within the UK from 2007 to 2016. CHI was diagnosed in 278 individuals based on inappropriately detectable insulin and/or C-peptide measurements at the time of hypoglycaemia which persisted beyond 6 months of age. From these data, we have calculated a minimum incidence of 1 in 28,389 live births for CHI in the UK. This is comparable to estimates from other outbred populations and provides an accurate estimate that will aid both health care provision and interpretation of genetic results, which will help advance our understanding of CHI.	[Yau, Daphne; Banerjee, Indraneel] Royal Manchester Childrens Hosp, Dept Paediat Endocrinol, Manchester, Lancs, England; [Laver, Thomas W.; Ellard, Sian; Flanagan, Sarah E.] Univ Exeter, Inst Biomed & Clin Sci, Med Sch, Exeter, Devon, England; [Dastamani, Antonia; Shah, Pratik] Great Ormond St Hosp Sick Children, Dept Paediat Endocrinol, London, England; [Senniappan, Senthil] Alder Hey Childrens Hosp, Dept Paediat Endocrinol, Liverpool, Merseyside, England; [Houghton, Jayne A. L.; Ellard, Sian] Royal Devon & Exeter NHS Fdn Trust, Genom Lab, Exeter, Devon, England; [Shaikh, Guftar] Royal Hosp Children, Dept Paediat Endocrinol, Glasgow, Lanark, Scotland; [Cheetham, Tim] Royal Victoria Infirm, Dept Paediat Endocrinol, Newcastle Upon Tyne, Tyne & Wear, England; [Mushtaq, Talat] Leeds Childrens Hosp, Dept Paediat Endocrinol, Leeds, W Yorkshire, England; [Kapoor, Ritika R.] Kings Coll London, Dept Paediat Endocrinol, London, England; [Randell, Tabitha] Nottingham Childrens Hosp, Dept Paediat Endocrinol, Nottingham, England	Royal Manchester Children's Hospital; University of Exeter; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Exeter; Newcastle University - UK; University of London; King's College London	Yau, D (corresponding author), Royal Manchester Childrens Hosp, Dept Paediat Endocrinol, Manchester, Lancs, England.	dyau@qmed.ca	SHAH, PRATIK/AAI-6068-2020	SHAH, PRATIK/0000-0002-4402-8297; Yau, Daphne/0000-0002-3559-6479; Kapoor, Ritika R/0000-0002-4335-2159; Shaikh, M Guftar/0000-0002-2316-3334; Laver, Thomas/0000-0001-6399-0089	Wellcome Trust; Royal Society [105636/Z/14/Z]	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	SEF has a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust (https://wellcome.ac.uk/funding) and the Royal Society (https://royalsociety.org/grants-schemes-awards/grants/) (Grant Number: 105636/Z/14/Z). The funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya VB, 2013, ARCH DIS CHILD-FETAL, V98, pF356, DOI 10.1136/archdischild-2012-302880; Banerjee I, 2019, DIABETIC MED, V36, P9, DOI 10.1111/dme.13823; Banerjee I, 2011, EUR J ENDOCRINOL, V164, P733, DOI 10.1530/EJE-10-1136; Bruining J., 1990, CURR OPIN PEDIATR, V2, P758, DOI DOI 10.1097/00008480-199008000-00024; Glaser B, 2000, ARCH DIS CHILD-FETAL, V82, pF79, DOI 10.1136/fn.82.2.F79; Hoe FM, 2006, J PEDIATR-US, V148, P207, DOI 10.1016/j.jpeds.2005.10.002; Kawakita R, 2011, NIHON SHONIKA GAKKAI, V115, P563; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Matthew PM, 1998, CLIN PEDIATR, V27, P148; Otonkoski T, 1999, DIABETES, V48, P408, DOI 10.2337/diabetes.48.2.408; Ramadan DG, 1999, ANN TROP PAEDIATR, V19, P55, DOI 10.1080/02724939992644; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rozenkova K, 2015, J CLIN ENDOCR METAB, V100, pE1540, DOI 10.1210/jc.2015-2763; Snider KE, 2013, J CLIN ENDOCR METAB, V98, pE355, DOI 10.1210/jc.2012-2169; Stanley CA, 2016, J CLIN ENDOCR METAB, V101, P815, DOI 10.1210/jc.2015-3651	15	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228417	10.1371/journal.pone.0228417	http://dx.doi.org/10.1371/journal.pone.0228417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027664	Green Published, gold, Green Accepted			2022-12-26	WOS:000534623800028
J	Rodriguez, AD; Cera, M; Portillo, JR				del Valle Rodriguez, Alberto; Cera, Martin; Portillo, Jose R.			A network approach to analyze neuronal lineage and layer innervation in the Drosophila optic lobes	PLOS ONE			English	Article							COMMUNITY STRUCTURE; BRAIN NETWORKS; NEUROGENESIS; PROGENITORS; DIVERSITY; PATHWAYS; MEDULLA; CIRCUIT; SYSTEM; COLOR	The optic lobes of the fruit fly Drosophila melanogaster form a highly wired neural network composed of roughly 130.000 neurons of more than 80 different types. How neuronal diversity arises from very few cell progenitors is a central question in developmental neurobiology. We use the optic lobe of the fruit fly as a paradigm to understand how neuroblasts, the neural stem cells, generate multiple neuron types. Although the development of the fly brain has been the subject of extensive research, very little is known about the lineage relationships of the cell types forming the adult optic lobes. Here we perform a large-scale lineage bioinformatics analysis using the graph theory. We generated a large collection of cell clones that genetically label the progeny of neuroblasts and built a database to draw graphs showing the lineage relationships between cell types. By establishing biological criteria that measures the strength of the neuronal relationships and applying community detection tools we have identified eight clusters of neurons. Each cluster contains different cell types that we pose are the product of eight distinct classes of neuroblasts. Three of these clusters match the available lineage data, supporting the predictive value of the analysis. Finally, we show that the neuronal progeny of a neuroblast do not have preferential innervation patterns, but instead become part of different layers and neuropils. Here we establish a new methodology that helps understanding the logic of Drosophila brain development and can be applied to the more complex vertebrate brains.	[del Valle Rodriguez, Alberto] New York Univ Abu Dhabi NYUAD, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates; [Cera, Martin; Portillo, Jose R.] Univ Seville, Dept Matemat Aplicada 1, Seville, Spain; [Cera, Martin; Portillo, Jose R.] Univ Sevilla IMUS, Inst Univ Invest Matemat, Seville, Spain	University of Sevilla; University of Sevilla	Rodriguez, AD (corresponding author), New York Univ Abu Dhabi NYUAD, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates.; Portillo, JR (corresponding author), Univ Seville, Dept Matemat Aplicada 1, Seville, Spain.; Portillo, JR (corresponding author), Univ Sevilla IMUS, Inst Univ Invest Matemat, Seville, Spain.	adv5@nyu.edu; josera@us.es	PORTILLO, JOSE R./M-2117-2013	PORTILLO, JOSE R./0000-0002-0940-068X	Center of Genomics and Systems Biology of NYU Abu Dhabi [FIS2014-60843-P, MTM2014-61312-EXP]	Center of Genomics and Systems Biology of NYU Abu Dhabi	AdV was supported by the Center of Genomics and Systems Biology of NYU Abu Dhabi. JP was supported by the grant FIS2014-60843-P and JP and MC were supported by the grant MTM2014-61312-EXP.bThe funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm E, 2003, CURR OPIN STRUC BIOL, V13, P193, DOI 10.1016/S0959-440X(03)00031-9; Apitz H, 2015, NAT NEUROSCI, V18, P46, DOI 10.1038/nn.3896; Apitz H, 2014, J NEUROGENET, V28, P233, DOI 10.3109/01677063.2014.922558; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Behnia R, 2014, NATURE, V512, P427, DOI 10.1038/nature13427; Bertet C, 2014, CELL, V158, P1173, DOI 10.1016/j.cell.2014.07.045; Boulos RE, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.118102; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen ZQ, 2016, CELL REP, V15, P774, DOI 10.1016/j.celrep.2016.03.061; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Erclik T, 2017, NATURE, V541, P365, DOI 10.1038/nature20794; Evsyukova I, 2013, ANNU REV CELL DEV BI, V29, P299, DOI 10.1146/annurev-cellbio-101512-122400; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Harwell CC, 2015, NEURON, V87, P999, DOI 10.1016/j.neuron.2015.07.030; Ito M, 2013, CURR BIOL, V23, P644, DOI 10.1016/j.cub.2013.03.015; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kaiser M, 2015, CURR BIOL, V25, pR416, DOI 10.1016/j.cub.2015.03.039; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li X, 2013, NATURE, V498, P456, DOI 10.1038/nature12319; Lin TY, 2016, J COMP NEUROL, V524, P213, DOI 10.1002/cne.23857; Mayer C, 2015, NEURON, V87, P989, DOI 10.1016/j.neuron.2015.07.011; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Petersen SE, 2015, NEURON, V88, P207, DOI 10.1016/j.neuron.2015.09.027; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rodriguez AD, 2012, NAT METHODS, V9, P47, DOI [10.1038/NMETH.1800, 10.1038/nmeth.1800]; Sanchez D., 1915, TRAB LAB INVEST BIOL, V13, P1, DOI DOI 10.5962/BHL.TITLE.37839; Shih CT, 2015, CURR BIOL, V25, P1249, DOI 10.1016/j.cub.2015.03.021; Snel B, 2002, P NATL ACAD SCI USA, V99, P5890, DOI 10.1073/pnas.092632599; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Ye YZ, 2004, GENOME RES, V14, P343, DOI 10.1101/gr.1610504; Yu HH, 2013, CURR BIOL, V23, P633, DOI 10.1016/j.cub.2013.02.057; Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345	49	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227897	10.1371/journal.pone.0227897	http://dx.doi.org/10.1371/journal.pone.0227897			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023281	Green Published, Green Submitted, gold			2022-12-26	WOS:000534621500028
J	Dias, S; Gama, A; Loos, J; Roxo, L; Simoes, D; Nostlinger, C				Dias, Sonia; Gama, Ana; Loos, Jasna; Roxo, Luis; Simoes, Daniel; Nostlinger, Christiana			The role of mobility in sexual risk behaviour and HIV acquisition among sub-Saharan African migrants residing in two European cities	PLOS ONE			English	Article							COUNTRIES; POPULATIONS; INFECTION; MIGRATION; MEN; TRANSMISSION; EXPERIENCES; IMMIGRANTS; COMMUNITY; ENGLAND	Background Migrants from high endemic countries accounted for 18% of newly diagnosed HIV infections in Europe in 2017. Knowledge on the link between HIV risk and post-migration travels and their impact on HIV acquisition is scarce, but critical to inform prevention. This study aims to explore risky sexual behaviour and HIV-acquisition among sub-Saharan African migrants, and to assess post-migration mobility as a determinant of sexual risk behaviour. Methods Data from two cross-sectional bio-behavioural surveys to assess HIV-prevalence conducted in Lisbon and Antwerp were analysed to explore migration-related characteristics, travel patterns, and sexual risk taking in the host country and abroad. Bi- and multivariate associations were estimated through adjusted odds ratios and 95% confidence intervals; multivariable logistic regression determined factors associated with condomless sexual intercourse. Results Among N = 1508 participants above 18 years (58% males), 68% travelled post-migration (49.2% reported intercourse abroad). The overall proportion of condomless sex at last sexual intercourse was high (68.1%). The odds of condomless sex in the host country was five times higher when the last sexual intercourse abroad was also condomless [OR:5.32; 95% CI:2.98-9.25]. About half of the travellers reported concurrency, i.e. a regular partner in the host country while having other sexual partners abroad. Almost three percent of the participants reported being HIV+, but 5% had a reactive HIV test-result, with similar proportions among travellers and non-travellers. Also, among the n = 75 participants with reactive HIV test-results, condomless sex occurred (n = 40) and was associated with mobility. Conclusions Sub-Saharan African migrants are mobile and engage in sexual risk behaviours in the countries of residence and while travelling, increasing risk of post-migration HIV-acquisition. A transnational perspective on HIV prevention and sexual health promotion is needed for effectively reducing migrants' HIV risk related to their mobility.	[Dias, Sonia; Gama, Ana; Roxo, Luis] Univ Nova Lisboa, NOVA Natl Sch Publ Hlth, Publ Hlth Res Ctr, Lisbon, Portugal; [Dias, Sonia; Gama, Ana; Roxo, Luis] Univ Nova Lisboa, Global Hlth & Trop Med, Lisbon, Portugal; [Dias, Sonia; Gama, Ana] Comprehens Hlth Res Ctr CHRC, Lisbon, Portugal; [Loos, Jasna; Nostlinger, Christiana] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Simoes, Daniel] Grp Ativistas Tratamentos, Lisbon, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Institute of Tropical Medicine (ITM)	Dias, S (corresponding author), Univ Nova Lisboa, NOVA Natl Sch Publ Hlth, Publ Hlth Res Ctr, Lisbon, Portugal.; Dias, S (corresponding author), Univ Nova Lisboa, Global Hlth & Trop Med, Lisbon, Portugal.; Dias, S (corresponding author), Comprehens Hlth Res Ctr CHRC, Lisbon, Portugal.	smfdias@yahoo.com	Roxo, Luis/AAA-4841-2022; Loos, Jasna/GVS-6862-2022; Simões, Daniel/AAU-6197-2020; Dias, Sónia/AAD-3788-2019; GAMA, ANA FILIPA/I-6520-2012	Roxo, Luis/0000-0001-6946-6501; Simões, Daniel/0000-0001-7799-9631; Dias, Sónia/0000-0001-5085-0685; Noestlinger, Christiana/0000-0001-9031-8503; GAMA, ANA FILIPA/0000-0001-6958-6159	Scientific Fund for Research on AIDS [2011-R20640-001]; Directorate-General for Health National Program for the Prevention and Control of HIV/AIDS Infection	Scientific Fund for Research on AIDS; Directorate-General for Health National Program for the Prevention and Control of HIV/AIDS Infection	ChN was supported by Scientific Fund for Research on AIDS, managed by the King Baudouin Foundation (hyyp://www.kbs-frb.be), project nr. 2011-R20640-001. SD was the Principal Investigator of the Portuguese survey which was supported by the Directorate-General for Health National Program for the Prevention and Control of HIV/AIDS Infection (http://www.dgs.pt/directorategeneral-of-health/about-us.aspx).	Almeida L, 2013, MATERN CHILD HLTH J, V17, P1346, DOI 10.1007/s10995-012-1149-x; Alvarez-del Arco D, 2017, AIDS, V31, P1979, DOI 10.1097/QAD.0000000000001571; Alvarez-del Arco D, 2013, EUR J PUBLIC HEALTH, V23, P1039, DOI 10.1093/eurpub/cks130; [Anonymous], 2017, EPIDEMIOLOGIE HIV AI; [Anonymous], 2017, GUID BEST PRACT IMPR; Aral Sevgi O, 2010, Curr Infect Dis Rep, V12, P134, DOI 10.1007/s11908-010-0087-2; Boerleider AW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-81; Burns Fiona, 2006, Psychol Health Med, V11, P117, DOI 10.1080/13548500500156527; Burns FM, 2011, SEX TRANSM INFECT, V87, P318, DOI 10.1136/sti.2010.047209; Camlin CS, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25136; Camlin CS, 2014, SOC SCI MED, V102, P146, DOI 10.1016/j.socscimed.2013.11.004; Cassels S, 2014, AIDS BEHAV, V18, P2302, DOI 10.1007/s10461-013-0665-z; Czaika M, 2014, INT MIGR REV, V48, P283, DOI 10.1111/imre.12095; Davies AA, 2009, EUROHEALTH, V16, P10; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; Deblonde Jessika, 2018, BMC Public Health, V18, P1191, DOI 10.1186/s12889-018-6107-0; Demart S, 2013, CAH ETUD AFR, P783, DOI 10.4000/etudesafricaines.17503; Desgrees-du-Lou A, 2015, EURO SURVEILLANCE, V20; Desgrees-du-Lou A, 2016, AIDS, V30, P645, DOI 10.1097/QAD.0000000000000957; Dias S., FINAL REPORT PROJECT, DOI [10.1155/2018/5845218, DOI 10.1155/2018/5845218]; Dias S, 2020, J SEX RES, V57, P906, DOI 10.1080/00224499.2019.1601154; Dias S, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5845218; Dias S, 2014, INT J ENV RES PUB HE, V11, P8552, DOI 10.3390/ijerph110808552; Dias S, 2011, INT J PUBLIC HEALTH, V56, P559, DOI 10.1007/s00038-010-0215-7; Dodds C, 2006, J COMMUNITY APPL SOC, V16, P472, DOI 10.1002/casp.895; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; ECDC, 2010, MIGR HLTH EP HIV AID; ECDC WHO Regional Office for Europe, 2018, HIV AIDS SURV EUR 20; European Centre for Disease Prevention and Control & World Health Organization. Regional Office for Europe, 2021, HIV AIDS SURV EUR 20, DOI DOI 10.2900/2767; Fakoya I, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25123; Fakoya I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1852-9; Farrington EM, 2016, AIDS BEHAV, V20, P2850, DOI 10.1007/s10461-016-1352-7; Fenton KA, 2001, AIDS, V15, P1442, DOI 10.1097/00002030-200107270-00017; Gama A, 2010, J IMMIGR MINOR HEALT, V12, P841, DOI 10.1007/s10903-010-9324-x; Hadj L., 2017, B EPIDEMIOLOGIQUE HE, V6, P110; Hernando V, 2015, JAIDS-J ACQ IMM DEF, V70, P204, DOI 10.1097/QAI.0000000000000717; Judah G, 2013, BRIT J HEALTH PSYCH, V18, P338, DOI 10.1111/j.2044-8287.2012.02086.x; Kramer MA, 2008, SEX TRANSM INFECT, V84, P554, DOI 10.1136/sti.2008.032094; Kramer MA, 2005, SEX TRANSM INFECT, V81, P508, DOI 10.1136/sti.2004.014282; Lehmiller JJ, 2012, J SEX MED, V12, P2022; Loos J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174677; Loos J, 2016, LANCET HIV, V3, pE505, DOI 10.1016/S2352-3018(16)30173-4; Manirankunda L, 2009, AIDS EDUC PREV, V21, P582, DOI 10.1521/aeap.2009.21.6.582; Marsicano E, 2013, CULT HEALTH SEX, V15, P819, DOI 10.1080/13691058.2013.785024; Marty L, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25371; Matteelli A, 2013, LANCET INFECT DIS, V13, P205, DOI 10.1016/S1473-3099(12)70291-8; McCormack SM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21103; McGrath N, 2015, LANCET HIV, V2, pE252, DOI 10.1016/S2352-3018(15)00045-4; Migration IOo, 2013, 22 INT ORG MIGR; Molina J-M, 2016, 21 INT AIDS C DURB S; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Nostlinger C, 2016, AIDS CARE, V28, P119, DOI 10.1080/09540121.2016.1146398; Olawore O, 2018, LANCET HIV, V5, pE181, DOI 10.1016/S2352-3018(18)30009-2; Peach E, 2018, SEXUAL HLTH; Pottie K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081700; Prah P, 2015, EPIDEMIOL INFECT, V143, P1500, DOI 10.1017/S0950268814002155; Prost A, 2008, AIDS BEHAV, V12, P170, DOI 10.1007/s10461-007-9237-4; Rade DA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071311; Rosenberg ES, 2013, JAIDS-J ACQ IMM DEF, V63, P514, DOI 10.1097/QAI.0b013e318294bcce; Senn TE, 2014, AIDS BEHAV, V18, P1420, DOI 10.1007/s10461-014-0726-y; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Stevens PE, 2007, AM J PUBLIC HEALTH, V97, P1015, DOI 10.2105/AJPH.2005.075705; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Swan DJ, 2016, J SEX RES, V53, P64, DOI 10.1080/00224499.2014.1003771; Tanton C, 2016, SEX TRANSM INFECT; Tavoschi L, 2017, LANCET HIV, V4, pE514, DOI 10.1016/S2352-3018(17)30155-8; UNAIDS/WHO, 2002, IN 2 GEN HIV SURV SY; Van Beckhoven D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1230-3; van Veen MG, 2009, AIDS CARE, V21, P683, DOI 10.1080/09540120802511984	69	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228584	10.1371/journal.pone.0228584	http://dx.doi.org/10.1371/journal.pone.0228584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9FN	32023309	Green Published, gold			2022-12-26	WOS:000534621500062
J	Jerez-Roig, J; Booth, J; Skelton, DA; Gine-Garriga, M; Chastin, SFM; Hagen, S				Jerez-Roig, Javier; Booth, Joanne; Skelton, Dawn A.; Gine-Garriga, Maria; Chastin, Sebastien F. M.; Hagen, Suzanne			Is urinary incontinence associated with sedentary behaviour in older women? Analysis of data from the National Health and Nutrition Examination Survey	PLOS ONE			English	Article							OVERACTIVE BLADDER; METABOLIC SYNDROME; LIFE-STYLE; OBESITY; RISK; PREVALENCE; FRAILTY; SCIENCE; TRACT; LINK	Background Urinary incontinence (UI) is a common geriatric syndrome associated with physical and cognitive impairments. The association between type of UI and sedentary behaviour (SB) has not been explored. Aim To determine association between moderate-severe UI, or any stress UI (SUI) or any urgency UI (UUI) and SB in community-dwelling older women. Methods Women aged 60 and over from the 2005-2006 cycle of the National Health and Nutrition Examination Survey (NHANES) with objectively measured (accelerometer) and selfreported SB and UI data were selected. Multivariate models exploring association between moderate-severe UI and SB, or SUI and SB, or UUI and SB were analysed using logistic regression adjusted for factors associated with UI. Results In the overall sample of 459 older women, 23.5% reported moderate-severe UI, 50.5% reported any SUI and 41.4% reported any UUI. In bivariate analysis objectively measured proportion of time in SB was associated with moderate-severe UI and UUI (p = 0.014 and p = 0.047) but not SUI. Average duration of SB bouts in those with moderate-severe UI or any SUI was no longer than older women reporting no continence issues, but it was significantly (19%) longer in older women with any UUI (mean difference 3.2 minutes; p = 0.001). Selfreported SB variables were not associated with any type of UI. Multivariate analysis showed an association between UUI and a longer average duration of SB bouts (OR = 1.05, 95% CI = 1.01-1.09, p = 0.006) but no association with moderate-severe UI or SUI. Conclusion UUI was significantly associated with increased average duration of SB bouts in communitydwelling older women. The importance of objective measurement of SB is highlighted and suggests that decreasing time in prolonged sitting may be a target intervention to reduce UUI. Future studies are required to further explore the association between SB and incontinence.	[Jerez-Roig, Javier] Cent Univ Catalonia UVic UCC, Res Grp Methodol Methods Models & Outcomes Hlth &, Fac Hlth Sci & Welf, Ctr Hlth & Social Care Res CESS,Univ Vic, Vic, Spain; [Booth, Joanne; Skelton, Dawn A.; Gine-Garriga, Maria; Chastin, Sebastien F. M.] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Gine-Garriga, Maria] Ramon Llull Univ, Blanquerna Fac Psychol Educ & Sport Sci, Barcelona, Spain; [Chastin, Sebastien F. M.] Univ Ghent, Dept Sport & Movement Sci, Ghent, Belgium; [Hagen, Suzanne] Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow, Lanark, Scotland	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Glasgow Caledonian University; Universitat Ramon Llull; Ghent University; Glasgow Caledonian University	Jerez-Roig, J (corresponding author), Cent Univ Catalonia UVic UCC, Res Grp Methodol Methods Models & Outcomes Hlth &, Fac Hlth Sci & Welf, Ctr Hlth & Social Care Res CESS,Univ Vic, Vic, Spain.	javier.jerez@uvic.cat	Skelton, Dawn A/B-7552-2013; Jerez-Roig, Javier/V-6119-2018; Chastin, Sebastien/ABF-1455-2020	Skelton, Dawn A/0000-0001-6223-9840; Jerez-Roig, Javier/0000-0002-1968-4452; Chastin, Sebastien/0000-0003-1421-9348; HAGEN, SUZANNE/0000-0002-9741-9160; Booth, Joanne/0000-0002-7870-6391				Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Aoki Y, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.42, 10.1038/nrdp.2017.97]; Bunn F, 2015, INT J CLIN PRACT, V69, P199, DOI 10.1111/ijcp.12518; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Chastin SFM, 2015, MEAS PHYS EDUC EXERC, V19, P138, DOI 10.1080/1091367X.2015.1050592; Chastin SFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082313; Copeland JL, 2017, BRIT J SPORT MED, V51, P1539, DOI 10.1136/bjsports-2016-097210; Dall PM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013844; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Huang AJ, 2007, OBSTET GYNECOL, V109, P909, DOI 10.1097/01.AOG.0000258277.01497.4b; Jackson RA, 2004, OBSTET GYNECOL, V104, P301, DOI 10.1097/01.AOG.0000133482.20685.d1; Jenkins KR, 2005, NEUROUROL URODYNAM, V24, P51, DOI 10.1002/nau.20089; Jerez-Roig J, 2016, NEUROUROL URODYNAM, V35, P102, DOI 10.1002/nau.22675; Kirby MG, 2010, NEUROUROL URODYNAM, V29, P1360, DOI 10.1002/nau.20892; Kumar V, 2005, CURR OPIN UROL, V15, P222, DOI 10.1097/01.mou.0000172393.52857.92; Lawrence JM, 2007, DIABETES CARE, V30, P2536, DOI 10.2337/dc07-0262; Lee Andy H, 2012, Curr Aging Sci, V5, P35; Leiros-Rodriguez R, 2017, ACTAS UROL ESP, V41, P624, DOI 10.1016/j.acuro.2017.04.002; Marques Larissa Pruner, 2015, Rev. bras. epidemiol., V18, P595, DOI 10.1590/1980-5497201500030006; McGrother CW, 2012, NEUROUROL URODYNAM, V31, P487, DOI 10.1002/nau.21200; Milsom I, 2014, EUR UROL, V65, P79, DOI 10.1016/j.eururo.2013.08.031; Moreno-Vecino B, 2015, MATURITAS, V82, P208, DOI 10.1016/j.maturitas.2015.07.008; National Center for Health Statistics Research Ethics Review Board (ERB), 2012, APPR CTR DIS CONTR P; Nygaard IE, 2016, AM J OBSTET GYNECOL, V214, P164, DOI 10.1016/j.ajog.2015.08.067; Pinggera GM, 2008, BJU INT, V101, P319, DOI 10.1111/j.1464-410X.2007.07339.x; Steenstrup B, 2018, PROG UROL, V28, P973, DOI 10.1016/j.purol.2018.07.006; Stenholm S, 2014, J GERONTOL A-BIOL, V69, P73, DOI 10.1093/gerona/glt052; Suskind AM, 2017, UROLOGY, V106, P26, DOI 10.1016/j.urology.2017.03.058; Virtuoso JF, REV BRAS FISIOTER, V15, P310, DOI [10.1590/s1413-, DOI 10.1590/S1413-]; Willis-Gray M, 2018, NEUROUROL URODYNAM, V37, P200, DOI 10.1002/nau.23274; Wu JM, 2015, J AM GERIATR SOC, V63, P947, DOI 10.1111/jgs.13385	34	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0227195	10.1371/journal.pone.0227195	http://dx.doi.org/10.1371/journal.pone.0227195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017767	Green Published, gold			2022-12-26	WOS:000534618100009
J	Son, YE; Cho, HJ; Lee, MK; Park, HS				Son, Ye-Eun; Cho, He-Jin; Lee, Mi-Kyung; Park, Hee-Soo			Characterizing the role of Zn cluster family transcription factor ZcfA in governing development in two Aspergillus species	PLOS ONE			English	Article							SEXUAL DEVELOPMENT; GENE ENCODES; NIDULANS; ACTIVATOR; BRLA; IDENTIFICATION; FUMIGATUS; INSIGHTS; BINDING; FLAVUS	Filamentous fungi reproduce asexually or sexually, and the processes of asexual and sexual development are tightly regulated by a variety of transcription factors. In this study, we characterized a Zn(2)Cys(6) transcription factor in two Aspergillus species, A. nidulans (AN5859) and A. flavus (AFLA_046870). AN5859 encodes a Zn(2)Cys(6) transcription factor, called ZcfA. In A. nidulans,.zcfA mutants exhibit decreased fungal growth, a reduction in cleistothecia production, and increased asexual reproduction. Overexpression of zcfA results in increased conidial production, suggesting that ZcfA is required for proper asexual and sexual development in A. nidulans. In conidia, deletion of zcfA causes decreased trehalose levels and decreased spore viability but increased thermal sensitivity. In A. flavus, the deletion of the zcfA homolog AFLA_046870 causes increased conidial production but decreased sclerotia production; these effects are similar to those of zcfA deletion in A. nidulans development. Overall, these results demonstrate that ZcfA is essential for maintaining a balance between asexual and sexual development and that some roles of ZcfA are conserved in Aspergillus spp.	[Son, Ye-Eun; Cho, He-Jin; Park, Hee-Soo] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu, South Korea; [Lee, Mi-Kyung] Korea Res Inst Biosci & Biotechnol KRIBB, Biol Resource Ctr BRC, Jeongeup Si, South Korea; [Park, Hee-Soo] Kyungpook Natl Univ, Dept Integrat Biol, Daegu, South Korea	Kyungpook National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University	Park, HS (corresponding author), Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu, South Korea.; Park, HS (corresponding author), Kyungpook Natl Univ, Dept Integrat Biol, Daegu, South Korea.	phsoo97@knu.ac.kr		PARK, HEE-SOO/0000-0003-4303-9418	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2016010945]; KRIBB Research Initiative Program [KGM5231921]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP); KRIBB Research Initiative Program	HSP is supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP: No. 2016010945). MKL is supported by the KRIBB Research Initiative Program (KGM5231921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; H.S.P. is supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP: No. 2016010945). M.K.L. is supported by the KRIBB Research Initiative Program (KGM5231921).	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; ADAMS TH, 1990, MOL CELL BIOL, V10, P1815, DOI 10.1128/MCB.10.4.1815; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; Bennett JW, 2010, ASPERGILLUS: MOLECULAR BIOLOGY AND GENOMICS, P1; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Casselton L, 2002, NAT REV GENET, V3, P683, DOI 10.1038/nrg889; CHANG YC, 1993, GENETICS, V133, P29; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; Eom TJ, 2018, J MICROBIOL, V56, P893, DOI 10.1007/s12275-018-8417-4; Etxebeste O, 2010, TRENDS MICROBIOL, V18, P569, DOI 10.1016/j.tim.2010.09.007; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Giles SS, 2011, APPL ENVIRON MICROB, V77, P3669, DOI 10.1128/AEM.02000-10; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; Han KH, 2001, MOL MICROBIOL, V41, P299, DOI 10.1046/j.1365-2958.2001.02472.x; Harris SD, 2011, FUNGAL BIOL-UK, V115, P475, DOI 10.1016/j.funbio.2011.02.002; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; He ZM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-104; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kamei K, 2005, MED MYCOL, V43, pS95, DOI 10.1080/13693780500051547; Keller NP, 2019, NAT REV MICROBIOL, V17, P167, DOI 10.1038/s41579-018-0121-1; Kim HR, 2009, GENETICS, V182, P771, DOI 10.1534/genetics.109.101667; Kim MJ, 2019, J MICROBIOL, V57, P893, DOI 10.1007/s12275-019-9214-4; Klich MA, 2007, MOL PLANT PATHOL, V8, P713, DOI 10.1111/J.1364-3703.2007.00436.X; Kocsube S, 2016, STUD MYCOL, P199, DOI 10.1016/j.simyco.2016.11.006; Krishnan S, 2009, MYCOSES, V52, P206, DOI 10.1111/j.1439-0507.2008.01642.x; Kwon NJ, 2010, FUNGAL GENET BIOL, V47, P981, DOI 10.1016/j.fgb.2010.08.009; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Lee MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28874; Lee MK, 2014, GENETICS, V197, P159, DOI 10.1534/genetics.114.161430; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Martinelli S D, 1994, Prog Ind Microbiol, V29, P33; MCKNIGHT GL, 1985, EMBO J, V4, P2093, DOI 10.1002/j.1460-2075.1985.tb03897.x; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Mitchell NJ, 2016, FOOD ADDIT CONTAM A, V33, P540, DOI 10.1080/19440049.2016.1138545; Murakoshi Y, 2012, APPL MICROBIOL BIOT, V94, P1629, DOI 10.1007/s00253-012-3874-x; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Noble LM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0819; Ojeda-Lopez M, 2018, STUD MYCOL, P37, DOI 10.1016/j.simyco.2018.10.002; Park H.-S., 2019, BIOL FUNGAL CELL, P63, DOI [10.1007/978-3-030-05448-9_4, DOI 10.1007/978-3-030-05448-9_4]; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Park Hee Soo, 2012, Methods Mol Biol, V944, P183, DOI 10.1007/978-1-62703-122-6_13; Park HS, 2017, ADV APPL MICROBIOL, V100, P161, DOI 10.1016/bs.aambs.2017.03.001; Park HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177099; Park HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10199; Park JH, 2014, INTEGR MED RES, V3, P4, DOI 10.1016/j.imr.2013.12.002; Paulussen C, 2017, MICROB BIOTECHNOL, V10, P296, DOI 10.1111/1751-7915.12367; Rudramurthy SM, 2019, J FUNGI, V5, DOI 10.3390/jof5030055; Shaaban MI, 2010, EUKARYOT CELL, V9, P1816, DOI 10.1128/EC.00189-10; Shelest E, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00053; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tani S, 2001, CURR GENET, V39, P10, DOI 10.1007/s002940000175; Tsang CC, 2018, COMPUT STRUCT BIOTEC, V16, P197, DOI 10.1016/j.csbj.2018.05.003; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8; Wei HJ, 2001, FUNGAL GENET BIOL, V34, P217, DOI 10.1006/fgbi.2001.1303; Wu MY, 2018, MBIO, V9, DOI 10.1128/mBio.01130-18; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yu JH, 1996, CURR GENET, V29, P549, DOI 10.1007/s002940050084	62	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228643	10.1371/journal.pone.0228643	http://dx.doi.org/10.1371/journal.pone.0228643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017793	Green Published, gold			2022-12-26	WOS:000534618100033
J	Bozek, A; Jarzab, J; Mielnik, M; Bogacz, A; Kozlowska, R; Mangold, D				Bozek, Andrzej; Jarzab, Jerzy; Mielnik, Michel; Bogacz, Agnieszka; Kozlowska, Renata; Mangold, Dominika			Can atopy have a protective effect against cancer?	PLOS ONE			English	Article							IMMUNOGLOBULIN-E; ALLERGY; RISK; POPULATION; MORTALITY; POLAND	Background An increased prevalence of allergies and an increased incidence of breast cancer have been observed. The hypothesis that atopy may have a protective effect against the risk of different types of breast cancer was evaluated. Methods In this study, 11,101 patients (11,101 women with a mean age of 55.2 +/- 14.7 years) with different types of breast cancer were tested for allergies. Allergies were confirmed based on the retrospective analysis of allergy diagnostic procedures in patients who had been previously diagnosed with breast cancer. The retrospective prevalence rates of active allergic diseases, including allergic rhinitis, bronchial asthma and atopic dermatitis, were assessed. All patients were also analyzed for bronchial asthma and allergic rhinitis according to the relevant guidelines. A group of healthy control patients was used for the comparisons. Results The women with breast cancer had a significantly lower incidence of IgE-mediated allergic diseases than the controls. The odds ratios (ORs) for allergic rhinitis, atopic dermatitis, and bronchial asthma were 0.61 (95% CI: 0.57-0.73), 0.17 (95% CI: 0.11-0.44), and 0.73 (95% CI: 0.65-0.83), respectively. The mean serum concentrations of total IgE were significantly lower in the study population of women with breast cancer than in the patients of the control group (39.2 +/- 26.2 kU/L vs. 108.5 +/- 38.5 kU/L; p = 0.002). Conclusion Our results suggest that the overall incidence of allergies, especially allergic rhinitis, is lower in patients with certain types of cancer than in individuals who did not have cancer. Further studies are needed to confirm our findings.	[Bozek, Andrzej; Jarzab, Jerzy; Bogacz, Agnieszka; Kozlowska, Renata; Mangold, Dominika] Med Univ Silesia, Clin Dept Internal Dis Dermatol & Allergol Zabrze, Katowice, Poland; [Mielnik, Michel] Dist Trauma & Orthopaed Hosp, Dept Trauma & Orthopaed, Piekary Slaskie, Poland	Medical University Silesia	Bozek, A (corresponding author), Med Univ Silesia, Clin Dept Internal Dis Dermatol & Allergol Zabrze, Katowice, Poland.	andrzejbozek@o2.pl		Kozlowska, Renata/0000-0002-1683-5649; Bogacz-Piaseczynska, Agnieszka/0000-0002-5127-6379; Jarzab, Jerzy/0000-0002-4564-485X; Bozek, Andrzej/0000-0003-2263-2263	Medical University of Silesia in Katowice [KNW/966/2015]	Medical University of Silesia in Katowice	The study was funded by Medical University of Silesia in Katowice (grant: KNW/966/2015). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, BREAST CANC TREATM P; [Anonymous], 2008, WORLD CANC REPORT; [Anonymous], 2014, WORLD CANC REPORT; Arana A, 2010, BRIT J DERMATOL, V163, P1036, DOI 10.1111/j.1365-2133.2010.09887.x; Dyzmann-Sroka A, 2014, REP PRACT ONCOL RADI, V19, P296, DOI 10.1016/j.rpor.2014.04.001; ERIKSSON NE, 1995, ALLERGY, V50, P718, DOI 10.1111/j.1398-9995.1995.tb01212.x; Ji J, 2009, BRIT J CANCER, V100, P829, DOI 10.1038/sj.bjc.6604890; Josephs DH, 2013, CLIN EXP ALLERGY, V43, P1110, DOI 10.1111/cea.12178; Kozlowska R, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0147-8; MCWHORTER WP, 1988, CANCER-AM CANCER SOC, V62, P451, DOI 10.1002/1097-0142(19880715)62:2<451::AID-CNCR2820620234>3.0.CO;2-D; MILLS PK, 1992, AM J EPIDEMIOL, V136, P287, DOI 10.1093/oxfordjournals.aje.a116494; PETROIANU A, 1995, J INT MED RES, V23, P358, DOI 10.1177/030006059502300505; Saunders C., 2015, BREAST CANC; Skaaby T, 2014, J ALLER CL IMM-PRACT, V2, P779, DOI 10.1016/j.jaip.2014.06.010; Sozanska B, 2014, J ALLERGY CLIN IMMUN, V133, P1347, DOI 10.1016/j.jaci.2013.10.035; Taghizadeh N, 2015, CANCER CAUSE CONTROL, V26, P99, DOI 10.1007/s10552-014-0489-9; Turner MC, 2012, CANCER IMMUNOL IMMUN, V61, P1493, DOI 10.1007/s00262-011-1180-6; Van Hemelrijck M, 2010, CANCER CAUSE CONTROL, V21, P1657, DOI 10.1007/s10552-010-9594-6; VENA JE, 1985, AM J EPIDEMIOL, V122, P66, DOI 10.1093/oxfordjournals.aje.a114087; Wang D, 2016, CNS NEUROSCI THER, V22, P558, DOI 10.1111/cns.12537; Wang H, 2005, ALLERGY, V60, P1098, DOI 10.1111/j.1398-9995.2005.00813.x; Wang H, 2006, INT J CANCER, V119, P695, DOI 10.1002/ijc.21883; Wieneger MB, 2003, J BIOMED INFORM, V36, P106	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0226950	10.1371/journal.pone.0226950	http://dx.doi.org/10.1371/journal.pone.0226950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32015564	gold, Green Published			2022-12-26	WOS:000534615800005
J	Ferreira, LC; Orso, F; Dettori, D; Lacerda, JZ; Borin, TF; Taverna, D; Zuccari, DAPC				Ferreira, Livia C.; Orso, Francesca; Dettori, Daniela; Lacerda, Jessica Z.; Borin, Thaiz F.; Taverna, Daniela; Zuccari, Debora A. P. C.			The role of melatonin on miRNAs modulation in triple-negative breast cancer cells	PLOS ONE			English	Article							TUMOR PROGRESSION; IN-VITRO; MICRORNA; HYPOXIA; MECHANISMS; RECEPTOR; MIR-210; METASTASIS; EXPRESSION; MELANOMA	Melatonin, a hormone secreted by pineal gland, exerts antimetastatic effects by reducing tumor cell proliferation, migration and invasion. MicroRNAs (miRNAs) are small, non-coding RNAs that play a crucial role in regulation of gene expression and biological processes of the cells. Herein, we search for a link between the tumor/metastatic-suppressive actions of melatonin and miRNA expression in triple-negative breast cancer cells. We demonstrated that melatonin exerts its anti-tumor actions by reducing proliferation, migration and c-Myc expression of triple negative breast cancer cells. By using Taqman-based assays, we analyzed the expression levels of a set of miRNAs following melatonin treatment of triple negative breast cancer cells and we identified 17 differentially expressed miRNAs, 6 down-regulated and 11 up-regulated. We focused on the anti-metastatic miR-148b and the oncogenic miR-210 both up-regulated by melatonin treatment and studied the effect of their modulation on melatonin-mediated impairment of tumor progression. Surprisingly, when miR-148b or miR-210 were depleted in triple-negative breast cancer cells, using a specific miR-148b sponge or anti-miR-210, melatonin effects on migration inhibition and c-myc downregulation were still visible suggesting that the increase of miR-148b and miR-210 expression observed following melatonin treatment was not required for the efficacy of melatonin action. Nevertheless, ours results suggest that melatonin exhibit a compound for metastatic trait inhibition, especially in MDA-MB-231 breast cancer cells even if a direct link between modulation of expression of certain proteins or miRNAs and melatonin effects has still to be established.	[Ferreira, Livia C.; Lacerda, Jessica Z.; Zuccari, Debora A. P. C.] Univ Estadual Paulista, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil; [Orso, Francesca; Dettori, Daniela; Taverna, Daniela] Univ Torino, Mol Biotechnol Ctr MBC, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Borin, Thaiz F.] Augusta Univ, Dept Biochem & Mol Biol, Tumor Angiogenesis Lab, Augusta, GA USA; [Zuccari, Debora A. P. C.] Fac Med Sao Jose do Rio Preto, Dept Mol Biol, Sao Jose Do Rio Preto, SP, Brazil	Universidade Estadual Paulista; University of Turin; University System of Georgia; Augusta University; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	Zuccari, DAPC (corresponding author), Univ Estadual Paulista, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil.; Zuccari, DAPC (corresponding author), Fac Med Sao Jose do Rio Preto, Dept Mol Biol, Sao Jose Do Rio Preto, SP, Brazil.	debora.zuccari@famerp.br	de Campos Zuccari, Debora Aparecida Pires/M-3560-2014	de Campos Zuccari, Debora Aparecida Pires/0000-0002-0146-9041	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo -FAPESP/Brazil [2015/04780-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo -FAPESP/Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo -FAPESP/Brazil (2015/04780-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo Mario, 2015, Adv Biol Regul, V57, P1, DOI 10.1016/j.jbior.2014.09.013; Blask DE, 2005, CANCER RES, V65, P11174, DOI 10.1158/0008-5472.CAN-05-1945; Borin TF, 2016, J PINEAL RES, V60, P3, DOI 10.1111/jpi.12270; Chen Y, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-43; Cos S, 2014, ONCOL LETT, V8, P487, DOI 10.3892/ol.2014.2203; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Di Bella G, 2013, INT J MOL SCI, V14, P2410, DOI 10.3390/ijms14022410; Di Leva G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003311; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Hevia D, 2015, J PINEAL RES, V58, P234, DOI 10.1111/jpi.12210; Hill SM, 2011, BREAST CANCER RES TR, V127, P91, DOI 10.1007/s10549-010-0958-0; Hill SM, 2009, INTEGR CANCER THER, V8, P337, DOI 10.1177/1534735409353332; Jardim-Perassi BV, 2016, ANTI-CANCER AGENT ME, V16, P347, DOI 10.2174/1871520615666150511094201; Kiefer TL, 2005, J PINEAL RES, V38, P231, DOI 10.1111/j.1600-079X.2004.00198.x; Kim KJ, 2013, J PINEAL RES, V54, P264, DOI 10.1111/j.1600-079X.2012.01030.x; Kim TH, 2017, ONCOL LETT, V14, P2511, DOI 10.3892/ol.2017.6434; Kronski E, 2014, MOL ONCOL, V8, P581, DOI 10.1016/j.molonc.2014.01.005; Dang K, 2015, INT J MOL SCI, V16, P6353, DOI 10.3390/ijms16036353; Lee SE, 2011, J PINEAL RES, V51, P345, DOI 10.1111/j.1600-079X.2011.00896.x; Li T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115577; Liu DY, 2016, ONCOTARGETS THER, V9, P5245, DOI 10.2147/OTT.S110969; Lopez A, 2009, J PINEAL RES, V46, P188, DOI 10.1111/j.1600-079X.2008.00647.x; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Mao LL, 2016, MOL CANCER RES, V14, P1159, DOI 10.1158/1541-7786.MCR-16-0158; Mao LL, 2010, J PINEAL RES, V49, P210, DOI 10.1111/j.1600-079X.2010.00781.x; Maschio-Signorini LB, 2016, ANTI-CANCER AGENT ME, V16, P1474, DOI 10.2174/1871520616666160422105920; Mediavilla MD, 2010, CURR MED CHEM, V17, P4462, DOI 10.2174/092986710794183015; Mori F, 2016, ONCOTARGET, V7, P20532, DOI 10.18632/oncotarget.7978; Orso F, 2016, CANCER RES, V76, P5151, DOI 10.1158/0008-5472.CAN-15-1322; Penna E, 2015, J INVEST DERMATOL, V135, P960, DOI 10.1038/jid.2014.479; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Proietti S, 2013, CELL MOL LIFE SCI, V70, P2139, DOI 10.1007/s00018-012-1161-8; Redig AJ, 2013, J INTERN MED, V274, P113, DOI 10.1111/joim.12084; Reiter RJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040843; Reiter RJ, 2010, CURR NEUROPHARMACOL, V8, P194, DOI 10.2174/157015910792246236; Robertson NM, 2014, WIRES RNA, V5, P823, DOI 10.1002/wrna.1248; Sanchez-Barcelo EJ, 2012, RECENT PATENTS ENDOC, V6, P108, DOI 10.2174/187221412800604581; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Sohn EJ, 2015, J CANCER, V6, P19, DOI 10.7150/jca.9591; Taubenberger AV, 2014, ADV DRUG DELIVER REV, V79-80, P135, DOI 10.1016/j.addr.2014.10.014; Vriend J, 2016, BBA-REV CANCER, V1865, P176, DOI 10.1016/j.bbcan.2016.02.004; Yahya SMM, 2015, CLIN BIOCHEM, V48, P388, DOI 10.1016/j.clinbiochem.2014.12.013; Yang JY, 2013, JALA-J LAB AUTOM, V18, P30, DOI 10.1177/2211068212453460; Zhang JG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08087; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	46	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228062	10.1371/journal.pone.0228062	http://dx.doi.org/10.1371/journal.pone.0228062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012171	Green Published, gold			2022-12-26	WOS:000534615800018
J	Ran, R; Harrison, H; Ariffin, NS; Ayubi, R; Pegg, HJ; Deng, WS; Mastro, A; Ottewell, PD; Mason, SM; Blyth, K; Holen, I; Shore, P				Ran, Ran; Harrison, Hannah; Ariffin, Nur Syamimi; Ayubi, Rahna; Pegg, Henry J.; Deng, Wensheng; Mastro, Andrea; Ottewell, Penny D.; Mason, Susan M.; Blyth, Karen; Holen, Ingunn; Shore, Paul			A role for CBF beta in maintaining the metastatic phenotype of breast cancer cells	ONCOGENE			English	Article							RUNX FAMILY; STEM-CELLS; EXPRESSION; PLASTICITY; MORPHOGENESIS; EMT	Epithelial to mesenchymal transition (EMT) is a dynamic process that drives cancer cell plasticity and is thought to play a major role in metastasis. Here we show, using MDA-MB-231 cells as a model, that the plasticity of at least some metastatic breast cancer cells is dependent on the transcriptional co-regulator CBF beta. We demonstrate that CBF beta is essential to maintain the mesenchymal phenotype of triple-negative breast cancer cells and that CBF beta-depleted cells undergo a mesenchymal to epithelial transition (MET) and re-organise into acini-like structures, reminiscent of those formed by epithelial breast cells. We subsequently show, using an inducible CBF beta system, that the MET can be reversed, thus demonstrating the plasticity of CBF beta-mediated EMT. Moreover, the MET can be reversed by expression of the EMT transcription factor Slug whose expression is dependent on CBF beta. Finally, we demonstrate that loss of CBF beta inhibits the ability of metastatic breast cancer cells to invade bone cell cultures and suppresses their ability to form bone metastases in vivo. Together our findings demonstrate that CBF beta can determine the plasticity of the metastatic cancer cell phenotype, suggesting that its regulation in different micro-environments may play a key role in the establishment of metastatic tumours.	[Ran, Ran; Harrison, Hannah; Ariffin, Nur Syamimi; Ayubi, Rahna; Pegg, Henry J.; Shore, Paul] Univ Manchester, Fac Biol Med & Hlth, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Deng, Wensheng] Wuhan Univ Sci & Technol, Jishi Rd, Wuhan 430065, Hubei, Peoples R China; [Mastro, Andrea] Penn State Univ, 428 South Frear Lab,Univ Pk, Philadelphia, PA 16802 USA; [Ottewell, Penny D.; Holen, Ingunn] Univ Sheffield, Dept Oncol & Metab, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England; [Mason, Susan M.; Blyth, Karen] CRUK Beatson Inst, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland; [Blyth, Karen] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland	University of Manchester; Wuhan University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Sheffield; Beatson Institute; University of Glasgow	Shore, P (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.; Holen, I (corresponding author), Univ Sheffield, Dept Oncol & Metab, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	i.holen@sheffield.ac.uk; paul.shore@manchester.ac.uk	Ariffin, Nur Syamimi/AAJ-3580-2020	Ariffin, Nur Syamimi/0000-0002-4183-8147; Ottewell, Penelope/0000-0002-4826-0771; Holen, Ingunn/0000-0002-8759-6913; Shore, Paul/0000-0002-1832-5976	Breast Cancer Now [PR018]; Cancer Research UK PhD Studentship; BBSRC PhD studentship; Manchester Alumni fund	Breast Cancer Now; Cancer Research UK PhD Studentship(Cancer Research UK); BBSRC PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Manchester Alumni fund	The work was funded by Breast Cancer Now (2013 May PR018; PS, IH and HH), a Cancer Research UK PhD Studentship (PS and HP), a BBSRC PhD studentship and the Manchester Alumni fund.	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Browne G, 2016, TUMOR BIOL, V37, P8825, DOI 10.1007/s13277-015-4710-6; Browne G, 2015, J CELL PHYSIOL, V230, P2522, DOI 10.1002/jcp.24989; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Chimge NO, 2013, ONCOGENE, V32, P2121, DOI 10.1038/onc.2012.328; Chimge NO, 2017, CELL CYCLE, V16, P312, DOI 10.1080/15384101.2016.1237325; Chimge NO, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3073; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deng WS, 2012, P NATL ACAD SCI USA, V109, P1524, DOI 10.1073/pnas.1107879109; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ferrari N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15658; Ferreira NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084531; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Holen I, 2016, ONCOTARGET, V7, P75571, DOI 10.18632/oncotarget.12289; Hong D, 2017, ONCOTARGET, V8, P17610, DOI 10.18632/oncotarget.15381; Illendula A, 2016, EBIOMEDICINE, V8, P117, DOI 10.1016/j.ebiom.2016.04.032; Ingthorsson S, 2016, J MAMMARY GLAND BIOL, V21, P139, DOI 10.1007/s10911-016-9366-3; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim DH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7010001; Kulkarni Madhura, 2018, Oncotarget, V9, P14175, DOI 10.18632/oncotarget.24419; Luo M, 2015, CURR PHARM DESIGN, V21, P1301, DOI 10.2174/1381612821666141211120604; Mastro AM, 2009, CANCER RES, V69, P4097, DOI 10.1158/0008-5472.CAN-08-4437; McDonald L, 2014, DIS MODEL MECH, V7, P525, DOI 10.1242/dmm.015040; Mendoza-Villanueva D, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3048; Mendoza-Villanueva D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-171; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Pratap J, 2011, BONE, V48, P30, DOI 10.1016/j.bone.2010.05.035; Pratap J, 2009, CANCER RES, V69, P6807, DOI 10.1158/0008-5472.CAN-09-1471; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rooney N, 2017, ADV EXP MED BIOL, V962, P353, DOI 10.1007/978-981-10-3233-2_22; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Shore P, 2005, J CELL BIOCHEM, V96, P484, DOI 10.1002/jcb.20557; Shore P, 2002, NUCLEIC ACIDS RES, V30, P1767, DOI 10.1093/nar/30.8.1767; Tahirov TH, 2017, ADV EXP MED BIOL, V962, P21, DOI 10.1007/978-981-10-3233-2_2; van Bragt MPA, 2014, ELIFE, V3, DOI 10.7554/eLife.03881; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zhu YY, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0032-3	39	5	5	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2624	2637		10.1038/s41388-020-1170-2	http://dx.doi.org/10.1038/s41388-020-1170-2		JAN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	32005976	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000510346700003
J	Ando, Y; Ohuchida, K; Otsubo, Y; Kibe, S; Takesue, S; Abe, T; Iwamoto, C; Shindo, K; Moriyama, T; Nakata, K; Miyasaka, Y; Ohtsuka, T; Oda, Y; Nakamura, M				Ando, Yohei; Ohuchida, Kenoki; Otsubo, Yoshiki; Kibe, Shin; Takesue, Shin; Abe, Toshiya; Iwamoto, Chika; Shindo, Koji; Moriyama, Taiki; Nakata, Kohei; Miyasaka, Yoshihiro; Ohtsuka, Takao; Oda, Yoshinao; Nakamura, Masafumi			Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5	PLOS ONE			English	Article							MIXED LINEAGE KINASE; PROGRAMMED NECROSIS; EXPRESSION; DEATH; PHOSPHORYLATION; ACTIVATION; TRIGGERS; METHYLATION; METASTASES; APOPTOSIS	Background Necroptosis is a form of programmed cell death that is accompanied by release of intracellular contents, and reportedly contributes to various diseases. Here, we investigate the significance of necroptosis in pancreatic cancer. Methods We used immunohistochemistry and western blot analysis to evaluate expression of the key mediators of necroptosis-receptor-interacting serine/threonine protein kinase 3 (RIP3) and mixed lineage kinase domain-like (MLKL)-in human pancreatic cancer. We also tested the effects of conditioned media (CM) from necroptotic cells on pancreatic cancer cells in Transwell migration and Matrigel invasion assays. Protein array analysis was used to investigate possible mediators derived from necroptotic cells. Results RIP3 and MLKL are highly expressed in human pancreatic cancer tissues compared with normal pancreas. MLKL expression was particularly intense at the tumor invasion front. CM derived from necroptotic cells promoted cancer cell migration and invasion, but not CM derived from apoptotic cells. C-X-C motif chemokine 5 (CXCL5) was upregulated in CM derived from necroptotic cells compared with CM derived from control or apoptotic cells. Moreover, expression of the receptor for CXCL5, C-X-C-motif chemokine receptor-2 (CXCR2), was upregulated in pancreatic cancer cells. Inhibition of CXCR2 suppressed cancer cell migratory and invasive behavior enhanced by necroptosis. Conclusion These findings indicate that necroptosis at the pancreatic cancer invasion front can promote cancer cell migration and invasion via the CXCL5-CXCR2 axis.	[Ando, Yohei; Ohuchida, Kenoki; Otsubo, Yoshiki; Kibe, Shin; Takesue, Shin; Abe, Toshiya; Shindo, Koji; Nakata, Kohei; Miyasaka, Yoshihiro; Ohtsuka, Takao; Nakamura, Masafumi] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan; [Iwamoto, Chika] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Fukuoka, Japan; [Moriyama, Taiki] Kyushu Univ, Grad Sch Med Sci, Dept Endoscop Diagnost & Therapeut, Fukuoka, Japan; [Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University	Ohuchida, K; Nakamura, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan.	kenoki@surg1.med.kyushu-u.ac.jp; mnaka@surg1.med.kyushu-u.ac.jp	Abe, Toshiya/AAT-2579-2021		Japan Society for the Promotion of Science [17H04284, 17K19602, 18H02881, 18K08708, 16H05418, 17K19605]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Japan Society for the Promotion of Science Grants in-Aid for Scientific Research (Grant Numbers 17H04284, 17K19602, 18H02881, 18K08708, 16H05418, and 17K19605). https://www.jsps.go.jp/english/index.html The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Brown MF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.104; Cai ZY, 2016, CELL RES, V26, P886, DOI 10.1038/cr.2016.87; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chopra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075737; Colbert LE, 2013, CANCER-AM CANCER SOC, V119, P3148, DOI 10.1002/cncr.28144; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Diao Y, 2016, CANCER LETT, V379, P12, DOI 10.1016/j.canlet.2016.05.003; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-5704; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Fuhrich DG, 2013, ANAL QUANT CYTOL, V35, P210; Fukasawa M, 2006, J HUM GENET, V51, P368, DOI 10.1007/s10038-005-0355-4; Garcia-Carbonero N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092468; Gundlach JP, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4688-8; Hannes S, 2016, CANCER LETT, V380, P31, DOI 10.1016/j.canlet.2016.05.036; He GW, 2017, J EXP MED, V214, P1655, DOI 10.1084/jem.20160442; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Jang MS, 2011, CANCER RES, V71, P7207, DOI 10.1158/0008-5472.CAN-11-0760; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koo GB, 2015, CELL RES, V25, P707, DOI 10.1038/cr.2015.56; Kozono S, 2013, CANCER RES, V73, P2345, DOI 10.1158/0008-5472.CAN-12-3180; Krysko O, 2017, IMMUNOL REV, V280, P207, DOI 10.1111/imr.12583; Lee SY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1027453; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu P, 2012, LEUKEMIA, V26, P1293, DOI 10.1038/leu.2011.357; Liu XJ, 2016, ONCOTARGET, V7, P22219, DOI 10.18632/oncotarget.7924; MAJNO G, 1995, AM J PATHOL, V146, P3; Moriwaki K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.16; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; Nugues AL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.347; Ohuchida K, 2004, INTERACTIONS, V1, P3215, DOI DOI 10.1158/0008-5472.CAN-03-2464; Qian Y, 2014, J ORAL PATHOL MED, V43, P658, DOI 10.1111/jop.12189; Saintigny P, 2013, CANCER RES, V73, P571, DOI 10.1158/0008-5472.CAN-12-0263; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Shindo K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-168; Shukla VC, 2016, J BIOMED MATER RES A, V104, P1182, DOI 10.1002/jbm.a.35655; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Strilic B, 2016, NATURE, V536, P215, DOI 10.1038/nature19076; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Teodorczyk M, 2015, CELL DEATH DIFFER, V22, P1192, DOI 10.1038/cdd.2014.217; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Varney ML, 2011, CANCER LETT, V300, P180, DOI 10.1016/j.canlet.2010.10.004; Vinci M, 2015, JOVE-J VIS EXP, DOI 10.3791/52686; Volakis LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086110; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang TZ, 2017, TUMOR BIOL, V39, P1, DOI 10.1177/1010428317711539; Wang WJ, 2017, CANCER LETT, V387, P46, DOI 10.1016/j.canlet.2016.06.004; Wente MN, 2006, CANCER LETT, V241, P221, DOI 10.1016/j.canlet.2005.10.041	56	43	43	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228015	10.1371/journal.pone.0228015	http://dx.doi.org/10.1371/journal.pone.0228015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999765	Green Published, gold			2022-12-26	WOS:000534612400042
J	Feng, ZM; Ma, QY; Liu, XL; Cui, W; Tan, CD; Liu, Y				Feng, Ziming; Ma, Qingyang; Liu, Xiaolei; Cui, Wei; Tan, Chaodong; Liu, Yang			Dynamic coupling modelling and application case analysis of high-slip motors and pumping units	PLOS ONE			English	Article								To solve the issues and difficulties in the high-coupling modelling of beam pumping units and high-slip motors, external characteristic experiments of high-slip motors were performed where the external database and characteristic correlation equations of the motors were obtained through data regression analysis. Based on the analysis of the kinematics, dynamics and driving characteristics of the beam pumping unit, a fully coupled mathematical model of a motor, pumping unit, sucker rod and oil pump was established. The differential pumping equation system of the pumping unit used a cyclic iteration method to solve the problem of high coupling among the motor, pumping unit, sucker rod and the pumping pump. The model was verified by experimental data of field l pumping wells. Theoretical calculations and experimental tests showed that the soft characteristic of the high-slip motor can reduce the peak suspension load of the sucker rod, peak net torque of the gearbox and peak power of the motor. In addition, the results show that the soft characteristic can also decrease the high-frequency fluctuation of the motor power curve and the torque curve of the gearbox. The high-slip motor can improve the smoothness and safety of the pumping well system.	[Feng, Ziming; Ma, Qingyang; Cui, Wei; Liu, Yang] Northeast Petr Univ, Sch Mech Sci & Engn, Daqing, Heilongjiang, Peoples R China; [Liu, Xiaolei] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland; [Tan, Chaodong] China Univ Petr, Sch Petr Engn, Beijing, Peoples R China	Northeast Petroleum University; University of Glasgow; China University of Petroleum	Feng, ZM (corresponding author), Northeast Petr Univ, Sch Mech Sci & Engn, Daqing, Heilongjiang, Peoples R China.; Liu, XL (corresponding author), Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland.	xueyuanfzm@163.com; Xiaolei.Liu@glasgow.ac.uk	feng, ziming/GXV-7332-2022	feng, ziming/0000-0001-7096-9720; Liu, Xiaolei/0000-0002-8530-3144	Natural Science Foundation of Heilongjiang province [LH2019E018]; China Postdoctoral Science Foundation [2018T110268, 2018M641804]; Natural Science Foundation of China [51774091, 51607035]	Natural Science Foundation of Heilongjiang province(Natural Science Foundation of Heilongjiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was funded by Natural Science Foundation of Heilongjiang province (No. LH2019E018), China Postdoctoral Science Foundation (No.2018T110268;2018M641804), Natural Science Foundation of China (No.51774091;51607035).	Allison A.P., 2018, P SPE ART LIFT C EXH, DOI [10.2118/190936-MS, DOI 10.2118/190936-MS]; Alwazeer A., 2017, SOC PETROLEUM ENG, DOI [10.2118/188137-MS, DOI 10.2118/188137-MS]; Burgstaller C., 2016, SPE EUR FEAT 78 EAGE, DOI [10.2118/180159-MS, DOI 10.2118/180159-MS, 10.2118/180159-MS.]; Carpenter C, 2015, J PETROL TECHNOL, V67, P96, DOI [10.2118/0715-0096-JPT, DOI 10.2118/0715-0096-JPT]; Clarke F., 2016, SPE N AM ART LIFT C, DOI [10.2118/181214-MS, DOI 10.2118/181214-MS]; Dong Shimin, 2016, Journal of Mechanical Engineering, V52, P63, DOI 10.3901/JME.2016.21.063; Dong Shimin, 2001, PETROLEUM MACHINERY, V29, P46, DOI DOI 10.3969/J.ISSN.1001-4578.2001.06.017; Dong SM, 1996, ACTA PETROLEI SINICA, V17, P138; DOTY DR, 1983, SOC PETROL ENG J, V23, P33, DOI 10.2118/10249-PA; Elmer B., 2015, ALRDC 11 ANN SUCK RO; Elmer WG, 2018, SPE PROD OPER, V33, P419, DOI 10.2118/181228-PA; Feng ZM, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/9205251; Ferrigno E., 2018, P SPE ART LIFT C EXH, DOI [10.2118/190932-MS, DOI 10.2118/190932-MS]; Gibbs S. G., 1987, SPE J, V7, P199, DOI DOI 10.2118/13198-PA; Gibbs S.G., 1963, J PETROL TECHNOL, V15, P69, DOI [10.2118/588-PA, DOI 10.2118/588-PA]; GIBBS SG, 1975, J PETROL TECHNOL, V27, P1153, DOI 10.2118/5149-PA; Lao LM, 2016, J PETROL SCI ENG, V146, P264, DOI 10.1016/j.petrol.2016.04.029; Lea JF, 1989, SPE PROD OP S SOC PE, DOI [10.2118/18827-MS, DOI 10.2118/18827-MS]; Li WC, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/4746210; Qi YG, 1996, PRODUCTION DRILLING, V19, P49; Sam G., 2011, SOC PETROLEUM ENG, DOI [10.2118/145434-MS, DOI 10.2118/145434-MS, 10.2118/145434-MS.]; Shen DC, 1992, ACTA PETROLEI SINICA, V13, P133; Tripp HA, 1990, SPE ANN TECHN C EXH, DOI [10.2118/20671-MS, DOI 10.2118/20671-MS]; Xing MM, 2016, ADV ENG SOFTW, V99, P49, DOI 10.1016/j.advengsoft.2016.05.004; Xing MM, 2015, SPE PROD OPER, V30, P130, DOI 10.2118/173190-PA; Xue CJ, 2002, CHINA PETROLEUM MACH, V30, P4, DOI [10.3969/j.issn.1001-4578.2002.01.002, DOI 10.3969/J.ISSN.1001-4578.2002.01.002]; Yao CD, 1991, OIL FIELD MACHINERY, V30, P4; Yu G. A., 1989, ACTA PET SIN, V10, P76, DOI DOI 10.7623/SYXB198902010	28	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227827	10.1371/journal.pone.0227827	http://dx.doi.org/10.1371/journal.pone.0227827			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3DU	31999730	gold, Green Published, Green Accepted			2022-12-26	WOS:000532823300001
J	Ito, T; Yamamoto, S; Yamaguchi, K; Sato, M; Kaneko, Y; Goto, S; Goto, Y; Narita, I				Ito, Toru; Yamamoto, Suguru; Yamaguchi, Keiichi; Sato, Mami; Kaneko, Yoshikatsu; Goto, Shin; Goto, Yuji; Narita, Ichiei			Inorganic polyphosphate potentiates lipopolysaccharide-induced macrophage inflammatory response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; lipopolysaccharide (LPS); infection; inflammation; micelle; polyphosphate; inflammatory response; LPS micelle formation	MOLECULE	Inorganic polyphosphate (polyP) is a linear polymer of orthophosphate units that are linked by phosphoanhydride bonds and is involved in various pathophysiological processes. However, the role of polyP in immune cell dysfunction is not well-understood. In this study, using several biochemical and cell biology approaches, including cytokine assays, immunofluorescence microscopy, receptor-binding assays with quartz crystal microbalance, and dynamic light scanning, we investigated the effect of polyP on in vitro lipopolysaccharide (LPS)-induced macrophage inflammatory response. PolyP up-regulated LPS-induced production of the inflammatory cytokines, such as tumor necrosis factor ?, interleukin-1?, and interleukin-6, in macrophages, and the effect was polyP dose? and chain length?dependent. However, orthophosphate did not exhibit this effect. PolyP enhanced the LPS-induced intracellular macrophage inflammatory signals. Affinity analysis revealed that polyP interacts with LPS, inducing formation of small micelles, and the polyP-LPS complex enhanced the binding affinity of LPS to Toll-like receptor 4 (TLR4) on macrophages. These results suggest that inorganic polyP plays a critical role in promoting inflammatory response by enhancing the interaction between LPS and TLR4 in macrophages.	[Ito, Toru; Yamamoto, Suguru; Sato, Mami; Kaneko, Yoshikatsu; Goto, Shin; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, 1-757 Asahimachi Dori, Niigata 9518510, Japan; [Yamaguchi, Keiichi; Goto, Yuji] Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan	Niigata University; Osaka University	Yamamoto, S (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	yamamots@med.niigata-u.ac.jp	Narita, Ichiei/G-5204-2017	Narita, Ichiei/0000-0001-7692-3096; Yamamoto, Suguru/0000-0002-8279-2966; Goto, Yuji/0000-0003-1221-1270; Sato, Mami/0000-0001-5292-8319				Bae JS, 2012, J THROMB HAEMOST, V10, P1145, DOI 10.1111/j.1538-7836.2012.04671.x; Biswas I, 2018, ARTERIOSCL THROM VAS, V38, P1868, DOI 10.1161/ATVBAHA.118.311165; Cremers CM, 2016, MOL CELL, V63, P768, DOI 10.1016/j.molcel.2016.07.016; Dinarvand P, 2014, BLOOD, V123, P935, DOI 10.1182/blood-2013-09-529602; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hori Y, 2017, J AM SOC NEPHROL, V28, P1783, DOI 10.1681/ASN.2016060606; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Schildberger A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/697972; Takakusagi Y, 2005, BIOORG MED CHEM LETT, V15, P4850, DOI 10.1016/j.bmcl.2005.07.017; Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b; Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316; Verhoef JJF, 2017, BLOOD, V129, P1707, DOI 10.1182/blood-2016-08-734988; Zhang CM, 2019, P NATL ACAD SCI USA, V116, P12833, DOI 10.1073/pnas.1819813116	20	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4014	4023		10.1074/jbc.RA119.011763	http://dx.doi.org/10.1074/jbc.RA119.011763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32041779	Green Published, hybrid			2022-12-26	WOS:000527704400025
J	Quin, C; Vicaretti, SD; Mohtarudin, NA; Garner, AM; Vollman, DM; Gibson, DL; Zandberg, WF				Quin, Candice; Vicaretti, Sara D.; Mohtarudin, Nina A.; Garner, Alexander M.; Vollman, Deanna M.; Gibson, Deanna L.; Zandberg, Wesley F.			Influence of sulfonated and diet-derived human milk oligosaccharides on the infant microbiome and immune markers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; oligosaccharide; microbiome; sialic acid; cytokine; diet; MS; capillary electrophoresis; prebiotic	N-GLYCOLYLNEURAMINIC ACID; SIALIC-ACID; GLYCAN; FECES; ACETYLLACTOSAMINE; MECHANISMS; GENERATION; EXPRESSION; MUCINS; GROWTH	Human milk oligosaccharides (HMOs) promote the development of the neonatal intestinal, immune, and nervous systems and has recently received considerable attention. Here we investigated how the maternal diet affects HMO biosynthesis and how any diet-induced HMO alterations influence the infant gut microbiome and immunity. Using capillary electrophoresis and MS-based analyses, we extracted and measured HMOs from breast milk samples and then correlated their levels with results from validated 24-h diet recall surveys and breast milk fatty acids. We found that fruit intake and unsaturated fatty acids in breast milk were positively correlated with an increased absolute abundance of numerous HMOs, including 16 sulfonated HMOs we identified here in humans for the first time. The diet-derived monosaccharide 5-N-glycolyl-neuraminic acid (Neu5Gc) was unambiguously detected in all samples. To gain insights into the potential impact of Neu5Gc on the infant microbiome, we used a constrained ordination approach and identified correlations between Neu5Gc levels and Bacteroides spp. in infant stool. However, Neu5Gc was not associated with marked changes in infant immune markers, in contrast with sulfonated HMOs, whose expression correlated with suppression of two major Th2 cytokines, IL-10 and IL-13. The findings of our work highlight the importance of maternal diet for HMO biosynthesis and provide as yet unexplored targets for future studies investigating interactions between HMOs and the intestinal microbiome and immunity in infants.	[Quin, Candice; Mohtarudin, Nina A.; Garner, Alexander M.; Vollman, Deanna M.; Gibson, Deanna L.] Univ British Columbia, IK Barber Sch Arts & Sci, Dept Biol, 1177 Res Rd, Kelowna, BC V1V 1V7, Canada; [Vicaretti, Sara D.; Zandberg, Wesley F.] Univ British Columbia, Dept Chem, IK Barber Sch Arts & Sci, 3247 Univ Way, Kelowna, BC V1V 1V7, Canada; [Gibson, Deanna L.] Fac Med, Dept Med, 317-2194 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Gibson, DL (corresponding author), Univ British Columbia, IK Barber Sch Arts & Sci, Dept Biol, 1177 Res Rd, Kelowna, BC V1V 1V7, Canada.; Zandberg, WF (corresponding author), Univ British Columbia, Dept Chem, IK Barber Sch Arts & Sci, 3247 Univ Way, Kelowna, BC V1V 1V7, Canada.	Deanna.Gibson@ubc.ca; wesley.zandberg@ubc.ca	Zandberg, Wesley/AAX-5568-2021; Gibson, Deanna L/CAF-4166-2022	Gibson, Deanna L/0000-0003-0052-7550; Hart, Gerald/0000-0001-7812-4351	Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Natural Sciences and Engineering Research Council of Canada; Crohn's and Colitis Canada; Bill and Melinda Gates Foundation; Canadian Foundation for Innovation John Evans Leaders Fund; BC Knowledge Development Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Crohn's and Colitis Canada; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Foundation for Innovation John Evans Leaders Fund; BC Knowledge Development Fund(General Electric)	Supported by scholarships from the Canadian Institutes of Health Research and the Canadian Association of Gastroenterology.; Supported by Natural Sciences and Engineering Research Council of Canada undergraduate student research awards.; Supported by a Natural Sciences and Engineering Research Council of Canada Discovery grant, Crohn's and Colitis Canada, and the Bill and Melinda Gates Foundation. To whom correspondence may be addressed. E-mail:Deanna.Gibson@ubc.ca.; Supported by a Natural Sciences and Engineering Research Council of Canada Discovery grant, the Canadian Foundation for Innovation John Evans Leaders Fund, and the BC Knowledge Development Fund. To whom correspondence may be addressed. E-mail: wesley.zandberg@ubc.ca.	Albrecht S, 2011, CARBOHYD RES, V346, P2540, DOI 10.1016/j.carres.2011.08.009; Albrecht S, 2010, ELECTROPHORESIS, V31, P1264, DOI 10.1002/elps.200900646; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Blank D, 2012, ADV NUTR, V3, p440S, DOI 10.3945/an.111.001446; Bosch AM, 2011, J INHERIT METAB DIS, V34, P257, DOI 10.1007/s10545-010-9157-8; Bruehl RE, 2000, J BIOL CHEM, V275, P32642, DOI 10.1074/jbc.M001703200; Bum-Erdene K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20289; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Chen Y, 2014, BRIT J NUTR, V111, P332, DOI 10.1017/S0007114513002468; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Corfield AP, 1996, GLYCOCONJUGATE J, V13, P809, DOI 10.1007/BF00702345; Davis JCC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40466; Davis JCC, 2016, MOL CELL PROTEOMICS, V15, P2987, DOI 10.1074/mcp.M116.060665; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Estaki M, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0189-7; Gnoth MJ, 2000, J NUTR, V130, P3014, DOI 10.1093/jn/130.12.3014; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Guerardel Y, 1999, CARBOHYD RES, V320, P230, DOI 10.1016/S0008-6215(99)00153-6; Hasnain SZ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006218; He Y, 2014, MUCOSAL IMMUNOL, V7, P1326, DOI 10.1038/mi.2014.20; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Hill DR, 2012, J BIOL CHEM, V287, P30610, DOI 10.1074/jbc.M112.356238; Jiang X, 2004, J INFECT DIS, V190, P1850, DOI 10.1086/425159; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Karav S, 2016, APPL ENVIRON MICROB, V82, P3622, DOI 10.1128/AEM.00547-16; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim H, 2017, BRIT J NUTR, V117, P556, DOI [10.1017/S0007114517000253, 10.1017/s0007114517000253]; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lacomba R, 2011, INT DAIRY J, V21, P887, DOI 10.1016/j.idairyj.2011.05.008; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z; Mahajan VS, 2016, IMMUNOL REV, V269, P145, DOI 10.1111/imr.12344; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Matsuki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11939; McGuire MK, 2017, AM J CLIN NUTR, V105, P1086, DOI 10.3945/ajcn.116.139980; MOPPER K, 1973, ANAL BIOCHEM, V56, P440, DOI 10.1016/0003-2697(73)90210-8; Noll AJ, 2016, GLYCOBIOLOGY, V26, P655, DOI 10.1093/glycob/cww002; Oliveros E, 2016, J NUTR BIOCHEM, V31, P20, DOI 10.1016/j.jnutbio.2015.12.014; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quin C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26423-3; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Rohrig CH, 2017, CRIT REV FOOD SCI, V57, P1017, DOI 10.1080/10408398.2015.1040113; Rudloff S, 2012, BRIT J NUTR, V107, P957, DOI 10.1017/S0007114511004016; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Schwab C, 2011, FEMS MICROBIOL LETT, V315, P141, DOI 10.1111/j.1574-6968.2010.02185.x; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; Smilowitz JT, 2014, ANNU REV NUTR, V34, P143, DOI 10.1146/annurev-nutr-071813-105721; Subar AF, 2012, J ACAD NUTR DIET, V112, P1134, DOI 10.1016/j.jand.2012.04.016; Suzuki A, 2001, J BIOL CHEM, V276, P24388, DOI 10.1074/jbc.M103135200; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; Totten SM, 2012, J PROTEOME RES, V11, P6124, DOI 10.1021/pr300769g; Urashima T, 2018, TRENDS GLYCOSCI GLYC, V30, pSE51, DOI 10.4052/tigg.1734.1SE; Vicaretti SD, 2018, J AGR FOOD CHEM, V66, P8574, DOI 10.1021/acs.jafc.8b01041; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wylie AD, 2018, J AGR FOOD CHEM, V66, P8114, DOI 10.1021/acs.jafc.8b01042; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu ZJ, 2015, BRIT J NUTR, V113, pS1, DOI 10.1017/S0007114514004127; Yu Y, 2012, J BIOL CHEM, V287, P44784, DOI 10.1074/jbc.M112.425819	70	24	26	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4035	4048		10.1074/jbc.RA119.011351	http://dx.doi.org/10.1074/jbc.RA119.011351			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32014993	Green Published, hybrid			2022-12-26	WOS:000527704400027
J	Aliboni, L; Pennati, F; Royston, TJ; Woods, JC; Aliverti, A				Aliboni, Lorenzo; Pennati, Francesca; Royston, Thomas J.; Woods, Jason C.; Aliverti, Andrea			Simulation of bronchial airway acoustics in healthy and asthmatic subjects	PLOS ONE			English	Article							INPUT IMPEDANCE; MECHANICAL-PROPERTIES; COMPUTED-TOMOGRAPHY; RESPIRATORY SYSTEM; SOUND-TRANSMISSION; WAVE-PROPAGATION; LUNG SOUNDS; RESONANCES; GEOMETRY; VELOCITY	The onset and development of many airway pathologies affect sound propagation throughout the respiratory system; changes in respiratory sounds are detected primarily by auscultation, which is highly skill dependent. The aim of the present study was to compare healthy and asthmatic pulmonary acoustics by applying a 1D model of wave propagation on CT-based patient-specific geometries. High-resolution CT lung images were acquired in five healthy volunteers and five asthmatic patients at total lung capacity (TLC) and functional residual capacity (FRC). Tracheobronchial trees were reconstructed from CT images. Acoustic pressure, impedance and wall radial velocity were measured by simulating acoustic wave propagation of two external, acoustic pressure waves (1 Pa, 200 and 600 Hz) from the trachea level to the 4th generation. In asthmatic patients, acoustic pressure averaged across the last three generations showed a reduction equal to 29.7% (p< 0.01) at FRC, at 200 Hz; input and terminal impedance were 34.5% (p< 0.05) higher both at FRC and TLC; wall radial velocity was more than 80% (p< 0.05) lower in higher generations both at FRC and TLC. Airway differences in asthma alter acoustic parameters at FRC and TLC, with the greatest difference at FRC and 200 Hz. Acoustic wave propagation analysis represents a quantitative approach that has potential to objectively characterize airway differences in individuals with diseases such as asthma.	[Aliboni, Lorenzo; Pennati, Francesca; Aliverti, Andrea] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy; [Royston, Thomas J.] Univ Illinois, Richard & Loan Hill Dept Bioengn, Chicago, IL USA; [Woods, Jason C.] Univ Cincinnati, Dept Pediat, Dept Radiol, Cincinnati, OH USA; [Woods, Jason C.] Washington Univ, Dept Phys, St Louis, MO 63130 USA	Polytechnic University of Milan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Ohio; University of Cincinnati; Washington University (WUSTL)	Aliboni, L (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy.	lorenzo.aliboni@polimi.it	Pennati, Francesca/K-5287-2016; Andrea, Aliverti/A-3901-2015	Pennati, Francesca/0000-0001-8896-8224; Andrea, Aliverti/0000-0002-2950-0231; Aliboni, Lorenzo/0000-0002-4146-8414				Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; BEAUPRE A, 1982, THORAX, V37, P124, DOI 10.1136/thx.37.2.124; Bohadana A, 2014, NEW ENGL J MED, V370, P744, DOI 10.1056/NEJMra1302901; BURNS CB, 1985, J APPL PHYSIOL, V59, P1590, DOI 10.1152/jappl.1985.59.5.1590; Dai Z., 2013, AUDIBLE HUMAN PROJEC; Dai ZJ, 2015, J SOUND VIB, V339, P215, DOI 10.1016/j.jsv.2014.11.026; Gillis HL, 1999, ANN BIOMED ENG, V27, P14, DOI 10.1114/1.161; Gross V, 2000, AM J RESP CRIT CARE, V162, P905, DOI 10.1164/ajrccm.162.3.9905104; HABIB RH, 1994, J APPL PHYSIOL, V77, P441, DOI 10.1152/jappl.1994.77.1.441; Harper P, 2001, IEEE T BIO-MED ENG, V48, P543, DOI 10.1109/10.918593; Henry B., 2018, ASME J, V1, DOI [10.1115/1.4039177, DOI 10.1115/1.4039177]; Henry B, 2018, J ACOUST SOC AM, V143, P1427, DOI 10.1121/1.5027239; Henry B, 2018, J ACOUST SOC AM, V143, P1297, DOI 10.1121/1.5025842; Henry B, 2017, J ACOUST SOC AM, V142, P1774, DOI 10.1121/1.5005497; Ionescu CM, 2009, IEEE T BIO-MED ENG, V56, P949, DOI 10.1109/TBME.2008.2007807; JACKSON AC, 1993, J APPL PHYSIOL, V75, P217, DOI 10.1152/jappl.1993.75.1.217; JACKSON AC, 1995, ANN BIOMED ENG, V23, P740, DOI 10.1007/BF02584473; King GG, 2004, EUR RESPIR J, V24, P211, DOI 10.1183/09031936.04.00047503; Korenbaum V., 2015, P M ACOUST, V23, DOI 10.1121/2.0000077; Korenbaum VI, 2011, ACOUST PHYS+, V57, P872, DOI 10.1134/S106377101106008X; Lee SLA, 2008, IEEE IJCNN, P2377, DOI 10.1109/IJCNN.2008.4634128; Lulich SM, 2015, J ACOUST SOC AM, V137, P3436, DOI 10.1121/1.4921281; Lulich SM, 2011, J ACOUST SOC AM, V130, P2108, DOI 10.1121/1.3632091; Miyawaki S, 2017, BIOMECH MODEL MECHAN, V16, P583, DOI 10.1007/s10237-016-0838-6; Montesantos S, 2013, ANAT REC, V296, P852, DOI 10.1002/ar.22695; Park SJ, 2007, INT MEAS SYST INTR A, P2544; Pasterkamp H, 1997, AM J RESP CRIT CARE, V156, P974, DOI 10.1164/ajrccm.156.3.9701115; Peng Y, 2016, MED BIOL ENG COMPUT, V54, P675, DOI 10.1007/s11517-015-1358-8; Peng Y, 2014, MED BIOL ENG COMPUT, V52, P695, DOI 10.1007/s11517-014-1172-8; Piirila P, 1995, EUR RESPIR J, V8, P2139, DOI 10.1183/09031936.95.08122139; Reyes BA, 2008, IEEE ENG MED BIO, P3620, DOI 10.1109/IEMBS.2008.4649990; Royston TJ, 2008, BIOMEDICAL APPL VIBR, P32; SUKI B, 1993, J APPL PHYSIOL, V75, P2755, DOI 10.1152/jappl.1993.75.6.2755; van Rikxoort EM, 2013, PHYS MED BIOL, V58, pR187, DOI 10.1088/0031-9155/58/17/R187; Wenzel S, 2005, AM J RESP CRIT CARE, V172, P149, DOI 10.1164/rccm.200409-1181PP; Wodicka GR, 1989, IEEE T BIOMED ENG, P36	36	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228603	10.1371/journal.pone.0228603	http://dx.doi.org/10.1371/journal.pone.0228603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040483	Green Published, gold			2022-12-26	WOS:000534629400030
J	Shapiro, AD; Grafton, ST				Shapiro, Allison D.; Grafton, Scott T.			Subjective value then confidence in human ventromedial prefrontal cortex	PLOS ONE			English	Article							ANTERIOR CINGULATE; DECISION-MAKING; VALUATION SYSTEM; CHOICE; INTEGRATION; ROBUST; OPTIMIZATION; REGISTRATION; NEUROBIOLOGY; INFORMATION	Two fundamental goals of decision making are to select actions that maximize rewards while minimizing costs and to have strong confidence in the accuracy of a judgment. Neural signatures of these two forms of value: the subjective value (SV) of choice alternatives and the value of the judgment (confidence), have both been observed in ventromedial prefrontal cortex (vmPFC). However, the relationship between these dual value signals and their relative time courses are unknown. Twenty-eight men and women underwent fMRI while performing a two-phase approach-avoidance (Ap-Av) task with mixed-outcomes of monetary rewards paired with painful shock stimuli. Neural responses were measured during offer valuation (offer phase) and choice valuation (commit phase) and analyzed with respect to observed decision outcomes, model-estimated SV and confidence. During the offer phase, vmPFC tracked SV and the decision but not confidence. During the commit phase, vmPFC tracked confidence, computed as the quadratic extension of SV, but not the offer valuation nor the decision. In fact, vmPFC responses from the commit phase were selective for confidence even for reject decisions wherein confidence and SV are inversely related. Conversely, activation of the cognitive control network, including within lateral prefrontal cortex (lPFC) and dorsal anterior cingulate cortex (dACC) was associated with ambivalence, during both the offer and commit phases. Taken together, our results reveal complementary representations in vmPFC during value-based decision making that temporally dissociate such that offer valuation (SV) emerges before decision valuation (confidence).	[Shapiro, Allison D.; Grafton, Scott T.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Shapiro, AD (corresponding author), Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA.	shapiro.alli@gmail.com		Shapiro, Allison/0000-0003-3110-0955; Grafton, Scott/0000-0003-4015-3151	Army Research Office of the Army Research Laboratory [W911NF-16-1-0474, W911NF-09-0001, W911NF-19-2-0026]	Army Research Office of the Army Research Laboratory	This work supported by Grant W911NF-16-1-0474, Contract W911NF-09-0001 and Cooperative Agreement W911NF-19-2-0026 with the Army Research Office of the Army Research Laboratory to STG. https://www.arl.army.mil/www/default.cfm.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemori K, 2015, J NEUROSCI, V35, P1939, DOI 10.1523/JNEUROSCI.1731-14.2015; Amemori KI, 2012, NAT NEUROSCI, V15, P776, DOI 10.1038/nn.3088; Andersson J.L.R., 2007, TR07JA2 FMRIB; Andersson J.L.R., 2007, TR07JA1 FMRIB, DOI DOI 10.1093/CERCOR/8.4.372; Aupperle RL, 2015, HUM BRAIN MAPP, V36, P449, DOI 10.1002/hbm.22639; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Badre D, 2012, NEURON, V73, P595, DOI 10.1016/j.neuron.2011.12.025; Bang D, 2018, P NATL ACAD SCI USA, V115, P6082, DOI 10.1073/pnas.1800795115; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Cieslak M, 2015, PSYCHOPHYSIOLOGY, V52, P481, DOI 10.1111/psyp.12385; De Martino B, 2017, J NEUROSCI, V37, P6066, DOI 10.1523/JNEUROSCI.3880-16.2017; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Dotan D, 2018, COGNITION, V171, P112, DOI 10.1016/j.cognition.2017.11.001; Economides M, 2014, J NEUROSCI, V34, P3340, DOI 10.1523/JNEUROSCI.4313-13.2014; Fleming SM, 2018, NAT NEUROSCI, V21, P617, DOI 10.1038/s41593-018-0104-6; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Gherman S, 2018, ELIFE, V7, DOI 10.7554/eLife.38293; Gherman S, 2015, NEUROIMAGE, V106, P134, DOI 10.1016/j.neuroimage.2014.11.036; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Hebscher M, 2016, NEUROPSYCHOLOGIA, V90, P46, DOI 10.1016/j.neuropsychologia.2016.05.003; Hebscher M, 2016, CEREB CORTEX, V26, P4590, DOI 10.1093/cercor/bhv220; Heereman J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00551; Hilgenstock R, 2014, NEUROIMAGE, V99, P323, DOI 10.1016/j.neuroimage.2014.05.049; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kahnt T, 2011, NEUROIMAGE, V56, P709, DOI 10.1016/j.neuroimage.2010.05.058; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2014, NEURON, V84, P1329, DOI 10.1016/j.neuron.2014.12.015; Lebreton M, 2015, NAT NEUROSCI, V18, P1159, DOI 10.1038/nn.4064; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; Lee D, 2013, NEURON, V78, P233, DOI 10.1016/j.neuron.2013.04.008; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Lopez-Persem A, 2016, ELIFE, V5, DOI 10.7554/eLife.20317; Morales J, 2018, J NEUROSCI, V38, P3534, DOI 10.1523/JNEUROSCI.2360-17.2018; Moran R, 2015, COGNITIVE PSYCHOL, V78, P99, DOI 10.1016/j.cogpsych.2015.01.002; Mumford JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126255; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Park SQ, 2011, J NEUROSCI, V31, P9307, DOI 10.1523/JNEUROSCI.4973-10.2011; Pessiglione M, 2015, CURR OPIN BEHAV SCI, V5, P78, DOI 10.1016/j.cobeha.2015.08.006; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Rolls ET, 2010, NEUROIMAGE, V53, P694, DOI 10.1016/j.neuroimage.2010.06.073; Rushworth MFS, 2012, CURR OPIN NEUROBIOL, V22, P946, DOI 10.1016/j.conb.2012.04.011; Rushworth MFS, 2009, CURR OPIN NEUROBIOL, V19, P75, DOI 10.1016/j.conb.2009.02.005; Schlund MW, 2016, NEUROIMAGE, V136, P94, DOI 10.1016/j.neuroimage.2016.04.070; Shenhav A, 2016, COGN AFFECT BEHAV NE, V16, P1127, DOI 10.3758/s13415-016-0458-8; Shenhav A, 2014, NAT NEUROSCI, V17, P1249, DOI 10.1038/nn.3771; Skvortsova V, 2014, J NEUROSCI, V34, P15621, DOI 10.1523/JNEUROSCI.1350-14.2014; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sokol-Hessner P, 2012, EUR J NEUROSCI, V35, P1065, DOI 10.1111/j.1460-9568.2012.08076.x; Talmi D, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00146; Talmi D, 2009, J NEUROSCI, V29, P14617, DOI 10.1523/JNEUROSCI.2026-09.2009; van den Berg R, 2016, ELIFE, V5, DOI 10.7554/eLife.12192; Volz LJ, 2017, P NATL ACAD SCI USA, V114, P7963, DOI 10.1073/pnas.1706693114; Wan XH, 2015, NAT NEUROSCI, V18, P752, DOI 10.1038/nn.3999; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107; Yu SL, 2015, J EXP PSYCHOL GEN, V144, P489, DOI 10.1037/xge0000062	64	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0225617	10.1371/journal.pone.0225617	http://dx.doi.org/10.1371/journal.pone.0225617			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9IO	32040474	Green Published, Green Submitted, gold			2022-12-26	WOS:000534629400005
J	Herwig, E; Schwean-Lardner, K; Van Kessel, A; Savary, RK; Classen, HL				Herwig, Eugenia; Schwean-Lardner, Karen; Van Kessel, Andrew; Savary, Rachel K.; Classen, Henry L.			Assessing the effect of starch digestion characteristics on ileal brake activation in broiler chickens	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CHAIN FATTY-ACIDS; FOOD-INTAKE; SMALL-INTESTINE; TRANSIT-TIME; LARGE-BOWEL; FERMENTATION; PYY; GLP-1; FEED	The objective of this research was to evaluate activation of the ileal brake in broiler chickens using diets containing semi-purified wheat (WS; rapidly and highly digested) and pea (PS; slowly and poorly digested) starch. Diets were formulated to contain six WS:PS ratios (100:0, 80:20, 60:40, 40:60, 20:80, 0:100) and each starch ratio was fed to 236 Ross 308 male broilers housed in 4 litter floor pens. At 28 d of age, the effect of PS concentration was assessed on starch digestion, digestive tract morphology, and digesta pH and short-chain fatty acid (SCFA) concentration. Glucagon-like peptide-1 (GLP-1) and peptide tyrosine-tyrosine (PYY) status were assessed in serum (ELISA) and via gene expression in jejunal and ileal tissue (proglucagon for GLP-1). Data were analyzed using regression analyses, and significance was accepted at P <= 0.05. Increasing dietary PS resulted in reduced starch digestibility in the small intestine, but had no effect in the colon. Crop content pH responded quadratically to PS level with an estimated minimum at 55% PS. Total SCFA increased linearly in the crop with PS level, but changed in a quadratic fashion in the ileum (estimated maximum at 62% PS). Ceacal SCFA concentrations were highest for the 80 and 100% PS levels. The relative empty weight (crop, small intestine, colon), length (small intestine) and content (crop jejunum, Ileum) of digestive tract sections increased linearly with increasing PS concentration. Dietary treatment did not affect serum GLP-1 or PYY or small intestine transcript abundance. In conclusion, feeding PS increased the presence of L-cell activators (starch, SCFA) and increased trophic development and content of the digestive tract, suggestive of L-cell activation. However, no direct evidence of ileal brake activation was found by measuring venous blood levels of GLP-1 or PYY or corresponding gene expression in small intestine tissue.	[Herwig, Eugenia; Schwean-Lardner, Karen; Van Kessel, Andrew; Savary, Rachel K.; Classen, Henry L.] Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK, Canada	University of Saskatchewan	Herwig, E; Classen, HL (corresponding author), Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK, Canada.	herwig.eugenia@usask.ca; hank.classen@usask.ca		Herwig, Eugenia/0000-0001-6630-5673	Aviagen North America [414702]; Canadian Poultry Research Council [414703]; Chicken Farmers of Saskatchewan [414704]; Sofina Foods Inc. [414705]; Poultry Industry Council [414706]; Prairie Pride Natural Foods Ltd. [414707]; Saskatchewan Broiler Hatching Egg Producer's Marketing Board [414708]; Saskatchewan Egg Producers [414709]; Saskatchewan Turkey Producers' Marketing Board [414710]; University of Saskatchewan [414739]; NSERC [414764]	Aviagen North America; Canadian Poultry Research Council; Chicken Farmers of Saskatchewan; Sofina Foods Inc.; Poultry Industry Council; Prairie Pride Natural Foods Ltd.; Saskatchewan Broiler Hatching Egg Producer's Marketing Board; Saskatchewan Egg Producers; Saskatchewan Turkey Producers' Marketing Board; University of Saskatchewan; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	HLC -Grant #414702 Aviagen North America http://en.aviagen.com/HLC -Grant #414703 Canadian Poultry Research Council http://cp-rc.ca/HLC -Grant #414704 Chicken Farmers of Saskatchewan http://www.saskatchewanchicken.ca/HLC -Grant #414705 Sofina Foods Inc. https://www.sofinafoods.com/HLC -Grant #414706 Poultry Industry Council https://www.poultryindustrycouncil.ca/HLC - Grant #414707 Prairie Pride Natural Foods Ltd. No website - 3535 Millar Avenue Saskatoon, SK S7P 0A2 HLC - Grant #414708 Saskatchewan Broiler Hatching Egg Producer's Marketing Board No website - 224 Pacific Ave., Suite 201 Saskatoon, SK, S7K 1N9 HLC - Grant #414709 Saskatchewan Egg Producers http://www.saskegg.ca/HLC Grant #414710 Saskatchewan Turkey Producers' Marketing Board https://www.saskturkey.com/HLC - Grant #414739 University of Saskatchewan https://www.usask.ca/HLC - Grant #414764 NSERC https://www.nserc-crsng.gc.ca/index_eng.asp	Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; AOAC International, 2019, OFFICIAL METHODS ANA, V21st; Aoki K, 2017, GEN COMP ENDOCR, V242, P11, DOI 10.1016/j.ygcen.2016.04.021; Asp NG, 1996, FOOD CHEM, V57, P9, DOI 10.1016/0308-8146(96)00055-6; Aviagen, 2014, BROIL ROSS 308 PERF; Bird AR, 2007, BRIT J NUTR, V97, P134, DOI 10.1017/S0007114507250433; Bohorquez DV, 2015, J CLIN INVEST, V125, P782, DOI 10.1172/JCI78361; Bohorquez DV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089881; Brooks L, 2017, MOL METAB, V6, P48, DOI 10.1016/j.molmet.2016.10.011; Burrin DG, 2003, DOMEST ANIM ENDOCRIN, V24, P103, DOI 10.1016/S0739-7240(02)00210-2; Canadian Council on Animal Care CCAC, 2009, CANADIAN COUNCIL ANI; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Chan JL, 2006, DIABETOLOGIA, V49, P169, DOI 10.1007/s00125-005-0041-2; CHAPLIN SB, 1992, PHYSIOL BEHAV, V52, P261, DOI 10.1016/0031-9384(92)90268-7; Cheled-Shoval SL, 2011, POULTRY SCI, V90, P2301, DOI 10.3382/ps.2011-01488; Chen CH, 1997, NEUROGASTROENT MOTIL, V9, P109, DOI 10.1046/j.1365-2982.1997.d01-26.x; Danicke S, 1999, POULTRY SCI, V78, P1292, DOI 10.1093/ps/78.9.1292; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; Enting H., 2005, Proceedings of the 17th Australian Poultry Science Symposium, Sydney, New South Wales, Australia, 7-9 February 2005, P17; Fouhse JM, 2015, J NUTR, V145, P2464, DOI 10.3945/jn.115.214353; Furuse M, 1997, BRAIN RES, V755, P167, DOI 10.1016/S0006-8993(97)00190-X; Ghatei MA, 2001, DIGEST DIS SCI, V46, P1255, DOI 10.1023/A:1010615429639; Gordon RW, 1997, POULTRY SCI, V76, P683, DOI 10.1093/ps/76.5.683; del Alamo AG, 2009, POULTRY SCI, V88, P1666, DOI 10.3382/ps.2008-00502; Herwig E., 2018, THESIS; Herwig E, 2019, APPL ANIM BEHAV SCI, V211, P54, DOI 10.1016/j.applanim.2018.11.002; Herwig E, 2019, POULTRY SCI, V98, P2940, DOI 10.3382/ps/pez044; Herwig E, 2019, POULTRY SCI, V98, P3676, DOI 10.3382/ps/pey580; Hetland H, 2001, BRIT POULTRY SCI, V42, P354, DOI 10.1080/00071660120055331; Hiramatsu Kohzy, 2005, Journal of Poultry Science, V42, P223, DOI 10.2141/jpsa.42.223; Honda K, 2014, PEPTIDES, V52, P98, DOI 10.1016/j.peptides.2013.12.008; Hu XF, 2010, POULTRY SCI, V89, P1967, DOI 10.3382/ps.2009-00547; Jozefiak D, 2004, ANIM FEED SCI TECH, V113, P1, DOI 10.1016/j.anifeedsci.2003.09.007; Kaji I, 2011, J MOL HISTOL, V42, P27, DOI 10.1007/s10735-010-9304-4; Karunaratne ND, 2018, CAN J ANIM SCI, V98, P463, DOI 10.1139/cjas-2017-0099; Kolodziejski PA, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-017-0227-8; Latorre R, 2016, NEUROGASTROENT MOTIL, V28, P620, DOI 10.1111/nmo.12754; Lindeboom N, 2004, STARCH-STARKE, V56, P89, DOI 10.1002/star.200300218; MACFARLANE GT, 1992, FEMS MICROBIOL ECOL, V101, P81, DOI 10.1111/j.1574-6968.1992.tb05764.x; Mansour A, 2013, NUTRITION, V29, P813, DOI 10.1016/j.nut.2012.11.015; Massimino SP, 1998, J NUTR, V128, P1786, DOI 10.1093/jn/128.10.1786; MCDONALD AML, 1988, J I BREWING, V94, P125, DOI 10.1002/j.2050-0416.1988.tb04568.x; Meyer JH, 1998, AM J PHYSIOL-REG I, V275, pR1293, DOI 10.1152/ajpregu.1998.275.4.R1293; Monir MM, 2014, ANAT HISTOL EMBRYOL, V43, P153, DOI 10.1111/ahe.12062; Myers WD, 2004, J ANIM SCI, V82, P179; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Olnood CG, 2015, ANIM NUTR, V1, P192, DOI 10.1016/j.aninu.2015.07.002; Onrust L, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00075; Parada J, 2011, FOOD SCI TECHNOL INT, V17, P187, DOI 10.1177/1082013210387712; POTKINS ZV, 1991, BRIT J NUTR, V65, P391, DOI 10.1079/BJN19910100; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Richards MP, 2008, GEN COMP ENDOCR, V156, P323, DOI 10.1016/j.ygcen.2008.01.014; Ring LL, 2018, EXPERT REV GASTROENT, V12, P257, DOI 10.1080/17474124.2018.1417032; SALIH ME, 1991, ANIM FEED SCI TECH, V33, P139, DOI 10.1016/0377-8401(91)90052-T; SAVAGE AP, 1987, GUT, V28, P166, DOI 10.1136/gut.28.2.166; Schirra J, 2005, REGUL PEPTIDES, V128, P109, DOI 10.1016/j.regpep.2004.06.018; Sengor E, 2006, TURK J VET ANIM SCI, V30, P561; Shynkaruk T, 2019, POULTRY SCI, V98, P2448, DOI 10.3382/ps/pez018; Tolhurst G, 2009, J PHYSIOL-LONDON, V587, P27, DOI 10.1113/jphysiol.2008.164012; Topping DL, 1997, J NUTR, V127, P615, DOI 10.1093/jn/127.4.615; Tsai CH, 1997, AM J PHYSIOL-ENDOC M, V273, pE77, DOI 10.1152/ajpendo.1997.273.1.E77; Tyler TR, 1982, THESIS; van Avesaat M, 2015, INT J OBESITY, V39, P235, DOI 10.1038/ijo.2014.112; VEERKAMP CH, 1986, POULTRY SCI, V65, P1299, DOI 10.3382/ps.0651299; Wachters-Hagedoorn RE, 2006, J NUTR, V136, P1511, DOI 10.1093/jn/136.6.1511; Weurding RE, 2003, POULTRY SCI, V82, P279, DOI 10.1093/ps/82.2.279; Weurding RE, 2001, J NUTR, V131, P2329, DOI 10.1093/jn/131.9.2329; Williams BA, 2001, NUTR RES REV, V14, P207, DOI 10.1079/NRR200127; Wu AC, 2014, CARBOHYD POLYM, V114, P36, DOI 10.1016/j.carbpol.2014.08.001; YUTSTE P, 1991, ANIM FEED SCI TECH, V35, P289, DOI 10.1016/0377-8401(91)90135-F; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zhou J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1160, DOI 10.1152/ajpendo.90637.2008	74	4	4	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228647	10.1371/journal.pone.0228647	http://dx.doi.org/10.1371/journal.pone.0228647			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032378	gold, Green Published			2022-12-26	WOS:000534626100019
J	Clark, DA; Donnellan, MB; Durbin, CE; Nuttall, AK; Hicks, BM; Robins, RW				Clark, D. Angus; Donnellan, M. Brent; Durbin, C. Emily; Nuttall, Amy K.; Hicks, Brian M.; Robins, Richard W.			Sex, drugs, and early emerging risk: Examining the association between sexual debut and substance use across adolescence	PLOS ONE			English	Article							BETWEEN-PERSON; WITHIN-PERSON; 1ST SEX; INTERCOURSE; BEHAVIOR; AGE; TWIN; GENDER; PEERS	Sexual debut, or first intercourse, predicts problem behaviors such as substance use. This association could reflect a direct effect of debut itself, general developmental trends, or the fact that some youth are more predisposed to a wide array of problem behaviors (e.g., risky sex, substance use). Understanding the association between sexual debut and substance use thus requires methods that can distinguish between these various accounts. In this study the association between sexual debut and substance use was investigated in a longitudinal sample of Mexican-origin youth (N = 674) assessed annually from 5th (M-age = 10.86 years, SD = 0.51) through 12th grade (M-age = 17.69 years, SD = 0.48). The longitudinal aspect of the data allowed the direct effect of sexual debut on substance use to be tested while accounting for long-term trends in substance use, and stable individual differences in those trends based on early risk and debut timing. Substance use increased over time, and early risk and debut were consistently associated with more substance use. Sexual debut also modestly predicted an increase in substance use after accounting for these effects, however. Taken together, results provide some evidence consistent with each of the potential explanations for the association between sexual debut and substance use across adolescence.	[Clark, D. Angus; Hicks, Brian M.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Clark, D. Angus; Hicks, Brian M.] Univ Michigan, Addict Ctr, Ann Arbor, MI 48109 USA; [Donnellan, M. Brent; Durbin, C. Emily] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Nuttall, Amy K.] Michigan State Univ, Dept Human Dev & Family Studies, E Lansing, MI 48824 USA; [Robins, Richard W.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Michigan State University; Michigan State University; University of California System; University of California Davis	Clark, DA (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.; Clark, DA (corresponding author), Univ Michigan, Addict Ctr, Ann Arbor, MI 48109 USA.	cladavid@med.umich.edu	Nuttall, Amy K/AAT-3831-2021	Nuttall, Amy K/0000-0003-3382-3516; Robins, Richard/0000-0002-5088-3484	National Institute on Drug Abuse [DA017902]; National Institute on Alcohol Abuse and Alcoholism [T32 AA007477]	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by a grant from the National Institute on Drug Abuse (DA017902; https://www.drugabuse.gov/) to Richard W. Robins and Rand D. Conger and by the National Institute on Alcohol Abuse and Alcoholism grant number T32 AA007477. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P.D, 2009, SAGE HDB QUANTITATIV, P72, DOI DOI 10.4135/9780857020994.N4; Armour S, 2007, J YOUTH ADOLESCENCE, V36, P141, DOI 10.1007/s10964-006-9128-4; Barnes JC, 2013, BEHAV GENET, V43, P120, DOI 10.1007/s10519-012-9580-8; Berry D, 2017, CHILD DEV, V88, P1186, DOI 10.1111/cdev.12660; Biello KB, 2013, PUBLIC HEALTH REP, V128, P23, DOI 10.1177/00333549131282S103; Bierman KL, 2014, PREV SCI, V15, pS33, DOI 10.1007/s11121-012-0328-8; Bozon M, 2003, POPULATION SOC, V391, P1; Cavazos-Rehg PA, 2009, CONTRACEPTION, V80, P158, DOI 10.1016/j.contraception.2009.02.014; Centers for Disease Control and Prevention, 2017, CURR CIG US YOUTH YO; Chassin L., 2004, HDB ADOLESCENT PSYCH, P665; Chen P., 2012, DEV TRAJECTORIES SUB; Clark DA, 2015, J ADOLESCENCE, V41, P121, DOI 10.1016/j.adolescence.2015.02.010; Cornelius JR, 2007, ADDICT BEHAV, V32, P850, DOI 10.1016/j.addbeh.2006.06.027; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Curran PJ, 2014, J CONSULT CLIN PSYCH, V82, P879, DOI 10.1037/a0035297; Curran PJ, 2012, CILVR SER LAT VAR, P217; D'Onofrio BM, 2013, AM J PUBLIC HEALTH, V103, P46, DOI 10.2105/AJPH.2013.301252; Deutsch AR, 2014, J ADOLESCENT HEALTH, V54, P114, DOI 10.1016/j.jadohealth.2013.07.013; Donahue KL, 2013, HEALTH PSYCHOL, V32, P180, DOI 10.1037/a0028922; Dumka LE, 2009, SEX ROLES, V60, P588, DOI 10.1007/s11199-008-9518-z; Elliott D. S., 1985, EXPLAINING DELINQUEN; Elliott D.S., 1990, NATL YOUTH SURVEY; Falk CF, 2018, STRUCT EQU MODELING, V25, P244, DOI 10.1080/10705511.2017.1367254; Gibbons FX, 2004, PERS SOC PSYCHOL B, V30, P1048, DOI 10.1177/0146167204264788; Halpern CT, 2012, AM J PUBLIC HEALTH, V102, P1221, DOI 10.2105/AJPH.2011.300394; Hancock G. R., 2012, BOOTSTRAPPING STANDA; Harden KP, 2008, J YOUTH ADOLESCENCE, V37, P373, DOI 10.1007/s10964-007-9228-9; Harden KP, 2014, PSYCHOL BULL, V140, P434, DOI 10.1037/a0033564; Haydon AA, 2012, J ADOLESCENT HEALTH, V50, P456, DOI 10.1016/j.jadohealth.2011.09.006; Hensel DJ, 2014, APA HDB SEXUALITY PS, P385, DOI [DOI 10.1037/14193-013, 10.1037/14193-013]; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Jessor R., 2014, DEV SCI ADOLESCENCE, P239; Johnson W, 2009, CURR DIR PSYCHOL SCI, V18, P217, DOI 10.1111/j.1467-8721.2009.01639.x; Krueger RF, 2002, J RES PERS, V36, P564, DOI 10.1016/S0092-6566(02)00506-8; Lesa KEM, 2001, 2001 BIENNIAL M SOC; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Muthen B., 2010, MPLUS USERS GUIDE; O'Sullivan L.F., 2014, APA HDB SEXUALITY PS, P433, DOI [https://doi.org/10.1037/14193-015, DOI 10.1037/14193-015]; Pillen M. B., 1992, DETERMINING YOUTH GA; Samejima F, 1969, PSYCHOMETRIKA MONO S; SAMHSA, 1997, NAT HOUS SURV DRUG A; Savin-Williams R. C., 2004, HDB ADOLESCENT PSYCH, P139; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Simoes C, 2014, PSICOL-REFLEX CRIT, V27, P179, DOI 10.1590/S0102-79722014000100020; SMALL SA, 1993, J MARRIAGE FAM, V55, P941, DOI 10.2307/352774; Thissen D., 2001, TEST SCORING; Thornberry Terence P., 1988, NATO ADV WORKSH SELF; U.S. Census, 2011, OVERVIEW RACE HISPAN; Wheeler LA, 2017, DEV PSYCHOL, V53, P126, DOI 10.1037/dev0000251; Windle M., 2003, BLACKWELL HDB ADOLES, P450; Wu W., 2013, OXFORD HDB QUANTITAT, P387; Wu W, 2016, STRUCT EQU MODELING, V23, P140, DOI 10.1080/10705511.2014.938578; Young SE, 2002, DRUG ALCOHOL DEPEN, V68, P309, DOI 10.1016/S0376-8716(02)00225-9; Zimmer-Gembeck M.J., 2008, BLACKWELL HDB ADOLES, P175, DOI [10.1002/9780470756607.ch9, DOI 10.1002/9780470756607.CH9]; Zimmer-Gembeck MJ, 2008, DEV REV, V28, P153, DOI 10.1016/j.dr.2007.06.001	55	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228432	10.1371/journal.pone.0228432	http://dx.doi.org/10.1371/journal.pone.0228432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9GK	32027682	Green Published, gold, Green Submitted			2022-12-26	WOS:000534623800032
J	Ram, HS; Ram, S; Miller, N; Rosental, YS; Chodick, G				Ram, Hila Shalev; Ram, Shai; Miller, Netanella; Rosental, Yael Shalev; Chodick, Gabriel			Air travel during pregnancy and the risk of adverse pregnancy outcomes as gestational age and weight at birth: A retrospective study among 284,069 women in Israel between the years 2000 to 2016	PLOS ONE			English	Article								Objective The American College of Gynecology (ACOG) recommendation does not limit air travel during pregnancy, yet the evidence for air travel effect on adverse pregnancy outcomes is limited and debatable. Study objectives were to examine the association between air travel during pregnancy and preterm birth together with decreased birth weight. Study design A retrospective cohort study. Methods The study evaluated 628,292 women who gave birth to singleton infants from 9/2000 to 9/2016 and classified them into "air travel during pregnancy" or not, based on flight insurance as proxy. Multiple linear regression models were utilized to examine the relationship between air travel during pregnancy and newborn's gestational age and birth weight, while accounting for socioeconomic status, diabetes, high-risk pregnancies, and smoking. Results A total of 41,677 (6.6%) births of women who air traveled during pregnancy was included, and 586,615 (93.4%) births of women who did not. Air travel during pregnancy was associated with a statistically significant (p<0.0001) but negligible increase in birth weight (9 gr. 95% CI: 4.8 to 14.5 gr.) and gestational age (0.36 days. 95% CI: 0.24-0.48). Conclusion The study results provide no evidence that air travel during pregnancy is related to adverse effects on gestational age or birth weight. These findings corroborate the current recommendations of ACOG.	[Ram, Hila Shalev; Ram, Shai] Technion, Fac Med, Haifa, Israel; [Miller, Netanella; Rosental, Yael Shalev; Chodick, Gabriel] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Miller, Netanella] Meir Med Ctr, Kefar Sava, Israel; [Chodick, Gabriel] Israel Meir Med Ctr, Maccabi Healthcare Serv, Tel Aviv, Kfar Saba, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Ram, HS (corresponding author), Technion, Fac Med, Haifa, Israel.	Hila6070@gmail.com		Shalev-Ram, Hila/0000-0002-8263-7026				[Anonymous], 2017, BEN GURION AIRPORT A; [Anonymous], 2016, HEALTHM ANN HEALTHCA; Artal R, 1995, AM J OBSTET GYNECOL; Ben Gurion H S., ANN REPORT 2017 DURA; Bian YH, 2013, J BIOMED RES, V27, P14, DOI 10.7555/JBR.27.20120046; Chibber R, 2006, AUST NZ J OBSTET GYN; Cnattingius S., 2004, NICOTINE TOB RES S2, V6; Daniell WE, 1990, AVIAT SP ENV MED; Freeman M, 2004, ARCH GYNECOL OBS; Gertler JP, 1991, J VASC SURG; Hsieh C.-L., 2017, BIOMED RES INT; Huch R, 1986, AM J OBSTET GYNECOL; Humphreys S, 2005, EFFECT HIGH ALTITUDE, P458, DOI [10.1111/j.1365-2044.2005.04124.x, DOI 10.1111/J.1365-2044.2005.04124.X]; Irgens A, 2003, SCAND J WORK ENV HLT; Magann EF, 2010, OBSTET GYNECOL SURV; Mellitus GD, 2015, LIT REV GESTATIONAL; Muhm JM, 2004, AVIAT SP ENV MED; Research QM, 2016, SURV AUSTR TRAV INS; Roberts WE, 1990, OBS GYNECOL S, V76; Statistics, 2011, ICB ISR CENTR BUR ST; The Consumers council, 2019, TRAV INS SURV; Zamudio S, 2017, J APPL PHYSIOL	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228639	10.1371/journal.pone.0228639	http://dx.doi.org/10.1371/journal.pone.0228639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027691	Green Published, gold			2022-12-26	WOS:000534623800061
J	Zafra-Tanaka, JH; Tenorio-Mucha, J; Villarreal-Zegarra, D; Carrillo-Larco, R; Bernabe-Ortiz, A				Zafra-Tanaka, Jessica H.; Tenorio-Mucha, Janeth; Villarreal-Zegarra, David; Carrillo-Larco, Rodrigo; Bernabe-Ortiz, Antonio			Cancer-related mortality in Peru: Trends from 2003 to 2016	PLOS ONE			English	Article							LUNG-CANCER; SURVIVAL; RESISTANCE; RATES	Objectives In the last decade, Latin American (LA) countries, like Peru, have undergone an epidemiological transition that has changed the pattern of oncological cases. Given that Peru's oncological pattern could illustrate those of other LA countries, we aimed at determining trends and changes in cancer-related mortality by age and sex in Peru between 2003 and 2016. Methods and results A secondary data analysis using national deaths registries was conducted. Categories were created according to the 27 most frequent sites of presentation of cancer. We found that deaths attributed to cancer increased from 15.4% of all deaths in 2003 to 18.1% in 2016 (p<0.001). According to the cancer site, stomach cancer (19.1%) and lung cancer (11.5%) were the most frequent causes of death overall. In childhood (0 to 14 years), the two most frequent fatal cancers were leukemia (54.6% for boys and 53.5% for girls) and brain and nervous system tumors (19.4% for boys and 20.3% for girls). For teenagers and young male adults (15-49 years), stomach cancer (18.1%) and brain cancer (17.4%) were the leading causes of death; in their female counterparts, cervix uteri (20.0%) and breast cancer (16.1%) were the most mortal cancers. In adults (>= 50 years), stomach (20.9% for men and 18.6% for women) and lung (12.7% for men and 10.4% for women) were the leading contributors to the burden of cancer deaths. Conclusions Between the years 2003 and 2016, almost one fifth of deaths were attributed to cancer in Peru. Absolute and relative number of deaths due to cancer has increased in this period for both men and women; however, standardized mortality rates due to cancer have declined.	[Zafra-Tanaka, Jessica H.; Tenorio-Mucha, Janeth; Villarreal-Zegarra, David; Carrillo-Larco, Rodrigo; Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Carrillo-Larco, Rodrigo] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Carrillo-Larco, Rodrigo] Univ Catolica Los Angeles Chimbote ULADECH, Ctr Estudios Poblac, Chimbote, Peru; [Bernabe-Ortiz, Antonio] Univ Cient Sur, Lima, Peru	Universidad Peruana Cayetano Heredia; Imperial College London; Universidad Cientifica del Sur (CIENTIFICA)	Bernabe-Ortiz, A (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.; Bernabe-Ortiz, A (corresponding author), Univ Cient Sur, Lima, Peru.	Antonio.Bernabe@upch.pe	Villarreal-Zegarra, David/HGV-1939-2022; Villarreal-Zegarra, David/AAH-3823-2020	Villarreal-Zegarra, David/0000-0002-2222-4764; Villarreal-Zegarra, David/0000-0002-2222-4764	Wellcome Trust International Training Fellowship [214185/Z/18/Z]	Wellcome Trust International Training Fellowship	RodrigoM Carrillo-Larco is supported by a Wellcome Trust International Training Fellowship (214185/Z/18/Z). The funder had no role in study design, data collection, data analysis, decision to publish or preparation of the manuscript.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Ang TL, 2014, SINGAP MED J, V55, P621, DOI 10.11622/smedj.2014174; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Barrera-Rodriguez R, 2012, LUNG CANCER-TARGETS, V3, P79, DOI 10.2147/LCTT.S37319; Benziger CP, 2018, HEART, V104, P1251, DOI 10.1136/heartjnl-2017-312255; Boehnke KF, 2017, INFECT DRUG RESIST, V10, P85, DOI 10.2147/IDR.S123798; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Camargo MC, 2014, AM J GASTROENTEROL, V109, P485, DOI 10.1038/ajg.2014.24; Centro Nacional de Epidemiologi a Prevencio n y Control de Enfermedades, 2017, B MENS OCT 2017; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Etzioni R, 2002, J NATL CANCER I, V94, P981; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ghotaslou Reza, 2015, World J Methodol, V5, P164, DOI 10.5662/wjm.v5.i3.164; Goldie SJ, 2012, REV PANAM SALUD PUBL, V32, P426, DOI 10.1590/S1020-49892012001400006; Han Renqiang, 2013, Zhongguo Fei Ai Za Zhi, V16, P445, DOI 10.3779/j.issn.1009-3419.2013.09.02; Hassanipour-Azgomi S, 2016, PROSTATE INT, V4, P118, DOI 10.1016/j.prnil.2016.07.001; Hosgood HD, 2010, ENVIRON HEALTH PERSP, V118, P1743, DOI 10.1289/ehp.1002217; Hussein S, 2015, J CLIN PATHOL, V68, P511, DOI 10.1136/jclinpath-2015-202993; Ilbawi AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3008853; Instituto Nacional de Estadi stica e Informatica, 80 7 HOG UT GAS COC; Instituto Nacional de Estadistica e Informatica, POBL TOT 30 JUN GRUP; Jaganath D, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0198-2; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Lozano-Ascencio R, 2009, SALUD PUBLICA MEXICO, V51, pS147, DOI 10.1590/S0036-36342009000800004; Martin RM, 2018, JAMA-J AM MED ASSOC, V319, P883, DOI 10.1001/jama.2018.0154; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Ministerio de Salud, 2014, CARG EMF ER EST SAL; Morgan BW, 2017, TOB INDUC DIS, V15, DOI 10.1186/s12971-017-0137-8; OECD Reviews of Health Systems, 2017, MON HLTH SYST PERF P; Office for National Statistics, 2017, ENGL 2015 CANC DIAGN; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Pineros M, 2017, LANCET ONCOL, V18, pE573, DOI 10.1016/S1470-2045(17)30377-7; Registro Nacional de Identificacio n y Estado Civil, 2018, QUIEN SOM; Salazar Miriam Rosario, 2013, Rev. perú. med. exp. salud publica, V30, P105, DOI 10.1590/s1726-46342013000100020; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Stewart B, 2014, WORLD CANC REPORT 20; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Vargas-Herrera Javier, 2018, Rev. perú. med. exp. salud publica, V35, P505, DOI 10.17843/rpmesp.2018.353.3913; Vidaurre T, 2017, LANCET ONCOL, V18, pE595, DOI 10.1016/S1470-2045(17)30598-3; Wakelee HA, 2006, J THORAC ONCOL, V1, P441, DOI 10.1097/01243894-200606000-00011; World Health Organization, 2016, GLOB DEATHS CAUS AG	43	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228867	10.1371/journal.pone.0228867	http://dx.doi.org/10.1371/journal.pone.0228867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027719	Green Published, gold			2022-12-26	WOS:000534623800076
J	Rhea, EM; Torres, ERS; Raber, J; Banks, WA				Rhea, Elizabeth M.; Torres, Eileen Ruth S.; Raber, Jacob; Banks, William A.			Insulin BBB pharmacokinetics in young apoE male and female transgenic mice	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; TARGETED REPLACEMENT; CEREBROSPINAL-FLUID; IDENTIFIES VARIANTS; SPATIAL MEMORY; BRAIN; TRANSPORT; EPSILON-4	In addition to age, apolipoprotein E4 (E4), female sex, or a combination of both synergistically increase the risk for the development of Alzheimer's disease (AD). Why these risk factors predispose an individual to developing AD later in life is the target of the current investigation. Central nervous system (CNS) insulin resistance is associated with cognitive impairment and AD. CNS insulin is acquired primarily from the circulation and therefore must negotiate the blood-brain barrier (BBB). Thus, changes in BBB transport of insulin could lead to alterations in CNS insulin signaling and resistance, which would then lead to changes in cognition. There has been recent evidence suggesting the relationship between CNS insulin; E4, a risk factor to develop AD as compared to E3; and the female sex in aged individuals and in pre-clinical models. However, this relationship has been largely unexplored at a younger age, in which some of these risk factors could predispose an individual to dysregulation of CNS insulin later in life. Here, we present the first findings of BBB insulin pharmacokinetics in young E3 and E4 male and female targeted replacement (TR) mice. We found that levels of insulin binding the vasculature at the BBB are different due to genotype and sex which could impact the function of the brain endothelial cell. These early alterations could contribute to or fully explain the age-related cognitive changes observed due to CNS insulin signaling in E4 and/or female individuals.	[Rhea, Elizabeth M.; Banks, William A.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Rhea, Elizabeth M.] Vet Affairs Puget Sound Hlth Care Syst, Res & Dev, Seattle, WA 98108 USA; [Torres, Eileen Ruth S.; Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Div Neurosci, Dept Neurol, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Div Neurosci, Dept Radiat Med, Portland, OR 97201 USA; [Banks, William A.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Rhea, EM (corresponding author), Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA.; Rhea, EM (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Res & Dev, Seattle, WA 98108 USA.	meredime@uw.edu	Banks, William A/K-1330-2017; Meredith, Elizabeth/AAM-4574-2021	Banks, William A/0000-0002-0496-3619; 	National Institute of Health [AG059088, T32 AG55378]; Veterans Affairs Research and Development; University of Washington Diabetes Research Center	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Research and Development(US Department of Veterans Affairs); University of Washington Diabetes Research Center	The National Institute of Health (AG059088 to JR, WAB; T32 AG55378 to ERT), Veterans Affairs Research and Development (to EMR and WAB), and the University of Washington Diabetes Research Center (to EMR) helped contribute to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemzadeh R, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-35; Banks WA, 2019, J PHARMACOL EXP THER, V371, P121, DOI 10.1124/jpet.119.260497; Banks WA, 1997, PEPTIDES, V18, P1423, DOI 10.1016/S0196-9781(97)00231-3; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Bennett DA, 2003, NEUROLOGY, V60, P246, DOI 10.1212/01.WNL.0000042478.08543.F7; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Bojsen-Moller KN, 2018, DIABETES, V67, P2129, DOI 10.2337/db18-0539; CANGIANO C, 1983, BIOCHEM INT, V7, P617; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Dea MK, 2002, DIABETES, V51, P762, DOI 10.2337/diabetes.51.3.762; Evans DA, 1997, JAMA-J AM MED ASSOC, V277, P822, DOI 10.1001/jama.277.10.822; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8; Ghasemi R, 2013, MOL NEUROBIOL, V47, P1045, DOI 10.1007/s12035-013-8404-z; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Holland D, 2013, AM J NEURORADIOL, V34, P2287, DOI 10.3174/ajnr.A3601; Johnson LA, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X17746186; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Licher S, 2019, NAT MED, V25, P1364, DOI 10.1038/s41591-019-0547-7; Lin Katherine A, 2015, Alzheimers Dement (N Y), V1, P103; MARGOLIS RU, 1967, NATURE, V215, P1375, DOI 10.1038/2151375a0; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2000, NATURE, V404, P352, DOI 10.1038/35006165; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; Rhea EM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00521; Rhea EM, 2018, J PHYSIOL-LONDON, V596, P4753, DOI 10.1113/JP276149; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Segev Y, 2013, NEUROBIOL AGING, V34, P863, DOI 10.1016/j.neurobiolaging.2012.06.020; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tagliamonte A, 1976, Adv Exp Med Biol, V69, P89; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; TRIGUERO D, 1990, J NEUROCHEM, V54, P1882, DOI 10.1111/j.1471-4159.1990.tb04886.x; Ungar L, 2014, BRAIN IMAGING BEHAV, V8, P262, DOI 10.1007/s11682-013-9272-x; WOODS SC, 1977, AM J PHYSIOL, V233, pE331, DOI 10.1152/ajpendo.1977.233.4.E331; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	43	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228455	10.1371/journal.pone.0228455	http://dx.doi.org/10.1371/journal.pone.0228455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004344	Green Published, gold			2022-12-26	WOS:000534614600039
J	Hsieh, HL; Hsu, SC; Cheng, HS; Chen, CY; Huang, WC; Sue, YM; Lin, FY; Shih, CM; Chen, JW; Lin, SJ; Huang, PH; Liu, CT				Hsieh, Hui-ling; Hsu, Shih-chang; Cheng, Ho-shun; Chen, Chun-you; Huang, Wen-cheng; Sue, Yuh-mou; Lin, Feng-yen; Shih, Chun-ming; Chen, Jaw-wen; Lin, Shing-jong; Huang, Po-hsun; Liu, Chung-te			The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis	PLOS ONE			English	Article							STAGE RENAL-DISEASE; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; CLINICAL-FEATURES; LIFETIME RISK; MANAGEMENT; ANTICOAGULATION; PREVALENCE; GUIDELINES; DIALYSIS	Background Atrial fibrillation (AF) is highly prevalent, occurring in 1%-2% of the adult population, increasing the risk of stroke, and resulting in considerable healthcare costs. While stroke is a major complication of AF, end-stage renal disease (ESRD) patients also have a high risk of stroke, suggesting that AF is a possible risk factor for mortality of ESRD patients. However, whether the existence of AF at the initiation of hemodialysis predicts higher mortality risk of incident ESRD patients remains to be defined. Methods This retrospective cohort study was performed at Wanfang Hospital from January 2004 to May 2018. The end points were mortality of patients or the end of the study. Incident ESRD patients who were on maintenance hemodialysis for more than 3 months were eligible for inclusion. Cox proportional regression and Kaplan-Meier survival curves were used to determine the association between predictors and mortality. The association between AF and echocardiographic parameters, causes of death were also investigated. Results Of the 393 incident ESRD patients at initiation of hemodialysis, 57 (14.5%) had AF and the median age was 71 years. Patients with AF were significantly older; showed significantly higher C-reactive protein levels, more heart failure, chronic obstructive pulmonary disease and mortality. Multivariate Cox regression showed that AF had a hazard ratio of 4.1 (95% confidence interval: 2.4-7.0) for mortality. Age-specific analysis showed that AF was significantly associated with mortality in all age groups. Echocardiography measurements including ejection fraction and left ventricular hypertrophy (LVH) were similar in AF and non-AF patients. Cause-specific analysis showed that AF significantly associated with overall cardiovascular death and death due to acute myocardial infarction/coronary artery disease and sepsis. Conclusions AF at the initiation of hemodialysis predicts higher mortality risk of incident ESRD patients regardless of age. The systolic function and degree of LVH were similar in AF and non-AF patients. The association between AF and sepsis-related death suggested the role of systemic inflammation on the pathogenesis of AF.	[Hsieh, Hui-ling; Sue, Yuh-mou; Liu, Chung-te] Taipei Med Univ, Wan Fang Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Hsieh, Hui-ling] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Hsu, Shih-chang; Huang, Wen-cheng] Taipei Med Univ, Wan Fang Hosp, Dept Emergency & Crit Med, Emergency Dept, Taipei, Taiwan; [Hsu, Shih-chang; Huang, Wen-cheng] Taipei Med Univ, Sch Med, Dept Emergency Med, Coll Med, Taipei, Taiwan; [Cheng, Ho-shun] Taipei Med Univ, Wan Fang Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Chen, Chun-you] Taipei Med Univ, Wan Fang Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Huang, Wen-cheng; Liu, Chung-te] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Lin, Feng-yen; Shih, Chun-ming; Liu, Chung-te] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan; [Lin, Feng-yen; Shih, Chun-ming] Taipei Med Univ Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Lin, Feng-yen; Shih, Chun-ming] Taipei Med Univ Hosp, Cardiovasc Res Ctr, Dept Internal Med, Taipei, Taiwan; [Chen, Jaw-wen; Lin, Shing-jong; Huang, Po-hsun] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Chen, Jaw-wen; Lin, Shing-jong; Huang, Po-hsun] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Chen, Jaw-wen; Lin, Shing-jong] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chen, Jaw-wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan; [Lin, Shing-jong; Huang, Po-hsun] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lin, Shing-jong] Taipei Med Univ, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; National Defense Medical Center; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University	Liu, CT (corresponding author), Taipei Med Univ, Wan Fang Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.; Liu, CT (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Liu, CT (corresponding author), Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan.	96320@w.tmu.edu.tw	Hsieh, Hui-Ling/ABB-5601-2021; Huang, Wen-Cheng/AAM-2191-2021; Hsieh, Hui-Ling/GPW-9991-2022; Hsu, Shih-Chang/I-4277-2012	Hsieh, Hui-Ling/0000-0003-3024-3639; Hsu, Shih-Chang/0000-0003-1010-1182	Wan Fang Hospital, Taipei Medical University [108-wfswf-05]; Ministry of Science and Technology of Taiwan [MOST 106-2314-B-350001-MY3, MOST 104-2314-B-075047]; Taiwan Ministry of Science and Technology Academic Excellence Program [MOST 106-2633-B009-001]; Ministry of Health and Welfare [MOHW106-TDU-B-211-113001]; Taipei Veterans General Hospital [V105C-0207, V106C-045]	Wan Fang Hospital, Taipei Medical University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Science and Technology Academic Excellence Program; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by the Wan Fang Hospital, Taipei Medical University, 108-wfswf-05 to C-tL; the Ministry of Science and Technology of Taiwan, MOST 104-2314-B-075047 to P-hH; the Ministry of Science and Technology of Taiwan, MOST 106-2314-B-350001-MY3 to P-hH; the Novel Bioengineering and Technological Approaches to Solve Two Major Health Problems in Taiwan program, sponsored by the Taiwan Ministry of Science and Technology Academic Excellence Program, MOST 106-2633-B009-001 to P-hH; the Ministry of Health and Welfare, MOHW106-TDU-B-211-113001 to P-hH and the Taipei Veterans General Hospital, V105C-0207, V106C-045 to P-hH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhasira R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21229-9; Bansal N, 2016, CLIN J AM SOC NEPHRO, V11, P1189, DOI 10.2215/CJN.10921015; Ceornodolea AD, 2017, STROKE RES TREAT, V2017, DOI 10.1155/2017/8593207; Chiang CE, 2016, J FORMOS MED ASSOC, V115, P893, DOI 10.1016/j.jfma.2016.10.005; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Esato M, 2017, CHEST, V152, P1266, DOI 10.1016/j.chest.2017.08.004; Gamst J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006486; Genovesi S, 2017, BLOOD PURIFICAT, V44, P77, DOI 10.1159/000464347; Glotzer TV, 2013, CAN J CARDIOL, V29, pS14, DOI 10.1016/j.cjca.2013.03.023; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goldstein BA, 2012, CIRCULATION, V126, P2293, DOI 10.1161/CIRCULATIONAHA.112.099606; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; JANUARY CT, 2014, CIRCULATION, V30, P2014; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Konigsbrugge O, 2017, THROMB RES, V158, P59, DOI 10.1016/j.thromres.2017.08.011; Kundu A, 2016, AM J CARDIOL, V117, P1213, DOI 10.1016/j.amjcard.2016.01.012; Lau YC, 2014, CHEST, V146, P1138, DOI 10.1378/chest.14-0986; Liao JN, 2015, KIDNEY INT, V87, P1209, DOI 10.1038/ki.2014.393; Lip GYH, 2012, CHEST, V142, P1489, DOI 10.1378/chest.11-2888; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Marwick TH, 2015, J AM SOC ECHOCARDIOG, V28, P727, DOI 10.1016/j.echo.2015.05.002; Mori K, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1271-8; Odutayo A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4482; Saran R, 2017, AM J KIDNEY DIS, V69, DOI 10.1053/j.ajkd.2016.12.004; Schmitt J, 2009, EUR HEART J, V30, P1038, DOI 10.1093/eurheartj/ehn579; Shah SR, 2018, J COMMUNITY HOSP INT, V8, P269, DOI 10.1080/20009666.2018.1514932; Shen CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003933; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Sud M, 2014, CIRCULATION, V130, P458, DOI 10.1161/CIRCULATIONAHA.113.007106; Tsai Chieh, 2017, Can J Kidney Health Dis, V4, p2054358117735532, DOI 10.1177/2054358117735532; Vermond RA, 2015, J AM COLL CARDIOL, V66, P1000, DOI 10.1016/j.jacc.2015.06.1314; Violi F, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003347; Walkey AJ, 2016, JAMA CARDIOL, V1, P682, DOI 10.1001/jamacardio.2016.2181; Winkelmayer WC, 2011, J AM SOC NEPHROL, V22, P349, DOI 10.1681/ASN.2010050459; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477; Wodchis WP, 2012, VALUE HEALTH, V15, P240, DOI 10.1016/j.jval.2011.09.009; Yamashita Y, 2016, HEART VESSELS, V31, P2025, DOI 10.1007/s00380-016-0818-x; Zhu JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131782	38	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228405	10.1371/journal.pone.0228405	http://dx.doi.org/10.1371/journal.pone.0228405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999778	Green Published, gold			2022-12-26	WOS:000534612400078
J	Yu, SR; Sha, HH; Qin, XB; Chen, Y; Li, XY; Shi, MQ; Feng, JF				Yu, Shaorong; Sha, Huanhuan; Qin, Xiaobing; Chen, Yan; Li, Xiaoyou; Shi, Meiqi; Feng, Jifeng			EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells	ONCOGENE			English	Article							TUMOR-DERIVED EXOSOMES; CHECKPOINT INHIBITORS; DOCETAXEL; CARCINOMA; BLOCKADE; PATHWAY; ALTERS	EGFR-mutant lung cancer (LC) patients display a poor response to PD-1/PD-L1 blockade. In the absence of independent genetic validation, whether EGFR mutation distorts host antitumor immunity is unknown. Here, we showed that in the clinic, LC with the E746-A750 deletion mutation (EGFR-19del) displayed a temporal association with the loss of intratumoral CD8+ T cells. In a xenograft model, EGFR-19del-expressing Lewis lung cancer (LLC) tumors had a low T cell density at the early stage of tumor development, along with dendritic cells (DCs) exhibiting variant phenotypes in the tumors and draining lymph nodes (LNs). Importantly, EGFR-19del DCs were observed in the LNs of tumor-bearing mice and LC patients. The proliferative activity of T cells within the LN was significantly dampened. In vitro experiments indicated that the function of DCs was repressed by EGFR-19del LLC cells through exosome uptake in which exosomes derived from the EGFR-19del LLC cells could efficiently transfer active EGFR-19del to the surface of the DCs. Injection of EGFR-19del tumor-derived exosomes promoted LLC tumor progression and induced immunosuppression. The combination of gefitinib and GM-CSF treatment recovered tumor T cell infiltration in EGFR-19del tumors by rescuing the function of DCs and increasing the efficacy of anti-PD-L1 treatment. Together, these results indicated that LC with the EGFR E746-A750 deletion mutation induced anergic DCs to repress antitumor immunity through exosomes.	[Yu, Shaorong; Sha, Huanhuan; Qin, Xiaobing; Li, Xiaoyou; Shi, Meiqi; Feng, Jifeng] Nanjing Med Univ, Affiliated Canc Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Yu, Shaorong; Sha, Huanhuan; Qin, Xiaobing; Chen, Yan; Li, Xiaoyou; Shi, Meiqi; Feng, Jifeng] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Yu, Shaorong; Sha, Huanhuan; Qin, Xiaobing; Chen, Yan; Li, Xiaoyou; Shi, Meiqi; Feng, Jifeng] Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China; [Qin, Xiaobing] Xuzhou Med Univ, Affiliated Hosp, Dept Med Oncol, Xuzhou, Jiangsu, Peoples R China; [Chen, Yan] Nanjing Med Univ, Affiliated Canc Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University; Nanjing Medical University	Feng, JF (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China.; Feng, JF (corresponding author), Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China.; Feng, JF (corresponding author), Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China.	fjif@vip.sina.com			National Natural Science Foundation of China [81871873]; Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Medical Youth Talent [QNRC2016646]; China Postdoctoral Science Foundation [2017M621680]; Six talent peaks project in Jiangsu Province [WSN-039]; talents program of Jiangsu Cancer Hospital [YC201807]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Medical Youth Talent; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Six talent peaks project in Jiangsu Province; talents program of Jiangsu Cancer Hospital	This work was supported by grants from the National Natural Science Foundation of China (81871873); the Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Medical Youth Talent (QNRC2016646); the China Postdoctoral Science Foundation (2017M621680); the Six talent peaks project in Jiangsu Province (WSN-039); and the talents program of Jiangsu Cancer Hospital (YC201807).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Anguille S, 2015, PHARMACOL REV, V67, P731, DOI 10.1124/pr.114.009456; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Choi D, 2018, MOL CELL PROTEOMICS, V17, P1948, DOI 10.1074/mcp.RA118.000644; Conejo-Garcia JR, 2016, PHARMACOL THERAPEUT, V164, P97, DOI 10.1016/j.pharmthera.2016.04.003; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Dong ZY, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1356145; Donnem T, 2015, CLIN CANCER RES, V21, P2635, DOI 10.1158/1078-0432.CCR-14-1905; Dresch C, 2012, TRENDS IMMUNOL, V33, P381, DOI 10.1016/j.it.2012.04.009; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Enamorado M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16073; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gainor JF, 2016, CLIN CANCER RES, V22, P4585, DOI 10.1158/1078-0432.CCR-15-3101; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Lee CK, 2018, JAMA ONCOL, V4, P210, DOI 10.1001/jamaoncol.2017.4427; Lee CK, 2017, J THORAC ONCOL, V12, P403, DOI 10.1016/j.jtho.2016.10.007; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mascia F, 2016, INT J CANCER, V139, P2593, DOI 10.1002/ijc.30376; Mondanelli G, 2017, IMMUNITY, V46, P233, DOI 10.1016/j.immuni.2017.01.005; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; Qin XB, 2017, INT J NANOMED, V12, P3721, DOI 10.2147/IJN.S131516; Raulf N, 2018, EUR J CANCER, V102, P52, DOI 10.1016/j.ejca.2018.07.123; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Wang SH, 2016, J BIOL CHEM, V291, P21085, DOI 10.1074/jbc.M116.717892; Zhang HY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15016; Zhang LL, 2019, THERANOSTICS, V9, P2541, DOI 10.7150/thno.32655; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020	33	22	22	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2643	2657		10.1038/s41388-020-1182-y	http://dx.doi.org/10.1038/s41388-020-1182-y		JAN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32001818				2022-12-26	WOS:000510328400002
J	Raetz, AG; Banda, DM; Ma, XY; Xu, GG; Rajavel, AN; McKibbin, PL; Lebrilla, CB; David, SS				Raetz, Alan G.; Banda, Douglas M.; Ma, Xiaoyan; Xu, Gege; Rajavel, Anisha N.; McKibbin, Paige L.; Lebrilla, Carlito B.; David, Sheila S.			The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; base excision repair (BER); mutY homolog (MUTYH); DNA methylation; DNA damage; DNA enzyme; DNA damage response; cancer biology; cancer chemoprevention; abasic sites	BASE-EXCISION-REPAIR; ADENINE GLYCOSYLASE ACTIVITY; INTERSTRAND CROSS-LINKS; SINGLE-STRAND BREAKS; ESCHERICHIA-COLI; METHYLATING AGENTS; ENDONUCLEASE ACTIVITIES; CATALYTIC MECHANISM; DUPLEX DNA; DAMAGE	Higher expression of the human DNA repair enzyme MUTYH has previously been shown to be strongly associated with reduced survival in a panel of 24 human lymphoblastoid cell lines exposed to the alkylating agent N-methyl-N?-nitro-N-nitrosoguanidine (MNNG). The molecular mechanism of MUTYH-enhanced MNNG cytotoxicity is unclear, because MUTYH has a well-established role in the repair of oxidative DNA lesions. Here, we show in mouse embryonic fibroblasts (MEFs) that this MNNG-dependent phenotype does not involve oxidative DNA damage and occurs independently of both O-6-methyl guanine adduct cytotoxicity and MUTYH-dependent glycosylase activity. We found that blocking of abasic (AP) sites abolishes higher survival of Mutyh-deficient (Mutyh(?/?)) MEFs, but this blockade had no additive cytotoxicity in WT MEFs, suggesting the cytotoxicity is due to MUTYH interactions with MNNG-induced AP sites. We found that recombinant mouse MUTYH tightly binds AP sites opposite all four canonical undamaged bases and stimulated apurinic/apyrimidinic endonuclease 1 (APE1)-mediated DNA incision. Consistent with these observations, we found that stable expression of WT, but not catalytically-inactive MUTYH, enhances MNNG cytotoxicity in Mutyh(?/?) MEFs and that MUTYH expression enhances MNNG-induced genomic strand breaks. Taken together, these results suggest that MUTYH enhances the rapid accumulation of AP-site intermediates by interacting with APE1, implicating MUTYH as a factor that modulates the delicate process of base-excision repair independently of its glycosylase activity.	[Raetz, Alan G.; Banda, Douglas M.; Ma, Xiaoyan; Xu, Gege; Rajavel, Anisha N.; McKibbin, Paige L.; Lebrilla, Carlito B.; David, Sheila S.] Univ Calif Davis, Dept Chem, One Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis	David, SS (corresponding author), Univ Calif Davis, Dept Chem, One Shields Ave, Davis, CA 95616 USA.	ssdavid@ucdavis.edu	Lebrilla, Carlito Bangeles/ABE-6369-2020	Raetz, Alan/0000-0003-2039-3692; Lebrilla, Carlito/0000-0001-7190-5323; David, Sheila/0000-0001-5873-7935; Banda, Douglas/0000-0001-6198-2923	National Institutes of Health [2RO1CA067985, RO1GM049077]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants 2RO1CA067985 (to S. S. D.) and RO1GM049077 (to C. B. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Admiraal SJ, 2015, BIOCHEMISTRY-US, V54, P1849, DOI 10.1021/bi501491z; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686; Bai HB, 2007, J BACTERIOL, V189, P902, DOI 10.1128/JB.01513-06; Banda DM, 2017, FREE RADICAL BIO MED, V107, P202, DOI 10.1016/j.freeradbiomed.2017.01.008; Bobola MS, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00176; Caimi PF, 2017, ONCOTARGET, V8, P79864, DOI 10.18632/oncotarget.20094; Calvo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003413; Cheadle JP, 2007, DNA REPAIR, V6, P274, DOI 10.1016/j.dnarep.2006.11.001; Chiu LY, 2011, BIOCHEM PHARMACOL, V81, P459, DOI 10.1016/j.bcp.2010.10.016; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; Ensminger M, 2014, J CELL BIOL, V206, P29, DOI 10.1083/jcb.201312078; Fouquerel E, 2014, DNA REPAIR, V23, P27, DOI 10.1016/j.dnarep.2014.09.004; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fry RC, 2008, GENE DEV, V22, P2621, DOI 10.1101/gad.1688508; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Giovannini S, 2019, NUCLEIC ACIDS RES, V47, P9132, DOI 10.1093/nar/gkz624; Grasso F, 2015, ONCOTARGET, V6, P7481, DOI 10.18632/oncotarget.3037; Gu YS, 2002, J BIOL CHEM, V277, P11135, DOI 10.1074/jbc.M108618200; Hahm SH, 2011, BMB REP, V44, P352, DOI 10.5483/BMBRep.2011.44.5.352; Hwang BJ, 2014, DNA REPAIR, V13, P10, DOI 10.1016/j.dnarep.2013.10.011; Jansson K, 2008, MUTAT RES-FUND MOL M, V644, P48, DOI 10.1016/j.mrfmmm.2008.07.001; Jansson K, 2013, ENVIRON MOL MUTAGEN, V54, P327, DOI 10.1002/em.21784; Khodyreva SN, 2010, P NATL ACAD SCI USA, V107, P22090, DOI 10.1073/pnas.1009182107; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; Kundu S, 2009, DNA REPAIR, V8, P1400, DOI 10.1016/j.dnarep.2009.09.009; Laverty DJ, 2017, ACS CHEM BIOL, V12, P1584, DOI 10.1021/acschembio.7b00211; Leipold MD, 2003, BIOCHEMISTRY-US, V42, P11373, DOI 10.1021/bi034951b; Leipold MD, 2000, BIOCHEMISTRY-US, V39, P14984, DOI 10.1021/bi0017982; Lim PX, 2015, J BIOL CHEM, V290, P14826, DOI 10.1074/jbc.M114.630640; Lipton L, 2003, CANCER RES, V63, P7595; Liu L, 1999, CLIN CANCER RES, V5, P2908; Liu LL, 2003, MOL CANCER THER, V2, P1061; Liu LL, 1996, CANCER RES, V56, P5375; Lu AL, 1996, J BIOL CHEM, V271, P24138, DOI 10.1074/jbc.271.39.24138; Luke AM, 2010, MUTAT RES-FUND MOL M, V694, P65, DOI 10.1016/j.mrfmmm.2010.08.008; Luncsford PJ, 2013, DNA REPAIR, V12, P1043, DOI 10.1016/j.dnarep.2013.09.007; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Manuel RC, 2004, J BIOL CHEM, V279, P46930, DOI 10.1074/jbc.M403944200; Markkanen Enni, 2013, Frontiers in Genetics, V4, P18, DOI 10.3389/fgene.2013.00018; Martin SA, 2010, CANCER CELL, V17, P235, DOI 10.1016/j.ccr.2009.12.046; Mazouzi A, 2017, MOL CELL, V68, P797, DOI 10.1016/j.molcel.2017.10.021; MCGOLDRICK JP, 1995, MOL CELL BIOL, V15, P989; Middeldorp A, 2008, J PATHOL, V216, P25, DOI 10.1002/path.2375; Mohni KN, 2019, CELL, V176, P144, DOI 10.1016/j.cell.2018.10.055; Mullins EA, 2013, METHODS, V64, P59, DOI 10.1016/j.ymeth.2013.07.020; Mutamba JT, 2011, DNA REPAIR, V10, P1282, DOI 10.1016/j.dnarep.2011.10.008; Nakamura J, 2000, J BIOL CHEM, V275, P5323, DOI 10.1074/jbc.275.8.5323; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Oka S, 2011, CANCER SCI, V102, P677, DOI 10.1111/j.1349-7006.2011.01869.x; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Pastoriza-Gallego M, 2007, MUTAGENESIS, V22, P343, DOI 10.1093/mutage/gem024; Pope MA, 2005, DNA REPAIR, V4, P315, DOI 10.1016/j.dnarep.2004.10.003; Pope MA, 2005, DNA REPAIR, V4, P91, DOI 10.1016/j.dnarep.2004.08.004; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Porello SL, 1996, J AM CHEM SOC, V118, P10684, DOI 10.1021/ja9602206; Posnick LM, 1999, J BACTERIOL, V181, P6763, DOI 10.1128/JB.181.21.6763-6771.1999; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Prasad R, 2014, NUCLEIC ACIDS RES, V42, P6337, DOI 10.1093/nar/gku288; Prystay L, 2001, J BIOMOL SCREEN, V6, P141, DOI 10.1177/108705710100600304; Quinones JL, 2016, DNA REPAIR, V44, P103, DOI 10.1016/j.dnarep.2016.05.014; Raetz AG, 2019, DNA REPAIR, V80, P16, DOI 10.1016/j.dnarep.2019.05.005; Rinne ML, 2005, NUCLEIC ACIDS RES, V33, P2859, DOI 10.1093/nar/gki601; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Rothwell DG, 1996, NUCLEIC ACIDS RES, V24, P4217, DOI 10.1093/nar/24.21.4217; Russo MT, 2009, CANCER RES, V69, P4372, DOI 10.1158/0008-5472.CAN-08-3292; Semlow DR, 2016, CELL, V167, P498, DOI 10.1016/j.cell.2016.09.008; Shen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151026; Stojic L, 2005, CELL CYCLE, V4, P473, DOI 10.4161/cc.4.3.1528; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Svilar D, 2012, MOL CANCER RES, V10, P1580, DOI 10.1158/1541-7786.MCR-12-0168; Tang JB, 2011, NEURO-ONCOLOGY, V13, P471, DOI 10.1093/neuonc/nor011; Taverna P, 2001, MUTAT RES-DNA REPAIR, V485, P269, DOI 10.1016/S0921-8777(01)00076-3; Tominaga Y, 2004, NUCLEIC ACIDS RES, V32, P3198, DOI 10.1093/nar/gkh642; Troll CJ, 2014, MUTAT RES-FUND MOL M, V763, P64, DOI 10.1016/j.mrfmmm.2014.03.007; TSAIWU JJ, 1992, P NATL ACAD SCI USA, V89, P8779, DOI 10.1073/pnas.89.18.8779; van Loon B, 2009, P NATL ACAD SCI USA, V106, P18201, DOI 10.1073/pnas.0907280106; VANHOUTEN B, 1987, J BACTERIOL, V169, P540, DOI 10.1128/jb.169.2.540-545.1987; Williams SD, 1998, NUCLEIC ACIDS RES, V26, P5123, DOI 10.1093/nar/26.22.5123; Williams SD, 1999, BIOCHEMISTRY-US, V38, P15417, DOI 10.1021/bi992013z; Williams SD, 2000, BIOCHEMISTRY-US, V39, P10098, DOI 10.1021/bi0004652; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Woods RD, 2016, NUCLEIC ACIDS RES, V44, P801, DOI 10.1093/nar/gkv1469; Wright PM, 1999, J BIOL CHEM, V274, P29011, DOI 10.1074/jbc.274.41.29011; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Xie YL, 2008, CARCINOGENESIS, V29, P722, DOI 10.1093/carcin/bgn033; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yang HJ, 2001, NUCLEIC ACIDS RES, V29, P743, DOI 10.1093/nar/29.3.743; Yang K, 2018, P NATL ACAD SCI USA, V115, pE11212, DOI 10.1073/pnas.1813338115; Yang ZY, 2017, NUCLEIC ACIDS RES, V45, P6275, DOI 10.1093/nar/gkx394; Zharkov DO, 1998, BIOCHEMISTRY-US, V37, P12384, DOI 10.1021/bi981066y	93	4	4	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3692	3707		10.1074/jbc.RA119.010497	http://dx.doi.org/10.1074/jbc.RA119.010497			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32001618	hybrid, Green Published			2022-12-26	WOS:000527725300025
J	Dhaliwal, DS; Williams, MM				Dhaliwal, Daljeet S.; Williams, Martin M., II			Understanding variability in optimum plant density and recommendation domains for crowding stress tolerant processing sweet corn	PLOS ONE			English	Article							YIELD RESPONSES; GROWING-SEASON; MAIZE; POPULATION; DATE; HYBRIDS; EFFICIENCY	Recent research shows significant economic benefit if the processing sweet corn [Zea mays L. var. rugosa (or saccharata)] industry grew crowding stress tolerant (CST) hybrids at their optimum plant densities, which may exceed current plant densities by up to 14,500 plants ha(-1). However, optimum plant density of individual fields varies over years and across the Upper Midwest (Illinois, Minnesota and Wisconsin), where processing sweet corn is concentrated. The objectives of this study were to: (1) determine the extent to which environmental and management practices affect optimum plant density and, (2) identify the most appropriate recommendation domain for making decisions on plant density. To capture spatial and temporal variability in optimum plant density, on-farm experiments were conducted at thirty fields across the states of Illinois, Minnesota and Wisconsin, from 2013 to 2017. Exploratory factor analysis of twelve environmental and management variables revealed two factors, one related to growing period and the other defining soil type, which explained the maximum variability observed across all the fields. These factors were then used to quantify the strength of associations with optimum plant density. Pearson's partial correlation coefficients of 'growing period' and 'soil type' with optimum plant density were low (rho(1) = -0.14 and rho(2) = -0.09, respectively) and non-significant (P = 0.47 and 0.65, respectively). To address the second objective, six candidate recommendation domain models (RDM) were developed and tested. Linear mixed effects models describing crop response to plant density were fit to each level of each candidate RDM. The difference in profitability observed at the current plant density for a field and the optimum plant density under RDM level represented the additional processor profit ($ ha(-1)) from a field. The RDM built around 'Production Area' (RDMPA) appears most suitable, because plant density recommendations based on RDMPA maximized processor profits as well grower returns better than other RDMs. Compared to current plant density, processor profits and grower returns increased by $448 ha(-1) and $82 ha(-1), respectively at plant densities under RDMPA.	[Dhaliwal, Daljeet S.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Williams, Martin M., II] USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Williams, MM (corresponding author), USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL 61801 USA.	martin.williams@ars.usda.gov		Williams, Martin/0000-0002-6302-7724; Dhaliwal, Daljeet/0000-0001-8116-4012				Assefa Y, 2016, CROP SCI, V56, P2802, DOI 10.2135/cropsci2016.04.0215; Boerboom C, 1999, CROP PROFILE CORN SW; CASAL JJ, 1985, ANN BOT-LONDON, V56, P553, DOI 10.1093/oxfordjournals.aob.a087040; CIMMYT, 1981, ASS FARM NEEDS DES A; Coulter J., 2010, PLAN NOW SUCCESSFUL; Dhaliwal DS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223107; Durgy R, 2012, EFFECTS PLANT DENSIT; EVERITT BS, 1975, BRIT J PSYCHIAT, V126, P237, DOI 10.1192/bjp.126.3.237; Francis CA, 1995, DET S ALT APPR ON FA; Fritz V.A., 2010, SWEET CORN VEGETABLE; Harrington LW, 1984, RECOMMENDATION DOMAI, P34; Hassell RL, 2003, HORTTECHNOLOGY, V13, P136, DOI 10.21273/HORTTECH.13.1.0136; HILDEBRAND PE, 1984, AGRON J, V76, P271, DOI 10.2134/agronj1984.00021962007600020023x; Johnson D., 1998, APPL MULTIVARIATE ME; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kalcic MM, 2015, J AM WATER RESOUR AS, V51, P973, DOI 10.1111/1752-1688.12336; Kaspar TC, 2004, AGRON J, V96, P700, DOI 10.2134/agronj2004.0700; Long NV, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02106; Maddonni GA, 2006, FIELD CROP RES, V97, P155, DOI 10.1016/j.fcr.2005.09.013; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Midwestern Regional Climate Center, CLI MAT DAIL COUNT D; Moscardi E, 1988, PLANNING TECHNOLOGIE; Mueller B, 2015, WEATHER CLIM EXTREME, V9, P47, DOI 10.1016/j.wace.2015.04.001; NAFZIGER ED, 1994, J PROD AGRIC, V7, P59, DOI 10.2134/jpa1994.0059; Nielsen RL, 2002, AGRON J, V94, P549; Norwood CA, 2001, AGRON J, V93, P540, DOI 10.2134/agronj2001.933540x; Nunnally J., 1978, PSYCHOMETRIC THEORY; Ogola J. B. O., 2005, South African Journal of Plant and Soil, V22, P116; Peltonen-Sainio P., 2012, Building resilience for adaptation to climate change in the agriculture sector. Proceedings of a Joint FAO/OECD Workshop, Rome, Italy, 23-24 April 2012, P183; Phiri D, 2004, AGR SYST, V79, P131, DOI 10.1016/S0308-521X(03)00055-6; Piana AT, 2008, CIENC RURAL, V38, P2608, DOI 10.1590/S0103-84782008000900032; Porter PM, 1997, J PROD AGRIC, V10, P293, DOI 10.2134/jpa1997.0293; Revelle W., 2018, PSYCH PROCEDURES PER; Shanahan John F., 2004, Precision Agriculture, V5, P207, DOI 10.1023/B:PRAG.0000032762.72510.10; Silva PRF, 2014, J AGR SCI, V9, P48; Singh N.P., 2002, SCI CROP PRODUCTION; Stanger TF, 2006, AGRON J, V98, P914, DOI 10.2134/agronj2005.0144; Takasu AT, 2014, AGRARIAN, V7, P34; Team R, 2016, RSTUDIO INT DEV R; Thompson WH, 2013, J AGRON CROP SCI, V199, P299, DOI 10.1111/jac.12015; Tokatlidis IS, 2011, FIELD CROP RES, V120, P345, DOI 10.1016/j.fcr.2010.11.006; Tokatlidis IS, 2015, AGRON J, V107, P1011, DOI 10.2134/agronj14.0599; Van Roekel RJ, 2011, AGRON J, V103, P1414, DOI 10.2134/agronj2011.0071; Williams MM, 2008, HORTSCIENCE, V43, P1775, DOI 10.21273/HORTSCI.43.6.1775; Williams MM, 2015, AGRON J, V107, P1782, DOI 10.2134/agronj15.0011; Williams MM, 2012, FIELD CROP RES, V128, P55, DOI 10.1016/j.fcr.2011.12.007	46	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228809	10.1371/journal.pone.0228809	http://dx.doi.org/10.1371/journal.pone.0228809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032371	Green Published, Green Submitted, gold			2022-12-26	WOS:000534626100027
J	Lazarian, G; Friedrich, C; Quinquenel, A; Tran, J; Ouriemmi, S; Dondi, E; Martin, A; Mihoub, I; Chiron, D; Bellanger, C; Fleury, C; Gelebart, P; McCormack, E; Ledoux, D; Thieblemont, C; Marzec, J; Gribben, JG; Cymbalista, F; Varin-Blank, N; Gardano, L; Baran-Marszak, F				Lazarian, Gregory; Friedrich, Chloe; Quinquenel, Anne; Tran, Julie; Ouriemmi, Souhail; Dondi, Elisabetta; Martin, Antoine; Mihoub, Imane; Chiron, David; Bellanger, Celine; Fleury, Carole; Gelebart, Pascal; McCormack, Emmet; Ledoux, Dominique; Thieblemont, Catherine; Marzec, Jacek; Gribben, John G.; Cymbalista, Florence; Varin-Blank, Nadine; Gardano, Laura; Baran-Marszak, Fanny			Stabilization of beta-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma	ONCOGENE			English	Article							KAPPA-B; WNT/BETA-CATENIN; SYNTHASE KINASE-3; CYCLIN D1; CONSTITUTIVE ACTIVATION; PATHWAY; WNT; INHIBITION; EXPRESSION; AKT	B-cell receptor (BCR) signaling pathways and interactions with the tumor microenvironment account for mantle cell lymphoma (MCL) cells survival in lymphoid organs. In several MCL cases, the WNT/beta-catenin canonical pathway is activated and beta-catenin accumulates into the nucleus. As both BCR and beta-catenin are important mediators of cell survival and interaction with the microenvironment, we investigated the crosstalk between BCR and WNT/beta-catenin signaling and analyzed their impact on cellular homeostasis as well as their targeting by specific inhibitors. beta-catenin was detected in all leukemic MCL samples and its level of expression rapidly increased upon BCR stimulation. This stabilization was hampered by the BCR-pathway inhibitor Ibrutinib, supporting beta-catenin as an effector of the BCR signaling. In parallel, MCL cells as compared with normal B cells expressed elevated levels of WNT16, a NF-kappa B target gene. Its expression increased further upon BCR stimulation to participate to the stabilization of beta-catenin. Upon BCR stimulation, beta-catenin translocated into the nucleus but did not induce a Wnt-like transcriptional response, i.e., TCF/LEF dependent. beta-catenin rather participated to the regulation of NF-kappa B transcriptional targets, such as IL6, IL8, and IL1. Oligo pull down and chromatin immunoprecipitation experiments demonstrated that beta-catenin is part of a protein complex that binds the NF-kappa B DNA consensus sequence, strengthening the idea of an association between the two proteins. An inhibitor targeting beta-catenin transcriptional interactions hindered both NF-kappa B DNA recruitment and induced primary MCL cells apoptosis. Thus, beta-catenin likely represents another player through which BCR signaling impacts on MCL cell survival.	[Lazarian, Gregory; Friedrich, Chloe; Quinquenel, Anne; Tran, Julie; Ouriemmi, Souhail; Dondi, Elisabetta; Martin, Antoine; Mihoub, Imane; Fleury, Carole; Ledoux, Dominique; Cymbalista, Florence; Varin-Blank, Nadine; Gardano, Laura; Baran-Marszak, Fanny] INSERM, U978, Bobigny, France; [Lazarian, Gregory; Friedrich, Chloe; Quinquenel, Anne; Tran, Julie; Ouriemmi, Souhail; Dondi, Elisabetta; Martin, Antoine; Mihoub, Imane; Fleury, Carole; Ledoux, Dominique; Cymbalista, Florence; Varin-Blank, Nadine; Gardano, Laura; Baran-Marszak, Fanny] Univ Paris 13, Sorbonne Paris Cite, Labex Inflamex, Bobigny, France; [Lazarian, Gregory; Fleury, Carole; Cymbalista, Florence; Baran-Marszak, Fanny] Hop Avicenne, Assistance Publ Hop Paris, Serv Hematol Biol, Bobigny, France; [Martin, Antoine] Hop Avicenne, Assistance Publ Hop Paris, Serv Anatomopathol, Bobigny, France; [Chiron, David; Bellanger, Celine] Univ Nantes, CNRS, U1232 INSERM, Ctr Rech Cancerol & Immunol Nantes Angers,ERL6001, Nantes, France; [Gelebart, Pascal; McCormack, Emmet] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Thieblemont, Catherine] Hop St Louis, Assistance Publ Hop Paris, Hematol, Paris, France; [Marzec, Jacek] Univ Melbourne, Dept Clin Pathol, Melbourne, Vic, Australia; [Gribben, John G.] Queen Mary Univ London, Barts Canc Inst, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris 13; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; University of Bergen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Melbourne; University of London; Queen Mary University London	Varin-Blank, N; Baran-Marszak, F (corresponding author), INSERM, U978, Bobigny, France.; Varin-Blank, N; Baran-Marszak, F (corresponding author), Univ Paris 13, Sorbonne Paris Cite, Labex Inflamex, Bobigny, France.; Baran-Marszak, F (corresponding author), Hop Avicenne, Assistance Publ Hop Paris, Serv Hematol Biol, Bobigny, France.	nadine.varin@inserm.fr; fanny.baran-marszak@aphp.fr	Cormack, Emmet Mc/D-2922-2012; Gelebart, Pascal/AAI-1439-2020; Thieblemont, Catherine/AAZ-8423-2020	Cormack, Emmet Mc/0000-0002-7621-4625; Gelebart, Pascal/0000-0003-2434-8987; Thieblemont, Catherine/0000-0002-9941-2448; VARIN-BLANK, Nadine/0000-0003-2769-018X; Dondi, Elisabetta/0000-0003-0975-459X; Lazarian, Gregory/0000-0002-4315-3440; LEDOUX, DOMINIQUE/0000-0002-5886-2266; Marzec, Jacek/0000-0001-6577-8866	APHP; Jansen fellowship; INSERM; Labex INFLAMEX [ANR11 IDEX00502]; University Paris 13	APHP; Jansen fellowship; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Labex INFLAMEX; University Paris 13	CF was the recipient of a "Annee Recherche" support from APHP. AQ was the recipient of a Jansen fellowship. This project was funded by a "Bonus Qualite Recherche" grant from University Paris 13 and benefited from the financial support of INSERM, University Paris 13 and the Labex INFLAMEX, contract ANR11 IDEX00502. We thank Dr C. Leroy for reading the manuscript, Dr L. Guittat for helpful discussion during the experimental work and Dr B. Papp for initiating collaboration with Dr P. Gelebart.	Argatoff LH, 1997, BLOOD, V89, P2067, DOI 10.1182/blood.V89.6.2067; Baran-Marszak F, 2010, HAEMATOL-HEMATOL J, V95, P1865, DOI 10.3324/haematol.2009.019745; Bernard S, 2015, INT J CANCER, V136, P2761, DOI 10.1002/ijc.29326; Bognar MK, 2016, ONCOGENE, V35, P4269, DOI 10.1038/onc.2015.493; BOSCH F, 1994, BLOOD, V84, P2726; Boukhiar MA, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-4; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Christian SL, 2002, J IMMUNOL, V169, P758, DOI 10.4049/jimmunol.169.2.758; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dal Col J, 2008, CELL CYCLE, V7, P2813, DOI 10.4161/cc.7.18.6733; de Rooij MFM, 2015, BLOOD, V125, P2306, DOI 10.1182/blood-2014-12-619163; Gandhirajan RK, 2010, CURR CANCER DRUG TAR, V10, P716; Gelebart P, 2008, BLOOD, V112, P5171, DOI 10.1182/blood-2008-02-139212; Gold MR, 1999, J IMMUNOL, V163, P1894; Gold MR, 2000, IMMUNOL REV, V176, P47; GOODE N, 1992, J BIOL CHEM, V267, P16878; Hadzidimitriou A, 2011, BLOOD, V118, P3088, DOI 10.1182/blood-2011-03-343434; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jares P, 2012, J CLIN INVEST, V122, P3416, DOI 10.1172/JCI61272; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Khan NI, 2007, BRIT J HAEMATOL, V138, P338, DOI 10.1111/j.1365-2141.2007.06667.x; Kimura Y, 2013, INT J ONCOL, V43, P457, DOI 10.3892/ijo.2013.1982; Koopmans T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01086; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Lindvall J, 2002, BIOCHEM BIOPH RES CO, V293, P1319, DOI 10.1016/S0006-291X(02)00382-0; Lovatt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012794; Ma B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00378; Mathur R, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0161-1; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Orchard J, 2003, BLOOD, V101, P4975, DOI 10.1182/blood-2002-06-1864; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P1023, DOI 10.1073/pnas.1118506109; Rizzatti EG, 2005, BRIT J HAEMATOL, V130, P516, DOI 10.1111/j.1365-2141.2005.05630.x; Saba NS, 2016, BLOOD, V128, P82, DOI 10.1182/blood-2015-11-681460; Spaargaren M, 2015, ONCOGENE, V34, P2426, DOI 10.1038/onc.2014.181; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Sun Y, 2016, ONCOGENE, V35, P4321, DOI 10.1038/onc.2015.494; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Zhang XQ, 2015, AM J CANCER RES, V5, P2344	45	7	8	4	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2934	2947		10.1038/s41388-020-1183-x	http://dx.doi.org/10.1038/s41388-020-1183-x		FEB 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32034308				2022-12-26	WOS:000511752600004
J	D'Andrea, G; Ceccarelli, M; Bernini, R; Clemente, M; Santi, L; Caruso, C; Micheli, L; Tirone, F				D'Andrea, Giorgio; Ceccarelli, Manuela; Bernini, Roberta; Clemente, Mariangela; Santi, Luca; Caruso, Carla; Micheli, Laura; Tirone, Felice			Hydroxytyrosol stimulates neurogenesis in aged dentate gyrus by enhancing stem and progenitor cell proliferation and neuron survival	FASEB JOURNAL			English	Article						aging; diet; hippocampus; neural stem cells; neurogenic stimuli	ADULT HIPPOCAMPAL NEUROGENESIS; IN-VITRO; DIFFERENTIATION; FLUOXETINE; EXPRESSION; EXERCISE; MEMORY; SUBPOPULATIONS; ACTIVATION; INDUCTION	The dentate gyrus of the hippocampus is one of two brain areas generating throughout life new neurons, which contribute to the formation of episodic/associative memories. During aging, the production of new neurons decreases and a cognitive decline occurs. Dietary factors influence neuronal function and synaptic plasticity; among them the phenolic compound hydroxytyrosol (HTyr), present in olive oil, displays neuroprotective effects. As age impacts primarily on the hippocampus-dependent cognitive processes, we wondered whether HTyr could stimulate hippocampal neurogenesis in vivo in adult and aged wild-type mice as well as in the B-cell translocation 1 gene (Btg1) knockout mouse model of accelerated neural aging. We found that treatment with HTyr activates neurogenesis in the dentate gyrus of adult, aged, and Btg1-null mice, by increasing survival of new neurons and decreasing apoptosis. Notably, however, in the aged and Btg1-null dentate gyrus, HTyr treatment also stimulates the proliferation of stem and progenitor cells, whereas in the adult dentate gyrus HTyr lacks any proliferative effect. Moreover, the new neurons generated in aged mice after HTyr treatment are recruited to existing circuits, as shown by the increase of BrdU(+)/c-fos(+) neurons. Finally, HTyr treatment also reduces the markers of aging lipofuscin and Iba1. Overall, our findings indicate that HTyr treatment counteracts neurogenesis decline during aging.	[D'Andrea, Giorgio; Ceccarelli, Manuela; Micheli, Laura; Tirone, Felice] CNR, IBBC, Via Ercole Ramarini 32, I-00015 Rome, Italy; [D'Andrea, Giorgio; Caruso, Carla] Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy; [Bernini, Roberta; Clemente, Mariangela; Santi, Luca] Univ Tuscia, Dept Agr & Forest Sci DAFNE, Viterbo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica e Biologia Cellulare (IBBC-CNR); Tuscia University; Tuscia University	Micheli, L; Tirone, F (corresponding author), CNR, IBBC, Via Ercole Ramarini 32, I-00015 Rome, Italy.	laura.micheli@cnr.it; felice.tirone@cnr.it	Micheli, Laura/AAY-1641-2020; Ceccarelli, Manuela/AAW-2934-2021; Tirone, Felice/P-6745-2014	SANTI, Luca/0000-0003-4638-5084; MICHELI, LAURA/0000-0001-8647-7261; Ceccarelli, Manuela/0000-0001-8741-1600	Regione Lazio (Lazio Region) [85-2017-14785]; Consiglio Nazionale delle Ricerche (CNR) [DSB.AD004.093]; Fondazione Cariplo (Cariplo Foundation) [AGER2-Rif.2016-0169]; University of Viterbo; Fondazione Giovanni Celeghin	Regione Lazio (Lazio Region); Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Fondazione Cariplo (Cariplo Foundation)(Fondazione Cariplo); University of Viterbo; Fondazione Giovanni Celeghin	Regione Lazio (Lazio Region), Grant/Award Number: 85-2017-14785; Consiglio Nazionale delle Ricerche (CNR), Grant/Award Number: DSB.AD004.093; Fondazione Cariplo (Cariplo Foundation), Grant/Award Number: AGER2-Rif.2016-0169; University of Viterbo, Grant/Award Number: PhD fellowship; Fondazione Giovanni Celeghin, Grant/Award Number: Fellowship	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Arunsundar M, 2015, NEUROTOX RES, V27, P143, DOI 10.1007/s12640-014-9492-x; Aunon-Calles D, 2013, FOOD CHEM TOXICOL, V55, P498, DOI 10.1016/j.fct.2013.01.030; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bernini R, 2013, CURR MED CHEM, V20, P655, DOI 10.2174/092986713804999367; Bernini R, 2008, J AGR FOOD CHEM, V56, P8897, DOI 10.1021/jf801558z; Bernini R, 2017, J AGR FOOD CHEM, V65, P6506, DOI 10.1021/acs.jafc.6b05457; Bizon JL, 2003, EUR J NEUROSCI, V18, P215, DOI 10.1046/j.1460-9568.2003.02733.x; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Brandt MD, 2010, EUR J NEUROSCI, V32, P1256, DOI 10.1111/j.1460-9568.2010.07410.x; Calahorra J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102430; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Cetrullo S, 2016, BBA-GEN SUBJECTS, V1860, P1181, DOI 10.1016/j.bbagen.2016.03.002; Chen MJ, 2009, HIPPOCAMPUS, V19, P962, DOI 10.1002/hipo.20579; Cheng Y, 2017, MOL MED REP, V16, P8826, DOI 10.3892/mmr.2017.7701; Clark PJ, 2010, BEHAV BRAIN RES, V213, P246, DOI 10.1016/j.bbr.2010.05.007; Cornejo F, 2016, ADV EXP MED BIOL, V949, P205, DOI 10.1007/978-3-319-40764-7_10; Couillard-Despres S, 2009, MOL PSYCHIATR, V14, P856, DOI 10.1038/mp.2008.147; D'Angelo S, 2001, DRUG METAB DISPOS, V29, P1492; Dias GP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/541971; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Farioli-Vecchioli S, 2014, STEM CELLS, V32, P1968, DOI 10.1002/stem.1679; Farioli-Vecchioli S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00124; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; FLOOD JF, 1995, PHYSIOL BEHAV, V58, P819, DOI 10.1016/0031-9384(95)00125-3; Fu P, 2016, EXP THER MED, V11, P1999, DOI 10.3892/etm.2016.3101; Fukuda S, 2003, J NEUROSCI, V23, P9357; Funakohi-Tago M, 2018, EUR J PHARMACOL, V834, P246, DOI 10.1016/j.ejphar.2018.07.043; Garcia-Martinez O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150045; GEBARA E, 2013, FRONT NEUROSCI SWITZ, V7; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hornedo-Ortega R, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00373; Imran M, 2018, J FOOD SCI, V83, P1781, DOI 10.1111/1750-3841.14198; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lamy S, 2016, J NUTR BIOCHEM, V27, P136, DOI 10.1016/j.jnutbio.2015.08.026; Li Y, 2015, PHARMACOL BIOCHEM BE, V135, P70, DOI 10.1016/j.pbb.2015.05.013; Hazas MCLD, 2018, J FUNCT FOODS, V46, P110, DOI 10.1016/j.jff.2018.04.028; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Martinez Lorena, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010013; Martinez-Lapiscina EH, 2013, J NUTR HEALTH AGING, V17, P544, DOI 10.1007/s12603-013-0027-6; McAvoy K, 2015, HIPPOCAMPUS, V25, P1429, DOI 10.1002/hipo.22464; Micheli L, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00010; Micheli L, 2018, NEUROPHARMACOLOGY, V141, P316, DOI 10.1016/j.neuropharm.2018.08.023; Micheli L, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00186; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Nardiello P, 2018, J ALZHEIMERS DIS, V63, P1161, DOI 10.3233/JAD-171124; NEWTON I, 1994, PESTIC SCI, V41, P187, DOI 10.1002/ps.2780410304; Omar SH, 2018, FITOTERAPIA, V128, P118, DOI 10.1016/j.fitote.2018.05.011; De la Cruz JP, 2015, J AGR FOOD CHEM, V63, P5957, DOI 10.1021/acs.jafc.5b00627; Peng SJ, 2015, FOOD FUNCT, V6, P2091, DOI [10.1039/C5FO00097A, 10.1039/c5fo00097a]; Reus GZ, 2012, J PSYCHIATR RES, V46, P1029, DOI 10.1016/j.jpsychires.2012.04.016; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Romani A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081776; Romani A, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8101002; Sarubbo F, 2018, NEUROSCI BIOBEHAV R, V90, P456, DOI 10.1016/j.neubiorev.2018.05.011; Schaffer S, 2007, J AGR FOOD CHEM, V55, P5043, DOI 10.1021/jf0703710; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Siette J, 2013, BIOL PSYCHIAT, V73, P435, DOI 10.1016/j.biopsych.2012.05.034; Stangl D, 2009, GENES NUTR, V4, P271, DOI 10.1007/s12263-009-0134-5; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Tirone F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00059; Vivar C, 2015, CURR TOP MED CHEM, V15, P2175, DOI 10.2174/1568026615666150610141524; Yamaguchi Y, 2015, CURR TOP DEV BIOL, V114, P159, DOI 10.1016/bs.ctdb.2015.07.016; Zhang ZX, 2019, J INTEGR NEUROSCI, V18, P65, DOI 10.31083/j.jin.2019.01.118; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng A, 2015, J NUTR BIOCHEM, V26, P190, DOI 10.1016/j.jnutbio.2014.10.006	83	12	12	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4512	4526		10.1096/fj.201902643R	http://dx.doi.org/10.1096/fj.201902643R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32027412				2022-12-26	WOS:000512077100001
J	Ehrlicher, SE; Stierwalt, HD; Miller, BF; Newsom, SA; Robinson, MM				Ehrlicher, Sarah E.; Stierwalt, Harrison D.; Miller, Benjamin F.; Newsom, Sean A.; Robinson, Matthew M.			Mitochondrial adaptations to exercise do not require Bcl2-mediated autophagy but occur with BNIP3/Parkin activation	FASEB JOURNAL			English	Article						mitochondrial respiration; protein turnover; skeletal muscle	FATTY-ACID OXIDATION; SKELETAL-MUSCLE; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; RATES; DIET; BIOGENESIS; MITOPHAGY; TURNOVER; OBESITY	Understanding the mechanisms regulating mitochondrial respiratory function and adaptations to metabolic challenges, such as exercise and high dietary fat, is necessary to promote skeletal muscle health and attenuate metabolic disease. Autophagy is a constitutively active degradation pathway that promotes mitochondrial turnover and transiently increases postexercise. Recent evidence indicates Bcl2 mediates exercise-induced autophagy and skeletal muscle adaptions to training during high-fat diet. We determined if improvements in mitochondrial respiration due to exercise training required Bcl2-mediated autophagy using a transgenic mouse model of impaired inducible autophagy (Bcl2(AAA)). Mitochondrial adaptations to a treadmill exercise training protocol, in either low-fat or high-fat diet fed mice, did not require Bcl2-mediated autophagy activation. Instead, training increased protein synthesis rates and basal autophagy in the Bcl2(AAA) mice, while acute exercise activated BNIP3 and Parkin autophagy. High-fat diet stimulated lipid-specific mitochondrial adaptations. These data demonstrate increases in basal mitochondrial turnover, not transient activation with exercise, mediate adaptations to exercise and high-fat diet.	[Ehrlicher, Sarah E.; Stierwalt, Harrison D.; Newsom, Sean A.; Robinson, Matthew M.] Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, 118F Milam Hall, Corvallis, OR 97331 USA; [Miller, Benjamin F.] Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA	Oregon State University; Oklahoma Medical Research Foundation	Ehrlicher, SE (corresponding author), Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, 118F Milam Hall, Corvallis, OR 97331 USA.	matthew.robinson@oregonstate.edu	Stierwalt, Harrison/ABC-4410-2020	Newsom, Sean/0000-0003-0585-3830	National Institutes of Health (NIH) [K01DK103829, KL2TR002370]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: K01DK103829 and KL2TR002370	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Antoun G, 2015, DIABETOLOGIA, V58, P2861, DOI 10.1007/s00125-015-3772-8; Boudina S, 2012, ENDOCRINOLOGY, V153, P2677, DOI 10.1210/en.2011-2147; Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Cardinale DA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01133; Chen CCW, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0157-y; Dasari S, 2018, AM J PHYSIOL-ENDOC M, V315, pE425, DOI 10.1152/ajpendo.00051.2018; DAVIES KJA, 1981, ARCH BIOCHEM BIOPHYS, V209, P539, DOI 10.1016/0003-9861(81)90312-X; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Ehrlicher SE, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13810; Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004; Fritzen AM, 2016, CELL SIGNAL, V28, P663, DOI 10.1016/j.cellsig.2016.03.005; Fu TT, 2018, CELL REP, V23, P1357, DOI 10.1016/j.celrep.2018.03.127; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070; Hamilton KL, 2017, J PHYSIOL-LONDON, V595, P6401, DOI 10.1113/JP274335; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Jaleel A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1255, DOI 10.1152/ajpendo.90586.2008; Ju JS, 2016, J PHYSIOL SCI, V66, P417, DOI 10.1007/s12576-016-0440-9; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Konopka AR, 2015, DIABETES, V64, P2104, DOI 10.2337/db14-1701; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Lai N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183978; Laker RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00520-9; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Lark DS, 2018, DIABETES, V67, P831, DOI 10.2337/db17-1293; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Lo Verso F, 2014, AUTOPHAGY, V10, P1883, DOI 10.4161/auto.32154; Lundsgaard AM, 2019, CELL METAB, V29, P50, DOI 10.1016/j.cmet.2018.08.022; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Miller BF, 2015, J APPL PHYSIOL, V118, P655, DOI 10.1152/japplphysiol.00987.2014; Miller BF, 2012, AGING CELL, V11, P150, DOI 10.1111/j.1474-9726.2011.00769.x; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moller AB, 2017, SCI REP-UK, V7, DOI 10.1038/srep43775; Nabben M, 2011, FEBS LETT, V585, P4010, DOI 10.1016/j.febslet.2011.11.012; Newsom SA, 2017, AM J PHYSIOL-ENDOC M, V313, pE552, DOI 10.1152/ajpendo.00144.2017; Nilsson MI, 2013, FASEB J, V27, P3905, DOI 10.1096/fj.12-224006; Nilsson MI, 2010, AM J PHYSIOL-ENDOC M, V299, pE466, DOI 10.1152/ajpendo.00118.2010; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Pinti MV, 2019, AM J PHYSIOL-ENDOC M, V316, pE268, DOI 10.1152/ajpendo.00314.2018; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Rosa-Caldwell ME, 2017, EXP PHYSIOL, V102, P1194, DOI 10.1113/EP086406; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Shimazu T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19615-4; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vainshtein A, 2016, J APPL PHYSIOL, V120, P664, DOI 10.1152/japplphysiol.00550.2015; Vainshtein A, 2015, AM J PHYSIOL-CELL PH, V308, pC710, DOI 10.1152/ajpcell.00380.2014; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Yan Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08480-2	61	6	6	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4602	4618		10.1096/fj.201902594RR	http://dx.doi.org/10.1096/fj.201902594RR		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030805	Bronze, Green Accepted			2022-12-26	WOS:000512333600001
J	Fujishiro, MA; Lidbury, JA; Pilla, R; Steiner, JM; Lappin, MR; Suchodolski, JS				Fujishiro, Madeline A.; Lidbury, Jonathan A.; Pilla, Rachel; Steiner, Jorg M.; Lappin, Michael R.; Suchodolski, Jan S.			Evaluation of the effects of anthelmintic administration on the fecal microbiome of healthy dogs with and without subclinical Giardia spp. and Cryptosporidium canis infections	PLOS ONE			English	Article							GUT MICROBIOTA; CLOSTRIDIUM-DIFFICILE; FENBENDAZOLE; EFFICACY; DIAGNOSIS; IMPACT	Background The gastrointestinal microbiome plays an important role in host health and there is increasing concern regarding the deleterious effects of pharmaceuticals on the fecal microbiome. The effect of anthelmintic therapy on the fecal microbiome in dogs has not yet been evaluated. The purpose of this study was to evaluate the effect of anthelmintic administration on the fecal microbiome of dogs with and without subclinical Giardia species and Cryptosporidium canis infections. Methodology/Principal findings Part 1: 6 healthy adult research beagles with subclinical giardiasis and cryptosporidiosis were administered a commercially available preparation of febantel combined with pyrantel and praziquantel (FPP) orally daily for three days. Part 2: 19 healthy staff-owned dogs without giardiasis or cryptosporidiosis were divided into a treatment group (n = 9) that was administered fenbendazole orally daily for five days and an untreated control group (n = 10). For both parts of the study, feces were collected at multiple time points before and after anthelmintic (FPP or fenbendazole) administration. Fecal DNA was extracted for Illumina sequencing of the bacterial 16S rRNA gene and qPCR assays. Neither FPP nor fenbendazole treatment caused a significant change in alpha or beta diversity or the relative abundance of bacterial species. Upon univariate statistical analysis neither FPP or fenbendazole caused minimal changes in the fecal microbiota. Conclusion FPP administration was associated with minimal alterations of the fecal microbiome of healthy research beagles with subclinical giardiasis and cryptosporidiosis. Fenbendazole administration was associated with minimal alterations of the fecal microbiome of healthy staff owned dogs.	[Fujishiro, Madeline A.; Lidbury, Jonathan A.; Pilla, Rachel; Steiner, Jorg M.; Suchodolski, Jan S.] Texas A&M Univ, Small Anim Clin Sci, Gastrointestinal Lab, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Lappin, Michael R.] Colorado State Univ, Ctr Compan Anim Studies, Ft Collins, CO 80523 USA	Texas A&M University System; Texas A&M University College Station; Colorado State University	Lidbury, JA (corresponding author), Texas A&M Univ, Small Anim Clin Sci, Gastrointestinal Lab, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	jlidbury@cvm.tamu.edu		Pilla, Rachel/0000-0001-7758-2609; Lidbury, Jonathan/0000-0001-5107-4577	Bayer Animal Health; Colorado State University Center for Companion Animal Studies	Bayer Animal Health(Bayer AG); Colorado State University Center for Companion Animal Studies	This study was funded by: Bayer Animal Health (https://animalhealth.bayer.com/) and the Colorado State University Center for Companion Animal Studies (http://csu-cvmbs.colostate.edu/vth/veterinarians/research/companion-animals/Pages/default.aspx).This study was also funded by a generous gift from Livingston and Saranne Kosberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlShawaqfeh MK, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix136; Barko PC, 2018, J VET INTERN MED, V32, P9, DOI 10.1111/jvim.14875; Caylor KB, 2001, J AM ANIM HOSP ASSOC, V37, P258, DOI 10.5326/15473317-37-3-258; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Crotch-Harvey Laura, 2018, Journal of Equine Science, V29, P47, DOI 10.1294/jes.29.47; DOW SW, 1989, J AM VET MED ASSOC, V195, P365; Gronvold AMR, 2010, FEMS MICROBIOL ECOL, V71, P313, DOI 10.1111/j.1574-6941.2009.00808.x; Gurjar AA, 2008, MOL CELL PROBE, V22, P90, DOI 10.1016/j.mcp.2007.08.001; He FP, 2018, BIOCHEM BIOPH RES CO, V499, P447, DOI 10.1016/j.bbrc.2018.03.158; Hoffmann AR, 2016, VET PATHOL, V53, P10, DOI 10.1177/0300985815595517; Isaiah A, 2017, ANAEROBE, V45, P50, DOI 10.1016/j.anaerobe.2017.02.010; Keith CL, 2003, AM J VET RES, V64, P1027, DOI 10.2460/ajvr.2003.64.1027; Korte SW, 2018, J AM ASSOC LAB ANIM, V57, P229; Kunz IGZ, 2019, J EQUINE VET SCI, V77, P98, DOI 10.1016/j.jevs.2019.01.018; Kunz IZ, 2017, J EQUINE VET SCI, V52, P53; Lawson PA, 2016, ANAEROBE, V40, P95, DOI 10.1016/j.anaerobe.2016.06.008; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Minamoto Y, 2015, GUT MICROBES, V6, P33, DOI 10.1080/19490976.2014.997612; Miro G, 2007, PARASITOL RES, V100, P317, DOI 10.1007/s00436-006-0258-0; Montoya A, 2008, PARASITOL RES, V103, P1141, DOI 10.1007/s00436-008-1107-0; Olson ME, 2009, PARASITOL RES, V105, pS135, DOI 10.1007/s00436-009-1504-z; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Scorza AV, 2004, J FELINE MED SURG, V6, P157, DOI 10.1016/j.jfms.2003.11.007; Slapeta J, 2015, INT J PARASITOL, V45, P585, DOI 10.1016/j.ijpara.2015.04.001; Suchodolski J, 2016, J VET INTERN MED, V30, P1455, DOI DOI 10.1111/JVIM.13952; Suchodolski JS, 2016, VET J, V215, P30, DOI 10.1016/j.tvjl.2016.04.011; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Tal M, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1188-z; Tangtrongsup S, 2010, TOP COMPANION ANIM M, V25, P155, DOI 10.1053/j.tcam.2010.07.003; Thompson RCA, 2008, VET J, V177, P18, DOI 10.1016/j.tvjl.2007.09.022; Thompson RCA, 2005, ADV PARASIT, V59, P77, DOI 10.1016/S0065-308X(05)59002-X; White R, 2017, GUT MICROBES, V8, P451, DOI 10.1080/19490976.2017.1334754; Zajac AM, 1998, AM J VET RES, V59, P61	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228145	10.1371/journal.pone.0228145	http://dx.doi.org/10.1371/journal.pone.0228145			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027665	gold, Green Published			2022-12-26	WOS:000534623800015
J	Taniguchi, Y; Oyama, N; Fumoto, S; Kinoshita, H; Yamashita, F; Shimizu, K; Hashida, M; Kawakami, S				Taniguchi, Yota; Oyama, Natsuko; Fumoto, Shintaro; Kinoshita, Hideyuki; Yamashita, Fumiyoshi; Shimizu, Kazunori; Hashida, Mitsuru; Kawakami, Shigeru			Tissue suction-mediated gene transfer to the beating heart in mice	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; DELIVERY; ANGIOGENESIS; PERMEABILITY; EXPRESSION; INJECTION; THERAPY; DRUGS	We previously developed an in vivo site-specific transfection method using a suction device in mice; namely, a tissue suction-mediated transfection method (tissue suction method). The aim of this study was to apply the tissue suction method for cardiac gene transfer. Naked plasmid DNA (pDNA) was intravenously injected in mice, followed by direct suction on the beating heart by using a suction device made of polydimethylsiloxane. We first examined the effects of suction conditions on transgene expression and toxicity. Subsequently, we analyzed transgene-expressing cells and the transfected region of the heart. We found that heart suction induced transgene expression, and that -75 kPa and -90 kPa of suction achieved high transgene expression. In addition, the inner diameter of the suction device was correlated with transgene expression, but the pressure hold time did not change transgene expression. Although the tissue suction method at -75 kPa induced a transient increase in the serum cardiac toxicity markers at 6 h after transfection, these markers returned to normal at 24 h. The cardiac damage was also analyzed through the measurement of hypertrophic gene expression, but no significant differences were found. In addition, the cardiac function monitored by echocardiography remained normal at 11 days after transfection. Immunohistochemical analysis revealed that CD31-positive endothelial cells coexpressed the ZsGreen1-N1 reporter gene. In conclusion, the tissue suction method can achieve an efficient and safe gene transfer to the beating heart in mice.	[Taniguchi, Yota; Oyama, Natsuko; Fumoto, Shintaro; Kawakami, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Sakamotomachi, Nagasaki, Japan; [Kinoshita, Hideyuki] Kyoto Univ, Grad Sch Med, Dept Community Med Supporting Syst, Kyoto, Japan; [Yamashita, Fumiyoshi; Hashida, Mitsuru] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Yoshida Shimoadachi Cho, Kyoto, Japan; [Shimizu, Kazunori] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan	Nagasaki University; Kyoto University; Kyoto University; Nagoya University	Kawakami, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Sakamotomachi, Nagasaki, Japan.	skawakam@nagasaki-u.ac.jp		hashida, mitsuru/0000-0001-7383-8080; Fumoto, Shintaro/0000-0002-2218-4547	JSPS KAKENHI [JP17K19496]; Ministry of Health, Labour and Welfare of Japan [H24-009]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was partly supported by JSPS KAKENHI (Grant Number JP17K19496) and a Health and Labour Sciences Research Grant for Research on Medical Device Development (No. H24-009 to K.S.) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonamassa B, 2011, PHARM RES-DORDR, V28, P694, DOI 10.1007/s11095-010-0338-9; Chen CM, 2018, MED RES REV, V38, P829, DOI 10.1002/med.21479; Deng Q, 2015, INT J MOL MED, V36, P335, DOI 10.3892/ijmm.2015.2226; Fujii H, 2011, EUR HEART J, V32, P2075, DOI 10.1093/eurheartj/ehq475; Fujii H, 2009, JACC-CARDIOVASC IMAG, V2, P869, DOI 10.1016/j.jcmg.2009.04.008; Hao HF, 2017, CIRCULATION, V135, P1253, DOI 10.1161/CIRCULATIONAHA.116.023027; Hu GC, 2008, CHEM-BIOL INTERACT, V171, P177, DOI 10.1016/j.cbi.2007.08.006; Hulot JS, 2016, EUR HEART J, V37, P1651, DOI 10.1093/eurheartj/ehw019; Jourde-Chiche N, 2019, NAT REV NEPHROL, V15, P87, DOI 10.1038/s41581-018-0098-z; Kawakami S, 2000, PHARMACEUT RES, V17, P306, DOI 10.1023/A:1007501122611; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; LAMPUGNANI MG, 1993, BAILLIERE CLIN HAEM, V6, P539, DOI 10.1016/S0950-3536(05)80187-8; Lucas T, 2018, CIRC RES, V123, P205, DOI 10.1161/CIRCRESAHA.117.311311; Lund M, 2000, EUR HEART J, V21, P245, DOI 10.1053/euhj.1999.1745; Mejia LC, 2011, MYCOLOGIA, V103, P379, DOI 10.3852/10-134; Okada H, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1841-8; Oyama N, 2017, DRUG DELIV, V24, P906, DOI 10.1080/10717544.2017.1333171; Piras BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075894; Port JD, 2011, PHYSIOL GENOMICS, V43, P1087, DOI 10.1152/physiolgenomics.00074.2011; Prasad KMR, 2011, J GENE MED, V13, P333, DOI 10.1002/jgm.1576; Pringle IA, 2012, BIOMATERIALS, V33, P6833, DOI 10.1016/j.biomaterials.2012.06.009; Rincon MY, 2015, CARDIOVASC RES, V108, P4, DOI 10.1093/cvr/cvv205; Savarese Gianluigi, 2017, Card Fail Rev, V3, P7, DOI 10.15420/cfr.2016:25:2; Schirone L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3920195; Shimizu K, 2014, BIOL PHARM BULL, V37, P569, DOI 10.1248/bpb.b13-00776; Shimizu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041319; Siu ICH, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2018.12.47; Suda T, 2007, GENE THER, V14, P129, DOI 10.1038/sj.gt.3302865; Tani, 2009, J JAPAN SOC COMPUTER, V11, P59, DOI DOI 10.5759/JSCAS.11.59; Taniguchi Y, 2016, J DRUG TARGET, V24, P450, DOI 10.3109/1061186X.2015.1087526; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhang HY, 2010, CIRC RES, V107, P800, DOI 10.1161/CIRCRESAHA.110.219220	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228203	10.1371/journal.pone.0228203	http://dx.doi.org/10.1371/journal.pone.0228203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027678	Green Published, gold			2022-12-26	WOS:000534623800017
J	Tong, X; Wang, SJ; Lei, Z; Li, C; Zhang, CJ; Su, ZY; Liu, X; Zhao, J; Zhang, HT				Tong, Xin; Wang, Shengjie; Lei, Zhe; Li, Chang; Zhang, Cuijuan; Su, Zhiyue; Liu, Xia; Zhao, Jun; Zhang, Hong-Tao			MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-beta-induced epithelial-mesenchymal transition in non-small cell lung cancer	ONCOGENE			English	Article							GENE-EXPRESSION; MYOCARDIN FAMILY; DIFFERENTIATION; TRANSCRIPTION; ACTIVATION; SNAIL; TRANSFORMATION; INDUCTION; PROTEINS; BINDING	Myocardin (MYOCD) promotes Smad3-mediated transforming growth factor-beta (TGF-beta) signaling in mouse fibroblast cells. Our previous studies show that TGF-beta/SMADs signaling activation enhances epithelial-mesenchymal transition (EMT) in human non-small cell lung cancer (NSCLC) cells. However, whether and how MYOCD contributes to TGF-beta-induced EMT of NSCLC cells are poorly elucidated. Here, we found that TGF-beta-induced EMT was accompanied by increased MYOCD expression. Interestingly, MYOCD overexpression augmented EMT and invasion of NSCLC cells induced by TGF-beta, whereas knockdown of MYOCD expression attenuated these effects. Overexpression and knockdown of MYOCD resulted in the upregulation and downregulation of TGF-beta-induced Snail mRNA, respectively. Moreover, MYOCD overexpression promoted TGF-beta-stimulated NSCLC cell metastasis in vivo. MYOCD was highly expressed and positively correlated with Snail in metastatic NSCLC tissues. Mechanistically, MYOCD directly interacted with SMAD3 and sustained the formation of TGF-beta-induced nuclear SMAD3/SMAD4 complex, facilitating TGF-beta/SMAD3-induced transactivation of Snail. Importantly, MYOCD was transcriptionally activated by TGF-beta-induced SMAD3/SMAD4 complex and CRISPR/Cas9-mediated silencing of SMAD3/SMAD4 led to a reduction in MYOCD mRNA expression. Taken together, our findings indicate that MYOCD promotes TGF-beta-induced EMT and metastasis of NSCLC and identify a positive feedback loop between MYOCD and SMAD3/SMAD4 driving TGF-beta-induced EMT.	[Tong, Xin; Wang, Shengjie; Lei, Zhe; Zhang, Cuijuan; Su, Zhiyue; Liu, Xia; Zhang, Hong-Tao] Soochow Univ, Med Coll, Lab Canc Mol Genet, Suzhou 215123, Jiangsu, Peoples R China; [Tong, Xin; Wang, Shengjie; Lei, Zhe; Zhang, Cuijuan; Su, Zhiyue; Liu, Xia; Zhang, Hong-Tao] Soochow Univ, Med Coll, Sch Biol & Basic Med Sci, Dept Genet, Suzhou 215123, Jiangsu, Peoples R China; [Wang, Shengjie] Nanjing Med Univ, Kangda Coll, Dept Basic Med, Lianyungang 222000, Peoples R China; [Li, Chang; Zhao, Jun] Soochow Univ, Med Coll, Affiliated Hosp 1, Dept Thorac Surg, Suzhou 215006, Jiangsu, Peoples R China; [Zhang, Hong-Tao] Suzhou Key Lab Mol Canc Genet, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Nanjing Medical University; Soochow University - China	Zhang, HT (corresponding author), Soochow Univ, Med Coll, Lab Canc Mol Genet, Suzhou 215123, Jiangsu, Peoples R China.; Zhang, HT (corresponding author), Soochow Univ, Med Coll, Sch Biol & Basic Med Sci, Dept Genet, Suzhou 215123, Jiangsu, Peoples R China.; Zhang, HT (corresponding author), Suzhou Key Lab Mol Canc Genet, Suzhou 215123, Jiangsu, Peoples R China.	htzhang@suda.edu.cn	Zhang, Hong-Tao/P-9661-2017; Lei, Zhe/AGZ-4963-2022	Zhang, Hong-Tao/0000-0003-4182-421X; 	National Natural Science Foundation of China [81872343, 81672277]; Suzhou Key Laboratory for Molecular Cancer Genetics [SZS201209]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Key Laboratory for Molecular Cancer Genetics; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	We are grateful for participation and cooperation from the patients with NSCLC. Funding was provided by grants from National Natural Science Foundation of China (81872343, 81672277), and Suzhou Key Laboratory for Molecular Cancer Genetics (SZS201209), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Ackers-Johnson M, 2015, ARTERIOSCL THROM VAS, V35, P817, DOI 10.1161/ATVBAHA.114.305218; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bunn PA, 2008, ONCOLOGIST, V13, P1, DOI 10.1634/theoncologist.13-S1-1; Chen J, 2011, ARTERIOSCL THROM VAS, V31, P368, DOI 10.1161/ATVBAHA.110.218149; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Donatelli SS, 2014, P NATL ACAD SCI USA, V111, P4203, DOI 10.1073/pnas.1319269111; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kimura Y, 2010, CANCER RES, V70, P501, DOI 10.1158/0008-5472.CAN-09-1469; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Marwitz S, 2016, CANCER RES, V76, P3785, DOI 10.1158/0008-5472.CAN-15-1326; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Mitra P, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7080097; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Morita T, 2018, MOL CANCER RES, V16, P880, DOI 10.1158/1541-7786.MCR-17-0715; O'Connor JW, 2015, J CELL PHYSIOL, V230, P1829, DOI 10.1002/jcp.24895; Perot G, 2009, CANCER RES, V69, P2269, DOI 10.1158/0008-5472.CAN-08-1443; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395; Sward K, 2016, J PHYSIOL-LONDON, V594, P4741, DOI 10.1113/JP271913; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang L, 2016, ONCOGENE, V35, P867, DOI 10.1038/onc.2015.141; Wang LQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0889-7; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Wu JY, 2017, CANCER LETT, V400, P18, DOI 10.1016/j.canlet.2017.04.021; Xia XD, 2017, ATHEROSCLEROSIS, V257, P266, DOI 10.1016/j.atherosclerosis.2016.12.002; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yang HP, 2015, LUNG CANCER, V87, P249, DOI 10.1016/j.lungcan.2014.12.015	50	22	24	3	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2890	2904		10.1038/s41388-020-1189-4	http://dx.doi.org/10.1038/s41388-020-1189-4		FEB 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32029901				2022-12-26	WOS:000511540800005
J	Wressnegger, A; Prosch, H; Moser, B; Klepetko, W; Jaksch, P; Lambers, C; Hoetzenecker, K; Schestak, C; De Bettignies, A; Beer, L; Apfaltrer, G; Ringl, H; Apfaltrer, P				Wressnegger, Alexander; Prosch, Helmut; Moser, Bernhard; Klepetko, Walter; Jaksch, Peter; Lambers, Christopher; Hoetzenecker, Konrad; Schestak, Christian; De Bettignies, Albert; Beer, Lucian; Apfaltrer, Georg; Ringl, Helmut; Apfaltrer, Paul			Chest CT in patients after lung transplantation: A retrospective analysis to evaluate impact on image quality and radiation dose using spectral filtration tin-filtered imaging	PLOS ONE			English	Article							STATISTICAL ITERATIVE RECONSTRUCTION; PULMONARY NODULE DETECTION; DUAL-SOURCE CT; COMPUTED-TOMOGRAPHY; BACK-PROJECTION	Objectives The purpose of this study was to investigate the impact of a 150kV spectral filtration chest imaging protocol (Sn150kVp) combined with advanced modeled iterative reconstruction (ADMIRE) on radiation dose and image quality in patients after lung-transplantation. Methods This study included 102 patients who had unenhanced chest-CT examinations available on both, a second-generation dual-source CT (DSCT) using standard protocol (100kVp, filtered-back-projection) and, on a third-generation DSCT using Sn150kVp protocol with ADMIRE. Signal-to-noise-ratio (SNR) was measured in 6 standardized regions. A 5-point Likert scale was used to evaluate subjective image quality. Radiation metrics were compared. Results The mean time interval between the two acquisitions was 1.1 +/- 0.7 years. Mean-volume-CT-dose-index, dose-length-product and effective dose were significantly lower for Sn150kVp protocol (2.1 +/- 0.5mGy; 72.6 +/- 16.9mGy*cm; 1.3 +/- 0.3mSv) compared to 100kVp protocol (6.2 +/- 1.8mGy; 203.6 +/- 55.6mGy*cm; 3.7 +/- 1.0mSv) (p<0.001), equaling a 65% dose reduction. All studies were considered of diagnostic quality. SNR measured in lung tissue, air inside trachea, vertebral body and air outside the body was significantly higher in 100kVp protocol compared to Sn150kVp protocol (12.5 +/- 2.7vs.9.6 +/- 1.5; 17.4 +/- 3.6vs.11.8 +/- 1.8; 0.7 +/- 0.3vs.0.4 +/- 0.2; 25.2 +/- 6.9vs.14.9 +/- 3.3; p<0.001). SNR measured in muscle tissue was significantly higher in Sn150kVp protocol (3.2 +/- 0.9vs.2.6 +/- 1.0; p<0.001). For SNR measured in descending aorta there was a trend towards higher values for Sn150kVp protocol (2.8 +/- 0.6 vs. 2.7 +/- 0.9; p = 0.3). Overall SNR was significantly higher in 100kVp protocol (5.0 +/- 4.0vs.4.0 +/- 4.0; p<0.001). On subjective analysis both protocols achieved a median Likert rating of 1 (25th-75th-percentile: 1-1; p = 0.122). Interobserver agreement was good (intraclass correlation coefficient = 0.73). Conclusions Combined use of 150kVp tin-filtered chest CT protocol with ADMIRE allows for significant dose reduction while maintaining highly diagnostic image quality in the follow up after lung transplantation when compared to a standard chest CT protocol using filtered back projection.	[Wressnegger, Alexander; Prosch, Helmut; Schestak, Christian; De Bettignies, Albert; Beer, Lucian; Ringl, Helmut; Apfaltrer, Paul] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Moser, Bernhard; Klepetko, Walter; Jaksch, Peter; Lambers, Christopher; Hoetzenecker, Konrad] Med Univ Vienna, Dept Thorac Surg, Div Surg, Vienna, Austria; [Apfaltrer, Georg] Med Univ Graz, Dept Radiol, Div Pediat Radiol, Graz, Austria; [Apfaltrer, Paul] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Neuroradiol, Mannheim, Germany	Medical University of Vienna; Medical University of Vienna; Medical University of Graz; Ruprecht Karls University Heidelberg	Apfaltrer, P (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.; Apfaltrer, P (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Neuroradiol, Mannheim, Germany.	paul.apfaltrer@meduniwien.ac.at	Prosch, Helmut/A-7619-2008; Moser, Bernhard/ABA-9436-2020	Prosch, Helmut/0000-0002-6119-6364; Moser, Bernhard/0000-0002-6037-5475; Beer, Lucian/0000-0003-4388-7580; jaksch, peter/0000-0003-4635-3242	Medical Scientific Fund of the Mayor of the City of Vienna; Siemens Healthineers [FA771B1201]	Medical Scientific Fund of the Mayor of the City of Vienna; Siemens Healthineers	This study was supported by the Medical Scientific Fund of the Mayor of the City of Vienna. This study was supported by Siemens Healthineers (Grant Number: FA771B1201 to PA).	Bodelle B, 2017, PEDIATR RADIOL, V47, P831, DOI 10.1007/s00247-017-3813-1; Braun FM, 2015, EUR RADIOL, V25, P1598, DOI 10.1007/s00330-014-3559-1; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Choo JY, 2014, EUR RADIOL, V24, P799, DOI 10.1007/s00330-013-3078-5; Debray MP, 2016, EUR RADIOL, V26, P3138, DOI 10.1007/s00330-015-4126-0; Fleischmann D, 2011, EUR RADIOL, V21, P510, DOI 10.1007/s00330-011-2056-z; Gordic S, 2014, INVEST RADIOL, V49, P465, DOI 10.1097/RLI.0000000000000037; Haubenreisser H, 2015, EUR J RADIOL, V84, P1608, DOI 10.1016/j.ejrad.2015.04.018; Huda W, 2011, MED PHYS, V38, P1261, DOI 10.1118/1.3544350; Ikonen T, 1997, CHEST, V111, P370, DOI 10.1378/chest.111.2.370; Katsura M, 2013, INVEST RADIOL, V48, P206, DOI 10.1097/RLI.0b013e31827efc3a; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee S, 2011, ACTA RADIOL, V52, P1101, DOI 10.1258/ar.2011.100295; Lell MM, 2015, AM J NEURORADIOL, V36, P1225, DOI 10.3174/ajnr.A4270; Messerli M, 2017, EUR RADIOL, V27, P3290, DOI 10.1007/s00330-017-4739-6; Mitsumori LM, 2012, EUR RADIOL, V22, P138, DOI 10.1007/s00330-011-2186-3; Neroladaki A, 2013, EUR RADIOL, V23, P360, DOI 10.1007/s00330-012-2627-7; Pontana F, 2011, EUR RADIOL, V21, P627, DOI 10.1007/s00330-010-1990-5; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Prakash P, 2010, RADIOLOGY, V256, P261, DOI 10.1148/radiol.10091487; Primak AN, 2009, MED PHYS, V36, P1359, DOI 10.1118/1.3083567; Robbins HY, 2011, CLIN CHEST MED, V32, P343, DOI 10.1016/j.ccm.2011.02.011; Tang K, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/130169; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Weis M, 2017, INVEST RADIOL, V52, P155, DOI 10.1097/RLI.0000000000000325	26	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228376	10.1371/journal.pone.0228376	http://dx.doi.org/10.1371/journal.pone.0228376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023294	Green Published, gold			2022-12-26	WOS:000534621500049
J	Chen, LR; Zhang, ZR; Cao, JF				Chen, Lerui; Zhang, Zerui; Cao, Jianfu			A novel method of combining generalized frequency response function and convolutional neural network for complex system fault diagnosis	PLOS ONE			English	Article							NONLINEAR-SYSTEMS; INDUCTION-MOTORS; TRANSFORM; FUSION	To solve the problem of low accuracy in traditional fault diagnosis methods, a novel method of combining generalized frequency response function(GFRF) and convolutional neural network(CNN) is proposed. In order to accurately characterize system state information, this paper proposed a variable step size least mean square (VSSLMS) adaptive algorithm to calculate the second-order GFRF spectrum values under normal and fault states; In order to improve the ability of fault feature extraction, a convolution neural network (CNN) with gradient descent learning rate and alternate convolution layer and pooling layer is designed to extract the fault features from GFRF spectrum. In the proposed method, the second-order GFRF spectrum of each state of Permanent Magnet Synchronous Motor (PMSM) is obtained by VSSLMS; Then, the two-dimension GFRF spectrum, which is regarded as the gray value of the image,will be further transformed into image. Finally, the CNN is trained with learning rate by gradient descent way to realize the fault diagnosis of PMSM. Experimental results indicate that the accuracy of proposed method is 98.75%, which verifies the reliability of the proposed method in application of PMSM fault diagnosis.	[Chen, Lerui; Zhang, Zerui; Cao, Jianfu] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Peoples R China	Xi'an Jiaotong University	Chen, LR (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Peoples R China.	chenlerui5566@163.com		, lerui/0000-0002-5239-3454	National Natural Science Foundation (NNSF) of China [61573272]; Shaanxi Key science and technology project; Foshan science and technology project [2016AG101813]	National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC)); Shaanxi Key science and technology project; Foshan science and technology project	This work was funded by the National Natural Science Foundation (NNSF) of China [NO.61573272], Shaanxi Key science and technology project [No.2019ZDLGY01-01-02], Foshan science and technology project [No.2016AG101813].	Amirkolaee HA, 2019, REMOTE SENS LETT, V10, P679, DOI 10.1080/2150704X.2019.1601277; [Anonymous], 2014, IFAC PAPERSONLINE, DOI DOI 10.3182/20140824-6-ZA-1003.02315; Ayaz E, 2009, COMPEL, V28, P454, DOI 10.1108/03321640910929326; Banerjee TP, 2012, INFORM SCIENCES, V217, P96, DOI 10.1016/j.ins.2012.06.016; Bayma RS, 2018, AUTOMATICA, V94, P452, DOI 10.1016/j.automatica.2018.04.030; Chen HT, 2018, IEEE T VEH TECHNOL, V67, P4819, DOI 10.1109/TVT.2018.2818538; Chen LR, 2020, MEASUREMENT, V151, DOI 10.1016/j.measurement.2019.107190; Chen XW, 2019, MECH SYST SIGNAL PR, V121, P636, DOI 10.1016/j.ymssp.2018.11.049; Glowacz A, 2019, MECH SYST SIGNAL PR, V117, P65, DOI 10.1016/j.ymssp.2018.07.044; Guo YD, 2019, IEEE T PATTERN ANAL, V41, P1294, DOI 10.1109/TPAMI.2018.2837742; He JY, 2019, OPT LETT, V44, P3745, DOI 10.1364/OL.44.003745; He YG, 2019, IEEE ACCESS, V7, P92410, DOI 10.1109/ACCESS.2019.2923017; Jian XZ, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19010122; Jing XJ, 2008, INT J CONTROL, V81, P1071, DOI 10.1080/00207170701636542; Jing XJ, 2009, CIRC SYST SIGNAL PR, V28, P699, DOI 10.1007/s00034-009-9106-7; Jing XJ, 2009, J DYN SYST-T ASME, V131, DOI 10.1115/1.3211088; Kao IH, 2019, IEEE T INSTRUM MEAS, V68, P310, DOI 10.1109/TIM.2018.2847800; Garcia AM, 2019, REV IBEROAM AUTOM IN, V16, P190, DOI 10.4995/riai.2018.9767; Monfared OA, 2019, COMPEL, V38, P167, DOI 10.1108/COMPEL-11-2017-0487; Peng ZK, 2008, COMPUT STRUCT, V86, P1809, DOI 10.1016/j.compstruc.2008.01.011; Peng ZK, 2007, J SOUND VIB, V301, P777, DOI 10.1016/j.jsv.2006.10.039; Peng ZK, 2010, J APPL MECH-T ASME, V77, DOI 10.1115/1.3173604; Shao SY, 2017, CHIN J MECH ENG-EN, V30, P1347, DOI 10.1007/s10033-017-0189-y; Taher SA, 2014, SIMUL MODEL PRACT TH, V44, P26, DOI 10.1016/j.simpat.2014.02.006; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Thai V, 2019, J VIBROENG, V21, P66, DOI 10.21595/jve.2018.19859; Wang LH, 2017, CHIN J MECH ENG-EN, V30, P1357, DOI 10.1007/s10033-017-0190-5; Wang LZ, 2019, J NONDESTRUCT EVAL, V38, DOI 10.1007/s10921-019-0587-4; Wen L, 2018, IEEE T IND ELECTRON, V65, P5990, DOI 10.1109/TIE.2017.2774777; Xu GW, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19051088; Yao YC, 2018, METALL MATER TRANS B, V49, P2077, DOI 10.1007/s11663-018-1254-3; Zhang AJ, 2019, INT J REMOTE SENS, V40, P3461, DOI 10.1080/01431161.2018.1547450; Zhang JL, 2017, T I MEAS CONTROL, V39, P1017, DOI 10.1177/0142331215625766; Zhang TF, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19112504; Zhao XP, 2018, CMC-COMPUT MATER CON, V57, P223, DOI 10.32604/cmc.2018.02490	36	8	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228324	10.1371/journal.pone.0228324	http://dx.doi.org/10.1371/journal.pone.0228324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017780	Green Published, gold			2022-12-26	WOS:000534618100017
J	Staehle, HF; Heinemann, J; Gruender, A; Omlor, AM; Pahl, HL; Jutzi, JS				Staehle, Hans F.; Heinemann, Johannes; Gruender, Albert; Omlor, Anne M.; Pahl, Heike Luise; Jutzi, Jonas Samuel			Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2(V617F)-driven myeloproliferative disease initiation in mice	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; EXPRESSION; MECHANISM; BINDING; CELLS	The histone demethylase JMJD1C is overexpressed in patients with myeloproliferative neoplasms (MPNs) and has been implicated in leukemic stem cell function of MLL-AF9 and HOXA9-driven leukemia. In the emerging field of histone demethylase inhibitors, JMJD1C therefore became a potential target. Depletion of Jmjd1c expression significantly reduced cytokine-independent growth in an MPN cell line, indicating a role for JMJD1C in MPN disease maintenance. Here, we investigated a potential role for the demethylase in MPN disease initiation. We introduced a Cre-inducible JAK2(V617F) mutation into Jmjd1c knockout mice. We show that Jmjd1c is dispensable, both for healthy hematopoiesis as well as for JAK2(V617F)-driven MPN disease initiation. Jmjd1c knockout mice did not show any significant changes in peripheral blood composition. Likewise, introduction of JAK2(V617F) into Jmjd1c(-/-) mice led to a similar MPN phenotype as JAK2(V617F) in a Jmjd1c wt background. This indicates that there is a difference between the role of JMJD1C in leukemic stem cells and in MPN. In the latter, JMJC domain-containing family members may serve redundant roles, compensating for the loss of individual proteins.	[Staehle, Hans F.; Heinemann, Johannes; Gruender, Albert; Omlor, Anne M.; Pahl, Heike Luise; Jutzi, Jonas Samuel] Univ Freiburg, Univ Med Ctr Freiburg, Fac Med, Div Mol Hematol, Freiburg, Baden Wurttembe, Germany; [Jutzi, Jonas Samuel] Brigham & Womens Hosp, Harvard Inst Med, 75 Francis St, Boston, MA 02115 USA	University of Freiburg; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jutzi, JS (corresponding author), Univ Freiburg, Univ Med Ctr Freiburg, Fac Med, Div Mol Hematol, Freiburg, Baden Wurttembe, Germany.; Jutzi, JS (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, 75 Francis St, Boston, MA 02115 USA.	jjutzi@bwh.harvard.edu	Pahl, Heike/AGM-5260-2022	Jutzi, Jonas S./0000-0002-1977-153X; Staehle, Hans Felix/0000-0001-5082-0646	Deutsche Forschungsgemeinschaft [Pa 611/91, SFB 992, Ju 3104/1-1]; Excellence Initiative of the German Federal and States Governments (GSC-4, Spemann Graduate School); M.D. mentoring program MOTI-VATE - Else Kroner-Fresenius-Stiftung (EKFS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and States Governments (GSC-4, Spemann Graduate School); M.D. mentoring program MOTI-VATE - Else Kroner-Fresenius-Stiftung (EKFS)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Pa 611/91 and SFB 992, project B02, to H.L. Pahl and Ju 3104/1-1 to J.S. Jutzi). J.S. Jutzi was funded by the Excellence Initiative of the German Federal and States Governments (GSC-4, Spemann Graduate School). H.F.S. was supported by the M.D. mentoring program MOTI-VATE funded by the Else Kroner-Fresenius-Stiftung (EKFS).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Chen M, 2015, GENE DEV, V29, P2123, DOI 10.1101/gad.267278.115; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Hasan S, 2013, BLOOD, V122, P1464, DOI 10.1182/blood-2013-04-498956; Katoh M, 2007, INT J ONCOL, V31, P219; Kaufmann KB, 2012, J EXP MED, V209, P35, DOI 10.1084/jem.20110540; Luo D, 2017, P NATL ACAD SCI USA, V114, pE3071, DOI 10.1073/pnas.1613592114; Magliulo D, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00255; Nervi C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0157-2; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Peeken JC, 2018, BLOOD, V131, P2065, DOI 10.1182/blood-2017-10-810622; Xu X., 2019, CHINA INDUS EC, P5, DOI [10.19581/j.cnki.ciejournal.2019.04.001, DOI 10.19581/J.CNKI.CIEJOURNAL.2019.04.001]; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zhu N, 2016, J CLIN INVEST, V126, P997, DOI 10.1172/JCI82978	14	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228362	10.1371/journal.pone.0228362	http://dx.doi.org/10.1371/journal.pone.0228362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017785	Green Published, Green Submitted, gold			2022-12-26	WOS:000534618100020
J	Arrebola-Moreno, M; Petrova, D; Sanchez, MJ; Rivera-Lopez, R; Ramirez-Hernandez, JA				Arrebola-Moreno, Mercedes; Petrova, Dafina; Sanchez, Maria-Jose; Rivera-Lopez, Ricardo; Antonio Ramirez-Hernandez, Jose			Who does what the cardiologist recommends? Psychosocial markers of unhealthy behavior in coronary disease patients	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK-FACTORS; HEART-DISEASE; SOCIAL SUPPORT; CARDIAC REHABILITATION; PHYSICAL-ACTIVITY; DEPRESSION; HEALTH; ASSOCIATION; MANAGEMENT	Patients diagnosed with coronary heart disease should follow lifestyle recommendations that can reduce their cardiovascular risk (e.g., avoid smoking). However, some patients fail to follow these recommendations and engage in unhealthy behavior. With the aim to identify psychosocial factors that characterize patients at high risk of repeated cardiovascular events, we investigated the relationship between social support, mental health (coping, self-esteem, and perceived stress), and unhealthy behavior. We conducted a cross-sectional study of 419 patients recently diagnosed with coronary heart disease (myocardial infarction or angina) who participated in the National Health Survey in Spain (2018). Unhealthy behaviors were defined according to the European Guidelines on cardiovascular disease prevention. Only 1% of patients reported no unhealthy behaviors, with 11% reporting one, 40% two, 35% three, and 13% four or more unhealthy behaviors. In multiple regression controlling for demographic and traditional risk factors, mental health was the only significant psychosocial factor, doubling the odds of accumulated unhealthy behaviors, OR(high vs. low) = 2.03, 95% CI [1.14, 3.64]. Mental health was especially strongly related to unhealthy behavior among patients with obesity, OR(high vs. low) = 3.50, 95% CI [1.49, 8.45]. The relationship between mental health and unhealthy behaviors suggests that a large proportion of patients may not adhere to lifestyle recommendations not because they purposefully choose to do so, but because they lack coping skills to maintain the recommended healthy behaviors. Low mental well-being may be especially detrimental for behavior change of patients with obesity.	[Arrebola-Moreno, Mercedes] Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain; [Petrova, Dafina; Sanchez, Maria-Jose] Escuela Andaluza Salud Publ, Granada, Spain; [Petrova, Dafina; Sanchez, Maria-Jose; Rivera-Lopez, Ricardo; Antonio Ramirez-Hernandez, Jose] Inst Invest Biosanitaria Ibs GRANADA, Granada, Spain; [Petrova, Dafina; Sanchez, Maria-Jose] GIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Sanchez, Maria-Jose] Univ Granada, Granada, Spain; [Rivera-Lopez, Ricardo; Antonio Ramirez-Hernandez, Jose] Virgen de las Nieves Univ Hosp, Cardiol Dept, Granada, Spain	University of Granada; Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Granada; Hospital Universitario Virgen de las Nieves	Petrova, D (corresponding author), Escuela Andaluza Salud Publ, Granada, Spain.; Petrova, D (corresponding author), Inst Invest Biosanitaria Ibs GRANADA, Granada, Spain.; Petrova, D (corresponding author), GIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	dafina.petrova.easp@juntadeandalucia.es		Petrova, Dafina/0000-0002-0346-6776; Rivera-Lopez, Ricardo/0000-0002-0787-9383	Juan de la Cierva Fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness [FJCI-2016-28279]	Juan de la Cierva Fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness	Dafina Petrova is supported by a Juan de la Cierva Fellowship (FJCI-2016-28279) from the Spanish Ministry of Economy, Industry, and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades PA, 2017, PREV MED, V104, P117, DOI 10.1016/j.ypmed.2017.04.013; Arrebola-Moreno AL, 2014, INT J CLIN HLTH PSYC, V14, P111, DOI 10.1016/S1697-2600(14)70044-4; Balady GJ, 2007, CIRCULATION, V115, P2675, DOI 10.1161/CIRCULATIONAHA.106.180945; Barth J, 2010, PSYCHOSOM MED, V72, P229, DOI 10.1097/PSY.0b013e3181d01611; Bellon Saameno J A, 1996, Aten Primaria, V18, P153; Bellon Saameno JA, 1996, ATEN PRIM, V18, P158; Bjarnason-Wehrens B, 2010, EUR J CARDIOV PREV R, V17, P410, DOI 10.1097/HJR.0b013e328334f42d; Cohen BE, 2015, AM J HYPERTENS, V28, P1295, DOI 10.1093/ajh/hpv047; De Smedt D, 2016, INT J CARDIOL, V209, P284, DOI 10.1016/j.ijcard.2016.02.015; Debnam K, 2012, J BEHAV MED, V35, P179, DOI 10.1007/s10865-011-9338-4; Domingo-Salvany A, 2013, GAC SANIT, V27, P263, DOI 10.1016/j.gaceta.2012.12.009; Frasure-Smith N, 2000, CIRCULATION, V101, P1919, DOI 10.1161/01.CIR.101.16.1919; French DP, 2006, J PSYCHOSOM RES, V61, P757, DOI 10.1016/j.jpsychores.2006.07.029; Gan Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0371-z; Garcia-Retamero R, 2016, BRIT J HEALTH PSYCH, V21, P694, DOI 10.1111/bjhp.12196; Graciani A, 2013, CIRC-CARDIOVASC QUAL, V6, P90, DOI 10.1161/CIRCOUTCOMES.112.967893; Graven LJ, 2014, INT J NURS STUD, V51, P320, DOI 10.1016/j.ijnurstu.2013.06.013; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Guallar-Castillon P, 2004, MED CLIN-BARCELONA, V123, P606, DOI 10.1157/13068435; Harvey SB, 2018, AM J PSYCHIAT, V175, P28, DOI 10.1176/appi.ajp.2017.16111223; Hwang WJ, 2015, ASIA-PAC J PUBLIC HE, V27, pNP691, DOI 10.1177/1010539513500338; Janssen V, 2013, EUR J PREV CARDIOL, V20, P620, DOI 10.1177/2047487312462824; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Kronish IM, 2006, J GEN INTERN MED, V21, P1178, DOI 10.1111/j.1525-1497.2006.00586.x; Leifheit-Limson EC, 2012, J PSYCHOSOM RES, V73, P35, DOI 10.1016/j.jpsychores.2012.04.006; Manfredini R, 2017, J WOMENS HEALTH, V26, P624, DOI 10.1089/jwh.2016.6103; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murray J, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-120; National Statistics Institute of Spain, 2017, DEATHS ACC CAUS DEAT; Neubeck L, 2012, EUR J PREV CARDIOL, V19, P494, DOI 10.1177/1741826711409326; Petrova D, 2015, PREV MED, V81, P202, DOI 10.1016/j.ypmed.2015.09.002; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Resurreccion DM, 2019, EUR J CARDIOVASC NUR, V18, P38, DOI 10.1177/1474515118783157; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Sanchez-Lopez MP, 2008, PSICOTHEMA, V20, P839; Scholz U, 2006, SOC SCI MED, V62, P3109, DOI 10.1016/j.socscimed.2005.11.035; Siegrist J, 2006, SCAND J WORK ENV HEA, V32, P473, DOI 10.5271/sjweh.1052; Sniehotta FF, 2006, BRIT J HEALTH PSYCH, V11, P23, DOI 10.1348/135910705X43804; Spanish Ministry of Health Social Services and Equality National Statistical Institute of Spain, 2018, NAT HLTH SURV 2017 M; Theorell T, 2016, EUR J PUBLIC HEALTH, V26, P470, DOI 10.1093/eurpub/ckw025; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; Wilkins E., 2017, EUROPEAN CARDIOVASCU; Zhao M, 2017, HEART, V103, P1587, DOI 10.1136/heartjnl-2017-311429; Zou HJ, 2017, J CARDIOVASC NURS, V32, P331, DOI 10.1097/JCN.0000000000000357	47	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228262	10.1371/journal.pone.0228262	http://dx.doi.org/10.1371/journal.pone.0228262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CX	32004332	Green Published, gold			2022-12-26	WOS:000534614600030
J	Charland-Verville, V; de Paula, DR; Martial, C; Cassol, H; Antonopoulos, G; Chronik, BA; Soddu, A; Laureys, S				Charland-Verville, Vanessa; de Paula, Demetrius Ribeiro; Martial, Charlotte; Cassol, Helena; Antonopoulos, Georgios; Chronik, Blaine Alexander; Soddu, Andrea; Laureys, Steven			Characterization of near death experiences using text mining analyses: A preliminary study	PLOS ONE			English	Article							CONSCIOUSNESS; SURVIVORS; FEATURES; ACCOUNTS; MODELS; SCALE	The notion that death represents a passing to an afterlife, where we are reunited with loved ones and live eternally in a utopian paradise, is common in the reports of people who have encountered a "Near-Death Experience" (NDE). NDEs are thoroughly portrayed by the media but empirical studies are rather recent. The definition of the phenomenon as well as the identification of NDE experiencers is still a matter of debate. To date, NDEs' identification and description in studies have mostly derived from answered items in questionnaires. However, questionnaires' content could be restricting and subject to personal interpretation. We believe that in addition to their use, user-independent statistical text examination of freely expressed NDEs narratives is of prior importance to help capture the phenomenology of such a subjective and complex phenomenon. Towards that aim, we included 158 participants with a firsthand retrospective narrative of their self-reported NDE that we analyzed using an automated text-mining method. The output revealed the top words expressed by experiencers. In a second step, a hierarchical clustering analysis was conducted to visualize the relationships between these words. It revealed three main clusters of features: visual perceptions, emotions and spatial components. We believe the user-independent and data-driven text mining approach used in this study is promising by contributing to the building a rigorous description and definition of NDEs.	[Charland-Verville, Vanessa; de Paula, Demetrius Ribeiro; Martial, Charlotte; Cassol, Helena; Antonopoulos, Georgios; Laureys, Steven] Univ Liege, GIGA Consciousness, Coma Sci Grp, Liege, Belgium; [Charland-Verville, Vanessa; de Paula, Demetrius Ribeiro; Martial, Charlotte; Cassol, Helena; Antonopoulos, Georgios; Laureys, Steven] Univ Hosp Liege, Liege, Belgium; [de Paula, Demetrius Ribeiro; Chronik, Blaine Alexander; Soddu, Andrea] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [de Paula, Demetrius Ribeiro; Chronik, Blaine Alexander; Soddu, Andrea] Western Univ, Dept Phys & Astron, London, ON, Canada	University of Liege; University of Liege; Western University (University of Western Ontario); Western University (University of Western Ontario)	Charland-Verville, V (corresponding author), Univ Liege, GIGA Consciousness, Coma Sci Grp, Liege, Belgium.; Charland-Verville, V (corresponding author), Univ Hosp Liege, Liege, Belgium.	vanessa.charland-verville@ulg.ac.be	Martial, Charlotte/O-6703-2016; Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011; Ribeiro de Paula, Demetrius/C-4728-2015	Martial, Charlotte/0000-0001-6291-3460; Laureys, Steven/0000-0002-3096-3807; Ribeiro de Paula, Demetrius/0000-0003-0590-8694	Belgian Funds for Scientific Research (FRS-FNRS); NSERC of Canada; European Commission; Luminous; Center-TBI; Human Brain Project; James McDonnell Foundation; European Space Agency; Belspo; Fondazione Europea di Ricerca Biomedica; BIAL Foundation; Wallonia-Brussels Federation Concerted Research Action; Mind Science Foundation	Belgian Funds for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Luminous; Center-TBI; Human Brain Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); James McDonnell Foundation; European Space Agency(European Space AgencyEuropean Commission); Belspo(Belgian Federal Science Policy Office); Fondazione Europea di Ricerca Biomedica; BIAL Foundation(Bial Foundation); Wallonia-Brussels Federation Concerted Research Action; Mind Science Foundation	This research was supported by the Belgian Funds for Scientific Research (FRS-FNRS), the NSERC of Canada discovery grant, European Commission, Luminous, Center-TBI, Human Brain Project, James McDonnell Foundation, European Space Agency, Belspo, "Fondazione Europea di Ricerca Biomedica", BIAL Foundation, Wallonia-Brussels Federation Concerted Research Action and Mind Science Foundation.	Athappilly GK, 2006, J NERV MENT DIS, V194, P218, DOI 10.1097/01.nmd.0000202513.65079.1e; Beauregard M, 2009, RESUSCITATION, V80, P1006, DOI 10.1016/j.resuscitation.2009.05.006; Belanti J, 2008, TRANSCULT PSYCHIATRY, V45, P121, DOI 10.1177/1363461507088001; Bianco S, 2017, DEATH STUD, V41, P562, DOI 10.1080/07481187.2017.1310768; Bush N.E., 2002, J NEAR DEATH STUDIES, V21, P99, DOI DOI 10.1023/A:1021223618666; Cassol H, 2019, NEUROSCI CONSCIOUS, V5, DOI 10.1093/nc/niz002; Cassol H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193001; Chandradasa M, 2018, J RELIG HEALTH, V57, P1599, DOI 10.1007/s10943-017-0442-9; Charland-Verville V, 2015, CONSCIOUS COGN, V34, P28, DOI 10.1016/j.concog.2015.03.011; Charland-Verville V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00203; Facco E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00490; Feinerer I, 2008, J STAT SOFTW, V25, P1; Feldman R., 2007, TEXT MINING HDB ADV; Gohil S, 2018, JMIR PUBLIC HLTH SUR, V4, P72, DOI 10.2196/publichealth.5789; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; GREYSON B, 1992, PSYCHIATRY, V55, P95; Greyson B, 2003, GEN HOSP PSYCHIAT, V25, P269, DOI 10.1016/S0163-8343(03)00042-2; GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007; Greyson B, 1997, J NERV MENT DIS, V185, P327, DOI 10.1097/00005053-199705000-00007; Greyson B., 1990, J NEAR DEATH STUD, V8, P151, DOI [DOI 10.1007/BF01074000, 10.1007/BF01074000]; Greyson B, 2007, RESUSCITATION, V73, P407, DOI 10.1016/j.resuscitation.2006.10.013; Greyson B, 2006, ZYGON, V41, P393, DOI 10.1111/j.1467-9744.2005.00745.x; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; He QW, 2012, PSYCHIAT RES, V198, P441, DOI 10.1016/j.psychres.2012.01.032; Hou YM, 2013, ANN INDIAN ACAD NEUR, V16, P75, DOI 10.4103/0972-2327.107715; Jansen KL, 1996, YB ETHNOMEDICINE STU, P51; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; KELLEHEAR A, 1993, J NERV MENT DIS, V181, P148, DOI 10.1097/00005053-199303000-00002; Kulkarni MUP, 2013, INT J ENG EXT TECHNO, V1; Lai CF, 2007, AM J KIDNEY DIS, V50, P124, DOI 10.1053/j.ajkd.2007.04.021; LANCE GN, 1967, COMPUT J, V10, P271, DOI 10.1093/comjnl/10.3.271; Lange R, 2004, BRIT J PSYCHOL, V95, P161, DOI 10.1348/000712604773952403; Lange R., 2015, Psychology of Consciousness, V2, P79, DOI DOI 10.1037/cns0000040; LEMPERT T, 1994, LANCET, V344, P829, DOI 10.1016/S0140-6736(94)92389-2; Maher Komal, 2016, INT J COMPUTER SCI I, V7, P1715; Martial C, 2019, CONSCIOUS COGN, V69, P52, DOI 10.1016/j.concog.2019.01.011; Martial C, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00311; Martial C, 2018, PSYCHOL RES-PSYCH FO, V82, P806, DOI 10.1007/s00426-017-0855-9; Michael W. B., 2003, SURVEY TEXT MINING C; Moody R.A., 1975, LIFE LIFE; Nelson KR, 2007, NEUROLOGY, V68, P794, DOI 10.1212/01.wnl.0000256784.85952.6f; Nelson KR, 2014, ANN NY ACAD SCI, V1330, P111, DOI 10.1111/nyas.12576; Nelson KR, 2006, NEUROLOGY, V66, P1003, DOI 10.1212/01.wnl.0000204296.15607.37; Palmieri A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00429; Parnia S, 2007, RESUSCITATION, V74, P215, DOI 10.1016/j.resuscitation.2007.01.020; Posner JB, 2007, PLUM POSNERS DIAGNOS; Ring K., 1984, HEADING OMEGA IIN SE; Sabom M. B., 1982, RECOLLECTIONS DEATH; Sarasso S, 2015, CURR BIOL, V25, P3099, DOI 10.1016/j.cub.2015.10.014; Schwaninger J., 2002, J NEAR DEATH STUD, V20, P215, DOI [10.1023/A:1015258818660, DOI 10.1023/A:1015258818660]; Schwartz S, 2002, TRENDS COGN SCI, V6, P23, DOI 10.1016/S1364-6613(00)01818-0; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Thonnard M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057620; Trusko B, 2010, J TRAUMA STRESS, V23, P794, DOI 10.1002/jts.20591; van Lommel P, 2001, LANCET, V358, P2039, DOI 10.1016/S0140-6736(01)07100-8; Vanhaudenhuyse A, 2009, YEARB INTENSIVE CARE, P961, DOI 10.1007/978-3-540-92276-6_85; Wajeed M. A., 2011, 2011 2nd International Conference on Computer and Communication Technology, P41, DOI 10.1109/ICCCT.2011.6075188; Zhu YJ, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0498-1	59	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227402	10.1371/journal.pone.0227402	http://dx.doi.org/10.1371/journal.pone.0227402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999716	Green Published, gold, Green Submitted			2022-12-26	WOS:000534612400016
J	Defne, Z; Aretxabaleta, AL; Ganju, NK; Kalra, TS; Jones, DK; Smith, KEL				Defne, Zafer; Aretxabaleta, Alfredo L.; Ganju, Neil K.; Kalra, Tarandeep S.; Jones, Daniel K.; Smith, Kathryn E. L.			A geospatially resolved wetland vulnerability index: Synthesis of physical drivers	PLOS ONE			English	Article							SALT-MARSH DIEBACK; PRINCIPAL-COMPONENTS; COASTAL WETLANDS; BARNEGAT BAY; ESTUARY; RESTORATION; RESILIENCE; TOXICITY; DROUGHT; SURFACE	Assessing wetland vulnerability to chronic and episodic physical drivers is fundamental for establishing restoration priorities. We synthesized multiple data sets from E.B. Forsythe National Wildlife Refuge, New Jersey, to establish a wetland vulnerability metric that integrates a range of physical processes, anthropogenic impact and physical/biophysical features. The geospatial data are based on aerial imagery, remote sensing, regulatory information, and hydrodynamic modeling; and include elevation, tidal range, unvegetated to vegetated marsh ratio (UVVR), shoreline erosion, potential exposure to contaminants, residence time, marsh condition change, change in salinity, salinity exposure and sediment concentration. First, we delineated the wetland complex into individual marsh units based on surface contours, and then defined a wetland vulnerability index that combined contributions from all parameters. We applied principal component and cluster analyses to explore the interrelations between the data layers, and separate regions that exhibited common characteristics. Our analysis shows that the spatial variation of vulnerability in this domain cannot be explained satisfactorily by a smaller subset of the variables. The most influential factor on the vulnerability index was the combined effect of elevation, tide range, residence time, and UVVR. Tide range and residence time had the highest correlation, and similar bay-wide spatial variation. Some variables (e.g., shoreline erosion) had no significant correlation with the rest of the variables. The aggregated index based on the complete dataset allows us to assess the overall state of a given marsh unit and quickly locate the most vulnerable units in a larger marsh complex. The application of geospatially complete datasets and consideration of chronic and episodic physical drivers represents an advance over traditional point-based methods for wetland assessment.	[Defne, Zafer; Aretxabaleta, Alfredo L.; Ganju, Neil K.] US Geol Survey, Woods Hole Coastal & Marine Sci Ctr, Woods Hole, MA 02543 USA; [Kalra, Tarandeep S.] US Geol Survey, Integrated Stat, Woods Hole, MA 02543 USA; [Jones, Daniel K.] US Geol Survey, Utah Water Sci Ctr, Salt Lake City, UT USA; [Smith, Kathryn E. L.] US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Defne, Z (corresponding author), US Geol Survey, Woods Hole Coastal & Marine Sci Ctr, Woods Hole, MA 02543 USA.	zdefne@usgs.gov	Aretxabaleta, Alfredo/H-6566-2019; Daniel, Jones/ABD-5429-2020	Aretxabaleta, Alfredo/0000-0002-9914-8018; Daniel, Jones/0000-0003-0724-8001; Smith, Kathryn/0000-0002-7521-7875; Kalra, Tarandeep/0000-0001-5468-248X	Department of the Interior Hurricane Sandy Recovery program [GS2-2D]; U.S. Geological Survey, Coastal and Marine Hazards/Resources Program	Department of the Interior Hurricane Sandy Recovery program; U.S. Geological Survey, Coastal and Marine Hazards/Resources Program	This study was part of the Estuarine Physical Response to Storms project (GS2-2D awarded to NKG), supported by the Department of the Interior Hurricane Sandy Recovery program. Support was also provided by the U.S. Geological Survey, Coastal and Marine Hazards/Resources Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abson DJ, 2012, APPL GEOGR, V35, P515, DOI 10.1016/j.apgeog.2012.08.004; Alber M, 2008, ESTUAR COAST SHELF S, V80, P1, DOI 10.1016/j.ecss.2008.08.009; Alizad K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205176; Allen S.T., 2018, ECOLOGICAL RESILIENC, P53; [Anonymous], 2013, 20131163 US GEOL SUR; Aretxabaleta AL, 2013, J MARINE SYST, V119, P11, DOI 10.1016/j.jmarsys.2013.03.001; Baker R.J., 2014, CONCENTRATIONS LOADS; Blake ES., 2013, NATL HURRICANE CTR, V12, P1; Cahoon D.R., 2010, NATL WETLANDS NEWSLE, V32, P8; Couvillion BR, 2016, WETLANDS, V36, P347, DOI 10.1007/s13157-016-0744-9; Cui LF, 2015, ESTUAR COAST SHELF S, V156, P42, DOI 10.1016/j.ecss.2014.06.015; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; Defne Z, 2014, HYDRODYNAMIC MODELIN; Defne Z, 2015, ESTUAR COAST, V38, P1719, DOI 10.1007/s12237-014-9885-3; Desianti N, 2017, J COASTAL RES, P127, DOI [10.2112/SI78-011.1, 10.2112/si78-011.1]; Ganju NK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14156; Ganju NK, 2015, GEOPHYS RES LETT, V42, P7992, DOI 10.1002/2015GL065980; Gutierrez BT, 2011, J GEOPHYS RES-EARTH, V116, DOI [10.1029/20101F001891, 10.1029/2010JF001891]; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00181.1; HARDISKY MA, 1986, BIOSCIENCE, V36, P453, DOI 10.2307/1310341; Hopper T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163495; Hou K, 2015, INT J ENV RES PUB HE, V12, P4292, DOI 10.3390/ijerph120404292; Houseago-Stokes RE, 2004, J ATMOS OCEAN TECH, V21, P1471, DOI 10.1175/1520-0426(2004)021<1471:UPTEEI>2.0.CO;2; Hughes ALH, 2012, ESTUAR COAST SHELF S, V111, P95, DOI 10.1016/j.ecss.2012.06.016; Jaiteh M., 2014, MALI CLIMATE VULNERA; Jollands N, 2004, J ENVIRON MANAGE, V73, P293, DOI 10.1016/j.jenvman.2004.07.002; Kennish MJ, 2007, ECOL APPL, V17, pS3, DOI 10.1890/05-0800.1; Kirwan M, 2009, QUATERNARY SCI REV, V28, P1801, DOI 10.1016/j.quascirev.2009.02.022; Kirwan ML, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001400; Klemas V, 2013, INT J REMOTE SENS, V34, P6286, DOI 10.1080/01431161.2013.800656; Leonardi N, 2018, GEOMORPHOLOGY, V301, P92, DOI 10.1016/j.geomorph.2017.11.001; Manly B.F.J., 1994, MULTIVARIATE STAT ME; MCKEE KL, 1988, ESTUARIES, V11, P143, DOI 10.2307/1351966; McKee KL, 2004, GLOBAL ECOL BIOGEOGR, V13, P65, DOI 10.1111/j.1466-882X.2004.00075.x; Mo Y, 2015, ECOL MODEL, V312, P191, DOI 10.1016/j.ecolmodel.2015.05.022; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Nagel JL, 2018, ESTUAR COAST, V41, P334, DOI 10.1007/s12237-017-0293-3; Neeson TM, 2016, ECOL APPL, V26, P1785, DOI 10.1890/15-0948.1; Nestlerode JA, 2014, ENVIRON MONIT ASSESS, V186, P3477, DOI 10.1007/s10661-014-3631-y; Olsen GH, 2013, MAR ENVIRON RES, V90, P9, DOI 10.1016/j.marenvres.2013.05.007; Pendleton EA, 2010, J COASTAL RES, V26, P176, DOI 10.2112/08-1102.1; Rangoonwala A, 2016, INT J REMOTE SENS, V37, P1692, DOI 10.1080/01431161.2016.1163748; Raposa KB, 2016, BIOL CONSERV, V204, P263, DOI 10.1016/j.biocon.2016.10.015; Reilly TJ, 2015, STRATEGY EVALUATE PE; Rodriguez-Lopez M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178528; Rogers K, 2014, ESTUAR COAST SHELF S, V149, P46, DOI 10.1016/j.ecss.2014.07.009; Romanok KM, 2016, MAR POLLUT BULL, V107, P472, DOI 10.1016/j.marpolbul.2016.04.018; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sharma S., 1996, APPL MULTIVARIATE TE; Smith KW, 2007, NONLINEAR PROC GEOPH, V14, P73, DOI 10.5194/npg-14-73-2007; Stagg CL, 2011, ECOL APPL, V21, P1731, DOI 10.1890/09-2128.1; Staszak LA, 2013, J COASTAL RES, V29, P410, DOI 10.2112/JCOASTRES-D-12-00075.1; STUMPF RP, 1983, ESTUAR COAST SHELF S, V17, P495, DOI 10.1016/0272-7714(83)90002-1; Thieler E.R., 1990, US GEOLOGICAL SURVEY, P99, DOI 10.3133/ofr99593; Valle S, 1999, IND ENG CHEM RES, V38, P4389, DOI 10.1021/ie990110i; Webb EL, 2013, NAT CLIM CHANGE, V3, P458, DOI [10.1038/NCLIMATE1756, 10.1038/nclimate1756]; Wilson CA, 2014, GEOMORPHOLOGY, V213, P99, DOI 10.1016/j.geomorph.2014.01.002; Zhou C., 2018, SEA LEVEL RISE COAST, P61, DOI DOI 10.5772/INTECHOPEN.73509	59	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228504	10.1371/journal.pone.0228504	http://dx.doi.org/10.1371/journal.pone.0228504			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999806	Green Published, gold			2022-12-26	WOS:000534612400092
J	Surleac, M; Barbu, IC; Paraschiv, S; Popa, LI; Gheorghe, I; Marutescu, L; Popa, M; Sarbu, I; Talapan, D; Nita, M; Iancu, AV; Arbune, M; Manole, A; Nicolescu, S; Sandulescu, O; Streinu-Cercel, A; Otelea, D; Chifiriuc, MC				Surleac, Marius; Barbu, Ilda Czobor; Paraschiv, Simona; Popa, Laura Ioana; Gheorghe, Irina; Marutescu, Luminita; Popa, Marcela; Sarbu, Ionela; Talapan, Daniela; Nita, Mihai; Iancu, Alina Viorica; Arbune, Manuela; Manole, Alina; Nicolescu, Serban; Sandulescu, Oana; Streinu-Cercel, Adrian; Otelea, Dan; Chifiriuc, Mariana Carmen			Whole genome sequencing snapshot of multi-drug resistant Klebsiella pneumoniae strains from hospitals and receiving wastewater treatment plants in Southern Romania	PLOS ONE			English	Article							CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE; CLASS 1 INTEGRON; ESCHERICHIA-COLI; EMERGENCE; SUSCEPTIBILITY; GENES; EPIDEMIOLOGY; FOSFOMYCIN; TRACKING; OXA-162	We report on the genomic characterization of 47 multi-drug resistant, carbapenem resistant and ESBL-producing K. pneumoniae isolates from the influent (I) and effluent (E) of three wastewater treatment plants (WWTPs) and from Romanian hospital units which are discharging the wastewater in the sampled WWTPs. The K. pneumoniae whole genome sequences were analyzed for antibiotic resistance genes (ARGs), virulence genes and sequence types (STs) in order to compare their distribution in C, I and E samples. Both clinical and environmental samples harbored prevalent and widely distributed ESBL genes, i.e. blaSHV, bla(OXA), bla(TEM) and bla(CTX M). The most prevalent carbapenemase genes were bla(NDM-1), bla(OXA-48) and bla(KPC-2). They were found in all types of isolates, while bla(OXA-162), a rare blaOXA-48 variant, was found exclusively in water samples. A higher diversity of carbapenemases genes was seen in wastewater isolates. The aminoglycoside modifying enzymes (AME) genes found in all types of samples were aac(6'), ant(2'')Ia, aph(3'), aaD, aac(3) and aph(6). Quinolone resistance gene qnrS1 and the multi-drug resistance oqxA/B pump gene were found in all samples, while qnrD and qnrB were associated to aquatic isolates. The antiseptics resistance gene qacEdelta1 was found in all samples, while qacE was detected exclusively in the clinical ones. Trimethroprim-sulfamethoxazole (dfrA, sul1 and sul2), tetracyclines (tetA and tetD) and fosfomycin (fosA6, known to be located on a transpozon) resistance genes were found in all samples, while for choramphenicol and macrolides some ARGs were detected in all samples (catA1 and catB3 / mphA), while other (catA2, cmIA5 and aac(6')Ib / mphE and msrE) only in wastewater samples. The rifampin resistance genes arr2 and 3 (both carried by class I integrons) were detected only in water samples. The highly prevalent ARGs preferentially associating with aquatic versus clinical samples could ascribe potential markers for the aquatic (blaSHV-145, qacEdelta1, sul1, aadA1, aadA2) and clinical (bla(OXA-1), bla(SHV-106),bla(TEM-150), aac(3)Iia, dfrA14, oqxA10; oqxB17,catB3, tetD) reservoirs of AR. Moreover, some ARGs (oqxA10; blaSHV-145; blaSHV-100, aac(6')Il, aph(3') VI, armA, arr2, cmlA5, blaCMY-4, mphE, msrE, oqxB13, blaOXA-10) showing decreased prevalence in influent versus effluent wastewater samples could be used as markers for the efficiency of the WWTPs in eliminating AR bacteria and ARGs. The highest number of virulence genes (75) was recorded for the I samples, while for E and C samples it was reduced to half. The most prevalent belong to three functional groups: adherence (fim genes), iron acquisition (ent, fep, fyu, irp and ybt genes) and the secretion system (omp genes). However, none of the genes associated with hypervirulent K. pneumoniae have been found. A total of 14 STs were identified. The most prevalent clones were ST101, ST219 in clinical samples and ST258, ST395 in aquatic isolates. These STs were also the most frequently associated with integrons. ST45 and ST485 were exclusively associated with I samples, ST11, ST35, ST364 with E and ST1564 with C samples. The less frequent ST17 and ST307 aquatic isolates harbored blaOXA-162, which was co-expressed in our strains with bla(CTX-M-15) and bla(OXA-1).	[Surleac, Marius; Paraschiv, Simona; Talapan, Daniela; Sandulescu, Oana; Streinu-Cercel, Adrian; Otelea, Dan] Natl Inst Infect Dis Matei Bals, Bucharest, Romania; [Surleac, Marius] Romanian Acad, Inst Biochem, Bucharest, Romania; [Barbu, Ilda Czobor; Popa, Laura Ioana; Gheorghe, Irina; Marutescu, Luminita; Popa, Marcela; Sarbu, Ionela; Chifiriuc, Mariana Carmen] Univ Bucharest, Res Inst, Bucharest, Romania; [Popa, Laura Ioana; Manole, Alina; Chifiriuc, Mariana Carmen] Univ Bucharest, Fac Biol, Dept Bot & Microbiol, Bucharest, Romania; [Popa, Laura Ioana] Natl Inst Res & Dev Biol Sci, Bucharest, Romania; [Gheorghe, Irina; Marutescu, Luminita; Sandulescu, Oana; Streinu-Cercel, Adrian] Univ Med & Pharm Carol Davila, Bucharest, Romania; [Sarbu, Ionela] Univ Bucharest, Fac Biol, Dept Genet, Bucharest, Romania; [Nita, Mihai] Natl Inst R&D Ind Ecol ECOIND, Bucharest, Romania; [Iancu, Alina Viorica; Arbune, Manuela] Infect Dis Hosp Galati, Galati, Romania; [Iancu, Alina Viorica; Arbune, Manuela] Univ Galatzi, Fac Med & Pharm Dunarea de Jos, Galati, Romania; [Nicolescu, Serban] Targoviste Cty Hosp, Targoviste, Romania	National Institute for Infectious Diseases "Matei Bals"; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; University of Bucharest; University of Bucharest; National Research Institute for Biological Sciences; Carol Davila University of Medicine & Pharmacy; University of Bucharest; Dunarea De Jos University Galati	Otelea, D (corresponding author), Natl Inst Infect Dis Matei Bals, Bucharest, Romania.	dotelea@mateibals.ro	Popa, Laura Ioana/AAA-5121-2020; Paraschiv, Simona/AAW-5691-2021; Otelea, Dan/AAV-6467-2021; Barbu, Ilda/N-5161-2015; Surleac, Marius D/C-6182-2017; AVRAM (SARBU), IONELA/A-2891-2014; Arbune, Manuela C/C-1258-2015; Sandulescu, Oana/M-6242-2017; Streinu-Cercel, Adrian/M-5835-2017; Mihai, Nita-Lazar/Q-2206-2016; Talapan, Daniela/AAM-3515-2021; Chifiriuc, Mariana Carmen/AFP-0825-2022; Paraschiv, Simona/N-6991-2015	Barbu, Ilda/0000-0001-5921-7632; Surleac, Marius D/0000-0003-3218-4644; AVRAM (SARBU), IONELA/0000-0002-9171-0846; Arbune, Manuela C/0000-0002-4762-0755; Sandulescu, Oana/0000-0002-2586-4070; Streinu-Cercel, Adrian/0000-0001-6382-5067; Mihai, Nita-Lazar/0000-0002-5099-1311; Talapan, Daniela/0000-0001-5202-8417; Chifiriuc, Mariana Carmen/0000-0001-6098-1857; Paraschiv, Simona/0000-0001-6707-3720; Popa, Laura/0000-0001-6446-737X; Otelea, Dan/0000-0002-0821-6346	Romanian Executive Agency for Higher Education, Research, Development and Inovation (UEFISCDI) [PN-III-P4-IDPCCF-2016-0114, ERANET-JPI-EC-AMR-AWARE-WWTP, PN-III-P11.1-PD-2016-2137 (PD 113/2018), PN-III-P11.1-PD-2016-1798 (PD 148/2018)]; program CRCBABI project [642/2014]	Romanian Executive Agency for Higher Education, Research, Development and Inovation (UEFISCDI)(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); program CRCBABI project	This study was supported by the Romanian Executive Agency for Higher Education, Research, Development and Inovation (UEFISCDI) (https://uefiscdi.gov.ro/) research project PN-III-P4-IDPCCF-2016-0114 POSCCE (RADAR). It was also partially supported by program CRCBABI project (642/2014) implemented in the National Institute for Infectious diseases "Matei Bals" and by ERANET-JPI-EC-AMR-AWARE-WWTP, PN-III-P11.1-PD-2016-2137 (PD 113/2018) and PN-III-P11.1-PD-2016-1798 (PD 148/2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Baloushi AE, 2018, ACTA MICROBIOL IMM H, V65, P135, DOI 10.1556/030.65.2018.005; Alouache S, 2014, MICROB DRUG RESIST, V20, P30, DOI 10.1089/mdr.2012.0264; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anssour L, 2016, J INFECT DEV COUNTR, V10, P728, DOI 10.3855/jidc.6727; Arlet G, 2001, ANTIMICROB AGENTS CH, V45, P2971, DOI 10.1128/AAC.45.10.2971-2972.2001; Becker L, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0352-y; Ben Said L, 2016, SCI TOTAL ENVIRON, V550, P1103, DOI 10.1016/j.scitotenv.2016.01.042; Caltagirone M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02232; Clegg S, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0005-2012; Clinical and Laboratory Standards Institute, 2018, M100 CLSI, V28th; Czobor I, 2016, INT J ANTIMICROB AG, V48, P223, DOI 10.1016/j.ijantimicag.2016.05.004; David S, 2019, NAT MICROBIOL, V4, P1919, DOI 10.1038/s41564-019-0492-8; Dropa M, 2016, ENVIRON SCI POLLUT R, V23, P4953, DOI 10.1007/s11356-016-6079-5; Ekwanzala MD, 2019, SCI TOTAL ENVIRON, V691, P80, DOI 10.1016/j.scitotenv.2019.06.533; Falagas ME, 2016, CLIN MICROBIOL REV, V29, P321, DOI 10.1128/CMR.00068-15; Founou LL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00188; Gadea R, 2017, FOOD MICROBIOL, V63, P58, DOI 10.1016/j.fm.2016.10.037; Ghafourian S, 2015, CURR ISSUES MOL BIOL, V17, P11; Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226; Guo QL, 2016, J ANTIMICROB CHEMOTH, V71, P2460, DOI 10.1093/jac/dkw177; Hristea A, 2015, INFECT DIS-NOR, V47, P46, DOI 10.3109/00365548.2014.959043; Ito R, 2017, MBIO, V8, DOI 10.1128/mBio.00749-17; Janvari L, 2014, SCAND J INFECT DIS, V46, P320, DOI 10.3109/00365548.2013.879993; Jin LY, 2018, J ANTIMICROB CHEMOTH, V73, P84, DOI 10.1093/jac/dkx355; Kampf G, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7040110; Kasap M, 2013, J ENZYM INHIB MED CH, V28, P990, DOI 10.3109/14756366.2012.702343; Khan FA, 2018, EUR J CLIN MICROBIOL, V37, P2241, DOI 10.1007/s10096-018-3365-9; Lee CR, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00483; Lepuschitz S, 2019, SCI TOTAL ENVIRON, V662, P227, DOI 10.1016/j.scitotenv.2019.01.179; Li J, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0489-3; Licker M, 2015, EUR REV MED PHARMACO, V19, P1888; Lixandru BE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143214; Luterbach CL, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy351; Mahon BM, 2019, SCI TOTAL ENVIRON, V690, P1, DOI 10.1016/j.scitotenv.2019.06.480; Nasiri G, 2018, INFECT GENET EVOL, V64, P219, DOI 10.1016/j.meegid.2018.06.030; Nguyen MCP, 2009, EMERG INFECT DIS, V15, P1648, DOI 10.3201/eid1510.090696; Obasi A, 2017, MICROB DRUG RESIST, V23, P1013, DOI 10.1089/mdr.2016.0269; Paterson DL, 2000, CLIN INFECT DIS, V30, P473, DOI 10.1086/313719; Perilli M, 2013, J GLOB ANTIMICROB RE, V1, P217, DOI 10.1016/j.jgar.2013.07.002; Pfeifer Y, 2012, ANTIMICROB AGENTS CH, V56, P2125, DOI 10.1128/AAC.05315-11; Pirii LE, 2018, EUR J CLIN MICROBIOL, V37, P175, DOI 10.1007/s10096-017-3118-1; Prokesch Bonnie C, 2016, Lancet Infect Dis, V16, pe190, DOI 10.1016/S1473-3099(16)30021-4; Rolain J.-M., 2018, MICROBIOL RES J INT, V23, P1; Sekizuka T, 2018, MSPHERE, V3, DOI [10.1128/msphere.00314-18, 10.1128/mSphere.00314-18]; Sghaier S, 2019, J GLOB ANTIMICROB RE, V17, P189, DOI 10.1016/j.jgar.2019.01.002; Shin HW, 2015, J MICROBIOL BIOTECHN, V25, P137, DOI 10.4014/jmb.1409.09041; Suk JE, 2011, AM J PUBLIC HEALTH, V101, P2068, DOI 10.2105/AJPH.2011.300181; Szekely E, 2013, INT J MED MICROBIOL, V303, P697, DOI 10.1016/j.ijmm.2013.10.001; Taitt CR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178880; Timofte D, 2015, EUR J CLIN MICROBIOL, V34, P2069, DOI 10.1007/s10096-015-2453-3; van Duin D, 2014, ANTIMICROB AGENTS CH, V58, P4035, DOI 10.1128/AAC.02636-14; Vardakas KZ, 2016, INT J ANTIMICROB AG, V47, P269, DOI 10.1016/j.ijantimicag.2016.02.001; Vijayakumar R, 2018, J INFECT PUBLIC HEAL, V11, P812, DOI 10.1016/j.jiph.2018.05.011; Voulgari E, 2016, ANTIMICROB AGENTS CH, V60, P1862, DOI 10.1128/AAC.01514-15; Wassenaar TM, 2015, EUR J MICROBIOL IMMU, V5, P44, DOI [10.1556/EUJMI-D-14-00038, 10.1556/EuJMI-D-14-00038]; Woodford N, 2014, J ANTIMICROB CHEMOTH, V69, P287, DOI 10.1093/jac/dkt392; Zhang YZ, 2019, INT J ANTIMICROB AG, V53, P864, DOI 10.1016/j.ijantimicag.2019.02.012	57	25	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228079	10.1371/journal.pone.0228079	http://dx.doi.org/10.1371/journal.pone.0228079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999747	Green Published, gold			2022-12-26	WOS:000534612400047
J	Zhang, XY; Ning, X; He, XX; Sun, X; Yu, XJ; Cheng, YX; Yu, RQ; Wu, YP				Zhang, Xiyang; Ning, Xi; He, Xiaoxiao; Sun, Xian; Yu, Xinjian; Cheng, Yuanxiong; Yu, Ri-Qing; Wu, Yuping			Fatty acid composition analyses of commercially important fish species from the Pearl River Estuary, China	PLOS ONE			English	Article							FRESH-WATER FISH; LIPID-CONTENT; MARINE; PROFILES; RATIO; OMEGA-3-FATTY-ACIDS; INFLAMMATION; DISEASE; N-6	Evaluation of fish nutritional content information could provide essential guidance for seafood consumption and human health protection. This study investigated the lipid contents, fatty acid compositions, and nutritional qualities of 22 commercially important marine fish species from the Pearl River Estuary (PRE), South China Sea. All the analyzed species had a low to moderate lipid content (0.51-7.35% fat), with no significant differences in fatty acid profiles among fishes from different lipid categories (p > 0.05). Compared with previous studies from other regions, the examined fish species exhibited higher proportions of saturated fatty acids (SFAs, 39.1 +/- 4.00%) and lower contents of polyunsaturated fatty acids (PUFAs, 21.6 +/- 5.44%), presumably due to the shifted diet influence from increased diatoms and decreased dinoflagellate over the past decades in the PRE. This study further revealed that there was a significantly negative correlation between the trophic levels and levels of PUFAs in the examined species (Pearson's r = -0.42, p = 0.04), likely associated with their differed dietary composition. Considering the health benefit of PUFAs, a few marine fish in PRE with low levels of PUFAs might have no significant contribution to the cardiovascular disease prevention, although fish with different fatty acid profiles most likely contribute differently towards human health. Additional studies are needed in order to comprehensively analyze the nutritional status of fish species in the PRE.	[Zhang, Xiyang; Ning, Xi; He, Xiaoxiao; Sun, Xian; Yu, Xinjian; Wu, Yuping] Sun Yat Sen Univ, Sch Marine Sci, Guangdong Prov Key Lab Marine Resources & Coastal, Zhuhai Key Lab Marine Bioresources & Environm, Zhuhai, Peoples R China; [Zhang, Xiyang; Ning, Xi; He, Xiaoxiao; Sun, Xian; Yu, Xinjian; Wu, Yuping] Southern Marine Sci & Engn Guangdong Lab Zhuhai, Zhuhai, Peoples R China; [Cheng, Yuanxiong] Southern Med Univ, Affiliated Hosp 3, Guangzhou, Peoples R China; [Yu, Ri-Qing] Univ Texas Tyler, Ctr Environm Biodivers & Conservat, Dept Biol, Tyler, TX 75799 USA	Guangdong Provincial Key Laboratory of Marine Resources & Coastal Engineering; Sun Yat Sen University; Southern Marine Science & Engineering Guangdong Laboratory; Southern Medical University - China; University of Texas System; University of Texas at Tyler	Wu, YP (corresponding author), Sun Yat Sen Univ, Sch Marine Sci, Guangdong Prov Key Lab Marine Resources & Coastal, Zhuhai Key Lab Marine Bioresources & Environm, Zhuhai, Peoples R China.; Wu, YP (corresponding author), Southern Marine Sci & Engn Guangdong Lab Zhuhai, Zhuhai, Peoples R China.; Yu, RQ (corresponding author), Univ Texas Tyler, Ctr Environm Biodivers & Conservat, Dept Biol, Tyler, TX 75799 USA.	ryu@uttyler.edu; exwyp@mail.sysu.edu.cn	Yu, Riqing/ABA-6643-2020		Natural Science Foundation of China [41576128]; China Postdoctoral Science Foundation [2019M653153]; Fundamental Research Funds for the Central Universities [19lgpy95]; Provincial Natural Science Foundation of Guangdong [2017A030308005]; Ocean Park Conservation Foundation of Hong Kong	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Provincial Natural Science Foundation of Guangdong; Ocean Park Conservation Foundation of Hong Kong	The research was supported by the Natural Science Foundation of China (41576128), the China Postdoctoral Science Foundation (2019M653153), the Fundamental Research Funds for the Central Universities (19lgpy95), the Provincial Natural Science Foundation of Guangdong (2017A030308005) in China, and the Ocean Park Conservation Foundation of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouel-Yazeed AM., 2013, J ARABIAN AQUACULT S, V8, P283; ACKMAN R G, 1990, Food Reviews International, V6, P617; Belling GB, 1997, LIPIDS, V32, P621, DOI 10.1007/s11745-997-0079-z; Berquin IM, 2008, CANCER LETT, V269, P363, DOI 10.1016/j.canlet.2008.03.044; Christie W.W., 2012, LIPID ANAL ISOLATION; CHUECAS L, 1969, J MAR BIOL ASSOC UK, V49, P97, DOI 10.1017/S0025315400046439; Dhaneesh KV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045439; DYERBERG J, 1975, AM J CLIN NUTR, V28, P958, DOI 10.1093/ajcn/28.9.958; El-Badry AM, 2007, J HEPATOL, V47, P718, DOI 10.1016/j.jhep.2007.08.005; Fernandes CE, 2014, FOOD CHEM, V160, P67, DOI 10.1016/j.foodchem.2014.03.055; FOLCH J, 1957, J BIOL CHEM, V226, P497; Griffin BA, 2008, CURR OPIN LIPIDOL, V19, P57, DOI 10.1097/MOL.0b013e3282f2e2a8; Hernandez-Martinez M, 2016, INT J FOOD PROP, V19, P1401, DOI 10.1080/10942912.2015.1079787; HMSO U., 1994, NUTR ASPECTS CARDIOV; Huynh MD, 2009, FOOD CHEM, V114, P912, DOI 10.1016/j.foodchem.2008.10.038; KAGAWA Y, 1982, J NUTR SCI VITAMINOL, V28, P441, DOI 10.3177/jnsv.28.441; Kocatepe D, 2012, LIPIDS, V47, P635, DOI 10.1007/s11745-012-3658-1; Kris-Etherton P, 2010, J AM DIET ASSOC, V110, P201, DOI 10.1016/j.jada.2009.12.006; [李春颖 Li Chunying], 2008, [生物技术通报, Biotechnology Bulletin], P63; Li GP, 2011, J AGR FOOD CHEM, V59, P1871, DOI 10.1021/jf104154q; Li Y.F., 2008, THESIS; Liu K., 2008, TENDENCY BIODIVERSIT; Murillo E, 2014, J FOOD COMPOS ANAL, V33, P1, DOI 10.1016/j.jfca.2013.08.007; Needham S, 2015, CONSUMPTION FISH FIS, V12; Ozogul Y, 2007, FOOD CHEM, V103, P217, DOI 10.1016/j.foodchem.2006.08.009; Pacetti D, 2010, FOOD CHEM, V122, P209, DOI 10.1016/j.foodchem.2010.02.059; Peet M, 2005, DRUGS, V65, P1051, DOI 10.2165/00003495-200565080-00002; Pereira DM, 2013, FOOD CHEM, V141, P2412, DOI 10.1016/j.foodchem.2013.04.120; Prato E, 2012, FOOD CHEM, V131, P1233, DOI 10.1016/j.foodchem.2011.09.110; Rodrigues BL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178898; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; Santos S, 2013, NUTR RES, V33, P687, DOI 10.1016/j.nutres.2013.07.002; Santos-Silva J, 2002, LIVEST PROD SCI, V77, P187, DOI 10.1016/S0301-6226(02)00059-3; Schneedorferova I, 2015, FOOD CHEM, V176, P205, DOI 10.1016/j.foodchem.2014.12.058; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Steffens W, 1997, AQUACULTURE, V151, P97, DOI 10.1016/S0044-8486(96)01493-7; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; Usydus Z, 2012, FOOD CHEM, V130, P97, DOI 10.1016/j.foodchem.2011.07.003; Usydus Z, 2011, FOOD CHEM, V126, P78, DOI 10.1016/j.foodchem.2010.10.080; Wu Zhiqiang, 2000, Journal of Fisheries of China, V24, P61; [张波 ZHANG Bo], 2008, [海洋水产研究, Marine Fisheries Research], V29, P11; Zhang Z., 2014, J FOOD NUTR RES, V2, P388, DOI DOI 10.12691/JFNR-2-7-10; Zhu HY, 2010, J NUTR BIOCHEM, V21, P954, DOI 10.1016/j.jnutbio.2009.07.011	45	36	38	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228276	10.1371/journal.pone.0228276	http://dx.doi.org/10.1371/journal.pone.0228276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999793	Green Published, gold			2022-12-26	WOS:000534612400062
J	Cao, TX; Sujkowski, A; Cobb, T; Wessells, RJ; Jin, JP				Cao, Tianxin; Sujkowski, Alyson; Cobb, Tyler; Wessells, Robert J.; Jin, Jian-Ping			The glutamic acid-rich?long C-terminal extension of troponin T has a critical role in insect muscle functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						troponin; Drosophila; molecular evolution; muscle physiology; invertebrate; contractile protein; tropomyosin; calcium homeostasis; striated muscle; TnT	NH2-TERMINAL VARIABLE REGION; SKELETAL-MUSCLE; LENGTH DEPENDENCE; PROTEIN; EXPRESSION; ISOFORMS; BINDING; CONTRACTION; EVOLUTION; FORCE	The troponin complex regulates the Ca2+ activation of myofilaments during striated muscle contraction and relaxation. Troponin genes emerged 500?700 million years ago during early animal evolution. Troponin T (TnT) is the thin-filament?anchoring subunit of troponin. Vertebrate and invertebrate TnTs have conserved core structures, reflecting conserved functions in regulating muscle contraction, and they also contain significantly diverged structures, reflecting muscle type- and species-specific adaptations. TnT in insects contains a highly-diverged structure consisting of a long glutamic acid?rich C-terminal extension of ?70 residues with unknown function. We found here that C-terminally truncated Drosophila TnT (TpnT?CD70) retains binding of tropomyosin, troponin I, and troponin C, indicating a preserved core structure of TnT. However, the mutant TpnT(CD70) gene residing on the X chromosome resulted in lethality in male flies. We demonstrate that this X-linked mutation produces dominant-negative phenotypes, including decreased flying and climbing abilities, in heterozygous female flies. Immunoblot quantification with a TpnT-specific mAb indicated expression of TpnT?CD70 in vivo and normal stoichiometry of total TnT in myofilaments of heterozygous female flies. Light and EM examinations revealed primarily normal sarcomere structures in female heterozygous animals, whereas Z-band streaming could be observed in the jump muscle of these flies. Although TpnT?CD70-expressing flies exhibited lower resistance to cardiac stress, their hearts were significantly more tolerant to Ca2+ overloading induced by high-frequency electrical pacing. Our findings suggest that the Glu-rich long C-terminal extension of insect TnT functions as a myofilament Ca2+ buffer/reservoir and is potentially critical to the high-frequency asynchronous contraction of flight muscles.	[Cao, Tianxin; Sujkowski, Alyson; Cobb, Tyler; Wessells, Robert J.; Jin, Jian-Ping] Wayne State Univ, Sch Med, Dept Physiol, 5374 Scott Hall,540 E Canfield, Detroit, MI 48201 USA	Wayne State University	Jin, JP (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 5374 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	jjin@med.wayne.edu		Sujkowski, Alyson/0000-0002-9909-9279; Jin, JP/0000-0001-9932-1063	National Institutes of Health [HL127691, HL138007, AG059683]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants HL127691 and HL138007 (to J.-P. J.) and AG059683 (to R. J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alayari Nakissa N, 2009, J Vis Exp, DOI 10.3791/1423; Alex A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500639; Babcock DT, 2014, JOVE-J VIS EXP, DOI 10.3791/51223; Biesiadecki BJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/421701; Bullard B, 2011, J MUSCLE RES CELL M, V32, P303, DOI 10.1007/s10974-011-9278-1; Cao TX, 2019, ARCH BIOCHEM BIOPHYS, V666, P40, DOI 10.1016/j.abb.2019.03.013; Chakraborty K, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2860; Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0; Damschroder D, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3037; Domingo A, 1998, J MUSCLE RES CELL M, V19, P393, DOI 10.1023/A:1005349704790; Feng HZ, 2009, ARCH BIOCHEM BIOPHYS, V487, P36, DOI 10.1016/j.abb.2009.05.001; FRIDEN J, 1992, MED SCI SPORT EXER, V24, P521; FYRBERG E, 1990, J MOL BIOL, V216, P657, DOI 10.1016/0022-2836(90)90390-8; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hanft LM, 2010, J PHYSIOL-LONDON, V588, P2891, DOI 10.1113/jphysiol.2010.190504; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jin JP, 2007, ARCH BIOCHEM BIOPHYS, V466, P1, DOI 10.1016/j.abb.2007.07.021; Jin JP, 1998, GENE, V214, P121, DOI 10.1016/S0378-1119(98)00214-5; JIN JP, 1995, J BIOL CHEM, V270, P6908; Jin JP, 2001, J MOL EVOL, V52, P103, DOI 10.1007/s002390010139; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Kagawa H, 2007, ADV EXP MED BIOL, V592, P153; Liu R, 2017, BIOCHEMISTRY-US, V56, P5526, DOI 10.1021/acs.biochem.7b00794; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nongthomba U, 2007, GENETICS, V177, P295, DOI 10.1534/genetics.106.056812; Ogut O, 1999, AM J PHYSIOL-CELL PH, V276, pC1162, DOI 10.1152/ajpcell.1999.276.5.C1162; Rassier DE, 2017, AM J PHYSIOL-CELL PH, V313, pC134, DOI 10.1152/ajpcell.00050.2017; Robinson P, 2018, J BIOL CHEM, V293, P10487, DOI 10.1074/jbc.RA118.002081; Rothwell Wendy F, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4825; Sanger JW, 2017, HANDB EXP PHARMACOL, V235, P39, DOI 10.1007/164_2016_53; Shattock MJ, 2015, J PHYSIOL-LONDON, V593, P1361, DOI 10.1113/jphysiol.2014.282319; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; van der Velden J, 2000, CARDIOVASC RES, V46, P487, DOI 10.1016/S0008-6363(00)00050-X; Vicente-Crespo M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001613; Wang J, 1998, BIOCHEMISTRY-US, V37, P14519, DOI 10.1021/bi9812322; Wang J, 1997, GENE, V193, P105, DOI 10.1016/S0378-1119(97)00100-5; Wang X, 2005, J BIOL CHEM, V280, P13241, DOI 10.1074/jbc.M413696200; WANG ZY, 1990, J BIOL CHEM, V265, P4953; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Xiao YS, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2606; YANAGIDA T, 1985, NATURE, V316, P366, DOI 10.1038/316366a0; Zhang ZL, 2004, BIOCHEMISTRY-US, V43, P2645, DOI 10.1021/bi035067o	44	8	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3794	3807		10.1074/jbc.RA119.012014	http://dx.doi.org/10.1074/jbc.RA119.012014			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32024695	hybrid, Green Published			2022-12-26	WOS:000527704400007
J	Li, X; Kong, LM; Yang, QH; Duan, AZ; Ju, XM; Cai, BC; Chen, L; An, T; Li, Y				Li, Xue; Kong, Lingmei; Yang, Qihong; Duan, Aizhu; Ju, Xiaoman; Cai, Bicheng; Chen, Lin; An, Tao; Li, Yan			Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small molecule; deubiquitylation (deubiquitination); Wnt signaling; pharmacology; enzyme inhibitor; ?-catenin; parthenolide; ubiquitination; USP7; Wnt signaling; ubiquitin-specific peptidase 7; colorectal cancer; proteasome system; protein homeostasis; deubiquitinating activity	NF-KAPPA-B; BETA-CATENIN; MULTIPLE-MYELOMA; DNA METHYLATION; PROMOTES; DEUBIQUITINATION; STABILIZATION; SYSTEM; TARGET; TRANSCRIPTION	It has been well-established that the deubiquitinating enzyme ubiquitin-specific peptidase 7 (USP7) supports cancer growth by up-regulating multiple cellular pathways, including Wnt/?-catenin signaling. Therefore, considerable efforts are directed at identifying and developing USP7 inhibitors. Here, we report that sesquiterpene lactone parthenolide (PTL) inhibits USP7 activity, assessed with deubiquitinating enzyme activity assays, including fluorogenic Ub-AMC/Ub-Rho110, Ub-VME/PA labeling, and Di-Ub hydrolysis assays. Further investigations using cellular thermal shift (CETSA), surface plasmon resonance (SPR), and mass spectrum (MS) assays revealed that PTL directly interacts with USP7. Consistent with the role of USP7 in stimulating Wnt signaling and carcinogenesis, PTL treatment inhibited the activity of Wnt signaling partly by destabilizing ?-catenin. Moreover, using cell viability assays, we found that PTL suppresses the proliferation of colorectal cancer cells and induces apoptosis in these cells. Additionally, we examined the effects of two other sesquiterpene lactones (costunolide and ?-santonin) on USP7 and Wnt signaling and found that ?-methylene-?-butyrolactone may provide a scaffold for future USP7 inhibitors. In summary, our findings reveal that PTL inhibits USP7 activity, identifying a potential mechanism by which PTL suppresses Wnt/?-catenin signaling. We further suggest that sesquiterpene lactones might represent a suitable scaffold for developing USP7 inhibitors and indicate that PTL holds promise as an anticancer agent targeting aberrant USP7/Wnt signaling.	[Li, Xue; Kong, Lingmei; Yang, Qihong; Duan, Aizhu; Ju, Xiaoman; Cai, Bicheng; Chen, Lin; An, Tao; Li, Yan] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming 650201, Yunnan, Peoples R China; [Li, Xue; Yang, Qihong; Duan, Aizhu; Ju, Xiaoman; Chen, Lin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Kong, Lingmei; An, Tao; Li, Yan] Chinese Acad Sci, Yunnan Key Lab Nat Med Chem, Kunming Inst Bot, Kunming 650201, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	An, T; Li, Y (corresponding author), Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming 650201, Yunnan, Peoples R China.; An, T; Li, Y (corresponding author), Chinese Acad Sci, Yunnan Key Lab Nat Med Chem, Kunming Inst Bot, Kunming 650201, Yunnan, Peoples R China.	antao@mail.kib.ac.cn; liyanb@mail.kib.ac.cn			Young Scientists Fund of National Science Foundation of China [81803587, 81603161]; National Natural Science Foundation of China [81773783]; Project of Science and Technology of Yunnan Province [2019FD054]; West Light Foundation of the Chinese Academy of Sciences; Youth Innovation Promotion Association CAS; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences	Young Scientists Fund of National Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology of Yunnan Province; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association CAS; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Young Scientists Fund of National Science Foundation of China Grant 81803587 (to T. A.); the National Natural Science Foundation of China Grant 81773783 (to Y. L.); the Young Scientists Fund of National Science Foundation of China Grant 81603161 (to L. K.); the Project of Science and Technology of Yunnan Province Grant 2019FD054 (to T. A.); the West Light Foundation of the Chinese Academy of Sciences (to T. A. and L. K.); and Youth Innovation Promotion Association CAS (to L. K.). The work was also supported by the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences (to T. A. and L. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Agathanggelou A, 2017, BLOOD, V130, P156, DOI 10.1182/blood-2016-12-758219; Alonso-de Vega I, 2014, CELL CYCLE, V13, P3921, DOI 10.4161/15384101.2014.973324; An T, 2017, BIOCHEM PHARMACOL, V131, P29, DOI 10.1016/j.bcp.2017.02.011; Berdan CA, 2019, CELL CHEM BIOL, V26, P1027, DOI 10.1016/j.chembiol.2019.03.016; Cai JB, 2015, HEPATOLOGY, V61, P1603, DOI 10.1002/hep.27682; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Franqui-Machin R, 2018, J CLIN INVEST, V128, P2877, DOI 10.1172/JCI98765; Garcia-Pineres AJ, 2004, LIFE SCI, V75, P841, DOI 10.1016/j.lfs.2004.01.024; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; Gopal YNV, 2009, MOL CANCER THER, V8, P552, DOI 10.1158/1535-7163.MCT-08-0661; Greenblatt MB, 2016, P NATL ACAD SCI USA, V113, pE1226, DOI 10.1073/pnas.1600813113; Gupta I, 2018, FRONT GENET, V9, DOI [10.3389/fgene.2018.00336, 10.3389/fgene.2018.00409]; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Inoue D, 2015, LEUKEMIA, V29, P2257, DOI 10.1038/leu.2015.90; Jackson PA, 2017, J MED CHEM, V60, P839, DOI 10.1021/acs.jmedchem.6b00788; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin Q, 2019, CLIN CANCER RES, V25, P222, DOI 10.1158/1078-0432.CCR-18-1740; Kim JC, 2018, AM J CANCER RES, V8, P1823; Kong FC, 2015, J HUAZHONG U SCI-MED, V35, P343, DOI 10.1007/s11596-015-1435-0; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lee MJ, 2019, J MED CHEM, V62, P4444, DOI 10.1021/acs.jmedchem.8b01943; Lei AH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00422; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Liu M, 2018, MOLECULES, V23, DOI 10.3390/molecules23061478; Liu YC, 2017, INTEST RES, V15, P174, DOI 10.5217/ir.2017.15.2.174; Liu ZF, 2009, J PHARMACOL EXP THER, V329, P505, DOI 10.1124/jpet.108.147934; Ma PC, 2014, MOL CELL BIOL, V34, P4355, DOI 10.1128/MCB.00731-14; Ma XJ, 2018, AM J CANCER RES, V8, P2284; Merin NM, 2015, PHARMACEUTICALS-BASE, V8, P1, DOI 10.3390/ph8010001; Nguyen Hoa Hong, 2019, Cell Physiol Biochem, V53, P157, DOI 10.33594/000000127; Novellasdemunt L, 2017, CELL REP, V21, P612, DOI 10.1016/j.celrep.2017.09.072; Poondla N, 2019, BMB REP, V52, P181, DOI 10.5483/BMBRep.2019.52.3.048; Pozhidaeva A, 2019, DNA REPAIR, V76, P30, DOI 10.1016/j.dnarep.2019.02.005; Rawat R, 2019, CURR OPIN CELL BIOL, V58, P85, DOI 10.1016/j.ceb.2019.02.008; Reverdy C, 2012, CHEM BIOL, V19, P467, DOI 10.1016/j.chembiol.2012.02.007; Shan HZ, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0028-3; Sheridan C, 2015, NAT BIOTECHNOL, V33, P1115, DOI 10.1038/nbt1115-1115; Shi JD, 2015, MOL CELL BIOL, V35, P3301, DOI 10.1128/MCB.00373-15; Song J, 2015, MOL CANCER RES, V13, P969, DOI 10.1158/1541-7786.MCR-13-0644; Sun XH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08334-7; Tavana O, 2017, J MOL CELL BIOL, V9, P45, DOI 10.1093/jmcb/mjw049; Tavana O, 2016, NAT MED, V22, P1180, DOI 10.1038/nm.4180; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Wang LQ, 2016, EBIOMEDICINE, V13, P99, DOI 10.1016/j.ebiom.2016.10.018; Wang Q, 2016, J CLIN INVEST, V126, P2205, DOI 10.1172/JCI85747; Weinstock J, 2012, ACS MED CHEM LETT, V3, P789, DOI 10.1021/ml200276j; Wu CM, 2018, CELL DEATH DIFFER, V25, P1855, DOI 10.1038/s41418-018-0138-z; Wu J, 2018, J MED CHEM, V61, P422, DOI 10.1021/acs.jmedchem.7b00498; Yang B, 2016, ONCOTARGET, V7, P79501, DOI 10.18632/oncotarget.12819; Zhou ZZ, 2015, DEV CELL, V34, P58, DOI 10.1016/j.devcel.2015.05.016; Zhu XL, 2018, J BIOL CHEM, V293, P5335, DOI 10.1074/jbc.M117.819300; Zhu YH, 2020, CELL DEATH DIFFER, V27, P1316, DOI 10.1038/s41418-019-0417-3	57	21	23	7	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3576	3589		10.1074/jbc.RA119.011396	http://dx.doi.org/10.1074/jbc.RA119.011396			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32029476	hybrid, Green Published			2022-12-26	WOS:000527725300017
J	Chen, A; Arora, PD; Lai, CC; Copeland, JW; Moraes, TF; McCulloch, CA; Lavoie, B; Wilde, A				Chen, Anan; Arora, Pam D.; Lai, Christine C.; Copeland, John W.; Moraes, Trevor F.; McCulloch, Christopher A.; Lavoie, Brigitte; Wilde, Andrew			The scaffold-protein IQGAP1 enhances and spatially restricts the actin-nucleating activity of Diaphanous-related formin 1 (DIAPH1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; formin; Rho (Rho GTPase); cytoskeleton; cell signaling; actin nucleation; Diaphanous-related formin 1 (DIAPH1); Flightless-I (Fli-I); IQ motif containing GTPase-activating protein 1 (IQGAP1)	FLIGHTLESS I; AURORA-B; PHOSPHORYLATION; MDIA1; RHO; BINDING; ORGANIZATION; ARCHITECTURE; MIGRATION	The actin cytoskeleton is a dynamic array of filaments that undergoes rapid remodeling to drive many cellular processes. An essential feature of filament remodeling is the spatio-temporal regulation of actin filament nucleation. One family of actin filament nucleators, the Diaphanous-related formins, is activated by the binding of small G-proteins such as RhoA. However, RhoA only partially activates formins, suggesting that additional factors are required to fully activate the formin. Here we identify one such factor, IQ motif containing GTPase activating protein-1 (IQGAP1), which enhances RhoA-mediated activation of the Diaphanous-related formin (DIAPH1) and targets DIAPH1 to the plasma membrane. We find that the inhibitory intramolecular interaction within DIAPH1 is disrupted by the sequential binding of RhoA and IQGAP1. Binding of RhoA and IQGAP1 robustly stimulates DIAPH1-mediated actin filament nucleation in vitro. In contrast, the actin capping protein Flightless-I, in conjunction with RhoA, only weakly stimulates DIAPH1 activity. IQGAP1, but not Flightless-I, is required to recruit DIAPH1 to the plasma membrane where actin filaments are generated. These results indicate that IQGAP1 enhances RhoA-mediated activation of DIAPH1 in vivo. Collectively these data support a model where the combined action of RhoA and an enhancer ensures the spatio-temporal regulation of actin nucleation to stimulate robust and localized actin filament production in vivo.	[Chen, Anan; Lai, Christine C.; Moraes, Trevor F.; Wilde, Andrew] Univ Toronto, Dept Biochem, Toronto, ON M5G 1M1, Canada; [Arora, Pam D.; McCulloch, Christopher A.] Univ Toronto, Fac Dent, Toronto, ON M5G 1M1, Canada; [Lavoie, Brigitte; Wilde, Andrew] Univ Toronto, Dept Mol Genet, 661 Univ Ave, Toronto, ON M5G 1M1, Canada; [Copeland, John W.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Ottawa	Wilde, A (corresponding author), Univ Toronto, Dept Mol Genet, 661 Univ Ave, Toronto, ON M5G 1M1, Canada.	andrew.wilde@utoronto.ca		Wilde, Andrew/0000-0002-9812-3847	Canadian Institutes of Health Research (CIHR) [PJT 148575]; Tier 1 Canada Research Chair [MOP-36332]; CIHR [MOP-36332]; National Science and Engineering Research Council [RGPIN-2018-06546]; Cancer Research Society [24154]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair(Canada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cancer Research Society	This work was supported by Canadian Institutes of Health Research (CIHR) Grant PJT 148575 (to A. W.), a Tier 1 Canada Research Chair and CIHR Grant MOP-36332 (to C. A. M.), National Science and Engineering Research Council Grant RGPIN-2018-06546 (to T. F. M.), and Cancer Research Society Grant 24154 (to J. W. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; Arora PD, 2017, J CELL SCI, V130, P2196, DOI 10.1242/jcs.201665; Arora PD, 2015, MOL BIOL CELL, V26, P2279, DOI 10.1091/mbc.E14-11-1536; Arora PD, 1996, J BIOL CHEM, V271, P20516, DOI 10.1074/jbc.271.34.20516; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brenig J, 2015, J BIOL CHEM, V290, P14314, DOI 10.1074/jbc.M114.621946; Chen A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01231-x; Cheng LN, 2011, DEV CELL, V20, P342, DOI 10.1016/j.devcel.2011.01.008; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Floyd S, 2013, J CELL SCI, V126, P2845, DOI 10.1242/jcs.123232; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Greseth MD, 2017, MOL CELL PROTEOMICS, V16, pS124, DOI 10.1074/mcp.M116.065003; Higashi T, 2010, J BIOL CHEM, V285, P16231, DOI 10.1074/jbc.M109.079236; Iskratsch T, 2013, CELL MOL LIFE SCI, V70, P893, DOI 10.1007/s00018-012-1154-7; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu JH, 2012, CURR BIOL, V22, P64, DOI 10.1016/j.cub.2011.11.040; Maiti S, 2012, CYTOSKELETON, V69, P393, DOI 10.1002/cm.21033; Mohammad I, 2012, FASEB J, V26, P3260, DOI 10.1096/fj.11-202051; Nezami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012992; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Pogoutse AK, 2016, ANAL BIOCHEM, V501, P35, DOI 10.1016/j.ab.2016.02.001; Renshaw MJ, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130190; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sakamoto S, 2012, J CELL SCI, V125, P108, DOI 10.1242/jcs.087411; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Skau CT, 2015, ANNU REV BIOPHYS, V44, P285, DOI 10.1146/annurev-biophys-060414-034308; Staus DP, 2011, BIOCHEM J, V439, P57, DOI 10.1042/BJ20101700; VOGT TF, 1993, P NATL ACAD SCI USA, V90, P5554, DOI 10.1073/pnas.90.12.5554; Wang YP, 2004, J BIOL CHEM, V279, P24420, DOI 10.1074/jbc.M313823200; Watanabe S, 2010, MOL BIOL CELL, V21, P3193, DOI 10.1091/mbc.E10-04-0324; Zhou Q, 2017, HYPERTENSION, V69, P1070, DOI 10.1161/HYPERTENSIONAHA.116.08662	37	5	5	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3134	3147		10.1074/jbc.RA119.010476	http://dx.doi.org/10.1074/jbc.RA119.010476			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005666	hybrid, Green Published			2022-12-26	WOS:000519597300020
J	Bleich, SN; Soto, MJ; Dunn, CG; Moran, AJ; Block, JP				Bleich, Sara N.; Soto, Mark J.; Dunn, Caroline Glagola; Moran, Alyssa J.; Block, Jason P.			Calorie and nutrient trends in large US chain restaurants, 2012-2018	PLOS ONE			English	Article							FAST-FOOD; WEIGHT-GAIN; MENU; OBESITY; CONSUMPTION; ENERGY; OVERWEIGHT	Introduction Large chain restaurants reduced calories in their newly-introduced menu items from 2012 to 2015. The objective of this study was to provide updated calorie trends through 2018 and examine trends in the macronutrient composition of menu items across this time period. Methods and findings Data were obtained from the MenuStat project and include 66 of the 100 largest revenue generating U.S. chain restaurants (N = 28,238 items) that had data available in all years from 2012 to 2018. Generalized linear models were used to examine per-item calorie and nutrient changes (saturated fat, trans fat, unsaturated fat, sugar, non-sugar carbohydrates, protein, sodium) among (1) items on the menu in all years (common items) and (2) newly introduced items (2013-2018). Overall, there were no significant changes in calories or nutrients among common items from 2012 to 2018. Among all newly introduced items, calories (-120 kcals, -25%, p = 0.01; p-for-trend = 0.02), saturated fat (-3.4g, -41%, p< 0.01, p-for-trend = 0.06), unsaturated fat (-4.5g, -37%, p = 0.02; p-for-trend = 0.04), non-sugar carbohydrates (-10.3g, -40%, p = 0.02, p-for-trend = 0.69), and protein (-4.3g, -25%, p = 0.04, p-for-trend = 0.02) declined. Conclusion Newly introduced menu items in large chain restaurants have continued to decline in calories through 2018, which may help to reduce calorie intake. Other changes in macronutrient content were sporadic and not clearly toward improved dietary quality.	[Bleich, Sara N.; Soto, Mark J.; Dunn, Caroline Glagola] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Moran, Alyssa J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Block, Jason P.] Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School	Bleich, SN (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA.	sbleich@hsph.harvard.edu		Dunn, Caroline/0000-0002-0088-9781	NIDDK NIH HHS [R01 DK115492] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		An R, 2016, EUR J CLIN NUTR, V70, P97, DOI 10.1038/ejcn.2015.104; [Anonymous], 2018, MEN METH; Bhutani S, 2018, AM J HEALTH PROMOT, V32, P75, DOI 10.1177/0890117116660772; Bleich SN, 2016, AM J PREV MED, V50, pE1, DOI 10.1016/j.amepre.2015.05.007; Bleich SN, 2015, HEALTH AFFAIR, V34, P1877, DOI 10.1377/hlthaff.2015.0512; Bleich SN, 2015, AM J PREV MED, V48, P70, DOI 10.1016/j.amepre.2014.08.026; Carreiro AL, 2016, ANNU REV NUTR, V36, P73, DOI 10.1146/annurev-nutr-121415-112624; Center for Science in the Public Interest, 2014, STAT MEN LAB POL; Center for Science in the Public Interest, 2018, CAL COUNTS CHAIN RES; Cleveland LP, 2018, AM J PUBLIC HEALTH, V108, P1099, DOI 10.2105/AJPH.2018.304513; Duffey KJ, 2009, J NUTR, V139, P2113, DOI 10.3945/jn.109.109520; Frelier JM, 2019, AM J PREV MED, V57, P231, DOI 10.1016/j.amepre.2019.03.023; Hales CM, 2017, PREVALENCE OBESITY A; Herrick K, 2018, PERCENTAGE YOUTHS AG; Hills AP, 2013, OBESITY FACTS, V6, P228, DOI 10.1159/000345030; Hughes JP, 2018, 322 DHHS; Jarlenski MP, 2016, AM J PREV MED, V51, pE91, DOI 10.1016/j.amepre.2016.03.023; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Moran AJ, 2017, AM J PREV MED, V52, P284, DOI 10.1016/j.amepre.2016.11.007; National Restaurant Association, 2019, STAT IND REP; National Restaurant Association, 2019, NAT STAT REST IND FA; New York City Department of Health and Mental Hygiene, 2014, NAT SALT RED IN CORP; New York City Department of Health and Mental Hygiene, SOD IN 2018; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Raynor HA, 2016, J ACAD NUTR DIET, V116, P129, DOI 10.1016/j.jand.2015.10.031; Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x; Saksena MJ, 2018, 196 USDA; Technomic, TOP 500 CHAIN REST R; U.S. Food and Drug Administration, 2018, FIN DET REG PART HYD; Urban LE, 2011, JAMA-J AM MED ASSOC, V306, P287, DOI 10.1001/jama.2011.993; Wolfson JA, 2018, AM J PREV MED, V54, P28, DOI 10.1016/j.amepre.2017.08.018	31	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228891	10.1371/journal.pone.0228891	http://dx.doi.org/10.1371/journal.pone.0228891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9IO	32040526	Green Published, gold			2022-12-26	WOS:000534629400052
J	Suh, YS; Kim, HO; Cheon, YH; Kim, M; Kim, RB; Park, KS; Park, HB; Na, JB; Moon, JI; Lee, SI				Suh, Young Sun; Kim, Hyun-Ok; Cheon, Yun-Hong; Kim, Mingyo; Kim, Rock-Bum; Park, Ki-Soo; Park, Hyung Bin; Na, Jae-Beom; Moon, Jin Il; Lee, Sang-Il			Metabolic and inflammatory links to rotator cuff tear in hand osteoarthritis: A cross sectional study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; EPIDEMIOLOGY; PREVALENCE; ASSOCIATIONS; CYTOKINES; GENETICS; PAIN	Objectives To estimate the prevalence and associated factors of rotator cuff tear (RCT) in patients with hand osteoarthritis (HOA). Methods Between June 2013 and December 2015, we recruited 1150 participants in rural area of South Korea. Of the 1150 participants, 307 participants with HOA were analyzed. Plain radiography of both hands, magnetic resonance imaging of both shoulders, and serum levels of high-sensitive C-reactive protein (hsCRP) and high-density lipoprotein (HDL) were obtained for all patients. HOA and RCT were diagnosed by clinical and radiologic findings. Results The prevalence of RCT in patients with HOA (192/307, 62.5%) was higher than that in those without HOA (410/827, 49.5%, p<0.001). Among the 307 patients with HOA, the patients with RCT were older, and had higher hsCRP and lower HDL levels than the patients without RCT. Multiple logistic regression analysis confirmed significant associations of age (odds ratio [OR], 1.06; 95% confidence interval [CI], 1.02-1.11), serum hsCRP levels.0.6mg/L (OR, 1.68; CI, 1.00-2.80), and low HDL levels (male, < 50 mg/dL; female, < 40 mg/dL) (OR, 1.93; CI, 1.05-3.56) with RCT in patients with HOA. For patients below 60 years old, the prevalence of RCT was 2.8-fold higher in the low HDL group than normal HDL group (p = 0.048). Finally, the prevalence of RCT was 2.6-fold higher in patients with HOA with both elevated hsCRP and low HDL levels compared with those with neither (p<0.05). Conclusions Our findings suggest inflammation and metabolic factors were associated with the prevalence of RCT in HOA patients.	[Suh, Young Sun; Kim, Hyun-Ok] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Chang Won, South Korea; [Suh, Young Sun; Kim, Hyun-Ok] Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea; [Cheon, Yun-Hong; Kim, Mingyo; Lee, Sang-Il] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Jinju, South Korea; [Cheon, Yun-Hong; Kim, Mingyo; Na, Jae-Beom; Lee, Sang-Il] Gyeongsang Natl Univ Hosp, Jinju, South Korea; [Kim, Rock-Bum; Park, Ki-Soo] Gyeongsang Natl Univ, Inst Hlth Sci, Dept Prevent Med, Sch Med, Jinju, South Korea; [Park, Hyung Bin] Gyeongsang Natl Univ, Sch Med, Dept Orthoped Surg, Chang Won, South Korea; [Park, Hyung Bin] Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea; [Na, Jae-Beom] Gyeongsang Natl Univ, Sch Med, Dept Radiol, Jinju, South Korea; [Moon, Jin Il] Gyeongsang Natl Univ, Changwon Hosp, Dept Radiol, Chang Won, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University	Lee, SI (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Jinju, South Korea.; Lee, SI (corresponding author), Gyeongsang Natl Univ Hosp, Jinju, South Korea.	goldgu@gnu.ac.kr	Suh, Young Sun/J-6828-2014	Suh, Young Sun/0000-0002-5378-2590; Kim, Mingyo/0000-0003-3744-8522	National Research Foundation of Korea (NRF) - Korean government [NRF-2015R1A5A2008833]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea [HI18C2039]	National Research Foundation of Korea (NRF) - Korean government; Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea	This work was supported by grants (NRF-2015R1A5A2008833) from the National Research Foundation of Korea (NRF) funded by the Korean government (http://www.nrf.re.kr/index) only. Thus, please delete the following part - (HI18C2039) from the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (https://www.khidi.or.kr/kps).	Abboud JA, 2010, CLIN ORTHOP RELAT R, V468, P1493, DOI 10.1007/s11999-009-1151-9; Addimanda O, 2012, SCAND J RHEUMATOL, V41, P310, DOI 10.3109/03009742.2012.656699; ALTMAN R, 1990, ARTHRITIS RHEUM, V33, P1601, DOI 10.1002/art.1780331101; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Blaine TA, 2005, J SHOULDER ELB SURG, V14, p84S, DOI 10.1016/j.jse.2004.09.022; Bos SD, 2008, ANN RHEUM DIS, V67, P877, DOI 10.1136/ard.2007.079228; Buckwalter J A, 2000, Instr Course Lect, V49, P481; BUSBY J, 1991, ANN HUM BIOL, V18, P417, DOI 10.1080/03014469100001712; Caspi D, 2001, SEMIN ARTHRITIS RHEU, V30, P321, DOI 10.1053/sarh.2001.19957; CHAKRAVARTY K, 1993, J RHEUMATOL, V20, P1359; Codman EA, 1931, ANN SURG, V93, P348, DOI 10.1097/00000658-193101000-00043; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; DAVIS MA, 1990, AM J EPIDEMIOL, V132, P701, DOI 10.1093/oxfordjournals.aje.a115711; Dean BJF, 2012, BONE JOINT RES, V1, P158, DOI 10.1302/2046-3758.17.2000115; Droz-Bartholet F, 2016, ARTHRITIS RHEUMATOL, V68, P647, DOI 10.1002/art.39512; Gill HS, 2007, AM J SPORT MED, V35, P1334, DOI 10.1177/0363546507300058; Gotoh M, 2001, RHEUMATOLOGY, V40, P995, DOI 10.1093/rheumatology/40.9.995; HART DJ, 1995, J RHEUMATOL, V22, P1118; Hart DJ, 2000, OSTEOARTHR CARTILAGE, V8, pS2, DOI 10.1053/joca.2000.0326; Haugen IK, 2011, ANN RHEUM DIS, V70, P1581, DOI 10.1136/ard.2011.150078; Hiligsmann M, 2013, SEMIN ARTHRITIS RHEU, V43, P303, DOI 10.1016/j.semarthrit.2013.07.003; Jeong J, 2017, J SHOULDER ELB SURG, V26, P30, DOI 10.1016/j.jse.2016.05.003; Jin XZ, 2015, ANN RHEUM DIS, V74, P703, DOI 10.1136/annrheumdis-2013-204494; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kim JM, 2016, ANN REHABIL MED-ARM, V40, P463, DOI 10.5535/arm.2016.40.3.463; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Longo UG, 2012, MED SPORT SCI, V57, P1, DOI 10.1159/000328868; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Mather RC, 2013, J BONE JOINT SURG AM, V95A, P1993, DOI 10.2106/JBJS.L.01495; Melchiorri C, 1998, ARTHRITIS RHEUM-US, V41, P2165, DOI 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.3.CO;2-F; Moon KW, 2012, RHEUMATOL INT, V32, P3551, DOI 10.1007/s00296-011-2227-x; Moosmayer S, 2010, ACTA ORTHOP, V81, P361, DOI 10.3109/17453674.2010.483993; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Neumann E, 2016, NAT REV RHEUMATOL, V12, P296, DOI 10.1038/nrrheum.2016.49; Ogawa K, 2005, J SHOULDER ELB SURG, V14, P591, DOI 10.1016/j.jse.2005.03.007; Sandell LJ, 2012, NAT REV RHEUMATOL, V8, P77, DOI 10.1038/nrrheum.2011.199; Solovieva S, 2005, RHEUMATOLOGY, V44, P521, DOI 10.1093/rheumatology/keh534; Stannus OP, 2013, ANN RHEUM DIS, V72, P535, DOI 10.1136/annrheumdis-2011-201047; Sturmer T, 1998, J RHEUMATOL, V25, P1827; Szomor ZL, 2006, J ORTHOP RES, V24, P80, DOI 10.1002/jor.20009; Tashjian RZ, 2012, CLIN SPORT MED, V31, P589, DOI 10.1016/j.csm.2012.07.001; Tempelhof S, 1999, J SHOULDER ELB SURG, V8, P296, DOI 10.1016/S1058-2746(99)90148-9; Thijssen E, 2015, RHEUMATOLOGY, V54, P588, DOI 10.1093/rheumatology/keu464; Tomi AL, 2016, ANN RHEUM DIS, V75, P2101, DOI 10.1136/annrheumdis-2016-209262; Visser AW, 2015, ANN RHEUM DIS, V74, P1842, DOI 10.1136/annrheumdis-2013-205012; Voloshin I, 2005, ARTHROSCOPY, V21, P1076, DOI 10.1016/j.arthro.2005.05.017; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; Zhang W, 2009, ANN RHEUM DIS, V68, P8, DOI 10.1136/ard.2007.084772	48	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228779	10.1371/journal.pone.0228779	http://dx.doi.org/10.1371/journal.pone.0228779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040493	gold, Green Published			2022-12-26	WOS:000534629400041
J	Watanabe, K; Narumi, T; Watanabe, T; Otaki, Y; Takahashi, T; Aono, T; Goto, J; Toshima, T; Sugai, T; Wanezaki, M; Kutsuzawa, D; Kato, S; Tamura, H; Nishiyama, S; Takahashi, H; Arimoto, T; Shishido, T; Watanabe, M				Watanabe, Ken; Narumi, Taro; Watanabe, Tetsu; Otaki, Yoichiro; Takahashi, Tetsuya; Aono, Tomonori; Goto, Jun; Toshima, Taku; Sugai, Takayuki; Wanezaki, Masahiro; Kutsuzawa, Daisuke; Kato, Shigehiko; Tamura, Harutoshi; Nishiyama, Satoshi; Takahashi, Hiroki; Arimoto, Takanori; Shishido, Tetsuro; Watanabe, Masafumi			The association between microRNA-21 and hypertension-induced cardiac remodeling	PLOS ONE			English	Article							HEART-FAILURE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; FIBROSIS; MIR-21; HYPERTROPHY; DETERIORATION; TGF-BETA(1); PROGRESSION; PREVALENCE	Hypertension is a major public health problem among the aging population worldwide. It causes cardiac remodeling, including hypertrophy and interstitial fibrosis, which leads to development of hypertensive heart disease (HHD). Although microRNA-21 (miR-21) is associated with fibrogenesis in multiple organs, its contribution to cardiac remodeling in hypertension is poorly understood. Circulating miR-21 level was higher in patients with HHD than that in the control subjects. It also positively correlated with serum myocardial fibrotic markers. MiR-21 expression levels were significantly upregulated in the mice hearts after angiotensin II (Ang II) infusion or transverse aortic constriction (TAC) compared with control mice. Expression level of programmed cell death 4 (PDCD4), a main target of miR-21, was significantly decreased in Ang II infused mice and TAC mice compared with control mice. Expression levels of transcriptional activator protein 1 (AP-1) and transforming growth factor-beta 1 (TGF-beta 1), which were downstream targets of PDCD4, were increased in Ang II infused mice and TAC mice compared with control mice. In vitro, mirVana-miR-21-specific inhibitor attenuated Ang II-induced PDCD4 downregulation and contributed to subsequent deactivation of AP-1/TGF-beta 1 signaling pathway in neonatal rat cardiomyocytes. Thus, suppression of miR-21 prevents hypertrophic stimulation-induced cardiac remodeling by regulating PDCD4, AP-1, and TGF-beta 1 signaling pathway.	[Watanabe, Ken; Watanabe, Tetsu; Takahashi, Tetsuya; Aono, Tomonori; Goto, Jun; Toshima, Taku; Sugai, Takayuki; Wanezaki, Masahiro; Kato, Shigehiko; Tamura, Harutoshi; Nishiyama, Satoshi; Arimoto, Takanori; Shishido, Tetsuro; Watanabe, Masafumi] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata, Japan; [Narumi, Taro] Hamamatsu Univ Sch Med, Internal Med 3, Dept Cardiol, Hamamatsu, Shizuoka, Japan; [Otaki, Yoichiro; Takahashi, Hiroki; Watanabe, Masafumi] Yamagata Univ, Sch Med, Dept Adv Cardiovasc Therapeut, Yamagata, Japan; [Kutsuzawa, Daisuke; Watanabe, Masafumi] Yamagata Univ, Sch Med, Dept Adv Heart Rhythm Therapeut, Yamagata, Japan	Yamagata University; Hamamatsu University School of Medicine; Yamagata University; Yamagata University	Narumi, T (corresponding author), Hamamatsu Univ Sch Med, Internal Med 3, Dept Cardiol, Hamamatsu, Shizuoka, Japan.	ajitaro910@gmail.com		Watanabe, Ken/0000-0001-8499-8717; Narumi, Taro/0000-0001-6466-9457	JSPS KAKENHI [18H06191]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Initial: TN -Grant number: 18H06191 Funder: JSPS KAKENHI -Website: https://www.jsps.go.jp/-The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball JP, 2017, ENDOCRINOLOGY, V158, P1859, DOI 10.1210/en.2016-1707; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Carnevale D, 2012, HYPERTENSION, V60, P188, DOI 10.1161/HYPERTENSIONAHA.112.195511; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Fang L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0672-0; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Huang Y, 2015, CURR PHARM DESIGN, V21, P2236, DOI 10.2174/1381612820666141226095701; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Kitahara T, 2007, CIRC J, V71, P929, DOI 10.1253/circj.71.929; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Kuster DWD, 2013, J MOL CELL CARDIOL, V65, P59, DOI 10.1016/j.yjmcc.2013.09.012; Li HP, 2016, CIRCULATION, V134, P734, DOI 10.1161/CIRCULATIONAHA.116.023926; Li XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125430; Liu RH, 2016, MOL MED REP, V13, P2359, DOI 10.3892/mmr.2016.4834; Lorenzen JM, 2015, EUR HEART J, V36, P2184, DOI 10.1093/eurheartj/ehv109; Mansour IN, 2016, J CARD FAIL, V22, P692, DOI 10.1016/j.cardfail.2015.12.016; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Netsu S, 2014, BIOCHEM BIOPH RES CO, V443, P205, DOI 10.1016/j.bbrc.2013.11.083; Otaki Y, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002485; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Pellman J, 2016, J MOL CELL CARDIOL, V94, P22, DOI 10.1016/j.yjmcc.2016.03.005; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Runte KE, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004311; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Song J, 2015, J MOL CELL CARDIOL, V79, P145, DOI 10.1016/j.yjmcc.2014.11.006; Sun NN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13305-3; Sun Q, 2018, J CELL SCI, V131, DOI 10.1242/jcs.202317; Syed M, 2018, AM J PHYSIOL-ENDOC M, V315, pE1154, DOI 10.1152/ajpendo.00155.2018; Takahashi H, 2005, CIRCULATION, V111, P1510, DOI 10.1161/01.CIR.0000159339.00703.22; TAKAHASHI N, 1994, J CLIN INVEST, V94, P1470, DOI 10.1172/JCI117485; Takahashi T, 2019, JACC-BASIC TRANSL SC, V4, P234, DOI 10.1016/j.jacbts.2018.11.011; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2009, CIRC RES, V104, P138, DOI 10.1161/CIRCRESAHA.108.192492; Weber KT, 2017, AM J HYPERTENS, V30, P1049, DOI 10.1093/ajh/hpx054; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Yang H, 2003, BONE MARROW TRANSPL, V32, P1021, DOI 10.1038/sj.bmt.1704247; Yuan JX, 2017, CELL PHYSIOL BIOCHEM, V42, P2207, DOI 10.1159/000479995; Zhang ZP, 2013, J BIOL CHEM, V288, P37082, DOI 10.1074/jbc.M113.517953; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5; Zhou QF, 2017, INT J CARDIOL, V230, P634, DOI 10.1016/j.ijcard.2016.12.171	50	15	17	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0226053	10.1371/journal.pone.0226053	http://dx.doi.org/10.1371/journal.pone.0226053			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040481	Green Published, gold			2022-12-26	WOS:000534629400007
J	Mitterer, H; Eger, NA; Reinisch, E				Mitterer, Holger; Eger, Nikola Anna; Reinisch, Eva			My English sounds better than yours: Second-language learners perceive their own accent as better than that of their peers	PLOS ONE			English	Article							FOREIGN ACCENT; L2 ACQUISITION; SPEECH; INTELLIGIBILITY; COMPREHENSIBILITY; PRONUNCIATION; DUTCH; FAMILIARITY; PERCEPTION; CATEGORIES	Second language (L2) learners are often aware of the typical pronunciation errors that speakers of their native language make, yet often persist in making these errors themselves. We hypothesised that L2 learners may perceive their own accent as closer to the target language than the accent of other learners, due to frequent exposure to their own productions. This was tested by recording 24 female native speakers of German producing 60 sentences. The same participants later rated these recordings for accentedness. Importantly, the recordings had been altered to sound male so that participants were unaware of their own productions in the to-be-rated samples. We found evidence supporting our hypothesis: participants rated their own altered voice, which they did not recognize as their own, as being closer to a native speaker than that of other learners. This finding suggests that objective feedback may be crucial in fostering L2 acquisition and reduce fossilization of erroneous patterns.	[Mitterer, Holger] Univ Malta, Fac Media & Knowledge Sci, Dept Cognit Sci, Msida, Malta; [Eger, Nikola Anna; Reinisch, Eva] Ludwig Maximilians Univ Munchen, Inst Phonet & Speech Proc, Munich, Germany; [Reinisch, Eva] Austrian Acad Sci, Acoust Res Inst, Vienna, Austria	University of Malta; University of Munich; Austrian Academy of Sciences	Mitterer, H (corresponding author), Univ Malta, Fac Media & Knowledge Sci, Dept Cognit Sci, Msida, Malta.	holger.mitterer@um.edu.mt	Eger, Nikola/ABB-5403-2020; Mitterer, Holger/D-1908-2010; Reinisch, Eva/R-1646-2016	Mitterer, Holger/0000-0003-4318-0032; Reinisch, Eva/0000-0002-1400-5473	Deutsche Forschungsgemeinschaft [RE 3047/1-1]; University of Malta Research Grant [CGSRP01-19]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Malta Research Grant	ER - grant nr. RE 3047/1-1, Deutsche Forschungsgemeinschaft, URL: https://www.dfg.de/, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HM - University of Malta Research Grant, CGSRP01-19, www.um.edu.mt, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bent T, 2003, J ACOUST SOC AM, V114, P1600, DOI 10.1121/1.1603234; Bissiri MP, 2009, SPEECH COMMUN, V51, P933, DOI 10.1016/j.specom.2009.03.001; Boersma P., 2018, PRAAT DOING PHONETIC; Bohn O. S., 1992, STUD SECOND LANG ACQ, P131, DOI DOI 10.1017/S0272263100010792; Carey MD, 2011, LANG TEST, V28, P201, DOI 10.1177/0265532210393704; Ding SJ, 2019, SPEECH COMMUN, V115, P51, DOI 10.1016/j.specom.2019.10.005; Draxler Cristoph, 2004, P 4 INT C LANG RES E, P559; Eger NA, 2019, J EXP PSYCHOL LEARN, V45, P552, DOI 10.1037/xlm0000599; FLEGE JE, 1995, J ACOUST SOC AM, V97, P3125, DOI 10.1121/1.413041; Hanulikova A, 2012, ATTEN PERCEPT PSYCHO, V74, P613, DOI 10.3758/s13414-011-0259-7; Hayes-Harb R, 2008, J PHONETICS, V36, P664, DOI 10.1016/j.wocn.2008.04.002; Imai S, 2003, J ACOUST SOC AM, V113, P2255, DOI [10.1121/1.4780439, DOI 10.1121/1.4780439]; Isaacs T, 2012, STUD SECOND LANG ACQ, V34, P475, DOI 10.1017/S0272263112000150; JOHN OP, 1994, J PERS SOC PSYCHOL, V66, P206, DOI 10.1037/0022-3514.66.1.206; Kuznetsova A., 2015, R PACKAGE VERSION, V2, P408, DOI [10.1080/09588220802447651, DOI 10.1080/09588220802447651]; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levine J., 2018, TDM, P1, DOI [10.1002/9781118784235.eelt0002, DOI 10.13140/RG.2.2.17512.11521, 10.13140/RG.2.2.17512.11521]; Li AK, 2014, STUD SECOND LANG ACQ, V36, P223, DOI 10.1017/S0272263113000752; Llompart M, 2019, LANG SPEECH, V62, P594, DOI 10.1177/0023830918803978; Montoya RM, 2017, PSYCHOL BULL, V143, P459, DOI 10.1037/bul0000085; MUNRO MJ, 1995, LANG LEARN, V45, P73, DOI 10.1111/j.1467-1770.1995.tb00963.x; Munro MJ, 1999, LANG LEARN, V49, P285, DOI 10.1111/0023-8333.49.s1.8; Neri A, 2008, COMPUT ASSIST LANG L, V21, P393, DOI 10.1080/09588220802447651; Norris D, 2003, COGNITIVE PSYCHOL, V47, P204, DOI 10.1016/S0010-0285(03)00006-9; Peabody M, 2006, LECT NOTES COMPUT SC, V4274, P602; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Reinisch E, 2013, J EXP PSYCHOL HUMAN, V39, P75, DOI 10.1037/a0027979; Reinisch E, 2012, J ACOUST SOC AM, V132, P1165, DOI 10.1121/1.4730884; Samuel AG, 2009, ATTEN PERCEPT PSYCHO, V71, P1207, DOI 10.3758/APP.71.6.1207; Schmid MS, 2014, LANG TEST, V31, P367, DOI 10.1177/0265532214526175; Schuerman WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129731; Sidaras SK, 2009, J ACOUST SOC AM, V125, P3306, DOI 10.1121/1.3101452; Smith BL, 2009, J PHONETICS, V37, P257, DOI 10.1016/j.wocn.2009.03.001; Sullivan Gail M, 2013, J Grad Med Educ, V5, P541, DOI 10.4300/JGME-5-4-18; THOMPSON I, 1991, LANG LEARN, V41, P177, DOI 10.1111/j.1467-1770.1991.tb00683.x; van Leussen JW, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01000; van Maastricht L, 2016, LANG LEARN, V66, P124, DOI 10.1111/lang.12141; van Wijngaarden SJ, 2001, SPEECH COMMUN, V35, P103, DOI 10.1016/S0167-6393(00)00098-4; vanBezooijen R, 1995, LANG SPEECH, V38, P253, DOI 10.1177/002383099503800303; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392; WHITE L, 2003, BILINGUALISM LANGUAG, V0006; Winke P, 2013, LANG TEST, V30, P231, DOI 10.1177/0265532212456968; Witteman MJ, 2013, ATTEN PERCEPT PSYCHO, V75, P537, DOI 10.3758/s13414-012-0404-y; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	45	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0227643	10.1371/journal.pone.0227643	http://dx.doi.org/10.1371/journal.pone.0227643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9HH	32032377	gold, Green Published			2022-12-26	WOS:000534626100005
J	Reyes-Ledezma, JL; Uribe-Ramirez, D; Cristiani-Urbina, E; Morales-Barrera, L				Lizeth Reyes-Ledezma, Jessica; Uribe-Ramirez, Daniel; Cristiani-Urbina, Eliseo; Morales-Barrera, Liliana			Biosorptive removal of acid orange 74 dye by HCl-pretreated Lemna sp.	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; SYNTHETIC DYES; METHYL VIOLET; AQUATIC WEEDS; ANIONIC DYES; ADSORPTION; DUCKWEED; DECOLORIZATION; WASTEWATERS; SORPTION	Acid orange 74 (AO74) is a chromium-complex monoazo acid dye widely used in the textile industry. Due to being highly toxic and non-biodegradable, it must be removed from polluted water to protect the health of people and the environment. The aim of this study was two-fold: to evaluate the biosorption of AO74 from an aqueous solution by utilizing HCl-pretreated Lemna sp. (HPL), and to examine dye desorption from the plant material. The maximum capacity of AO74 biosorption (64.24 mg g(-1)) was reached after 4 h at the most adequate pH, which was 2. The biosorption capacity decreased 25% (to 48.18 mg g(-1)) during the second biosorption/desorption cycle and remained essentially unchanged during the third cycle. The pseudo-second-order kinetics model concurred well with the experimental results of assays involving various levels of pH in the eluent solution and distinct initial concentrations of AO74. NaOH (0.01 M) was the best eluent solution. The Toth isotherm model best described AO74 biosorption equilibrium data. FTIR analysis confirmed the crucial role of HPL proteins in AO74 biosorption. SEM-EDX and CLSM techniques verified the effective biosorption/desorption of the dye during the three cycles. Therefore, HPL has potential for the removal of AO74 dye from wastewaters.	[Lizeth Reyes-Ledezma, Jessica; Uribe-Ramirez, Daniel; Cristiani-Urbina, Eliseo; Morales-Barrera, Liliana] Inst Politecn Nacl, Dept Ingn Bioquim, Escuela Nacl Ciencias Biol, Unidad Profes Adolfo Lopez Mateos, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico	Morales-Barrera, L (corresponding author), Inst Politecn Nacl, Dept Ingn Bioquim, Escuela Nacl Ciencias Biol, Unidad Profes Adolfo Lopez Mateos, Mexico City, DF, Mexico.	lilianamor@prodigy.net.mx	MORALES-BARRERA, LILIANA/GSD-2320-2022; Morales-Barrera, Liliana/GSD-2373-2022	Morales-Barrera, Liliana/0000-0003-2656-6937; Cristiani-Urbina, Eliseo/0000-0002-8470-0711				Adegoke KA, 2015, WATER RESOUR IND, V12, P8, DOI 10.1016/j.wri.2015.09.002; Akar ST, 2011, CHEM ENG J, V168, P125, DOI 10.1016/j.cej.2010.12.049; Albrecht R. M., 2018, BASIC CONFOCAL MICRO, P99, DOI DOI 10.1007/978-3-319-97454-5_5; Alvarado S, 2008, BIORESOURCE TECHNOL, V99, P8436, DOI 10.1016/j.biortech.2008.02.051; [Anonymous], 2007, IND DYES CHEM PROPER; Arango Ruíz Álvaro, 2009, Rev. Lasallista Investig., V6, P31; Asgher M, 2012, WATER AIR SOIL POLL, V223, P2417, DOI 10.1007/s11270-011-1034-z; Bhole BD, 2004, CURR SCI INDIA, V86, P1641; Cheng JJ, 2009, CLEAN-SOIL AIR WATER, V37, P17, DOI 10.1002/clen.200800210; Choudhury A.R., 2006, TEXTILE PREPARATION; Claus H, 2002, APPL MICROBIOL BIOT, V59, P672, DOI 10.1007/s00253-002-1047-z; Elmaci A, 2009, FRESEN ENVIRON BULL, V18, P538; Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013; Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001; Gad HMH, 2009, J HAZARD MATER, V168, P1070, DOI 10.1016/j.jhazmat.2009.02.155; Guendouz S, 2016, DESALIN WATER TREAT, V57, P4624, DOI 10.1080/19443994.2014.991944; Guerrero-Coronilla I, 2014, ENVIRON ENG MANAG J, V13, P1917; Gurbuz F, 2019, INT J ENVIRON SCI TE, V16, P8653, DOI 10.1007/s13762-019-02430-3; Gusain R, 2017, PROCESS SAF ENVIRON, V109, P233, DOI 10.1016/j.psep.2017.03.030; Han RP, 2008, J ENVIRON SCI-CHINA, V20, P1035, DOI 10.1016/S1001-0742(08)62146-4; Hernandez-Botello MT, 2020, REV MEX ING QUIM, V19, P215, DOI 10.24275/rmiq/IA501; Hubbe MA, 2019, BIORESOURCES, V14, P7582; Hyka P, 2013, BIOTECHNOL ADV, V31, P2, DOI 10.1016/j.biotechadv.2012.04.007; Jinendra Usha, 2019, Materials Science for Energy Technologies, V2, P657, DOI 10.1016/j.mset.2019.08.005; Johnson CR, 2018, CHEM GEOL, V483, P21, DOI 10.1016/j.chemgeo.2018.02.020; Kalita P, 2007, FOOD CHEM, V103, P204, DOI 10.1016/j.foodchem.2006.08.007; Berber-Villamar NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196428; Kausp D., 2010, ION EXCH LETT, V3, P19; Khataee AR, 2013, INT BIODETER BIODEGR, V83, P33, DOI 10.1016/j.ibiod.2013.04.004; Lacasse K., 2004, TEXTILE CHEM ENV DAT; Landolt E, 1987, PHYTOCHEMISTRY PHYSL, V2; Lawrence JR, 2019, MICROBES ENVIRON, V34, P76, DOI 10.1264/jsme2.ME18134; Le Marechal AM, 2012, TEXTILE FINISHING IN; Li SX, 2011, J HAZARD MATER, V186, P423, DOI 10.1016/j.jhazmat.2010.11.009; Lim LBL, 2014, ARAB J SCI ENG, V39, P6757, DOI 10.1007/s13369-014-1224-2; Lipatova IM, 2019, CARBOHYD POLYM, V209, P320, DOI 10.1016/j.carbpol.2019.01.038; Lipatova IM, 2018, CHEMOSPHERE, V212, P1155, DOI 10.1016/j.chemosphere.2018.08.158; Mckay G, 2014, CHEM ENG J, V251, P236, DOI 10.1016/j.cej.2014.04.054; Mertens D., 2005, OFFICIAL METHODS ANA, V18th ed., P1; MKandawire M., 2007, BIOREM BIODIV BIOAVA, V1, P56; Mondal S., 2018, ADV DYE REMOVAL TECH; Muradov N, 2012, BIOMASS BIOENERG, V42, P123, DOI 10.1016/j.biombioe.2012.03.003; Plazinski W, 2009, ADV COLLOID INTERFAC, V152, P2, DOI 10.1016/j.cis.2009.07.009; Rakhshaee R, 2009, J HAZARD MATER, V163, P165, DOI 10.1016/j.jhazmat.2008.06.074; Ramrakhiani L, 2011, CHEM ENG J, V171, P1060, DOI 10.1016/j.cej.2011.05.002; Reema RM, 2011, SEP SCI TECHNOL, V46, P1052, DOI 10.1080/01496395.2010.528503; Rodriguez A, 2009, WATER SCI TECHNOL, V60, P1989, DOI 10.2166/wst.2009.526; Romero-Guzman ET, 2013, CHEM ECOL, V29, P459, DOI 10.1080/02757540.2013.772589; Salleh MAM, 2011, DESALINATION, V280, P1, DOI 10.1016/j.desal.2011.07.019; Saygideger S, 2005, J HAZARD MATER, V126, P96, DOI 10.1016/j.jhazmat.2005.06.012; Sharma A, 2015, RSC ADV, V5, P43815, DOI 10.1039/c5ra04179a; Su XP, 2017, BIORESOURCES, V12, P3413, DOI 10.15376/biores.12.2.3413-3424; Suazo-Madrid A, 2011, J IND MICROBIOL BIOT, V38, P51, DOI 10.1007/s10295-010-0828-0; Tang YK, 2013, J HAZARD MATER, V244, P603, DOI 10.1016/j.jhazmat.2012.10.047; Uysal Y, 2009, INT J PHYTOREMEDIAT, V11, P591, DOI 10.1080/15226510902717648; Vieira LC, 2019, J ENVIRON RADIOACTIV, V203, P179, DOI 10.1016/j.jenvrad.2019.03.019; Young L, 1997, WATER RES, V31, P1187, DOI 10.1016/S0043-1354(96)00380-6; Zhang SP, 2016, BIORESOURCE TECHNOL, V218, P1157, DOI 10.1016/j.biortech.2016.07.086; Zhang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138820; ZHANG Y, 2013, MATH PROBL ENG, DOI DOI 10.1155/2013/; Zhao X, 2014, CARBOHYD POLYM, V111, P410, DOI 10.1016/j.carbpol.2014.04.079	61	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228595	10.1371/journal.pone.0228595	http://dx.doi.org/10.1371/journal.pone.0228595			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027708	Green Published, gold			2022-12-26	WOS:000534623800052
J	Debellut, F; Jaber, S; Bouzya, Y; Sabbah, J; Barham, M; Abu-Awwad, F; Hjaija, D; Ramlawi, A; Pecenka, C; Clark, A; Mvundura, M				Debellut, Frederic; Jaber, Samer; Bouzya, Yaser; Sabbah, Jehad; Barham, Mustafa; Abu-Awwad, Fakhr; Hjaija, Diaa; Ramlawi, Assad; Pecenka, Clint; Clark, Andrew; Mvundura, Mercy			Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC	PLOS ONE			English	Article							GLOBAL BURDEN; SYSTEMATIC ANALYSIS; DIARRHEA; DISEASE; EPIDEMIOLOGY; MORTALITY	Introduction The Palestinian Ministry of Health (MOH) started a routine rotavirus immunization program with ROTARIX in May 2016, with support for vaccine procurement and introduction provided through a global development organization. In 2018, financial responsibility for rotavirus vaccine procurement was transferred to the Palestinian government, which elected to shift to ROTAVAC vaccine because of its lower price per dose. This study aims to assess the cost, impact, and cost-effectiveness of rotavirus vaccination, specifically evaluating the economic implications of the change in vaccine product, accounting for the different characteristics of each rotavirus vaccine used. Methods We conducted primary and secondary data collection to assess the introduction, procurement, supply chain, and service delivery costs related to each vaccine. We used the UNIVAC model to project costs and benefits of rotavirus vaccination over a 10-year period comparing the use of ROTARIX versus no vaccination; ROTAVAC versus no vaccination; and ROTAVAC versus ROTARIX. We undertook scenario and probabilistic analyses to capture uncertainty in some of the study parameters. We used a 3% discount rate, and all costs are in 2018 US$. Results The cost to deliver one dose was lower for ROTAVAC than ROTARIX (US$2.36 versus $2.70), but the total cost per course, excluding vaccine cost, favored ROTARIX ($7.09 versus $5.39). Both vaccines had high probability of being cost-effective interventions Palestine compared to no vaccine. Because of lower vaccination program costs for ROTAVAC, however, switching from ROTARIX to ROTAVAC was cost-saving. Conclusion National decision-makers should consider systematically assessing multiple criteria beyond vaccine price when comparing the health and economic value of several products in order to fully account for all characteristics including product presentation, number of doses per course, cold chain volume, cost of delivery, and wastage.	[Debellut, Frederic] PATH, Geneva, Switzerland; [Jaber, Samer] Palestinian Minist Hlth, Nablus, West Bank, Palestine; [Bouzya, Yaser; Hjaija, Diaa; Ramlawi, Assad] Palestinian Minist Hlth, Ramallah, West Bank, Palestine; [Sabbah, Jehad] United Nations Relief & Works Agcy Palestine Refu, East Jerusalem, Palestinian Ter, Palestine; [Barham, Mustafa] Rostropovich Vishnevskaya Fdn, Ramallah, West Bank, Palestine; [Abu-Awwad, Fakhr] Rostropovich Vishnevskaya Fdn, Gaza City, Gaza, Palestine; [Pecenka, Clint; Mvundura, Mercy] PATH, Seattle, WA USA; [Clark, Andrew] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	Debellut, F (corresponding author), PATH, Geneva, Switzerland.	fdebellut@path.org		Debellut, Frederic/0000-0002-3027-2838	Bill & Melinda Gates Foundation, Seattle, WA [OPP1199552]	Bill & Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA [grant number OPP1199552]	Alnawajha SK, 2015, J HEALTH POPUL NUTR, V33, P1; [Anonymous], COMMUNICATION; Anwari P, 2018, VACCINE, V36; Bhandari N, 2014, LANCET, V383, P2136, DOI 10.1016/S0140-6736(13)62630-6; Bilcke J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006060; Brenzel L., 2013, COMMON APPROACH COST; Clark A, 2019, LANCET GLOB HEALTH, V7, pE1541, DOI 10.1016/S2214-109X(19)30412-7; Clark A, 2019, LANCET INFECT DIS, V19, P717, DOI 10.1016/S1473-3099(19)30126-4; Clark A, 2013, VACCINE, V31, pC19, DOI 10.1016/j.vaccine.2013.05.045; Griffiths UK, 2016, VACCINE, V34, P4213, DOI 10.1016/j.vaccine.2016.06.050; Hasso-Agopsowicz M, 2019, CLIN INFECT DIS; Javanbakht M, 2015, VACCINE, V33, pA192, DOI 10.1016/j.vaccine.2014.12.035; Lusvan ME, 2019, VACCINE, V37, P798, DOI 10.1016/j.vaccine.2018.12.056; Malek MA, 2010, J INFECT DIS, V202, pS12, DOI 10.1086/653579; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ngabo F, 2015, VACCINE, V33, P7357, DOI 10.1016/j.vaccine.2015.10.022; Palestinian Central Bureau of Statistics, 2015, PAL MULT IND CLUST S; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Pecenka C, 2018, VACCINE, V36, P7472, DOI 10.1016/j.vaccine.2018.10.068; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Rennert WP, 2019, J PUBLIC HEALTH-UK, V41, pE78, DOI 10.1093/pubmed/fdy101; Rheingans R, 2018, VACCINE, V36, P7780, DOI 10.1016/j.vaccine.2018.02.008; Salomon JA, 2015, ARTICLES LANCET GLOB, V3, DOI [10.1016/S2214-109X(15)00069-8, DOI 10.1016/S2214-109X]; State of Palestine, 2018, TRANSP STAT PAL; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2016, WHO PREQ VACC; World Health Organization, 2013, WKLY EPIDEMIOL, V88, P49; World Health organization. Department of Vaccines and Biologicals, 2002, GUID EST COSTS INTR; Worldbank, GROSS DOM PROD CAPT; Younis MZ, 2013, INT J HEALTH PLAN M, V28, P320, DOI 10.1002/hpm.2147; Zaraket H, 2017, VACCINE, V35, P6047, DOI 10.1016/j.vaccine.2017.09.067	32	12	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228506	10.1371/journal.pone.0228506	http://dx.doi.org/10.1371/journal.pone.0228506			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023295	Green Published, gold			2022-12-26	WOS:000534621500059
J	Mnkugwe, RH; Minzi, OS; Kinung'hi, SM; Kamuhabwa, AA; Aklillu, E				Mnkugwe, Rajabu Hussein; Minzi, Omary S.; Kinung'hi, Safari M.; Kamuhabwa, Appolinary A.; Aklillu, Eleni			Prevalence and correlates of intestinal schistosomiasis infection among school-aged children in North-Western Tanzania	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; MALARIA; AFRICA; HELMINTH; IMPACTS	Background Schistosomiasis is a neglected tropical disease that continues to cause morbidity and mortality in Sub Saharan Africa. Due to its endemicity, co-infection with malaria is common. The diseases cause anaemia and impaired nutritional status among children. We investigated the prevalence of intestinal schistosomiasis and its association with malaria, anaemia and nutritional status among school children. Methods This was a cross sectional survey among 830 children in Nyamikoma village along Lake Victoria in Tanzania. A pre-tested questionnaire was used to collect socio-demographic data, history of drug use, and clinical data. Two faecal samples were collected on two consecutive days and analyzed using thick smears Kato Katz method. Diagnosis of malaria was done by malaria rapid diagnostic test, and haemoglobin concentration was determined using HemoCue. Nutritional status was assessed by anthropometric measurements. Results The overall prevalence of intestinal schistosomiasis was 90.6% (95% CI = 88.6% -92.6%). Intensity of infection was light 24.1% (200/830), moderate 38.4% (319/830) and heavy 28.1% (233/830). Pre-adolescents (<= 12 years) were more infected with intestinal schistosomiasis (93.2%) than adolescents (> 12 years) (84.7%) (p < 0.001). Prevalence of malaria was 1.7% (14/824), and that of intestinal schistosomiasis-malaria co-infection was 1.6% (13/824). The overall prevalence of anaemia was 24.6% (95%CI = 18.7% -30.5%). Severe anaemia was found in 2.3% (19/824) of study participants. The prevalence of stunting and wasting were 29.0% and 11.3%, respectively. On both univariate and multivariate regression analysis, only lower age was significantly associated intestinal schistosomiasis infection, but not anemia, malaria, stunting or wasting. However among those infected, a negative binomial regression analysis indicated independent significant association of male sex, loose stool consistency, and stunting with high eggs count/gram of stool. Conclusions Despite several rounds of annual mass praziquantel administration, intestinal schistosomiasis is highly prevalent among school children particularly in younger children living in the study area. Biannual targeted mass praziquantel treatments or alternative regimens may be considered in future in the study area to redress the situation.	[Mnkugwe, Rajabu Hussein] Muhimbili Univ Hlth & Allied Sci, Sch Med, Dept Clin Pharmacol, Dar Es Salaam, Tanzania; [Mnkugwe, Rajabu Hussein; Aklillu, Eleni] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Minzi, Omary S.; Kamuhabwa, Appolinary A.] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dept Clin Pharm & Pharmacol, Dar Es Salaam, Tanzania; [Kinung'hi, Safari M.] Mwanza Res Ctr, Natl Inst Med Res NIMR, Mwanza, Tanzania	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Karolinska University Hospital; Muhimbili University of Health & Allied Sciences; National Institute of Medical Research	Mnkugwe, RH (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Med, Dept Clin Pharmacol, Dar Es Salaam, Tanzania.; Mnkugwe, RH (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden.	rajabu.mnkugwe@ki.se	Aklillu, Eleni/ABG-3461-2021	Mnkugwe, Rajabu/0000-0002-0746-3169	Swedish International Development Cooperation Agency (Sida) for capacity building at MUHAS	Swedish International Development Cooperation Agency (Sida) for capacity building at MUHAS	The study received financial support from the Swedish International Development Cooperation Agency (Sida) for capacity building at MUHAS and formed part of the PhD training program for RHM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenowo AF, 2015, BRAZ J INFECT DIS, V19, P196, DOI 10.1016/j.bjid.2014.11.004; Ahmed AM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-108; [Anonymous], 2013, SCHIST PROGR REP 200; Baird S, 2016, Q J ECON, V131, P1637, DOI 10.1093/qje/qjw022; Bangert M, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0288-0; Bergquist R, 2018, TROP MED INFECT DIS, V3, DOI 10.3390/tropicalmed3040125; Booth M, 2006, TRENDS PARASITOL, V22, P359, DOI 10.1016/j.pt.2006.06.007; Brolan Claire E, 2017, BMJ Glob Health, V2, pe000353, DOI 10.1136/bmjgh-2017-000353; Garba A, 2013, ACTA TROP, V128, P334, DOI 10.1016/j.actatropica.2012.08.008; Hotez PJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003618; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Inobaya MT, 2014, RES REP TROP MED, V5, P65, DOI 10.2147/RRTM.S44274; Kabatereine Narcis, 2014, BMC Res Notes, V7, P900, DOI 10.1186/1756-0500-7-900; Kabatereine NB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-232; Kabuyaya M, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0448-x; Kinung'hi Safari M, 2017, BMC Res Notes, V10, P583, DOI 10.1186/s13104-017-2904-2; Kinung'hi SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086510; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Matangila R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110789; Mazigo HD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-274; Mazigo HD, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-44; Mbah MLN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003234; Mboera LEG, 2011, ACTA TROP, V120, P95, DOI 10.1016/j.actatropica.2011.06.007; Ministry of Health CD MoH/Zanzibar M of H- NBS/Tanzania NB of S- OCGS/Zanzibar O of CGS- ICF, 2016, TANZ DEM HLTH SURV M; Mohamed I, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006373; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Mugono M, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0612-5; Munisi David Z, 2016, J Parasitol Res, V2016, P1859737; Munisi DZ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4767-9; Munisi DZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167122; Nagi S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002991; Nankabirwa J, 2014, TROP MED INT HEALTH, V19, P1294, DOI 10.1111/tmi.12374; NBS, 2012, POP HOUS CENS; Nkrumah B, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-5; Odhiambo GO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002784; Odiere MR, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-278; OSADA M, 2011, J BIOMED BIOTECHNOL, V2011, DOI DOI 10.1155/2011/264173; Samuels F, 2013, WHY NEGLECTED TROPIC; Simon GG, 2016, INT J INFECT DIS, V42, P54, DOI 10.1016/j.ijid.2015.11.006; Sousa-Figueiredo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033189; Spencer SA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2249-7; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; Tchuente LAT, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0256-8; The Ministry of Health Community development Gender Elderly and Children (MoHCDEC), 2016, UN REP TANZ UN COMB; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; WHO, 2017, WORLD MALARIA REPORT; World Health Organization, 1991, BAS LAB METH MED PAR; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2009, WHO ANTHR SOFTW SOFT; World Health Organization, 2013, ASS EFF ANTH DRUGS S	52	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228770	10.1371/journal.pone.0228770	http://dx.doi.org/10.1371/journal.pone.0228770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023307	Green Published, gold, Green Submitted			2022-12-26	WOS:000534621500070
J	Raaf, C; Markovic, N; Tondel, M; Walinder, R; Isaksson, M				Raaf, Christopher; Markovic, Nikola; Tondel, Martin; Walinder, Robert; Isaksson, Mats			Introduction of a method to calculate cumulative age- and gender-specific lifetime attributable risk (LAR) of cancer in populations after a large-scale nuclear power plant accident	PLOS ONE			English	Article							RADIATION-EXPOSURE; CHERNOBYL DEBRIS; WEAPONS FALLOUT; CS-137	The effect of age and gender in risk estimates related to long-term residence in areas contaminated by nuclear power plant fallout was evaluated by applying the lifetime attributable risk (LAR) concept to an existing exposure model that was previously used for cumulative effective dose estimates. In this study, we investigated the influence of age distribution on the number of cancer cases by applying five different age distributions from nuclear power-producing countries (India, Japan, South Korea, and the United States), and Egypt because of intentions to develop nuclear power. The model was also used to estimate the effective dose and gender-specific LAR as a function of time after fallout for the offspring of the population living in Cs-137 fallout areas. The principal findings of this study are that the LAR of cancer incidence (excluding non-fatal skin cancers) over 70 y is about 4.5 times higher for newborn females (5.4% per MBq m(-2) of initial Cs-137 ground deposition) than the corresponding values for 30 y old women (1.2% per MBq m(-2) Cs-137 deposition). The cumulative LAR for newborn males is more than 3 times higher (3.2% versus 1.0% per MBq m(-2) Cs-137 deposition). The model predicts a generally higher LAR for women until 50 y of age, after which the gender difference converges. Furthermore, the detriment for newborns in the fallout areas initially decreases rapidly (about threefold during the first decade) and then decreases gradually with an approximate half-time of 10-12 y after the first decade. The age distribution of the exposed cohort has a decisive impact on the average risk estimates, and in our model, these are up to about 65% higher in countries with high birth rates compared to low birth rates. This trend implies larger average lifetime attributable risks in countries with a highly proportional younger population. In conclusion, the large dispersion (up to a factor of 4 between newborns and 30 y olds) in the lifetime detriment per unit ground deposition of Cs-137 over gender and age in connection with accidental nuclear releases justifies the effort in developing risk models that account for the higher radiation sensitivity in younger populations.	[Raaf, Christopher] Lund Univ, Dept Translat Med, Med Radiat Phys, Malmo, Sweden; [Markovic, Nikola; Isaksson, Mats] Sahlgrenska Acad Univ Gothenburg, Inst Clin Sci, Dept Radiat Phys, Gothenburg, Sweden; [Tondel, Martin; Walinder, Robert] Uppsala Univ, Dept Med Sci, Occupat & Environm Med, Uppsala, Sweden; [Tondel, Martin; Walinder, Robert] Uppsala Univ Hosp, Occupat & Environm Med, Uppsala, Sweden	Lund University; University of Gothenburg; Uppsala University; Uppsala University; Uppsala University Hospital	Raaf, C (corresponding author), Lund Univ, Dept Translat Med, Med Radiat Phys, Malmo, Sweden.	christopher.raaf@med.lu.se	Rääf, Christopher/I-1409-2019; Isaksson, Mats/ACH-5507-2022	Tondel, Martin/0000-0003-4469-2451; Walinder, Robert/0000-0002-8387-7881; Isaksson, Mats/0000-0001-9854-5030; Raaf, Christopher/0000-0002-9495-7166; Markovic, Nikola/0000-0003-4603-2721	Swedish Radiation Protection Authority; Swedish Civil Contingency [MSB 2017-7043]; Region Uppsala [1040418]; Uppsala University	Swedish Radiation Protection Authority; Swedish Civil Contingency; Region Uppsala; Uppsala University	This study was partly funded by the Swedish Radiation Protection Authority and the Swedish Civil Contingency, grant number MSB 2017-7043, and by the Region Uppsala, grant number 1040418, through the agreement on medical training and clinical research (ALF) with Uppsala University.	Alinaghizadeh H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011924; Almgren S, 2008, J ENVIRON RADIOACTIV, V99, P394, DOI 10.1016/j.jenvrad.2007.10.020; Almgrena S, 2008, J ENVIRON RADIOACTIV, V99, P1750, DOI 10.1016/j.jenvrad.2008.06.013; Andersson M, 2017, PHYS MED BIOL, V62, P9177, DOI 10.1088/1361-6560/aa959c; Andersson P., 2007, 200702 SSI, P02; [Anonymous], 1991, Ann ICRP, V21, P1; Bernhardsson C, 2011, SCI TOTAL ENVIRON, V409, P4811, DOI 10.1016/j.scitotenv.2011.07.066; Brown L., 1983, Radiation Protection Dosimetry, V5, P203; Bystrom S., 2000, SSIP107598; Chaisan K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02520; Edvarson K., 1991, CHERNOBYL FALLOUT SW, P47; EPA, 2011, 402R11001 EPA, P1; Falk R, 1991, CHERNOBYL FALLOUT SW, P547; Finck RR, 1992, THESIS; ICRP, 2010, ICRP PUBL, V40; Imanaka T, 2015, J RADIAT RES, V56, pI56, DOI 10.1093/jrr/rrv074; International Commission on Radiation Units and Measurements ICRU, 1992, J INT COMMISSION RAD, V24; International Commission on Radiological Protection ICRP, 1990, ICRP PUBL, V20; Isaksson M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215081; Izrael YA, 1997, RADIOECOLOGICAL CONS, P1; Jonsson M, 2017, J ENVIRON RADIOACTIV, V178, P16, DOI 10.1016/j.jenvrad.2017.07.003; Kim S, 2019, RADIAT PROT DOSIM, V184, P54, DOI 10.1093/rpd/ncy183; Leggett R, 1984, ORNLTM8265 US NUCL R; Lindgren J, 2007, MICROSOFT EXCEL TM C; Marant-Micallef C, 2019, INT J CANCER, V144, P2954, DOI 10.1002/ijc.32048; MULLER H, 1993, HEALTH PHYS, V64, P232, DOI 10.1097/00004032-199303000-00002; National Research Council of the National Academies NRC, 2006, HLTH RISKS EXP LOW L; Onda Y, 2015, J ENVIRON RADIOACTIV, V139, P300, DOI 10.1016/j.jenvrad.2014.06.002; Raaf CL, 2006, SCI TOTAL ENVIRON, V367, P324, DOI 10.1016/j.scitotenv.2005.12.006; Raaf CL, 2019, J RADIOL PROT, V39, P522, DOI 10.1088/1361-6498/ab0577; Raaf CL, 2006, HEALTH PHYS, V90, P446; Richardson DB, 2018, EPIDEMIOLOGY, V29, P31, DOI [10.1097/ede.0000000000000761, 10.1097/EDE.0000000000000761]; Samuelsson C, 2019, DECONTAMINATION NUCL; Snyder WS, 1975, MIRD PAMPHLET, V11; Soumela J, 1992, 9220 SSI; Ulanowski A, 2019, RADIAT ENVIRON BIOPH, V58, P305, DOI 10.1007/s00411-019-00794-1; United Nations, 2015, WORLD POP PROSP 2015; United Nations Scientific Committee on the Effects of Atomic Radiation, 1988, UNSCEAR REP ANN D EX; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, UNSCEAR 2013 REP ANN; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216; World Health Organisation WHO, 2013, HLTH RISK ASS NUCL A; World Health Organization, 1999, STRAT APPR IND AIR P; Yasuda H, 2018, J RADIAT RES, V59, DOI 10.1093/jrr/rry020; Zankl M, 1997, CALCULATION DOSE E 7	44	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228549	10.1371/journal.pone.0228549	http://dx.doi.org/10.1371/journal.pone.0228549			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023299	Green Published, gold			2022-12-26	WOS:000534621500060
J	Wirthl, B; Kremheller, J; Schrefler, BA; Wall, WA				Wirthl, Barbara; Kremheller, Johannes; Schrefler, Bernhard A.; Wall, Wolfgang A.			Extension of a multiphase tumour growth model to study nanoparticle delivery to solid tumours	PLOS ONE			English	Article							INTERSTITIAL PRESSURE; DRUG-DELIVERY; BLOOD-VESSELS; VASCULAR NORMALIZATION; CANCER-CHEMOTHERAPY; TRANSPORT; FLUID; NANOMEDICINE; SIMULATION; BARRIERS	One of the main challenges in increasing the efficacy of conventional chemotherapeutics is the fact that they do not reach cancerous cells at a sufficiently high dosage. In order to remedy this deficiency, nanoparticle-based drugs have evolved as a promising novel approach to more specific tumour targeting. Nevertheless, several biophysical phenomena prevent the sufficient penetration of nanoparticles in order to target the entire tumour. We therefore extend our vascular multiphase tumour growth model, enabling it to investigate the influence of different biophysical factors on the distribution of nanoparticles in the tumour microenvironment. The novel model permits the examination of the interplay between the size of vessel-wall pores, the permeability of the blood-vessel endothelium and the lymphatic drainage on the delivery of particles of different sizes. Solid tumours develop a non-perfused core and increased interstitial pressure. Our model confirms that those two typical features of solid tumours limit nanoparticle delivery. Only in case of small nanoparticles is the transport dominated by diffusion, and particles can reach the entire tumour. The size of the vessel-wall pores and the permeability of the blood-vessel endothelium have a major impact on the amount of delivered nanoparticles. This extended in-silico tumour growth model permits the examination of the characteristics and of the limitations of nanoparticle delivery to solid tumours, which currently complicate the translation of nanoparticle therapy to a clinical stage.	[Wirthl, Barbara; Kremheller, Johannes; Wall, Wolfgang A.] Tech Univ Munich, Inst Computat Mech, Garching, Germany; [Schrefler, Bernhard A.] Tech Univ Munich, Inst Adv Study, Garching, Germany; [Schrefler, Bernhard A.] Univ Padua, Dept Civil Environm & Architectural Engn, Padua, Italy	Technical University of Munich; Technical University of Munich; University of Padua	Kremheller, J (corresponding author), Tech Univ Munich, Inst Computat Mech, Garching, Germany.	kremheller@lnm.mw.tum.de	Wall, Wolfgang A./I-3787-2012	Wall, Wolfgang A./0000-0001-7419-3384; Kremheller, Johannes/0000-0001-7659-3509; Wirthl, Barbara/0000-0002-3688-2952	Technical University of Munich - Institute for Advanced Study - German Excellence Initiative; TUV SUD Foundation; CITO Award, Houston Methodist Research Institute, Houston, NCI [U54 CA210181]	Technical University of Munich - Institute for Advanced Study - German Excellence Initiative; TUV SUD Foundation; CITO Award, Houston Methodist Research Institute, Houston, NCI	JK, BAS and WAW gratefully acknowledge the support of the Technical University of Munich - Institute for Advanced Study, funded by the German Excellence Initiative and the TUV SUD Foundation. BAS gratefully acknowledges the support of the CITO Award, Houston Methodist Research Institute, Houston, NCI U54 CA210181. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, BASIC PHARMACOKINETI, P54; Arpawong TE, 2013, HEALTH PSYCHOL, V32, P397, DOI 10.1037/a0028223; Bahrami B, 2017, IMMUNOL LETT, V190, P64, DOI 10.1016/j.imlet.2017.07.015; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; BOUCHER Y, 1990, CANCER RES, V50, P4478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chatterjee DK, 2011, THER DELIV, V2, P1001, DOI 10.4155/TDE.11.72; Chauhan VP, 2014, CANCER CELL, V26, P14, DOI 10.1016/j.ccr.2014.06.003; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Chou CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059135; Cui SB, 2006, ACTA MATH SCI, V26, P781, DOI 10.1016/S0252-9602(06)60104-5; Curtis LT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144888; Danhier F, 2016, J CONTROL RELEASE, V244, P108, DOI 10.1016/j.jconrel.2016.11.015; Danhier F, 2015, CANC CELL MICROENVIR, V2, P1, DOI [10.14800/ccm.808, DOI 10.14800/CCM.808]; de la Fuente JM, 2012, FRONTIERS NANOSCIENC; Dewhirst MW, 2017, NAT REV CANCER, V17, P738, DOI 10.1038/nrc.2017.93; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Ehrlich P., 1911, FOLIA SEROLOGICA, V7, P698; Feng YS, 2009, ENG COMPUT-GERMANY, V25, P3, DOI 10.1007/s00366-008-0109-y; Ferrari M, 2010, TRENDS BIOTECHNOL, V28, P181, DOI 10.1016/j.tibtech.2009.12.007; Gillies Robert J., 1999, Neoplasia (New York), V1, P197, DOI 10.1038/sj.neo.7900037; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gray WG, 2014, CHAM ADV GEOPHYS ENV; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Ho YT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00750-3; Howlader N, 2011, SEER CANC STAT REV 1, P140; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; JAIN RK, 1988, CANCER RES, V48, P2641; Kaddi CD, 2013, NANOMEDICINE-UK, V8, P1323, DOI [10.2217/NNM.13.117, 10.2217/nnm.13.117]; Kremheller J, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3253; Kremheller J, 2018, COMPUT METHOD APPL M, V340, P657, DOI 10.1016/j.cma.2018.06.009; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Mascheroni P, 2018, CURR MED CHEM, V25, P4192, DOI 10.2174/0929867324666170417120725; Mascheroni P, 2017, J THEOR BIOL, V421, P179, DOI 10.1016/j.jtbi.2017.03.027; Mascheroni P, 2016, BIOMECH MODEL MECHAN, V15, P1215, DOI 10.1007/s10237-015-0755-0; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Moghimi SM, 2018, J NANOPART RES, V20, DOI 10.1007/s11051-018-4273-8; Moore JE, 2018, ANNU REV FLUID MECH, V50, P459, DOI 10.1146/annurev-fluid-122316-045259; Muller B, 2008, PROC SPIE, V7078, DOI 10.1117/12.794157; Nabil M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150447; Nabil M, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160287; Nichols JW, 2014, J CONTROL RELEASE, V190, P451, DOI 10.1016/j.jconrel.2014.03.057; Nizzero S, 2018, TRENDS CANCER, V4, P277, DOI 10.1016/j.trecan.2018.02.008; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Purushotham S, 2010, J APPL PHYS, V107, DOI 10.1063/1.3432757; Rast L, 2010, PIERS ONLINE, V6, P5, DOI [10.2529/PIERS091218133748, DOI 10.2529/PIERS091218133748]; Rockne RC, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/ab1a09; Santagiuliana R, 2016, COMPUT METHOD APPL M, V304, P197, DOI 10.1016/j.cma.2016.02.022; Santagiuliana R., 2015, ADV MODEL SIMUL ENG, V2, P19, DOI DOI 10.1186/S40323-015-0040-X; Sciume G, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/6/065004; Sciume G, 2014, COMPUT MECH, V53, P465, DOI 10.1007/s00466-013-0956-2; Sciume G, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015005; Secomb T., 1998, 3 DIMENSIONAL NETWOR; Shipley RJ, 2010, B MATH BIOL, V72, P1464, DOI 10.1007/s11538-010-9504-9; Stewart BW., 2014, WORLD CANC REPORT 20, P350; Stohrer M, 2000, CANCER RES, V60, P4251; Stylianopoulos T, 2013, P NATL ACAD SCI USA, V110, P18632, DOI 10.1073/pnas.1318415110; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34; Terentyuk GS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3122371; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Vavourakis V, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006460; Venuta A, 2017, J MATER CHEM B, V5, P207, DOI [10.1039/c6tb01978a, 10.1039/C6TB01978A]; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Zhang YR, 2019, WIRES NANOMED NANOBI, V11, DOI 10.1002/wnan.1519; Ziemys A, 2018, J CONTROL RELEASE, V291, P99, DOI 10.1016/j.jconrel.2018.10.014	78	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228443	10.1371/journal.pone.0228443	http://dx.doi.org/10.1371/journal.pone.0228443			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023318	Green Published, Green Submitted, gold			2022-12-26	WOS:000534621500053
J	Chowdhury, F; Bin Shahid, AMS; Ghosh, PK; Rahman, M; Hassan, Z; Akhtar, MZ; Mah-E-Muneer, S; Shahrin, L; Ahmed, T; Chisti, MJ				Chowdhury, Fahmida; Bin Shahid, Abu Sadat Mohammad Sayeem; Ghosh, Probir Kumar; Rahman, Mustafizur; Hassan, Zakiul; Akhtar, Md Zubair; Mah-E-Muneer, S.; Shahrin, Lubaba; Ahmed, Tahmeed; Chisti, Mohammod Jobayer			Viral etiology of pneumonia among severely malnourished under-five children in an urban hospital, Bangladesh	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY VIRUS DETECTION; REQUIRING HOSPITALIZATION; CHILDHOOD PNEUMONIA; MORTALITY; DIARRHEA; INFANTS; RSV; INFECTIONS; CHALLENGES	Background In Bangladesh, pneumonia has a higher mortality among malnourished children aged <5 years. Evaluating pneumonia etiology among malnourished children may help improve empiric treatment guidelines. Methods During April 2015-December 2017, we conducted a case-control study among severe acute malnourished (SAM) children aged <5 years admitted to the Dhaka hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). We enrolled hospital admitted SAM children with clinical or radiological pneumonia as cases (during April 2015 to March 2017) and hospital admitted SAM children without any respiratory symptom in the past 10 days before admission as controls (during February 2016 to December 2017). We tested nasopharyngeal wash from both case and control for respiratory syncytial virus (RSV), human metapneumovirus (HMPV), influenza viruses, human parainfluenza viruses (HPIV), rhinovirus and adenovirus by singleplex real-time reverse transcriptase polymerase chain reaction. To identify the independent association of pneumonia with viral pathogens during February 2016 to March 2017, we used multivariable logistic regression for calculating adjusted odds ratios. Results We enrolled 360 cases and 334 controls. For case and control the median age was 8 months (IQR: 5-13) and 11 months (IQR: 6-18) (p = 0.001) respectively. Weight/age Z-score was -4.3 (SD +/- 0.7) for cases and -4.1 (SD +/- 1.1) for controls (p = 0.01). Among cases 68% had both clinical and radiological pneumonia, 1% had clinical pneumonia and 31% had only radiological pneumonia. Respiratory virus detection was high in cases compared to controls [69.9% (251) vs. 44.8% (148), p = 0.0001]. The most frequently detected viruses among cases were rhinoviruses (79, 22.0%) followed by RSV (32, 8.9%), adenovirus (23, 6.4%), HPIV (22, 6.1%), influenza virus (16, 4.5%), and HMPV (16, 4.5%). Among the controls, rhinoviruses (82, 24.8%) were most commonly detected one followed by adenovirus (26,7.9%), HMPV (5, 1.5%), HPIV (4, 1.2%), RSV (3, 0.9%), and influenza virus (2, 0.6%). RSV (OR 13.1; 95% CI: 1.6, 106.1), influenza virus (OR 8.7; 95% CI: 1.0, 78.9), HPIV (3.8; 95% CI: 1.0, 14.8), and HMPV (2.7; 95% CI: 1.3, 5.5) were independently associated with pneumonia while compared between 178 cases and 174 controls. Conclusion Viral etiology of pneumonia in SAM children were mainly attributable to RSV, influenza, HPIV and HMPV. Our study findings may help in planning further studies targeting vaccines or drugs against common respiratory viruses responsible for pneumonia among SAM children.	[Chowdhury, Fahmida; Ghosh, Probir Kumar; Rahman, Mustafizur; Hassan, Zakiul; Akhtar, Md Zubair; Mah-E-Muneer, S.] Int Ctr Diarrhoea Dis Res Bangladesh Icddr B, Infect Dis Div, Dhaka, Bangladesh; [Bin Shahid, Abu Sadat Mohammad Sayeem; Shahrin, Lubaba; Ahmed, Tahmeed; Chisti, Mohammod Jobayer] Int Ctr Diarrhoea Dis Res Bangladesh Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Chowdhury, F (corresponding author), Int Ctr Diarrhoea Dis Res Bangladesh Icddr B, Infect Dis Div, Dhaka, Bangladesh.	fahmida_chow@icddrb.org	Shahrin, Lubaba/AAF-1019-2020	Shahrin, Lubaba/0000-0002-5676-3280; Ghosh, Probir Kumar/0000-0003-1580-5883; Zubair Akhtar, Abu Muhammad/0000-0001-5054-9243	Centers for Disease Control and Prevention (CDC) [1U51GH00120901]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research study was funded by Centers for Disease Control and Prevention (CDC), grant number CDC Cooperative #1U51GH00120901. US CDC provided technical support in the study design and had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Ali A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074756; Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; [Anonymous], 2016, BANGL DEM HLTH SURV; [Anonymous], ANN REPORT; Anthony D., 2017, GENERATION 2030 AFRI; Ashraf H, 2012, TREATMENT CHILDHOOD; Ayieko P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047622; Benet T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145447; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chisti MJ, 2015, LANCET, V386, P1057, DOI 10.1016/S0140-6736(15)60249-5; Chisti MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093776; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Chowdhury F, 2017, PATIENT PREFER ADHER, V11, P479, DOI 10.2147/PPA.S121800; Clara W, 2012, B WORLD HEALTH ORGAN, V90, P756, DOI 10.2471/BLT.11.098202; DeByle C, 2012, J VIROL METHODS, V185, P89, DOI 10.1016/j.jviromet.2012.06.009; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Erdman DD, 2003, J CLIN MICROBIOL, V41, P4298, DOI 10.1128/JCM.41.9.4298-4303.2003; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Haynes LM, 2013, J INFECT DIS, V208, pS177, DOI 10.1093/infdis/jit512; Homaira N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147982; Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056; Iwane MK, 2011, J INFECT DIS, V204, P1702, DOI 10.1093/infdis/jir634; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jartti T, 2008, EUR RESPIR J, V32, P314, DOI 10.1183/09031936.00161907; Jonnalagadda S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171687; Manikam Logan, 2012, Paediatr Child Health (Oxford), V22, P299, DOI 10.1016/j.paed.2012.05.002; Mathisen M, 2010, PEDIATR INFECT DIS J, V29, P731, DOI 10.1097/INF.0b013e3181d9bcce; Morrow BM, 2006, J PAEDIATR CHILD H, V42, P174, DOI 10.1111/j.1440-1754.2006.00825.x; O'Brien KL, 2019, LANCET, V394, P757, DOI 10.1016/S0140-6736(19)30721-4; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Obando-Pacheco P, 2018, J INFECT DIS, V217, P1356, DOI 10.1093/infdis/jiy056; Palache A, 2015, VACCINE, V33, P5598, DOI 10.1016/j.vaccine.2015.08.082; Ramachandran P, 2012, INDIAN PEDIATR, V49, P889, DOI 10.1007/s13312-012-0221-3; Rhedin S, 2015, THORAX; Rhedin S, 2015, THORAX, V70, P847, DOI 10.1136/thoraxjnl-2015-206933; Rhedin S, 2014, PEDIATRICS, V133, pE538, DOI 10.1542/peds.2013-3042; Schmidt AC, 2001, J VIROL, V75, P4594, DOI 10.1128/JVI.75.10.4594-4603.2001; Shokrollahi MR, 2014, JUNDISHAPUR J MICROB, V7; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Suskind RM, 1990, MALNOURISHED CHILD; Unicef, 2015, COMMITTING CHILD SUR; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization, 2013, POCK BOOK HOSP CAR C; Wright PF, 2007, VACCINE, V25, P7372, DOI 10.1016/j.vaccine.2007.08.014; Wurzel DF, 2013, J CLIN VIROL, V58, P683, DOI 10.1016/j.jcv.2013.09.016; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452; Zampoli M, 2017, SAMJ S AFR MED J, V107, P123, DOI [10.7196/SAMJ.2017.v107i2.11451, 10.7196/samj.2017.v107i2.11451]; Zar HJ, 2016, LANCET RESP MED, V4, P463, DOI 10.1016/S2213-2600(16)00096-5	56	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228329	10.1371/journal.pone.0228329	http://dx.doi.org/10.1371/journal.pone.0228329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017782	gold, Green Published			2022-12-26	WOS:000534618100018
J	Tarullo, SE; Hill, RC; Hansen, KC; Behbod, F; Borges, VF; Nelson, AC; Lyons, TR				Tarullo, Sarah E.; Hill, Ryan C.; Hansen, Kirk C.; Behbod, Fariba; Borges, Virginia F.; Nelson, Andrew C.; Lyons, Traci R.			Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival	ONCOGENE			English	Article							HUMAN OVARIAN-CANCER; X-LINKED INHIBITOR; CARCINOMA IN-SITU; MOLECULAR-MECHANISMS; 7A; RESISTANCE; FIBRONECTIN; APOPTOSIS; GROWTH; CELLS	Young women diagnosed with breast cancer (BC) have poor prognosis due to increased rates of metastasis. In addition, women diagnosed within 10 years of most recent childbirth are approximately three times more likely to develop metastasis than age- and stage-matched nulliparous women. We define these cases as postpartum BC (PPBC) and propose that the unique biology of the postpartum mammary gland drives tumor progression. Our published results revealed roles for SEMA7A in breast tumor cell growth, motility, invasion, and tumor-associated lymphangiogenesis, all of which are also increased in preclinical models of PPBC. However, whether SEMA7A drives progression in PPBC remains largely unexplored. Our results presented herein show that silencing of SEMA7A decreases tumor growth in a model of PPBC, while overexpression is sufficient to increase growth in nulliparous hosts. Further, we show that SEMA7A promotes multiple known drivers of PPBC progression including tumor-associated COX-2 expression and fibroblast-mediated collagen deposition in the tumor microenvironment. In addition, we show for the first time that SEMA7A-expressing cells deposit fibronectin to promote tumor cell survival. Finally, we show that co-expression of SEMA7A/COX-2/FN predicts for poor prognosis in breast cancer patient cohorts. These studies suggest SEMA7A as a key mediator of BC progression, and that targeting SEMA7A may open avenues for novel therapeutic strategies.	[Tarullo, Sarah E.; Borges, Virginia F.; Lyons, Traci R.] CU, Dept Med, Div Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA; [Tarullo, Sarah E.; Borges, Virginia F.; Lyons, Traci R.] CU, Young Womens BC Translat Program, Anschutz Med Campus, Aurora, CO 80045 USA; [Hill, Ryan C.; Hansen, Kirk C.] CU, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO 80045 USA; [Behbod, Fariba] Univ Kansas, Med Ctr, Div Canc & Dev Biol, Kansas City, KS 66160 USA; [Borges, Virginia F.; Lyons, Traci R.] Univ Colorado, Ctr Canc, Aurora, CO 80045 USA; [Nelson, Andrew C.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Kansas; University of Kansas Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Minnesota System; University of Minnesota Twin Cities	Lyons, TR (corresponding author), CU, Dept Med, Div Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA.; Lyons, TR (corresponding author), CU, Young Womens BC Translat Program, Anschutz Med Campus, Aurora, CO 80045 USA.; Lyons, TR (corresponding author), Univ Colorado, Ctr Canc, Aurora, CO 80045 USA.	traci.lyons@cuanschutz.edu		Tarullo, Sarah/0000-0002-7551-5733	American Cancer Society [RSG 16-171-01-CSM]; NIH/NCI [R01CA211696-01A1]; NIH/CCTSI/CTSA [TL1 TR001081]	American Cancer Society(American Cancer Society); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/CCTSI/CTSA	MCF10DCIS cells were obtained from K. Polyak and A. Marusyk (Harvard University, Cambridge, MA). MDA-MB-231 cells were obtained from P. Schedin (Oregon Heath and Sciences University, Portland OR). HLF-1 cells were gifted from M. Fini (CU Anschutz Medical Campus, Denver, CO). We thank H. Ford for the pcDNA3.1 vector (CU Anschutz Medical Campus, Denver, CO) and R. Medzhitov (Yale University, New Haven, CT) for the SEMA7A-Fc overexpression vector. We also acknowledge V. Wessells, A. Elder, L. Crump, T. Wallace, C. Young, A. Stoller, M. Kobritz, and C. Hoang for technical support and advice. This work was supported by the American Cancer Society (RSG 16-171-01-CSM) and NIH/NCI (R01CA211696-01A1) to TRL and NIH/CCTSI/CTSA (TL1 TR001081) to SET.	Albrektsen G, 2005, BRIT J CANCER, V92, P167, DOI 10.1038/sj.bjc.6602302; Allegra M, 2012, MOL BIOL CELL, V23, P3873, DOI 10.1091/mbc.E12-04-0276; Asztalos S, 2010, CANCER PREV RES, V3, P301, DOI 10.1158/1940-6207.CAPR-09-0069; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Baritaki S, 2009, CANCER RES, V69, P8376, DOI 10.1158/0008-5472.CAN-09-1069; Barrett AS, 2017, J PROTEOME RES, V16, P4177, DOI 10.1021/acs.jproteome.7b00527; Black SA, 2016, ONCOGENE, V35, P5170, DOI 10.1038/onc.2016.49; Callihan EB, 2013, BREAST CANCER RES TR, V138, P549, DOI 10.1007/s10549-013-2437-x; Cerny J, 1996, EUR J IMMUNOL, V26, P2335, DOI 10.1002/eji.1830261010; Chao Y, 2012, CANCER MICROENVIRON, V5, P19, DOI 10.1007/s12307-011-0085-4; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cheng JQ, 2002, DRUG RESIST UPDATE, V5, P131, DOI 10.1016/S1368-7646(02)00003-1; Chong J, 2018, BIOINFORMATICS, V34, P4313, DOI 10.1093/bioinformatics/bty528; Crump LS, 2019, HORMONAL REGULATION; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dean JL, 2012, CELL CYCLE, V11, P2756, DOI 10.4161/cc.21195; Deep G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-37; Denkert C, 2003, CANCER-AM CANCER SOC, V97, P2978, DOI 10.1002/cncr.11437; Eke I, 2013, CANCER RES, V73, P5869, DOI 10.1158/0008-5472.CAN-13-0344; Elder AM, 2018, CANCER RES, V78, P6473, DOI 10.1158/0008-5472.CAN-18-1642; Fong KP, 2011, BLOOD, V117, pE15, DOI 10.1182/blood-2010-05-283838; Fraser M, 2003, CANCER RES, V63, P7081; Gan Y, 2011, ARTHRITIS RHEUM-US, V63, P2484, DOI 10.1002/art.30386; Garcia-Areas R, 2017, INT J ONCOL, V51, P1395, DOI 10.3892/ijo.2017.4144; Garcia-Areas R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00017; Gilmore AP, 2009, CURR OPIN CELL BIOL, V21, P654, DOI 10.1016/j.ceb.2009.05.009; Goddard ET, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6997; Goddard ET, 2018, JAMA NETWORK; Guo QC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89206; Gupta PB, 2007, CANCER RES, V67, P2062, DOI 10.1158/0008-5472.CAN-06-3895; Gurrapu S, 2018, CELL DEATH DIFFER, V25, P1259, DOI 10.1038/s41418-018-0097-4; Han SW, 2006, ONCOGENE, V25, P4341, DOI 10.1038/sj.onc.1209460; Hattar R, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2220; Hua M, 2009, P NATL ACAD SCI USA, V106, P3372, DOI 10.1073/pnas.0813306106; Jacob A, 2013, J CELL SCI, V126, P4647, DOI 10.1242/jcs.126573; Jaimes Y, 2012, J THROMB HAEMOST, V10, P1100, DOI 10.1111/j.1538-7836.2012.04708.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kinehara Y, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123093; Knowles LM, 2013, CANCER RES, V73, P6175, DOI 10.1158/0008-5472.CAN-13-0602; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Kopp MA, 2010, GLIA, V58, P1748, DOI 10.1002/glia.21045; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li JL, 2001, ENDOCRINOLOGY, V142, P370, DOI 10.1210/en.142.1.370; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Lyons TR, 2014, J CLIN INVEST, V124, P3901, DOI 10.1172/JCI73777; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Ma B, 2015, CANCER RES, V75, P487, DOI 10.1158/0008-5472.CAN-13-3339; Maller O, 2013, J CELL SCI, V126, P4108, DOI 10.1242/jcs.121590; McKeithen D, 2010, PROSTATE, V70, P982, DOI 10.1002/pros.21132; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Nichols HB, 2019, ANN INTERN MED, V170, P22, DOI 10.7326/M18-1323; Nurwidya F, 2012, CANCER RES TREAT, V44, P151, DOI 10.4143/crt.2012.44.3.151; Nurwidya Fariz, 2012, Cancer Biology Medicine, V9, P18, DOI 10.3969/j.issn.2095-3941.2012.01.003; Parkash J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7385; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pontiggia O, 2012, BREAST CANCER RES TR, V133, P459, DOI 10.1007/s10549-011-1766-x; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Rehman M, 2013, SEMIN CELL DEV BIOL, V24, P179, DOI 10.1016/j.semcdb.2012.10.005; Reilkoff RA, 2013, AM J RESP CRIT CARE, V187, P180, DOI 10.1164/rccm.201206-1109OC; Reisz JA, 2018, TRANSFUSION, V58, P2978, DOI 10.1111/trf.14936; Ristimaki A, 2002, CANCER RES, V62, P632; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Scott GA, 2009, J INVEST DERMATOL, V129, P954, DOI 10.1038/jid.2008.329; Slepicka PF, 2019, TRENDS MOL MED, V25, P866, DOI 10.1016/j.molmed.2019.06.003; Slocum E, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1142-z; Smith BN, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020017; St-Germain ME, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-7; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Uchikado Y, 2011, GASTRIC CANCER, V14, P41, DOI 10.1007/s10120-011-0004-x; Valdez KE, 2011, J PATHOL, V225, P565, DOI 10.1002/path.2969; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Welch DR, 2019, CANCER RES, V79, P3011, DOI 10.1158/0008-5472.CAN-19-0458; Xie JM, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1217-5; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	80	13	13	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2772	2785		10.1038/s41388-020-1192-9	http://dx.doi.org/10.1038/s41388-020-1192-9		FEB 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32020054	Green Accepted, Green Submitted			2022-12-26	WOS:000511084200002
J	Salmi, A; Nieminen, HJ; Canle, DV; Haeggstrom, E; Kontiola, A				Salmi, Ari; Nieminen, Heikki J.; Canle, Daniel Veira; Haeggstrom, Edward; Kontiola, Antti			Non-contact determination of intra-ocular pressure in an ex vivo porcine model	PLOS ONE			English	Article							PREVALENCE; GLAUCOMA	People suffering from glaucoma often endure high intra-ocular pressure (IOP). Methods for determining IOP either contact the eye or are unpleasant to some patients. There is therefore a need for a rapid and patient friendly non-contacting method to determine IOP. To address this need, we developed a tonometer prototype that employs spark-gap induced shock waves and a laser Doppler vibrometer (LDV) that reads the amplitude of membrane waves. The IOP was first identified from the membrane wave propagation velocity first in a custom-made ocular phantom and was then verified in ex vivo porcine eyes. The time-of-flight (TOF) of the membrane wave travelling on a hemispherical membrane was compared to reference IOP values in the sample obtained with an iCare TA01 tonometer. The shock front was characterized by high speed photography. Within one eye, the method achieved an agreement of 5 mmHg (1.96 standard deviation between the shock wave tonometer and the commercial manometer) and high method-to-method association (Pearson correlation, R-2 = 0.98). The results indicate that the presented method could potentially be developed into a non-contacting technique for measuring IOP in vivo.	[Salmi, Ari; Nieminen, Heikki J.; Canle, Daniel Veira; Haeggstrom, Edward] Univ Helsinki, Dept Phys, Div Mat Phys, Helsinki, Finland; [Canle, Daniel Veira; Kontiola, Antti] Photono Oy, Helsinki, Finland	University of Helsinki	Salmi, A (corresponding author), Univ Helsinki, Dept Phys, Div Mat Phys, Helsinki, Finland.	ari.salmi@helsinki.fi	Nieminen, Heikki J./AGX-8430-2022	Nieminen, Heikki J./0000-0001-6084-1272; Salmi, Ari/0000-0001-8768-1205; Veira Canle, Daniel/0000-0001-5863-3191				Alam SK, IEEE 1992 ULTRASONIC, P1057; Ambrozinski L, 2016, SCI REP-UK, V6, DOI 10.1038/srep38967; Badehi AP, 2004, United States Patent; US, Patent No. 6673014B2; Bisnovatyi-Kogan GS, 2016, ASTROPHYSICS+, V59, P1, DOI 10.1007/s10511-016-9410-4; Bonomi L, 2000, OPHTHALMOLOGY, V107, P998, DOI 10.1016/S0161-6420(00)00022-1; British Standards Institution, 6082512014 IEC BRIT; Chechersky V, 2000, United States patent; US, Patent No. 6030343A; Cuzzani O, 2007, United States Patent; US, Patent No. 7201720B2; Han Z, QUANTITATIVE ASSESSM; HON Y, 2017, SCI REP, V7, DOI DOI 10.1038/241598-01714750-22; ISO, 2007, 150042 ISO; Kim HJ, 2018, INT J PRECIS ENG MAN, V19, P737, DOI 10.1007/s12541-018-0088-x; Kontiola A, 2015, WO, Patent No. [2015132467 A1, 2015132467A1]; Lampsijarvi E, 2016, 2016 IEEE INT ULTRAS, P1; Masayuki TM, 2010, United States Pat-ent; US, Patent No. [20100312087A1, 20100312087A1/en]; Massie NA, 1997, [Non-contact tonometer, United States Patent; US], Patent No. 5636635A; Morris DE, 1993, NONINVASIVE MEASUREM; Occupational Safety and Health Administration, 1992, OCCUPATIONAL EXPOSUR; OSHA, LIM AIR CONT; Ruiz-Ederra J, 2005, EXP EYE RES, V81, P561, DOI 10.1016/j.exer.2005.03.014; Sanchez I, 2011, GRAEF ARCH CLIN EXP, V249, P475, DOI 10.1007/s00417-011-1617-9; Simek M, 2002, J PHYS D APPL PHYS, V35, P1171, DOI 10.1088/0022-3727/35/11/311; Smedowski A, 2014, INVEST OPHTH VIS SCI, V55, P666, DOI 10.1167/iovs.13-13172; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0227488	10.1371/journal.pone.0227488	http://dx.doi.org/10.1371/journal.pone.0227488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012155	Green Published, gold			2022-12-26	WOS:000534615800008
J	Kumar, SK; Arya, S; Aggarwal, A; Kapoor, P; Nath, A; Misra, R; Sinha, S				Kumar, Shashi Kant; Arya, Suvrat; Aggarwal, Amita; Kapoor, Prerna; Nath, Alok; Misra, Ramnath; Sinha, Sudhir			y Immune responses to Mycobacterium tuberculosis membrane-associated antigens including alpha crystallin can potentially discriminate between latent infection and active tuberculosis disease	PLOS ONE			English	Article							ANTIBODY-RESPONSES; T-CELLS; HEALTHY; PROTEIN; SPECIFICITY; RECOGNITION; ACTIVATION; AVIDITY; LEVEL; KDA	Changes in expression of membrane antigens may accompany the transition of Mycobacterium tuberculosis (Mtb) from 'dormant' to 'active' states. We have determined whether antibody and T cell responses to Mtb membrane (MtM)-associated antigens, especially the latency-induced protein alpha crystallin (Acr), can discriminate between latent tuberculosis infection (LTBI) and active TB (ATB) disease. Study subjects comprised a previously described cohort of healthcare workers (HCWs, n = 43) and smear-positive ATB patients (n = 10). HCWs were further categorized as occupational contacts (OC, n = 30), household contacts of TB (HC, n = 8) and cured TB (CTB, n = 5). Levels (Delta OD) of serum antibody isotypes (IgG, IgA and IgM) were determined by ELISA and blood T cell proliferative responses were determined by flow cytometry using Ki67 protein as marker for DNA synthesis. Antibodies to MtM and Acr were predominantly IgG and their levels in HCWs and ATB did not differ significantly. However, HCWs showed a significantly higher level of anti-MtM IgM and a significantly lower level of anti-Acr IgA antibodies than the ATB patients. Also, a larger proportion of HCWs showed a high (> 1)Delta ODAcr/Delta ODMtM ratio for IgG. HCWs also showed a higher, though not significantly different from ATB, avidity of anti-MtM (IgG) antibodies. A higher proportion of HCWs (35% of OC, 62.5% of HC and 20% of CTB), compared with ATB (10%) showed a positive T cell response to Acr along with significant difference (P <0.05) between HC and ATB. A significant correlation (r = 0.60, P <0.0001) was noted between T cell responses of HCWs towards Acr and MtM (reported earlier by us) and both responses tended to decline with rising exposure to the infection. Even so, positive responses to Acr (38.5%) were significantly lower than to MtM (92%). Neither antibody nor T cell responses to either antigen appeared affected by BCG vaccination or reactivity to tuberculin. Results of the study suggest that the levels of IgM antibodies to MtM, IgA antibodies to Acr and proliferative T cell responses to both the antigens can potentially discriminate between LTBI and active TB disease. They also underscore the necessity of SOPs for antibody assays.	[Kumar, Shashi Kant; Arya, Suvrat; Aggarwal, Amita; Misra, Ramnath; Sinha, Sudhir] Sanjay Gandhi Postgrad Inst Med Sci, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India; [Kapoor, Prerna] Sanjay Gandhi Postgrad Inst Med Sci, DOTS Ctr, Lucknow, Uttar Pradesh, India; [Nath, Alok] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pulm Med, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Sinha, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India.	ssinha@sgpgi.ac.in	Sinha, Sudhir/C-7268-2009	Sinha, Sudhir/0000-0003-3149-1116				Abebe F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190989; [Anonymous], 2011, COMM SER TESTS DIAGN; Arias-Bouda LMP, 2003, CLIN DIAGN LAB IMMUN, V10, P702, DOI 10.1128/CDLI.10.4.702-709.2003; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Arya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204429; Awoniyi DO, 2017, ONCOTARGET, V8, P37525, DOI 10.18632/oncotarget.16401; BOTHAMLEY GH, 1992, THORAX, V47, P270, DOI 10.1136/thx.47.4.270; BOTHAMLEY GH, 1992, J INFECT DIS, V166, P182, DOI 10.1093/infdis/166.1.182; Byeon HS, 2015, J VET SCI, V16, P31, DOI [10.4142/jvs.2015.16.1.25, 10.4142/jvs.2015.16.1.31]; CARTER PH, 1992, CYTOMETRY, V13, P68, DOI 10.1002/cyto.990130111; Castro-Garza J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181714; CHANDRAMUKI A, 1989, J CLIN MICROBIOL, V27, P821, DOI 10.1128/JCM.27.5.821-825.1989; CONGER JD, 1988, J IMMUNOL METHODS, V106, P181, DOI 10.1016/0022-1759(88)90195-0; Davidow A, 2005, INFECT IMMUN, V73, P6846, DOI 10.1128/IAI.73.10.6846-6851.2005; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; DEVRIES DD, 1992, ANN RHEUM DIS, V51, P783, DOI 10.1136/ard.51.6.783; FUJII K, 1989, J IMMUNOL METHODS, V124, P63; Gaikwad AN, 2008, CLIN EXP IMMUNOL, V151, P414, DOI 10.1111/j.1365-2249.2007.03585.x; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; HUSSAIN R, 1995, CLIN DIAGN LAB IMMUN, V2, P726, DOI 10.1128/CDLI.2.6.726-732.1995; JACKETT PS, 1988, J CLIN MICROBIOL, V26, P2313, DOI 10.1128/JCM.26.11.2313-2318.1988; Khayyam Khalid Umer, 2010, Indian J Tuberc, V57, P192; Klimashevskaya S, 2007, J CLIN MICROBIOL, V45, P3400, DOI 10.1128/JCM.01012-07; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kumar SK, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150171; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Legesse M, 2013, SCAND J IMMUNOL, V78, P266, DOI 10.1111/sji.12080; Li HF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39402-z; Lu LL, 2019, NAT MED, V25, P977, DOI 10.1038/s41591-019-0441-3; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mehrotra J, 1999, SCAND J IMMUNOL, V50, P411, DOI 10.1046/j.1365-3083.1999.00616.x; Perley CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098938; Rabahi MF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-148; Senoputra MA, 2015, DIAGN MICR INFEC DIS, V83, P278, DOI 10.1016/j.diagmicrobio.2015.07.021; Sharma SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169539; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Silva VMC, 2003, INT J TUBERC LUNG D, V7, P478; Sinha S, 2005, MICROBIOL-SGM, V151, P2411, DOI 10.1099/mic.0.27799-0; Sireci G, 2007, CLIN VACCINE IMMUNOL, V14, P1231, DOI 10.1128/CVI.00057-07; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Talavera-Paulin M, 2016, INT J TUBERC LUNG D, V20, P1681, DOI 10.5588/ijtld.16.0250; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2017, WHOHTMTB201718; Wilkinson RJ, 1998, SCAND J IMMUNOL, V48, P403; World Health Organization, 2011, WHOHTMTB201118; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996; Ziegenbalg A, 2013, TUBERCULOSIS, V93, P448, DOI 10.1016/j.tube.2013.03.001; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330	53	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228359	10.1371/journal.pone.0228359	http://dx.doi.org/10.1371/journal.pone.0228359			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004357	gold, Green Published, Green Submitted			2022-12-26	WOS:000534614600033
J	Longchamps, RJ; Castellani, CA; Yang, SY; Newcomb, CE; Sumpter, JA; Lane, J; Grove, ML; Guallar, E; Pankratz, N; Taylor, KD; Rotter, JI; Boerwinkle, E; Arking, DE				Longchamps, Ryan J.; Castellani, Christina A.; Yang, Stephanie Y.; Newcomb, Charles E.; Sumpter, Jason A.; Lane, John; Grove, Megan L.; Guallar, Eliseo; Pankratz, Nathan; Taylor, Kent D.; Rotter, Jerome, I; Boerwinkle, Eric; Arking, Dan E.			Evaluation of mitochondrial DNA copy number estimation techniques	PLOS ONE			English	Article							PERIPHERAL-BLOOD; ASSOCIATION; DISEASE; RISK	Mitochondrial DNA copy number (mtDNA-CN), a measure of the number of mitochondrial genomes per cell, is a minimally invasive proxy measure for mitochondrial function and has been associated with several aging-related diseases. Although quantitative real-time PCR (qPCR) is the current gold standard method for measuring mtDNA-CN, mtDNA-CN can also be measured from genotyping microarray probe intensities and DNA sequencing read counts. To conduct a comprehensive examination on the performance of these methods, we use known mtDNA-CN correlates (age, sex, white blood cell count, Duffy locus genotype, incident cardiovascular disease) to evaluate mtDNA-CN calculated from qPCR, two microarray platforms, as well as whole genome (WGS) and whole exome sequence (WES) data across 1,085 participants from the Atherosclerosis Risk in Communities (ARIC) study and 3,489 participants from the Multi-Ethnic Study of Atherosclerosis (MESA). We observe mtDNA-CN derived from WGS data is significantly more associated with known correlates compared to all other methods (p < 0.001). Additionally, mtDNA-CN measured from WGS is on average more significantly associated with traits by 5.6 orders of magnitude and has effect size estimates 5.8 times more extreme than the current gold standard of qPCR. We further investigated the role of DNA extraction method on mtDNA-CN estimate reproducibility and found mtDNA-CN estimated from cell lysate is significantly less variable than traditional phenol-chloroform-isoamyl alcohol (p = 5.44x10(-4)) and silica-based column selection (p = 2.82x10(-7)). In conclusion, we recommend the field moves towards more accurate methods for mtDNA-CN, as well as re-analyze trait associations as more WGS data becomes available from larger initiatives such as TOPMed.	[Longchamps, Ryan J.; Castellani, Christina A.; Yang, Stephanie Y.; Newcomb, Charles E.; Sumpter, Jason A.; Arking, Dan E.] Johns Hopkins Univ, McKusick Nathans Inst, Dept Genet Med, Sch Med, Baltimore, MD 21205 USA; [Lane, John; Pankratz, Nathan] Univ Minnesota, Dept Lab Med & Pathol, Med Sch, Minneapolis, MN 55455 USA; [Grove, Megan L.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Dept Epidemiol, Human Genet & Environm Sci,Sch Publ Hlth, Houston, TX 77030 USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Taylor, Kent D.; Rotter, Jerome, I] Harbor UCLA Med Ctr, LABioMed, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Taylor, Kent D.; Rotter, Jerome, I] Harbor UCLA Med Ctr, Dept Pediat, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Baylor College of Medicine	Arking, DE (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst, Dept Genet Med, Sch Med, Baltimore, MD 21205 USA.	arking@jhmi.edu	Rotter, Jerome/AAY-6598-2021	Castellani, Christina/0000-0003-2737-0549; Newcomb, Charles/0000-0002-2646-7288; Taylor, Kent/0000-0002-2756-4370	US National Institutes of Health [R01HL131573]; Johns Hopkins University Claude D. Pepper Older Americans Independence Center National Institute on Aging [P30AG021334]; National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I]; National Heart, Lung, and Blood Institute [HHSN268201500003I, N01-HC 95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, N02-HL-64278]; National Center for Advancing Translational Sciences (NCATS) [UL1-TR-000040, UL1-TR-001079, UL1-TR-001420]; National Center for Advancing Translational Sciences, CTSI [UL1TR001881]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) [DK063491]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Claude D. Pepper Older Americans Independence Center National Institute on Aging; National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences, CTSI; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC)	This research was supported by grant R01HL131573 from the US National Institutes of Health (Longchamps, Castellani, Guallar, and Arking) and by grant P30AG021334 from the Johns Hopkins University Claude D. Pepper Older Americans Independence Center National Institute on Aging (Dr Arking). The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I). The Multi-Ethnic Study of Atherosclerosis is supported by contracts HHSN268201500003I, N01-HC 95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420 from the National Center for Advancing Translational Sciences (NCATS). Dr. Rotter and Dr. Taylor's efforts were supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR001881, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. Funding for SHARe genotyping was provided by National Heart, Lung, and Blood Institute contract N02-HL-64278. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683; Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3; Cai N, 2015, CURR BIOL, V25, P3170, DOI 10.1016/j.cub.2015.10.065; Chanda P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068585; Chen SY, 2014, ATHEROSCLEROSIS, V237, P220, DOI 10.1016/j.atherosclerosis.2014.08.051; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]; Gomez-Serrano M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1435934; Gouhier TC, 2014, METHODS ECOL EVOL, V5, P524, DOI 10.1111/2041-210X.12188; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Hertweck KL, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00262; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hurtado-Roca Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163770; Keller MF, 2014, HUM MOL GENET, V23, P6944, DOI 10.1093/hmg/ddu401; Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175; Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7; Li B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29621-1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Memon Ashfaque A, 2017, Biomol Detect Quantif, V13, P32, DOI 10.1016/j.bdq.2017.08.001; Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671; Nacheva E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180467; Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887; Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033; Qian Y, 2017, BIOINFORMATICS, V33, P1399, DOI 10.1093/bioinformatics/btw835; Quan PL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041271; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927; Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T; Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661; Wei W., 2017, ACTA NEUROPATHOL COM, V5; Ye W, 2017, ANAL BIOANAL CHEM, V409, P2727, DOI 10.1007/s00216-017-0217-x; Yu B, 2015, CIRC-CARDIOVASC GENE, V8, P351, DOI 10.1161/CIRCGENETICS.114.000697; Zhang YH, 2017, MITOCHONDRIAL DNA A, V28, P725, DOI 10.1080/24701394.2016.1177038	35	39	40	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228166	10.1371/journal.pone.0228166	http://dx.doi.org/10.1371/journal.pone.0228166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004343	Green Published, Green Submitted, gold			2022-12-26	WOS:000534614600022
J	Tcheandjieu, C; Cordina-Duverger, E; Mulot, C; Baron-Dubourdieu, D; Guizard, AV; Schvartz, C; Laurent-Puig, P; Guenel, P; Truong, T				Tcheandjieu, Catherine; Cordina-Duverger, Emilie; Mulot, Claire; Baron-Dubourdieu, Dominique; Guizard, Anne-Valerie; Schvartz, Claire; Laurent-Puig, Pierre; Guenel, Pascal; Truong, Therese			Role of GSTM1 and GSTT1 genotypes in differentiated thyroid cancer and interaction with lifestyle factors: Results from case-control studies in France and New Caledonia	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; COPY NUMBER VARIATION; BODY-MASS INDEX; ALCOHOL-CONSUMPTION; POOLED ANALYSIS; RISK-FACTORS; GENETIC POLYMORPHISMS; SMOKING; M1; OBESITY	Background GSTM1 and GSTT1 are involved in detoxification of xenobiotics, products of oxidative stress and in steroid hormones metabolism. We investigated whether GSTM1 and GSTT1 gene deletion was associated with DTC risk and explored interaction with non-genetic risk factors of DTC. Methods The study included 661 DTC cases and 736 controls from two case-control studies conducted in France and New Caledonia. Odds ratios (OR) and their confidence interval (CI) for DTC associated with GST genotypes, alcohol drinking, tobacco smoking, body mass index and hormonal factors were calculated using logistic regression models. Results Results are presented for Europeans and Melanesians combined, as no heterogeneity between groups was detected. We found that DTC risk increased with obesity and decrease with alcohol drinking. After stratification by gene deletion status, the OR for obesity was 5.75, (95%CI 2.25-14.7) among individuals with GSTT1 and GSTM1-deleted genotype, and 1.26, (95%CI 0.89-1.77) in carriers of both genes (p-interaction = 0.02). The OR for drinking.1 glass/week was 0.33 (95%CI 0.15-0.74) in GSTT1-null individuals while it was 1.01 (95%CI 0.67-1.52) in non-null carriers of the gene (p-interaction = 0.01). No interaction between GST genotypes and other non-genetic risk factors was detected. Conclusion GSTM1 and GSTT1 genotypes may modulate the DTC risk associated with BMI and alcohol consumption.	[Tcheandjieu, Catherine; Cordina-Duverger, Emilie; Guenel, Pascal; Truong, Therese] Univ Paris Saclay, UVSQ, INSERM, CESP, Villejuif, France; [Mulot, Claire; Laurent-Puig, Pierre] Univ Paris Diderot, Sorbonne Univ, Ctr Rech Cordeliers, INSERM,USPC,Univ Paris Descartes,EPIGENETEC, Paris, France; [Baron-Dubourdieu, Dominique] Lab Anat & Cytopathol, Noumea, New Caledonia, New Caledonia; [Guizard, Anne-Valerie] Ctr Francois Baclesse, Registre Gen Tumeurs Calvados, Caen, France; [Guizard, Anne-Valerie] INSERM UCN ANTICIPE, U1086, Caen, France; [Schvartz, Claire] Registre Specialise Canc Thyroide Marne Ardennes, Reims, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Centre Francois Baclesse; Universite de Caen Normandie	Guenel, P; Truong, T (corresponding author), Univ Paris Saclay, UVSQ, INSERM, CESP, Villejuif, France.	pascal.guenel@inserm.fr; therese.truong@inserm.fr	Tcheandjieu, Catherine/AAH-1861-2020; Guenel, Pascal/AAS-7688-2021; truong, therese/A-2837-2013; GUIZARD, Anne-Valérie/L-7252-2015	Guenel, Pascal/0000-0002-8359-518X; truong, therese/0000-0002-2943-6786; 	Fondation de France; Association pour la Recherche contre le Cancer (ARC); Agence Francaise de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES); ANSES, Ligue Nationale Contre le Cancer, Institut National du Cancer; Epidemiology Committee of EDF	Fondation de France(Fondation de France); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Francaise de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES); ANSES, Ligue Nationale Contre le Cancer, Institut National du Cancer; Epidemiology Committee of EDF	The New Caledonia study was supported by grants from Fondation de France, Association pour la Recherche contre le Cancer (ARC), and Agence Francaise de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES, ex-AFSSET). The CATHY study was supported by grants from the ANSES, Ligue Nationale Contre le Cancer, Institut National du Cancer, Fondation de France, and the Epidemiology Committee of EDF. Catherine Tcheandjieu performed this work during her PhD studies with the support of Ecole des Hautes Etudes en Sante Publique (EHESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/103515; Cho YA, 2014, CANCER CAUSE CONTROL, V25, P1187, DOI 10.1007/s10552-014-0422-2; Clero E, 2010, THYROID, V20, P1285, DOI 10.1089/thy.2009.0456; Colonna M, 2015, CANCER EPIDEMIOL, V39, P511, DOI 10.1016/j.canep.2015.04.015; Cordina-Duverger E, 2017, CANCER EPIDEMIOL, V48, P78, DOI 10.1016/j.canep.2017.04.001; Ferlay J, GLOBOCAN 2012 V1 0 C, V11; Guignard R, 2007, AM J EPIDEMIOL, V166, P1140, DOI 10.1093/aje/kwm204; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Hemminki K, 1999, EUR J CANCER, V35, P1109, DOI 10.1016/S0959-8049(99)00066-0; Hermann D, 2002, ADDICTION, V97, P1369, DOI 10.1046/j.1360-0443.2002.00200.x; Hong S-H, 2016, CANC RES TREAT; Horn-Ross PL, 2011, CANCER EPIDEM BIOMAR, V20, P1751, DOI 10.1158/1055-9965.EPI-11-0381; Huang PC, 2010, HUM REPROD, V25, P986, DOI 10.1093/humrep/deq015; Huang RS, 2009, HUM MOL GENET, V18, P366, DOI 10.1093/hmg/ddn345; Kabat GC, 2012, CANCER EPIDEMIOL, V36, P335, DOI 10.1016/j.canep.2012.03.013; Kitahara CM, 2016, NAT REV ENDOCRINOL, V12, P646, DOI 10.1038/nrendo.2016.110; Kitahara CM, 2014, CANCER RES, V74, P235, DOI 10.1158/0008-5472.CAN-13-2228; Kitahara CM, 2012, CANCER CAUSE CONTROL, V23, P1615, DOI 10.1007/s10552-012-0039-2; Kitahara CM, 2011, CANCER EPIDEM BIOMAR, V20, P464, DOI 10.1158/1055-9965.EPI-10-1220; Kweon SS, 2014, MOL BIOL REP, V41, P3793, DOI 10.1007/s11033-014-3245-z; Landa I, 2011, J MOL ENDOCRINOL; Lao XJ, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0127-3; Leux C, 2010, REV EPIDEMIOL SANTE, V58, P359, DOI 10.1016/j.respe.2010.05.005; Li JL, 2012, CANCER EPIDEMIOL, V36, pE333, DOI 10.1016/j.canep.2012.06.002; Mansoori Abdul Anvesh, 2015, Asian Pac J Cancer Prev, V16, P4803; Marcello MA, 2014, ENDOCR-RELAT CANCER, V21, pT255, DOI 10.1530/ERC-14-0070; McLellan RA, 1997, MOL PHARMACOL, V52, P958, DOI 10.1124/mol.52.6.958; Meinhold CL, 2009, BRIT J CANCER, V101, P1630, DOI 10.1038/sj.bjc.6605337; Moore MA, 2010, ASIAN PAC J CANCER P, V11, P99; Mota P, 2015, J CANCER RES CLIN, V141, P851, DOI 10.1007/s00432-014-1868-z; Negri E, 1999, CANCER CAUSE CONTROL, V10, P143, DOI 10.1023/A:1008880429862; Norskov MS, 2011, PHARMACOGENOMICS J, V11, P292, DOI 10.1038/tpj.2010.38; Norskov MS, 2009, CLIN BIOCHEM, V42, P201, DOI 10.1016/j.clinbiochem.2008.10.020; Paiva P, 2016, MOL HUM REPROD, V22, P898, DOI 10.1093/molehr/gaw060; Pazaitou-Panayiotou K, 2013, OBES REV, V14, P1006, DOI 10.1111/obr.12070; Rebbeck TR, 1997, CANCER EPIDEM BIOMAR, V6, P733; Sen A, 2015, BRIT J CANCER, V113, P840, DOI 10.1038/bjc.2015.280; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Truong T, 2005, AM J EPIDEMIOL, V161, P1056, DOI 10.1093/aje/kwi136; Truong T, 2007, EUR J CANCER PREV, V16, P62, DOI 10.1097/01.cej.0000236244.32995.e1; Vaccarella S, 2015, THYROID, V25, P1127, DOI 10.1089/thy.2015.0116; Valeix P, 2008, CLIN ENDOCRINOL, V68, P988, DOI 10.1111/j.1365-2265.2007.03123.x; Xhaard C, 2014, AM J EPIDEMIOL; Zamora-Ros R, 2015, INT J CANCER, V136, P1218, DOI 10.1002/ijc.29067; Zheng T, 2003, BRIT J CANCER, V88, P58, DOI 10.1038/sj.bjc.6600708	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228187	10.1371/journal.pone.0228187	http://dx.doi.org/10.1371/journal.pone.0228187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999731	Green Published, gold			2022-12-26	WOS:000534612400053
J	Shen, JJ; Zhai, J; You, Q; Zhang, GX; He, MF; Yao, XQ; Shen, LZ				Shen, Jiajia; Zhai, Jing; You, Qiang; Zhang, Guoxin; He, Mingfang; Yao, Xuequan; Shen, Lizong			Cancer-associated fibroblasts-derived VCAM1 induced by H. pylori infection facilitates tumor invasion in gastric cancer	ONCOGENE			English	Article							CELL-ADHESION MOLECULE-1; HELICOBACTER-PYLORI; EXPRESSION; PROGNOSIS	Cancer-associated fibroblasts (CAFs) play a major role in the progression of stomach cancer, but the related mechanisms are not fully understood. H. pylori infection is recognized as one of the strongest risk factors for gastric carcinoma, but its effects on CAFs remain unknown. We aimed to determine the causative relationship between H. pylori infection in fibroblasts and the promoted cancer pathogenesis and progression in gastric cancer. Primary CAFs and normal activated fibroblasts (NAFs) were generated from gastric cancer patients. Gene signature of H. pylori-infected human stomach fibroblasts was performed using the RNA-seq analysis. Spheroid cell invasion assay and zebrafish cell line-derived xenograft (zCDX) model were introduced to evaluate tumor invasion induced by CAFs. The molecule interactions were determined using the kinetic binding analysis with the Biolayer Interferometry (BLI). Clinical significance and relevance were also assessed using the database analyses. H. pylori infection activated stomach fibroblasts and caused multiple gene alterations, including vascular adhesion molecule 1 (VCAM1). H. pylori infection increased VCAM1 expression in CAFs in gastric carcinoma via activation of JAK/STAT1 signaling pathway, and VCAM1 levels were positively associated with tumor progression and dismal prognosis in stomach cancer patients. Furthermore, CAFs-derived VCAM1 molecularly interacted with integrin alpha v beta 1/5 in gastric cancer cells facilitated tumor invasion in vitro and in vivo. Our results identify a novel mechanism underlying CAFs to promote tumor invasion during H. pylori infection. These studies facilitate us for a better understanding of the molecular process of gastric carcinoma progression, and provide the potential strategies for gastric cancer therapy.	[Shen, Jiajia; Shen, Lizong] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Div Gastrointestinal Surg, Nanjing 210029, Peoples R China; [Zhai, Jing; Yao, Xuequan] Nanjing Univ Chinese Med, Affiliated Hosp, Jiangsu Prov Hosp Chinese Med, Dept Surg Oncol, Nanjing 210029, Peoples R China; [You, Qiang] Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing 210003, Peoples R China; [Zhang, Guoxin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing 210029, Peoples R China; [He, Mingfang] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Inst Translat Med, Nanjing 211800, Peoples R China	Nanjing Medical University; Nanjing University of Chinese Medicine; Nanjing Medical University; Nanjing Medical University; Nanjing Tech University	Shen, LZ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Div Gastrointestinal Surg, Nanjing 210029, Peoples R China.	shenlz@njmu.edu.cn		You, Qiang/0000-0003-3308-4127	National Natural Science Foundation of China [81272711, 81871959]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]; Key Medical Talents Program of Jiangsu Province [ZDRCA2016014]; Key R&D Program of Jiangsu Province (Social Development) [BE2018758]; Programs of Jiangsu Province Hospital of Chinese Medicine [Y2018RC14, Y2018CX71]; Jiangsu Graduate Research Innovation Program [KYCX18_1479]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Key Medical Talents Program of Jiangsu Province; Key R&D Program of Jiangsu Province (Social Development); Programs of Jiangsu Province Hospital of Chinese Medicine; Jiangsu Graduate Research Innovation Program	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81272711 and 81871959 to LS), the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801 to LS), the Key Medical Talents Program of Jiangsu Province (ZDRCA2016014 to LS), the Key R&D Program of Jiangsu Province (Social Development, BE2018758 to LS), the Programs of Jiangsu Province Hospital of Chinese Medicine (Y2018RC14 to LS and Y2018CX71 to JZ), and the Jiangsu Graduate Research Innovation Program (KYCX18_1479 to JS).	Attieh Y, 2017, J CELL BIOL, V216, P3509, DOI 10.1083/jcb.201702033; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cerutti C, 2017, EXP CELL RES, V358, P31, DOI 10.1016/j.yexcr.2017.06.003; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Coburn N, 2018, CANCER TREAT REV, V63, P104, DOI 10.1016/j.ctrv.2017.12.006; Crowe SE, 2019, NEW ENGL J MED, V380, P1158, DOI 10.1056/NEJMcp1710945; Fujii S, 2015, CANCER MED-US, V4, P1667, DOI 10.1002/cam4.515; Galamb O, 2008, HELICOBACTER, V13, P112, DOI 10.1111/j.1523-5378.2008.00584.x; Horvat A, 2018, ONCOGENE, V37, P5054, DOI 10.1038/s41388-018-0343-8; Huelsken J, 2018, CELL, V172, P643, DOI 10.1016/j.cell.2018.01.028; Ishimoto T, 2017, GASTROENTEROLOGY, V153, P191, DOI 10.1053/j.gastro.2017.03.046; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Karakasheva TA, 2018, CANCER RES, V78, P4957, DOI 10.1158/0008-5472.CAN-17-2268; Kiga K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5497; Kong DH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041057; Krzysiek-Maczka G, 2013, J PHYSIOL PHARMACOL, V64, P77; Krzysiek-Maczka G, 2018, HELICOBACTER, V23, DOI 10.1111/hel.12538; LeBleu VS, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.029447; Liu CJ, 2018, CANCERS, V10, DOI 10.3390/cancers10120479; Liu YS, 2017, ONCOGENE, V36, P5006, DOI 10.1038/onc.2017.129; Maeda M, 2020, GUT, V69, P243, DOI 10.1136/gutjnl-2018-317645; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Plummer M, 2015, INT J CANCER, V136, P487, DOI 10.1002/ijc.28999; RICE GE, 1989, SCIENCE, V246, P1303, DOI 10.1126/science.2588007; Satoyoshi R, 2015, ONCOGENE, V34, P650, DOI 10.1038/onc.2013.584; Scalici JM, 2017, CANCER-AM CANCER SOC, V123, P977, DOI 10.1002/cncr.30415; Schlesinger M, 2015, INT J CANCER, V136, P2504, DOI 10.1002/ijc.28927; Sharma R, 2017, CELL ONCOL, V40, P199, DOI 10.1007/s13402-017-0324-x; Sigal M, 2017, NATURE, V548, P451, DOI 10.1038/nature23642; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Terai S, 2015, GASTRIC CANCER, V18, P306, DOI 10.1007/s10120-014-0380-0; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Velikova G, 1997, BRIT J CANCER, V76, P1398, DOI 10.1038/bjc.1997.569; Wadhwa R, 2013, NAT REV CLIN ONCOL, V10, P643, DOI 10.1038/nrclinonc.2013.170; Wang XF, 2017, INT J CANCER, V141, P998, DOI 10.1002/ijc.30801; Wen JF, 2018, ONCOGENE, V37, P3549, DOI 10.1038/s41388-018-0208-1; Wu JQ, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0631-0; Yang L, 2018, CHINESE J CANCER RES, V30, P291, DOI 10.21147/j.issn.1000-9604.2018.03.01; Zhai J, 2019, CANCER LETT, V454, P37, DOI 10.1016/j.canlet.2019.04.002	42	27	29	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2961	2974		10.1038/s41388-020-1197-4	http://dx.doi.org/10.1038/s41388-020-1197-4		FEB 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32034307				2022-12-26	WOS:000511752600001
J	Sanfilippo, KRM; Spiro, N; Molina-Solana, M; Lamont, A				Sanfilippo, Katie Rose M.; Spiro, Neta; Molina-Solana, Miguel; Lamont, Alexandra			Do the shuffle: Exploring reasons for music listening through shuffled play	PLOS ONE			English	Article							SELF-REGULATION; EVERYDAY LIFE; PREFERENCES	Adults listen to music for an average of 18 hours a week (with some people reaching more than double that). With rapidly changing technology, music collections have become overwhelmingly digital ushering in changes in listening habits, especially when it comes to listening on personal devices. By using interactive visualizations, descriptive analysis and thematic analysis, this project aims to explore why people download and listen to music and which aspects of the music listening experience are prioritized when people talk about tracks on their device. Using a newly developed data collection method, Shuffled Play, 397 participants answered open-ended and closed research questions through a short online questionnaire after shuffling their music library and playing two pieces as prompts for reflections. The findings of this study highlight that when talking about tracks on their personal devices, people prioritise characterizing them using sound and musical features and associating them with the informational context around them (artist, album, and genre) over their emotional responses to them. The results also highlight that people listen to and download music because they like it-a straightforward but important observation that is sometimes glossed over in previous research. These findings have implications for future work in understanding music, its uses and its functions in peoples' everyday lives.	[Sanfilippo, Katie Rose M.] Goldsmiths Univ London, Psychol Dept, London, England; [Spiro, Neta] Royal Coll Mus, Ctr Performance Sci, London, England; [Spiro, Neta; Molina-Solana, Miguel] Imperial Coll London, London, England; [Molina-Solana, Miguel] Univ Granada, Granada, Spain; [Lamont, Alexandra] Keele Univ, Sch Psychol, Keele, Staffs, England	University of London; Goldsmiths University London; Royal College of Music - UK; Imperial College London; University of Granada; Keele University	Spiro, N (corresponding author), Royal Coll Mus, Ctr Performance Sci, London, England.; Spiro, N (corresponding author), Imperial Coll London, London, England.	neta.spiro@rcm.ac.uk	Lamont, Alexandra/AAU-7469-2021; Sanfilippo, Katie Rose/GRF-4847-2022; Molina-Solana, Miguel/F-4111-2012	Lamont, Alexandra/0000-0003-4113-1018; Molina-Solana, Miguel/0000-0001-5688-2039; Sanfilippo, Katie Rose M./0000-0003-2236-3307	EU H2020 programme [743623]; HEartS - UK's Arts and Humanities Research Council [AH/P005888/1]; Nordoff Robbins; Royal College of Music; AHRC [AH/P005888/1] Funding Source: UKRI	EU H2020 programme; HEartS - UK's Arts and Humanities Research Council; Nordoff Robbins; Royal College of Music; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This work is funded by the EU H2020 programme (ga No. 743623). NS has been supported by HEartS, a project funded by the UK's Arts and Humanities Research Council to investigate the health, economic and social impact of the arts (grant ref. AH/P005888/1) to MMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Nordoff Robbins and the Royal College of Music for supporting the project. We would also like to thank Victoria McCrea for her help with survey design, participant recruitment and data analysis; Megan Kibler and Chloe Parks for their help with data analysis; and Li-Ching Wang and Owen Coggins for help and advice throughout.	Anglada-Tort M, 2019, PSYCHOL AESTHET CREA, V13, P277, DOI 10.1037/aca0000172; Anglada-Tort M, 2019, MEMORY, V27, P612, DOI 10.1080/09658211.2018.1545858; [Anonymous], 2021, LANG ENV STAT COMP; Avdeeff M., 2012, J AUDIENCE RECEPTION, VIX, P265; Aydogan G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24528-3; Baltazar M, 2016, PSYCHOL MUSIC, V44, P1500, DOI 10.1177/0305735616663313; Belfi AM, 2016, MEMORY, V24, P979, DOI 10.1080/09658211.2015.1061012; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; COLEMAN JS, 1958, HUM ORGAN, V17, P28, DOI 10.17730/humo.17.4.q5604m676260q8n7; Gabrielsson A, 2008, STRONG EXPERIENCES M; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Greasley A, 2013, QUAL RES PSYCHOL, V10, P402, DOI 10.1080/14780887.2011.647259; Greasley AE, 2011, MUSIC SCI, V15, P45, DOI 10.1177/1029864910393417; Greb F., 2018, MUSIC SCI LOND, V1, DOI [10.1177/20592043187, DOI 10.1177/2059204318755950, 10.1177/2059204318755950]; Greb F, 2018, PSYCHOL MUSIC, V46, P763, DOI 10.1177/0305735617724883; Heye A, 2010, MUSIC SCI, V14, P95, DOI 10.1177/102986491001400104; IBM Corporation, 2017, BM SPSS STAT WIND VE; Juslin PN, 2008, EMOTION, V8, P668, DOI 10.1037/a0013505; Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008; Khatri C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118899; Knox D, 2017, PSYCHOL MUSIC, V45, P645, DOI 10.1177/0305735616670497; Krause AE, 2016, PSYCHOL POP MEDIA CU, V5, P232, DOI 10.1037/ppm0000059; Krause AE, 2014, PSYCHOL WELL-BEING, V4, DOI 10.1186/s13612-014-0022-7; Krause AE, 2015, PSYCHOL MUSIC, V43, P155, DOI 10.1177/0305735613496860; Krause AE, 2013, PSYCHOL MUSIC, V41, P531, DOI 10.1177/0305735612440612; Margulis EH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179145; Margulis EH, 2010, PSYCHOL MUSIC, V38, P285, DOI 10.1177/0305735609351921; Mas-Herrero E, 2013, MUSIC PERCEPT, V31, P118, DOI 10.1525/MP.2013.31.2.118; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; North AC, 2000, AM J PSYCHOL, V113, P43, DOI 10.2307/1423460; North AC, 2004, MUSIC PERCEPT, V22, P41, DOI 10.1525/mp.2004.22.1.41; Saarikallio S, 2011, PSYCHOL MUSIC, V39, P307, DOI 10.1177/0305735610374894; Saarikallio SH, 2019, PSYCHOL MUSIC, V47, P644, DOI 10.1177/0305735618778768; Sallavanti MI, 2016, PSYCHOL MUSIC, V44, P757, DOI 10.1177/0305735615591843; Schafer T, 2009, PSYCHOL MUSIC, V37, P279, DOI 10.1177/0305735608097247; Schafer T, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00004, DOI 10.3389/FPSYG.2013.00004]; SLOBODA J. A., 2001, MUSIC SCI, V5, P9, DOI [10.1177/102986490100500102, DOI 10.1177/102986490100500102]; Ter Bogt TFM, 2011, PSYCHOL MUSIC, V39, P147, DOI 10.1177/0305735610370223; van Goethem A, 2011, MUSIC SCI, V15, P208, DOI 10.1177/1029864911401174	39	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228457	10.1371/journal.pone.0228457	http://dx.doi.org/10.1371/journal.pone.0228457			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9GK	32027672	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000534623800037
J	Sanga, LA; Mtuy, T; Philemon, RN; Mahande, MJ				Sanga, Leah Anku; Mtuy, Tara; Philemon, Rune Nathaniel; Mahande, Michael Johnson			Inter-pregnancy interval and associated adverse maternal outcomes among women who delivered at Kilimanjaro Christian Medical Centre in Tanzania, 2000-2015	PLOS ONE			English	Article							INTERPREGNANCY INTERVAL; MORBIDITY	Inter-pregnancy interval is an important determinant of both maternal and child health. Suboptimal inter-pregnancy interval has been associated with adverse maternal outcomes-including postpartum hemorrhage and hypertensive disorders, direct causes of maternal mortality. Both overall maternal mortality and the contribution of postpartum hemorrhage on maternal mortality have increased in Tanzania. If we are to achieve sustainable development goal (SDG) number 3.1 to reduce the global maternal mortality ration to less than 70 per 100,000 live births by 2030, it is highly important that such contributors are dealt with. This study aimed to determine the distribution and trends of inter-pregnancy interval and to deduce its association with adverse maternal outcomes among women who delivered at Kilimanjaro Christian Medical Centre (2000-2015). A retrospective cohort study was designed using Kilimanjaro Christian Medical Centre medical birth registry data for women who delivered from 2000 to 2015. Women with at least two births recorded in the registry were included. A total of 7,995 births from 6,612 mothers were analyzed. Anemia during pregnancy, post-partum hemorrhage and pre-eclampsia were adverse maternal outcomes of interest. Data analysis was performed using multivariable logistic regression models allowing for robust standard errors. Crude and adjusted odds ratio with their respective 95% confidence intervals were estimated. More than half (51.7%) of non-first births were born within sub-optimal IPI. The median IPI was 34 months (IQR: 33.5 months). The median IPI increased from 11 months in 2002 to 35 months in 2006 and plateaued until 2014, but it rose to 41.6 months in 2015. Median IPI was shorter in young women <20 years and in birth order seven and above (16 vs. 27 months, respectively). Short IPI was associated with lower risk of pre-eclampsia [aOR: 0.71, 95%CI: 0.52, 0.97] while long IPI was associated with lower risk of post-partum hemorrhage [aOR: 0.70, 95%CI: 0.52, 0.94]. This study found an association between long and short IPI with adverse maternal outcomes. Even though these results should be interpreted with caution based on the fact that the data was sampled from a referral hospital and hence there could be overrepresentation of women with maternal complications, our findings still warrant the importance of supporting modern family planning methods as a measure to improve IPI and thereby improve maternal outcomes as well.	[Sanga, Leah Anku; Mtuy, Tara; Philemon, Rune Nathaniel; Mahande, Michael Johnson] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Kilimanjaro, Tanzania; [Mtuy, Tara] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Philemon, Rune Nathaniel] Kilimanjaro Christian Med Univ Coll, Dept Community Hlth, Inst Publ Hlth, Kilimanjaro, Tanzania	University of London; London School of Hygiene & Tropical Medicine	Sanga, LA (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Kilimanjaro, Tanzania.	leah.amye@gmail.com		Philemon, Rune/0000-0002-4054-0760; Mtuy, Tara/0000-0003-3436-0162; Sanga, Leah/0000-0003-1604-0771				Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Begna Z, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-116; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Conde-Agudelo A, 2012, EFFECTS BIRTH SPACIN, V43; de Jonge HCC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0427-6; DEFRANCO EA, 2015, AM J OBSTET GYNECOL, V212, DOI DOI 10.1016/J.AJOG.2014.11.017; Dutta DC, 2015, TXB OBSTET INCLUDING; Exavery A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-152; Habimana-Kabano I, 2015, AFR J REPROD HEALTH, V19, P77; Hanley GE, 2017, OBSTET GYNECOL, V129, P408, DOI 10.1097/AOG.0000000000001891; Illah Evance, 2013, Afr J Reprod Health, V17, P119; Lilungulu Athanase, 2015, Matern Health Neonatol Perinatol, V1, P1, DOI 10.1186/s40748-014-0002-1; Ministry of Health and Social Welfare (MOHSW) [Tanzania], 2010, NAT FAM PLANN COST I; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) Ministry of Health (MoH) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and ICF, 2016, TANZ DEM HLTH SURV M; MoHSW, 2008, NAT ROAD MAP STRAT P, P1; MOHSW, 2015, NAT ROAD MAP STRAT P; NBS & ICF Macro, 2011, TANZ DEM HLTH SURV 2; NBS ORC-Macro, 2005, TANZ DEM HLTH SURV 2; Norton M, 2005, INT J GYNECOL OBSTET, V89, pS1, DOI 10.1016/j.ijgo.2004.12.012; Pile JM, 2006, REPOSITIONING FAMILY; Rutstein SO, 2011, DHS COMP REPORTS, V28; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Seham FA., 2015, IOSR J NURS HEAL SCI, V4, P2320; United Nations, 2015, NATL INJ PREV STRAT; USAID, 2005, STRENGTH FAM PLANN P; Wendt A, 2012, PAEDIATR PERINAT EP, V26, P239, DOI 10.1111/j.1365-3016.2012.01285.x; WHO, 2014, MAT MORT FACT SHEET, V4; WHO UNICEF UNFPA World Bank United Nations, 2019, TRENDS MAT MORT 2000; WHO World Bank, 2012, TRENDS MAT MORT 1990; World Health Organization, 2016, MAT MORT; World Health Organization, 2007, REP WHO TECHN CONS B; World Health Organization, 2017, SDG 3 ENS HLTH LIV P	32	2	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228330	10.1371/journal.pone.0228330	http://dx.doi.org/10.1371/journal.pone.0228330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027674	Green Published, gold			2022-12-26	WOS:000534623800023
J	Cai, Y; Ying, F; Liu, H; Ge, L; Song, EF; Wang, L; Zhang, DW; Tang, EHC; Xia, ZY; Irwin, MG				Cai, Yin; Ying, Fan; Liu, Hao; Ge, Liang; Song, Erfei; Wang, Lin; Zhang, Dengwen; Tang, Eva Hoi Ching; Xia, Zhengyuan; Irwin, Michael G.			Deletion of Rap1 protects against myocardial ischemia/reperfusion injury through suppressing cell apoptosis via activation of STAT3 signaling	FASEB JOURNAL			English	Article						cardiomyocytes; ischemic heart disease; stattic; telomere	NF-KAPPA-B; ISCHEMIA-REPERFUSION INJURY; ISCHAEMIA/REPERFUSION INJURY; DIABETIC-RATS; CARDIOPROTECTION; TRANSDUCER; HEART; MICE; TRANSCRIPTION-3; INHIBITION	Ischemic heart disease is a leading cause of morbidity and mortality. Repressor activator protein 1 (Rap1), an established telomere-associated protein, is a novel modulator of hypoxia-induced apoptosis. This study aimed to explore the potential direct role of Rap1 in myocardial ischemia/reperfusion injury (I/RI) and to determine the underlying molecular mechanism. In a mouse model of myocardial I/RI (30-min of left descending coronary artery ligation followed by 2-h reperfusion), Rap1 deficiency significantly reduced myocardial infarct size (IS) and improved cardiac systolic/diastolic function. This was associated with a reduction in apoptosis in the post-ischemic myocardium. In H9C2 and primary cardiomyocytes, Rap1 knockdown or knockout significantly suppressed hypoxia/reoxygenation (H/R)-induced cell injury and apoptosis through increasing the phosphorylation/activation of STAT3 at site Ser(727) and translocation of STAT3 to the nucleus. We surmise this since Stattic (selective STAT3 inhibitor) pretreatment canceled the abovementioned protective effect. Furthermore, co-immunoprecipitation assay revealed a direct interaction between Rap1 and STAT3, but not JAK2, suggesting that the association of Rap1 with STAT3 may contribute to the reduced activity of STAT3 (Ser(727)) upon H/R stimulation. In conclusion, Rap1 deficiency protects the heart from ischemic damage through STAT3-dependent reduction of cardiomyocyte apoptosis, which may yield viable target for pharmacological intervention in ischemic heart disease.	[Cai, Yin; Ying, Fan; Liu, Hao; Wang, Lin; Xia, Zhengyuan; Irwin, Michael G.] Univ Hong Kong, Dept Anaesthesiol, Hong Kong, Peoples R China; [Liu, Hao] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Dept Cardiol, Affiliated Hosp 2, Guangzhou, Peoples R China; [Ge, Liang] Jilin Univ, Hosp 1, Dept Anesthesiol, Changchun, Peoples R China; [Song, Erfei] Jinan Univ, Affiliated Hosp 1, Guangzhou, Peoples R China; [Zhang, Dengwen] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Cardiovasc Inst, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Tang, Eva Hoi Ching] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Peoples R China; [Tang, Eva Hoi Ching] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China	University of Hong Kong; Guangzhou Medical University; Jilin University; Jinan University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; University of Hong Kong; University of Hong Kong	Irwin, MG (corresponding author), Univ Hong Kong, Dept Anaesthesiol, Li Ka Shing Fac Med, 102 Pokfulam Rd, Hong Kong, Peoples R China.	mgirwin@hku.hk	Irwin, Michael Garnet/GLR-9714-2022; Irwin, Michael Garnet/C-4286-2009	Irwin, Michael Garnet/0000-0001-5801-274X; Irwin, Michael Garnet/0000-0001-5801-274X; Cai, Yin/0000-0002-7763-0612	Health and Medical Research Fund (Hong Kong) [04151816]; General Research Fund (Research Grants Council of Hong Kong) [17123718, 17118619, 17117217]	Health and Medical Research Fund (Hong Kong); General Research Fund (Research Grants Council of Hong Kong)(Hong Kong Research Grants Council)	The authors' research was supported by the Health and Medical Research Fund (grant number 04151816 to Y. Cai, Hong Kong) and General Research Fund (grant numbers 17123718 and 17118619 to Z. Xia and 17117217 to MG Irwin, Research Grants Council of Hong Kong).	Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Cai Y, 2017, CELL CYCLE, V16, P1765, DOI 10.1080/15384101.2017.1371886; Cai Y, 2015, CELL CYCLE, V14, P3580, DOI 10.1080/15384101.2015.1100771; Cai Y, 2015, FASEB J, V29, P4924, DOI 10.1096/fj.15-274597; Cai Y, 2015, EUR J PHARMACOL, V747, P18, DOI 10.1016/j.ejphar.2014.11.036; Choi HJ, 2009, EXP MOL MED, V41, P94, DOI 10.3858/emm.2009.41.2.012; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dhingra R, 2010, J CARDIOVASC TRANSL, V3, P344, DOI 10.1007/s12265-010-9195-5; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Gao SM, 2017, CELL PHYSIOL BIOCHEM, V43, P1140, DOI 10.1159/000481755; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Kabir S, 2010, CELL CYCLE, V9, P4061, DOI 10.4161/cc.9.20.13579; Knight Richard A, 2012, JAKSTAT, V1, P111, DOI 10.4161/jkst.20078; Kosuru R, 2018, CELL PHYSIOL BIOCHEM, V46, P1381, DOI 10.1159/000489154; Le Page S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164066; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Li CX, 2016, ONCOTARGET, V7, P27711, DOI 10.18632/oncotarget.8509; Li HB, 2016, DIABETES, V65, P942, DOI 10.2337/db15-0782; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068949; Martinez P, 2016, AGING CELL, V15, P1113, DOI 10.1111/acel.12517; Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; O'Sullivan KE, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0543-8; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pang L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3453059; Pang L, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1324347; PIPICZ M, 2018, INT J MOL SCI, V12, P19; Poon MW, 2015, INVEST OPHTH VIS SCI, V56, P711, DOI 10.1167/iovs.14-15268; Qian MY, 2020, ONCOGENE, V39, P428, DOI 10.1038/s41388-019-0996-y; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Teo HL, 2010, NAT CELL BIOL, V12, P758, DOI 10.1038/ncb2080; Teringova E, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1191-y; Wang CY, 2018, CELL PHYSIOL BIOCHEM, V45, P2107, DOI 10.1159/000488047; Wang TT, 2013, FREE RADICAL BIO MED, V63, P291, DOI 10.1016/j.freeradbiomed.2013.05.043; Wang YM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-32; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wong KHK, 2018, J MOL CELL CARDIOL, V115, P1, DOI 10.1016/j.yjmcc.2017.12.009; Xia P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9583268; Xue R, 2016, CLIN SCI, V130, P377, DOI 10.1042/CS20150496; Yada M, 2004, J THORAC CARDIOV SUR, V128, P588, DOI 10.1016/j.jtcvs.2004.02.007; Ye XD, 2018, ACTA PHARMACOL SIN, V39, P1155, DOI 10.1038/aps.2018.37; Zhang Y, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.7; Zhou M, 2015, CLIN SCI, V129, P547, DOI 10.1042/CS20150073; Zouein Fouad A, 2015, Front Cardiovasc Med, V2, P36, DOI 10.3389/fcvm.2015.00036	53	14	18	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4482	4496		10.1096/fj.201901592RR	http://dx.doi.org/10.1096/fj.201901592RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32020680				2022-12-26	WOS:000512308900001
J	Stojanovic, O; Kuhlmann, L; Pipa, G				Stojanovic, Olivera; Kuhlmann, Levin; Pipa, Gordon			Predicting epileptic seizures using nonnegative matrix factorization	PLOS ONE			English	Article							SPECTRAL POWER	This paper presents a procedure for the patient-specific prediction of epileptic seizures. To this end, a combination of nonnegative matrix factorization (NMF) and smooth basis functions with robust regression is applied to power spectra of intracranial electroencephalographic (iEEG) signals. The resulting time and frequency components capture the dominant information from power spectra, while removing outliers and noise. This makes it possible to detect structure in preictal states, which is used for classification. Linear support vector machines (SVM) with L1 regularization are used to select and weigh the contributions from different number of not equally informative channels among patients. Due to class imbalance in data, synthetic minority over-sampling technique (SMOTE) is applied. The resulting method yields a computationally and conceptually simple, interpretable model of EEG signals of preictal and interictal states, which shows a good performance for the task of seizure prediction on two datasets (the EPILEPSIAE and on the public Epilepsyecosystem dataset).	[Stojanovic, Olivera; Pipa, Gordon] Osnabruck Univ, Inst Cognit Sci, Dept Neuroinformat, Osnabruck, Germany; [Kuhlmann, Levin] Monash Univ, Fac Informat Technol, Data Sci & AI Grp, Clayton, Vic, Australia	University Osnabruck; Monash University	Stojanovic, O (corresponding author), Osnabruck Univ, Inst Cognit Sci, Dept Neuroinformat, Osnabruck, Germany.	ostojanovic@uos.de		Stojanovic, Olivera/0000-0001-9820-3479	National Health and Medical Research Council [GNT1160815]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health and Medical Research Council (GNT1160815) to Dr Levin Kuhlmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi A, 2014, CLIN NEUROPHYSIOL, V125, P930, DOI 10.1016/j.clinph.2013.10.051; Alotaiby TN, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-183; ANTTILA P, 1995, ATMOS ENVIRON, V29, P1705, DOI 10.1016/1352-2310(94)00367-T; Bandarabadi M, 2015, CLIN NEUROPHYSIOL, V126, P237, DOI 10.1016/j.clinph.2014.05.022; Baud MO, 2017, NEUROSURGERY; Bishop C. M, 2006, PATTERN RECOGNITION; Brinkmann BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133900; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; Gadhoumi K, 2016, J NEUROSCI METH, V260, P270, DOI 10.1016/j.jneumeth.2015.06.010; Gillis N., 2014, NONNEGATIVE MATRIX F; Gotman J, 2011, EPILEPSY BEHAV, V22, pS2, DOI 10.1016/j.yebeh.2011.08.025; Guillamet D, 2002, LECT NOTES ARTIF INT, V2504, P336; IASEMIDIS L D, 1990, Brain Topography, V2, P187, DOI 10.1007/BF01140588; Ihle M, 2012, COMPUT METH PROG BIO, V106, P127, DOI 10.1016/j.cmpb.2010.08.011; Karoly PJ, 2017, BRAIN, V140, P2169, DOI 10.1093/brain/awx173; Kuhlmann L, 2018, NAT REV NEUROL, V14, P618, DOI 10.1038/s41582-018-0055-2; Kuhlmann L, 2018, BRAIN, V141, P2619, DOI 10.1093/brain/awy210; Kuhlmann L, 2010, EPILEPSY RES, V91, P214, DOI 10.1016/j.eplepsyres.2010.07.014; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Truong ND, 2019, IEEE ACCESS, V7, P143999, DOI 10.1109/ACCESS.2019.2944691; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Panayiotopoulos CP, 2010, ATLAS EPILEPSIES; Park Y, 2011, EPILEPSIA, V52, P1761, DOI 10.1111/j.1528-1167.2011.03138.x; Paulus M, 2001, IEEE J MAGAZINE; Rajapakse M, 2003, P 3 INT S IM SIGN PR; Schulze-Bonhage A, 2010, EPILEPSY BEHAV, V18, P388, DOI 10.1016/j.yebeh.2010.05.008; Steuer R, 2004, INT J BIFURCAT CHAOS, V14, P815, DOI 10.1142/S021812740400948X; Traitruengsakul S, 2015, 37 ANN INT C IEEE EN; Ung H, 2017, DEP NEUROSURGERY FAC; van Stralen KJ, 2009, KIDNEY INT, V75, P1257, DOI 10.1038/ki.2009.92; Zheng Y, 2014, CLIN NEUROPHYSIOL, V125, P1104, DOI 10.1016/j.clinph.2013.09.047	35	15	15	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228025	10.1371/journal.pone.0228025	http://dx.doi.org/10.1371/journal.pone.0228025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023272	Green Published, gold, Green Submitted			2022-12-26	WOS:000534621500032
J	van der Leeuw, J; de Borst, MH; Kieneker, LM; Bakker, SJL; Gansevoort, RT; Rookmaaker, MB				van der Leeuw, Joep; de Borst, Martin H.; Kieneker, Lyanne M.; Bakker, Stephan J. L.; Gansevoort, Ron T.; Rookmaaker, Maarten B.			Separating the effects of 24-hour urinary chloride and sodium excretion on blood pressure and risk of hypertension: Results from PREVEND	PLOS ONE			English	Article							POTASSIUM EXCRETION; ALBUMIN EXCRETION; ASSOCIATION; MEN; BICARBONATE; INTERSALT; CROSSOVER; OUTCOMES; CITRATE; RENIN	Objective Research into dietary factors associated with hypertension has focused on the sodium component of salt. However, chloride has distinct physiological effects that may surpass the effect of sodium on blood pressure. This study aims to separate the specific effects of chloride and sodium intake on blood pressure. Methods We studied 5673 participants from the Prevention of Renal and Vascular End-Stage Disease(PREVEND) study. Urinary chloride(uCl) and sodium(uNa) were measured in two 24-hour collections. We used generalized-linear-regression to evaluate the relation of uCl and uNa with baseline blood pressure and Cox-proportional-hazards-analysis to assess the association with hypertension. Multicollinearity was assessed with Ridge regression. Results Baseline 24-hour uCl was 135 +/- 39mmol and uNa was 144 +/- 54mmol. The correlation between uCl and uNa was high (Pearson's r = 0.96). UCl and uNa had similar non-significant positive and linear associations with blood pressure. In 3515 normotensive patients, 1021 patients developed hypertension during a median follow-up of 7.4 years. UCl and uNa had a comparable but non-significant J-shaped effect on the risk of hypertension. Adding both uCl and uNa to the same model produced instability, demonstrated by Ridge coefficients that converged or changed sign. The single index of uNa minus uCl showed a non-significant higher risk of hypertension of 2% per 10mmol/24-hour difference (HR1.02, 95%CI 0.98-1.06). Conclusion UCl and uNa had similar positive but non-significant associations with blood pressure and risk of hypertension and their effects could not be disentangled. Hence, the alleged adverse effects of high salt intake could be due to sodium, chloride or both. This encourages further study into the effect of chloride in order to complement dietary recommendations currently focused on sodium alone.	[van der Leeuw, Joep; Rookmaaker, Maarten B.] Univ Med Ctr Utrecht, Dept Nephrol, Utrecht, Netherlands; [de Borst, Martin H.; Kieneker, Lyanne M.; Bakker, Stephan J. L.; Gansevoort, Ron T.] Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen	van der Leeuw, J (corresponding author), Univ Med Ctr Utrecht, Dept Nephrol, Utrecht, Netherlands.	c.f.m.franssen@umcg.nl		De Borst, Martin/0000-0002-4127-8733	Dutch Kidney Foundation; Astellas	Dutch Kidney Foundation; Astellas(Astellas Pharmaceuticals)	The PREVEND study has been made possible by grants from the Dutch Kidney Foundation. This work was supported by a grant from Astellas (www.astellas.com) to JvdL and MBR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Ambard L, 1904, ARCH GEN MED, V1, P520; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Birukov A, 2016, AM J CLIN NUTR, V104, P49, DOI 10.3945/ajcn.116.132951; Braschi A, 2008, BRIT J NUTR, V99, P1284, DOI 10.1017/S0007114507864853; Capuano E, 2013, J FOOD COMPOS ANAL, V31, P129, DOI 10.1016/j.jfca.2013.04.004; Cobb LK, 2014, CIRCULATION, V129, P1173, DOI 10.1161/CIR.0000000000000015; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Forman JP, 2012, CIRCULATION, V125, P3108, DOI 10.1161/CIRCULATIONAHA.112.096115; GRIMM RH, 1990, NEW ENGL J MED, V322, P569, DOI 10.1056/NEJM199003013220901; He F. J., 2013, BMJ, V346; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; KAUP SM, 1991, J NUTR, V121, P330, DOI 10.1093/jn/121.3.330; Kidney Disease Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT SUPPL, V2, P337, DOI DOI 10.1038/kisup.2012.46; Kieneker LM, 2014, HYPERTENSION, V64, P769, DOI 10.1161/HYPERTENSIONAHA.114.03750; KIRCHNER KA, 1978, AM J PHYSIOL, V235, pF444, DOI 10.1152/ajprenal.1978.235.5.F444; KOTCHEN TA, 1983, ANN INTERN MED, V98, P817, DOI 10.7326/0003-4819-98-5-817; Kotchen TA, 2005, HYPERTENSION, V45, P849, DOI 10.1161/01.HYP.0000164629.94634.27; KURTZ TW, 1987, NEW ENGL J MED, V317, P1043, DOI 10.1056/NEJM198710223171702; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LUFT FC, 1990, J HYPERTENS, V8, P663, DOI 10.1097/00004872-199007000-00010; McCallum L, 2015, PFLUG ARCH EUR J PHY, V467, P595, DOI 10.1007/s00424-015-1690-8; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; OVERLACK A, 1995, DEUT MED WOCHENSCHR, V120, P631, DOI 10.1055/s-2008-1055388; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Schmidlin O, 2005, HYPERTENSION, V45, P867, DOI 10.1161/01.HYP.0000164628.46415.66; Schorr U, 1996, J HYPERTENS, V14, P131; Severs D, 2015, AM J KIDNEY DIS, V66, P147, DOI 10.1053/j.ajkd.2015.01.031; SHORE AC, 1988, J HYPERTENS, V6, P613, DOI 10.1097/00004872-198808000-00003; Stamler J, 2003, J HUM HYPERTENS, V17, P591, DOI 10.1038/sj.jhh.1001603; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Vatcheva Kristina P, 2016, Epidemiology (Sunnyvale), V6; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; WHITESCARVER SA, 1984, SCIENCE, V223, P1430, DOI 10.1126/science.6322303; Williams B, 2018, J HYPERTENS, V36, P1953, DOI 10.1097/HJH.0000000000001940	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228490	10.1371/journal.pone.0228490	http://dx.doi.org/10.1371/journal.pone.0228490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023312	gold, Green Published, Green Submitted			2022-12-26	WOS:000534621500057
J	Fukumoto, J; Yamano, A; Matsuzaki, M; Kyan, H; Masatani, T; Matsuo, T; Matsui, T; Murakami, M; Takashima, Y; Matsubara, R; Tahara, M; Sakura, T; Takeuchi, F; Nagamune, K				Fukumoto, Junpei; Yamano, Akinori; Matsuzaki, Motomichi; Kyan, Hisako; Masatani, Tatsunori; Matsuo, Tomohide; Matsui, Toshihiro; Murakami, Mami; Takashima, Yasuhiro; Matsubara, Ryuma; Tahara, Michiru; Sakura, Takaya; Takeuchi, Fumihiko; Nagamune, Kisaburo			Molecular and biological analysis revealed genetic diversity and high virulence strain of Toxoplasma gondii in Japan	PLOS ONE			English	Article							POPULATION-STRUCTURE; BRADYZOITES; TACHYZOITES; ALIGNMENT; GENOTYPE; COMPRISE; SURVIVAL; IMMUNITY; FAMILY	Toxoplasma gondii is classified into 16 haplogroups based on a worldwide genotyping study of the parasite. However, only a few isolates from Japan were included in this analysis. To conduct more precise genotyping of T. gondii, we examined the genotypes of Japanese isolates in this study. DNA sequences of 6 loci were determined in 17 Japanese isolates and compared with those of strains of 16 haplogroups. As a result, Japanese isolates were classified into four groups. We investigated the virulence of some Japanese isolates and found a highly virulent strain in mice, comparable to that of RH strain, although this Japanese isolate was sister to strains of haplogroup 2, which show moderate virulence in mice. We further investigated whether this high virulence isolate had different virulence mechanism and strategy to adapt to Japanese host from other strains by comparing the virulence-related genes, ROP5, 18 and the immunomodulatory gene, ROP16 of the isolate with those of archetypical strains (GT1, ME49 and VEG). This analysis indicated the high virulence of the isolate in mice was partly explained by gene sequences of ROP5 and ROP16. These findings lead to the elucidation of biodiversity of T. gondii and have potential to optimize the diagnostic protocol.	[Fukumoto, Junpei; Yamano, Akinori; Matsuzaki, Motomichi; Matsubara, Ryuma; Tahara, Michiru; Sakura, Takaya; Nagamune, Kisaburo] Natl Inst Infect Dis, Dept Parasitol, Shinjyuku Ku, Tokyo, Japan; [Fukumoto, Junpei; Yamano, Akinori; Matsubara, Ryuma] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Matsuzaki, Motomichi] RIKEN, Ctr Adv Intelligence Project, Chuo Ku, Tokyo, Japan; [Kyan, Hisako] Okinawa Prefectural Inst Hlth & Environm, Uruma, Okinawa, Japan; [Masatani, Tatsunori] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Res Ctr, Korimoto, Kagoshima, Japan; [Matsuo, Tomohide; Matsui, Toshihiro] Kagoshima Univ, Joint Fac Vet Med, Lab Parasitol, Korimoto, Kagoshima, Japan; [Murakami, Mami; Takashima, Yasuhiro] Univ Gifu, Grad Sch Appl Biol Sci, Gifu, Gifu, Japan; [Murakami, Mami; Takashima, Yasuhiro] Univ Gifu, Fac Appl Biol Sci, Gifu, Gifu, Japan; [Takeuchi, Fumihiko] Res Inst Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Shinjyuku Ku, Tokyo, Japan; [Nagamune, Kisaburo] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Matsubara, Ryuma] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Sakura, Takaya] Univ Nagasaki, Sch Trop Med & Global Hlth, Nagasaki, Japan	National Institute of Infectious Diseases (NIID); University of Tsukuba; RIKEN; Kagoshima University; Kagoshima University; Gifu University; Gifu University; University of Tsukuba; University of Bern; Nagasaki University	Nagamune, K (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjyuku Ku, Tokyo, Japan.; Nagamune, K (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	nagamune@niid.go.jp	Sakura, Takaya/AAX-2971-2021; MASATANI, Tatsunori/AAH-1192-2021; Matsuzaki, Motomichi/D-4043-2016	Sakura, Takaya/0000-0002-8320-8485; MASATANI, Tatsunori/0000-0002-2347-4079; Matsuzaki, Motomichi/0000-0001-5811-798X; Matsubara, Ryuma/0000-0001-7989-4104	Ministry of Education, Culture, Sports, Science and Technology, Japan [24390103, 15H04726, 16J01376, 23117007]; Ministry of Health, Labor and Welfare of Japan [H23-Shinkosaiko-ippan-014]; Japan Health Sciences Foundation [KHA1101]; Emerging/Re-emerging Infectious Diseases Project of Japan from Japan Agency for Medical Research and development (AMED) [40104600]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Emerging/Re-emerging Infectious Diseases Project of Japan from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by Grants-in-Aids for Scientific Research 24390103, 15H04726 and 16J01376, and for Scientific Research on Innovative Areas 23117007 from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was also supported by a grant for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labor and Welfare of Japan H23-Shinkosaiko-ippan-014, a grant for research to promote the development of anti-AIDS pharmaceuticals from the Japan Health Sciences Foundation KHA1101, the Emerging/Re-emerging Infectious Diseases Project of Japan 40104600 from Japan Agency for Medical Research and development (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2015, FUTURE MICROBIOL, V10, P689, DOI [10.2217/FMB.15.23, 10.2217/fmb.15.23]; [Anonymous], 1986, TOKYO J KYORIN MED S; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Dubey JP, 1999, J PARASITOL, V85, P657, DOI 10.2307/3285739; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Falush D, 2003, GENETICS, V164, P1567; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Grigg ME, 2009, INT J PARASITOL, V39, P925, DOI 10.1016/j.ijpara.2009.02.005; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Khan A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000404; Kyan H, 2012, JPN J INFECT DIS, V65, P167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehmann T, 2006, P NATL ACAD SCI USA, V103, P11423, DOI 10.1073/pnas.0601438103; Lorenzi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10147; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; SHARMA SP, 1981, AM J VET RES, V42, P128; Shwab EK, 2014, PARASITOLOGY, V141, P453, DOI 10.1017/S0031182013001844; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Taniguchi Y, 2018, PARASITOL INT, V67, P587, DOI 10.1016/j.parint.2018.05.010; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Weissmann J, 2003, CAN VET J, V44, P322; Yamamoto M, 2011, J EXP MED, V208, P1533, DOI 10.1084/jem.20101660; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Zakimi S, 2006, J VET MED SCI, V68, P1105, DOI 10.1292/jvms.68.1105	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0227749	10.1371/journal.pone.0227749	http://dx.doi.org/10.1371/journal.pone.0227749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012177	gold, Green Published			2022-12-26	WOS:000534615800011
J	Nosetti, L; Paglietti, MG; Brunetti, L; Masini, L; La Grutta, S; Cilluffo, G; Ferrante, G; Zaffanello, M; Verrillo, E; Pavone, M; Niespolo, AC; Broggi, G; Cutrera, R				Nosetti, Luana; Paglietti, Maria Giovanna; Brunetti, Luigia; Masini, Luigi; La Grutta, Stefania; Cilluffo, Giovanna; Ferrante, Giuliana; Zaffanello, Marco; Verrillo, Elisabetta; Pavone, Martino; Niespolo, Alessandra Cristina; Broggi, Giacomo; Cutrera, Renato		IPRS SIMRI Task Force Sleep Disord	Application of latent class analysis in assessing the awareness, attitude, practice and satisfaction of paediatricians on sleep disorder management in children in Italy	PLOS ONE			English	Article							CARE PHYSICIANS; FIT INDEXES; KNOWLEDGE; APNEA; PREVALENCE; EDUCATION; BARRIERS; EFFICACY; CRITERIA	Aim To identify subgroups regarding paediatricians' awareness, attitude, practice and satisfaction about management of Sleep-Disordered Breathing (SDB) in Italy using Latent Class Analysis (LCA). Methods A cross-sectional study was conducted on a large sample of Italian paediatricians. Using a self-administered questionnaire, the study collected information on 420 Paediatric Hospital Paediatricians (PHPs) and 594 Family Care Paediatricians (FCPs). LCA was used to discover underlying response patterns, thus allowing identification of respondent groups with similar awareness, attitude, practice and satisfaction. A logistic regression model was used to investigate which independent variables influenced latent class membership. Analyses were performed using R 3.5.2 software. A p-value < 0.05 was considered statistically significant. Results Two classes were identified: Class 1 (n = 368, 36.29%) "Untrained and poorly satisfied" and Class 2 (n = 646, 63.71%) "Trained and satisfied." Involving paediatric pneumologists or oto-rhinolaryngologists in clinical practice was associated with an increased probability of Class 2 membership (OR = 5.88, 95%CI [2.94-13.19]; OR = 15.95, 95% CI [10.92-23.81] respectively). Examining more than 20 children with SDB during the last month decreased the probability of Class 2 membership (OR = 0.29, 95% CI [0.14-0.61]). FCPs showed a higher probability of Class 2 membership than PHPs (OR = 4.64, 95% CI [3.31-6.55]). Conclusions These findings suggest that the LCA approach can provide important information on how education and training could be tailored for different subgroups of paediatricians. In Italy standardized educational interventions improving paediatricians' screening of SDB are needed in order to guarantee efficient management of children with SDB and reduce the burden of disease.	[Nosetti, Luana; Niespolo, Alessandra Cristina] Univ Insubria, Dept Paediat, Varese, Italy; [Paglietti, Maria Giovanna; Verrillo, Elisabetta; Pavone, Martino; Cutrera, Renato] Bambino Gesu Paediat Hosp IRCCS, Rome, Italy; [Brunetti, Luigia] Tricase Hosp Lecce Bari, Bari, Italy; [Masini, Luigi] Azienda Osped Santobono Pausillipon Napoli, Naples, Italy; [La Grutta, Stefania; Cilluffo, Giovanna] Natl Res Council CNR, Inst Res & Biomed Innovat IRIB, Palermo, Italy; [Ferrante, Giuliana] Univ Palermo, Dept Hlth Promot Sci Maternal & Infant Care, Internal Med & Med Special, Palermo, Italy; [Zaffanello, Marco] Univ Verona, Paediat Clin, Verona, Italy; [Broggi, Giacomo] Bocconi Univ, Milan, Italy	University of Insubria; IRCCS Bambino Gesu; Consiglio Nazionale delle Ricerche (CNR); Istituto Ricerca l'Innovazione Biomedica (IRIB-CNR); University of Palermo; University of Verona; Bocconi University	Cilluffo, G (corresponding author), Natl Res Council CNR, Inst Res & Biomed Innovat IRIB, Palermo, Italy.	giovanna.cilluffo@irib.cnr.it	Cilluffo, Giovanna/AAC-6724-2019; Cutrera, Renato/E-9894-2012; Paglietti, Maria Giovanna/AAI-1963-2019; Ferrante, Giuliana/AAA-2478-2019; Verrillo, Elisabetta/HHM-9964-2022; La Grutta, Stefania/N-3615-2014; Zaffanello, Marco/K-8474-2016	Cilluffo, Giovanna/0000-0003-4305-3981; Cutrera, Renato/0000-0001-7711-5672; Paglietti, Maria Giovanna/0000-0003-2882-2375; Ferrante, Giuliana/0000-0001-9917-2387; La Grutta, Stefania/0000-0001-8026-0715; Zaffanello, Marco/0000-0002-8659-5505				Atkinson TM, 2011, J PAIN SYMPTOM MANAG, V41, P558, DOI 10.1016/j.jpainsymman.2010.05.008; BaHammam AS, 2000, SAUDI MED J, V21, P1164; Balbani Aracy Pereira Silveira, 2005, Rev. Assoc. Med. Bras., V51, P80, DOI 10.1590/S0104-42302005000200014; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Boerner KE, 2015, BEHAV SLEEP MED, V13, P36, DOI 10.1080/15402002.2013.838766; Brambilla P, 2017, ITAL J PEDIAT, V43; Brunetti L, 2001, CHEST, V120, P1930, DOI 10.1378/chest.120.6.1930; Castronovo V, 2003, J PEDIATR-US, V142, P377, DOI 10.1067/mpd.2003.118; Cilluffo G, 2019, METHOD INFORM MED, V58, pe27, DOI 10.1055/s-0039-1693732; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; COLLINS LM, 1994, MULTIVAR BEHAV RES, V29, P165, DOI 10.1207/s15327906mbr2902_3; DiStefano C, 2006, EDUC PSYCHOL MEAS, V66, P778, DOI 10.1177/0013164405284033; Erichsen D, 2012, CLIN PEDIATR, V51, P1125, DOI 10.1177/0009922812464548; Faruqui F, 2011, PEDIATRICS, V128, P539, DOI 10.1542/peds.2011-0344; Ferrante G, 2017, PEDIAT ALLERG IMM-UK, V28, P393, DOI 10.1111/pai.12707; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Garbutt JM, 2012, CLIN PEDIATR, V51, P840, DOI 10.1177/0009922812455093; Gruber R, 2017, PAED CHILD HEALT-CAN, V22, P322, DOI 10.1093/pch/pxx069; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joyce C, 2015, J HEALTH SERV RES PO, V20, P224, DOI 10.1177/1355819615591022; Kaditis AG, 2015, EUR RESPIR J; Katz Eliot S, 2008, Proc Am Thorac Soc, V5, P253, DOI 10.1513/pats.200707-111MG; Lin TH, 1997, J EDUC BEHAV STAT, V22, P249, DOI 10.2307/1165284; Linzer DA, 2011, J STAT SOFTW, V42, P1, DOI 10.18637/jss.v042.i10; Liu Z, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-1039-4; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Malizia V, 2017, INT ARCH ALLERGY IMM, V174, P97, DOI 10.1159/000481093; McLachlan Geoffrey J, 2000, ANN REV STAT ITS APP; Meltzer LJ, 2014, J CLIN SLEEP MED, V10, P421, DOI 10.5664/jcsm.3620; Nosetti L, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0658-2; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ojeda IC, 2013, SLEEP MED, V14, P973, DOI 10.1016/j.sleep.2013.06.005; Owens JA, 2003, PEDIATRICS, V111, pE628, DOI 10.1542/peds.111.5.e628; Owens JA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e51; Parthasarathy S, 2014, J CLIN SLEEP MED, V10, P243, DOI 10.5664/jcsm.3518; Porcu M, 2017, J EARLY ADOLESCENCE, V37, P129, DOI 10.1177/0272431616648452; Saleem AH, 2017, SAUDI MED J, V38, P553, DOI 10.15537/smj.2017.5.17936; Sateia MJ, 2005, SLEEP MED, V6, P47, DOI 10.1016/j.sleep.2004.07.013; Schreiber JB, 2014, CURATOR, V57, P45, DOI 10.1111/cura.12050; Senthilvel E, 2011, J CLIN SLEEP MED, V7, P41; Sia CH, 2017, SLEEP MED, V36, P10, DOI 10.1016/j.sleep.2017.03.030; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stojanovski SD, 2007, SLEEP, V30, P1013, DOI 10.1093/sleep/30.8.1013; Tamana SK, 2018, SLEEP, V41, DOI 10.1093/sleep/zsx177; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Zhang YP, 2013, CHINESE SCI BULL, V58, P4182, DOI 10.1007/s11434-013-5914-z; Zozula R, 2001, SLEEP, V24, P227	47	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228377	10.1371/journal.pone.0228377	http://dx.doi.org/10.1371/journal.pone.0228377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9DJ	32012194	Green Published, gold			2022-12-26	WOS:000534615800032
J	Yau, XH; Low, FW; Khe, CS; Lai, CW; Tiong, SK; Amin, N				Yau, Xin Hui; Low, Foo Wah; Khe, Cheng Seong; Lai, Chin Wei; Tiong, Sieh Kiong; Amin, Nowshad			An investigation of the stirring duration effect on synthesized graphene oxide for dye-sensitized solar cells	PLOS ONE			English	Article							GRAPHITE OXIDE; EFFICIENCY; SHEETS; CARBON	This study investigates the effects of stirring duration on the synthesis of graphene oxide (GO) using an improved Hummers' method. Various samples are examined under different stirring durations (20, 40, 60, 72, and 80 h). The synthesized GO samples are evaluated through X-ray diffraction (XRD), field emission scanning electron microscopy (FESEM), energy dispersive spectroscopy (EDX), Fourier transform infrared spectroscopy (FTIR), and Raman spectroscopy. The GO sample with 72 h stirring duration (GO72) has the highest d-spacing in the XRD results, highest atomic percentage of oxygen in EDX (49.57%), highest intensity of oxygen functional group in FTIR spectra, and highest intensity ratio in Raman analysis (I-D/I-G = 0.756). Results show that GO72 with continuous stirring has the highest degree of oxidation among other samples. Electrochemical impedance spectroscopy analysis shows that GO72-titanium dioxide (TiO2) exhibits smaller charge transfer resistance and higher electron lifetime compared with the TiO2-based photoanode. The GO72 sample incorporating TiO2 nanocomposites achieves 6.25% photoconversion efficiency, indicating an increase of more than twice than that of the mesoporous TiO2 sample. This condition is fully attributed to the efficient absorption rate of nanocomposites and the reduction of the recombination rate of TiO2 by GO in dye-sensitized solar cells.	[Yau, Xin Hui; Khe, Cheng Seong] Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Seri Iskandar, Perak, Malaysia; [Yau, Xin Hui; Khe, Cheng Seong] Univ Teknol PETRONAS, Ctr Innovat Nanostruct & Nanodevices COINN, Seri Iskandar, Perak, Malaysia; [Low, Foo Wah; Tiong, Sieh Kiong; Amin, Nowshad] Univ Tenaga Nas, Inst Sustainable Energy, Jalan IKRAM UNITEN, Kajang, Selangor, Malaysia; [Lai, Chin Wei] Univ Malaya, Inst Postgrad Studies IPS, Nanotechnol & Catalysis Res Ctr NANOCAT, Kuala Lumpur, Malaysia	Universiti Teknologi Petronas; Universiti Teknologi Petronas; Universiti Tenaga Nasional; Universiti Malaya	Khe, CS (corresponding author), Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Seri Iskandar, Perak, Malaysia.; Khe, CS (corresponding author), Univ Teknol PETRONAS, Ctr Innovat Nanostruct & Nanodevices COINN, Seri Iskandar, Perak, Malaysia.	chengseong.khe@utp.edu.my	Wah, Low Foo/B-3654-2016; Tiong, Sieh Kiong/GLR-1734-2022; Amin, Nowshad/C-1558-2010; Seong, Khe Cheng/AAA-1302-2020; Lai, Chin Wei/E-7062-2013	Wah, Low Foo/0000-0003-2551-7623; Amin, Nowshad/0000-0002-3250-1307; Seong, Khe Cheng/0000-0002-5494-8601; Lai, Chin Wei/0000-0002-7549-5015	Yayasan Universiti Teknologi PETRONAS (YUTP) Grant [YUTP 0153AA-E40]; Fundamental Research Grant Scheme [FRGS/1/2019/STG07/UTP/02/6]; Universiti Tenaga Nasional BOLD2025 Grant [10436494/B/2019097]; Universiti Tenaga Nasional BOLD2025 Publication [RJ010289176]	Yayasan Universiti Teknologi PETRONAS (YUTP) Grant; Fundamental Research Grant Scheme; Universiti Tenaga Nasional BOLD2025 Grant; Universiti Tenaga Nasional BOLD2025 Publication	This research is supported financially by the Yayasan Universiti Teknologi PETRONAS (YUTP) Grant (YUTP 0153AA-E40), the Fundamental Research Grant Scheme (FRGS/1/2019/STG07/UTP/02/6), Universiti Tenaga Nasional BOLD2025 Grant (No. 10436494/B/2019097) and Universiti Tenaga Nasional BOLD2025 Publication (RJ010289176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S. N., 2017, GRAPHENE, V6, P1, DOI [10.4236/graphene.2017.61001, DOI 10.4236/GRAPHENE.2017.61001]; Buda S, 2017, RESULTS PHYS, V7, P2311, DOI 10.1016/j.rinp.2017.07.009; Lavin-Lopez MD, 2016, IND ENG CHEM RES, V55, P12836, DOI 10.1021/acs.iecr.6b03533; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Hamandi M, 2017, MOL CATAL, V432, P125, DOI 10.1016/j.mcat.2017.01.003; Huang CC, 2012, ENERG ENVIRON SCI, V5, P8848, DOI 10.1039/c2ee22238h; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Jena AK, 2019, CHEM REV, V119, P3036, DOI 10.1021/acs.chemrev.8b00539; Kanevce A, 2017, J APPL PHYS, V121, DOI 10.1063/1.4984320; Kim J, 2010, J AM CHEM SOC, V132, P8180, DOI 10.1021/ja102777p; Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y; Kyzas GZ, 2014, J CHEM TECHNOL BIOT, V89, P196, DOI 10.1002/jctb.4220; Low FW, 2017, J MATER SCI-MATER EL, V28, P3819, DOI 10.1007/s10854-016-5993-0; Low FW, 2015, J NANOSCI NANOTECHNO, V15, P6769, DOI 10.1166/jnn.2015.10903; Low FW, 2015, CERAM INT, V41, P5798, DOI 10.1016/j.ceramint.2015.01.008; Lu C.-H., 2009, ANGEW CHEM, V121, P4879, DOI DOI 10.1002/ANGE.200901479; Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368; Nandamuri G, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/14/145604; Nethravathi C, 2008, LANGMUIR, V24, P8240, DOI 10.1021/la8000027; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Ramli A.M., 2017, MALAYSIAN J ANAL SCI, V21, P928, DOI [10.17576/mjas-2017-2104-20, DOI 10.17576/MJAS-2017-2104-20]; Roy-Mayhew JD, 2014, CHEM REV, V114, P6323, DOI 10.1021/cr400412a; Saxena S, 2010, ACS NANO, V4, P3515, DOI 10.1021/nn100626z; Shakir S, 2018, J ALLOY COMPD, V737, P740, DOI 10.1016/j.jallcom.2017.12.165; Tayyebi A, 2016, RSC ADV, V6, P13898, DOI 10.1039/c5ra19057f; Trihutomo P, 2019, INT J PHOTOENERGY, V2019, DOI 10.1155/2019/4384728; Yong V, 2010, SMALL, V6, P313, DOI 10.1002/smll.200901364; Yu HT, 2016, SCI REP-UK, V6, DOI 10.1038/srep36143; Zhang SH, 2019, RSC ADV, V9, P22092, DOI 10.1039/c9ra03344k	30	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228322	10.1371/journal.pone.0228322	http://dx.doi.org/10.1371/journal.pone.0228322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012195	gold, Green Published			2022-12-26	WOS:000534615800028
J	Gregorio, I; Barros, T; Pando, D; Morante, J; Fonseca, C; Ferreira, E				Gregorio, Ines; Barros, Tania; Pando, Doriana; Morante, Joaquin; Fonseca, Carlos; Ferreira, Eduardo			Paths for colonization or exodus? New insights from the brown bear (Ursus arctos) population of the Cantabrian Mountains	PLOS ONE			English	Article							DEER CAPREOLUS-CAPREOLUS; MICROSATELLITE ANALYSIS; GENE FLOW; CONSERVATION GENETICS; SOFTWARE; SIZE; DNA; INFERENCE; MODEL; DIFFERENTIATION	Over the centuries, the geographical distribution of brown bear (Ursus arctos) across the Iberian Peninsula has been decreasing, with the species currently confined to North Iberia. The Cantabrian brown bear population is one of the smallest in Europe and is structured into two subpopulations, positioned along an east-west axis. Given the current critically endangered status of this population, it is essential to have a clear picture of its within-population genetic patterns and processes. We use a set of three molecular markers (mitochondrial DNA, autosomal microsatellites and sex markers) to clarify the genetic origins and assess the migration patterns and gene flow of the Cantabrian brown bear population. Our results reveal the presence of two different mitochondrial (matrilineal) haplotypes in the Cantabrian population, both belonging to European brown bear clade 1a. The two haplotypes are geographically structured between Eastern (haplotype CanE) and Western Cantabrian (haplotype CanW) subpopulations, which is consistent with the genetic structure previously identified using nuclear markers. Additionally, we show that CanE is closer to the historical Pyrenean (Pyr) haplotype than to CanW. Despite strong structuring at the levels of mtDNA and nuclear loci, there is evidence of bidirectional gene flow and admixture among subpopulations. Gene flow is asymmetrical and significantly more intense from the Eastern to the Western Cantabrian subpopulation. In fact, we only detected first generation male migrants from the Eastern to the Western Cantabrian subpopulation. These results suggest more intense migration from the smaller and more vulnerable Eastern Cantabrian subpopulation towards the larger and more stable Western Cantabrian subpopulation. These new insights are relevant for assessments of on-going conservation measures, namely the role of dispersal corridors and enhanced connectivity. We discuss the importance of complementary conservation measures, such as human-wildlife conflict mitigation and habitat improvement, for the conservation of a viable Cantabrian brown bear population.	[Gregorio, Ines; Barros, Tania; Fonseca, Carlos; Ferreira, Eduardo] Univ Aveiro, Dept Biol, Campus Univ Santiago, Aveiro, Portugal; [Gregorio, Ines; Barros, Tania; Fonseca, Carlos; Ferreira, Eduardo] Univ Aveiro, CESAM, Campus Univ Santiago, Aveiro, Portugal; [Pando, Doriana; Morante, Joaquin] Fondo Protecc Anim Salvajes, Santo Adriano, Asturias, Spain	Universidade de Aveiro; Universidade de Aveiro	Ferreira, E (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, Aveiro, Portugal.; Ferreira, E (corresponding author), Univ Aveiro, CESAM, Campus Univ Santiago, Aveiro, Portugal.	elferreira@ua.pt	Fonseca, Carlos MMS/D-9744-2011; Ferreira, Eduardo/G-2291-2010	Fonseca, Carlos MMS/0000-0001-6559-7133; Ferreira, Eduardo/0000-0003-0497-6118; Gregorio, Ines/0000-0002-2855-529X; Barros, Tania/0000-0001-7541-2278	project "Protection of the brown bear in the Cantabrian mountain range" - Euronatur [ES-18-450-45]; FCT (Fundacao para a Ciencia e a Tecnologia, Program POPHQREN) [SFRH/BPD/72895/2010]; FCT/MCTES [UID/AMB/50017/2019]	project "Protection of the brown bear in the Cantabrian mountain range" - Euronatur; FCT (Fundacao para a Ciencia e a Tecnologia, Program POPHQREN); FCT/MCTES(Portuguese Foundation for Science and Technology)	This study was supported by the project "Protection of the brown bear in the Cantabrian mountain range" (ES-18-450-45), funded by Euronatur. Eduardo Ferreira was supported by a post-doctoral grant from FCT (Fundacao para a Ciencia e a Tecnologia, Program POPHQREN, ref: SFRH/BPD/72895/2010). Thanks are due to FCT/MCTES for the financial support to CESAM (UID/AMB/50017/2019), through national funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arquilliere A, 1998, ORYX, V32, P8, DOI 10.1046/j.1365-3008.1998.00007.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bellemain E, 2004, MOL ECOL NOTES, V4, P519, DOI 10.1111/j.1471-8286.2004.00711.x; Benazzo A, 2017, P NATL ACAD SCI USA, V114, pE9589, DOI 10.1073/pnas.1707279114; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Caussimont G., OSO PIRINEOS CORDILL; Chapron G, 2003, CR BIOL, V326, pS174, DOI 10.1016/S1631-0691(03)00055-6; Cornuet JM, 1996, GENETICS, V144, P2001; Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Draper JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186701; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garcia D, 2005, FOREST ECOL MANAG, V208, P29, DOI 10.1016/j.foreco.2004.10.071; Garcia P, 2007, ECOL INFORM, V2, P297, DOI 10.1016/j.ecoinf.2007.08.003; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gonzalez EG, 2016, PEERJ, V4, DOI 10.7717/peerj.1928; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Holland MM, 2011, J FORENSIC SCI, V56, P29, DOI 10.1111/j.1556-4029.2010.01565.x; Karamanlidis AA, 2012, EUR J WILDLIFE RES, V58, P511, DOI 10.1007/s10344-011-0598-7; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kopatz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097558; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lamamy C, 2019, MAMMAL RES, V64, P559, DOI 10.1007/s13364-019-00440-7; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Sanchez MCM, 2014, INT J GEOGR INF SCI, V28, P1531, DOI 10.1080/13658816.2013.776684; Mateo-Sanchez MC, 2014, ANIM CONSERV, V17, P430, DOI 10.1111/acv.12109; Mateo-Sanchez MC, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00387.1; Matosiuk M, 2019, ECOL EVOL, V9, P1501, DOI 10.1002/ece3.4872; McLellan BN, 2017, IUCN RED LIST THREAT, V2017, DOI [10.2305/IUCN.UK.2017-3.RLTS.T41688A121229971.en, DOI 10.2305/IUCN.UK.2017-3.RLTS.T41688A121229971.EN]; MORENO JM, 1990, J VEG SCI, V1, P233, DOI 10.2307/3235660; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Nomura T, 2008, EVOL APPL, V1, P462, DOI 10.1111/j.1752-4571.2008.00015.x; nores c., 1993, OSO PARDO URSUSARCTO, P13; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pages M, 2009, CONSERV GENET, V10, P897, DOI 10.1007/s10592-008-9650-x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez T, 2014, WILDLIFE BIOL, V20, P300, DOI 10.2981/wlb.00069; Perez T, 2010, URSUS, V21, P104, DOI 10.2192/09SC018.1; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Pritchard JK, 2000, GENETICS, V155, P945; Purroy F., 1758, ENCICLOPEDIA VIRTUAL; Quenette PY, 2001, URSUS-SERIES, V12, P115; Rambaut A., 2012, FIGTREE VERSION 1 4; Randi E, 2004, MOL ECOL, V13, P3071, DOI 10.1111/j.1365-294X.2004.02279.x; RANDI E, 1994, HEREDITY, V73, P480, DOI 10.1038/hdy.1994.146; Randi E, 2007, Phylogeography of Southern European Refugia, P101, DOI 10.1007/1-4020-4904-8_3; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Royo LJ, 2007, MOL PHYLOGENET EVOL, V42, P47, DOI 10.1016/j.ympev.2006.05.020; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Schregel J, 2012, MOL ECOL, V21, P3474, DOI 10.1111/j.1365-294X.2012.05631.x; Sundqvist L, 2016, ECOL EVOL, V6, P3461, DOI 10.1002/ece3.2096; Swenson, 2000, NATURE ENV, V114, P1; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdiosera CE, 2008, P NATL ACAD SCI USA, V105, P5123, DOI 10.1073/pnas.0712223105; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Velickovic N, 2016, HEREDITY, V117, P348, DOI 10.1038/hdy.2016.53; Velickovic N, 2015, J BIOGEOGR, V42, P716, DOI 10.1111/jbi.12458; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1978, VARIABILITY NATURAL, V4; Xenikoudakis G, 2015, MOL ECOL, V24, P3441, DOI 10.1111/mec.13239; Zedrosser A, 2001, URSUS-SERIES, V12, P9; Zedrosser A, 2007, ANIM BEHAV, V74, P369, DOI 10.1016/j.anbehav.2006.09.015	73	5	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0227302	10.1371/journal.pone.0227302	http://dx.doi.org/10.1371/journal.pone.0227302			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004321	Green Submitted, Green Published, gold			2022-12-26	WOS:000534614600005
J	Mao, HY; Hsu, HC; Lee, SD				Mao, Hsin-Yu; Hsu, Hui-Chuan; Lee, Shin-Da			Gender differences in related influential factors of regular exercise behavior among people in Taiwan in 2007: A cross-sectional study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TRANSTHEORETICAL MODEL; RURAL ADULTS; BARRIERS; PARTICIPATION; MOTIVATORS; BELIEFS; RISK	Purpose The purpose was to explore the exercise behavior of the Taiwanese population during leisure time and to examine the gender differences in related influential factors. Methods The Leisure Time and Sport Questionnaire (LTSQ) conducted by the Academia Sinica in 2007 was used for analysis. Participants were drawn from the Taiwanese population aged over 18 years old. Multinomial logistic regression models were used to test the association between the frequency of exercise and related factors in all the participants, male, and female participants, respectively. Results In the total 2,147 participants, 47.8% reported they regularly exercised, 34.1% irregularly exercised, and 18.1% never exercised. There were no significant gender differences in the frequency of exercise, but a significant gender difference was found in the types of exercise most often practiced. Participants in one of following conditions, over 65 and under 40 years old, living in the city, having higher education levels, having a spouse or partner, enjoying exercise, feeling worthwhile to spend money on exercise, and not having to take care of others, were more likely to be engaged in regular exercise in the total population. The "enjoyment" in exercise was a significant influential factor for both sexes. Women were more likely to exercise regularly if they were aged 40-64 years old compared with those over 65 years old, have lower self-rated health scores, felt it was more worthwhile to spend money on exercise and did not have to care for another, whereas men who have higher education level and did not feel a lack of time were more likely to exercise regularly. Conclusions There are gender differences in regular exercise behavior during leisure time and related influential factors among Taiwanese adults. The findings of the present study can be used when designing gender-specific health promotion programs.	[Mao, Hsin-Yu] Asia Univ, Dept Hlth Care Adm, Taichung, Taiwan; [Mao, Hsin-Yu] Tzu Hui Inst Technol, Dept Phys Therapy, Pingtung, Taiwan; [Hsu, Hui-Chuan] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Lee, Shin-Da] Asia Univ, Dept Occupat Therapy, Taichung, Taiwan; [Lee, Shin-Da] China Med Univ, Dept Phys Therapy, Taichung, Taiwan; [Lee, Shin-Da] Shandong Univ Tradit Chinese Med, Sch Rehabil Sci, Jinan, Shandong, Peoples R China	Asia University Taiwan; Taipei Medical University; Asia University Taiwan; China Medical University Taiwan; Shandong University of Traditional Chinese Medicine	Lee, SD (corresponding author), Asia Univ, Dept Occupat Therapy, Taichung, Taiwan.; Lee, SD (corresponding author), China Med Univ, Dept Phys Therapy, Taichung, Taiwan.; Lee, SD (corresponding author), Shandong Univ Tradit Chinese Med, Sch Rehabil Sci, Jinan, Shandong, Peoples R China.	leeshinda@gmail.com	Lee, Shin-Da/Q-2798-2015	Lee, Shin-Da/0000-0002-8393-8349; Hsu, Hui-Chuan/0000-0002-3830-2480				Abe T, 2019, J EPIDEMIOL; Anokye NK, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0117-9; Barkley JE, 2016, COMPUT HUM BEHAV, V56, P29, DOI 10.1016/j.chb.2015.11.001; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bethancourt HJ, 2014, CLIN MED RES, V12, P10, DOI 10.3121/cmr.2013.1171; Borodulin K, 2016, SCAND J MED SCI SPOR, V26, P93, DOI 10.1111/sms.12401; Bort-Roig J, 2014, SPORTS MED, V44, P671, DOI 10.1007/s40279-014-0142-5; Caperchione CM, 2015, J PHYS ACT HEALTH, V12, P686, DOI 10.1123/jpah.2013-0208; Cheah Yong Kang, 2014, Osong Public Health Res Perspect, V5, P20, DOI 10.1016/j.phrp.2013.12.002; Chen ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132918; Chen YJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-427; Chrisman M, 2014, J RURAL HEALTH, V30, P352, DOI 10.1111/jrh.12065; Costello E, 2011, J GERIATR PHYS THER, V34, P138, DOI 10.1519/JPT.0b013e31820e0e71; de Farias JC, 2014, CAD SAUDE PUBLICA, V30, P941, DOI 10.1590/0102-311X00010813; Dishman RK, 2014, ANN BEHAV MED, V48, P80, DOI 10.1007/s12160-013-9573-8; Fahrenwald NL, 2003, PUBLIC HEALTH NURS, V20, P307, DOI 10.1046/j.1525-1446.2003.20408.x; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Jurj AL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-213; Lee KS, 2011, INT J BEHAV MED, V17, P279, DOI 10.1007/s12529-009-9060-6; Zagalaz-Sanchez ML, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01307; Molanorouzi K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1429-7; Pan LY, 2015, INT J BEHAV MED, V22, P62, DOI 10.1007/s12529-014-9409-3; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Soto SH, 2019, INT J BEHAV MED, V26, P522, DOI 10.1007/s12529-019-09806-2; STEPTOE A, 1989, J PSYCHOSOM RES, V33, P537, DOI 10.1016/0022-3999(89)90061-5; Steptoe A, 1997, PREV MED, V26, P845, DOI 10.1006/pmed.1997.0224; Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047; Tsai LT, 2015, INT J ENV RES PUB HE, V12, P829, DOI 10.3390/ijerph120100829; Wen CP, 2007, TAIWAN J PUBLIC HEAL, V26, P386; Woods C, 2002, HEALTH EDUC RES, V17, P451, DOI 10.1093/her/17.4.451; You S, 2017, HEALTH CARE WOMEN IN, V38, P1263, DOI 10.1080/07399332.2017.1323905	34	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228191	10.1371/journal.pone.0228191	http://dx.doi.org/10.1371/journal.pone.0228191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CX	32004330	Green Published, Green Submitted, gold			2022-12-26	WOS:000534614600023
J	Chuang, WC; Tsang, NM; Chuang, CC; Chang, KP; Pai, PC; Chen, KH; Chou, WC; Tai, SF; Liu, SC; Lei, KF				Chuang, Wen Ching; Tsang, Ngan Ming; Chuang, Chi Cheng; Chang, Kai Ping; Pai, Ping Ching; Chen, Kuan Hung; Chou, Wen Chi; Tai, Shiao Fwu; Liu, Shu Chen; Lei, Kin Fong			Association of subcutaneous and visceral adipose tissue with overall survival in Taiwanese patients with bone metastases - results from a retrospective analysis of consecutively collected data	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; CANCER-PATIENTS; RISK-FACTORS; OBESITY; OVERWEIGHT; PROGNOSIS; PREDICT; SLICE; INDEX	Background Growing evidence indicates that measures of body composition may be related to clinical outcomes in patients with malignancies. The aim of this study was to investigate whether measures of regional adiposity-including subcutaneous adipose tissue index (SATI) and visceral adipose tissue index (VATI)-can be associated with overall survival (OS) in Taiwanese patients with bone metastases. Methods This is a retrospective analysis of prospectively collected data. We examined 1280 patients with bone metastases who had undergone radiotherapy (RT) between March 2005 and August 2013. Body composition (SATI, VATI, and muscle index) was assessed by computed tomography at the third lumbar vertebra and normalized for patient height. Patients were divided into low- and high-adiposity groups (for both SATI and VATI) according to sex-specific median values. Results Both SATI (hazard ratio [HR]: 0.696; P<0.001) and VATI (HR: 0.87; P = 0.037)-but not muscle index-were independently associated with a more favorable OS, with the former showing a stronger relationship. The most favorable OS was observed in women with high SATI (11.21 months; 95% confidence interval: 9.434-12.988; P<0.001). Conclusions High SATI and VATI are associated with a more favorable OS in Taiwanese patients with bone metastases referred for RT. The question as to whether clinical measures aimed at improving adiposity may improve OS in this clinical population deserves further scrutiny.	[Chuang, Wen Ching; Chen, Kuan Hung] Chang Gung Univ, Med, Taoyuan, Taiwan; [Chuang, Wen Ching; Chen, Kuan Hung] Chang Gung Mem Hosp, Linkou Branch, Taoyuan, Taiwan; [Tsang, Ngan Ming; Pai, Ping Ching] Linkou Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Tsang, Ngan Ming; Pai, Ping Ching] Chang Gung Univ, Taoyuan, Taiwan; [Tsang, Ngan Ming] Chang Gung Univ, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Chuang, Chi Cheng] Chang Gung Mem Hosp, Dept Neurosurg, Taoyuan, Taiwan; [Chuang, Chi Cheng; Chang, Kai Ping] Univ Lin Kou, Taoyuan, Taiwan; [Chang, Kai Ping] Linkou Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Chou, Wen Chi] Chang Gung Mem Hosp, Linkou Branch, Dept Internal Med, Div Hematol Oncol, Taoyuan, Taiwan; [Chou, Wen Chi] Chang Gung, Sch Med, Taoyuan, Taiwan; [Tai, Shiao Fwu] Chang Gung Mem Hosp, Dept Otorhinolaryngol, Linkou Branch, Taoyuan, Taiwan; [Liu, Shu Chen] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Lei, Kin Fong] Chang Gung Univ, Grad Inst Biomed Engn, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Central University; Chang Gung University	Tsang, NM (corresponding author), Linkou Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan.; Tsang, NM (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.; Tsang, NM (corresponding author), Chang Gung Univ, Sch Tradit Chinese Med, Taoyuan, Taiwan.	vstsang@cgmh.org.tw		Lei, Kin Fong/0000-0002-5356-2221; Chuang, Chi-Cheng/0000-0003-1898-7264	Ministry of Science and Technology, Taiwan [NZRPD1H1231]; Chang Gung Memorial Hospital (CGMH) [CMRPG3H1221, CMRPG3H1851, BMRP238]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital (CGMH)(Chang Gung Memorial Hospital)	This work was supported by Ministry of Science and Technology, Taiwan [NZRPD1H1231] and Chang Gung Memorial Hospital (CGMH) research grants [CMRPG3H1221, CMRPG3H1851, and BMRP238]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoun S, 2015, EUR J CANCER, V51, P2570, DOI 10.1016/j.ejca.2015.07.042; Bays H, 2014, CURR OPIN ENDOCRINOL, V21, P345, DOI 10.1097/MED.0000000000000093; Chou YC, 2017, CANCER MED-US, V6, P2087, DOI 10.1002/cam4.1150; Christen T, 2010, JACC-CARDIOVASC IMAG, V3, P843, DOI 10.1016/j.jcmg.2010.06.004; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Cozzo AJ, 2018, COMPR PHYSIOL, V8, P237, DOI 10.1002/cphy.c170008; Demark-Wahnefried W, 2012, CANCER EPIDEM BIOMAR, V21, P1244, DOI 10.1158/1055-9965.EPI-12-0485; Demerath EW, 2007, AM J CLIN NUTR, V85, P362, DOI 10.1093/ajcn/85.2.362; Ebadi M, 2017, BRIT J CANCER, V117, P148, DOI 10.1038/bjc.2017.149; Fujiwara N, 2015, J HEPATOL, V63, P131, DOI 10.1016/j.jhep.2015.02.031; Grignol VP, 2015, SURG ONCOL, V24, P353, DOI 10.1016/j.suronc.2015.09.002; Harada K, 2015, ANN SURG ONCOL, V22, P3946, DOI 10.1245/s10434-015-4432-4; Heymsfield SB, 2016, OBES REV, V17, P262, DOI 10.1111/obr.12358; Ladoire S, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2010-0227; Lee HW, 2015, INT J UROL, V22, P455, DOI 10.1111/iju.12716; Lee KH, 2018, INT J COLORECTAL DIS, V33, P1303, DOI 10.1007/s00384-018-3065-z; Lennon H, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-016-0539-4; McCarty MF, 2001, MED HYPOTHESES, V57, P192, DOI 10.1054/mehy.2001.1317; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Noumura Y, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20170253; Otunctemur A, 2016, INT BRAZ J UROL, V42, P955, DOI 10.1590/S1677-5538.IBJU.2015.0396; Oudin MJ, 2016, CANCER DISCOV, V6, P516, DOI 10.1158/2159-8290.CD-15-1183; Pai PC, 2018, CANCER MED-US, V7, P1630, DOI 10.1002/cam4.1365; Riihimaki M, 2014, LUNG CANCER, V86, P78, DOI 10.1016/j.lungcan.2014.07.020; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273; Schweitzer L, 2015, AM J CLIN NUTR, V102, P58, DOI 10.3945/ajcn.115.111203; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Tsang NM, 2016, CANCER MED-US, V5, P665, DOI 10.1002/cam4.634; Valencak TG, 2017, REDOX BIOL, V12, P806, DOI 10.1016/j.redox.2017.04.012; Wu SJ, 2014, CANCER CAUSE CONTROL, V25, P1489, DOI 10.1007/s10552-014-0450-y; Zhang HW, 2018, J BONE ONCOL, V11, P38, DOI 10.1016/j.jbo.2018.01.004; Zhang L, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.902971	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228360	10.1371/journal.pone.0228360	http://dx.doi.org/10.1371/journal.pone.0228360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999771	Green Published, gold			2022-12-26	WOS:000534612400072
J	Semmler, S; Gagne, M; Garg, P; Pickles, SR; Baudouin, C; Hamon-Keromen, E; Destroismaisons, L; Khalfallah, Y; Chaineau, M; Caron, E; Bayne, AN; Trempe, JF; Cashman, NR; Star, AT; Haqqani, AS; Durcan, TM; Meiering, EM; Robertson, J; Grandvaux, N; Plotkin, SS; McBride, HM; Velde, CV				Semmler, Sabrina; Gagne, Myriam; Garg, Pranav; Pickles, Sarah R.; Baudouin, Charlotte; Hamon-Keromen, Emeline; Destroismaisons, Laurie; Khalfallah, Yousra; Chaineau, Mathilde; Caron, Elise; Bayne, Andrew N.; Trempe, Jean-Francois; Cashman, Neil R.; Star, Alexandra T.; Haqqani, Arsalan S.; Durcan, Thomas M.; Meiering, Elizabeth M.; Robertson, Janice; Grandvaux, Nathalie; Plotkin, Steven S.; McBride, Heidi M.; Vande Velde, Christine			TNF receptor?associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); superoxide dismutase (SOD); protein misfolding; mitochondria; TNF receptor?associated factor (TRAF); ubiquitin; protein aggregation	NF-KAPPA-B; AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT SOD1; PARKINSONS-DISEASE; MOUSE MODEL; ATYPICAL UBIQUITINATION; MONOCLONAL-ANTIBODY; INDUCED ACTIVATION; IN-VIVO; TRAF6	Amyotrophic lateral sclerosis (ALS) is a fatal disease, characterized by the selective loss of motor neurons leading to paralysis. Mutations in the gene encoding superoxide dismutase 1 (SOD1) are the second most common cause of familial ALS, and considerable evidence suggests that these mutations result in an increase in toxicity due to protein misfolding. We previously demonstrated in the SOD1(G93A) rat model that misfolded SOD1 exists as distinct conformers and forms deposits on mitochondrial subpopulations. Here, using SOD1(G93A) rats and conformation-restricted antibodies specific for misfolded SOD1 (B8H10 and AMF7-63), we identified the interactomes of the mitochondrial pools of misfolded SOD1. This strategy identified binding proteins that uniquely interacted with either AMF7-63 or B8H10-reactive SOD1 conformers as well as a high proportion of interactors common to both conformers. Of this latter set, we identified the E3 ubiquitin ligase TNF receptor?associated factor 6 (TRAF6) as a SOD1 interactor, and we determined that exposure of the SOD1 functional loops facilitates this interaction. Of note, this conformational change was not universally fulfilled by all SOD1 variants and differentiated TRAF6 interacting from TRAF6 noninteracting SOD1 variants. Functionally, TRAF6 stimulated polyubiquitination and aggregation of the interacting SOD1 variants. TRAF6 E3 ubiquitin ligase activity was required for the former but was dispensable for the latter, indicating that TRAF6-mediated polyubiquitination and aggregation of the SOD1 variants are independent events. We propose that the interaction between misfolded SOD1 and TRAF6 may be relevant to the etiology of ALS.	[Semmler, Sabrina; Chaineau, Mathilde; Durcan, Thomas M.; McBride, Heidi M.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Bayne, Andrew N.; Trempe, Jean-Francois] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3A 2B4, Canada; [Chaineau, Mathilde; Durcan, Thomas M.; McBride, Heidi M.] McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada; [Semmler, Sabrina; Gagne, Myriam; Pickles, Sarah R.; Baudouin, Charlotte; Hamon-Keromen, Emeline; Destroismaisons, Laurie; Khalfallah, Yousra; Caron, Elise; Grandvaux, Nathalie; Vande Velde, Christine] CHU Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada; [Gagne, Myriam; Pickles, Sarah R.; Grandvaux, Nathalie; Vande Velde, Christine] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3T 1J4, Canada; [Khalfallah, Yousra; Vande Velde, Christine] Univ Montreal, Dept Neurosci, Montreal, PQ H3T 1J4, Canada; [Garg, Pranav; Plotkin, Steven S.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Baudouin, Charlotte] Catholic Univ Louvain, B-1348 Louvain La Neuve, Belgium; [Hamon-Keromen, Emeline] Univ Paris 06, F-75005 Paris, France; [Cashman, Neil R.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V6T 2B5, Canada; [Cashman, Neil R.] Brain Res Ctr, Vancouver Coastal Hlth Res Inst, Vancouver, BC V6T 2B5, Canada; [Star, Alexandra T.; Haqqani, Arsalan S.] Natl Res Council Canada, Human Hlth Therapeut Portfolio, Ottawa, ON K1A 0R6, Canada; [Meiering, Elizabeth M.] Univ Waterloo, Guelph Waterloo Ctr Grad Work Chem & Biochem, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Robertson, Janice] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 0S8, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of British Columbia; Universite Catholique Louvain; UDICE-French Research Universities; Sorbonne Universite; University of British Columbia; Vancouver Coastal Health Research Institute; National Research Council Canada; University of Guelph; University of Waterloo; Guelph-Waterloo Centre for Graduate Work in Chemistry & Biochemistry; University of Toronto	Velde, CV (corresponding author), Univ Montreal, Dept Neurosci, CHU Montreal, Ctr Rech, 900 St Denis,R09-442, Montreal, PQ H2X 0A9, Canada.	c.vande.velde@umontreal.ca	McBride, Heidi M/C-1162-2008; McBride, Heidi M./ABD-5774-2021; Plotkin, Steven/AAO-3257-2020	McBride, Heidi M/0000-0003-4666-2280; McBride, Heidi M./0000-0003-4666-2280; Plotkin, Steven/0000-0001-8998-877X; Semmler, Sabrina/0000-0001-7422-9068	ALS Society of Canada; Muscular Dystrophy Association; Frick Foundation for ALS Research; Rare Disease Foundation	ALS Society of Canada; Muscular Dystrophy Association(Muscular Dystrophy Association); Frick Foundation for ALS Research; Rare Disease Foundation	This work was supported by grants from the ALS Society of Canada (to C. V. V.), the Muscular Dystrophy Association (to C. V. V.), the Frick Foundation for ALS Research (to C. V. V.), and the Rare Disease Foundation (to S. S. and C. V. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Atlasi RS, 2018, ACS CHEM BIOL, V13, P2794, DOI 10.1021/acschembio.8b00729; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Bergh J, 2015, P NATL ACAD SCI USA, V112, P4489, DOI 10.1073/pnas.1419228112; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Broering TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061210; Broom HR, 2016, BIOCHEMISTRY-US, V55, P519, DOI 10.1021/acs.biochem.5b01187; Broom HR, 2015, PROTEIN SCI, V24, P2081, DOI 10.1002/pro.2803; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chung JY, 2013, LAB INVEST, V93, P663, DOI 10.1038/labinvest.2013.60; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Coyaud E, 2015, MOL CELL PROTEOMICS, V14, P1781, DOI 10.1074/mcp.M114.045658; Doyle CM, 2016, BIOCHEMISTRY-US, V55, P1346, DOI 10.1021/acs.biochem.5b01133; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Fang J, 2018, CELL REP, V22, P1250, DOI 10.1016/j.celrep.2018.01.013; Fang J, 2017, NAT IMMUNOL, V18, P236, DOI 10.1038/ni.3654; Fink K, 2008, J IMMUNOL, V180, P6911, DOI 10.4049/jimmunol.180.10.6911; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Fujisawa T, 2012, ANN NEUROL, V72, P739, DOI 10.1002/ana.23668; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gal J, 2013, J BIOL CHEM, V288, P15035, DOI 10.1074/jbc.M112.431957; Gaudette M, 2000, AMYOTROPH LATERAL SC, V1, P83, DOI 10.1080/14660820050515377; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; Goslin K., 1998, CULTURING NERVE CELL, P339; Granatiero V, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020036; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Haqqani AS, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-4; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Iconomou M, 2016, BIOCHEM J, V473, P4083, DOI 10.1042/BCJ20160719; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Jain MR, 2008, PROTEOM CLIN APPL, V2, P670, DOI 10.1002/prca.200780023; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Khalfallah Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25767-0; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Korchnak AC, 2009, CELL SIGNAL, V21, P1620, DOI 10.1016/j.cellsig.2009.06.008; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Lee NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02096; Lim GGY, 2015, J BIOL CHEM, V290, P16882, DOI 10.1074/jbc.M114.622399; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Liu HN, 2012, J NEUROSCI, V32, P8791, DOI 10.1523/JNEUROSCI.5053-11.2012; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Maier M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aah3924; Matheoud D, 2019, NATURE, V571, P565, DOI 10.1038/s41586-019-1405-y; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; Min Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00094; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Ouali Alami N, 2018, EMBO J, V37, DOI 10.15252/embj.201798697; Patel P, 2014, MOL THER, V22, P498, DOI 10.1038/mt.2013.239; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Peng XB, 2018, J PHYS CHEM B, V122, P11662, DOI 10.1021/acs.jpcb.8b07680; Pickles S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0313-8; Pickles Sarah, 2014, J Vis Exp, P51887, DOI 10.3791/51887; Pickles S, 2013, HUM MOL GENET, V22, P3947, DOI 10.1093/hmg/ddt249; Pickles S, 2012, AMYOTROPH LATERAL SC, V13, P333, DOI 10.3109/17482968.2012.648645; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Rengachari S, 2018, P NATL ACAD SCI USA, V115, pE601, DOI 10.1073/pnas.1718426115; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Roberts BR, 2014, J NEUROSCI, V34, P8021, DOI 10.1523/JNEUROSCI.4196-13.2014; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ruegsegger C, 2016, ACTA NEUROPATHOL, V131, P427, DOI 10.1007/s00401-015-1510-4; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Saxena S, 2013, NEURON, V80, P80, DOI 10.1016/j.neuron.2013.07.027; Schimmack G, 2017, ELIFE, V6, DOI 10.7554/eLife.22416; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shi ZB, 2015, J BIOL CHEM, V290, P26811, DOI 10.1074/jbc.M115.666578; Strickson S, 2017, P NATL ACAD SCI USA, V114, pE3481, DOI 10.1073/pnas.1702367114; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Takeuchi S, 2010, J NEUROPATH EXP NEUR, V69, P1044, DOI 10.1097/NEN.0b013e3181f4a90a; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Tarr IS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44765-4; Tenekeci U, 2016, MOL CELL, V62, P943, DOI 10.1016/j.molcel.2016.05.017; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Velde CV, 2008, P NATL ACAD SCI USA, V105, P4022, DOI 10.1073/pnas.0712209105; Velde CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022031; Vilotti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035051; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Walsh MC, 2015, IMMUNOL REV, V266, P72, DOI 10.1111/imr.12302; Wang KZQ, 2010, J CELL BIOCHEM, V110, P763, DOI 10.1002/jcb.22589; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003497; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wright GSA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27691; Yan R, 2013, CELL SIGNAL, V25, P1769, DOI 10.1016/j.cellsig.2013.05.015; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zetterstrom P, 2011, J BIOL CHEM, V286, P20130, DOI 10.1074/jbc.M111.218842; Zhao BB, 2019, VACCINE, V37, P4920, DOI 10.1016/j.vaccine.2019.07.044; Zucchelli S, 2011, J BIOL CHEM, V286, P25108, DOI 10.1074/jbc.M110.187591; Zucchelli S, 2010, HUM MOL GENET, V19, P3759, DOI 10.1093/hmg/ddq290	103	10	10	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3808	3825		10.1074/jbc.RA119.011215	http://dx.doi.org/10.1074/jbc.RA119.011215			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32029478	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000527704400008
J	Collinson, NP; Mann, RC; Giri, K; Malipatil, M; Kaur, J; Spangenberg, G; Valenzuela, I				Collinson, Nicholas Paul; Mann, Ross Cameron; Giri, Khageswor; Malipatil, Mallik; Kaur, Jatinder; Spangenberg, German; Valenzuela, Isabel			Novel bioassay to assess antibiotic effects of fungal endophytes on aphids	PLOS ONE			English	Article							DIURAPHIS-NOXIA HOMOPTERA; RYEGRASS LOLIUM-PERENNE; RUSSIAN WHEAT APHID; NEOTYPHODIUM-LOLII; WILD BARLEY; PERFORMANCE; RESISTANCE; ALKALOIDS; POPULATION; GRASSES	Perennial ryegrass is an important feed base for the dairy and livestock industries around the world. It is often infected with mutualistic fungal endophytes that confer protection to the plant against biotic and abiotic stresses. Bioassays that test their antibiotic effect on invertebrates are varied and range from excised leaves to whole plants. The aim of this study was to design and validate a "high-throughput" in-planta bioassay using 7-day-old seedlings confined in small cups, allowing for rapid assessments of aphid life history to be made while maintaining high replication and treatment numbers. Antibiosis was evaluated on the foliar and the root aphid species; Diuraphis noxia (Mordvilko) and Aploneura lentisci (Passerini) feeding on a range of perennial ryegrass-Epichloe festucae var. Lolii endophyte symbiota. As expected, both D. noxia and A. lentisci reared on endophyte-infected plants showed negatively affected life history traits by comparison to non-infected plants. Both species exhibited the highest mortality at the nymphal stage with an average total mortality across all endophyte treatments of 91% and 89% for D. noxia and A. lentisci respectively. Fecundity decreased significantly on all endophyte treatments with an average total reduction of 18% and 16% for D. noxia and A. lentisci respectively by comparison to non-infected plants. Overall, the bioassay proved to be a rapid method of evaluating the insecticidal activity of perennial ryegrass-endophyte symbiota on aphids (nymph mortality could be assessed in as little as 24 and 48 hours for D. noxia and A. lentisci respectively). This rapid and simple approach can be used to benchmark novel grass-endophyte symbiota on a range of aphid species that feed on leaves of plants, however we would caution that it may not be suitable for the assessment of root-feeding aphids, as this species exhibited relatively high mortality on the control as well.	[Collinson, Nicholas Paul; Mann, Ross Cameron; Giri, Khageswor; Malipatil, Mallik; Kaur, Jatinder; Spangenberg, German; Valenzuela, Isabel] AgriBio Ctr AgriBiosci, Agr Victoria Res, Bundoora, Vic, Australia; [Collinson, Nicholas Paul; Malipatil, Mallik; Spangenberg, German] La Trobe Univ, Dept Sci Hlth & Engn, Sch Appl Syst Biol, Bundoora, Vic, Australia	La Trobe University	Collinson, NP (corresponding author), AgriBio Ctr AgriBiosci, Agr Victoria Res, Bundoora, Vic, Australia.; Collinson, NP (corresponding author), La Trobe Univ, Dept Sci Hlth & Engn, Sch Appl Syst Biol, Bundoora, Vic, Australia.	nicholas.collinson@agriculture.vic.gov.au		Malipatil, Mallik/0000-0002-3088-1035; Collinson, Nicholas/0000-0002-6866-8344	DairyBio; Victorian Department of Jobs, Precincts and Regions (Agriculture Victoria Research); Dairy Australia; Gardiner Foundation	DairyBio; Victorian Department of Jobs, Precincts and Regions (Agriculture Victoria Research); Dairy Australia(Dairy Australia); Gardiner Foundation	NPC was supported by a research scholarship from DairyBio (dairybio.com.au), a joint venture of the Victorian Department of Jobs, Precincts and Regions (Agriculture Victoria Research), Dairy Australia and The Gardiner Foundation. The funder provided support in the form of salaries for NPC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 1994, BIOTECHNOLOGY ENDOPH; Bailey P., 2007, PESTS FIELD CROPS PA; Bastias DA, 2017, OECOLOGIA, V185, P245, DOI 10.1007/s00442-017-3940-2; BREEN JP, 1993, J ECON ENTOMOL, V86, P1279, DOI 10.1093/jee/86.4.1279; BREEN JP, 1994, ANNU REV ENTOMOL, V39, P401, DOI 10.1146/annurev.en.39.010194.002153; Bush LP, 1997, PLANT PHYSIOL, V114, P1, DOI 10.1104/pp.114.1.1; Chapman D., 2012, Australasian Dairy Science Symposium 2012. Proceedings of the 5th Australasian Dairy Science Symposium, Melbourne, Australia, 13-15 November 2012, P422; Chapman DF, 2017, GRASS FORAGE SCI, V72, P1, DOI 10.1111/gfs.12213; CLAY K, 1985, OECOLOGIA, V66, P1, DOI 10.1007/BF00378545; Clement SL, 2005, ENTOMOL EXP APPL, V114, P119, DOI 10.1111/j.1570-7458.2005.00236.x; Clement SL, 1997, ENTOMOL EXP APPL, V82, P275, DOI 10.1023/A:1002988526984; CLEMENT SL, 1992, J ECON ENTOMOL, V85, P583, DOI 10.1093/jee/85.2.583; CUNNINGHAM PJ, 1994, NEW ZEAL J AGR RES, V37, P295, DOI 10.1080/00288233.1994.9513068; Curry JP, 1994, GRASSLAND INVERTEBRA, P95; Curry JP, 1993, EFFECTS HERBIVORES G, P303; Curry JP, 1994, GRASSLAND INVERTEBRA, P33; de Jong EV, 2008, AUST J AGR RES, V59, P214, DOI 10.1071/AR07270; Devine GJ, 2007, AGR HUM VALUES, V24, P281, DOI 10.1007/s10460-007-9067-z; Edwards OR, 2008, AUST J EXP AGR, V48, P1523, DOI 10.1071/EA07426; ESQUEDA MK, 2017, FRONT PLANT SCI, V8, DOI DOI 10.3389/FPLS.2017.00008; Faeth SH, 2002, J CHEM ECOL, V28, P1511, DOI 10.1023/A:1019916227153; Ferguson CM, 2019, NEW ZEAL J AGR RES, V62, P255, DOI 10.1080/00288233.2018.1478860; FLETCHER LR, 1981, NEW ZEAL VET J, V29, P185, DOI 10.1080/00480169.1981.34839; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Food and Agriculture Organization of the United Nations World Health Organization, 2016, JOINT M PEST SPEC MA; GALLAGHER RT, 1981, NEW ZEAL VET J, V29, P189, DOI 10.1080/00480169.1981.34843; Gaynor DL, 1986, P NZ GRASSLAND ASS, V47, P115; GRAVES H, 2016, FRONT PLANT SCI, V6, DOI DOI 10.3389/FPLS.2016.00006; Hesse U, 2003, GRASS FORAGE SCI, V58, P407, DOI 10.1111/j.1365-2494.2003.00393.x; Hettiarachchige IK, 2019, MOL GENET GENOMICS, V294, P315, DOI 10.1007/s00438-018-1510-x; Holland PT, 2000, ROY SOC CH, P29, DOI 10.1039/9781847551757-00029; HOVELAND CS, 1993, AGR ECOSYST ENVIRON, V44, P3, DOI 10.1016/0167-8809(93)90036-O; HUGHES RD, 1990, B ENTOMOL RES, V80, P165, DOI 10.1017/S0007485300013389; Hunt MG, 2005, J APPL ECOL, V42, P762, DOI 10.1111/j.1365-2664.2005.01061.x; JOHNSON MC, 1985, APPL ENVIRON MICROB, V49, P568, DOI 10.1128/AEM.49.3.568-571.1985; Jones RAC, 2013, CROP PASTURE SCI, V64, P216, DOI 10.1071/CP13134; Kauppinen M, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.224, 10.1038/nplants.2015.224]; KINDLER SD, 1989, J ECON ENTOMOL, V82, P1358, DOI 10.1093/jee/82.5.1358; Kingshay, 2019, DAIRY COSTING FOCUS; Klotz JL, 2007, J ANIM SCI, V85, P2330, DOI 10.2527/jas.2006-803; Leddin CM, 2018, ANIM PROD SCI, V58, P1552, DOI [10.1071/AN17815, 10.1071/an17815]; Mann SP, 2011, Patent No. [US20110150853A1, 20110150853]; Meister B, 2006, BASIC APPL ECOL, V7, P244, DOI 10.1016/j.baae.2005.06.002; Mustafa T. M., 1987, Dirasat, V14, P83; New Ag International, 2015, BIOC AS GAIN MOM SEE; O'Callaghan M, 2016, APPL MICROBIOL BIOT, V100, P5729, DOI 10.1007/s00253-016-7590-9; Ostlind DA, 1997, MED VET ENTOMOL, V11, P407, DOI 10.1111/j.1365-2915.1997.tb00431.x; Plumb R. T., 1988, The grass crop. The physiological basis of production, P277; Popay A. J., 2009, Proceedings of the New Zealand Grassland Association, V71, P121; Popay AJ., 2011, GRASSL RES PRACT SER, V15, P149; Popay AJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01395; Reed KFM, 2004, AUST J EXP AGR, V44, P1185, DOI 10.1071/EA03242; Ridland PM, 1988, SIMPLE REARING SYSTE, V17, P3; ROYLANCE JT, 1994, J CHEM ECOL, V20, P2171, DOI 10.1007/BF02033195; Ryan GD, 2015, FUNGAL ECOL, V18, P115, DOI 10.1016/j.funeco.2015.07.006; Shufran KA, 2011, ANN ENTOMOL SOC AM, V104, P39, DOI 10.1603/AN10129; SIEGEL MR, 1987, ANNU REV PHYTOPATHOL, V25, P293, DOI 10.1146/annurev.py.25.090187.001453; SIEGEL MR, 1990, J CHEM ECOL, V16, P3301, DOI 10.1007/BF00982100; Spiering MJ, 2005, PHYTOCHEMISTRY, V66, P195, DOI 10.1016/j.phytochem.2004.11.021; Tian P, 2013, CROP PASTURE SCI, V64, P716, DOI 10.1071/CP13067; Valenzuela I, 2010, ANN ENTOMOL SOC AM, V103, P886, DOI 10.1603/AN09113; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; VSN International, 2015, GENSTAT WINDOWS, V18th; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WILKINS PW, 1991, EUPHYTICA, V52, P201, DOI 10.1007/BF00029397; Wilkinson HH, 2000, MOL PLANT MICROBE IN, V13, P1027, DOI 10.1094/MPMI.2000.13.10.1027; WYATT IJ, 1977, J APPL ECOL, V14, P757, DOI 10.2307/2402807; Yazdani M, 2018, AUSTRAL ENTOMOL, V57, P410, DOI 10.1111/aen.12292	68	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228813	10.1371/journal.pone.0228813	http://dx.doi.org/10.1371/journal.pone.0228813			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040957	Green Published, gold			2022-12-26	WOS:000534629400044
J	Darba, J; Marsa, A				Darba, Josep; Marsa, Alicia			Results after 10 years of colorectal cancer screenings in Spain: Hospital incidence and in-hospital mortality (2011-2016)	PLOS ONE			English	Article							SURGERY; LENGTH; IMPACT; STAY	Background Colorectal cancer incidence in Spain increased considerably between the early nineties and 2010. To reverse this tendency, screenings were progressively implemented starting the year 2001, targeting the population aged 50 to 69 years. Objectives This study aimed to update colorectal cancer incidence and mortality trends in Spain and provide a detailed analysis of disease management and risk factors involved in in-hospital mortality. Methods To this aim, anonymised primary and specialised care admission records from 2011 to 2016 were extracted from a Spanish claims database representative of all Spanish regions. Results Primary care files from 37,317 patients and specialised care files from 192,048 patients were obtained, in which males represented the 56.17% and 60.70% of patients respectively. In-hospital mortality rate was 10.07% and remained stable during the study period, similarly to colorectal cancer incidence within the hospitalised population, which was 106 per 10,000 patients. Patients deceased during the hospitalisation presented an increased presence of metastatic tumours. Mean length of hospital stay decreased significantly over the study period from 13.43 days to 11.67 days (p<0.001), similarly to patients' 30-day readmission rate, which registered a decrease from the 15.29% to 13.58% (p<0.001). In consequence, the direct medical cost measured per patient, of (sic)10,992, decreased over time. The implementation of colorectal cancer screening programmes caused a significant decrease in the number of new diagnoses in patients aged 75 to 79 years that may be attributable to the implementation of colorectal cancer screening programmes; however, in-hospital mortality was not reduced. Metastatic tumours and other conditions as anaemia are associated with higher in-hospital mortality rates.	[Darba, Josep] Univ Barcelona, Dept Econ, Barcelona, Spain; [Marsa, Alicia] BCN Hlth Econ & Outcomes Res SL, Dept Hlth Econ, Barcelona, Spain	University of Barcelona	Darba, J (corresponding author), Univ Barcelona, Dept Econ, Barcelona, Spain.	darba@ub.edu		Darba, Josep/0000-0003-2371-0999; Marsa, Alicia/0000-0001-8116-7029	BCN Health Economics & Outcomes Research SL	BCN Health Economics & Outcomes Research SL	The author(s) received no specific funding for this work. BCN Health Economics & Outcomes Research SL provided support in the form of salaries for the author AM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section	Aleksandrova K, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0168-4; Bare M, 2017, INT J CHRONIC OBSTR, V12, P1233, DOI 10.2147/COPD.S130377; Binefa G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19532; Blanco-Calvo M, 2015, INT J MOL SCI, V16, P13610, DOI 10.3390/ijms160613610; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Corral J, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1297-6; Corral J, 2015, GAC SANIT, V29, P437, DOI 10.1016/j.gaceta.2015.07.005; Esteva M, 2014, CANCER EPIDEMIOL, V38, P346, DOI 10.1016/j.canep.2014.05.002; Garcia-Torrecillas JM, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5502-y; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Lopez-Abente G, 2010, ANN ONCOL, V21, piii76, DOI 10.1093/annonc/mdq091; Mengual-Ballester M, 2018, INT J COLORECTAL DIS, V33, P23, DOI 10.1007/s00384-017-2928-z; Ministerio de Sanidad Consumo y Bienestar Social, SAN DAT; Navarro M, 2017, WORLD J GASTROENTERO, V23, P3632, DOI 10.3748/wjg.v23.i20.3632; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Pucciarelli S, 2017, EJSO-EUR J SURG ONC, V43, P1312, DOI 10.1016/j.ejso.2017.03.003; Trejo DS, 2017, EUR J CANCER PREV, V26, P17, DOI 10.1097/CEJ.0000000000000232; Shah PM, 2017, DIS COLON RECTUM, V60, P219, DOI 10.1097/DCR.0000000000000748; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Tauriello DVF, 2017, MOL ONCOL, V11, P97, DOI 10.1002/1878-0261.12018; Teloken PE, 2016, ANZ J SURG, V86, P454, DOI 10.1111/ans.13523; Vayrynen JP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19572-y; Ventura L, 2014, DIGEST LIVER DIS, V46, P82, DOI 10.1016/j.dld.2013.07.017; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997; Zhu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176068	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228795	10.1371/journal.pone.0228795	http://dx.doi.org/10.1371/journal.pone.0228795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040530	Green Published, gold			2022-12-26	WOS:000534629400042
J	Serra, LSM; de Araujo, JG; Vieira, ALS; da Silva, EM; de Andrade, RR; Kuckelhau, SAS; Sampaio, ALL				Martins Serra, Lucieny Silva; de Araujo, Juliana Gusmao; Sarkis Vieira, Ana Luiza; da Silva, Eduardo Magalhaes; de Andrade, Rafael Rocha; Souza Kuckelhau, Selma Aparecida; Lopes Sampaio, Andre Luiz			Role of melatonin in prevention of age-related hearing loss	PLOS ONE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; PLASMA LEPTIN; ANTIOXIDANTS; INSULIN	Introduction Age-related hearing loss (ARHL) is a consequence of aging of the auditory system. The best known mechanism of cell death in ARHL is apoptosis due to increased production of reactive oxygen species. In this context, it is hypothesized that melatonin, owing to its high antioxidant potential and its action in the mitochondria, helps prevent or delay outer hair cell dysfunction (HCD). Aims To evaluate the effect of melatonin on the prevention of HCD dysfunction in the ARHL process in a susceptible murine C57BL/6J model. Method C57BL/6J animals were divided into two groups: control (CG) and melatonin (MG). The CG received a saline and ethanol solution and the MG, melatonin (10 mg/kg/day). The solutions were offered daily (50 mu l) orally over a 10-month period. Distortion Product Otoacoustic Emissions (DPOAE) measurements were conducted once a month. Results There was a decrease in DPOAE values in both groups over time and a differentiation between them from the 10th month of life onwards. At 10 months, the MG maintained higher DPOAE values than the CG at all frequencies tested. Conclusion The use of melatonin has otoprotective effects on HCD in the ARHL process in the C57BL/6J model.	[Martins Serra, Lucieny Silva; de Araujo, Juliana Gusmao; Lopes Sampaio, Andre Luiz] Univ Brasilia, Lab Otorhinolaryngol Res, Brasilia, DF, Brazil; [Sarkis Vieira, Ana Luiza] Univ Brasilia, Dept Trop Med, Brasilia, DF, Brazil; [da Silva, Eduardo Magalhaes] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil; [de Andrade, Rafael Rocha] Univ Brasilia, Lab Expt Surg, Brasilia, DF, Brazil; [Souza Kuckelhau, Selma Aparecida] Univ Brasilia, Dept Morphol, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	Serra, LSM (corresponding author), Univ Brasilia, Lab Otorhinolaryngol Res, Brasilia, DF, Brazil.	lucienymserra@gmail.com		Kuckelhaus, Selma/0000-0001-7677-772X; Silva, Eduardo Magalhaes da/0000-0001-5132-8370; SM SERRA, LUCIENY/0000-0002-8113-7222				Anastasio ART., 2015, TRATADO AUDIOLOGIA, V2nd; Bernabei R, 2014, AGING CLIN EXP RES, V26, P567, DOI 10.1007/s40520-014-0266-3; Bowl MR, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a033217; Bowl MR, 2015, GERONTOLOGY, V61, P149, DOI 10.1159/000368399; Cipolla-Neto J, 2018, ENDOCR REV, V39, P990, DOI 10.1210/er.2018-00084; De Araujo JG, 2019, ANTICANCER RES, V39, P2453, DOI 10.21873/anticanres.13364; de Mello JM, 2014, CODAS, V26, P3, DOI 10.1590/s2317-17822014000100002; Dong Y, 2018, MOL MED REP, V18, P1726, DOI 10.3892/mmr.2018.9118; Fujimoto C, 2014, HEARING LOSS OXID ME, V2014, P1; Garcia JJ, 2014, J PINEAL RES, V56, P225, DOI 10.1111/jpi.12128; Gorecka MM, 2018, EXP GERONTOL, V111, P253, DOI 10.1016/j.exger.2018.07.015; Heman-Ackah SE, 2010, OTOLARYNG HEAD NECK, V143, P429, DOI 10.1016/j.otohns.2010.04.266; Kamogashira T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/617207; Karlidag T, 2002, AURIS NASUS LARYNX, V29, P147, DOI 10.1016/S0385-8146(01)00137-7; Lasisi TJ, 2015, AGING CLIN EXP RES, V27, P265, DOI 10.1007/s40520-014-0282-3; Le T, 2007, HEARING RES, V226, P194, DOI 10.1016/j.heares.2006.04.003; Liu SW, 2012, GENE, V499, P309, DOI 10.1016/j.gene.2012.01.084; Mock BE, 2016, NEUROBIOL AGING, V43, P13, DOI 10.1016/j.neurobiolaging.2016.03.013; Morrill Seth, 2017, J Otol, V12, P151, DOI 10.1016/j.joto.2017.08.001; Narui Y, 2009, INT J AUDIOL, V48, P576, DOI 10.1080/14992020902858959; Parham K, 1997, HEARING RES, V112, P216, DOI 10.1016/S0378-5955(97)00124-X; Park SN, 2010, CLIN EXP OTORHINOLAR, V3, P126, DOI 10.3342/ceo.2010.3.3.126; Polanski JF, 2013, J LARYNGOL OTOL, V127, P134, DOI 10.1017/S0022215112003118; Rasmussen DD, 1999, ENDOCRINOLOGY, V140, P1009, DOI 10.1210/en.140.2.1009; Rocha AB., 2007, REV BRAS CANCEROL, V53, P335, DOI DOI 10.1590/S0102-311X2003000200031; Seidman MD, 2000, LARYNGOSCOPE, V110, P727, DOI 10.1097/00005537-200005000-00003; Sletten TL, 2010, FRONT NEUROL, V1, P1; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Tavanai E, 2017, EUR ARCH OTO-RHINO-L, V274, P1821, DOI 10.1007/s00405-016-4378-6; Tretbar K, 2019, HNO, V67, P36, DOI 10.1007/s00106-018-0576-4; Volquind D., 2016, D VOLQUIND EFEITOS M; Wolden-Hanson T, 2000, ENDOCRINOLOGY, V141, P487, DOI 10.1210/en.141.2.487; Wong ACY, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00058; Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004	34	3	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228943	10.1371/journal.pone.0228943	http://dx.doi.org/10.1371/journal.pone.0228943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040524	Green Published, gold			2022-12-26	WOS:000534629400057
J	Rohling, S; Linne, A; Schellhorn, J; Hosseini, M; Dencker, T; Morgenstern, B				Roehling, Sophie; Linne, Alexander; Schellhorn, Jendrik; Hosseini, Morteza; Dencker, Thomas; Morgenstern, Burkhard			The number of k-mer matches between two DNA sequences as a function of k and applications to estimate phylogenetic distances	PLOS ONE			English	Article							COMMON SUBSTRING APPROACH; ALIGNMENT	We study the number N-k of length-k word matches between pairs of evolutionarily related DNA sequences, as a function of k. We show that the Jukes-Cantor distance between two genome sequences-i.e. the number of substitutions per site that occurred since they evolved from their last common ancestor-can be estimated from the slope of a function F that depends on N-k and that is affine-linear within a certain range of k. Integers k(min) and k(max) can be calculated depending on the length of the input sequences, such that the slope of F in the relevant range can be estimated from the values F(k(min)) and F(k(max)). This approach can be generalized to so-called Spaced-word Matches (SpaM), where mismatches are allowed at positions specified by a user-defined binary pattern. Based on these theoretical results, we implemented a prototype software program for alignment-free sequence comparison called Slope-SpaM. Test runs on real and simulated sequence data show that Slope-SpaM can accurately estimate phylogenetic distances for distances up to around 0.5 substitutions per position. The statistical stability of our results is improved if spaced words are used instead of contiguous words. Unlike previous alignment-free methods that are based on the number of (spaced) word matches, Slope-SpaM produces accurate results, even if sequences share only local homologies.	[Roehling, Sophie; Linne, Alexander; Schellhorn, Jendrik; Dencker, Thomas; Morgenstern, Burkhard] Univ Gottingen, Dept Bioinformat, Gottingen, Germany; [Hosseini, Morteza] Univ Aveiro, IEETA, Aveiro, Portugal; [Morgenstern, Burkhard] Gottingen Ctr Mol Biosci GZMB, Gottingen, Germany	University of Gottingen; Universidade de Aveiro	Morgenstern, B (corresponding author), Univ Gottingen, Dept Bioinformat, Gottingen, Germany.; Morgenstern, B (corresponding author), Gottingen Ctr Mol Biosci GZMB, Gottingen, Germany.	bmorgen@gwdg.de	Hosseini, Morteza/AAR-8433-2020; Morgenstern, Burkhard/A-7486-2008	Hosseini, Morteza/0000-0002-1492-7443; Morgenstern, Burkhard/0000-0002-7431-2862; Hosseini, Morteza/0000-0001-8962-8985; Rohling, Sophie/0000-0002-4797-0536; Schellhorn, Jendrik/0000-0002-4478-7998	VW Foundation [VWZN3157]; Foundation for Science and Technology (FCT) [UID/CEC/00127/2019]; Open Access Publication Funds of Gottingen University	VW Foundation(Volkswagen); Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Open Access Publication Funds of Gottingen University	The project was funded by VW Foundation, project VWZN3157 to BM, and by the Portuguese national funds through Foundation for Science and Technology (FCT), in the context of the project UID/CEC/00127/2019. We acknowledge support by the Open Access Publication Funds of Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflitos SA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0806-7; Ahlgren NA, 2017, NUCLEIC ACIDS RES, V45, P39, DOI 10.1093/nar/gkw1002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Balaban M, 2020, SYST BIOL, V69, P566, DOI 10.1093/sysbio/syz063; Bernard G, 2019, BRIEF BIOINFORM, V20, P426, DOI 10.1093/bib/bbx067; Brinda K, 2018, BIORXIV; Brinda K, 2015, BIOINFORMATICS, V31, P3584, DOI 10.1093/bioinformatics/btv419; Broder AZ, 2000, LECT NOTES COMPUT SC, V1848, P1; Bromberg R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004985; Brown DG, 2008, BIOINFORMATICS ALGOR, V126, P152, DOI [10.1002/9780470253441.ch6, DOI 10.1002/9780470253441.CH6]; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Dencker T, 2020, NAR GENOMICS BIOINFO, V2, DOI [10.1093/nargab/Iz013, DOI 10.1093/NARGABANZ013]; Egidi L, 2014, THEOR COMPUT SCI, V522, P62, DOI 10.1016/j.tcs.2013.12.007; Fan H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1647-5; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fischer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067048; Gerth M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6117; Gusfield D., 1997, ALGORITHMS STRINGS T; Hatje K, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00192; Haubold B, 2015, BIOINFORMATICS, V31, P1169, DOI 10.1093/bioinformatics/btu815; Haubold B, 2014, BRIEF BIOINFORM, V15, P407, DOI 10.1093/bib/bbt083; Haubold B, 2009, J COMPUT BIOL, V16, P1487, DOI 10.1089/cmb.2009.0106; Horwege S, 2014, NUCLEIC ACIDS RES, V42, pW7, DOI 10.1093/nar/gku398; Hosseini M, 2019, BIORXIV; Ilie L, 2011, BIOINFORMATICS, V27, P2433, DOI 10.1093/bioinformatics/btr368; Jain C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07641-9; Jukes TH, 1969, EVOLUTION PROTEIN MO; Klotzl F., BIOINFORMATICS; Kucherov G, 2019, BIOINFORMATICS, V35, P3547, DOI 10.1093/bioinformatics/btz272; Lau AK, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3205-7; Lees JA, GENOME RES; Leimeister CA, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giy148; Leimeister CA, 2017, BIOINFORMATICS, V33, P971, DOI 10.1093/bioinformatics/btw776; Leimeister CA, 2014, BIOINFORMATICS, V30, P1991, DOI 10.1093/bioinformatics/btu177; Leimeister CA, 2014, BIOINFORMATICS, V30, P2000, DOI 10.1093/bioinformatics/btu331; Li M, 2006, PROCEEDINGS OF THE SEVENTHEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P444, DOI 10.1145/1109557.1109607; Li Ming, 2003, Genome Inform, V14, P164; Linard B, 2019, BIOINFORMATICS, V35, P3303, DOI 10.1093/bioinformatics/btz068; Lu YY, 2017, NUCLEIC ACIDS RES, V45, pW554, DOI 10.1093/nar/gkx351; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Morgenstern B., 2019, BIORXIV; Morgenstern B, 2017, ALGORITHM MOL BIOL, V12, DOI 10.1186/s13015-017-0118-8; Morgenstern B, 2015, ALGORITHM MOL BIOL, V10, DOI 10.1186/s13015-015-0032-x; Murray KD, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005727; Noe L, 2017, ALGORITHM MOL BIOL, V12, DOI 10.1186/s13015-017-0092-1; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Qi J, 2004, NUCLEIC ACIDS RES, V32, pW45, DOI 10.1093/nar/gkh362; Reinert G, 2009, J COMPUT BIOL, V16, P1615, DOI 10.1089/cmb.2009.0198; Ren J, 2018, ANNU REV BIOMED DA S, V1, P93, DOI 10.1146/annurev-biodatasci-080917-013431; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Rohling S., 2019, THESIS; Rowe WPM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1809-x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarmashghi S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1632-4; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Skippington E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-532; Song K, 2014, BRIEF BIOINFORM, V15, P343, DOI 10.1093/bib/bbt067; Song K, 2013, J COMPUT BIOL, V20, P64, DOI 10.1089/cmb.2012.0228; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; Wan L, 2010, J COMPUT BIOL, V17, P1467, DOI 10.1089/cmb.2010.0056; Yi HG, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt003; Zhang Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep40712; Zielezinski A, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1755-7; Zielezinski A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1319-7	65	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228070	10.1371/journal.pone.0228070	http://dx.doi.org/10.1371/journal.pone.0228070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040534	Green Published, gold			2022-12-26	WOS:000534629400013
J	Freccero, F; Petrucelli, M; Cipone, M; Nocera, I; Sgorbini, M				Freccero, Francesca; Petrucelli, Marina; Cipone, Mario; Nocera, Irene; Sgorbini, Micaela			Doppler evaluation of renal resistivity index in healthy conscious horses and donkeys	PLOS ONE			English	Article							ULTRASONOGRAPHIC ESTIMATION; VASCULAR-RESISTANCE; NORMAL DOGS; BODY-FAT; ULTRASOUND; KIDNEYS; DIMENSIONS; REJECTION; ARTERIES; LIVER	The renal resistive index (RRI) is used as a measurement of downstream resistance in arteries. The aim of this study was to assess the RRI of the arcuate arteries by pulsed-wave Doppler ultrasonography in healthy conscious horses and donkeys, and to verify any differences related to age, breed, bodyweight (BW) or body condition (BCS). Thirty-three healthy conscious horses and nine donkeys had their systolic and diastolic flow velocities at the level of the arcuate arteries estimated by pulsed-wave Doppler ultrasound, and the RRI was calculated. The relationship of RRI with age, breed (Trotters vs. other breeds), bodyweight (BW), and body condition score (BCS) were evaluated. PW Doppler evaluation of RRI was successfully applied in most of the horses, but to date not in the donkeys. In horses, median RRI values for the right kidney (0.58 +/- 0.006) were statistically higher than for the left (0.51 +/- 0.006). For the donkeys the values were comparable. There was no significant difference in RRI between horses younger or older than 15 years, and between breeds in horses. No correlation with age, BW or BCS was found in either horses or donkeys.	[Freccero, Francesca; Cipone, Mario] Dept Vet Med Sci, Bologna, Italy; [Petrucelli, Marina] Vet Teaching Hosp, Sch Biosci & Vet Med, Matelica, MC, Italy; [Nocera, Irene; Sgorbini, Micaela] Vet Teaching Hosp Mario Modenato, Dept Vet Sci, San Piero A Grado, PI, Italy		Sgorbini, M (corresponding author), Vet Teaching Hosp Mario Modenato, Dept Vet Sci, San Piero A Grado, PI, Italy.	micaela.sgorbini@unipi.it	Nocera, Irene/ABG-2371-2020	Nocera, Irene/0000-0001-9536-4453; Sgorbini, Micaela/0000-0002-0294-1803; petrucelli, marina/0000-0003-0137-8403	Universita di Pisa	Universita di Pisa	This study was funded by the Universita di Pisa (2017-18 years). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikou I, 2018, J CLIN HYPERTENS, V20, P1739, DOI 10.1111/jch.13410; Ansarin K, 2010, INT J GEN MED, V3, P371, DOI 10.2147/IJGM.S14119; Barone R., 2003, ANATOMIA COMP MAMMIF, V4, P7; Bolat D, 2013, ANAT HISTOL EMBRYOL, V42, P448, DOI 10.1111/ahe.12036; Buscemi S, 2009, DIABETES RES CLIN PR, V86, P177, DOI 10.1016/j.diabres.2009.09.015; Chang YJ, 2010, VET RADIOL ULTRASOUN, V51, P335, DOI 10.1111/j.1740-8261.2010.01669.x; Di Nicolo P, 2017, CLIN EXP NEPHROL, V21, P359, DOI 10.1007/s10157-016-1323-3; Draper ACE, 2012, VET RADIOL ULTRASOUN, V53, P336, DOI 10.1111/j.1740-8261.2011.01902.x; Dugdale AHA, 2012, VET J, V194, P173, DOI 10.1016/j.tvjl.2012.03.024; Gottlieb RH, 1997, AM J ROENTGENOL, V168, P627, DOI 10.2214/ajr.168.3.9057503; Habershon-Butcher J, 2014, VET RADIOL ULTRASOUN, V55, P323, DOI 10.1111/vru.12112; Halling KB, 2003, VET RADIOL ULTRASOUN, V44, P707, DOI 10.1111/j.1740-8261.2003.tb00535.x; HOFFMANN KL, 1995, AM J VET RES, V56, P1403; Hoffmann KL, 1997, AM J VET RES, V58, P697; Kaiser C, 2007, EUR J MED RES, V12, P191; Keogan MT, 1996, RADIOLOGY, V199, P165, DOI 10.1148/radiology.199.1.8633141; Kwakernaak AJ, 2013, NEPHROL DIAL TRANSPL, V28, P42, DOI 10.1093/ndt/gft331; Macri F, 2015, J EQUINE VET SCI, V35, P111, DOI 10.1016/j.jevs.2014.12.005; Mai HM, 2014, ANATOMY PHYSL CURREN, V4, P2161; Mellor DJ, 1999, VET REC, V145, P299, DOI 10.1136/vr.145.11.299; Meola M., 2007, ECOGRAFIA CLIN COLOR, P185; Meucci V, 2015, J EQUINE VET SCI, V35, P36, DOI 10.1016/j.jevs.2014.11.003; Novellas R, 2010, VET REC, V166, P618, DOI 10.1136/vr.b4820; Novellas R, 2008, VET J, V178, P257, DOI 10.1016/j.tvjl.2007.07.026; Novellas R, 2007, VET RADIOL ULTRASOUN, V48, P69, DOI 10.1111/j.1740-8261.2007.00206.x; Ostrowska J, 2016, PAK VET J, V36, P45; Park IC, 2008, J VET SCI, V9, P415, DOI 10.4142/jvs.2008.9.4.415; Pearson R.A., 2000, GUIDE BODY CONDITION; Reef V.B., 1998, EQUINE DIAGNOSTIC UL, P322; Castiglioni MCR, 2018, J EQUINE VET SCI, V70, P71, DOI 10.1016/j.jevs.2018.07.011; RIFKIN MD, 1987, AM J ROENTGENOL, V148, P759, DOI 10.2214/ajr.148.4.759; Rivers BJ, 1996, J VET INTERN MED, V10, P28, DOI 10.1111/j.1939-1676.1996.tb02020.x; Schott HC, 2007, VET CLIN N AM-EQUINE, V23, P593, DOI 10.1016/j.cveq.2007.10.002; Schwarzwald CC, 2017, EQUINE INTERNAL MED, P410; Tipisca V, 2016, J FELINE MED SURG, V18, P471, DOI 10.1177/1098612X15587573; Tublin ME, 2003, AM J ROENTGENOL, V180, P885, DOI 10.2214/ajr.180.4.1800885; Viazzi F, 2014, J HYPERTENS, V32, P149, DOI 10.1097/HJH.0b013e328365b29c; WALSH DM, 1992, AM J VET RES, V53, P776	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228741	10.1371/journal.pone.0228741	http://dx.doi.org/10.1371/journal.pone.0228741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027703	Green Published, gold			2022-12-26	WOS:000534623800070
J	Li, X; Bi, ZH; Sun, YD; Li, C; Li, YX; Liu, ZY				Li, Xiang; Bi, Zhenghong; Sun, Yidi; Li, Chao; Li, Yixue; Liu, Zhiyong			In vivo ectopic Ngn1 and Neurod1 convert neonatal cochlear glial cells into spiral ganglion neurons	FASEB JOURNAL			English	Article						cochlea; glial cells; inner ear; Neurog1; Neurod1; regeneration; spiral ganglion neurons	INNER-EAR; NERVE DEGENERATION; SENSORY EPITHELIA; GENE-EXPRESSION; MULLER GLIA; GENERATION; INJURY; MODEL	Damage or degeneration of inner ear spiral ganglion neurons (SGNs) causes hearing impairment. Previous in vitro studies indicate that cochlear glial cells can be reprogrammed into SGNs, however, it remains unknown whether this can occur in vivo. Here, we show that glial cells can be converted, in vivo, into SGNs (defined as new SGNs) by simultaneous induction of Neurog1 (Ngn1) and Neurod1. New SGNs express SGN markers, Tuj1, Map2, Prox1, Mafb and Gata3, and reduce glial cell marker Sox10 and Scn7a. The heterogeneity within new SGNs is illustrated by immunostaining and transcriptomic assays. Transcriptomes analysis indicates that well reprogrammed SGNs are similar to type I SGNs. In addition, reprogramming efficiency is positively correlated with the dosage of Ngn1 and Neurod1, but declined with aging. Taken together, our in vivo data demonstrates the plasticity of cochlear glial cells and the capacity of Ngn1 and Neurod1 to reprogram glial cells into SGNs. Looking ahead, we expect that combination of Neurog1 and Neurod1 along with other factors will further boost the percentage of fully converted (Mafb+/Gata3+) new SGNs.	[Li, Xiang; Bi, Zhenghong; Li, Chao; Liu, Zhiyong] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Neurosci, Inst Neurosci, Shanghai 200031, Peoples R China; [Sun, Yidi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, CAS Key Lab Syst Biol,CAS Ctr Excellence Mol Cell, Shanghai, Peoples R China; [Sun, Yidi; Li, Yixue] Univ Chinese Acad Sci, Shanghai, Peoples R China; [Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Nutr & Hlth, Biomed Big Data Ctr,Key Lab Computat Biol,CAS MPG, Shanghai, Peoples R China; [Liu, Zhiyong] Shanghai Ctr Brain Sci & Brain Inspired Intellige, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Liu, ZY (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Neurosci, Inst Neurosci, Shanghai 200031, Peoples R China.	Zhiyongliu@ion.ac.cn		Bi, Zhenghong/0000-0002-7811-8012; Li, Xiang/0000-0002-0098-9133	Ministry of Science and Technology of the People's Republic of China (MOST) [2017YFA0103901]; Chinese Academy of Sciences (CAS) [XDB32060100]; National Natural Science Foundation of China (NSFC) [81771012]; Science and Technology Commission of Shanghai Municipality (STCSM) [2018SHZDZX05]; Boehringer Ingelheim [DE811138149]	Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM)); Boehringer Ingelheim(Boehringer Ingelheim)	Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2017YFA0103901; Chinese Academy of Sciences (CAS), Grant/Award Number: XDB32060100; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81771012; Science and Technology Commission of Shanghai Municipality (STCSM), Grant/Award Number: 2018SHZDZX05; Boehringer Ingelheim, Grant/Award Number: DE811138149	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barclay M, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-33; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Cox BC, 2012, JARO-J ASSOC RES OTO, V13, P295, DOI 10.1007/s10162-012-0324-5; Deng M, 2014, GENE EXPR PATTERNS, V15, P31, DOI 10.1016/j.gep.2014.03.001; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Froud KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8115; Gomez-Casati ME, 2010, JARO-J ASSOC RES OTO, V11, P19, DOI 10.1007/s10162-009-0191-x; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Jen HI, 2019, ELIFE, V8, DOI 10.7554/eLife.44328; Jorstad NL, 2017, NATURE, V548, P103, DOI 10.1038/nature23283; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Knipper M, 1998, DEVELOPMENT, V125, P3709; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lang H, 2005, JARO-J ASSOC RES OTO, V6, P63, DOI 10.1007/s10162-004-5021-6; Lang HN, 2011, JARO-J ASSOC RES OTO, V12, P151, DOI 10.1007/s10162-010-0244-1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li C, 2018, HEARING RES, V364, P12, DOI 10.1016/j.heares.2018.04.006; Li XN, 2018, P NATL ACAD SCI USA, V115, P415, DOI 10.1073/pnas.1703601115; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086273; Liu ZY, 2010, DEV DYNAM, V239, P1674, DOI 10.1002/dvdy.22302; Loffler K, 2015, GLIA, V63, P1809, DOI 10.1002/glia.22846; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Nishimura K, 2014, NEUROSCIENCE, V275, P125, DOI 10.1016/j.neuroscience.2014.05.067; Nishimura K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170568; Nishimura K, 2012, CELL TRANSPLANT, V21, P763, DOI 10.3727/096368911X623907; Noda T, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00016; Pataskar A, 2016, EMBO J, V35, P24, DOI 10.15252/embj.201591206; Petitpre C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06033-3; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Schmiedt RA, 2002, JARO, V3, P223, DOI 10.1007/s1016200220017; Sherrill HE, 2019, J NEUROSCI, V39, P5284, DOI 10.1523/JNEUROSCI.2728-18.2019; Shrestha BR, 2018, CELL, V174, P1229, DOI 10.1016/j.cell.2018.07.007; Song ZC, 2017, STEM CELL REP, V9, P1516, DOI 10.1016/j.stemcr.2017.09.011; Sun SH, 2018, CELL, V174, P1247, DOI 10.1016/j.cell.2018.07.008; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Wan GQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14487; Wise AK, 2011, HEARING RES, V278, P69, DOI 10.1016/j.heares.2011.04.010; Xing YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034500; Yao K, 2018, NATURE, V560, P484, DOI 10.1038/s41586-018-0425-3; Yu WM, 2013, ELIFE, V2, DOI 10.7554/eLife.01341; Yuan YS, 2014, JARO-J ASSOC RES OTO, V15, P31, DOI 10.1007/s10162-013-0419-7; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	46	8	8	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4764	4782		10.1096/fj.201902118R	http://dx.doi.org/10.1096/fj.201902118R		FEB 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32027432				2022-12-26	WOS:000512074600001
J	Klingler, C; Ashley, J; Shi, K; Stiefvater, A; Kyba, M; Sinnreich, M; Aihara, H; Kinter, J				Klingler, Christian; Ashley, Jon; Shi, Ke; Stiefvater, Adeline; Kyba, Michael; Sinnreich, Michael; Aihara, Hideki; Kinter, Jochen			DNA aptamers against the DUX4 protein reveal novel therapeutic implications for FSHD	FASEB JOURNAL			English	Article						bulge loop; decoy; PAX7; PROP1; transcription factor	FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; OPEN-ACCESS DATABASE; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; CANDIDATE GENE; BULGE LOOP; STEM-CELL; RNA; EXPRESSION; BINDING	Aberrant expression of the transcription factor double homeobox protein 4 (DUX4) can lead to a number of diseases including facio-scapulo-humeral muscular dystrophy (FSHD), acute lymphoblastic leukemia, and sarcomas. Inhibition of DUX4 may represent a therapeutic strategy for these diseases. By applying Systematic Evolution of Ligands by EXponential Enrichment (SELEX), we identified aptamers against DUX4 with specific secondary structural elements conveying high affinity to DUX4 as assessed by fluorescence resonance energy transfer and fluorescence polarization techniques. Sequences analysis of these aptamers revealed the presence of two consensus DUX4 motifs in a reverse complementary fashion forming hairpins interspersed with bulge loops at distinct positions that enlarged the binding surface with the DUX4 protein, as determined by crystal structure analysis. We demonstrate that insertion of specific structural elements into transcription factor binding oligonucleotides can enhance specificity and affinity.	[Klingler, Christian; Ashley, Jon; Stiefvater, Adeline; Sinnreich, Michael; Kinter, Jochen] Univ Hosp Basel, Dept Neurol, Neuromuscular Res Grp, CH-4031 Basel, Switzerland; [Klingler, Christian; Ashley, Jon; Stiefvater, Adeline; Sinnreich, Michael; Kinter, Jochen] Univ Hosp Basel, Dept Biomed, Neuromuscular Res Grp, Basel, Switzerland; [Ashley, Jon] Tech Univ Denmark, Dept Hlth Technol, Lyngby, Denmark; [Shi, Ke; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	University of Basel; University of Basel; Technical University of Denmark; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sinnreich, M (corresponding author), Univ Hosp Basel, Dept Neurol, Neuromuscular Res Grp, CH-4031 Basel, Switzerland.	michael.sinnreich@unibas.ch	Ashley, Jon/H-5064-2016	Ashley, Jon/0000-0002-7062-1019; , Ke/0000-0003-4175-3714; Sinnreich, Michael/0000-0002-9835-1276; Kyba, Michael/0000-0002-5579-7534	US Department of Energy (DOE) [DE-AC02-06CH11357]; National Institutes of Health [GM118047, S10OD021527, P30 GM124165]; CSL Behring	US Department of Energy (DOE)(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSL Behring	US Department of Energy (DOE), Grant/Award Number: DE-AC02-06CH11357; National Institutes of Health, Grant/Award Number: GM118047, S10OD021527 and P30 GM124165; CSL Behring	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bae ON, 2012, ARCH PHARM RES, V35, P1693, DOI 10.1007/s12272-012-1000-3; Banerji CRS, 2019, HUM MOL GENET, V28, P2224, DOI 10.1093/hmg/ddz043; Banerji CRS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01200-4; Bevilacqua PC, 2016, ANNU REV GENET, V50, P235, DOI 10.1146/annurev-genet-120215-035034; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bing T, 2010, BIOORGAN MED CHEM, V18, P1798, DOI 10.1016/j.bmc.2010.01.054; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Bosnakovski D, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw7781; Bosnakovski D, 2017, J CELL SCI, V130, P3685, DOI 10.1242/jcs.205427; Bosnakovski D, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-4; Chen JCJ, 2016, MOL THER, V24, P1405, DOI 10.1038/mt.2016.111; Chen ZY, 2019, NAT GENET, V51, P947, DOI 10.1038/s41588-019-0418-7; Chew GL, 2019, DEV CELL, V50, P658, DOI 10.1016/j.devcel.2019.06.011; Chiu TP, 2016, BIOINFORMATICS, V32, P1211, DOI 10.1093/bioinformatics/btv735; Choi SH, 2016, J BIOMOL SCREEN, V21, P680, DOI 10.1177/1087057116651868; Choi SH, 2016, NUCLEIC ACIDS RES, V44, P5161, DOI 10.1093/nar/gkw141; Correa FA, 2019, ARCH ENDOCRIN METAB, V63, P167, DOI 10.20945/2359-3997000000139; Cruz JM, 2018, J BIOL CHEM, V293, P11837, DOI 10.1074/jbc.RA118.002633; Corona ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075614; Das S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160022; Davis SW, 2013, CURR TOP DEV BIOL, V106, P1, DOI 10.1016/B978-0-12-416021-7.00001-8; De Iaco A, 2017, NAT GENET, V49, P941, DOI 10.1038/ng.3858; Deenen JCW, 2014, NEUROLOGY, V83, P1056, DOI 10.1212/WNL.0000000000000797; Degtyareva N, 2001, J BIOL CHEM, V276, P8778, DOI 10.1074/jbc.M006795200; Dib C, 2019, TRENDS CANCER, V5, P268, DOI 10.1016/j.trecan.2019.03.001; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dornberger U, 1999, BIOCHEMISTRY-US, V38, P12860, DOI 10.1021/bi9906874; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Gollmick FA, 2002, NUCLEIC ACIDS RES, V30, P2669, DOI 10.1093/nar/gkf375; Haynes P, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0130-1; Hecker M, 2017, BIOCHEM PHARMACOL, V144, P29, DOI 10.1016/j.bcp.2017.06.122; Hendrickson PG, 2017, NAT GENET, V49, P925, DOI 10.1038/ng.3844; Himeda CL, 2019, ANNU REV GENOM HUM G, V20, P265, DOI 10.1146/annurev-genom-083118-014933; Himeda CL, 2016, MOL THER, V24, P527, DOI 10.1038/mt.2015.200; Hoinka J, 2018, MOL THER-NUCL ACIDS, V11, P515, DOI 10.1016/j.omtn.2018.04.006; Hosoya T, 1999, FEBS LETT, V461, P136, DOI 10.1016/S0014-5793(99)01450-7; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaur H, 2018, THERANOSTICS, V8, P4016, DOI 10.7150/thno.25958; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Ku TH, 2015, SENSORS-BASEL, V15, P16281, DOI 10.3390/s150716281; Lee JK, 2018, CELL REP, V25, P2955, DOI 10.1016/j.celrep.2018.11.060; Lee SW, 1997, NAT BIOTECHNOL, V15, P41, DOI 10.1038/nbt0197-41; Leidenroth A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-364; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Li YY, 2018, BIOCHEM BIOPH RES CO, V505, P1161, DOI 10.1016/j.bbrc.2018.10.056; Lilljebjorn H, 2017, BLOOD, V130, P1395, DOI 10.1182/blood-2017-05-742643; Lilljebjorn H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11790; Liu YF, 2016, EBIOMEDICINE, V8, P173, DOI 10.1016/j.ebiom.2016.04.038; Lu JR, 2019, INTRACTABLE RARE DIS, V8, P9, DOI 10.5582/irdr.2019.01016; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menne J, 2017, NEPHROL DIAL TRANSPL, V32, P307, DOI 10.1093/ndt/gfv459; Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088; Mitsuhashi H, 2018, BIOL OPEN, V7, DOI 10.1242/bio.033977; Mitsuhashi H, 2013, HUM MOL GENET, V22, P568, DOI 10.1093/hmg/dds467; Mul Karlien, 2016, Pract Neurol, V16, P201, DOI 10.1136/practneurol-2015-001353; Nakayama M, 2009, MOL CELL ENDOCRINOL, V307, P36, DOI 10.1016/j.mce.2009.03.010; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Osako MK, 2007, J GENE MED, V9, P812, DOI 10.1002/jgm.1077; Pfeiffer F, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00025; Poolsup S, 2017, CURR OPIN BIOTECH, V48, P180, DOI 10.1016/j.copbio.2017.05.004; Rickard AM, 2015, HUM MOL GENET, V24, P5901, DOI 10.1093/hmg/ddv315; Ritz C, 2005, J STAT SOFTW, V12, P1; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schreck JS, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4917199; Sen M, 2012, CANCER DISCOV, V2, P694, DOI 10.1158/2159-8290.CD-12-0191; Siddiqui MAA, 2005, DRUGS, V65, P1571, DOI 10.2165/00003495-200565110-00010; Sirvent N, 2009, CANCER GENET CYTOGEN, V195, P12, DOI 10.1016/j.cancergencyto.2009.06.011; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Specht K, 2014, GENE CHROMOSOME CANC, V53, P622, DOI 10.1002/gcc.22172; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van den Boogaard ML, 2016, AM J HUM GENET, V98, P1020, DOI 10.1016/j.ajhg.2016.03.013; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; VARANI G, 1995, ANNU REV BIOPH BIOM, V24, P379, DOI 10.1146/annurev.biophys.24.1.379; Volker J, 2014, BIOPOLYMERS, V101, P1, DOI 10.1002/bip.22236; von Maltzahn J, 2013, P NATL ACAD SCI USA, V110, P16474, DOI 10.1073/pnas.1307680110; Wallace LM, 2012, MOL THER, V20, P1417, DOI 10.1038/mt.2012.68; Yasuda T, 2016, NAT GENET, V48, P569, DOI 10.1038/ng.3535; Yoon S, 2016, MOL THER, V24, P1106, DOI 10.1038/mt.2016.60; Yoshimoto T, 2017, CANCER RES, V77, P2927, DOI 10.1158/0008-5472.CAN-16-3351; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947; Zboralski D, 2017, CANCER IMMUNOL RES, V5, P950, DOI 10.1158/2326-6066.CIR-16-0303; Zhang JH, 2016, NAT GENET, V48, P1481, DOI 10.1038/ng.3691; Zhang Y, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0080-z; Zhang YZ, 2017, MOL BIOTECHNOL, V59, P159, DOI 10.1007/s12033-017-9998-6	101	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4573	4590		10.1096/fj.201902696	http://dx.doi.org/10.1096/fj.201902696		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32020675	Green Published, hybrid			2022-12-26	WOS:000512309200001
J	Li, JF; Jeewon, R; Mortimer, PE; Doilom, M; Phookamsak, R; Promputtha, I				Li, Junfu; Jeewon, Rajesh; Mortimer, Peter E.; Doilom, Mingkwan; Phookamsak, Rungtiwa; Promputtha, Itthayakorn			Multigene phylogeny and taxonomy of Dendryphion hydei and Torula hydei spp. nov. from herbaceous litter in northern Thailand	PLOS ONE			English	Article							PLEOSPORALEAN FAMILY; BAYESIAN-INFERENCE; GENERA; FUNGI; REVISION; NAMES; GENUS; TAXA	During our studies on asexual fungi colonizing herbaceous litter in northern Thailand, we discovered two new fungal species, viz. Dendryphion hydei and Torula hydei spp. nov. The latter are examined, and their morphological characters are described as well as their DNA sequences from ribosomal and protein coding genes are analysed to infer their phylogenetic relationships with extant fungi. Torula hydei is different from other similar Torula species in having tiny and catenate conidia. Dendryphion hydei can be distinguished from other similar Dendryphion species in having large conidiophores and subhyaline to pale olivaceous brown, 2-4(-5)-septate conidia. Multigene phylogenetic analyses of a combined LSU, SSU, TEF1-alpha, RPB2 and ITS DNA sequence dataset generated from maximum likelihood and Bayesian inference analyses indicate that T. hydei forms a distinct lineage and basal to T. fici. Dendryphion hydei forms a distinct lineage and basal to D. europaeum, D. comosum, D. aquaticum and D. fluminicola within Torulaceae (Pleosporales, Dothideomycetes).	[Li, Junfu; Promputtha, Itthayakorn] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai, Thailand; [Li, Junfu; Promputtha, Itthayakorn] Chiang Mai Univ, Ctr Excellence Bioresources Agr Ind & Med, Fac Sci, Chiang Mai, Thailand; [Li, Junfu; Mortimer, Peter E.; Doilom, Mingkwan; Phookamsak, Rungtiwa] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Li, Junfu; Phookamsak, Rungtiwa] Mae Fah Luang Univ, Ctr Excellence Fungal Res, Chiang Rai, Thailand; [Jeewon, Rajesh] Univ Mauritius, Fac Sci, Dept Hlth Sci, Reduit, Mauritius; [Doilom, Mingkwan; Phookamsak, Rungtiwa] World Agroforestry Ctr, East & Cent Asia, Kunming, Yunnan, Peoples R China	Chiang Mai University; Chiang Mai University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Mae Fah Luang University; University of Mauritius	Promputtha, I (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai, Thailand.; Promputtha, I (corresponding author), Chiang Mai Univ, Ctr Excellence Bioresources Agr Ind & Med, Fac Sci, Chiang Mai, Thailand.; Phookamsak, R (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.; Phookamsak, R (corresponding author), Mae Fah Luang Univ, Ctr Excellence Fungal Res, Chiang Rai, Thailand.; Phookamsak, R (corresponding author), World Agroforestry Ctr, East & Cent Asia, Kunming, Yunnan, Peoples R China.	jomjam.rp2@gmail.com; itthayakorn.p@cmu.ac.th	Phookamsak, Rungtiwa/O-9441-2019	Phookamsak, Rungtiwa/0000-0002-6321-8416; Promputtha, Itthayakorn/0000-0003-3376-4376	Mushroom Research Foundation, Chiang Mai, Thailand; Key Research Program of Frontier Sciences of the Chinese Academy of Sciences [QYZDYSSW-SMC014]; CAS President's International Fellowship Initiative (PIFI) [Y9215811Q1]; National Science Foundation of China (NSFC) [31850410489, Y81I982211]; National Science Foundation of China; South East Asian Biodiversity resources Institute, Chinese Academy of Sciences [41761144055, 41771063, Y4ZK111B01]	Mushroom Research Foundation, Chiang Mai, Thailand; Key Research Program of Frontier Sciences of the Chinese Academy of Sciences; CAS President's International Fellowship Initiative (PIFI); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); South East Asian Biodiversity resources Institute, Chinese Academy of Sciences	The authors are grateful the Mushroom Research Foundation, Chiang Mai, Thailand and the Key Research Program of Frontier Sciences of the Chinese Academy of Sciences (grant no. QYZDYSSW-SMC014) for supporting this research. Rungtiwa Phookamsak thanks CAS President's International Fellowship Initiative (PIFI) for young staff (grant no. Y9215811Q1) and National Science Foundation of China (NSFC) project code 31850410489 (grant no. Y81I982211) for financial support. Peter E Mortimer would like to thank the National Science Foundation of China and the South East Asian Biodiversity resources Institute, Chinese Academy of Sciences, for financial support under the following grants: 41761144055, 41771063, Y4ZK111B01. Mingkwan Doilom thanks the 5th batch of Postdoctoral Orientation Training Personnel in Yunnan Province and the 64th batch of China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2014, PERSOONIA, V33, P141, DOI 10.3767/003158514X684744; Ariyawansa HA, 2015, FUNGAL DIVERS, V75, P27, DOI 10.1007/s13225-015-0346-5; Bhat DJ, 2017, FASCINATING MICROFUN; Boehm EWA, 2009, STUD MYCOL, P49, DOI 10.3114/sim.2009.64.03; Chomnunti P, 2014, FUNGAL DIVERS, V66, P1, DOI 10.1007/s13225-014-0278-5; Crane JL, 2016, IMA FUNGUS, V7, P29, DOI 10.5598/imafungus.2016.07.01.03; CRANE JL, 1977, CAN J BOT, V55, P3013, DOI 10.1139/b77-339; Crous P. W., 2020, Fungal Systematics and Evolution, V5, P77, DOI 10.3114/fuse.2020.05.04; Crous PW, 2016, PERSOONIA, V37, P218, DOI 10.3767/003158516X694499; Crous PW, 2014, PERSOONIA, V32, P184, DOI 10.3767/003158514X682395; Crous PW, 2015, IMA FUNGUS, V6, P163, DOI 10.5598/imafungus.2015.06.01.11; Dai DQ, 2017, FUNGAL DIVERS, V82, P1, DOI 10.1007/s13225-016-0367-8; Devadatha B, 2018, MYCOL PROG, V17, P791, DOI 10.1007/s11557-018-1387-4; Doilom M, 2017, FUNGAL DIVERS, V82, P107, DOI 10.1007/s13225-016-0368-7; Ellis M. B., 1976, More dematiaceous hyphomycetes.; Ellis MB, 1971, DEMATIACEOUS HYPHOMY; Farr DF., FUNGAL DATABASES; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES SJ, 1953, CAN J BOT, V31, P577, DOI 10.1139/b53-046; Hyde KD, 2019, FUNGAL DIVERS, V96, P1, DOI 10.1007/s13225-019-00429-2; Hyde KD, 2017, FUNGAL DIVERS, V87, P1, DOI 10.1007/s13225-017-0391-3; Hyde KD, 2016, FUNGAL DIVERS, V80, P1, DOI 10.1007/s13225-016-0373-x; Jaklitsch WM, 2016, STUD MYCOL, P35, DOI 10.1016/j.simyco.2016.09.002; Jayasiri SC, 2015, FUNGAL DIVERS, V74, P3, DOI 10.1007/s13225-015-0351-8; Jeewon R, 2016, MYCOSPHERE, V7, P1669, DOI 10.5943/mycosphere/7/11/4; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Li J, 2017, MYCOL PROG, V16, P191, DOI 10.1007/s11557-016-1266-9; Li JF, 2016, MYCOL PROG, V15, P1169, DOI 10.1007/s11557-016-1238-0; Liu JK, 2014, PHYTOTAXA, V181, P1; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Mason EW, 1941, COMMONW MYCOLOGICAL, V5, P1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Phookamsak R, 2019, FUNGAL DIVERS, V95, P1, DOI [10.1007/s13225-019-00421-w, 10.1007/s13225-020-00439-5]; Pratibha J., 2017, Webbia, V72, P171, DOI 10.1080/00837792.2017.1349237; Rehner S., 2001, PRIMERS ELONGATION F; Seifert KA, 2011, GENERA HYPHOMYCETES, DOI [DOI 10.3767/003158511X617435, 10.3767/003158511X617435]; Shaw JJ, 2015, APPL MICROBIOL BIOT, V99, P3715, DOI 10.1007/s00253-014-6206-5; Shenoy BD, 2006, MYCOL RES, V110, P916, DOI 10.1016/j.mycres.2006.06.004; Silvestro D., 2010, RAXML GUI GRAPHICAL; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sturm J., 1829, PILZE DEUTSCHLANDS, V2, P1; Su HY, 2016, FUNGAL DIVERS, V80, P375, DOI 10.1007/s13225-016-0362-0; Su XJ, 2018, MYCOL PROG, V17, P531, DOI 10.1007/s11557-018-1388-3; Subramanian C. V., 1971, HYPHOMYCETES ACCOUNT; Suetrong S, 2009, STUD MYCOL, P155, DOI 10.3114/sim.2009.64.09; Tanaka K, 2009, STUD MYCOL, P175, DOI 10.3114/sim.2009.64.10; Tibpromma S, 2018, FUNGAL DIVERS, V93, P1, DOI 10.1007/s13225-018-0408-6; Tibpromma S, 2017, FUNGAL DIVERS, V83, P1, DOI 10.1007/s13225-017-0378-0; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vu D, 2019, STUD MYCOL, P135, DOI 10.1016/j.simyco.2018.05.001; Wallroth CFW, 1833, FLORA CRYPTOGAMICA G, V2, P1; Wanasinghe DN, 2018, FUNGAL DIVERS, V89, P1, DOI 10.1007/s13225-018-0395-7; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	57	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228067	10.1371/journal.pone.0228067	http://dx.doi.org/10.1371/journal.pone.0228067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023268	Green Published, gold			2022-12-26	WOS:000534621500034
J	Lopez-Ejeda, N; Charle-Cuellar, P; Ale, FGB; Alvarez, JL; Vargas, A; Guerrero, S				Lopez-Ejeda, Noemi; Charle-Cuellar, Pilar; Ale, Franck G. B.; Alvarez, Jose Luis; Vargas, Antonio; Guerrero, Saul			Bringing severe acute malnutrition treatment close to households through community health workers can lead to early admissions and improved discharge outcomes	PLOS ONE			English	Article							CASE-MANAGEMENT; CARE; CHILDREN	Severe acute malnutrition (SAM) affects over 16.6 million children worldwide. The integrated Community Case Management (iCCM) strategy seeks to improve essential health by means of nonmedical community health workers (CHWs) who treat the deadliest infectious diseases in remote rural areas where there is no nearby health center. The objective of this study was to assess whether SAM treatment delivered by CHWs close to families' locations may improve the early identification of cases compared to outpatient treatment at health facilities (HFs), with a decreased number complicated cases referred to stabilization centers, increased anthropometric measurements at admission (closer to the admission threshold) and similarity in clinical outcomes (cure, death, and default). The study included 930 children aged 6 to 59 months suffering from SAM in the Kita district of the Kayes Region in Mali; 552 children were treated by trained CHWs. Anthropometric measurements, the presence of edema, and other medical signs were recorded at admission, and the length of stay and clinical outcomes were recorded at discharge. The results showed fewer children with edema at admission in the CHW group than in the HF group (0.4% vs. 3.7%; OR = 10.585 [2.222-50.416], p = 0.003). Anthropometric measurements at admission were higher in the CHW group, with fewer children falling into the lowest quartiles of both weight-for-height z-scores (20.2% vs. 31.5%; p = 0.002) and mid-upper arm circumference (18.0% vs. 32.4%; p<0.001), than in the HF group. There was no difference in the length of stay. More children in the CHW group were cured (95.9% vs. 88.7%; RR = 3.311 [1.772-6.185]; p<0.001), and there were fewer defaulters (3.7% vs. 9.8%; RR = 3.345 [1.702-6.577]; p<0.001) than in the HF group. Regression analyses demonstrated that less severe anthropometric measurements at admission resulted in an increased probability of cure at discharge. The study results also showed that CHWs provided more integrated care, as they diagnosed and treated significantly more cases of infectious diseases than HFs (diarrhea: 36.0% vs. 18.3%, p<0.001; malaria: 41.7% vs. 19.8%, p<0.001; acute respiratory infection: 34.8% vs. 25.2%, p = 0.007). The addition of SAM treatment in the curative tasks that the CHWs provided to the families resulted in earlier admission and more integrated care for children than those associated with HFs. CHW treatment also achieved better discharge outcomes than standard community treatment.	[Lopez-Ejeda, Noemi; Charle-Cuellar, Pilar; Vargas, Antonio] Act Hunger, Madrid, Spain; [Lopez-Ejeda, Noemi] Univ Complutense Madrid, EPINUT Res Grp Ref 920325, Madrid, Spain; [Ale, Franck G. B.] Act Hunger, Bamako, Mali; [Alvarez, Jose Luis] Act Hunger, London, England; [Guerrero, Saul] Act Hunger, New York, NY USA	Complutense University of Madrid	Lopez-Ejeda, N (corresponding author), Act Hunger, Madrid, Spain.; Lopez-Ejeda, N (corresponding author), Univ Complutense Madrid, EPINUT Res Grp Ref 920325, Madrid, Spain.	nlopez@accioncontraelhambre.org	Ejeda, Noemi Lopez/AAB-3384-2020	Ejeda, Noemi Lopez/0000-0003-1310-0134; vargas, Antonio/0000-0001-6507-1529	Innocent Foundation	Innocent Foundation	This research was made possible by the financial support of the Innocent Foundation. https://www.innocentfoundation.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PANCREATOLOGY, V13, pe1; [Anonymous], 2018, J CANC RES THER, V14, pS622; Chisti MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107663; Chitete L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123021; Collins S, 2002, LANCET, V360, P1824, DOI 10.1016/S0140-6736(02)11770-3; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Desalegn M., 2016, INT J NUTR METAB, V8, P12, DOI [10.5897/IJNAM2015.0193, DOI 10.5897/IJNAM2015.0193]; Gebremichael DY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2593-5; Goossens S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049320; Goudet S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205688; John C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196971; Kabalo MY, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0083-3; Kerac M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096030; Lenters LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S23; Linneman Z, 2007, MATERN CHILD NUTR, V3, P206, DOI 10.1111/j.1740-8709.2007.00095.x; Lopez-Ejeda N, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12719; Mengesha MM, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30704; Ministere de la Sante et de L'Hygiene Publique et Direction National de la Sante Republique du Mali, 2015, GUID NAT MIS UVR; Moran JLA, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2987-z; Navarro-Colorado C, 2015, STANDARD INDICATORS; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; Paintain LS, 2014, AM J TROP MED HYG, V91, P461, DOI 10.4269/ajtmh.14-0094; Pandey P, 2018, TROP DOCT, V48, P277, DOI 10.1177/0049475518786854; Puett C, 2013, HEALTH POLICY PLANN, V28, P386, DOI 10.1093/heapol/czs070; Puett C, 2012, FOOD NUTR BULL, V33, P273, DOI 10.1177/156482651203300408; Roberfroid D., 2013, MANAGEMENT OEDEMATOU; Rogers E, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0273-0; Rogers E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128666; Sadler K., 2011, COMMUNITY CASE MANAG; Shanka NA., 2015, NUTR DISORDERS THERA, V5, P2; Stobaugh HC, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12702; The Lancet Global Health, 2018, LANCET GLOB HEALTH, V6, pE593; The Sphere Project,, 2018, HUM CHART MIN STAND; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; UNDP, 2018, HUMAN DEV INDICES IN; UNICEF, 2017, ENQ NAT NUTR ANTHR M; UNICEF WHO The World Bank Group, 2019, JOINT CHILD MALN EST; United Nations Children's Fund (UNICEF), 2015, SEV AC MALN; United Nations Office for the Coordination of Humanitarian Affairs (OCHA), 2018, MAL HUM RESP PLAN; United States Agency for International Development (USAID), 2018, TRAIN GUID COMM BAS; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA, DOI 10.1093/tropej/fmn002; World Health Organization, 2013, GUID UPD MAN SEV AC; Young M, 2012, AM J TROP MED HYG, V87, P6, DOI 10.4269/ajtmh.2012.12-0221	43	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227939	10.1371/journal.pone.0227939	http://dx.doi.org/10.1371/journal.pone.0227939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KO3IG	32023265	Green Published, gold			2022-12-26	WOS:000515441500001
J	Richter, H; Bucker, P; Dunker, C; Karst, U; Kircher, PR				Richter, Henning; Buecker, Patrick; Dunker, Calvin; Karst, Uwe; Kircher, Patrick Robert			Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents	PLOS ONE			English	Article							T1-WEIGHTED MR-IMAGES; HIGH-SIGNAL INTENSITY; DEEP CEREBELLAR NUCLEI; DENTATE NUCLEUS; GLOBUS-PALLIDUS; MAGNETIC-RESONANCE; PROGRESSIVE INCREASE; RENAL-FUNCTION; HEALTHY RATS; GADODIAMIDE	Objective To determine the effect of a linear gadolinium-based contrast agent (GBCA) on the signal intensity (SI) of the deep cerebellar nuclei (DCN) in a retrospective clinical study on dogs after multiple magnetic resonance (MR) examinations with intravenous injections of gadodiamide and LA-ICP-MS analysis of a canine cerebellum after gadodiamide administration. Animals 15 client-owned dogs of different breeds and additionally 1 research beagle dog cadaver. Procedures In the retrospective study part, 15 dogs who underwent multiple consecutive MR imaging examinations with intravenous injection of linear GBCA gadodiamide were analyzed. SI ratio differences on unenhanced T1-weighted MR images before and after gadodiamide injections was calculated by subtracting SI ratios between DCN and pons of the first examination from the ratio of the last examination. Additionally, 1 research beagle dog cadaver was used for LA-ICP-MS (Laser ablation inductively coupled plasma mass spectrometry) analysis of gadolinium in the cerebellum as an add-on to another animal study. Descriptive and non-parametrical statistical analysis was performed and a p-value of < 0.05 was considered significant. Results No statistically significant differences of SI ratios, between DCN and pons, were detectable based on unenhanced T1-weighted MR images. LA-ICP-MS analyses showed between 1.5 to 2.5 mu g gadolinium/g tissue in the cerebellum of the examined dog, 35 months after the last of 3 MRI examination with gadodiamide (two examinations at a dose of 1 x 0.1mmol/kg, last examination at a dose of 3 x 0.05mmol/kg). Conclusion and clinical relevance Although the retrospective MRI study did not indicate any visible effect of SI increase after multiple gadodiamide exposures, further studies based on LA-ICP-MS showed that the optical threshold was not reached for a potential visible effect. Gadolinium was detectable at a level of 1.5 to 2.5 mu g gadolinium/g tissue by using LA-ICP-MS in the cerebellum 35 months after last MRI examination. The general importance of gadolinium retention of subvisible contents requires further investigation.	[Richter, Henning; Kircher, Patrick Robert] Univ Zurich, Vetsuisse Fac, Dept Clin Diagnost & Serv, Diagnost Imaging Res Unit DIRU, Zurich, Switzerland; [Buecker, Patrick; Dunker, Calvin; Karst, Uwe] Univ Munster, Inst Inorgan & Analyt Chem, Munster, Germany	University of Zurich; University of Munster	Richter, H (corresponding author), Univ Zurich, Vetsuisse Fac, Dept Clin Diagnost & Serv, Diagnost Imaging Res Unit DIRU, Zurich, Switzerland.	henning.richter@uzh.ch	Kircher, Patrick R/I-2055-2013	Kircher, Patrick R/0000-0002-9677-0522; Dunker, Calvin/0000-0002-2109-5817; Richter, Henning/0000-0003-3696-6993				Adin ME, 2015, AM J NEURORADIOL, V36, P1859, DOI 10.3174/ajnr.A4378; Bishop DP, 2016, J ANAL ATOM SPECTROM, V31, P197, DOI 10.1039/c5ja00293a; Boyken J, 2018, INVEST RADIOL, V53, P278, DOI 10.1097/RLI.0000000000000440; Cao Y, 2016, INVEST RADIOL, V51, P677, DOI 10.1097/RLI.0000000000000294; Cao Y, 2016, AM J ROENTGENOL, V206, P414, DOI 10.2214/AJR.15.15327; Eisele P, 2017, J NEUROIMAGING, V27, P372, DOI 10.1111/jon.12448; Eisele P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004624; El-Khatib AH, 2019, NEUROL-NEUROIMMUNOL, V6, DOI 10.1212/NXI.0000000000000515; Errante Y, 2014, INVEST RADIOL, V49, P685, DOI 10.1097/RLI.0000000000000072; Espagnet MCR, 2017, PEDIATR RADIOL, V47, P1345, DOI 10.1007/s00247-017-3874-1; Feldmann J, 2002, J ANAL ATOM SPECTROM, V17, P813, DOI 10.1039/b201960d; Fingerhut S, 2018, J TRACE ELEM MED BIO, V45, P125, DOI 10.1016/j.jtemb.2017.10.004; Flood TF, 2017, RADIOLOGY, V282, P222, DOI 10.1148/radiol.2016160356; Frenzel T, 2017, INVEST RADIOL, V52, P396, DOI 10.1097/RLI.0000000000000352; Gianolio E, 2017, RADIOLOGY, V285, P839, DOI 10.1148/radiol.2017162857; Hu HCH, 2016, PEDIATR RADIOL, V46, P1590, DOI 10.1007/s00247-016-3646-3; Ichikawa S, 2017, INVEST RADIOL, V52, P389, DOI 10.1097/RLI.0000000000000360; Jost G, 2017, EUR RADIOL, V27, P2877, DOI 10.1007/s00330-016-4654-2; Jost G, 2016, INVEST RADIOL, V51, P83, DOI 10.1097/RLI.0000000000000242; Kanda T, 2015, RADIOLOGY, V276, P228, DOI 10.1148/radiol.2015142690; Kanda T, 2015, RADIOLOGY, V275, P803, DOI 10.1148/radiol.14140364; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Kartamihardja AAP, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160509; Khant ZA, 2017, MAGN RESON MED SCI, V16, P84, DOI 10.2463/mrms.mp.2016-0054; Kiviniemi A, 2019, NEURORADIOLOGY, V61, P535, DOI 10.1007/s00234-019-02172-6; Korkusuz H, 2013, MOL IMAGING BIOL, V15, P148, DOI 10.1007/s11307-012-0579-6; Kuno H, 2017, RADIOLOGY, V283, P195, DOI 10.1148/radiol.2016160674; Lohrke J, 2017, INVEST RADIOL, V52, P324, DOI 10.1097/RLI.0000000000000344; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Miller JH, 2015, PEDIATRICS, V136, pE1637, DOI 10.1542/peds.2015-2222; Moser FG, 2018, AM J NEURORADIOL, V39, P421, DOI 10.3174/ajnr.A5538; Murata N, 2016, INVEST RADIOL, V51, P447, DOI 10.1097/RLI.0000000000000252; Quattrocchi CC, 2019, EUR RADIOL, V29, P3959, DOI 10.1007/s00330-018-5803-6; Quattrocchi CC, 2018, INVEST RADIOL, V53, P214, DOI 10.1097/RLI.0000000000000431; Quattrocchi CC, 2015, RADIOLOGY, V276, P616, DOI 10.1148/radiol.2015150464; Quattrocchi CC, 2015, INVEST RADIOL, V50, P470, DOI 10.1097/RLI.0000000000000154; Radbruch A, 2019, INVEST RADIOL, V54, P531, DOI 10.1097/RLI.0000000000000575; Radbruch A, 2017, RADIOLOGY, V283, P827, DOI 10.1148/radiol.2017162980; Radbruch A, 2017, RADIOLOGY, V282, P699, DOI 10.1148/radiol.2016162241; Radbruch A, 2016, INVEST RADIOL, V51, P683, DOI 10.1097/RLI.0000000000000308; Radbruch A, 2015, INVEST RADIOL, V50, P805, DOI 10.1097/RLI.0000000000000227; Radbruch A, 2015, RADIOLOGY, V275, P783, DOI 10.1148/radiol.2015150337; Ramalho J, 2016, AM J NEURORADIOL, V37, P1427, DOI 10.3174/ajnr.A4757; Ramalho J, 2016, EUR RADIOL, V26, P4080, DOI 10.1007/s00330-016-4269-7; Ramalho J, 2015, RADIOLOGY, V276, P836, DOI 10.1148/radiol.2015150872; Rasschaert M, 2017, INVEST RADIOL, V52, P255, DOI 10.1097/RLI.0000000000000339; Robert P, 2018, RADIOLOGY, V288, P424, DOI 10.1148/radiol.2018172746; Robert P, 2016, INVEST RADIOL, V51, P73, DOI 10.1097/RLI.0000000000000241; Robert P, 2015, INVEST RADIOL, V50, P473, DOI 10.1097/RLI.0000000000000181; Roberts DR, 2016, AM J NEURORADIOL, V37, P2340, DOI 10.3174/ajnr.A4891; Roberts DR, 2017, NEUROLOGY, V88, P1206, DOI 10.1212/WNL.0000000000003735; Roberts DR, 2016, BRAIN DEV-JPN, V38, P331, DOI 10.1016/j.braindev.2015.08.009; Schlemm L, 2017, MULT SCLER, P23; Stojanov DA, 2016, EUR RADIOL, V26, P807, DOI 10.1007/s00330-015-3879-9; Tanaka M, 2016, EUR NEUROL, V75, P195, DOI 10.1159/000445431; Tedeschi E, 2016, EUR RADIOL, V26, P4577, DOI 10.1007/s00330-016-4245-2; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Wang SQ, 2019, INVEST RADIOL, V54, P617, DOI 10.1097/RLI.0000000000000571; Weberling LD, 2015, INVEST RADIOL, V50, P743, DOI 10.1097/RLI.0000000000000206; Young JR, 2018, CLIN RADIOL, V73, P290, DOI 10.1016/j.crad.2017.11.005; Zhang Y, 2017, RADIOLOGY, V282, P516, DOI 10.1148/radiol.2016152864	61	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0227649	10.1371/journal.pone.0227649	http://dx.doi.org/10.1371/journal.pone.0227649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012163	Green Accepted, Green Published, gold			2022-12-26	WOS:000534615800009
J	Tahir, RA; Bashir, A; Yousaf, MN; Ahmed, A; Dali, Y; Khan, S; Sehgal, SA				Tahir, Rana Adnan; Bashir, Afsheen; Yousaf, Muhammad Noaman; Ahmed, Azka; Dali, Yasmine; Khan, Sanaullah; Sehgal, Sheikh Arslan			In Silico identification of angiotensin-converting enzyme inhibitory peptides from MRJP1	PLOS ONE			English	Article							PRIMARY PULMONARY-HYPERTENSION; PROTEIN-STRUCTURE; BIOACTIVE PEPTIDES; MOLECULAR DOCKING; ANTIHYPERTENSIVE PEPTIDES; STRUCTURAL REQUIREMENTS; ARTERIAL-HYPERTENSION; GERMLINE MUTATIONS; BLOOD-PRESSURE; SOUR MILK	Hypertension is considered as one of the most common diseases that affect human beings (both male and female) due to its high prevalence and also extending widely to both industrialize and developing countries. Angiotensin-converting enzyme (ACE) has a significant role in the regulation of blood pressure and ACE inhibition with inhibitory peptides is considered as a major target to prevent hypertension. In the current study, a blood pressure regulating honey protein (MRJP1) was examined to identify the ACE inhibitory peptides. The 3D structure of MRJP1 was predicted by utilizing the threading approach and further optimized by performing molecular dynamics simulation for 30 nanoseconds (ns) to improve the quality factor up to 92.43%. Root mean square deviation and root mean square fluctuations were calculated to evaluate the structural features and observed the fluctuations in the timescale of 30 ns. AHTpin server based on scoring vector machine of regression models, proteolysis and structural characterization approaches were implemented to identify the potential inhibitory peptides. The anti-hypertensive peptides were scrutinized based on the QSAR models of anti-hypertensive activity and the molecular docking analyses were performed to explore the binding affinities and potential interacting residues. The peptide "EALPHVPIFDR" showed the strong binding affinity and higher anti-hypertensive activity along with the global energy of -58.29 and docking score of 9590. The aromatic amino acids especially Tyr was observed as the key residue to design the dietary peptides and drugs like ACE inhibitors.	[Tahir, Rana Adnan] Beijing Inst Technol, Sch Life Sci, Dept Biol, Key Lab Mol Med & Biotherapy,Minist Ind & Informa, Beijing, Peoples R China; [Tahir, Rana Adnan; Ahmed, Azka] COMSATS Univ Islamabad, Dept Biosci, Sahiwal Campus, Sahiwal, Pakistan; [Bashir, Afsheen; Yousaf, Muhammad Noaman] Khyber Girls Med Coll, Peshawar, Pakistan; [Dali, Yasmine] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China; [Khan, Sanaullah] Univ Peshawar, Dept Zool, Peshawar, Pakistan; [Sehgal, Sheikh Arslan] Govt Coll Univ Faisalabad, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan	Beijing Institute of Technology; COMSATS University Islamabad (CUI); Chinese Academy of Sciences; Institute of Zoology, CAS; University of Peshawar; Government College University Faisalabad	Sehgal, SA (corresponding author), Govt Coll Univ Faisalabad, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan.	arslansehgal@yahoo.com		Tahir, Rana Adnan/0000-0002-2738-7132				Aderinola TA, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00877; Aldred MA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9398; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Arakaki AK, 2004, BIOINFORMATICS, V20, P1087, DOI 10.1093/bioinformatics/bth044; ATKINSON AB, 1979, LANCET, V2, P836; Audie J, 2010, CURR PHARM DESIGN, V16, P567, DOI 10.2174/138161210790361425; Baig MH, 2018, BIOMED PHARMACOTHER, V103, P574, DOI 10.1016/j.biopha.2018.04.025; Bellmann-Sickert K, 2010, TRENDS PHARMACOL SCI, V31, P434, DOI 10.1016/j.tips.2010.06.003; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Boyd A, 2008, GENETICS, V180, P165, DOI 10.1534/genetics.108.090423; Briand JP, 2010, CURR PHARM DESIGN, V16, P1136, DOI 10.2174/138161210790963805; Case DA, 2014, AMBER 14; CHEUNG HS, 1980, J BIOL CHEM, V255, P401; Clare DA, 2000, J DAIRY SCI, V83, P1187, DOI 10.3168/jds.S0022-0302(00)74983-6; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Daliri EBM, 2017, PROBIOTICS ANTIMICRO, V9, P91, DOI 10.1007/s12602-016-9241-y; Deng ZZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16090299; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Dorn M, 2014, COMPUT BIOL CHEM, V53, P251, DOI 10.1016/j.compbiolchem.2014.10.001; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P7118, DOI 10.1021/bi00243a012; Fang H, 2008, PEPTIDES, V29, P1062, DOI 10.1016/j.peptides.2008.02.005; Fernandez L, 2018, CURR PROTEIN PEPT SC, V19, P958, DOI 10.2174/1389203718666170828123449; FitzGerald RJ, 2004, J NUTR, V134, p980S, DOI 10.1093/jn/134.4.980S; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Friedman M, 1996, J AGR FOOD CHEM, V44, P6, DOI 10.1021/jf9400167; Fu Y, 2017, INT J BIOL MACROMOL, V101, P207, DOI 10.1016/j.ijbiomac.2017.03.054; Geleijnse JM, 2010, CURR OPIN LIPIDOL, V21, P58, DOI 10.1097/MOL.0b013e3283333813; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hartmann R, 2007, CURR OPIN BIOTECH, V18, P163, DOI 10.1016/j.copbio.2007.01.013; Hata Y, 1996, AM J CLIN NUTR, V64, P767, DOI 10.1093/ajcn/64.5.767; Hruby VJ, 2002, NAT REV DRUG DISCOV, V1, P847, DOI 10.1038/nrd939; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; Iwaniak A, 2014, COMPR REV FOOD SCI F, V13, P114, DOI 10.1111/1541-4337.12051; Iwaniak A, 2009, FOOD TECHNOL BIOTECH, V47, P441; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Joo K, 2007, PROTEINS, V69, P83, DOI 10.1002/prot.21628; Kanwal S, 2017, INTERDISCIP SCI, V9, P214, DOI 10.1007/s12539-016-0145-z; Kawasaki T, 2000, J HUM HYPERTENS, V14, P519, DOI 10.1038/sj.jhh.1001065; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Korhonen H, 2003, CURR PHARM DESIGN, V9, P1297, DOI 10.2174/1381612033454892; Koyama M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105802; Kumar R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12512; Kushwaha S.K., 2009, INT J INTEG BIOL, V7, P135; Lai YC, 2014, CIRC RES, V115, P115, DOI 10.1161/CIRCRESAHA.115.301146; Lance BK, 2010, BIOINFORMATICS, V26, P1849, DOI 10.1093/bioinformatics/btq294; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Ma FF, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01579; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Mancia G, 2015, CIRC RES, V116, P923, DOI 10.1161/CIRCRESAHA.115.305755; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Massague J, 2000, GENE DEV, V14, P627; Masuda O, 1996, J NUTR, V126, P3063, DOI 10.1093/jn/126.12.3063; Matsui T, 1999, J PEPT SCI, V5, P289, DOI 10.1002/(SICI)1099-1387(199907)5:7<289::AID-PSC196>3.0.CO;2-6; Matsui T, 2002, J NUTR BIOCHEM, V13, P80, DOI 10.1016/S0955-2863(01)00198-X; Misura KMS, 2005, PROTEINS, V59, P15, DOI 10.1002/prot.20376; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; Ohashi K, 1997, EUR J BIOCHEM, V249, P797, DOI 10.1111/j.1432-1033.1997.t01-1-00797.x; OKUNISHI H, 1991, CLIN EXP PHARMACOL P, V18, P649, DOI 10.1111/j.1440-1681.1991.tb01639.x; Pan DD, 2012, FOOD CHEM, V130, P121, DOI 10.1016/j.foodchem.2011.07.011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pina AS, 2009, J MOL RECOGNIT, V22, P162, DOI 10.1002/jmr.905; Rigelsky CM, 2008, AM J MED GENET A, V146A, P2551, DOI 10.1002/ajmg.a.32468; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sehgal S., 2014, J THEOR COMPUT SCI, V1, P2; Sehgal SA, 2018, TROP J PHARM RES, V17, P491, DOI 10.4314/tjpr.v17i3.15; Sehgal SA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5925714; Sehgal SA, 2017, MED CHEM RES, V26, P314, DOI 10.1007/s00044-016-1752-2; Sehgal SA, 2016, DRUG DES DEV THER, V10, P1605, DOI 10.2147/DDDT.S101929; Sehgal SA, 2015, DRUG DES DEV THER, V9, P3471, DOI 10.2147/DDDT.S63946; Sehgal SA, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-3; Senthilkumar B., 2016, J BIONANOSCI, V10, P1, DOI [10.1166/jbns.2016.1354, DOI 10.1166/JBNS.2016.1354]; Tahir RA, 2019, J CELL PHYSIOL, V234, P13263, DOI 10.1002/jcp.27999; Tahir RA, 2018, J THEOR BIOL, V459, P162, DOI 10.1016/j.jtbi.2018.10.005; Tahir RA, 2018, COMB CHEM HIGH T SCR, V21, P175, DOI 10.2174/1386207321666180213092018; Tahir RA, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-38; Takase H, 1996, HYPERTENSION, V27, P25, DOI 10.1161/01.HYP.27.1.25; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Uno kK, 1995, CLIN REPORT, V29, P10; Vercruysse L, 2005, J AGR FOOD CHEM, V53, P8106, DOI 10.1021/jf0508908; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wu JP, 2006, QSAR COMB SCI, V25, P873, DOI 10.1002/qsar.200630005; Wu JP, 2006, J AGR FOOD CHEM, V54, P732, DOI 10.1021/jf051263l; Ye Yuzhen, 2006, Pac Symp Biocomput, P439, DOI 10.1142/9789812701626_0040; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005	95	9	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228265	10.1371/journal.pone.0228265	http://dx.doi.org/10.1371/journal.pone.0228265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012183	Green Published, gold			2022-12-26	WOS:000534615800025
J	Tudoran, M; Tudoran, C; Ciocarlie, T; Giurgi-Oncu, C				Tudoran, Mariana; Tudoran, Cristina; Ciocarlie, Tudor; Giurgi-Oncu, Catalina			Aspects of diastolic dysfunction in patients with new and recurrent depression	PLOS ONE			English	Article							RECOMMENDATIONS; ASSOCIATION	Objective The main objective of this study was to evidence the potential impact of the intensity, duration and recurrence of depression on the development of arterial stiffness (AS) leading to left ventricular hypertrophy (LVH) and diastolic dysfunction (DD) in patients with new onset depression (NOD) and recurrent depression (RD) in comparison to 33 control subjects without depression. Another aim was to identify potential predictive factors regarding the occurrence of diastolic dysfunction (DD). Methods Our study group included 58 patients diagnosed with NOD and 128 diagnosed with RD, without any previously diagnosed significant heart diseases. The intensity of depression was evaluated by means of the Montgomery-Asberg Depression Rating Scale (MADRS). Assessment of pulse wave velocity (PWV), left ventricular mass index (LVMI) and echocardiographic parameters characterizing DD were performed for each patient. Results The cardiology evaluations suggested an increased prevalence of AS in all patients, of significantly higher rate than in controls (p<0.001), which was statistically correlated with the severity and duration of depression. Another significant finding was an increased prevalence of DD (29.31% and 63.28%, respectively; p<0.001) correlated with the MADRS score, total duration and number of recurrences/relapses. The multivariate logistic regression analysis identified PWV, the intensity and duration of depression as significant predictive factors for the occurrence of DD. Conclusions In our study, diastolic dysfunction was a common finding among patients with RD, but it was also noted, to a lesser extent, in those suffering with NOD. DD was associated with altered AS, and strongly correlated with the intensity and the duration of depressive symptoms. The two latter factors, together with an increased PWV, were strong predictors for the occurrence of DD.	[Tudoran, Mariana; Tudoran, Cristina; Ciocarlie, Tudor] Univ Med & Farm Timisoara, Cty Clin Emergency Hosp, Dept Internal Med 7 2, Timisoara, Timis, Romania; [Tudoran, Mariana; Tudoran, Cristina; Ciocarlie, Tudor; Giurgi-Oncu, Catalina] Cty Clin Emergency Hosp, Timisoara, Romania; [Giurgi-Oncu, Catalina] Univ Med & Farm Timisoara, Discipline Psychiat, Neurosci Dept 8, Timisoara, Timis, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Tudoran, C (corresponding author), Univ Med & Farm Timisoara, Cty Clin Emergency Hosp, Dept Internal Med 7 2, Timisoara, Timis, Romania.; Tudoran, C (corresponding author), Cty Clin Emergency Hosp, Timisoara, Romania.	cristina13.tudoran@gmail.com	Giurgi-Oncu, Catalina/AAD-6183-2019; Cristina, Tudoran/AAO-8869-2021; Tudoran, Mariana M/C-8126-2015	Giurgi-Oncu, Catalina/0000-0001-8962-0000; Cristina, Tudoran/0000-0002-7351-741X; Tudoran, Mariana M/0000-0001-8989-5899				Al-Abbudi SJ., 2018, J PSYCHIAT, V21, P438; Allen J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00386; Celano CM., 2016, PSYCHIAT TIMES, V33, P1; Effendy E, 2018, IOP C SER EARTH ENV, V125, DOI 10.1088/1755-1315/125/1/012187; Feola M, 2013, OPEN CARDIOVASC MED, V7, P54, DOI 10.2174/1874192401307010054; Gan GCH, 2018, CARDIOVASC DIAGN THE, V8, P29, DOI 10.21037/cdt.2017.06.08; Gan Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0371-z; Gustad LT, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000363; Huffman J. C., 2013, CARDIOVASC PSYCHIAT, V2013, P1, DOI DOI 10.1155/2013/695925; Khandoker AH, 2015, COMPUT CARDIOL CONF, V42, P1061, DOI 10.1109/CIC.2015.7411097; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Malpas SC, 2010, PHYSIOL REV, V90, P513, DOI 10.1152/physrev.00007.2009; Maust D, 2012, HAND CLINIC, V106, P227, DOI 10.1016/B978-0-444-52002-9.00013-9; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Muraro C, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9173631; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Ogilvie RP, 2016, CIRC-HEART FAIL, P1; Onete V, 2018, J PSYCHIATR NEUROSCI, V43, P111, DOI 10.1503/jpn.160246; Penninx BWJH, 2017, NEUROSCI BIOBEHAV R, V74, P277, DOI 10.1016/j.neubiorev.2016.07.003; Silberman GA, 2010, CIRCULATION, V121, P519, DOI 10.1161/CIRCULATIONAHA.109.883777; SKILLING EJ, 2016, CARDIOVASCULAR DIS D, P187, DOI DOI 10.1016/B978-0-12-803806-2.00011-X; Tudoran M, 2015, KARDIOL POL, V73, P337, DOI 10.5603/KP.a2014.0241; Van Sloten T, 2014, ARTERY RES, V8, P141; Wang Y, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0664-5	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228449	10.1371/journal.pone.0228449	http://dx.doi.org/10.1371/journal.pone.0228449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32005035	Green Published, gold			2022-12-26	WOS:000534614600037
J	Sasaki, T; Harada, S; Yamamoto, S; Ohkushi, D; Hayama, B; Takeda, K; Hoashi, K; Shiotani, J; Takehana, K; Doi, Y				Sasaki, Toshiharu; Harada, Sohei; Yamamoto, Shungo; Ohkushi, Daisuke; Hayama, Brian; Takeda, Koichi; Hoashi, Kosuke; Shiotani, Joji; Takehana, Kazumi; Doi, Yohei			Clinical characteristics of peripheral venous catheter-associated gram-negative bloodstream infection among patients with malignancy	PLOS ONE			English	Article							SHORT-TERM; EPIDEMIOLOGY; THROMBOSIS; NATIONWIDE; THERAPY	Purpose Previous studies have suggested that peripheral venous catheter is a significant source of gram-negative bacteraemia in patients with malignancy. We aimed to identify risk factors and develop a clinical prediction rule for the involvement of gram-negative organisms in peripheral venous catheter-associated bloodstream infections (PVC-BSIs) among patients with malignancy. Methods This retrospective cohort study was conducted at a 700-bed cancer hospital in Japan. Consecutive patients diagnosed with PVC-BSI based on clinical and microbiological criteria were included in this study. Based on clinical and microbiological characteristics of PVC-BSIs in cancer patients, a logistic regression model for predicting gram-negative organisms as causative organisms in PVC-BSIs was then developed. Results Of the 99 patients included in our cohort, 60 patients (60.6%) had gram-negative PVC-BSIs. The median age of patients with PVC-BSIs was 67 years (interquartile range [IQR], 59-74 years), and the median Pitt bactearemia score was 1 (IQR, 0-3). The median duration of catherization was 5 days (IQR, 4-7 days) and 70 patients (70.7%) received peripheral parenteral nutrition that contained amino acids. On multivariable analysis, age >= 65 years (odds ratio [OR], 3.07; 95% confidence interval [CI], 1.10-8.62), showering (OR, 3.15; 95% CI, 1.07-9.26), Pitt bacteraemia score >= 2 points (OR, 6.96; 95% CI, 2.52-19.2), and use of peripheral parenteral nutrition (OR, 0.31; 95% CI, 0.10-0.98) were independent predictors for gram-negative PVC-BSIs among all PVC-BSIs. The simplified PVC-GN scores established to predict gram-negative PVC-BSIs had a optimism-corrected c-index of 0.775. Conclusion Gram-negative bacteria were more commonly responsible for PVC-BSI than Gram-positive bacteria among cancer patients in this cohort. Involvement of Gram-negative bacteria in PVC-BSIs could be predicted with readily available clinical variables.	[Sasaki, Toshiharu; Harada, Sohei; Doi, Yohei] Fujita Hlth Univ, Sch Med, Dept Infect Dis, Toyoake, Aichi, Japan; [Sasaki, Toshiharu; Doi, Yohei] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi, Japan; [Sasaki, Toshiharu; Harada, Sohei; Ohkushi, Daisuke; Hayama, Brian; Takeda, Koichi; Hoashi, Kosuke] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Infect Dis, Tokyo, Japan; [Yamamoto, Shungo] Kyoto City Hosp, Dept Infect Dis, Kyoto, Japan; [Yamamoto, Shungo] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Healthcare Epidemiol, Kyoto, Japan; [Shiotani, Joji; Takehana, Kazumi] Japanese Fdn Canc Res, Canc Inst Hosp, Clin Lab, Tokyo, Japan; [Doi, Yohei] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA	Fujita Health University; Fujita Health University; Japanese Foundation for Cancer Research; Kyoto City Hospital; Kyoto University; Japanese Foundation for Cancer Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Harada, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Infect Dis, Toyoake, Aichi, Japan.; Harada, S (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Infect Dis, Tokyo, Japan.	haradas-tky@umin.ac.jp		Harada, Sohei/0000-0003-3073-6564				[Anonymous], 2006, J INFECTION, V53, P190, DOI [10.1016/j.jinf.2005.10.024, DOI 10.1016/J.JINF.2005.10.024]; [Anonymous], 2019, BLOODSTR INF EV CENT; Austin ED, 2016, OPEN FORUM INFECT DI, V3, DOI [10.1093/ofid/ofw072, 10.1093/ofid/ofw234]; Buetti N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013665; Chee L, 2008, J INFECTION, V56, P227, DOI 10.1016/j.jinf.2008.01.046; Crowley AL, 2008, CRIT CARE MED, V36, P385, DOI 10.1097/01.CCM.0B013E3181611F914; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Donlan RM, 2011, CLIN INFECT DIS, V52, P1038, DOI 10.1093/cid/cir077; Dooley DP, 1996, J CLIN MICROBIOL, V34, P409, DOI 10.1128/JCM.34.2.409-412.1996; Extermann M, 2000, EUR J CANCER, V36, P453, DOI 10.1016/S0959-8049(99)00319-6; Guembe M, 2017, J HOSP INFECT, V97, P260, DOI 10.1016/j.jhin.2017.07.008; Guembe M, 2015, J HOSP INFECT, V90, P135, DOI 10.1016/j.jhin.2015.01.024; Ielapi N, 2020, REV RECENT CLIN TRIA, V15, P22, DOI 10.2174/1574887114666191018144739; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; Marcos M, 2011, J ANTIMICROB CHEMOTH, V66, P2119, DOI 10.1093/jac/dkr231; Mermel LA, 2017, CLIN INFECT DIS, V65, P1757, DOI 10.1093/cid/cix562; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Pujol M, 2007, J HOSP INFECT, V67, P22, DOI 10.1016/j.jhin.2007.06.017; Raad I, 2007, EUR J CLIN MICROBIOL, V26, P549, DOI 10.1007/s10096-007-0320-6; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sakihama T, 2016, JPN J INFECT DIS, V69, P531, DOI 10.7883/yoken.JJID.2015.489; Salibe P, 2018, J HOSP INFECT, V100, pE178, DOI 10.1016/j.jhin.2018.06.010; Sato A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2536-0; Steyerberg E., 2009, CLIN PREDICTION MODE; Timsit JF, 1998, CHEST, V114, P207, DOI 10.1378/chest.114.1.207; Toscano CM, 2009, AM J INFECT CONTROL, V37, P327, DOI 10.1016/j.ajic.2008.01.012; Trinh TT, 2011, INFECT CONT HOSP EP, V32, P579, DOI 10.1086/660099; Tsuboi M, 2019, AM J INFECT CONTROL, V47, P208, DOI 10.1016/j.ajic.2018.08.016; van der Mee-Marquet NL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00646; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228396	10.1371/journal.pone.0228396	http://dx.doi.org/10.1371/journal.pone.0228396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999762	Green Published, gold			2022-12-26	WOS:000534612400077
J	Totoiu, CA; Phillips, JM; Reese, AT; Majumdar, S; Girguis, PR; Raston, CL; Weiss, GA				Totoiu, Christian A.; Phillips, Jessica M.; Reese, Aspen T.; Majumdar, Sudipta; Girguis, Peter R.; Raston, Colin L.; Weiss, Gregory A.			Vortex fluidics-mediated DNA rescue from formalin-fixed museum specimens	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; PCR AMPLIFICATION; NATURAL-HISTORY; CHAIN BREAKAGE; COLLECTIONS; TISSUES; SITES; EXTRACTION; DUPLEX	DNA from formalin-preserved tissue could unlock a vast repository of genetic information stored in museums worldwide. However, formaldehyde crosslinks proteins and DNA, and prevents ready amplification and DNA sequencing. Formaldehyde acylation also fragments the DNA. Treatment with proteinase K proteolyzes crosslinked proteins to rescue the DNA, though the process is quite slow. To reduce processing time and improve rescue efficiency, we applied the mechanical energy of a vortex fluidic device (VFD) to drive the catalytic activity of proteinase K and recover DNA from American lobster tissue (Homarus americanus) fixed in 3.7% formalin for > 1-year. A scan of VFD rotational speeds identified the optimal rotational speed for recovery of PCR-amplifiable DNA and while 500+ base pairs were sequenced, shorter read lengths were more consistently obtained. This VFD-based method also effectively recovered DNA from formalin-preserved samples. The results provide a roadmap for exploring DNA from millions of historical and even extinct species.	[Totoiu, Christian A.; Majumdar, Sudipta; Weiss, Gregory A.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Phillips, Jessica M.; Raston, Colin L.] Flinders Univ S Australia, Flinders Inst Nanoscale Sci & Technol, Coll Sci & Engn, Adelaide, SA, Australia; [Reese, Aspen T.; Girguis, Peter R.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Weiss, Gregory A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Weiss, Gregory A.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; Flinders University South Australia; Harvard University; University of California System; University of California Irvine; University of California System; University of California Irvine	Weiss, GA (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA.; Weiss, GA (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.; Weiss, GA (corresponding author), Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA.	gweiss@uci.edu	Weiss, Gregory/AEN-4604-2022		National Human Genome Research Institute (NHGRI) of the National Institutes of Health [1R01HG009188-01]; Star Family Foundation Challenge for Promising Scientific Research; University of California at Irvine Undergraduate Research Opportunities Program; University of California at Irvine Summer Undergraduate Research Program	National Human Genome Research Institute (NHGRI) of the National Institutes of Health; Star Family Foundation Challenge for Promising Scientific Research; University of California at Irvine Undergraduate Research Opportunities Program(University of California System); University of California at Irvine Summer Undergraduate Research Program(University of California System)	This work was supported by the National Human Genome Research Institute (NHGRI, https://www.genome.gov) of the National Institutes of Health [1R01HG009188-01 to G.A.W.]; the Star Family Foundation Challenge for Promising Scientific Research [to A.T.R. and P.R.G.]; and the University of California at Irvine's Undergraduate Research Opportunities Program and Summer Undergraduate Research Program [to C.A.T.]. Funding for open access charge: NHGRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britton J, 2017, CHEM-EUR J, V23, P13270, DOI 10.1002/chem.201700888; Britton J, 2016, ANGEW CHEM INT EDIT, V55, P11387, DOI 10.1002/anie.201604014; Butler JM, 2013, J ASSIST REPROD GEN, V30, P1389, DOI 10.1007/s10815-013-0064-4; Campos P.F., 2012, ANCIENT DNA METHODS, V840; CARROLL SP, 1992, EVOLUTION, V46, P1052, DOI 10.1111/j.1558-5646.1992.tb00619.x; Didelot A, 2013, CLIN CHEM, V59, P815, DOI 10.1373/clinchem.2012.193409; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Dutta S, 2007, J AM CHEM SOC, V129, P1852, DOI 10.1021/ja067294u; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; Greer C E, 1991, PCR Methods Appl, V1, P46; Hassani A, 2015, EXP MOL PATHOL, V99, P558, DOI 10.1016/j.yexmp.2015.09.013; Hoffman EA, 2015, J BIOL CHEM, V290, P26404, DOI 10.1074/jbc.R115.651679; Holmes MW, 2016, MOL ECOL, V25, P864, DOI 10.1111/mec.13529; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Hu QQ, 2015, FORENSIC SCI INT-GEN, V16, P94, DOI 10.1016/j.fsigen.2014.12.001; Hykin SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141579; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kennedy-Darling J, 2014, ANAL CHEM, V86, P5678, DOI 10.1021/ac501354y; Kim S, 2011, MITOCHONDR DNA, V22, P47, DOI 10.3109/19401736.2011.597389; Leggate J, 2006, BIOTECHNOL LETT, V28, P1587, DOI 10.1007/s10529-006-9128-1; Lens L, 2002, SCIENCE, V298, P1236, DOI 10.1126/science.1075664; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Luo X, 2018, ACS APPL MATER INTER, V10, P27224, DOI 10.1021/acsami.8b09316; Mikheyev AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8991; Munchel S, 2015, ONCOTARGET, V6, P25943, DOI 10.18632/oncotarget.4671; Paireder S, 2013, ANAL BIOCHEM, V439, P152, DOI 10.1016/j.ab.2013.04.006; Pergams ORW, 2001, J MAMMAL, V82, P984, DOI 10.1644/1545-1542(2001)082<0984:MCOMCT>2.0.CO;2; Sitepu EK, 2018, BIORESOURCE TECHNOL, V266, P488, DOI 10.1016/j.biortech.2018.06.103; Spurgin LG, 2014, EVOL APPL, V7, P1134, DOI 10.1111/eva.12191; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; SUZUKI T, 1994, NUCLEIC ACIDS RES, V22, P4997, DOI 10.1093/nar/22.23.4997; VESNAVER G, 1989, P NATL ACAD SCI USA, V86, P3614, DOI 10.1073/pnas.86.10.3614; Yazawa K, 2016, ACS CATAL, V6, P3036, DOI 10.1021/acscatal.6b00100; Yuan TZ, 2015, CHEMBIOCHEM, V16, P393, DOI 10.1002/cbic.201402427	38	8	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0225807	10.1371/journal.pone.0225807	http://dx.doi.org/10.1371/journal.pone.0225807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999723	Green Published, Green Submitted, gold			2022-12-26	WOS:000534612400007
J	Braunstein, I; Engelman, R; Yitzhaki, O; Ziv, T; Galardon, E; Benhar, M				Braunstein, Ilana; Engelman, Rotem; Yitzhaki, Ofer; Ziv, Tamar; Galardon, Erwan; Benhar, Moran			Opposing effects of polysulfides and thioredoxin on apoptosis through caspase persulfidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; redox regulation; cell signaling; thioredoxin; cancer; caspases; depersulfidation; hydrogen sulfide (H2S); polysulfides; protein persulfidation; sulfhydration	HYDROGEN-SULFIDE; CANCER CELLS; ACTIVATION; GASOTRANSMITTER; NITROSYLATION; INHIBITION; MECHANISMS; REDUCTASE; SULFUR	Hydrogen sulfide has been implicated in a large number of physiological processes including cell survival and death, encouraging research into its mechanisms of action and therapeutic potential. Results from recent studies suggest that the cellular effects of hydrogen sulfide are mediated in part by sulfane sulfur species, including persulfides and polysulfides. In the present study, we investigated the apoptosis-modulating effects of polysulfides, especially on the caspase cascade, which mediates the intrinsic apoptotic pathway. Biochemical analyses revealed that organic or synthetic polysulfides strongly and rapidly inhibit the enzymatic activity of caspase-3, a major effector protease in apoptosis. We attributed the caspase-3 inhibition to persulfidation of its catalytic cysteine. In apoptotically stimulated HeLa cells, short-term exposure to polysulfides triggered the persulfidation and deactivation of cleaved caspase-3. These effects were antagonized by the thioredoxin/thioredoxin reductase system (Trx/TrxR). Trx/TrxR restored the activity of polysulfide-inactivated caspase-3 in vitro, and TrxR inhibition potentiated polysulfide-mediated suppression of caspase-3 activity in situ. We further found that under conditions of low TrxR activity, early cell exposure to polysulfides leads to enhanced persulfidation of initiator caspase-9 and decreases apoptosis. Notably, we show that the proenzymes procaspase-3 and -9 are basally persulfidated in resting (unstimulated) cells and become depersulfidated during their processing and activation. Inhibition of TrxR attenuated the depersulfidation and activation of caspase-9. Taken together, our results reveal that polysulfides target the caspase-9/3 cascade and thereby suppress cancer cell apoptosis, and highlight the role of Trx/TrxR-mediated depersulfidation in enabling caspase activation.	[Braunstein, Ilana; Engelman, Rotem; Yitzhaki, Ofer; Benhar, Moran] Technion Israel Inst Technol, Dept Biochem, Rappaport Inst Res Med Sci, Fac Med, IL-3200003 Haifa, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Smoler Prote Ctr, IL-31096 Haifa, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Fac Biol, IL-31096 Haifa, Israel; [Galardon, Erwan] Univ Paris 05, Sorbonne Paris Cite, UMR 8601, CNRS, F-75006 Paris, France	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Benhar, M (corresponding author), Technion Israel Inst Technol, Dept Biochem, Rappaport Inst Res Med Sci, Fac Med, IL-3200003 Haifa, Israel.	benhar@technion.ac.il	Benhar, Moran/AAV-5764-2020; Galardon, Erwan/K-1063-2018	Benhar, Moran/0000-0002-7094-3456; Ziv, Tamar/0000-0003-4299-7454; Yitzhaki, Ofer/0000-0002-4508-8208; Galardon, Erwan/0000-0002-4371-6119	Israel Science Foundation [1574/14]; Allen and Jewell Prince Center for Neurodegenerative Diseases of the Brain Grant [86607114]	Israel Science Foundation(Israel Science Foundation); Allen and Jewell Prince Center for Neurodegenerative Diseases of the Brain Grant	This work was supported by Israel Science Foundation Grant 1574/14 (to M. B.) and Allen and Jewell Prince Center for Neurodegenerative Diseases of the Brain Grant 86607114 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Artaud I, 2014, CHEMBIOCHEM, V15, P2361, DOI 10.1002/cbic.201402312; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Cao X, 2019, ANTIOXID REDOX SIGN, V31, P1, DOI 10.1089/ars.2017.7058; Chattopadhyay M, 2012, BIOCHEM PHARMACOL, V83, P723, DOI 10.1016/j.bcp.2011.12.019; Choi YH, 2017, BIOMED PHARMACOTHER, V94, P63, DOI 10.1016/j.biopha.2017.07.055; Doka E, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500968; Engelman R, 2016, FREE RADICAL BIO MED, V97, P375, DOI 10.1016/j.freeradbiomed.2016.06.032; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Fu L, 2020, ANTIOXID REDOX SIGN, V33, P1061, DOI 10.1089/ars.2019.7777; Fujita E, 2001, CELL DEATH DIFFER, V8, P335, DOI 10.1038/sj.cdd.4400824; Fukuto JM, 2018, FEBS LETT, V592, P2140, DOI 10.1002/1873-3468.13090; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Greiner R, 2013, ANTIOXID REDOX SIGN, V19, P1749, DOI 10.1089/ars.2012.5041; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Johnson CR, 2004, APOPTOSIS, V9, P423, DOI 10.1023/B:APPT.0000031457.90890.13; Kimura H, 2020, BRIT J PHARMACOL, V177, P720, DOI 10.1111/bph.14579; Kimura H, 2014, MOLECULES, V19, P16146, DOI 10.3390/molecules191016146; Kimura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14774; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Longen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29808; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Munchberg U, 2007, ORG BIOMOL CHEM, V5, P1505, DOI 10.1039/b703832a; Murata T, 2014, EXP CELL RES, V320, P247, DOI 10.1016/j.yexcr.2013.10.023; Nagy P, 2015, METHOD ENZYMOL, V554, P3, DOI 10.1016/bs.mie.2014.11.036; Olson KR, 2019, FREE RADICAL BIO MED, V140, P74, DOI 10.1016/j.freeradbiomed.2019.01.020; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Paul BD, 2015, TRENDS BIOCHEM SCI, V40, P687, DOI 10.1016/j.tibs.2015.08.007; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rose P, 2005, WORLD J GASTROENTERO, V11, P3990, DOI 10.3748/wjg.v11.i26.3990; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Stafford WC, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaf7444; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Toohey JI, 2014, MOLECULES, V19, P12789, DOI 10.3390/molecules190812789; Vitvitsky V, 2018, ACS CHEM BIOL, V13, P2300, DOI 10.1021/acschembio.8b00463; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wedmann R, 2016, CHEM SCI, V7, P3414, DOI 10.1039/c5sc04818d; Yuan S, 2017, ANTIOXID REDOX SIGN, V27, P634, DOI 10.1089/ars.2017.7096; Zhang TL, 2019, CELL CHEM BIOL, V26, P686, DOI 10.1016/j.chembiol.2019.02.003; Zhen YL, 2015, INT J ONCOL, V46, P2194, DOI 10.3892/ijo.2015.2914	48	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3590	3600		10.1074/jbc.RA119.012357	http://dx.doi.org/10.1074/jbc.RA119.012357			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32041780	hybrid, Green Published			2022-12-26	WOS:000527725300018
J	Korasick, DA; Kandoth, PK; Tanner, JJ; Mitchum, MG; Beamer, LJ				Korasick, David A.; Kandoth, Pramod K.; Tanner, John J.; Mitchum, Melissa G.; Beamer, Lesa J.			Impaired folate binding of serine hydroxymethyltransferase 8 from soybean underlies resistance to the soybean cyst nematode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; X-ray crystallography; plant defense; folate; ligand-binding protein; host-pathogen interaction; disease resistance; Glycine max; quantitative trait loci (QTL); serine hydroxymethyltransferase 8 (SHMT8); soybean cyst nematode	BACILLUS-STEAROTHERMOPHILUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; INHIBITORS; GLYCINE; ENZYME; SHMT; MECHANISM; POLYGLUTAMYLATION; COMPLEX	Management of the agricultural pathogen soybean cyst nematode (SCN) relies on the use of SCN-resistant soybean cultivars, a strategy that has been failing in recent years. An underutilized source of resistance in the soybean genotype Peking is linked to two polymorphisms in serine hydroxy-methyltransferase 8 (SHMT8). SHMT is a pyridoxal 5?-phosphate?dependent enzyme that converts l-serine and (6S)-tetrahydrofolate to glycine and 5,10-methylenetetrahydrofolate. Here, we determined five crystal structures of the 1884-residue SHMT8 tetramers from the SCN-susceptible cultivar (cv.) Essex and the SCN-resistant cv. Forrest (whose resistance is derived from the SHMT8 polymorphisms in Peking); the crystal structures were determined in complex with various ligands at 1.4?2.35 ? resolutions. We find that the two Forrest-specific polymorphic substitutions (P130R and N358Y) impact the mobility of a loop near the entrance of the (6S)-tetrahydrofolate?binding site. Ligand-binding and kinetic studies indicate severely reduced affinity for folate and dramatically impaired enzyme activity in Forrest SHMT8. These findings imply widespread effects on folate metabolism in soybean cv. Forrest that have implications for combating the widespread increase in virulent SCN.	[Korasick, David A.; Tanner, John J.; Beamer, Lesa J.] Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA; [Tanner, John J.; Beamer, Lesa J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Kandoth, Pramod K.; Mitchum, Melissa G.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Kandoth, Pramod K.; Mitchum, Melissa G.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Kandoth, Pramod K.] Natl Agrifood Biotechnol Inst, Mohali 140308, Punjab, India; [Mitchum, Melissa G.] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; [Mitchum, Melissa G.] Univ Georgia, Inst Plant Breeding Genet & Genom, Ctr Appl Genet Technol, Athens, GA 30602 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Beamer, LJ (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.	beamerl@missouri.edu		Tanner, John/0000-0001-8314-113X; Beamer, Lesa/0000-0001-5689-200X; Korasick, David/0000-0002-6337-2085	NIGMS, National Institutes of Health [9 P41 GM103622]; National Institute of Food and Agriculture Award from the U.S. Department of Agriculture National Institute of Food and Agriculture [2019-67012-29653]; Missouri Soybean Mercchanising Council Project [258]; University of Missouri Bond Life Sciences Center	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Food and Agriculture Award from the U.S. Department of Agriculture National Institute of Food and Agriculture; Missouri Soybean Mercchanising Council Project; University of Missouri Bond Life Sciences Center	This work was supported by Grant 9 P41 GM103622 from the NIGMS, National Institutes of Health. This work was also supported by National Institute of Food and Agriculture Award 2019-67012-29653 from the U.S. Department of Agriculture National Institute of Food and Agriculture (to D. A. K.), the Missouri Soybean Mercchanising Council Project 258 (to M. G. M.), and by a seed grant from the University of Missouri Bond Life Sciences Center (to M. G. M., J. J. T., and L. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen TW, 2017, PLANT HLTH PROG, V18, P19, DOI 10.1094/PHP-RS-16-0066; Chiba Y, 2012, FEBS J, V279, P504, DOI 10.1111/j.1742-4658.2011.08443.x; Chitnumsub P, 2014, ACTA CRYSTALLOGR D, V70, P3177, DOI 10.1107/S1399004714023128; Contestabile R, 2000, BIOCHEMISTRY-US, V39, P7492, DOI 10.1021/bi000032z; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Ducker GS, 2017, P NATL ACAD SCI USA, V114, P11404, DOI 10.1073/pnas.1706617114; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FLORINI JR, 1957, BIOCHIM BIOPHYS ACTA, V25, P575, DOI 10.1016/0006-3002(57)90529-2; Fu TF, 2003, J BIOL CHEM, V278, P2645, DOI 10.1074/jbc.M210649200; Giardina G, 2018, FEBS J, V285, P3238, DOI 10.1111/febs.14610; Goverse A, 2014, ANNU REV PHYTOPATHOL, V52, P243, DOI 10.1146/annurev-phyto-102313-050118; HARTWIG EE, 1973, CROP SCI, V13, P287, DOI 10.2135/cropsci1973.0011183X001300020047x; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lakhssassi N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37815-w; Lightfoot David A, 2008, Int J Plant Genomics, V2008, P793158, DOI 10.1155/2008/793158; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; McCarville MT, 2017, PLANT HLTH PROG, V18, P146, DOI [10.1094/php-rs-16-0062, 10.1094/PHP-RS-16-0062]; Mehrshahi P, 2010, PLANT J, V64, P267, DOI 10.1111/j.1365-313X.2010.04336.x; Nonaka H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08833-7; Pai VR, 2009, BIOCHEM J, V418, P635, DOI 10.1042/BJ20081739; Paone A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.482; Patil GB, 2019, PLANT BIOTECHNOL J, V17, P1595, DOI 10.1111/pbi.13086; Pinthong C, 2014, FEBS J, V281, P2570, DOI 10.1111/febs.12803; Ruszkowski M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56043-4; Ruszkowski M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00584; Sah S, 2015, BIOCHEMISTRY-US, V54, P3504, DOI 10.1021/acs.biochem.5b00400; Scarsdale JN, 2000, J MOL BIOL, V296, P155, DOI 10.1006/jmbi.1999.3453; SCHIRCH LV, 1967, BIOCHEMISTRY-US, V6, P253, DOI 10.1021/bi00853a039; Schwertz G, 2018, CHEMMEDCHEM, V13, P931, DOI 10.1002/cmdc.201800053; Schwertz G, 2017, CHEM-EUR J, V23, P14345, DOI 10.1002/chem.201703244; Schwertz G, 2017, J MED CHEM, V60, P4840, DOI 10.1021/acs.jmedchem.7b00008; Sopitthummakhun K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-194; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; Tramonti A, 2018, BIOCHEMISTRY-US, V57, P6984, DOI 10.1021/acs.biochem.8b01074; Trivedi V, 2002, J BIOL CHEM, V277, P17161, DOI 10.1074/jbc.M111976200; Ubonprasert S, 2019, J BIOL CHEM, V294, P10490, DOI 10.1074/jbc.RA119.007454; ULEVITCH RJ, 1977, BIOCHEMISTRY-US, V16, P5342, DOI 10.1021/bi00643a027; Wei ZY, 2013, ARCH BIOCHEM BIOPHYS, V536, P87, DOI 10.1016/j.abb.2013.06.004; Witschel MC, 2015, J MED CHEM, V58, P3117, DOI 10.1021/jm501987h; Wu XY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00998; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	46	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3708	3718		10.1074/jbc.RA119.012256	http://dx.doi.org/10.1074/jbc.RA119.012256			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32014996	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000527725300026
J	Eckmair, B; Jin, CS; Karlsson, NG; Abed-Navandi, D; Wilson, IBH; Paschinger, K				Eckmair, Barbara; Jin, Chunsheng; Karlsson, Niclas G.; Abed-Navandi, Daniel; Wilson, Iain B. H.; Paschinger, Katharina			Glycosylation at an evolutionary nexus: the brittle star Ophiactis savignyi expresses both vertebrate and invertebrate N-glycomic features	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; glycomics; N-linked glycosylation; glycosylation; MS; deuterostomes; echinoderms; invertebrate evolution; N-glycans	SIALIC ACIDS; LINKED OLIGOSACCHARIDES; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; ASTERIAS-RUBENS; DICTYOSTELIUM-DISCOIDEUM; ACETYLNEURAMINIC ACID; SPECIES RECOGNITION; POLYSIALIC ACID; IDENTIFICATION	Echinoderms are among the most primitive deuterostomes and have been used as model organisms to understand chordate biology because of their close evolutionary relationship to this phylogenetic group. However, there are almost no data available regarding the N-glycomic capacity of echinoderms, which are otherwise known to produce a diverse set of species-specific glycoconjugates, including ones heavily modified by fucose, sulfate, and sialic acid residues. To increase the knowledge of diversity of carbohydrate structures within this phylum, here we conducted an in-depth analysis of N-glycans from a brittle star (Ophiactis savignyi) as an example member of the class Ophiuroidea. To this end, we performed a multi-step N-glycan analysis by HPLC and various exoglyosidase and chemical treatments in combination with MALDI-TOF MS and MS/MS. Using this approach, we found a wealth of hybrid and complex oligosaccharide structures reminiscent of those in higher vertebrates as well as some classical invertebrate glycan structures. 70% of these N-glycans were anionic, carrying either sialic acid, sulfate, or phosphate residues. In terms of glycophylogeny, our data position the brittle star between invertebrates and vertebrates and confirm the high diversity of N-glycosylation in lower organisms.	[Eckmair, Barbara; Wilson, Iain B. H.; Paschinger, Katharina] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria; [Jin, Chunsheng; Karlsson, Niclas G.] Gothenburg Univ, Inst Biomed, S-40530 Gothenburg, Sweden; [Abed-Navandi, Daniel] Haus Meeres Aqua Terra Zoo, A-1060 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Gothenburg	Paschinger, K (corresponding author), Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria.	katharina.paschinger@boku.ac.at	Karlsson, Niclas/G-5235-2013; Wilson, Iain/B-3326-2009	Karlsson, Niclas/0000-0002-3045-2628; Wilson, Iain/0000-0001-8996-1518; Paschinger, Katharina/0000-0002-3594-7136; Eckmair, Barbara/0000-0003-0818-867X	Austrian Science Fund [P25058, W1224]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Grants P25058 (to K. P.) and W1224 (to B. E.).	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BERGWERFF AA, 1992, BIOCHIMIE, V74, P25, DOI 10.1016/0300-9084(92)90181-D; Biermann CH, 2004, EVOL DEV, V6, P353, DOI 10.1111/j.1525-142X.2004.04043.x; Bottjer DJ, 2006, SCIENCE, V314, P956, DOI 10.1126/science.1132310; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; CORFIELD AP, 1981, BIOCHEM J, V197, P293, DOI 10.1042/bj1970293; de Haan N, 2015, ANAL CHEM, V87, P8284, DOI 10.1021/acs.analchem.5b02426; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; FARACHCARSON MC, 1989, J CELL BIOL, V109, P1289, DOI 10.1083/jcb.109.3.1289; GALILI U, 1988, J BIOL CHEM, V263, P17755; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Handa-Narumi M, 2018, CELL STRUCT FUNCT, V43, P141, DOI 10.1247/csf.18009; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-258; HEIFETZ A, 1979, J BIOL CHEM, V254, P6119; Higuchi R, 2007, J NAT MED-TOKYO, V61, P367, DOI 10.1007/s11418-007-0171-6; HOSHI M, 1975, BIOCHIM BIOPHYS ACTA, V388, P152; Hykollari A, 2017, METHODS MOL BIOL, V1503, P167, DOI 10.1007/978-1-4939-6493-2_13; Hykollari A, 2014, ELECTROPHORESIS, V35, P2116, DOI 10.1002/elps.201300612; Hykollari A, 2013, J PROTEOME RES, V12, P1173, DOI 10.1021/pr300806b; Ijuin T, 1996, GLYCOCONJUGATE J, V13, P401, DOI 10.1007/BF00731473; Inagaki M, 2005, CHEM PHARM BULL, V53, P1551, DOI 10.1248/cpb.53.1551; Inagaki M, 2001, CHEM PHARM BULL, V49, P1521, DOI 10.1248/cpb.49.1521; Jin CS, 2015, J PROTEOME RES, V14, P3239, DOI 10.1021/acs.jproteome.5b00232; KABAKOFF B, 1990, J CELL BIOL, V111, P391, DOI 10.1083/jcb.111.2.391; KABAKOFF B, 1992, DEV BIOL, V150, P294, DOI 10.1016/0012-1606(92)90243-A; Kelm A, 1998, EUR J BIOCHEM, V251, P874, DOI 10.1046/j.1432-1327.1998.2510874.x; Kisa F, 2006, CHEM PHARM BULL, V54, P1293, DOI 10.1248/cpb.54.1293; Kitazume S, 1996, J BIOL CHEM, V271, P6694, DOI 10.1074/jbc.271.12.6694; KitazumeKawaguchi S, 1997, P NATL ACAD SCI USA, V94, P3650, DOI 10.1073/pnas.94.8.3650; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; KLEINEIDAM RG, 1990, BIOL CHEM H-S, V371, P715, DOI 10.1515/bchm3.1990.371.2.715; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kurz S, 2015, J PROTEOMICS, V126, P172, DOI 10.1016/j.jprot.2015.05.030; Kurz S, 2013, J BIOL CHEM, V288, P24410, DOI 10.1074/jbc.M113.478933; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Liu JN, 2015, J BIOTECHNOL, V199, P77, DOI 10.1016/j.jbiotec.2015.02.017; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; McGovern TM, 2003, P ROY SOC B-BIOL SCI, V270, P2517, DOI 10.1098/rspb.2003.2529; Mengerink KJ, 2001, GLYCOBIOLOGY, V11, p37R, DOI 10.1093/glycob/11.4.37R; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Minamisawa T, 2005, RAPID COMMUN MASS SP, V19, P1788, DOI 10.1002/rcm.1985; Minowa MT, 1998, J BIOL CHEM, V273, P11556, DOI 10.1074/jbc.273.19.11556; Miyata S, 2004, GLYCOBIOLOGY, V14, P827, DOI 10.1093/glycob/cwh100; Miyata S, 2006, GLYCOBIOLOGY, V16, P1229, DOI 10.1093/glycob/cwl036; Miyata S, 2011, GLYCOBIOLOGY, V21, P1596, DOI 10.1093/glycob/cwr081; NISHIMURA H, 1989, J BIOL CHEM, V264, P20320; Paschinger K, 2019, PARASITOLOGY, V146, P1733, DOI 10.1017/S0031182019000398; Paschinger K, 2016, GLYCOCONJUGATE J, V33, P273, DOI 10.1007/s10719-016-9650-x; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; PAULSON JC, 1984, EUR J BIOCHEM, V140, P523, DOI 10.1111/j.1432-1033.1984.tb08133.x; Petit D, 2015, MOL BIOL EVOL, V32, P906, DOI 10.1093/molbev/msu395; Pomin VH, 2010, GLYCOCONJUGATE J, V27, P1, DOI 10.1007/s10719-009-9251-z; Powell AK, 1996, RAPID COMMUN MASS SP, V10, P1027; PROKAZOVA NV, 1981, EUR J BIOCHEM, V115, P671; Sahar U, 2017, MOL REPROD DEV, V84, P401, DOI 10.1002/mrd.22794; Santos GRC, 2017, GLYCOBIOLOGY, V27, P625, DOI 10.1093/glycob/cwx031; SCHLENZKA W, 1993, BIOCHIM BIOPHYS ACTA, V1161, P131, DOI 10.1016/0167-4838(93)90206-7; Stanton R, 2017, BBA-GEN SUBJECTS, V1861, P699, DOI 10.1016/j.bbagen.2017.01.009; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Suzuki N, 2009, GLYCOBIOLOGY, V19, P693, DOI 10.1093/glycob/cwp025; Torii T, 2014, GLYCOCONJUGATE J, V31, P671, DOI 10.1007/s10719-014-9566-2; Vanbeselaere J, 2020, J BIOL CHEM, V295, P3159, DOI 10.1074/jbc.RA119.011701; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; Vaughn R, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-19; Vilela-Silva ACES, 2008, INT J DEV BIOL, V52, P551, DOI 10.1387/ijdb.072531av; WARREN L, 1964, BIOCHIM BIOPHYS ACTA, V83, P129, DOI 10.1016/0926-6526(64)90062-X; Yamada K, 2003, CHEM PHARM BULL, V51, P46, DOI 10.1248/cpb.51.46; Yamakawa N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06950-3; Zueva O, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-017-0247-4	70	8	8	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3173	3188		10.1074/jbc.RA119.011703	http://dx.doi.org/10.1074/jbc.RA119.011703			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32001617	Green Published, hybrid			2022-12-26	WOS:000519597300023
J	Rege, NK; Liu, M; Dhayalan, B; Chen, YS; Smith, NA; Rahimi, L; Sun, JH; Guo, H; Yang, YW; Haataja, L; Phillips, NFB; Whittaker, J; Smith, B; Arvan, P; Ismail-Beigi, F; Weiss, MA				Rege, Nischay K.; Liu, Ming; Dhayalan, Balamurugan; Chen, Yen Shan; Smith, Nicholas A.; Rahimi, Leili; Sun, Jinhong; Guo, Huan; Yang, Yanwu; Haataja, Leena; Phillips, Nelson F. B.; Whittaker, Jonathan; Smith, Brian; Arvan, Peter; Ismail-Beigi, Faramarz; Weiss, Michael A.			?Register-shift? insulin analogs uncover constraints of proteotoxicity in protein evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; protein structure; molecular evolution; hormone; peptide biosynthesis; protein biosynthesis	PHENYLALANINE-B25 SIDE-CHAIN; MUTANT HUMAN INSULIN; ENDOPLASMIC-RETICULUM; STRUCTURAL SWITCH; IN-VIVO; ACTIVE CONFORMATION; BETA-CELL; IGF-I; RECEPTOR; PROINSULIN	Globular protein sequences encode not only functional structures (the native state) but also protein foldability, i.e. a conformational search that is both efficient and robustly minimizes misfolding. Studies of mutations associated with toxic misfolding have yielded insights into molecular determinants of protein foldability. Of particular interest are residues that are conserved yet dispensable in the native state. Here, we exploited the mutant proinsulin syndrome (a major cause of permanent neonatal-onset diabetes mellitus) to investigate whether toxic misfolding poses an evolutionary constraint. Our experiments focused on an invariant aromatic motif (Phe(B24)?Phe(B25)?Tyr(B26)) with complementary roles in native self-assembly and receptor binding. A novel class of mutations provided evidence that insulin can bind to the insulin receptor (IR) in two different modes, distinguished by a ?register shift? in this motif, as visualized by molecular dynamics (MD) simulations. Register-shift variants are active but defective in cellular foldability and exquisitely susceptible to fibrillation in vitro. Indeed, expression of the corresponding proinsulin variant induced endoplasmic reticulum stress, a general feature of the mutant proinsulin syndrome. Although not present among vertebrate insulin and insulin-like sequences, a prototypical variant ([Gly(B24)]insulin) was as potent as WT insulin in a rat model of diabetes. Although in MD simulations the shifted register of receptor engagement is compatible with the structure and allosteric reorganization of the IR-signaling complex, our results suggest that this binding mode is associated with toxic misfolding and so is disallowed in evolution. The implicit threat of proteotoxicity limits sequence variation among vertebrate insulins and insulin-like growth factors.	[Rege, Nischay K.; Rahimi, Leili; Phillips, Nelson F. B.; Whittaker, Jonathan; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Rahimi, Leili; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Liu, Ming] Tianjin Med Univ, Dept Endocrinol & Metab, Gen Hosp, Tianjin 300052, Peoples R China; [Liu, Ming; Sun, Jinhong; Guo, Huan; Haataja, Leena; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48105 USA; [Smith, Nicholas A.; Smith, Brian] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Dhayalan, Balamurugan; Chen, Yen Shan; Yang, Yanwu; Weiss, Michael A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Case Western Reserve University; Case Western Reserve University; Tianjin Medical University; University of Michigan System; University of Michigan; La Trobe University; Indiana University System; Indiana University Bloomington	Weiss, MA (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	weissma@iu.edu	Smith, Brian J/F-8282-2011; Smith, Nicholas/I-7422-2016	Smith, Brian J/0000-0003-0498-1910; Dhayalan, Balamurugan/0000-0001-6002-1207; Smith, Nicholas/0000-0001-8894-4249; Rahimi, Leili/0000-0002-3908-8324	National Institutes of Health [R01 DK040949, R01 DK48280]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R01 DK040949 (to M. A. W.) and R01 DK48280 (to P. A.). M. A. W. has equity in Thermalin, Inc. (Cleveland, OH), where he serves as Chief Innovation Officer; he has also been a consultant to Merck Research Laboratories and DEKA Research & Development Corp. N. F. B. P. is a consultant to Thermalin, Inc. F. I.-B. has equity in Thermalin, Inc., and is a consultant to COVANCE, Sanofi, and Novo Nordisk. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arunagiri A, 2019, ELIFE, V8, DOI 10.7554/eLife.44532; Attri AK, 2010, BIOPHYS CHEM, V148, P23, DOI 10.1016/j.bpc.2010.02.001; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barany G., 1980, PEPTIDES, P273; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Betts S, 1999, STRUCT FOLD DES, V7, pR131, DOI 10.1016/S0969-2126(99)80078-1; Birnbaum DT, 1997, PHARMACEUT RES, V14, P25, DOI 10.1023/A:1012095115151; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CHAN SJ, 1987, P NATL ACAD SCI USA, V84, P2194, DOI 10.1073/pnas.84.8.2194; Chan SJ, 2000, AM ZOOL, V40, P213; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Conlon JM, 2000, AM ZOOL, V40, P200; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; De Meyts P, 2015, BIOESSAYS, V37, P389, DOI 10.1002/bies.201400190; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2001, BIOCHEM SOC SYMP, V68, P1; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Glidden MD, 2018, J BIOL CHEM, V293, P47, DOI 10.1074/jbc.M117.808626; Greenfield JR, 2004, CLIN DERMATOL, V22, P289, DOI 10.1016/j.clindermatol.2004.01.011; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Haataja L, 2013, J BIOL CHEM, V288, P1896, DOI 10.1074/jbc.M112.420018; Hansen BF, 2011, DIABETOLOGIA, V54, P2226, DOI 10.1007/s00125-011-2203-8; HELLMAN U, 1990, BIOCHEM BIOPH RES CO, V169, P571, DOI 10.1016/0006-291X(90)90369-X; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; HUA QX, 1992, BIOCHEMISTRY-US, V31, P11940, DOI 10.1021/bi00162a037; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; INOUYE K, 1979, J AM CHEM SOC, V101, P751, DOI 10.1021/ja00497a051; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; JORGENSEN AMM, 1992, J MOL BIOL, V227, P1146, DOI 10.1016/0022-2836(92)90527-Q; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Karplus M, 1997, FOLD DES, V2, pS69, DOI 10.1016/S1359-0278(97)00067-9; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; Knudsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051972; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; Listov-Saabye N, 2009, J APPL TOXICOL, V29, P470, DOI 10.1002/jat.1428; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2018, DIABETES OBES METAB, V20, P28, DOI 10.1111/dom.13378; Liu M, 2015, MOL ASPECTS MED, V42, P3, DOI 10.1016/j.mam.2014.12.001; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Liu M, 2010, J BIOL CHEM, V285, P30989, DOI 10.1074/jbc.M110.152645; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; Menting JG, 2016, NAT STRUCT MOL BIOL, V23, P916, DOI 10.1038/nsmb.3292; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; MIRMIRA RG, 1991, BIOCHEMISTRY-US, V30, P8222, DOI 10.1021/bi00247a019; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; NISHI M, 1990, MOL ENDOCRINOL, V4, P1192, DOI 10.1210/mend-4-8-1192; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Pace CN, 2000, PROTEINS, P1; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P34709, DOI 10.1074/jbc.M114.608562; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; Paramo T, 2014, J CHEM THEORY COMPUT, V10, P2151, DOI 10.1021/ct401098b; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; Pedersen JS, 2008, PROTEIN SCI, V17, P2, DOI 10.1110/ps.073127808; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Raile K, 2011, EUR J ENDOCRINOL, V165, P255, DOI 10.1530/EJE-11-0208; RIBEL U, 1990, DIABETES, V39, P1033, DOI 10.2337/diabetes.39.9.1033; ROY M, 1989, J BIOL CHEM, V264, P19081; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Scapin G, 2018, NATURE, V556, P122, DOI 10.1038/nature26153; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; SHOELSON S, 1983, P NATL ACAD SCI-BIOL, V80, P7390, DOI 10.1073/pnas.80.24.7390; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Steiner D F, 1969, Recent Prog Horm Res, V25, P207; STEINER DF, 1967, P NATL ACAD SCI USA, V57, P473, DOI 10.1073/pnas.57.2.473; STEINER DF, 1968, DIABETES, V17, P309; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Subbian E., 2015, ADV BIOSCI BIOTECHNO, V06, P73; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; THOMAS GJ, 1990, BIOCHEMISTRY-US, V29, P4181, DOI 10.1021/bi00469a022; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Upton Z, 1998, COMP BIOCHEM PHYS B, V121, P35, DOI 10.1016/S0305-0491(98)10111-6; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; VINIK A, 1988, HORM METAB RES, V20, P1, DOI 10.1055/s-2007-1010736; Vinther TN, 2013, PROTEIN SCI, V22, P296, DOI 10.1002/pro.2211; WANG CC, 1991, TRENDS BIOCHEM SCI, V16, P279, DOI 10.1016/0968-0004(91)90114-B; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weiss MA, 2018, DIABETES OBES METAB, V20, P51, DOI 10.1111/dom.13402; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; Westermark P, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P3, DOI 10.1533/9781845690878.1.1; Wright J, 2013, J BIOL CHEM, V288, P31010, DOI 10.1074/jbc.M113.510065; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; YU MH, 1984, P NATL ACAD SCI-BIOL, V81, P6584, DOI 10.1073/pnas.81.21.6584; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	122	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3080	3098		10.1074/jbc.RA119.011389	http://dx.doi.org/10.1074/jbc.RA119.011389			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005662	Green Published, hybrid			2022-12-26	WOS:000519597300017
J	Kusi, KA; Aggor, FE; Amoah, LE; Anum, D; Nartey, Y; Amoako-Sakyi, D; Obiri-Yeboah, D; Hollingdale, M; Ganeshan, H; Belmonte, M; Peters, B; Kim, Y; Tetteh, J; Kyei-Baafour, E; Dodoo, D; Villasante, E; Sedegah, M				Kusi, Kwadwo A.; Aggor, Felix E.; Amoah, Linda E.; Anum, Dorothy; Nartey, Yvonne; Amoako-Sakyi, Daniel; Obiri-Yeboah, Dorcas; Hollingdale, Michael; Ganeshan, Harini; Belmonte, Maria; Peters, Bjoern; Kim, Yohan; Tetteh, John; Kyei-Baafour, Eric; Dodoo, Daniel; Villasante, Eileen; Sedegah, Martha			Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+T cell epitopes in a malaria exposed population	PLOS ONE			English	Article							HLA CLASS-I; ALLELE PROMISCUITY; T-CELLS; VACCINE; PEPTIDE; IMMUNIZATION; SPOROZOITES; PROTECTION; RESPONSES; ANTIGENS	Background Sterile protection against malaria, most likely mediated by parasite-specific CD8+ T cells, has been achieved by attenuated sporozoite vaccination of animals as well as malaria-naive and malaria-exposed subjects. The circumsporozoite protein (CSP)-based vaccine, RTS,S, shows low efficacy partly due to limited CD8+ T cell induction, and inclusion of such epitopes could improve RTS,S. This study assessed 8-10mer CSP peptide epitopes, present in predicted or previously positive P. falciparum 3D7 CSP 15mer overlapping peptide pools, for their ability to induce CD8+ T cell IFN-gamma responses in natural malaria-exposed subjects. Methods Cryopreserved PBMCs from nine HLA-typed subjects were stimulated with 23 8-10mer CSP peptides from the 3D7 parasite in IFN-gamma ELISpot assays. The CD8+ T cell specificity of IFN-gamma responses was confirmed in ELISpot assays using CD8+ T cell-enriched PBMC fractions after CD4+ cell depletion. Results Ten of 23 peptide epitopes elicited responses in whole PBMCs from five of the nine subjects. Four peptides tested positive in CD8+ T cell-enriched PBMCs from two previously positive responders and one new subject. All four immunodominant peptides are restricted by globally common HLA supertypes (A02, A03, B07) and mapped to regions of the CSP antigen with limited or no reported polymorphism. Association of these peptide-specific responses with anti-malarial protection remains to be confirmed. Conclusions The relatively conserved nature of the four identified epitopes and their binding to globally common HLA supertypes makes them good candidates for inclusion in potential multi-epitope malaria vaccines.	[Kusi, Kwadwo A.; Amoah, Linda E.; Anum, Dorothy; Tetteh, John; Kyei-Baafour, Eric; Dodoo, Daniel] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Accra, Ghana; [Kusi, Kwadwo A.; Aggor, Felix E.; Amoah, Linda E.] Univ Ghana, Coll Basic & Appl Sci, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana; [Nartey, Yvonne; Amoako-Sakyi, Daniel; Obiri-Yeboah, Dorcas] Univ Cape Coast, Dept Microbiol & Immunol, Coll Hlth & Allied Sci, Cape Coast, Ghana; [Hollingdale, Michael; Ganeshan, Harini; Belmonte, Maria; Villasante, Eileen; Sedegah, Martha] Naval Med Res Ctr, Malaria Dept, Silver Spring, MD USA; [Peters, Bjoern; Kim, Yohan] La Jolla Inst Immunol, La Jolla, CA USA	University of Ghana; University of Ghana; University of Cape Coast; Naval Medical Research Center (NMRC); La Jolla Institute for Immunology	Kusi, KA (corresponding author), Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Accra, Ghana.; Kusi, KA (corresponding author), Univ Ghana, Coll Basic & Appl Sci, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana.	akusi@noguchi.ug.edu.gh	Kusi, Kwadwo Asamoah/J-5941-2019; Amoah, Linda/AAY-6198-2021; Obiri-Yeboah, Dorcas/AAE-7672-2019; Eric, Kyei-Baafour/X-7280-2019	Kusi, Kwadwo Asamoah/0000-0001-5483-9985; Amoah, Linda/0000-0002-1652-8489; Eric, Kyei-Baafour/0000-0001-6423-1885; Nartey, Yvonne Ayerki/0000-0003-2891-3082; Aggor, Felix/0000-0002-0327-0095; Belmonte, Maria/0000-0002-4103-6611	University of Ghana [URF/6/ILG-003/2012-2013]; Naval Medical Research Center [6000.RAD1.F.A0309]	University of Ghana; Naval Medical Research Center	This study was supported by a University of Ghana Research Fund Grant number URF/6/ILG-003/2012-2013, awarded to KAK, and with resources from the Naval Medical Research Center (work unit number 6000.RAD1.F.A0309). The views expressed herein are the personal ones of the authors and do not purport to reflect the views of the US Navy or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDOO M, 1995, LANCET, V345, P1003, DOI 10.1016/S0140-6736(95)90754-8; Anum D, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0539-5; Audran R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007304; Babiuk LA, 1999, VACCINE, V17, P1587, DOI 10.1016/S0264-410X(98)00419-8; Balam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051875; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-168; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Epstein JE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89154; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Ganeshan H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1098-8; Gjertsen MK, 1997, INT J CANCER, V72, P784, DOI 10.1002/(SICI)1097-0215(19970904)72:5<784::AID-IJC14>3.0.CO;2-9; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; Good MF, 2013, J CLIN INVEST, V123, P3353, DOI 10.1172/JCI66634; HERRINGTON D, 1991, AM J TROP MED HYG, V45, P539, DOI 10.4269/ajtmh.1991.45.539; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Kaba SA, 2018, VACCINE, V36, P906, DOI 10.1016/j.vaccine.2017.12.001; Mahajan B, 2010, INFECT IMMUN, V78, P4613, DOI 10.1128/IAI.00533-10; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nlinwe ON, 2018, VACCINE, V36, P2237, DOI 10.1016/j.vaccine.2018.03.023; Ou DW, 1999, HUM IMMUNOL, V60, P652, DOI 10.1016/S0198-8859(99)00037-3; Patarroyo ME, 2008, J CELL MOL MED, V12, P1915, DOI 10.1111/j.1582-4934.2008.00174.x; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; Roestenbeng M, 2013, AM J TROP MED HYG, V88, P5, DOI 10.4269/ajtmh.2012.12-0613; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Schwenk RJ, 2011, TRENDS PARASITOL, V27, P306, DOI 10.1016/j.pt.2011.02.002; Sedegah M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106241; Sedegah M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-185; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Seth L, 2017, VACCINE, V35, P5448, DOI 10.1016/j.vaccine.2017.02.040; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Stanisic DI, 2015, VACCINE, V33, P7469, DOI 10.1016/j.vaccine.2015.09.057; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WIZEL B, 1995, J EXP MED, V182, P1435, DOI 10.1084/jem.182.5.1435; ZEVERING Y, 1990, INT IMMUNOL, V2, P945, DOI 10.1093/intimm/2.10.945	41	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228177	10.1371/journal.pone.0228177	http://dx.doi.org/10.1371/journal.pone.0228177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040522	Green Published, gold			2022-12-26	WOS:000534629400017
J	Angom, S; Tuboi, C; Ghazi, MGU; Badola, R; Hussain, SA				Angom, Sangeeta; Tuboi, Chongpi; Ghazi, Mirza Ghazanfar Ullah; Badola, Ruchi; Hussain, Syed Ainul			Demographic and genetic structure of a severely fragmented population of the endangered hog deer (Axis porcinus) in the Indo-Burma biodiversity hotspot	PLOS ONE			English	Article							RED DEER; NONINVASIVE SAMPLES; COMPUTER-PROGRAM; SIKA-DEER; DIVERSITY; DNA; MICROSATELLITES; CONSEQUENCES; CONSERVATION; PROBABILITY	The population of the globally endangered hog deer (Axis porcinus) has declined severely across its geographic range. Intensive monitoring of its demographic and genetic status is necessary. We examined the demographic and genetic structure of a small hog deer population in Keibul Lamjao National Park (KLNP), located on the western fringe of the IndoBurma biodiversity hotspot for conservation planning. The distribution pattern of hog deer in the Park was derived based on the presence/absence of faecal pellets in 1 km x 1 km grids. We used double-observer distance sampling method to derive the hog deer abundance and population structure and compared with previous data to derive the population trend. We determined the genetic diversity of the population through microsatellite screening and bottleneck detection. The overall pellet density was 0.34 +/- 0.02 pellets km(-2) restricted to only 22.34 +/- 0.20 km(2) area of the park. The estimated density of the deer in the park was 1.82-4.32 individuals km-2. The population showed a declining trend from 2006-08 (p < 0.05, R-2 = 0.916) with 8% annum(-1) and an increasing trend from 2003-2018 (p < 0.05, R-2 = 0.9304) with 10% annum(-1). The adult male-to-female ratio and fawn-to-doe ratio were 36.2 +/- 1.9 males per 100 females and 16.5 +/- 0.4 fawns per 100 females, respectively. The molecular examination suggested that the mean number of alleles at 23 loci was 2.70 +/- 0.18, the observed heterozygosity (Ho) ranged from 0.26 to 0.63 (mean 0.42 +/- 0.02), the expected heterozygosity (He) ranged from 0.23 to 0.73 (chi = 0.51 +/- 0.03), and the polymorphic information content (PIC) ranged from 0.2 to 0.67 (chi = 0.43 +/- 0.03) indicating a moderate level of genetic diversity. Although no bottleneck in the population was observed, the loss of genetic diversity may affect the evolutionary potential of the species at the site by limiting the selection flexibility. Conservation planning coupled with scientific management regime will help in the long term persistence of the population in the region.	[Angom, Sangeeta; Tuboi, Chongpi; Ghazi, Mirza Ghazanfar Ullah; Badola, Ruchi; Hussain, Syed Ainul] Wildlife Inst India, Dehra Dun, Uttarakhand, India	Wildlife Institute of India	Hussain, SA (corresponding author), Wildlife Inst India, Dehra Dun, Uttarakhand, India.	hussain@wii.gov.in			Wildlife Institute of India; Ministry of Environment, Forest and Climate Change through the Wildlife Institute of India	Wildlife Institute of India; Ministry of Environment, Forest and Climate Change through the Wildlife Institute of India	The project under which the study was carried out was funded by the Wildlife Institute of India and Ministry of Environment, Forest and Climate Change through the Wildlife Institute of India in Grant-in-aid funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted under the project "Conservation Ecology of Eld's Deer and Its Wetland Habitat" and "Conservation action plan for Manipur's brow-antlered deer or Sangai: an integrated approach". We are grateful to the Department of Forests, Government of Manipur for granting us logistic support. We thank the Director and the Dean at the Wildlife Institute of India for their support.	Akaike H., 1973, 2 INT S INF THEOR BU, P26; Anderson JD, 2002, J WILDLIFE MANAGE, V66, P67, DOI 10.2307/3802872; Angom S, 2015, CONSERV GENET RESOUR, V7, P647, DOI 10.1007/s12686-015-0469-8; [Anonymous], 2004, HOTSPOTS REVISITED E; Arshad M., 2012, REC ZOOL SURV PAK, V21, P25; Ayala F.J., 1984, MODERN GENETICS; Biswas Tanushree, 2000, Indian Forester, V126, P1068; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Buckland S.T., 2001, pi; Buckland S. T., 2000, METRON, V58, P3; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Buza L, 2000, BIOL CONSERV, V93, P177, DOI 10.1016/S0006-3207(99)00150-0; Caughley G., 1977, ANAL VERTEBRATE POPU; Choudhury A., 2013, MAMMALS N E INDIA; Choudhury Anwaruddin, 2007, Journal of the Bombay Natural History Society, V104, P208; Conservational International, 2011, WORLDS 10 MOST THREA; COOK RD, 1979, BIOMETRICS, V35, P735, DOI 10.2307/2530104; Cornuet JM, 1996, GENETICS, V144, P2001; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; de Garine-Wichatitsky M, 2009, GENETICA, V137, P313, DOI 10.1007/s10709-009-9395-6; DeYoung RW, 2003, MOL ECOL, V12, P3237, DOI 10.1046/j.1365-294X.2003.01996.x; Eisenberg J.F., 1972, ECOLOGICAL RECONNAIS; Galela RS, 2004, DISTANCE SAMPLING SI; Gaur A, 2003, MOL ECOL NOTES, V3, P607, DOI 10.1046/j.1471-8286.2003.00528.x; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Gupta SK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34482-9; Hajji GM, 2007, ANIM CONSERV, V10, P229, DOI 10.1111/j.1469-1795.2007.00098.x; Hartl DL., 1997, PRINCIPLES POPULATIO, P74; He Ya, 2014, Zoological Research, V35, P528, DOI 10.13918/j.issn.2095-8137.2014.6.528; Hussain S. A., 2006, Indian Forester, V132, P40; Hussain SA, 2013, CONSERVATION 1 UNPUB; IUCN Red List of Threatened Species, 2015, IUCN GLOB SPEC PROGR; Jones KC, 2002, MOL ECOL NOTES, V2, P425, DOI 10.1046/j.1471-8286.2002.00264.x; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; Kalinowski ST, 2006, CONSERV GENET, V7, P319, DOI 10.1007/s10592-005-9024-6; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kang M, 2005, ANN BOT-LONDON, V95, P1145, DOI 10.1093/aob/mci125; Khater M, 2011, LECT NOTES ARTIF INT, V7106, P422, DOI 10.1007/978-3-642-25832-9_43; Lande R, 1999, GENETICS AND THE EXTINCTION OF SPECIES, P1; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Meijaard E, 2004, J ZOOL, V263, P179, DOI 10.1017/S0952836904005011; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Norusis MJ, 1990, SPSS GUIDE DATA ANAL; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Poetsch M, 2001, FORENSIC SCI INT, V116, P1, DOI 10.1016/S0379-0738(00)00337-6; Primack R.B., 1993, ESSENTIALS CONSERVAT; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Say Ludovic, 2005, Biological Letters, V42, P3; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Shea KL, 2002, AM J BOT, V89, P783, DOI 10.3732/ajb.89.5.783; Singh K. J., 2011, Zoos' Print, V26, P3; Singh T., 1992, ASS WORKSH BRIEF BOO; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Timmins R, 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK, DOI 10.2305/IUCN.UK]; Timmins RJ, 2012, 2008 IUCN RED LIST T; Tomimatsu H, 2003, BIOL CONSERV, V109, P249, DOI 10.1016/S0006-3207(02)00153-2; Tuboi C., 2012, MANIPUR NEBI, V3, P1; Tuboi C., 2013, THESIS; Tuboi C, 2016, MAMM BIOL, V81, P53, DOI 10.1016/j.mambio.2014.10.006; Vishvanath Nilantha, 2014, Journal of Threatened Taxa, V6, P6515; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wu Hua, 2008, Acta Theriologica Sinica, V28, P109; Yang J, 2011, CONSERV GENET, V12, P1457, DOI 10.1007/s10592-011-0244-7; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zachos FE, 2007, EUR J WILDLIFE RES, V53, P61, DOI 10.1007/s10344-006-0065-z; Zeng Y, 2007, CONSERV GENET, V8, P1051, DOI 10.1007/s10592-006-9256-0; Zhang Qiong, 2005, Acta Zoologica Sinica, V51, P530; Zhou FD, 2005, ZOOL SCI, V22, P593, DOI DOI 10.2108/ZSJ.22	72	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0210382	10.1371/journal.pone.0210382	http://dx.doi.org/10.1371/journal.pone.0210382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027650	Green Submitted, gold, Green Published			2022-12-26	WOS:000534623800001
J	Chen, CL; Gupta, P; Parashar, D; Nair, GG; George, J; Geethadevi, A; Wang, W; Tsaih, SW; Bradley, W; Ramchandran, R; Rader, JS; Chaluvally-Raghavan, P; Pradeep, S				Chen, Changliang; Gupta, Prachi; Parashar, Deepak; Nair, Gopakumar G.; George, Jasmine; Geethadevi, Anjali; Wang, Wei; Tsaih, Shirng-Wern; Bradley, William; Ramchandran, Ramani; Rader, Janet S.; Chaluvally-Raghavan, Pradeep; Pradeep, Sunila			ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis	ONCOGENE			English	Article							STAT3; MUTATIONS; SURVIVAL; PATHWAY; TARGET; GROWTH; HEAD	High-grade serous carcinoma, accounts for up to 70% of all ovarian cases. Furin, a proprotein convertase, is highly expressed in high-grade serous carcinoma of ovarian cancer patients, and its expression is even higher in tumor omentum than in normal omentum, the preferred site of ovarian cancer metastasis. The proteolytic actions of this cellular endoprotease help the maturation of several important precursors of protein substrates and its levels increase the risk of several cancer. We show that furin activates the IGF1R/STAT3 signaling axis in ovarian cancer cells. Conversely, furin knockdown downregulated IGF1R-beta and p-STAT3 (Tyr705) expression. Further, silencing furin reduced tumor cell migration and invasion in vitro and tumor growth and metastasis in vivo. Collectively, our findings show that furin can be an effective therapeutic target for ovarian cancer prevention or treatment.	[Chen, Changliang; Gupta, Prachi; Parashar, Deepak; Nair, Gopakumar G.; George, Jasmine; Geethadevi, Anjali; Tsaih, Shirng-Wern; Bradley, William; Ramchandran, Ramani; Rader, Janet S.; Chaluvally-Raghavan, Pradeep; Pradeep, Sunila] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Wang, Wei] Case Western Reserve Univ, Metrohlth Med Res Ctr, Cleveland, OH 44106 USA; [Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Rader, Janet S.; Chaluvally-Raghavan, Pradeep; Pradeep, Sunila] Med Coll Wisconsin, Canc Ctr, Milwaukee, WI 53226 USA; [Chaluvally-Raghavan, Pradeep; Pradeep, Sunila] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Case Western Reserve University; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Pradeep, S (corresponding author), Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA.; Pradeep, S (corresponding author), Med Coll Wisconsin, Canc Ctr, Milwaukee, WI 53226 USA.; Pradeep, S (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	spradeep@mcw.edu	GEETHADEVI, ANJALI/AAI-3798-2020; GOPINADHAN NAIR, GOPA KUMAR/J-6473-2014; Chen, Chang-Liang/AAO-6738-2021; Parashar, Deepak/T-8609-2017	GEETHADEVI, ANJALI/0000-0001-5486-7919; GOPINADHAN NAIR, GOPA KUMAR/0000-0002-2694-8401; Parashar, Deepak/0000-0002-5062-8950	Ovarian Cancer Research Fund Alliance (OCRFA); Women's Health Research Program (WHRP) in the Department of Obstetrics and Gynecology at the Medical College of Wisconsin (MCW); OCRFA; WHRP; DoD Breast Cancer Research Program [W81XWH-18-1-0024]; Children's Research Institute; NIH grants; Department of OBGYN; Department of Pediatrics;  [1R01CA229907]	Ovarian Cancer Research Fund Alliance (OCRFA); Women's Health Research Program (WHRP) in the Department of Obstetrics and Gynecology at the Medical College of Wisconsin (MCW); OCRFA; WHRP; DoD Breast Cancer Research Program(United States Department of Defense); Children's Research Institute; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of OBGYN; Department of Pediatrics; 	SP is supported by the Ovarian Cancer Research Fund Alliance (OCRFA) and by research funds from the Women's Health Research Program (WHRP) in the Department of Obstetrics and Gynecology at the Medical College of Wisconsin (MCW). PCR is supported by the 1R01CA229907, OCRFA, and WHRP as well as by the DoD Breast Cancer Research Program (W81XWH-18-1-0024). RR is supported by Children's Research Institute, Department of Pediatrics, Department of OBGYN and funds from NIH grants. Authors acknowledge Dr Anil Sood for providing tissue slides collected from the nude mice, treated with NRG1 siRNA-encapsulated nanoparticle.	Bassi DE, 2003, AM J PATHOL, V162, P439, DOI 10.1016/S0002-9440(10)63838-2; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Baumann J, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.111503; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chaluvally-Raghavan P, 2016, CELL REP, V15, P1493, DOI 10.1016/j.celrep.2016.04.034; Chaluvally-Raghavan P, 2014, CANCER CELL, V26, P863, DOI 10.1016/j.ccell.2014.10.010; Chen CL, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0902-4; Coleman RL, 2013, NAT REV CLIN ONCOL, V10, P211, DOI 10.1038/nrclinonc.2013.5; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Elster N, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758835918778297; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fang D, 2017, ONCOGENE, V36, P1546, DOI 10.1038/onc.2016.323; Furtek SL, 2016, ACS CHEM BIOL, V11, P308, DOI 10.1021/acschembio.5b00945; Gaitskell K, 2018, INT J CANCER, V142, P281, DOI 10.1002/ijc.31063; Geethadevi Anjali, 2017, Genes Cancer, V8, P746, DOI 10.18632/genesandcancer.162; Geiger JL, 2016, ORAL ONCOL, V56, P84, DOI 10.1016/j.oraloncology.2015.11.022; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; HORIMOTO T, 1994, J VIROL, V68, P6074, DOI 10.1128/JVI.68.9.6074-6078.1994; Huang GY, 2014, STEM CELLS, V32, P1149, DOI 10.1002/stem.1609; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Jaaks P, 2017, INT J CANCER, V141, P654, DOI 10.1002/ijc.30714; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Lee JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29142-x; Linardou H, 2009, NAT REV CLIN ONCOL, V6, P352, DOI 10.1038/nrclinonc.2009.62; Ma YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033414; Page RE, 2007, CELL ONCOL, V29, P289; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Pradeep S, 2015, CANCER CELL, V28, P610, DOI 10.1016/j.ccell.2015.09.008; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Wang T, 2007, CANCER RES, V67, P11830, DOI 10.1158/0008-5472.CAN-07-1160; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	40	21	21	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2921	2933		10.1038/s41388-020-1194-7	http://dx.doi.org/10.1038/s41388-020-1194-7		FEB 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32029900	Green Accepted			2022-12-26	WOS:000511540800004
J	Ramdasi, AY; Arankalle, VA				Ramdasi, Ashwini Y.; Arankalle, Vidya A.			The expression patterns of immune response genes in the Peripheral Blood Mononuclear cells of pregnant women presenting with subclinical or clinical HEV infection are different and trimester-dependent: A whole transcriptome analysis	PLOS ONE			English	Article							HEPATITIS-E VIRUS; PROTEIN S100A4 P9KA; NON-B-HEPATITIS; SPORADIC NON-A; VIRAL-HEPATITIS; C VIRUS; INDIA; ASSOCIATION; CYTOKINES; SEVERITY	Hepatitis E is an enteric disease highly prevalent in the developing countries. The basis for high mortality among pregnant hepatitis E patients remains unclear. Importantly, a large proportion of infected pregnant women present with subclinical infection as well. In order to understand the possible mechanisms influencing clinical presentation of hepatitis E in pregnant women, we explored a system biology approach. For this, PBMCs from various categories were subjected to RNAseq analysis. These included non-pregnant (NPR, acute and convalescent phases) and pregnant (PR, 2nd and 3rd trimesters, acute phase and subclinical HEV infections) patients and corresponding healthy controls. The current study deals with immune response genes. In contrast to exclusive up-regulation of nonspecific, early immune response transcripts in the NPR patients, the PR patients exhibited broader and heightened expression of genes associated with innate as well as adaptive T and B cell responses. The study identified for the first time (1) inverse relationship of immunoglobulin (Ig) genes overexpression and (2) association of differential expression of S100 series genes with disease presentation. The data suggests possible involvement of TLR4 and NOD1 in pregnant patients and alpha defensins in all patient categories suggesting a role in protection. Induction of IFN gamma gene was not detected during the acute phase irrespective of pregnancy. Association of response to vitamin D, transcripts related to NK/NKT and regulatory T cells during subclinical infection are noteworthy. The data obtained here could be correlated with several studies reported earlier in hepatitis E patients suggesting utility of PBMCs as an alternate specimen. The extensive, informative data provided here for the first time should form basis for future studies that will help in understanding pathogenesis of fulminant hepatitis E.	[Ramdasi, Ashwini Y.; Arankalle, Vidya A.] ICMR Natl Inst Virol, Hepatitis Div, Pune, Maharashtra, India; [Arankalle, Vidya A.] Bharati Vidyapeeth Deemed Univ, Dept Communicable Dis, Interact Res Sch Hlth Affairs & RSHA, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Bharati Vidyapeeth Deemed University	Arankalle, VA (corresponding author), ICMR Natl Inst Virol, Hepatitis Div, Pune, Maharashtra, India.; Arankalle, VA (corresponding author), Bharati Vidyapeeth Deemed Univ, Dept Communicable Dis, Interact Res Sch Hlth Affairs & RSHA, Pune, Maharashtra, India.	varankalle@yahoo.com		Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research (ICMR), Ministry of health and family welfare, Government of India	Indian Council of Medical Research (ICMR), Ministry of health and family welfare, Government of India(Indian Council of Medical Research (ICMR))	VAA Financial support for this study was provided by the Indian Council of Medical Research (ICMR), Ministry of health and family welfare, Government of India. https://www.icmr.nic.in/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anshuja S, 2016, J OBSTET GYNECOL IND, V66, P166, DOI 10.1007/s13224-014-0666-5; Arankalle VA, 2007, J VIRAL HEPATITIS, V14, P435, DOI 10.1111/j.1365-2893.2006.00801.x; Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P293, DOI 10.1046/j.1365-2893.2001.00279.x; Arankalle VA, 1998, J VIRAL HEPATITIS, V5, P199, DOI 10.1046/j.1365-2893.1998.00096.x; ARANKALLE VA, 1994, P NATL ACAD SCI USA, V91, P3428, DOI 10.1073/pnas.91.8.3428; ARANKALLE VA, 1993, J MED VIROL, V40, P121, DOI 10.1002/jmv.1890400208; Arankalle VA, 2002, J HEPATOL, V36, P417, DOI 10.1016/S0168-8278(01)00297-5; ARANKALLE VA, 1995, J VIRAL HEPATITIS, V2, P189, DOI 10.1111/j.1365-2893.1995.tb00028.x; ARANKALLE VA, 1993, INDIAN J MED RES-A, V97, P4; Arankalle VA, 1999, J GEN VIROL, V80, P1691, DOI 10.1099/0022-1317-80-7-1691; Arya RP, 2019, HUM IMMUNOL, V80, P855, DOI 10.1016/j.humimm.2019.06.011; Arya RP, 2014, HUM IMMUNOL, V75, P1147, DOI 10.1016/j.humimm.2014.10.011; Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Borkakoti J, 2013, J MED VIROL, V85, P620, DOI 10.1002/jmv.23508; Chadha Mandeep S, 2003, Indian J Gastroenterol, V22, P11; Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115828; Das R, 2014, MED MICROBIOL IMMUN, V203, P303, DOI 10.1007/s00430-014-0338-1; Devi SG, 2014, J MED VIROL, V86, P1366, DOI 10.1002/jmv.23925; El-Rifai W, 2001, INT J CANCER, V92, P832, DOI 10.1002/ijc.1264; Gouilly J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07200-2; Gounder AP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005474; Grace H., 1986, NATURE, V323, P819, DOI [10.1038/323819a0, DOI 10.1038/323819A0]; Gupta N, 2018, INDIAN J GASTROENTER, V37, P44, DOI 10.1007/s12664-018-0819-z; Haagsma EB, 2008, LIVER TRANSPLANT, V14, P547, DOI 10.1002/lt.21480; Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234; Iankov ID, 2006, J VIROL, V80, P8530, DOI 10.1128/JVI.00593-06; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kashyap Rajesh, 2019, J Assoc Physicians India, V67, P20; Khuroo MS, 2016, J VIRAL HEPATITIS, V23, P68, DOI 10.1111/jvh.12445; KHUROO MS, 1983, AM J EPIDEMIOL, V118, P360, DOI 10.1093/oxfordjournals.aje.a113643; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kmush BL, 2016, AM J TROP MED HYG, V94, P203, DOI 10.4269/ajtmh.15-0238; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Kumar A, 2014, CYTOKINE, V65, P95, DOI 10.1016/j.cyto.2013.09.022; Lachish T, 2015, J CLIN VIROL, V73, P20, DOI 10.1016/j.jcv.2015.10.011; Lee N, 2006, J CLIN VIROL, V35, P179, DOI 10.1016/j.jcv.2005.07.005; Majumdar M, 2015, J CLIN VIROL, V73, P8, DOI 10.1016/j.jcv.2015.09.011; Mor G, 2002, IMMUNOL ALLERGY CLIN, V22, P545, DOI 10.1016/S0889-8561(02)00009-7; Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64; Mozer-Lisewska I, 2011, FOLIA HISTOCHEM CYTO, V49, P410, DOI 10.5603/FHC.2011.0058; Naru T, 2017, J PAK MED ASSOC, V67, P538; Platt-Higgins AM, 2000, INT J CANCER, V89, P198, DOI 10.1002/(SICI)1097-0215(20000320)89:2<198::AID-IJC16>3.0.CO;2-L; Prasad GS, 2016, J OBSTET GYN INDIA, V66, P18, DOI 10.1007/s13224-015-0749-y; Ramdasi AY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103257; REUMAN PD, 1990, ANTIVIR RES, V13, P103, DOI 10.1016/0166-3542(90)90026-4; Romero R, 2005, AM J REPROD IMMUNOL, V53, P275; Rosty C, 2002, AM J PATHOL, V160, P45, DOI 10.1016/S0002-9440(10)64347-7; Rudland PS, 2000, CANCER RES, V60, P1595; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Salam GD, 2013, HEPATOL RES, V43, P826, DOI 10.1111/hepr.12028; Saravanabalaji S, 2009, INTERVIROLOGY, V52, P78, DOI 10.1159/000214862; Sehgal R, 2015, HEPATOLOGY, V62, P1683, DOI 10.1002/hep.28143; Srivastava R, 2011, J GASTROEN HEPATOL, V26, P306, DOI 10.1111/j.1440-1746.2010.06356.x; Takenaga K, 1997, CLIN CANCER RES, V3, P2309; Te HS, 2013, TRANSPL P, V45, P810, DOI 10.1016/j.transproceed.2012.08.020; Tolfvenstam T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-209; Trehanpati N, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00287; TSAREV SA, 1995, J INFECT DIS, V172, P31, DOI 10.1093/infdis/172.1.31; Vegna S, 2016, J VIROL, V90, P6022, DOI 10.1128/JVI.03230-15; Xia J, 2015, J VIRAL HEPATITIS, V22, P850, DOI 10.1111/jvh.12406; Yang C, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9020039; Yu C, 2010, J VIROL, V84, P11264, DOI 10.1128/JVI.01205-10	63	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228068	10.1371/journal.pone.0228068	http://dx.doi.org/10.1371/journal.pone.0228068			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012176	gold, Green Published			2022-12-26	WOS:000534615800019
J	Qi, M; Dai, D; Liu, J; Li, ZQ; Liang, PP; Wang, Y; Cheng, L; Zhan, YH; An, ZF; Song, YY; Yang, YN; Yan, XH; Xiao, H; Shao, HJ				Qi, Miao; Dai, Dan; Liu, Jin; Li, Zhongqi; Liang, Panpan; Wang, Yue; Cheng, Lu; Zhan, Yihong; An, Zhifeng; Song, Yaoyao; Yang, Yana; Yan, Xiaohui; Xiao, Hui; Shao, Huanjie			AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics	ONCOGENE			English	Article							NF-KAPPA-B; DNA SENSOR; FISSION; INFLAMMASOME; FUSION; PHOSPHORYLATION; PROLIFERATION; TUMORIGENESIS; PROGRESSION; EXPRESSION	Mitochondrial fusion and fission dynamics fine-tune cellular calcium homeostasis, ATP production capacity and ROS production and play important roles in cell proliferation and migration. Dysregulated mitochondrial dynamics is closely related to tumor development, but the mechanism of mitochondrial dynamics dysregulation and its role in the development of lung cancer remains unclear. Here, we demonstrate that the DNA sensor protein absent in melanoma 2 (AIM2) is highly expressed in non-small cell lung cancer (NSCLC) cells and that high AIM2 expression is associated with poor prognosis in patients with NSCLC. High expression of AIM2 contributes to tumor cell growth and proliferation independent of inflammasome activation in vitro and in vivo. Further studies have shown that AIM2 colocalizes with mitochondria in NSCLC cells and that AIM2 knockdown leads to enhanced mitochondrial fusion and decreased cell proliferation. Mechanistic studies have shown that AIM2 downregulation promotes MFN2 upregulation, thereby enhancing mitochondrial fusion. Moreover, we found that mitochondrial fusion driven by AIM2 knockdown leads to a decrease of cellular reactive oxygen species (ROS) production, which further causes inactivation of the MAPK/ERK signaling pathway. Together, we discovered a novel function of AIM2 in promoting NSCLC development by regulating mitochondrial dynamics and revealed its underlying mechanism. Our work provides new intervention targets for the treatment of NSCLC.	[Qi, Miao; Dai, Dan; Liu, Jin; Li, Zhongqi; Liang, Panpan; Wang, Yue; Cheng, Lu; Zhan, Yihong; An, Zhifeng; Song, Yaoyao; Yang, Yana; Yan, Xiaohui; Xiao, Hui; Shao, Huanjie] Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Developing Endangered Chin, Key Lab,Minist Educ Med Resources & Nat Pharmaceu, Xian 710119, Shaanxi, Peoples R China	Shaanxi Normal University	Shao, HJ (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Developing Endangered Chin, Key Lab,Minist Educ Med Resources & Nat Pharmaceu, Xian 710119, Shaanxi, Peoples R China.	hshao@snnu.edu.cn			National Natural Science Foundation of China [81872250]; Natural Science Foundation of Shaanxi Province, China [2016JM8102]; key industrial chain projects of Shaanxi Province [2019TD-033]; program of Innovative Research Team for the Central Universities [GK201701005]; Student Innovation Training Program, Shaanxi Normal University [201810718056, 201910718048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province); key industrial chain projects of Shaanxi Province; program of Innovative Research Team for the Central Universities; Student Innovation Training Program, Shaanxi Normal University	We are thankful for financial support of National Natural Science Foundation of China (81872250), the Natural Science Foundation of Shaanxi Province, China (2016JM8102), the key industrial chain projects of Shaanxi Province (2019TD-033), the program of Innovative Research Team for the Central Universities (GK201701005), and the Student Innovation Training Program (201810718056, 201910718048), Shaanxi Normal University. The authors like to thank Dr Ling Guo and Yaohui Ren for assistance with TEM.	Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Azim HA, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0538-7; Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Cai JY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.370; Che TF, 2015, ONCOTARGET, V6, P37349, DOI 10.18632/oncotarget.5736; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2017, CELL METAB, V26, P39, DOI 10.1016/j.cmet.2017.05.016; Chen IF, 2006, MOL CANCER THER, V5, P1, DOI 10.1158/1535-7163.MCT-05-0310; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Deheshi S, 2015, J NEUROCHEM, V133, P684, DOI 10.1111/jnc.13090; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Farshchian M, 2017, ONCOTARGET, V8, P45825, DOI 10.18632/oncotarget.17573; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Inoue-Yamauchi A, 2012, BIOCHEM BIOPH RES CO, V421, P81, DOI 10.1016/j.bbrc.2012.03.118; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kondo Y, 2012, CANCER SCI, V103, P782, DOI 10.1111/j.1349-7006.2012.02211.x; Kong H, 2015, TUMOR BIOL, V36, P7501, DOI 10.1007/s13277-015-3473-4; Lei H, 2009, J BIOL CHEM, V284, P6329, DOI 10.1074/jbc.M808426200; Lennon FE, 2014, EXPERT OPIN INV DRUG, V23, P675, DOI 10.1517/13543784.2014.899350; Li J, 2017, ONCOGENE, V36, P4901, DOI 10.1038/onc.2017.98; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Lugrin J, 2018, IMMUNOL REV, V281, P99, DOI 10.1111/imr.12618; Ma LM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1447-y; Ma XM, 2016, ONCOTARGET, V7, P36185, DOI 10.18632/oncotarget.9154; Ponomareva L, 2013, MOL CANCER RES, V11, P1193, DOI 10.1158/1541-7786.MCR-13-0145; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Shao HJ, 2013, MOL CANCER THER, V12, P2640, DOI 10.1158/1535-7163.MCT-13-0066; Simula L, 2017, SEMIN CANCER BIOL, V47, P29, DOI 10.1016/j.semcancer.2017.06.007; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Trotta AP, 2017, CELL MOL LIFE SCI, V74, P1999, DOI 10.1007/s00018-016-2451-3; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Xia MH, 2014, INT J ONCOL, V45, P2341, DOI 10.3892/ijo.2014.2669; Yan XH, 2018, BIOCHEM PHARMACOL, V150, P72, DOI 10.1016/j.bcp.2018.01.031; Yeo W, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1334-6; Zhang JH, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101116; Zhang MD, 2019, J CELL PHYSIOL, V234, P20161, DOI 10.1002/jcp.28617; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	48	27	28	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2707	2723		10.1038/s41388-020-1176-9	http://dx.doi.org/10.1038/s41388-020-1176-9		JAN 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32005973				2022-12-26	WOS:000510346700001
J	Gebeyehu, HR; Bayissa, LD				Gebeyehu, Hailu Reta; Bayissa, Leta Danno			Levels of heavy metals in soil and vegetables and associated health risks in Mojo area, Ethiopia	PLOS ONE			English	Article							PEARL RIVER DELTA; WASTE-WATER; AGRICULTURAL SOILS; FOOD CROPS; CONTAMINATION; INDUSTRIAL; FRUITS; ACCUMULATION; CONSUMPTION; URBAN	Health implications to the population due to the consumption of contaminated vegetables has been a great concern all over the world. In this study, the levels of heavy metals (Cr, Cd, Zn, Fe, Pb, As, Mn, Cu, Hg, Ni and Co) in soil and commonly consumed vegetables from Mojo area in central Ethiopia have been determined using Inductively Coupled Plasma Optical Emission Spectrophotometer (ICP-OES) and possible health risks due to the consumptions of the vegetables have also been estimated. The levels of As, Pb, Cd, Zn, Cu, Hg and Co were exceeded the reference level in agricultural soil. Likewise, As, Pb, Cd, Cr and Hg levels exceeded the recommended values in vegetable samples with concentrations ranging from 1.93-5.73, 3.63-7.56, 0.56-1.56, 1.49-4.63 and 3.43-4.23 mg/kg, respectively. It was observed that leafy vegetable (cabbage) has accumulated heavy metals to greater extent compared with tomato. The estimated daily intake (EDI) of toxic metals due to the consumption of the vegetables were below the maximum tolerable daily intake (MTDI). However, the total health quotient (THQ), calculated based on EDI of the heavy metals were found > 1 for As and Hg due to tomato consumption and for As, Hg and Co due to cabbage consumption, suggesting significant health risk. The health index (HI) due to the intake of toxic metals from the consumption of both vegetables were much > 1, with HI values of 7.205 and 15.078 due to tomato and cabbage consumption, respectively. This clearly suggests the possible adverse health effect to adult population from the consumption of tomato and cabbage from the study area. The total cancer risk (TCR) analysis have also revealed the potential adverse cancer risk induced by As, Cd, Hg, and Ni from the consumption of both tomato and cabbage as their TCR values were above the threshold level. Based on the results of this study, there would be a significant health risk (both non-carcinogenic and carcinogenic) to the consumer associated with the consumption of cabbage and tomato being cultivated in Mojo area. Consequently, we recommend a strict regulatory control on the safety of vegetables originated from the study area.	[Gebeyehu, Hailu Reta; Bayissa, Leta Danno] Ambo Univ, Dept Chem, Coll Nat & Computat Sci, Ambo, Ethiopia; [Gebeyehu, Hailu Reta] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia	Ambo University; Ethiopian Institute of Agricultural Research (EIAR)	Bayissa, LD (corresponding author), Ambo Univ, Dept Chem, Coll Nat & Computat Sci, Ambo, Ethiopia.	bayissa.leta@ambou.edu.et	Danno, Bayissa Leta/AAA-4484-2020	Danno, Bayissa Leta/0000-0001-9564-8798	Ethiopian Institute of Agricultural Research (EIAR)	Ethiopian Institute of Agricultural Research (EIAR)	The project was financially supported by Ethiopian Institute of Agricultural Research (EIAR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad JU, 2010, ENVIRON MONIT ASSESS, V166, P347, DOI 10.1007/s10661-009-1006-6; Alam MGM, 2003, SCI TOTAL ENVIRON, V308, P83, DOI 10.1016/S0048-9697(02)00651-4; Alghobar M. A., 2017, Journal of the Saudi Society of Agricultural Sciences, V16, P49, DOI 10.1016/j.jssas.2015.02.002; Antoine JMR, 2017, TOXICOL REP, V4, P181, DOI 10.1016/j.toxrep.2017.03.006; Arora M, 2008, FOOD CHEM, V111, P811, DOI 10.1016/j.foodchem.2008.04.049; Asfaw A., 2013, INT J SCI RES PUBL, V3, P1; Basha AM, 2014, TOXICOL REP, V1, P505, DOI 10.1016/j.toxrep.2014.07.011; Bencko Vladimir, 2013, NATO Advanced Study Institute on Environmental Security Assessment and Management of Obsolete Pesticides in Southeast Europe. Proceedings, P131, DOI 10.1007/978-94-007-6461-3_11; Bencko V, 2017, ANN AGR ENV MED, V24, P312, DOI 10.26444/aaem/74715; Bigdeli M., 2008, American-Eurasian Journal of Agricultural and Environmental Science, V4, P86; Brown J, 1987, SOIL TESTING SAMPLIN; Chang CY, 2014, ENVIRON MONIT ASSESS, V186, P1547, DOI 10.1007/s10661-013-3472-0; Chaoua S., 2019, Journal of the Saudi Society of Agricultural Sciences, V18, P429, DOI 10.1016/j.jssas.2018.02.003; Chen C, 2011, J FOOD SCI, V76, pT181, DOI 10.1111/j.1750-3841.2011.02341.x; Das HK, 2004, ENVIRON INT, V30, P383, DOI 10.1016/j.envint.2003.09.005; Desta Woldetsadik, 2017, International Journal of Food Contamination, V4, DOI 10.1186/s40550-017-0053-y; Elias E., 2017, ENV POLLUT CLIMATE C, V1, P1, DOI DOI 10.4172/2753-458X.1000116; ELLEN G, 1990, Z LEBENSM UNTERS FOR, V190, P34, DOI 10.1007/BF01188261; Esmaeilzadeh M, 2019, HUM ECOL RISK ASSESS, V25, P1125, DOI 10.1080/10807039.2018.1460798; Ezemonye LI, 2019, TOXICOL REP, V6, P1, DOI 10.1016/j.toxrep.2018.11.010; Fergusson JE, 1990, HEAVY ELEMENTS CHEM; Getachew B, 2019, ENVIRON SCI POLLUT R, V26, P18593, DOI 10.1007/s11356-019-05018-z; Grisso R. B. M. A. W. G., 2009, VIRGINIA COOPERATIVE, P442; Gupta UC, 1998, COMMUN SOIL SCI PLAN, V29, P1491, DOI 10.1080/00103629809370045; Harmanescu M, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-64; Carneiro MFH, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3586071; Hu BF, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091042; Huong NTL, 2010, COMMUN SOIL SCI PLAN, V41, P390, DOI 10.1080/00103620903494350; Ismail A, 2014, FOOD ADDIT CONTAM B, V7, P213, DOI 10.1080/19393210.2014.888783; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Javed M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2471-3; Kabir E, 2012, SCI WORLD J, DOI 10.1100/2012/916705; Kachenko A, 2006, WATER AIR SOIL POLL, V169, P101, DOI 10.1007/s11270-006-2027-1; Kachenko AG, 2004, NZ SOILS C, P1; Kamani H, 2017, INT J ENVIRON SCI TE, V14, P2675, DOI 10.1007/s13762-017-1327-x; Kamunda C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070663; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; Li XY, 2018, ECOTOX ENVIRON SAFE, V161, P99, DOI 10.1016/j.ecoenv.2018.05.080; Liang G, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16060909; Liu C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080832; Luo CL, 2011, J HAZARD MATER, V186, P481, DOI 10.1016/j.jhazmat.2010.11.024; Mahmood A, 2014, ARAB J CHEM, V7, P91, DOI 10.1016/j.arabjc.2013.07.002; McGrath SP, 2001, PLANT SOIL, V232, P207, DOI 10.1023/A:1010358708525; Mekki A, 2017, WATER AIR SOIL POLL, V228, DOI 10.1007/s11270-017-3399-0; Muchuweti A, 2006, AGR ECOSYST ENVIRON, V112, P41, DOI 10.1016/j.agee.2005.04.028; Mukhopadhyay S, 2019, PHYTOMANAGEMENT OF POLLUTED SITES: MARKET OPPORTUNITIES IN SUSTAINABLE PHYTOREMEDIATION, P361, DOI 10.1016/B978-0-12-813912-7.00014-4; Naser H. M., 2012, Bangladesh Journal of Agricultural Research, V37, P9, DOI 10.3329/bjar.v37i1.11170; Odai SN, 2008, RES J ENV TOXICOL, V2, P92, DOI [DOI 10.3923/RJET.2008.92.99, 10.3923/rjet.2008.92.99]; Patra R C, 2011, Vet Med Int, V2011, P457327, DOI 10.4061/2011/457327; Pinto E, 2003, J PHYCOL, V39, P1008, DOI 10.1111/j.0022-3646.2003.02-193.x; Plunkett M., 2010, SOIL ORGANIC MATTER; Punshon T, 2017, SCI TOTAL ENVIRON, V581, P209, DOI 10.1016/j.scitotenv.2016.12.111; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Shaheen N, 2016, CHEMOSPHERE, V152, P431, DOI 10.1016/j.chemosphere.2016.02.060; Sharma B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/640754; Sharma RK, 2008, ENVIRON POLLUT, V154, P254, DOI 10.1016/j.envpol.2007.10.010; Sharma RK, 2007, ECOTOX ENVIRON SAFE, V66, P258, DOI 10.1016/j.ecoenv.2005.11.007; Sharma RK, 2009, FOOD CHEM TOXICOL, V47, P583, DOI 10.1016/j.fct.2008.12.016; Sharma S, 2018, FOOD CHEM, V255, P15, DOI 10.1016/j.foodchem.2018.02.037; Shrivastava A, 2017, J HAZARD MATER, V324, P526, DOI 10.1016/j.jhazmat.2016.11.022; Shukla A., 2017, GREEN TECHNOLOGIES E, P395, DOI [10.1007/978-3-319-50654-8_17, DOI 10.1007/978-3-319-50654-8_17]; Singh S, 2006, ENVIRON MONIT ASSESS, V120, P79, DOI 10.1007/s10661-005-9050-3; Srinivas N, 2009, APPL ECOL ENV RES, V7, P131, DOI 10.15666/aeer/0702_131139; STREAT M, 1992, ION EXCHANGE ADVANCES, P264; SUGIYAMA M, 1994, CELL BIOL TOXICOL, V10, P1, DOI 10.1007/BF00757183; Suruchi, 2011, Research Journal of Environmental Toxicology, V5, P162, DOI 10.3923/rjet.2011.162.179; Tasrina R.C., 2015, J ENV ANAL CHEM, V2, P2, DOI DOI 10.4172/JREAC.1000142; Tiwari KK, 2011, ECOTOX ENVIRON SAFE, V74, P1670, DOI 10.1016/j.ecoenv.2011.04.029; Tom M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112441; Vongdala N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010022; Wilson Bob, 2005, Toxicological and Environmental Chemistry, V87, P335, DOI 10.1080/02772240500165570; Wong CSC, 2003, ATMOS ENVIRON, V37, P767, DOI 10.1016/S1352-2310(02)00929-9; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yang J, 2018, J INT MED RES, V46, P3374, DOI 10.1177/0300060518758585; Yusuf AA, 2003, FOOD CHEM TOXICOL, V41, P375, DOI 10.1016/S0278-6915(02)00223-5; Yusuf K. A., 2009, Research Journal of Environmental Sciences, V3, P292, DOI 10.3923/rjes.2009.292.298; Zeng FF, 2015, INT J ENV RES PUB HE, V12, P15584, DOI 10.3390/ijerph121215005; Zheng N, 2007, SCI TOTAL ENVIRON, V387, P96, DOI 10.1016/j.scitotenv.2007.07.044	78	103	108	13	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227883	10.1371/journal.pone.0227883	http://dx.doi.org/10.1371/journal.pone.0227883			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999756	Green Submitted, Green Published, gold			2022-12-26	WOS:000534612400035
J	Lindqvist, PG; Epstein, E; Landin-Olsson, M; Akerlund, M; Olsson, H				Lindqvist, Pelle G.; Epstein, Elisabeth; Landin-Olsson, Mona; Akerlund, Mans; Olsson, Hakan			Women with fair phenotypes seem to confer a survival advantage in a low UV milieu. A nested matched case control study	PLOS ONE			English	Article							SUN EXPOSURE; VITAMIN-D; RISK-FACTOR; SKIN COLOR; MORTALITY; PIGMENTATION; AVOIDANCE; MELANOMA; HABITS; BNC2	Background Sun exposure in combination with skin pigmentation is the main determinant for vitamin D status. Human skin color seems to be adapted and optimized for regional sun ultraviolet (UV) intensity. However, we do not know if fair, UV-sensitive skin is a survival advantage in regions with low UV radiation. Methods A population-based nested case-control study of 29,518 Caucasian women, ages 25 to 64 years from Southern Sweden who responded to a questionnaire regarding risk-factors for malignant melanoma in 1990 and followed for 25 years. For each fair woman, defined as having red hair or freckles (n = 11,993), a control was randomly selected from all non-fair women from within the cohort of similar age, smoking habits, education, marital status, income, and comorbidity, i.e., 11,993 pairs. The main outcome was the difference in all-cause mortality between fair and non-fair women in a low UV milieu, defined as living in Sweden and having low-to-moderate sun exposure habits. Secondary outcomes were mortality by sun exposure, and among those non-overweight. Results In a low UV milieu, fair women were at a significantly lower all-cause mortality risk as compared to non-fair women (log rank test p = 0.04) with an 8% lower all-cause mortality rate (hazard ratio [HR] = 0.92, 95% CI 0.84-1.0), including a 59% greater risk of dying from skin cancer among fair women (HR 1.59, 95% CI 1.26-2.0). Thus, it seem that the beneficial health effect from low skin coloration outweigh the risk of skin cancer at high latitudes. Conclusion In a region with low UV milieu, evolution seems to improve all-cause survival by selecting a fair skin phenotype, i.e., comprising fair women with a survival advantage.	[Lindqvist, Pelle G.; Epstein, Elisabeth] Karolinska Inst, Dept Clin Sci & Educ, Huddinge, Sweden; [Lindqvist, Pelle G.; Epstein, Elisabeth] Soder Sjukhuset, Dept Obstet & Gynecol, Stockholm, Sweden; [Landin-Olsson, Mona] Lund Univ Hosp, Dept Endocrinol, Clin Sci, Lund, Sweden; [Akerlund, Mans] Harvard Univ, Harvard Extens Sch, Cambridge, MA 02138 USA; [Olsson, Hakan] Lund Univ Hosp, Dept Oncol, Lund, Sweden; [Olsson, Hakan] Lund Univ Hosp, Dept Canc Epidemiol, Lund, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Lund University; Skane University Hospital; Harvard University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Lindqvist, PG (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Huddinge, Sweden.; Lindqvist, PG (corresponding author), Soder Sjukhuset, Dept Obstet & Gynecol, Stockholm, Sweden.	Pelle.lindqvist@ki.se	Lindqvist, Pelle G/N-9205-2013; epstein, elisabeth/F-4586-2014; Epstein, Elisabeth/GRO-7235-2022	Lindqvist, Pelle G/0000-0002-1652-8235; epstein, elisabeth/0000-0003-2298-7785; Olsson, Hakan/0000-0002-8794-9635	Vetenskapsradet [S113106103]; ALF (Faculty of Medicine, Stockholm); Swedish Cancer Society; Swedish Medical Research Council; Lund University Hospital, Region Skane; Gustav V Jubilee Fund; Gunnar Nilsson Foundation; Kamprad Foundation; European Research Council [ERC-2011-294576]	Vetenskapsradet(Swedish Research Council); ALF (Faculty of Medicine, Stockholm); Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Lund University Hospital, Region Skane; Gustav V Jubilee Fund; Gunnar Nilsson Foundation; Kamprad Foundation; European Research Council(European Research Council (ERC)European Commission)	This work was supported by Vetenskapsradet S113106103 to PGL; ALF (Faculty of Medicine, Stockholm to EE; The Swedish Cancer Society to HO; Swedish Medical Research Council to HO; Lund University Hospital, Region Skane to HO; The Gustav V Jubilee Fund to HO; The Gunnar Nilsson Foundation to HO; The Kamprad Foundation to HO and the European Research Council Advanced Grant ERC-2011-294576 to HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodmer W. F., 1976, GENETICS EVOLUTION M; Brot C, 2001, BRIT J NUTR, V86, pS97, DOI 10.1079/BJN2001345; CLEMENS TL, 1982, LANCET, V1, P74; Epstein E, 2009, BRIT J CANCER, V101, P537, DOI 10.1038/sj.bjc.6605149; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Frost P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190238; Gidlof S, 2015, ACTA OBSTET GYN SCAN, V94, P904, DOI 10.1111/aogs.12658; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Holick MF, 2008, CLIN J AM SOC NEPHRO, V3, P1548, DOI 10.2215/CJN.01350308; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Jacobs LC, 2013, HUM GENET, V132, P147, DOI 10.1007/s00439-012-1232-9; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Lin SW, 2013, AM J EPIDEMIOL, V178, P521, DOI 10.1093/aje/kws589; Lindqvist PG, 2016, J INTERN MED, V280, P375, DOI 10.1111/joim.12496; Lindqvist PG, 2014, J INTERN MED, V276, P77, DOI 10.1111/joim.12251; Lindqvist PG, 2018, ANTICANCER RES, V38, P1173, DOI 10.21873/anticanres.12337; Lindqvist PG, 2010, DIABETES RES CLIN PR, V90, P109, DOI 10.1016/j.diabres.2010.06.007; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Visser M, 2014, HUM MOL GENET, V23, P5750, DOI 10.1093/hmg/ddu289; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yang L, 2011, CANCER EPIDEM BIOMAR, V20, P683, DOI 10.1158/1055-9965.EPI-10-0982	27	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228582	10.1371/journal.pone.0228582	http://dx.doi.org/10.1371/journal.pone.0228582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999788	Green Published, gold			2022-12-26	WOS:000534612400096
J	Zhao, LP; Fiore-Gartland, A; Carpp, LN; Cohen, KW; Rouphael, N; Fleurs, L; Dintwe, O; Zhao, M; Moodie, Z; Fong, YY; Garrett, N; Huang, Y; Innes, C; Janes, HE; Lazarus, E; Michael, NL; Nitayaphan, S; Pitisuttithum, P; Rerks-Ngarm, S; Robb, ML; De Rosa, SC; Corey, L; Gray, GE; Seaton, KE; Yates, NL; McElrath, MJ; Frahm, N; Tomaras, GD; Gilbert, PB				Zhao, Lue Ping; Fiore-Gartland, Andrew; Carpp, Lindsay N.; Cohen, Kristen W.; Rouphael, Nadine; Fleurs, Llewellyn; Dintwe, One; Zhao, Michael; Moodie, Zoe; Fong, Youyi; Garrett, Nigel; Huang, Ying; Innes, Craig; Janes, Holly E.; Lazarus, Erica; Michael, Nelson L.; Nitayaphan, Sorachai; Pitisuttithum, Punnee; Rerks-Ngarm, Supachai; Robb, Merlin L.; De Rosa, Stephen C.; Corey, Lawrence; Gray, Glenda E.; Seaton, Kelly E.; Yates, Nicole L.; McElrath, M. Juliana; Frahm, Nicole; Tomaras, Georgia D.; Gilbert, Peter B.			Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans	PLOS ONE			English	Article							DOUBLE-BLIND; EFFICACY TRIAL; IMMUNITY; VACCINATION; TYPE-1; STEP	Background HIV vaccine trials routinely measure multiple vaccine-elicited immune responses to compare regimens and study their potential associations with protection. Here we employ unsupervised learning tools facilitated by a bidirectional power transformation to explore the multivariate binding antibody and T-cell response patterns of immune responses elicited by two pox-protein HIV vaccine regimens. Both regimens utilized a recombinant canarypox vector (ALVAC-HIV) prime and a bivalent recombinant HIV-1 Envelope glycoprotein 120 subunit boost. We hypothesized that within each trial, there were participant subgroups sharing similar immune responses and that their frequencies differed across trials. Methods and findings We analyzed data from three trials-RV144 (NCT00223080), HVTN 097 (NCT02109354), and HVTN 100 (NCT02404311), the latter of which was pivotal in advancing the tested poxprotein HIV vaccine regimen to the HVTN 702 Phase 2b/3 efficacy trial. We found that bivariate CD4+ T-cell and anti-V1V2 IgG/IgG3 antibody response patterns were similar by age, sex-at-birth, and body mass index, but differed for the pox-protein clade AE/B alum-adjuvanted regimen studied in RV144 and HVTN 097 (PAE/B/alum) compared to the pox-protein clade C/C MF59-adjuvanted regimen studied in HVTN 100 (PC/MF59). Specifically, more PAE/B/alum recipients had low CD4+ T-cell and high anti-V1V2 IgG/IgG3 responses, and more PC/MF59 recipients had broad responses of both types. Analyses limited to "vaccine-matched" antigens suggested that some of the differences in responses between the regimens could have been due to antigens in the assays that did not match the vaccine immunogens. Our approach was also useful in identifying subgroups with unusually absent or high co-responses across assay types, flagging individuals for further characterization by functional assays. We also found that co-responses of anti-V1V2 IgG/IgG3 and CD4+ T cells had broad variability. As additional immune response assays are standardized and validated, we anticipate our framework will be increasingly valuable for multivariate analysis. Conclusions Our approach can be used to advance vaccine development objectives, including the characterization and comparison of candidate vaccine multivariate immune responses and improved design of studies to identify correlates of protection. For instance, results suggested that HVTN 702 will have adequate power to interrogate immune correlates involving anti-V1V2 IgG/IgG3 and CD4+ T-cell co-readouts, but will have lower power to study anti-gp120/gp140 IgG/IgG3 due to their lower dynamic ranges. The findings also generate hypotheses for future testing in experimental and computational analyses aimed at achieving a mechanistic understanding of vaccine-elicited immune response heterogeneity.	[Zhao, Lue Ping; Moodie, Zoe; Fong, Youyi; Huang, Ying; Janes, Holly E.; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Zhao, Lue Ping; Fiore-Gartland, Andrew; Carpp, Lindsay N.; Cohen, Kristen W.; Zhao, Michael; Moodie, Zoe; Fong, Youyi; Huang, Ying; Janes, Holly E.; De Rosa, Stephen C.; Corey, Lawrence; McElrath, M. Juliana; Frahm, Nicole; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Rouphael, Nadine] Emory Univ, Div Infect Dis, Hope Clin, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Fleurs, Llewellyn] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa; [Dintwe, One] NPC HCRISA, Cape Town HVTN Immunol Lab, Hutchinson Ctr Res Inst South Africa, Cape Town, South Africa; [Zhao, Michael] Univ Washington, Dept Informat, Sch Arts & Sci, Seattle, WA 98195 USA; [Garrett, Nigel] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Innes, Craig] Klerksdorp Res Ctr, Aurum Inst, Klerksdorp, South Africa; [Lazarus, Erica; Gray, Glenda E.] Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Michael, Nelson L.; Robb, Merlin L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Michael, Nelson L.; Robb, Merlin L.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Nitayaphan, Sorachai] Armed Forces Res Inst Med Sci AFRIMS, Bangkok, Thailand; [Pitisuttithum, Punnee] Mahidol Univ, Fac Trop Med, Vaccine Trial Ctr, Bangkok, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Gray, Glenda E.] South African Med Res Council, Cape Town, South Africa; [Seaton, Kelly E.; Yates, Nicole L.; Tomaras, Georgia D.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27708 USA; [Seaton, Kelly E.; Yates, Nicole L.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Frahm, Nicole] Bill & Melinda Gates Med Res Inst, Cambridge, MA USA; [Tomaras, Georgia D.] Duke Univ, Dept Surg, Durham, NC 27708 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Emory University; University of Cape Town; University of Washington; University of Washington Seattle; University of Kwazulu Natal; University of Witwatersrand; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol University; Ministry of Public Health - Thailand; South African Medical Research Council; Duke University; Duke University; Duke University	Gilbert, PB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Gilbert, PB (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Tomaras, GD (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27708 USA.; Tomaras, GD (corresponding author), Duke Univ, Dept Surg, Durham, NC 27708 USA.	georgia.tomaras@duke.edu; pgilbert@scharp.org	Carpp, Lindsay/AAM-1148-2021	Fiore-Gartland, Andrew/0000-0001-7627-2166; Moodie, Zoe/0000-0001-8701-2001; Innes, Craig/0000-0002-6872-5687; Dintwe, One/0000-0002-5642-7121	U.S. Army Medical Research and Materiel Command; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health; Henry M. Jackson Foundation for the Advancement of Military Medicine; U.S. Department of Defense; NIAID; Bill AMP; Melinda Gates Foundation; GlaxoSmithKline Biologicals SA; NIAID [UM1 AI068635, UM1 AI068618, UM1 AI068614]	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine; U.S. Department of Defense(United States Department of Defense); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill AMP; Melinda Gates Foundation(CGIAR); GlaxoSmithKline Biologicals SA(GlaxoSmithKline); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The RV144 trial was funded in part by an Interagency Agreement between the U.S. Army Medical Research and Materiel Command and the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health and by an agreement between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Department of Defense. Sanofi Pasteur provided the ALVAC-HIV vaccine in the RV144 trial, and Global Solutions for Infectious Diseases (VaxGen) provided reagents for immunogenicity assays in the RV144 trial. The HVTN 097 trial was funded by NIAID. The HVTN 100 trial was funded by NIAID and the Bill & Melinda Gates Foundation, with GlaxoSmithKline Biologicals SA also providing financial support. The analysis described in this paper was supported by NIAID (https://www.niaid.nih.gov/) through awards UM1 AI068635 (Statistical and Data Management Center: HIV Vaccine Trials Network, awarded to PBG), UM1 AI068618 (Laboratory Center: HIV Vaccine Trials Network, awarded to MJM) and UM1 AI068614 (Leadership and Operations Center: HIV Vaccine Trials Network, awarded to LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIAID, the National Institutes of Health, or The Bill & Melinda Gates Foundation. The views expressed are those of the authors and should not be construed to represent the positions of the US Army or the Department of Defense.	Ackerman ME, 2017, IMMUNOL REV, V275, P262, DOI 10.1111/imr.12503; Bekker LG, 2018, LANCET HIV, V5, pE366, DOI 10.1016/S2352-3018(18)30071-7; BOX GEP, 1982, J AM STAT ASSOC, V77, P209, DOI 10.2307/2287791; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Corey L, 2017, P NATL ACAD SCI USA, V114, P3798, DOI 10.1073/pnas.1703236114; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Everitt BS, 1998, CLUSTER ANAL SUBJECT, P713; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Gilbert PB, 2016, STAT MED, V35, P3745, DOI 10.1002/sim.6952; Gray GE, 2014, AIDS RES HUM RETROV, V30, pA33, DOI 10.1089/aid.2014.5052a.abstract; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Greene CS, 2014, J CELL PHYSIOL, V229, P1896, DOI 10.1002/jcp.24662; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hopkins KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102820; Huang Y, 2016, AIDS RES HUM RETROV, V32, P76; Jin X, 2015, VACCINE, V33, P2347, DOI 10.1016/j.vaccine.2015.03.036; Kijak GH, 2013, J VIROL, V87, P7265, DOI 10.1128/JVI.03070-12; Li C, 2012, BIOMETRIKA, V99, P473, DOI 10.1093/biomet/asr073; Li SYS, 2014, J CLIN INVEST, V124, P3879, DOI 10.1172/JCI75539; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Liu Q, 2018, BIOMETRICS, V74, P595, DOI 10.1111/biom.12812; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Medlock J, 2017, P NATL ACAD SCI USA, V114, P4017, DOI 10.1073/pnas.1620788114; Moncunill G, 2015, CYTOM PART A, V87A, P289, DOI 10.1002/cyto.a.22590; Montefiori DC, 2004, J INFECT DIS, V190, P1962, DOI 10.1086/425518; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Plotkin SA, 2015, J INFECT DIS, V212, pS12, DOI 10.1093/infdis/jiu568; Prentice HA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4005; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Shen XY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57491-z; Shepherd BE, 2016, CAN J STAT, V44, P463, DOI 10.1002/cjs.11302; Silverman B.W., 1986, DENSITY ESTIMATION S; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; *UNAIDS, UNAIDS DAT 2018; Watanaveeradej V, 2006, AIDS RES HUM RETROV, V22, P801, DOI 10.1089/aid.2006.22.801; World Health Organization, GLOB HLTH OBS GHO DA; Yates NL, 2018, J VIROL, V92, DOI 10.1128/JVI.01843-17; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	43	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0226803	10.1371/journal.pone.0226803	http://dx.doi.org/10.1371/journal.pone.0226803			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999736	Green Published, gold, Green Submitted			2022-12-26	WOS:000534612400011
J	Mancl, JM; Suarez, C; Liang, WGG; Kovar, DR; Tang, WJ				Mancl, Jordan M.; Suarez, Cristian; Liang, Wenguang G.; Kovar, David R.; Tang, Wei-Jen			Pseudomonas aeruginosa exoenzyme Y directly bundles actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; bacterial pathogenesis; bacterial toxin; protein-protein interaction; Pseudomonas aeruginosa; host-pathogen interaction; cytoskeleton; virulence factor; actin bundling; exoenzyme Y (ExoY); host-microbe interactions	F-ACTIN; CYCLASE TOXIN; EPITHELIAL-CELLS; NUCLEOTIDYL CYCLASE; BINDING PROTEINS; STRUCTURAL BASIS; CROSS-LINKING; EXOY; COMPLEX; CYTOSKELETON	Pseudomonas aeruginosa uses a type III secretion system (T3SS) to inject cytotoxic effector proteins into host cells. The promiscuous nucleotidyl cyclase, exoenzyme Y (ExoY), is one of the most common effectors found in clinical P. aeruginosa isolates. Recent studies have revealed that the nucleotidyl cyclase activity of ExoY is stimulated by actin filaments (F-actin) and that ExoY alters actin cytoskeleton dynamics in vitro, via an unknown mechanism. The actin cytoskeleton plays an important role in numerous key biological processes and is targeted by many pathogens to gain competitive advantages. We utilized total internal reflection fluorescence microscopy, bulk actin assays, and EM to investigate how ExoY impacts actin dynamics. We found that ExoY can directly bundle actin filaments with high affinity, comparable with eukaryotic F-actin?bundling proteins, such as fimbrin. Of note, ExoY enzymatic activity was not required for F-actin bundling. Bundling is known to require multiple actin-binding sites, yet small-angle X-ray scattering experiments revealed that ExoY is a monomer in solution, and previous data suggested that ExoY possesses only one actin-binding site. We therefore hypothesized that ExoY oligomerizes in response to F-actin binding and have used the ExoY structure to construct a dimer-based structural model for the ExoY?F-actin complex. Subsequent mutational analyses suggested that the ExoY oligomerization interface plays a crucial role in mediating F-actin bundling. Our results indicate that ExoY represents a new class of actin-binding proteins that modulate the actin cytoskeleton both directly, via F-actin bundling, and indirectly, via actin-activated nucleotidyl cyclase activity.	[Mancl, Jordan M.; Liang, Wenguang G.; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Suarez, Cristian; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Tang, WJ (corresponding author), Univ Chicago, Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@bsd.uchicago.edu		Tang, Wei-Jen/0000-0002-8267-8995; Mancl, Jordan/0000-0003-3368-6275	National Institutes of Health [GM121964]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants GM121964 (20). As a result, many bacteria have evolved virulence factors (to W.-J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Angus AA, 2008, INFECT IMMUN, V76, P1992, DOI 10.1128/IAI.01221-07; [Anonymous], 2018, PYMOL MOL GRAPHICS S; Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Beckert U, 2014, BIOCHEM BIOPH RES CO, V450, P870, DOI 10.1016/j.bbrc.2014.06.088; Belyy A, 2018, J BIOL CHEM, V293, P19785, DOI 10.1074/jbc.RA118.003784; Belyy A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13582; Benanti EL, 2015, CELL, V161, P348, DOI 10.1016/j.cell.2015.02.044; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Chang JH, 2007, MOL MICROBIOL, V66, P1548, DOI 10.1111/j.1365-2958.2007.06024.x; Chatterjee M, 2016, INT J MED MICROBIOL, V306, P48, DOI 10.1016/j.ijmm.2015.11.004; Christensen JR, 2017, ELIFE, V6, DOI 10.7554/eLife.23152; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Cowell BA, 2005, FEMS MICROBIOL LETT, V250, P71, DOI 10.1016/j.femsle.2005.06.044; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; GLENNEY JR, 1981, J BIOL CHEM, V256, P9283; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Hritonenko V, 2011, MICROB PATHOGENESIS, V51, P305, DOI 10.1016/j.micpath.2011.08.001; Jiwani S, 2013, J BACTERIOL, V195, P708, DOI 10.1128/JB.01768-12; Khanppnavar B, 2018, BBA-GEN SUBJECTS, V1862, P2090, DOI 10.1016/j.bbagen.2018.05.021; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Li YJ, 2016, MOL BIOL CELL, V27, P1821, DOI 10.1091/mbc.E16-01-0010; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Micek ST, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0926-5; Morrow KA, 2015, AM J PHYSIOL-LUNG C, V309, pL1199, DOI 10.1152/ajplung.00165.2015; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Myeni SK, 2010, J BIOL CHEM, V285, P13357, DOI 10.1074/jbc.M109.094045; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Piiadov V, 2019, PROTEIN SCI, V28, P454, DOI 10.1002/pro.3528; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Schmoller KM, 2011, J STRUCT BIOL, V173, P350, DOI 10.1016/j.jsb.2010.09.003; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Skau CT, 2010, CURR BIOL, V20, P1415, DOI 10.1016/j.cub.2010.06.020; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tanaka K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04290-w; Tang WJ, 2009, MOL ASPECTS MED, V30, P423, DOI 10.1016/j.mam.2009.06.001; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Vojtova J, 2006, MICROSC RES TECHNIQ, V69, P119, DOI 10.1002/jemt.20277; Winkelman JD, 2016, CURR BIOL, V26, P2697, DOI 10.1016/j.cub.2016.07.080; Winkelman JD, 2014, P NATL ACAD SCI USA, V111, P4121, DOI 10.1073/pnas.1322093111; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Zimmermann D, 2016, METHODS MOL BIOL, V1369, P151, DOI 10.1007/978-1-4939-3145-3_12	57	4	4	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3506	3517		10.1074/jbc.RA119.012320	http://dx.doi.org/10.1074/jbc.RA119.012320			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32019868	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000527725300012
J	Griffie, J; Peters, R; Owen, DM				Griffie, Juliette; Peters, Ruby; Owen, Dylan M.			An agent-based model of molecular aggregation at the cell membrane	PLOS ONE			English	Article							LIPID RAFTS; PLASMA-MEMBRANE; COMPUTATIONAL ECONOMICS; CLUSTER IDENTIFICATION; NANOSCALE ORGANIZATION; PROTEIN HETEROGENEITY; SIGNALING COMPLEXES; H-RAS; MICROSCOPY; ACTIN	Molecular clustering at the plasma membrane has long been identified as a key process and is associated with regulating signalling pathways across cell types. Recent advances in microscopy, in particular the rise of super-resolution, have allowed the experimental observation of nanoscale molecular clusters in the plasma membrane. However, modelling approaches capable of recapitulating these observations are in their infancy, partly because of the extremely complex array of biophysical factors which influence molecular distributions and dynamics in the plasma membrane. We propose here a highly abstracted approach: an agent-based model dedicated to the study of molecular aggregation at the plasma membrane. We show that when molecules are modelled as though they can act (diffuse) in a manner which is influenced by their molecular neighbourhood, many of the distributions observed in cells can be recapitulated, even though such sensing and response is not possible for real membrane molecules. As such, agent-based offers a unique platform which may lead to a new understanding of how molecular clustering in extremely complex molecular environments can be abstracted, simulated and interpreted using simple rules.	[Griffie, Juliette; Peters, Ruby; Owen, Dylan M.] Kings Coll London, Dept Phys, London, England; [Griffie, Juliette; Peters, Ruby; Owen, Dylan M.] Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England	University of London; King's College London; University of London; King's College London	Griffie, J; Owen, DM (corresponding author), Kings Coll London, Dept Phys, London, England.	juliette.griffie@kcl.ac.uk; dylan.owen@kcl.ac.uk		Peters, Ruby/0000-0003-2946-7504	ERC [337187]	ERC(European Research Council (ERC)European Commission)	This work was supported by: D.M.O., ERC Starter Grant #337187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht D, 2016, J CELL BIOL, V215, P37, DOI 10.1083/jcb.201603108; Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Beemiller P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002444; Berry BJL, 2002, P NATL ACAD SCI USA, V99, P7187, DOI 10.1073/pnas.092078899; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Burn GL, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2195; Cebecauer M, 2010, J CELL SCI, V123, P309, DOI 10.1242/jcs.061739; Chaudhuri A, 2011, P NATL ACAD SCI USA, V108, P14825, DOI 10.1073/pnas.1100007108; Claus J, 2018, ELIFE, V7, DOI 10.7554/eLife.32271; de la Serna JB, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00106; Dharana N, 2017, SOFT MATTER, V13, P6938, DOI 10.1039/c7sm01064h; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Epstein J. M., 1999, Complexity, V4, P41, DOI 10.1002/(SICI)1099-0526(199905/06)4:5<41::AID-CPLX9>3.0.CO;2-F; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Germain RN, 2010, FEBS LETT, V584, P4814, DOI 10.1016/j.febslet.2010.10.027; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Griffie J, 2018, SMALL METHODS, V2, DOI 10.1002/smtd.201800008; Griffie J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04450-w; Griffie J, 2016, NAT PROTOC, V11, P2499, DOI 10.1038/nprot.2016.149; Griffie J, 2015, J BIOPHOTONICS, V8, P925, DOI 10.1002/jbio.201400127; Griffie J, 2015, CURR TOP MEMBR, V75, P125, DOI 10.1016/bs.ctm.2015.03.004; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Honigmann A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6412; Jayasinghe I, 2018, CELL REP, V22, P557, DOI 10.1016/j.celrep.2017.12.045; Kenworthy Anne K, 2007, Nat Cell Biol, V9, P875, DOI 10.1038/ncb0807-875; Ketchum C, 2014, BIOPHYS J, V106, P26, DOI 10.1016/j.bpj.2013.10.043; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; Kusumi A, 2012, ANNU REV CELL DEV BI, V28, P215, DOI 10.1146/annurev-cellbio-100809-151736; Lewitzky M, 2012, FEBS LETT, V586, P2740, DOI 10.1016/j.febslet.2012.04.029; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Magee T, 2002, BIOL RES, V35, P127, DOI 10.4067/S0716-97602002000200003; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Najumudeen AK, 2016, ONCOGENE, V35, P5248, DOI 10.1038/onc.2016.59; Neve-Oz Y, 2015, BBA-MOL CELL RES, V1853, P810, DOI 10.1016/j.bbamcr.2014.09.025; Owen DM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2273; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x; Pageon SV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003947; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pizzo P, 2004, MICROBES INFECT, V6, P686, DOI 10.1016/j.micinf.2004.02.017; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Prior Ian A, 2003, Sci STKE, V2003, pPL9, DOI 10.1126/stke.2003.177.pl9; Richiardi MG, 2012, KNOWL ENG REV, V27, P137, DOI 10.1017/S0269888912000100; Roob E, 2016, BIOPHYS J, V110, P1661, DOI 10.1016/j.bpj.2016.02.031; Rubin-Delanchy P, 2015, NAT METHODS, V12, P1072, DOI [10.1038/nmeth.3612, 10.1038/NMETH.3612]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Salbreux G, 2012, TRENDS CELL BIOL, V22, P536, DOI 10.1016/j.tcb.2012.07.001; Schmid EM, 2016, NAT PHYS, V12, P704, DOI [10.1038/NPHYS3678, 10.1038/nphys3678]; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Tesfatsion L, 2003, INFORM SCIENCES, V149, P263, DOI 10.1016/S0020-0255(02)00280-3; van Meer G, 2004, TRAFFIC, V5, P211, DOI 10.1111/j.1600-0854.2004.00176.x; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251	66	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0226825	10.1371/journal.pone.0226825	http://dx.doi.org/10.1371/journal.pone.0226825			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032349	Green Published, gold, Green Submitted			2022-12-26	WOS:000534626100004
J	Wu, KW; Lu, TW; Lee, WC; Ho, YT; Huang, TC; Wang, JH; Wang, TM				Wu, Kuan-Wen; Lu, Tung-Wu; Lee, Wei-Chun; Ho, Ya-Ting; Huang, Ting-Chun; Wang, Jyh-Horng; Wang, Ting-Ming			Altered balance control in thoracic adolescent idiopathic scoliosis during obstructed gait	PLOS ONE			English	Article							CENTER-OF-MASS; PRESSURE INCLINATION; STABILITY; MOTION; FUSION; KINEMATICS; PARAMETERS; HEIGHT; LIMB	Adolescent idiopathic scoliosis (AIS) is the most common spinal deformity during adolescence, leading to altered postural control with compromised stability. To identify the effects of AIS on whole-body balance control during obstacle-crossing, 14 adolescents with Lenke 1 thoracic AIS and 14 healthy controls were compared in terms of the inclination angle (IA) of the body's center of mass (COM) relative to the center of pressure (COP), the rate of change of IA (RCIA) and the jerk index of IA. Between-side comparisons were also performed for the AIS group. The patients showed less smooth COM-COP motion in the sagittal plane with significantly increased anterior RCIA and IA jerk index during crossing with either the concave side (p = 0.001) or the convex side (p = 0.001) leading when compared to healthy controls. In the frontal plane, the patients showed close-to-zero RCIA (p = 0.002) while crossing with the leading limb, with an increased IA magnitude (p = 0.039) only while crossing with the concave-side limb leading. The patients with Lenke 1 thoracic AIS were found to cross obstacles with altered, compromised COM-COP control in both sagittal and frontal planes when compared to healthy controls. The results suggest that the thoracic spinal deformity in Lenke 1 AIS affects the whole-body balance control during obstaclecrossing, which should be monitored for signs of increased risk of loss of balance in the management of such patient groups.	[Wu, Kuan-Wen; Lu, Tung-Wu; Lee, Wei-Chun; Ho, Ya-Ting] Natl Taiwan Univ, Dept Biomed Engn, Taipei, Taiwan; [Wu, Kuan-Wen; Lu, Tung-Wu; Wang, Jyh-Horng; Wang, Ting-Ming] Natl Taiwan Univ, Sch Med, Dept Orthopaed Surg, Taipei, Taiwan; [Wu, Kuan-Wen; Ho, Ya-Ting; Wang, Jyh-Horng; Wang, Ting-Ming] Natl Taiwan Univ Hosp, Dept Orthopaed Surg, Taipei, Taiwan; [Lee, Wei-Chun] Chang Gung Mem Hosp, Dept Orthopaed Surg, Taoyuan, Taiwan; [Huang, Ting-Chun] Natl Taiwan Univ Hosp, Dept Orthopaed Surg, Chu Tung Branch, Zhudong Township, Hsinchu County, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Wang, TM (corresponding author), Natl Taiwan Univ, Sch Med, Dept Orthopaed Surg, Taipei, Taiwan.; Wang, TM (corresponding author), Natl Taiwan Univ Hosp, Dept Orthopaed Surg, Taipei, Taiwan.	dtorth76@gmail.com		Wang, Ting-Ming/0000-0002-2263-5993; Huang, Ting-Chun/0000-0002-7701-6428; Wang, Jyh- Horng/0000-0002-1531-5297; WU, KUAN-WEN/0000-0001-8170-9879				BARRACK RL, 1984, SPINE, V9, P681, DOI 10.1097/00007632-198410000-00005; Bruijn SM, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0816; Chen HL, 2006, GAIT POSTURE, V23, P69, DOI 10.1016/j.gaitpost.2004.12.001; Chen PQ, 1998, CLIN BIOMECH, V13, pS52, DOI 10.1016/S0268-0033(97)00075-2; Chen SC, 2011, GAIT POSTURE, V33, P695, DOI 10.1016/j.gaitpost.2011.03.004; Chien HL, 2013, GAIT POSTURE, V38, P391, DOI 10.1016/j.gaitpost.2012.12.015; Chockalingam N, 2008, SCOLIOSIS SPINAL DIS, V3, DOI 10.1186/1748-7161-3-10; Chou LS, 2003, GAIT POSTURE, V18, P125, DOI 10.1016/S0966-6362(02)00067-X; Cromwell RL, 2001, J ORTHOP SPORT PHYS, V31, P255, DOI 10.2519/jospt.2001.31.5.255; Danielsson AJ, 2006, SPINE, V31, P275, DOI 10.1097/01.brs.0000197652.52890.71; EDELMAN S, 1987, BIOL CYBERN, V57, P25, DOI 10.1007/BF00318713; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Hak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082842; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; Hong SW, 2015, GAIT POSTURE, V42, P523, DOI 10.1016/j.gaitpost.2015.08.007; Hsu WC, 2010, J MECH, V26, P229, DOI 10.1017/S1727719100003087; Huang SC, 2008, MED ENG PHYS, V30, P968, DOI 10.1016/j.medengphy.2007.12.005; Karimi MT, 2016, J BACK MUSCULOSKELET, V29, P403, DOI 10.3233/BMR-150641; Kramers-de Quervain IA, 2004, EUR SPINE J, V13, P449, DOI 10.1007/s00586-003-0588-x; LEBLANC R, 1995, ANN CHIR, V49, P762; Lee HJ, 2006, ARCH PHYS MED REHAB, V87, P569, DOI 10.1016/j.apmr.2005.11.033; Lenke LG, 2001, SPINE, V26, P2347, DOI 10.1097/00007632-200111010-00011; Mahaudens P, 2009, EUR SPINE J, V18, P512, DOI 10.1007/s00586-009-0899-7; Masso PD, 2000, SPINE, V25, P457, DOI 10.1097/00007632-200002150-00011; Nault ML, 2002, SPINE, V27, P1911, DOI 10.1097/00007632-200209010-00018; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Paul JC, 2014, GAIT POSTURE, V40, P510, DOI 10.1016/j.gaitpost.2014.06.006; PETERSEN I, 1979, ACTA ORTHOP SCAND, V50, P283, DOI 10.3109/17453677908989769; RIDDLE HFV, 1955, LANCET, V1, P1245, DOI 10.1016/S0140-6736(55)91020-5; Rohrer B, 2002, J NEUROSCI, V22, P8297; Sarwahi V, 2002, SPINE, V27, P2328, DOI 10.1097/00007632-200211010-00005; Schizas C G, 1998, Eur Spine J, V7, P95, DOI 10.1007/s005860050037; Simon AL, 2015, ORTHOP TRAUMATOL-SUR, V101, P235, DOI 10.1016/j.otsr.2014.11.021; Sivakumaran S, 2018, HUM MOVEMENT SCI, V57, P366, DOI 10.1016/j.humov.2017.09.014; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Wang TM, 2007, J CHIN INST ENG, V30, P471, DOI 10.1080/02533839.2007.9671275; Wank V, 1998, INT J SPORTS MED, V19, P455, DOI 10.1055/s-2007-971944; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; Wu KW, 2019, GAIT POSTURE, V71, P211, DOI 10.1016/j.gaitpost.2019.05.007; Wu KW, 2019, GAIT POSTURE, V68, P423, DOI 10.1016/j.gaitpost.2018.12.024; Young RP, 1997, HUM MOVEMENT SCI, V16, P677, DOI 10.1016/S0167-9457(97)00010-9	46	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228752	10.1371/journal.pone.0228752	http://dx.doi.org/10.1371/journal.pone.0228752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9GK	32027721	Green Published, gold			2022-12-26	WOS:000534623800071
J	Zhu, Q; Dong, H; Bukhari, AAS; Zhao, AR; Li, M; Sun, YF; Zhang, X; Cao, CC; Su, DM; Liang, XB				Zhu, Qian; Dong, Hao; Bukhari, Ashfaq-Ahmad-Shah; Zhao, Anran; Li, Min; Sun, Yifei; Zhang, Xue; Cao, Changchun; Su, Dongming; Liang, Xiubin			HUWE1 promotes EGFR ubiquitination and degradation to protect against renal tubulointerstitial fibrosis	FASEB JOURNAL			English	Article						EGFR; HUWE1; protein-protein interaction; renal tubulointerstitial fibrosis; ubiquitination	GROWTH-FACTOR RECEPTOR; CHRONIC KIDNEY-DISEASE; ANGIOTENSIN-II; ACTIVATION; PROGRESSION; MECHANISMS; THERAPY; CANCER; BETA	Injury of renal tubular epithelial cells is a key feature of the pathogenicity associated with tubulointerstitial fibrosis and other kidney diseases. HUWE1, an E3 ubiquitin ligase, acts by participating in ubiquitination and degradation of its target proteins. However, the detailed mechanisms by which HUWE1 might regulate fibrosis in renal tubular epithelial cells have not been established. Here, the possible regulation of renal tubulointerstitial fibrosis by HUWE1 was investigated by examining the expression of HUWE1 and EGFR in unilateral ureteral obstruction (UUO) mice. Markedly consistent reciprocal changes in HUWE1 and EGFR expression were observed at the protein and mRNA levels in the kidney after UUO injury. Expression of HUWE1 inhibited TGF-beta-induced injury to HK-2 cells, while HUWE1 overexpression decreased the expression of EGFR. Further analysis indicated that HUWE1 physically interacted with EGFR and promoted its ubiquitination and degradation. HUWE1 expression also showed clinical relevance in renal disease, as it notably decreased in multiple types of clinical nephropathy, while EGFR expression significantly increased when compared to the normal kidney. Therefore, this study demonstrated that HUWE1, which serves as an E3 ubiquitin ligase specific for EGFR, promotes EGFR ubiquitination and degradation, thereby regulating EGFR expression and providing protection against kidney injury.	[Zhu, Qian; Dong, Hao; Bukhari, Ashfaq-Ahmad-Shah; Zhao, Anran; Sun, Yifei; Zhang, Xue; Liang, Xiubin] Nanjing Med Univ, Dept Pathophysiol, Nanjing 211166, Jiangsu, Peoples R China; [Li, Min; Su, Dongming] Nanjing Med Univ, Dept Pathol, Nanjing, Peoples R China; [Cao, Changchun; Liang, Xiubin] Nanjing Med Univ, Dept Nephrol, Affiliated Sir Run Run Hosp, Nanjing, Peoples R China; [Su, Dongming] Nanjing Med Univ, Ctr Pathol & Clin Lab, Affiliated Sir Run Run Hosp, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liang, XB (corresponding author), Nanjing Med Univ, Dept Pathophysiol, Nanjing 211166, Jiangsu, Peoples R China.	liangxiubin@njmu.edu.cn			National Natural Science Foundation of China (NSFC) [81870467, 81670619, 81570779]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870467, 81670619 and 81570779	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Appenroth D, 2001, EXP TOXICOL PATHOL, V53, P316, DOI 10.1078/0940-2993-00197; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; Cappuzzo F, 2006, NEW ENGL J MED, V354, P2619, DOI 10.1056/NEJMc060020; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; ElNahas AM, 1997, INT J BIOCHEM CELL B, V29, P55, DOI 10.1016/S1357-2725(96)00119-7; Fogo AB, 2001, KIDNEY INT, V59, P804, DOI 10.1046/j.1523-1755.2001.059002804.x; Gagliardini E, 2006, CYTOKINE GROWTH F R, V17, P89, DOI 10.1016/j.cytogfr.2005.09.005; Gao CL, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/918396; Harskamp LR, 2016, NAT REV NEPHROL, V12, P496, DOI 10.1038/nrneph.2016.91; Huang YJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0002-y; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Izzedine H, 2017, NEPHROL DIAL TRANSPL, V32, P1089, DOI 10.1093/ndt/gfw467; Jiang L, 2013, J AM SOC NEPHROL, V24, P1114, DOI 10.1681/ASN.2012050476; Kao SH, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0470-0; Klahr S, 2000, KIDNEY INT, V57, pS7, DOI 10.1046/j.1523-1755.2000.07509.x; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Li YA, 2010, AM J PHYSIOL-HEART C, V299, pH1959, DOI 10.1152/ajpheart.00526.2010; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Melenhorst WBWH, 2008, HYPERTENSION, V52, P987, DOI 10.1161/HYPERTENSIONAHA.108.113860; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Rego RL, 2010, BRIT J CANCER, V102, P165, DOI 10.1038/sj.bjc.6605473; Rosell R, 2008, ANN ONCOL, V19, P362, DOI 10.1093/annonc/mdm474; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Swanton C, 2006, CLIN CANCER RES, V12, p4377S, DOI 10.1158/1078-0432.CCR-06-0115; Tang JH, 2013, AM J PATHOL, V183, P160, DOI 10.1016/j.ajpath.2013.04.005; Tang JH, 2013, KIDNEY INT, V83, P804, DOI 10.1038/ki.2012.435; Tong JF, 2014, MOL CELL PROTEOMICS, V13, P1644, DOI 10.1074/mcp.M114.038596; Wang X, 2016, BIOCHEM PHARMACOL, V116, P200, DOI 10.1016/j.bcp.2016.07.017; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; You H, 2017, J CELL SCI, V130, P1027, DOI 10.1242/jcs.198242; ZHUANG S, 2011, KIDNEY INT S, V4, P70	38	11	12	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4591	4601		10.1096/fj.201902751R	http://dx.doi.org/10.1096/fj.201902751R		FEB 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32017279				2022-12-26	WOS:000511114300001
J	Kawao, N; Takafuji, Y; Ishida, M; Okumoto, K; Morita, H; Muratani, M; Kaji, H				Kawao, Naoyuki; Takafuji, Yoshimasa; Ishida, Masayoshi; Okumoto, Katsumi; Morita, Hironobu; Muratani, Masafumi; Kaji, Hiroshi			Roles of the vestibular system in obesity and impaired glucose metabolism in high-fat diet-fed mice	PLOS ONE			English	Article							BONE-MINERAL DENSITY; MUSCLE; MODULATION	The vestibular system controls balance, posture, blood pressure, and gaze. However, the roles of the vestibular system in energy and glucose metabolism remain unknown. We herein examined the roles of the vestibular system in obesity and impaired glucose metabolism using mice with vestibular lesions (VL) fed a high-sucrose/high-fat diet (HSHFD). VL was induced by surgery or arsenic. VL significantly suppressed body fat enhanced by HSHFD in mice. Glucose intolerance was improved by VL in mice fed HSHFD. VL blunted the levels of adipogenic factors and pro-inflammatory adipokines elevated by HSHFD in the epididymal white adipose tissue of mice. A beta-blocker antagonized body fat and glucose intolerance enhanced by HSHFD in mice. The results of an RNA sequencing analysis showed that HSHFD induced alterations in genes, such as insulin-like growth factor-2 and glial fibrillary acidic protein, in the vestibular nuclei of mice through the vestibular system. In conclusion, we herein demonstrated that the dysregulation of the vestibular system influences an obese state and impaired glucose metabolism induced by HSHFD in mice. The vestibular system may contribute to the regulation of set points under excess energy conditions.	[Kawao, Naoyuki; Takafuji, Yoshimasa; Ishida, Masayoshi; Kaji, Hiroshi] Kindai Univ, Dept Physiol & Regenerat Med, Fac Med, Osakasayama, Japan; [Okumoto, Katsumi] Kindai Univ, Life Sci Res Inst, Osakasayama, Japan; [Morita, Hironobu] Gifu Univ, Dept Physiol, Grad Sch Med, Gifu, Japan; [Muratani, Masafumi] Univ Tsukuba, Fac Med, Dept Genome Biol, Tsukuba, Ibaraki, Japan	Gifu University; University of Tsukuba	Kaji, H (corresponding author), Kindai Univ, Dept Physiol & Regenerat Med, Fac Med, Osakasayama, Japan.	hkaji@med.kindai.ac.jp	Takafuji, Yoshimasa/HDO-7262-2022	Ishida, Masayoshi/0000-0003-2807-651X; Kawao, Naoyuki/0000-0002-4148-5476	Takeda Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [16K08534, 19K07310, 15H05935]; Kindai Research Enhancement Grant (21st Century Joint Research Enhancement Grant)	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kindai Research Enhancement Grant (21st Century Joint Research Enhancement Grant)	This study was partly supported by a grant from the Takeda Science Foundation to N.K., a grant from the Kindai Research Enhancement Grant (21st Century Joint Research Enhancement Grant) to H.K., a Grant-in-Aid for Scientific Research (C:16K08534, 19K07310) to N.K., and a Grant-in-Aid for Scientific Research on Innovative Areas (grant number 15H05935, "Living in Space") to H.K. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe C, 2010, J APPL PHYSIOL, V109, P1635, DOI 10.1152/japplphysiol.00515.2010; Atsmoni SC, 2019, DIABETES METAB SYND, V13, P1141, DOI 10.1016/j.dsx.2019.01.006; Baek K, AVIAKOSM EKOLOG MED, DOI [10.1007/s00223-018-0407-3, DOI 10.1007/S00223-018-0407-3]; Baek K, 2018, CALCIFIED TISSUE INT, V103, P217, DOI 10.1007/s00223-018-0407-3; Barth E, 2007, CRIT CARE MED, V35, pS508, DOI 10.1097/01.CCM.0000278047.06965.20; Barzel B, 2016, J HYPERTENS, V34, P464, DOI 10.1097/HJH.0000000000000811; Chen XX, 2015, J BONE MINER METAB, V33, P474, DOI 10.1007/s00774-014-0569-7; Clarke AH, 2000, EXP BRAIN RES, V134, P322, DOI 10.1007/s002210000476; Craig AD, 2015, DO YOU FEEL INTEROCE, P19; da Silva AA, 2009, CURR HYPERTENS REP, V11, P206, DOI 10.1007/s11906-009-0036-3; Degerman E, 2013, CELL TISSUE RES, V352, P469, DOI 10.1007/s00441-013-1614-x; Denise P, 2009, Aviakosm Ekolog Med, V43, P36; Fruhbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X; Fujimoto C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00900; Fuller PM, 2004, NEUROSCIENCE, V129, P461, DOI 10.1016/j.neuroscience.2004.05.059; Fuller PM, 2002, P NATL ACAD SCI USA, V99, P15723, DOI 10.1073/pnas.242251499; Galego-Martinez A, 2018, J NEUROL, V265, P29, DOI 10.1007/s00415-018-8842-7; Hao Z, 2016, OBESITY, V24, P654, DOI 10.1002/oby.21400; Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453; Hughson RL, 2016, AM J PHYSIOL-HEART C, V310, pH628, DOI 10.1152/ajpheart.00802.2015; Kawao N, 2018, CALCIFIED TISSUE INT, V103, P24, DOI 10.1007/s00223-018-0387-3; Kawao N, 2018, J CELL PHYSIOL, V233, P1191, DOI 10.1002/jcp.25986; Kawao N, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12979; Kuan L, 2015, METHODS, V73, P4, DOI 10.1016/j.ymeth.2014.12.013; Kuntz AL, 1998, J COMP NEUROL, V399, P413; Lambert GW, 2019, ANN NY ACAD SCI, V1454, P56, DOI 10.1111/nyas.14140; Levasseur R, 2004, J VESTIBUL RES-EQUIL, V14, P361; Luxa N, 2013, J VESTIBUL RES-EQUIL, V23, P187, DOI 10.3233/VES-130499; McGeoch PD, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201800197; McKeown J, 2020, DIABETIC MED, V37, P20, DOI 10.1111/dme.14166; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Morita H, 2016, SCI REP-UK, V6, DOI 10.1038/srep33405; Morita H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133981; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; Pardo M, 2018, REV NEUROSCI RES; Pitale PM, 2017, J CELL PHYSIOL, V232, P477, DOI 10.1002/jcp.25498; Richards JB, 2007, J CLIN ENDOCR METAB, V92, P1517, DOI 10.1210/jc.2006-2097; Rodriguez S, 2007, HUM GENET, V122, P1, DOI 10.1007/s00439-007-0378-3; Sailesh Kumar Sai, 2015, J Nat Sci Biol Med, V6, P321, DOI 10.4103/0976-9668.159991; Smith JK, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00574; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Vignaux G, 2015, J BONE MINER RES, V30, P1103, DOI 10.1002/jbmr.2426; Xing Y, 2017, BIOMED PHARMACOTHER, V86, P531, DOI 10.1016/j.biopha.2016.12.025; Yamamoto Y, 2005, ANN NEUROL, V58, P175, DOI 10.1002/ana.20574; Yamaoka Y, 2018, J NEUROSCI METH, V295, P58, DOI 10.1016/j.jneumeth.2017.11.021; Yates BJ, 2014, COMPR PHYSIOL, V4, P851, DOI 10.1002/cphy.c130041	46	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228685	10.1371/journal.pone.0228685	http://dx.doi.org/10.1371/journal.pone.0228685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012199	Green Published, gold			2022-12-26	WOS:000534615800045
J	Ramos-Nino, ME; Fitzpatrick, DM; Tighe, S; Eckstrom, KM; Hattaway, LM; Hsueh, AN; Stone, DM; Dragon, J; Cheetham, S				Ramos-Nino, Maria E.; Fitzpatrick, Daniel M.; Tighe, Scott; Eckstrom, Korin M.; Hattaway, Lindsey M.; Hsueh, Andy N.; Stone, Diana M.; Dragon, Julie; Cheetham, Sonia			High prevalence of Phasi Charoen-like virus from wild-caught Aedes aegypti in Grenada, W. I. as revealed by metagenomic analysis	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; EILAT VIRUS; FLAVIVIRUS; CHIKUNGUNYA; MECHANISMS; ALPHAVIRUS; EVOLUTION; DISCOVERY; TRANSMISSION; ARBOVIRUSES	Arboviruses cause diseases of significant global health concerns. Interactions between mosquitoes and their microbiota as well as the important role of this interaction in the mosquito's capacity to harbor and transmit pathogens have emerged as important fields of research. Aedes aegypti is one of the most abundant mosquitoes in many geographic locations, a vector capable of transmitting a number of arboviruses such as dengue and Zika. Currently, there are few studies on the metavirome of this mosquito particularly in the Americas. This study analyzes the metavirome of A. aegypti from Grenada, a Caribbean nation with tropical weather, abundant A. aegypti, and both endemic and arboviral pathogens transmitted by this mosquito. Between January and December 2018, 1152 mosquitoes were collected from six semi-rural locations near houses in St. George Parish, Grenada, by weekly trapping using BG-Sentinel traps. From these, 300 A. aegypti were selected for analysis. The metavirome was analyzed using the Illumina HiSeq 1500 for deep sequencing. The generation sequencing library construction protocol used was NuGEN Universal RNA with an average read length of 125 bp. Reads were mapped to the A. aegypti assembly. Non-mosquito reads were analyzed using the tools FastViromeExplorer. The NCBI total virus, RNA virus, and eukaryotic virus databases were used as references. The metagenomic comparison analysis showed that the most abundant virus-related reads among all databases and assemblies was Phasi Charoen-like virus. The Phasi Charoen-like virus results are in agreement to other studies in America, Asia and Australia. Further studies using wild-caught mosquitoes is needed to assess the impact of this insect-specific virus on the A. aegypti lifecycle and vector capacity.	[Ramos-Nino, Maria E.] St Georges Univ, Sch Med, Dept Microbiol, St Georges, Grenada; [Fitzpatrick, Daniel M.; Hsueh, Andy N.; Stone, Diana M.; Cheetham, Sonia] St Georges Univ, Sch Vet Med, Dept Pathobiol, St Georges, Grenada; [Tighe, Scott; Eckstrom, Korin M.; Hattaway, Lindsey M.; Dragon, Julie] Univ Vermont, Massively Parallel Sequencing Facil, Burlington, VT USA	University of Vermont	Ramos-Nino, ME (corresponding author), St Georges Univ, Sch Med, Dept Microbiol, St Georges, Grenada.; Cheetham, S (corresponding author), St Georges Univ, Sch Vet Med, Dept Pathobiol, St Georges, Grenada.	mramosni@sgu.edu; scheetha@sgu.edu	Cheetham, Sonia/AAS-5409-2020	Cheetham, Sonia/0000-0002-0878-1222; Eckstrom, Korin/0000-0002-6941-7627; Ramos-Nino, Maria/0000-0002-4976-5333; Fitzpatrick, Daniel/0000-0002-1411-4178	Windward Islands Research and Education Foundation's One Health Research Initiative Grant [4-11-10]	Windward Islands Research and Education Foundation's One Health Research Initiative Grant	This research was funded by The Windward Islands Research and Education Foundation's One Health Research Initiative Grant 4-11-10.	Aldridge RL, 2016, J AM MOSQUITO CONTR, V32, P282, DOI 10.2987/16-6609.1; Atyame CM, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2273; Ballinger MJ, 2014, J VIROL, V88, P8783, DOI 10.1128/JVI.00531-14; Beckmann JF, 2012, J MED ENTOMOL, V49, P1103, DOI 10.1603/ME12049; Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474; Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851; Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016; Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006; Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0; Chandler JA, 2014, VIROLOGY, V464, P312, DOI 10.1016/j.virol.2014.06.036; Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Darsie JR, 2005, IDENTIFICATION GEOGR, DOI [10.1017/s0031182005228834, DOI 10.1017/S0031182005228834]; Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004; Dudas G, 2015, ELIFE, V4, DOI 10.7554/eLife.06837; Fitzpatrick DM, 2019, J MED ENTOMOL, P1, DOI [10.1093/jme/tjy197, DOI 10.1093/JME/TJY197]; Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226; Fredericks AC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007346; Fujita R, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00736; Gaffigan TV, 2015, SYSTEMATIC CATALOG C; Grywna K, 2010, J CLIN MICROBIOL, V48, P3386, DOI 10.1128/JCM.00317-10; Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2; Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008; Hermanns K, 2017, J GEN VIROL, V98, P43, DOI 10.1099/jgv.0.000694; Hill CL, 2014, ACTA TROP, V140, P151, DOI 10.1016/j.actatropica.2014.07.015; Hobson-Peters J, 2016, VIROLOGY, V489, P269, DOI 10.1016/j.virol.2015.11.003; Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534; Jakob W, 1967, AEDES AEGYPTI HDB SE, V6; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; Johnson KN, 2015, CURR OPIN INSECT SCI, V8, P97, DOI 10.1016/j.cois.2015.01.008; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671; Klasson L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-33; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kumar Satish, 2015, Biotechnol Res Int, V2015, P121735, DOI 10.1155/2015/121735; Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005; Kuwata R, 2015, J MED ENTOMOL, V52, P222, DOI 10.1093/jme/tju059; Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112; Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175; Nasar F, 2015, J VIROL, V89, P1404, DOI 10.1128/JVI.01856-14; Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109; Ohlund P, 2019, VIRUS GENES, V55, P127, DOI 10.1007/s11262-018-01629-9; Olmo RP, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920190122; Parry R, 2018, J VIROL, V92, DOI [10.1128/JVI.00224-18, 10.1128/jvi.00224-18]; Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904; Plyusnin A, 2014, VIRUS RES, V187, P22, DOI 10.1016/j.virusres.2014.01.008; Powell JR, 2018, AM J TROP MED HYG, V98, P1563, DOI 10.4269/ajtmh.17-0866; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Richard V, 2019, New Microbes and New Infections, V31, P100569, DOI 10.1016/j.nmni.2019.100569; Romo H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0180-4; Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1; Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043; Sangdee K, 2013, SE ASIAN J TROP MED; Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617; Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022; Scolari F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02036; Shi CY, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0734-2; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009; Sultan M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-675; Talavera S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2887-4; Tandina F, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3045-8; Tithi SS, 2018, PEERJ, V6, DOI 10.7717/peerj.4227; Vasilakis N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-97; Villegas LEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190352; Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122; Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y; Zhang GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02347-2; Zhang XM, 2018, VIROLOGY, V523, P35, DOI 10.1016/j.virol.2018.07.021	78	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0227998	10.1371/journal.pone.0227998	http://dx.doi.org/10.1371/journal.pone.0227998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004323	Green Submitted, gold, Green Published			2022-12-26	WOS:000534614600010
J	Bradley, PM; Journey, CA; Button, DT; Carlisle, DM; Huffman, BJ; Qi, SL; Romanok, KM; Van Metre, PC				Bradley, Paul M.; Journey, Celeste A.; Button, Daniel T.; Carlisle, Daren M.; Huffman, Bradley J.; Qi, Sharon L.; Romanok, Kristin M.; Van Metre, Peter C.			Multi-region assessment of pharmaceutical exposures and predicted effects in USA wadeable urban-gradient streams	PLOS ONE			English	Article							ANTIDIABETIC DRUG METFORMIN; COMBINED SEWER OVERFLOWS; PERSONAL CARE PRODUCTS; POTENTIOMETRIC ANALYTICAL MICROSYSTEM; THROUGHPUT SCREENING DATA; WASTE-WATER; ENDOCRINE DISRUPTION; GREAT-LAKES; AQUATIC ENVIRONMENT; ORGANIC-COMPOUNDS	Human-use pharmaceuticals in urban streams link aquatic-ecosystem health to human health. Pharmaceutical mixtures have been widely reported in larger streams due to historical emphasis on wastewater-treatment plant (WWTP) sources, with limited investigation of pharmaceutical exposures and potential effects in smaller headwater streams. In 2014-2017, the United States Geological Survey measured 111 pharmaceutical compounds in 308 headwater streams (261 urban-gradient sites sampled 3-5 times, 47 putative lowimpact sites sampled once) in 4 regions across the US. Simultaneous exposures to multiple pharmaceutical compounds (pharmaceutical mixtures) were observed in 91% of streams (248 urban-gradient, 32 low-impact), with 88 analytes detected across all sites and cumulative maximum concentrations up to 36,142 ng/L per site. Cumulative detections and concentrations correlated to urban land use and presence/absence of permitted WWTP discharges, but pharmaceutical mixtures also were common in the 75% of sampled streams without WWTP. Cumulative exposure-activity ratios (EAR) indicated widespread transient exposures with high probability of molecular effects to vertebrates. Considering the potential individual and interactive effects of the detected pharmaceuticals and the recognized analytical underestimation of the pharmaceutical-contaminant (unassessed parent compounds, metabolites, degradates) space, these results demonstrate a nation-wide environmental concern and the need for watershed-scale mitigation of in-stream pharmaceutical contamination.	[Bradley, Paul M.; Journey, Celeste A.; Huffman, Bradley J.] US Geol Survey, Columbia, SC 29201 USA; [Button, Daniel T.] US Geol Survey, Columbus, OH USA; [Carlisle, Daren M.] US Geol Survey, Lawrence, KS USA; [Qi, Sharon L.] US Geol Survey, Beaverton, OR USA; [Romanok, Kristin M.] US Geol Survey, Lawrenceville, NJ USA; [Van Metre, Peter C.] US Geol Survey, Austin, TX USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Bradley, PM (corresponding author), US Geol Survey, Columbia, SC 29201 USA.	pbradley@usgs.gov	Bradley, Paul M./AAC-2451-2020	Bradley, Paul M./0000-0001-7522-8606; Van Metre, Peter/0000-0001-7564-9814; Journey, Celeste/0000-0002-2284-5851				Ahn MS, 2018, J COLLOID INTERF SCI, V516, P364, DOI 10.1016/j.jcis.2018.01.081; Altenburger R, 2013, ENVIRON TOXICOL CHEM, V32, P1685, DOI 10.1002/etc.2294; Altenburger R, 2012, ENVIRON SCI TECHNOL, V46, P2508, DOI 10.1021/es2038036; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2015, US GEOLOGICAL SURVEY, DOI DOI 10.3133/DS948; Arnold KE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0569; Artemyeva AA, 2016, ACTA ASTRONAUT, V126, P11, DOI 10.1016/j.actaastro.2016.04.016; ASTM International, 2018, D7729122018E1 ASTM A, DOI [10.1520/D7729-12R18E01, DOI 10.1520/D7729-12R18E01]; Bai Hua, 2013, Huanjing Kexue, V34, P2493; Barber LB, 2015, SCI TOTAL ENVIRON, V529, P264, DOI 10.1016/j.scitotenv.2015.04.112; Barber LB, 2012, ENVIRON SCI TECHNOL, V46, P2121, DOI 10.1021/es202880e; Batt AL, 2016, ENVIRON TOXICOL CHEM, V35, P874, DOI 10.1002/etc.3161; Becker RA, 2015, REGUL TOXICOL PHARM, V71, P398, DOI 10.1016/j.yrtph.2015.01.008; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bishop K, 2008, HYDROL PROCESS, V22, P1239, DOI 10.1002/hyp.7049; Black L, 2019, 2018 NATL HLTH INTER; Blackwell BR, 2017, ENVIRON SCI TECHNOL, V51, P8713, DOI 10.1021/acs.est.7b01613; Blair BD, 2013, CHEMOSPHERE, V93, P2116, DOI 10.1016/j.chemosphere.2013.07.057; Bostrom ML, 2015, WATER RES, V72, P154, DOI 10.1016/j.watres.2014.08.040; Boxall ABA, 2010, HANDB EXP PHARMACOL, V199, P291, DOI 10.1007/978-3-642-10324-7_12; Bradbury S P, 1994, SAR QSAR Environ Res, V2, P89, DOI 10.1080/10629369408028842; Bradley PM, 2019, SCI TOTAL ENVIRON, V655, P70, DOI 10.1016/j.scitotenv.2018.11.186; Bradley PM, 2017, ENVIRON SCI TECHNOL, V51, P4792, DOI 10.1021/acs.est.7b00012; Bradley PM, 2016, ENVIRON SCI TECH LET, V3, P243, DOI 10.1021/acs.estlett.6b00170; Bradley PM, 2016, SCI TOTAL ENVIRON, V568, P916, DOI 10.1016/j.scitotenv.2016.06.104; Bradley PM, 2016, REMEDIATION, V26, P9, DOI 10.1002/rem.21455; Brodin T, 2013, SCIENCE, V339, P814, DOI 10.1126/science.1226850; Brodin T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0580; Bronmark C, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P272; Brooks BW, 2014, AQUAT TOXICOL, V151, P61, DOI 10.1016/j.aquatox.2014.01.007; Brown AR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0576; Calvo-Lopez A, 2017, ANAL CHIM ACTA, V995, P77, DOI 10.1016/j.aca.2017.08.043; Calvo-Lopez A, 2013, ANAL CHIM ACTA, V804, P190, DOI 10.1016/j.aca.2013.10.013; Capiotti KM, 2014, COMP BIOCHEM PHYS B, V171, P58, DOI 10.1016/j.cbpb.2014.03.005; Carrara C, 2008, ENVIRON SCI TECHNOL, V42, P2805, DOI 10.1021/es070344q; Carter LJ, 2015, ENVIRON SCI TECHNOL, V49, P12509, DOI 10.1021/acs.est.5b03468; Cedergreen N, 2008, ENVIRON TOXICOL CHEM, V27, P1621, DOI [10.1897/07-474.1, 10.1897/07-474]; Cedergreen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096580; Clarke A, 2008, FRESHWATER BIOL, V53, P1707, DOI 10.1111/j.1365-2427.2008.02041.x; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Coles J. F., 2019, OPEN FILE REPORT 201, DOI [10.3133/ofr20181183, DOI 10.3133/OFR20181183]; Conn KE, 2010, ENVIRON ENG SCI, V27, P347, DOI 10.1089/ees.2009.0364; Connor NP, 2014, APPL GEOCHEM, V47, P209, DOI 10.1016/j.apgeochem.2014.06.012; Corcoran J, 2010, CRIT REV TOXICOL, V40, P287, DOI 10.3109/10408440903373590; Corsi SR, 2019, SCI TOTAL ENVIRON, V686, P995, DOI 10.1016/j.scitotenv.2019.05.457; Corsi SR, 2015, SCI TOTAL ENVIRON, V508, P488, DOI 10.1016/j.scitotenv.2014.12.012; Corsi SR, 2010, ENVIRON SCI TECHNOL, V44, P7376, DOI 10.1021/es101333u; Crago J, 2018, CHEMOSPHERE, V193, P1226, DOI 10.1016/j.chemosphere.2017.11.043; Crago J, 2016, GEN COMP ENDOCR, V232, P185, DOI 10.1016/j.ygcen.2015.12.030; Cummings C, 2018, PAED CHILD HEALT-CAN, V23, pE18, DOI 10.1093/pch/pxx165; Daughton C, 2011, ENV CONTAMINANTS BIO, P288; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Davies PJ, 2010, URBAN WATER J, V7, P233, DOI 10.1080/1573062X.2010.484502; DeCicco L.A., 2018, TOXEVAL EVALUATION M; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; Downing JA, 2012, INLAND WATERS, V2, P229, DOI 10.5268/IW-2.4.502; Elo B, 2007, J MOL ENDOCRINOL, V38, P433, DOI 10.1677/JME-06-0037; Eriksson E, 2003, WATER SA, V29, P135; Ermler S, 2011, TOXICOL APPL PHARM, V257, P189, DOI 10.1016/j.taap.2011.09.005; Fatta-Kassinos D, 2011, CHEMOSPHERE, V85, P693, DOI 10.1016/j.chemosphere.2011.06.082; Fatta-Kassinos D, 2011, SCI TOTAL ENVIRON, V409, P3555, DOI 10.1016/j.scitotenv.2010.03.036; Ferrell GM, 2014, USGS OPEN-FILE REP, DOI [10.3133/ofr20141215, DOI 10.3133/ofr20141215]; Fick J, 2010, ENVIRON SCI TECHNOL, V44, P2661, DOI 10.1021/es903440m; Fissore C, 2012, URBAN ECOSYST, V15, P1, DOI 10.1007/s11252-011-0189-0; Freeman MC, 2007, J AM WATER RESOUR AS, V43, P5, DOI 10.1111/j.1752-1688.2007.00002.x; Fuentes AV, 2018, PHARMACY, V6, DOI 10.3390/pharmacy6020043; Furlong E. T., 2014, US GEOLOGICAL SURVEY, V5, P49, DOI [10.3133/tm5B10, DOI 10.3133/TM5B10]; Gallagher HC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011091.pub2; Giacomini ACVV, 2016, BEHAV BRAIN RES, V296, P301, DOI 10.1016/j.bbr.2015.09.027; Gong L, 2012, PHARMACOGENET GENOM, V22, P820, DOI 10.1097/FPC.0b013e3283559b22; Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hossain SM, 2016, CLIN J PAIN, V32, P1005, DOI 10.1097/AJP.0000000000000343; Hughes SR, 2013, ENVIRON SCI TECHNOL, V47, P661, DOI 10.1021/es3030148; Humphrey C, 2015, WATER SCI TECHNOL, V72, P1851, DOI 10.2166/wst.2015.411; Jaywant SA, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19214781; Jiang JQ, 2006, CHEMOSPHERE, V63, P212, DOI 10.1016/j.chemosphere.2005.08.020; Jonsson H, 1997, WATER SCI TECHNOL, V35, P145, DOI 10.1016/S0273-1223(97)00192-3; Jonsson M, 2014, SCI TOTAL ENVIRON, V472, P108, DOI 10.1016/j.scitotenv.2013.10.104; Kaiser Family Foundation's State Health Facts INPAD, 2018, IQVIA 2018 RET SAL P; Kane S P, 2020, FLECAINIDE ACETATE C; Kaushal SS, 2018, P NATL ACAD SCI USA, V115, pE574, DOI 10.1073/pnas.1711234115; Kaushal SS, 2017, APPL GEOCHEM, V83, P121, DOI 10.1016/j.apgeochem.2017.02.006; Kaushal SS, 2014, BIOGEOCHEMISTRY, V121, P1, DOI 10.1007/s10533-014-0014-y; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Kidd KA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0578; KONEMANN H, 1981, TOXICOLOGY, V19, P209, DOI 10.1016/0300-483X(81)90130-X; Kortenkamp A., 2009, STATE ART REPORT MIX; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; LEOPOLD LB, 1962, AM SCI, V50, P511; Li SB, 2017, SCI TOTAL ENVIRON, V579, P825, DOI 10.1016/j.scitotenv.2016.11.021; Li WC, 2014, ENVIRON POLLUT, V187, P193, DOI 10.1016/j.envpol.2014.01.015; Lienert J, 2007, WATER SCI TECHNOL, V56, P87, DOI 10.2166/wst.2007.560; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; Lowe WH, 2005, BIOSCIENCE, V55, P196, DOI 10.1641/0006-3568(2005)055[0196:MHSTTH]2.0.CO;2; Luo YL, 2014, SCI TOTAL ENVIRON, V473, P619, DOI 10.1016/j.scitotenv.2013.12.065; LYDEARD C, 1995, CONSERV BIOL, V9, P800, DOI 10.1046/j.1523-1739.1995.09040800.x; MacLaren RD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197259; Margalida A, 2014, SCIENCE, V346, P1296, DOI 10.1126/science.1260260; Masoner JR, 2019, ENVIRON SCI TECHNOL, V53, P10070, DOI 10.1021/acs.est.9b02867; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; Meyer JL, 2007, J AM WATER RESOUR AS, V43, P86, DOI 10.1111/j.1752-1688.2007.00008.x; Michael I, 2013, WATER RES, V47, P957, DOI 10.1016/j.watres.2012.11.027; <monospace>R</monospace>Development Core Team, 2019, R LANG ENV STAT COMP; Monteiro SC, 2010, REV ENVIRON CONTAM T, V202, P53, DOI 10.1007/978-1-4419-1157-5_2; Moore RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008242.pub3; Moretto A, 2017, CRIT REV TOXICOL, V47, P85, DOI 10.1080/10408444.2016.1211618; National Water Information System (NWIS), 2019, WEB INT; Niemuth NJ, 2018, AQUAT TOXICOL, V195, P33, DOI 10.1016/j.aquatox.2017.12.003; Niemuth NJ, 2015, ENVIRON TOXICOL CHEM, V34, P291, DOI 10.1002/etc.2793; Nodler K, 2011, APPL GEOCHEM, V26, P2172, DOI 10.1016/j.apgeochem.2011.08.001; NORTON SB, 1992, ENVIRON TOXICOL CHEM, V11, P1663, DOI 10.1897/1552-8618(1992)11[1663:AFFERA]2.0.CO;2; Oosterhuis M, 2013, SCI TOTAL ENVIRON, V442, P380, DOI 10.1016/j.scitotenv.2012.10.046; Oteng-Peprah M, 2018, WATER AIR SOIL POLL, V229, DOI 10.1007/s11270-018-3909-8; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Painter MM, 2009, ENVIRON TOXICOL CHEM, V28, P2677, DOI 10.1897/08-556.1; Peacor S., 2015, REV ENVIRON CONTAM T, V235, P1, DOI DOI 10.1007/978-3-319-10861-2_1; Peters NE, 2009, HYDROL PROCESS, V23, P2860, DOI 10.1002/hyp.7373; Phillips P, 2009, J AM WATER RESOUR AS, V45, P45, DOI 10.1111/j.1752-1688.2008.00288.x; Phillips PJ, 2012, ENVIRON SCI TECHNOL, V46, P5336, DOI 10.1021/es3001294; Pol R, 2017, TRAC-TREND ANAL CHEM, V95, P62, DOI 10.1016/j.trac.2017.08.001; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042; Quinlan EL, 2011, ENVIRON SCI TECHNOL, V45, P10684, DOI 10.1021/es202004k; Raldua D, 2014, EXPERT OPIN DRUG MET, V10, P685, DOI 10.1517/17425255.2014.896339; Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a; Richard AM, 2016, CHEM RES TOXICOL, V29, P1225, DOI 10.1021/acs.chemrestox.6b00135; Richmond EK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06822-w; Rodier D, EPA630R92001; Romanok KM, 2019, CONCENTRATIONS PHARM, DOI [10.5066/P97MW2T8, DOI 10.5066/P97MW2T8]; Rosi-Marshall EJ, 2013, ECOL APPL, V23, P583, DOI 10.1890/12-0491.1; Rosi-Marshall EJ, 2012, ECOSYSTEMS, V15, P867, DOI 10.1007/s10021-012-9553-z; Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514; Rutsch M, 2008, WATER RES, V42, P2385, DOI 10.1016/j.watres.2008.01.019; Sanchez W, 2011, ENVIRON INT, V37, P1342, DOI 10.1016/j.envint.2011.06.002; Scheurer M, 2012, WATER RES, V46, P4790, DOI 10.1016/j.watres.2012.06.019; Scheurer M, 2009, J ENVIRON MONITOR, V11, P1608, DOI 10.1039/b909311g; Schroeder AL, 2016, ENVIRON TOXICOL CHEM, V35, P513, DOI 10.1002/etc.3309; Schultz MM, 2011, AQUAT TOXICOL, V104, P38, DOI 10.1016/j.aquatox.2011.03.011; Scott MC, 2006, BIOL CONSERV, V127, P301, DOI 10.1016/j.biocon.2005.07.020; Tang T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub5; Temnerud J, 2010, HYDROL PROCESS, V24, P2269, DOI 10.1002/hyp.7615; Terando AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102261; Thrupp TJ, 2018, SCI TOTAL ENVIRON, V619, P1482, DOI 10.1016/j.scitotenv.2017.11.081; Trautwein C, 2014, ENVIRON INT, V70, P203, DOI 10.1016/j.envint.2014.05.008; Trautwein C, 2011, CHEMOSPHERE, V85, P765, DOI 10.1016/j.chemosphere.2011.06.057; U.S. Census Bureau, 2019, ANN EST RES POP; U.S. Environmental Protection Agency, 2013, NPDES PERM NAT; U.S. Geological Survey, 2014, NAT LAND COC DAT NLC; U.S. Geological Survey, 2020, USGS NEXT GEN WAT OB; U.S. Geological Survey, 2020, NEXT GEN WAT OBS SYS; United States Census Bureau, 2016, TIGER LIN SHAP; US Food and Drug Administration, 2018, OR BOOK APPR DRUG PR; Ussery E, 2019, ENVIRON TOXICOL CHEM, V38, P1023, DOI 10.1002/etc.4403; Ussery E, 2018, AQUAT TOXICOL, V205, P58, DOI 10.1016/j.aquatox.2018.10.003; van der Wouden J, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009321.pub2, DOI 10.1002/14651858.CD009321.PUB2]; Van Metre PC, 2014, SE STREAM QUALITY AS, DOI [10.3133/fs20143023, DOI 10.3133/FS20143023]; Van Metre PC, 20163021 US GEOL SUR, DOI [10.3133/fs20163021, DOI 10.3133/FS20163021]; Van Metre PC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222714; Vasquez MI, 2014, J HAZARD MATER, V279, P169, DOI 10.1016/j.jhazmat.2014.06.069; VEITH GD, 1983, CAN J FISH AQUAT SCI, V40, P743, DOI 10.1139/f83-096; Villarroel M, 2018, 2018 NATL HLTH INTER; Warner W, 2019, SCI TOTAL ENVIRON, V686, P75, DOI 10.1016/j.scitotenv.2019.05.385; Warren ML, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:DDACSO>2.0.CO;2; Weinberger J, 2014, AQUAT TOXICOL, V151, P77, DOI 10.1016/j.aquatox.2013.10.012; Weyrauch P, 2010, WATER RES, V44, P4451, DOI 10.1016/j.watres.2010.06.011; WHO, 2016, GLOB REP PSOR; Wiffen PJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007938.pub4; Winker M, 2008, SCI TOTAL ENVIRON, V399, P96, DOI 10.1016/j.scitotenv.2008.03.027; Winker M, 2009, BIORESOURCE TECHNOL, V100, P4090, DOI 10.1016/j.biortech.2009.03.024; Wolf L, 2012, SCI TOTAL ENVIRON, V430, P8, DOI 10.1016/j.scitotenv.2012.04.059; Yu ZLT, 2013, WATER ENVIRON RES, V85, P650, DOI 10.2175/106143013X13698672321580; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	180	24	24	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228214	10.1371/journal.pone.0228214	http://dx.doi.org/10.1371/journal.pone.0228214			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999738	gold, Green Published			2022-12-26	WOS:000534612400056
J	Klich, D; Lopucki, R; Stachniuk, A; Sporek, M; Fornal, E; Wojciechowska, M; Olech, W				Klich, Daniel; Lopucki, Rafal; Stachniuk, Anna; Sporek, Monika; Fornal, Emilia; Wojciechowska, Marlena; Olech, Wanda			Pesticides and conservation of large ungulates: Health risk to European bison from plant protection products as a result of crop depredation	PLOS ONE			English	Article							CARBENDAZIM; WILD	The coexistence of large mammals and humans in the contemporary landscape is a big challenge for conservationists. Wild ungulates that forage on arable fields are exposed to the negative effects of pesticides, and this problem also applies to protected species for which intoxication by pesticides may pose a health risk and directly affect the effectiveness of conservation efforts. In this paper we assessed the threat posed by pesticides to the European bison Bison bonasus, a species successfully restituted after being extinct in the wild. We studied samples of B. bonasus liver from three free-living populations in Poland (Bialowieska, Knyszynska, and Borecka forests) and captive individuals from breeding centres. LC-QTOF-MS/MS two-step analysis for the detection, identification and confirmation of pesticide residues in liver samples, which included MS and targeted MS/MS scans, was conducted. It was found that European bison are exposed to pesticides as a result of crop depredation: the presence of tetraconazole, fluopyram and diazinon residues in 12 liver samples was confirmed. The concentration levels of the detected substances were quite low, but in the liver samples more than one substance was usually found, and the potential health risk to European bison may result from the synergistic interaction of these substances. The place of occurrence of the population, abundance, and the management regime affect the exposure of European bison to pesticides. Due to the high conservation status of the European bison, the monitoring of intoxication by pesticides should be included in the conservation plans of this species. This issue should also be more widely included in the study of other wild ungulates because knowledge about the impact of pesticides on wildlife is still insufficient.	[Klich, Daniel; Wojciechowska, Marlena; Olech, Wanda] Warsaw Univ Life Sci SGGW, Inst Anim Sci, Warsaw, Poland; [Lopucki, Rafal] John Paul II Catholic Univ Lublin, Ctr Interdisciplinary Res, Lublin, Poland; [Stachniuk, Anna; Fornal, Emilia] Med Univ Lublin, Dept Pathophysiol, Lublin, Poland; [Sporek, Monika] Univ Opole, Inst Biol, Opole, Poland	Warsaw University of Life Sciences; Catholic University of Lublin; Medical University of Lublin; University of Opole	Klich, D (corresponding author), Warsaw Univ Life Sci SGGW, Inst Anim Sci, Warsaw, Poland.	daniel_klich@sggw.pl	Fornal, Emilia/ABE-8988-2020; Stachniuk, Anna/ABC-2418-2020; Sporek, Monika/AAN-8850-2021; Klich, Daniel/AAD-7611-2020; Olech, Wanda/AAB-5072-2022	Fornal, Emilia/0000-0002-0503-0706; Stachniuk, Anna/0000-0001-6384-1999; Sporek, Monika/0000-0002-3566-6860; Olech, Wanda/0000-0002-6166-3954; Lopucki, Rafal/0000-0003-2137-8742	Forest Fund, Poland [OR.271.3.10.2017]	Forest Fund, Poland	This work was funded by the Forest Fund, Poland in frame of "Complex project of European bison conservation by State Forests" (contract no. OR.271.3.10.2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aire TA, 2005, ANAT EMBRYOL, V210, P43, DOI 10.1007/s00429-005-0001-0; Anisimava A., 2015, EUROPEAN BISON CONSE, V8, P25; Bielecki W., 2013, EUROPEAN BISON CONSE, V6, P91; Celik A, 2019, BIOMARKERS, V24, P720, DOI 10.1080/1354750X.2019.1658804; Clements MH, 2002, COMMUNITY ECOTOXICOL; European Central Bank, 2017, GUID BANKS NONP LOAN; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; Gustavsson M, 2017, SCI TOTAL ENVIRON, V598, P973, DOI 10.1016/j.scitotenv.2017.04.122; Hofman-Kaminska E, 2012, ENVIRON MANAGE, V50, P530, DOI 10.1007/s00267-012-9913-7; Horoszkiewicz-Janka J, 2016, PROGRAM OCHRONY ROSL; Hoy J., 2015, POULTRY FISHERIES WI, V3, P1; Hoy J.A., 2011, Wildlife Biology in Practice, V7, P15; Huang YY, 2012, J VET DIAGN INVEST, V24, P96, DOI 10.1177/1040638711425939; JANES NF, 1973, J AGR FOOD CHEM, V21, P121, DOI 10.1021/jf60185a030; Klich D., 2019, Annals of Warsaw University of Life Sciences - SGGW, Animal Science, V58, P29, DOI 10.22630/AAS.2019.58.1.4; Klich D, 2018, EUR J WILDLIFE RES, V64, DOI 10.1007/s10344-018-1219-5; Krasinska M, 2000, ACTA THERIOL, V45, P321, DOI 10.4098/AT.arch.00-32; Larska M., 2019, WILDLIFE POPULATION; Levine SL, 2018, CHEMOSPHERE, V209, P124, DOI 10.1016/j.chemosphere.2018.06.081; Lyons G., 2008, EFFECTS POLLUTANTS R; Maliszewska J, 2014, EUROPEAN BISON CONSE, V7, P9; Menegola E, 2005, TOXICOL IN VITRO, V19, P737, DOI 10.1016/j.tiv.2005.04.005; Menegola E, 2001, REPROD TOXICOL, V15, P421, DOI 10.1016/S0890-6238(01)00143-5; National Center for Biotechnology Information, 2019, 80277 CID NAT CTR BI; Olech W., 2016, EUR BISON CONSERV NE, V9, P5; Olech W., 2014, BEST PRACTICES MANUA; Olech W, 2018, UWM OLSZTYN, P67; Olech W, 2019, ORYX, V53, P214, DOI 10.1017/S0030605318001369; Oleszek W, 2003, POL J ENVIRON STUD, V12, P261; Paszkiewicz R., 2010, EUROPEAN BISON CONSE, V3, P53; Przezdziecki Z., 1980, BIOL PRZEMIANY SUBST; Pucek Z., 2004, STATUS SURVEY CONSER; Radwan J, 2010, BIOL CONSERV, V143, P2049, DOI 10.1016/j.biocon.2010.05.012; Rajeswary S, 2007, REPROD TOXICOL, V24, P371, DOI 10.1016/j.reprotox.2007.03.010; Slotkin TA, 2006, ENVIRON HEALTH PERSP, V114, P746, DOI 10.1289/ehp.8828; Slowik-Borowiec M., 2012, POL J AGRON, V11, P47; Sobczuk M., 2016, EUROPEAN BISON CONSE, V9, P39; Sobczuk M, 2007, RAPORT ROK 2018 REAL, P35; Tinwell H, 2014, REGUL TOXICOL PHARM, V70, P648, DOI 10.1016/j.yrtph.2014.09.011; Velki M, 2019, ENVIRON SCI POLLUT R, V26, P4821, DOI 10.1007/s11356-018-3959-x; Walker C.H., 2001, ORGANIC POLLUTANTS E, V2nd; Zhu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176837; Ziolkowska E, 2016, BIOL CONSERV, V195, P106, DOI 10.1016/j.biocon.2015.12.032	43	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228243	10.1371/journal.pone.0228243	http://dx.doi.org/10.1371/journal.pone.0228243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999727	gold, Green Published			2022-12-26	WOS:000534612400057
J	Iburg, M; Puchkov, D; Rosas-Brugada, IU; Bergemann, L; Rieprecht, U; Kirstein, J				Iburg, Manuel; Puchkov, Dmytro; Rosas-Brugada, Irving U.; Bergemann, Linda; Rieprecht, Ulrike; Kirstein, Janine			The noncanonical small heat shock protein HSP-17 from Caenorhabditis elegans is a selective protein aggregase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; protein folding; chaperone; small heat shock protein (sHsp); Caenorhabditis elegans (C; elegans); protein aggregates; proteostasis; selective protein aggregase	ALPHA-B-CRYSTALLIN; CHAPERONE PATHWAY; ESCHERICHIA-COLI; SEQUESTRATION; DISAGGREGATION; FIBRILS; DISEASE; STRESS; HSP110; LINE	Small heat shock proteins (sHsps) are conserved, ubiquitous members of the proteostasis network. Canonically, they act as ?holdases? and buffer unfolded or misfolded proteins against aggregation in an ATP-independent manner. Whereas bacteria and yeast each have only two sHsps in their genomes, this number is higher in metazoan genomes, suggesting a spatiotemporal and functional specialization in higher eukaryotes. Here, using recombinantly expressed and purified proteins, static light-scattering analysis, and disaggregation assays, we report that the noncanonical sHsp HSP-17 of Caenorhabditis elegans facilitates aggregation of model substrates, such as malate dehydrogenase (MDH), and inhibits disaggregation of luciferase in vitro. Experiments with fluorescently tagged HSP-17 under the control of its endogenous promoter revealed that HSP-17 is expressed in the digestive and excretory organs, where its overexpression promotes the aggregation of polyQ proteins and of the endogenous kinase KIN-19. Systemic depletion of hsp-17 shortens C. elegans lifespan and severely reduces fecundity and survival upon prolonged heat stress. HSP-17 is an abundant protein exhibiting opposing chaperone activities on different substrates, indicating that it is a selective protein aggregase with physiological roles in development, digestion, and osmoregulation.	[Iburg, Manuel; Puchkov, Dmytro; Rosas-Brugada, Irving U.; Bergemann, Linda; Rieprecht, Ulrike; Kirstein, Janine] Forschungsverbund Berlin eV, Leibniz Res Inst Mol Pharmacol, R Roessle Str 10, D-13125 Berlin, Germany; [Kirstein, Janine] Univ Bremen, Fac Cell Biol 2, Leobener Str, D-28359 Bremen, Germany; [Rosas-Brugada, Irving U.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Bergemann, Linda] Lab Berlin Charite Vivantes GmbH, Fachbereich Humangenet, Sylter Str 2, D-13353 Berlin, Germany	Technical University of Berlin; University of Bremen; University of Toronto; Labor Berlin - Charite Vivantes GmbH	Kirstein, J (corresponding author), Univ Bremen, Fac Cell Biol 2, Leobener Str, D-28359 Bremen, Germany.	kirstein@uni-bremen.de		Iburg, Manuel/0000-0002-1073-9023; Kirstein, Janine/0000-0003-4990-2497; Puchkov, Dmytro/0000-0001-8341-4847	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]	National Institutes of Health Office of Research Infrastructure Programs	We acknowledge Della David (DZNE Tubingen) for providing strain DCD214, the Leube laboratory (RWTH Aachen) for strain BJ49, Richard Morimoto (Northwestern University, Evanston, IL) for sharing strain iQ85, and the Caenorhabditis Genetics Center (CGC), which is funded by the National Institutes of Health Office of Research Infrastructure Programs (Grant P40 OD010440), for providing additional strains. We thank Ellen Malovrh for cloning the hsp-12.6 construct. We thank Alice Baumann (FMP Berlin) for support in carrying out QTof experiments. We also acknowledge Johannes Buchner and Martin Haslbeck (TU Munich) for discussion.	Aevermann BD, 2008, GENETICA, V133, P307, DOI 10.1007/s10709-007-9215-9; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrigo A., 2015, BIG BOOK SMALL HEAT, P155; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Candido E Peter M, 2002, Prog Mol Subcell Biol, V28, P61; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; El Mouridi S, 2017, G3-GENES GENOM GENET, V7, P1429, DOI 10.1534/g3.117.040824; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Ezemaduka AN, 2017, J NEMATOL, V49, P334, DOI 10.21307/jofnem-2017-081; Ezemaduka AN, 2014, J BACTERIOL, V196, P2004, DOI 10.1128/JB.01473-14; Feleciano DR, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00009; Grousl T, 2018, J CELL BIOL, V217, P1269, DOI 10.1083/jcb.201708116; Hantke I, 2019, MOL MICROBIOL, V111, P423, DOI 10.1111/mmi.14164; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Ho CT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12868-1; Horn T, 2010, NUCLEIC ACIDS RES, V38, pW332, DOI 10.1093/nar/gkq317; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kampinga HH, 2012, INT J BIOCHEM CELL B, V44, P1706, DOI 10.1016/j.biocel.2012.06.005; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller SBM, 2015, J MOL BIOL, V427, P1564, DOI 10.1016/j.jmb.2015.02.006; Mohri-Shiomi A, 2008, J BIOL CHEM, V283, P194, DOI 10.1074/jbc.M707956200; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Oliveira AO, 2016, HUM MOL GENET, V25, P1677, DOI 10.1093/hmg/ddw028; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Ratajczak E, 2009, J MOL BIOL, V386, P178, DOI 10.1016/j.jmb.2008.12.009; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saarikangas J, 2015, ELIFE, V4, DOI 10.7554/eLife.06197; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scior A, 2018, EMBO J, V37, P282, DOI 10.15252/embj.201797212; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Stauffer W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33592-8; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Stiernagle Theresa, 2006, WormBook, P1; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Ungelenk S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13673; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Zhang KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08811	58	3	3	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3064	3079		10.1074/jbc.RA119.011185	http://dx.doi.org/10.1074/jbc.RA119.011185			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32001616	Green Published, hybrid			2022-12-26	WOS:000519597300016
J	Su, VL; Simon, B; Draheim, KM; Calderwood, DA				Su, Valerie L.; Simon, Bertrand; Draheim, Kyle M.; Calderwood, David A.			Serine phosphorylation of the small phosphoprotein ICAP1 inhibits its nuclear accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cerebral cavernous malformation; cell compartmentalization; KRIT1 (Krev interaction trapped); nuclear translocation; nuclear transport; phosphorylation; ICAP1 (integrin cytoplasmic domain-associated protein-1); nuclear import; nucleocytoplasmic shuttling; phosphoprotein	CEREBRAL CAVERNOUS MALFORMATIONS; DOMAIN-ASSOCIATED PROTEIN; CYTOPLASMIC DOMAIN; ANKYRIN REPEAT; CELL-ADHESION; INTEGRIN; KRIT1; KINASE; LOCALIZATION; MECHANISM	Nuclear accumulation of the small phosphoprotein integrin cytoplasmic domain?associated protein-1 (ICAP1) results in recruitment of its binding partner, Krev/Rap1 interaction trapped-1 (KRIT1), to the nucleus. KRIT1 loss is the most common cause of cerebral cavernous malformation, a neurovascular dysplasia resulting in dilated, thin-walled vessels that tend to rupture, increasing the risk for hemorrhagic stroke. KRIT1's nuclear roles are unknown, but it is known to function as a scaffolding or adaptor protein at cell-cell junctions and in the cytosol, supporting normal blood vessel integrity and development. As ICAP1 controls KRIT1 subcellular localization, presumably influencing KRIT1 function, in this work, we investigated the signals that regulate ICAP1 and, hence, KRIT1 nuclear localization. ICAP1 contains a nuclear localization signal within an unstructured, N-terminal region that is rich in serine and threonine residues, several of which are reportedly phosphorylated. Using quantitative microscopy, we revealed that phosphorylation-mimicking substitutions at Ser-10, or to a lesser extent at Ser-25, within this N-terminal region inhibit ICAP1 nuclear accumulation. Conversely, phosphorylation-blocking substitutions at these sites enhanced ICAP1 nuclear accumulation. We further demonstrate that p21-activated kinase 4 (PAK4) can phosphorylate ICAP1 at Ser-10 both in vitro and in cultured cells and that active PAK4 inhibits ICAP1 nuclear accumulation in a Ser-10?dependent manner. Finally, we show that ICAP1 phosphorylation controls nuclear localization of the ICAP1-KRIT1 complex. We conclude that serine phosphorylation within the ICAP1 N-terminal region can prevent nuclear ICAP1 accumulation, providing a mechanism that regulates KRIT1 localization and signaling, potentially influencing vascular development.	[Su, Valerie L.; Simon, Bertrand; Draheim, Kyle M.; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, POB 208066,333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University	Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.; Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	david.calderwood@yale.edu		Su, Valerie/0000-0003-2919-0162; Calderwood, David/0000-0002-0791-4142	National Institutes of Health [R01NS085078, GM007324, F31HL143831]; American Heart Association [18POST33960340]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants R01NS085078 (to D. A. C.) and GM007324 and F31HL143831 (to V. L. S.) and American Heart Association Grant 18POST33960340 (to B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Bouvard D, 2003, J BIOL CHEM, V278, P6567, DOI 10.1074/jbc.M211258200; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Cave-Riant F, 2002, EUR J HUM GENET, V10, P733, DOI 10.1038/sj.ejhg.5200870; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Cuttano R, 2016, EMBO MOL MED, V8, P6, DOI 10.15252/emmm.201505433; Degani S, 2002, J CELL BIOL, V156, P377, DOI 10.1083/jcb.200108030; Denier C, 2006, ANN NEUROL, V60, P550, DOI 10.1002/ana.20947; DiStefano PV, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582304; Draheim KM, 2017, J BIOL CHEM, V292, P1884, DOI 10.1074/jbc.M116.762393; Draheim KM, 2014, J CELL SCI, V127, P701, DOI 10.1242/jcs.138388; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Faurobert E, 2013, J CELL BIOL, V202, P545, DOI 10.1083/jcb.201303044; Fisher OS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8937; Fisher OS, 2015, J BIOL CHEM, V290, P2842, DOI 10.1074/jbc.M114.616433; Fournier HN, 2002, J BIOL CHEM, V277, P20895, DOI 10.1074/jbc.M200200200; Fournier HN, 2005, MOL BIOL CELL, V16, P1859, DOI 10.1091/mbc.E04-08-0744; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077818; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goitre L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08373-4; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; Ha BH, 2015, J BIOL CHEM, V290, P12975, DOI 10.1074/jbc.R115.650416; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Kadry YA, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221184; Kim J, 2011, J CELL SCI, V124, P3929, DOI 10.1242/jcs.095471; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kurth JH, 1994, AM J HUM GENET S3, V55, pA15; Lisowska J, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216093; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Liu WZ, 2013, ACTA CRYSTALLOGR F, V69, P494, DOI 10.1107/S1744309113010762; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Lopez-Ramirez MA, 2019, BLOOD, V133, P193, DOI 10.1182/blood-2018-06-856062; Lopez-Ramirez MA, 2017, J EXP MED, V214, P3331, DOI 10.1084/jem.20171178; MARCHUK DA, 1995, GENOMICS, V28, P311, DOI 10.1006/geno.1995.1147; Marzo S, 2014, EUR J HISTOCHEM, V58, P62, DOI 10.4081/ejh.2014.2358; MCCORMICK WF, 1966, J NEUROSURG, V24, P807, DOI 10.3171/jns.1966.24.4.0807; Miller CJ, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006540; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Millon-Fremillon A, 2013, J BIOL CHEM, V288, P20248, DOI 10.1074/jbc.M113.455956; Morse EM, 2016, J CELL SCI, V129, P380, DOI 10.1242/jcs.177493; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nekrasova T, 2012, TRANSGENIC RES, V21, P797, DOI 10.1007/s11248-011-9578-7; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Riant F, 2013, NEUROGENETICS, V14, P133, DOI 10.1007/s10048-013-0362-0; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Stroeken PJM, 2006, J CELL PHYSIOL, V208, P620, DOI 10.1002/jcp.20699; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wong JH, 2000, NEUROSURGERY, V46, P1454, DOI 10.1097/00006123-200006000-00027; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang R, 2015, J STRUCT BIOL, V192, P449, DOI 10.1016/j.jsb.2015.10.006; Zhang XA, 1999, J BIOL CHEM, V274, P11, DOI 10.1074/jbc.274.1.11; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178; Zhou ZN, 2015, DEV CELL, V32, P168, DOI 10.1016/j.devcel.2014.12.009	68	6	6	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3269	3284		10.1074/jbc.RA119.009794	http://dx.doi.org/10.1074/jbc.RA119.009794			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005669	hybrid, Green Published			2022-12-26	WOS:000519597300031
J	Chou, E; Lasek-Nesselquist, E; Taubner, B; Pilar, A; Guignon, E; Page, W; Lin, YP; Cady, NC				Chou, Eunice; Lasek-Nesselquist, Erica; Taubner, Benjamin; Pilar, Arturo; Guignon, Ernest; Page, William; Lin, Yi-Pin; Cady, Nathaniel C.			A fluorescent plasmonic biochip assay for multiplex screening of diagnostic serum antibody targets in human Lyme disease	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; LABORATORY DIAGNOSIS; ERYTHEMA MIGRANS; IMMUNOGLOBULIN-M; C6 ANTIGENS; FOLLOW-UP; SERODIAGNOSIS; RESPONSES; FUTURE; OSPC	Lyme disease (LD) diagnosis using the current two-tier algorithm is constrained by low sensitivity for early-stage infection and ambiguity in determining treatment response. We recently developed a protein microarray biochip that measures diagnostic serum antibody targets using grating-coupled fluorescent plasmonics (GC-FP) technology. This strategy requires microliters of blood serum to enable multiplexed biomarker screening on a compact surface and generates quantitative results that can be further processed for diagnostic scoring. The GC-FP biochip was used to detect serum antibodies in patients with active and convalescent LD, as well as various negative controls. We hypothesized that the quantitative, high-sensitivity attributes of the GC-FP approach permit: 1) screening of antibody targets predictive for LD status, and 2) development a diagnostic algorithm that is more sensitive, specific, and informative than the standard ELISA and Western blot assays. Notably, our findings led to a diagnostic algorithm that may be more sensitive than the current standard for detecting early LD, while maintaining 100% specificity. We further show that analysis of relative antibody levels to predict disease status, such as in acute and convalescent stages of infection, is possible with a highly sensitive and quantitative platform like GC-FP. The results from this study add to the urgent conversation regarding better diagnostic strategies and more effective treatment for patients affected by tick-borne disease.	[Chou, Eunice; Cady, Nathaniel C.] SUNY Albany, Coll Nanoscale Sci & Engn, Polytech Inst, Albany, NY 12222 USA; [Chou, Eunice] Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [Lasek-Nesselquist, Erica] New York State Dept Hlth, Bioinformat Core, Wadsworth Ctr, Albany, NY USA; [Taubner, Benjamin; Lin, Yi-Pin] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA; [Taubner, Benjamin] Mercer Univ, Dept Biomed Engn, Macon, GA 31207 USA; [Pilar, Arturo; Guignon, Ernest; Page, William] Ciencia Inc, E Hartford, CT USA; [Lin, Yi-Pin] SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; Wadsworth Center; Mercer University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Cady, NC (corresponding author), SUNY Albany, Coll Nanoscale Sci & Engn, Polytech Inst, Albany, NY 12222 USA.	ncady@sunypoly.edu		Chou, Eunice/0000-0002-1015-8704	National Science Foundation [DBI1757170, IOS1755286]; Department of Defense [TB170111]; New York State Department of Health Wadsworth Center Start-Up Grant; SUNY Polytechnic Faculty Seed Award; Ciencia, Inc.	National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); New York State Department of Health Wadsworth Center Start-Up Grant; SUNY Polytechnic Faculty Seed Award; Ciencia, Inc.	This work was supported by National Science Foundation IOS1755286 (Y.L. and B.T.), National Science Foundation DBI1757170 (B.T.), Department of Defense TB170111 (Y.L. and B.T.), New York State Department of Health Wadsworth Center Start-Up Grant (Y.L. and B.T.), SUNY Polytechnic Faculty Seed Award (N.C.). Funding agencies did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ciencia, Inc. provided support in the form of salaries for authors A.P., E.G., and W.P., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors have no conflict of interest to declare.	ABERER E, 2012, ISRN IMMUNOLOGY, V2012, P1, DOI DOI 10.5402/2012/719821; Aguero-Rosenfeld ME, 2008, INFECT DIS CLIN N AM, V22, P301, DOI 10.1016/j.idc.2007.12.005; AGUEROROSENFELD ME, 1993, J CLIN MICROBIOL, V31, P3090, DOI 10.1128/JCM.31.12.3090-3095.1993; Arvikar SL, 2015, INFECT DIS CLIN N AM, V29, P269, DOI 10.1016/j.idc.2015.02.004; Bauch M, 2014, OPT EXPRESS, V22, P32026, DOI 10.1364/OE.22.032026; Bauch M, 2014, PLASMONICS, V9, P781, DOI 10.1007/s11468-013-9660-5; Borchers AT, 2015, J AUTOIMMUN, V57, P82, DOI 10.1016/j.jaut.2014.09.004; Branda JA, 2018, CLIN INFECT DIS, V66, P1133, DOI 10.1093/cid/cix943; Branda JA, 2017, CLIN INFECT DIS, V64, P1074, DOI 10.1093/cid/cix043; Brandt KS, 2019, DIAGN MICR INFEC DIS, V93, P196, DOI 10.1016/j.diagmicrobio.2018.09.012; Carpentier G., 2010, IMAGEJ USER DEVELOPE; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Chaaya G, 2016, J FAM PRACTICE, V65, P373; Chandra A, 2011, CLIN VACCINE IMMUNOL, V18, P767, DOI 10.1128/CVI.00002-11; Chou E, 2018, GRATING COUPLED SURF; Chou E., 2019, FRONTIERS BIOLOGICAL, V10895; Chou E, 2018, SCI PROGRESS-UK, V101, P311, DOI 10.3184/003685018X15360040523730; CRAFT JE, 1986, J CLIN INVEST, V78, P934, DOI 10.1172/JCI112683; DeLong AK, 2012, CONTEMP CLIN TRIALS, V33, P1132, DOI 10.1016/j.cct.2012.08.009; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; Earnhart CG, 2005, INFECT IMMUN, V73, P7869, DOI 10.1128/IAI.73.12.7869-7877.2005; Embers ME, 2016, CLIN VACCINE IMMUNOL, V23, P294, DOI 10.1128/CVI.00685-15; Embers ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029914; ENGSTROM SM, 1995, J CLIN MICROBIOL, V33, P419, DOI 10.1128/JCM.33.2.419-427.1995; FEDER HM, 1995, AM J MED, V99, P412, DOI 10.1016/S0002-9343(99)80190-9; Glatz M, 2006, ARCH DERMATOL, V142, P862, DOI 10.1001/archderm.142.7.862; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; HAMMERSBERGGREN S, 1994, J CLIN MICROBIOL, V32, P1519, DOI 10.1128/JCM.32.6.1519-1525.1994; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Jin GB, 2006, BIOSENS BIOELECTRON, V22, P200, DOI 10.1016/j.bios.2005.12.021; Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669; Kalish RA, 2001, J INFECT DIS, V183, P453, DOI 10.1086/318082; Kannian P, 2007, ARTHRITIS RHEUM-US, V56, P4216, DOI 10.1002/art.23135; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; Liang FT, 2000, J CLIN MICROBIOL, V38, P4160, DOI 10.1128/JCM.38.11.4160-4166.2000; Liang FT, 1999, INFECT IMMUN, V67, P6702; Lin YP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00182; Lohr B, 2018, CRIT REV CL LAB SCI, V55, P219, DOI 10.1080/10408363.2018.1450353; Mac S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210280; Maulden AB, 2020, J PEDIAT INF DIS SOC, V9, P128, DOI 10.1093/jpids/piy133; Molins CR, 2016, J CLIN MICROBIOL, V54, P2726, DOI 10.1128/JCM.00874-16; Molins CR, 2014, J CLIN MICROBIOL, V52, P3755, DOI 10.1128/JCM.01409-14; Molony Ryan D, 2012, Curr Protoc Toxicol, VChapter 18, DOI 10.1002/0471140856.tx1816s53; Moore A, 2016, EMERG INFECT DIS, V22, P1169, DOI 10.3201/eid2207.151694; Pavlickova P, 2002, J PROTEOME RES, V1, P227, DOI 10.1021/pr0200036; Pegalajar-Jurado A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01943-17, 10.1128/JCM.01943-17]; Philipp MT, 2005, CLIN DIAGN LAB IMMUN, V12, P1069, DOI 10.1128/CDLI.12.9.1069-1074.2005; Rebman AW, 2015, CLIN RHEUMATOL, V34, P585, DOI 10.1007/s10067-014-2706-z; Rice JM, 2012, BIOSENS BIOELECTRON, V31, P264, DOI 10.1016/j.bios.2011.10.029; Schoen RT, 2013, CLIN INFECT DIS, V57, P341, DOI 10.1093/cid/cit238; Schutzer SE, 2019, CLIN INFECT DIS, V68, P1052, DOI 10.1093/cid/ciy614; Seriburi V, 2012, CLIN MICROBIOL INFEC, V18, P1236, DOI 10.1111/j.1469-0691.2011.03749.x; SHADICK NA, 1994, ANN INTERN MED, V121, P560, DOI 10.7326/0003-4819-121-8-199410150-00002; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; Simmons JH, 2008, ILAR J, V49, P157, DOI 10.1093/ilar.49.2.157; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SITHIGORNGUL P, 1991, J IMMUNOL METHODS, V141, P23, DOI 10.1016/0022-1759(91)90206-U; Stevenson B, 1998, INFECT IMMUN, V66, P2648, DOI 10.1128/IAI.66.6.2648-2654.1998; Stone BL, 2017, VECTOR-BORNE ZOONOT, V17, P619, DOI 10.1089/vbz.2017.2127; Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.00992-18, 10.1128/JCM.00992-18]; Theel ES, 2016, J CLIN MICROBIOL, V54, P1191, DOI 10.1128/JCM.03394-15; Tibbles CD, 2007, JAMA-J AM MED ASSOC, V297, P2617, DOI 10.1001/jama.297.23.2617; Tokarz R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21349-2; Verhey TB, 2018, CELL REP, V23, P2595, DOI 10.1016/j.celrep.2018.04.117; Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168613; Wagner B, 2013, EQUINE VET J, V45, P533, DOI 10.1111/evj.12033; Wagner B, 2012, CLIN VACCINE IMMUNOL, V19, P527, DOI 10.1128/CVI.05653-11; Wright WF, 2012, AM FAM PHYSICIAN, V85, P1086	69	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228772	10.1371/journal.pone.0228772	http://dx.doi.org/10.1371/journal.pone.0228772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040491	gold, Green Published			2022-12-26	WOS:000534629400040
J	Kim, TY; Jeon, MJ				Kim, Tae Yeon; Jeon, Myung Jae			Risk factors for vaginal mesh erosion after sacrocolpopexy in Korean women	PLOS ONE			English	Article							ABDOMINAL SACRAL COLPOPEXY; PROLAPSE; ESTROGEN; SURGERY; COMPLICATIONS; HYSTERECTOMY; EXPRESSION; ANTERIOR; OUTCOMES; SUPPORT	Objective Although sacrocolpopexy (SCP) can provide durable apical support, the use of mesh may give rise to various complications, including vaginal mesh erosion. The aim of this study was to identify the risk factors for vaginal mesh erosion after SCP in Korean women. Methods This retrospective cohort study included 363 women who underwent SCP with type 1 polypropylene mesh. They were evaluated at 1, 4, and 12 months after surgery and then annually thereafter with respect to anatomy and complications. Univariate and multivariate analyses using the Cox proportional hazard model were performed to identify the risk factors for mesh erosion. Results During the median 2-year follow-up period, vaginal mesh erosion was found in 29 women (8.0%). Among them, 19 (65.5%) required surgical correction. Estrogenic status was the only independent risk factor for mesh erosion. The risk for mesh erosion was 4.5 times higher in premenopausal women than in menopausal women not on estrogen replacement therapy (ERT) (95% confidence intervals [CI] 1.9-10.9, p< 0.01). Menopausal women on ERT also had an increased risk, with a statistically marginal significance (hazard ratio 2.5, 95% CI 0.9-6.6; p = 0.07). Conclusions Premenopausal or menopausal women on ERT are at high risk for mesh erosion after SCP with type 1 polypropylene mesh, and two-thirds of mesh erosion cases require reoperation. This information should be incorporated into patient counseling and treatment decisions.	[Kim, Tae Yeon; Jeon, Myung Jae] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Jeon, Myung Jae] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Jeon, MJ (corresponding author), Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea.; Jeon, MJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jeonmj@snu.ac.kr		Jeon, Myung Jae/0000-0001-5582-1488				Achtari C, 2005, INT UROGYNECOL J, V16, P389, DOI 10.1007/s00192-004-1272-3; Akyol A, 2014, J OBSTET GYNAECOL RE, V40, P1368, DOI 10.1111/jog.12363; Askew AL, 2020, FEMALE PELVIC MED RE, V26, P536, DOI 10.1097/SPV.0000000000000632; Bensinger G, 2005, AM J OBSTET GYNECOL, V193, P2094, DOI 10.1016/j.ajog.2005.07.066; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Clark AL, 2005, AM J OBSTET GYNECOL, V192, P1523, DOI 10.1016/j.ajog.2004.11.042; Coolen ALWM, 2017, INT UROGYNECOL J, V28, P1767, DOI 10.1007/s00192-017-3493-2; Culligan PJ, 2002, AM J OBSTET GYNECOL, V187, P1473, DOI 10.1067/mob.2002.129160; Cundiff GW, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.029; Deng T, 2016, BJU INT, V117, P323, DOI 10.1111/bju.13158; Durst PJ, 2018, FEMALE PELVIC MED RE, V24, P360, DOI 10.1097/SPV.0000000000000452; Eilber KS, 2013, OBSTET GYNECOL, V122, P981, DOI 10.1097/AOG.0b013e3182a8a5e4; Falconer C, 1996, MATURITAS, V24, P197, DOI 10.1016/S0378-5122(96)82010-X; Haya N, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.017; Jeon MJ, 2009, YONSEI MED J, V50, P807, DOI 10.3349/ymj.2009.50.6.807; Kong Mi Kyung, 2016, Obstet Gynecol Sci, V59, P253, DOI 10.5468/ogs.2016.59.4.253; Liang R, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.008; Lowder JL, 2008, OBSTET GYNECOL, V111, P152, DOI 10.1097/01.AOG.0000297309.25091.a0; Lowman JK, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.048; Maher C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub6; Moalli PA, 2002, AM J OBSTET GYNECOL, V187, P72, DOI 10.1067/mob.2002.124845; Nosti PA, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.053; Nygaard IE, 2004, OBSTET GYNECOL, V104, P805, DOI 10.1097/01.AOG.0000139514.90897.07; Nygaard I, 2013, JAMA-J AM MED ASSOC, V309, P2016, DOI 10.1001/jama.2013.4919; Ripperda CM, 2017, MENOPAUSE, V24, P838, DOI 10.1097/GME.0000000000000840; Rooney K, 2006, AM J OBSTET GYNECOL, V195, P1837, DOI 10.1016/j.ajog.2006.06.065; Smith FJ, 2010, OBSTET GYNECOL, V116, P1096, DOI 10.1097/AOG.0b013e3181f73729; Stepanian AA, 2008, J MINIM INVAS GYN, V15, P188, DOI 10.1016/j.jmig.2007.11.006; Tan-Kim J, 2011, INT UROGYNECOL J, V22, P205, DOI 10.1007/s00192-010-1265-3; Wu JM, 2006, AM J OBSTET GYNECOL, V194, P1418, DOI 10.1016/j.ajog.2006.01.051; Yuk JS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19692-5	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228566	10.1371/journal.pone.0228566	http://dx.doi.org/10.1371/journal.pone.0228566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040517	Green Published, gold			2022-12-26	WOS:000534629400026
J	Modiyinji, AF; Sanding, GMAM; Atsama, MA; Monamele, CG; Nola, M; Njouom, R				Modiyinji, Abdou Fatawou; Sanding, Georges Marc Arthur Mveng; Atsama, Marie Amougou; Monamele, Chavely Gwladys; Nola, Moise; Njouom, Richard			Serological and molecular investigation of hepatitis E virus in pigs reservoirs from Cameroon reveals elevated seroprevalence and presence of genotype 3	PLOS ONE			English	Article							DOMESTIC PIGS; INFECTION; PREVALENCE; SWINE; MEAT	Background Hepatitis E virus (HEV) is a zoonotic pathogen of which pigs have been established as reservoirs. In the present study, we investigated the presence of HEV among pigs in the Center and Littoral regions of Cameroon and performed the molecular characterization of positive strains. Methodology A total of 453 serum and stool samples were randomly collected from pigs in slaughterhouses in Obala, Douala and Yaounde. All samples were examined for the presence of antiHEV IgG and IgM antibodies using ELISA assays. IgM positive stool samples were tested for HEV RNA using an RT-PCR assay, followed by a nested PCR assay for sequencing and phylogenetic analysis. Results Overall, 216 samples (47.7%, 95% Cl: 43.1%-52.3%) were positive for at least one of the serological markers of HEV infection. Amongst these, 21.0% were positives for anti-HEV IgM, 17.7% for anti-HEV IgG, and 9.1% for both. A total of eight stool samples (5.9%) were positive for HEV RNA by nested RT-PCR. Phylogenetic analysis showed that the retrieved sequences clustered within HEV genotype 3. Conclusion This study shows a high prevalence of anti-HEV antibodies and the circulation of genotype 3 in the swine population in Cameroon. Subsequent studies will be needed to elucidate the zoonotic transmission of HEV from pigs to humans in Cameroon.	[Modiyinji, Abdou Fatawou; Atsama, Marie Amougou; Monamele, Chavely Gwladys; Njouom, Richard] Ctr Pasteur Cameroon, Dept Virol, Yaounde, Cameroon; [Modiyinji, Abdou Fatawou; Nola, Moise] Univ Yaounde I, Fac Sci, Dept Anim Biol & Physiol, Yaounde, Cameroon; [Sanding, Georges Marc Arthur Mveng] Minist Livestock Fisheries & Anim Ind, Yaounde, Cameroon	University of Yaounde I	Njouom, R (corresponding author), Ctr Pasteur Cameroon, Dept Virol, Yaounde, Cameroon.	njouom@pasteur-yaounde.org						Adjei AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-108; Borghesi J., 2014, Open Journal of Animal Sciences, V4, P323; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Crossan C, 2015, EPIDEMIOL INFECT, V143, P2237, DOI 10.1017/S0950268814003100; de Paula VS, 2013, EMERG INFECT DIS, V19, P666, DOI 10.3201/eid1904.121634; Garcia-Hernandez ME, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1208-z; Guthmann JP, 2006, CLIN INFECT DIS, V42, P1685, DOI 10.1086/504321; Huang FF, 2002, J CLIN MICROBIOL, V40, P1326, DOI 10.1128/JCM.40.4.1326-1332.2002; Junaid S. A., 2014, British Microbiology Research Journal, V4, P924, DOI 10.9734/BMRJ/2014/10203; Kim JH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-308; Lee GH, 2016, GASTROENTEROLOGY, V150, P355, DOI 10.1053/j.gastro.2015.10.048; Modiyinji AF, 2018, J INFECT DEV COUNTR, V12, P676, DOI 10.3855/jidc.10310; Modiyinji AF, 2019, J MED PRIMATOL; Owolodun OA, 2014, AM J TROP MED HYG, V91, P699, DOI 10.4269/ajtmh.14-0144; Perez-Gracia MT, 2007, AM J TROP MED HYG, V77, P893, DOI 10.4269/ajtmh.2007.77.893; Seminati C, 2008, VET J, V175, P130, DOI 10.1016/j.tvjl.2006.11.018; Spahr C, 2017, HEPATITIS E VIRUS RE, DOI [10.1111/zph.12405, DOI 10.1111/ZPH.12405]; Sridhar S, 2017, INT J MOL SCI, P18; Tei S, 2004, J MED VIROL, V74, P67, DOI 10.1002/jmv.20147; Temmam S, 2013, AM J TROP MED HYG, V88, P329, DOI 10.4269/ajtmh.2012.12-0615; Wang Yongxia, 2010, Weishengwu Xuebao, V50, P937	21	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0229073	10.1371/journal.pone.0229073	http://dx.doi.org/10.1371/journal.pone.0229073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040501	Green Published, gold, Green Submitted			2022-12-26	WOS:000534629400060
J	Fischer, D; Mostaghim, S; Albantakis, L				Fischer, Dominik; Mostaghim, Sanaz; Albantakis, Larissa			How cognitive and environmental constraints influence the reliability of simulated animats in groups	PLOS ONE			English	Article							GROUP-SIZE; EVOLUTION	Evolving in groups can either enhance or reduce an individual's task performance. Still, we know little about the factors underlying group performance, which may be reduced to three major dimensions: (a) the individual's ability to perform a task, (b) the dependency on environmental conditions, and (c) the perception of, and the reaction to, other group members. In our research, we investigated how these dimensions interrelate in simulated evolution experiments using adaptive agents equipped with Markov brains ("animats"). We evolved the animats to perform a spatial-navigation task under various evolutionary setups. The last generation of each evolution simulation was tested across modified conditions to evaluate and compare the animats' reliability when faced with change. Moreover, the complexity of the evolved Markov brains was assessed based on measures of information integration. We found that, under the right conditions, specialized animats could be as reliable as animats already evolved for the modified tasks, and that reliability across varying group sizes correlated with evolved fitness in most tested evolutionary setups. Our results moreover suggest that balancing the number of individuals in a group may lead to higher reliability but also lower individual performance. Besides, high brain complexity was associated with balanced group sizes and, thus, high reliability under limited sensory capacity. However, additional sensors allowed for even higher reliability across modified environments without a need for complex, integrated Markov brains. Despite complex dependencies between the individual, the group, and the environment, our computational approach provides a way to study reliability in group behavior under controlled conditions. In all, our study revealed that balancing the group size and individual cognitive abilities prevents over-specialization and can help to evolve better reliability under unknown environmental situations.	[Fischer, Dominik] Tech Univ Munich, Sch Management, Munich, Germany; [Mostaghim, Sanaz] Otto von Guericke Univ, Fac Comp Sci, Magdeburg, Germany; [Albantakis, Larissa] Univ Wisconsin, Wisconsin Inst Sleep & Consciousness, Dept Psychiat, Madison, WI USA; [Fischer, Dominik] Tech Univ Munich, Sch Management, Full Professorship Financial Accounting, Munich, Germany	Technical University of Munich; Otto von Guericke University; University of Wisconsin System; University of Wisconsin Madison; Technical University of Munich	Fischer, D (corresponding author), Tech Univ Munich, Sch Management, Munich, Germany.; Fischer, D (corresponding author), Tech Univ Munich, Sch Management, Full Professorship Financial Accounting, Munich, Germany.	d.fischer@tum.de	Albantakis, Larissa/K-5235-2019	Albantakis, Larissa/0000-0003-1000-9917; Fischer, Dominik/0000-0002-4801-7595; Mostaghim, Sanaz/0000-0002-9917-5227	Templeton World Charity Foundation, Inc. [TWCF0196]; Tiny Blue Dot Foundation [UW 133AAG3451]; "Digitaler Campus Bayern" Fund of the Free State of Bavaria, Germany [Kap. 15 06 TG 98]	Templeton World Charity Foundation, Inc.; Tiny Blue Dot Foundation; "Digitaler Campus Bayern" Fund of the Free State of Bavaria, Germany	This project was made possible through the support of a grant from Templeton World Charity Foundation, Inc. (#TWCF0196) received by L.A.. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of Templeton World Charity Foundation, Inc. In addition, L.A. was supported by the Tiny Blue Dot Foundation (UW 133AAG3451). https://www.templetonworldcharity.org.D.F.receives funding from the "Digitaler Campus Bayern" (Kap. 15 06 TG 98) Fund of the Free State of Bavaria, Germany. https://www.stmwk.bayern.de/studenten/digitalisierung/hochschule-digitalercampus.html.S.M.does not receive specific funding, which supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other authors receive no specific funding for this work.	Albantakis L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003966; Ay N, 2008, ADV COMPLEX SYST, V11, P17, DOI 10.1142/S0219525908001465; Beer RD, 2015, COGNITIVE SCI, V39, P1, DOI 10.1111/cogs.12142; Bohm C, 2017, FOURTEENTH EUROPEAN CONFERENCE ON ARTIFICIAL LIFE (ECAL 2017), P76; BROWN JL, 1982, J THEOR BIOL, V95, P793, DOI 10.1016/0022-5193(82)90354-X; Dorigo M, 2004, AUTON ROBOT, V17, P223, DOI 10.1023/B:AURO.0000033973.24945.f3; Edlund JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002236; Engel D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205335; Fischer D, 2018, GECCO'18: PROCEEDINGS OF THE 2018 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P77, DOI 10.1145/3205455.3205646; Fleck L., 1983, GENESIS DEV SCI FACT, DOI [10.2307/2067139, DOI 10.2307/2067139]; GARDNER H, 1987, ANN DYSLEXIA, V37, P19, DOI 10.1007/BF02648057; Garnier Simon, 2007, Swarm Intelligence, V1, P3, DOI 10.1007/s11721-007-0004-y; Garnier S, 2014, LNCS, V8667; Hamann H, 2014, ALIFE 2014: THE FOURTEENTH INTERNATIONAL CONFERENCE ON THE SYNTHESIS AND SIMULATION OF LIVING SYSTEMS, P344, DOI 10.7551/978-0-262-32621-6-ch055; Hintze A., 2019, GENETIC PROGRAMMING, P17, DOI [10.1007/978-3-030-04735-1_2, DOI 10.1007/978-3-030-04735-1_2]; Hintze A., 2017, MARKOV BRAINS TECHNI; Hintze A, 2018, STRUCTURE EVOLVED RE; Ishiwata H, 2010, LECT NOTES ARTIF INT, V6464, P364, DOI 10.1007/978-3-642-17432-2_37; Joshi NJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003111; Karpov IV, 2015, IEEE CONF COMPU INTE, P292, DOI 10.1109/CIG.2015.7317946; King Daniel, ACAD MANAGEMENT P, V2017, P11804, DOI [10.5465/ambpp.2017.11804abstract, DOI 10.5465/AMBPP.2017.12706ABSTRACT, DOI 10.5465/AMBPP.2017.12905]; Konig L, 2009, INT J INTELL COMPUT, V2, P695, DOI 10.1108/17563780911005845; List C, 2006, SOUTHERN J PHILOS, V44, P85, DOI 10.1111/j.2041-6962.2006.tb00032.x; LIU Shen, 2017, SCI REP-UK, V7, P1, DOI 10.1038/s41598-016-0028-x; Lizier JT, 2014, EMERGENCE COMPLEX CO, V9, P115, DOI 10.1007/978-3-642-53734-9_5; Marshall W, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0358; Marshall W, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00926; Marstaller L, 2013, NEURAL COMPUT, V25, P2079, DOI 10.1162/NECO_a_00475; Mayner WGP, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006343; Miikkulainen Risto, 2012, Advances in Computational Intelligence. IEEE World Congress on Computational Intelligence (WCCI 2012). Plenary/Invited Lectures, P24, DOI 10.1007/978-3-642-30687-7_2; Nonaka I., 2000, IND CORP CHANGE, V9, P1, DOI DOI 10.1093/ICC/9.1.1; Oizumi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003588; Olson RS, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P247; Olson RS, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0305; Olson RS, 2015, THESIS; Pacala SW, 1996, EVOL ECOL, V10, P127, DOI 10.1007/BF01241782; Pinter-Wollman N, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0232; Reid CR, 2015, P NATL ACAD SCI USA, V112, P15113, DOI 10.1073/pnas.1512241112; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stanley KO, 2005, IEEE T EVOLUT COMPUT, V9, P653, DOI 10.1109/TEVC.2005.856210; Stanley KO, 2003, P 1 ART INT INT DIG, P2003; Tononi G., 2015, SCHOLARPEDIA, V10, P4164, DOI [10.4249/scholarpedia.4164, DOI 10.4249/SCHOLARPEDIA.4164]; Tsoukas H, 1996, STRATEGIC MANAGE J, V17, P11, DOI 10.1002/smj.4250171104; WALSH JP, 1991, ACAD MANAGE REV, V16, P57, DOI 10.2307/258607; Weick K.E., 2008, CRISIS MANAGEMENT, V3, P81, DOI DOI 10.1177/0020764009106599; WEICK KE, 1993, ADMIN SCI QUART, V38, P357, DOI 10.2307/2393372; Zenil H., 2009, ARXIV09104042, P1	47	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228879	10.1371/journal.pone.0228879	http://dx.doi.org/10.1371/journal.pone.0228879			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9HH	32032380	Green Published, Green Submitted, gold			2022-12-26	WOS:000534626100032
J	Galli, G; Alves, FC; Morosini, JS; Fritsche-Neto, R				Galli, Giovanni; Alves, Filipe Couto; Morosini, Julia Silva; Fritsche-Neto, Roberto			On the usefulness of parental lines GWAS for predicting low heritability traits in tropical maize hybrids	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; USE EFFICIENCY; SELECTION; PERFORMANCE; MODELS; ARCHITECTURE; REGRESSION; FRAMEWORK; POWERFUL; TOOL	Genome-wide association studies (GWAS) is one of the most popular methods of studying the genetic control of traits. This methodology has been intensely performed on inbred genotypes to identify causal variants. Nonetheless, the lack of covariance between the phenotype of inbred lines and their offspring in cross-pollinated species (such as maize) raises questions on the applicability of these findings in a hybrid breeding context. To address this topic, we incorporated previously reported parental lines GWAS information into the prediction of a low heritability trait in hybrids. This was done by marker-assisted selection based on significant markers identified in the lines and by genomic prediction having these markers as fixed effects. Additive-dominance GWAS of hybrids, a non-conventional procedure, was also performed for comparison purposes. Our results suggest that incorporating information from parental inbred lines GWAS led to decreases in the predictive ability of hybrids. Correspondingly, inbred lines and hybrids-based GWAS yielded different results. These findings do not invalidate GWAS on inbred lines for selection purposes, but mean that it may not be directly useful for hybrid breeding.	[Galli, Giovanni; Morosini, Julia Silva; Fritsche-Neto, Roberto] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Piracicaba, SP, Brazil; [Alves, Filipe Couto] Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA	Universidade de Sao Paulo; Michigan State University	Galli, G (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Piracicaba, SP, Brazil.	giovannigalli@usp.br	Galli, Giovanni/N-7015-2017; Fritsche-Neto, Roberto/B-2256-2013; Silva Morosini, Julia/D-5183-2018	Galli, Giovanni/0000-0002-3400-7978; Fritsche-Neto, Roberto/0000-0003-4310-0047; Silva Morosini, Julia/0000-0002-4106-6941	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2017/25549-6, 2017/24327-0, 2013/24135-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financed by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance Code 001, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2017/25549-6, 2017/24327-0, and 2013/24135-2 Dr. Roberto Fritsche-Neto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanno EC, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0405-y; Alves F, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0388-x; BERNARDO R, 1991, THEOR APPL GENET, V82, P17, DOI 10.1007/BF00231272; Bernardo R., 2010, BREEDING QUANTITATIV, V2; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Bernardo R, 2014, CROP SCI, V54, P68, DOI 10.2135/cropsci2013.05.0315; Bonnafous F, 2018, THEOR APPL GENET, V131, P319, DOI 10.1007/s00122-017-3003-4; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Covarrubias-Pazaran G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156744; de los Campos G, 2009, J ANIM SCI, V87, P1883, DOI 10.2527/jas.2008-1259; Farfan IDB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117737; Fritsche-Neto R., 2019, **DATA OBJECT**, V3, P1, DOI 10.17632/tpcw383fkm.3; Fritsche-Neto R, 2018, THEOR APPL GENET, V131, P1153, DOI 10.1007/s00122-018-3068-8; Gilmour AR, 2009, ASREML USER GUIDE RE; Gowda M, 2015, THEOR APPL GENET, V128, P1957, DOI 10.1007/s00122-015-2559-0; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; LANDE R, 1990, GENETICS, V124, P743; Li HD, 2015, GENETICA, V143, P299, DOI 10.1007/s10709-015-9826-5; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Lopes MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105867; Lyra DH, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0681-1; Mammadov J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2171-3; Mendonca LD, 2017, SCI AGR, V74, P481, DOI [10.1590/1678-992x-2016-0313, 10.1590/1678-992X-2016-0313]; Meuwissen THE, 2001, GENETICS, V157, P1819; Miti F, 2004, S1 SELECTION LOCAL M, V4, P67; Monir MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep38600; Morosini JS, 2017, PLANT SOIL, V421, P453, DOI 10.1007/s11104-017-3479-3; Pace J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1226-9; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Peiffer JA, 2014, GENETICS, V196, P1337, DOI 10.1534/genetics.113.159152; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Rice B, 2019, PLANT GENOME-US, V12, DOI 10.3835/plantgenome2018.07.0052; Schrag TA, 2009, MAYDICA, V54, P353; SMITH OS, 1986, CROP SCI, V26, P540, DOI 10.2135/cropsci1986.0011183X002600030023x; Spindel JE, 2016, HEREDITY, V116, P395, DOI 10.1038/hdy.2015.113; Technow F, 2012, THEOR APPL GENET, V125, P1181, DOI 10.1007/s00122-012-1905-8; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang JB, 2018, HEREDITY, V121, P648, DOI 10.1038/s41437-018-0075-0; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Xiao YJ, 2017, MOL PLANT, V10, P359, DOI 10.1016/j.molp.2016.12.008; Xu SZ, 2003, GENETICS, V165, P2259; Zhang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093017	44	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228724	10.1371/journal.pone.0228724	http://dx.doi.org/10.1371/journal.pone.0228724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032385	gold, Green Published			2022-12-26	WOS:000534626100021
J	Kamtchum-Tatuene, J; Mwandumba, HC; Kachingwe, GM; Bonnett, LJ; Kayange, N; Solomon, T; Benjamin, LA				Kamtchum-Tatuene, Joseph; Mwandumba, Henry C.; Kachingwe, Gloria Mwangalika; Bonnett, Laura J.; Kayange, Noel; Solomon, Tom; Benjamin, Laura A.			A cross-sectional feasibility study of neurovascular ultrasound in Malawian adults with acute stroke-like syndrome	PLOS ONE			English	Article							CAROTID-ARTERY STENOSIS; TRANSCRANIAL DOPPLER; HYPERTENSION; THICKNESS; CARE	Background In sub-Saharan Africa, there is a dearth of epidemiologic data on the burden of cerebral atherosclerosis. This is explained by the limited availability and the high cost of standard vascular imaging techniques. Neurovascular ultrasound is portable, cheaper and non-invasive and could, therefore, represent a reasonable alternative to fill this knowledge gap. We explored the feasibility of neurovascular ultrasound in Malawian adults with acute stroke-like syndrome to inform the design of future large stroke studies comparing its diagnostic performance to that of gold standard vascular imaging techniques in sub-Saharan Africa. Methods We enrolled consecutive patients diagnosed with acute stroke-like syndrome based on the World Health Organization definition. Clinical and demographic data were recorded, and a comprehensive neurovascular ultrasound was performed. Fisher's exact and Kruskal-Wallis tests were used to study the relationship between atherosclerosis and potential risk factors. Results Sixty-six patients were enrolled (mean age: 58.7 years). The frequency of extracranial atherosclerosis was 39.4% (n = 26, 95% CI: 28.6-52.2). There were 12 patients with abnormal carotid intima media thickness (18.2%, 95% CI: 9.8-29.6) and 14 patients with a carotid plaque (21.2%, 95% CI: 12.1-33.0). The frequency of intracranial atherosclerosis was 19.2% (95%CI: 6.6-39.4) in 26 patients with successful transcranial insonation. Hypertension (80.8 versus 52.5%, p = 0.03) and hypercholesterolemia (11.5 versus 0.0%, p = 0.05) were more prevalent in patients with extracranial atherosclerosis. Conclusions This study demonstrates the feasibility of neurovascular ultrasound to assess cervical arteries in adults with stroke-like syndrome in sub-Saharan Africa. There is a high rate of transcranial insonation failure in this setting, highlighting the need for echocontrast agents.	[Kamtchum-Tatuene, Joseph; Mwandumba, Henry C.; Kachingwe, Gloria Mwangalika] Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Coll Med, Blantyre, Malawi; [Mwandumba, Henry C.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Bonnett, Laura J.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Kayange, Noel] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Solomon, Tom; Benjamin, Laura A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Kamtchum-Tatuene, Joseph] Univ Alberta, Fac Med & Dent, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Benjamin, Laura A.] UCL, Stroke Res Ctr, Queen Sq Inst Neurol, London, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Liverpool; University of Alberta; University of London; University College London	Kamtchum-Tatuene, J (corresponding author), Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Coll Med, Blantyre, Malawi.; Kamtchum-Tatuene, J (corresponding author), Univ Alberta, Fac Med & Dent, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.	kamtchum@ualberta.ca	TATUENE, Joseph KAMTCHUM/W-3028-2017; Bonnett, Laura/A-2159-2015	TATUENE, Joseph KAMTCHUM/0000-0002-1041-4202; Benjamin, Laura/0000-0002-9685-1664; Bonnett, Laura/0000-0002-6981-9212	Wellcome Trust [106829/Z/15/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Wellcome Trust, grant number 106829/Z/15/Z (https://wellcome.ac.uk/) to JKT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Allah FA, 2010, INT J STROKE, V5, P516, DOI 10.1111/j.1747-4949.2010.00526.x; Battistella V, 2014, EUR J NEUROL, V21, P956, DOI 10.1111/ene.12385; Benjamin LA, 2017, J INFECT DIS, V216, P545, DOI 10.1093/infdis/jix340; Benjamin LA, 2016, NEUROLOGY, V86, P324, DOI 10.1212/WNL.0000000000002278; Choi YJ, 2015, J STROKE, V17, P238, DOI 10.5853/jos.2015.17.3.238; Del Brutto OH, 2016, J CLIN ULTRASOUND, V44, P55, DOI 10.1002/jcu.22284; Droste DW, 2008, EUR NEUROL, V59, P2, DOI 10.1159/000114454; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Guan JX, 2013, NEUROL RES, V35, P930, DOI 10.1179/1743132813Y.0000000230; Jahromi AS, 2005, J VASC SURG, V41, P962, DOI 10.1016/j.jvs.2005.02.044; Nedelmann M, 2009, STROKE, V40, P3238, DOI 10.1161/STROKEAHA.109.555169; Oladapo OO., 2013, NIGERIAN J CARDIOLOG, V10, P62, DOI [10.4103/0189-7969.127002, DOI 10.4103/0189-7969.127002]; Olatunji RB, 2018, CEREBROVASC DIS EXTR, V8, P26, DOI 10.1159/000485195; Price AJ, 2018, LANCET DIABETES ENDO, V6, P208, DOI 10.1016/S2213-8587(17)30432-1; Qureshi AI, 2014, LANCET, V383, P984, DOI 10.1016/S0140-6736(13)61088-0; ROTHWELL PM, 1994, STROKE, V25, P2435, DOI 10.1161/01.STR.25.12.2435; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Zhao LM, 2011, STROKE, V42, P3429, DOI 10.1161/STROKEAHA.111.621235; Zunker P, 2002, STROKE, V33, P2600, DOI 10.1161/01.STR.0000035285.43467.FF	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0229033	10.1371/journal.pone.0229033	http://dx.doi.org/10.1371/journal.pone.0229033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032392	gold, Green Published, Green Accepted			2022-12-26	WOS:000534626100036
J	Elisia, I; Lam, V; Cho, B; Hay, M; Li, MY; Kapeluto, J; Elliott, T; Harris, D; Bu, L; Jia, W; Leung, H; Mohn, W; Krystal, G				Elisia, Ingrid; Lam, Vivian; Cho, Brandon; Hay, Mariah; Li, Michael Yu; Kapeluto, Jordanna; Elliott, Tom; Harris, David; Bu, Luke; Jia, William; Leung, Hilary; Mohn, William; Krystal, Gerald			Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; DIET-INDUCED OBESITY; ADIPOSE-TISSUE; T-CELLS; HOMEOSTASIS; OVERWEIGHT; EXPRESSION; RESISTANCE; HEPARIN; PROTEIN	Obesity has reached epidemic proportions and is often accompanied by elevated levels of pro-inflammatory cytokines that promote many chronic diseases, including cancer. However, not all obese people develop these diseases and it would be very helpful to identify those at high risk early on so that preventative measures can be instituted. We performed an extensive evaluation of the effects of obesity on inflammatory markers, on innate and adaptive immune responses, and on blood cell composition to identify markers that might be useful in distinguishing those at elevated risk of cancer. Plasma samples from 42 volunteers with a BMI>35 had significantly higher CRP, PGE(2), IL-1RA, IL-6 and IL-17 levels than 34 volunteers with normal BMIs. Of the cytokines and chemokines tested, only IL-17 was significantly higher in men with a BMI>35 than women with a BMI>35. As well, only IL-17 was significantly higher in those with a BMI>35 that had type 2 diabetes versus those without type 2 diabetes. Whole blood samples from participants with a BMI>35, when challenged with E. coli, produced significantly higher levels of IL-1RA while HSV-1 challenge resulted in significantly elevated IL-1RA and VEGF, and a non-significant increase in G-CSF and IL-8 levels. T cell activation of PBMCs, via anti-CD3 plus anti-CD28, resulted in significantly higher IFN gamma production from volunteers with a BMI>35. In terms of blood cells, red blood cell distribution width (RDW), monocytes, granulocytes, CD4(+) T cells and Tregs were all significantly higher while, natural killer (NK) and CD8(+) T cells were all significantly lower in the BMI>35 cohort, suggesting that obesity may reduce the ability to kill nascent tumor cells. Importantly, however, there was considerable person-to-person variation amongst participants with a BMI>35, with some volunteers showing markedly different values from controls and others showing normal levels of many parameters measured. These person-to-person variations may prove useful in identifying those at high risk of developing cancer.	[Elisia, Ingrid; Lam, Vivian; Cho, Brandon; Hay, Mariah; Li, Michael Yu; Krystal, Gerald] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Kapeluto, Jordanna] Univ British Columbia, Dept Med, Div Endocrinol, Vancouver, BC, Canada; [Elliott, Tom] BC Diabet, Vancouver, BC, Canada; [Harris, David] Richmond Gen Hosp Metab & Bariatr Surg, Richmond, BC, Canada; [Bu, Luke; Jia, William] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada; [Leung, Hilary] Microbiome Insights, Vancouver, BC, Canada; [Mohn, William] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Krystal, G (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada.	gkrystal@bccrc.ca		Krystal, Gerald/0000-0002-1961-6281	Lotte & John Hecht Memorial Foundation [3693]; BC Cancer Foundation; BC Cancer Agency	Lotte & John Hecht Memorial Foundation; BC Cancer Foundation; BC Cancer Agency	The research was supported by the Lotte & John Hecht Memorial Foundation, grant number 3693 (http://www.hecht.org/), with core support from the BC Cancer Foundation and the BC Cancer Agency, to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moneim A, 2018, BIOMED PHARMACOTHER, V101, P287, DOI 10.1016/j.biopha.2018.02.103; Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; BESSMAN JD, 1983, AM J CLIN PATHOL, V80, P322, DOI 10.1093/ajcp/80.3.322; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Brinkworth GD, 2004, INT J OBESITY, V28, P661, DOI 10.1038/sj.ijo.0802617; Charles BA, 2011, J CLIN ENDOCR METAB, V96, pE2018, DOI 10.1210/jc.2011-1497; Cherayil BJ, 2015, J PEDIATR-US, V167, pS15, DOI 10.1016/j.jpeds.2015.07.015; Costache MI, 2015, ROM J INTERN MED, V53, P199, DOI 10.1515/rjim-2015-0027; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Deng T, 2016, ANNU REV PATHOL-MECH, V11, P421, DOI 10.1146/annurev-pathol-012615-044359; Dicker D, 2013, OBESITY FACTS, V6, P146, DOI 10.1159/000350775; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Elisia I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188881; Frasca D, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01745, 10.3389/fimmu.2017.01003]; Fujita B, 2013, PEDIATR OBES, V8, P385, DOI 10.1111/j.2047-6310.2012.00111.x; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Gabay C, 2001, J CLIN ENDOCR METAB, V86, P783, DOI 10.1210/jc.86.2.783; Gao XL, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0384-x; Honce R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01071; Hooper KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179184; Huang L, 2018, PULM CIRC, V8, DOI 10.1177/2045893218755987; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Idborg H, 2018, LUPUS SCI MED, V5, DOI 10.1136/lupus-2018-000260; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kern L, 2019, CANCERS, V11, DOI 10.3390/cancers11010024; Kim J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29855-z; Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932; Maddur MS, 2015, CELL MOL IMMUNOL, V12, P650, DOI 10.1038/cmi.2014.117; Maloney JP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/387842; Mao YM, 2014, CLIN CANCER RES, V20, P4096, DOI 10.1158/1078-0432.CCR-14-0635; Meier CA, 2002, J CLIN ENDOCR METAB, V87, P1184, DOI 10.1210/jc.87.3.1184; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Milner JJ, 2015, J IMMUNOL, V194, P4846, DOI 10.4049/jimmunol.1402295; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Moretta L, 2010, BLOOD, V116, P3689, DOI 10.1182/blood-2010-09-303057; Muniz MGR, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3412732; Murray PJ, 2014, CELL METAB, V19, P735, DOI 10.1016/j.cmet.2014.04.010; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Newhall KJ, 2010, CLIN CHEM, V56, P1483, DOI 10.1373/clinchem.2006.144618; Ngwa DN, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00166; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Rourke RW, 2006, CLIN EXP IMMUNOL, V146, P39, DOI 10.1111/j.1365-2249.2006.03186.x; O'Shea D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008660; Obermann HL, 2012, IMMUNITY, V36, P159, DOI 10.1016/j.immuni.2012.02.003; Pandolfi JB, 2016, J IMMUNOL, V196, P3287, DOI 10.4049/jimmunol.1502506; Paquissi FC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01195; Pinti M, 2016, EUR J IMMUNOL, V46, P2286, DOI 10.1002/eji.201546178; Pirola Luciano, 2017, World J Biol Chem, V8, P120, DOI 10.4331/wjbc.v8.i2.120; SABA HI, 1984, AM J HEMATOL, V17, P295, DOI 10.1002/ajh.2830170310; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Somm E, 2006, DIABETOLOGIA, V49, P387, DOI 10.1007/s00125-005-0046-x; Striz I, 2017, CLIN SCI, V131, P2241, DOI 10.1042/CS20170098; Sudhakar M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01167; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Sung HK, 2013, CELL METAB, V17, P61, DOI 10.1016/j.cmet.2012.12.010; Swift ML, 1997, J CHEM INF COMP SCI, V37, P411, DOI 10.1021/ci960402j; Trim W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00169; van der Weerd K, 2012, DIABETES, V61, P401, DOI 10.2337/db11-1065; Viel S, 2017, CLIN IMMUNOL, V177, P12, DOI 10.1016/j.clim.2016.01.007; Vuong J, 2014, AM J HEMATOL, V89, P671, DOI 10.1002/ajh.23713; Wan TM, 2016, OBESITY, V24, P2101, DOI 10.1002/oby.21608; Wedell-Neergaard AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190645; Woolcott OO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29362-1; Yang HZ, 2017, INT SYMP WIREL, P380; Zhang Z, 2018, HIV CLIN TRIALS, V19, P172, DOI 10.1080/15284336.2018.1514821	71	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228633	10.1371/journal.pone.0228633	http://dx.doi.org/10.1371/journal.pone.0228633			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027700	Green Published, Green Submitted, gold			2022-12-26	WOS:000534623800059
J	Zhang, BB; Zhang, H; Jing, Q; Wu, YX; Ma, SQ				Zhang, Beibei; Zhang, Hui; Jing, Qi; Wu, Yuexuan; Ma, Shuqin			Differences in species diversity, biomass, and soil properties of five types of alpine grasslands in the Northern Tibetan Plateau	PLOS ONE			English	Article							PARTICLE-SIZE DISTRIBUTION; ENVIRONMENTAL-FACTORS; ABOVEGROUND BIOMASS; PLANT DIVERSITY; PRODUCTIVITY; VEGETATION; STEPPE; CHINA; BIODIVERSITY; MANAGEMENT	Approximately 94% of the land area of the Northern Tibetan Plateau is covered by grasslands, which comprise one of five key livestock producing regions in China. In contrast to most other regions worldwide, these alpine grasslands are much more sensitive to global climate change, thus they are under intense study. The differences in species diversity, plant biomass, and soil properties of five representative's alpine grassland types in the Northern Tibetan Plateau were investigated in this research. The results revealed that 11 community types were identified according to the importance of dominant species and constructive species. There were significant differences in the Margalef index (H), Simpson diversity index (D), Shannon-wiener diversity index (H'), and Pielou evenness index (J) indices between these five alpine grasslands. Further, the above-ground biomass (AGB), below-ground biomass (BGB), total biomass (TB), root:shoot (R/S) ratio, and coverage showed significant differences in 5 alpine grasslands. There were also considerable variations in the pH, total nitrogen concentration (TN), total phosphorus concentration (TP), soil organic carbon (SOC) and C-to-N ratio (C:N) among the five alpine grasslands. The highest value of biomass and soil characteristics was always in the alpine steppe (AS), or AM, while the lowest of that was in the alpine desert steppe (ADS), or alpine desert (AD). Moreover, there were significant differences in the soil particle size fractions between the five alpine grasslands. In the AM and AS, the dominant soil particle was clay, while in the alpine meadow-steppe (AMS), ADS, and AD it was fine and medium sand. Substantial correlations were found between the biomass and species diversity indices H, D or H' and soil TN, TP, or SOC. Moreover, silt had a significantly positive correlation with soil C:N, BGB, TB, and R/S, while medium sand and coarse sand was significant negatively correlated. With regard to these grassland types, it is proposed that the AM or AS may be an actively changing grassland types in the Northern Tibetan Plateau.	[Zhang, Beibei; Zhang, Hui; Jing, Qi; Wu, Yuexuan] Baoji Univ Arts & Sci, Coll Geog & Environm, Shaanxi Key Lab Disaster Monitoring & Mech Simula, Baoji, Peoples R China; [Zhang, Beibei] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Ma, Shuqin] Henan Normal Univ, Coll Tourism, Xinxiang, Henan, Peoples R China	Baoji University of Arts & Sciences; Northern Arizona University; Henan Normal University	Zhang, H (corresponding author), Baoji Univ Arts & Sci, Coll Geog & Environm, Shaanxi Key Lab Disaster Monitoring & Mech Simula, Baoji, Peoples R China.	huizai207@126.com			National Natural Science Foundation of China (NSFC) [41601016]; Special Support Program for HighLevel Personnel Recruitment (Youth Top-Talent) of Shaanxi province; National Natural Science Foundation of Shaanxi province [2017JQ4023]; Key Project of Baoji University of Arts and Sciences [ZK2018012]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Support Program for HighLevel Personnel Recruitment (Youth Top-Talent) of Shaanxi province; National Natural Science Foundation of Shaanxi province; Key Project of Baoji University of Arts and Sciences	This work was supported by the National Natural Science Foundation of China (NSFC, No. 41601016), Special Support Program for HighLevel Personnel Recruitment (Youth Top-Talent) of Shaanxi province, National Natural Science Foundation of Shaanxi province (No. 2017JQ4023), The Key Project of Baoji University of Arts and Sciences (No. ZK2018012).	AGBU PA, 1990, SOIL SCI, V150, P777, DOI 10.1097/00010694-199011000-00004; Braakhekke WG, 1999, J VEG SCI, V10, P187, DOI 10.2307/3237140; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; Chala D, 2016, ECOL EVOL, V6, P8931, DOI 10.1002/ece3.2603; CHANG DHS, 1986, ECOLOGY, V67, P1568, DOI 10.2307/1939087; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen WN, 2008, J MT SCI-ENGL, V5, P327, DOI 10.1007/s11629-008-0182-0; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Dong SK, 2020, AGR ECOSYST ENVIRON, V287, DOI 10.1016/j.agee.2019.106684; Dukes JS, 2001, OIKOS, V94, P468, DOI 10.1034/j.1600-0706.2001.940309.x; Elliott KJ, 1997, FOREST ECOL MANAG, V92, P67, DOI 10.1016/S0378-1127(96)03947-3; Fan JW, 2008, CLIMATIC CHANGE, V86, P375, DOI 10.1007/s10584-007-9316-6; Gamito S, 2010, ECOL INDIC, V10, P550, DOI 10.1016/j.ecolind.2009.07.006; Ganjurjav H, 2016, AGR FOREST METEOROL, V223, P233, DOI 10.1016/j.agrformet.2016.03.017; Gao QZ, 2010, QUATERN INT, V226, P143, DOI 10.1016/j.quaint.2009.10.035; Gao QZ, 2009, CLIMATIC CHANGE, V97, P515, DOI 10.1007/s10584-009-9617-z; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huston M. A., 1994, BIOL DIVERSITY; Kandeler E, 1999, SOIL BIOL BIOCHEM, V31, P261, DOI 10.1016/S0038-0717(98)00115-1; Li W., 1993, FORESTS HIMALAYAN HE; Li XJ, 2011, ENVIRON EARTH SCI, V64, P1911, DOI 10.1007/s12665-011-1004-1; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Lu XY, 2011, J MT SCI-ENGL, V8, P838, DOI 10.1007/s11629-011-2182-8; Luo TX, 2002, ECOL APPL, V12, P980, DOI 10.1890/1051-0761(2002)012[0980:EBAPON]2.0.CO;2; Maynard DS, 2017, P NATL ACAD SCI USA, V114, P11464, DOI 10.1073/pnas.1712211114; McIntosh PD, 1997, J ENVIRON MANAGE, V51, P169, DOI 10.1006/jema.1997.0143; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Ricotta C, 2003, ECOL INDIC, V2, P361, DOI 10.1016/S1470-160X(03)00005-0; Ryzak M, 2011, J PLANT NUTR SOIL SC, V174, P624, DOI 10.1002/jpln.201000255; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schnyder H, 2010, NUTR CYCL AGROECOSYS, V88, P183, DOI 10.1007/s10705-009-9334-z; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; Shang Z., 2007, FRONT AGR CHINA, V1, P197, DOI [10.1007/s11703-007-0034-7, DOI 10.1007/S11703-007-0034-7]; Shang ZH, 2016, ECOL ENG, V90, P268, DOI 10.1016/j.ecoleng.2016.01.067; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shukla MK, 2004, SOIL SCI, V169, P215, DOI 10.1097/01.ss.0000122521.03492.eb; Spehn EM, 2000, PLANT SOIL, V224, P217, DOI 10.1023/A:1004891807664; Su YZ, 2004, GEODERMA, V122, P43, DOI 10.1016/j.geoderma.2003.12.003; Sun J, 2013, BIOGEOSCIENCES, V10, P1707, DOI 10.5194/bg-10-1707-2013; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Wang CT, 2007, AUST J BOT, V55, P110, DOI 10.1071/BT04070; Wang CT, 2008, SCI CHINA SER C, V51, P86, DOI 10.1007/s11427-008-0011-2; Wang D, 2008, CATENA, V72, P29, DOI 10.1016/j.catena.2007.03.019; Wang WY, 2006, ECOL RES, V21, P181, DOI 10.1007/s11284-005-0108-z; Wei YX, 2001, NEW ZEAL J AGR RES, V44, P253; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wu JB, 2013, PLOS ONE, V12, P1; Wu Y, 2018, PLANT SOIL, V432, P107, DOI 10.1007/s11104-018-3781-8; Yang YH, 2009, J ARID ENVIRON, V73, P91, DOI 10.1016/j.jaridenv.2008.09.027; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; Zhao GS, 2017, ECOL EVOL, V7, P7201, DOI 10.1002/ece3.3283	55	6	6	11	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228277	10.1371/journal.pone.0228277	http://dx.doi.org/10.1371/journal.pone.0228277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027662	gold, Green Published			2022-12-26	WOS:000534623800019
J	Binder, J; Carta, S; Carvalho, JS; Kalafat, E; Khalil, A; Thilaganathan, B				Binder, Julia; Carta, Silvia; Carvalho, Julene S.; Kalafat, Erkan; Khalil, Asma; Thilaganathan, Basky			Evidence for uteroplacental malperfusion in fetuses with major congenital heart defects	PLOS ONE			English	Article							REFERENCE RANGES; HUMAN PLACENTA; GROWTH-FACTOR; FETAL; DOPPLER; ARTERY; EXPRESSION; VCAM-1; RATIO	Aims Fetuses affected by congenital heart defects (CHD) are considered to be at increased risk of fetal growth restriction and intrauterine demise. Whether these risks are a direct consequence of fetal CHD or a result of associated uteroplacental dysfunction is not evident from the data of recent studies. The aim of this study was to investigate the prevalence of uteroplacental dysfunction reflected by abnormal uterine artery Doppler indices and reduced fetal growth in CHD pregnancies. Methods This is a retrospective case-control study including singleton pregnancies referred for detailed fetal cardiac assessment subsequently diagnosed with or without CHD. Mid-trimester uterine artery Doppler assessment at 20-24 weeks as well as third trimester fetal biometry and arterial Doppler pulsatility indices (PI) were performed. All fetal biometry were converted into centiles and Doppler values to multiples of median (MoM) to adjust for physiological changes with gestation. Results The study included 811 pregnancies including 153 cases where the fetus was diagnosed with CHD. Mid-pregnancy uterine artery PI was significantly higher in women with fetal CHD compared to controls (0.90MoM vs 0.83MoM; p = 0.006). In the third trimester, median centiles for fetal head circumference (45.4 vs 57.07; p<0.001), abdominal circumference (51.17 vs 55.71; p = 0.014), estimated fetal weight (33.6 vs 56.7; p<0.001) and cerebroplacental ratio (CPR: 0.84MoM vs 0.95MoM; p<0.001) were significantly lower in fetuses with CHD compared to controls. The percentage of small for gestational age births < 10th centile (24.0% vs 10.7%; < 0.001) and low CPR < 0.6MoM (11.7% vs 2.5%; p<0.001) were significantly higher in the fetal CHD cohort. Conclusions Mid-pregnancy uterine artery resistance is increased and subsequent fetal biometry reduced in pregnancies with CHD fetuses. These findings suggest that fetal CHD are associated with uteroplacental dysfunction, secondary to impaired maternal uteroplacental perfusion resulting in relative fetal hypoxaemia and reduced fetal growth.	[Binder, Julia; Carta, Silvia; Carvalho, Julene S.; Kalafat, Erkan; Khalil, Asma; Thilaganathan, Basky] St Georges Univ London, St Georges Univ Hosp NHS Fdn Trust, Fetal Med Unit, London, England; [Binder, Julia; Carta, Silvia; Carvalho, Julene S.; Kalafat, Erkan; Khalil, Asma; Thilaganathan, Basky] St Georges Univ London, Mol & Clin Sci Res Inst, London, England; [Binder, Julia] Med Univ Vienna, Dept Obstet & Fetomaternal Med, Vienna, Austria; [Carvalho, Julene S.] Royal Brompton Hosp, Brompton Ctr Fetal Cardiol, London, England; [Kalafat, Erkan] Ankara Univ, Dept Obstet & Gynecol, Fac Med, Ankara, Turkey; [Kalafat, Erkan] Middle East Tech Univ, Dept Stat, Ankara, Turkey	St Georges University London; St Georges University London; Medical University of Vienna; Royal Brompton Hospital; Ankara University; Middle East Technical University	Thilaganathan, B (corresponding author), St Georges Univ London, St Georges Univ Hosp NHS Fdn Trust, Fetal Med Unit, London, England.; Thilaganathan, B (corresponding author), St Georges Univ London, Mol & Clin Sci Res Inst, London, England.	basky@pobox.com	Carvalho, Julene/E-8842-2015; Kalafat, Erkan/S-4762-2019	Carvalho, Julene/0000-0002-5698-5828; Kalafat, Erkan/0000-0003-0658-138X; Binder, Julia/0000-0002-5725-9270; Thilaganathan, Basky/0000-0002-5531-4301				Acharya G, 2005, AM J OBSTET GYNECOL, V192, P937, DOI 10.1016/j.ajog.2004.09.019; Bahlmann F, 2002, J PERINAT MED, V30, P490, DOI 10.1515/JPM.2002.077; Baschat AA, 2003, ULTRASOUND OBST GYN, V21, P124, DOI 10.1002/uog.20; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Boyd HA, 2017, CIRCULATION, V136, P39, DOI 10.1161/CIRCULATIONAHA.116.024600; Courtney JA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01045; De Falco M, 2007, PLACENTA, V28, P118, DOI 10.1016/j.placenta.2006.03.010; Fantasia I, 2018, ULTRASOUND OBST GYN, V51, P194, DOI 10.1002/uog.18839; Gomez O, 2008, ULTRASOUND OBST GYN, V32, P128, DOI 10.1002/uog.5315; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; HADLOCK FP, 1987, AM J OBSTET GYNECOL, V156, P955, DOI 10.1016/0002-9378(87)90365-6; Khalil A, 2014, ULTRASOUND OBST GYN, V43, P14, DOI 10.1002/uog.12526; Khalil A, 2016, ULTRASOUND OBSTET GY; KWEE L, 1995, DEVELOPMENT, V121, P489; Lee YM, 2006, DEV DYNAM, V235, P29, DOI 10.1002/dvdy.20559; Llurba E, 2013, ULTRASOUND OBST GYN, V42, P169, DOI 10.1002/uog.12346; Llurba E, 2014, EUR HEART J, V35, P701, DOI 10.1093/eurheartj/eht389; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; Masoller N, 2016, ULTRASOUND OBST GYN, V47, P65, DOI 10.1002/uog.14919; Masoller N, 2016, FETAL DIAGN THER, V39, P269, DOI 10.1159/000439527; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Poon LCY, 2016, ULTRASOUND OBST GYN, V48, P602, DOI 10.1002/uog.17287; Rajashekhar G, 2003, J SOC GYNECOL INVEST, V10, P352, DOI 10.1016/S1071-5576(03)00121-7; Ruiz A, 2016, J MATERN-FETAL NEO M, P1; Ruiz A, 2016, ULTRASOUND OBSTET GY; Sun LQ, 2015, CIRCULATION, V131, P1313, DOI 10.1161/CIRCULATIONAHA.114.013051; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0226741	10.1371/journal.pone.0226741	http://dx.doi.org/10.1371/journal.pone.0226741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023263	Green Accepted, Green Published, gold			2022-12-26	WOS:000534621500011
J	Bollig, N; Clarke, L; Elsmo, E; Craven, M				Bollig, Nathan; Clarke, Lorelei; Elsmo, Elizabeth; Craven, Mark			Machine learning for syndromic surveillance using veterinary necropsy reports	PLOS ONE			English	Article							DISEASE; CODES	The use of natural language data for animal population surveillance represents a valuable opportunity to gather information about potential disease outbreaks, emerging zoonotic diseases, or bioterrorism threats. In this study, we evaluate machine learning methods for conducting syndromic surveillance using free-text veterinary necropsy reports. We train a system to detect if a necropsy report from the Wisconsin Veterinary Diagnostic Laboratory contains evidence of gastrointestinal, respiratory, or urinary pathology. We evaluate the performance of several machine learning algorithms including deep learning with a long short-term memory network. Although no single algorithm was superior, random forest using feature vectors of TF-IDF statistics ranked among the top-performing models with F1 scores of 0.923 (gastrointestinal), 0.960 (respiratory), and 0.888 (urinary). This model was applied to over 33,000 necropsy reports and was used to describe temporal and spatial features of diseases within a 14-year period, exposing epidemiological trends and detecting a potential focus of gastrointestinal disease from a single submitting producer in the fall of 2016.	[Bollig, Nathan; Craven, Mark] Univ Wisconsin, Dept Comp Sci, 1210 W Dayton St, Madison, WI 53706 USA; [Bollig, Nathan] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Clarke, Lorelei; Elsmo, Elizabeth] Univ Wisconsin, Wisconsin Vet Diagnost Lab, Madison, WI USA; [Craven, Mark] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bollig, N (corresponding author), Univ Wisconsin, Dept Comp Sci, 1210 W Dayton St, Madison, WI 53706 USA.; Bollig, N (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.	nbollig@wisc.edu			Comparative Biomedical Sciences Training Program [NIH T32OD010423]; Wisconsin Veterinary Diagnostic Laboratory; NIH/NCATS [UL1 TR000427]	Comparative Biomedical Sciences Training Program; Wisconsin Veterinary Diagnostic Laboratory; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding was provided by the Comparative Biomedical Sciences Training Program (NIH T32OD010423) and the Wisconsin Veterinary Diagnostic Laboratory. The Wisconsin Veterinary Diagnostic Laboratory provided support for the study in the form of salaries for authors LC, EE and in the form of the article publication fee. MC was supported by NIH/NCATS UL1 TR000427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Arsevska E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199960; Arsevska E, 2016, COMPUT ELECTRON AGR, V123, P104, DOI 10.1016/j.compag.2016.02.010; Baumel T., 2017, ARXIV170909587; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buckley Julliette M, 2012, J Pathol Inform, V3, P23, DOI 10.4103/2153-3539.97788; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chollet F., 2015, KERAS; Coden A, 2009, J BIOMED INFORM, V42, P937, DOI 10.1016/j.jbi.2008.12.005; Conway M, 2013, J BIOMED INFORM, V46, P734, DOI 10.1016/j.jbi.2013.04.003; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Currie Anne-Marie, 2006, AMIA Annu Symp Proc, P899; de Lima OA, 2013, P IEEE RAP SYST PROT, P51, DOI 10.1109/RSP.2013.6683958; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dorea FC, 2016, VET MED-RES REP, V7, P157, DOI 10.2147/VMRR.S90182; Dorea FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057334; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; FURRER L, 2015, P C TERM ART INT, V2015, P61, DOI DOI 10.5167/UZH-114496; Gao S, 2018, J AM MED INFORM ASSN, V25, P321, DOI 10.1093/jamia/ocx131; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hanauer DA, 2007, J AM COLL SURGEONS, V205, P690, DOI 10.1016/j.jamcollsurg.2007.05.014; Henning K, 2004, MORB MORTAL WKLY R S, V53, P7, DOI DOI 10.1037/e307182005-001; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kavuluru R, 2015, ARTIF INTELL MED, V65, P155, DOI 10.1016/j.artmed.2015.04.007; Khor RC, 2019, INT J MED INFORM, V121, P53, DOI 10.1016/j.ijmedinf.2018.10.008; Kingma DP., 2014, ADAM METHOD STOCHAST; Kuker S, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1505-1; Lee SH, 2019, J BIOMED INFORM, V93, DOI 10.1016/j.jbi.2019.103158; Lu HM, 2008, J BIOMED INFORM, V41, P340, DOI 10.1016/j.jbi.2007.08.009; Neo JPS, 2017, VET MICROBIOL, V203, P40, DOI 10.1016/j.vetmic.2017.02.007; Nie A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0067-8; O'Toole D, 2010, VET PATHOL, V47, P40, DOI 10.1177/0300985809354349; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pennington J., 2014, P 2014 C EMPIRICAL M, P1532, DOI DOI 10.3115/V1/D14-1162; Pivovarov R, 2015, J BIOMED INFORM, V58, P156, DOI 10.1016/j.jbi.2015.10.001; R Core Team, 2021, R LANGUAGE ENV STAT; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Solt I, 2009, J AM MED INFORM ASSN, V16, P580, DOI 10.1197/jamia.M3087; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Subotin M, 2016, J AM MED INFORM ASSN, V23, P866, DOI 10.1093/jamia/ocv201; Tixier AJP, 2016, PROCEEDINGS OF 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL-2016): SYSTEM DEMONSTRATIONS, P151; Wang YS, 2018, J BIOMED INFORM, V77, P34, DOI 10.1016/j.jbi.2017.11.011; Yip Vincent, 2010, Summit Transl Bioinform, V2010, P43; Yoon HJ, 2017, 2017 IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL & HEALTH INFORMATICS (BHI), P369, DOI 10.1109/BHI.2017.7897282; Zhang YL, 2009, DECIS SUPPORT SYST, V47, P508, DOI 10.1016/j.dss.2009.04.016	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228105	10.1371/journal.pone.0228105	http://dx.doi.org/10.1371/journal.pone.0228105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9FN	32023271	Green Published, gold			2022-12-26	WOS:000534621500037
J	Lu, JM; Zang, HJ; Zheng, HM; Zhan, YT; Yang, Y; Zhang, YT; Liu, SL; Feng, J; Wen, QY; Long, MP; Fan, SQ				Lu, Junmi; Zang, Hongjing; Zheng, Hongmei; Zhan, Yuting; Yang, Yang; Zhang, Yuting; Liu, Sile; Feng, Juan; Wen, Qiuyuan; Long, Mengping; Fan, Songqing			Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; EXPRESSION; PATHWAY; CARCINOMA; EIF4E; PAKT	The Akt (protein kinase B)/mammalian target of rapamycin (mTOR) pathway, which is dysregulated in various cancers, controls the assembly of eukaryotic translation initiation factor 4F (eIF4E) complex. However, whether aberrant expression of phosphorylated Akt (p-Akt), phosphorylated mTOR (p-mTOR) and phosphorylated eIF4E (p-eIF4E) is associated with clinicopathological characteristics in surgically resected non-small cell lung cancer (NSCLC) has been rarely reported. Here, we investigated expression of p-Akt, p-mTOR and p-eIF4E proteins in NSCLC by immunohistochemistry and evaluated their correlation with clinicopathological characteristics and prognostic significance. The results showed that the positive percentage of p-Akt, p-mTOR and p-eIF4E was higher in NSCLC. Additionally, p-mTOR and p-eIF4E was dramatically higher in lung adenocarcinoma (both P< 0.05). Most importantly, NSCLC patients with lymph node metastasis had significantly elevated expression of p-Akt, p-mTOR and p-eIF4E (all P< 0.05). Positive expression of p-Akt, and any positive expression of p-Akt, p-mTOR and p-eIF4E proteins were positively correlated with clinical stages (both P< 0.05). Spearman's rank correlation test revealed that expression of p-Akt was correlated with p-eIF4E and p-mTOR (r = 0.107, P = 0.047; r = 0.287, P<0.001, respectively). Also, p-eIF4E had positive correlation with p-mTOR (r = 0.265, P< 0.001). Furthermore, NSCLC patients with increased expression of p-Akt, p-mTOR and p-eIF4E, and any positive expression of above three proteins had lower overall survival rates (all P< 0.05). Multivariate Cox regression analysis further indicated thatp-eIF4E was an independent prognostic factor for NSCLC patients (P = 0.046). Taken together, overexpression of p-Akt, p-mTOR and p-eIF4E proteins is associated with metastasis and poor prognosis of NSCLC patients after surgical resection, and positive expression of p-eIF4E protein may act as an independent unfavorable prognostic biomarker for overall survival of NSCLC patients.	[Lu, Junmi; Zang, Hongjing; Zheng, Hongmei; Zhan, Yuting; Yang, Yang; Zhang, Yuting; Liu, Sile; Feng, Juan; Wen, Qiuyuan; Long, Mengping; Fan, Songqing] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China	Central South University	Fan, SQ (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.	songqingfan@csu.edu.cn			National Natural Sciences Foundations of China [81773218, 81703009, 81472773]; Natural Sciences Foundations of Hunan Province [2017JJ3457]	National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundations of Hunan Province	The work was supported by grants from The National Natural Sciences Foundations of China (No: 81773218, 81703009 and 81472773) and The Natural Sciences Foundations of Hunan Province (No: 2017JJ3457).	An JY, 2010, INT J CANCER, V126, P2904, DOI 10.1002/ijc.24872; Ben Bahria-Sediki I, 2016, TUMOR BIOL, V37, P7873, DOI 10.1007/s13277-015-4678-2; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cargnello M, 2015, MUTAGENESIS, V30, P169, DOI 10.1093/mutage/geu045; Chang A, 2011, LUNG CANCER, V71, P3, DOI 10.1016/j.lungcan.2010.08.022; Dennis MD, 2012, J BIOL CHEM, V287, P42890, DOI 10.1074/jbc.M112.404822; Detterbeck FC, 2017, CHEST, V151, P193, DOI 10.1016/j.chest.2016.10.010; Ersahin T, 2015, MOL BIOSYST, V11, P1946, DOI 10.1039/c5mb00101c; Fan SQ, 2009, CANCER BIOL THER, V8, P1463, DOI 10.4161/cbt.8.15.8960; Fan WB, 2017, J NEURO-ONCOL, V131, P485, DOI 10.1007/s11060-016-2327-2; Feng J, 2019, HISTOPATHOLOGY, V75, P202, DOI 10.1111/his.13862; Ferrandiz-Pulido C, 2013, J UROLOGY, V190, P2288, DOI 10.1016/j.juro.2013.06.015; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Hager M, 2009, J CELL MOL MED, V13, P2181, DOI 10.1111/j.1582-4934.2008.00488.x; Heavey S, 2014, CANCER TREAT REV, V40, P445, DOI 10.1016/j.ctrv.2013.08.006; Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771; Kim TJ, 2006, BRIT J CANCER, V94, P1678, DOI 10.1038/sj.bjc.6603180; Li XM, 2016, ONCOTARGET, V7, P33440, DOI [10.18632/oncotarget.7961, 10.18632/oncotarget.6497]; Lu JM, 2018, INT J BIOL SCI, V14, P390, DOI 10.7150/ijbs.22243; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Oh MH, 2012, VIRCHOWS ARCH, V460, P601, DOI 10.1007/s00428-012-1239-6; Peng JW, 2019, J CANCER, V10, P3046, DOI 10.7150/jca.30587; Roux PP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00070-18; Sacco PC, 2014, FRONT BIOSCI-LANDMRK, V19, P259, DOI 10.2741/4205; Schettino C, 2013, CURR PHARM DESIGN, V19, P5333, DOI 10.2174/13816128113199990343; Setsu N, 2013, CANCER-AM CANCER SOC, V119, P3504, DOI 10.1002/cncr.28255; Shan ZZ, 2017, ONCOL LETT, V14, P2859, DOI 10.3892/ol.2017.6526; Shin E, 2015, LUNG CANCER, V89, P13, DOI 10.1016/j.lungcan.2015.04.003; Siddiqui N, 2015, BIOCHEM SOC T, V43, P763, DOI 10.1042/BST20150126; Thomas A, 2015, NAT REV CLIN ONCOL, V12, P511, DOI 10.1038/nrclinonc.2015.90; Topisirovic I, 2011, COLD SH Q B, V76, P355, DOI 10.1101/sqb.2011.76.010785; Wang WY, 2017, THERANOSTICS, V7, P2134, DOI 10.7150/thno.17665; Wang WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106098; Wen QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132190; Yang Y, 2014, INT J CANCER, V135, P1417, DOI 10.1002/ijc.28788; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Yu P, 2010, J CANCER RES CLIN, V136, P1283, DOI 10.1007/s00432-010-0779-x; Zanchi NE, 2008, EUR J APPL PHYSIOL, V102, P253, DOI 10.1007/s00421-007-0588-3; Zhang Y, 2013, ASIAN PAC J CANCER P, V14, P3725, DOI 10.7314/APJCP.2013.14.6.3725; Zheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089220	41	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227768	10.1371/journal.pone.0227768	http://dx.doi.org/10.1371/journal.pone.0227768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023262	Green Published, gold			2022-12-26	WOS:000534621500021
J	Assad, RS; Rocha, EAV; Aiello, VD; Meniconi, TA; Abduch, MCD; Thomaz, PG; Jatene, MB; Moreira, LFP				Assad, Renato S.; Rocha, Eduardo A., V; Aiello, Vera D.; Meniconi, Tiago A.; Abduch, Maria C. D.; Thomaz, Petronio G.; Jatene, Marcelo B.; Moreira, Luiz F. P.			Reversible pulmonary trunk banding: Myocardial vascular endothelial growth factor expression in young goats submitted to ventricular retraining	PLOS ONE			English	Article							ARTERIAL SWITCH OPERATION; CARDIAC-HYPERTROPHY; STRETCH; TRANSPOSITION; ANGIOGENESIS; RECEPTORS; FIBROSIS; HYPOXIA	Background Ventricle retraining has been extensively studied by our laboratory. Previous studies have demonstrated that intermittent overload causes a more efficient ventricular hypertrophy. The adaptive mechanisms involved in the ventricle retraining are not completely established. This study assessed vascular endothelial growth factor (VEGF) expression in the ventricles of goats submitted to systolic overload. Methods Twenty-one young goats were divided into 3 groups (7 animals each): control, 96-hour continuous systolic overload, and intermittent systolic overload (four 12-hour periods of systolic overload paired with 12-hour resting period). During the 96-hour protocol, systolic overload was adjusted to achieve a right ventricular (RV) / aortic pressure ratio of 0.7. Hemodynamic evaluations were performed daily before and after systolic overload. Echocardiograms were obtained preoperatively and at protocol end to measure cardiac masses thickness. At study end, the animals were killed for morphologic evaluation and immunohistochemical assessment of VEGF expression. Results RV-trained groups developed hypertrophy of RV and septal masses, confirmed by increased weight and thickness, as expected. In the study groups, there was a small but significantly increased water content of the RV and septum compared with those in the control group (p<0.002). VEGF expression in the RV myocardium was greater in the intermittent group (2.89% +/- 0.41%) than in the continuous (1.80% +/- 0.19%) and control (1.43% +/- 0.18%) groups (p<0.023). Conclusions Intermittent systolic overload promotes greater upregulation of VEGF expression in the sub-pulmonary ventricle, an adaptation that provides a mechanism for increased myocardial perfusion during the rapid myocardial hypertrophy of young goats.	[Assad, Renato S.; Thomaz, Petronio G.; Moreira, Luiz F. P.] Univ Sao Paulo, Lab Cardiovasc Surg Res, Heart Inst, Sch Med, Sao Paulo, Brazil; [Rocha, Eduardo A., V] FASEH Sch Med, Dept Surg, Vespasiano, Brazil; [Aiello, Vera D.] Univ Sao Paulo, Lab Pathol, Heart Inst, Sch Med, Sao Paulo, Brazil; [Meniconi, Tiago A.] ABC Sch Med, Santo Andre, SP, Brazil; [Abduch, Maria C. D.] Univ Sao Paulo, Lab Echocardiog, Heart Inst, Sch Med, Sao Paulo, Brazil; [Jatene, Marcelo B.] Univ Sao Paulo, Div Pediat Cardiac Surg, Heart Inst, Sch Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Assad, RS (corresponding author), Univ Sao Paulo, Lab Cardiovasc Surg Res, Heart Inst, Sch Med, Sao Paulo, Brazil.	rsassad@cardiol.br	Moreira, Luiz Felipe Pinho/F-9882-2012; Cirurgia Torácica e Cardiovascular, Teses - Pós-Graduação/AAY-2301-2021; Rocha, Eduardo Augusto Victor/J-6484-2019; Jatene, Marcelo Biscegli/AAZ-6246-2020; Assad, Renato/I-1393-2012	Moreira, Luiz Felipe Pinho/0000-0003-0179-4976; Rocha, Eduardo Augusto Victor/0000-0001-8851-947X; Jatene, Marcelo Biscegli/0000-0002-3465-0533; Assad, Renato/0000-0001-9466-8199	Zerbini Foundation	Zerbini Foundation	This study was funded by the Zerbini Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abduch MCD, 2007, J THORAC CARDIOV SUR, V133, P1510, DOI 10.1016/j.jtcvs.2006.12.010; Assad RS, 2011, J THORAC CARDIOV SUR, V142, P1108, DOI 10.1016/j.jtcvs.2011.08.007; Bautista-Hernandez V, 2006, ANN THORAC SURG, V82, P2059, DOI 10.1016/j.athoracsur.2006.06.045; Birukov KG, 2009, ANTIOXID REDOX SIGN, V11, P1651, DOI 10.1089/ARS.2008.2390; BISHOP SP, 1976, CIRC RES, V39, P238, DOI 10.1161/01.RES.39.2.238; BOUTIN C, 1994, CIRCULATION, V90, P1294, DOI 10.1161/01.CIR.90.3.1294; Chang H, 2003, CLIN SCI, V104, P421, DOI 10.1042/CS20020210; Dias CA, 2002, J THORAC CARDIOV SUR, V124, P999, DOI 10.1067/mtc.2002.124234; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Favaro GAG, 2013, J THORAC CARDIOV SUR, V145, P1345, DOI 10.1016/j.jtcvs.2012.07.068; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Guimaraes GC, 2017, THERIOGENOLOGY, V92, P63, DOI 10.1016/j.theriogenology.2017.01.002; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; HUTTNER I, 1982, LAB INVEST, V47, P409; JONAS RA, 1989, CIRCULATION, V80, P203; Lim HG, 2013, EUR J CARDIO-THORAC, V43, P325, DOI 10.1093/ejcts/ezs264; Locatelli P, 2015, GENE THER, V22, P449, DOI 10.1038/gt.2015.28; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Miana LA, 2010, ARQ BRAS CARDIOL, V95, P364, DOI 10.1590/S0066-782X2010005000105; Ostadal B, 1999, PHYSIOL REV, V79, P635, DOI 10.1152/physrev.1999.79.3.635; Ostadal B, 2009, PHYSIOL RES, V58, pS1, DOI 10.33549/physiolres.931920; Pontes SC, 2005, J AM SOC ECHOCARDIOG, V18, P427, DOI 10.1016/j.echo.2005.01.036; RAKUSAN K, 1985, CIRC RES, V57, P393, DOI 10.1161/01.RES.57.3.393; Ramasamy S, 2018, EXP CELL RES, V365, P46, DOI 10.1016/j.yexcr.2018.02.016; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; RUDOLPH AM, 1970, CIRCULATION, V41, P343, DOI 10.1161/01.CIR.41.2.343; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; TAKAHASHI Y, 1991, CIRCULATION, V84, P180; Tomaiuolo R, 2013, CLIN CHEM LAB MED, V51, P2227, DOI 10.1515/cclm-2013-0200; Valente AS, 2008, REV BRAS CIR CARDIOV, V23, P60, DOI 10.1590/S0102-76382008000100011; Zheng W, 2004, AM J PHYSIOL-HEART C, V287, pH2739, DOI 10.1152/ajpheart.00410.2004; Zheng W, 2008, AM J PHYSIOL-HEART C, V295, pH794, DOI 10.1152/ajpheart.00343.2008	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0217732	10.1371/journal.pone.0217732	http://dx.doi.org/10.1371/journal.pone.0217732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012157	Green Submitted, Green Published, gold			2022-12-26	WOS:000534615800001
J	Nguyen, CTK; Sawangarun, W; Mandasari, M; Morita, K; Harada, H; Kayamori, K; Yamaguchi, A; Sakamoto, K				Chi Thi Kim Nguyen; Sawangarun, Wanlada; Mandasari, Masita; Morita, Kei-ichi; Harada, Hiroyuki; Kayamori, Kou; Yamaguchi, Akira; Sakamoto, Kei			AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression	PLOS ONE			English	Article							AUTOIMMUNE REGULATOR AIRE; ICAM-1 EXPRESSION; INTERFERON-GAMMA; PREDICTIVE MARKER; ADHESION; KERATINOCYTES; PROGRESSION; ACTIVATION; RNA	Autoimmune regulator (AIRE) is a transcriptional regulator that is primarily expressed in medullary epithelial cells, where it induces tissue-specific antigen expression. Under pathological conditions, AIRE expression is induced in epidermal cells and promotes skin tumor development. This study aimed to clarify the role of AIRE in the pathogenesis of oral squamous cell carcinoma (OSCC). AIRE expression was evaluated in six OSCC cell lines and in OSCC tissue specimens. Expression of STAT1, ICAM1, CXCL10, CXCL11, and MMP9 was elevated in 293A cells stably expressing AIRE, and conversely, was decreased in AIRE-knockout HSC3 OSCC cells when compared to the respective controls. Upregulation of STAT1, and ICAM in OSCC cells was confirmed in tissue specimens by immunohistochemistry. We provide evidence that AIRE exerts transcriptional control in cooperation with ETS1. Expression of STAT1, ICAM1, CXCL10, CXCL11, and MMP9 was increased in 293A cells upon Ets1 transfection, and coexpression of AIRE further increased the expression of these proteins. AIRE coprecipitated with ETS1 in a modified immunoprecipitation assay using formaldehyde crosslinking. Chromatin immunoprecipitation and quantitative PCR analysis revealed that promoter fragments of STAT1, ICAM1, CXCL10, and MMP9 were enriched in the AIRE precipitates. These results indicate that AIRE is induced in OSCC and supports cancer-related gene expression in cooperation with ETS1. This is a novel function of AIRE in extrathymic tissues under the pathological condition.	[Chi Thi Kim Nguyen; Sawangarun, Wanlada; Mandasari, Masita; Kayamori, Kou; Yamaguchi, Akira; Sakamoto, Kei] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Tokyo, Japan; [Morita, Kei-ichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Surg, Tokyo, Japan; [Morita, Kei-ichi] Tokyo Med & Dent Univ, Bioresource Res Ctr, Tokyo, Japan; [Harada, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Yamaguchi, Akira] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan; [Chi Thi Kim Nguyen] Univ Med & Pharm, Fac Dent, Oral Pathol Dept, Hochiminh City, Vietnam; [Sawangarun, Wanlada] Naresuan Univ, Fac Dent, Dept Oral Diag, Phitsanulok, Thailand; [Mandasari, Masita] Univ Indonesia, Fac Dent, Oral Med Dept, Jakarta, Indonesia	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Dental College; Hochiminh City University of Medicine & Pharmacy; Naresuan University; University of Indonesia	Sakamoto, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Tokyo, Japan.	s-kei.mpa@tmd.ac.jp	Mandasari, Masita/GPX-3108-2022; Yamaguchi, Akira/AAX-9286-2020	Mandasari, Masita/0000-0003-0114-755X; 	JSPS (Japan Society for the Promotion of Science) KAKENHI [JP25462848, JP16K11438]; MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan)	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by JSPS (Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/index.html) KAKENHI [JP25462848 and JP16K11438] to K.S.. This work was supported in parts by a grant for Private University Branding Project to Tokyo Dental College from MEXT (Ministry of Education, Culture, Sports, Science and Technology, YJapan, http://www.mext.go.jp/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2016, NAT REV IMMUNOL, V16, P247, DOI 10.1038/nri.2016.9; Bansal K, 2017, NAT IMMUNOL, V18, P263, DOI 10.1038/ni.3675; Chang YJ, 2002, J BIOL CHEM, V277, P7118, DOI 10.1074/jbc.M109924200; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Nguyen CTK, 2017, J ORAL PATHOL MED, V46, P223, DOI 10.1111/jop.12485; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; DUSTIN ML, 1988, J EXP MED, V167, P1323, DOI 10.1084/jem.167.4.1323; Eldershaw SA, 2011, CLIN EXP IMMUNOL, V163, P296, DOI 10.1111/j.1365-2249.2010.04316.x; Gillard GO, 2007, J IMMUNOL, V178, P3007, DOI 10.4049/jimmunol.178.5.3007; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Hobbs RP, 2015, NAT GENET, V47, P933, DOI 10.1038/ng.3355; Kawamata H, 1997, INT J CANCER, V70, P120, DOI 10.1002/(SICI)1097-0215(19970106)70:1<120::AID-IJC18>3.0.CO;2-P; Khanom R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161163; Klamp T, 2006, IMMUNOL LETT, V106, P172, DOI 10.1016/j.imlet.2006.06.006; Kumar V, 2011, AM J PATHOL, V178, P983, DOI 10.1016/j.ajpath.2010.12.007; Laimer K, 2007, CANCER, V110, P326, DOI 10.1002/cncr.22813; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Murumagi A, 2003, J BIOL CHEM, V278, P19784, DOI 10.1074/jbc.M210437200; Murumagi A, 2006, BIOCHEM BIOPH RES CO, V348, P768, DOI 10.1016/j.bbrc.2006.07.135; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nagarajan P, 2010, J CELL SCI, V123, P3566, DOI 10.1242/jcs.062240; Ohkura S, 2005, ORAL ONCOL, V41, P607, DOI 10.1016/j.oraloncology.2005.01.011; Oue E, 2012, BIOCHEM BIOPH RES CO, V424, P456, DOI 10.1016/j.bbrc.2012.06.132; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Poliani PL, 2010, AM J PATHOL, V176, P1104, DOI 10.2353/ajpath.2010.090956; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reis PP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-437; Rinderle C, 1999, HUM MOL GENET, V8, P277, DOI 10.1093/hmg/8.2.277; Sakamoto K, 2011, HISTOPATHOLOGY, V58, P531, DOI 10.1111/j.1365-2559.2011.03759.x; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Usami Y, 2013, INT J CANCER, V133, P568, DOI 10.1002/ijc.28066; Walter MJ, 1997, J BIOL CHEM, V272, P28582, DOI 10.1074/jbc.272.45.28582; Wasylyk C, 2002, MOL CELL BIOL, V22, P2687, DOI 10.1128/MCB.22.8.2687-2702.2002; Xin Z, 2014, VIRCHOWS ARCH, V465, P35, DOI 10.1007/s00428-014-1594-6; Yordy JS, 2004, ONCOGENE, V23, P6654, DOI 10.1038/sj.onc.1207891; YOSHIDA H, 1993, CONNECT TISSUE RES, V30, P23, DOI 10.3109/03008209309032928; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976; Zumer K, 2013, J IMMUNOL, V190, P2479, DOI 10.4049/jimmunol.1203210	42	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0222689	10.1371/journal.pone.0222689	http://dx.doi.org/10.1371/journal.pone.0222689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012175	Green Submitted, gold, Green Published			2022-12-26	WOS:000534615800002
J	Bartolini, I; Rivera, J; Nolazco, N; Olortegui, A				Bartolini, Ida; Rivera, Julio; Nolazco, Norma; Olortegui, Arturo			Towards the implementation of a DNA barcode library for the identification of Peruvian species of Anastrepha (Diptera: Tephritidae)	PLOS ONE			English	Article							FRATERCULUS COMPLEX DIPTERA; CLIMATE-CHANGE; RESOLUTION; TAXONOMY; LARVAE; KEY	The genus Anastrepha is a diverse lineage of fruit-damaging tephritid flies widespread across the Neotropical Region. Accurate taxonomic identification of these flies is therefore of paramount importance in agricultural contexts. DNA barcoding libraries are molecular-based tools based on a short sequence of the mitochondrial COI gene enabling rapid taxonomic identification of biological species. In this study, we evaluate the utility of this method for species identification of Peruvian species of Anastrepha and assemble a preliminary barcode profile for the group. We obtained 73 individual sequences representing the 15 most common species, 13 of which were either assigned to previously recognized or newly established BINs. Intraspecific genetic divergence between sampled species averaged 1.01% (range 0-3.3%), whereas maximum interspecific values averaged 8.67 (range 8.26-17.12%). DNA barcoding was found to be an effective method to discriminate between many Peruvian species of Anastrepha that were tested, except for most species of the fraterculus species group, which were all assigned to the same BIN as they shared similar and, in some cases, identical barcodes. We complemented this newly produced dataset with 86 published sequences to build a DNA barcoding library of 159 sequences representing 56 Peruvian species of Anastrepha (approx. 58% of species reported from that country). We conclude that DNA barcoding is an effective method to distinguish among Peruvian species of Anastrepha outside the fraterculus group, and that complementary methods (e.g., morphometrics, additional genetic markers) would be desirable to assist sensu stricto species identification for phytosanitary surveillance and management practices of this important group of pestiferous flies.	[Bartolini, Ida; Olortegui, Arturo] Serv Nacl Sanidad Agr, Lab Biol Mol, Lima, Peru; [Rivera, Julio] Univ San Ignacio Loyola, Unidad Invest Entomol & Medio Ambiente, Lima, Peru; [Nolazco, Norma] Ctr Diagnost Sanidad Vegetal, Lab Entomol, Serv Nacl Sanidad Agr, Lima, Peru	Universidad San Ignacio de Loyola	Bartolini, I (corresponding author), Serv Nacl Sanidad Agr, Lab Biol Mol, Lima, Peru.	ibartolini@senasa.gob.pe			National Agrarian Innovation Program (PNIA) of Peru	National Agrarian Innovation Program (PNIA) of Peru	This work was supported by the project: "Optimization of the identification of entomological pests in crops of economic importance through DNA barcode and database construction" granted by the National Agrarian Innovation Program (PNIA) of Peru.	Alberti AC, 2002, ANN ENTOMOL SOC AM, V95, P505, DOI 10.1603/0013-8746(2002)095[0505:EITAPO]2.0.CO;2; Aluja M, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Ayyasamy A, 2019, ORIENT INSECTS, V27, P1; Barr N, 2017, FLA ENTOMOL, V100, P182, DOI 10.1653/024.100.0129; Barr NB, 2018, J ECON ENTOMOL, V111, P405, DOI 10.1093/jee/tox300; Bellard C, 2018, ECOL EVOL, V8, P5688, DOI 10.1002/ece3.4098; Boykin LM, 2014, J APPL ENTOMOL, V138, P235, DOI 10.1111/jen.12047; Boykin LM, 2012, EVOLUTIONARY BIOINFO, V8; Canal NA, 2015, ZOOKEYS, P41, DOI 10.3897/zookeys.540.6012; Carroll LE, 2019, PEST FRUIT FLIES WOR; Chown SL, 2015, EVOL APPL, V8, P23, DOI 10.1111/eva.12234; Evans Nathaniel, 2012, Methods Mol Biol, V858, P47, DOI 10.1007/978-1-61779-591-6_4; Farris RE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.2601; Gilligan TM, 2019, J ECON ENTOMOL, V112, P603, DOI 10.1093/jee/toy402; Godefroid M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135209; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez-Ortiz V, 2015, ZOOKEYS, P95, DOI 10.3897/zookeys.540.6027; Hernandez-Ortiz V, 2012, ANN ENTOMOL SOC AM, V105, P305, DOI 10.1603/AN11123; Jiang F, 2014, MOL ECOL RESOUR, V14, P1114, DOI 10.1111/1755-0998.12259; Gallo-Franco JJ, 2017, GENETICA, V145, P79, DOI 10.1007/s10709-016-9947-5; Khamis FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044862; Koohkanzadeh M, 2019, NEOTROP ENTOMOL, V12, P1; Korytkowski Cheslavo A., 2001, Revista Peruana de Entomologia, V42, P97; Lanzavecchia SB, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S13; Lobo Aguirre C., 1997, DISTRIBUCION REGISTR; Lopes GN, 2013, NEOTROP ENTOMOL, V42, P618, DOI 10.1007/s13744-013-0162-0; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Mengual X, 2017, MOL PHYLOGENET EVOL, V113, P84, DOI 10.1016/j.ympev.2017.05.011; Norrbom A.L., 2019, ANASTREPHA TOXOTRYPA; Norrbom AL, 2018, P ENTOMOL SOC WASH, V120, P834, DOI 10.4289/0013-8797.120.4.834; Norrbom AL, 2015, ZOOTAXA, V4041, P1, DOI 10.11646/zootaxa.4041.1.1; Norrbom AL, 2012, ZOOTAXA, P510, DOI 10.11646/zootaxa.3478.1.43; Norrbom AL, 2011, ZOOTAXA, P1; Norrbom AL, 2009, ZOOTAXA, P1; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Oliveira CM, 2013, J APPL ENTOMOL, V137, P1, DOI 10.1111/jen.12018; ROSEN D, 1986, AGR ECOSYST ENVIRON, V15, P121, DOI 10.1016/0167-8809(86)90085-X; Scally M, 2016, MOL PHYLOGENET EVOL, V101, P286, DOI 10.1016/j.ympev.2016.04.020; Schutze MK, 2017, ANNU REV ENTOMOL, V62, P147, DOI 10.1146/annurev-ento-031616-035518; Selivon D, 2005, ANN ENTOMOL SOC AM, V98, P367, DOI 10.1603/0013-8746(2005)098[0367:AGCOTC]2.0.CO;2; Smit J, 2013, ZOOKEYS, P279, DOI 10.3897/zookeys.365.5819; STECK GJ, 1990, P ENTOMOL SOC WASH, V92, P333; Steck GJ, 1999, IAEATECDOC1064; Sun Z, 2009, GENES GENOM, V31, P65, DOI 10.1007/BF03191139; van Nieukerken EJ, 2012, CONTRIB ZOOL, V81, P1	46	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228136	10.1371/journal.pone.0228136	http://dx.doi.org/10.1371/journal.pone.0228136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004351	Green Published, gold			2022-12-26	WOS:000534614600019
J	Aranha, MP; Penfound, TA; Spencer, JA; Agarwal, R; Baudry, J; Dale, JB; Smith, JC				Aranha, Michelle P.; Penfound, Thomas A.; Spencer, Jay A.; Agarwal, Rupesh; Baudry, Jerome; Dale, James B.; Smith, Jeremy C.			Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein?derived peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus pyogenes (S; pyogenes); structural biology; bioinformatics; vaccine development; humoral response; vaccine; coiled coil; cross-reactive epitope; heptad site identity; M proteins; multivalent vaccine	IMMUNOGENICITY; PROTEINS; PYOGENES; SAFETY; NORTH	Group A streptococcus (Strep A) surface M protein, an ?-helical coiled-coil dimer, is a vaccine target and a major determinant of streptococcal virulence. The sequence-variable N-terminal region of the M protein defines the M type and also contains epitopes that promote opsonophagocytic killing of streptococci. Recent reports have reported considerable cross-reactivity among different M types, suggesting the prospect of identifying cross-protective epitopes that would constitute a broadly protective multivalent vaccine against Strep A isolates. Here, we have used a combination of immunological assays, structural biology, and cheminformatics to construct a recombinant M protein?based vaccine that included six Strep A M peptides that were predicted to elicit antisera that would cross-react with an additional 15 nonvaccine M types of Strep A. Rabbit antisera against this recombinant vaccine cross-reacted with 10 of the 15 nonvaccine M peptides. Two of the five nonvaccine M peptides that did not cross-react shared high sequence identity (?50%) with the vaccine peptides, implying that high sequence identity alone was insufficient for cross-reactivity among the M peptides. Additional structural analyses revealed that the sequence identity at corresponding polar helical-wheel heptad sites between vaccine and nonvaccine peptides accurately distinguishes cross-reactive from non?cross-reactive peptides. On the basis of these observations, we developed a scoring algorithm based on the sequence identity at polar heptad sites. When applied to all epidemiologically important M types, this algorithm should enable the selection of a minimal number of M peptide?based vaccine candidates that elicit broadly protective immunity against Strep A.	[Aranha, Michelle P.; Agarwal, Rupesh; Smith, Jeremy C.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Agarwal, Rupesh] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Aranha, Michelle P.; Smith, Jeremy C.] Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN 37830 USA; [Penfound, Thomas A.; Dale, James B.] Univ Tennessee, Div Infect Dis, Dept Med, Hlth Sci Ctr, Memphis, TN 38163 USA; [Spencer, Jay A.; Baudry, Jerome] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Huntsville	Aranha, MP (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	maranha@utk.edu	Aranha, Michelle/ABC-6512-2020	Aranha, Michelle/0000-0002-8230-5726; Agarwal, Rupesh/0000-0003-1029-2281	National Institutes of Health [AI-R01AI132117]; University of Tennessee Research Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tennessee Research Foundation	This work was supported by National Institutes of Health Grant AI-R01AI132117. J. B. D. is the inventor of certain technologies related to the development of Strep A vaccines. The technology has been licensed from the University of Tennessee Research Foundation to Vaxent, LLC, of which J. B. D. is a member and Chief Scientific Officer. All other authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; BENJAMIN DC, 1984, ANNU REV IMMUNOL, V2, P67, DOI 10.1146/annurev.iy.02.040184.000435; Buffalo CZ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.155, 10.1038/nmicrobiol.2016.155]; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Dale JB, 2017, VACCINE, V35, P19, DOI 10.1016/j.vaccine.2016.11.065; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; Dale JB, 1999, VACCINE, V17, P193, DOI 10.1016/S0264-410X(98)00150-9; Dale JB, 2016, STREPTOCOCCUS PYOGEN; Davies MR, 2019, NAT GENET, V51, P1035, DOI 10.1038/s41588-019-0417-8; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fritzer A, 2010, INFECT IMMUN, V78, P4051, DOI 10.1128/IAI.00295-10; Frost HR, 2017, CLIN INFECT DIS, V65, P1523, DOI 10.1093/cid/cix599; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Haggar A, 2012, J CLIN MICROBIOL, V50, P1626, DOI 10.1128/JCM.06697-11; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; Kotloff KL, 2004, JAMA-J AM MED ASSOC, V292, P709, DOI 10.1001/jama.292.6.709; Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Steer AC, 2016, VACCINE, V34, P2953, DOI 10.1016/j.vaccine.2016.03.073; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Vekemans J, 2019, CLIN INFECT DIS, V69, P877, DOI 10.1093/cid/ciy1143; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545	34	3	3	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3826	3836		10.1074/jbc.RA119.011258	http://dx.doi.org/10.1074/jbc.RA119.011258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32029479	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000527704400009
J	Singh, S; Szlachta, K; Manukyan, A; Raimer, HM; Dinda, M; Bekiranov, S; Wang, YH				Singh, Sandeep; Szlachta, Karol; Manukyan, Arkadi; Raimer, Heather M.; Dinda, Manikarna; Bekiranov, Stefan; Wang Yuh-Hwa			Pausing sites of RNA polymerase II on actively transcribed genes are enriched in DNA double-stranded breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase II; DNA topoisomerase; DNA transcription; transcription regulation; DNA sequencing; DNA damage; gene expression; DNA double-stranded breaks; HeLa cells; RNA polymerase II promoter-proximal pausing; topoisomerase inhibitors; topoisomerase I and II	TOPOISOMERASE-II; EUKARYOTIC TOPOISOMERASES; CLEAVAGE; MUTATION; HOTSPOTS; HAIRPIN	DNA double-stranded breaks (DSBs) are strongly associated with active transcription, and promoter-proximal pausing of RNA polymerase II (Pol II) is a critical step in transcriptional regulation. Mapping the distribution of DSBs along actively expressed genes and identifying the location of DSBs relative to pausing sites can provide mechanistic insights into transcriptional regulation. Using genome-wide DNA break mapping/sequencing techniques at single-nucleotide resolution in human cells, we found that DSBs are preferentially located around transcription start sites of highly transcribed and paused genes and that Pol II promoter-proximal pausing sites are enriched in DSBs. We observed that DSB frequency at pausing sites increases as the strength of pausing increases, regardless of whether the pausing sites are near or far from annotated transcription start sites. Inhibition of topoisomerase I and II by camptothecin and etoposide treatment, respectively, increased DSBs at the pausing sites as the concentrations of drugs increased, demonstrating the involvement of topoisomerases in DSB generation at the pausing sites. DNA breaks generated by topoisomerases are short-lived because of the religation activity of these enzymes, which these drugs inhibit; therefore, the observation of increased DSBs with increasing drug doses at pausing sites indicated active recruitment of topoisomerases to these sites. Furthermore, the enrichment and locations of DSBs at pausing sites were shared among different cell types, suggesting that Pol II promoter-proximal pausing is a common regulatory mechanism. Our findings support a model in which topoisomerases participate in Pol II promoter-proximal pausing and indicated that DSBs at pausing sites contribute to transcriptional activation.	[Singh, Sandeep; Szlachta, Karol; Manukyan, Arkadi; Raimer, Heather M.; Dinda, Manikarna; Bekiranov, Stefan; Wang Yuh-Hwa] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Wang, YH (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	yw4b@virginia.edu	DINDA, MANIKARNA/ABB-2631-2021	Singh, Sandeep/0000-0001-5361-4303; Raimer Young, Heather/0000-0002-7415-6011	NIGMS, National Institutes of Health [RO1GM101192, T32GM008136]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants RO1GM101192 (to Y.-H. W.) and T32GM008136 (to H. M. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BEEN MD, 1984, J MOL BIOL, V180, P515, DOI 10.1016/0022-2836(84)90025-1; Bigioni M, 1996, BIOCHEMISTRY-US, V35, P153, DOI 10.1021/bi951736p; Bunch H, 2016, GENOMICS, V108, P64, DOI 10.1016/j.ygeno.2016.07.003; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Canela A, 2019, MOL CELL, V75, P252, DOI 10.1016/j.molcel.2019.04.030; Core L, 2019, GENE DEV, V33, P960, DOI 10.1101/gad.325142.119; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; D'Alessandro G, 2017, J MOL BIOL, V429, P3215, DOI 10.1016/j.jmb.2016.11.002; Dellino GI, 2019, NAT GENET, V51, P1011, DOI 10.1038/s41588-019-0421-z; Eddy J, 2011, NUCLEIC ACIDS RES, V39, P4975, DOI 10.1093/nar/gkr079; FROELICHAMMON SJ, 1994, J BIOL CHEM, V269, P7719; Gittens WH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12802-5; Gothe HJ, 2019, MOL CELL, V75, P267, DOI 10.1016/j.molcel.2019.05.015; Gressel S, 2017, ELIFE, V6, DOI 10.7554/eLife.29736; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Jonstrup AT, 2008, NUCLEIC ACIDS RES, V36, P6165, DOI 10.1093/nar/gkn640; Kaiser VB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006207; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kellner WA, 2015, GENOME RES, V25, P1600, DOI 10.1101/gr.189068.114; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kingma PS, 1998, BBA-GENE STRUCT EXPR, V1400, P223, DOI 10.1016/S0167-4781(98)00138-9; Lensing SV, 2016, NAT METHODS, V13, P855, DOI 10.1038/nmeth.3960; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Mills WE, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020534; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Schwer B, 2016, P NATL ACAD SCI USA, V113, P2258, DOI 10.1073/pnas.1525564113; Seo J, 2012, NUCLEIC ACIDS RES, V40, P5965, DOI 10.1093/nar/gks287; Spence JM, 2005, CHROMOSOME RES, V13, P637, DOI 10.1007/s10577-005-1003-8; Szlachta K, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-019-6436-0; Szlachta K, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1463-8; Tanwar VS, 2019, MUTAT RES-REV MUTAT, V780, P61, DOI 10.1016/j.mrrev.2018.02.002; Tchasovnikarova IA, 2017, NAT GENET, V49, P1035, DOI 10.1038/ng.3878; West KL, 1999, NUCLEIC ACIDS RES, V27, P984, DOI 10.1093/nar/27.4.984	40	9	9	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3990	4000		10.1074/jbc.RA119.011665	http://dx.doi.org/10.1074/jbc.RA119.011665			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32029477	Green Published, hybrid			2022-12-26	WOS:000527704400023
J	Homma, K; Takahashi, H; Tsuburaya, N; Naguro, I; Fujisawa, T; Ichijo, H				Homma, Kengo; Takahashi, Hiromitsu; Tsuburaya, Naomi; Naguro, Isao; Fujisawa, Takao; Ichijo, Hidenori			Genome-wide siRNA screening reveals that DCAF4-mediated ubiquitination of optineurin stimulates autophagic degradation of Cu,Zn-superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); proteostasis; autophagy; protein misfolding; protein aggregation; DDB1 and CUL4 associated factor 4 (DCAF4); genome-wide siRNA screen; superoxide dismutase 1 (SOD1)	MOTOR-NEURON DEATH; ALS-LINKED SOD1; STATISTICAL-METHODS; WILD-TYPE; MUTATIONS; DISEASE; ASTROCYTES; PROTEINS; GENES; MICE	Cu, Zn superoxide dismutase (SOD1) is one of the genes implicated in the devastating neurodegenerative disorder amyotrophic lateral sclerosis (ALS). Although the precise mechanisms of SOD1 mutant (SOD1(mut))-induced motoneuron toxicity are still unclear, defects in SOD1 proteostasis are known to have a critical role in ALS pathogenesis. We previously reported that the SOD1(mut) adopts a conformation that exposes a Derlin-1?binding region (DBR) and that DBR-exposed SOD1 interacts with Derlin-1, leading to motoneuron death. We also found that an environmental change, i.e. zinc depletion, induces a conformational change in WT SOD1 (SOD1(WT)) to the DBR-exposed conformation, suggesting the presence of an equilibrium state between the DBR-masked and DBR-exposed states even with SOD1(WT). Here, we conducted a high-throughput screening based on time-resolved FRET to further investigate the SOD1(WT) conformational change, and we used a genome-wide siRNA screen to search for regulators of SOD1 proteostasis. This screen yielded 30 candidate genes that maintained an absence of the DBR-exposed SOD1(WT) conformation. Among these genes was one encoding DDB1- and CUL4-associated factor 4 (DCAF4), a substrate receptor of the E3 ubiquitin?protein ligase complex. Of note, we found that DCAF4 mediates the ubiquitination of an ALS-associated protein and autophagy receptor, optineurin (OPTN), and facilitates autophagic degradation of DBR-exposed SOD1. In summary, our screen identifies DCAF4 as being required for proper proteostasis of DBR-exposed SOD1, which may have potential relevance for the development of therapies for managing ALS.	[Homma, Kengo; Takahashi, Hiromitsu; Tsuburaya, Naomi; Naguro, Isao; Fujisawa, Takao; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Homma, Kengo] TMDU, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU)	Homma, K (corresponding author), TMDU, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kenx5.homma@gmail.com		Naguro, Isao/0000-0002-0338-8026; Fujisawa, Takao/0000-0001-7401-5457; Homma, Kengo/0000-0002-6609-9272	Japanese Society for the Promotion of Science; MEXT [25221302, JP18H03995, 16K18513, JP18H02569, 18K15358]; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation; Project for Elucidating and Controlling Mechanisms of Aging and Longevity from Japan Agency for Medical Research and Development (AMED) [JP17gm5010001, JP19gm5010001]; Kowa Life Science Foundation; SERIKA Fund; Tokyo Biochemical Research Foundation [161000000310]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation; Project for Elucidating and Controlling Mechanisms of Aging and Longevity from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Kowa Life Science Foundation; SERIKA Fund; Tokyo Biochemical Research Foundation	This work was supported by Grants-in-aid for Scientific Research from the Japanese Society for the Promotion of Science; MEXT Grants 25221302 and JP18H03995 (to H. I.), 16K18513 (to K. H.), JP18H02569 (to I. N.) and 18K15358 (to T. F.); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (to H. I.); Project for Elucidating and Controlling Mechanisms of Aging and Longevity from Japan Agency for Medical Research and Development (AMED) Grant JP17gm5010001 and JP19gm5010001 (to H. I.); the Kowa Life Science Foundation (to T. F.); the SERIKA Fund (to T. F.); and Grant-in-aid from the Tokyo Biochemical Research Foundation Grant 161000000310 (to K. H.). A portion of this study resulted from "Understanding of molecular and environmental bases for brain health" conducted under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to H. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; CLEVELAND DW, 1995, NATURE, V378, P342, DOI 10.1038/378342a0; Ferraiuolo L, 2016, P NATL ACAD SCI USA, V113, pE6496, DOI 10.1073/pnas.1607496113; Fujisawa T, 2015, NEUROBIOL DIS, V82, P478, DOI 10.1016/j.nbd.2015.08.010; Fujisawa T, 2012, ANN NEUROL, V72, P739, DOI 10.1002/ana.23668; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Homma K, 2013, MOL CELL, V52, P75, DOI 10.1016/j.molcel.2013.08.038; Nguyen HP, 2018, TRENDS GENET, V34, P404, DOI 10.1016/j.tig.2018.03.001; Ikenaka K, 2012, INT J MOL SCI, V13, P1225, DOI 10.3390/ijms13011225; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Imamura K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf3962; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Markovinovic A, 2017, PROG NEUROBIOL, V154, P1, DOI 10.1016/j.pneurobio.2017.04.005; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Rea SL, 2014, EXP CELL RES, V325, P27, DOI 10.1016/j.yexcr.2014.01.020; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Tsuburaya N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05127-2; Watanabe K, 2018, CELL REP, V22, P2809, DOI 10.1016/j.celrep.2018.02.045; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhai JB, 2015, J NEUROSCI, V35, P9088, DOI 10.1523/JNEUROSCI.5032-13.2015	35	1	1	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3148	3158		10.1074/jbc.RA119.010239	http://dx.doi.org/10.1074/jbc.RA119.010239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32014991	hybrid, Green Published			2022-12-26	WOS:000519597300021
J	Cai, BH; Yi, HM; Zhang, W				Cai, Baohuan; Yi, Huiming; Zhang, Wei			Reference intervals of mesenteric lymph node size according to lymphocyte counts in asymptomatic children	PLOS ONE			English	Article							RECURRENT ABDOMINAL-PAIN; LYMPHADENITIS; SUBSETS; AGE	There is no acknowledged reference interval of mesenteric lymph node size in healthy children, and the size criterion for mesenteric lymph node enlargement (MLNE) has long been controversial. This study aimed to explore the reference intervals of mesenteric lymph node size according to lymphocyte counts in asymptomatic children and to develop a more appropriate definition of MLNE. The asymptomatic children included were divided into five age strata: 2 to 3 yr; 3 to 4 yr; 4 to 5 yr; 5 to 6 yr; and 6 to 7 yr. Correlation analyses between lymphocyte counts and the long-axis diameter, short-axis diameter, and average diameter of the largest mesenteric lymph node (LMLN) were performed. A reference interval of the short-axis diameter of LMLN was established according to this correlation analysis in each age group. We also report a reference interval of lymphocyte count in each age group. This study revealed significant correlations between the short-axis diameter of LMLN and lymphocyte count in all age groups, as well as in subdivided boy groups and girl groups. The overall reference interval of the short-axis diameter of LMLN in children was 0.54 cm-1.03 cm, with mean value of 0.75 cm. This study supports the use of the short-axis diameter greater than 8-10 mm as the diagnostic criterion for primary mesenteric lymphadenitis based on the presence of a cluster of three or more mesenteric lymph nodes and in the absence of other abnormalities.	[Cai, Baohuan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Hubei, Peoples R China; [Yi, Huiming; Zhang, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, W (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China.	zhangweitjh@qq.com		Zhang, Wei/0000-0001-9959-2584				Alfven G, 2001, ACTA PAEDIATR, V90, P599, DOI 10.1080/080352501750258612; APLEY J, 1958, ARCH DIS CHILD, V33, P165, DOI 10.1136/adc.33.168.165; Benetti C, 2018, EUR J PEDIATR, V177, P243, DOI 10.1007/s00431-017-3010-0; Carlow DA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205685; Carty HML, 2002, EUR RADIOL, V12, P2835, DOI 10.1007/s00330-002-1499-7; Conrad MA, 2017, PEDIATR CLIN N AM, V64, P577, DOI 10.1016/j.pcl.2017.01.005; Grimwood Keith, 2009, Pediatr Clin North Am, V56, P1343, DOI 10.1016/j.pcl.2009.09.004; Gross I, 2017, EUR J PEDIATR, V176, P199, DOI 10.1007/s00431-016-2822-7; Helbling R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9784565; Jia LT, 2015, CYTOM PART A, V87A, P1116, DOI 10.1002/cyto.a.22716; Karmazyn B, 2005, PEDIATR RADIOL, V35, P774, DOI 10.1007/s00247-005-1462-2; Krille L, 2012, RADIAT ENVIRON BIOPH, V51, P103, DOI 10.1007/s00411-012-0405-1; Langman G, 2015, DIS COLON RECTUM, V58, P406, DOI 10.1097/DCR.0000000000000321; Macari M, 2002, AM J ROENTGENOL, V178, P853, DOI 10.2214/ajr.178.4.1780853; Manson David, 2004, Paediatr Child Health, V9, P93; Rathaus V, 2005, BRIT J RADIOL, V78, P30, DOI 10.1259/bjr/68274086; Schulte B, 1998, Eur J Ultrasound, V8, P177, DOI 10.1016/S0929-8266(98)00075-5; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Sikorska-Wisniewska Grazyna, 2006, Med Wieku Rozwoj, V10, P453; Simanovsky N, 2007, J ULTRAS MED, V26, P581, DOI 10.7863/jum.2007.26.5.581; Stordal K, 2001, ACTA PAEDIATR, V90, P638, DOI 10.1080/080352501750258694; Toorenvliet B, 2011, EUR J PEDIATR SURG, V21, P120, DOI 10.1055/s-0030-1267979; Ushigome H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211675; Vayner N, 2003, PEDIATR RADIOL, V33, P864, DOI 10.1007/s00247-003-0985-7; WANG Wen-gang, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P522; Wewer V, 1997, EUR J PEDIATR, V156, P787, DOI 10.1007/s004310050713; Yip WCL, 1998, J CLIN ULTRASOUND, V26, P397	27	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228734	10.1371/journal.pone.0228734	http://dx.doi.org/10.1371/journal.pone.0228734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040486	Green Published, gold			2022-12-26	WOS:000534629400038
J	Kaneshige, Y; Hayashi, F; Morigaki, K; Tanimoto, Y; Yamashita, H; Fujii, M; Awazu, A				Kaneshige, Yukito; Hayashi, Fumio; Morigaki, Kenichi; Tanimoto, Yasushi; Yamashita, Hayato; Fujii, Masashi; Awazu, Akinori			Affinity of rhodopsin to raft enables the aligned oligomer formation from dimers: Coarse-grained molecular dynamics simulation of disk membranes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LIPID RAFTS; CRYSTAL-STRUCTURE; PALMITOYLATION; ORGANIZATION; OPSIN; PHOTORECEPTORS; RAFTOPHILICITY; ASSOCIATION; TRANSDUCIN	The visual photopigment protein rhodopsin (Rh) is a typical G protein-coupled receptor (GPCR) that initiates the phototransduction cascade in retinal disk membrane of rod-photoreceptor cells. Rh molecule has a tendency to form dimer, and the dimer tends to form rows, which is suggested to heighten phototransduction efficiency in single-photon regime. In addition, the dimerization confers Rh an affinity for lipid raft, i.e. raftophilicity. However, the mechanism by which Rh-dimer raftophilicity contributes to the organization of the higher order structure remains unknown. In this study, we performed coarse-grained molecular dynamics simulations of a disk membrane model containing unsaturated lipids, saturated lipids with cholesterol, and Rh-dimers. We described the Rh-dimers by two-dimensional particle populations where the palmitoyl moieties of each Rh exhibits raftophilicity. We simulated the structuring of Rh in a disk for two types of Rh-dimer, i.e., the most and second most stable Rh dimers, which exposes the raftophilic regions at the dimerization-interface (H1/H8 dimer) and two edges away from the interface (H4/H5 dimer), respectively. Our simulations revealed that only the H1/H8 dimer could form a row structure. A small number of raftophilic lipids recruited to and intercalated in a narrow space between H1/H8 dimers stabilize the side-by-side interaction between dimers in a row. Our results implicate that the nano-sized lipid raft domains act as a "glue" to organize the long row structures of Rh-dimers.	[Kaneshige, Yukito; Fujii, Masashi; Awazu, Akinori] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima, Japan; [Hayashi, Fumio; Tanimoto, Yasushi] Kobe Univ, Grad Sch Sci, Nada Ku, Kobe, Hyogo, Japan; [Morigaki, Kenichi] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo, Japan; [Yamashita, Hayato] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka, Japan	Hiroshima University; Kobe University; Kobe University; Osaka University	Awazu, A (corresponding author), Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima, Japan.	awa@hiroshima-u.ac.jp	Fujii, Masashi/S-1516-2019; Yamashita, Hayato/AAB-9676-2021	Fujii, Masashi/0000-0002-1586-6435; Yamashita, Hayato/0000-0003-4473-5773	JSPS KAKENHI [17KT0024, 17K05614]; Japan-Korea Basic Scientific Cooperation Program	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan-Korea Basic Scientific Cooperation Program	This work was supported by: A.A., JSPS KAKENHI Grant Number 17K05614, https://www.jsps.go.jp/english/index.html, No; A.A., Japan-Korea Basic Scientific Cooperation Program, https://www.jsps.go.jp/english/index.html, No; K. M., JSPS KAKENHI Grant Number 17KT0024, https://www.jsps.go.jp/english/index.html, No.	Boesze-Battaglia K, 1997, J EXP BIOL, V200, P2927; Borsatto A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205009; Buzhynskyy N, 2011, J MOL RECOGNIT, V24, P483, DOI 10.1002/jmr.1086; Cangiano L, 2013, FEBS LETT, V587, P1, DOI 10.1016/j.febslet.2012.11.015; Chandrasekhar S., 1992, LIQ CRYST, DOI 10.1017/CBO9780511622496; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Comar WD, 2014, J AM CHEM SOC, V136, P8342, DOI 10.1021/ja501948w; Dell'Orco D, 2008, J PHYS CHEM B, V112, P4419, DOI 10.1021/jp709963f; Dell'Orco D, 2011, BIOCHEM J, V440, P263, DOI 10.1042/BJ20110871; Duft D, 2003, NATURE, V421, P128, DOI 10.1038/421128a; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; Gahbauer S, 2016, FRONT PHYSIOL, V7, P1, DOI DOI 10.3389/FPHYS.2016.00001; Gunkel M, 2015, STRUCTURE, V23, P628, DOI 10.1016/j.str.2015.01.015; Hayashi F, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0459-6; Herincs Z, 2005, J CELL SCI, V118, P1687, DOI 10.1242/jcs.02296; Huang BB, 2018, PHYS CHEM CHEM PHYS, V20, P29249, DOI 10.1039/c8cp04740e; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; KUSUMI A, 1982, BIOCHEMISTRY-US, V21, P5978, DOI 10.1021/bi00266a039; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental KR, 2016, BIOPHYS J, V110, P1800, DOI 10.1016/j.bpj.2016.03.012; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lin YT, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.208102; Mishra AK, 2016, BIOCHEM J, V473, P3819, DOI 10.1042/BCJ20160422; Nagao M, 2017, J PHYS CHEM LETT, V8, P4679, DOI 10.1021/acs.jpclett.7b01830; Najafi M, 2012, J GEN PHYSIOL, V140, P249, DOI 10.1085/jgp.201210818; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Park PSH, 2019, J MEMBRANE BIOL, V252, P413, DOI 10.1007/s00232-019-00078-1; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Peter E. P., 1992, NUMERICAL SOLUTION S; Polozova A, 2000, BIOPHYS J, V79, P2632, DOI 10.1016/S0006-3495(00)76502-7; Rakshit T, 2017, BBA-MOL CELL RES, V1864, P1691, DOI 10.1016/j.bbamcr.2017.06.013; Rakshit T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141114; Rakshit T, 2015, BIOCHEMISTRY-US, V54, P2885, DOI 10.1021/acs.biochem.5b00003; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scherfeld D, 2003, BIOPHYS J, V85, P3758, DOI 10.1016/S0006-3495(03)74791-2; Senapati S, 2018, BBA-BIOMEMBRANES, V1860, P1403, DOI 10.1016/j.bbamem.2018.03.030; Seno K, 2017, J BIOL CHEM, V292, P15321, DOI 10.1074/jbc.M117.804880; Shrimpton CN, 2002, J EXP MED, V196, P1057, DOI 10.1084/jem.20020143; Stenkamp RE, 2008, ACTA CRYSTALLOGR D, V64, P902, DOI 10.1107/S0907444908017162; Tanimoto Y, 2015, BIOPHYS J, V109, P2307, DOI 10.1016/j.bpj.2015.10.015; Timr S, 2017, ACS CENTRAL SCI, V3, P868, DOI 10.1021/acscentsci.7b00210; Travkova OG, 2013, LANGMUIR, V29, P12203, DOI 10.1021/la402340d; Whited AM, 2015, BBA-BIOMEMBRANES, V1848, P26, DOI 10.1016/j.bbamem.2014.10.007; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhao DY, 2019, J BIOL CHEM, V294, P14215, DOI 10.1074/jbc.RA119.010089	49	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0226123	10.1371/journal.pone.0226123	http://dx.doi.org/10.1371/journal.pone.0226123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032370	Green Published, gold, Green Submitted			2022-12-26	WOS:000534626100002
J	Wronska, AK; Bogus, MI				Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena			Heat shock proteins (HSP 90, 70, 60, and 27) in Galleria mellonella (Lepidoptera) hemolymph are affected by infection with Conidiobolus coronatus (Entomophthorales)	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; MODEL HOST; DROSOPHILA; INNATE; VIRULENCE; ROLES; HEAT-SHOCK-PROTEIN-60; ACTIVATION; HEMOCYTES; LARVAE	Invertebrates are becoming more popular models for research on the immune system. The innate immunity possessed by insects shows both structural and functional similarity to the resistance displayed by mammals, and many processes occurring in insect hemocytes are similar to those that occur in mammals. The humoral immune response in insects acts by melanization, clotting and the production of reactive oxygen species and antimicrobial peptides, while the cellular immunity system is based on nodulation, encapsulation and phagocytosis. An increasingly popular insect model in biological research is Galleria mellonella, whose larvae are sensitive to infection by the entomopathogenic fungus Conidiobolus coronatus, which can also be dangerous to humans. One group of factors that modulate the response of the immune system during infection in mammals are heat shock proteins (HSPs). The aim of this study was to investigate whether infection by C. coronatus in G. mellonella hemolymph is accompanied by an increase of HSP90, HSP70, HSP60 and HSP27. Larvae (five-day-old last instar) were exposed for 24 hours to fully-grown and sporulating fungus. Hemolymph was collected either immediately after termination of exposure (F24) or 24 hours later (F48). The concentration of the HSPs in hemolymph was determined using ELISA. Immunolocalization in hemocytes was performed using fluorescence microscopy and flow cytometry. HSP90, HSP70, HSP60 and HSP27 were found to be present in the G. mellonella hemocytes. HSP60 and HSP90 predominated in healthy insects, with HSP70 and HSP27 being found in trace amounts; HSP60 and HSP27 were elevated in F24 and F48, and HSP90 was elevated in F48. The fungal infection had no effect on HSP70 levels. These findings shed light on the mechanisms underlying the interaction between the innate insect immune response and entomopathogen infection. The results of this innovative study may have a considerable impact on research concerning innate immunology and insect physiology.	[Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland; [Bogus, Mieczyslawa Irena] BIOMIBO, Warsaw, Poland	Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences	Wronska, AK (corresponding author), Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland.	a.wronska@twarda.pan.pl	Wrońska, Anna/AAN-8684-2020; Wrońska, Anna/HHZ-6185-2022	Wrońska, Anna/0000-0001-5171-0828; Bogus, Mieczyslawa/0000-0003-4357-2335	National Centre for Research and Development [POIG.01.04.00-14-019/12]; Masovian district grant [RPMA.01.02.00-14-5626/16-00]	National Centre for Research and Development; Masovian district grant	This work was partly supported by two grants: National Centre for Research and Development grant POIG.01.04.00-14-019/12 and Masovian district grant RPMA.01.02.00-14-5626/16-00 to the Biomibo company. There was no additional external funding received for this study. The funders provided support in the form of salaries for author MIB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; Bausinger H, 2002, TRENDS IMMUNOL, V23, P342, DOI 10.1016/S1471-4906(02)02249-4; Binder RJ, 2014, J IMMUNOL, V193, P5765, DOI 10.4049/jimmunol.1401417; Binder U, 2016, FUNGAL BIOL-UK, V120, P288, DOI 10.1016/j.funbio.2015.06.002; Bogus MI, 2007, J INSECT PHYSIOL, V53, P909, DOI 10.1016/j.jinsphys.2007.02.016; Bogus MI, 2017, B ENTOMOL RES, V107, P66, DOI 10.1017/S0007485316000638; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Browne N, 2013, VIRULENCE, V4, P597, DOI 10.4161/viru.25906; Moncada DC, 2016, BIOMEDICA, V36, P15, DOI 10.7705/biomedica.v36i2.2806; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Coates CJ, 2018, CELL BIOL TOXICOL; Cook SM, 2013, VIRULENCE, V4, P350, DOI 10.4161/viru.25240; Desalermos A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002451; Desbois AP, 2011, J ANTIMICROB CHEMOTH, V66, P1785, DOI 10.1093/jac/dkr198; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Fischer N, 2008, INFECTION, V36, P594, DOI 10.1007/s15010-008-8056-5; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Huang XW, 2018, FUTURE MICROBIOL, V13, P1021, DOI 10.2217/fmb-2018-0036; Jacobsen ID, 2014, VIRULENCE, V5, P237, DOI 10.4161/viru.27434; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Joyce SA, 2010, MICROBIOL-SGM, V156, P3456, DOI 10.1099/mic.0.040782-0; Kedra E, 2006, J INVERTEBR PATHOL, V91, P50, DOI 10.1016/j.jip.2005.06.013; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Li ZH, 2002, CURR OPIN IMMUNOL, V14, P45, DOI 10.1016/S0952-7915(01)00297-7; Lionakis MS, 2011, VIRULENCE, V2, P521, DOI 10.4161/viru.2.6.18520; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; Miller-Graziano Carol L, 2008, Novartis Found Symp, V291, P196; More SH, 2001, INT IMMUNOL, V13, P1121, DOI 10.1093/intimm/13.9.1121; Mowlds P, 2008, MYCOPATHOLOGIA, V165, P5, DOI 10.1007/s11046-007-9069-9; Myllymaki H, 2014, SCAND J IMMUNOL, V79, P377, DOI 10.1111/sji.12170; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Rillich J, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00233; RITOSSA P., 1962, RIV 1ST SIEROTERAPITAL, V37, P79; SEHNAL F, 1966, Z WISS ZOOL ABT A, V174, P53; Shia AKH, 2009, J CELL SCI, V122, P4505, DOI 10.1242/jcs.049155; Song FP, 2014, GUT MICROBES, V5, P58, DOI 10.4161/gmic.27092; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; Subramanian C, 2011, MED MYCOL, V49, P427, DOI 10.3109/13693786.2010.537700; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; van Noort JM, 2012, INT J BIOCHEM CELL B, V44, P1670, DOI 10.1016/j.biocel.2011.12.010; Whitley D, 1999, J VASC SURG, V29, P748, DOI 10.1016/S0741-5214(99)70329-0; Wieloch W, 2011, TOXICON, V58, P369, DOI 10.1016/j.toxicon.2011.07.007; Wilson-Sanders SE, 2011, ILAR J, V52, P126, DOI 10.1093/ilar.52.2.126; Wojda I, 2007, J INSECT PHYSIOL, V53, P1134, DOI 10.1016/j.jinsphys.2007.06.003; Wojda I, 2017, INSECT SCI, V24, P342, DOI 10.1111/1744-7917.12325; Wojda I, 2013, CENT EUR J BIOL, V8, P561, DOI 10.2478/s11535-013-0162-9; Wojda I, 2009, J INSECT PHYSIOL, V55, P525, DOI 10.1016/j.jinsphys.2009.01.014; Wronska AK, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0291-1; Wronska AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192715; Wu GQ, 2016, TISSUE CELL, V48, P297, DOI 10.1016/j.tice.2016.06.007; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zhao L, 2012, EXPRESSION HEAT SHOC, V9, DOI [10.4049/jimmunol.164.2.558, DOI 10.4049/JIMMUNOL.164.2.558]; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	60	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228556	10.1371/journal.pone.0228556	http://dx.doi.org/10.1371/journal.pone.0228556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027696	Green Published, gold			2022-12-26	WOS:000534623800047
J	Greenwood, F; Nelson, EL; Greenough, PG				Greenwood, Faine; Nelson, Erica L.; Greenough, P. Gregg			Flying into the hurricane: A case study of UAV use in damage assessment during the 2017 hurricanes in Texas and Florida	PLOS ONE			English	Article								Unmanned aerial vehicles (UAVs) or drones have been used by disaster relief organizations in the United States since 2005. However, their place in the disaster response ecosystemthe standardization, utility, ethical, and legal challenges of drone use-remains largely unstudied. This case series describes how UAVs were used by two teams of responders for damage assessment purposes during the 2017 southeastern US Hurricanes Harvey and Irma. Data streams ranged from social media, direct observation, participant-observation and semi-directed interviews. Qualitative analysis was performed for thematic content derived from field observation and from post-hoc interviews. Outcomes of the qualitative analysis emphasize the barriers to deploying drones in the disaster context, their tactical implementation, programmatic integration, and ethical and legal challenges. These observations lay the groundwork for both future research on the utilization of drones and the prudent and ethical implementation of programs that employ drones in post-disaster settings.	[Greenwood, Faine] Harvard Humanitarian Initiat, Signal Program, Cambridge, MA 02138 USA; [Greenwood, Faine] Harvard Univ, Cambridge, MA 02138 USA; [Greenwood, Faine; Greenough, P. Gregg] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA; [Nelson, Erica L.; Greenough, P. Gregg] Harvard Univ, Humanitarian Geoanalyt Program, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Nelson, Erica L.; Greenough, P. Gregg] Harvard Sch Med, Brigham & Womens Hosp, Dept Emergency Med, Boston, MA USA	Harvard University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Greenwood, F (corresponding author), Harvard Humanitarian Initiat, Signal Program, Cambridge, MA 02138 USA.; Greenwood, F (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.; Greenwood, F (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA.	greenwood@hsph.harvard.edu			Harvard Humanitarian Initiative [275.23715. XXX.326161.556001.0000.32264]	Harvard Humanitarian Initiative	This work was supported by: F.G., E.N., Grant Numbers: 275.23715. XXX.326161.556001.0000.32264, Harvard Humanitarian Initiative, https://hhi.harvard.edu.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABC News, 2017, ABC NEWS; American Red Cross, 2015, DRON DIS RESP REL OP; Anhorn J, 2016, 13 INT C INF SYST CR; [Anonymous], 2008, EESCAPCDR2; [Anonymous], 2005, SCIENCEDAILY; [Anonymous], 2014, OSO WASH MUDSL WE HA; Atherton Kelsey D., 2013, POPULAR SCI; Auerbach C. F, 2003, QUALITATIVE DATA INT; Bajde D, GEN PUBLICS PRIVACY; Buitrago A., 2018, WORLD FOOD PROGRAMME; Burwell M., 2017, NEW USE DRONES PHILI; Cangialosi JP, 2018, AD12017; CARROLL L, 2017, TRIALS S1, V18; Chadwick M., 2017, LINKEDIN PULSE; ComRes, 2016, ROYAL AER SOC DRON P; CRASAR, 2016, MISS COIC SUAS PLATF; Denzin NK, 2006, INT J QUAL STUD EDUC, V19, P769, DOI 10.1080/09518390600975990; DERHEIDE EA, 2003, ANN EMERG MED, V41, P463, DOI DOI 10.1067/MEM.2003.126; Drabek T.E., 2013, DISASTER PREVENTION, V12, P97, DOI [10.1108/09653560310474214, DOI 10.1108/09653560310474214]; Drew K., 2016, UNHCR INNOVATION; Drone Rogers K., 2017, DEVEX, P6; Ellfeldt A., 2018, MIND GAP DRONE PRIVA; Federal Aviation Administration, 2020, FED AV ADM GRAPH TFR; Federal Aviation Administration, FAAS HURR HARV UPD; Federal Aviation Administration, 2017, FAAS HURR IRM UPD; Federal Aviation Administration, 2005, UNM AIRCR SYST OP US; FEMA, 2017, RES TYP DEF RESP SIT; Fernandes O., 2018, 2018 IEEE INT S SAF, P1, DOI [10.1109/SSRR.2018, DOI 10.1109/SSRR.2018]; Franzen Carl, 2013, VERGE 0510; Glaser B.G., 1968, DISCOV GROUNDED THEO; Hafner K., 2017, PILOTONLINE     0909; Helsloot I, J CONTINGENCIES CRIS, V12; Johnson EM, 2017, REUTERS; Kennedy PA, 2004, HURRICANE HARVEY FLO; Kwong M., 2015, CBC             0427; Lewis K., 2003, J APPL PYSCHOLOGY, V88; Lilian B., 2017, UNMANNED AERIAL ONLI; Luterbacher C., 2018, SWISSINFO; Majchrzak A, 2007, ORGAN SCI, V18, P147, DOI 10.1287/orsc.1060.0228; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Markowitz EM, 2017, BIOSCIENCE, V67, P381, DOI 10.1093/biosci/bix003; McDaniel J., 2014, UNMANNED AERIAL VEHI; McNabb M. FAA, 2017, DRONELIFE; Merlin P.W., 2009, IKHANA UNMANNED AIRC; Miller PC, 2016, UAS MAGAZINE    0619; Miller R., 2018, COVABIZ         0710; Moreland RL, 2000, ORGAN BEHAV HUM DEC, V82, P117, DOI 10.1006/obhd.2000.2891; Morse JM, 2004, QUAL HEALTH RES, V14, P151, DOI 10.1177/1049732303260863; Murphy R., 2015, SPACE; Narian A., 2017, GEOSPATIAL WORLD; New Hampshire, 2018, DRONES DRONES UAVUAS; NOAA (National Oceanic and Atmospheric Administration), 2019, HURR COSTS; Palm Kathleen M, 2004, Prehosp Disaster Med, V19, P73; Phillippi J, 2018, QUAL HEALTH RES, V28, P381, DOI 10.1177/1049732317697102; Phillips A., 2014, DRONELIFE; Read R, 2016, THIRD WORLD Q, V37, P1314, DOI 10.1080/01436597.2015.1136208; Riley T., DRONES GET BAD RAP; S.W.A.R.M, 2018, SEARCH AER RC MULT; Sakiyama M, 2017, SECUR J, V30, P1027, DOI 10.1057/sj.2016.3; School DartDP, 2020, DISASTER RESPONSE DR; Sharma G., 2016, REUTERS; Soesilo D., 2016, EUROPEAN CIVIL PROTE; Soesilo D., DRONES CAN HELP HUMA; Stallings RA, 2001, PUBLIC ADMIN REV, V45, P9; Swiss Foundation for Mine Action, 2016, 8 SWISS FDN MIN ACT; Swiss Foundation for Mine Action, 2016, 9 SWISS FDN MIN ACT; Thompson MS, 2013, QUANT METH EDUC BEHA, P163; UAViators, 2015, HUMANITARIAN UAV COD, P1; United Nations Office for Disaster Risk Reduction, 2007, WORDS ACT GUID IMPL; Von Castor, 2017, PADAMAGE4; Von Castor, 2017, PA3DAMAGE; Whittaker J, 2015, INT J DISAST RISK RE, V13, P358, DOI 10.1016/j.ijdrr.2015.07.010; Wright T., 2017, AIR SPACE MAGAZINE; Yin R.K, 2017, APPL CASE STUDY RES	74	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227808	10.1371/journal.pone.0227808	http://dx.doi.org/10.1371/journal.pone.0227808			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9FN	32023260	Green Published, gold			2022-12-26	WOS:000534621500022
J	Duver, F; Weissbrich, B; Eyrich, M; Wolfl, M; Schlegel, PG; Wiegering, V				Duever, Franziska; Weissbrich, Benedikt; Eyrich, Matthias; Woelfl, Matthias; Schlegel, Paul G.; Wiegering, Verena			Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; VERSUS-HOST-DISEASE; VARICELLA-ZOSTER-VIRUS; ACUTE MYELOID-LEUKEMIA; HERPES-SIMPLEX-VIRUS; RISK-FACTORS; CYTOMEGALOVIRUS REACTIVATION; ADENOVIRUS INFECTION; HEMATOLOGICAL MALIGNANCIES; IMMUNE RECONSTITUTION	Viral reactivation occurs frequently in the context of immunodeficiency and immunosuppression after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and can cause severe complications. The aim of this single-center retrospective analysis was to characterize viral infections in the first year after HSCT, to investigate risk factors and to study the impact of viral infections on transplantation outcome. This will facilitate the identification of at-risk patients and the development of new preventive strategies. 107 pediatric allo-HSCT from January 2005 through December 2015 were analyzed for infections with Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), adenovirus (ADV), herpes simplex virus (HSV) and varicella zoster virus (VZV). Viral infections were detected after 68.2% of transplantations. The viruses most commonly encountered were HHV-6 (36/107) and EBV (30/107). Severe viral disease was rare (7/107) and none of the patients died as result of viral reactivation. Important risk factors for viral infections were higher age at HSCT, donor type and occurrence of acute graft-versus-host disease (aGvHD). Especially for EBV, transplant from an unrelated donor and in-vivo T-cell depletion (TCD) had a significant effect on infection rates, whereas for CMV the strongest effect was seen by donor and recipient serostatus with recipient seropositivity most predictive for reactivation. The occurrence of severe aGvHD was associated with EBV and ADV infections. For HSV, the recipient serostatus was identified as prognostic factor for HSV infections, while we found higher age at time of HSCT as risk factor for VZV infections. The overall survival of patients with or without viral infections did not differ significantly. Interestingly, when looking at the 85 patients in our cohort who had received an HSCT for a malignant disease, a tendency towards lower relapse rates was seen in patients affected by viral infections (HR 0.51, 95% CI 0.25 - 1.06, p = 0.072). Viral reactivations are common after pediatric allo-HSCT, though severe complications were rare in our collective. Determining risk factors for viral reactivations may help to identify patients in need of intensified monitoring and to individualize preventive strategies.	[Duever, Franziska; Eyrich, Matthias; Woelfl, Matthias; Schlegel, Paul G.; Wiegering, Verena] Univ Childrens Hosp Wurzburg, Dept Oncol Hematol & Stem Cell Transplantat, Wurzburg, Germany; [Weissbrich, Benedikt] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Wiegering, V (corresponding author), Univ Childrens Hosp Wurzburg, Dept Oncol Hematol & Stem Cell Transplantat, Wurzburg, Germany.	wiegering_v@ukw.de	Eyrich, Matthias/AAU-8273-2020	Eyrich, Matthias/0000-0002-8099-5903				Agut H, 2015, CLIN MICROBIOL REV, V28, P313, DOI 10.1128/CMR.00122-14; Annels NE, 2006, CLIN INFECT DIS, V42, P1743, DOI 10.1086/503838; Aoki J, 2015, BIOL BLOOD MARROW TR, V21, P2017, DOI 10.1016/j.bbmt.2015.07.022; Auger S, 2014, EUR J HAEMATOL, V92, P421, DOI 10.1111/ejh.12260; Auletta JJ, 2001, FRONT BIOSCI, V6, pG23; Aytac S, 2011, EPIDEMIOL INFECT, V139, P1701, DOI 10.1017/S0950268810003031; Berman JN, 2006, BONE MARROW TRANSPL, V37, P73, DOI 10.1038/sj.bmt.1705191; Bil-Lula I, 2010, ARCH VIROL, V155, P2007, DOI 10.1007/s00705-010-0802-1; Boeckh M, 2005, PEDIATR TRANSPLANT, V9, P48, DOI 10.1111/j.1399-3046.2005.00442.x; Bordon V, 2008, TRANSPL INFECT DIS, V10, P19, DOI 10.1111/j.1399-3062.2007.00242.x; Bordon V, 2012, PEDIATR TRANSPLANT, V16, P144, DOI 10.1111/j.1399-3046.2011.01634.x; Cheng FWT, 2010, PEDIATR TRANSPLANT, V14, P761, DOI 10.1111/j.1399-3046.2010.01333.x; de Koning C, 2016, BIOL BLOOD MARROW TR, V22, P195, DOI 10.1016/j.bbmt.2015.08.028; Elmaagacli AH, 2011, BLOOD, V118, P1402, DOI 10.1182/blood-2010-08-304121; Eyrich M, 2005, BIOL BLOOD MARROW TR, V11, P194, DOI 10.1016/j.bbmt.2004.12.001; Feghoul L, 2015, CLIN MICROBIOL INFEC, V21, P701, DOI 10.1016/j.cmi.2015.03.011; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Grube M, 2016, CLIN TRANSPLANT, V30, P1457, DOI 10.1111/ctr.12840; Haastrup E, 2005, PEDIATR TRANSPLANT, V9, P734, DOI 10.1111/j.1399-3046.2005.00370.x; HAN SB, 2017, MEDICINE, V96, DOI DOI 10.1097/MD; Inagaki J, 2016, BIOL BLOOD MARROW TR, V22, P300, DOI 10.1016/j.bbmt.2015.09.006; Jacobsohn DA, 2008, BONE MARROW TRANSPL, V41, P215, DOI 10.1038/sj.bmt.1705885; L'Huillier AG, 2015, HUM VACC IMMUNOTHER, V11, P2852, DOI 10.1080/21645515.2015.1078043; Leong HN, 2007, J MED VIROL, V79, P45, DOI 10.1002/jmv.20760; Leung TF, 2000, BONE MARROW TRANSPL, V25, P167, DOI 10.1038/sj.bmt.1702119; Ljungman P, 2008, BONE MARROW TRANSPL, V42, P227, DOI 10.1038/bmt.2008.162; Maltezou HC, 2000, PEDIATR INFECT DIS J, V19, P307, DOI 10.1097/00006454-200004000-00009; Matthes-Martin S, 2003, BONE MARROW TRANSPL, V31, P803, DOI 10.1038/sj.bmt.1703927; Matthes-Martin S, 2012, TRANSPL INFECT DIS, V14, P555, DOI 10.1111/tid.12022; Meijer E, 2005, TRANSPL INFECT DIS, V7, P4, DOI 10.1111/j.1399-3062.2005.00084.x; MEYERS JD, 1980, J INFECT DIS, V142, P338, DOI 10.1093/infdis/142.3.338; Mynarek M, 2014, BIOL BLOOD MARROW TR, V20, P250, DOI 10.1016/j.bbmt.2013.11.009; Nordlander A, 2004, BIOL BLOOD MARROW TR, V10, P195, DOI 10.1016/j.bbmt.2003.11.002; Olkinuora HA, 2010, PEDIATR TRANSPLANT, V14, P242, DOI 10.1111/j.1399-3046.2009.01226.x; Or-Geva N, 2016, BRIT J HAEMATOL, V172, P667, DOI 10.1111/bjh.13868; Pellett PE, 2012, REV MED VIROL, V22, P144, DOI 10.1002/rmv.715; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Przybylski M, 2017, J CLIN VIROL, V87, P67, DOI 10.1016/j.jcv.2016.12.008; Qayed M, 2015, PEDIATR BLOOD CANCER, V62, P364, DOI 10.1002/pbc.25237; Quintela A, 2016, J INFECTION, V72, P214, DOI 10.1016/j.jinf.2015.09.039; Servais S, 2014, BIOL BLOOD MARROW TR, V20, P507, DOI 10.1016/j.bbmt.2014.01.001; Srinivasan A, 2013, BIOL BLOOD MARROW TR, V19, P94, DOI 10.1016/j.bbmt.2012.08.012; Streng A, 2016, PEDIATR HEMAT ONCOL, V33, P468, DOI 10.1080/08880018.2016.1245805; Styczynski J, 2009, BONE MARROW TRANSPL, V43, P757, DOI 10.1038/bmt.2008.386; Takenaka K, 2015, BIOL BLOOD MARROW TR, V21, P2008, DOI 10.1016/j.bbmt.2015.07.019; Teira P, 2016, BLOOD, V127, P2427, DOI 10.1182/blood-2015-11-679639; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Tsigrelis C, 2016, BLOOD REV, V30, P139, DOI 10.1016/j.blre.2015.10.001; Verhoeven DHJ, 2015, PEDIATR INFECT DIS J, V34, P1118, DOI 10.1097/INF.0000000000000824; Vermont CL, 2014, TRANSPL INFECT DIS, V16, P188, DOI 10.1111/tid.12180; Yoon HS, 2009, PEDIATR TRANSPLANT, V13, P898, DOI 10.1111/j.1399-3046.2008.01084.x; Zerr DM, 2005, CLIN INFECT DIS, V40, P932, DOI 10.1086/428060	52	23	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228451	10.1371/journal.pone.0228451	http://dx.doi.org/10.1371/journal.pone.0228451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017805	gold, Green Published			2022-12-26	WOS:000534618100026
J	Cardona, L; Campos, P; Velasquez-Vacca, A				Cardona, Luis; Campos, Patricia; Velasquez-Vacca, Adriana			Contribution of green turtles Chelonia mydas to total herbivore biomass in shallow tropical reefs of oceanic islands	PLOS ONE			English	Article							DE-NORONHA ARCHIPELAGO; MARINE PROTECTED AREAS; SEA-TURTLES; COMMUNITY STRUCTURE; GENUS ECHINOMETRA; FISH ASSEMBLAGES; TROPHIC STATUS; CORAL-REEFS; ABUNDANCE; HABITAT	Green turtles are megaherbivores with a key role in the dynamics of tropical seagrass meadows, but little is known about their relevance as herbivores in tropical reef habitats. We conducted underwater censuses of green turtles, herbivorous fishes and sea urchins in two distinct tropical regions: Fernando de Noronha (Western Atlantic Ocean) and the Hawaiian Archipelago (Central Pacific Ocean), to assess the contribution of green turtles to the total herbivore biomass in shallow reef habitats of tropical oceanic islands. Juvenile green turtles ranging 40-60 cm were observed at most of the surveyed sites, and hence, could be considered typical components of the shallow reef fauna of tropical oceanic islands. Furthermore, they were usually one of the most abundant species of roving herbivores in many of the sites surveyed. However, the biomass of green turtles was usually much lower than the aggregated biomass of fishes or sea urchins, which usually constituted most of the total herbivore biomass. Green turtles made a major contribution to the total herbivore biomass only in sheltered sites with low rugosity, low coral cover and high algal cover. Further investigation on the trophic redundancy between herbivores is required to assess the actual relevance of green turtles in reef ecosystems of oceanic islands, compared to herbivorous fishes and sea urchins, because different herbivores may target different algal resources and complementarity may be needed to maintain ecosystem functioning across large, naturally varied reefscapes.	[Cardona, Luis; Campos, Patricia; Velasquez-Vacca, Adriana] Univ Barcelona, Fac Biol, IRBio, Barcelona, Spain; [Cardona, Luis; Campos, Patricia; Velasquez-Vacca, Adriana] Univ Barcelona, Fac Biol, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain	University of Barcelona; University of Barcelona	Velasquez-Vacca, A (corresponding author), Univ Barcelona, Fac Biol, IRBio, Barcelona, Spain.	adrianavelasquezvacca@gmail.com	Cardona, Luis/AAL-1354-2021; Cardona, Luis/L-1680-2014; Vacca, Adriana Velásquez/L-6787-2013	Cardona, Luis/0000-0002-7892-1323; Cardona, Luis/0000-0002-7892-1323; Vacca, Adriana Velásquez/0000-0002-4867-6371	CNP-q (Brazil); Fundacio Bosch i Gimpera, Barcelona, Spain [309765]	CNP-q (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacio Bosch i Gimpera, Barcelona, Spain	This work was supported by a grant from CNP-q (Brazil) to PC (http://www.cnpq.br/english/cnpq/index.htm) and the Fundacio Bosch i Gimpera, Barcelona, Spain, Project: 309765 (http://www.fbg.ub.edu/en/) to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre J, 2005, WILDLIFE RES, V32, P53, DOI 10.1071/WR04015; Arthur KE, 2008, PAC SCI, V62, P205, DOI 10.2984/1534-6188(2008)62[205:ACOIGT]2.0.CO;2; Balazs George H., 2017, Micronesica, P04; Balazs GH, 2004, MAR BIOL, V145, P1043, DOI 10.1007/s00227-004-1387-6; Ballorain K, 2010, MAR BIOL, V157, P2581, DOI 10.1007/s00227-010-1520-7; Becker SL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214972; Bonaldo RM, 2006, MAR BIOL, V149, P423, DOI 10.1007/s00227-005-0233-9; Broderick A., 2019, IUCN RED LIST THREAT, DOI [https://dx.doi.org/10.2305/IUCN.UK.2019-2.RLTS.T142121866A142086337.en, DOI 10.2305/IUCN.UK.2019-2.RLTS.T142121866A142086337.EN]; Bruno JF, 2019, ANNU REV MAR SCI, V11, P307, DOI 10.1146/annurev-marine-010318-095300; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkholder DA, 2013, J ANIM ECOL, V82, P1192, DOI 10.1111/1365-2656.12097; Chaloupka M. Y., 2019, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2019-2.RLTS.T16285718A142098300.en, DOI 10.2305/IUCN.UK.2019-2.RLTS.T16285718A142098300.EN]; Chaloupka M, 2008, GLOBAL ECOL BIOGEOGR, V17, P297, DOI 10.1111/j.1466-8238.2007.00367.x; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Crossman DJ, 2005, MAR ECOL PROG SER, V296, P129, DOI 10.3354/meps296129; de Eston V.R., 1986, Boletim do Instituto Oceanografico, V34, P37; Drupp P, 2011, AQUAT GEOCHEM, V17, P473, DOI 10.1007/s10498-010-9115-y; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Francis FT, 2019, GLOB ECOL CONSERV, V17, DOI 10.1016/j.gecco.2019.e00593; Friedlander Alan, 2005, NOAA Technical Memorandum NOS NCCOS, V11, P270; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Fuentes MMPB, 2006, WILDLIFE RES, V33, P671, DOI 10.1071/WR05081; Gitirana Humberto M., 2012, Marine Turtle Newsletter, P9; Goatley CHR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039979; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Helyer J, 2017, MAR ECOL PROG SER, V575, P1, DOI 10.3354/meps12235; Hiratsuka Y, 2007, COMP BIOCHEM PHYS A, V148, P223, DOI 10.1016/j.cbpa.2007.04.009; Howell LN, 2016, MAR ECOL PROG SER, V559, P217, DOI 10.3354/meps11897; Jantzen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081834; Johansson CL, 2013, J EXP MAR BIOL ECOL, V442, P39, DOI 10.1016/j.jembe.2013.01.027; Jones R. S., 1968, Micronesica, V4, P309; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; Kelkar N, 2013, MAR ECOL PROG SER, V485, P235, DOI 10.3354/meps10406; Kittinger JN, 2013, ECOGRAPHY, V36, P868, DOI 10.1111/j.1600-0587.2013.00245.x; Krajewski JP, 2011, ENVIRON BIOL FISH, V92, P25, DOI 10.1007/s10641-011-9813-3; Lefcheck JS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav6420; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; MCCLANAHAN TR, 1988, OECOLOGIA, V77, P210, DOI 10.1007/BF00379188; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; Mill AC, 2007, FUNCT ECOL, V21, P1137, DOI 10.1111/j.1365-2435.2007.01330.x; Moran KL, 2005, MAR ECOL PROG SER, V305, P235, DOI 10.3354/meps305235; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; OGDEN NB, 1989, B MAR SCI, V45, P539; Reaka, 1985, ECOLOGY CORAL REEFS, P163; Roos D, 2005, AQUAT LIVING RESOUR, V18, P193, DOI 10.1051/alr:2005021; Russell DF, 2009, PAC SCI, V63, P181, DOI 10.2984/049.063.0202; RUSSO AR, 1977, AUST J MAR FRESH RES, V28, P693; Santos RG, 2015, MAR ECOL PROG SER, V529, P265, DOI 10.3354/meps11276; Seminoff JA, 2015, ENDANGERED SPECIES A; Short FT, 2003, WORLD ATLAS SEAGRASS; Silva BMG, 2017, ECOL INDIC, V79, P254, DOI 10.1016/j.ecolind.2017.04.008; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Vinueza LR, 2006, ECOL MONOGR, V76, P111, DOI 10.1890/04-1957; Vroom PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009733; Wabnitz CCC, 2010, MAR ECOL PROG SER, V420, P27, DOI 10.3354/meps08846; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876	61	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228548	10.1371/journal.pone.0228548	http://dx.doi.org/10.1371/journal.pone.0228548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999812	Green Published, gold			2022-12-26	WOS:000534612400093
J	Martin, MV; Venkatesan, R; Beyline, M; Mol, VPL; Divya, L				Martin, M. V.; Venkatesan, Ramasamy; Beyline, M.; Mol, V. P. Limna; Divya, L.			Influence of environmental factors on macrofoulant assemblages on moored buoys in the eastern Arabian Sea	PLOS ONE			English	Article							RELATIVE IMPORTANCE; SPATIAL-PATTERNS; CLIMATE-CHANGE; NORTHERN GULF; TOP-DOWN; TEMPERATURE; BARNACLE; COMMUNITY; OCEAN; BIODIVERSITY	Factors governing the distribution of organisms in the pelagic ocean are understudied. In this paper we describe environmental parameters and macrofouling assemblages on 11 buoys deployed in the Arabian Sea for an average duration of 322 days. Macrofoulants on all the mooring components extending from the sea-surface to a depth of 1800-4300 m were documented. Role of temperature, salinity, dissolved oxygen, biological productivity and zooplankton community in governing the macrofoulant distribution are described. Species composition, vertical zonation and wet biomass exhibited significant spatial variations. Lepas anatifera constituted more than 90% of foulant wet biomass on all moorings. Assemblages in the southeastern (SEAS), east-central (ECAS) and northeast (NEAS) regions were distinct. Density of L. anatifera on surface buoys were low in SEAS (0.2 +/- 0.09 no./cm(2)), high in ECAS (0.32 +/- 0.11 no./cm(2)) and moderate in NEAS (0.23 +/- 0.04no./cm(2)). Macrofoulants were observed up to a depth of 75 m in SEAS, 130 m in ECAS and 120 m in NEAS. The depth profile of macrofoulant assemblages on moorings could be related to the prevalent hypoxic condition. Vertical profiles of wet biomass on all moorings exhibited subsurface maxima at depth ranging from 10 to 20 m, consequent to the abundance of L. anatifera in a thermally stable depth of water column, wherein diurnal and semidiurnal temperature variability was minimal. We attribute the observed variation in fouling assemblages to dissolved oxygen levels, salinity and diurnal variability in temperature and salinity.	[Martin, M. V.; Venkatesan, Ramasamy] Natl Inst Ocean Technol, Ocean Observat Syst, Chennai, Tamil Nadu, India; [Beyline, M.; Divya, L.] Cent Univ Kerala, Dept Zool, Kasaragod, Kerala, India; [Mol, V. P. Limna] Kerala Univ Fisheries & Ocean Studies, Sch Ocean Sci & Technol, Kochi, Kerala, India	Ministry of Earth Sciences (MoES) - India; National Institute of Ocean Technology (NIOT); Central University of Kerala; Kerala University of Fisheries & Ocean Studies	Martin, MV; Venkatesan, R (corresponding author), Natl Inst Ocean Technol, Ocean Observat Syst, Chennai, Tamil Nadu, India.; Beyline, M (corresponding author), Cent Univ Kerala, Dept Zool, Kasaragod, Kerala, India.	vmartinmathew@gmail.com; dr.r.venkatesan@gmail.com; beyline.maxwell@gmail.com	Lekha, Divya/ABF-6047-2021	Lekha, Divya/0000-0002-5613-5284; Martin, Mathew V/0000-0003-1672-1622; Ramasamy, Venkatesan/0000-0001-7386-1539	Central University of Kerala; Department of Biotechnology, Government of India	Central University of Kerala; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Authors are thankful to all participants of 'ORV Sagar Nidhi' cruise during October-November 2016 (SN-108), for their support in data collection. We are thankful to Merlin Jeejo for her contribution towards taxonomical identification of macrofoulants on moorings. We thank Joycelyn Fernandez and Navaneeth K. N. for proof reading the manuscript. The comments of two anonymous reviewers and academic editor have greatly helped in improving the manuscript.MVM and RV, are grateful to Ministry of Earth Sciences, Government of India. MB is grateful to Central University of Kerala and LD is grateful to Department of Biotechnology, Government of India for their support.	Andersson MH, 2009, HELGOLAND MAR RES, V63, P249, DOI 10.1007/s10152-009-0156-9; ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x; [Anonymous], 2013, NOAA ATLAS NESDIS; BADEN SP, 1990, AMBIO, V19, P113; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Bernhard JM, 1999, MODERN FORAMINIFERA, P201; Blanchette CA, 2007, J EXP MAR BIOL ECOL, V340, P126, DOI 10.1016/j.jembe.2006.09.022; Blanchette CA, 2006, MAR BIOL, V149, P689, DOI 10.1007/s00227-005-0239-3; Blanco R, 2013, DEEP-SEA RES PT II, V98, P370, DOI 10.1016/j.dsr2.2013.01.019; Bongiorni L, 2013, DEEP-SEA RES PT II, V98, P75, DOI 10.1016/j.dsr2.2013.08.006; Bonicelli J, 2014, J EXP MAR BIOL ECOL, V461, P350, DOI 10.1016/j.jembe.2014.09.003; Bonjean F, 2002, J PHYS OCEANOGR, V32, P2938, DOI 10.1175/1520-0485(2002)032<2938:DMAAOT>2.0.CO;2; Brennan CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167411; BUSTAMANTE RH, 1995, OECOLOGIA, V102, P189, DOI 10.1007/BF00333251; Canning-Clode J, 2009, BASIC APPL ECOL, V10, P745, DOI 10.1016/j.baae.2009.05.005; Carton JA, 2008, J CLIMATE, V21, P1029, DOI 10.1175/2007JCLI1798.1; Chang CY, 2016, ECOL EVOL, V6, P8330, DOI 10.1002/ece3.2462; Chen YY, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.214.3291; Claar DC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190957; Cowie P. R., 2010, BIOFOULING, P87, DOI DOI 10.1002/9781444315462.CH6; Crickenberger S, 2015, INVERTEBR BIOL, V134, P291, DOI 10.1111/ivb.12104; Daigle ST, 2013, MAR COAST FISH, V5, P53, DOI 10.1080/19425120.2013.774301; Danovaro R, 2004, ECOL LETT, V7, P821, DOI 10.1111/j.1461-0248.2004.00634.x; Donlon CJ, 2002, J CLIMATE, V15, P353, DOI 10.1175/1520-0442(2002)015<0353:TIVOSS>2.0.CO;2; Dutertre M, 2013, ICES J MAR SCI, V70, P294, DOI 10.1093/icesjms/fss170; Ellingsen KE, 2002, MAR ECOL PROG SER, V232, P15, DOI 10.3354/meps232015; FORTEATH GNR, 1982, MAR ECOL PROG SER, V8, P61, DOI 10.3354/meps008061; Friedrich J., 2013, BIOGEOSCIENCES DISCU, V10, P12, DOI [10.5194/bgd-10-12655-2013, DOI 10.5194/BGD-10-12655-2013]; Frith D.W., 1976, Research Bull Phuket mar biol Cent, VNo. 10, P1; Gardner WD, 2018, EARTH PLANET SC LETT, V482, P126, DOI 10.1016/j.epsl.2017.11.008; Giberto DA, 2004, ESTUAR COAST SHELF S, V61, P1, DOI 10.1016/j.ecss.2004.03.015; Giere O., 2013, MEIOBENTHOLOGY MICRO; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Gupta GVM, 2016, J GEOPHYS RES-BIOGEO, V121, P159, DOI 10.1002/2015JG003163; Hollmann R, 2013, B AM METEOROL SOC, V94, P1541, DOI 10.1175/BAMS-D-11-00254.1; Huey RB, 2002, INTEGR COMP BIOL, V42, P415, DOI 10.1093/icb/42.3.415; Jost J, 2012, MAR SCI FAC PUBL; KAMYKOWSKI D, 1990, DEEP-SEA RES, V37, P1861, DOI 10.1016/0198-0149(90)90082-7; Kavanaugh MT, 2016, ICES J MAR SCI, V73, P1839, DOI 10.1093/icesjms/fsw086; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Kogan I, 2006, CONT SHELF RES, V26, P771, DOI 10.1016/j.csr.2006.01.010; Kraufvelin P, 2011, MAR ECOL PROG SER, V426, P13, DOI 10.3354/meps09038; Krone R, 2017, MAR ENVIRON RES, V123, P53, DOI 10.1016/j.marenvres.2016.11.011; Kumar SP, 1999, J GEOPHYS RES-OCEANS, V104, P1455, DOI 10.1029/1998JC900022; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; LEWBEL GS, 1987, MAR ENVIRON RES, V21, P199, DOI 10.1016/0141-1136(87)90066-3; Lim SC, 2009, RAFFLES B ZOOL, P41; MARKAGER S, 1992, MAR ECOL PROG SER, V88, P83, DOI 10.3354/meps088083; McCreary JP, 2013, PROG OCEANOGR, V112, P15, DOI 10.1016/j.pocean.2013.03.002; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; McPhaden M.J., 2010, P OCEANOBS, V9, P668, DOI [DOI 10.5270/OCEANOBS09.CWP.61, 10.5270/OceanObs09.cwp.61]; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; MENGE BA, 1991, J EXP MAR BIOL ECOL, V146, P69, DOI 10.1016/0022-0981(91)90255-U; Menge BA, 1999, ECOL MONOGR, V69, P297, DOI 10.1890/0012-9615(1999)069[0297:TDABUR]2.0.CO;2; Nishizaki MT, 2015, J THERM BIOL, V54, P37, DOI 10.1016/j.jtherbio.2015.02.002; Orton J.H., 1920, J MAR BIOL ASSOC UK, V12, P339, DOI [10.1017/s0025315400000102, DOI 10.1017/S0025315400000102]; Palmer MD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031712; PATEL B, 1959, J MAR BIOL ASSOC UK, V38, P589, DOI 10.1017/S0025315400007013; Petersen JK, 2006, AMBIO, V35, P75, DOI 10.1579/0044-7447(2006)35[75:OWFTTO]2.0.CO;2; Phillippi AL, 2001, AQUACULTURE, V195, P225, DOI 10.1016/S0044-8486(00)00556-1; Phillips NE, 2005, MAR ECOL PROG SER, V295, P79, DOI 10.3354/meps295079; PLATT T, 1988, SCIENCE, V241, P1613, DOI 10.1126/science.241.4873.1613; Pochai A, 2017, ZOOSYST EVOL, V93, P13, DOI 10.3897/zse.93.10769; Qiu JW, 1999, MAR ECOL PROG SER, V188, P123, DOI 10.3354/meps188123; Reeves DB, 2019, T AM FISH SOC, V148, P324, DOI 10.1002/tafs.10135; Rogers AD, 2004, WORLD CONS UN 7 CONV; Schoepf V, 2015, SCI REP-UK, V5, DOI 10.1038/srep17639; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Sergeeva N, 2013, ACTA ZOOL BULGAR, V65, P139; Shankar D, 2002, PROG OCEANOGR, V52, P63, DOI 10.1016/S0079-6611(02)00024-1; Shriver JF, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008170; Thiyagarajan V, 2003, J EXP MAR BIOL ECOL, V287, P223, DOI 10.1016/S0022-0981(02)00570-1; Tsang LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045120; Turnewitsch R, 2004, EARTH PLANET SC LETT, V222, P1023, DOI 10.1016/j.epsl.2004.03.042; Valdivia N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024062; van der Stap T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146324; Veiga P, 2016, MAR ENVIRON RES, V120, P191, DOI 10.1016/j.marenvres.2016.08.011; Venugopalan VP, 1990, IJMS, V191; Wilhelmsson D, 2008, ESTUAR COAST SHELF S, V79, P459, DOI 10.1016/j.ecss.2008.04.020; Xie XH, 2013, GEOPHYS RES LETT, V40, P2748, DOI 10.1002/grl.50533; Yan T, 2009, INT BIODETER BIODEGR, V63, P1079, DOI 10.1016/j.ibiod.2009.09.003; Zeppilli D, 2015, MAR BIODIVERS, V45, P505, DOI 10.1007/s12526-015-0359-z; Zhang H, 2015, INT BIODETER BIODEGR, V104, P92, DOI 10.1016/j.ibiod.2015.05.003	84	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0223560	10.1371/journal.pone.0223560	http://dx.doi.org/10.1371/journal.pone.0223560			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999725	gold, Green Published			2022-12-26	WOS:000534612400004
J	Meng, DL; Yang, QM; Wang, HY; Melick, CH; Navlani, R; Frank, AR; Jewell, JL				Meng, Delong; Yang, Qianmei; Wang, Huanyu; Melick, Chase H.; Navlani, Rishika; Frank, Anderson R.; Jewell, Jenna L.			Glutamine and asparagine activate mTORC1 independently of Rag GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; glutamine; mTOR complex (mTORC); metabolism; signal transduction; ADP-ribosylation factor 1 (Arf1); asparagine; glutamine; mTORC1; Rag GTPase; amino acid sensing; v-ATPase; lysosome; metabolic regulation	TUBEROUS SCLEROSIS COMPLEX; AMINO-ACID SUFFICIENCY; TUMOR-SUPPRESSOR; REGULATES MTOR; DIRECT TARGET; GAP ACTIVITY; PROTEIN; METABOLISM; MECHANISM; UPSTREAM	Nutrient sensing by cells is crucial, and when this sensing mechanism is disturbed, human disease can occur. mTOR complex 1 (mTORC1) senses amino acids to control cell growth, metabolism, and autophagy. Leucine, arginine, and methionine signal to mTORC1 through the well-characterized Rag GTPase signaling pathway. In contrast, glutamine activates mTORC1 through a Rag GTPase?independent mechanism that requires ADP-ribosylation factor 1 (Arf1). Here, using several biochemical and genetic approaches, we show that eight amino acids filter through the Rag GTPase pathway. Like glutamine, asparagine signals to mTORC1 through Arf1 in the absence of the Rag GTPases. Both the Rag-dependent and Rag-independent pathways required the lysosome and lysosomal function for mTORC1 activation. Our results show that mTORC1 is differentially regulated by amino acids through two distinct pathways.	[Meng, Delong; Yang, Qianmei; Wang, Huanyu; Melick, Chase H.; Navlani, Rishika; Frank, Anderson R.; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-508A, Dallas, TX 75390 USA; [Meng, Delong; Yang, Qianmei; Wang, Huanyu; Melick, Chase H.; Navlani, Rishika; Frank, Anderson R.; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Meng, Delong; Yang, Qianmei; Wang, Huanyu; Melick, Chase H.; Navlani, Rishika; Frank, Anderson R.; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jewell, JL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-508A, Dallas, TX 75390 USA.	Jenna.Jewell@UTSouthwestern.edu		Wang, Huanyu/0000-0003-3981-3394; Meng, Delong/0000-0001-5183-4564; Frank, Anderson/0000-0003-2239-9975; Jewell, Jenna/0000-0002-8021-9453; Melick, Chase/0000-0003-3977-9886	CPRIT Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant [RR150032]; CPRIT High-Impact/High-Risk Research Award [RP160713]; Welch Foundation [I-1927]; 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society (ACS) [ACS-IRG-17-174-13]; National Institutes of Health [R01GM129097-01]	CPRIT Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant; CPRIT High-Impact/High-Risk Research Award; Welch Foundation(The Welch Foundation); 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society (ACS)(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by CPRIT Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant RR150032; CPRIT High-Impact/High-Risk Research Award RP160713; Welch Foundation Grant I-1927; the 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society (ACS) Institutional Research Grant ACS-IRG-17-174-13; and National Institutes of Health Grant R01GM129097-01 (to J. L. J.). TheX authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bauchart-Thevret C, 2010, AM J PHYSIOL-ENDOC M, V299, pE899, DOI 10.1152/ajpendo.00068.2010; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; FRAME EG, 1958, J CLIN INVEST, V37, P1710, DOI 10.1172/JCI103763; Gomes AP, 2015, CURR OPIN BIOTECH, V34, P110, DOI 10.1016/j.copbio.2014.12.007; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kim A, 2015, MOL BIOL CELL, V26, P4631, DOI 10.1091/mbc.E15-08-0581; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Krall AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11457; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Luo M, 2018, CELL METAB, V27, P947, DOI 10.1016/j.cmet.2018.04.012; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Palm W, 2017, NATURE, V546, P234, DOI 10.1038/nature22379; Pavlova NN, 2018, CELL METAB, V27, P428, DOI 10.1016/j.cmet.2017.12.006; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Saxton RA, 2016, NATURE, V536, P229, DOI 10.1038/nature19079; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; STEIN WH, 1954, J BIOL CHEM, V211, P915; Stracka D, 2014, J BIOL CHEM, V289, P25010, DOI 10.1074/jbc.M114.574335; Tanigawa M, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00075-17; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Ukai H, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007334; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wolfson RL, 2017, NATURE, V543, P438, DOI 10.1038/nature21423; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Wyant GA, 2017, CELL, V171, P642, DOI 10.1016/j.cell.2017.09.046; Yang HJ, 2017, NATURE, V552, P368, DOI 10.1038/nature25023; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	55	66	67	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2890	2899		10.1074/jbc.AC119.011578	http://dx.doi.org/10.1074/jbc.AC119.011578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32019866	Green Published, hybrid			2022-12-26	WOS:000519597300001
J	Goshima, Y; Nakaoka, S; Ohashi, K; Sakamaki, H; Shibuya, K; Shibuya, A				Goshima, Yuki; Nakaoka, Shinji; Ohashi, Kazuteru; Sakamaki, Hisashi; Shibuya, Kazuko; Shibuya, Akira			A mathematical model for dynamics of soluble form of DNAM-1 as a biomarker for graft-versus-host disease	PLOS ONE			English	Article							T-CELLS	DNAM-1 (CD226) is an activating immunoreceptor expressed on T cells and NK cells and involved in the pathogenesis of acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We previously reported that a soluble form of DNAM-1 (sDNAM-1) is generated by shedding from activated T cells. Moreover, higher serum levels of sDNAM-1 in patients before allo-HSCT is a predictive biomarker for the development of aGVHD based on the retrospective univariate and multivariate analyses in allo-HSCT patients. However, it remains unclear how the serum levels of sDNAM-1 are regulated after allo-HSCT and whether they are associated with the development of aGVHD. Here, we constructed a mathematical model to assess the dynamics of sDNAM-1 after allo-HSCT by assuming that there are three types of sDNAM-1 (the first and the second were from alloreactive and non-alloreactive donor lymphocytes, respectively, and the third from recipient lymphocytes). Our mathematical model fitted well to the data set of sDNAM-1 in patients (n = 67) who had undergone allo-HSCT and suggest that the high proportion of the first type of sDNAM-1 to the total of the first and second types is associated with high risk of the development of severe aGVHD. Thus, sDNAM-1 after allo-HSCT can be a biomarker for the development of aGVHD.	[Goshima, Yuki; Shibuya, Kazuko; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan; [Goshima, Yuki] Univ Tsukuba, Sch Med, Tsukuba, Ibaraki, Japan; [Nakaoka, Shinji] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Nakaoka, Shinji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Ohashi, Kazuteru; Sakamaki, Hisashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan; [Shibuya, Kazuko; Shibuya, Akira] Univ Tsukuba, R&D Ctr Innovat Drug Discovery, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, Tsukuba Adv Res Alliance TARA, Life Sci Ctr Survival Dynam, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; Hokkaido University; Japan Science & Technology Agency (JST); Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; University of Tsukuba; University of Tsukuba	Shibuya, A (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, R&D Ctr Innovat Drug Discovery, Tsukuba, Ibaraki, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, Tsukuba Adv Res Alliance TARA, Life Sci Ctr Survival Dynam, Tsukuba, Ibaraki, Japan.	ashibuya@md.tsukuba.ac.jp		Goshima, Yuki/0000-0003-4596-3663	Ministry of Education, Culture, Sports, Science and Technology, Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan	This work was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan and the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan.	Akaike H., 1973, P 2 INT S INF THEOR, P267; Alho AC, 2016, UNBALANCED RECOVERY; Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X; Ferrara JLM, 2011, BLOOD, V118, P6702, DOI 10.1182/blood-2011-08-375006; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Harris AC, 2013, BRIT J HAEMATOL, V160, P288, DOI 10.1111/bjh.12142; Harris AC, 2012, BLOOD, V119, P2960, DOI 10.1182/blood-2011-10-387357; Iwami S, 2015, ELIFE, V4, DOI 10.7554/eLife.08150; Kanaya M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154173; KORNGOLD R, 1987, J EXP MED, V165, P1552, DOI 10.1084/jem.165.6.1552; Koyama M, 2013, BLOOD, V121, P3511, DOI 10.1182/blood-2012-07-444026; Lee C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190610; Matthews K, 2009, HAEMATOL-HEMATOL J, V94, P956, DOI 10.3324/haematol.2008.003103; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Nakaoka S, 2012, J BIOL DYNAM, V6, P836, DOI 10.1080/17513758.2011.588343; Paczesny S, 2010, BLOOD, V116; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Petzoldt T., 2018, MOL EPIDEMEOLOGY PRE, V33; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586; Yew PY, 2015, BONE MARROW TRANSPL, V50, P1227, DOI 10.1038/bmt.2015.133; Zhang LL, 2016, J LEUKOCYTE BIOL, V99, P279, DOI 10.1189/jlb.4RU0615-254RR; Zhang YQ, 2005, 2005 IEEE 2ND SYMPOSIUM ON MULTI-AGENT SECURITY AND SURVIVABILITY, PROCEEDINGS, P1	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228508	10.1371/journal.pone.0228508	http://dx.doi.org/10.1371/journal.pone.0228508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040515	gold, Green Published			2022-12-26	WOS:000534629400023
J	Kandell, WM; Donatelli, SS; Trinh, TL; Calescibetta, AR; So, T; Tu, N; Gilvary, DL; Chen, XH; Cheng, PY; Adams, WA; Chen, YK; Liu, JH; Djeu, JY; Wei, S; Eksioglu, EA				Kandell, Wendy M.; Donatelli, Sarah S.; Thu Le Trinh; Calescibetta, Alexandra R.; Tina So; Nhan Tu; Gilvary, Danielle L.; Chen, Xianghong; Cheng, Pingyan; Adams, William A.; Chen, Yin-Kai; Liu, Jinhong; Djeu, Julie Y.; Wei, Sheng; Eksioglu, Erika A.			MicroRNA-155 governs SHIP-1 expression and localization in NK cells and regulates subsequent infiltration into murine AT3 mammary carcinoma	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IFN-GAMMA PRODUCTION; LYTIC FUNCTION; ACTIVATION; EXPANSION; RECEPTOR; FILAMIN; CANCER; MECHANISM; INFECTION	NK cell migration and activation are crucial elements of tumor immune surveillance. In mammary carcinomas, the number and function of NK cells is diminished, despite being positively associated with clinical outcome. MicroRNA-155 (miR-155) has been shown to be an important regulator of NK cell activation through its interaction with SHIP-1 downstream of inhibitory NK receptor signaling, but has not been explored in regard to NK cell migration. Here, we explored the migratory potential and function of NK cells in subcutaneous AT3 in mice lacking miR-155. Without tumor, these bic/miR-155(-/-) mice possess similar numbers of NK cells that exhibit comparable surface levels of cytotoxic receptors as NK cells from wildtype (WT) mice. Isolated miR-155(-/-) NK cells also exhibit equivalent cytotoxicity towards tumor targets in vitro compared to isolated WT control NK cells, despite overexpression of known miR-155 gene targets. NK cells isolated from miR-155(-/-) mice exhibit impaired F-actin polymerization and migratory capacity in Boyden-chamber assays in response chemokine (C-C motif) ligand 2 (CCL2). This migratory capacity could be normalized in the presence of SHIP-1 inhibitors. Of note, miR-155(-/-) mice challenged with mammary carcinomas exhibited heightened tumor burden which correlated with a lower number of tumor-infiltrating NK1.1(+) cells. Our results support a novel, physiological role for SHIP-1 in the control of NK cell tumor trafficking, and implicate miR-155 in the regulation of NK cell chemotaxis, in the context of mammary carcinoma. This may implicate dysfunctional NK cells in the lack of tumor clearance in mice.	[Kandell, Wendy M.; Donatelli, Sarah S.; Thu Le Trinh; Calescibetta, Alexandra R.; Tina So; Nhan Tu; Gilvary, Danielle L.; Chen, Xianghong; Cheng, Pingyan; Adams, William A.; Chen, Yin-Kai; Liu, Jinhong; Djeu, Julie Y.; Wei, Sheng; Eksioglu, Erika A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA; [Kandell, Wendy M.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33620 USA; [Thu Le Trinh] Dong Nai Technol Univ, Dong Nai, Dong Nai Provin, Vietnam	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Eksioglu, EA (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA.	Erika.Eksioglu@moffitt.org	Eksioglu, Erika/E-6315-2015	Eksioglu, Erika/0000-0003-4458-7192	Adeline Garcia Endowed Chair; DOD [LC140270, LC140277]; NIH [CA115308]; NCI [K01CA187020]	Adeline Garcia Endowed Chair; DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Manuel and Adeline Garcia Endowed Chair to J.Y.D.; DOD LC140277 to J.Y.D., https://www.grants.gov/learngrants/grant-making-agencies/department-of-defense.html; DOD LC140270 to T.L.T., https://www.grants.gov/learn-grants/grant-makingagencies/department-of-defense.html; NIH T32 Training Grant CA115308 to N.T., https://grants.nih.gov/funding/index.htm; NCI K01CA187020 to E.A.E., https://www.cancer.gov/grants-training/grants-funding/funding-opportunities.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P., 1996, Methods (Orlando), V10, P145, DOI 10.1006/meth.1996.0088; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Banh C, 2012, BLOOD, V120, P4583, DOI 10.1182/blood-2012-04-425009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; Brooks R, 2010, J IMMUNOL, V184, P3582, DOI 10.4049/jimmunol.0902844; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Conde C, 2011, BIOCHEM PHARMACOL, V82, P1320, DOI 10.1016/j.bcp.2011.05.031; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Gumbleton M, 2015, J IMMUNOL, V194, P2847, DOI 10.4049/jimmunol.1402930; Hope JL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01696; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lebel-Haziv Y, 2014, NEOPLASIA, V16, P723, DOI 10.1016/j.neo.2014.08.004; Lehmann MH, 2016, J LEUKOCYTE BIOL, V99, P1057, DOI 10.1189/jlb.4MA0815-376RR; Lesourne R, 2005, J IMMUNOL, V174, P1365, DOI 10.4049/jimmunol.174.3.1365; Levi I, 2015, ONCOTARGET, V6, P1, DOI 10.18632/oncotarget.3453; Li LM, 2014, J IMMUNOL, V192, P1034, DOI 10.4049/jimmunol.1301309; LIU JH, 1994, CELL IMMUNOL, V156, P24, DOI 10.1006/cimm.1994.1150; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Morrison BE, 2003, J CLIN INVEST, V112, P1862, DOI 10.1172/JCI200318125; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Parihar R, 2005, CANCER RES, V65, P9099, DOI 10.1158/0008-5472.CAN-04-4424; Tili E, 2011, P NATL ACAD SCI USA, V108, P4908, DOI 10.1073/pnas.1101795108; Trotta R, 2013, BLOOD, V121, P3126, DOI 10.1182/blood-2012-12-467597; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Wang JL, 2014, INT J CANCER, V135, P956, DOI 10.1002/ijc.28738; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Wu Y, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00930; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Zawislak CL, 2013, P NATL ACAD SCI USA, V110, P6967, DOI 10.1073/pnas.1304410110	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0225820	10.1371/journal.pone.0225820	http://dx.doi.org/10.1371/journal.pone.0225820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040476	Green Published, gold			2022-12-26	WOS:000534629400006
J	Zong, S; Mi, T; Flores, LG; Alpert, A; Olivares, S; Patel, K; Maiti, S; Mcnamara, G; Cooper, LJN; Torikai, H				Zong, Shan; Mi, Tiejuan; Flores, Leo G., II; Alpert, Amir; Olivares, Simon; Patel, Krina; Maiti, Sourindra; Mcnamara, George; Cooper, Laurence J. N.; Torikai, Hiroki			Very rapid cloning, expression and identifying specificity of T-cell receptors for T-cell engineering	PLOS ONE			English	Article							MUTATIONAL LANDSCAPE; IMMUNE CONTEXTURE; SLEEPING-BEAUTY; HUMAN-MELANOMA; MOUSE MODELS; LYMPHOCYTES; ACTIVATION; IDENTIFICATION; SENSITIVITY; INDUCTION	Neoantigens can be predicted and in some cases identified using the data obtained from the whole exome sequencing and transcriptome sequencing of tumor cells. These sequencing data can be coupled with single-cell RNA sequencing for the direct interrogation of the transcriptome, surfaceome, and pairing of alpha beta T-cell receptors (TCR alpha beta) from hundreds of single T cells. Using these 2 large datasets, we established a platform for identifying antigens recognized by TCR alpha beta s obtained from single T cells. Our approach is based on the rapid expression of cloned TCR alpha beta genes as Sleeping Beauty transposons and the determination of the introduced TCR alpha beta s' antigen specificity and avidity using a reporter cell line. The platform enables the very rapid identification of tumor-reactive TCRs for the bioengineering of T cells with redirected specificity.	[Zong, Shan; Mi, Tiejuan; Flores, Leo G., II; Alpert, Amir; Olivares, Simon; Maiti, Sourindra; Mcnamara, George; Cooper, Laurence J. N.; Torikai, Hiroki] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [Patel, Krina] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Cooper, Laurence J. N.] Ziopharm Oncol Inc, Boston, MA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Torikai, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA.	htorikai@mdanderson.org		TORIKAI, HIROKI/0000-0001-5248-9723	Pediatric Research Funding - MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center Support Grant [P30 CA016672]	Pediatric Research Funding - MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Pediatric Research Funding - MD Anderson Cancer Center. This is the department fund from the institution. This study used MD Anderson's Flow Cytometry and Cellular Imaging Core, which is supported by the National Institutes of Health through MD Anderson's Cancer Center Support Grant (P30 CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse CA, 2002, INT J CANCER, V99, P7, DOI 10.1002/ijc.10317; Akatsuka Y, 2002, TISSUE ANTIGENS, V59, P502, DOI 10.1034/j.1399-0039.2002.590607.x; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Balakrishnan A, 2016, CURR OPIN ORGAN TRAN, V21, P22, DOI 10.1097/MOT.0000000000000261; Barlic J, 2004, J BIOL CHEM, V279, P48520, DOI 10.1074/jbc.M406978200; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Black CB, 2011, ASSAY DRUG DEV TECHN, V9, P13, DOI 10.1089/adt.2010.0308; Brickner AG, 2001, J EXP MED, V193, P195, DOI 10.1084/jem.193.2.195; Chabanon RM, 2016, CLIN CANCER RES, V22, P4309, DOI 10.1158/1078-0432.CCR-16-0903; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Fassett MS, 2012, P NATL ACAD SCI USA, V109, P3891, DOI 10.1073/pnas.1200090109; Fernandez-Poma SM, 2017, CANCER RES, V77, P3672, DOI 10.1158/0008-5472.CAN-17-0236; Fridman WH, 2017, NAT REV CLIN ONCOL, V14, P717, DOI 10.1038/nrclinonc.2017.101; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Guo XZJ, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2015.54; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Hansen TH, 2010, TRENDS IMMUNOL, V31, P363, DOI 10.1016/j.it.2010.07.003; Heemskerk MHM, 2003, BLOOD, V102, P3530, DOI 10.1182/blood-2003-05-1524; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Hinz T, 2001, INT ARCH ALLERGY IMM, V125, P16, DOI 10.1159/000053792; Hooijberg E, 2000, BLOOD, V96, P459; Hosoi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19548-y; Hu ZT, 2018, BLOOD, V132, P1911, DOI 10.1182/blood-2018-04-843763; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Kebriaei P, 2016, J CLIN INVEST, V126, P3363, DOI 10.1172/JCI86721; Lam BYH, 2010, J NEUROCHEM, V112, P1065, DOI 10.1111/j.1471-4159.2009.06521.x; Leisegang M, 2016, J CLIN INVEST, V126, P854, DOI 10.1172/JCI83465; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morimoto Soyoko, 2018, Oncotarget, V9, P34132, DOI 10.18632/oncotarget.26139; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Petersen TR, 2004, INT IMMUNOL, V16, P889, DOI 10.1093/intimm/dxh098; Ponomarev V, 2001, NEOPLASIA, V3, P480, DOI 10.1038/sj.neo.7900204; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Roth TL, 2018, NATURE, V559, P405, DOI 10.1038/s41586-018-0326-5; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Schaft N, 2003, J IMMUNOL METHODS, V280, P13, DOI 10.1016/S0022-1759(03)00067-X; Siewert K, 2012, NAT MED, V18, P824, DOI 10.1038/nm.2720; Singh H, 2014, IMMUNOL REV, V257, P181, DOI 10.1111/imr.12137; Stubbington MJT, 2017, SCIENCE, V358, P58, DOI 10.1126/science.aan6828; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Woronicz JD, 1994, REQUIREMENT ORPHAN S; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415	61	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228112	10.1371/journal.pone.0228112	http://dx.doi.org/10.1371/journal.pone.0228112			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040512	Green Published, gold			2022-12-26	WOS:000534629400015
J	Christians, JK; Munoz, MFH				Christians, Julian K.; Munoz, Maria F. Huicochea			Pregnancy complications recur independently of maternal vascular malperfusion lesions	PLOS ONE			English	Article							ADVERSE PERINATAL OUTCOMES; PLASMA PROTEIN-A; RISK; MISCARRIAGE; WOMEN; BIRTH; PREECLAMPSIA; POLYMORPHISMS; PATHOLOGY; ABORTIONS	Background Spontaneous abortions, intrauterine growth restriction, and preeclampsia are thought to be caused by defective placentation and are associated with increased risk of adverse outcomes in subsequent pregnancies. However, it is not known whether the recurrence of adverse outcomes is associated with the recurrence of placental pathology. We hypothesized that recurrent maternal vascular malperfusion (MVM) underlies the recurrence of adverse outcomes. Methods Using data from the National Collaborative Perinatal Project, we assessed the recurrence of pregnancy complications and MVM lesions (N = 3865), associations between a history of spontaneous abortions and MVM lesions or adverse outcomes in subsequent pregnancies (N = 8312), and whether the recurrence of pregnancy complications occurred independently of the presence of MVM lesions. Results The odds of an MVM lesion were higher for a woman who had had an MVM lesion in a previous pregnancy (aOR = 1.6; 95% CI 1.3-1.9), although this was marginally non-significant after adjusting for covariates such as gestational age, race and BMI. The odds of preeclampsia, a small-for-gestational-age infant, premature delivery and early pregnancy loss were 2.7-5.0 times higher if there had been that same adverse outcome in a previous pregnancy. A history of spontaneous abortions was associated with higher risk of a small-forgestational-age baby (aOR = 2.4; 95% CI 1.7-3.4) and prematurity (aOR = 5.1; 95% CI 2.3-11.5 for extremely preterm), but not preeclampsia. The recurrence of adverse outcomes was significant when restricting analyses to women without MVM lesions. Similarly, associations between adverse outcomes and previous spontaneous abortions were significant when statistically controlling for the presence of MVM lesions, or excluding pregnancies with MVM lesions. Conclusions Women with adverse outcomes in one pregnancy are at higher risk of complications in subsequent pregnancies. However, there is significant recurrence of adverse outcomes even in the absence of MVM.	[Christians, Julian K.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Christians, Julian K.] Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada; [Christians, Julian K.] British Columbia Childrens Hosp Res Inst, Vancouver, BC, Canada; [Christians, Julian K.] Womens Hlth Res Inst, Vancouver, BC, Canada; [Munoz, Maria F. Huicochea] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada	Simon Fraser University; Simon Fraser University; McMaster University	Christians, JK (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.; Christians, JK (corresponding author), Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada.; Christians, JK (corresponding author), British Columbia Childrens Hosp Res Inst, Vancouver, BC, Canada.; Christians, JK (corresponding author), Womens Hlth Res Inst, Vancouver, BC, Canada.	julian_christians@sfu.ca	Christians, J.K./AAL-2547-2020	Christians, J.K./0000-0003-1797-0591				Agrawal S, 2018, HYPERTENSION, V71, P306, DOI 10.1161/HYPERTENSIONAHA.117.10182; Assibey-Mensah V, 2018, PLACENTA, V69, P102, DOI 10.1016/j.placenta.2018.07.017; Audette MC, 2018, PLACENTA, V66, P40, DOI 10.1016/j.placenta.2018.04.014; Basso O, 1998, INT J EPIDEMIOL, V27, P642, DOI 10.1093/ije/27.4.642; Bhattacharya S, 2008, BJOG-INT J OBSTET GY, V115, P1623, DOI 10.1111/j.1471-0528.2008.01943.x; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Catov JM, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.022; Christians JK, 2019, PLACENTA, V76, P1, DOI 10.1016/j.placenta.2019.01.012; Christians JK, 2018, PLACENTA, V68, P52, DOI 10.1016/j.placenta.2018.06.311; Christians JK, 2010, PRENATAL DIAG, V30, P815, DOI 10.1002/pd.2583; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; Daher S, 2012, AM J REPROD IMMUNOL, V67, P341, DOI 10.1111/j.1600-0897.2012.01123.x; Dempsey MA, 2015, J MATERN-FETAL NEO M, V28, P522, DOI 10.3109/14767058.2014.923394; Ernst LM, 2018, APMIS, V126, P551, DOI 10.1111/apm.12833; Fawzy M, 2016, HUM FERTIL, V19, P9, DOI 10.3109/14647273.2016.1142214; Field K, 2015, HUM REPROD, V30, P1239, DOI 10.1093/humrep/dev044; Gannoun MBA, 2017, CYTOKINE, V97, P175, DOI 10.1016/j.cyto.2017.06.010; Germain AM, 2007, HYPERTENSION, V49, P90, DOI 10.1161/01.HYP.0000251522.18094.d4; Ghidini A, 1997, OBSTET GYNECOL, V90, P542, DOI 10.1016/S0029-7844(97)00360-8; Gunnarsdottir J, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.01.041; Hardy JB, 2003, ANN EPIDEMIOL, V13, P303, DOI 10.1016/S1047-2797(02)00479-9; Harmon QE, 2014, AM J REPROD IMMUNOL, V71, P472, DOI 10.1111/aji.12241; Hauspurg A, 2018, PLACENTA, V74, P14, DOI 10.1016/j.placenta.2018.12.008; Helfrich BB, 2017, PLACENTA, V52, P106, DOI 10.1016/j.placenta.2017.02.016; Huynh J, 2015, PLACENTA, V36, P101, DOI 10.1016/j.placenta.2014.11.021; Jivraj S, 2001, HUM REPROD, V16, P102, DOI 10.1093/humrep/16.1.102; Kaitu'u-Lino TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072437; Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC; Levy M, 2018, REPROD SCI, V25, P1485, DOI 10.1177/1933719117749757; Li HH, 2016, REPROD BIOL ENDOCRIN, V14, P1, DOI 10.1186/s12958-016-0140-6; Muravska A, 2011, CLIN BIOCHEM, V44, P1380, DOI 10.1016/j.clinbiochem.2011.09.015; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Nijman TAJ, 2016, PLACENTA, V48, P56, DOI 10.1016/j.placenta.2016.10.006; Romero R, 2018, J PERINAT MED, V46, P613, DOI 10.1515/jpm-2018-0055; Scifres CM, 2017, PLACENTA, V49, P10, DOI 10.1016/j.placenta.2016.11.004; Seaton SE, 2013, ARCH DIS CHILD-FETAL, V98, pF15, DOI 10.1136/fetalneonatal-2011-301572; Sheiner E, 2005, EUR J OBSTET GYN R B, V118, P61, DOI 10.1016/j.ejogrb.2004.06.015; Srinivas SK, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.040; Suzuki K, 2006, J REPROD IMMUNOL, V70, P99, DOI 10.1016/j.jri.2005.11.004; Tong S, 2004, FERTIL STERIL, V82, P1468, DOI 10.1016/j.fertnstert.2004.05.078; Trogstad L, 2009, BJOG-INT J OBSTET GY, V116, P108, DOI 10.1111/j.1471-0528.2008.01978.x; Trogstad L, 2008, INT J EPIDEMIOL, V37, P1333, DOI 10.1093/ije/dyn167; Weiner E, 2016, PRENATAL DIAG, V36, P953, DOI 10.1002/pd.4918; Weintraub Adi Y., 2005, Archives of Gynecology and Obstetrics, V271, P350, DOI 10.1007/s00404-004-0640-z; Weintraub AY, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.053; Wright E, 2017, OBSTET GYNECOL, V130, P1112, DOI 10.1097/AOG.0000000000002264; Xu XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123696; Yang J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4359424; Zhang Y, 2013, EXP THER MED, V6, P485, DOI 10.3892/etm.2013.1149	50	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228664	10.1371/journal.pone.0228664	http://dx.doi.org/10.1371/journal.pone.0228664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027702	Green Published, gold			2022-12-26	WOS:000534623800066
J	Nelson, ES; Myers, JG; Lewandowski, BE; Ethier, CR; Samuels, BC				Nelson, Emily S.; Myers, Jerry G., Jr.; Lewandowski, Beth E.; Ethier, C. Ross; Samuels, Brian C.			Acute effects of posture on intraocular pressure	PLOS ONE			English	Article							HEAD-DOWN TILT; EPISCLERAL VENOUS-PRESSURE; APPLANATION TONOMETRY; NONCONTACT TONOMETRY; BODY POSITION; BLOOD; AGREEMENT; THICKNESS; SUPINE; MIN	Many experiments have documented the response of intraocular pressure (IOP) to postural change. External forces caused by gravitational orientation change produce a dynamic response that is encountered every day during normal activities. Tilting the body at a small downward angle is also relevant to studying the effects of hypogravity (spaceflight), including ocular changes. We examined data from 36 independent datasets from 30 articles on IOP response to postural change, representing a total population of 821 subjects (>= 1173 eyes) with widely varying initial and final postures. We confirmed that IOP was well predicted by a simple quantity, namely the hydrostatic pressure at the level of the eye, although the dependence was complex (nonlinear). Our results show that posturally induced IOP change can be explained by hydrostatic forcing plus an autoregulatory contribution that is dependent on hydrostatic effects. This study represents data from thousands of IOP measurements and provides insight for future studies that consider postural change in relation to ocular physiology, intraocular pressure, ocular blood flow and aqueous humor dynamics.	[Nelson, Emily S.; Myers, Jerry G., Jr.; Lewandowski, Beth E.] NASA, Glenn Res Ctr, Cleveland, OH USA; [Ethier, C. Ross] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Ethier, C. Ross] Emory Univ, Atlanta, GA 30322 USA; [Samuels, Brian C.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA	National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; University System of Georgia; Georgia Institute of Technology; Emory University; University of Alabama System; University of Alabama Birmingham	Samuels, BC (corresponding author), Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA.	BSamuels@uabmc.edu		Ethier, Ross/0000-0001-6110-3052	NASA's Human Research Program through the Cross-Cutting Computational Modeling Project; NASA [NNX13AP91G, NNX16AT06G]; Research to Prevent Blindness; RPB	NASA's Human Research Program through the Cross-Cutting Computational Modeling Project; NASA(National Aeronautics & Space Administration (NASA)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); RPB	NASA's Human Research Program (http://www.nasa.gov/hrp) supported this work through the Cross-Cutting Computational Modeling Project and NASA grant numbers NNX13AP91G and NNX16AT06G. Research to Prevent Blindness provided a grant to the University of Alabama at Birmingham. This unrestricted funding from RPB is given to the authors' department to support research and research infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman N, 2016, NAT METHODS, V13, P385, DOI 10.1038/nmeth.3854; Anderson AP, 2017, J APPL PHYSIOL, V123, P415, DOI 10.1152/japplphysiol.00687.2016; Anderson AP, 2016, J APPL PHYSIOL, V120, P939, DOI 10.1152/japplphysiol.00730.2015; Balasubramanian S, 2018, OPHTHALMOLOGY, V125, P459, DOI 10.1016/j.ophtha.2017.10.023; Barkana Y, 2014, J GLAUCOMA, V23, pE23, DOI 10.1097/IJG.0b013e3182a0762f; Baskaran M, 2006, OPHTHALMOLOGY, V113, P1327, DOI 10.1016/j.ophtha.2006.02.063; CARLSON KH, 1987, INVEST OPHTH VIS SCI, V28, P1346; Chiquet C, 2003, J GLAUCOMA, V12, P204, DOI 10.1097/00061198-200306000-00004; Cook JA, 2012, OPHTHALMOLOGY, V119, P1552, DOI 10.1016/j.ophtha.2012.02.030; Dastiridou AI, 2009, INVEST OPHTH VIS SCI, V50, P5718, DOI 10.1167/iovs.09-3760; De Moraes CGV, 2008, J OPTOM, V01, P43; DRAEGER J, 1986, OPHTHALMIC RES, V18, P55, DOI 10.1159/000265415; Eklund A, 2016, ANN NEUROL, V80, P269, DOI 10.1002/ana.24713; FRIBERG TR, 1985, JAMA-J AM MED ASSOC, V253, P1755, DOI 10.1001/jama.253.12.1755; FRIBERG TR, 1987, AM J OPHTHALMOL, V103, P523, DOI 10.1016/S0002-9394(14)74275-8; GALIN MA, 1963, AM J OPHTHALMOL, V55, P720, DOI 10.1016/0002-9394(63)92431-0; Hinghofer-Szalkay H, 2011, EUR J APPL PHYSIOL, V111, P163, DOI 10.1007/s00421-010-1646-9; Hsu SY, 2009, EYE, V23, P1582, DOI 10.1038/eye.2009.77; Iman R. L., 2014, LATIN HYPERCUBE SAMP; JAIN MR, 1976, BRIT J OPHTHALMOL, V60, P687, DOI 10.1136/bjo.60.10.687; JAMES C B, 1991, Eye (London), V5, P309; Katsanos A, 2017, J OCUL PHARMACOL TH, V33, P598, DOI 10.1089/jop.2017.0030; Kotecha A, 2010, OPHTHALMOLOGY, V117, P730, DOI 10.1016/j.ophtha.2009.09.020; Kouchaki B, 2017, J CURR OPHTHALMOL, V29, P92, DOI 10.1016/j.joco.2016.08.010; Lam A, 2013, J OPTOM, V6, P95, DOI [10.1016/J.0PT0M.2012.12.002, DOI 10.1016/J.0PT0M.2012.12.002]; Laurie SS, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13302; Linden C, 2018, OPHTHALMOLOGY, V125, P361, DOI 10.1016/j.ophtha.2017.09.022; LINDER BJ, 1987, AVIAT SPACE ENVIR MD, V58, pA139; LINDER BJ, 1988, INVEST OPHTH VIS SCI, V29, P1492; LINNER ERIK, 1950, ACTA OPHTHALMOL, V28, P469; Liu JHK, 2005, OPHTHALMOLOGY, V112, P1670, DOI 10.1016/j.ophtha.2005.05.007; Longo A, 2004, INVEST OPHTH VIS SCI, V45, P546, DOI 10.1167/iovs.03-0757; Lucovsky G, 2009, ULIS 2009: 10TH INTERNATIONAL CONFERENCE ON ULTIMATE INTEGRATION OF SILICON, P95, DOI 10.1109/ULIS.2009.4897547; Macias BR, 2015, AEROSP MED HUM PERF, V86, P3, DOI 10.3357/AMHP.4044.2015; MADER TH, 1990, AVIAT SPACE ENVIR MD, V61, P810; Marshall-Goebel K, 2017, AEROSP MED HUM PERF, V88, P10, DOI 10.3357/AMHP.4653.2017; NASA, 2012, EVIDENCE REPORT RISK; Nelson ES, 2017, J APPL PHYSIOL, V123, P352, DOI 10.1152/japplphysiol.00102.2017; Selvadurai D, 2010, INVEST OPHTH VIS SCI, V51, P1453, DOI 10.1167/iovs.09-4058; Shinojima A, 2012, AVIAT SPACE ENVIR MD, V83, P388, DOI 10.3357/ASEM.3191.2012; Silver DM, 2000, CURR EYE RES, V20, P115, DOI 10.1076/0271-3683(200002)20:2;1-D;FT115; Singh M, 1986, Med J Malaysia, V41, P38; Singleton CD, 2003, CIRCULATION, V108, P2349, DOI 10.1161/01.CIR.0000097114.11038.26; SOUZA SA, 1987, PHYS THER, V67, P680, DOI 10.1093/ptj/67.5.680; Sultan M, 2003, J GLAUCOMA, V12, P370, DOI 10.1097/00061198-200308000-00013; Taibbi G, 2014, AVIAT SPACE ENVIR MD, V85, P983, DOI 10.3357/ASEM.4055.2014; TARKKANEN A, 1967, ACTA OPHTHALMOL, V45, P569; Thomassen TL, 1949, ACTA OPHTHALMOL, V27, P413; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P847, DOI 10.1136/bjo.2004.056614; Ventura LM, 2013, J GLAUCOMA, V22, P255, DOI 10.1097/IJG.0b013e318232973b; Xu X, 2010, AVIAT SPACE ENVIR MD, V81, P418, DOI 10.3357/ASEM.2629.2010; Yeon DY, 2014, EYE, V28, P1328, DOI 10.1038/eye.2014.211	53	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0226915	10.1371/journal.pone.0226915	http://dx.doi.org/10.1371/journal.pone.0226915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027692	gold, Green Published			2022-12-26	WOS:000534623800009
J	Ramsbottom, KA; Carr, DF; Rigden, DJ; Jones, AR				Ramsbottom, Kerry A.; Carr, Daniel F.; Rigden, Daniel J.; Jones, Andrew R.			Informatics investigations into anti-thyroid drug induced agranulocytosis associated with multiple HLA-B alleles	PLOS ONE			English	Article							MHC CLASS-I; CRYSTAL-STRUCTURES; PEPTIDE BINDING; HYPERSENSITIVITY; PREDICTION; MODE	Introduction Adverse drug reactions have been linked with HLA alleles in different studies. These HLA proteins play an essential role in the adaptive immune response for the presentation of self and non-self peptides. Anti-thyroid drugs methimazole and propylthiouracil have been associated with drug induced agranulocytosis (severe lower white blood cell count) in patients with B* 27:05, B* 38:02 and DRB1* 08:03 alleles in different populations: Taiwanese, Vietnamese, Han Chinese and Caucasian. Methods In this study, informatics methods were used to investigate if any sequence or structural similarities exist between the two associated HLA-B alleles, compared with a set of "control" alleles assumed not be associated, which could help explain the molecular basis of the adverse drug reaction. We demonstrated using MHC Motif Viewer and MHC cluster that the two alleles do not have a propensity to bind similar peptides, and thus at a gross level the structure of the antigen presentation region of the two alleles are not similar. We also performed multiple sequence alignment to identify polymorphisms shared by the risk but not by the control alleles and molecular docking to compare the predicted binding poses of the drug-allele combinations. Results Two residues, Cys67 and Thr80, were identified from the multiple sequence alignments to be unique to these risk alleles alone. The molecular docking showed the poses of the risk alleles to favour the F-pocket of the peptide binding groove, close to the Thr80 residue, with the control alleles generally favouring a different pocket. The data are thus suggestive that Thr80 may be a critical residue in HLA-mediated anti-thyroid drug induced agranulocytosis, and thus can guide future research and risk assessment.	[Ramsbottom, Kerry A.; Rigden, Daniel J.; Jones, Andrew R.] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England; [Carr, Daniel F.] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool	Jones, AR (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.	Andrew.Jones@liverpool.ac.uk		Ramsbottom, Kerry A/0000-0002-7432-9293; Jones, Andrew/0000-0001-6118-9327	Medical Research Council grant for the Centre for Drug Safety Science, University of Liverpool [MR/L006758/1]; BBSRC [BB/L024462/1] Funding Source: UKRI	Medical Research Council grant for the Centre for Drug Safety Science, University of Liverpool; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research was part-funded by the Medical Research Council grant for the Centre for Drug Safety Science, University of Liverpool (Grant Number: MR/L006758/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andres E, 2006, EUR J INTERN MED, V17, P529, DOI 10.1016/j.ejim.2006.07.012; Chen CB, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/6431694; Chen PL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8633; Coico R, 2015, IMMUNOLOGY ELECT BOO; Dimitropoulos Dimitris, 2006, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1403s15; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Hallberg P, 2016, LANCET DIABETES ENDO, V4, P507, DOI 10.1016/S2213-8587(16)00113-3; He YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12350-2; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Illing PT, 2017, IMMUNOGENETICS, V69, P617, DOI 10.1007/s00251-017-1007-5; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Johansen TE, 1997, SCAND J IMMUNOL, V46, P137, DOI 10.1046/j.1365-3083.1997.d01-102.x; John Mathew, 2015, Indian J Endocrinol Metab, V19, P340, DOI 10.4103/2230-8210.152766; KAMPMANN JP, 1981, CLIN PHARMACOKINET, V6, P401, DOI 10.2165/00003088-198106060-00001; Maenaka K, 2000, J IMMUNOL, V165, P3260, DOI 10.4049/jimmunol.165.6.3260; Thao MP, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/7965346; Negrini S, 2017, PHARMACOGENOMICS, V18, P1441, DOI 10.2217/pgs-2017-0090; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; Pavlos R, 2012, PHARMACOGENOMICS, V13, P1285, DOI [10.2217/PGS.12.108, 10.2217/pgs.12.108]; Pires DEV, 2016, NUCLEIC ACIDS RES, V44, pW557, DOI 10.1093/nar/gkw390; Pradhan S, 2017, J MOL IMAGING DYNAMI; Ramsbottom KA, 2018, MOL IMMUNOL, V101, P488, DOI 10.1016/j.molimm.2018.08.003; Rapin N, 2008, IMMUNOGENETICS, V60, P759, DOI 10.1007/s00251-008-0330-2; Ravindranath PA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004586; Roder G, 2006, ACTA CRYSTALLOGR D, V62, P1300, DOI 10.1107/S0907444906027636; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Singh RP, 2015, ACTA CRYSTALLOGR F, V71, P304, DOI 10.1107/S2053230X15001806; Singh RP, 2016, FEBS OPEN BIO, V6, P640, DOI 10.1002/2211-5463.12051; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomsen M, 2013, IMMUNOGENETICS, V65, P655, DOI 10.1007/s00251-013-0714-9; van Staa TP, 2003, AM J HEMATOL, V72, P248, DOI 10.1002/ajh.10295; Vicente N, 2017, DRUGS R&D, V17, P91, DOI 10.1007/s40268-017-0172-1; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Webb B, METHOD COMP PROTEIN; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Yun J, 2016, ASIA PAC ALLERGY, V6, P77, DOI 10.5415/apallergy.2016.6.2.77; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	43	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0220754	10.1371/journal.pone.0220754	http://dx.doi.org/10.1371/journal.pone.0220754			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027661	Green Published, Green Submitted, gold			2022-12-26	WOS:000534623800004
J	Safar, HA; Mustafa, A; Amoudy, HA; El-Hashim, A				Safar, Hussain A.; Mustafa, Abu Salim; Amoudy, Hanady A.; El-Hashim, Ahmed			The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins	PLOS ONE			English	Article							DNA VACCINE CONSTRUCTS; GENOMIC REGIONS; BOVIS BCG; IN-VITRO; SMEGMATIS; DIFFERENCE; EFFICIENT; ANTIGENS; GENES; IMMUNOGENICITY	Tuberculosis (TB) is a major health problem of global concern. The control of this disease requires appropriate preventive measures, including vaccines. In TB, T helper (Th)1 cytokines provide protection whereas Th2 and T regulatory (Treg) cytokines contribute to the pathogenesis and Th17 cytokines play a role in both protection and pathogenesis. Previous studies with Mycobacterium tuberculosis-specific proteins have identified seven low molecular weight proteins, PE35, ESXA, ESXB, Rv2346c, Rv2347c, Rv3619c, and Rv3620c, as immunodominant antigens inducing Th1-cell responses in humans following natural infection with M. tuberculosis. The aim of this study was to characterize the cytokine responses induced in mice immunized with these proteins, using various adjuvants and delivery systems, i.e. chemical adjuvants (Alum and IFA), non-pathogenic mycobacteria (M. smegmatis and M. vaccae) and a DNA vaccine plasmid (pUMVC6). The immune responses were monitored by quantifying the marker cytokines secreted by Th1 (IFN-gamma), Th2 (IL-5), Treg (IL-10), and Th17 (IL-17A) cells. DNA corresponding to pe35, esxa, esxb, rv2346c, rv2347c, rv3619c, and rv3620c genes were cloned into the expression vectors pGES-TH-1, pDE22 and pUMVC6 for expression in Escherichia coli, mycobacteria and eukaryotic cells, respectively. Mice were immunized with the recombinants using different adjuvants and delivery systems, and spleen cells were stimulated in vitro with peptides of immunizing proteins to investigate antigen-specific secretion of Th1 (IFN-gamma), Th2 (IL-5), Treg (IL-10), and Th17 (IL-17A) cytokines. The results showed that spleen cells, from mice immunized with all antigens, secreted the protective Th1 cytokine IFN-gamma, except ESXB, with one or more adjuvants and delivery systems. However, only Rv3619c consistently induced Th1-biased responses, without the secretion of significant concentrations of Th2, Th17 and Treg cytokines, with all adjuvants and delivery systems. Rv3619c also induced antigen-specific IgG antibodies in immunized mice.	[Safar, Hussain A.; Mustafa, Abu Salim; Amoudy, Hanady A.] Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait; [El-Hashim, Ahmed] Fac Pharm, Dept Pharmacol & Therapeut, Kuwait, Kuwait	Kuwait University	Mustafa, A (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait.	abusalim@hsc.edu.kw		Mustafa, AbuSalim/0000-0002-6074-1041	College of Graduate Studies, Kuwait University; Kuwait University [YM06/15, SRU02/13]; Kuwait Foundation for the Advancement of Sciences [CB17-63MM-03]	College of Graduate Studies, Kuwait University; Kuwait University; Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS))	ASM HAA AE HAS: A graduate research grant from the College of Graduate Studies, Kuwait University (kuniv.edu/COGS/index.htm) ASM HAA AE HAS: grant numbers YM06/15 and SRU02/13 from the Research Sector, Kuwait University (www.ovpr.kuniv.edu/) ASM HAS: grant number CB17-63MM-03 from Kuwait Foundation for the Advancement of Sciences (kfas.org.kw/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Achkar JM, 2015, IMMUNOL REV, V264, P167, DOI 10.1111/imr.12276; Agger EM, 2008, IMMUNOLOGY, V124, P175, DOI 10.1111/j.1365-2567.2007.02751.x; Ahmad S, 2005, SCAND J IMMUNOL, V62, P16, DOI 10.1111/j.1365-3083.2005.01639.x; Ahmad S, 2003, PROTEIN EXPRES PURIF, V29, P167, DOI 10.1016/S1046-5928(03)00052-4; Al-Attiyah R, 2008, INFECT IMMUN, V76, P4190, DOI 10.1128/IAI.00199-08; Al-Attiyah R, 2010, FEMS IMMUNOL MED MIC, V59, P177, DOI 10.1111/j.1574-695X.2010.00677.x; Alving CR, 2014, VACCINE, V32, P5382, DOI 10.1016/j.vaccine.2014.07.085; Amoudy HA, 2014, SAUDI MED J, V35, P350; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Chen Qunfei, 2011, J Evid Based Med, V4, P122, DOI 10.1111/j.1756-5391.2011.01121.x; Ciabattini A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00427; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Correia-Neves M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01968; Counoupas C, 2019, EXPERT REV VACCINES, V18, P353, DOI 10.1080/14760584.2019.1585246; Da Silva DA, 2014, J VET MED SCI, V76, P979, DOI 10.1292/jvms.13-0338; de Cerio ALD, 1999, INT IMMUNOL, V11, P2025, DOI 10.1093/intimm/11.12.2025; Garcia MD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/273129; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Ha SJ, 2003, GENE THER, V10, P1592, DOI 10.1038/sj.gt.3302057; Hanif SNM, 2011, SCAND J IMMUNOL, V74, P554, DOI 10.1111/j.1365-3083.2011.02604.x; Hanif SNM, 2010, SCAND J IMMUNOL, V72, P408, DOI 10.1111/j.1365-3083.2010.02452.x; Hanif SNM, 2010, SCAND J IMMUNOL, V71, P353, DOI 10.1111/j.1365-3083.2010.02388.x; Hanif SNM, 2017, INT J MYCOBACT, V6, P281, DOI 10.4103/ijmy.ijmy_98_17; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Huang CY, 2017, HUM VACC IMMUNOTHER, V13, P1960, DOI 10.1080/21645515.2017.1335374; Jacobs AJ, 2016, TUBERCULOSIS, V101, P102, DOI 10.1016/j.tube.2016.08.001; Junqueira-Kipnis AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078639; Kadir NA, 2016, INT J MYCOBACT, V5, P7, DOI 10.1016/j.ijmyco.2015.09.006; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kaufmann SHE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01203; Kaufmann SHE, 2017, INT J INFECT DIS, V56, P263, DOI 10.1016/j.ijid.2016.10.018; Kwon BE, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e17; LoBue PA, 2010, INT J TUBERC LUNG D, V14, P1226; Luo ZC, 2012, MOL MED REP, V6, P1309, DOI 10.3892/mmr.2012.1079; Lyadova IV, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/854507; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Mahmood A, 2011, FEBS J, V278, P341, DOI 10.1111/j.1742-4658.2010.07958.x; Mani R, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00537-18; Mustafa A., 2013, J MYCOBAC DIS, V03; Mustafa AS, 2012, MED PRIN PRACT, V21, P195, DOI 10.1159/000337919; Mustafa AS, 2011, MICROBIOL IMMUNOL, V55, P267, DOI 10.1111/j.1348-0421.2011.00307.x; Mustafa AS, 2009, EXPERT REV VACCINES, V8, P1309, DOI [10.1586/erv.09.93, 10.1586/ERV.09.93]; O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009; Orr MT, 2013, J CONTROL RELEASE, V172, P190, DOI 10.1016/j.jconrel.2013.07.030; Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036; Rodriguez L, 2011, VACCINE, V29, P6236, DOI 10.1016/j.vaccine.2011.06.077; Shaban K, 2013, CLIN VACCINE IMMUNOL, V20, P1230, DOI 10.1128/CVI.00090-12; Sun SQ, 1998, J EXP MED, V187, P1145, DOI 10.1084/jem.187.7.1145; Tirado Y, 2016, TUBERCULOSIS, V101, P44, DOI 10.1016/j.tube.2016.07.017; World Health Organization, 2018, GLOB TUB REP 2018; Xiang ZH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00226; Yin YL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00407; Young SL, 2004, INT J CANCER, V112, P653, DOI 10.1002/ijc.20442; Yu DH, 2008, GENE THER, V15, P652, DOI 10.1038/gt.2008.13; Zhang H, 2010, SCAND J IMMUNOL, V72, P349, DOI 10.1111/j.1365-3083.2010.02448.x	61	19	22	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228381	10.1371/journal.pone.0228381	http://dx.doi.org/10.1371/journal.pone.0228381			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027660	gold, Green Published			2022-12-26	WOS:000534623800026
J	Zhang, T; Liu, Y; Yan, JK; Cai, W				Zhang, Tian; Liu, Yang; Yan, Jun-Kai; Cai, Wei			Early downregulation of P-glycoprotein facilitates bacterial attachment to intestinal epithelial cells and thereby triggers barrier dysfunction in a rodent model of total parenteral nutrition	FASEB JOURNAL			English	Article						Escherichia coli; intestinal barrier function; Occludin; P-glycoprotein; total parenteral nutrition	ENTEROPATHOGENIC ESCHERICHIA-COLI; MOUSE MODEL; LIVER-DISEASE; CACO-2 CELLS; I INTERFERON; INFLAMMATION; PERMEABILITY; ACTIVATION; MICROBIOTA; EXPRESSION	Intestinal barrier dysfunction is a major complication of total parenteral nutrition (TPN). Our preliminary study revealed that intestinal P-glycoprotein (P-gp) was significantly downregulated under TPN treatment followed by disruption of barrier function, and thus the significance of early downregulation of P-gp needs to be addressed. Herein, we report a pivotal role of P-gp in the development of intestinal barrier dysfunction under TPN. Functional suppression of P-gp may facilitate bacterial attachment to intestinal epithelial cells (IECs) and thereby induce degradation of tight junctions to trigger barrier dysfunction. By using a rat model of TPN, we found early downregulation of P-gp function in ileum after 3-day TPN, followed by disruption of barrier function after 7-day TPN. By using Escherichia coli (E. coli) k88 and DH5 alpha as type strains, we found significantly increased bacterial attachment to IECs in TPN group compared to sham. By using Caco-2 cells as an IEC model in vitro, we found that functional suppression of P-gp remarkably facilitated bacterial attachment to Caco-2 cells, leading to subsequent disruption of intestinal barrier function. Of note, Occludin was significantly downregulated by bacterial attachment when P-gp was functionally suppressed. Mechanistically, changes on Occludin were attributed to enhanced protein degradation instead of suppressed protein translation. Despite the half-life of Occludin protein being unchanged by DH5 alpha treatment alone, it was decreased by about 40% when P-gp was simultaneously suppressed. Taken together, our findings revealed that early downregulation of intestinal P-gp under TPN may be a potential therapeutic target to prevent the development of barrier dysfunction.	[Zhang, Tian; Liu, Yang; Yan, Jun-Kai; Cai, Wei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai, Peoples R China; [Yan, Jun-Kai; Cai, Wei] Shanghai Inst Pediat Res, Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University	Yan, JK; Cai, W (corresponding author), Shanghai Inst Pediat Res, Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai 200092, Peoples R China.	yanjunkai@xinhuamed.com.cn; caiw204@sjtu.edu.cn			Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation) [20184Y0337]; National Natural Science Foundation of China (NSFC) [81630039, 81700787]; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [17DZ2272000]	Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition	Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation), Grant/Award Number: 20184Y0337; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81630039 and 81700787; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Grant/Award Number: 17DZ2272000	Aluko K, 2017, ANIM NUTR, V3, P353, DOI 10.1016/j.aninu.2017.06.006; [Anonymous], 2017, NUTRIENTS, DOI [DOI 10.3390/nu9090987, DOI 10.3390/NU9090987]; Bielawska B, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050466; Bleier BS, 2016, INT FORUM ALLERGY RH, V6, P169, DOI 10.1002/alr.21566; Braga M, 2009, CLIN NUTR, V28, P378, DOI 10.1016/j.clnu.2009.04.002; Buyse M, 2005, BIOCHEM PHARMACOL, V69, P1745, DOI 10.1016/j.bcp.2005.03.025; Crowe A, 2012, EUR J PHARMACOL, V689, P204, DOI 10.1016/j.ejphar.2012.05.047; Crowe A, 2011, J CROHNS COLITIS, V5, P531, DOI 10.1016/j.crohns.2011.05.002; Demehri FR, 2015, NUTR CLIN PRACT, V30, P798, DOI 10.1177/0884533615609904; Didziapetris R, 2003, J DRUG TARGET, V11, P391, DOI 10.1080/10611860310001648248; Feng YJ, 2016, AM J PHYSIOL-GASTR L, V310, pG273, DOI 10.1152/ajpgi.00335.2015; Feng YJ, 2013, J PHYSIOL-LONDON, V591, P3709, DOI 10.1113/jphysiol.2013.253518; Freeman JJ, 2015, FASEB J, V29, P2943, DOI 10.1096/fj.14-269480; Glotfelty LG, 2014, CELL MICROBIOL, V16, P1767, DOI 10.1111/cmi.12323; Groschwitz KR, 2013, AM J PHYSIOL-GASTR L, V304, pG479, DOI 10.1152/ajpgi.00186.2012; Heneghan AF, 2013, ANN SURG, V258, P1065, DOI 10.1097/SLA.0b013e318277ea9e; Ho GT, 2003, GUT, V52, P759, DOI 10.1136/gut.52.5.759; Hodin CM, 2012, J NUTR, V142, P2141, DOI 10.3945/jn.112.162388; Huang YH, 2017, J GASTROEN HEPATOL, V32, P1949, DOI 10.1111/jgh.13806; Jirsova Z, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7084734; Kim J, 2012, GRAEF ARCH CLIN EXP, V250, P691, DOI 10.1007/s00417-011-1912-5; Lavallee CM, 2017, JPEN-PARENTER ENTER, V41, P1301, DOI 10.1177/0148607116662972; Lei QC, 2018, NUTR RES, V49, P56, DOI 10.1016/j.nutres.2017.10.007; Li QR, 2008, FEBS J, V275, P6022, DOI 10.1111/j.1742-4658.2008.06731.x; Lilja HE, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0084-7; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Long TM, 2014, INFECT IMMUN, V82, P2802, DOI 10.1128/IAI.00105-14; Lu A, 2013, NEUROSCIENCE, V253, P361, DOI 10.1016/j.neuroscience.2013.08.068; Mitra A, 2017, CLIN LIVER DIS, V21, P687, DOI 10.1016/j.cld.2017.06.008; Miyasaka EA, 2013, J IMMUNOL, V190, P6607, DOI 10.4049/jimmunol.1201746; Neudeck BL, 2004, INFECT IMMUN, V72, P3849, DOI 10.1128/IAI.72.7.3849-3854.2004; Parm U, 2015, NUTR RES, V35, P496, DOI 10.1016/j.nutres.2015.04.006; Parveen Z, 2011, MOL PHARMACOL, V79, P443, DOI 10.1124/mol.110.067611; Peralta-Ramirez J, 2008, INFECT IMMUN, V76, P3854, DOI 10.1128/IAI.00072-08; Ralls MW, 2014, JPEN-PARENTER ENTER, V38, P392, DOI 10.1177/0148607113486482; Roselli M, 2006, BRIT J NUTR, V95, P1177, DOI 10.1079/BJN20051681; Sigal N, 2015, INFECT IMMUN, V83, P2358, DOI 10.1128/IAI.00380-15; Szabady RL, 2018, J CLIN INVEST, V128, P4044, DOI 10.1172/JCI96817; Takizawa Y, 2013, INT J PHARMACEUT, V450, P31, DOI 10.1016/j.ijpharm.2013.04.026; Xiao WD, 2014, FASEB J, V28, P2073, DOI 10.1096/fj.13-238311; Yamada H, 2013, BIOCHEM PHARMACOL, V85, P1770, DOI 10.1016/j.bcp.2013.04.006; Yan JK, 2019, FASEB J, V33, P3378, DOI [10.1096/fj.201801695r, 10.1096/fj.201801695R]; Yan JK, 2018, J CELL MOL MED, V22, P1562, DOI 10.1111/jcmm.13430; Yan JK, 2017, CELL PHYSIOL BIOCHEM, V41, P711, DOI 10.1159/000458430; Yan JK, 2016, CELL PHYSIOL BIOCHEM, V39, P1581, DOI 10.1159/000447860	45	1	1	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4670	4683		10.1096/fj.201902513R	http://dx.doi.org/10.1096/fj.201902513R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32027421				2022-12-26	WOS:000520982300001
J	Mesquita, RD; Kyrylchuk, A; Grafova, I; Kliukovskyi, D; Bezdudnyy, A; Rozhenko, A; Tadei, WP; Leskela, M; Grafov, A				Mesquita, Rochelly da Silva; Kyrylchuk, Andrii; Grafova, Iryna; Kliukovskyi, Denys; Bezdudnyy, Andriy; Rozhenko, Alexander; Tadei, Wanderli Pedro; Leskela, Markku; Grafov, Andriy			Synthesis, molecular docking studies, and larvicidal activity evaluation of new fluorinated neonicotinoids against Anopheles darlingi larvae	PLOS ONE			English	Article							INSECTICIDES; PHOTODEGRADATION; APPROXIMATION; PESTICIDES; EFFICIENT; TOXICITY; EXPOSURE; HEALTH; ENERGY	Anopheles darlingi is the main vector of malaria in Brazil, characterized by a high level of anthropophilia and endophagy. Imidacloprid, thiacloprid, and acetamiprid are the most widespread insecticides of the neonicotinoid group. However, they produce adverse effects on the non-target insects. Flupyradifurone has been marketed as an alternative to non-fluorinated neonicotinoids. Neonicotinoids containing trifluoroacethyl substituent reveal increased insecticidal activity due to higher hydrophobicity and metabolic stability. We synthesized novel neonicotinoid insecticides containing fluorinated acceptor groups and their interactions were estimated with the nicotinic acetylcholine receptor (nAChR) binding site by molecular docking studies, to evaluate their larvicidal activity against A. darlingi, and to assess their outdoor photodegradation behavior. New neonicotinoid analogues were prepared and characterized by NMR and mass-spectrometry. The synthesized molecules were modelled by time-dependent density functional theory and analyzed, their interaction with nAChR was investigated by molecular docking. Their insecticide activity was tested on Anopheles larvae collected in suburban area of Manaus, Brazil. Four new fluorinated neonicotinoid analogs were prepared and tested against 3(rd) instars larvae of A. darlingi showing high larvicidal activity. Docking studies reveal binding modes of the synthesized compounds and suggest that their insecticidal potency is governed by specific interactions with the receptor binding site and enhanced lipophilicity. 2-Chloro-5-(2-trifluoromethyl-pyrrolidin-1-ylmethyl)pyridine 5 showed fast degradation in water maintaining high larvicidal activity. All obtained substances possessed high larvicidal activity in low concentrations in 48 hours of exposure, compared to commercial flupyradifurone. Such activity is connected to a unique binding pattern of the synthesized compounds to insect's nAChR and to their enhanced bioavailability owing to introduction of fluorinated amino-moieties. Therefore, the compounds in question have a high potential for application as control agents for insects transmitting tropical diseases, and they will be less persistent in the environment.	[Mesquita, Rochelly da Silva] Univ Fed Amazonas, Dept Chem, Manaus, Amazonas, Brazil; [Kyrylchuk, Andrii; Kliukovskyi, Denys; Bezdudnyy, Andriy; Rozhenko, Alexander] Natl Acad Sci Ukraine, Inst Organ Chem, Kiev, Ukraine; [Grafova, Iryna; Leskela, Markku; Grafov, Andriy] Univ Helsinki, Dept Chem, Helsinki, Finland; [Tadei, Wanderli Pedro] Natl Inst Amazonian Res, Malaria & Dengue Lab, Manaus, Amazonas, Brazil	Universidade Federal de Amazonas; National Academy of Sciences Ukraine; Institute of Organic Chemistry of NASU; University of Helsinki; Institute Nacional de Pesquisas da Amazonia	Grafov, A (corresponding author), Univ Helsinki, Dept Chem, Helsinki, Finland.	andriy.grafov@helsinki.fi	Grafov, Andriy/AAF-1458-2021; mesquita, rochelly/AAW-2965-2020; Volochnyuk, Dmitriy/AAD-5257-2022; Tadei, Wanderli Pedro/N-4486-2018; Kyrylchuk, Andrii/F-8759-2016	Grafov, Andriy/0000-0002-7387-3676; Volochnyuk, Dmitriy/0000-0001-6519-1467; Tadei, Wanderli Pedro/0000-0002-0612-3285; Kyrylchuk, Andrii/0000-0002-8845-5194; Rozhenko, Alexander/0000-0003-4022-7851; DA SILVA MESQUITA, ROCHELLY/0000-0003-2770-7965; Leskela, Markku/0000-0001-5830-2800	European project [Horizon2020-MSCA-RISE-2016-734759]; Magnus Ehnrooth Foundation (Finland); Finnish Center of Excellence in ALD (Finland); Adaptation of the Amazonian Aquatic Biota Project (ADAPTA) (Brazil); Malaria Network Project (Rede Malaria) - National Council for Scientific Development - CNPq (Brazil); Foundation for Research Support in the State of Amazonas - FAPEAM (Brazil)	European project; Magnus Ehnrooth Foundation (Finland); Finnish Center of Excellence in ALD (Finland); Adaptation of the Amazonian Aquatic Biota Project (ADAPTA) (Brazil); Malaria Network Project (Rede Malaria) - National Council for Scientific Development - CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support in the State of Amazonas - FAPEAM (Brazil)	The authors gratefully acknowledge financial support of the present research by: the European project Horizon2020-MSCA-RISE-2016-734759, acronym VAHVISTUS; Magnus Ehnrooth Foundation and Finnish Center of Excellence in ALD (Finland); the Adaptation of the Amazonian Aquatic Biota Project (ADAPTA) (Brazil); Malaria Network Project (Rede Malaria) financially supported by the National Council for Scientific Development - CNPq (Brazil); and the Foundation for Research Support in the State of Amazonas - FAPEAM (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; [Anonymous], 2016, EFSA J, V14, P1, DOI DOI 10.2903/J.EFSA.2016.4572; [Anonymous], 2018, OJEU, V132, P31; [Anonymous], 2010, GUIA PRAT TRAT MAL B; [Anonymous], 2005, GUID LAB FIELD TEST; [Anonymous], 2014, MAL CONTR MAL EL MAN; APVMA, 2018, EV NEW PROD SIV PRIM; Bani ND, 2014, WATER AIR SOIL POLL, V225; BARNETTE WE, 1984, CRC CR REV BIOCH MOL, V15, P201, DOI 10.3109/10409238409102802; Bartlett AJ, 2018, ENVIRON POLLUT, V238, P63, DOI 10.1016/j.envpol.2018.03.004; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bezdudny AV, 2011, EUR J ORG CHEM, V2011, P1782, DOI 10.1002/ejoc.201001362; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bohaty R. B., 2015, STANDARD OPERATING P; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; Burrows HD, 2002, J PHOTOCH PHOTOBIO B, V67, P71, DOI 10.1016/S1011-1344(02)00277-4; Chen Y, 2012, SCI CHINA CHEM, V56, P159; Clark DA, 2008, BIOORGAN MED CHEM, V16, P3163, DOI 10.1016/j.bmc.2007.12.017; da Silva Mesquita R, 2018, J ENTOMOL NEMATOL, V10, P37, DOI DOI 10.5897/JEN2018.0207; Dassault Systemes BIOVIA, 2015, DISC STUD MOD ENV RE; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; European Commi, 2019, CURR STAT NEON EU; European Commission, 2018, OFFICIAL J EUROPEAN, DOI DOI 10.2903/J.EFSA.2016.4606; Forattini O.P., 2002, CULICIDOLOGIA MED ID; Gerus II, 2012, J ORG CHEM, V77, P47, DOI 10.1021/jo202305c; Giorio C, 2017, ENVIRON SCI POLLUT R, P1, DOI [10.1007/s11356-017-0394-3, DOI 10.1007/S11356-017-0394-3]; Glaberman S., 2014, ENV FATE ECOLOGICAL; Hesselbach H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23200-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ihara Makoto, 2008, Invertebrate Neuroscience, V8, P71, DOI 10.1007/s10158-008-0069-3; Jaunzems Janis, 2015, FLUORINATION PROCESS; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Kagabu S, 2011, J AGR FOOD CHEM, V59, P2887, DOI 10.1021/jf101824y; Kagabu S, 2009, BIOORG MED CHEM LETT, V19, P2947, DOI 10.1016/j.bmcl.2009.04.053; Katagi T, 2004, REV ENVIRON CONTAM T, V182, P1; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Kirsch P., 2004, MODERN FLUOROORGANIC, DOI 10.1002/352760393X; Kurwadkar S, 2016, ENVIRON TOXICOL CHEM, V35, P1718, DOI 10.1002/etc.3335; Lu T, 2012, J MOL GRAPH MODEL, V38, P314, DOI 10.1016/j.jmgm.2012.07.004; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Lu Z, 2015, ENVIRON SCI TECH LET, V2, P188, DOI 10.1021/acs.estlett.5b00136; MAGINNITY PM, 1951, J AM CHEM SOC, V73, P3579, DOI 10.1021/ja01152a009; Maheu-Giroux M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071638; Martins-Campos KM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-351; Ministerio da Saude Brasil Secretaria de Vigilancia em Saude Departamento de Vigilancia Epidemiologica, 2006, AC CONTR MAL MAN PRO; Moffitt B, 2014, POLITICAL STUDIES, V62, P381; MORIYA K, 1992, BIOSCI BIOTECH BIOCH, V56, P364, DOI 10.1271/bbb.56.364; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris Garrett M., 2008, V443, P365, DOI 10.1007/978-1-59745-177-2_19; Morrissey CA, 2015, ENVIRON INT, V74, P291, DOI 10.1016/j.envint.2014.10.024; Moutinho PR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-174; OHagan D, 1997, CHEM COMMUN, P645, DOI 10.1039/a604140j; Ohno I, 2010, J AGR FOOD CHEM, V58, P4999, DOI 10.1021/jf100272a; Ohno I, 2009, J AGR FOOD CHEM, V57, P2436, DOI 10.1021/jf803985r; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103; Rotraut A, 1994, PRINCIPAIS MOSQUITOS; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SANTOS J M M D, 1981, Acta Amazonica, V11, P789; Scalmani G., 2016, GAUSSIAN 09; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Shah P, 2007, J ENZYM INHIB MED CH, V22, P527, DOI 10.1080/14756360701425014; Shao XS, 2008, BIOORG MED CHEM LETT, V18, P6513, DOI 10.1016/j.bmcl.2008.10.048; Shao XS, 2011, J AGR FOOD CHEM, V59, P2943, DOI 10.1021/jf103499x; SHEPPARD WA, 1964, J ORG CHEM, V29, P1, DOI 10.1021/jo01024a001; Smith DA, 2001, PHARMACOKINETICS MET, DOI DOI 10.1002/3527600213; Stojanovich CJ, 1967, CLAVE ILUSTRADA MOSQ; Swain C, 1999, PROGR DEV NEUROKININ, P51; Tadei WP, 2017, HYDROBIOLOGIA, V789, P179, DOI 10.1007/s10750-016-2960-y; Tadei WP, 2010, LAB VETORES MALARIA; Tadei WP, 1993, BASES CIENTIFICAS ES, P167; The European Commission, 2018, OFF J EUR UNION, V61, P40; The European Commission, 2018, OFF J EUR UNION, V61, P7; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tomizawa M, 2008, J MED CHEM, V51, P4213, DOI 10.1021/jm800191a; Tressaud A, 2008, FLUORINE AND HEALTH: MOLECULAR IMAGING, BIOMEDICAL MATERIALS AND PHARMACEUTICALS, pXI, DOI 10.1016/B978-0-444-53086-8.00020-5; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Tsvetkov N, 2017, SCIENCE, V356, P1395, DOI 10.1126/science.aam7470; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Wang BZ, 2012, MOLECULES, V17, P10014, DOI 10.3390/molecules170910014; Wang XL, 2003, HANDBOOK OF NANOPHASE AND NANOSTRUCTURED MATERIALS, VOL 2: CHARACTERIZATION, P1, DOI 10.1115/HT2003-47003; WHO, 2008, GLOB MAL CONTR EL RE; WHO, 2013, LARV SOURC MAN SUPPL; Yarmolchuk VS, 2012, SYNTHESIS-STUTTGART, V44, P1152, DOI 10.1055/s-0031-1289711; Zalesskaya IM, 1980, J ORG CHEM USSR, V16, P1031	87	5	6	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227811	10.1371/journal.pone.0227811	http://dx.doi.org/10.1371/journal.pone.0227811			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KQ8VH	32023266	Green Published, gold			2022-12-26	WOS:000517199000001
J	NavaneethaKrishnan, S; Rosales, JL; Lee, KY				NavaneethaKrishnan, Saranya; Rosales, Jesusa L.; Lee, Ki-Young			mPTP opening caused by Cdk5 loss is due to increased mitochondrial Ca2+ uptake	ONCOGENE			English	Article							CYCLIN-DEPENDENT KINASE-5; PERMEABILITY TRANSITION PORE; ENDOPLASMIC-RETICULUM; CELL-DEATH; CALCIUM; ER; INHIBITION; MEMBRANES; CONTACTS; COMPLEX	We previously demonstrated that loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death by inducing mitochondrial permeability transition pore (mPTP) opening (Oncogene 37, 1788-1804). However, the molecular mechanism by which Cdk5 loss causes mPTP opening remains to be investigated. Using primary mouse embryonic fibroblasts (MEFs) isolated from Cdk5(-/-) mouse embryos, we show that absence of Cdk5 causes a significant increase in both mPTP opening and mitochondrial Ca2+ level. Analysis of subcellular fractions of MEFs demonstrates that Cdk5 localizes in the mitochondria-associated endoplasmic reticulum (ER) membrane (MAM) and Cdk5 loss in MAMs causes increased ER-mitochondria tethering, a process required for Ca2+ transfer from the ER to the mitochondria. Loss of Cdk5 also causes increased ATP-mediated mitochondrial Ca2+ uptake from the ER. Inhibition of ER Ca2+ release or mitochondrial Ca2+ uptake in Cdk5(-/-) MEFs prevents mPTP opening, indicating that mPTP opening in Cdk5(-/-) MEFs is due to increased Ca2+ transfer from the ER to the mitochondria. Altogether, our findings suggest that Cdk5 in MAMs regulates mitochondrial Ca2+ homeostasis that is disturbed upon Cdk5 loss, which leads to mPTP opening.	[NavaneethaKrishnan, Saranya; Rosales, Jesusa L.; Lee, Ki-Young] Univ Calgary, Dept Cell Biol & Anat, Arnie Charbonneau Canc Inst, Calgary, AB, Canada; [NavaneethaKrishnan, Saranya; Rosales, Jesusa L.; Lee, Ki-Young] Univ Calgary, Alberta Childrens Hosp, Res Inst, Cumming Sch Med, Calgary, AB, Canada	University of Calgary; Alberta Childrens Hospital; University of Calgary	Lee, KY (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Arnie Charbonneau Canc Inst, Calgary, AB, Canada.; Lee, KY (corresponding author), Univ Calgary, Alberta Childrens Hosp, Res Inst, Cumming Sch Med, Calgary, AB, Canada.	kylee@ucalgary.ca			CIHR [MOP-123400]; NSERC [RGPIN/06270-2019]; Alberta Cancer Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Cancer Foundation	We thank Novartis Pharma AG for providing SfA. This work was supported in part by grants from the CIHR (MOP-123400) and NSERC (RGPIN/06270-2019) to KYL and an Alberta Cancer Foundation graduate studentship to SN.	ALTSCHULD RA, 1992, AM J PHYSIOL, V262, pH1699, DOI 10.1152/ajpheart.1992.262.6.H1699; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Bravo-Sagua R, 2013, CURR MOL MED, V13, P317, DOI 10.2174/156652413804810781; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; CROMPTON M, 1988, BIOCHEM J, V255, P357; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Decuypere, 2011, J AGING RES, V2011, P920178, DOI [10.4061/2011/920178, DOI 10.4061/2011/920178]; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Durkin M.E., 2013, BIOPROTOC, V3, pE908, DOI DOI 10.21769/BioProtoc.908; Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484; Fitzgerald JC, 2012, CELL DEATH DIFFER, V19, P257, DOI 10.1038/cdd.2011.90; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Giacomello M, 2016, CELL DEATH DIFFER, V23, P1417, DOI 10.1038/cdd.2016.52; Giaime E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040501; Giorgi C, 2018, NAT REV MOL CELL BIO, V19, P713, DOI 10.1038/s41580-018-0052-8; Gomez-Suaga P, 2017, CURR BIOL, V27, P371, DOI 10.1016/j.cub.2016.12.038; Grimm S, 2012, BBA-MOL CELL RES, V1823, P327, DOI 10.1016/j.bbamcr.2011.11.018; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Liu Y, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0092-6; Ma JHJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02213-1; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; Michel AH, 2012, BIOCHEM SOC T, V40, P445, DOI 10.1042/BST20110758; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Naon D, 2014, BBA-MOL CELL RES, V1843, P2184, DOI 10.1016/j.bbamcr.2014.05.011; NavaneethaKrishnan S, 2018, ONCOGENE, V37, P1788, DOI 10.1038/s41388-017-0103-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ortiz-Sandoval C. G., 2014, CELL LOGIST, P2799, DOI [10.4161/21592799.2014.986399, DOI 10.4161/21592799.2014.986399]; Patergnani S, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00173; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Paupe V, 2018, BIOCHEM BIOPH RES CO, V500, P75, DOI 10.1016/j.bbrc.2017.05.039; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; Poston CN, 2013, J PROTEOMICS, V79, P219, DOI 10.1016/j.jprot.2012.12.018; Pozzan T, 2009, BBA-BIOENERGETICS, V1787, P1317, DOI 10.1016/j.bbabio.2008.11.012; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Raffaello A, 2016, TRENDS BIOCHEM SCI, V41, P1035, DOI 10.1016/j.tibs.2016.09.001; Rieusset J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0416-1; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Shoshan-Barmatz V, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00060; SMITH JB, 1985, J BIOL CHEM, V260, P4413; Solanes P, 2015, EMBO J, V34, P798, DOI 10.15252/embj.201489056; Sun KH, 2008, J NEUROCHEM, V107, P265, DOI 10.1111/j.1471-4159.2008.05616.x; Tagaya M, 2017, ADV EXP MED BIOL, V997, P33, DOI 10.1007/978-981-10-4567-7_3; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Weishaupt JH, 2003, MOL CELL NEUROSCI, V24, P489, DOI 10.1016/S1044-7431(03)00221-5; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wiedemann N, 2009, SCIENCE, V325, P403, DOI 10.1126/science.1178016	60	12	12	3	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	13					2797	2806		10.1038/s41388-020-1188-5	http://dx.doi.org/10.1038/s41388-020-1188-5		FEB 2020	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KX4EF	32024968	hybrid, Green Published			2022-12-26	WOS:000511273600002
J	Chen, SL; Xu, J; Liu, MY; Rao, ALN; Zandi, R; Gill, SS; Mohideen, U				Chen, Shaolong; Xu, Jun; Liu, Mingyue; Rao, A. L. N.; Zandi, Roya; Gill, Sarjeet S.; Mohideen, Umar			Investigation of HIV-1 Gag binding with RNAs and lipids using Atomic Force Microscopy	PLOS ONE			English	Article							VIRUS TYPE-1 GAG; MEMBRANE-BINDING; PLASMA-MEMBRANE; NUCLEIC-ACIDS; PROTEIN; DIMERIZATION; IDENTIFICATION; DETERMINANTS; ARCHITECTURE; RESOLUTION	Atomic Force Microscopy was utilized to study the morphology of Gag, psi RNA, and their binding complexes with lipids in a solution environment with 0.1A vertical and 1nm lateral resolution. TARpolyA RNA was used as a RNA control. The lipid used was phospha-tidylinositol-(4,5)-bisphosphate (PI(4,5)P2). The morphology of specific complexes Gag-psi RNA, Gag-TARpolyA RNA, Gag-PI(4,5)P2 and PI(4,5)P2-psi RNA-Gag were studied. They were imaged on either positively or negatively charged mica substrates depending on the net charges carried. Gag and its complexes consist of monomers, dimers and tetramers, which was confirmed by gel electrophoresis. The addition of specific psi RNA to Gag is found to increase Gag multimerization. Non-specific TARpolyA RNA was found not to lead to an increase in Gag multimerization. The addition PI(4,5)P2 to Gag increases Gag multimerization, but to a lesser extent than psi RNA. When both psi RNA and PI(4,5)P2 are present Gag undergoes comformational changes and an even higher degree of multimerization.	[Chen, Shaolong; Xu, Jun; Liu, Mingyue; Zandi, Roya; Mohideen, Umar] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA; [Rao, A. L. N.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Gill, Sarjeet S.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Mohideen, U (corresponding author), Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA.	umar.mohideen@ucr.edu	Liu, Mingyue/AAK-7892-2021; Xu, Jun/N-8564-2018	Liu, Mingyue/0000-0002-4334-5354; Xu, Jun/0000-0001-7735-9554				Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Andersen ES, 2004, J BIOL CHEM, V279, P22243, DOI 10.1074/jbc.M314326200; Ares P, 2016, NANOSCALE, V8, P11818, DOI 10.1039/c5nr07445b; ARNOTT S, 1972, BIOCHEM BIOPH RES CO, V48, P1392, DOI 10.1016/0006-291X(72)90867-4; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Bussiek M, 2014, HANDBOOK OF RNA BIOCHEMISTRY, VOLS 1 AND 2, 2ND EDITION, P527; Carlson LA, 2012, P NATL ACAD SCI USA, V109, P16928, DOI 10.1073/pnas.1211759109; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Comas-Garcia M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090246; Datta SAK, 2007, J MOL BIOL, V365, P812, DOI 10.1016/j.jmb.2006.10.073; Datta SAK, 2011, J MOL BIOL, V406, P205, DOI 10.1016/j.jmb.2010.11.051; De Guzman R.N., 1998, SCIENCE, V16, P5349; Didierlaurent L, 2011, NUCLEIC ACIDS RES, V39, P8915, DOI 10.1093/nar/gkr577; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Freed EO, 2006, P NATL ACAD SCI USA, V103, P11101, DOI 10.1073/pnas.0604715103; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Godet J, 2012, VIRUS RES, V169, P349, DOI 10.1016/j.virusres.2012.06.021; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; Hansma HG, 2003, J MICROSC-OXFORD, V212, P273, DOI 10.1111/j.1365-2818.2003.01276.x; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Jones CP, 2014, P NATL ACAD SCI USA, V111, P3395, DOI 10.1073/pnas.1319658111; Kafaie J, 2008, VIROLOGY, V375, P592, DOI 10.1016/j.virol.2008.02.001; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Kienberger F, 2007, BIOMATERIALS, V28, P2403, DOI 10.1016/j.biomaterials.2007.01.025; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; Lyubchenko YL, 2011, METHODS, V54, P274, DOI 10.1016/j.ymeth.2011.02.001; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Moore MD, 2009, AIDS REV, V11, P91; Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875; Muller DJ, 1997, BIOSENS BIOELECTRON, V12, P867, DOI 10.1016/S0956-5663(97)00051-1; Ono A, 2000, J VIROL, V74, P5142, DOI 10.1128/JVI.74.11.5142-5150.2000; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Pan YG, 2017, BIOCHEMISTRY-US, V56, P1473, DOI 10.1021/acs.biochem.6b01189; Pastre D, 2003, BIOPHYS J, V85, P2507, DOI 10.1016/S0006-3495(03)74673-6; Pettit SC, 1998, ADV EXP MED BIOL, V436, P15; Pfreundschuh M, 2014, NAT PROTOC, V9, P1113, DOI 10.1038/nprot.2014.070; Raposo M, 2007, MOD RES ED TOP MICRO, P758, DOI [10.1002/sia.2294, DOI 10.1002/SIA.2294]; Rein A, 2011, TRENDS BIOCHEM SCI, V36, P373, DOI 10.1016/j.tibs.2011.04.001; Rojas O., 2002, ENCY SURFACE COLLOID, P517; Russell RS, 2003, J VIROL, V77, P84, DOI 10.1128/JVI.77.1.84-96.2003; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Spearman P, 1997, J VIROL, V71, P6582, DOI 10.1128/JVI.71.9.6582-6592.1997; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tanaka Y, 1999, NUCLEIC ACIDS RES, V27, P949, DOI 10.1093/nar/27.4.949; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Valbuena A, 2015, NANOSCALE, V7, P14953, DOI 10.1039/c5nr04023j; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Webb JA, 2013, RNA, V19, P1078, DOI 10.1261/rna.038869.113; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994; Zhou WJ, 1996, J VIROL, V70, P8540, DOI 10.1128/JVI.70.12.8540-8548.1996	66	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228036	10.1371/journal.pone.0228036	http://dx.doi.org/10.1371/journal.pone.0228036			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32015565	Green Published, gold, Green Submitted			2022-12-26	WOS:000534615800016
J	Chen, L; Liu, LT; Lu, B; Ma, TT; Jiang, D; Li, J; Zhang, K; Sun, HC; Zhang, YJ; Bai, Z; Li, CD				Chen, Li; Liu, Liantao; Lu, Bin; Ma, Tongtong; Jiang, Dan; Li, Jin; Zhang, Ke; Sun, Hongchun; Zhang, Yongjiang; Bai, Zhiying; Li, Cundong			Exogenous melatonin promotes seed germination and osmotic regulation under salt stress in cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							LEAF SENESCENCE; ANTIOXIDANT CAPACITY; PLANT-GROWTH; TOLERANCE; SALINITY; ACCUMULATION; HOMEOSTASIS; PATHWAY; LEAVES; ABA	Melatonin (MT; N-acetyI-5-methoxytryptamine) is an amine hormone involved in abiotic stress resistance. Previous studies have confirmed that melatonin can promote seed germination, mediate physiological regulation mechanisms, and stimulate crop growth under stress. However, the osmotic regulation mechanism by which exogenous melatonin mediates salt tolerance in cotton is still largely unknown. To investigate the effect of salt stress on melatonin concentration in germinating cotton seeds, we analyzed melatonin content over time during seed germination under different treatments. Melatonin content reached its minimum at day 6, while cotton germination rates peaked at day 6, indicating melatonin content and seed germination are correlated. Then we investigated the effects of 10-100 mu M melatonin treatments on membrane lipid peroxides and osmotic adjustment substances during cotton seed germination under salt stress. Salt stress led to electrolyte leakage (EL) as well as accumulations of hydrogen peroxide (H2O2), malondialdehyde (MDA), organic osmotic substances (i.e., proline, soluble sugars), and inorganic osmotic substances (i.e., Na+, Cl-). Meanwhile, the contents of melatonin, soluble proteins, and K+ as well as the K+/Na+ balance decreased, indicating that salt stress inhibited melatonin synthesis and damaged cellular membranes, seriously affecting seed germination. However, melatonin pretreatment at different concentrations alleviated the adverse effects of salt stress on cotton seeds and reduced EL as well as the contents of H2O2, MDA, Na+, and Cl-. The exogenous application of melatonin also promoted melatonin, soluble sugar, soluble proteins, proline, and K+/Na+ contents under salt stress. These results demonstrate that supplemental melatonin can effectively ameliorate the repression of cotton seed germination by enhancing osmotic regulating substances and adjusting ion homeostasis under salt stress. Thus, melatonin may potentially be used to protect cotton seeds from salt stress, with the 20 mu M melatonin treatment most effectively promoting cotton seed germination and improving salt stress tolerance.	[Chen, Li; Ma, Tongtong; Jiang, Dan; Li, Jin; Bai, Zhiying] Hebei Agr Univ, Coll Life Sci, Baoding, Peoples R China; [Chen, Li; Liu, Liantao; Ma, Tongtong; Jiang, Dan; Li, Jin; Zhang, Ke; Sun, Hongchun; Zhang, Yongjiang; Bai, Zhiying; Li, Cundong] Hebei Agr Univ, Key Lab Crop Growth Regulat Hebei Prov, Baoding, Hebei, Peoples R China; [Liu, Liantao; Zhang, Ke; Sun, Hongchun; Zhang, Yongjiang; Li, Cundong] Hebei Agr Univ, Coll Agron, Baoding, Peoples R China; [Lu, Bin] Hebei Agr Univ, Coll Landscape & Tourism, Baoding, Peoples R China	Hebei Agricultural University; Hebei Agricultural University; Hebei Agricultural University; Hebei Agricultural University	Bai, Z (corresponding author), Hebei Agr Univ, Coll Life Sci, Baoding, Peoples R China.; Bai, Z; Li, CD (corresponding author), Hebei Agr Univ, Key Lab Crop Growth Regulat Hebei Prov, Baoding, Hebei, Peoples R China.; Li, CD (corresponding author), Hebei Agr Univ, Coll Agron, Baoding, Peoples R China.	zhiyingbai@126.com; auhlcd@163.com	Zhang, Yongjiang/R-6250-2019; Liu/AAR-5480-2020	Zhang, Yongjiang/0000-0001-5846-6004; Bai, zhiying/0000-0001-7208-845X	National Science Foundation of China [31871569, 31571610]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (No. 31871569 and 31571610).	Arnao MB, 2018, ANN BOT-LONDON, V121, P195, DOI 10.1093/aob/mcx114; Arnao MB, 2015, J PINEAL RES, V59, P133, DOI 10.1111/jpi.12253; ASHRAF M, 1994, CRIT REV PLANT SCI, V13, P17, DOI 10.1080/713608051; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Chen YE, 2018, PHYSIOL PLANTARUM, V164, P349, DOI 10.1111/ppl.12737; Cui F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00217; Cui GB, 2017, PLANT PHYSIOL BIOCH, V118, P138, DOI 10.1016/j.plaphy.2017.06.014; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Flowers TJ, 2015, ANN BOT-LONDON, V115, P327, DOI 10.1093/aob/mcu267; Gao WY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051176; Gong B, 2017, PHYSIOL PLANTARUM, V160, P396, DOI 10.1111/ppl.12581; Han ZM, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.02045, 10.3389/fpls.2015.01270, 10.3389/fpls.2016.01270, 10.3389/fpls.2016.01814]; [胡涛 Hu Tao], 2018, [分子植物育种, Molecular Plant Breeding], V16, P3006; Kaya C, 2019, CHEMOSPHERE, V225, P627, DOI 10.1016/j.chemosphere.2019.03.026; Ke QB, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00914; Li C, 2015, J EXP BOT, V66, P669, DOI 10.1093/jxb/eru476; Li H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00295; Li JH, 2019, MOLECULES, V24, DOI 10.3390/molecules24091826; Li JP, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071735; Li MQ, 2016, J PINEAL RES, V61, P291, DOI 10.1111/jpi.12346; Liang CZ, 2015, J PINEAL RES, V59, P91, DOI 10.1111/jpi.12243; Liang D, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00426; Liang WJ, 2018, BIOCHEM BIOPH RES CO, V495, P286, DOI 10.1016/j.bbrc.2017.11.043; Castanares JL, 2019, HORTIC PLANT J, V5, P79, DOI 10.1016/j.hpj.2019.01.002; Maathuis FJM, 2014, J EXP BOT, V65, P849, DOI 10.1093/jxb/ert326; Malcolm E, 1998, SODIC SOILS DISTRIBU; Park HJ, 2016, MOL CELLS, V39, P447, DOI 10.14348/molcells.2016.0083; Pevet P, 2017, BEST PRACT RES CL EN, V31, P547, DOI 10.1016/j.beem.2017.10.010; Samea-Andabjadid S, 2018, ACTA BIOL HUNG, V69, P86, DOI 10.1556/018.68.2018.1.7; Sapre S, 2018, MICROBIOL RES, V206, P25, DOI 10.1016/j.micres.2017.09.009; Sharafi Y, 2019, SCI HORTIC-AMSTERDAM, V254, P222, DOI 10.1016/j.scienta.2019.04.056; Shi HT, 2014, J INTEGR PLANT BIOL, V56, P1064, DOI 10.1111/jipb.12167; Siddiqui MH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020353; Sun CL, 2014, NEW PHYTOL, V201, P1240, DOI 10.1111/nph.12597; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tan DX, 2013, J PINEAL RES, V54, P127, DOI 10.1111/jpi.12026; Wang P, 2013, J PINEAL RES, V55, P424, DOI 10.1111/jpi.12091; Wang P, 2013, J PINEAL RES, V54, P292, DOI [10.1111/j.1600-079X.2012.00999.x, 10.1111/jpi.12017]; Wei W, 2015, J EXP BOT, V66, P695, DOI 10.1093/jxb/eru392; Wu HH, 2018, CROP J, V6, P215, DOI 10.1016/j.cj.2018.01.003; Wu WH, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00287; Xu L, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0904-5; You J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01092; Yu YC, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00256; Yuan F, 2016, PLANT MOL BIOL, V91, P241, DOI 10.1007/s11103-016-0460-0; Zeng L, 2018, J INTEGR AGR, V17, P328, DOI [10.1016/S2095-3119(17)61757-X, 10.1016/s2095-3119(17)61757-x]; Zhan HS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030709; Zhang HJ, 2014, J PINEAL RES, V57, P269, DOI 10.1111/jpi.12167; Zhang N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00566-1; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	51	56	57	40	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228241	10.1371/journal.pone.0228241	http://dx.doi.org/10.1371/journal.pone.0228241			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004326	Green Submitted, Green Published, gold			2022-12-26	WOS:000534614600029
J	Mittmann, N; Liu, N; MacKinnon, M; Seung, SJ; Hong, NJL; Earle, CC; Gradin, S; Sati, S; Buchman, S; Jakda, A; Wright, FC				Mittmann, Nicole; Liu, Ning; MacKinnon, Marnie; Seung, Soo Jin; Hong, Nicole J. Look; Earle, Craig C.; Gradin, Sharon; Sati, Saurabh; Buchman, Sandy; Jakda, Ahmed; Wright, Frances C.			Does early palliative identification improve the use of palliative care services?	PLOS ONE			English	Article							ADVANCED CANCER; OUTCOMES; PATIENT; LUNG; TOOL	Purpose To evaluate whether the early identification of patients who may benefit from palliative care impacts on the use of palliative, community and acute-based care services. Methods Between 2014 and 2017, physicians from eight sites were encouraged to systematically identify patients who were likely to die within one year and would were thought to benefit from early palliative care. Patients in the INTEGRATE Intervention Group were 1:1 matched to controls selected from provincial healthcare administrative data using propensity score-matching. The use of palliative care, community-based care services (home care, physician home visit, and outpatient opioid use) and acute care (emergency department, hospitalization) was each evaluated within one year after the date of identification. The hazard ratio (HR) in the Intervention Group was calculated for each outcome. Results Of the 1,185 patients in the Intervention Group, 951 (80.3%) used palliative care services during follow-up, compared to 739 (62.4%) among 1,185 patients in the Control Group [HR of 1.69 (95% CI 1.56 to 1.82)]. The Intervention Group also had higher proportions of patients who used home care [81.4% vs. 55.2%; HR 2.07 (95% CI 1.89 to 2.27)], had physician home visits [35.5% vs. 23.7%; HR 1.63 (95% CI 1.46 to 1.92)] or had increased outpatient opioid use [64.3% vs. 52.1%); HR 1.43 (95% CI 1.30 to 1.57]. The Intervention Group was also more likely to have a hospitalization that was not primarily focused on palliative care (1.42 (95% CI 1.28 to 1.58)) and an unplanned emergency department visit for non-palliative care purpose (1.47 (95% CI 1.32 to 1.64)). Conclusion Physicians actively identifying patients who would benefit from palliative care resulted in increased use of palliative and community-based care services, but also increased use of acute care services.	[Mittmann, Nicole; MacKinnon, Marnie; Gradin, Sharon; Sati, Saurabh] Canc Care Ontario, Toronto, ON, Canada; [Mittmann, Nicole; Seung, Soo Jin] Sunnybrook Res Inst, Toronto, ON, Canada; [Liu, Ning; Hong, Nicole J. Look; Earle, Craig C.] ICES, Toronto, ON, Canada; [Seung, Soo Jin] Hlth Outcomes & PharmacoEcon HOPE Res Ctr, Toronto, ON, Canada; [Hong, Nicole J. Look; Earle, Craig C.; Wright, Frances C.] Odette Canc Ctr, Toronto, ON, Canada; [Earle, Craig C.] Canadian Partnership Canc, Toronto, ON, Canada; [Buchman, Sandy] Sinai Hlth Syst, Temmy Latner Ctr Palliat Care, Toronto, ON, Canada; [Jakda, Ahmed] McMaster Univ, Hamilton, ON, Canada; [Jakda, Ahmed] Ontario Palliat Care Network, Toronto, ON, Canada; [Jakda, Ahmed] Grand River Reg Canc Ctr, Kitchener, ON, Canada	Cancer Care Ontario; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; McMaster University	Mittmann, N (corresponding author), Canc Care Ontario, Toronto, ON, Canada.; Mittmann, N (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.	nicole.mittmann@sunnybook.ca		Liu, Ning/0000-0001-9215-475X	Cancer Care Ontario through the Ontario Ministry of Health and Long-Term Care; Canadian Partnership Against Cancer	Cancer Care Ontario through the Ontario Ministry of Health and Long-Term Care; Canadian Partnership Against Cancer	This study was conducted with the support of Cancer Care Ontario through funding provided by the Ontario Ministry of Health and Long-Term Care. This is a secondary analysis of a study that was funded by the Canadian Partnership Against Cancer.	Ambroggi M, 2018, SUPPORT CARE CANCER, V26, P2945, DOI 10.1007/s00520-018-4184-3; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Badger F, 2012, INT J NURS STUD, V49, P586, DOI 10.1016/j.ijnurstu.2011.10.021; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Bakitas MA, 2015, J CLIN ONCOL, V33, P1438, DOI 10.1200/JCO.2014.58.6362; Buchman S, 2018, PSYCHO-ONCOLOGY, V27, P2673, DOI 10.1002/pon.4858; Canadian Institute for Health Information, 2018, ACC PALL CAR CAN; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gold Standards Framework, 2013, GSF IMPR OUTC ALL SE; Gomes B, 2015, J CLIN ONCOL, V33, P1420, DOI 10.1200/JCO.2014.60.5386; Gomez-Batiste X, 2013, BMJ SUPPORT PALLIAT, V3, P300, DOI 10.1136/bmjspcare-2012-000211; Health Improvement Scotland, 2018, PALL CAR ID TOOLS CO; Health Quality Ontario, 2018, PALL CAR CAR AD PROG; Highet G, 2014, BMJ SUPPORT PALLIAT, V4, P285, DOI 10.1136/bmjspcare-2013-000488; ICES, 2017, DAT REP; Jones A, 2018, CAN MED ASSOC J, V190, pE525, DOI 10.1503/cmaj.170892; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lutz ST, 2014, J CLIN ONCOL, V32, P2913, DOI 10.1200/JCO.2014.55.1143; Merchant SJ, 2018, ANN SURG ONCOL, V25, P1478, DOI 10.1245/s10434-018-6430-9; Mittmann N, 2014, CURR ONCOL, V21, P281, DOI 10.3747/co.21.2143; Pallium Canada, 2016, LEARN ESS APPR PALL; Seow H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3496; Tanuseputro P, 2017, PALLIATIVE MED, V31, P247, DOI 10.1177/0269216316653524; Temel JS, 2017, J CLIN ONCOL, V35, P834, DOI 10.1200/JCO.2016.70.5046; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; The Johns Hoplins University, 2017, ACG SYST VERS 10 0 T; World Health Organization, 2007, CANC CONTR KNOWL ACT; Wright F, 2017, J CLIN ONCOL S8, V35; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	32	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0226597	10.1371/journal.pone.0226597	http://dx.doi.org/10.1371/journal.pone.0226597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32005036	Green Published, gold			2022-12-26	WOS:000534614600004
J	Theys, C; Kovacs, S; Peeters, R; Melzer, TR; van Wieringen, A; De Nil, LF				Theys, Catherine; Kovacs, Silvia; Peeters, Ronald; Melzer, Tracy R.; van Wieringen, Astrid; De Nil, Luc F.			Brain activation during non-habitual speech production: Revisiting the effects of simulated disfluencies in fluent speakers	PLOS ONE			English	Article							NEURAL ACTIVATION; ALE METAANALYSIS; MOTOR; CEREBELLAR; MECHANISMS; PATTERNS; WORD; SUPPLEMENTARY; ORGANIZATION; CORTEX	Over the past decades, brain imaging studies in fluently speaking participants have greatly advanced our knowledge of the brain areas involved in speech production. In addition, complementary information has been provided by investigations of brain activation patterns associated with disordered speech. In the present study we specifically aimed to revisit and expand an earlier study by De Nil and colleagues, by investigating the effects of simulating disfluencies on the brain activation patterns of fluent speakers during overt and covert speech production. In contrast to the De Nil et al. study, the current findings show that the production of voluntary, self-generated disfluencies by fluent speakers resulted in increased recruitment and activation of brain areas involved in speech production. These areas show substantial overlap with the neural networks involved in motor sequence learning in general, and learning of speech production, in particular. The implications of these findings for the interpretation of brain imaging studies on disordered and non-habitual speech production are discussed.	[Theys, Catherine] Univ Canterbury, Coll Sci, Sch Psychol Speech & Hearing, Christchurch, New Zealand; [Theys, Catherine] Univ Canterbury, New Zealand Inst Language Brain & Behav, Christchurch, New Zealand; [Kovacs, Silvia; Peeters, Ronald] Univ Hosp Leuven, Dept Radiol, Leuven, Belgium; [Melzer, Tracy R.] New Zealand Brain Res Inst, Christchurch, New Zealand; [Melzer, Tracy R.] Univ Otago, Dept Med, Christchurch, New Zealand; [van Wieringen, Astrid] KULeuven, Expt ORL, Leuven, Belgium; [De Nil, Luc F.] Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada	University of Canterbury; University of Canterbury; KU Leuven; University Hospital Leuven; University of Otago; KU Leuven; University of Toronto	Theys, C (corresponding author), Univ Canterbury, Coll Sci, Sch Psychol Speech & Hearing, Christchurch, New Zealand.; Theys, C (corresponding author), Univ Canterbury, New Zealand Inst Language Brain & Behav, Christchurch, New Zealand.	catherine.theys@canterbury.ac.nz			Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen) [KAN20091.5.136.0]; Royal Society of New Zealand Marsden Fund [M1180]	Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen)(FWO); Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was partially funded by the Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen), Grant number KAN20091.5.136.0 (https://www.fwo.be/en/) to AvW and CT and was partially funded by the Royal Society of New Zealand Marsden Fund, Grant number M1180 (https://royalsociety.org.nz/what-we-do/funds-and-opportunities/marsden/) to CT and TM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe M, 2009, BEHAV BRAIN RES, V198, P13, DOI 10.1016/j.bbr.2008.10.046; Ackerman H, 1996, APHASIOLOGY, V10, P409, DOI 10.1080/02687039608248420; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Belyk M, 2017, EUR J NEUROSCI, V45, P622, DOI 10.1111/ejn.13512; Belyk M, 2015, EUR J NEUROSCI, V41, P275, DOI 10.1111/ejn.12765; Blomgren M, 2013, PSYCHOL RES BEHAV MA, V6, P9, DOI 10.2147/PRBM.S31450; Bohland JW, 2006, NEUROIMAGE, V32, P821, DOI 10.1016/j.neuroimage.2006.04.173; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Brendel B, 2010, NEUROIMAGE, V50, P1219, DOI 10.1016/j.neuroimage.2010.01.039; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Budde KS, 2014, BRAIN LANG, V139, P99, DOI 10.1016/j.bandl.2014.10.002; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; De Nil LF, 2008, BRAIN LANG, V107, P114, DOI 10.1016/j.bandl.2008.07.003; DvM Sharoh, 2019, P NATL ACAD SCI US; Etchell AC, 2018, J FLUENCY DISORD, V55, P6, DOI 10.1016/j.jfludis.2017.03.007; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Golfinopoulos E, 2011, NEUROIMAGE, V55, P1324, DOI 10.1016/j.neuroimage.2010.12.065; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Hartwigsen G, 2013, J COGNITIVE NEUROSCI, V25, P580, DOI 10.1162/jocn_a_00342; Hertrich I, 2016, NEUROSCI BIOBEHAV R, V68, P602, DOI 10.1016/j.neubiorev.2016.06.030; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Ingham RJ, 2000, BRAIN LANG, V75, P163, DOI 10.1006/brln.2000.2351; Jang SH, 2012, NEUROSCI LETT, V506, P146, DOI 10.1016/j.neulet.2011.10.069; Kearney E, 2019, LANG COGN NEUROSCI, V34, P1214, DOI 10.1080/23273798.2019.1589541; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Marchina S, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00069; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Namasivayam AK, 2008, J FLUENCY DISORD, V33, P32, DOI 10.1016/j.jfludis.2007.11.005; Neumann K, 2009, TREATMENT STUTTERING, P355; Ogar J, 2005, NEUROCASE, V11, P427, DOI 10.1080/13554790500263529; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Packman A, 2001, CLIN LINGUIST PHONET, V15, P487; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Riecker A, 2006, NEUROIMAGE, V29, P46, DOI 10.1016/j.neuroimage.2005.03.046; Rong F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196381; Segawa JA, 2015, J COGNITIVE NEUROSCI, V27, P819, DOI 10.1162/jocn_a_00737; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Shimizu RE, 2016, BEHAV NEUROSCI, V130, P572, DOI 10.1037/bne0000164; Shuster LI, 2005, BRAIN LANG, V93, P20, DOI 10.1016/j.bandl.2004.07.007; Smith A, 2010, J FLUENCY DISORD, V35, P1, DOI 10.1016/j.jfludis.2009.12.001; Stager SV, 2003, J FLUENCY DISORD, V28, P319, DOI 10.1016/j.jfludis.2003.08.004; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Toyomura A, 2011, NEUROIMAGE, V57, P1507, DOI 10.1016/j.neuroimage.2011.05.039; Tremblay P, 2013, CORTEX, V49, P143, DOI 10.1016/j.cortex.2011.09.004; Uit den Boogaart PC, 1975, WOORDFREQUENTIES GES; Van Strien, 1992, NEDERLANDS TIJDSCHRI, V47, P88; Vigneau M, 2005, NEUROIMAGE, V27, P694, DOI 10.1016/j.neuroimage.2005.04.038; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228452	10.1371/journal.pone.0228452	http://dx.doi.org/10.1371/journal.pone.0228452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CX	32004353	Green Published, gold			2022-12-26	WOS:000534614600038
J	Chan, JCY; Diakos, CI; Engel, A; Chan, DLH; Pavlakis, N; Gill, A; Clarke, SJ				Chan, Joseph Chung Yan; Diakos, Connie Irene; Engel, Alexander; Chan, David Lok Hang; Pavlakis, Nick; Gill, Anthony; Clarke, Stephen John			Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer	PLOS ONE			English	Article							P-POSSUM; INFLAMMATION; IMMUNOHISTOCHEMISTRY; RATIO; RISK	Aims Inflammation is a hallmark of cancer whose activity is modulated within the tumor microenvironment by low tumoral pH. Recent evidence in the literature has suggested a link between low serum bicarbonate, low tumoral pH and cancer related inflammation. There is however little clinical evidence in human patients regarding the prognostic role of serum bicarbonate. Therefore, the primary aim of this study was to investigate the short and long-term prognostic utility of serum bicarbonate in colorectal cancer (CRC) patients undergoing resection of their primary tumor. The study also aimed to investigate the association of serum bicarbonate with known markers of systemic inflammation. Methods A total of 3281 consecutive patients who underwent surgical resection of their primary CRC from January 1998 to December 2012. Of these, 2223 stage I-IV patients had available data for analysis. The association of serum bicarbonate with overall survival was assessed using univariate and multivariate cox regression analyses. The association of bicarbonate with other clinicopathological variables was assessed by chi squared and Fisher's exact tests. Results Serum bicarbonate was associated with peri-operative mortality in multivariate analysis (p<0.001). Age (p = 0.004), grade (p = 0.043), creatinine (p = 0.036) and sodium (p = 0.036) were also markers associated with peri-operative mortality. For long term survival at 5 years, bicarbonate was significantly associated with overall survival in univariate analysis (p<0.001) but was not significant in multivariate analysis (p = 0.075). In exploratory analysis, serum bicarbonate was found to be significantly associated with the lymphocyte-to-monocyte ratio (p<0.001) and neutrophil-to-lymphocyte ratio (p<0.001). Conclusions In peri-operative colorectal cancer patients, serum bicarbonate was associated with 30-day survival but not 5-year survival.	[Chan, Joseph Chung Yan; Diakos, Connie Irene; Chan, David Lok Hang; Pavlakis, Nick; Clarke, Stephen John] Kolling Inst Med Res, Bill Walsh Translat Res Labs, St Leonards, NSW, Australia; [Chan, Joseph Chung Yan; Diakos, Connie Irene; Engel, Alexander; Chan, David Lok Hang; Pavlakis, Nick; Gill, Anthony] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Diakos, Connie Irene; Chan, David Lok Hang; Pavlakis, Nick; Clarke, Stephen John] Royal North Shore Hosp, Northern Sydney Canc Ctr, St Leonards, NSW, Australia; [Engel, Alexander] Royal North Shore Hosp, Dept Colorectal Surg, St Leonards, NSW, Australia; [Gill, Anthony; Clarke, Stephen John] Kolling Inst Med Res, Canc Diag & Pathol Grp, St Leonards, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; University of Sydney; Royal North Shore Hospital; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Clarke, SJ (corresponding author), Kolling Inst Med Res, Bill Walsh Translat Res Labs, St Leonards, NSW, Australia.; Clarke, SJ (corresponding author), Royal North Shore Hosp, Northern Sydney Canc Ctr, St Leonards, NSW, Australia.; Clarke, SJ (corresponding author), Kolling Inst Med Res, Canc Diag & Pathol Grp, St Leonards, NSW, Australia.	Stephen.clarke@sydney.edu.au	Gill, Anthony/D-4215-2015	Gill, Anthony/0000-0002-9447-1967; Clarke, Stephen/0000-0001-5817-1222; Chan, Joseph/0000-0002-2537-9729				Antony P, 2019, J SURG ONCOL, V119, P1170, DOI 10.1002/jso.25469; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Brosens RP, 2006, DIS COLON RECTUM, V49, P825, DOI 10.1007/s10350-005-0284-5; Chan JCY, 2017, ANN SURG, V265, P539, DOI 10.1097/SLA.0000000000001743; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Edge S.B., 2010, AJCC CANC STAGING MA, V14; Fenton TR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010438; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hall G, 2010, PATHOLOGY, V42, P409, DOI 10.3109/00313025.2010.493871; Horzic M, 2007, ARCH SURG-CHICAGO, V142, P1043, DOI 10.1001/archsurg.142.11.1043; Huber V, 2017, SEMIN CANCER BIOL, V43, P74, DOI 10.1016/j.semcancer.2017.03.001; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; Koltai T, 2016, ONCOTARGETS THER, V9, P6343, DOI 10.2147/OTT.S115438; Kuchuk O, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1445452; Lakatos PL, 2008, WORLD J GASTROENTERO, V14, P3937, DOI 10.3748/wjg.14.3937; Mohil RS, 2004, BRIT J SURG, V91, P500, DOI 10.1002/bjs.4465; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Robey IF, 2015, J INTEGRATIVE ONCOLO, V4, DOI [10.4172/2329-6771, DOI 10.4172/2329-6771]; Toon CW, 2014, MODERN PATHOL, V27, P644, DOI 10.1038/modpathol.2013.200; Weixler B, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2239-8	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228466	10.1371/journal.pone.0228466	http://dx.doi.org/10.1371/journal.pone.0228466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999779	Green Published, gold			2022-12-26	WOS:000534612400089
J	Devkota, B; Maskey, J; Pandey, AR; Karki, D; Godwin, P; Gartoulla, P; Mehata, S; Aryal, KK				Devkota, Bikash; Maskey, Jasmine; Pandey, Achyut Raj; Karki, Deepak; Godwin, Peter; Gartoulla, Pragya; Mehata, Suresh; Aryal, Krishna Kumar			Determinants of home delivery in Nepal - A disaggregated analysis of marginalised and non-marginalised women from the 2016 Nepal Demographic and Health Survey	PLOS ONE			English	Article							PLANNED HOME; BIRTHS; PREGNANCY; BARRIERS; OUTCOMES; PLACE; RISK	Introduction In Nepal, a substantial proportion of women still deliver their child at home. Disparities have been observed in utilisation of institutional delivery and skilled birth attendant services. We performed a disaggregated analysis among marginalised and non-marginalised women to identify if different factors are associated with home delivery among these groups. Materials and methods This study used data from the 2016 Nepal Demographic and Health Survey. It involves the analysis of 3,837 women who had experienced at least one live birth in the five years preceding the survey. Women were categorised as marginalised and non-marginalised based on ethnic group. Bivariate and multivariable logistic regression analysis were performed to identify factors associated with home delivery. Results A higher proportion of marginalised women delivered at home (47%) than non-marginalised women (26%). Compared to non-marginalised women (35%), a larger proportion of marginalised women (64%) felt that it was not necessary to give birth at health facility. The multivariable analysis indicated an independent association of having no or basic education, belonging to middle, poorer and the poorest wealth quintile, residing in Province 2 and not having completed of four antenatal care visits per protocol with home delivery among both marginalised and non-marginalised women. Whereas residing in a rural area, residing in Province 7, and at a distance of >30 minutes to a health facility were factors independently associated with home delivery only among marginalised women. Conclusion We conclude that poor education, poor economic status, non-completion of four ANC visits and belonging to Province 2 particularly determined either group of women to deliver at home, whereas residing in rural areas, living far from health facility, and belonging to Province 7 determined marginalised women to deliver at home. Preventing mothers from delivering at home would thus require focusing on specific geographical areas besides considering wider socio-economic determinants.	[Devkota, Bikash; Mehata, Suresh] Minist Hlth & Populat, Policy Planning & Monitoring Div, Kathmandu, Nepal; [Maskey, Jasmine; Pandey, Achyut Raj; Godwin, Peter; Gartoulla, Pragya; Aryal, Krishna Kumar] Abt Associates Inc, DFID Nepal Hlth Sect Programme Monitoring Evaluat, Kathmandu, Nepal; [Karki, Deepak] UK Dept Int Dev Nepal, Kathmandu, Nepal; [Gartoulla, Pragya] Monash Univ, Melbourne, Vic, Australia	Monash University	Maskey, J (corresponding author), Abt Associates Inc, DFID Nepal Hlth Sect Programme Monitoring Evaluat, Kathmandu, Nepal.	jasmine.maskey@abtassoc.com.au			United Kingdom Department of International development (DFID) Nepal Health Sector Programme 3 (NHSP3)	United Kingdom Department of International development (DFID) Nepal Health Sector Programme 3 (NHSP3)	We acknowledge the Demographic and Health Surveys (DHS) programme for availing the Nepal DHS for public use. We appreciate the support of Ms. Fiona Mactaggart for reviewing and copyediting the manuscript. This manuscript is produced as a part of the evidence generation activities within Monitoring, Evaluation and Operational Research (MEOR) project supported by the United Kingdom Department of International development (DFID) Nepal Health Sector Programme 3 (NHSP3). The content is solely the responsibility of authors and does not necessarily represent the official views of DFID Nepal or the UK Government.	Acharya P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185667; Adamson PC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-30; Adinew YM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3249786; Agadjanian V, 2016, INT PERSPECT SEX R H, V42, P21, DOI 10.1363/42e0116; [Anonymous], 2015, CONST NEP; Bennett L., 2008, CASTE ETHNIC REGIONA; Boateng D, 2017, CIRCULATION CARDIOVA, V10; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Davies-Tuck ML, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1996-6; de Jonge E, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0834-9; Department of Economic and Social Affairs United Nations, SUST DEV GOALS GOAL; Department of Health Services Ministry of Health and Population, 2016, ANN REPORT, V2073; Dhakal S, 2011, J HEALTH POPUL NUTR, V29, P371, DOI 10.3329/jhpn.v29i4.8453; Exavery A, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-48; Ganle JK, 2015, SOCIOCULTURAL BARRIE; Geidam AD, 2011, J OBSTET GYNAECOL, V31, P404, DOI 10.3109/01443615.2011.561383; Government of Nepal, 2018, MULT POV IND AN ACT; Government of Nepal Ministry of Health, 2015, NAT STRAT REACH UNR; Gunnarsson B, 2014, ACTA OBSTET GYN SCAN, V93, P1003, DOI 10.1111/aogs.12450; Gupta N, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6282-z; Gurung Mongal Singh, 2018, WHO South East Asia J Public Health, V7, P36, DOI 10.4103/2224-3151.228426; Huang Y, 2018, LANCET GLOB HEALTH, V6, pE39, DOI [10.1016/S2214-109X(17)30445-X, 10.1016/s2214-109x(17)30445-x]; Javed SA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-137; Karkee R, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-193; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Li Y, 2015, BJOG-INT J OBSTET GY, V122, P741, DOI 10.1111/1471-0528.13283; Ministry of Health and Population Government of Nepal., 2015, NEP HLTH SECT STRAT; Ministry of Health and Population New ERA ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health-MOH/Nepal New ERA/Nepal ICF., 2017, NEP DEM HLTH SURV 20; Morrison J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-89; Pandey J.P., 2013, MATERNAL CHILD HLTH; Pokharel T., 2015, HUMAN DEV, V11; Pradhan A, 2010, NEPAL MATERNAL MORTA; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rossi AC, 2018, EUR J OBSTET GYN R B, V222, P102, DOI 10.1016/j.ejogrb.2018.01.016; Sahoo J, 2015, J EPIDEMIOL GLOB HEA, V5, pS27, DOI 10.1016/j.jegh.2015.05.002; Scott NA, 2018, INT J WOMENS HEALTH, V10, P589, DOI 10.2147/IJWH.S169067; Seward N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001180; Shah R, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0454-y; Shahabuddin ASM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012446; Simkhada B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-34; Sprague DA, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0049-8; Stuart E., 2016, GENDER DEV, V24, P69, DOI [10.1080/13552074.2016.1142206, DOI 10.1080/13552074.2016.1142206]; Sumankuuro J, 2018, PUBLIC HEALTH, V157, P77, DOI 10.1016/j.puhe.2018.01.014; UN Department of Economic and Social Affairs Statistic Division, SDG IND MET REP 2018; UNICEF, 2018, DEL CAR UNICEF WHO J; World Health Organization, 2015, TRACK UN HLTH COV 1; World Health Organization, 2018, FACT SHEETS MAT MORT; World Health Organization, 2019, WORLD HLTH STAT MON; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; World Health Statistics, 2017, WORLD HLTH STAT 2017; Yaya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196896; Yebyo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124718	53	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228440	10.1371/journal.pone.0228440	http://dx.doi.org/10.1371/journal.pone.0228440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999784	Green Published, gold			2022-12-26	WOS:000534612400083
J	Zhang, ZY; Wu, L; Gray, R; Chhetri, DK				Zhang, Zhaoyan; Wu, Liang; Gray, Raluca; Chhetri, Dinesh K.			Three-dimensional vocal fold structural change due to implant insertion in medialization laryngoplasty	PLOS ONE			English	Article							PHONATION THRESHOLD PRESSURE; PHYSICAL MODEL; STIFFNESS; FREQUENCY; ONSET; CORD	Glottal insufficiency due to vocal fold paralysis, paresis, or atrophy often leads to degraded voice quality. One of the primary surgical intervention procedures to treat glottal insufficiency is medialization laryngoplasty, in which an implant is inserted through a lateral window on the thyroid cartilage to medialize the vocal folds. While the goal of medialization is to modify the vocal fold structure to restore normal phonation, few studies have attempted to quantify such structural changes of the vocal folds. The goal of this study is to quantify the three-dimensional structural changes of the vocal folds due to implant insertion in medialization laryngoplasty, and evaluate its potential effect on voice production. Medialization laryngoplasty were performed in excised human larynges using implants of different stiffness. Magnetic resonance images of the larynges were obtained with and without implant insertion. The results showed that implant insertion significantly changed the original body-cover structure of the vocal folds, with the implant taking over the large space used to be occupied by the original body layer and the vocal fold being stretched into a thin layer wrapped around the implant. The medial-lateral dimension of the vocal fold was significantly reduced from about 4 mm to 1 mm, and the vocal fold was stretched in the coronal plane by about 70%. It is hypothesized that use of implants with stiffness comparable to that of the vocal folds is beneficial because the degree of medialization can be adjusted without much negative effects on phonation frequency, phonation threshold pressure, or vibration amplitude.	[Zhang, Zhaoyan; Wu, Liang; Gray, Raluca; Chhetri, Dinesh K.] Univ Calif Los Angeles, Dept Head & Neck Surg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Zhang, ZY (corresponding author), Univ Calif Los Angeles, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.	zyzhang@ucla.edu	Chhetri, Dinesh Khatri/AAT-4951-2020; Zhang, Zhaoyan/E-5215-2013	Zhang, Zhaoyan/0000-0002-2379-6086; Gray, Raluca/0000-0003-3403-2345	NIH [R01DC009229, R01DC011300]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was funded by NIH grants R01DC009229 and R01DC011300.	Anderson TD, 2003, J VOICE, V17, P442, DOI 10.1067/S0892-1997(03)00080-8; Bryant NJ, 1996, LARYNGOSCOPE, V106, P1386, DOI 10.1097/00005537-199611000-00015; Chan RW, 1997, J ACOUST SOC AM, V101, P3722, DOI 10.1121/1.418331; Chhetri DK, 2013, LARYNGOSCOPE, V123, P3110, DOI 10.1002/lary.24209; Dion GR, 2018, LARYNGOSCOPE, V128, P1163, DOI 10.1002/lary.26963; FORD CN, 1995, LARYNGOSCOPE, V105, P498, DOI 10.1288/00005537-199505000-00010; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; Kumar VA, 2006, AM J NEURORADIOL, V27, P1643; Lucero JC, 1998, J VOICE, V12, P151, DOI 10.1016/S0892-1997(98)80034-9; Mau T, 2012, LARYNGOSCOPE, V122, P2005, DOI 10.1002/lary.23451; Mendelsohn AH, 2011, J ACOUST SOC AM, V130, P2961, DOI 10.1121/1.3644913; NIDCD, VOCAL FOLD PARALYSIS; Sundberg J, 2001, Logoped Phoniatr Vocol, V26, P26, DOI 10.1080/140154301300109107; VANDENBERG JW, 1968, ANN NY ACAD SCI, V155, P129; Wu L, 2016, J ACOUST SOC AM, V140, pEL159, DOI 10.1121/1.4959599; Zhang ZY, 2018, J ACOUST SOC AM, V144, P1216, DOI 10.1121/1.5053116; Zhang ZY, 2017, J ACOUST SOC AM, V142, P2311, DOI 10.1121/1.5008497; Zhang ZY, 2016, J ACOUST SOC AM, V139, P1493, DOI 10.1121/1.4944754; Zhang ZY, 2015, J VOICE, V29, P230, DOI 10.1016/j.jvoice.2014.07.003; Zhang ZY, 2012, J ACOUST SOC AM, V132, P1626, DOI 10.1121/1.4739437; Zhang ZY, 2009, J ACOUST SOC AM, V125, P1091, DOI 10.1121/1.3050285	21	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228464	10.1371/journal.pone.0228464	http://dx.doi.org/10.1371/journal.pone.0228464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999758	gold, Green Published			2022-12-26	WOS:000534612400088
J	Crowe, A; Henderson, MJ; Anderson, J; Titus, SA; Zakharov, A; Simeonov, A; Buist, A; Delay, C; Moechars, D; Trojanowski, JQ; Lee, VMY; Brunden, KR				Crowe, Alex; Henderson, Mark J.; Anderson, Johnathon; Titus, Steven A.; Zakharov, Alexey; Simeonov, Anton; Buist, Arjan; Delay, Charlotte; Moechars, Diederik; Trojanowski, John Q.; Lee, Virginia M. -Y.; Brunden, Kurt R.			Compound screening in cell-based models of tau inclusion formation: Comparison of primary neuron and HEK293 cell assays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tau protein (tau); Alzheimer disease; aggregation; inhibitor; drug screening; neurodegeneration; drug discovery; amyloid plaque; neurotoxicity	ALZHEIMERS-DISEASE; HYPOTHETICAL MODEL; CORTICAL-NEURONS; AGGREGATION; PATHOLOGY; PROTEIN; MICROTUBULES; FIBRILLIZATION; INHIBITORS; DEMENTIA	The hallmark pathological features of Alzheimer's disease (AD) brains are senile plaques, comprising ?-amyloid (A?) peptides, and neuronal inclusions formed from tau protein. These plaques form 10?20 years before AD symptom onset, whereas robust tau pathology is more closely associated with symptoms and correlates with cognitive status. This temporal sequence of AD pathology development, coupled with repeated clinical failures of A?-directed drugs, suggests that molecules that reduce tau inclusions have therapeutic potential. Few tau-directed drugs are presently in clinical testing, in part because of the difficulty in identifying molecules that reduce tau inclusions. We describe here two cell-based assays of tau inclusion formation that we employed to screen for compounds that inhibit tau pathology: a HEK293 cell-based tau overexpression assay, and a primary rat cortical neuron assay with physiological tau expression. Screening a collection of ?3500 pharmaceutical compounds with the HEK293 cell tau aggregation assay, we obtained only a low number of hit compounds. Moreover, these compounds generally failed to inhibit tau inclusion formation in the cortical neuron assay. We then screened the Prestwick library of mostly approved drugs in the cortical neuron assay, leading to the identification of a greater number of tau inclusion inhibitors. These included four dopamine D2 receptor antagonists, with D2 receptors having previously been suggested to regulate tau inclusions in a Caenorhabditis elegans model. These results suggest that neurons, the cells most affected by tau pathology in AD, are very suitable for screening for tau inclusion inhibitors.	[Crowe, Alex; Anderson, Johnathon; Trojanowski, John Q.; Lee, Virginia M. -Y.; Brunden, Kurt R.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, 3600 Spruce St,Maloney 3, Philadelphia, PA 19104 USA; [Henderson, Mark J.; Titus, Steven A.; Zakharov, Alexey; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Buist, Arjan; Delay, Charlotte; Moechars, Diederik] Janssen Pharmaceut NV, Janssen Res & Dev, Dept Neurosci, B-2340 Beerse, Belgium	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Johnson & Johnson; Janssen Pharmaceuticals	Brunden, KR (corresponding author), Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, 3600 Spruce St,Maloney 3, Philadelphia, PA 19104 USA.	kbrunden@upenn.edu		Henderson, Mark/0000-0001-8590-7338	Janssen Pharmaceutica NV; National Center for Advancing Translational Sciences, National Institutes of Health	Janssen Pharmaceutica NV(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Janssen Pharmaceutica NV and in part by the Intramural Research Program, National Center for Advancing Translational Sciences, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Barten DM, 2012, J NEUROSCI, V32, P7137, DOI 10.1523/JNEUROSCI.0188-12.2012; Bhat RV, 2018, J ALZHEIMERS DIS, V64, pS547, DOI 10.3233/JAD-179934; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; CHIVERS JK, 1988, J PHARM PHARMACOL, V40, P415, DOI 10.1111/j.2042-7158.1988.tb06306.x; Cho H, 2016, NEUROLOGY, V87, P375, DOI 10.1212/WNL.0000000000002892; Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056; Crowe A, 2013, J BIOL CHEM, V288, P11024, DOI 10.1074/jbc.M112.436006; Crowe A, 2009, BIOCHEMISTRY-US, V48, P7732, DOI 10.1021/bi9006435; Despres C, 2017, P NATL ACAD SCI USA, V114, P9080, DOI 10.1073/pnas.1708448114; DICHTER MA, 1978, BRAIN RES, V149, P279, DOI 10.1016/0006-8993(78)90476-6; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Goedert M, 2005, MOVEMENT DISORD, V20, pS45, DOI 10.1002/mds.20539; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Guo JL, 2016, J BIOL CHEM, V291, P13175, DOI 10.1074/jbc.M115.712083; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hanseeuw BJ, 2019, JAMA NEUROL, V76, P915, DOI 10.1001/jamaneurol.2019.1424; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrington CR, 2015, J BIOL CHEM, V290, P10862, DOI 10.1074/jbc.M114.616029; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Honson NS, 2007, NEUROBIOL DIS, V28, P251, DOI 10.1016/j.nbd.2007.07.018; Hoskin JL, 2019, EXPERT OPIN INV DRUG, V28, P545, DOI 10.1080/13543784.2019.1619694; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Khanna MR, 2016, ALZHEIMERS DEMENT, V12, P1051, DOI 10.1016/j.jalz.2016.06.006; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Koppel Jeremy, 2016, Alzheimers Dement (N Y), V2, P121, DOI 10.1016/j.trci.2016.05.003; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Koss DJ, 2016, ACTA NEUROPATHOL, V132, P875, DOI 10.1007/s00401-016-1632-3; Kow RL, 2018, BIOL PSYCHIAT, V83, P438, DOI 10.1016/j.biopsych.2017.06.007; Lane RF, 2012, ADV PHARMACOL, V64, P213, DOI 10.1016/B978-0-12-394816-8.00007-6; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; Lim S, 2014, COMPUT STRUCT BIOTEC, V12, P7, DOI 10.1016/j.csbj.2014.09.011; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Maust DT, 2015, JAMA PSYCHIAT, V72, P438, DOI 10.1001/jamapsychiatry.2014.3018; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; McCormick AV, 2013, BIOL PSYCHIAT, V73, P464, DOI 10.1016/j.biopsych.2012.08.027; Medda X, 2016, J BIOMOL SCREEN, V21, P804, DOI 10.1177/1087057116638029; Merrick SE, 1997, J NEUROSCI, V17, P5726; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Necula M, 2004, J BIOL CHEM, V279, P49694, DOI 10.1074/jbc.M405527200; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Pickhardt M, 2019, NEUROBIOL AGING, V76, P24, DOI 10.1016/j.neurobiolaging.2018.11.026; Pickhardt M, 2017, CURR ALZHEIMER RES, V14, P742, DOI 10.2174/1567205014666170202103136; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tell V, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00189; Titus Steven A, 2012, Curr Chem Genomics, V6, P79, DOI 10.2174/1875397301206010079; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Vigen CLP, 2011, AM J PSYCHIAT, V168, P831, DOI 10.1176/appi.ajp.2011.08121844; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wagner U, 1996, J CELL SCI, V109, P1537; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	68	6	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4001	4013		10.1074/jbc.RA119.010532	http://dx.doi.org/10.1074/jbc.RA119.010532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32034092	Green Published, hybrid			2022-12-26	WOS:000527704400024
J	Toda, A; Nishikawa, Y; Tanaka, H; Yagi, T; Kurisu, G				Toda, Akiyuki; Nishikawa, Yosuke; Tanaka, Hideaki; Yagi, Toshiki; Kurisu, Genji			The complex of outer-arm dynein light chain-1 and the microtubule-binding domain of the ? heavy chain shows how axonemal dynein tunes ciliary beating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dynein; molecular motor; X-ray crystallography; structural biology; protein complex; axonemal dynein; light chain; cilium; flagellum; axoneme	CONFORMATIONAL SWITCH; CRYSTAL-STRUCTURE; COILED-COIL; CHLAMYDOMONAS; ARCHITECTURE; ATPASE	Axonemal dynein is a microtubule-based molecular motor that drives ciliary/flagellar beating in eukaryotes. In axonemal dynein, the outer-arm dynein (OAD) complex, which comprises three heavy chains (?, ?, and ?), produces the main driving force for ciliary/flagellar motility. It has recently been shown that axonemal dynein light chain-1 (LC1) binds to the microtubule-binding domain (MTBD) of OAD?, leading to a decrease in its microtubule-binding affinity. However, it remains unclear how LC1 interacts with the MTBD and controls the microtubule-binding affinity of OAD?. Here, we have used X-ray crystallography and pulldown assays to examine the interaction between LC1 and the MTBD, identifying two important sites of interaction in the MTBD. Solving the LC1-MTBD complex from Chlamydomonas reinhardtii at 1.7 ? resolution, we observed that one site is located in the H5 helix and that the other is located in the flap region that is unique to some axonemal dynein MTBDs. Mutational analysis of key residues in these sites indicated that the H5 helix is the main LC1-binding site. We modeled the ternary structure of the LC1-MTBD complex bound to microtubules based on the known dynein-microtubule complex. This enabled us to propose a structural basis for both formations of the ternary LC1-MTBD-microtubule complex and LC1-mediated tuning of MTBD binding to the microtubule, suggesting a molecular model for how axonemal dynein senses the curvature of the axoneme and tunes ciliary/flagellar beating.	[Toda, Akiyuki; Kurisu, Genji] Osaka Univ, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Toda, Akiyuki; Nishikawa, Yosuke; Tanaka, Hideaki; Kurisu, Genji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Yagi, Toshiki] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Hiroshima 7270023, Japan; [Nishikawa, Yosuke] Daiichi Sankyo RD Novare Co Ltd, Dept Organ Synth, Edogawa Ku, 1-16-13 Kita Kasai, Tokyo 1348630, Japan	Osaka University; Osaka University; Daiichi Sankyo Company Limited	Kurisu, G (corresponding author), Osaka Univ, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan.; Kurisu, G (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan.	gkurisu@protein.osaka-u.ac.jp	Tanaka, Hideaki/AGY-8426-2022; KURISU, GENJI/AAD-7109-2022; KURISU, GENJI/ABA-5960-2020	KURISU, GENJI/0000-0002-5354-0807; KURISU, GENJI/0000-0002-5354-0807; Yagi, Toshiki/0000-0002-1379-460X	 [17J07553];  [18H02390]	; 	This work was supported by a Grant-in-Aid for JSPS Fellows Number 17J07553 (to A. T.) and a Grant-in-Aid for Scientific Research B number 18H02390 (to G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bui KH, 2008, J CELL BIOL, V183, P923, DOI 10.1083/jcb.200808050; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Horvath J, 2005, AM J RESP CELL MOL, V33, P41, DOI 10.1165/rcmb.2004-0335OC; Ichikawaa M, 2015, MOL BIOL CELL, V26, P4236, DOI 10.1091/mbc.E15-05-0289; Kato YS, 2014, STRUCTURE, V22, P1628, DOI 10.1016/j.str.2014.08.021; Kikushima K, 2008, BIOPHYS J, V94, P4014, DOI 10.1529/biophysj.107.123083; King SM, 2012, J BIOL CHEM, V287, P3108, DOI 10.1074/jbc.M111.286211; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Lacey SE, 2019, ELIFE, V8, DOI 10.7554/eLife.47145; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lin JF, 2018, SCIENCE, V360, DOI 10.1126/science.aar1968; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Nair R, 2009, NEW BIOTECHNOL, V26, P282, DOI 10.1016/j.nbt.2009.08.002; Nishikawa Y, 2016, J MOL BIOL, V428, P1886, DOI 10.1016/j.jmb.2015.11.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel-King RS, 2009, J CELL BIOL, V186, P283, DOI 10.1083/jcb.200905083; Pigino G, 2012, J STRUCT BIOL, V178, P199, DOI 10.1016/j.jsb.2012.02.012; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Toda Akiyuki, 2018, Biophys Rev, V10, P677, DOI 10.1007/s12551-018-0402-y; Uchimura S, 2015, J CELL BIOL, V208, P211, DOI 10.1083/jcb.201407039; Wu HW, 2003, BIOCHEMISTRY-US, V42, P57, DOI 10.1021/bi026762j; Yamaguchi S, 2015, BIOPHYS J, V108, P872, DOI 10.1016/j.bpj.2014.12.038	32	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3982	3989		10.1074/jbc.RA119.011541	http://dx.doi.org/10.1074/jbc.RA119.011541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32014992	Green Published, hybrid			2022-12-26	WOS:000527704400022
J	Kang, CY; Huang, IH; Chou, CC; Wu, TY; Chang, JC; Hsiao, YY; Cheng, CH; Tsai, WJ; Hsu, KC; Wang, SY				Kang, Chia-Yu; Huang, I-Hsiu; Chou, Chi-Chi; Wu, Tsai-Yu; Chang, Jyun-Cyuan; Hsiao, Yu-Yuan; Cheng, Cheng-Hsuan; Tsai, Wei-Jiun; Hsu, Kai-Cheng; Wang, Shuying			Functional analysis of Clostridium difficile sortase B reveals key residues for catalytic activity and substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; fluorescence resonance energy transfer (FRET); protein structure; substrate specificity; protein chemistry; protein purification; protein sorting; Clostridium difficile; crystal structure; cysteine transpeptidase; sortase B; substrate specificity	STAPHYLOCOCCUS-AUREUS SORTASE; SURFACE-PROTEINS; CELL-WALL; SORTING SIGNAL; A TRANSPEPTIDASE; UNITED-STATES; INFECTION; RECOGNITION; ENZYME; SRTB	Most of Gram-positive bacteria anchor surface proteins to the peptidoglycan cell wall by sortase, a cysteine transpeptidase that targets proteins displaying a cell wall sorting signal. Unlike other bacteria, Clostridium difficile, the major human pathogen responsible for antibiotic-associated diarrhea, has only a single functional sortase (SrtB). Sortase's vital importance in bacterial virulence has been long recognized, and C. difficile sortase B (Cd-SrtB) has become an attractive therapeutic target for managing C. difficile infection. A better understanding of the molecular activity of Cd-SrtB may help spur the development of effective agents against C. difficile infection. In this study, using site-directed mutagenesis, biochemical and biophysical tools, LC-MS/MS, and crystallographic analyses, we identified key residues essential for Cd-SrtB catalysis and substrate recognition. To the best of our knowledge, we report the first evidence that a conserved serine residue near the active site participates in the catalytic activity of Cd-SrtB and also SrtB from Staphylococcus aureus. The serine residue indispensable for SrtB activity may be involved in stabilizing a thioacyl-enzyme intermediate because it is neither a nucleophilic residue nor a substrate-interacting residue, based on the LC-MS/MS data and available structural models of SrtB?substrate complexes. Furthermore, we also demonstrated that residues 163?168 located on the ?6/?7 loop of Cd-SrtB dominate specific recognition of the peptide substrate PPKTG. The results of this work reveal key residues with roles in catalysis and substrate specificity of Cd-SrtB.	[Kang, Chia-Yu; Huang, I-Hsiu; Wu, Tsai-Yu; Chang, Jyun-Cyuan; Cheng, Cheng-Hsuan; Tsai, Wei-Jiun; Wang, Shuying] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 701, Taiwan; [Cheng, Cheng-Hsuan; Tsai, Wei-Jiun; Wang, Shuying] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan; [Kang, Chia-Yu; Huang, I-Hsiu; Wu, Tsai-Yu; Chang, Jyun-Cyuan; Cheng, Cheng-Hsuan; Tsai, Wei-Jiun; Wang, Shuying] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan; [Chou, Chi-Chi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Hsiao, Yu-Yuan] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu 300, Taiwan; [Hsiao, Yu-Yuan] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan; [Hsiao, Yu-Yuan] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu 300, Taiwan; [Hsu, Kai-Cheng] Taipei Med Univ, Grad Inst Canc Mol Biol & Drug Discovery, Coll Med Sci & Technol, Taipei 110, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University	Wang, SY (corresponding author), Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 701, Taiwan.; Wang, SY (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan.; Wang, SY (corresponding author), Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan.	sswang23@mail.ncku.edu.tw	Huang, I-Hsiu/CAF-2125-2022; Chou, Chi-Chi/X-6053-2019; wang, shuying/HHZ-4516-2022; Hsiao, Yu-Yuan/AAA-7408-2022	Huang, I-Hsiu/0000-0001-9667-0612; Chou, Chi-Chi/0000-0002-7862-7757; Hsiao, Yu-Yuan/0000-0002-9648-5879	Taiwan Protein Project [AS-KPQ-109-TPP2]; Ministry of Science and Technology of Taiwan [106-2320-B-006-010, 107-2320-B-006-048, 108-2320-B006-012]	Taiwan Protein Project; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Taiwan Protein Project Grant AS-KPQ-109-TPP2 and by Grants 106-2320-B-006-010, 107-2320-B-006-048, and 108-2320-B006-012 from the Ministry of Science and Technology of Taiwan (to S. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Asempa TE, 2017, CLIN INTERV AGING, V12, P1799, DOI 10.2147/CIA.S149089; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bradshaw WJ, 2015, FEBS J, V282, P2097, DOI 10.1111/febs.13288; Cascioferro S, 2014, MICROB PATHOGENESIS, V77, P105, DOI 10.1016/j.micpath.2014.10.007; Chambers CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09449; Chan AH, 2015, J BIOL CHEM, V290, P25461, DOI 10.1074/jbc.M115.670984; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cole SA, 2015, CLIN COLON RECT SURG, V28, P65, DOI 10.1055/s-0035-1547333; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Donahue EH, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0219-1; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dubberke ER, 2008, INFECT CONT HOSP EP, V29, pS81, DOI 10.1086/591065; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Honda H, 2014, ANAEROBE, V25, P5, DOI 10.1016/j.anaerobe.2013.10.004; Jacobitz AW, 2017, ADV PROTEIN CHEM STR, V109, P223, DOI 10.1016/bs.apcsb.2017.04.008; Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273; Johnson S, 2009, J INFECTION, V58, P403, DOI 10.1016/j.jinf.2009.03.010; Jonsson IM, 2003, MICROBES INFECT, V5, P775, DOI 10.1016/S1286-4579(03)00143-6; Kang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015969; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Ma GK, 2017, ANN INTERN MED, V167, P152, DOI [10.7326/M16-2733, 10.7326/m16-2733]; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Roshan N, 2018, ANAEROBE, V49, P103, DOI 10.1016/j.anaerobe.2018.01.003; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; van Leeuwen HC, 2014, FEBS LETT, V588, P4325, DOI 10.1016/j.febslet.2014.09.041; Yin JC, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00160; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	54	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3734	3745		10.1074/jbc.RA119.011322	http://dx.doi.org/10.1074/jbc.RA119.011322			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32005667	hybrid, Green Published			2022-12-26	WOS:000527725300028
J	Jeannot, E; Darrigues, L; Michel, M; Stern, MH; Pierga, JY; Rampanou, A; Melaabi, S; Benoist, C; Bieche, I; Vincent-Salomon, A; El Ayachy, R; Noret, A; Epaillard, N; Cabel, L; Bidard, FC; Proudhon, C				Jeannot, Emmanuelle; Darrigues, Lauren; Michel, Marc; Stern, Marc-Henri; Pierga, Jean-Yves; Rampanou, Aurore; Melaabi, Samia; Benoist, Camille; Bieche, Ivan; Vincent-Salomon, Anne; El Ayachy, Radouane; Noret, Aurelien; Epaillard, Nicolas; Cabel, Luc; Bidard, Francois-Clement; Proudhon, Charlotte			A single droplet digital PCR for ESR1 activating mutations detection in plasma	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; CELL-FREE DNA; BREAST-CANCER; RESISTANCE	Activating mutations in the estrogen receptor 1 (ESR1) gene confer resistance to aromatase inhibitors (AI), and may be targeted by selective estrogen receptor downregulators. We designed a multiplex droplet digital PCR (ddPCR), which combines a drop-off assay, targeting the clustered hotspot mutations found in exon 8, with an unconventional assay interrogating the E380Q mutation in exon 5. We assessed its sensitivity in vitro using synthetic oligonucleotides, harboring E380Q, L536R, Y537C, Y537N, Y537S, or D538G mutations. Further validation was performed on plasma samples from a prospective study and compared with next generation sequencing (NGS) data. The multiplex ESR1-ddPCR showed a high sensitivity with a limit of detection ranging from 0.07 to 0.19% in mutant allele frequency. The screening of plasma samples from patients with AI-resistant metastatic breast cancer identified ESR1 mutations in 29% of them, all mutations being confirmed by NGS. In addition, this test identifies patients harboring polyclonal alterations. Furthermore, the monitoring of circulating tumor DNA using this technique during treatment follow-up predicts the clinical benefit of palbociclib-fulvestrant. The multiplex ESR1-ddPCR detects, in a single reaction, the most frequent ESR1 activating mutations with good sensitivity. This method allows real-time liquid biopsy for ESR1 mutation monitoring in large cohorts of patients.	[Jeannot, Emmanuelle; Darrigues, Lauren; Michel, Marc; Pierga, Jean-Yves; Rampanou, Aurore; Bidard, Francois-Clement; Proudhon, Charlotte] PSL Res Univ, Inst Curie, Circulating Tumor Biomarkers Lab, Inserm CIC 1428, Paris, France; [Jeannot, Emmanuelle; Melaabi, Samia; Benoist, Camille; Bieche, Ivan; Vincent-Salomon, Anne] PSL Res Univ, Inst Curie, Dept Biopathol & Genet, Paris, France; [Stern, Marc-Henri] PSL Res Univ, Inst Curie, INSERM U830, Paris, France; [Pierga, Jean-Yves; El Ayachy, Radouane; Noret, Aurelien; Epaillard, Nicolas; Cabel, Luc; Bidard, Francois-Clement] PSL Res Univ, Inst Curie, Dept Med Oncol, Paris, France; [Pierga, Jean-Yves; El Ayachy, Radouane; Noret, Aurelien; Epaillard, Nicolas; Cabel, Luc; Bidard, Francois-Clement] PSL Res Univ, Inst Curie, Dept Med Oncol, St Cloud, France; [Pierga, Jean-Yves] Univ Paris, Paris, France; [Pierga, Jean-Yves] Dept Inst Curie, Med Oncol, Paris, France; [Cabel, Luc; Bidard, Francois-Clement] Versailles St Quentin Univ, Paris Saclay Univ, St Cloud, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Proudhon, C (corresponding author), PSL Res Univ, Inst Curie, Circulating Tumor Biomarkers Lab, Inserm CIC 1428, Paris, France.	charlotte.proudhon@curie.fr	Stern, Marc-Henri/A-2728-2011	Stern, Marc-Henri/0000-0002-8100-2272; Proudhon, Charlotte/0000-0002-4649-4574; Michel, Marc/0000-0001-6613-8027	Innovative Medicines Initiative Joint Undertaking [115749]; SIRIC 2 Curie [INCa-DGOS-Inserm_12554]	Innovative Medicines Initiative Joint Undertaking; SIRIC 2 Curie	SIRIC 2 Curie (grant INCa-DGOS-Inserm_12554) and the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115749 (project Cancer-ID). The funding sources of the study had no role in the design of the study, collection, analysis, or interpretation of the data or in the writing of this report.	Bidard FC, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.SABCS18-PD2-06; Bidard FC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006305; Bidshahri R, 2016, J MOL DIAGN, V18, P190, DOI 10.1016/j.jmoldx.2015.09.003; Carausu M, 2019, EXPERT REV MOL DIAGN, V19, P599, DOI 10.1080/14737159.2019.1631799; Chandarlapaty S, 2016, JAMA ONCOL, V2, P1310, DOI 10.1001/jamaoncol.2016.1279; Chu D, 2016, CLIN CANCER RES, V22, P993, DOI 10.1158/1078-0432.CCR-15-0943; Chung JH, 2017, ANN ONCOL, V28, P2866, DOI 10.1093/annonc/mdx490; Clatot F, 2016, ONCOTARGET, V7, P74448, DOI 10.18632/oncotarget.12950; Decraene C, 2018, JOVE-J VIS EXP, V139, P1; Decraene C, 2018, CLIN CHEM, V64, P317, DOI 10.1373/clinchem.2017.272518; Fribbens C, 2016, J CLIN ONCOL, V34, P2961, DOI 10.1200/JCO.2016.67.3061; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Gyanchandani R, 2017, ONCOTARGET, V8, P66901, DOI 10.18632/oncotarget.11383; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Lupini L, 2018, SCI REP, V8, P1; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Niu JX, 2015, ONCOTARGETS THER, V8, P3323, DOI 10.2147/OTT.S92443; O'Leary B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03215-x; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Seki Y, 2016, ONCOLOGIST, V21, P156, DOI 10.1634/theoncologist.2015-0288; Takeshita T, 2017, ONCOTARGET, V8, P52142, DOI 10.18632/oncotarget.18479; Takeshita T, 2015, TRANSL RES, V166, P540, DOI 10.1016/j.trsl.2015.09.003; Toy W, 2017, CANCER DISCOV, V7, P277, DOI 10.1158/2159-8290.CD-15-1523; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Wang PL, 2016, CLIN CANCER RES, V22, P1130, DOI 10.1158/1078-0432.CCR-15-1534	26	21	21	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2987	2995		10.1038/s41388-020-1174-y	http://dx.doi.org/10.1038/s41388-020-1174-y		FEB 2020	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32042112	Green Submitted			2022-12-26	WOS:000512528200003
J	Holloway, KA; Ivanovska, V; Manikandan, S; Jayanthi, M; Mohan, A; Forte, G; Henry, D				Holloway, Kathleen Anne; Ivanovska, Verica; Manikandan, Solaiappan; Jayanthi, Mathaiyan; Mohan, Anbarasan; Forte, Gilles; Henry, David			Identifying the most effective essential medicines policies for quality use of medicines: A replicability study using three World Health Organisation data-sets	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; PERFORMANCE; RESISTANCE; WORKERS	Background Poor quality use of medicines (QUM) has adverse outcomes. Governments' implementation of essential medicines (EM) policies is often suboptimal and there is limited information on which policies are most effective. Methods We analysed data on policy implementation from World Health Organisation (WHO) surveys in 2007 and 2011, and QUM data from surveys during 2006-2012 in developing and transitional countries. We compared QUM scores in countries that did or did not implement specific policies and regressed QUM composite scores on the numbers of policies implemented. We compared the ranking of policies in this and two previous studies, one from the same WHO databases (2003-2007) the other from data obtained during country visits in South-East Asia (2010-2015). The rankings of a common set of 17 policies were correlated and we identified those that were consistently highly ranked. Findings Fifty-three countries had data on both QUM and policy implementation. Forty policies were associated with effect sizes ranging from +13% to -5%. There was positive correlation between the composite QUM indicator and the number of policies reported implemented: (r) = 0.437 (95% CI 0.188 to 0.632). Comparison of policy rankings between the present and previous studies showed positive correlation with the WHO 2003-7 study: Spearman's rank correlation coefficient 0.498 (95% CI 0.022 to 0.789). Across the three studies, five policies were in the top five ranked positions 11 out of a possible 15 times: drugs available free at the point of care; a government QUM unit; undergraduate training of prescribers in standard treatment guidelines, antibiotics not available without prescription and generic substitution in the public sector. Interpretation Certain EM policies are associated with better QUM and impact increases with co-implementation. Analysis across three datasets provides a policy short-list as a minimum investment by countries trying to improve QUM and reduce antimicrobial drug misuse.	[Holloway, Kathleen Anne] Univ Sussex, Inst Dev Studies, Hlth & Nutr, Brighton, E Sussex, England; [Ivanovska, Verica; Forte, Gilles] WHO, Essential Med & Hlth Prod, Geneva, Switzerland; [Manikandan, Solaiappan; Jayanthi, Mathaiyan] Jawarhalal Nehru Inst Med Educ & Res, Dept Pharmacol, Pondicherry, India; [Mohan, Anbarasan] Govt Theni Med Coll, Dept Pharmacol, Theni, Tamil Nadu, India; [Henry, David] Bond Univ, Inst Evidence Based Healthcare, Gold Coast, Qld, Australia; [Henry, David] Univ Melbourne, Melbourne, Vic, Australia	University of Sussex; World Health Organization; Bond University; University of Melbourne	Holloway, KA (corresponding author), Univ Sussex, Inst Dev Studies, Hlth & Nutr, Brighton, E Sussex, England.	kaholloway54@gmail.com	Henry, David/AAU-4650-2020; Henry, David/AAJ-4332-2020	Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Bavestrello L, 2002, REV MED CHILE, V130, P1265; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Harbarth S, 2005, EMERG INFECT DIS, V11, P794, DOI 10.3201/eid1106.050167; Hitchen L, 2006, BRIT MED J, V332, P1109, DOI 10.1136/bmj.332.7550.1109; Holloway K, 2011, WHOEMPMIE201122; Holloway KA, 2013, TROP MED INT HEALTH, V18, P656, DOI 10.1111/tmi.12123; Holloway KA, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3333-1; Holloway KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152020; Holloway KA, 2015, PAEDIATR INT CHILD H, V35, P5, DOI 10.1179/2046905514Y.0000000115; Holloway KA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001724; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Jaffer B., 2007, WHO NGO TECHN BRIEF; Laing RO, 2001, HEALTH POLICY PLANN, V16, P13, DOI 10.1093/heapol/16.1.13; Livermore DM, 2003, CLIN INFECT DIS, V36, pS11, DOI 10.1086/344654; Park S, 2005, HEALTH POLICY PLANN, V20, P302, DOI 10.1093/heapol/czi033; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Sketris IS, 2009, J POPUL THER CLIN PH, V16, pE103; Trap B, 2002, HEALTH POLICY PLANN, V17, P288, DOI 10.1093/heapol/17.3.288; Trap B, 2002, J CLIN PHARM THER, V27, P289, DOI 10.1046/j.1365-2710.2002.00425.x; Vang C, 2006, EUR J CLIN PHARMACOL, V62, P57, DOI 10.1007/s00228-005-0069-8; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organisation, 2002, WHO POL PERSP MED, V5; World Health Organisation, 2004, EDM RES SER, V32; World Health Organisation, 2011, COUNTR PHARM PROF; World Health Organization, 2007, WHOTCM20072; World Health Organization, 1993, INVESTIGATE DRUG USE; World Health Organization, 2009, MED US PRIM CAR DEV; World Health Organization, 2010, WHOEMPMPC20101	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228201	10.1371/journal.pone.0228201	http://dx.doi.org/10.1371/journal.pone.0228201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9GK	32027679	gold, Green Published			2022-12-26	WOS:000534623800016
J	Menarim, BC; Gillis, KH; Oliver, A; Mason, C; Werre, SR; Luo, X; Byron, CR; Kalbfleisch, TS; MacLeod, JN; Dahlgren, LA				Menarim, Bruno C.; Gillis, Kiersten H.; Oliver, Andrea; Mason, Caitlin; Werre, Stephen R.; Luo, Xin; Byron, Christopher R.; Kalbfleisch, Theodore S.; MacLeod, James N.; Dahlgren, Linda A.			Inflamed synovial fluid induces a homeostatic response in bone marrow mononuclear cells in vitro: Implications for joint therapy	FASEB JOURNAL			English	Article						cell therapy; homeostasis; joint; macrophage; osteoarthritis	EXPERIMENTALLY-INDUCED ARTHRITIS; PRORESOLVING LIPID MEDIATORS; AUTOLOGOUS CONDITIONED SERUM; MESENCHYMAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; MACROPHAGE DEPLETION; ARTICULAR-CARTILAGE; CD14 EXPRESSION	Synovial inflammation is a central feature of osteoarthritis (OA), elicited when local regulatory macrophages (M2-like) become overwhelmed, activating an inflammatory response (M1-like). Bone marrow mononuclear cells (BMNC) are a source of naive macrophages capable of reducing joint inflammation and producing molecules essential for cartilage metabolism. This study investigated the response of BMNC to normal (SF) and inflamed synovial fluid (ISF). Equine BMNC cultured in autologous SF or ISF (n = 8 horses) developed into macrophage-rich cultures with phenotypes similar to cells native to normal SF and became more confluent in ISF (similar to 100%) than SF (similar to 25%). BMNC cultured in SF or ISF were neither M1- nor M2-like, but exhibited aspects of both phenotypes and a regulatory immune response, characterized by increasing counts of IL-10(+) macrophages, decreasing IL-1 beta concentrations and progressively increasing IL-10 and IGF-1 concentrations. Changes were more marked in ISF and suggest that homeostatic mechanisms were preserved over time and were potentially favored by progressive cell proliferation. Collectively, our data suggest that intra-articular BMNC could increase synovial macrophage counts, potentiating the macrophage- and IL-10-associated mechanisms of joint homeostasis lost during the progression of OA, preserving the production of cytokines involved in tissue repair (PGE(2), IL-10) generally impaired by frequently used corticosteroids.	[Menarim, Bruno C.; Gillis, Kiersten H.; Oliver, Andrea; Mason, Caitlin; Byron, Christopher R.; Dahlgren, Linda A.] Virginia Tech, Dept Large Anim Clin Sci, Virginia Maryland Coll Vet Med, 205 Duck Pond Dr, Blacksburg, VA 24061 USA; [Werre, Stephen R.] Virginia Tech, Lab Study Design & Stat Anal, Virginia Maryland Coll Vet Med, Blacksburg, VA 24061 USA; [Luo, Xin] Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med, Blacksburg, VA 24061 USA; [Kalbfleisch, Theodore S.; MacLeod, James N.] Univ Kentucky, Coll Agr & Vet Sci, Maxwell Gluck Equine Res Ctr, Lexington, KY USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Kentucky	Dahlgren, LA (corresponding author), Virginia Tech, Dept Large Anim Clin Sci, Virginia Maryland Coll Vet Med, 205 Duck Pond Dr, Blacksburg, VA 24061 USA.	lad11@vt.edu	Luo, Xin M/J-6544-2016; Kalbfleisch, Theodore/AAN-5407-2021	Luo, Xin M/0000-0002-2809-5836; Kalbfleisch, Theodore/0000-0002-2370-8189; Menarim, Bruno/0000-0003-1829-4978	Grayson-Jockey Club Research Foundation	Grayson-Jockey Club Research Foundation	Grayson-Jockey Club Research Foundation	Abramson SB, 2004, J RHEUMATOL, V31, P70, DOI 10.1097/BOR.0b013e328349c2b1; Agadi S, 2015, STEM CELLS, V33, P2093, DOI 10.1002/stem.2029; Amin AR, 2014, DNA CELL BIOL, V33, P550, DOI 10.1089/dna.2013.2198; [Anonymous], 2016, BRAZ ARCH BIOL TECHN; Barrera P, 2000, ARTHRITIS RHEUM-US, V43, P1951, DOI 10.1002/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K; Barussi FCM, 2016, RESP PHYSIOL NEUROBI, V232, P35, DOI 10.1016/j.resp.2016.07.002; Baxter GT, 1999, J BIOL CHEM, V274, P9539, DOI 10.1074/jbc.274.14.9539; Behrendt P, 2018, OSTEOARTHR CARTILAGE, V26, P264, DOI 10.1016/j.joca.2017.11.007; Bekkers JEJ, 2013, OSTEOARTHR CARTILAGE, V21, P950, DOI 10.1016/j.joca.2013.03.015; Bellac CL, 2014, CELL REP, V9, P618, DOI 10.1016/j.celrep.2014.09.006; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Bruyere O, 2016, SEMIN ARTHRITIS RHEU, V45, pS3, DOI 10.1016/j.semarthrit.2015.11.010; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Caron JP, 2019, PROSTAG OTH LIPID M, V142, P1, DOI 10.1016/j.prostaglandins.2019.02.007; Chan MWY, 2019, CYTOTHERAPY, V21, P393, DOI 10.1016/j.jcyt.2019.02.002; Chang KV, 2014, ARCH PHYS MED REHAB, V95, P562, DOI 10.1016/j.apmr.2013.11.006; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Cruz FF, 2016, STEM CELL TRANSL MED, V5, P488, DOI 10.5966/sctm.2015-0141; Cuende N, 2012, STEM CELL TRANSL MED, V1, P403, DOI 10.5966/sctm.2011-0064; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; Daniel B, 2018, NUCLEIC ACIDS RES, V46, P4425, DOI 10.1093/nar/gky157; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; de Grauw JC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2640; Elhage R, 2001, ATHEROSCLEROSIS, V156, P315, DOI 10.1016/S0021-9150(00)00682-1; Fahy N, 2014, OSTEOARTHR CARTILAGE, V22, P1167, DOI 10.1016/j.joca.2014.05.021; Feehan KT, 2019, TRENDS MOL MED, V25, P198, DOI 10.1016/j.molmed.2019.01.006; Fendl B, 2019, BIOCHEM BIOPH RES CO, V517, P709, DOI 10.1016/j.bbrc.2019.07.120; Fichadiya A, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0120-9; Filardo G, 2015, Knee Surg Sports Traumatol Arthrosc, V23, P2459, DOI 10.1007/s00167-013-2743-1; Finnegan A, 2012, AUTOIMMUNITY, V45, P353, DOI 10.3109/08916934.2012.665526; Flaminio MJBF, 2007, VET IMMUNOL IMMUNOP, V119, P92, DOI 10.1016/j.vetimm.2007.06.035; Fortier LA, 1999, J ORTHOP RES, V17, P467, DOI 10.1002/jor.1100170403; Freeman SA, 2018, CELL, V172, P305, DOI 10.1016/j.cell.2017.12.023; Frisbie DD, 2007, AM J VET RES, V68, P290, DOI 10.2460/ajvr.68.3.290; Fuster JJ, 2014, EMBO J, V33, P1425, DOI 10.15252/embj.201488856; Giraldi-Guimaraes A, 2012, BRAIN RES, V1452, P173, DOI 10.1016/j.brainres.2012.03.002; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; GOLDRING MB, 1990, ANN NY ACAD SCI, V580, P536, DOI 10.1111/j.1749-6632.1990.tb17983.x; Goncars V, 2019, CARTILAGE, V10, P26, DOI 10.1177/1947603517746721; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Iannone F, 2001, CLIN EXP RHEUMATOL, V19, P139; Ibrahim S, 2007, VET IMMUNOL IMMUNOP, V119, P63, DOI 10.1016/j.vetimm.2007.06.034; Ibrahim S, 2012, VET IMMUNOL IMMUNOP, V145, P7, DOI 10.1016/j.vetimm.2011.07.021; Iijima H, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-018-0041-8; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jain S, 2015, BIOMATERIALS, V61, P162, DOI 10.1016/j.biomaterials.2015.05.028; Jansen NWD, 2008, BRIT J HAEMATOL, V142, P953, DOI 10.1111/j.1365-2141.2008.07278.x; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kabithe E, 2010, VET IMMUNOL IMMUNOP, V138, P149, DOI 10.1016/j.vetimm.2010.07.003; Kadri N, 2007, IMMUNOL LETT, V108, P129, DOI 10.1016/j.imlet.2006.11.007; Kalbfleisch TS, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0199-z; Karagianni AE, 2017, EQUINE VET J, V49, P375, DOI 10.1111/evj.12584; Kay AT, 2008, AM J VET RES, V69, P1646, DOI 10.2460/ajvr.69.12.1646; King A, 2014, ADV WOUND CARE, V3, P315, DOI 10.1089/wound.2013.0461; Lasarzik J, 2018, J EQUINE VET SCI, V60, P35, DOI 10.1016/j.jevs.2016.09.014; Laudy ABM, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094036; Leveque M, 2017, FASEB J, V31, P1891, DOI 10.1096/fj.201600772R; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; MALEFYT RD, 1991, J EXP MED, V174, P1209; Manferdini C, 2017, OSTEOARTHR CARTILAGE, V25, P1161, DOI 10.1016/j.joca.2017.01.011; Manferdini C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0983-4; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; McIlwraith CW, 2012, BONE JOINT RES, V1, P297, DOI 10.1302/2046-3758.111.2000132; McIlwraith CW, 2011, CARTILAGE, V2, P317, DOI 10.1177/1947603511406531; MCILWRAITH CW, 1979, AM J VET RES, V40, P11; MCILWRAITH CW, 1981, AM J VET RES, V42, P209; Menarim BC, 2019, FASEB J, V33, P14337, DOI 10.1096/fj.201901684RR; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morin J, 2003, CLIN EXP IMMUNOL, V134, P388, DOI 10.1111/j.1365-2249.2003.02308.x; MORRIS EA, 1994, AM J VET RES, V55, P138; MORRIS EA, 1990, AM J VET RES, V51, P59; Morton AJ, 2005, RES VET SCI, V78, P189, DOI 10.1016/j.rvsc.2004.07.006; Murphy LB, 2018, ARTHRIT CARE RES, V70, P869, DOI 10.1002/acr.23425; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nawaz A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00231-1; Liem NT, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0992-x; Odobasic D, 2008, IMMUNOLOGY, V124, P503, DOI 10.1111/j.1365-2567.2007.02802.x; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; Orlowsky EW, 2015, J RHEUMATOL, V42, P363, DOI 10.3899/jrheum.140382; Ortved KF, 2012, EQUINE VET J, V44, P606, DOI 10.1111/j.2042-3306.2011.00510.x; PALMER JL, 1994, EQUINE VET J, V26, P492, DOI 10.1111/j.2042-3306.1994.tb04056.x; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Peffers MJ, 2015, OSTEOARTHR CARTILAGE, V23, P1204, DOI 10.1016/j.joca.2015.03.019; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Poulsen RC, 2008, AM J HEMATOL, V83, P437, DOI 10.1002/ajh.21170; Rannou F, 2014, ATLAS OSTEOARTHRITIS, P37; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Riyazi N, 2005, ARTHRITIS RHEUM-US, V52, P1443, DOI 10.1002/art.21014; Ross TN, 2012, OSTEOARTHR CARTILAGE, V20, P1583, DOI 10.1016/j.joca.2012.08.008; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Ryncarz RE, 1998, BLOOD, V91, P3892, DOI 10.1182/blood.V91.10.3892.3892_3892_3900; Safi W, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.11; Saw KY, 2009, ARTHROSCOPY, V25, P1391, DOI 10.1016/j.arthro.2009.07.011; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Shizhu J, 2012, TURK J GASTROENTEROL, V23, P344, DOI 10.4318/tjg.2012.0344; St Clair EW, 1999, ANN RHEUM DIS, V58, P99; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; SUZUKI Y, 2018, SCI REP UK, V8; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Todhunter PG, 1996, AM J VET RES, V57, P1080; Trombetta AC, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0891-z; Tsubosaka Y, 2019, FASEB J, V33, P6829, DOI 10.1096/fj.201802153R; TYLER JA, 1989, BIOCHEM J, V260, P543, DOI 10.1042/bj2600543; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; van de Water E, 2017, EQUINE VET J, V49, P532, DOI 10.1111/evj.12629; van den Berg WB, 2000, ANN RHEUM DIS, V59, P81, DOI 10.1136/ard.59.suppl_1.i81; van Loon JPAM, 2013, VET J, V196, P40, DOI 10.1016/j.tvjl.2012.07.030; VANLENT PLEM, 1993, AM J PATHOL, V143, P1226; Verde CK, 2001, J VET PHARMACOL THER, V24, P179, DOI 10.1046/j.1365-2885.2001.00336.x; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; Wagner B, 2008, VET IMMUNOL IMMUNOP, V122, P57, DOI 10.1016/j.vetimm.2007.10.012; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Williams LB, 2016, EQUINE VET J, V48, P619, DOI 10.1111/evj.12477; Wu CL, 2017, ARTHRITIS RHEUMATOL, V69, P1772, DOI 10.1002/art.40161; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zamani F, 2013, ADV PHARM BULL, V3, P329, DOI 10.5681/apb.2013.053; ZHANG DE, 1994, J IMMUNOL, V153, P3276; Zhou YD, 2017, MOL MED REP, V15, P3949, DOI 10.3892/mmr.2017.6491	128	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4430	4444		10.1096/fj.201902698R	http://dx.doi.org/10.1096/fj.201902698R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030831	Bronze			2022-12-26	WOS:000512333500001
J	Munera-Echeverri, JL; Martinsen, V; Strand, LT; Cornelissen, G; Mulder, J				Munera-Echeverri, Jose Luis; Martinsen, Vegard; Strand, Line Tau; Cornelissen, Gerard; Mulder, Jan			Effect of conservation farming and biochar addition on soil organic carbon quality, nitrogen mineralization, and crop productivity in a light textured Acrisol in the sub-humid tropics	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MATTER FRACTIONS; LONG-TERM; C INPUTS; NO-TILL; AGRICULTURE; MAIZE; YIELD; MECHANISMS; STABILITY	Conservation farming (CF), involving basin tillage, residue retention and crop rotation, combined with biochar may help to mitigate negative impacts of conventional agriculture. In this study, the effects of CF on the amount and quality of soil organic matter (SOM) and potential nitrogen (N) mineralization were investigated in a maize-soya-maize rotation in an Acrisol in Zambia. A large field was run under CF for 7 years and in the subsequent three growing seasons (2015-2018), four management practices were introduced to study effects on soil characteristics and crop yield. We tested i) a continuation of regular CF (CF-NORM) ii) CF without residue retention (CF-NO-RES); iii) Conventional (CONV), with full tillage and removal of residues; and iv) CF with 4 ton ha(-1) pigeon pea biochar inside basins and residue retention (CF-BC). The experiment involved the addition of fertilizer only to maize, while soya received none. Soya yield was significantly higher in CF systems than in CONV. Maize yields were not affected by the different management practices probably due to the ample fertilizer addition. CF-NORM had a higher stock of soil organic carbon (SOC), higher N mineralization rates, more hot-water extractable carbon (HWEC; labile SOC) and particulate organic matter (POM) inside basins compared to the surrounding soil (outside basins). Our results suggest that the input of roots inside basins are more effective increasing SOM and N mineralization, than the crop residues that are placed outside basins. CONV reduced both quality and quantity of SOM and N mineralization as compared to CF inside basins. CF-BC increased the amount of SOC as compared with CF-NORM, whereas N mineralization rate and HWEC remained unaffected. The results suggest benefits on yield of CF and none of biochar; larger impact of root biomass on the build-up of SOM than crop residues; and high stability of biochar in soil.	[Munera-Echeverri, Jose Luis; Martinsen, Vegard; Strand, Line Tau; Cornelissen, Gerard; Mulder, Jan] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Cornelissen, Gerard] Norwegian Geotech Inst NGI, Oslo, Norway	Norwegian University of Life Sciences; Norwegian Geotechnical Institute, NGI	Munera-Echeverri, JL; Martinsen, V (corresponding author), Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway.	jlmunera88@hotmail.com; vegard.martinsen@nmbu.no		Munera Echeverri, Jose Luis/0000-0002-8162-9649	Faculty of Environmental Sciences and Nature Resource Management at NMBU; R&D project "Climate Smart Agriculture in Zambia (CSAZ): Soil benefits parameters research, conventional and conservation agriculture" by Conservation Farming Unit (CFU) of Zambia; DFID; Faculty of Environmental Sciences and Natural Resource Management at the Norwegian University of Life Sciences; R&D project "Soil Benefits Parameters Research, Conventional and Conservation Agriculture" by Conservation Farming Unit (CFU) in Zambia; Norwegian University of Life Sciences (NMBU)	Faculty of Environmental Sciences and Nature Resource Management at NMBU; R&D project "Climate Smart Agriculture in Zambia (CSAZ): Soil benefits parameters research, conventional and conservation agriculture" by Conservation Farming Unit (CFU) of Zambia; DFID; Faculty of Environmental Sciences and Natural Resource Management at the Norwegian University of Life Sciences; R&D project "Soil Benefits Parameters Research, Conventional and Conservation Agriculture" by Conservation Farming Unit (CFU) in Zambia; Norwegian University of Life Sciences (NMBU)	of Life Sciences (NMBU) (https://www.nmbu.no/en) through PhD internal financing to Munera-Echeverri J.L and by the Faculty of Environmental Sciences and Nature Resource Management at NMBU (https://www.nmbu.no/en/faculty/mina) as part of the stipend to Vegard Martinsen and by the R&D project "Climate Smart Agriculture in Zambia (CSAZ): Soil benefits parameters research, conventional and conservation agriculture" funded by the Conservation Farming Unit (CFU) of Zambia (https://conservationagriculture.org/).The sponsors did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by the Faculty of Environmental Sciences and Natural Resource Management at the Norwegian University of Life Sciences and by the R&D project "Soil Benefits Parameters Research, Conventional and Conservation Agriculture" funded by the Conservation Farming Unit (CFU) in Zambia with support from DFID. We are grateful to Victor Shitumbanuma for facilitating the permission for transportation of the soil samples. Thanks to Jeremy Selby for allowing access to his fields, for careful management of the research plots and for his hospitality. Thanks to Edward Bwalya and Kelvin for their help during the field work.	Abiven S, 2015, PLANT SOIL, V395, P45, DOI 10.1007/s11104-015-2533-2; ANDERSON EL, 1988, PLANT SOIL, V108, P245, DOI 10.1007/BF02375655; Bolinder MA, 1999, PLANT SOIL, V215, P85, DOI 10.1023/A:1004765024519; BOONE RD, 1994, SOIL BIOL BIOCHEM, V26, P1459, DOI 10.1016/0038-0717(94)90085-X; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Chalise KS, 2019, AGRON J, V111, P99, DOI 10.2134/agronj2018.03.0213; Corbeels M., 2015, CONSERVATION AGR, P443, DOI DOI 10.1007/978-3-319-11620-4_18; Cornelissen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154617; Cornelissen G, 2013, AGRONOMY-BASEL, V3, P256, DOI 10.3390/agronomy3020256; Curtin D, 2016, GEODERMA, V271, P161, DOI 10.1016/j.geoderma.2016.02.009; Dari B, 2016, GEODERMA, V280, P82, DOI 10.1016/j.geoderma.2016.06.018; Dzanku FM, 2015, WORLD DEV, V67, P336, DOI 10.1016/j.worlddev.2014.10.030; Fan RQ, 2013, ACTA AGR SCAND B-S P, V63, P37, DOI 10.1080/09064710.2012.711353; FAO, 2013, CLIM SMART AGR SOURC, P1; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Ghani A, 2003, SOIL BIOL BIOCHEM, V35, P1231, DOI 10.1016/S0038-0717(03)00186-X; Giller KE, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00870; Hutsch BW, 2002, J PLANT NUTR SOIL SC, V165, P397, DOI 10.1002/1522-2624(200208)165:4<397::AID-JPLN397>3.0.CO;2-C; Jeffery S, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa67bd; Kong AYY, 2010, SOIL SCI SOC AM J, V74, P1201, DOI 10.2136/sssaj2009.0346; KUZYAKOV Y, 2014, J SOIL BIOL BIOCH, V14, DOI DOI 10.1016/J.S0ILBI0.2013.12.021; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Lehmann J., 2009, BIOCHAR ENV MANAGEME, DOI DOI 10.1007/S13593-016-0372-Z; Lehmann J, 2015, NATURE, V528, P60, DOI 10.1038/nature16069; Leifeld J, 2005, GEODERMA, V124, P143, DOI 10.1016/j.geoderma.2004.04.009; Maiga A, 2019, SOIL RES, V57, P149, DOI 10.1071/SR18068; Major J, 2012, J ENVIRON QUAL, V41, P1076, DOI 10.2134/jeq2011.0128; Manlay RJ, 2007, AGR ECOSYST ENVIRON, V119, P217, DOI 10.1016/j.agee.2006.07.011; Martinsen V, 2017, AGR ECOSYST ENVIRON, V241, P168, DOI 10.1016/j.agee.2017.03.010; Martinsen V, 2019, SCI TOTAL ENVIRON, V660, P97, DOI 10.1016/j.scitotenv.2018.12.452; Martinsen V, 2014, J PLANT NUTR SOIL SC, V177, P681, DOI 10.1002/jpln.201300590; Mashingaidze AB, 2009, ANN APPL BIOL, V155, P207, DOI 10.1111/j.1744-7348.2009.00331.x; MCDONAGH JF, 1993, PLANT SOIL, V154, P267, DOI 10.1007/BF00012532; Munera-Echeverri JL, 2018, SCI TOTAL ENVIRON, V642, P190, DOI 10.1016/j.scitotenv.2018.06.017; Mutsamba EF, 2016, CROP PROT, V82, P60, DOI 10.1016/j.cropro.2016.01.004; Nair VD, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02051; OADES JM, 1984, PLANT SOIL, V76, P319, DOI 10.1007/BF02205590; Obia A, 2017, SOIL TILL RES, V165, P34, DOI 10.1016/j.still.2016.07.016; Paustian K, 2016, NATURE, V532, P49, DOI 10.1038/nature17174; Poeplau C, 2018, SOIL BIOL BIOCHEM, V125, P10, DOI 10.1016/j.soilbio.2018.06.025; Powlson DS, 2016, AGR ECOSYST ENVIRON, V220, P164, DOI 10.1016/j.agee.2016.01.005; R Core Team, 2021, R LANGUAGE ENV STAT; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Ros GH, 2011, SOIL BIOL BIOCHEM, V43, P1714, DOI 10.1016/j.soilbio.2011.04.017; Sakonnakhon SPN, 2005, PLANT SOIL, V272; Sihi D, 2017, J PLANT NUTR SOIL SC, V180, P389, DOI 10.1002/jpln.201700128; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Sommer R, 2018, AGR ECOSYST ENVIRON, V254, P82, DOI 10.1016/j.agee.2017.11.004; Swanepoel CM, 2018, SOIL TILL RES, V183, P72, DOI 10.1016/j.still.2018.05.016; Tebrugge F, 1999, SOIL TILL RES, V53, P15, DOI 10.1016/S0167-1987(99)00073-2; Thierfelder C, 2018, AGRON SUSTAIN DEV, V38, DOI 10.1007/s13593-018-0492-8; Thierfelder C, 2013, SOIL TILL RES, V126, P246, DOI 10.1016/j.still.2012.09.002; Tivet F, 2013, GEODERMA, V209, P214, DOI 10.1016/j.geoderma.2013.06.008; TOOMSAN B, 1995, PLANT SOIL, V175, P45, DOI 10.1007/BF02413009; Tully K, 2015, SUSTAINABILITY-BASEL, V7, P6523, DOI 10.3390/su7066523; Turmel MS, 2015, AGR SYST, V134, P6, DOI 10.1016/j.agsy.2014.05.009; Vanlauwe B, 2014, FIELD CROP RES, V155, P10, DOI 10.1016/j.fcr.2013.10.002; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Weng Z, 2015, SOIL BIOL BIOCHEM, V90, P111, DOI 10.1016/j.soilbio.2015.08.005; Zhao SS, 2013, J FORESTRY RES, V24, P509, DOI 10.1007/s11676-013-0382-5; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	62	16	17	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228717	10.1371/journal.pone.0228717	http://dx.doi.org/10.1371/journal.pone.0228717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027704	Green Published, gold			2022-12-26	WOS:000534623800069
J	Pahk, K; Kim, EJ; Lee, YJ; Kim, S; Seo, HS				Pahk, Kisoo; Kim, Eung Ju; Lee, Yong-Jik; Kim, Sungeun; Seo, Hong Seog			Characterization of glucose uptake metabolism in visceral fat by F-18-FDG PET/CT reflects inflammatory status in metabolic syndrome	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; TISSUE FDG UPTAKE; ADIPOSE-TISSUE; INSULIN ACTION; MACROPHAGES; OBESITY; ADIPOCYTES; EXPRESSION; ARTERIAL; MUSCLE	Objective The inflammatory activity of visceral adipose tissue (VAT) is elevated in metabolic syndrome (MS), and associated with vulnerability to atherosclerosis. Inflammation can be assessed by glucose uptake in atherosclerotic plaques. We investigated whether the glucose uptake of VAT, assessed by F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT), is associated with systemic inflammatory status, and related to the number of MS components. Methods F-18-FDG PET/CT was performed in a total of 203 participants: 59 without MS component; M (0), 92 with one or two MS components; M(1-2), and 52 with MS. Glucose uptake in VAT was evaluated using the mean standardized uptake value (SUVmean) and the maximum SUV (SUVmax). Glucose uptakes of immune-related organs such as the spleen and bone marrow (BM) were evaluated using the SUVmax. Results VAT SUVmax correlated with high-sensitivity C-reactive protein (hsCRP) and the SUVmax of spleen and BM, which reflect the status of systemic inflammation. Both hsCRP and the SUVmax of the spleen and BM were higher in the MS group than in the M(1-2) or M(0) groups. In VAT, SUVmax increased with increasing number of MS components, while SUV-mean decreased. Conclusions The SUVmax and SUVmean of VAT assessed by F-18-FDG PET/CT reflected inflammation-driven unique glucose metabolism in the VAT of MS patients, distinct from that of atherosclerotic plaques.	[Pahk, Kisoo; Kim, Sungeun] Korea Univ, Dept Nucl Med, Anam Hosp, Seoul, South Korea; [Kim, Eung Ju; Lee, Yong-Jik; Seo, Hong Seog] Korea Univ, Cardiovasc Ctr, Guro Hosp, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, S (corresponding author), Korea Univ, Dept Nucl Med, Anam Hosp, Seoul, South Korea.; Seo, HS (corresponding author), Korea Univ, Cardiovasc Ctr, Guro Hosp, Seoul, South Korea.	seiong@korea.ac.kr; mdhsseo@korea.ac.kr		Seo, Hong Seog/0000-0002-3228-7988; Kim, Eung Ju/0000-0003-2322-6267; Lee, Yong-Jik/0000-0001-8814-0099; Pahk, Kisoo/0000-0003-2971-4202	National Research Foundation of Korea [NRF-2016R1A2B3013825]; Ministry of Future Creation and Science of Korea [2018K000255]; Korea University Guro Hospital [O1600121]; BK21 PLUS Korea University Medical Science Graduate Program	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Future Creation and Science of Korea; Korea University Guro Hospital; BK21 PLUS Korea University Medical Science Graduate Program	This research was supported by grants from the National Research Foundation of Korea (NRF-2016R1A2B3013825), Ministry of Future Creation and Science of Korea (2018K000255), Korea University Guro Hospital (O1600121), and BK21 PLUS Korea University Medical Science Graduate Program.	Abe M, 2008, ARTERIOSCL THROM VAS, V28, P871, DOI 10.1161/ATVBAHA.107.160663; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bucerius J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000725; Bucerius J, 2014, EUR J NUCL MED MOL I, V41, P369, DOI 10.1007/s00259-013-2569-6; Christen T, 2010, JACC-CARDIOVASC IMAG, V3, P843, DOI 10.1016/j.jcmg.2010.06.004; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Elsegood CL, 2009, ARTERIOSCL THROM VAS, V29, P1283, DOI 10.1161/ATVBAHA.108.180778; Emami H, 2015, JACC-CARDIOVASC IMAG, V8, P121, DOI 10.1016/j.jcmg.2014.10.009; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Fuster JJ, 2016, CIRC RES, V118, P1786, DOI 10.1161/CIRCRESAHA.115.306885; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Goncalves MD, 2017, ACAD RADIOL, V24, P1288, DOI 10.1016/j.acra.2017.04.010; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Hong AR, 2015, J DIABETES INVEST, V6, P508, DOI 10.1111/jdi.12313; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Joshi NV, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001956; Kamimura K, 2010, ANN NUCL MED, V24, P157, DOI 10.1007/s12149-009-0338-1; Kim EJ, 2014, CIRC-CARDIOVASC IMAG, V7, P455, DOI 10.1161/CIRCIMAGING.113.001093; Kwon HW, 2017, OBES RES CLIN PRACT, V11, P133, DOI 10.1016/j.orcp.2016.12.007; Lesna IK, 2018, EUR J PREV CARDIOL, V25, P328, DOI 10.1177/2047487317743355; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Moraes-Vieira PM, 2016, DIABETES, V65, P1808, DOI 10.2337/db16-0221; Nam HY, 2017, KOREAN J RADIOL, V18, P392, DOI 10.3348/kjr.2017.18.2.392; Oliveira AL, 2015, OBESITY, V23, P286, DOI 10.1002/oby.20957; Pahk K, 2018, CLIN ENDOCRINOL, V88, P963, DOI 10.1111/cen.13604; Pahk K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148776; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenson RS, 2009, OBESITY, V17, P504, DOI 10.1038/oby.2008.530; Ruparelia N, 2013, INFLAMM RES, V62, P515, DOI 10.1007/s00011-013-0605-4; Scheen AJ, 2015, DIABETES METAB, V41, P183, DOI 10.1016/j.diabet.2015.02.003; Tahara N, 2007, J AM COLL CARDIOL, V49, P1533, DOI 10.1016/j.jacc.2006.11.046; Takaoka M, 2006, ARTERIOSCL THROM VAS, V26, P2083, DOI 10.1161/01.ATV.0000232528.93786.0a; Tarkin JM, 2014, NAT REV CARDIOL, V11, P443, DOI 10.1038/nrcardio.2014.80; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; van der Valk FM, 2016, JACC-CARDIOVASC IMAG, V9, P1198, DOI 10.1016/j.jcmg.2016.04.007; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wright AP, 2010, ATHEROSCLEROSIS, V212, P414, DOI 10.1016/j.atherosclerosis.2010.06.022; Xie LL, 2010, CLIN VACCINE IMMUNOL, V17, P651, DOI 10.1128/CVI.00494-09	43	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228602	10.1371/journal.pone.0228602	http://dx.doi.org/10.1371/journal.pone.0228602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027706	Green Published, gold			2022-12-26	WOS:000534623800055
J	Thorpe, SG; Thibeault, CM; Canac, N; Jalaleddini, K; Dorn, A; Wilk, SJ; Devlin, T; Scalzo, F; Hamilton, RB				Thorpe, Samuel G.; Thibeault, Corey M.; Canac, Nicolas; Jalaleddini, Kian; Dorn, Amber; Wilk, Seth J.; Devlin, Thomas; Scalzo, Fabien; Hamilton, Robert B.			Toward automated classification of pathological transcranial Doppler waveform morphology via spectral clustering	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; CEREBRAL-ANGIOGRAPHY; ARTERIAL-OCCLUSION; ISCHEMIC-STROKE; FLOW-VELOCITY; ULTRASONOGRAPHY; THROMBOLYSIS; SONOGRAPHY; PREDICTION	Cerebral Blood Flow Velocity waveforms acquired via Transcranial Doppler (TCD) can provide evidence for cerebrovascular occlusion and stenosis. Thrombolysis in Brain Ischemia (TIBI) flow grades are widely used for this purpose, but require subjective assessment by expert evaluators to be reliable. In this work we seek to determine whether TCD morphology can be objectively assessed using an unsupervised machine learning approach to waveform categorization. TCD beat waveforms were recorded at multiple depths from the Middle Cerebral Arteries of 106 subjects; 33 with Large Vessel Occlusion (LVO). From each waveform, three morphological features were extracted, quantifying onset of maximal velocity, systolic canopy length, and the number/prominence of peaks/troughs. Spectral clustering identified groups implicit in the resultant three-dimensional feature space, with gap statistic criteria establishing the optimal cluster number. We found that gap statistic disparity was maximized at four clusters, referred to as flow types I, II, III, and IV. Types I and II were primarily composed of control subject waveforms, whereas types III and IV derived mainly from LVO patients. Cluster morphologies for types I and IV aligned clearly with Normal and Blunted TIBI flows, respectively. Types II and III represented commonly observed flow-types not delineated by TIBI, which nonetheless deviate from normal and blunted flows. We conclude that important morphological variability exists beyond that currently quantified by TIBI in populations experiencing or at-risk for acute ischemic stroke, and posit that the observed flow-types provide the foundation for objective methods of real-time automated flow type classification.	[Thorpe, Samuel G.; Thibeault, Corey M.; Canac, Nicolas; Jalaleddini, Kian; Dorn, Amber; Wilk, Seth J.; Hamilton, Robert B.] Neural Analyt Inc, Dept Res, Los Angeles, CA 90064 USA; [Devlin, Thomas] Erlanger Med Ctr, Dept Neurol, Chattanooga, TN USA; [Scalzo, Fabien] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Thorpe, SG (corresponding author), Neural Analyt Inc, Dept Res, Los Angeles, CA 90064 USA.	samuel.thorpe@neuralanalytics.com		Thorpe, Samuel/0000-0002-1825-4207; Dorn, Amber/0000-0002-3139-4183; Hamilton, Robert/0000-0003-3372-5561	Neural Analytics, Inc.; National Institute of Neurological Disorders and Stroke (US) [1R43NS105340]	Neural Analytics, Inc.; National Institute of Neurological Disorders and Stroke (US)	The primary funding Institution, Neural Analytics, Inc., provided support in the form of salaries for authors ST, CT, KJ, AD, NC, SW, and RH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. This research was also supported in part by National Institute of Neurological Disorders and Stroke (US), 1R43NS105340.	AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R., 1986, TRANSCRANIAL DOPPLER, P39; Adams RJ, 1997, ANN NEUROL, V42, P699, DOI 10.1002/ana.410420505; ADAMS RJ, 1992, STROKE, V23, P1073, DOI 10.1161/01.STR.23.8.1073; Aggarwal S, 2008, LIVER TRANSPLANT, V14, P1048, DOI 10.1002/lt.21499; Aghoram R, 2018, ANN INDIAN ACAD NEUR, V21, P193, DOI 10.4103/aian.AIAN_417_17; Alberts MJ, 2005, STROKE, V36, P1597, DOI 10.1161/01.STR.0000170622.07210.b4; Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; Alexandrov AV, 2010, CLIN INDICATIONS EXP, P215; Alexandrov AV, 2011, CEREBROVASCULAR ULTR; Alexandrov AV., 2013, NEUROVASCULAR EXAMIN; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bathala L, 2013, ANN INDIAN ACAD NEUR, V16, P174, DOI 10.4103/0972-2327.112460; Brunser AM, 2009, STROKE, V40, P2037, DOI 10.1161/STROKEAHA.108.542704; Canac N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01072; Cardim D, 2017, NEUROCRIT CARE, V26, P330, DOI 10.1007/s12028-016-0356-5; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; D'Andrea A, 2016, WORLD J CARDIOL, V8, P383, DOI 10.4330/wjc.v8.i7.383; Demchuk AM, 2001, STROKE, V32, P89, DOI 10.1161/01.STR.32.1.89; Demchuk AM, 2000, J NEUROIMAGING, V10, P1; Demchuk AM, 2000, STROKE, V31, P140, DOI 10.1161/01.STR.31.1.140; Elzaafarany K, 2019, J ULTRAS MED, V38, P2191, DOI 10.1002/jum.14916; Fanti C, 2004, ADV NEUR IN, V16, P1603; HASSLER W, 1988, J NEUROSURG, V68, P745; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Jalaleddini K, 2020, IEEE T BIO-MED ENG, V67, P883, DOI 10.1109/TBME.2019.2923146; Kim S, 2011, P 2011 WORKSH DAT MI, P68; Kim S, 2013, IEEE T BIO-MED ENG, V60, P1126, DOI 10.1109/TBME.2012.2227477; Kim S, 2011, NEUROCRIT CARE, V14, P229, DOI 10.1007/s12028-010-9471-x; KLINGELHOFER J, 1987, KLIN WOCHENSCHR, V65, P542, DOI 10.1007/BF01727619; Kral MC, 2003, PEDIATRICS, V112, P324, DOI 10.1542/peds.112.2.324; Kumar S, 2016, J MOD TRANSP, V24, P62, DOI 10.1007/s40534-016-0095-5; Kurji A, 2006, MENOPAUSE, V13, P303, DOI 10.1097/01.gme.0000177905.94515.24; KUSHNER MJ, 1991, NEUROLOGY, V41, P109, DOI 10.1212/WNL.41.1.109; Larose DT, 2005, DISCOVERING KNOWLEDG, P1, DOI DOI 10.1002/0471687545.CH1; Latchaw RE, 2009, STROKE, V40, P3646, DOI 10.1161/STROKEAHA.108.192616; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lockhart CJ, 2006, CLIN SCI, V111, P47, DOI 10.1042/cs20050365; Malhotra K, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00651; Malhotra K, 2015, J NEUROIMAGING, V25, P517, DOI 10.1111/jon.12272; Minhas JS, 2019, J CLIN ULTRASOUND, V47, P14, DOI 10.1002/jcu.22645; Mohamad I.B., 2013, RES J APPL SCI ENG T, V6, P3299; Ng AY, 2002, ADV NEUR IN, V14, P849; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Purvis D, 2013, J ULTRAS MED, V32, P1023, DOI 10.7863/ultra.32.6.1023; Rathod RR, 2017, INT J ENERGY SECT MA, V11, P295, DOI 10.1108/IJESM-02-2016-0005; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Scalzo F, 2012, MED ENG PHYS, V34, P1058, DOI 10.1016/j.medengphy.2011.11.010; Schaafsma A, 2012, ULTRASOUND MED BIOL, V38, P1451, DOI 10.1016/j.ultrasmedbio.2012.03.016; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Seera M, 2017, NEUROCOMPUTING, V249, P337, DOI 10.1016/j.neucom.2016.05.117; Sheth SA, 2015, ANN NEUROL, V78, P584, DOI 10.1002/ana.24474; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Smith WS, 2006, NEUROCRIT CARE, V4, P14, DOI 10.1385/NCC:4:1:014; Spencer MP, 1981, CEREBROVASCULAR EVAL; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Thorpe SG, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00847; Thorpe SG, 2019, TRANSL STROKE RES, V10, P475, DOI 10.1007/s12975-018-0667-2; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tsivgoulis G, 2007, STROKE, V38, P1245, DOI 10.1161/01.STR.0000259712.64772.85; Uguz H, 2012, COMPUT METH PROG BIO, V107, P598, DOI 10.1016/j.cmpb.2011.03.013; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wijnhoud AD, 2011, ACTA NEUROL SCAND, V124, P238, DOI 10.1111/j.1600-0404.2010.01462.x; Xiang LI, 2017, CHINESE J; ZANETTE EM, 1989, STROKE, V20, P899, DOI 10.1161/01.STR.20.7.899; Zerna C, 2016, CIRC RES, V118, P1425, DOI 10.1161/CIRCRESAHA.116.307005	71	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228642	10.1371/journal.pone.0228642	http://dx.doi.org/10.1371/journal.pone.0228642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027714	Green Published, Green Submitted, gold			2022-12-26	WOS:000534623800062
J	Hait, NC; Maiti, A; Xu, P; Qi, QY; Kawaguchi, T; Okano, M; Takabe, K; Yan, L; Luo, C				Hait, Nitai C.; Maiti, Aparna; Xu, Pan; Qi, Qianya; Kawaguchi, Tsutomu; Okano, Maiko; Takabe, Kazuaki; Yan, Li; Luo, Cheng			Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate	FASEB JOURNAL			English	Article						hypoxia-inducible factors; sphingosine-1-phosphate; sphingosine kinase 2; triple-negative breast cancer	SPHINGOSINE KINASE 2; BREAST-CANCER; HISTONE ACETYLATION; EXPRESSION; PROTEIN; SPHK2; GROWTH; ACID; CHEMORESISTANCE; OVEREXPRESSION	Sphingosine kinase 2 (SphK2) is known to phosphorylate the nuclear sphingolipid metabolite to generate sphingosine-1-phosphate (S1P). Nuclear S1P is involved in epigenetic regulation of gene expression; however, the underlying mechanisms are not well understood. In this work, we have identified the role of nuclear S1P and SphK2 in regulating hypoxia-responsive master transcription factors hypoxia-inducible factor (HIF)-1 alpha/2 alpha, and their functions in breast cancer, with a focus on triple-negative breast cancer (TNBC). We have shown SphK2 is associated with HIF-1 alpha in protein complexes, and is enriched at the promoters of HIF target genes, including vascular endothelial growth factor (VEGF), where it enhances local histone H3 acetylation and transcription. S1P specifically binds to the PAS domains of HIF-1 alpha. SphK2, and HIF-1 alpha expression levels are elevated in metastatic estrogen receptor-positive (ER+) and TNBC clinical tissue specimens compared to healthy breast tissue samples. To determine if S1P formation in the nucleus by SphK2 is a key regulator of HIF functions, we found using a preclinical TNBC xenograft mouse model, and an existing selective SphK2 inhibitor K-145, that nuclear S1P, histone acetylation, HIF-1 alpha expression, and TNBC tumor growth were all reduced in vivo. Our results suggest that S1P and SphK2 in the nucleus are linked to the regulation of HIF-1 alpha/2 alpha functions associated with breast cancer progression, and may provide potential therapeutic targets.	[Hait, Nitai C.; Maiti, Aparna; Kawaguchi, Tsutomu; Okano, Maiko; Takabe, Kazuaki] Roswell Park Comprehens Canc Ctr, Div Breast Surg, Buffalo, NY USA; [Hait, Nitai C.; Maiti, Aparna; Kawaguchi, Tsutomu; Okano, Maiko; Takabe, Kazuaki] Roswell Park Comprehens Canc Ctr, Dept Surg Oncol, Buffalo, NY USA; [Hait, Nitai C.; Maiti, Aparna] Roswell Park Comprehens Canc Ctr, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA; [Xu, Pan; Luo, Cheng] Chinese Acad Sci, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai, Peoples R China; [Xu, Pan; Luo, Cheng] Univ Chinese Acad Sci, Sch Pharm, Beijing, Peoples R China; [Qi, Qianya; Yan, Li] Roswell Park Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hait, NC (corresponding author), Roswell Park Comprehens Canc Ctr, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA.; Hait, NC (corresponding author), Roswell Park Comprehens Canc Ctr, Div Breast Surg, Dept Surg Oncol, Elm & Carlton St, Buffalo, NY 14263 USA.	nitai.hait@roswellpark.org			Roswell Park Cancer Institute (RPCI) [714084-01]	Roswell Park Cancer Institute (RPCI)	Roswell Park Cancer Institute (RPCI), Grant/Award Number: 714084-01	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Antoon JW, 2011, CANCER BIOL THER, V11, P678, DOI 10.4161/cbt.11.7.14903; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Asby DJ, 2014, MOL BIOSYST, V10, P2505, DOI 10.1039/c4mb00351a; Bouquerel P, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.13; Britten CD, 2017, CLIN CANCER RES, V23, P4642, DOI 10.1158/1078-0432.CCR-16-2363; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chu JH, 2014, BIOMED PHARMACOTHER, V68, P1089, DOI 10.1016/j.biopha.2014.10.001; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeRose Yoko S, 2013, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1423s60; Downes NL, 2018, MOL THER, V26, P1735, DOI 10.1016/j.ymthe.2018.05.004; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Gangavarapu KJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt343; Gates LA, 2017, J BIOL CHEM, V292, P14456, DOI 10.1074/jbc.M117.802074; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/fon.13.92, 10.2217/FON.13.92]; Guan SH, 2016, BIOCHEM BIOPH RES CO, V476, P230, DOI 10.1016/j.bbrc.2016.05.102; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hait NC, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.16; Hait NC, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4806541; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hashimoto T, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00033; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hohenberger P, 1998, BREAST CANCER RES TR, V48, P97, DOI 10.1023/A:1005921513083; Hutt DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106224; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Jung JE, 2007, CARCINOGENESIS, V28, P1780, DOI 10.1093/carcin/bgm130; Kawaguchi T, 2017, J MAMMARY GLAND BIOL, V22, P131, DOI 10.1007/s10911-017-9378-7; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Khaitan D, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-12; Kim SH, 2007, ONCOL REP, V17, P647; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; LeBlanc M, 2002, STAT METHODS MED RES, V11, P247, DOI 10.1191/0962280202sm286ra; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin Q, 2011, MOL CANCER RES, V9, P757, DOI 10.1158/1541-7786.MCR-11-0053; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056471; Liu W, 2016, TUMOR BIOL, V37, P6331, DOI 10.1007/s13277-015-4480-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maiti A, 2019, INT J ONCOL, V55, P116, DOI 10.3892/ijo.2019.4796; Maiti A, 2017, CELL SIGNAL, V32, P85, DOI 10.1016/j.cellsig.2017.01.021; Mendonca Daniela B, 2013, Methods Mol Biol, V977, P323, DOI 10.1007/978-1-62703-284-1_26; Mendonca DBS, 2011, BIOCHEM BIOPH RES CO, V404, P997, DOI 10.1016/j.bbrc.2010.12.098; Nagahashi M, 2018, CANCER RES, V78, P1713, DOI 10.1158/0008-5472.CAN-17-1423; Nagahashi M, 2015, HEPATOLOGY, V61, P1216, DOI 10.1002/hep.27592; Neubauer HA, 2016, ONCOTARGET, V7, P64886, DOI 10.18632/oncotarget.11714; Newton J, 2017, FASEB J, V31, P1719, DOI 10.1096/fj.201601041R; Nguyen-Tran DH, 2014, DIS MODEL MECH, V7, P41, DOI 10.1242/dmm.013631; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Poljakova J, 2014, ONCOL REP, V31, P1928, DOI 10.3892/or.2014.2999; Qiu WW, 2016, ONCOTARGET, V7, P39907, DOI 10.18632/oncotarget.9530; Rex K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068328; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sengupta T, 2011, MOL CELL BIOL, V31, P3885, DOI 10.1128/MCB.05089-11; Shi WN, 2017, ONCOTARGET, V8, P39605, DOI 10.18632/oncotarget.17174; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Sun E, 2016, TUMOR BIOL, V37, P473, DOI 10.1007/s13277-015-3818-z; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Wainwright EN, 2017, TRENDS CANCER, V3, P372, DOI 10.1016/j.trecan.2017.04.004; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wallington-Beddoe CT, 2014, CANCER RES, V74, P2803, DOI 10.1158/0008-5472.CAN-13-2732; Wang QS, 2014, TUMOR BIOL, V35, P363, DOI 10.1007/s13277-013-1051-1; Wang W, 2014, CLIN CHIM ACTA, V428, P32, DOI 10.1016/j.cca.2013.10.018; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883; Xun C, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0205-y; Zhang C, 2017, ONCOTARGET, V8, P56110, DOI 10.18632/oncotarget.18125; Zhang Xiaomei, 2013, Curr Protoc Mouse Biol, V3, P21, DOI 10.1002/9780470942390.mo120140	83	15	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4293	4310		10.1096/fj.201901734RR	http://dx.doi.org/10.1096/fj.201901734RR		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32017264				2022-12-26	WOS:000511114000001
J	Liu, JB; Chen, J; Chen, GS; Guo, JF; Li, YQ				Liu, Jiebao; Chen, Ji; Chen, Guangshui; Guo, Jianfen; Li, Yiqing			Enzyme stoichiometry indicates the variation of microbial nutrient requirements at different soil depths in subtropical forests	PLOS ONE			English	Article							ECOENZYMATIC STOICHIOMETRY; NITROGEN LIMITATION; RESOURCE LIMITATION; ORGANIC-MATTER; CARBON; MINERALIZATION; GRASSLAND; TRANSECT; PATTERN; ACQUISITION	Soil extracellular enzyme activities and associated enzymatic stoichiometry are considered sensitive indicators of nutrient availability and microbial substrate limitation. However, many of previous studies have been focusing on uppermost soil layer with a single enzyme as representative of the whole nutrient acquisition, leading to critical uncertainties in understanding soil nutrient availability and its relationship with microbial activities in deeper soils. In the current study, we investigated C-, N- and P-acquiring enzyme activities across a range of soil layers (0-10, 10-20, 20-40 and 40-60 cm), and examined the microbial C, N and P limitation in natural secondary forests (NSF) and Chinese fir (Cunninghamia lanceolata) plantation forests (CPF) in subtropical China. The results showed that microbial C and P colimitation was detected in the two typical subtropical forests at all soil depths, rather than microbial N limitation. Microbial C and P limitation fluctuated along soil depth, but higher N was demanded by microbes in soil under 20 cm in both forests. The present results highlight the asymmetrical patterns of microbial nutrient limitation along the whole soil profile, and provide essential information in understanding nutrient limitations in deeper soils. These vertical and asymmetrical nutrient limitation patterns should be incorporated into future research studies priority.	[Liu, Jiebao; Chen, Guangshui; Guo, Jianfen] Fujian Normal Univ, Sch Geog Sci, Key Lab Subtrop Mt Ecol, Minist Sci & Technol & Fujian Prov Funded, Fuzhou, Fujian, Peoples R China; [Chen, Ji] Aarhus Univ, Ctr Circular Bioecon, Dept Agroecol, Aarhus, Denmark; [Li, Yiqing] Univ Hawaii, Coll Agr Forestry & Nat Resources Management, Hilo, HI 96720 USA	Fujian Normal University; Aarhus University; University of Hawaii System; University Hawaii Hilo	Guo, JF (corresponding author), Fujian Normal Univ, Sch Geog Sci, Key Lab Subtrop Mt Ecol, Minist Sci & Technol & Fujian Prov Funded, Fuzhou, Fujian, Peoples R China.; Li, YQ (corresponding author), Univ Hawaii, Coll Agr Forestry & Nat Resources Management, Hilo, HI 96720 USA.	jfguo@fjnu.edu.cn; Yiqing@hawaii.edu	Chen, Ji/A-6299-2018; Chen, Guangshui/B-8065-2013	Chen, Ji/0000-0001-7026-6312; Liu, Jiebao/0000-0002-0807-6347				Allison SD, 2005, ECOL LETT, V8, P626, DOI 10.1111/j.1461-0248.2005.00756.x; Bui EN, 2013, PLANT SOIL, V373, P553, DOI 10.1007/s11104-013-1823-9; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Camenzind T, 2018, ECOL MONOGR, V88, P4, DOI 10.1002/ecm.1279; Chen H, 2019, SCI TOTAL ENVIRON, V650, P241, DOI 10.1016/j.scitotenv.2018.09.036; Chen H, 2018, GEODERMA, V329, P61, DOI 10.1016/j.geoderma.2018.05.019; Chen H, 2018, FUNCT ECOL, V32, P1400, DOI 10.1111/1365-2435.13069; Chen J, 2018, GLOBAL CHANGE BIOL, V24, P4816, DOI 10.1111/gcb.14394; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Cui YX, 2019, SCI TOTAL ENVIRON, V648, P388, DOI 10.1016/j.scitotenv.2018.08.173; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Fanin N, 2016, BIOGEOCHEMISTRY, V129, P21, DOI 10.1007/s10533-016-0217-5; FAO, 2014, WORLD REF BAS SOIL R; German DP, 2011, SOIL BIOL BIOCHEM, V43, P1387, DOI 10.1016/j.soilbio.2011.03.017; Gunina A, 2015, SOIL BIOL BIOCHEM, V90, P87, DOI 10.1016/j.soilbio.2015.07.021; Hasselquist NJ, 2016, ECOLOGY, V97, P1012, DOI 10.1890/15-1222.1; Heitkotter J, 2017, GEODERMA, V302, P89, DOI 10.1016/j.geoderma.2017.04.029; Hill BH, 2014, BIOGEOCHEMISTRY, V120, P203, DOI 10.1007/s10533-014-9991-0; Hill BH, 2012, ECOL INDIC, V18, P540, DOI 10.1016/j.ecolind.2012.01.007; Jing X, 2017, SCI TOTAL ENVIRON, V607, P806, DOI 10.1016/j.scitotenv.2017.07.060; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Lang F, 2016, J PLANT NUTR SOIL SC, V179, P129, DOI 10.1002/jpln.201500541; Lashermes G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01315; Luo L, 2017, J ENVIRON MANAGE, V197, P539, DOI 10.1016/j.jenvman.2017.04.023; Maly S, 2014, PEDOBIOLOGIA, V57, P235, DOI 10.1016/j.pedobi.2014.09.003; Marx MC, 2001, SOIL BIOL BIOCHEM, V33, P1633, DOI 10.1016/S0038-0717(01)00079-7; Moorhead DL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00223; Moorhead DL, 2016, SOIL BIOL BIOCHEM, V93, P1, DOI 10.1016/j.soilbio.2015.10.019; Moorhead DL, 2012, SOIL BIOL BIOCHEM, V53, P133, DOI 10.1016/j.soilbio.2012.05.011; Nannipieri P, 2012, BIOL FERT SOILS, V48, P743, DOI 10.1007/s00374-012-0723-0; Nannipieri P, 2018, BIOL FERT SOILS, V54, P11, DOI 10.1007/s00374-017-1245-6; Oulehle F, 2018, ENVIRON POLLUT, V238, P884, DOI 10.1016/j.envpol.2018.03.081; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paz-Ferreiro J, 2010, EUR J SOIL BIOL, V46, P136, DOI 10.1016/j.ejsobi.2009.12.007; Pei ZQ, 2017, BIOGEOCHEMISTRY, V134, P163, DOI 10.1007/s10533-017-0353-6; Peng XQ, 2016, SOIL BIOL BIOCHEM, V98, P74, DOI 10.1016/j.soilbio.2016.04.008; Phillips RP, 2012, ECOL LETT, V15, P1042, DOI 10.1111/j.1461-0248.2012.01827.x; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Reich PB, 2014, P NATL ACAD SCI USA, V111, P13721, DOI 10.1073/pnas.1216053111; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Schaller J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37104-6; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schnecker J, 2015, SOIL BIOL BIOCHEM, V83, P106, DOI 10.1016/j.soilbio.2015.01.016; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sinsabaugh RL, 2012, BIOGEOCHEMISTRY, V111, P455, DOI 10.1007/s10533-011-9676-x; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; State Soil Survey Service of China, 1998, CHIN SOIL; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Stone MM, 2014, SOIL BIOL BIOCHEM, V75, P237, DOI 10.1016/j.soilbio.2014.04.017; Tian QX, 2017, SOIL BIOL BIOCHEM, V109, P135, DOI 10.1016/j.soilbio.2017.02.009; Tian QX, 2016, BIOGEOCHEMISTRY, V128, P125, DOI 10.1007/s10533-016-0198-4; Waring BG, 2014, BIOGEOCHEMISTRY, V117, P101, DOI 10.1007/s10533-013-9849-x; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183; Wittmann C, 2004, SOIL BIOL BIOCHEM, V36, P425, DOI 10.1016/j.soilbio.2003.10.019; Xu ZW, 2017, SOIL BIOL BIOCHEM, V104, P152, DOI 10.1016/j.soilbio.2016.10.020; Yang YS, 2004, ANN FOREST SCI, V61, P617, DOI 10.1051/forest:2004062; Yu, 2008, FRONTIERS FORESTRY C, V3, P117, DOI DOI 10.1007/S11461-008-0014-Y; Yu GR, 2014, P NATL ACAD SCI USA, V111, P4910, DOI 10.1073/pnas.1317065111; Yu ZP, 2018, GLOBAL CHANGE BIOL, V24, P1308, DOI 10.1111/gcb.13939; Zechmeister-Boltenstern S, 2015, ECOL MONOGR, V85, P133, DOI 10.1890/14-0777.1; Zhang JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02342; Zhao W, 2007, PLANT SOIL, V297, P213, DOI 10.1007/s11104-007-9334-1; Zuo YP, 2018, BIOGEOCHEMISTRY, V141, P23, DOI 10.1007/s10533-018-0499-x	64	21	26	15	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0220599	10.1371/journal.pone.0220599	http://dx.doi.org/10.1371/journal.pone.0220599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017763	Green Submitted, gold, Green Published			2022-12-26	WOS:000534618100004
J	Zhang, XP; Wang, LQ; Lan, XT; Dan, JM; Ren, ZH; Cao, SZ; Shen, LH; Deng, JL; Zuo, ZC; Yu, SM; Wang, Y; Ma, XP; Liu, HF; Zhou, ZY; Hu, YC; Fu, HL; He, CL; Geng, Y; Gu, XB; Peng, GN; Wang, YF; Zhong, ZJ				Zhang, Xueping; Wang, Liqin; Lan, Xinting; Dan, Jiaming; Ren, Zhihua; Cao, Suizhong; Shen, Liuhong; Deng, Junliang; Zuo, Zhicai; Yu, Shumin; Wang, Ya; Ma, Xiaoping; Liu, Haifeng; Zhou, Ziyao; Hu, Yanchun; Fu, Hualin; He, Changliang; Geng, Yi; Gu, Xiaobin; Peng, Guangneng; Wang, Yufei; Zhong, Zhijun			Occurrence and multilocus genotyping of Giardia duodenalis in captive non-human primates from 12 zoos in China	PLOS ONE			English	Article							CRYPTOSPORIDIUM SPP.; ENTEROCYTOZOON-BIENEUSI; MOLECULAR EPIDEMIOLOGY; ASSEMBLAGE B; MACAQUES; TRANSMISSION; PREVALENCE; INFECTION; MONKEYS	Giardia duodenalis is a common enteric protozoan that infects a range of hosts including humans and other mammals. Multilocus genotyping of G. duodenalis in captive non-human primates (NHPs) from zoos in China is limited. In this study, we evaluated 302 NHP fecal samples collected from 32 different NHP species. The primates were from 12 zoos distributed across eight provinces and two municipalities (Chongqing and Beijing) of China. The overall infection rate was 8.3% (25/302). The six G. duodenalis-positive zoos and their infection rates were: Suzhou Zoo (40.0%, 4/10), Yangzhou Zoo (22.2%, 2/9), Dalian Zoo (16.7%, 4/24), Chengdu Zoo (12.8%, 6/47), Guiyang Forest Wildlife Zoo (12.1%, 7/58), and Changsha Zoo (4.7%, 2/43). Molecular analysis of three loci, beta-giardin (bg), triose phosphate isomerase (tpi), and glutamate dehydrogenase (gdh), showed high genetic heterogeneity, and seven novel subtypes (BIII-1, MB10-1, WB8-1, B14-1, MB9-1, DN7-1, and BIV-1) were detected within assemblage B. Additional analysis revealed 12 different assemblage B multilocus genotypes (MLGs), one known MLG and 11 novel MLGs. Based on phylogenetic analysis, 12 assemblage B MLGs formed two main clades, MLG-SW (10-12, 18) and MLG-SW (13, 14, 16, 17), the other four MLG-SW (15, 19, 20, 21) were scattered throughout the phylogenetic tree in this study. Using multilocus genotyping, this study expands our understanding of the occurrence of Giardia infection and genetic variation in Giardia in captive non-human primates from zoos in China.	[Zhang, Xueping; Lan, Xinting; Dan, Jiaming; Ren, Zhihua; Cao, Suizhong; Shen, Liuhong; Deng, Junliang; Zuo, Zhicai; Yu, Shumin; Wang, Ya; Ma, Xiaoping; Liu, Haifeng; Zhou, Ziyao; Hu, Yanchun; Fu, Hualin; He, Changliang; Geng, Yi; Gu, Xiaobin; Peng, Guangneng; Zhong, Zhijun] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan, Chengdu, Peoples R China; [Wang, Liqin] Inst Wild Anim, Chengdu Zoo, Chengdu, Peoples R China; [Wang, Yufei] Chinese Peoples Liberat Army, Med Ctr 3, Dept Lab Med, Gen Hosp, Beijing, Peoples R China	Sichuan Agricultural University	Peng, GN; Zhong, ZJ (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan, Chengdu, Peoples R China.; Wang, YF (corresponding author), Chinese Peoples Liberat Army, Med Ctr 3, Dept Lab Med, Gen Hosp, Beijing, Peoples R China.	pgn.sicau@163.com; yufeiwang21@yahoo.com; zhongzhijun488@126.com			National Key Research and Development Program of China [2018YFD0500900, 2016YFD0501009]; Chengdu Giant Panda Breeding Research Foundation [CPF2017-05, CPF2015-4]	National Key Research and Development Program of China; Chengdu Giant Panda Breeding Research Foundation	This work was funded by the National Key Research and Development Program of China (2018YFD0500900, 2016YFD0501009) and the Chengdu Giant Panda Breeding Research Foundation (CPF2017-05, CPF2015-4).	Al-Mekhlafi HM, 2017, ASIAN PAC J TROP MED, V10, P987, DOI 10.1016/j.apjtm.2017.09.011; Martinez-Diaz RA, 2011, PARASITOL RES, V109, P539, DOI 10.1007/s00436-011-2281-z; Brynildsrud O, 2018, ZOONOSES PUBLIC HLTH, V65, P637, DOI 10.1111/zph.12470; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Certad G, 2017, TRENDS PARASITOL, V33, P561, DOI 10.1016/j.pt.2017.02.006; Chen L, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3511-y; Debenham JJ, 2017, INT J PARASITOL-PAR, V6, P29, DOI 10.1016/j.ijppaw.2016.12.002; Du SZ, 2015, KOREAN J PARASITOL, V53, P395, DOI 10.3347/kjp.2015.53.4.395; Durigan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115489; Einarsson E, 2016, CURR OPIN MICROBIOL, V34, P47, DOI 10.1016/j.mib.2016.07.019; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Karim MR, 2015, INFECT GENET EVOL, V30, P82, DOI 10.1016/j.meegid.2014.12.013; Karim MR, 2014, INT J PARASITOL, V44, P1039, DOI 10.1016/j.ijpara.2014.07.006; Kowalewski MM, 2011, AM J PRIMATOL, V73, P75, DOI 10.1002/ajp.20803; Lebbad M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001262; Levecke B, 2009, INT J PARASITOL, V39, P1595, DOI 10.1016/j.ijpara.2009.05.013; Li JQ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02004; Ma'ayeh SY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006120; Mbae C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1436-z; Naguib D, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2981-7; Plutzer J, 2010, INT J HYG ENVIR HEAL, V213, P321, DOI 10.1016/j.ijheh.2010.06.005; Prystajecky N, 2015, APPL ENVIRON MICROB, V81, P4827, DOI 10.1128/AEM.00524-15; Ryan U, 2019, INT J PARASITOL, V49, P1, DOI 10.1016/j.ijpara.2018.07.003; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Sricharern W, 2016, INFECT GENET EVOL, V40, P310, DOI 10.1016/j.meegid.2016.02.004; Tsui CKM, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00090-18, 10.1128/msphere.00090-18]; Ye JB, 2014, PARASITOL INT, V63, P132, DOI 10.1016/j.parint.2013.10.007; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhong ZJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184913	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228673	10.1371/journal.pone.0228673	http://dx.doi.org/10.1371/journal.pone.0228673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017796	gold, Green Published			2022-12-26	WOS:000534618100037
J	Jaworska, J; Ropka-Molik, K; Woclawek-Potocka, I; Siemieniuch, M				Jaworska, Joanna; Ropka-Molik, Katarzyna; Woclawek-Potocka, Izabela; Siemieniuch, Marta			Inter- and intrabreed diversity of the major histocompatibility complex (MHC) in primitive and draft horse breeds	PLOS ONE			English	Article							INSECT BITE HYPERSENSITIVITY; GENETIC DIVERSITY; RETAINED PLACENTA; BALANCING SELECTION; RISK-FACTORS; CLASS-I; POPULATION-STRUCTURE; NATURAL-SELECTION; RECOMBINATION; EVOLUTION	Background Polymorphism of major histocompatibility complex (MHC) genes ensures effective immune responses against a wide array of pathogens. However, artificial selection, as performed in the case of domestic animals, may influence MHC diversity. Here, we investigate and compare the MHC diversity of three populations of horses, for which different breeding policies were applied, to evaluate the impact of artificial selection and the environment on MHC polymorphism. Methods Samples of DNA were taken from 100 Polish draft horses, 38 stabled Konik Polski horses and 32 semiferal Konik Polski horses. MHC alleles and haplotype diversity within and between these populations of horses was estimated from 11 MHC microsatellite loci. Results MHC diversity measured based on allelic richness, observed heterozygosity, expected heterozygosity and polymorphism content was similar across the MHC microsatellite loci in all three populations. The highest expected heterozygosity was detected in semiferal primitive horses (He = 0.74), while the lowest was calculated for draft horses (He = 0.65). In total, 203 haplotypes were determined (111 in Polish draft horses, 43 in semiferal Konik Polski horses and 49 in stabled Konik Polski horses), and four haplotypes were shared between the two populations of Koniks. None of these haplotypes were present in any of the previously investigated horse breeds. Intra-MHC recombination events were detected in all three populations. However, the population of semiferal Konik horses showed the highest recombination frequency among the three horse populations. In addition, three recombination events were detected. Conclusions These results showed that despite the different breeding policies, the MHC allele and haplotype diversity was similarly high in all three horse populations. Nevertheless, the proportion of new haplotypes in the offspring was the highest in semiferal Konik Polski horses, which indicates the influence of the environment on MHC diversity in horses. Thus, we speculate that the genetic makeup of the domestic horse MHC might be more strongly influenced by the environment than by artificial selection. Moreover, intra-MHC conversion, insertion, and deletion and intra-MHC recombination may be proposed as mechanisms underlying the generation of new MHC haplotypes in horses.	[Jaworska, Joanna; Woclawek-Potocka, Izabela] Polish Acad Sci, Dept Gamete & Embryo Biol, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Ropka-Molik, Katarzyna] Natl Res Inst Anim Prod, Dept Anim Mol Biol, Balice, Poland; [Siemieniuch, Marta] Polish Acad Sci Popielno, Res Stn Inst Reprod & Food Res, Ruciane Nida, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; National Research Institute of Animal Production	Jaworska, J (corresponding author), Polish Acad Sci, Dept Gamete & Embryo Biol, Inst Anim Reprod & Food Res, Olsztyn, Poland.	joanna.jaworska11@gmail.com	Wocławek-Potocka, Izabela M./H-7266-2017	Wocławek-Potocka, Izabela M./0000-0002-1270-3438; SIEMIENIUCH, Marta J./0000-0002-5117-9659; JAWORSKA, Joanna/0000-0001-7998-5567	Polish National Science Centre [2015/19/N/NZ5/00655]	Polish National Science Centre	This work was supported by Polish National Science Centre grant 2015/19/N/NZ5/00655, (https://www.ncn.gov.pl/) to JJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; ANDERSSON L, 1988, IMMUNOGENETICS, V27, P273, DOI 10.1007/BF00376122; Andersson LS, 2012, IMMUNOGENETICS, V64, P201, DOI 10.1007/s00251-011-0573-1; [Anonymous], [No title captured]; Azab W, 2014, J GEN VIROL, V95, P1554, DOI 10.1099/vir.0.066407-0; Bahr A, 2012, GENE, V497, P52, DOI 10.1016/j.gene.2012.01.017; Behl R, 2002, ASIAN AUSTRAL J ANIM, V15, P1822, DOI 10.5713/ajas.2002.1822; Benedictus L, 2013, ANIM REPROD SCI, V137, P1, DOI 10.1016/j.anireprosci.2012.12.006; Brandt DYC, 2018, G3-GENES GENOM GENET, V8, P2805, DOI 10.1534/g3.118.200367; Brinkmeyer-Langford CL, 2013, ANIM GENET, V44, P267, DOI 10.1111/age.12003; Canisso IF, 2013, J EQUINE VET SCI, V33, P570, DOI 10.1016/j.jevs.2012.08.006; Vieira MLC, 2016, GENET MOL BIOL, V39, P312, DOI 10.1590/1678-4685-GMB-2016-0027; de la Concha EG, 2000, HUM IMMUNOL, V61, P513, DOI 10.1016/S0198-8859(99)00187-1; Gouveia JJD, 2014, GENET MOL BIOL, V37, P330, DOI 10.1590/S1415-47572014000300004; Deakin JE, 2006, BMC GENOMICS, P7, DOI [10.1186/1471-2164-7-7, DOI 10.1186/1471-2164-7-7]; Doboszewski P, 2017, ANIM SCI PAP REP, V35, P333; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Ejsmond MJ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004627; Endler M, 2018, BJOG-INT J OBSTET GY, V125, P737, DOI 10.1111/1471-0528.14828; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Florese RH, 2008, VACCINE, V26, P3312, DOI 10.1016/j.vaccine.2008.03.100; Fritz KL, 2014, ANIM GENET, V45, P392, DOI 10.1111/age.12129; Gao CX, 2015, INFECT GENET EVOL, V29, P15, DOI 10.1016/j.meegid.2014.10.031; Glazewska I, 2006, LIVEST SCI, V105, P272, DOI 10.1016/j.livsci.2006.06.004; Glowatzki-Mullis ML, 2006, ANIM GENET, V37, P33, DOI 10.1111/j.1365-2052.2005.01376.x; Golebiewska K, 2013, ANN ANIM SCI, V13, P687, DOI 10.2478/aoas-2013-0045; Gorecka-Bruzda A, 2017, APPL ANIM BEHAV SCI, V195, P50, DOI 10.1016/j.applanim.2017.05.020; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gruen JR, 2001, FRONT BIOSCI-LANDMRK, V6, pD960, DOI 10.2741/Gruen; Holmes CM, GENES IMMUNITY, DOI [10.1038/, DOI 10.1038/]; Horecky C, 2018, HLA, V91, P271, DOI 10.1111/tan.13211; Iwanczyk E, 2006, J APPL GENETICS, V47, P353, DOI 10.1007/BF03194645; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Janova E, 2013, J APPL GENET, V54, P285, DOI 10.1007/s13353-013-0151-3; Janova E, 2009, IMMUNOGENETICS, V61, P513, DOI 10.1007/s00251-009-0380-0; Jastrzebska E, 2015, ACTA SCI POL ZOOT, V14; Jaworska J, 2019, THERIOGENOLOGY, V126, P1, DOI 10.1016/j.theriogenology.2018.11.029; Kauppi L, 2003, HUM MOL GENET, V12, P33, DOI 10.1093/hmg/ddg008; Khanshour A, 2013, J HERED, V104, P386, DOI 10.1093/jhered/est003; Klumplerova M, 2013, MOL BIOL REP, V40, P3333, DOI 10.1007/s11033-012-2408-z; Kydd JH, 2016, VET MICROBIOL, V188, P34, DOI 10.1016/j.vetmic.2016.04.004; Lee SY, 2006, J VET SCI, V7, P63, DOI 10.4142/jvs.2006.7.1.63; Leroy G, 2009, GENET SEL EVOL, P41; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Lopez C, 2010, GENE, V467, P1, DOI 10.1016/j.gene.2010.07.008; Luis C, 2005, J ANIM BREED GENET, V122, P69, DOI 10.1111/j.1439-0388.2004.00485.x; Luis C, 2002, GENET MOL BIOL, V25, P131, DOI 10.1590/S1415-47572002000200003; Mackowski M, 2015, ARCH TIERZUCHT, V58, P23, DOI 10.5194/aab-58-23-2015; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McCairns RJS, 2011, MOL ECOL, V20, P486, DOI 10.1111/j.1365-294X.2010.04950.x; Meyer D, 2018, IMMUNOGENETICS, V70, P5, DOI 10.1007/s00251-017-1017-3; Miller D, 2017, IMMUNOGENETICS, V69, P145, DOI 10.1007/s00251-016-0964-4; Morris KM, 2014, J HERED, V105, P493, DOI 10.1093/jhered/esu017; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Ooi EE, 1997, INT J CANCER, V74, P229; Pasicka E., 2013, Acta Scientiarum Polonorum - Medicina Veterinaria, V12, P25; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Romaniuk Konstanty, 2008, Medycyna Weterynaryjna, V64, P1335; Sadeghi R, 2018, IMMUNOGENETICS, V70, P305, DOI 10.1007/s00251-017-1039-x; Sanchez-Mazas A, 2007, TISSUE ANTIGENS, V69, P198, DOI 10.1111/j.1399-0039.2006.00802.x; Schaschl H, 2006, HEREDITY, V97, P427, DOI 10.1038/sj.hdy.6800892; Sevinga M, 2004, THERIOGENOLOGY, V61, P851, DOI 10.1016/S0093-691X(03)00260-7; Sevinga M, 2004, J ANIM SCI, V82, P982; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2011, MOL ECOL, V20, P5213, DOI 10.1111/j.1365-294X.2011.05367.x; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stachurska A, 2014, CZECH J ANIM SCI, V59, P257, DOI 10.17221/7496-CJAS; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Szwaczkowski T, 2016, CAN J ANIM SCI, V96, P570, DOI 10.1139/cjas-2015-0173; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Tseng CT, 2010, ANIM GENET, V41, P150, DOI 10.1111/j.1365-2052.2010.02125.x; van Nieuwenhoven ALV, 2003, HUM REPROD UPDATE, V9, P347, DOI 10.1093/humupd/dmg026; Vostra-Vydrova H, 2018, CZECH J ANIM SCI, V63, P85, DOI 10.17221/51/2017-CJAS; Warnakulasooriya DN, 2018, FRONT VET SCI, P5; Webster MS, 2005, METHOD ENZYMOL, V395, P222, DOI 10.1016/S0076-6879(05)95014-3; Yasukochi Y, 2013, IMMUNOGENETICS, V65, P479, DOI 10.1007/s00251-013-0693-x; Zhu Y, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-227	82	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228658	10.1371/journal.pone.0228658	http://dx.doi.org/10.1371/journal.pone.0228658			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012208	Green Published, gold			2022-12-26	WOS:000534615800044
J	Atuhaire, P; Brummel, SS; Mmbaga, BT; Angelidou, K; Fairlie, L; Violari, A; Theron, G; Mukuzunga, C; Mawlana, S; Mubiana-Mbewe, M; Naidoo, M; Makanani, B; Mandima, P; Nematadzira, T; Suryavanshi, N; Mbengeranwa, T; Loftis, A; Basar, M; McCarthy, K; Currier, JS; Fowler, MG				Atuhaire, Patience; Brummel, Sean S.; Mmbaga, Blandina Theophil; Angelidou, Konstantia; Fairlie, Lee; Violari, Avy; Theron, Gerhard; Mukuzunga, Cornelius; Mawlana, Sajeeda; Mubiana-Mbewe, Mwangelwa; Naidoo, Megeshinee; Makanani, Bonus; Mandima, Patricia; Nematadzira, Teacler; Suryavanshi, Nishi; Mbengeranwa, Tapiwa; Loftis, Amy; Basar, Michael; McCarthy, Katie; Currier, Judith S.; Fowler, Mary Glenn		1077BF-1077FF PROMISE Team	The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial	PLOS ONE			English	Article							WOMEN; PREGNANCY	Background Given well documented challenges faced by pregnant women living with HIV taking lifetime ART, it is critical to understand the impact of short-term ART exposure followed by treatment interruption on maternal health outcomes. Methods HIV+ breastfeeding (BF) and Formula Feeding (FF) women with CD4 counts > 350 cells/mm3, enrolled in the 1077BF/1077FF PROMISE trial were followed to assess the effect of ART during pregnancy and breastfeeding respectively. The first analysis compared ART use limited to the antepartum period (AP-only) relative to women randomized to Zidovudine. The second analysis included women with no pregnancy combination ART exposure; and compared women randomized to either ART or no ART during postpartum (PP-only). Both analyses included follow-up time beyond breastfeeding period. The primary outcome was progression to AIDS and/or death. Secondary outcomes included adverse events and HIV-related events. Results 3490 and 1137 HIV+ women were enrolled from 14 sites in Africa and India from April 2011 through September 2014 in cohort AP-only and PP-only, respectively. Most were Black African (96%); median age was 27 years; 97% were WHO Clinical Stage I; and most had a screening CD4 count >= 500 cells/mm3 (78%). The rate of progression to AIDS and/or death was similar and low across all comparison arms (AP comparison, HR = 1.14, 95%CI (0.44, 2.96), p-value = 0.79). In the PP-only cohort, the rate of WHO stage 2-3 events was lower for women randomized to ART(HR = 0.65, 95% CI 0.42, 1.01, p-value = 0.05). Conclusion The incidence of AIDS and/or death was low in pregnant/postpartum HIV+ women with highCD4 cell counts for all comparison arms. This provides some reassurance that there were limited consequences for short term ART interruption in this group of asymptomatic HIV+ women during up to 4 years of follow up; and underscores that even short term ART exposure postpartum may reduce the risk of WHO grade 2-3 disease progression.	[Atuhaire, Patience] Makerere Univ John Hopkins Univ Res Collaborat MU, Kampala, Uganda; [Brummel, Sean S.; Angelidou, Konstantia] Harvard Sch Publ Hlth, Boston, MA USA; [Mmbaga, Blandina Theophil] Kilimanjaro Christian Med Ctr KCMC, Moshi, Tanzania; [Fairlie, Lee] Wits RHI Shandukani Res Ctr CRS, Johannesburg, South Africa; [Violari, Avy] Soweto IMPAACT CRS, Johannesburg, South Africa; [Theron, Gerhard] FAM CRU CRS, Cape Town, South Africa; [Mukuzunga, Cornelius] Malawi CRS, Lilongwe, Malawi; [Mawlana, Sajeeda] Durban Paediat HIV CRS, Durban, South Africa; [Mubiana-Mbewe, Mwangelwa] George CRS, Lusaka, Zambia; [Naidoo, Megeshinee] Umlazi CRS, Durban, South Africa; [Makanani, Bonus] Blantyre CRS, Blantyre, Malawi; [Mandima, Patricia] St Marys CRS, Harare, Zimbabwe; [Nematadzira, Teacler] Seke North CRS, Harare, Zimbabwe; [Suryavanshi, Nishi] Byramjee Jeejeebhoy Med Coll BJMC CRS, Pune, Maharashtra, India; [Mbengeranwa, Tapiwa] Harare Family Care CRS, Harare, Zimbabwe; [Loftis, Amy] UNC, Chapel Hill, NC USA; [Basar, Michael] Frontier Sci, Amherst, MA USA; [McCarthy, Katie] FHI 360, Durham, NC USA; [Currier, Judith S.] Univ Calif Los Angeles, Ctr Clin AIDS Res & Educ, Los Angeles, CA USA; [Fowler, Mary Glenn] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Fowler, Mary Glenn] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Kilimanjaro Christian Medical Centre; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; University of North Carolina; University of North Carolina Chapel Hill; FHI 360; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins University	Atuhaire, P (corresponding author), Makerere Univ John Hopkins Univ Res Collaborat MU, Kampala, Uganda.	patuhaire@mujhu.org	Mmbaga, Blandina Theophil/AAR-8707-2021; Nematadzira, Teacler/GNW-2713-2022	Mmbaga, Blandina Theophil/0000-0002-5550-1916; Atuhaire, Patience/0000-0002-2662-0756; Nematadzira, Teacler/0000-0003-4786-1396; Mubiana-Mbewe, Mwangelwa/0000-0002-7122-842X	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH)	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). Study drugs were provided by AbbVie, BoehringerIngelheim, Gilead Sciences, and ViiV/GlaxoSmithKline.	[Anonymous], 2018, WOM GIRLS HIV; Bernardino JI, 2015, LANCET HIV, V2, pE464, DOI 10.1016/S2352-3018(15)00181-2; Currier JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176009; DAIDS, 2009, DIV AIDS TABL GRAD S; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Flynn PM, 2018, JAIDS-J ACQ IMM DEF, V77, P383, DOI 10.1097/QAI.0000000000001612; Fowler MG, 2016, NEW ENGL J MED, V375, P1726, DOI 10.1056/NEJMoa1511691; Hoffman RM, 2018, HIV CLIN TRIALS, V19, P209, DOI 10.1080/15284336.2018.1537327; Hoffmann CJ, 2016, JAIDS-J ACQ IMM DEF, V71, P31, DOI 10.1097/QAI.0000000000000811; Kourtis AP, 2017, JAIDS-J ACQ IMM DEF, V74, P38, DOI 10.1097/QAI.0000000000001199; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Taha E., 2018, C RETR OPP INF MARCH	13	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228003	10.1371/journal.pone.0228003	http://dx.doi.org/10.1371/journal.pone.0228003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999753	gold, Green Published			2022-12-26	WOS:000534612400038
J	Rashidi, A; Sandalcioglu, IE; Luchtmann, M				Rashidi, Ali; Sandalcioglu, I. Erol; Luchtmann, Michael			Aseptic bone-flap resorption after cranioplasty - incidence and risk factors	PLOS ONE			English	Article							DECOMPRESSIVE CRANIECTOMY; FROZEN; IMPACT; COMPLICATIONS; CHILDREN; DEFECTS; STORAGE	Objective One of the common complications occurring after cranioplasty (CP) is aseptic bone-flap resorption (ABFR). Reoperation necessary because of the development of ABFR can lead to unfavorable complications during subsequent surgery using a synthetic skull implant, and also necessarily leads to higher costs. The aim of this study is to identify prognostic factors that may help to predict the development of ABFR. Methods In this study, 303 CP surgeries performed between 2002 and 2017 were examined retrospectively to identify factors predicting the occurrence of ABFR. A number of these factors (e.g., time lapse between decompressive craniectomy (DC) and CP, bone-flap size, specific laboratory signs, and the reason for the original DC) were analyzed as possibly influencing the risk of developing ABFR. Results ABFR of an autologous bone flap that subsequently required a CP with synthetic skull implants occurred in 10 of 303 patients (3.0%). CP timing and patients' Karnofsky Performance Scores (KPS) (p = 0.008; p = 0.012) were identified as significant factors with an impact on the development of ABRF. Age did not reveal a significant value, but statistical analysis shows a clear trend. The younger the age, the more likely it was that an ABFR would develop. Conclusion The risk of ABFR lessens the longer the period of time elapsed between DC and CP. Age does not reveal a significant value, but statistical analysis shows that there is a clear trend.	[Rashidi, Ali; Sandalcioglu, I. Erol; Luchtmann, Michael] Otto von Guericke Univ, Med Fac, Dept Neurosurg, Magdeburg, Germany	Otto von Guericke University	Luchtmann, M (corresponding author), Otto von Guericke Univ, Med Fac, Dept Neurosurg, Magdeburg, Germany.	michael.luchtmann@med.ovgu.de		Luchtmann, Michael/0000-0002-9947-9095	Department of Neuroradiology	Department of Neuroradiology	This research was supported by the Department of Neuroradiology. We thank Prof. Skalej for providing the imaging data.	Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Barzaghi LR, 2019, ACTA NEUROCHIR WIEN; Bhaskar IP, 2014, WORLD NEUROSURG, V82, pE531, DOI 10.1016/j.wneu.2013.01.013; Blum KS, 1997, PEDIATR NEUROSURG, V26, P33, DOI 10.1159/000121158; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Chan DYC, 2017, J CLIN NEUROSCI, V42, P81, DOI 10.1016/j.jocn.2017.04.016; Cheng Cheng-Hsin, 2014, Clin Neurol Neurosurg, V124, P85, DOI 10.1016/j.clineuro.2014.06.029; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Corliss B, 2016, WORLD NEUROSURG, V96, P510, DOI 10.1016/j.wneu.2016.09.025; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Ernst G, 2018, J NEUROSURG, V129, P1604, DOI 10.3171/2017.6.JNS17943; Ewald C, 2014, NEUROCRIT CARE, V20, P91, DOI 10.1007/s12028-013-9892-4; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Hng D, 2015, CRANIOMAX TRAUM REC, V8, P190, DOI 10.1055/s-0034-1395383; Honeybul S, 2012, PLAST RECONSTR SURG, V130, P1110, DOI 10.1097/PRS.0b013e318267d4de; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46; Kim JH, 2019, ACTA NEUROCHIR, V161, P25, DOI 10.1007/s00701-018-3749-8; Kim JH, 2018, WORLD NEUROSURG, V115, pE111, DOI 10.1016/j.wneu.2018.03.197; Kriegel RJ, 2007, ZBL NEUROCHIR, V68, P182, DOI 10.1055/s-2007-985857; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Mustroph CM, 2017, WORLD NEUROSURG, V103, P686, DOI 10.1016/j.wneu.2017.04.066; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; PROLO DJ, 1979, NEUROSURGERY, V4, P18, DOI 10.1227/00006123-197901000-00005; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Stieglitz LH, 2015, ACTA NEUROCHIR, V157, P275, DOI 10.1007/s00701-014-2310-7; Wang JC, 2012, J CRANIOFAC SURG, V23, P1802, DOI 10.1097/SCS.0b013e318271012a; Wen L, 2015, BRAIN INJURY, V29, P1654, DOI 10.3109/02699052.2015.1075248; Xu H, 2015, CLIN NEUROL NEUROSUR, V136, P33, DOI 10.1016/j.clineuro.2015.05.031; Zhang J, 2017, J NEUROSURG, V127, P1449, DOI 10.3171/2016.8.JNS16204; Zhang QM, 2018, WORLD NEUROSURG, V112, pE645, DOI 10.1016/j.wneu.2018.01.114	37	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228009	10.1371/journal.pone.0228009	http://dx.doi.org/10.1371/journal.pone.0228009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999739	Green Published, gold			2022-12-26	WOS:000534612400040
J	Dhawan, K; Naslavsky, N; Caplan, S				Dhawan, Kanika; Naslavsky, Naava; Caplan, Steve			Sorting nexin 17 (SNX17) links endosomal sorting to Eps15 homology domain protein 1 (EHD1)?mediated fission machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; sorting; sorting nexin (SNX); trafficking; vesicles; receptor recycling; receptor endocytosis; receptor; intracellular trafficking; endocytosis; endosomal fission; Eps15 homology domain protein 1 (EHD1); LDL receptor?related protein 1 (LRP1); retromer; sorting nexin 17 (SNX17)	TERMINAL EH-DOMAIN; ENDOCYTIC TRAFFICKING; PLASMA-MEMBRANE; WASH COMPLEX; RETROMER; RECEPTOR; FAMILY; RME-1; TAIL; RECOGNITION	Following endocytosis, receptors that are internalized to sorting endosomes are sorted to different pathways, in part by sorting nexin (SNX) proteins. Notably, SNX17 interacts with a multitude of receptors in a sequence-specific manner to regulate their recycling. However, the mechanisms by which SNX17-labeled vesicles that contain sorted receptors bud and undergo vesicular fission from the sorting endosomes remain elusive. Recent studies suggest that a dynamin-homolog, Eps15 homology domain protein 1, catalyzes fission and releases endosome-derived vesicles for recycling to the plasma membrane. However, the mechanism by which EHD1 is coupled to various receptors and regulates their recycling remains unknown. Here we sought to characterize the mechanism by which EHD1 couples with SNX17 to regulate recycling of SNX17-interacting receptors. We hypothesized that SNX17 couples receptors to the EHD1 fission machinery in mammalian cells. Coimmunoprecipitation experiments and in vitro assays provided evidence that EHD1 and SNX17 directly interact. We also found that inducing internalization of a SNX17 cargo receptor, low-density lipoprotein receptor?related protein 1 (LRP1), led to recruitment of cytoplasmic EHD1 to endosomal membranes. Moreover, surface rendering and quantification of overlap volumes indicated that SNX17 and EHD1 partially colocalize on endosomes and that this overlap further increases upon LRP1 internalization. Additionally, SNX17-containing endosomes were larger in EHD1-depleted cells than in WT cells, suggesting that EHD1 depletion impairs SNX17-mediated endosomal fission. Our findings help clarify our current understanding of endocytic trafficking, providing significant additional insight into the process of endosomal fission and connecting the sorting and fission machineries.	[Dhawan, Kanika; Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Caplan, Steve] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Caplan, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Caplan, S (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	scaplan@unmc.edu		Dhawan, Kanika/0000-0002-6267-0312	National Institutes of Health [1R01GM123557, P20 GM103427]; Nebraska Department of Health and Human Services Grant [2019-41]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Department of Health and Human Services Grant	This work was supported by National Institutes of Health Grants 1R01GM123557 and P20 GM103427 (to S. C.) and Nebraska Department of Health and Human Services Grant 2019-41 (to N. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Cai BS, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00022; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chen KE, 2019, TRAFFIC, V20, P465, DOI 10.1111/tra.12649; Clairfeuille T, 2016, NAT STRUCT MOL BIOL, V23, P921, DOI 10.1038/nsmb.3290; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Deo R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07586-z; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Donoso M, 2009, MOL BIOL CELL, V20, P481, DOI 10.1091/mbc.E08-08-0805; Farfan P, 2013, TRAFFIC, V14, P823, DOI 10.1111/tra.12076; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Ghai Rajesh, 2011, Small GTPases, V2, P259; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; Giridharan Sai Srinivas Panapakkam, 2012, Commun Integr Biol, V5, P384, DOI 10.4161/cib.20064; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; Jakobsson J, 2011, J NEUROSCI, V31, P13972, DOI 10.1523/JNEUROSCI.1289-11.2011; Jia D, 2012, MOL BIOL CELL, V23, P2352, DOI 10.1091/mbc.E11-12-1059; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Jia ZG, 2014, PROTEINS, V82, P2332, DOI 10.1002/prot.24593; Kamerkar SC, 2019, BIOCHEMISTRY-US, V58, P65, DOI 10.1021/acs.biochem.8b00925; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Knauth P, 2005, J MOL BIOL, V347, P813, DOI 10.1016/j.jmb.2005.02.004; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lee S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10939; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; McNally KE, 2017, NAT CELL BIOL, V19, P1214, DOI 10.1038/ncb3610; Melo AA, 2017, P NATL ACAD SCI USA, V114, P5629, DOI 10.1073/pnas.1614075114; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216499; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Nguyen TN, 2006, NAT METHODS, V3, P135, DOI 10.1038/nmeth0206-135; Osborne DG, 2015, J IMMUNOL, V194, P4555, DOI 10.4049/jimmunol.1402734; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Sharma Mahak, 2010, Commun Integr Biol, V3, P181; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Stockinger W, 2002, EMBO J, V21, P4259, DOI 10.1093/emboj/cdf435; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; Wang J, 2018, TRAFFIC, V19, P578, DOI 10.1111/tra.12574; Xie SW, 2018, MOL BIOL CELL, V29, P2622, DOI 10.1091/mbc.E18-04-0241; Xu Y, 2004, MOL MEMBR BIOL, V21, P269, DOI 10.1080/09687680410001716871; Yeow I, 2017, CURR BIOL, V27, P2951, DOI 10.1016/j.cub.2017.07.047; Zhang J, 2012, TRAFFIC, V13, P745, DOI 10.1111/j.1600-0854.2012.01334.x	64	13	13	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3837	3850		10.1074/jbc.RA119.011368	http://dx.doi.org/10.1074/jbc.RA119.011368			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32041776	Green Published, hybrid			2022-12-26	WOS:000527704400010
J	Al Nasr, RS; Altharwi, K; Derbah, MS; Gharibo, SO; Fallatah, SA; Alotaibi, SG; Almutairi, KA; Asdaqid, SMB				Al Nasr, Raneem Seif; Altharwi, Kareemah; Derbah, Maria Seraj; Gharibo, Salma Omar; Fallatah, Samah Abdulsallam; Alotaibi, Sara Ghallab; Almutairi, Khattam Alhumidi; Asdaqid, Syed Mohammed Basheeruddin			Prevalence and predictors of postpartum depression in Riyadh, Saudi Arabia: A cross sectional study	PLOS ONE			English	Article							EDINBURGH POSTNATAL DEPRESSION; STRESSFUL LIFE EVENTS; RISK-FACTORS; PERINATAL DEPRESSION; MATERNAL DEPRESSION; CESAREAN-SECTION; PARTNER SUPPORT; SCALE EPDS; MOTHERS; IMPACT	Objective Postpartum depression (PPD) is inversely correlated with women's functioning, marital and personal relationships, mother-infant interaction quality, and children's social, behavioural, and cognitive development. The purpose of this study was to determine the prevalence of postpartum depression (PPD) in Riyadh and correlate them with possible predictors by a cross-sectional approach. Methods In this study, 174 mothers receiving treatments in different hospitals of Riyadh completed self-administered measures of the Edinburgh Postnatal Depression Scale (EPDS) along with a list of probable predictors. The data was analyzed by logistic regression analysis using SPSS-IBM 25. Results Of 174 participants of the study, 38.50% (n = 67) reported postpartum depression. Around (115) of the participants were in an age group of 25-45 years with most of them highly educated (101) but unemployed (136). Significant association was noted between occurrence of PPD with unsupportive spouse (P value = 0.023) and recent stressful life events (P value = 0.003). The significant predictors for PPD were unsupportive spouse (OR = 4.53, P = 0.049), recent stressful life events (OR = 2.677, P = 0.005), and Caesarean section as a mode of delivery (OR = 1.958, P = 0.049) Conclusion The prevalence of PPD among the study participants was high, especially those with recent stressful life event and unsupportive spouse. To promote health and wellbeing of mothers, it was recommended to screen all high-risk mothers for PPD, when they visit hospitals for postnatal follow ups. Prevention of PPD is not only essential for wellbeing of mothers but it is important to provide good conducive atmosphere for the new born.	[Al Nasr, Raneem Seif; Altharwi, Kareemah; Derbah, Maria Seraj; Gharibo, Salma Omar; Fallatah, Samah Abdulsallam; Alotaibi, Sara Ghallab; Almutairi, Khattam Alhumidi; Asdaqid, Syed Mohammed Basheeruddin] Al Maarefa Univ, Coll Pharm, Riyadh, Saudi Arabia	Almaarefa University	Asdaqid, SMB (corresponding author), Al Maarefa Univ, Coll Pharm, Riyadh, Saudi Arabia.	sasdag@mcst.edu.sa	asdaq, Syed Mohammed Basheeruddin/AAH-8283-2019	asdaq, Syed Mohammed Basheeruddin/0000-0003-1533-9667				Agoub M, 2005, ARCH WOMEN MENT HLTH, V8, P37, DOI 10.1007/s00737-005-0069-9; Alasoom Lamia I, 2014, J Family Med Prim Care, V3, P146, DOI 10.4103/2249-4863.137654; Alharbi AA, 2014, NEUROPSYCH DIS TREAT, V10, P311, DOI 10.2147/NDT.S57556; Almutairi AF, 2017, NEUROPSYCH DIS TREAT, V13, P1929, DOI 10.2147/NDT.S135680; American Psychiatric Association, 2013, AM PSYCH ASS DIAGN S, P81; Assari S, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00049; Beck CT, 1996, NURS RES, V45, P297, DOI 10.1097/00006199-199609000-00008; Beck CT, 1999, J ADV NURS, V29, P623, DOI 10.1046/j.1365-2648.1999.00943.x; Beck CT, 1996, NURS RES, V45, P225, DOI 10.1097/00006199-199607000-00006; Benazon NR, 2000, J FAM PSYCHOL, V14, P71, DOI 10.1037/0893-3200.14.1.70; Brugha TS, 1998, PSYCHOL MED, V28, P63, DOI 10.1017/S0033291797005655; Buist A, 1998, AUST NZ J PSYCHIAT, V32, P370, DOI 10.3109/00048679809065529; Burgut FT, 2013, J PSYCHOSOM OBST GYN, V34, P90, DOI 10.3109/0167482X.2013.786036; Clavenna A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1205-6; Cooper PJ, 2003, BRIT J PSYCHIAT, V182, P412, DOI 10.1192/bjp.182.5.412; Cox J., 2003, PERINATAL MENTAL HLT; Deng AW, 2014, ASIAN PAC J TROP MED, V7, P244, DOI 10.1016/S1995-7645(14)60030-4; Depression WH, 2017, OTHER COMMON MENTAL, P1; Drewett R, 2004, J CHILD PSYCHOL PSYC, V45, P359, DOI 10.1111/j.1469-7610.2004.00226.x; El-Hachem C, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0242-7; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; Gaffney KF, 2014, J PEDIATR HEALTH CAR, V28, P43, DOI 10.1016/j.pedhc.2012.10.005; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Ghubash R, 1997, BRIT J PSYCHIAT, V171, P65, DOI 10.1192/bjp.171.1.65; Guedeney N, 1998, EUR PSYCHIAT, V13, P83, DOI 10.1016/S0924-9338(98)80023-0; Hamdan A, 2011, ARCH WOMEN MENT HLTH, V14, P125, DOI 10.1007/s00737-010-0189-8; Hewitt CE, NIHR HLTH TECHNOLOGY; Hickey AR, 1998, MED J AUSTRALIA, V168, P420, DOI 10.5694/j.1326-5377.1998.tb139011.x; Hipwell AE, 2000, DEV PSYCHOPATHOL, V12, P157, DOI 10.1017/S0954579400002030; Inandi T, 2002, INT J EPIDEMIOL, V31, P1201, DOI 10.1093/ije/31.6.1201; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kheirabadi GR, 2009, ARCH IRAN MED, V12, P461; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Kurstjens S, 2001, J CHILD PSYCHOL PSYC, V42, P623, DOI 10.1017/S0021963001007296; Low NCP, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-116; Melo EF, 2012, J AFFECT DISORDERS, V136, P1204, DOI 10.1016/j.jad.2011.11.023; Misri S, 2000, CAN J PSYCHIAT, V45, P554, DOI 10.1177/070674370004500607; Mohammed ES, 2014, PUBLIC HEALTH, V128, P817, DOI 10.1016/j.puhe.2014.06.006; Montazeri A, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-11; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Osler M, 2016, BRAIN BEHAV IMMUN, V58, P248, DOI 10.1016/j.bbi.2016.07.154; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Pearlstein T, 2009, AM J OBSTET GYNECOL, V200, P357, DOI 10.1016/j.ajog.2008.11.033; Righetti-Veltema M, 2003, EUR CHILD ADOLES PSY, V12, P75, DOI 10.1007/s00787-003-0311-9; Serhan N, 2013, J CLIN NURS, V22, P279, DOI 10.1111/j.1365-2702.2012.04281.x; Teissedre F, 2004, ENCEPHALE, V30, P376; van Doesum KTM, 2007, J AM ACAD CHILD PSY, V46, P747, DOI 10.1097/CHI.0b013e318040b272; Wilson LM, 1996, CAN MED ASSOC J, V154, P785; World Health Organsization, 2022, WORLD MENT HLTH REP; Xie RH, 2011, J WOMENS HEALTH, V20, P1881, DOI 10.1089/jwh.2011.2842; Xu H, 2017, J PSYCHOSOM RES, V97, P118, DOI 10.1016/j.jpsychores.2017.04.016; Yusuff ASM, 2015, WOMEN BIRTH, V28, P25, DOI 10.1016/j.wombi.2014.11.002	52	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228666	10.1371/journal.pone.0228666	http://dx.doi.org/10.1371/journal.pone.0228666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9IO	32040495	Green Published, Green Submitted, gold			2022-12-26	WOS:000534629400032
J	Cui, X; Huang, CZ; Wu, JP; Liu, XH; Hong, YG				Cui, Xia; Huang, Caizhu; Wu, Jiapeng; Liu, Xiaohan; Hong, Yiguo			Temporal and spatial variations of net anthropogenic nitrogen inputs (NANI) in the Pearl River Basin of China from 1986 to 2015	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; EXPORT; WATERSHEDS; CYCLE; PHOSPHORUS; BUDGETS; CLIMATE; FLUXES; EUTROPHICATION; CONSEQUENCES	Human activities have greatly influenced the natural nitrogen cycle, causing dramatic degradation of ecosystem function. Net anthropogenic nitrogen input (NANI) is an important factor contributing to the impact of human activities on the regional nitrogen cycle. Here, we analyzed the temporal and spatial variation of NANI in the Pearl River Basin of China between 1986 to 2015, and found that the total amount of NANI significantly increased from 3,362.25 kg N km(-2) yr(-1) to 8,071.15 kg N km(-2) yr(-1). Application of nitrogen fertilizers was the largest component of NANI in the Basin, accounting for 55.53% in the total NANI, followed by food/feed net nitrogen input (21.26%), atmospheric nitrogen deposition (12.95%), and crop nitrogen fixation (10.26%). Over the last three decades, nitrogen inputs from atmospheric nitrogen deposition have become the second largest source of NANI due to rapid industrialization and urbanization in the region. Regression analysis showed that the rapid growth of both GDP and population density were the main contributors to the increase of NANI. In addition, the increase in the number of red tides in the Pearl River Estuary was strongly correlated with NANI discharge (R-2 = 0.90, p<0.01), suggesting the NANI's eutrophication effect. In total, this study provides a quantitative understanding of the temporal and spatial variations of NANI in the Pearl River Basin as well as the effects of NANI on estuarine waters, and offered key information for developing an integrated strategy for watershed nitrogen management.	[Cui, Xia; Huang, Caizhu; Hong, Yiguo] Guangzhou Univ, Sch Econ & Stat, Guangzhou, Peoples R China; [Wu, Jiapeng; Liu, Xiaohan; Hong, Yiguo] Guangzhou Univ, Key Lab Water Qual & Conservat Pearl River Delta, Minist Educ, Inst Environm Res Greater Bay, Guangzhou, Peoples R China	Guangzhou University; Guangzhou University	Hong, YG (corresponding author), Guangzhou Univ, Sch Econ & Stat, Guangzhou, Peoples R China.; Hong, YG (corresponding author), Guangzhou Univ, Key Lab Water Qual & Conservat Pearl River Delta, Minist Educ, Inst Environm Res Greater Bay, Guangzhou, Peoples R China.	yghong@gzhu.edu.cn	Hong, Yiguo/K-7082-2018	Hong, Yiguo/0000-0002-6255-4100	National Natural Science Foundation of China [31870100, 91851111, 11871173]; Research Foundation for Talented Scholars of Guangzhou University [GU2017001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation for Talented Scholars of Guangzhou University	This work was supported by the National Natural Science Foundation of China (Grant No. 31870100, 91851111, 11871173),and the Research Foundation for Talented Scholars of Guangzhou University (Grant No. GU2017001).	Alexander RB, 2002, BIOGEOCHEMISTRY, V57, P295, DOI 10.1023/A:1015752801818; Anderson KA, 2006, WATER AIR SOIL POLL, V176, P351, DOI 10.1007/s11270-006-9172-4; Boyer EW, 2002, BIOGEOCHEMISTRY, V57, P137, DOI 10.1023/A:1015709302073; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Chen DJ, 2014, ENVIRON SCI TECHNOL, V48, P5683, DOI 10.1021/es500127t; Chen FJ, 2009, BIOGEOCHEMISTRY, V94, P163, DOI 10.1007/s10533-009-9316-x; Chen F, 2016, J GEOPHYS RES-BIOGEO, V121, P451, DOI 10.1002/2015JG003186; China MoEPo, 2016, CHIN B ENV QUAL COAS; Committee CSYC, CHINA STAT YB; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Erisman JW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0116; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gao W, 2014, BIOGEOSCIENCES, V11, P4577, DOI 10.5194/bg-11-4577-2014; Gao W, 2015, AMBIO, V44, P635, DOI 10.1007/s13280-015-0638-8; Gao Wei, 2014, Acta Scientiarum Naturalium Universitatis Pekinensis, V50, P951, DOI 10.13209/j.0479-8023.2014.129; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gu BJ, 2015, P NATL ACAD SCI USA, V112, P8792, DOI 10.1073/pnas.1510211112; Han HJ, 2009, ENVIRON SCI TECHNOL, V43, P1916, DOI 10.1021/es801985x; Han HJ, 2008, BIOGEOCHEMISTRY, V91, P177, DOI 10.1007/s10533-008-9279-3; Han YG, 2014, GEODERMA, V213, P87, DOI 10.1016/j.geoderma.2013.07.019; Hong BG, 2013, ENVIRON SCI TECHNOL, V47, P5199, DOI 10.1021/es303437c; Hong B, 2012, ECOL MODEL, V227, P117, DOI 10.1016/j.ecolmodel.2011.12.002; Hong B, 2011, ENVIRON MODELL SOFTW, V26, P623, DOI 10.1016/j.envsoft.2010.11.012; Howarth RW, 2006, BIOGEOCHEMISTRY, V79, P163, DOI 10.1007/s10533-006-9010-1; Howarth R, 2012, FRONT ECOL ENVIRON, V10, P37, DOI 10.1890/100178; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Howarth RW, 2004, WATER SCI TECHNOL, V49, P7, DOI 10.2166/wst.2004.0731; Huang XP, 2003, MAR POLLUT BULL, V47, P30, DOI 10.1016/S0025-326X(02)00474-5; Jia GD, 2003, MAR CHEM, V82, P47, DOI 10.1016/S0304-4203(03)00050-1; Jordan TE, 1996, BIOSCIENCE, V46, P655, DOI 10.2307/1312895; Lassaletta L, 2014, REG ENVIRON CHANGE, V14, P785, DOI 10.1007/s10113-013-0536-1; Li L, 2019, J OCEANOL LIMNOL, V37, P535, DOI 10.1007/s00343-019-8088-y; Li ShuTian, 2011, Scientia Agricultura Sinica, V44, P4207; Lu P., 2018, GEOCHEMICAL CHARACTE; Novotny Vladimir, 2010, Environment Development and Sustainability, V12, P491, DOI 10.1007/s10668-009-9207-2; Qian Honglin, 1999, Marine Environmental Science, V18, P69; Schaefer SC, 2009, BIOGEOCHEMISTRY, V93, P219, DOI 10.1007/s10533-009-9299-7; Seitzinger S.P., 2010, AM GEOPHYS UNION, V24, P2621, DOI DOI 10.1029/2009GB003587; Strokal M, 2015, BIOGEOCHEMISTRY, V125, P221, DOI 10.1007/s10533-015-0124-1; Swaney DP, 2015, J MARINE SYST, V141, P45, DOI 10.1016/j.jmarsys.2014.09.004; Swaney DP, 2012, CURR OPIN ENV SUST, V4, P203, DOI 10.1016/j.cosust.2012.03.004; Ti CP, 2012, BIOGEOCHEMISTRY, V108, P381, DOI 10.1007/s10533-011-9606-y; Ti ChaoPu, 2010, Journal of Agro-Environment Science, V29, P1606; Tian ZB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170993; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wang SF, 2008, HYDROBIOLOGIA, V596, P79, DOI 10.1007/s10750-007-9059-4; Xing GX, 2002, BIOGEOCHEMISTRY, V57, P405, DOI 10.1023/A:1016508323200; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Yan YX, 2014, QUATERN INT, V336, P117, DOI 10.1016/j.quaint.2013.08.002; Zhang Bai-fa, 2014, Huanjing Kexue, V35, P2911; Zhang SR, 2008, GLOBAL PLANET CHANGE, V60, P365, DOI 10.1016/j.gloplacha.2007.04.003; Zhou T, 2012, ECOL INDIC, V23, P166, DOI 10.1016/j.ecolind.2012.03.013; Zhu JX, 2015, SCI TOTAL ENVIRON, V511, P777, DOI 10.1016/j.scitotenv.2014.12.038; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	59	14	15	16	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228683	10.1371/journal.pone.0228683	http://dx.doi.org/10.1371/journal.pone.0228683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040490	gold, Green Published			2022-12-26	WOS:000534629400035
J	Do, TD; Heim, J; Melzig, C; Vollherbst, DF; Kauczor, HU; Skornitzke, S; Sommer, CM				Do, T. D.; Heim, J.; Melzig, C.; Vollherbst, D. F.; Kauczor, H. U.; Skornitzke, S.; Sommer, C. M.			Virtual monochromatic spectral imaging versus linearly blended dual-energy and single-energy imaging during CT-guided biopsy needle positioning: Optimization of keV settings and impact on image quality	PLOS ONE			English	Article							METAL ARTIFACT REDUCTION; LIVER-LESIONS; AGREEMENT; RECONSTRUCTION; ANGIOGRAPHY	Objectives To compare image quality and metal artifact reduction between virtual monochromatic spectral imaging (VMSI), linearly blended dual-energy (DE) and single-energy (SE) images, each with and without dedicated iterative metal artifact reduction (iMAR) for CT-guided biopsy. Materials and methods A biopsy trocar was positioned in the liver of six pigs. DE (Sn140/100kVp) and SE (120kVp/200mAs) acquisitions were performed with equivalent dose. From dual-energy datasets DE Q30-3 images and VMSI between 40-180 keV in steps of 20 keV were generated. From SE datasets I30-3 images were reconstructed. All images were reconstructed with and without iMAR. Objective image quality was analyzed applying density measurements at standardized positions (e.g. trocar tip and liver parenchyma adjacent to the trocar tip) and semi-automated threshold based segmentation. Subjective image quality was performed using semiquantitative scores. Analyses were performed by two observers. Results At the trocar tip quantitative image analysis revealed significant difference in CT numbers between reconstructions with iMAR compared to reconstructions without iMAR for VMSI at lower keV levels (80 and 100 keV; p = 0.03) and DE (p = 0.03). For liver parenchyma CT numbers were significantly higher in VMSI at high keV compared to low keV (p <= 0.01). VMSI at high keV also showed higher CT numbers compared to DE and SE images, though not the level of statistical significance. The best signal-to-noise ratio for VMSI was at 80 keV and comparable to DE and SE. Noise was lowest at 80 keV and lower than in DE and SE. Subjective image quality was best with VMSI at 80 keV regardless of the application of iMAR. iMAR significantly improved image quality at levels of 140 keV and 160 keV. Interreader-agreement was good for quantitative and qualitative analysis. Conclusion iMAR improved image quality in all settings. VMSI with iMAR provided metal artifact reduction and better image quality at 80 keV and thus could improve the accurate positioning in CT-guided needle biopsy. In comparison, DE imaging did not improve image quality compared to SE.	[Do, T. D.; Heim, J.; Melzig, C.; Kauczor, H. U.; Skornitzke, S.; Sommer, C. M.] Univ Hosp Heidelberg, Clin Diagnost & Intervent Radiol, Heidelberg, Germany; [Vollherbst, D. F.] Univ Hosp Heidelberg, Dept Neuroradiol, Heidelberg, Germany; [Sommer, C. M.] Klinikum Stuttgart, Clin Diagnost & Intervent Radiol, Stuttgart, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Klinikum Stuttgart	Do, TD (corresponding author), Univ Hosp Heidelberg, Clin Diagnost & Intervent Radiol, Heidelberg, Germany.	thuy.do@med.uni-heidelberg.de	Kauczor, HU/AAX-6033-2021; Kauczor, Hans-Ulrich/AAU-5955-2021		Medical Faculty of the University of Heidelberg	Medical Faculty of the University of Heidelberg	This study was supported by a grant from the Medical Faculty of the University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bamberg F, 2011, EUR RADIOL, V21, P1424, DOI 10.1007/s00330-011-2062-1; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chojniak Rubens, 2006, Sao Paulo Med. J., V124, P10, DOI 10.1590/S1516-31802006000100003; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Do TD, 2017, ROFO; Do TD, 2019, INVEST RADIOL, V54, P365, DOI 10.1097/RLI.0000000000000549; Dong Y, 2016, EUR SPINE J, V25, P1754, DOI 10.1007/s00586-015-4053-4; Haage P, 1999, ROFO-FORTSCHR RONTG, V171, P44, DOI 10.1055/s-1999-9895; Johnson TRC, 2012, AM J ROENTGENOL, V199, pS3, DOI 10.2214/AJR.12.9116; Kotsenas AL, 2015, AM J NEURORADIOL, V36, P2184, DOI 10.3174/ajnr.A4416; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEHMANN LA, 1981, MED PHYS, V8, P659, DOI 10.1118/1.595025; Mangold S, 2014, INVEST RADIOL, V49, P788, DOI 10.1097/RLI.0000000000000083; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; McWilliams SR, 2014, J VASC INTERV RADIOL, V25, P1929, DOI 10.1016/j.jvir.2014.08.028; Meyer E, 2012, MED PHYS, V39, P1904, DOI 10.1118/1.3691902; Meyer E, 2010, MED PHYS, V37, P5482, DOI 10.1118/1.3484090; Mokry T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110201; Morsbach F, 2013, EUR RADIOL, V23, P2687, DOI 10.1007/s00330-013-2885-z; Morsbach F, 2013, RADIOLOGY, V268, P237, DOI 10.1148/radiol.13122089; Nattenmuller J, 2015, EUR RADIOL, V25, P3567, DOI 10.1007/s00330-015-3772-6; Pessis E, 2013, RADIOGRAPHICS, V33, P573, DOI 10.1148/rg.332125124; Pomerantz SR, 2013, RADIOLOGY, V266, P318, DOI 10.1148/radiol.12111604; Stattaus J, 2007, CARDIOVASC INTER RAD, V30, P928, DOI 10.1007/s00270-007-9023-8; Wichmann JL, 2016, INVEST RADIOL, V51, P139, DOI 10.1097/RLI.0000000000000216; Wolf I, 2005, MED IMAGE ANAL, V9, P594, DOI 10.1016/j.media.2005.04.005; Xia T, 2010, P SOC PHOTO-OPT INS, V7622, DOI 10.1117/12.844075; Yamada Y, 2012, INVEST RADIOL, V47, P292, DOI 10.1097/RLI.0b013e318240a874; Zhang D, 2011, MED PHYS, V38, P1178, DOI 10.1118/1.3551999	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228578	10.1371/journal.pone.0228578	http://dx.doi.org/10.1371/journal.pone.0228578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040496	Green Published, gold			2022-12-26	WOS:000534629400028
J	Eich, T; Parker, D; Gazes, Y; Razlighi, Q; Habeck, C; Stern, Y				Eich, Teal; Parker, David; Gazes, Yunglin; Razlighi, Qolamreza; Habeck, Christian; Stern, Yaakov			Towards an ontology of cognitive processes and their neural substrates: A structural equation modeling approach	PLOS ONE			English	Article							ADULT AGE-DIFFERENCES; FUNCTIONAL NEUROANATOMY; PARIETAL CORTEX; BRAIN-AREAS; LANGUAGE; NETWORKS; FMRI; RECOGNITION; MECHANISMS; RETRIEVAL	A key challenge in the field of cognitive neuroscience is to identify discriminable cognitive functions, and then map these functions to brain activity. In the current study, we set out to explore the relationships between performance arising from different cognitive tasks thought to tap different domains of cognition, and then to test whether these distinct latent cognitive abilities also are subserved by corresponding "latent" brain substrates. To this end, we tested a large sample of adults under the age of 40 on twelve cognitive tasks as they underwent fMRI scanning. Exploratory factor analysis revealed 4-factor model, dissociating tasks into processes corresponding to episodic memory retrieval, reasoning, speed of processing and vocabulary. An analysis of the topographic covariance patterns of the BOLD-response acquired during each task similarity also converged on four neural networks that corresponded to the 4 latent factors. These results suggest that distinct ontologies of cognition are subserved by corresponding distinct neural networks.	[Eich, Teal] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Agneles, CA 90007 USA; [Eich, Teal; Parker, David; Gazes, Yunglin; Razlighi, Qolamreza; Habeck, Christian; Stern, Yaakov] Columbia Univ, Dept Neurol, Cognit Neurosci Div, New York, NY USA	University of Southern California; Columbia University	Eich, T (corresponding author), Univ Southern Calif, Leonard Davis Sch Gerontol, Los Agneles, CA 90007 USA.; Eich, T (corresponding author), Columbia Univ, Dept Neurol, Cognit Neurosci Div, New York, NY USA.	teich@usc.edu		Eich, Teal/0000-0003-4094-3276	National Institute on Aging [R00AG055684, R01AG038465, K01AG044467, K01AG051777]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	TE (National Institute on Aging, R00AG055684), https://www.nia.nih.gov, NO YS (National Institute on Aging, R01AG038465), https://www.nia.nih.gov, NO QR (National Institute on Aging, K01AG044467), https://www.nia.nih.gov, NO YG (National Institute on Aging, K01AG051777), https://www.nia.nih.gov, NO.	Ackermann H, 2004, BRAIN LANG, V89, P320, DOI 10.1016/S0093-934X(03)00347-X; Ardila A, 2016, ARCH CLIN NEUROPSYCH, V31, P112, DOI 10.1093/arclin/acv081; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bertolero MA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01189-w; Bertolero MA, 2018, NAT HUM BEHAV, V2, P765, DOI 10.1038/s41562-018-0420-6; Bertolero MA, 2015, P NATL ACAD SCI USA, V112, pE6798, DOI 10.1073/pnas.1510619112; Bollen KA, 1989, STRUCTURAL EQUATIONS; Borowsky R, 2006, BRAIN TOPOGR, V18, P233, DOI 10.1007/s10548-006-0001-2; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1996, SEMIN NEUROSCI, V8, P47, DOI 10.1006/smns.1996.0007; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P254, DOI 10.1162/jocn.1997.9.2.254; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Comrey A, 1992, 1 COURSE FACTOR ANAL, V2nd, P2; De Carli D, 2007, MAGN RESON IMAGING, V25, P933, DOI 10.1016/j.mri.2007.03.031; De Smet HJ, 2013, BRAIN LANG, V127, P334, DOI 10.1016/j.bandl.2012.11.001; Ekstrom R., 1976, MANUAL KIT FACTOR RE; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Fokin V A, 2007, Ross Fiziol Zh Im I M Sechenova, V93, P1089; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; Gerstmann J, 1940, ARCH NEURO PSYCHIATR, V44, P398, DOI 10.1001/archneurpsyc.1940.02280080158009; Habeck C, 2016, NEUROIMAGE, V125, P693, DOI 10.1016/j.neuroimage.2015.10.077; Habeck C., 2018, NEUROIMAGE; Habeck C, 2015, J COGNITIVE NEUROSCI, V27, P1249, DOI 10.1162/jocn_a_00778; Henschen SL, 1919, Z GESAMTE NEUROL PSY, V52, P273, DOI 10.1007/BF02872428; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Lahey BB, 2012, NEUROIMAGE, V60, P1982, DOI 10.1016/j.neuroimage.2012.02.002; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Marcar VL, 2004, NEUROIMAGE, V23, P947, DOI 10.1016/j.neuroimage.2004.05.028; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Omrani M, 2017, J NEUROPHYSIOL, V118, P1828, DOI 10.1152/jn.00795.2016; Owen WJ, 2004, BRAIN LANG, V90, P40, DOI 10.1016/S0093-934X(03)00418-8; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Poldrack RA, 2016, ANNU REV PSYCHOL, V67, P587, DOI 10.1146/annurev-psych-122414-033729; Poldrack RA, 2012, NEUROIMAGE, V62, P1216, DOI 10.1016/j.neuroimage.2011.08.007; Price CJ, 1999, BRAIN, V122, P2221, DOI 10.1093/brain/122.12.2221; Raven J., 1962, ADV PROGR MATRICES S; Razlighi Q., 2016, CEREB CORTEX; Salthouse TA, 1998, DEV PSYCHOL, V34, P851, DOI 10.1037/0012-1649.34.5.851; Salthouse TA, 2006, DEV REV, V26, P31, DOI 10.1016/j.dr.2005.09.001; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; SALTHOUSE TA, 1993, J GERONTOL, V48, pP29, DOI 10.1093/geronj/48.1.P29; Salthouse TA, 2008, INTELLIGENCE, V36, P464, DOI 10.1016/j.intell.2007.10.003; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schwaighofer M, 2015, EDUC PSYCHOL-US, V50, P138, DOI 10.1080/00461520.2015.1036274; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stern Y, 2014, NEUROIMAGE, V103, P139, DOI 10.1016/j.neuroimage.2014.09.029; Trimble M., 2008, HDB BEHAV NEUROSCIEN, V18; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Waechter RL, 2013, NEUROPSYCHOLOGIA, V51, P464, DOI 10.1016/j.neuropsychologia.2012.11.026; Woodcock R.W., 1989, WOODCOCK JOHNSON PSY; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yeo BTT, 2015, CEREB CORTEX, V25, P3654, DOI 10.1093/cercor/bhu217; Yu CY, 2002, ANN C AM ED RES ASS	61	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228167	10.1371/journal.pone.0228167	http://dx.doi.org/10.1371/journal.pone.0228167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9IO	32040518	Green Published, gold			2022-12-26	WOS:000534629400016
J	Nomura, S; Yoneoka, D; Tanaka, S; Makuuchi, R; Sakamoto, H; Ishizuka, A; Nakamura, H; Kubota, A; Shibuya, K				Nomura, Shuhei; Yoneoka, Daisuke; Tanaka, Shiori; Makuuchi, Ryoko; Sakamoto, Haruka; Ishizuka, Aya; Nakamura, Haruyo; Kubota, Anna; Shibuya, Kenji			Limited alignment of publicly competitive disease funding with disease burden in Japan	PLOS ONE			English	Article							INSTITUTES-OF-HEALTH; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; BIOMEDICAL-RESEARCH; REGIONS; AREAS; NIH; UK	Objective The need to align investments in health research and development (R&D) with public health needs is one of the most important public health challenges in Japan. We examined the alignment of disease-specific publicly competitive R&D funding to the disease burden in the country. Methods We analyzed publicly available data on competitive public funding for health in 2015 and 2016 and compared it to disability-adjusted life year (DALYs) in 2016, which were obtained from the Global Burden of Disease (GBD) 2017 study. Their alignment was assessed as a percentage distribution among 22 GBD disease groups. Funding was allocated to the 22 disease groups based on natural language processing, using textual information such as project title and abstract for each research project, while considering for the frequency of information. Results Total publicly competitive funding in health R&D in 2015 and 2016 reached 344.1 billion JPY (about 3.0 billion USD) for 32,204 awarded projects. About 49.5% of the funding was classifiable for disease-specific projects. Five GDB disease groups were significantly and relatively well-funded compared to their contributions to Japan's DALY, including neglected tropical diseases and malaria (funding vs DALY = 1.7% vs 0.0%, p< 0.01) and neoplasms (28.5% vs 19.2%, p< 0.001). In contrast, four GDB disease groups were significantly underfunded, including cardiovascular diseases (8.0% vs 14.8%, p< 0.001) and musculoskeletal disorders (1.0% vs 11.9%, p< 0.001). These percentages do not include unclassifiable funding. Conclusions While caution is necessary as this study was not able to consider public in-house funding and the methodological uncertainties could not be ruled out, the analysis may provide a snapshot of the limited alignment between publicly competitive disease-specific funding and the disease burden in the country. The results call for greater management over the allocation of scarce resources on health R&D. DALYs will serve as a crucial, but not the only, consideration in aligning Japan's research priorities with the public health needs. In addition, the algorithms for natural language processing used in this study require continued efforts to improve accuracy.	[Nomura, Shuhei; Yoneoka, Daisuke; Tanaka, Shiori; Makuuchi, Ryoko; Sakamoto, Haruka; Ishizuka, Aya; Nakamura, Haruyo; Kubota, Anna; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Nomura, Shuhei; Kubota, Anna] Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo, Japan; [Nomura, Shuhei; Tanaka, Shiori] Natl Canc Ctr, Ctr Publ Hlth Sci, Epidemiol & Prevent Grp, Tokyo, Japan; [Yoneoka, Daisuke] St Lukes Int Univ, Grad Sch Publ Hlth, Tokyo, Japan; [Makuuchi, Ryoko] Charles Univ Prague, Fac Med, Hradec Kralove, Czech Republic	University of Tokyo; Keio University; National Cancer Center - Japan; St. Luke's International Hospital; Charles University Prague; University Hospital Hradec Kralove	Nomura, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan.; Nomura, S (corresponding author), Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo, Japan.; Nomura, S (corresponding author), Natl Canc Ctr, Ctr Publ Hlth Sci, Epidemiol & Prevent Grp, Tokyo, Japan.	s-nomura@m.u-tokyo.ac.jp	Nomura, Shuhei/HCH-5356-2022; Yoneoka, Daisuke/A-9336-2016	Shibuya, Kenji/0000-0003-2528-7530; Nomura, Shuhei/0000-0002-2963-7297; Yoneoka, Daisuke/0000-0002-3525-5092	Ministry of Health, Labour and Welfare of Japan [H30-Tokubetsu-Shitei-005]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Ministry of Health, Labour and Welfare of Japan (H30-Tokubetsu-Shitei-005). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, results, and conclusions reported in this paper are those of the authors and are independent of the funding sources.	Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Achoki T, 2019, LANCET GLOB HEALTH, V7, pE81, DOI 10.1016/S2214-109X(18)30472-8; Adam T, 2019, B WORLD HEALTH ORGAN, V97, P516, DOI 10.2471/BLT.19.240499; AMED, 2015, KEY POINTS FY 2016 R; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; ANDERSON C, 1993, SCIENCE, V260, P483, DOI 10.1126/science.8475380; [Anonymous], 2018, LANCET, V392, P1683, DOI 10.1016/S0140-6736(18)32858-7; Cabinet Office, 2016, BAS PRINC AS HLTH WE; Cabinet Office, 2014, MED RES DEV PROM PLA; Cabinet Office, 2006, SCI TECHN BAS PLAN; Chapman N, 2019, G FINDER 2018 REPORT; Chinnery F, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2489-7; Dandona L, 2017, NATL MED J INDIA, V30, P309, DOI 10.4103/0970-258X.239069; Devlin J., 2018, ARXIV181004805; Fujiwara Y, 2017, COMPREHENSIVE ANAL J; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Gomez-Dantes H, 2016, LANCET, V388, P2386, DOI 10.1016/S0140-6736(16)31773-1; GREENE WH, 1991, REV ECON STAT, V73, P563, DOI 10.2307/2109587; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Hagstrom EL, 2015, J AM ACAD DERMATOL, V73, P383, DOI 10.1016/j.jaad.2015.04.039; Hatano Kenji, 2003, AMIA Annu Symp Proc, P859; HATZIANDREU E, 1988, REV INFECT DIS, V10, P159; Hay SI, 2017, LANCET, V389, pE1; Head MG, 2016, EBIOMEDICINE, V3, P180, DOI 10.1016/j.ebiom.2015.12.016; Head MG, 2013, LANCET INFECT DIS, V13, P55, DOI 10.1016/S1473-3099(12)70261-X; Io Medicine, 1998, SCI OPP PUBL NEEDS I; Johansson LA, 2006, B WORLD HEALTH ORGAN, V84, P254; Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3; Lamarre-Cliche M, 2001, CLIN INVEST MED, V24, P83; Lichtenberg FR, 1999, ALLOCATION PUBLIC FU; LIEW CK, 1976, J AM STAT ASSOC, V71, P746, DOI 10.2307/2285614; Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2; Matsuda T, 2015, INT J CLIN ONCOL, V20, P11, DOI 10.1007/s10147-014-0765-4; Mboi N, 2018, LANCET, V392, P581, DOI 10.1016/S0140-6736(18)30595-6; MEXT, DAT GRANTS AID SCI R; MHLW, MHLW GRANTS SYST; Ministry of Health Labour and Welfare, 2016, NAT ACT PLAN ANT RES; Misganaw A, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0146-0; Miyata H, 2014, SURG TODAY, V44, P1991, DOI 10.1007/s00595-013-0802-3; Murray C.J, 1996, GLOBAL BURDEN DIS CO; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; NIH, 2015, NIH WID STRAT PLAN F; Nomura S, 2017, LANCET, V390, P1521, DOI 10.1016/S0140-6736(17)31544-1; Nonaka R., 2019, NOBEL LAUREATE LEAD; OECD, EXCH RAT PAR; OECD, GROSS DOM SPEND R D; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Steel N, 2018, LANCET, V392, P1647, DOI [10.1016/S0140-6736(18)32207-4, 10.1016/s0140-6736(18)32207-4]; Tessema GA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4071-8; Varmus H, 1999, NEW ENGL J MED, V340, P1914, DOI 10.1056/NEJM199906173402411; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Bank, 2018, MON MICR STRENGTH CL; World Health Organization, 2019, NUMB GRANTS BIOM RES; World Health Organization, 2019, HLTH PROD PIP DISC M; , 2018, REP NIH FUND VS GLOB	58	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2020	15	2							e0228542	10.1371/journal.pone.0228542	http://dx.doi.org/10.1371/journal.pone.0228542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9IO	32040510	Green Published, Green Submitted, gold			2022-12-26	WOS:000534629400024
J	Bowers, MR; Reist, NE				Bowers, Matthew R.; Reist, Noreen E.			The C(2)A domain of synaptotagmin is an essential component of the calcium sensor for synaptic transmission	PLOS ONE			English	Article							MEMBRANE-PENETRATION ACTIVITY; CA2+ BINDING; TRANSMITTER RELEASE; C2B DOMAIN; DROSOPHILA; MUTATIONS; MUTANTS; EXPRESSION; ABSENCE; MOTIF	The synaptic vesicle protein, synaptotagmin, is the principle Ca2+ sensor for synaptic transmission. Ca2+ influx into active nerve terminals is translated into neurotransmitter release by Ca2+ binding to synaptotagmin's tandem C2 domains, triggering the fast, synchronous fusion of multiple synaptic vesicles. Two hydrophobic residues, shown to mediate Ca2+-dependent membrane insertion of these C2 domains, are required for this process. Previous research suggested that one of its tandem C2 domains (C2B) is critical for fusion, while the other domain (C(2)A) plays only a facilitatory role. However, the function of the two hydrophobic residues in C(2)A have not been adequately tested in vivo. Here we show that these two hydrophobic residues are absolutely required for synaptotagmin to trigger vesicle fusion. Using in vivo electrophysiological recording at the Drosophila larval neuromuscular junction, we found that mutation of these two key C(2)A hydrophobic residues almost completely abolished neurotransmitter release. Significantly, mutation of both hydrophobic residues resulted in more severe deficits than those seen in synaptotagmin null mutants. Thus, we report the most severe phenotype of a C(2)A mutation to date, demonstrating that the C(2)A domain is absolutely essential for synaptotagmin's function as the electrostatic switch.	[Bowers, Matthew R.; Reist, Noreen E.] Colorado State Univ, Mol Cellular Integrat Neurosci Program, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	Reist, NE (corresponding author), Colorado State Univ, Mol Cellular Integrat Neurosci Program, Dept Biomed Sci, Ft Collins, CO 80523 USA.	reist@colostate.edu		Reist, Noreen/0000-0002-1647-3166	National Science Foundation [IOS-1257363]; CRC from the College of Veterinary Medicine and Biomedical Sciences award	National Science Foundation(National Science Foundation (NSF)); CRC from the College of Veterinary Medicine and Biomedical Sciences award	NER - IOS-1257363 from the National Science Foundation. www.nsf.gov.NER - CRC from the College of Veterinary Medicine and Biomedical Sciences award. https://vetmedbiosci.colostate.edu.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsen B, 2004, J CELL BIOL, V166, P249, DOI 10.1083/jcb.200312054; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Catherine CR, 2005, MOL CELL NEUROSCI, V29, P462, DOI 10.1016/j.mcn.2005.03.015; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GERBER SH, 2002, DIABETES S1, V51, pS1, DOI DOI 10.2337/DIABETES.51.2007.S12; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Kiessling V, 2018, NAT STRUCT MOL BIOL, V25, P911, DOI 10.1038/s41594-018-0130-9; Lai AL, 2011, J BIOL CHEM, V286, P25291, DOI 10.1074/jbc.M111.258848; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Mace KE, 2009, GENESIS, V47, P337, DOI 10.1002/dvg.20502; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Paddock BE, 2008, J NEUROSCI, V28, P7458, DOI 10.1523/JNEUROSCI.0197-08.2008; Paddock BE, 2011, J NEUROSCI, V31, P2248, DOI 10.1523/JNEUROSCI.3153-09.2011; PERIN MS, 1991, J BIOL CHEM, V266, P615; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Striegel AR, 2012, J NEUROSCI, V32, P1253, DOI 10.1523/JNEUROSCI.4652-11.2012; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Vermaas JV, 2017, BIOCHEMISTRY-US, V56, P281, DOI 10.1021/acs.biochem.6b00468; Wang P, 2003, J BIOL CHEM, V278, P47030, DOI 10.1074/jbc.M306728200; YAO KM, 1994, J NEUROCHEM, V63, P41; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	48	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228348	10.1371/journal.pone.0228348	http://dx.doi.org/10.1371/journal.pone.0228348			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032373	Green Published, Green Submitted, gold			2022-12-26	WOS:000534626100013
J	Reynolds, DA; Yoo, MJ; Dixson, DL; Ross, C				Reynolds, David A.; Yoo, Mi-Jeong; Dixson, Danielle L.; Ross, Cliff			Exposure to the Florida red tide dinoflagellate, Karenia brevis, and its associated brevetoxins induces ecophysiological and proteomic alterations in Porites astreoides	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HARMFUL ALGAL BLOOMS; OXIDATIVE STRESS; HISTONE ACETYLATION; REDUCTIVE CARBOXYLATION; CELLULAR-PROTEINS; MARINE AEROSOL; TRANSCRIPTOME; DEGRADATION; HOMEOSTASIS	As reef-building corals are increasingly being exposed to persistent threats that operate on both regional and global scales, there is a pressing need to better understand the complex processes that diminish coral populations. This study investigated the impacts of the Florida red tide dinoflagellate Karenia brevis and associated brevetoxins on selected facets of coral biology using Porites astreoides as a model system. When provided with choice assays, P. astreoides larvae were shown to actively avoid seawater containing red tide (5x10(5) cells L-1 -7.6x10(6) cells L-1) or purified brevetoxins (0.018 mu g mL(-1) brevetoxin-2 and 0.0018 mu g mL(-1) brevetoxin-3). However, forced exposure to similar treatments induced time-dependent physiological and behavioral changes that were captured by PAM fluorometry and settlement and survival assays, respectively. Adult fragments of P. astreoides exposed to red tide or associated brevetoxins displayed signs of proteomic alterations that were characterized by the use of an iTRAQ-based quantitative proteomic analysis. The novel use of this technique with P. astreoides demonstrated that protein regulation was highly contingent upon biological versus chemical treatment (i.e. live K. brevis vs. solely brevetoxin exposure) and that several broad pathways associated with cell stress were affected including redox homeostasis, protein folding, energy metabolism and reactive oxygen species production. The results herein provide new insight into the ecology, behavior and sublethal stress of reef-building corals in response to K. brevis exposure and underscore the importance of recognizing the potential of red tide to act as a regional stressor to these important foundation species.	[Reynolds, David A.; Ross, Cliff] Univ North Florida, Dept Biol, Jacksonville, FL 32224 USA; [Yoo, Mi-Jeong] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA; [Dixson, Danielle L.] Univ Delaware, Sch Marine Sci & Policy, Delaware, OH USA	State University System of Florida; University of North Florida; Clarkson University; University of Delaware	Ross, C (corresponding author), Univ North Florida, Dept Biol, Jacksonville, FL 32224 USA.	cliff.ross@unf.edu	Yoo, Mi-Jeong/ABH-9752-2020	Yoo, Mi-Jeong/0000-0003-4991-2636	Corals Program of the Florida Fish and Wildlife Research Institute	Corals Program of the Florida Fish and Wildlife Research Institute	We greatly appreciate the efforts of Dr. Kate Semon Lunz for her assistance and support through the Corals Program of the Florida Fish and Wildlife Research Institute. We also thank Matt Garrett for his generosity and providing K. brevis cultures. We thank two anonymous reviewers who provided helpful comments on an earlier draft of this manuscript. This work was conducted under permit no. FKNMS-2016-023 issued by the Florida Keys National Marine Sanctuary.	Abbasi FM, 2004, PROTEOMICS, V4, P2072, DOI 10.1002/pmic.200300741; Baden D.G., 2000, FOOD SCI TECHNOL N M, P505, DOI [10.1201/9780203909539.ch23, DOI 10.1201/9780203909539.CH23]; Baden DG, 2005, ENVIRON HEALTH PERSP, V113, P621, DOI 10.1289/ehp.7499; Bando Y, 2004, APOPTOSIS, V9, P501, DOI 10.1023/B:APPT.0000031446.95532.ad; Bantscheff M, 2008, MOL CELL PROTEOMICS, V7, P1702, DOI 10.1074/mcp.M800029-MCP200; Baptista T, 2013, ONCOTARGET, V4, P1673, DOI 10.18632/oncotarget.1237; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Brand LE, 2007, HARMFUL ALGAE, V6, P232, DOI 10.1016/j.hal.2006.08.005; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Cheng YS, 2005, ENVIRON SCI TECHNOL, V39, P3443, DOI 10.1021/es048680j; Cheng YS, 2005, ENVIRON HEALTH PERSP, V113, P638, DOI 10.1289/ehp.7496; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Cohen JH, 2007, J PLANKTON RES, V29, P301, DOI 10.1093/plankt/fbm016; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Dryhurst D, 2012, CANCER LETT, V315, P38, DOI 10.1016/j.canlet.2011.10.003; Dupont JM, 2010, MAR ECOL PROG SER, V415, P189, DOI 10.3354/meps08739; Echevarria M, 2012, AQUAT TOXICOL, V106, P85, DOI 10.1016/j.aquatox.2011.10.011; Errera RM, 2014, HARMFUL ALGAE, V37, P110, DOI 10.1016/j.hal.2014.05.012; Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/nmeth.2227, 10.1038/NMETH.2227]; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Fu FX, 2012, MAR ECOL PROG SER, V470, P207, DOI 10.3354/meps10047; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Grune T, 1998, J BIOL CHEM, V273, P10857, DOI 10.1074/jbc.273.18.10857; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hardman Ron C, 2004, Harmful Algae 2002 (2002), V10, P153; Heil CA, 2014, HARMFUL ALGAE, V38, P3, DOI 10.1016/j.hal.2014.07.015; Heim S, 2002, J BACTERIOL, V184, P6739, DOI 10.1128/JB.184.23.6739-6745.2002; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu C, 2008, CONT SHELF RES, V28, P159, DOI 10.1016/j.csr.2007.04.014; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Huang TS, 2009, COMP BIOCHEM PHYS B, V154, P435, DOI 10.1016/j.cbpb.2009.08.009; Imbs AB, 2012, CORAL REEFS, V31, P41, DOI 10.1007/s00338-011-0817-4; Jaap Walter C., 2008, V1, P75, DOI 10.1007/978-1-4020-6847-8_3; Jacobson J, 2002, J CELL SCI, V115, P1175; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kenkel CD, 2013, MOL ECOL, V22, P4322, DOI 10.1111/mec.12390; Koh J, 2015, J PROTEOME RES, V14, P3068, DOI 10.1021/pr501323d; Koh J, 2012, NEW PHYTOL, V196, P292, DOI 10.1111/j.1469-8137.2012.04251.x; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Leverone JR, 2006, TOXICON, V48, P75, DOI 10.1016/j.toxicon.2006.04.012; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Lizak B, 2006, AM J PHYSIOL-CELL PH, V291, pC511, DOI 10.1152/ajpcell.00274.2005; LOEBLICH AR, 1968, LIPIDS, V3, P5, DOI 10.1007/BF02530961; Lough JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24530-9; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mansour TA, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0138-1; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Mayfield Anderson B., 2018, Open Journal of Marine Science, V8, P223; Mayfield AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192001; McGuire MP, 1998, CORAL REEFS, V17, P369, DOI 10.1007/s003380050141; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Murrell RN, 2009, ARCH TOXICOL, V83, P1009, DOI 10.1007/s00204-009-0443-x; Nitschke MR, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00045; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Oakley CA, 2017, J PROTEOME RES, V16, P2121, DOI 10.1021/acs.jproteome.6b00797; Oakley CA, 2016, CELL MICROBIOL, V18, P1009, DOI 10.1111/cmi.12564; Olsen K, 2013, MAR BIOL, V160, P2609, DOI 10.1007/s00227-013-2255-z; Olsen K, 2014, MAR ECOL PROG SER, V509, P181, DOI 10.3354/meps10880; Ow SY, 2011, PROTEOMICS, V11, P2341, DOI 10.1002/pmic.201000752; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; Pierce R, 2008, CONT SHELF RES, V28, P45, DOI 10.1016/j.csr.2007.04.012; Pierce RH, 2008, ECOTOXICOLOGY, V17, P623, DOI 10.1007/s10646-008-0241-x; Pierce RH, 2003, B ENVIRON CONTAM TOX, V70, P161, DOI 10.1007/s00128-002-0170-y; Pinzon JH, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140214; POLI MA, 1986, MOL PHARMACOL, V30, P129; Rasher Douglas B., 2010, Communicative & Integrative Biology, V3, P564, DOI 10.4161/cib.3.6.12978; Reich HG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171768; Rentzsch F, 2019, CURR OPIN NEUROBIOL, V56, P87, DOI 10.1016/j.conb.2018.12.004; Ritson-Williams R, 2016, MAR ECOL PROG SER, V548, P127, DOI 10.3354/meps11688; Rolton A, 2014, AQUAT TOXICOL, V155, P199, DOI 10.1016/j.aquatox.2014.06.023; Rosic N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1052; Ross C, 2010, HARMFUL ALGAE, V9, P173, DOI 10.1016/j.hal.2009.09.001; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Serrano XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21619; Sheynkman GM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-703; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shinzato C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085182; Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490; Steidinger KA, 2009, HARMFUL ALGAE, V8, P549, DOI 10.1016/j.hal.2008.11.009; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Svotelis A, 2010, CELL CYCLE, V9, P364, DOI 10.4161/cc.9.2.10465; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Tester PA, 1997, LIMNOL OCEANOGR, V42, P1039, DOI 10.4319/lo.1997.42.5_part_2.1039; Thompson JR, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00176; Tian L, 2011, AQUAT TOXICOL, V104, P211, DOI 10.1016/j.aquatox.2011.04.019; Toonen RJ, 2013, PEERJ, V1, DOI 10.7717/peerj.203; Traylor-Knowles N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-585; Trinh Hung V, 2013, Int J Proteomics, V2013, P581862, DOI 10.1155/2013/581862; Ullrich O, 1999, ARCH BIOCHEM BIOPHYS, V362, P211, DOI 10.1006/abbi.1998.1031; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Valdes-Mora F, 2012, GENOME RES, V22, P307, DOI 10.1101/gr.118919.110; van Hooidonk R, 2014, GLOBAL CHANGE BIOL, V20, P103, DOI 10.1111/gcb.12394; Veal EA, 2002, J BIOL CHEM, V277, P35523, DOI 10.1074/jbc.M111548200; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652; Viner RI, 2000, FREE RADICAL BIO MED, V29, P489, DOI 10.1016/S0891-5849(00)00325-7; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang XJ, 2012, J PROTEOME RES, V11, P1009, DOI 10.1021/pr200766z; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Warlen SM, 1998, B MAR SCI, V63, P83; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Weisberg RH, 2009, HARMFUL ALGAE, V8, P585, DOI 10.1016/j.hal.2008.11.003; Wen B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1133-3; Wen B, 2014, BIOINFORMATICS, V30, P3136, DOI 10.1093/bioinformatics/btu397; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P2072, DOI 10.1016/j.freeradbiomed.2004.09.011; Wendt DE, 2000, BIOL BULL, V198, P346, DOI 10.2307/1542690; Wolny JL, 2015, ALGAE-SEOUL, V30, P49, DOI 10.4490/algae.2015.30.1.049; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Wynne JW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0532-x; Yoshida T, 2015, ARCH BIOCHEM BIOPHYS, V574, P49, DOI 10.1016/j.abb.2015.01.022	128	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228414	10.1371/journal.pone.0228414	http://dx.doi.org/10.1371/journal.pone.0228414			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9HH	32032360	gold, Green Published			2022-12-26	WOS:000534626100014
J	Saghafi-Asl, M; Aliasgharzadeh, S; Asghari-Jafarabadi, M				Saghafi-Asl, Maryam; Aliasgharzadeh, Soghra; Asghari-Jafarabadi, Mohammad			Factors influencing weight management behavior among college students: An application of the Health Belief Model	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; UNIVERSITY-STUDENTS; EATING HABITS; LIFE-STYLE; PREDICTORS; OBESITY; HOME	Background Overweight and obesity have become a significant public health concern in both developing and developed countries. Due to the health implications of weight-reduction behaviors, it is important to explore the factors that predict their occurrence. Therefore, the present study was performed to examine factors affecting the behavioral intention of weight management as well as assess the predictive power of the Health Belief Model (HBM) for body mass index (BMI). Methods This cross-sectional study was conducted among 336 female students recruited from dormitories of Tabriz University of Medical Sciences, using quota sampling technique. Data were collected by a structured questionnaire in seven parts (including perceived severity, perceived susceptibility, perceived benefit, perceived barrier, cue to action, self-efficacy in dieting and physical activity, and behavioral intention of weight management), based on the HBM. Structural equation modeling (SEM) was conducted to identify the relationship between HBM constructs and behavioral intention of weight management. Linear regression model was performed to test the ability of the HBM to predict students' BMIs. Results Higher level of perceived threats (sum of perceived susceptibility and severity) (beta = 0.41, P < 0.001), perceived benefits (beta = 0.19, P = 0.009), self-efficacy in exercise (beta = 0.17, P = 0.001), and self-efficacy in dieting (beta = 0.16, P = 0.025) scales was significantly related to greater behavioral intention of weight management. Moreover, perceived threat mediated the relationships between perceived cue to action, perceived benefits, self-efficacy in exercise, and weight management practices. The fit indices of the SEM model seemed acceptable. The final regression model explained approximately 40% of variance in BMI (P<0.001). Additionally, perceived severity, barrier, and self-efficacy in dietary life were the significant variables to predict students' BMIs. Conclusions These findings suggest that health education programs based on the HBM needs to be integrated in preventive health programs and health interventions strategies to ensure adherence and well-being of the participants.	[Saghafi-Asl, Maryam] Tabriz Univ Med Sci, Nutr Res Ctr, Sch Nutr & Food Sci, Tabriz, Iran; [Aliasgharzadeh, Soghra] Tabriz Univ Med Sci, Sch Nutr & Food Sci, Student Res Comm, Tabriz, Iran; [Asghari-Jafarabadi, Mohammad] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Aliasgharzadeh, S (corresponding author), Tabriz Univ Med Sci, Sch Nutr & Food Sci, Student Res Comm, Tabriz, Iran.	Soghra.aliasgharzadeh@gmail.com		aliasgharzadeh, soghra/0000-0002-7846-0248	Tabriz University of Medical Sciences; Student Research Committee of Tabriz University of Medical Sciences	Tabriz University of Medical Sciences; Student Research Committee of Tabriz University of Medical Sciences	This work was supported by the Tabriz University of Medical Sciences to MS-A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Hossein Karimzadeh, Assistant Professor, Department of Urban Planning of Tabriz University for his assistance with data analysis, and also the participants who involved in this study. Also, the authors would like to acknowledge the support of this work by Student Research Committee of Tabriz University of Medical Sciences.	Allison PD, 2003, J ABNORM PSYCHOL, V112, P545, DOI 10.1037/0021-843X.112.4.545; [Anonymous], 2016, NEW INSIGHTS AM PERC; Basto-Abreu A, 2018, OBESITY, V26, P176, DOI 10.1002/oby.22042; Bhurosy T, 2014, SCI WORLD J, V2014; Bishop AC, 2015, HEALTH EXPECT, V18, P3019, DOI 10.1111/hex.12286; Burgess E, 2017, CLIN OBES, V7, P123, DOI 10.1111/cob.12183; Cheng L, 2019, BRIT FOOD J; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Deshpande Sameer, 2009, Health Mark Q, V26, P145, DOI 10.1080/07359680802619834; Emery CF, 2015, INT J OBESITY, V39, P1401, DOI 10.1038/ijo.2015.70; Faghri P, 2016, J OBESITY WEIGHT LOS, V6; Frech A, 2012, ADV LIFE COURSE RES, V17, P59, DOI 10.1016/j.alcr.2012.01.003; Garcia K, 2003, J HEALTH PSYCHOL, V8, P347, DOI 10.1177/13591053030083005; Glanz K., 2008, HLTH BEHAV HLTH ED T; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Hays Laura M, 2014, Diabetes Spectr, V27, P270, DOI 10.2337/diaspect.27.4.270; Heymsfield S, 2018, NAM PERSPECTIVES; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang HT, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040395; James DCS, 2012, J ACAD NUTR DIET, V112, P664, DOI 10.1016/j.jand.2012.02.003; Kang Y, 1998, KOREAN J PREV MED, V31, P199; Karabulut US, 2018, EXERC MED, V2; Kearns K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-143; Kline R. B, 2015, PRINCIPLES PRACTICE, DOI DOI 10.1111/j.1467-8721.2009.01598.x; Laranjo L, 2016, SOCIAL MEDIA HLTH BE, P83; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Lazzeretti L, 2015, WORLD J PSYCHIATR, V5, P56, DOI 10.5498/wjp.v5.i1.56; Lupi S, 2015, ANN I SUPER SANITA, V51, P154, DOI 10.4415/ANN_15_02_14; Marques A, 2014, EUR J PUBLIC HEALTH, V28, P295, DOI DOI 10.1093/eurpub/ckx143; McArthur LH, 2018, J NUTR EDUC BEHAV, V50, P485, DOI 10.1016/j.jneb.2017.09.010; Mendez-Hernandez P, 2010, INT J PUBLIC HEALTH, V55, P221, DOI 10.1007/s00038-009-0104-0; Moore SE, 2010, J NATL MED ASSOC, V102, P119, DOI 10.1016/S0027-9684(15)30499-5; Morgenstern M, 2009, ARCH PEDIAT ADOL MED, V163, P731, DOI 10.1001/archpediatrics.2009.78; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; OCONNELL JK, 1985, HEALTH EDUC QUART, V12, P343, DOI 10.1177/109019818501200401; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Papadaki A, 2007, APPETITE, V49, P169, DOI 10.1016/j.appet.2007.01.008; Park DY, 2011, NUTR RES PRACT, V5, P337, DOI 10.4162/nrp.2011.5.4.337; Pengpid S, 2015, HOMO, V66, P176, DOI 10.1016/j.jchb.2014.11.002; Richman RM, 2001, INT J OBESITY, V25, P907, DOI 10.1038/sj.ijo.0801606; Senekal M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3576-x; Stubbs J, 2011, OBES REV, V12, P688, DOI 10.1111/j.1467-789X.2011.00883.x; Stutts Wanda C, 2002, AAOHN J, V50, P499; Tremmel M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040435; Vella-Zarb RA, 2009, J AM COLL HEALTH, V58, P161, DOI 10.1080/07448480903221392; World Health Organization, OB OV; Wronka I, 2012, ANTHROPOL ANZ, V69, P85, DOI 10.1127/0003-5548/2011/0131; Zhu DQ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-131	49	22	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2020	15	2							e0228058	10.1371/journal.pone.0228058	http://dx.doi.org/10.1371/journal.pone.0228058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9HH	32032376	Green Submitted, Green Published, gold			2022-12-26	WOS:000534626100009
J	Rafiei, A; Baghlaninezhad, R; Koster, PC; Bailo, B; de Mingo, MH; Carmena, D; Panabad, E; Beiromvand, M				Rafiei, Abdollah; Baghlaninezhad, Raheleh; Koster, Pamela C.; Bailo, Begona; Hernandez de Mingo, Marta; Carmena, David; Panabad, Esmat; Beiromvand, Molouk			Multilocus genotyping of Giardia duodenalis in Southwestern Iran. A community survey	PLOS ONE			English	Article							INTESTINAL PARASITIC INFECTIONS; MOLECULAR CHARACTERIZATION; WATERBORNE TRANSMISSION; WORLDWIDE OUTBREAKS; FARS PROVINCE; LAMBLIA; CHILDREN; PCR; CRYPTOSPORIDIUM; EPIDEMIOLOGY	Giardia duodenalis is one of the main enteric pathogens associated with diarrheal disease. In developing countries, giardiasis is a major public health concern, particularly in children under five years of age. This study aimed to evaluate the occurrence and genetic diversity of G. duodenalis causing human infections in Shushtar County, Southwestern Iran. Individual faecal specimens were collected from 1,163 individuals (male/female ratio: 0.9; age range 2-75 years) with (n = 258) and without (n = 905) gastrointestinal symptoms living in rural and urban settings during the period 2017-2018. Conventional (sucrose flotation and microscopy) methods were used for the initial detection of G. duodenalis cysts in faecal specimens. Microscopy-positive samples were confirmed by PCR amplification and sequencing of the small subunit rRNA (ssu rRNA) gene of the parasite. A multilocus genotyping (MLG) scheme targeting the triose phosphate isomerase (tpi), the glutamate dehydrogenase (gdh), and the beta-giardin (bg) genes was used for genotyping purposes. Giardia duodenalis cysts were detected in 7.7% (90/1,163) of samples by microscopy, of which 82 were confirmed by ssu-PCR. Successful amplification and sequencing results were obtained for 23.2% (19/82), 9.8% (8/82), and 8.5% (7/82) of the confirmed samples at the tpi, gdh, and bg loci, respectively. MLG data for the three loci were available for two samples only. Out of the 24 samples genotyped at any loci, 50% (12/24) were identified as assemblage A and the remaining half as assemblage B. Overall, AII was the most prevalent sub-assemblage detected (41.7%, 10/24), followed by BIII (25.0%, 6/24), discordant BIII/BIV (5/24) or AII/AIII (2/24) sequences, and BIV (1/24). No significant correlation was demonstrated between a given assemblage/sub-assemblage and the occurrence of clinical symptoms. No genotypes adapted to animal hosts other than humans (e.g. assemblages C-F) were found circulating in the investigated human population, suggesting that transmission of human giardiasis in this Iranian region is primarily of anthroponotic nature. Further molecular-based studies are needed to confirm and expand these results, and to ascertain the presence and public health relevance of the parasite in environmental (e.g. drinking water) samples.	[Rafiei, Abdollah; Baghlaninezhad, Raheleh; Beiromvand, Molouk] Ahvaz Jundishapur Univ Med Sci, Infect & Trop Dis Res Ctr, Hlth Res Inst, Ahvaz, Khuzestan, Iran; [Rafiei, Abdollah; Baghlaninezhad, Raheleh; Panabad, Esmat; Beiromvand, Molouk] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Parasitol, Ahvaz, Khuzestan, Iran; [Koster, Pamela C.; Bailo, Begona; Hernandez de Mingo, Marta; Carmena, David] Natl Ctr Microbiol, Parasitol Reference & Res Lab, Madrid, Spain	Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Beiromvand, M (corresponding author), Ahvaz Jundishapur Univ Med Sci, Infect & Trop Dis Res Ctr, Hlth Res Inst, Ahvaz, Khuzestan, Iran.; Beiromvand, M (corresponding author), Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Parasitol, Ahvaz, Khuzestan, Iran.; Carmena, D (corresponding author), Natl Ctr Microbiol, Parasitol Reference & Res Lab, Madrid, Spain.	dacarmena@isciii.es; beiromvand-m@ajums.ac.ir	Beiromvand, Molouk/AAA-8757-2021; Beiromvand, Molouk/L-4062-2018	Beiromvand, Molouk/0000-0002-8190-8349; Carmena, David/0000-0002-4015-8553; Koster, Pamela Carolina/0000-0001-5963-8824; rafiei, abdollah/0000-0001-8997-9056	Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz (Iran) [OG/9731]; Health Institute Carlos III (ISCIII), Ministry of Economy and Competitiveness (Spain) [PI16CIII/00024]	Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz (Iran); Health Institute Carlos III (ISCIII), Ministry of Economy and Competitiveness (Spain)	This study was funded by the Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz (Iran) under grant OG/9731 to MB. Additional funding was obtained from the Health Institute Carlos III (ISCIII), Ministry of Economy and Competitiveness (Spain), under project PI16CIII/00024 to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2013, GENOME BIOL EVOL, V5, P2498, DOI 10.1093/gbe/evt197; Akbarian A, 2012, SCI J KURDISTAN U ME, V17, P61; Akinkuotu OA, 2019, INFECT GENET EVOL, V70, P53, DOI 10.1016/j.meegid.2019.02.017; ANDREWS RH, 1989, INT J PARASITOL, V19, P183, DOI 10.1016/0020-7519(89)90006-4; Ankarklev J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-65; Babaei Z, 2008, IRAN J PUBLIC HEALTH, V37, P75; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Beiromvand M, 2019, ASIAN PAC J TROP MED, V12, P130, DOI 10.4103/1995-7645.254939; Caccio SM, 2018, INFECT GENET EVOL, V66, P335, DOI 10.1016/j.meegid.2017.12.001; Dacal E, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2640-z; Daryani A, 2017, ACTA TROP, V169, P69, DOI 10.1016/j.actatropica.2017.01.019; Ramirez JD, 2015, INFECT GENET EVOL, V32, P208, DOI 10.1016/j.meegid.2015.03.015; de Lucio A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159992; de Lucio A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143981; Ebner J, 2015, INFECT GENET EVOL, V36, P389, DOI 10.1016/j.meegid.2015.08.034; Efstratiou A, 2017, WATER RES, V114, P14, DOI 10.1016/j.watres.2017.01.036; Einarsson E, 2016, CURR OPIN MICROBIOL, V34, P47, DOI 10.1016/j.mib.2016.07.019; Erismann S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1835-4; Fallah E., 2008, Journal of Biological Sciences, V8, P896; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Gelanew T, 2007, ACTA TROP, V102, P92, DOI 10.1016/j.actatropica.2007.04.003; Gillhuber J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-346; Ortega-Pierres MG, 2018, ACTA TROP, V184, P67, DOI 10.1016/j.actatropica.2017.09.004; Hooshyar H, 2017, IRAN J PARASITOL, V12, P83; Jafari Hedieh, 2014, Journal of Parasitic Diseases, V38, P81, DOI 10.1007/s12639-012-0199-8; Puebla LJ, 2014, INFECT GENET EVOL, V23, P7, DOI 10.1016/j.meegid.2014.01.007; Kasaei R, 2018, PARASITOL RES, V117, P1425, DOI 10.1007/s00436-018-5826-6; Kiani-Salmi N, 2019, INFECT GENET EVOL, V75, DOI 10.1016/j.meegid.2019.104021; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Lebbad M, 2008, ACTA TROP, V106, P44, DOI 10.1016/j.actatropica.2008.01.004; Mahmoudi MR, 2013, T ROY SOC TROP MED H, V107, P511, DOI 10.1093/trstmh/trt042; Azcona-Gutierrez JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178575; Mirrezaie E, 2019, ACTA PARASITOL, V64, P376, DOI 10.2478/s11686-019-00051-x; Mirzavand S, 2019, TROP BIOMED, V36, P44; Monis PT, 2003, INFECT GENET EVOL, V3, P29, DOI 10.1016/S1567-1348(02)00149-1; Mowlavi G. R., 2008, Govaresh, V12, P219; Omarova A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030495; Pijnacker R, 2016, EUR J CLIN MICROBIOL, V35, P2005, DOI 10.1007/s10096-016-2753-2; Plutzer J, 2010, INT J HYG ENVIR HEAL, V213, P321, DOI 10.1016/j.ijheh.2010.06.005; Rafiei A, 2014, JUNDISHAPUR J HLTH S, V6, P23462, DOI [10.5812/jjhs.23462, DOI 10.5812/JJHS.23462]; Rafiei A, 2013, IRAN J PARASITOL, V8, P389; Rayani M, 2017, IRAN J PARASITOL, V12, P522; Rayani M, 2014, IRAN J PARASITOL, V9, P70; Razmjou E, 2017, MULTILOCUS GENOTYPIN; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Rogawski ET, 2017, J PEDIATR INFECT DIS, V6, P153, DOI 10.1093/jpids/piw082; Roointan ES, 2013, JUNDISHAPUR J MICROB, V6, P279, DOI 10.5812/jjm.6443; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Sarkari B, 2012, TROP BIOMED, V29, P366; Siripattanapipong S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-206; Skhal D, 2017, INFECT GENET EVOL, V47, P155, DOI 10.1016/j.meegid.2016.11.030; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Taherkhani H, 2009, J CLIN DIAGN RES, V3, P1416; Tappeh KH, 2014, IRAN J PARASITOL, V9, P541; Thompson RCA, 2016, INFECT GENET EVOL, V40, P315, DOI 10.1016/j.meegid.2015.09.028; WEISS JB, 1992, MOL BIOCHEM PARASIT, V54, P73, DOI 10.1016/0166-6851(92)90096-3; Yason JADL, 2007, PARASITOL RES, V101, P681, DOI 10.1007/s00436-007-0533-8	58	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228317	10.1371/journal.pone.0228317	http://dx.doi.org/10.1371/journal.pone.0228317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027684	Green Published, gold			2022-12-26	WOS:000534623800022
J	Suzuki, K; Kimura, N; Mieno, M; Hori, D; Sezai, A; Yamaguchi, A; Tanaka, M				Suzuki, Keito; Kimura, Naoyuki; Mieno, Makiko; Hori, Daijiro; Sezai, Akira; Yamaguchi, Atsushi; Tanaka, Masashi			Factors related to white blood cell elevation in acute type A aortic dissection	PLOS ONE			English	Article							LYMPHOCYTE RATIO; NEUTROPHIL; OUTCOMES; MORTALITY; INFLAMMATION; EXPRESSION; MANAGEMENT; REGISTRY	Aortic dissection may induce a systemic inflammatory reaction. The etiological backgrounds for elevation of the white blood cell count remain to be clarified. In 466 patients with acute type A aortic dissection treated surgically within 48 hours of symptom onset, the etiologic background of an elevated admission white blood cell count and the effect of such elevation on outcomes were assessed retrospectively. Patients' white blood cell count differed significantly in relation to the extent of dissection, with a median (25th, 75th percentile) white blood cell count of 10.4 (8.1, 13.9) x 10(3)/mu L for dissection confined to the ascending aorta, 10.5 (8.2,13.) 10(3)/mu L for dissection extending to the aortic arch/descending aorta, 11.1 (8.2, 13.7) x 10(3)/mu L for extension to the abdominal aorta, and 13.3 (9.8, 15.9) x 10(3)/mu L for extension to the iliac artery (p<0.001). With 11.0 x 10(3)/mu L used as the cut-off value for white blood cell count elevation, multivariable analysis showed current smoking (p<0.001; odds ratio, 2.79), dissection extending to the iliac artery (p = 0.006; odds ratio, 1.79), age (p = 0.007, odds ratio, 0.98), and no coronary ischemia (p = 0.027, odds ratio, 2.22) to be factors related to the elevated white blood cell count. Mean age differed significantly between patients with and without an elevated white blood cell count (62.3 vs. 68.3 years, p < 0.001). Although in-hospital mortality was similar (7.5% vs.10.9%, p = 0.19), 5-year survival was lower in patients without an elevated count (85.7% vs. 78.6%, p = 0.019), reflecting their more advanced age. In conclusion, our data suggest that dissection morphology and patient age influence the acute phase systemic inflammatory response associated with an elevated white blood cell count in patients with ATAAD. A better understanding of this relation may help optimize diagnosis and perioperative care.	[Suzuki, Keito; Sezai, Akira; Tanaka, Masashi] Nihon Univ, Dept Cardiovasc Surg, Itabashi Ku, Tokyo, Japan; [Kimura, Naoyuki; Hori, Daijiro; Yamaguchi, Atsushi] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Omiya Ku, Saitama, Japan; [Mieno, Makiko] Jichi Med Univ, Ctr Informat, Dept Med Informat, Shimotsuke, Tochigi, Japan	Nihon University; Jichi Medical University; Jichi Medical University	Kimura, N (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Omiya Ku, Saitama, Japan.	kimura-n@omiya.jichi.ac.jp	Hori, Daijiro/ABC-6562-2020		Ministry of Education, Culture, Sports, Science and Technology, Japan [17K10768]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research C (#17K10768 to M.T.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2015, CIRC RES, V116, P612, DOI 10.1161/CIRCRESAHA.116.304918; Augoustides JGT, 2009, NAT CLIN PRACT CARD, V6, P140, DOI 10.1038/ncpcardio1417; Czerny M, 2015, J AM COLL CARDIOL, V65, P2628, DOI 10.1016/j.jacc.2015.04.030; Dong J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43957; Duan XZ, 2018, J THORAC DIS, V10, P1628, DOI 10.21037/jtd.2018.03.48; Fan XH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001761; Henke PK, 2011, ARTERIOSCL THROM VAS, V31, P43, DOI 10.1161/ATVBAHA.110.216317; Itagaki R, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009144; Kale S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013852; Kale SS, 2011, AGING DIS, V2, P501; Kalkan ME, 2017, PERFUSION-UK, V32, P321, DOI 10.1177/0267659115590625; Kawahito K, 2019, GEN THORAC CARDIOVAS, V67, P594, DOI 10.1007/s11748-019-01072-z; Kermani TA, 2016, JCR-J CLIN RHEUMATOL, V22, P184, DOI 10.1097/RHU.0000000000000381; Kimura N, 2017, EUR J CARDIO-THORAC, V52, P810, DOI 10.1093/ejcts/ezx095; Kimura N, 2015, J THORAC CARDIOV SUR, V149, pS91, DOI 10.1016/j.jtcvs.2014.08.008; Kimura N, 2014, AM J CARDIOL, V113, P724, DOI 10.1016/j.amjcard.2013.11.017; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Malenica Maja, 2017, Med Arch, V71, P132, DOI 10.5455/medarh.2017.71.132-136; Mehta RH, 2002, J AM COLL CARDIOL, V40, P685, DOI 10.1016/S0735-1097(02)02005-3; Nagaoka K, 2010, INTERNAL MED, V49, P1943, DOI 10.2169/internalmedicine.49.3770; Onuk T, 2015, CLIN LAB, V61, P1275, DOI 10.7754/Clin.Lab.2015.150216; Oz K, 2017, HEART SURG FORUM, V20, pE119, DOI 10.1532/hsf.1736; Rylski B, 2014, ANN SURG, V259, P598, DOI 10.1097/SLA.0b013e3182902cca; Saha P, 2011, ARTERIOSCL THROM VAS, V31, P506, DOI 10.1161/ATVBAHA.110.213405; Sakakura K, 2010, HYPERTENSION, V55, P422, DOI 10.1161/HYPERTENSIONAHA.109.143131; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Song JK, 2009, CIRCULATION, V120, P2046, DOI 10.1161/CIRCULATIONAHA.109.879783; Sugano Y, 2005, INT J CARDIOL, V102, P39, DOI 10.1016/j.ijcard.2004.03.076; Suzuki T, 2009, CIRCULATION, V119, P2702, DOI 10.1161/CIRCULATIONAHA.108.833004; Tavora F, 2005, CARDIOVASC PATHOL, V14, P320, DOI 10.1016/j.carpath.2005.08.006; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Yoshida S, 2019, ANN VASC DIS, V12, P187, DOI 10.3400/avd.oa.19-00007; Zhang RX, 2016, INT HEART J, V57, P622, DOI 10.1536/ihj.15-484	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228954	10.1371/journal.pone.0228954	http://dx.doi.org/10.1371/journal.pone.0228954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	32027731	Green Published, gold			2022-12-26	WOS:000534623800078
J	Caetano, DG; de Paula, HHS; Bello, G; Hoagland, B; Villela, LM; Grinsztejn, B; Veloso, VG; Morgado, MG; Guimaraes, ML; Cortes, FH				Caetano, Diogo G.; de Paula, Hury H. S.; Bello, Gonzalo; Hoagland, Brenda; Villela, Larissa M.; Grinsztejn, Beatriz; Veloso, Valdilea G.; Morgado, Mariza G.; Guimaraes, Monick L.; Cortes, Fernanda H.			HIV-1 elite controllers present a high frequency of activated regulatory T and Th17 cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE ACTIVATION; DISEASE PROGRESSION; ANTIRETROVIRAL THERAPY; VIRAL REPLICATION; LYMPHOID-TISSUE; NEUTROPHIL RECRUITMENT; INFECTED PATIENTS; CUTTING EDGE; RNA LEVELS	HIV-1 infection is characterized by generalized deregulation of the immune system, resulting in increased chronic immune activation. However, some individuals called HIV controllers (HICs) present spontaneous control of viral replication and have a more preserved immune system. Among HICs, discordant results have been observed regarding immune activation and the frequency of different T cell subsets, including Treg and Th17 cells. We evaluated T cell immune activation, differentiation and regulatory profiles in two groups of HICs-elite controllers (ECs) and viremic controllers (VCs)-and compared them to those of cART-treated individuals (cART) and HIV-1-negative (HIV-neg) individuals. ECs demonstrated similar levels of activated CD4(+) and CD8(+) T cells in comparison to HIV-neg, while cART and VCs showed elevated T cell activation. CD4(+) T cell subset analyses showed differences only for transitional memory T cell frequency between the EC and HIVneg groups. However, VC individuals showed higher frequencies of terminally differentiated, naive, and stem cell memory T cells and lower frequencies of transitional memory and central memory T cells compared to the HIV-neg group. Among CD8(+) T cell subsets, ECs presented higher frequencies of stem cell memory T cells, while VCs presented higher frequencies of terminally differentiated T cells compared to the HIV-neg group. HICs showed lower frequencies of total Treg cells compared to the HIV-neg and cART groups. ECs also presented higher frequencies of activated and a lower frequency of resting Treg cells than the HIV-neg and cART groups. Furthermore, we observed a high frequency of Th17 cells in ECs and high Th17/Treg ratios in both HIC groups. Our data showed that ECs had low levels of activated T cells and a high frequency of activated Treg and Th17 cells, which could restrict chronic immune activation and be indicative of a preserved mucosal response in these individuals.	[Caetano, Diogo G.; de Paula, Hury H. S.; Bello, Gonzalo; Morgado, Mariza G.; Guimaraes, Monick L.; Cortes, Fernanda H.] Fiocruz MS, Lab AIDS & Imunol Mol, Inst Oswaldo Cruz IOC, Rio De Janeiro, Brazil; [Hoagland, Brenda; Villela, Larissa M.; Grinsztejn, Beatriz; Veloso, Valdilea G.] Fiocruz MS, Inst Nacl Infectol Evandro Chagas INI, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Cortes, FH (corresponding author), Fiocruz MS, Lab AIDS & Imunol Mol, Inst Oswaldo Cruz IOC, Rio De Janeiro, Brazil.	fheloise@ioc.fiocruz.br	Côrtes, Fernanda/AID-1002-2022	Caetano, Diogo Gama/0000-0002-8889-0655	PrInt Fiocruz-CAPES Program; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro -FAPERJ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq; Fiocruz; CNPq; FIOCRUZ PDTIS Flow Cytometry Platform [RPT08A]	PrInt Fiocruz-CAPES Program; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro -FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fiocruz; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ PDTIS Flow Cytometry Platform	This work was supported by the PrInt Fiocruz-CAPES Program, the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro -FAPERJ and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq and Fiocruz. MLG, GB, and MGM are recipients of a CNPq Fellowship. A CNPq Ph.D. fellowship funds DGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the patients, nurses, and clinicians who participated in the study. We also thank Egydio Sampaio for support in the recruitment of patients and all INI staff from the blood collection sector. Finally, we thank CD4+ T cell counts and HIV-1 viral load clinical services from the Brazilian Ministry of Health National Network, and the FIOCRUZ PDTIS Flow Cytometry Platform (RPT08A).	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Almeida CAM, 2002, AIDS RES HUM RETROV, V18, P1351, DOI 10.1089/088922202320935429; Anderson AM, 2017, J INFECT DIS, V215, P105, DOI 10.1093/infdis/jiw505; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Angin M, 2012, J INFECT DIS, V205, P1495, DOI 10.1093/infdis/jis236; Baker CAR, 2007, CLIN EXP IMMUNOL, V147, P533, DOI 10.1111/j.1365-2249.2006.03319.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bi X, 2009, EUR J IMMUNOL, V39, P301, DOI 10.1002/eji.200838667; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Boffito M, 2020, AIDS RES HUM RETROV, V36, P13, DOI [10.1089/aid.2019.0171, 10.1089/AID.2019.0171]; Brandt L, 2011, JAIDS-J ACQ IMM DEF, V57, P101, DOI 10.1097/QAI.0b013e318215a991; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Caetano DG, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0444-z; Card CM, 2012, JAIDS-J ACQ IMM DEF, V59, P427, DOI 10.1097/QAI.0b013e3182454fcd; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Christensen-Quick A, 2019, J VIROL, V93, DOI 10.1128/JVI.00179-19; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Ciccone EJ, 2011, J VIROL, V85, P5880, DOI 10.1128/JVI.02643-10; Cohen J, 2011, SCIENCE, V334, P1614, DOI 10.1126/science.334.6063.1614; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cortes FH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01576; Cortes FH, 2015, JAIDS-J ACQ IMM DEF, V68, P377, DOI 10.1097/QAI.0000000000000500; Dandekar S, 2010, CURR OPIN HIV AIDS, V5, P173, DOI 10.1097/COH.0b013e328335eda3; de Azevedo SSD, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0354-5; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Elrefaei M, 2004, J IMMUNOL, V173, P2184, DOI 10.4049/jimmunol.173.3.2184; Falivene J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11511; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Flannigan KL, 2017, MUCOSAL IMMUNOL, V10, P673, DOI 10.1038/mi.2016.80; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Gaardbo JC, 2014, JAIDS-J ACQ IMM DEF, V65, P10, DOI 10.1097/QAI.0b013e3182a7c932; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Ghiglione Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104235; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Hasenkrug KJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006776; He T, 2016, J IMMUNOL, V197, P4535, DOI 10.4049/jimmunol.1601539; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jenabian MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078146; Jiang W, 2014, J VIROL, V88, P5369, DOI 10.1128/JVI.00017-14; Jiao YM, 2009, IMMUNOLOGY, V128, pe366, DOI 10.1111/j.1365-2567.2008.02978.x; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Klatt NR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004345; Krishnan S, 2014, J INFECT DIS, V209, P931, DOI 10.1093/infdis/jit581; Kulpa DA, 2019, J VIROL, V93, DOI 10.1128/JVI.00969-19; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Li GM, 2017, J INFECT DIS, V216, P1579, DOI 10.1093/infdis/jix547; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Luo ZW, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0646-1; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; Mens H, 2010, J VIROL, V84, P12971, DOI 10.1128/JVI.00387-10; Mildvan D, 2005, CLIN INFECT DIS, V40, P853, DOI 10.1086/427877; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Montes M, 2011, J INFECT DIS, V203, P496, DOI 10.1093/infdis/jiq073; Ndhlovu LC, 2008, AIDS, V22, P990, DOI 10.1097/QAD.0b013e3282ff884e; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Okulicz J F., 2012, J AIDS CLIN RES, V03, DOI [10.4172/2155-6113.1000139, DOI 10.4172/2155-6113.1000139]; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; RABIN RL, 1995, J CLIN INVEST, V95, P2054, DOI 10.1172/JCI117891; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Ribeiro SP, 2014, J VIROL, V88, P13836, DOI 10.1128/JVI.01948-14; Rodger AJ, 2019, LANCET, V393, P2428, DOI 10.1016/S0140-6736(19)30418-0; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Saez-Cirion A, 2013, IMMUNOL REV, V254, P281, DOI 10.1111/imr.12076; Salgado M, 2011, CLIN IMMUNOL, V139, P110, DOI 10.1016/j.clim.2011.02.008; Shaw JM, 2011, J VIROL, V85, P11422, DOI 10.1128/JVI.05608-11; Simonetta F, 2012, J INFECT DIS, V205, P1510, DOI 10.1093/infdis/jis235; Sokoya T, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6825493; Suchard MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011762; Teeraananchai S, 2017, HIV MED, V18, P256, DOI 10.1111/hiv.12421; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Valverde-Villegas JM, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/647916; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Younas M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02185; Zangerle R, 1998, INT ARCH ALLERGY IMM, V116, P228, DOI 10.1159/000023949; Zelinskyy G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000406; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	103	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0228745	10.1371/journal.pone.0228745	http://dx.doi.org/10.1371/journal.pone.0228745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023301	Green Published, gold			2022-12-26	WOS:000534621500066
J	Hong, L; Huang, YJ; Peng, SY				Hong, Liang; Huang, Yajun; Peng, Shuangyun			Monitoring the trends of water-erosion desertification on the Yunnan-Guizhou Plateau, China from 1989 to 2016 using time-series Landsat images	PLOS ONE			English	Article							KARST ROCKY DESERTIFICATION; PROVINCE; TIBET	The Yunnan-Guizhou Plateau (YGP) is a typical ecologically fragile region in southwest China. Water-erosion desertification (WED) is one of the most significant environmental and socio-economic issues on the YGP and has seriously restricted the socio-economic development of this region. However, the research on monitoring of the desertification trends in this region has been limited to long time-series Landsat imagery. The objectives of this research were to monitor the WED trends on the YGP using time-series Landsat imagery data from 1989 to 2016. In this paper, we present a multi-indicator rule-based method, which was used to map the WED on the YGP during this period. The results show that the addition of multiple indicators improved the WED classification accuracy to 90.61%. Overall, the following results were obtained by using the proposed method. (1) The slight desertification area on the YGP increased from 89,617.09 km(2) in 1989 to 100,976.47 km(2) in 2016 with an annual growth ratio (AGR) of 0.48%, the moderate desertification area increased from 80,276.65 km(2) in 1989 to 90,768.39 km(2) in 2016 with an AGR of 0.50%, and the severe desertification area increased from 8149.3 km(2) in 1989 to 13,220.16 km(2) in 2016 with an AGR of 2.39%. (2) The WED expansion on the YGP can be divided into three stages. Firstly, the total WED area increased slowly from 17.80x10(4) km(2) in 1989 to 17.98x10(4) km(2) in 2010 with an AGR of 0.05%. Then, the WED rapidly expanded from 17.98x10(4) km(2) in 2010 to 20.28x10(4) km(2) in 2013 with an AGR of 4.26%. Finally, the WED increased slightly from 20.28x10(4) km(2) in 2013 to 20.50x10(4) km(2) in 2016 with an AGR of 0.36%. The total areas of the different degrees of WED decreased in 1992, 1998, 2001, and 2004. (3) The driving factors of WED were analyzed based on the Geographically Weighted Regression (GWR) model. We found that precipitation, vegetation area, and gross domestic product have key roles in the processes of desertification reversion and development. However, the regression coefficients between WED and these factors exhibited considerable spatial variations. The regression coefficients of the key driving factors showed different spatial distributions based on the GWR model in the YGP. The research results can provide scientific reference information for the prevention and control of WED in the YGP.	[Hong, Liang; Huang, Yajun; Peng, Shuangyun] Yunnan Normal Univ, Coll Tourism & Geog Sci, Kunming, Yunnan, Peoples R China; [Hong, Liang; Huang, Yajun; Peng, Shuangyun] Yunnan Normal Univ, Minist Educ, GIS Technol Res Ctr Resource & Environm Western C, Kunming, Yunnan, Peoples R China; [Hong, Liang; Huang, Yajun; Peng, Shuangyun] Yunnan Normal Univ, Ctr Geospatial Informat Engn & Technol Yunnan Pro, Kunming, Yunnan, Peoples R China; [Hong, Liang; Huang, Yajun; Peng, Shuangyun] Yunnan Normal Univ, Key Lab Resources & Environm Remote Sensing Univ, Kunming, Yunnan, Peoples R China	Yunnan Normal University; Yunnan Normal University; Yunnan Normal University; Yunnan Normal University	Huang, YJ (corresponding author), Yunnan Normal Univ, Coll Tourism & Geog Sci, Kunming, Yunnan, Peoples R China.; Huang, YJ (corresponding author), Yunnan Normal Univ, Minist Educ, GIS Technol Res Ctr Resource & Environm Western C, Kunming, Yunnan, Peoples R China.; Huang, YJ (corresponding author), Yunnan Normal Univ, Ctr Geospatial Informat Engn & Technol Yunnan Pro, Kunming, Yunnan, Peoples R China.; Huang, YJ (corresponding author), Yunnan Normal Univ, Key Lab Resources & Environm Remote Sensing Univ, Kunming, Yunnan, Peoples R China.	huong66@163.com	Peng, Shuangyun/GQQ-7841-2022; Peng, shuang/GPX-0999-2022	hong, liang/0000-0002-3670-526X	National Natural Science Foundation of China [41661082, 41861048, 41201463, 41561086]; Natural Science Foundation of Yunnan Province [2018FB082]; National Social Science Key Foundation of China [16ZDA041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); National Social Science Key Foundation of China	This work was supported by the National Natural Science Foundation of China (Grant Nos. 41661082, 41861048, 41201463, and 41561086), the Natural Science Foundation of Yunnan Province (Grant No. 2018FB082), and the National Social Science Key Foundation of China (Grant No. 16ZDA041).	Azzouzi SA, 2018, IEEE ACCESS, V6, P30844, DOI 10.1109/ACCESS.2018.2837081; Auerswald K., 2018, SCI TOTAL ENVIRON, P613; CHEN Hongsong, 2018, J SOIL WATER CONSERV; Dregne HE, 1983, DESERTIFICATION ARID, V3; Gholami V, 2013, SOIL WATER RES, V8, P158, DOI 10.17221/13/2012-SWR; Guo RX, 2015, J ARID METEOROLOGY, V33, P505; Han LY, 2015, NAT HAZARDS, V75, P2715, DOI 10.1007/s11069-014-1457-0; He X, 2015, SUSTAINABILITY-BASEL, V7, P12910, DOI 10.3390/su70912910; Huang QH, 2007, ENVIRON GEOL, V52, P1325, DOI 10.1007/s00254-006-0572-y; Huang XiaoYun, 2013, World Forestry Research, V26, P45; Jia K, 2016, REMOTE SENS ENVIRON, V177, P184, DOI 10.1016/j.rse.2016.02.019; Jiang ZC, 2014, EARTH-SCI REV, V132, P1, DOI 10.1016/j.earscirev.2014.01.005; Johnson P.M., 2006, GOVERNING GLOBAL DES; Li JY, 2015, INT J REMOTE SENS, V36, P5137, DOI 10.1080/01431161.2015.1029596; Li S, 2015, REMOTE SENS LETT, V6, P657, DOI 10.1080/2150704X.2015.1070315; Ling KY, 2017, ORE GEOL REV, V82, P198, DOI 10.1016/j.oregeorev.2016.11.033; Mohammad Jafari, 2018, MANAGEMENT WATER RES; Qiang Guo, 2017, Remote Sensing, V9, DOI 10.3390/rs9060525; Rao EM, 2016, CHINESE GEOGR SCI, V26, P165, DOI 10.1007/s11769-015-0759-9; Ren Hai, 2007, Landscape and Ecological Engineering, V3, P1, DOI 10.1007/s11355-006-0018-4; [任柯蒙 Ren Kemeng], 2018, [生态学报, Acta Ecologica Sinica], V38, P5067; Song X, 2015, ENVIRON EARTH SCI, V74, P3123, DOI 10.1007/s12665-015-4350-6; Sun B, 2015, ENVIRON EARTH SCI, V73, P3717, DOI 10.1007/s12665-014-3659-x; Tana G, 2013, IEEE J-STARS, V6, P2391, DOI 10.1109/JSTARS.2013.2249499; Tu Z.F., 2016, FOREST RESOURCES MAN, V1, P1; Wang HB, 2015, NAT HAZARDS, V79, P1753, DOI 10.1007/s11069-015-1924-2; Wang JX, 2014, ENVIRON EARTH SCI, V72, P2751, DOI 10.1007/s12665-014-3182-0; Wang SJ, 2004, LAND DEGRAD DEV, V15, P115, DOI 10.1002/ldr.592; Wang T, 2004, SCI CHINA SER D, V47, P78, DOI 10.1360/04zd0009; Wang YF, 2017, CATENA, V157, P286, DOI 10.1016/j.catena.2017.05.030; Xu B, 2015, INT J REMOTE SENS, V36, P5150, DOI 10.1080/01431161.2015.1066526; Xu HQ, 2013, INT J REMOTE SENS, V34, P27, DOI 10.1080/01431161.2012.703343; Xu K, 2015, J HYDROL, V526, P253, DOI 10.1016/j.jhydrol.2014.09.047; Yecui H., 2008, T CHINESE SOC AGR EN, V2008; Yue YM, 2013, INT J REMOTE SENS, V34, P5136, DOI 10.1080/01431161.2013.787500; Yue YM, 2010, INT J REMOTE SENS, V31, P2115, DOI 10.1080/01431160903382892; Zanchetta A, 2016, NAT HAZARDS, V83, pS223, DOI 10.1007/s11069-016-2342-9; Zhang F, 2015, ENVIRON EARTH SCI, V73, P5731, DOI 10.1007/s12665-014-3830-4; Zhang ZM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040743; Zhao CH, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10091428; Zhao L, 2018, SCI SOIL WATER CONSE; Zheng XB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034482; Ziaei Z, 2014, GEOCARTO INT, V29, P554, DOI 10.1080/10106049.2013.819039	43	4	4	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2020	15	2							e0227498	10.1371/journal.pone.0227498	http://dx.doi.org/10.1371/journal.pone.0227498			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9FN	32023250	gold, Green Published			2022-12-26	WOS:000534621500016
J	Dehelean, L; Romosan, AM; Papaya, I; Bredicean, CA; Dumitrascu, V; Ursoniu, S; Romosan, RS				Dehelean, Liana; Romosan, Ana-Maria; Papaya, Ion; Bredicean, Cristina Ana; Dumitrascu, Victor; Ursoniu, Sorin; Romosan, Radu-Stefan			Prolactin response to antipsychotics: An inpatient study	PLOS ONE			English	Article							SERUM PROLACTIN; RECEPTOR OCCUPANCY; CLINICAL-RESPONSE; HYPERPROLACTINEMIA; SCHIZOPHRENIA; PITUITARY; NEUROLEPTICS; 1ST-EPISODE; ASSOCIATION; DIAGNOSIS	Background Antipsychotic medication, stress, gender, and age are factors that influence prolactin levels in patients with psychosis. The aim of the study was to investigate the level of prolactin response to antipsychotic treatment in acute patients, taking into account the total duration of psychosis. Methods and findings The study was conducted on 170 acute patients with schizophrenia spectrum disorders and bipolar disorder. Subjects were divided into three subgroups according to the duration of the psychosis (less than 5 years, between 5 and 10 years and more than 10 years of disorder duration). The initial prolactin response under antipsychotic treatment was measured, while the severity of the psychiatric symptoms was assessed with the BPRS (Brief Psychiatric Rating Scale). Hyperprolactinemia was found in 120 (70.6%) patients, amongst which 80 (66.7%) were females and 40 (33.3%) were males. The average increase in prolactinemia was 2.46 times the maximum value in women, and 1.59 times in men. Gender (beta = 0.27, p<0.0001), type of antipsychotic medication according to potency of inducing hyperprolactinemia (beta = -0.23, p< 0.003), and the duration of psychosis over 10 years (beta = -0.15, p = 0.04) significantly predicted prolactin levels, when age, diagnosis, antipsychotic category (conventional/atypical/combinations of antipsychotics), and BPRS total scores were controlled for. Conclusions and relevance Prolactin levels in patients treated with antipsychotic medication appeared to depend on patients' gender, on the type of antipsychotic medication according to potency of inducing hyperprolactinemia, and on the duration of the psychosis. An increase in prolactin levels was associated with female gender, while the use of prolactin sparing antipsychotics and a duration of psychosis over 10 years were associated with lower prolactin levels.	[Dehelean, Liana; Romosan, Ana-Maria; Papaya, Ion; Bredicean, Cristina Ana; Romosan, Radu-Stefan] Victor Babes Univ Med & Pharm, Psychiat Discipline, Neurosci Dept, Timisoara, Romania; [Dumitrascu, Victor] Victor Babes Univ Med & Pharm, Biochem & Pharmacol Dept, Timisoara, Romania; [Ursoniu, Sorin] Victor Babes Univ Med & Pharm, Publ Hlth Discipline, Funct Sci Dept, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Romosan, AM (corresponding author), Victor Babes Univ Med & Pharm, Psychiat Discipline, Neurosci Dept, Timisoara, Romania.	ana.romosan@gmail.com	Ursoniu, Sorin/D-1935-2015; Romosan, Radu-Stefan/AAO-2228-2021	Ursoniu, Sorin/0000-0001-9215-5154; ROMOSAN, RADU-STEFAN/0000-0001-6823-5277				Arakawa R, 2010, J CLIN PSYCHIAT, V71, P1131, DOI 10.4088/JCP.08m04307yel; Bahar A, 2011, CASP J INTERN MED, V2, P229; Bressan RA, 2004, PSYCHOPHARMACOLOGY, V175, P367, DOI 10.1007/s00213-004-1826-6; BROWN WA, 1981, PSYCHIAT RES, V5, P317, DOI 10.1016/0165-1781(81)90078-0; Brown WA, 1984, PSYCHONEUROENDOCRINE, P569, DOI [10.4088/jcp.v61n1213, DOI 10.4088/JCP.V61N1213]; Casanueva FF, 2006, CLIN ENDOCRINOL, V65, P265, DOI 10.1111/j.1365-2265.2006.02562.x; Cookson J, 2012, J PSYCHOPHARMACOL, V26, P42, DOI 10.1177/0269881112442016; Danivas V, 2013, INDIAN J PSYCHIAT, V55, P207, DOI 10.4103/0019-5545.111475; DERIVERA JL, 1976, CLIN ENDOCRINOL, V5, P273, DOI 10.1111/j.1365-2265.1976.tb01953.x; Eberhard J, 2007, ACTA PSYCHIAT SCAND, V115, P268, DOI 10.1111/j.1600-0447.2006.00897.x; Faraone SV, 1987, J CLIN PSYCHIAT; Garver DL, 2000, J CLIN PSYCHIAT, V61, P964, DOI 10.4088/JCP.v61n1213; GRUEN PH, 1978, ARCH GEN PSYCHIAT, V35, P108; GRUEN PH, 1978, ARCH GEN PSYCHIAT, V35, P1222; Haddad PM, 2007, CNS DRUGS, V21, P911, DOI 10.2165/00023210-200721110-00004; Halbreich U, 2003, PSYCHONEUROENDOCRINO, V28, P53, DOI 10.1016/S0306-4530(02)00112-9; Halbreich Uriel, 2003, J Psychiatr Pract, V9, P344, DOI 10.1097/00131746-200309000-00003; Inder WJ, 2011, AUST NZ J PSYCHIAT, V45, P830, DOI 10.3109/00048674.2011.589044; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; KAROUM F, 1987, ARCH GEN PSYCHIAT, V44, P604; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; Kinon BJ, 2003, PSYCHONEUROENDOCRINO, V28, P69, DOI 10.1016/S0306-4530(02)00128-2; Lieberman JA, 1996, NEUROPSYCHOPHARMACOL, V14, pS13, DOI 10.1016/0893-133X(95)00200-W; Lum C, 2002, MAGNETIC RESONANCE I, P1283; Madhusoodanan S, 2010, HUM PSYCHOPHARM CLIN, V25, P281, DOI 10.1002/hup.1116; MELTZER HY, 1974, ARCH GEN PSYCHIAT, V31, P564; MELTZER HY, 1976, ARCH GEN PSYCHIAT, V33, P279; Milano W, 2011, REV RECENT CLIN TRIA, V6, P52, DOI 10.2174/157488711793980138; Molitch ME, 2005, MAYO CLIN PROC, V80, P1050, DOI 10.4065/80.8.1050; Montejo AL, 2016, REV PSIQUIATR SALUD, V9, P158, DOI 10.1016/j.rpsm.2015.11.003; Montgomery J, 2004, J CLIN PSYCHIAT, V65, P1491, DOI 10.4088/JCP.v65n1108; MUNEYYIRCIDELALE O, 1989, NEW YORK STATE J MED, V89, P205; Naber D, 1984, PSYCHONEUROENDOCRINE, P599; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pariante CM, 2004, BRIT J PSYCHIAT, V185, P5, DOI 10.1192/bjp.185.1.5; Raber W, 2003, CLIN ENDOCRINOL, V58, P185, DOI 10.1046/j.1365-2265.2003.01694.x; RAO ML, 1994, BIOL PSYCHIAT, V35, P151, DOI 10.1016/0006-3223(94)91147-9; Segal M, 2004, PSYCHIAT RES, V127, P227, DOI 10.1016/j.psychres.2004.01.010; Sonino N, 2004, EUR J ENDOCRINOL, V151, P61, DOI 10.1530/eje.0.1510061; TANDON R, 1991, BIOL PSYCHIAT, V29, P953, DOI 10.1016/0006-3223(91)90353-N; Taylor DM, 2018, MAUDSLEY PRESCRIBING; Torre Daria La, 2007, Ther Clin Risk Manag, V3, P929; Vilar L, 2017, FRONT NEUROENDOCRIN, V45, P25, DOI [10.1016/j.yfrne, DOI 10.1016/J.YFRNE]; Vitiello B, 2009, EUR NEUROPSYCHOPHARM, V19, P629, DOI 10.1016/j.euroneuro.2009.04.008; Wieck A, 2003, BRIT J PSYCHIAT, V182, P199, DOI 10.1192/bjp.182.3.199; Zhang XY, 2002, PSYCHIAT RES, V109, P297, DOI 10.1016/S0165-1781(02)00022-7	46	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228648	10.1371/journal.pone.0228648	http://dx.doi.org/10.1371/journal.pone.0228648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9EF	32017792	Green Published, gold			2022-12-26	WOS:000534618100034
J	Lee, JM; Lee, HJ; Moon, IS; Choi, JY				Lee, Jeon Mi; Lee, Hyun Jin; Moon, In Seok; Choi, Jae Young			Effects of Vibrant Soundbridge on tinnitus accompanied by sensorineural hearing loss	PLOS ONE			English	Article							COMFORTABLE LISTENING LEVEL; COCHLEAR; MECHANISMS; AIDS	Objectives Tinnitus is a common symptom among patients with hearing loss, and many studies have reported successful tinnitus suppression with hearing devices. Active middle ear implantation of the Vibrant Soundbridge (VSB) is a good alternative to existing hearing devices. This study evaluated the effects of VSB implantation on tinnitus and sought to identify the main audiological factor that affects tinnitus suppression. Methods The study participants were 16 adults who had tinnitus with sensorineural hearing loss, and who underwent VSB implantations. Pure-tone audiometry; word recognition test; tinnitus handicap inventory (THI); and visual analog scale (VAS) assessment of loudness, awareness, and annoyance were performed before and 12 months after surgery. Changes in hearing threshold, word recognition scores (WRS), THI scores, and VAS scores were analyzed. Results VAS scores for loudness (mean difference: 1.9, 95% CI: 0.6, 3.1), awareness (mean difference: 1.6, 95% CI: 0.4, 2.8), and annoyance (mean difference: 1.7, 95% CI: 0.7, 2.8) showed significant improvements from baseline to 12 months after surgery. In addition, THI scores showed a significant decrease (mean difference: 13.8, 95% CI: 2.9, 24.9). The average hearing threshold level, WRS, and most comfortable level (MCL) also showed significant improvements at 12 months after surgery (mean difference: 17.3, 95% CI: 13.3, 21.3; mean difference: -7.6, 95% CI: -15.1, -0.1; mean difference: 26.3, 95% CI: 22.9, 29.6, respectively). Among the aforementioned factors, changes in MCL were best correlated with those in THI scores (mean difference: 2.55, 95% CI: 0.90, 4.21). Conclusion A VSB implant is beneficial to subjects with tinnitus accompanied by sensorineural hearing loss. The changes in THI scores best correlated with those in MCL. This improvement may represent a masking effect that contributes to tinnitus suppression in patients with VSB implants.	[Lee, Jeon Mi] Inje Univ, Ilsan Paik Hosp, Dept Otorhinolaryngol, Coll Med, Goyang, South Korea; [Lee, Hyun Jin] Catholic Univ Korea, Incheon St Marys Hosp, Dept Otorhinolaryngol, Incheon, South Korea; [Moon, In Seok; Choi, Jae Young] Yonsei Univ, Dept Otorhinolaryngol, Coll Med, Seoul, South Korea	Inje University; Catholic University of Korea; Yonsei University; Yonsei University Health System	Moon, IS (corresponding author), Yonsei Univ, Dept Otorhinolaryngol, Coll Med, Seoul, South Korea.	ismoonmd@yuhs.ac		choi, jae young/0000-0001-9493-3458; Lee, Hyun Jin/0000-0003-3826-8830; Moon, In Seok/0000-0002-3951-5074; Lee, Jeon Mi/0000-0003-2793-9045	National Research Foundation of Korea (NRF) - Ministry of Education [2018R1D1A1A02085472]	National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by a grant from the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2018R1D1A1A02085472) to I.S.M.	Amoodi HA, 2011, LARYNGOSCOPE, V121, P1536, DOI 10.1002/lary.21851; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Bovo R, 2011, AURIS NASUS LARYNX, V38, P14, DOI 10.1016/j.anl.2010.05.003; Bruchhage KL, 2017, EUR ARCH OTO-RHINO-L, V274, P1797, DOI 10.1007/s00405-016-4361-2; de Heyning PV, 2008, ANN OTO RHINOL LARYN, V117, P645, DOI 10.1177/000348940811700903; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Del Bo L, 2007, PROG BRAIN RES, V166, P341, DOI 10.1016/S0079-6123(07)66032-4; Di Nardo W, 2007, EUR ARCH OTO-RHINO-L, V264, P1145, DOI 10.1007/s00405-007-0352-7; Folmer RL, 2006, OTOLARYNG HEAD NECK, V134, P132, DOI 10.1016/j.otohns.2005.09.030; Han T., 1981, KOREAN J OTORHINOLAR, V24, P265; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Hobson J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006371.pub3; HOOD JD, 1957, P ROY SOC MED, V50, P689, DOI 10.1177/003591575705000912; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jung J, 2018, CLIN OTOLARYNGOL, V43, P369, DOI 10.1111/coa.12958; Khedr EM, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127712; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Lee JM, 2017, LARYNGOSCOPE, V127, P1435, DOI 10.1002/lary.26244; Moller AR, 2007, PROG BRAIN RES, V166, P37, DOI 10.1016/S0079-6123(07)66003-8; Nava E, 2011, PROG BRAIN RES, V191, P177, DOI 10.1016/B978-0-444-53752-2.00005-9; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Ruckenstein MJ, 2001, OTOL NEUROTOL, V22, P200, DOI 10.1097/00129492-200103000-00014; SALTZMAN M, 1947, LARYNGOSCOPE, V57, P358; Seo YJ, 2015, EAR HEARING, V36, P705, DOI 10.1097/AUD.0000000000000187; SURR RK, 1985, EAR HEARING, V6, P71, DOI 10.1097/00003446-198503000-00002; Trotrer MI, 2008, J LARYNGOL OTOL, V122, P1052, DOI 10.1017/S002221510800203X; ULLRICH K, 1976, AUDIOLOGY, V15, P338	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2020	15	2							e0228498	10.1371/journal.pone.0228498	http://dx.doi.org/10.1371/journal.pone.0228498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9EF	32017804	gold, Green Published			2022-12-26	WOS:000534618100030
J	Alvaro, CG; Braz, JM; Bernstein, M; Hamel, KA; Craik, V; Yamanaka, H; Basbaum, AI				Alvaro, Christopher G.; Braz, Joao M.; Bernstein, Mollie; Hamel, Katherine A.; Craik, Veronica; Yamanaka, Hiroki; Basbaum, Allan, I			Hippocalcin-like 4, a neural calcium sensor, has a limited contribution to pain and itch processing	PLOS ONE			English	Article							SUPERFICIAL DORSAL-HORN; TRACT NEURONS; PHYSIOLOGICAL-PROPERTIES; KINASE-II; CIRCUITS; RECEPTOR; MOUSE; CONNECTIVITY; ORGANIZATION; NOCICEPTION	Calcium binding proteins are expressed throughout the central and peripheral nervous system and disruption of their activity has major consequences in a wide array of cellular processes, including transmission of nociceptive signals that are processed at the level of the spinal cord. We previously reported that the calcium binding protein, hippocalcin-like 4 (Hpcal4), is heavily expressed in interneurons of the superficial dorsal horn, and that its expression is significantly downregulated in a TR4 mutant mouse model that exhibits major pain and itch deficits due to loss of a subpopulation of excitatory interneurons. That finding suggested that Hpcal4 may be a contributor to the behavioral phenotype of the TR4 mutant mouse. To address this question, here we investigated the behavioral consequences of global deletion of Hpcal4 in a battery of acute and persistent pain and itch tests. Unexpectedly, with the exception of a mild reduction in acute baseline thermal responses, Hpcal4-deficient mice exhibit no major deficits in pain or itch responses, under normal conditions or in the setting of tissue or nerve injury. Taken together, our results indicate that the neural calcium sensor Hpcal4 likely makes a limited contribution to pain and itch processing.	[Alvaro, Christopher G.; Braz, Joao M.; Bernstein, Mollie; Hamel, Katherine A.; Craik, Veronica; Yamanaka, Hiroki; Basbaum, Allan, I] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Yamanaka, Hiroki] Hyogo Coll Med, Dept Anat & Neurosci, Kobe, Hyogo, Japan	University of California System; University of California San Francisco; Hyogo College of Medicine; University of Hyogo	Basbaum, AI (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	allan.basbaum@ucsf.edu		Bernstein, Mollie/0000-0003-2327-5771; Craik, Veronica/0000-0001-5463-1199	NIH [R35 NS097306, IRACDA K12GM081266]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH R35 NS097306 (AIB; JB; MB; KH; VC); IRACDA K12GM081266 (CA) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopians AL, 2008, EUR J NEUROSCI, V27, P523, DOI 10.1111/j.1460-9568.2008.06056.x; Bester H, 2000, J NEUROPHYSIOL, V83, P2239, DOI 10.1152/jn.2000.83.4.2239; Boeckel GR, 2018, BBA-MOL CELL RES, V1865, P1660, DOI 10.1016/j.bbamcr.2018.05.005; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Carstens EE, 2010, NEUROREPORT, V21, P303, DOI 10.1097/WNR.0b013e328337310a; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; CRAIG AD, 1985, J PHYSIOL-LONDON, V365, P197, DOI 10.1113/jphysiol.1985.sp015767; Davidson S, 2012, J NEUROPHYSIOL, V108, P1711, DOI 10.1152/jn.00206.2012; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Egea J, 2012, PFLUG ARCH EUR J PHY, V463, P449, DOI 10.1007/s00424-011-1063-x; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; Goswami SC, 2014, J PAIN, V15, P1338, DOI 10.1016/j.jpain.2014.09.010; Haring M, 2018, NAT NEUROSCI, V21, P869, DOI 10.1038/s41593-018-0141-1; Jansen NA, 2015, J NEUROPHYSIOL, V113, P58, DOI 10.1152/jn.00596.2014; Kato G, 2009, J NEUROSCI, V29, P5088, DOI 10.1523/JNEUROSCI.6175-08.2009; Kobayashi K, 2005, J COMP NEUROL, V481, P377, DOI 10.1002/cne.20393; Kosugi M, 2013, J PHYSIOL-LONDON, V591, P1935, DOI 10.1113/jphysiol.2012.244210; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Moser HR, 2014, J NEUROPHYSIOL, V111, P1574, DOI 10.1152/jn.00668.2013; Peirs C, 2015, NEURON, V87, P797, DOI 10.1016/j.neuron.2015.07.029; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Villeda SA, 2006, NEUROSCIENCE, V139, P1385, DOI 10.1016/j.neuroscience.2006.01.042; Wang X, 2012, NEUROSCIENCE, V226, P441, DOI 10.1016/j.neuroscience.2012.09.027; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Yasaka T, 2007, J PHYSIOL-LONDON, V581, P603, DOI 10.1113/jphysiol.2006.123919; Zeitz KP, 2004, NEUROSCIENCE, V128, P889, DOI 10.1016/j.neuroscience.2004.07.029	34	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0226289	10.1371/journal.pone.0226289	http://dx.doi.org/10.1371/journal.pone.0226289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32015563	Green Published, gold			2022-12-26	WOS:000534615800003
J	Baba, T; Momen, M; Campbell, MT; Walia, H; Morota, G				Baba, Toshimi; Momen, Mehdi; Campbell, Malachy T.; Walia, Harkamal; Morota, Gota			Multi-trait random regression models increase genomic prediction accuracy for a temporal physiological trait derived from high-throughput phenotyping	PLOS ONE			English	Article							GENETIC ARCHITECTURE; WATER-USE; SELECTION; ASSOCIATION; EFFICIENCY; PHENOMICS	Random regression models (RRM) are used extensively for genomic inference and prediction of time-valued traits in animal breeding, but only recently have been used in plant systems. High-throughput phenotyping (HTP) platforms provide a powerful means to collect high-dimensional phenotypes throughout the growing season for large populations. However, to date, selection of an appropriate statistical genomic framework to integrate multiple temporal traits for genomic prediction in plants remains unexplored. Here, we demonstrate the utility of a multi-trait RRM (MT-RRM) for genomic prediction of daily water usage (WU) in rice (Oryza sativa) through joint modeling with shoot biomass (projected shoot area, PSA). Three hundred and fifty-seven accessions were phenotyped daily for WU and PSA over 20 days using a greenhouse-based HTP platform. MT-RRMs that modeled additive genetic and permanent environmental effects for both traits using quadratic Legendre polynomials were used to assess genomic correlations between traits and genomic prediction for WU. Predictive abilities of the MT-RRMs were assessed using two cross-validation (CV) scenarios. The first scenario was designed to predict genetic values for WU at all time points for a set of accessions with unobserved WU. The second scenario was designed to forecast future genetic values for WU for a panel of known accessions with records for WU at earlier time periods. In each scenario we evaluated two MT-RRMs in which PSA records were absent or available for time points in the testing population. Weak to strong genomic correlations between WU and PSA were observed across the days of imaging (0.29-0.870.38-0.80). In both CV scenarios, MT-RRMs showed better predictive abilities compared to single-trait RRM, and prediction accuracies were greatly improved when PSA records were available for the testing population. In summary, these frameworks provide an effective approach to predict temporal physiological traits that are difficult or expensive to quantify in large populations.	[Baba, Toshimi; Momen, Mehdi; Campbell, Malachy T.; Morota, Gota] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Walia, Harkamal] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	Virginia Polytechnic Institute & State University; University of Nebraska System; University of Nebraska Lincoln	Morota, G (corresponding author), Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	morota@vt.edu	Morota, Gota/D-5538-2013	Campbell, Malachy/0000-0002-8257-3595	National Science Foundation [1736192]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation under Grant Number 1736192 to HW and GM.	Berger B, 2010, J EXP BOT, V61, P3519, DOI 10.1093/jxb/erq201; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Calus MPL, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-26; Campbell M, 2019, PLANT GENOME-US, V12, DOI 10.3835/plantgenome2018.10.0075; Campbell M, 2018, PLANT DIRECT, V2, DOI 10.1002/pld3.80; Campbell MT, 2015, PLANT PHYSIOL, V168, P1476, DOI 10.1104/pp.15.00450; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Fahlgren N, 2015, CURR OPIN PLANT BIOL, V24, P93, DOI 10.1016/j.pbi.2015.02.006; Feldman MJ, 2018, PLANT PHYSIOL, V178, P699, DOI 10.1104/pp.18.00146; Fernandes SB, 2018, THEOR APPL GENET, V131, P747, DOI 10.1007/s00122-017-3033-y; Gengler N, 1999, J DAIRY SCI, V82, P1849, DOI 10.3168/jds.S0022-0302(99)75417-2; Golzarian MR, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-2; Guo G, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-30; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Juliana P, 2019, THEOR APPL GENET, V132, P177, DOI 10.1007/s00122-018-3206-3; Kadarmideen HN, 2003, LIVEST PROD SCI, V81, P183, DOI 10.1016/S0301-6226(02)00274-9; KIRKPATRICK M, 1990, GENETICS, V124, P979; Knecht AC, 2016, J EXP BOT, V67, P3587, DOI 10.1093/jxb/erw176; Araus JL, 2018, TRENDS PLANT SCI, V23, P451, DOI 10.1016/j.tplants.2018.02.001; Meyer K, 1997, LIVEST PROD SCI, V47, P185, DOI 10.1016/S0301-6226(96)01414-5; Misztal I., 2002, P 7 WORLD C GEN APPL; Mohring J, 2009, CROP SCI, V49, P1977, DOI 10.2135/cropsci2009.02.0083; Momen M, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0493-x; Momen M, 2019, G3-GENES GENOM GENET, V9, P3369, DOI 10.1534/g3.119.400346; Morota G., 2019, ARXIV190412341; Mrode R.A, 2014, LINEAR MODELS PREDIC; Okeke UG, 2011, GENET SEL EVOL, V43, P26; Piepho HP, 2012, BIOMETRICAL J, V54, P844, DOI 10.1002/bimj.201100219; Rebolledo MC, 2013, FUNCT PLANT BIOL, V40, P582, DOI 10.1071/FP12312; Schaeffer L.R., 1994, P 5 WORLD C GEN APPL, V18, P443; Schaeffer LR, 2004, LIVEST PROD SCI, V86, P35, DOI 10.1016/S0301-6226(03)00151-9; Smith A, 2001, AUST NZ J STAT, V43, P129, DOI 10.1111/1467-842X.00163; Sun J, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.11.0111; Tardieu F, 2017, CURR BIOL, V27, pR770, DOI 10.1016/j.cub.2017.05.055; This D, 2010, RICE, V3, P72, DOI 10.1007/s12284-010-9036-9; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Voss-Fels KP, 2019, THEOR APPL GENET, V132, P669, DOI 10.1007/s00122-018-3270-8; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228118	10.1371/journal.pone.0228118	http://dx.doi.org/10.1371/journal.pone.0228118			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012182	Green Published, Green Submitted, gold			2022-12-26	WOS:000534615800021
J	Hjorth, M; Dandu, N; Mellergard, J				Hjorth, Maria; Dandu, Nicolae; Mellergard, Johan			Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets	PLOS ONE			English	Article							ORAL FINGOLIMOD; NATALIZUMAB TREATMENT; DISEASE-ACTIVITY; CELL SUBSETS; EFFICACY; FTY720; IMPACT; SAFETY; NK	Background Treatment with fingolimod reduces inflammation in multiple sclerosis (MS) by inhibiting lymphocyte egress from lymph nodes. We aimed to map, in detail, the alterations in peripheral blood lymphocyte subpopulations in relation to clinical outcome in MS patients treated with fingolimod. Methods Paired blood samples from relapsing-remitting MS patients (n = 19) were collected before and after one year of treatment with fingolimod (0.5 mg/day). Absolute counts and relative proportions of a broad set of T- B- and NK-cell subsets were analyzed by flow cytometry. Blood samples from 18 healthy controls were used for baseline comparisons. Results Treatment with fingolimod markedly decreased the absolute numbers of all major lymphocyte subsets, except for NK cells. The reduction was most pronounced within the T helper (Th) and B cell populations (p < 0.001). By phenotyping differentiation status of T cells, dramatic reductions within the naive and central memory (CM) cell populations were found (p < 0.001), while a less pronounced reduction was observed among effector memory (EM) cells (p < 0.001). The numbers of regulatory T cells (Tregs) were also decreased (p < 0.001), but to a lesser extent than other T cell populations, resulting in a relative preservation of Tregs with a memory phenotype (p = 0.002). Conclusions Our results confirm that fingolimod therapy markedly reduces lymphocyte counts in peripheral blood of MS patients. Subgroup analysis of T cells showed that naive and CM Th cells were the most profoundly affected and that memory Tregs were relatively preserved.	[Hjorth, Maria] Linkoping Univ, Dept Clin Immunol & Transfus Med, Linkoping, Sweden; [Hjorth, Maria; Dandu, Nicolae; Mellergard, Johan] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden; [Dandu, Nicolae; Mellergard, Johan] Linkoping Univ, Dept Neurol Linkoping, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Hjorth, M (corresponding author), Linkoping Univ, Dept Clin Immunol & Transfus Med, Linkoping, Sweden.; Hjorth, M (corresponding author), Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden.	maria.hjorth@liu.se		Hjorth, Maria/0000-0002-4195-9387	University Hospital of Linkoping; County Council ofOstergotland [LIO-621191, LIO-709281]; Neuro Sweden	University Hospital of Linkoping; County Council ofOstergotland; Neuro Sweden	This study was supported by grants from the University Hospital of Linkoping, the County Council ofOstergotland (M.H (LIO-621191), J.M (LIO-709281)https://www.researchweb.org/is/lio/) and Neuro Sweden (J.M https://neuro.se/)).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backteman K, 2007, J IMMUNOL METHODS, V322, P20, DOI 10.1016/j.jim.2007.01.021; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Carrega P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00347; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Danikowski KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0892-8; Fox RJ, 2014, NEUROLOGY, V82, P1491, DOI 10.1212/WNL.0000000000000355; Haas J, 2015, MULT SCLER J, V21, P1521, DOI 10.1177/1352458514564589; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Henault D, 2013, NEUROLOGY, V81, P1768, DOI 10.1212/01.wnl.0000435564.92609.2c; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hoffmann Franziska, 2014, Eur J Immunol, V44, P1247, DOI 10.1002/eji.201470045; Izquierdo G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176174; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Mellergard J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081685; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Pinschewer DD, 2011, NEUROLOGY, V76, pS15, DOI 10.1212/WNL.0b013e31820d9596; Plavina T, 2017, NEUROLOGY, V89, P1584, DOI 10.1212/WNL.0000000000004485; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Soliven B, 2011, NEUROLOGY, V76, pS9, DOI 10.1212/WNL.0b013e31820d9507; Song ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124923; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Yshii L, 2015, EUR J IMMUNOL, V45, P2712, DOI 10.1002/eji.201545759	33	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2020	15	2							e0228380	10.1371/journal.pone.0228380	http://dx.doi.org/10.1371/journal.pone.0228380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9DJ	32012202	Green Published, gold			2022-12-26	WOS:000534615800033
J	Moreira, AR; de Castro, TBP; Kohler, JB; Ito, JT; Silva, LED; Lourenco, JD; Almeida, RR; Santana, FR; Brito, JM; Rivero, DHRF; Vale, MICA; Prado, CM; Camara, NOS; Saldiva, PHN; Olivo, CR; Lopes, FDTQD				Moreira, Alyne Riani; Pereira de Castro, Thamyres Barros; Kohler, Julia Benini; Ito, Juliana Tiyaki; de Franca Silva, Larissa Emidio; Lourenco, Juliana Dias; Almeida, Rafael Ribeiro; Santana, Fernanda Roncon; Brito, Jose Mara; Rodriguez Ferreira Rivero, Dolores Helena; Cardoso Alonso Vale, Maria Isabel; Prado, Carla Maximo; Saraiva Camara, Niels Olsen; Nascimento Saldiva, Paulo Hilario; Olivo, Clarice Rosa; Quirino dos Santos Lopes, Fernanda Degobbi Tenorio			Chronic exposure to diesel particles worsened emphysema and increased M2-like phenotype macrophages in a PPE-induced model	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; PULMONARY; LUNG; INFLAMMATION; APOPTOSIS; PANEL	Chronic exposure to ambient levels of air pollution induces respiratory illness exacerbation by increasing inflammatory responses and apoptotic cells in pulmonary tissues. The ineffective phagocytosis of these apoptotic cells (efferocytosis) by macrophages has been considered an important factor in these pathological mechanisms. Depending on microenvironmental stimuli, macrophages can assume different phenotypes with different functional actions. M1 macrophages are recognized by their proinflammatory activity, whereas M2 macrophages play pivotal roles in responding to microorganisms and in efferocytosis to avoid the progression of inflammatory conditions. To verify how exposure to air pollutants interferes with macrophage polarization in emphysema development, we evaluated the different macrophage phenotypes in a PPE-induced model with the exposure to diesel exhaust particles. C57BL/6 mice received intranasal instillation of porcine pancreatic elastase (PPE) to induce emphysema, and the control groups received saline. Both groups were exposed to diesel exhaust particles or filtered air for 60 days according to the groups. We observed that both the diesel and PPE groups had an increase in alveolar enlargement, collagen and elastic fibers in the parenchyma and the number of macrophages, lymphocytes and epithelial cells in BAL, and these responses were exacerbated in animals that received PPE instillation prior to exposure to diesel exhaust particles. The same response pattern was found inCaspase-3 positive cell analysis, attesting to an increase in cell apoptosis, which is in agreement with the increase in M2 phenotype markers, measured by RT-PCR and flow cytometry analysis. We did not verify differences among the groups for the M1 phenotype. In conclusion, our results showed that both chronic exposure to diesel exhaust particles and PPE instillation induced inflammatory conditions, cell apoptosis and emphysema development, as well as an increase in M2 phenotype macrophages, and the combination of these two factors exacerbated these responses. The predominance of the M2-like phenotype likely occurred due to the increased demand for efferocytosis. However, M2 macrophage activity was ineffective, resulting in emphysema development and worsening of symptoms.	[Moreira, Alyne Riani; Kohler, Julia Benini; Ito, Juliana Tiyaki; de Franca Silva, Larissa Emidio; Lourenco, Juliana Dias; Olivo, Clarice Rosa; Quirino dos Santos Lopes, Fernanda Degobbi Tenorio] Univ Sao Paulo, Sch Med, Dept Clin Med LIM 20, Sao Paulo, Brazil; [Pereira de Castro, Thamyres Barros; Olivo, Clarice Rosa] Inst Med Assistance State Publ Servant IAMSPE, Sao Paulo, Brazil; [Pereira de Castro, Thamyres Barros; Olivo, Clarice Rosa] Univ City Sao Paulo UNICID, Sao Paulo, Brazil; [Almeida, Rafael Ribeiro; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Almeida, Rafael Ribeiro] Univ Sao Paulo, Heart Inst InCor, Sch Med, Sao Paulo, Brazil; [Santana, Fernanda Roncon; Cardoso Alonso Vale, Maria Isabel] Univ Fed Sao Paulo, Dept Biosci, Diadema, SP, Brazil; [Brito, Jose Mara; Rodriguez Ferreira Rivero, Dolores Helena; Nascimento Saldiva, Paulo Hilario] Univ Sao Paulo, Sch Med, Dept Pathol LIM 5, Sao Paulo, Brazil; [Prado, Carla Maximo] Univ Fed Sao Paulo, Dept Biosci, Santos, SP, Brazil; [Saraiva Camara, Niels Olsen] Univ Sao Paulo, Sch Med, Dept Clin Med LIM 16, Sao Paulo, Brazil; [Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Dept Med, Nephrol Div, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Cidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Lopes, FDTQD (corresponding author), Univ Sao Paulo, Sch Med, Dept Clin Med LIM 20, Sao Paulo, Brazil.	fernandadtqsl@gmail.com	Prado, Carla M/G-3327-2012; Almeida, Rafael Ribeiro/F-8014-2014; Lourenço, Juliana D./C-5326-2013; Novelli, Fernanda Paula Roncon Santana/S-5891-2019; Olsen Saraiva Camara, Niels/AAX-3269-2020	Prado, Carla M/0000-0003-1160-0442; Almeida, Rafael Ribeiro/0000-0003-3984-7527; Lourenço, Juliana D./0000-0002-9291-5237; Novelli, Fernanda Paula Roncon Santana/0000-0001-5837-4310; ALONSO-VALE, MARIA ISABEL/0000-0001-5847-8080; DTQS Lopes, Fernanda/0000-0002-6402-3055; Olsen Saraiva Camara, Niels/0000-0001-5436-1248	FAPESP; Instituto dos Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Brazil (LIM/HC/FMUSP)	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto dos Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Brazil (LIM/HC/FMUSP)	This research was supported by FAPESP and the Instituto dos Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Brazil (LIM/HC/FMUSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anciaes AM, 2011, CLINICS; [Anonymous], 2018, SER REL EM ES VEICH; Block ML, 2009, TRENDS NEUROSCIENCES, V32; Bonvallot V, 2001, AM J RESP CELL MOL B; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/769214, DOI 10.1155/2013/769214]; BOWDEN DH, 1984, ENVIRON HEALTH PERSP, V55, P327, DOI 10.2307/3429712; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Carvalho-Oliveira R, 2015, CLINICS, V70, P706, DOI 10.6061/clinics/2015(10)09; Chen YC, 2002, J ENV SCI HLTH A; de Brito JM, 2018, SCI TOTAL ENVIRON, V628-629, P1223, DOI 10.1016/j.scitotenv.2018.02.019; de Genaro IS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30851-6; Dolhnikoff M, 1999, AM J RESP CRITICAL C, V160; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Doornaert B, 2003, AM J PHYSL LUNG CELL; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; Geiser M, 2002, MICROSC RES TECHNIQ, V57, P512, DOI 10.1002/jemt.10105; George L, 2014, MACROPHAGE POLARIZAT; Ghio AJ, 2012, ENV HLTH PERSPECTIVE, V120; GOLD, 2019, GLOB IN CHRON OBSTR; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hiraiwa K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/619523; Hiura TS, 1999, J IMMUNOL, V163, P5582; KREYLING WG, 1992, ENVIRON HEALTH PERSP, V97, P121, DOI 10.2307/3431339; Lancas T, 2006, J APPL PHYSL; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; Lopes FDTQS, 2013, HISTOL HISTOPATHOL, V28, P269, DOI 10.14670/HH-28.269; Lopes FDTQS, 2009, ENVIRON RES, V109, P544, DOI 10.1016/j.envres.2009.03.002; Lourenco JD, 2018, HISTOL HISTOPATHOL, V33, P289, DOI 10.14670/HH-11-927; Lourenco JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098216; MacNee W, 2003, EUR RESPIR J, V21, p47S, DOI 10.1183/09031936.03.00403203; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391; Mauad T, 2008, AM J RESP CRIT CARE, V178, P721, DOI 10.1164/rccm.200803-436OC; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; MORROW PE, 1988, FUND APPL TOXICOL, V10, P369, DOI 10.1016/0272-0590(88)90284-9; Obot CJ, 2002, TOXICOL APPL PHARM, V184, P98, DOI 10.1006/taap.2002.9493; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Pritchard RJ, 1996, INHALATION TOXICOLOG, V8; Pulido MD, 2003, MUTATION REFUNDAME, V533; Rodrigues R, 2017, J BRAS PNEUMOL, V43, P95, DOI [10.1590/s1806-37562016000000179, 10.1590/S1806-37562016000000179]; Seriani R, 2015, J TOXICOLOGY ENV HLT; Seriani R, 2016, ENV SCI POLLUTION RE, V23; Seriani R, 2015, EXPT TOXICOLOGIC PAT; Shifren A, 2006, P AM THORACIC SOC, V3; Sint T, 2008, INHAL TOXICOL, V20, P25, DOI [10.1080/08958370701758759, 10.1080/08958370701758759 ]; Stern ST, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-20; Timmerman T, 2019, ENV POLLUTION; Toledo AC, 2012, EUR RESPIR J, V39, P254, DOI 10.1183/09031936.00003411; Valavanidis A, 2005, REDOX REPORT, V10; WHO, 2005, GLOB UPD; Wu S, 2013, ENV RES; Yoshizaki K, 2005, RESP RES	55	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2020	15	1							e0228393	10.1371/journal.pone.0228393	http://dx.doi.org/10.1371/journal.pone.0228393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CX	32004356	gold, Green Published, Green Submitted			2022-12-26	WOS:000534614600035
J	DeNegre, AA; Myers, K; Fefferman, NH				DeNegre, Ashley A.; Myers, Kellen; Fefferman, Nina H.			Impact of chemorophylaxis policy for AIDS-immunocompromised patients on emergence of bacterial resistance	PLOS ONE			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; ANTIBIOTIC SELECTIVE PRESSURE; ANTIMICROBIAL RESISTANCE; DEVELOPING-COUNTRIES; OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY; INCOME COUNTRIES; HIV-INFECTION; PROPHYLAXIS; TUBERCULOSIS	Chemoprophylaxis (antibiotic prophylaxis) is a long relied-upon means of opportunistic infection management among HIV/AIDS patients, but its use represents an evolutionary tradeoff: Despite the benefits of chemoprophylaxis, widespread use of antibiotics creates a selective advantage for drug-resistant bacterial strains. Especially in the developing world, with combined resource limitations, antibiotic misuse, and often-poor infection control, the emergence of antibiotic resistance may pose a critical health risk. Extending previous work that demonstrated that this risk is heightened when a significant proportion of the population is HIV/AIDS-immunocompromised, we work to address the relationship between HIV/AIDS patients' use of antibiotic chemoprophylaxis and the emergence of resistance. We apply an SEIR compartmental model, parameterized to reflect varying percentages of chemoprophylaxis use among HIV/AIDS+ patients in a resource-limited setting, to investigate the magnitude of the risk of prophylaxis-associated emergence versus the individual-level benefits it is presumed to provide. The results from this model suggest that, while still providing tangible benefits to the individual, chemoprophylaxis is associated with negligible decreases in population-wide morbidity and mortality from bacterial infection, and may also fail to provide assumed efficacy in reduction of TB prevalence.	[DeNegre, Ashley A.; Fefferman, Nina H.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [DeNegre, Ashley A.; Fefferman, Nina H.] Rutgers State Univ, Command Control & Interoperabil Ctr Adv Data Anal, New Brunswick, NJ 08901 USA; [Myers, Kellen; Fefferman, Nina H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Myers, Kellen; Fefferman, Nina H.] Univ Tennessee, Dept Math, Knoxville, TN 37996 USA; [Myers, Kellen; Fefferman, Nina H.] Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN 37996 USA; [Myers, Kellen] Tusculum Univ, Dept Math, Greeneville, TN USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Fefferman, NH (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.; Fefferman, NH (corresponding author), Rutgers State Univ, Command Control & Interoperabil Ctr Adv Data Anal, New Brunswick, NJ 08901 USA.; Fefferman, NH (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.; Fefferman, NH (corresponding author), Univ Tennessee, Dept Math, Knoxville, TN 37996 USA.; Fefferman, NH (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN 37996 USA.	nina.h.fefferman@gmail.com	Fefferman, Nina/AAQ-7378-2021	Fefferman, Nina/0000-0003-0233-1404				Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Alonso A, 1999, MICROBIOL-SGM, V145, P2857, DOI 10.1099/00221287-145-10-2857; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; [Anonymous], 2012, GLOB TUB REP 2012; Aronson BS, 2006, J AM ACAD NURSE PRAC, V18, P591, DOI 10.1111/j.1745-7599.2006.00184.x; Avorn J, 2000, ANN INTERN MED, V133, P128, DOI 10.7326/0003-4819-133-2-200007180-00012; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bishai WR, 1996, NEW ENGL J MED, V334, P1573, DOI 10.1056/NEJM199606133342404; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Buke C, 2005, J INFECTION, V51, P135, DOI 10.1016/j.jinf.2004.12.001; Byarugaba DK, 2004, INT J ANTIMICROB AG, V24, P105, DOI 10.1016/j.ijantimicag.2004.02.015; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Chou SW, 1997, J INFECT DIS, V176, P786, DOI 10.1086/517302; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Coovadia YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077712; COURVALIN P, 1994, ANTIMICROB AGENTS CH, V38, P1447, DOI 10.1128/AAC.38.7.1447; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; DeNegre AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212969; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Feasey NA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003748; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Gemmell CG, 2006, J ANTIMICROB CHEMOTH, V57, P589, DOI 10.1093/jac/dkl017; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916; Hobbs CV, 2013, J INFECT DIS, V208, P139, DOI 10.1093/infdis/jit132; Holmes CB, 2003, CLIN INFECT DIS, V36, P652, DOI 10.1086/367655; HOMEDES N, 1993, HEALTH POLICY PLANN, V8, P291, DOI 10.1093/heapol/8.4.291; Hung CC, 2004, J ANTIMICROB CHEMOTH, V54, P849, DOI 10.1093/jac/dkh438; Kolar M, 2001, INT J ANTIMICROB AG, V17, P357, DOI 10.1016/S0924-8579(01)00317-X; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Levin SA, 1999, P NATL ACAD SCI USA, V96, P800, DOI 10.1073/pnas.96.3.800; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Levy SB, 2007, CONCRETE TEACHING RE, P1, DOI DOI 10.1002/9780470515358.CH1; Maranan MC, 1997, INFECT DIS CLIN N AM, V11, P813, DOI 10.1016/S0891-5520(05)70392-5; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; MEYER CN, 1994, SCAND J INFECT DIS, V26, P635, DOI 10.3109/00365549409008630; Mkhize-Kwitshana ZL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-273; Moodley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063273; Muko K N, 2004, SAHARA J, V1, P107; Napoli PA, 1998, EUR J EPIDEMIOL, V14, P41, DOI 10.1023/A:1007400519792; Okeke IN, 2005, LANCET INFECT DIS, V5, P568, DOI 10.1016/S1473-3099(05)70217-6; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Okeke IN, 1999, EMERG INFECT DIS, V5, P18, DOI 10.3201/eid0501.990103; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Pray L., 2008, NAT ED, V1, P30; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Riyarto S, 2010, HEALTH POLICY PLANN, V25, P272, DOI 10.1093/heapol/czq004; Rizzardini G, 1998, AIDS, V12, P2387, DOI 10.1097/00002030-199818000-00007; RUF B, 1993, EUR J CLIN MICROBIOL, V12, P325, DOI 10.1007/BF01964427; Shepard CW, 2002, EMERG INFECT DIS, V8, P1124, DOI 10.3201/eid0810.020349; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; 't Hoen E, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-15; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Uplekar M, 2006, STOP TB STRATEGY BUI; Vernet G, 2014, EMERG INFECT DIS, V20, P434, DOI [10.3201/eid2003.121157, 10.3201/EID2003.121157]; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Winnick S, 2005, PEDIATRICS, V115, pE718, DOI 10.1542/peds.2004-1133; Yousaf MZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-401	69	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0225861	10.1371/journal.pone.0225861	http://dx.doi.org/10.1371/journal.pone.0225861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999715	Green Published, gold			2022-12-26	WOS:000534612400008
